PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Dammak, I; Neves, MA; Nabetani, H; Isoda, H; Sayadi, S; Nakajima, M				Dammak, Ilyes; Neves, Marcos A.; Nabetani, Hiroshi; Isoda, Hiroko; Sayadi, Sami; Nakajima, Mitsutoshi			Transport properties of oleuropein through nanofiltration membranes	FOOD AND BIOPRODUCTS PROCESSING			English	Article						Nanofiltration; Concentration polarization; Osmotic pressure; Oleuropein; Flux decline	OLEA-EUROPAEA L.; UNSTIRRED BATCH CELL; REVERSE-OSMOSIS; PHENOLIC-COMPOUNDS; DRINKING-WATER; CONCENTRATION POLARIZATION; OSMOTIC-PRESSURE; ORGANIC SOLUTES; WASTE-WATER; ULTRAFILTRATION	The present work investigates the effect of feed concentration and magnitudes of applied pressure of olive-extracted oleuropein on permeate flux and membrane transport properties through concentration polarization in a nanofiltration (NF) membrane. The filtration of oleuropein model solution by an NF membrane using different feed concentrations (0.3, 0.9, or 2.7 kg m(-3)) enables the correlation of a transport model, comprised concentration polarization and osmotic pressure models, to membrane retention performance, evaluated using the Spiegler-Kedem model. Moreover, osmotic pressure was observed and interpreted using the van't Hoff equation at different levels of feed concentration and applied pressure. Transport parameters (reflection coefficient, water and oleuropein permeability, and mass transfer coefficient) were correlated with experiment values by developing a mathematical model that reflects the flux decline by increasing osmotic pressure. (C) 2014 The Institution of Chemical Engineers. Published by Elsevier BM. All rights reserved.	[Dammak, Ilyes] Univ Tsukuba, Grad Sch Life & Environm Sci, Ibaraki 3058572, Japan; [Neves, Marcos A.; Isoda, Hiroko; Nakajima, Mitsutoshi] Univ Tsukuba, Fac Life & Environm Sci, Ibaraki 3058572, Japan; [Dammak, Ilyes; Neves, Marcos A.; Nabetani, Hiroshi; Nakajima, Mitsutoshi] NARO, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan; [Sayadi, Sami] Ctr Biotechnol Sfax, Environm Bioproc Lab, Sfax 3038, Tunisia	Nakajima, M (reprint author), Univ Tsukuba, Fac Life & Environm Sci, Ibaraki 3058572, Japan.	nakajima.m.fu@u.tsukuba.ac.jp			Science and Technology Research Partnership for Sustainable Development (SATREPS) project of JICA/JST, Japan	This research was funded by the Science and Technology Research Partnership for Sustainable Development (SATREPS) project of JICA/JST, Japan.	Stafie N, 2005, SEP PURIF TECHNOL, V45, P220, DOI 10.1016/j.seppur.2005.04.001; Verliefde ARD, 2009, ENVIRON SCI TECHNOL, V43, P2400, DOI 10.1021/es803146r; Saliha B, 2009, CHEM ENG SCI, V64, P3789, DOI 10.1016/j.ces.2009.05.020; Liu L, 2013, J MEMBRANE SCI, V446, P433, DOI 10.1016/j.memsci.2013.06.001; Van der Bruggen B, 1999, J MEMBRANE SCI, V156, P29, DOI 10.1016/S0376-7388(98)00326-3; Krishna R, 2011, J MEMBRANE SCI, V369, P545, DOI 10.1016/j.memsci.2010.12.042; LETUTOUR B, 1992, PHYTOCHEMISTRY, V31, P1173, DOI 10.1016/0031-9422(92)80255-D; Braghetta A, 1997, J ENVIRON ENG-ASCE, V123, P628, DOI 10.1061/(ASCE)0733-9372(1997)123:7(628); Nicolas S, 2000, J MEMBRANE SCI, V164, P141, DOI 10.1016/S0376-7388(99)00191-X; Bellona C, 2004, WATER RES, V38, P2795, DOI 10.1016/j.watres.2004.03.034; Servili M, 1999, J AGR FOOD CHEM, V47, P12, DOI 10.1021/jf9806210; Pontalier PY, 1997, SEP PURIF TECHNOL, V12, P175, DOI 10.1016/S1383-5866(97)00047-6; Van der Bruggen B, 2003, ENVIRON PROG, V22, P46, DOI 10.1002/ep.670220116; Tang CYY, 2011, ADV COLLOID INTERFAC, V164, P126, DOI 10.1016/j.cis.2010.10.007; Al-Azzawie HF, 2006, LIFE SCI, V78, P1371, DOI 10.1016/j.lfs.2005.07.029; VANDENBERG GB, 1989, J MEMBRANE SCI, V47, P25, DOI 10.1016/S0376-7388(00)80858-3; KEDEM O, 1958, BIOCHIM BIOPHYS ACTA, V27, P229, DOI 10.1016/0006-3002(58)90330-5; Garcia-Castello E, 2010, WATER RES, V44, P3883, DOI 10.1016/j.watres.2010.05.005; VILKER VL, 1981, J COLLOID INTERF SCI, V79, P548, DOI 10.1016/0021-9797(81)90106-5; Sheu JR, 2004, J AGR FOOD CHEM, V52, P4414, DOI 10.1021/jf040059f; Levenstein R, 1996, J MEMBRANE SCI, V116, P77, DOI 10.1016/0376-7388(96)00029-4; Malik NSA, 2008, J FOOD AGRIC ENVIRON, V6, P8; Dobrak-Van Berlo A, 2011, J MEMBRANE SCI, V374, P138, DOI 10.1016/j.memsci.2011.03.027; Richards LA, 2011, J MEMBRANE SCI, V369, P188, DOI 10.1016/j.memsci.2010.11.069; Agalias A, 2007, J AGR FOOD CHEM, V55, P2671, DOI 10.1021/jf063091d; Balannec B, 1999, DESALINATION, V122, P43, DOI 10.1016/S0011-9164(99)00026-0; Bhattacharjee S, 1996, J MEMBRANE SCI, V111, P243, DOI 10.1016/0376-7388(95)00255-3; Cancino-Madariaga B, 2011, AQUACULT ENG, V45, P103, DOI 10.1016/j.aquaeng.2011.08.002; Causserand C, 2004, J MEMBRANE SCI, V238, P177, DOI 10.1016/j.memsci.2004.04.003; Cheryan M, 1986, ULTRAFILTRATION HDB, P73; Cornelissen ER, 2005, DESALINATION, V178, P179, DOI 10.1016/j.desal.2004.11.047; Diawara CK, 2003, J MEMBRANE SCI, V219, P103, DOI 10.1016/S0376-7388(03)00189-3; El Khabbaze H, 2008, TRAITEMENT SOLUTIONS, P121; Flory J. P., 1953, PRINCIPLES POLYM CHE; Gutierrez-Rosales F, 2012, J AGR FOOD CHEM, V60, P4348, DOI 10.1021/jf205209y; KIMURA S, 1967, AICHE J, V13, P497, DOI 10.1002/aic.690130319; Macoun R.G, 1998, THESIS U NEW S WALES, P121; Mitchell B.D., 1986, J COLLOID INTERF SCI, V113, P1132; NABETANI H, 1990, AICHE J, V36, P907, DOI 10.1002/aic.690360612; Nagy E, 2010, DESALIN WATER TREAT, V14, P220, DOI 10.5004/dwt.2010.1031; Nakao S., 1986, MEMBRANE TRANSPORT P, P987; OPONG WS, 1991, AICHE J, V37, P1497, DOI 10.1002/aic.690371007; Paugam L, 2004, J MEMBRANE SCI, V231, P37, DOI 10.1016/j.memsci.2003.11.003; Pontalier PY, 1999, J FOOD ENG, V40, P145, DOI 10.1016/S0260-8774(99)00041-2; Qi BK, 2011, BIORESOURCE TECHNOL, V102, P7111, DOI 10.1016/j.biortech.2011.04.041; Ranalli A, 2006, J AGR FOOD CHEM, V54, P434, DOI 10.1021/jf051647b; Song LF, 2012, J MEMBRANE SCI, V401, P313, DOI 10.1016/j.memsci.2012.02.023; Spiegler K. S., 1966, DESALINATION, V1, P311, DOI 10.1016/S0011-9164(00)80018-1; Strathmann H., 1979, TRENNUNG MOLEKULAREN, P215; Takac Serpil, 2009, Recent Patents on Chemical Engineering, V2, DOI 10.2174/1874478810902030230; Trettin D.R., 1981, SYNTHETIC MEMBRANES, V2, P373; Whu JA, 2000, J MEMBRANE SCI, V170, P159, DOI 10.1016/S0376-7388(99)00374-9; WIJMANS JG, 1985, J MEMBRANE SCI, V22, P117, DOI 10.1016/S0376-7388(00)80534-7; Yaroshchuk AE, 2008, ADV COLLOID INTERFAC, V139, P150, DOI 10.1016/j.cis.2008.01.004	54	0	0	INST CHEMICAL ENGINEERS	RUGBY	165-189 RAILWAY TERRACE, DAVIS BLDG, RUGBY CV21 3HQ, ENGLAND	0960-3085	1744-3571		FOOD BIOPROD PROCESS	Food Bioprod. Process.	APR	2015	94						342	353		10.1016/j.fbp.2014.04.002		12	Biotechnology & Applied Microbiology; Engineering, Chemical; Food Science & Technology	Biotechnology & Applied Microbiology; Engineering; Food Science & Technology	CH6IO	WOS:000354140500036		
J	Okuno, H; Hasegawa, J; Sanada, T; Yagi, T				Okuno, Hirotsugu; Hasegawa, Jun; Sanada, Tadashi; Yagi, Tetsuya			Real-Time Emulator for Reproducing Graded Potentials in Vertebrate Retina	IEEE TRANSACTIONS ON BIOMEDICAL CIRCUITS AND SYSTEMS			English	Article						Emulation; graded potential; neuromorphic; retina	OPTIC-NERVE SIGNALS; NEUROMORPHIC CHIP; CELL RESPONSES; VISION SENSOR; SYSTEMS; ADAPTATION; LIGHT; MODEL; PHOTORECEPTORS; CIRCUIT	In most parts of the retina, neuronal circuits process visual signals represented by slowly changing membrane potentials, or so-called graded potentials. A feasible approach to speculate about the functional roles of retinal neuronal circuits is to reproduce the graded potentials of retinal neurons in response to natural scenes. In this study, we developed a simulation platform for reproducing graded potentials with the following features: real-time reproduction of retinal neural activities in response to natural scenes, a configurable model structure, and compact hardware. The spatio-temporal properties of neurons were emulated efficiently by a mixed analog-digital architecture that consisted of analog resistive networks and a field-programmable gate array. The neural activities on sustained and transient pathways were emulated from 128 x 128 inputs at 200 frames per second.	[Okuno, Hirotsugu; Hasegawa, Jun; Sanada, Tadashi; Yagi, Tetsuya] Osaka Univ, Suita, Osaka 5650871, Japan	Okuno, H (reprint author), Osaka Univ, Suita, Osaka 5650871, Japan.	h-okuno@eei.eng.osaka-u.ac.jp			Challenging Exploratory Research from Ministry of Education, Culture, Sports, Science and Technology [24650314]	This work was supported by Challenging Exploratory Research (24650314) from The Ministry of Education, Culture, Sports, Science and Technology. This paper was recommended by Associate Editor J. Van der Spiegel.	Fu ZM, 2008, IEEE T BIOMED CIRC S, V2, P88, DOI 10.1109/TBCAS.2008.924448; Schneeweis DM, 1999, J NEUROSCI, V19, P1203; MEAD CA, 1988, NEURAL NETWORKS, V1, P91, DOI 10.1016/0893-6080(88)90024-X; Lichtsteiner P, 2008, IEEE J SOLID-ST CIRC, V43, P566, DOI 10.1109/JSSC.2007.914337; Zaghloul KA, 2004, IEEE T BIO-MED ENG, V51, P657, DOI 10.1109/TBME.2003.821039; Gollisch T, 2008, BIOL CYBERN, V99, P263, DOI 10.1007/s00422-008-0252-y; Kameda S, 2003, IEEE T NEURAL NETWOR, V14, P1405, DOI 10.1109/TNN.2003.816343; Lorach H, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/6/066004; Zamarreno-Ramos C, 2013, IEEE T BIOMED CIRC S, V7, P82, DOI 10.1109/TBCAS.2012.2195725; Liu SC, 2010, CURR OPIN NEUROBIOL, V20, P288, DOI 10.1016/j.conb.2010.03.007; LAMB TD, 1976, J PHYSIOL-LONDON, V263, P257; Delbruck T, 2004, VISION RES, V44, P2083, DOI 10.1016/j.visres.2004.03.021; Lin LJ, 2007, IEEE SENS J, V7, P1248, DOI 10.1109/JSEN.2007.901194; Okuno H, 2012, IEEE T BIOMED CIRC S, V6, P375, DOI 10.1109/TBCAS.2012.2185048; Costas-Santos J, 2007, IEEE T CIRCUITS-I, V54, P1444, DOI 10.1109/TCSI.2007.900179; Zaghloul KA, 2004, IEEE T BIO-MED ENG, V51, P667, DOI 10.1109/TBME.2003.821040; Shimonomura K, 2011, IEEE T NEURAL NETWOR, V22, P1482, DOI 10.1109/TNN.2011.2161591; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Baccus SA, 2008, J NEUROSCI, V28, P6807, DOI 10.1523/JNEUROSCI.4206-07.2008; EtienneCummings R, 1997, IEEE T CIRCUITS-I, V44, P55, DOI 10.1109/81.558442; Park DS, 2003, SENSOR ACTUAT A-PHYS, V108, P75, DOI 10.1016/S0924-4247(03)00292-9; WERBLIN FS, 1969, J NEUROPHYSIOL, V32, P339; BAYLOR DA, 1974, J PHYSIOL-LONDON, V242, P685; BAYLOR DA, 1987, INVEST OPHTH VIS SCI, V28, P34; Boahen K. A., 1991, ADV NEURAL INFORMATI, V4, P764; Chung-Yu Wu P., 1995, IEEE J SOLID-ST CIRC, V30, P890; DELANGEDZN H, 1958, J OPT SOC AM, V48, P777, DOI 10.1364/JOSA.48.000777; Dowling JE, 1987, RETINA APPROACHABLE; Etienne-Cummings R, 2000, IEEE T CIRCUITS-II, V47, P504, DOI 10.1109/82.847066; Hasegawa J, 2010, IEICE ELECTRON EXPR, V7, P184, DOI 10.1587/elex.7.184; Hasegawa J, 2008, J PHYSIOL SCI, V58, P507, DOI 10.2170/physiolsci.RP013108; Hasegawa J., 2009, P 2009 IEEE BIOM CIR, P197; Hennig MH, 2002, J NEUROSCI, V22, P8726; Ikeda H, 1998, IEEE PHOTONIC TECH L, V10, P261, DOI 10.1109/68.655378; Indiveri G, 2000, SCIENCE, V288, P1189, DOI 10.1126/science.288.5469.1189; KANEKO A, 1970, J PHYSIOL-LONDON, V207, P623; KELLY DH, 1961, J OPT SOC AM, V51, P422, DOI 10.1364/JOSA.51.000422; MEAD C, 1990, P IEEE, V78, P1629, DOI 10.1109/5.58356; NAKA KI, 1967, J PHYSIOL-LONDON, V192, P437; OHSHIMA S, 1995, VISION RES, V35, P149, DOI 10.1016/0042-6989(94)E0043-K; Rodieck R. W., 1998, 1 STEPS SEEING; Serrano-Gotarredona R, 2009, IEEE T NEURAL NETWOR, V20, P1417, DOI 10.1109/TNN.2009.2023653; Shi BE, 2000, IEEE T CIRCUITS-II, V47, P435, DOI 10.1109/82.842111; Svaetichin G., 1953, ACTA PHYSIOL SC S106, V29, P565; Teeters J, 1997, J COMPUT NEUROSCI, V4, P5, DOI 10.1023/A:1008840709467; Thiel A, 2006, J COMPUT NEUROSCI, V21, P131, DOI 10.1007/s10827-006-7863-x; TOMITA T, 1965, P COLD SPRING HARB S, V30, P559; Yagi T, 1997, BIOL CYBERN, V77, P163, DOI 10.1007/s004220050377	48	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1932-4545	1940-9990		IEEE T BIOMED CIRC S	IEEE Trans. Biomed. Circuits Syst.	APR	2015	9	2			SI		284	295		10.1109/TBCAS.2014.2327103		12	Engineering, Biomedical; Engineering, Electrical & Electronic	Engineering	CH3BJ	WOS:000353900400014		
J	Hirano, Y; Hattori, M; Douden, K; Hashizume, Y				Hirano, Yasumitsu; Hattori, Masakazu; Douden, Kenji; Hashizume, Yasuo			Single-Incision Laparoscopic Surgery for Colon Cancer in Patient with Situs Inversus Totalis: Report of a Case	INDIAN JOURNAL OF SURGERY			English	Article						Colon cancer; Single-incision laparoscopic surgery; Situs inversus totalis; Laparoscopic colectomy	RECTAL-CANCER; HEMICOLECTOMY; RESECTION	A preliminary experience with single-incision laparoscopic colectomy for colon cancer with situs inversus totalis (SIT) is reported. An 87-year-old man was admitted because of a fecal occult blood. A colonoscopy revealed cecal cancer. An air-barium and a computed tomography contrast enema showed the right-sided descending colon and the left-sided ascending colon and cecum. The surgical procedures were as follows: First, a Lap protector was inserted through a 2.5-cm transumbilical incision. Three 5-mm ports were placed in the Lap protector. We successfully performed ileocolectomy with lymph node dissection by using a single-incision laparoscopic approach without any technical problems. The operative time was 125 min, and blood loss was negligible. Postoperative follow-up did not reveal any umbilical wound complications and recurrences.	[Hirano, Yasumitsu; Hattori, Masakazu; Douden, Kenji; Hashizume, Yasuo] Fukui Prefectural Hosp, Dept Surg, Fukui 9108526, Japan	Hirano, Y (reprint author), Fukui Prefectural Hosp, Dept Surg, 2-8-1 Yotsui, Fukui 9108526, Japan.	yasumitsuhira@yahoo.co.jp					Fujiwara Y, 2007, WORLD J GASTROENTERO, V13, P5035; Kobus C, 2004, LANGENBECK ARCH SURG, V389, P396, DOI 10.1007/s00423-004-0500-0; Choi SI, 2011, SURG LAPARO ENDO PER, V21, pE87, DOI 10.1097/SLE.0b013e31820b0258; Davies H, 2003, Surg Endosc, V17, P160; Huh JW, 2010, J KOREAN MED SCI, V25, P790, DOI 10.3346/jkms.2010.25.5.790; Jobanputra S, 2007, SURG INNOV, V14, P284, DOI 10.1177/1553350607311089; Kim HJ, 2011, SURG TODAY, V41, P1538, DOI 10.1007/s00595-010-4530-7; Nursal TZ, 2001, J LAPAROENDOSC ADV A, V11, P239, DOI 10.1089/109264201750539772	8	0	0	SPRINGER INDIA	NEW DELHI	7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001, INDIA	0972-2068	0973-9793		INDIAN J SURG	Indian J. Surg	APR	2015	77			1			S26	S28		10.1007/s12262-014-1075-9		3	Surgery	Surgery	CH7DE	WOS:000354195000010		
J	Funabashi, M				Funabashi, Masatoshi			Synthetic Modeling of Autonomous Learning with a Chaotic Neural Network	INTERNATIONAL JOURNAL OF BIFURCATION AND CHAOS			English	Article						Chaotic itinerancy; invariant subspace; blowout bifurcation; riddled basins; Hebbian and STDP learning	BLOWOUT BIFURCATIONS; COMPLEXITY; DYNAMICS; SYSTEMS; MAP	We investigate the possible role of intermittent chaotic dynamics called chaotic itinerancy, in interaction with nonsupervised learnings that reinforce and weaken the neural connection depending on the dynamics itself. We first performed hierarchical stability analysis of the Chaotic Neural Network model (CNN) according to the structure of invariant subspaces. Irregular transition between two attractor ruins with positive maximum Lyapunov exponent was triggered by the blowout bifurcation of the attractor spaces, and was associated with riddled basins structure. We secondly modeled two autonomous learnings, Hebbian learning and spike-timing-dependent plasticity (STDP) rule, and simulated the effect on the chaotic itinerancy state of CNN. Hebbian learning increased the residence time on attractor ruins, and produced novel attractors in the minimum higher-dimensional subspace. It also augmented the neuronal synchrony and established the uniform modularity in chaotic itinerancy. STDP rule reduced the residence time on attractor ruins, and brought a wide range of periodicity in emerged attractors, possibly including strange attractors. Both learning rules selectively destroyed and preserved the specific invariant subspaces, depending on the neuron synchrony of the subspace where the orbits are situated. Computational rationale of the autonomous learning is discussed in connectionist perspective.	Sony Comp Sci Labs Inc, Shinagawa Ku, Tokyo 1410022, Japan	Funabashi, M (reprint author), Sony Comp Sci Labs Inc, Shinagawa Ku, 3-14-13 Higashi Gotanda, Tokyo 1410022, Japan.	masa_funabashi@csl.sony.co.jp			CNRS; long term study abroad support program of the University of Tokyo; French government (Promotion Simone de Beauvoir)	This study was partially supported by CNRS, the long term study abroad support program of the University of Tokyo, and the French government (Promotion Simone de Beauvoir).	Adachi M, 1997, NEURAL NETWORKS, V10, P83, DOI 10.1016/S0893-6080(96)00061-5; AIHARA K, 1985, PHYS LETT A, V111, P251, DOI 10.1016/0375-9601(85)90256-7; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Ito J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.028701; AIHARA K, 1990, PHYS LETT A, V144, P333, DOI 10.1016/0375-9601(90)90136-C; OTT E, 1994, PHYS LETT A, V188, P39, DOI 10.1016/0375-9601(94)90114-7; TSUDA I, 1992, NEURAL NETWORKS, V5, P313, DOI 10.1016/S0893-6080(05)80029-2; Tsuda I, 2004, LECT NOTES COMPUT SC, V3146, P109; AIHARA K, 1984, J THEOR BIOL, V109, P249, DOI 10.1016/S0022-5193(84)80005-3; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; RIEGEL KF, 1973, HUM DEV, V16, P346; MacKay RS, 2008, NONLINEARITY, V21, pT273, DOI 10.1088/0951-7715/21/12/T03; Ay N., 2006, UNIFYING FRAMEWORK C; Demetriou A, 2004, J COGN DEV, V5, P89, DOI 10.1207/s15327647jcd0501_6; Fischer KW, 1997, J PIAGET SY, P117; Fischer K. W., 2006, HDB CHILD PSYCHOL, V1, P313; Fujii Hiroshi, 2004, Journal of Integrative Neuroscience, V3, P183, DOI 10.1142/S0219635204000506; Fujii H, 2004, NEUROCOMPUTING, V58, P151, DOI 10.1016/j.neucom.2004.01.036; Funabashi M, 2014, ENTROPY-SWITZ, V16, P4132, DOI 10.3390/e16074132; Funabashi Masatoshi, 2007, Artificial Life and Robotics, V11, DOI 10.1007/510015-007-0422-3; Hebb D., 1949, ORG BEHAV NEUROPSYCH; Hegel G. W. F., 1970, PHANOMENOLOGIE GEIST; Hoffman W. C, 2003, MIND TIME DYNAMICS T; Hoffman W. C, 2003, VIS MATH, V5; Kaneko K., 2004, J INTEGR NEUROSCI, V3, P159; Kaneko K., 2003, CHAOS, V13, P937; Kang S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000022; Komuro K., 2001, JAPAN J IND APPL MAT, V18, P335; Lewis M. D., 2000, EMOTION DEV SELF ORG, P37, DOI 10.1017/CBO9780511527883.004; Lewis M. D., 2001, APPRAISAL PROCESSES, P205; MacKay RS, 2005, LECT NOTES PHYS, V671, P65; Morra S., 2007, COGNITIVE DEV NEOPIA, P367; Oizumi M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003588; Ott E, 1995, LECT NOTES PHYS, V450, P182, DOI 10.1007/3-540-59222-9_34; Pascual-Leone J., 1970, ACTA PSYCHOL, V32, P302; Russel S., 2009, ARTIFICIAL INTELLIGE; Sheffer HM, 1913, T AM MATH SOC, V14, P481, DOI 10.2307/1988701; SKARDA CA, 1987, BEHAV BRAIN SCI, V10, P161; Tononi Giulio, 2004, BMC Neurosci, V5, P42, DOI 10.1186/1471-2202-5-42; Tsuda I., 1991, WORLD FUTURES, V32, P167; Tsuda I, 2004, BEHAV BRAIN SCI, V27, P585	41	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0218-1274	1793-6551		INT J BIFURCAT CHAOS	Int. J. Bifurcation Chaos	APR	2015	25	4							1550054	10.1142/S0218127415500546		25	Mathematics, Interdisciplinary Applications; Multidisciplinary Sciences	Mathematics; Science & Technology - Other Topics	CH3TP	WOS:000353953500010		
J	Tahara, N; Yamagishi, S; Matsui, T; Nishino, Y; Honda, A; Tahara, A; Igata, S; Fukumoto, Y				Tahara, Nobuhiro; Yamagishi, Sho-ichi; Matsui, Takanori; Nishino, Yuri; Honda, Akihiro; Tahara, Atsuko; Igata, Sachiyo; Fukumoto, Yoshihiro			Serum levels of pigment epithelium-derived factor (PEDF) are inversely associated with circulating levels of dipeptidyl peptidase-4 (DPP-4) in humans	INTERNATIONAL JOURNAL OF CARDIOLOGY			English	Article						DPP-4; Diabetes; PEDF; Cardiovascular disease; Adipocytokine	GLYCATION END-PRODUCTS; VASCULAR INFLAMMATION; METABOLIC SYNDROME; DIABETES-MELLITUS; AGES; ACTIVATION; DISORDERS; IV	Background: We have previously found that advanced glycation end products (AGEs) stimulate the proteolytic cleavage of dipeptidyl peptidase-4 (DPP-4) from plasma membranes, and circulating AGE levels are independently correlated with serum DPP-4 values. Since pigment epithelium-derived factor (PEDF), one of the adipocytokines, inhibits the AGEs-induced insulin resistance and vascular damage, it is conceivable that besides AGEs, PEDF might also regulate soluble DPP-4 levels. In this study, we addressed the issue. Study design and methods: The study involved 188 subjects (123 males and 65 females; mean age of 61.1 +/- 9.2) who visited our hospital for a risk-screening test or treatment for cardiovascular disease. They underwent complete history and physical examinations, and determination of blood chemistry and anthropometric variables, including visceral and subcutaneous fat areas. Serum levels of DPP-4 and PEDF levels were examined by enzyme-linked immunosorbent assay. Results: Median (interquartile range) serum levels of DPP-4 and PEDF were 466.6 (400.2-545.1) ng/mL and 14.0 (10.6-17.0) mu g/mL, respectively. Multiple stepwise regression analysis revealed that female (p < 0.001), aspartate aminotransferase (p < 0.001), glycated hemoglobin (p < 0.001) and PEDF (inversely, p = 0.020) were independently associated with DPP-4 levels (R-2 = 0.267). Conclusion: We found here for the first time that serum PEDF levels were one of the independent correlates of circulating DPP-4 levels in humans. Since DPP-4 could impair insulin action and evoke vascular damage, our present study suggests that insulin-sensitizing and atheroprotective properties of PEDF might be ascribed partly to its inhibitory actions on DPP-4. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Tahara, Nobuhiro; Honda, Akihiro; Tahara, Atsuko; Igata, Sachiyo; Fukumoto, Yoshihiro] Kurume Univ, Sch Med, Div Cardiovasc Med, Dept Med, Kurume, Fukuoka 830, Japan; [Yamagishi, Sho-ichi; Matsui, Takanori; Nishino, Yuri] Kurume Univ, Sch Med, Dept Pathophysiol & Therapeut Diabet Vasc Complic, Kurume, Fukuoka 830, Japan	Tahara, N (reprint author), Kurume Univ, Sch Med, Div Cardiovasc Med, Dept Med, Kurume, Fukuoka 830, Japan.	ntahara@med.kurume-u.ac.jp; shoichi@med.kurume-u.ac.jp			Mitsui Life Social Welfare Foundation [Tahara N]; Ministry of Education, Culture, Sports, Science and Technology, Japan [25293127]	This study was supported in part by a grant from the Mitsui Life Social Welfare Foundation (to N.T.) (Grant Number Tahara N) and by Grants-in-Aid by Grants-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to S.Y.) (Grant Number 25293127).	Maeda S, 2011, PHARMACOL RES, V63, P241, DOI 10.1016/j.phrs.2010.11.008; Gorrell MD, 2005, CLIN SCI, V108, P277, DOI 10.1042/CS20040302; Yamagishi S, 2014, CURR PHARM DESIGN, V20, P2377; Balaban YH, 2007, ANN HEPATOL, V6, P242; Lamers D, 2011, DIABETES, V60, P1917, DOI 10.2337/db10-1707; Fukami K, 2014, CURR PHARM DESIGN, V20, P2395; Vlassara H, 2011, NAT REV ENDOCRINOL, V7, P526, DOI 10.1038/nrendo.2011.74; TOMBRANTINK J, 1991, EXP EYE RES, V53, P411, DOI 10.1016/0014-4835(91)90248-D; Yamagishi S, 2011, CURR PHARM DESIGN, V17, P4379; Yamagishi S, 2006, J CLIN ENDOCR METAB, V91, P2447, DOI 10.1210/jc.2005-2654; Yamagishi S, 2006, MICROVASC RES, V72, P86, DOI 10.1016/j.mvr.2006.04.002; Tahara N, 2012, DIABETES CARE, V35, P2618, DOI 10.2337/dc12-0087; Tahara N, 2013, CLIN BIOCHEM, V46, P300, DOI 10.1016/j.clinbiochem.2012.11.023; Ishibashi Y, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-125; Kodama N, 2013, J CLIN ENDOCR METAB, V98, P4438, DOI 10.1210/jc.2013-2920; Maeda S., 2010, INT J CARDIOL, V152, P408; Tahara N, 2012, INT J CARDIOL, V158, P461, DOI 10.1016/j.ijcard.2012.05.015; Unoki Yamagishi S., 2008, CURR PHARM DESIGN, V14, P987; Yamagishi SI, 2009, DIABETES-METAB RES, V25, P266, DOI 10.1002/dmrr.906; Yoshida T, 2008, HORM METAB RES, V40, P620, DOI 10.1055/s-0028-1083785	20	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-5273	1874-1754		INT J CARDIOL	Int. J. Cardiol.	APR 1	2015	184						14	16		10.1016/j.ijcard.2015.02.010		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CH1EL	WOS:000353763800004		
J	Ogasawara, S; Mukawa, H; Sone, T; Tsuboi, H; Morishima, I; Uesugi, M; Matsushita, E; Morita, Y; Okumura, K; Murohara, T				Ogasawara, Shinyu; Mukawa, Hiroaki; Sone, Takahito; Tsuboi, Hideyuki; Morishima, Itsuro; Uesugi, Michitaka; Matsushita, Etsushi; Morita, Yasuhiro; Okumura, Kenji; Murohara, Toyoaki			Presence of myocardial hypoenhancement on multidetector computed tomography after primary percutaneous coronary intervention in acute myocardial infarction predicts poor prognosis	INTERNATIONAL JOURNAL OF CARDIOLOGY			English	Article						Myocardial hypoenhancement; Microvascular obstruction; Acute myocardial infarction; Delayed contrast-enhanced multidetector computed tomography	ST-SEGMENT ELEVATION; NO-REFLOW PHENOMENON; SEVERE MICROVASCULAR OBSTRUCTION; ENHANCED MAGNETIC-RESONANCE; SIZE; ANGIOPLASTY; TRANSMURALITY; REPERFUSION; ANGIOGRAPHY; CT	Background: Recent research has suggested that patients with greater delayed contrast-enhanced size by multi-detector computed tomography (MDCT) are more likely to experience adverse cardiac events and have poor prognoses over the long term. The myocardial hypoenhancement area in the delayed contrast-enhanced effect suggests microvascular obstruction. The outcomes of patients with a hypoenhancement area detected by MDCT have not been clear. We examined the clinical importance of myocardial hypoenhancement detected by delayed contrast-enhanced MDCT after percutaneous coronary intervention (PCI) in patients with acutemyocardial infarction. Methods and results: In 80 patients with acutemyocardial infarction, MDCT was performed immediately after primary PCI. We investigated the outcomes of the patients with hypoenhancement detected by MDCT. Myocardial hypoenhancement was observed in 14 patients (17.5%). All 14 of these patients with hypoenhancement had a transmural infarction, and their infarct volume was significantly higher than those of the patients without hypoenhancement (n = 66). During the median follow-up period of 309 days, the appearance of myocardial hypoenhancement was associated with the presence of slow flow/no-reflow, time from onset to reperfusion >= 6 h, aging, smoking, chronic kidney disease, and hyper-low-density lipoprotein cholesterolemia. The incidence of major adverse cardiovascular events (MACE) was significantly higher in the patients with hypoenhancement compared to those without hypoenhancement, regardless of the myocardial infarct volume. Conclusions: These results indicate that the presence of myocardial hypoenhancement in delayed contrast-enhanced MDCT after PCI as well as the extent of infarct area is an important predictor of MACE. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Ogasawara, Shinyu; Mukawa, Hiroaki; Sone, Takahito; Tsuboi, Hideyuki; Morishima, Itsuro; Uesugi, Michitaka; Matsushita, Etsushi; Morita, Yasuhiro] Ogaki Municipal Hosp, Dept Cardiol, Ogaki, Japan; [Okumura, Kenji] Tohno Kosei Hosp, Dept Cardiol, Mizunami, Japan; [Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4648601, Japan	Okumura, K (reprint author), Tohno Mosel Hosp, 76-1 Tokicho, Mizunami 5096101, Japan.	kenji@med.nagoya-u.ac.jp	Murohara, Toyoaki/M-4958-2014				Ahn KT, 2013, INT J CARDIOVAS IMAG, V29, P835, DOI 10.1007/s10554-012-0155-9; Amanieu C, 2013, EUR RADIOL, V23, P2405, DOI 10.1007/s00330-013-2853-7; Jaffe R, 2008, CIRCULATION, V117, P3152, DOI 10.1161/CIRCULATIONAHA.107.742312; Gerber BL, 2006, CIRCULATION, V113, P823, DOI 10.1161/CIRCULATIONAHA.104.529511; Hombach V, 2005, EUR HEART J, V26, P549, DOI 10.1093/eurheartj/ehi147; Ichikawa Y, 2009, JACC-CARDIOVASC IMAG, V2, P548, DOI 10.1016/j.jcmg.2009.01.010; Sato A, 2012, J AM COLL CARDIOL, V59, P730, DOI 10.1016/j.jacc.2011.10.890; Gibbons RJ, 2000, CIRCULATION, V101, P101; Sharma A, 2014, AM J CARDIOL, V113, P731, DOI 10.1016/j.amjcard.2013.11.016; Husser O, 2013, INT J CARDIOL, V167, P2047, DOI 10.1016/j.ijcard.2012.05.055; MORISHIMA I, 1995, AM HEART J, V130, P239, DOI 10.1016/0002-8703(95)90434-4; Tarantini G, 2005, J AM COLL CARDIOL, V46, P1229, DOI 10.1016/j.jacc.2005.06.054; Kimura F, 2010, RADIOGRAPHICS, V30, P1587, DOI 10.1148/rg.306105519; de Waha S, 2012, CLIN RES CARDIOL, V101, P487, DOI 10.1007/s00392-012-0419-3; Bodi V, 2009, JACC-CARDIOVASC IMAG, V2, P835, DOI 10.1016/j.jcmg.2009.03.011; Morishima I, 2000, J AM COLL CARDIOL, V36, P1202, DOI 10.1016/S0735-1097(00)00865-2; [Anonymous], 1987, LANCET, V2, P871; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Wu KC, 1998, CIRCULATION, V97, P765; Van Herck PL, 2013, INT J CARDIOL, V167, P351, DOI 10.1016/j.ijcard.2011.12.099; ISIS Steering Committee, 1987, LANCET, V1, P502; Kramer CM, 2005, EUR HEART J, V26, P532, DOI 10.1093/eurheartj/ehi147; Mahnken AH, 2005, J AM COLL CARDIOL, V45, P2042, DOI 10.1016/j.jacc.2005.03.035; Okuda J, 2008, CIRC J, V72, P409, DOI 10.1253/circj.72.409; O'Sullivan JF, 2013, J AM COLL CARDIOL, V61, P208, DOI 10.1016/j.jacc.2012.08.1014; Rochitte CE, 2008, J AM COLL CARDIOL, V51, P2239, DOI 10.1016/j.jacc.2008.02.064; Takaoka H, 2014, INT J CARDIOL, V173, P525, DOI 10.1016/j.ijcard.2014.03.039; Tarantini G, 2006, AM J CARDIOL, V98, P1033, DOI 10.1016/j.amjcard.2006.05.022; Wong DTL, 2013, INT J CARDIOL, V165, P61, DOI 10.1016/j.ijcard.2011.07.078; Zanzonico P, 2006, J AM COLL CARDIOL, V47, P1846, DOI 10.1016/j.jacc.2005.10.075	30	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-5273	1874-1754		INT J CARDIOL	Int. J. Cardiol.	APR 1	2015	184						101	107		10.1016/j.ijcard.2015.01.085		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CH1EL	WOS:000353763800017		
J	Ozawa, K; Funabashi, N; Takaoka, H; Kamata, T; Kanaeda, A; Saito, M; Nomura, F; Kobayashi, Y				Ozawa, Koya; Funabashi, Nobusada; Takaoka, Hiroyuki; Kamata, Tomoko; Kanaeda, Akiyo; Saito, Mariko; Nomura, Fumio; Kobayashi, Yoshio			Characteristic myocardial strain identified in hypertrophic cardiomyopathy subjects with preserved left ventricular ejection fraction using a novel multi-layer transthoracic echocardiography technique	INTERNATIONAL JOURNAL OF CARDIOLOGY			English	Article						Myocardial strain; Hypertrophic cardiomyopathy; Preserved left ventricular ejection fraction; Novel multi-layer technique; Speckle tracking transthoracic; echocardiography technique	MAGNETIC-RESONANCE; QUANTIFICATION; ENHANCEMENT	Purpose: In order to evaluate compensatory mechanisms in hypertrophic-cardiomyopathy (HCM) subjects with preserved left-ventricular (LV) ejection-fraction (EF), we measured myocardial percentage endocardial strain dependency, as represented by 2D LV global longitudinal (GLS) and circumferential-strain (GCS), using a novel, multi-layer, speckle-tracking transthoracic-echocardiography (TTE) technique. Methods: A total of 60 subjects (40 HCM with preserved LV EF (30 male; 62 +/- 15 years, all LV EF > 50%)) and 20 controls (10 male; 59 +/- 10 years) underwent TTE (Vivid-E9). Quantitative strain-measurements of: endocardial, all and epicardial layers were performed at each-site. We defined percentage endocardial strain dependency as the ratio of endocardial strain to epicardial strain. Results: Absolute GLS values at all views in all, endocardial and epicardial myocardial layers were significantly smaller in HCM subjects than in controls (all P < 0.001). There were no significant differences between both groups in absolute GCS values in the endocardial layers, at the mitral valve and papillary muscle levels. Percentage endocardial GCS dependency at all levels were greater in HCM subjects than in controls (all P < 0.01). In HCM subjects, percentage endocardial GCS dependency at the mitral valve and papillary muscle levels revealed significant, moderate, negative correlations with LV end-diastolic and systolic dimensions (correlation coefficients -0.505, -0.451 (mitral valve level) and -0.533, -0.591 (papillary muscle level), respectively). Conclusions: In HCM subjects with preserved LV EF, 2D LV GLS was lower than in controls, but endocardial GCS was maintained in compensation for reduction in endocardial GLS; thus percentage endocardial GCS dependency may increase, and the larger the LV size, the smaller this compensatory effect. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Ozawa, Koya; Funabashi, Nobusada; Takaoka, Hiroyuki; Kobayashi, Yoshio] Chiba Univ, Grad Sch Med, Dept Cardiovasc Med, Chuo Ku, Chiba, Chiba 2608670, Japan; [Kamata, Tomoko; Kanaeda, Akiyo; Saito, Mariko; Nomura, Fumio] Chiba Univ, Grad Sch Med, Dept Mol Diag, Chuo Ku, Chiba, Chiba 2608670, Japan	Funabashi, N (reprint author), Chiba Univ, Grad Sch Med, Dept Cardiovasc Med, Chuo Ku, 1-8-1 Inohana, Chiba, Chiba 2608670, Japan.	nobusada@w8.dion.ne.jp			Kao Research Council for the Study of Healthcare Science [A-31016]; Japan Heart Foundation Research Grant	This work is partially supported by a Grant from the Kao Research Council for the Study of Healthcare Science (A-31016) and the Japan Heart Foundation Research Grant. The authors of this manuscript have certified that they comply with the Principles of Ethical Publishing in the International Journal of Cardiology.	Chan RH, 2014, CIRCULATION, V130, P484, DOI 10.1161/CIRCULATIONAHA.113.007094; Ishizu T, 2010, EUR J ECHOCARDIOGR, V11, P377, DOI 10.1093/ejechocard/jep221; Serri K, 2006, J AM COLL CARDIOL, V47, P1175, DOI 10.1016/j.jacc.2005.10.061; Carasso S, 2008, J AM SOC ECHOCARDIOG, V21, P675, DOI 10.1016/j.echo.2007.10.021; Zhao L, 2014, EUR J RADIOL, V83, P1778, DOI 10.1016/j.ejrad.2014.05.035; MARON BJ, 1981, AM J CARDIOL, V48, P418, DOI 10.1016/0002-9149(81)90068-0; Gersh BJ, 2011, J AM COLL CARDIOL, V58, pE212, DOI 10.1016/j.jacc.2011.06.011; Bogaert J, 2014, RADIOLOGY, V273, P328, DOI 10.1148/radiol.14131626; Ellims AH, 2014, EUR HEART J-CARD IMG, V15, P1108, DOI 10.1093/ehjci/jeu077; Hanneman K, 2014, J THORAC IMAG, V29, P331, DOI 10.1097/RTI.0000000000000115; Kebed KY, 2014, AM J CARDIOL, V114, P777, DOI 10.1016/j.amjcard.2014.05.067; Kramer CM, 2013, JACC-CARDIOVASC IMAG, V6, P532, DOI 10.1016/j.jcmg.2013.02.002; Yajima R, 2012, INT J CARDIOL, V158, P423, DOI 10.1016/j.ijcard.2011.01.096; Zhang Q, 2011, INT J CARDIOL, V147, P32, DOI 10.1016/j.ijcard.2009.07.041	14	3	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-5273	1874-1754		INT J CARDIOL	Int. J. Cardiol.	APR 1	2015	184						237	243		10.1016/j.ijcard.2015.01.070		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CH1EL	WOS:000353763800036		
J	Hisamatsu, T; Miura, K; Fujiyoshi, A; Okamura, T; Ohkubo, T; Nagasawa, SY; Horie, M; Okayama, A; Ueshima, H				Hisamatsu, Takashi; Miura, Katsuyuki; Fujiyoshi, Akira; Okamura, Tomonori; Ohkubo, Takayoshi; Nagasawa, Shin-ya; Horie, Minoru; Okayama, Akira; Ueshima, Hirotsugu		NIPPON DATA80 Res Grp	Long-term outcomes associated with prolonged PR interval in the general Japanese population	INTERNATIONAL JOURNAL OF CARDIOLOGY			English	Letter						Prolonged PR interval; Mortality; Electrocardiography; Epidemiology	NIPPON DATA80; BLOCK; MORTALITY		[Hisamatsu, Takashi; Miura, Katsuyuki; Fujiyoshi, Akira; Ueshima, Hirotsugu] Shiga Univ Med Sci, Dept Publ Hlth, Otsu, Shiga 5202192, Japan; [Hisamatsu, Takashi; Horie, Minoru] Shiga Univ Med Sci, Dept Cordiovasc & Resp Med, Otsu, Shiga 5202192, Japan; [Okamura, Tomonori] Keio Univ, Dept Prevent Med & Publ Hlth, Tokyo, Japan; [Ohkubo, Takayoshi] Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Tokyo 173, Japan; [Nagasawa, Shin-ya] Kanazawa Med Univ, Dept Epidemiol & Publ Hlth, Uchinada, Ishikawa 92002, Japan; [Okayama, Akira] Res Inst Strategy Prevent, Tokyo, Japan	Hisamatsu, T (reprint author), Shiga Univ Med Sci, Dept Publ Hlth, Setatsukinowa Cho, Otsu, Shiga 5202192, Japan.	hisataka@belle.shiga-med.ac.jp	Okamura, Tomonori/L-1693-2013				Magnani JW, 2011, HEART RHYTHM, V8, P93, DOI 10.1016/j.hrthm.2010.09.020; Aro AL, 2014, EUR HEART J, V35, P123, DOI 10.1093/eurheartj/eht176; Cheng S, 2009, JAMA-J AM MED ASSOC, V301, P2571, DOI 10.1001/jama.2009.888; DHINGRA RC, 1981, CIRCULATION, V64, P1265; MYMIN D, 1986, NEW ENGL J MED, V315, P1183, DOI 10.1056/NEJM198611063151902; Nakamura Y, 2012, CIRCULATION, V125, P1226, DOI 10.1161/CIRCULATIONAHA.111.070045; Prineas R. J., 1982, MINNESOTA CODE MANUA, P98; Ueshima H, 2004, STROKE, V35, P1836, DOI 10.1161/01.STR.0000131747.84423.74	8	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-5273	1874-1754		INT J CARDIOL	Int. J. Cardiol.	APR 1	2015	184						291	293		10.1016/j.ijcard.2015.02.028		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CH1EL	WOS:000353763800056		
J	Kiyokuni, M; Goda, M; Okiyama, M; Kawashima, C; Doi, H; Hisa, A; Tomari, S; Mitsuhashi, T; Iwaki, H; Endo, T; Umemura, S; Masuda, M				Kiyokuni, Masayoshi; Goda, Motohiko; Okiyama, Makoto; Kawashima, Chika; Doi, Hiroshi; Hisa, Akio; Tomari, Sakie; Mitsuhashi, Takayuki; Iwaki, Hideyuki; Endo, Tsutomu; Umemura, Satoshi; Masuda, Munetaka			A case of cardio-pulmonary arrest caused by anomalous origin of left main coronary artery from right sinus of valsalva	INTERNATIONAL JOURNAL OF CARDIOLOGY			English	Letter						Coronary vessels; Anomalous origin; Myocardial ischemia; Chest pain; Cardio-pulmonary arrest	INTERARTERIAL COURSE		[Kiyokuni, Masayoshi; Umemura, Satoshi] Yokohama City Univ, Sch Med, Dept Med Sci & Cardiorenal Med, Yokohama, Kanagawa 2360004, Japan; [Kawashima, Chika; Doi, Hiroshi; Hisa, Akio; Tomari, Sakie; Mitsuhashi, Takayuki; Endo, Tsutomu] Saiseikai Yokohama City Southern Hosp, Div Cardiol, Yokohama, Kanagawa, Japan; [Goda, Motohiko; Masuda, Munetaka] Yokohama City Univ, Sch Med, Dept Surg, Yokohama, Kanagawa 2360004, Japan; [Okiyama, Makoto; Iwaki, Hideyuki] Saiseikai Yokohama City Southern Hosp, Div Surg, Yokohama, Kanagawa, Japan	Kiyokuni, M (reprint author), Yokohama City Univ, Sch Med, Dept Med Sci & Cardiorenal Med, Yokohama, Kanagawa 2360004, Japan.	masakiyo@yokohama-cu.ac.jp					Angelini P, 2002, CIRCULATION, V105, P2449, DOI 10.1161/01.CIR.0000016175.49835.57; Jaffe R, 2009, CIRC-CARDIOVASC IMAG, V2, P351, DOI 10.1161/CIRCIMAGING.108.825810; Ni J, 2014, INT J CARDIOL, V174, pE32, DOI 10.1016/j.ijcard.2014.03.203; Nimdet K, 2012, CARDIOL YOUNG, V22, P536, DOI 10.1017/S1047951111002113	4	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-5273	1874-1754		INT J CARDIOL	Int. J. Cardiol.	APR 1	2015	184						296	298		10.1016/j.ijcard.2015.02.069		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CH1EL	WOS:000353763800058		
J	Okina, N; Enzan, N; Uchida, T; Fukumoto, Y				Okina, Norihito; Enzan, Nobuyuki; Uchida, Takayuki; Fukumoto, Yoshihiro			Double cardiac myxomas in the left atrium and ventricle	INTERNATIONAL JOURNAL OF CARDIOLOGY			English	Letter						Multiple myxomas; Left atrium; Left ventricle			[Okina, Norihito] Social Insurance Tagawa Hosp, Dept Internal Med, Tagawa, Japan; [Enzan, Nobuyuki] Iizuka Hosp, Dept Cardiovasc Med, Iizuka, Fukuoka, Japan; [Uchida, Takayuki] Iizuka Hosp, Dept Cardiovasc Surg, Iizuka, Fukuoka, Japan; [Fukumoto, Yoshihiro] Kurume Univ, Sch Med, Dept Internal Med, Div Cardiovasc Med, Kurume, Fukuoka 8300011, Japan	Fukumoto, Y (reprint author), Kurume Univ, Sch Med, Dept Internal Med, Div Cardiovasc Med, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	yofukumoto-circ@umin.net					CARNEY JA, 1986, MAYO CLIN PROC, V61, P165; Castillo Javier G, 2010, Semin Cardiothorac Vasc Anesth, V14, P6, DOI 10.1177/1089253210362596; Chow DHF, 2014, INT J CARDIOL, V172, pE13, DOI 10.1016/j.ijcard.2013.12.097; Jorge C, 2013, INT J CARDIOL, V167, pE104, DOI 10.1016/j.ijcard.2013.03.190; Satish OS, 2013, CIRCULATION, V127, pE360, DOI 10.1161/CIRCULATIONAHA.112.105528	5	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-5273	1874-1754		INT J CARDIOL	Int. J. Cardiol.	APR 1	2015	184						364	365		10.1016/j.ijcard.2015.02.036		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CH1EL	WOS:000353763800074		
J	Ito, T; Fujita, H; Tani, T; Sugiura, T; Ohte, N				Ito, Tsuyoshi; Fujita, Hiroshi; Tani, Tomomitsu; Sugiura, Tomonori; Ohte, Nobuyuki			Increased circulating malondialdehyde-modified low-density lipoprotein levels in patients with ergonovine-induced coronary artery spasm	INTERNATIONAL JOURNAL OF CARDIOLOGY			English	Article						Malondialdehyde-modified low-density lipoprotein; Ergonovine; Coronary spasm	VARIANT ANGINA; VASOSPASTIC ANGINA; CIGARETTE-SMOKING; MODIFIED LDL; SERUM; ATHEROSCLEROSIS; ACETYLCHOLINE; ARTERIOGRAPHY; ATHEROGENESIS; CHOLESTEROL	Objective: Coronary endothelial dysfunction is thought to underlie the development of coronary artery spasms. Malondialdehyde-modified low-density lipoprotein (MDA-LDL) was suggested as a marker of endothelial damage. This study investigated the diagnostic impact of MDA-LDL on ergonovine-induced coronary spasms. Methods: We included 152 patients with suspected coronary spastic angina. MDA-LDL levels were measured before an ergonovine provocation test. Coronary spasm was defined as total or subtotal occlusion, compared to the relaxed state after nitroglycerin, associated with ischemic ECG changes and concurrent chest pain. Changes in vessel diameter in response to ergonovine were evaluated with quantitative coronary angiography. Results: Coronary spasms were observed in 41 patients (27%). MDA-LDL levels were significantly higher in patients with spasms compared to those without spasms (139.9 +/- 45.9 U/L vs. 109.6 +/- 36.6 U/L, p < 0.01). Univariate logistic regression analyses indicated significant relationships between coronary spasms and MDA-LDL (per 10 U/L, odds ratio (OR): 1.20; p < 0.01), high-density lipoprotein (per 10 mg/dL, OR: 0.76; p = 0.03), smoking (OR: 3.04; p < 0.01), and male gender (OR: 3.51; p < 0.01). In the multivariate model, MDA-LDL (per 10 U/L, OR: 1.17; p < 0.01) remained a significant predictor of coronary spasm. Regression analysis showed a positive correlation between MDA-LDL levels and coronary luminal diameter changes induced by ergonovine (r = 0.57, p < 0.01). The optimal MDA-LDL threshold for predicting coronary spasm was 121.3 U/L, identified with a receiver operating characteristic curve. Conclusions: Increased circulating MDA-LDL levels were associated with ergonovine-induced coronary artery spasm. (c) 2015 Elsevier Ireland Ltd. All rights reserved.	[Ito, Tsuyoshi; Fujita, Hiroshi; Tani, Tomomitsu; Sugiura, Tomonori; Ohte, Nobuyuki] Nagoya City Univ, Grad Sch Med Sci, Dept Cardiorenal Med & Hypertens, Nagoya, Aichi 4678601, Japan	Ito, T (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Cardiorenal Med & Hypertens, 1 Kawasumi,Mizuhocho, Nagoya, Aichi 4678601, Japan.	tuyosiito@gmail.com					OLIVA PB, 1973, NEW ENGL J MED, V288, P745, DOI 10.1056/NEJM197304122881501; YAMAGISHI M, 1994, J AM COLL CARDIOL, V23, P352; Sueda S, 1999, AM J CARDIOL, V83, P1186, DOI 10.1016/S0002-9149(99)00057-0; KOTANI K, 1994, BBA-LIPID LIPID MET, V1215, P121, DOI 10.1016/0005-2760(94)90100-7; Heitzer T, 1996, CIRCULATION, V93, P1346; YASUE H, 1988, CIRCULATION, V78, P1; BERTRAND ME, 1982, CIRCULATION, V65, P1299; Ong P, 2011, J AM COLL CARDIOL, V57, P147, DOI 10.1016/j.jacc.2010.08.626; Ong P, 2008, J AM COLL CARDIOL, V52, P523, DOI 10.1016/j.jacc.2008.04.050; Amaki T, 2004, HEART, V90, P1211, DOI 10.1136/hrt.2003.018226; Steinberg D, 1997, CIRCULATION, V95, P1062; YASUE H, 1986, CIRCULATION, V74, P955; Sugiuchi H, 1998, CLIN CHEM, V44, P522; NAKAMURA M, 1987, CIRCULATION, V75, P1110; Kugiyama K, 1998, J AM COLL CARDIOL, V32, P103, DOI 10.1016/S0735-1097(98)00185-5; Nishino M, 2014, HEART VESSELS, V29, P186, DOI 10.1007/s00380-013-0346-x; Ito T, 2012, CIRC-CARDIOVASC IMAG, V5, P226, DOI 10.1161/CIRCIMAGING.111.967075; Itoh T, 2007, CIRC J, V71, P1074, DOI 10.1253/circj.71.1074; Ogawa H, 2010, CIRC J, V74, P1745, DOI 10.1253/circj.CJ-10-74-0802; MIWA K, 1995, J AM COLL CARDIOL, V26, P632, DOI 10.1016/0735-1097(95)00207-K; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Sugano Y, 2010, INT J CARDIOL, V140, P175, DOI 10.1016/j.ijcard.2008.11.053; SUGIISHI M, 1993, CIRCULATION, V87, P76; Sugiura T, 2011, INT J CARDIOL, V147, P461, DOI 10.1016/j.ijcard.2010.12.112; SZLACHCIC J, 1984, AM HEART J, V107, P20, DOI 10.1016/0002-8703(84)90127-3; Tamura A, 2003, CIRC J, V67, P816, DOI 10.1253/circj.67.816; WILLIAMS JK, 1990, CIRCULATION, V81, P1680; WITZTUM JL, 1994, LANCET, V344, P793; WITZTUM JL, 1991, J CLIN INVEST, V88, P1785, DOI 10.1172/JCI115499	29	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-5273	1874-1754		INT J CARDIOL	Int. J. Cardiol.	APR 1	2015	184						475	480		10.1016/j.ijcard.2015.03.040		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CH1EL	WOS:000353763800107		
J	Taruya, A; Tanaka, A; Nishiguchi, T; Iwaguro, T; Ueno, S; Okumoto, Y; Kubo, T; Akagi, H; Akasaka, T				Taruya, Akira; Tanaka, Atsushi; Nishiguchi, Tsuyoshi; Iwaguro, Tetsuya; Ueno, Satoshi; Okumoto, Yasushi; Kubo, Takashi; Akagi, Hideharu; Akasaka, Takashi			Necessity of magnetic resonance imaging examinations after permanent pacemaker implantation	INTERNATIONAL JOURNAL OF CARDIOLOGY			English	Letter						Pacemaker; Magnetic resonance imaging; Prognosis; Arrhythmia; Cerebral ischemia	INDUSTRY VIEWPOINT; DEFIBRILLATOR PATIENTS; MRI; ICDS		[Taruya, Akira; Tanaka, Atsushi; Nishiguchi, Tsuyoshi; Kubo, Takashi; Akasaka, Takashi] Wakayama Med Univ, Dept Cardiovasc Med, Wakayama 6418510, Japan; [Iwaguro, Tetsuya; Ueno, Satoshi; Okumoto, Yasushi; Akagi, Hideharu] Kinan Hosp, Dept Cardiovasc Med, Tanabe, Japan	Tanaka, A (reprint author), Wakayama Med Univ, Dept Cardiovasc Med, 811-1 Kimiidera, Wakayama 6418510, Japan.	a-tanaka@wakayama-med.ac.jp					Levine GN, 2007, CIRCULATION, V116, P2878, DOI 10.1161/CIRCULATIONAHA.107.187256; Kalin R, 2005, PACE, V28, P326, DOI 10.1111/j.1540-8159.2005.50024.x; Faris OP, 2006, CIRCULATION, V114, P1232, DOI 10.1161/CIRCULATIONAHA.106.647800; Sakakibara Y, 1999, JPN HEART J, V40, P737, DOI 10.1536/jhj.40.737; Faris OP, 2005, PACE, V28, P268, DOI 10.1111/j.1540-8159.2005.50035.x; Irnich W, 2005, EUROPACE, V7, P353, DOI 10.1016/j.eupc.2005.02.120; Levine PA, 2005, PACE, V28, P266, DOI 10.1111/j.1540-8159.2005.50027.x; Smith JM, 2005, PACE, V28, P264, DOI 10.1111/j.1540-8159.2005.09591.x; Sommer T, 2006, CIRCULATION, V114, P1285, DOI 10.1161/CIRCULATIONAHA.105.597013; Stanton MS, 2005, PACE, V28, P265, DOI 10.1111/j.1540-8159.2005.50025.x	10	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-5273	1874-1754		INT J CARDIOL	Int. J. Cardiol.	APR 1	2015	184						497	498		10.1016/j.ijcard.2015.02.080		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CH1EL	WOS:000353763800116		
J	Kawada, T				Kawada, Tomoyuki			Brachial-ankle pulse wave velocity and blood pressure control in treated hypertensive patients	INTERNATIONAL JOURNAL OF CARDIOLOGY			English	Letter						Brachial-ankle pulse wave velocity; Hypertension; Blood pressure control; Prospective study	ARTERIAL STIFFNESS		[Kawada, Tomoyuki] Nippon Med Sch, Dept Hyg & Publ Hlth, Tokyo 1138602, Japan	Kawada, T (reprint author), Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	kawada@nms.ac.jp					Otsuka T, 2013, HYPERTENS RES, V36, P910, DOI 10.1038/hr.2013.56; Cat ena C, 2014, AM J HYPERTENS; Montero D, 2014, INT J CARDIOL, V173, P361, DOI 10.1016/j.ijcard.2014.03.072; Talikoti P., 2014, J CLIN DIAGN RES, V8, pCC07; Zheng ML, 2015, INT J CARDIOL, V178, P226, DOI 10.1016/j.ijcard.2014.10.049	5	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-5273	1874-1754		INT J CARDIOL	Int. J. Cardiol.	APR 1	2015	184						611	611		10.1016/j.ijcard.2015.03.028		1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CH1EL	WOS:000353763800146		
J	Ohuchi, H; Negishi, J; Hayama, Y; Sasaki, O; Taniguchi, Y; Noritake, K; Miyazaki, A; Yamada, O				Ohuchi, Hideo; Negishi, Jun; Hayama, Yosuke; Sasaki, Osamu; Taniguchi, Yuki; Noritake, Kanae; Miyazaki, Aya; Yamada, Osamu			Hyperuricemia reflects global Fontan pathophysiology and associates with morbidity and mortality in patients after the Fontan operation	INTERNATIONAL JOURNAL OF CARDIOLOGY			English	Article						Fontan; Uric acid; Hypeuricemia; Heart failure; Prognosis	CHRONIC HEART-FAILURE; SERUM URIC-ACID; INSULIN-RESISTANCE; NITRIC-OXIDE; ENDOTHELIAL DYSFUNCTION; PROGNOSTIC-SIGNIFICANCE; SUPEROXIDE-DISMUTASE; EXERCISE CAPACITY; OXIDATIVE STRESS; ADULT PATIENTS	Background: Serum uric acid (UA, mg/dl) levels associate with the pathophysiology and prognosis in patients with chronic heart failure. Purpose: To clarify the clinical significance of hyperuricemia (HUA, UA > 7.0) in Fontan patients. Methods and results: We prospectively measured UA in 197 child and 102 adult Fontan patients and compared the results with the clinical variables, including hemodynamics, exercise capacity, and plasma levels of norepinephrine (NE) and brain natriuretic peptide, and unscheduled hospitalization (USH), including all-cause mortality. The mean UA was 5.8 +/- 1.7 and 66 patients (22%, 34% in the adults) showed HUA. HUA was associated with lower peak oxygen uptake only in adults (r=-0.35, p < 0.0001). In children the use of diuretics, central venous pressure, liver enzymes, NE, and plasma creatinine (Cr) independently associated with UA. Of those, in addition to hypoxia, the use of diuretics and Cr independently predicted HUA (p < 0.05-0.001). In adults, hypoxia, plasma levels of sodium and Cr independently determined UA. Of those, hypoxia and hyponatremia independently predicted HUA (p < 0.05-0.001). During a follow-up of 49 +/- 27 months, 67 USH, including 17 deaths, occurred. In all patients, on univariate analysis, HUA predicted mortality (hazard ratio: 3.2, 95% confidence interval: 1.2-8.6, p = 0.0193). HUA predicted USH in all, adult and child Fontan patients (p < 0.05-0.0001), however, these prognostic values, including for mortality, were not independent in the multivariate analyses. Conclusions: UA reflects global postoperative Fontan pathophysiology, including the prognosis, with some differences between child and adult patients. However, the prognostic value of HUA may be limited in multivariate models in this particular cohort. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Ohuchi, Hideo] Natl Cerebral & Cardiovasc Ctr, Dept Pediat Cardiol, Suita, Osaka 5658565, Japan; Natl Cerebral & Cardiovasc Ctr, Adult Congenital Heart Dis, Suita, Osaka 5658565, Japan	Ohuchi, H (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Pediat Cardiol, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	hohuchi@hsp.ncvc.go.jp					Ambrosio G, 1997, CARDIOVASC RES, V34, P445, DOI 10.1016/S0008-6363(97)00101-6; Harrison R, 2002, FREE RADICAL BIO MED, V33, P774, DOI 10.1016/S0891-5849(02)00956-5; Chao TF, 2013, INT J CARDIOL, V168, P4027, DOI 10.1016/j.ijcard.2013.06.067; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Ford ES, 2007, CIRCULATION, V115, P2526, DOI 10.1161/CIRCULATIONAHA.106.657627; Landmesser U, 2002, CIRCULATION, V106, P3073, DOI 10.1161/01.CIR.0000041431.57222.AF; Ohuchi H, 1996, PEDIATR CARDIOL, V17, P7, DOI 10.1007/BF02505805; Reyes AJ, 2003, CARDIOVASC DRUG THER, V17, P397, DOI 10.1023/B:CARD.0000015855.02485.e3; Kim JA, 2006, CIRCULATION, V113, P1888, DOI 10.1161/CIRCULATIONAHA.105.563213; Muscelli E, 1996, AM J HYPERTENS, V9, P746, DOI 10.1016/0895-7061(96)00098-2; Sakai H, 2006, CIRC J, V70, P1006, DOI 10.1253/circj.70.1006; Kinugawa S, 2005, CIRCULATION, V111, P1480, DOI 10.1161/01.CIR.0000159261.11520.63; Strazzullo P, 2007, NUTR METAB CARDIOVAS, V17, P409, DOI 10.1016/j.numecd.2007.02.011; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; Zucker IH, 2006, HYPERTENSION, V48, P1005, DOI 10.1161/01.HYP.0000246614.47231.25; Rafey MA, 2003, CURR OPIN NEPHROL HY, V12, P511, DOI 10.1097/01.mnh.0000088729.87142.07; Ostrow AM, 2006, ANN THORAC SURG, V82, P695, DOI 10.1016/j.athoracsur.2006.02.048; Zhu YZ, 2014, BIOCHEM BIOPH RES CO, V447, P707, DOI 10.1016/j.bbrc.2014.04.080; LJUNGMAN S, 1990, DRUGS, V39, P10, DOI 10.2165/00003495-199000394-00004; Kang DH, 2005, J AM SOC NEPHROL, V16, P3553, DOI 10.1681/ASN.2005050572; Khairy P, 2008, CIRCULATION, V117, P85, DOI 10.1161/CIRCULATIONAHA.107.738559; Rychik J, 2012, PEDIATR CARDIOL, V33, P1001, DOI 10.1007/s00246-012-0315-7; Anker SD, 2003, CIRCULATION, V107, P1991, DOI 10.1161/01.CIR.0000065637.10517.A0; Bruns LA, 2001, J PEDIATR-US, V138, P505, DOI 10.1067/mpd.2001.113045; Berry CE, 2004, J PHYSIOL-LONDON, V555, P589, DOI 10.1113/jphysiol.2003.055913; DOMAGK GF, 1968, ANAL BIOCHEM, V22, P219, DOI 10.1016/0003-2697(68)90309-6; Kono M., 1993, KAKU IGAKU, V13, P2; MORI K, 1981, J CHROMATOGR, V218, P631, DOI 10.1016/S0021-9673(00)82088-9; Ohuchi H, 2004, PEDIATR CARDIOL, V25, P513, DOI 10.1007/s00246-003-0652-7; Ohuchi H, 2011, CONGENIT HEART DIS, V6, P304, DOI 10.1111/j.1747-0803.2011.00503.x; Ohuchi H, 2014, INT J CARDIOL, V173, P277, DOI 10.1016/j.ijcard.2014.03.001; Ohuchi H, 2001, J AM COLL CARDIOL, V37, P1967, DOI 10.1016/S0735-1097(01)01266-9; Ohuchi H., 2014, PEDIAT CARDIOL CARD, V30, P635; Oya H, 2000, HEART, V84, P53, DOI 10.1136/heart.84.1.53; Peixoto  M R, 2001, Arq Bras Cardiol, V76, P463; ROSS EA, 1986, CIRCULATION, V73, P396; Santos CXC, 1999, ARCH BIOCHEM BIOPHYS, V372, P285, DOI 10.1006/abbi.1999.1491; Wang JG, 2001, HYPERTENSION, V37, P1069; Yamamoto Tetsuya, 2008, Nihon Rinsho, V66, P636; Yamamoto T, 2001, METABOLISM, V50, P1230, DOI 10.1053/meta.2001.26709	40	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-5273	1874-1754		INT J CARDIOL	Int. J. Cardiol.	APR 1	2015	184						623	630		10.1016/j.ijcard.2015.02.026		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CH1EL	WOS:000353763800150		
J	Ohsawa, M; Okamura, T; Ogasawara, K; Ogawa, A; Fujioka, T; Tanno, K; Yonekura, Y; Omama, S; Turin, TC; Itai, K; Ishibashi, Y; Morino, Y; Itoh, T; Miyamatsu, N; Onoda, T; Kuribayashi, T; Makita, S; Yoshida, Y; Nakamura, M; Tanaka, F; Ohta, M; Sakata, K; Okayama, A				Ohsawa, Masaki; Okamura, Tomonori; Ogasawara, Kuniaki; Ogawa, Akira; Fujioka, Tomoaki; Tanno, Kozo; Yonekura, Yuki; Omama, Shinichi; Turin, Tanvir Chowdhury; Itai, Kazuyoshi; Ishibashi, Yasuhiro; Morino, Yoshihiro; Itoh, Tomonori; Miyamatsu, Naomi; Onoda, Toshiyuki; Kuribayashi, Toru; Makita, Shinji; Yoshida, Yuki; Nakamura, Motoyuki; Tanaka, Fumitaka; Ohta, Mutsuko; Sakata, Kiyomi; Okayama, Akira			Relative and absolute risks of all-cause and cause-specific deaths attributable to atrial fibrillation in middle-aged and elderly community dwellers	INTERNATIONAL JOURNAL OF CARDIOLOGY			English	Article						Atrial fibrillation; Cardiovascular death; Non-cardiovascular death; Sudden cardiac death; Relative risk; Absolute risk difference	JAPANESE GENERAL-POPULATION; SUDDEN CARDIAC DEATH; FOLLOW-UP; CEREBROVASCULAR DISEASES; CARDIOVASCULAR EVENTS; CEREBRAL INFARCTION; MORTALITY; STROKE; IWATE; ONSET	Background: The relative and absolute risks of outcomes other than all-cause death (ACD) attributable to atrial fibrillation (AF) stratified age have not been sufficiently investigated. Methods: A prospective study of 23,634 community dwellers aged 40 years or older without organic cardiovascular disease (AF = 335, non-AF = 23,299) was conducted. Multivariate-adjusted rates, rate ratios (RRs) and excess deaths (EDs) for ACD, cardiovascular death (CVD) and non-cardiovascular death (non-CVD), and sex-and age-adjusted RR and ED in middle-aged (40 to 69) and elderly (70 years or older) for ACD, CVD, non-CVD, sudden cardiac death (SCD), stroke-related death (Str-D), neoplasm-related death (NPD), and infection-related death (IFD) attributable to AF were estimated using Poisson regression. Results: Multivariate-adjusted analysis revealed that AF significantly increased the risk of ACD (RR [95% confidence interval]: 1.70 [1.23-2.95]) and CVD (3.86 [2.38-6.27]), but not non-CVD. Age-stratified analysis revealed that AF increased the risk of Str-D in middle-aged (14.5 [4.77-44.3]) and elderly individuals (4.92 [1.91-12.7]), SCD in elderly individuals (3.21 [1.37-7.51]), and might increase the risk of IFD in elderly individuals (2.02 [0.80-4.65], p = 0.098). The RR of CVD was higher in middle-aged versus elderly individuals (RRs, 6.19 vs. 3.57) but the absolute risk difference was larger in elderly individuals (EDs: 7.6 vs. 3.0 per 1000 person-years). Conclusions: Larger absolute risk differences for ACD and CVD attributable to AF among elderly people indicate that the absolute burden of AF is higher in elderly versus middle-aged people despite the relatively small RR. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Ohsawa, Masaki; Tanno, Kozo; Yonekura, Yuki; Onoda, Toshiyuki; Sakata, Kiyomi] Iwate Med Univ, Dept Hyg & Prevent Med, Yahaba, Iwate 0283694, Japan; [Okamura, Tomonori] Keio Univ, Dept Prevent Med & Publ Hlth, Tokyo, Japan; [Ogasawara, Kuniaki; Ogawa, Akira; Omama, Shinichi; Yoshida, Yuki] Iwate Med Univ, Dept Neurosurg, Morioka, Iwate 020, Japan; [Fujioka, Tomoaki] Iwate Med Univ, Dept Urol, Morioka, Iwate 020, Japan; [Turin, Tanvir Chowdhury] Univ Calgary, Dept Community Hlth Sci, Calgary, AB T2N 1N4, Canada; [Itai, Kazuyoshi] Morioka Univ, Dept Nutr Sci, Takizawa, Japan; [Ishibashi, Yasuhiro; Morino, Yoshihiro; Itoh, Tomonori; Makita, Shinji; Nakamura, Motoyuki; Tanaka, Fumitaka] Iwate Med Univ, Dept Internal Med, Morioka, Iwate 020, Japan; [Miyamatsu, Naomi] Shiga Univ Med Sci, Dept Clin Nursing, Otsu, Shiga 52021, Japan; [Kuribayashi, Toru] Iwate Univ, Fac Educ, Dept Hlth & Phys Educ, Morioka, Iwate 020, Japan; [Ohta, Mutsuko] Iwate Hlth Serv Assoc, Morioka, Iwate, Japan; [Okayama, Akira] Res Inst Strategy Prevent, Tokyo, Japan	Ohsawa, M (reprint author), Iwate Med Univ, Dept Hyg & Prevent Med, 2-1-1 Nishitokuta, Yahaba, Iwate 0283694, Japan.	masakio@iwate-med.ac.jp	Okamura, Tomonori/L-1693-2013		Japan Society for the Promotion of Science [Ippan C 21590660, Ippan B 24390155]; Japanese Ministry of Health, Labour and Welfare [H21-Jinshikkan-ippan-003, H17-Choju-ippan-025, H19-Choju-ippan-030, H23-Junkankitou [Seishuu]-Ippan-005, H26-Junkankitou [Seisaku]-Ippan-001]; Japan Arteriosclerosis Prevention Fund	The study was supported by grants to Masaki Ohsawa (Grants-in-Aid for Scientific Research, Ippan C 21590660 and Ippan B 24390155) from the Japan Society for the Promotion of Science, grants to Tomoaki Fujioka (H21-Jinshikkan-ippan-003), Akira Ogawa (H17-Choju-ippan-025; H19-Choju-ippan-030) and Tomonori Okamura (Comprehensive Research on Cardiovascular and Life-Style Related Diseases: H23-Junkankitou [Seishuu]-Ippan-005 and Comprehensive Research on Cardiovascular and Life-Style Related Diseases: H26-Junkankitou [Seisaku]-Ippan-001) from the Japanese Ministry of Health, Labour and Welfare and grants to Akira Okayama, Kuniaki Ogasawara and Kazuyoshi Itai from the Japan Arteriosclerosis Prevention Fund.	Miyasaka Y, 2007, J AM COLL CARDIOL, V49, P986, DOI 10.1016/j.jacc.2006.10.062; Haywood LJ, 2009, J AM COLL CARDIOL, V54, P2023, DOI 10.1016/j.jacc.2009.08.020; Conen D, 2011, JAMA-J AM MED ASSOC, V305, P2080, DOI 10.1001/jama.2011.659; Ohsawa M, 2013, CIRC J, V77, P1315, DOI 10.1253/circj.CJ-12-0982; Okin PM, 2013, CIRC-ARRHYTHMIA ELEC, V6, P243, DOI 10.1161/CIRCEP.112.977777; Tanizaki Y, 2000, STROKE, V31, P2616; Omama S, 2013, STROKE, V44, P1518, DOI 10.1161/STROKEAHA.111.000442; Lip GYH, 2006, HEART, V92, P155, DOI 10.1136/hrt.2005.066944; Chen LY, 2013, JAMA INTERN MED, V173, P29, DOI 10.1001/2013.jamainternmed.744; Lip GYH, 2012, CHEST, V142, P1489, DOI 10.1378/chest.11-2888; Benjamin EJ, 1998, CIRCULATION, V98, P946; WOLF PA, 1987, ARCH INTERN MED, V147, P1561, DOI 10.1001/archinte.147.9.1561; Wilke T, 2013, EUROPACE, V15, P486, DOI 10.1093/europace/eus333; Takahashi T, 2009, ATHEROSCLEROSIS, V207, P298, DOI 10.1016/j.atherosclerosis.2009.04.029; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Makita S, 2009, ATHEROSCLEROSIS, V204, P234, DOI 10.1016/j.atherosclerosis.2008.07.040; Ball J, 2013, INT J CARDIOL, V167, P1807, DOI 10.1016/j.ijcard.2012.12.093; Omama S, 2006, J NEUROL NEUROSUR PS, V77, P1345, DOI 10.1136/jnnp.2006.090373; [Anonymous], 1988, J CLIN EPIDEMIOL, V41, P105; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Stewart S, 2002, AM J MED, V113, P359, DOI 10.1016/S0002-9343(02)01236-6; WOLF PA, 1991, STROKE, V22, P983; Ohsawa M, 2007, CIRC J, V71, P814, DOI 10.1253/circj.71.814; KRAHN AD, 1995, AM J MED, V98, P476, DOI 10.1016/S0002-9343(99)80348-9; Andersson T, 2013, EUR HEART J, V34, P1061, DOI 10.1093/eurheartj/ehs469; FLEGEL KM, 1987, LANCET, V1, P526; KANNEL WB, 1982, NEW ENGL J MED, V306, P1018, DOI 10.1056/NEJM198204293061703; Ogawa M, 2007, CIRC J, V71, P455, DOI 10.1253/circj.71.455; Ohsawa M, 2013, INT J CARDIOL, V170, P167, DOI 10.1016/j.ijcard.2013.10.076; Ohsawa M, 2009, INT J CARDIOL, V137, P226, DOI 10.1016/j.ijcard.2008.06.052; Omama S, 2013, J STROKE CEREBROVASC, V22, pE317, DOI 10.1016/j.jstrokecerebrovasdis.2012.12.011; Ruigómez Ana, 2002, BMC Cardiovasc Disord, V2, P5, DOI 10.1186/1471-2261-2-5; Tanno K, 2010, CLIN CHIM ACTA, V411, P1774, DOI 10.1016/j.cca.2010.07.034; Turakhia MP, 2013, AM HEART J, V166, P573, DOI 10.1016/j.ahj.2013.07.003; Wodchis WP, 2012, VALUE HEALTH, V15, P240, DOI 10.1016/j.jval.2011.09.009	35	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-5273	1874-1754		INT J CARDIOL	Int. J. Cardiol.	APR 1	2015	184						692	698		10.1016/j.ijcard.2015.03.068		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CH1EL	WOS:000353763800162		
J	Katayama, Y; Iio, S; Veerapun, S; Uchiyama, T				Katayama, Yusuke; Iio, Shouichiro; Veerapun, Salisa; Uchiyama, Tomomi			Investigation of Blade Angle of an Open Cross-Flow Runner	INTERNATIONAL JOURNAL OF TURBO & JET-ENGINES			English	Article						cross-flow runner; blade angle; power performance; hydraulic turbine; MPS method	PARTICLE SEMIIMPLICIT METHOD; BREAKING WAVES; PERFORMANCE; TURBINE	The aim of this study was to develop a nano-hydraulic turbine utilizing drop structure in irrigation channels or industrial waterways. This study was focused on an open-type cross-flow turbine without any attached equipment for cost reduction and easy maintenance. In this study, the authors used an artificial indoor waterfall as lab model. Test runner which is a simple structure of 20 circular arc-shaped blades sandwiched by two circular plates was used The optimum inlet blade angle and the relationship between the power performance and the flow rate approaching theoretically and experimentally were investigated. As a result, the optimum inlet blade angle due to the flow rate was changed. Additionally, allocation rate of power output in 1st stage and 2nd stage is changed by the blade inlet angle.	[Katayama, Yusuke] Shinshu Univ, Dept Math & Syst Dev, Nagano 3808553, Japan; [Iio, Shouichiro] Shinshu Univ, Dept Environm Sci & Technol, Nagano 3808553, Japan; [Veerapun, Salisa] Naresuan Univ, Dept Mech Engn, Muang 65000, Phitsanulok, Thailand; [Uchiyama, Tomomi] Nagoya Univ, EcoTopia Sci Inst, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Katayama, Y (reprint author), Shinshu Univ, Dept Math & Syst Dev, 4-17-1 Wakasato, Nagano 3808553, Japan.	13st201c@shinshu-u.ac.jp; shouiio@shinshu-u.ac.jp; salisav@nu.ac.th; uchiyama@is.nagoya-u.ac.jp			JSPS [2510285]; JSPS KAKENHI [26820043]; EcoTopia Science Institute, Nagoya University	This work was supported by JSPS Fellows Grant Number 2510285, JSPS KAKENHI 26820043 and the joint research program of the EcoTopia Science Institute, Nagoya University.	Amsden A. A., 1970, Journal of Computational Physics, V6, DOI 10.1016/0021-9991(70)90029-X; Ikeda T, 2010, RENEW ENERG, V35, P293, DOI 10.1016/j.renene.2009.07.004; Koshizuka S, 1998, INT J NUMER METH FL, V26, P751, DOI 10.1002/(SICI)1097-0363(19980415)26:7<751::AID-FLD671>3.0.CO;2-C; Khayyer A, 2008, COAST ENG J, V50, P179, DOI 10.1142/S0578563408001788; Koshizuka S, 1996, NUCL SCI ENG, V123, P421; Iio S, 2012, TURBOMACHINERY, V40, P745; Kanemoto T, 2011, T JSME B, V70, P413; Mockmore CA, 1949, B SERIES OREGON STAT, V25; Oike S, 2011, TURBOMACHINERY, V39, P177; Shimokawa K, 2010, SCI CHINA TECHNOL SC, V53, P93, DOI 10.1007/s11431-010-0014-7; Uchiyama T, 2013, INT J ROTATING MACH, V2013, P1	11	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0334-0082	2191-0332		INT J TURBO JET ENG	Int. J. Turbo. Jet-Engines	APR	2015	32	1					65	72		10.1515/tjj-2015-0005		8	Engineering, Aerospace	Engineering	CH5YS	WOS:000354112700006		
J	Kamada, T; Mashima, N; Nakashima, Y; Lmai, H; Takeba, J; Miura, H				Kamada, Tomomi; Mashima, Naohiko; Nakashima, Yasuharu; Lmai, Hiroshi; Takeba, Jun; Miura, Hiromasa			Mid-Term Clinical and Radiographic Outcomes of Porous Tantalum Modular Acetabular Components for Hip Dysplasia	JOURNAL OF ARTHROPLASTY			English	Article						total hip arthroplasty; trabecular metal cup of modular type; developmental dysplasia of the hip; cementless; bone ingrowth	RADIOLOGICAL EVALUATION; SUPERIOR PLACEMENT; FOLLOW-UP; ARTHROPLASTY; RECONSTRUCTION; 10-YEAR; REPLACEMENT; BIOMATERIAL; INTERFACE; FIXATION	It is still challenging to perform successful cementless cup fixation during total hip arthroplasty for hip dysplasia. In this multicenter study we evaluated the clinical results of porous tantalum modular acetabular cups (TM cups) in 45 dysplastic hips with a mean follow-up period of 9.8 years. The mean Japanese Orthopaedic Association hip score improved from 48.2 preoperatively to 92.1 at the most recent follow-up. All of the cups were radiographically stable with no evidence of progressive radiolucencies or osteolysis regardless of bone grafting. Sixteen hips with bone grafts showed the integration of grafted bone without any radiolucencies. There were no revisions of TM cups. The use of TM cups for dysplastic hips provided satisfactory 10-year clinical and radiographic results. (C) 2014 Elsevier Inc. All rights reserved.	[Kamada, Tomomi; Mashima, Naohiko; Lmai, Hiroshi; Takeba, Jun; Miura, Hiromasa] Ehime Univ, Grad Sch Med, Dept Bone & Joint Surg, Toon, Ehime 7910295, Japan; [Nakashima, Yasuharu] Kyushu Univ, Sch Med, Dept Orthopaed Surg, Higashi Ku, Fukuoka 812, Japan	Kamada, T (reprint author), Ehime Univ, Grad Sch Med, Dept Bone & Joint Surg, Toon, Ehime 7910295, Japan.						Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283; CALLAGHAN JJ, 1988, J BONE JOINT SURG AM, V70A, P337; Nakashima Y, 2013, MOD RHEUMATOL, V23, P112, DOI 10.1007/s10165-012-0618-9; Kim M, 2010, CLIN ORTHOP RELAT R, V468, P1611, DOI 10.1007/s11999-010-1288-6; Hartofilakidis G, 1996, J BONE JOINT SURG AM, V78A, P683; Levine B, 2006, J AM ACAD ORTHOP SUR, V14, P646; Simon JP, 2009, ACTA ORTHOP BELG, V75, P623; Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123; Takao M, 2011, J ARTHROPLASTY, V26, P562, DOI 10.1016/j.arth.2010.05.025; Gruen TA, 2005, J ARTHROPLASTY, V20, P369, DOI 10.1016/j.arth.2004.12.049; Delp SL, 1996, CLIN ORTHOP RELAT R, P137; Hartofilakidis G, 2008, J BONE JOINT SURG BR, V90B, P724, DOI 10.1302/0301-620X.90B6.20490; Engesaeter LB, 2008, J ARTHROPLASTY, V23, P235, DOI 10.1016/j.arth.2007.03.023; SCHMALZRIED TP, 1992, J BONE JOINT SURG AM, V74A, P1130; HASEGAWA Y, 1992, ARCH ORTHOP TRAUM SU, V111, P187, DOI 10.1007/BF00571474; Malizos KN, 2008, CLIN ORTHOP RELAT R, V466, P159, DOI 10.1007/s11999-007-0008-3; Cameron HU, 1996, J ARTHROPLASTY, V11, P582, DOI 10.1016/S0883-5403(96)80113-6; DELEE JG, 1976, CLIN ORTHOP RELAT R, P20; Doehring TC, 1996, J ARTHROPLASTY, V11, P693, DOI 10.1016/S0883-5403(96)80008-8; Hendrich C, 2006, J BONE JOINT SURG AM, V88A, P387, DOI 10.2106/JBJS.D.02373; Kiyama T, 2009, J ARTHROPLASTY, V24, P240, DOI 10.1016/j.arth.2008.08.012; Komarasamy Baskaran, 2006, Acta Orthop Belg, V72, P320; Macheras G, 2009, J ARTHROPLASTY, V24, P705, DOI 10.1016/j.arth.2008.06.020; Macheras GA, 2006, J BONE JOINT SURG BR, V88B, P304, DOI 10.1302/0301-620X.88B3.16940; Montgomery AA, 2002, BMC HEALTH SERV RES, V26, P1; Mulier Michiel, 2006, Acta Orthop Belg, V72, P326; Mulroy RD, 1986, J BONE JOINT SURG AM, V72, P1241; Ogawa H, 2010, J ARTHROPLASTY, V25, P375, DOI 10.1016/j.arth.2009.01.012; Pagnano W, 1996, J Bone Joint Surg Am, V78, P1004; Sanchez-Sotelo Joaquin, 2002, J Am Acad Orthop Surg, V10, P334; SUGANO N, 1995, J BONE JOINT SURG BR, V77B, P548	31	2	2	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0883-5403	1532-8406		J ARTHROPLASTY	J. Arthroplast.	APR	2015	30	4					607	610		10.1016/j.arth.2014.11.007		4	Orthopedics	Orthopedics	CG7SV	WOS:000353506300022		
J	Nakamura, S; Sharma, A; Ito, H; Nakamura, K; Zingde, SM; Komistek, RD				Nakamura, Shinichiro; Sharma, Adrija; Ito, Hiromu; Nakamura, Kenji; Zingde, Sumesh M.; Komistek, Richard D.			Kinematic Difference Between Various Geometric Centers and Contact Points for Tri-Condylar Bi-Surface Knee System	JOURNAL OF ARTHROPLASTY			English	Article						total knee arthroplasty; geometric centers; kinematics; deep flexion; multi-radii femoral component	HIGH-FLEXION; ARTHROPLASTY; REPLACEMENTS; DESIGN; MOTION; AXES; TKA	The purpose of the study was to analyze themotion of contact points (CPs), lowest points (LPs), and component facet centers of tri-condylar implants. In vivo knee kinematics was assessed for 43 knees implanted with a multi-radii femoral component during deep knee bend activity, using a model fitting approach. Both LPs had the similar positions to the corresponding geometric centers of the femoral component, and the LP and geometric center angles represented the same component rotation angle defined by Grood and Suntay. Antero-posterior translation of both CPs was significantly overestimated, compared to LPs, and the CP angle showed significant differences from other rotation angles. In conclusion LPs seemed better to evaluate kinematics than CPs because polyethylene congruity had considerable effects on CP analysis. (C) 2014 Elsevier Inc. All rights reserved.	[Nakamura, Shinichiro; Sharma, Adrija; Zingde, Sumesh M.; Komistek, Richard D.] Univ Tennessee, Ctr Musculoskeletal Res, Knoxville, TN 37996 USA; [Nakamura, Shinichiro; Ito, Hiromu] Kyoto Univ, Grad Sch Med, Dept Orthoped Surg, Kyoto, Japan; [Nakamura, Kenji] Tamatsukuri Koseinenkin Hosp, Dept Orthoped Surg, Matsue, Shimane, Japan	Nakamura, S (reprint author), Univ Tennessee, Ctr Musculoskeletal Res, 301 Perkins Hall, Knoxville, TN 37996 USA.				Kyocera Medical	Grants: Benefits or funds were received in partial or total support of the research material described in this article from Kyocera Medical.	Akagi M, 2000, J BONE JOINT SURG AM, V82A, P1626; Akagi M, 2002, J BONE JOINT SURG BR, V84B, P561, DOI 10.1302/0301-620X.84B4.12016; Akagi M, 2002, J ARTHROPLASTY, V17, P627, DOI 10.1054/arth.2002.32694; Leszko F, 2011, CLIN ORTHOP RELAT R, V469, P95, DOI 10.1007/s11999-010-1517-z; Mahfouz MR, 2003, IEEE T MED IMAGING, V22, P1561, DOI 10.1109/TMI.2003.820027; Dennis DA, 1998, CLIN ORTHOP RELAT R, P47; Stoddard JE, 2013, J ORTHOP RES, V31, P53, DOI 10.1002/jor.22170; Nakamura S, 2010, KNEE, V17, P274, DOI 10.1016/j.knee.2010.02.015; Walker PS, 2011, KNEE, V18, P312, DOI 10.1016/j.knee.2010.07.005; Cates HE, 2008, J ARTHROPLASTY, V23, P1057, DOI 10.1016/j.arth.2007.09.019; Most E, 2004, J BIOMECH, V37, P1743, DOI 10.1016/j.jbiomech.2004.01.025; [Anonymous], 2003, CLIN ORTHOP REALT RE, DOI 10.1097/01.blo.0000092986.12414.b5; Nakamura S, 2010, J ARTHROPLASTY, V25, P486, DOI 10.1016/j.arth.2008.12.006; Churchill DL, 1998, CLIN ORTHOP RELAT R, P111; Argenson JNA, 2005, J BIOMECH, V38, P277, DOI 10.1016/j.jbiomech.2004.02.027; ASANO T, 2001, CLINORTHOPAEDICS REL, V388, P157, DOI 10.1097/00003086-200107000-00023; GROOD ES, 1983, J BIOMECH ENG-T ASME, V105, P136; Most E, 2006, CLIN ORTHOP RELAT R, P59, DOI 10.1097/01.blo.0000238843.11176.42; Tamaki M, 2008, J ARTHROPLASTY, V23, P879, DOI 10.1016/j.arth.2008.04.009	19	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0883-5403	1532-8406		J ARTHROPLASTY	J. Arthroplast.	APR	2015	30	4					701	705		10.1016/j.arth.2014.11.020		5	Orthopedics	Orthopedics	CG7SV	WOS:000353506300037		
J	Stiefl, N; Gedeck, P; Chin, D; Hunt, P; Lindvall, M; Spiegel, K; Springer, C; Biller, S; Buenemann, C; Kanazawa, T; Kato, M; Lewis, R; Martin, E; Polyakov, V; Tommasi, R; van Drie, J; Vash, B; Whitehead, L; Xu, YJ; Abagyan, R; Raush, E; Totrov, M				Stiefl, Nikolaus; Gedeck, Peter; Chin, Donovan; Hunt, Peter; Lindvall, Mika; Spiegel, Katrin; Springer, Clayton; Biller, Scott; Buenemann, Christoph; Kanazawa, Takanori; Kato, Mitsunori; Lewis, Richard; Martin, Eric; Polyakov, Valery; Tommasi, Ruben; van Drie, John; Vash, Brian; Whitehead, Lewis; Xu, Yongjin; Abagyan, Ruben; Raush, Eugene; Totrov, Max			FOCUS - Development of a Global Communication and Modeling Platform for Applied and Computational Medicinal Chemists	JOURNAL OF CHEMICAL INFORMATION AND MODELING			English	Article							LIGAND DOCKING; PREDICTION; PEPTIDES; PROTEINS; ENERGY	Communication of data and ideas within a medicinal chemistry project on a global as well as local level is a crucial aspect in the drug design cycle. Over a time frame of eight years, we built and optimized FOCUS, a platform to produce, visualite, and share information on various aspects of a drug discovery project such as Cheminformatics, data analysis, stnictinal information, and design. FOCUS is tightly integrated with internal services that involve among others data retrieval, systems and in-silico Models and provides, easy access to automated modeling, procedures such as pharrnacophore searches, A-group analysis, and similarity searches. In addition, an interactive 3D editor was developed to assist,users in the generation and docking of dose analogues of a known lead. In this paper, we will specifically concentrate on issues we faced during development, deployment, and maintenance of the software and how we continually adapted the software in order to improve usability. We will provide usage. examples' to highlight the functionality as well as limitations of FOCUS at the various stages of the development process. We aim, to make the diScussion as independent of the software platform as pcissible, so that our experiences can be of more general value, to the thug discovery community.	[Stiefl, Nikolaus; Lewis, Richard] Novartis Inst Biomed Res, CH-4002 Basel, Switzerland; [Gedeck, Peter] Novartis Inst Trop Dis Pte Ltd, Singapore 138670, Singapore; [Chin, Donovan; Springer, Clayton; Biller, Scott; Kato, Mitsunori; Tommasi, Ruben; van Drie, John; Vash, Brian; Whitehead, Lewis] Novartis Inst Biomed Res, Cambridge, MA 02139 USA; [Hunt, Peter; Spiegel, Katrin] Novartis Inst Biomed Res, Horsham RH12 5AB, W Sussex, England; [Lindvall, Mika; Martin, Eric; Polyakov, Valery; Xu, Yongjin] Novartis Inst Biomed Res, Emeryville, CA 94608 USA; [Buenemann, Christoph] Novartis Inst Biomed Res, A-1190 Vienna, Austria; [Kanazawa, Takanori; Kato, Mitsunori] Novartis Inst BioMed Res, Tsukuba, Ibaraki 3002611, Japan; [Abagyan, Ruben; Raush, Eugene; Totrov, Max] Molsoft LLC, San Diego, CA 92121 USA	Stiefl, N (reprint author), Novartis Inst Biomed Res, CH-4002 Basel, Switzerland.	nikolaus.stiefl@novartis.com					ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Agrafiotis A. K., 2007, J CHEM INF MODEL, V47, P1999; Totrov M, 2001, BIOPOLYMERS, V60, P124, DOI 10.1002/1097-0282(2001)60:2<124::AID-BIP1008>3.0.CO;2-S; [Anonymous], 2013, PYMOL MOL GRAPH SYST; [Anonymous], INST JCHEM 14 7 7; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Fernandez-Recio J, 2002, PROTEIN SCI, V11, P280, DOI 10.1110/ps.19202; Abagyan R, 2006, TRENDS BIOCHEM SCI, V31, P76, DOI 10.1016/j.tibs.2005.12.006; [Anonymous], 2014, MOL OP ENV; Bottegoni G, 2009, J MED CHEM, V52, P397, DOI 10.1021/jm8009958; Ritchie TJ, 2011, DRUG DISCOV TODAY, V16, P65, DOI 10.1016/j.drudis.2010.11.002; Sander T, 2009, J CHEM INF MODEL, V49, P232, DOI 10.1021/ci800305f; Schapira M, 1999, J MOL RECOGNIT, V12, P177, DOI 10.1002/(SICI)1099-1352(199905/06)12:3<177::AID-JMR451>3.0.CO;2-Z; ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; Totrov M, 1997, Proteins, VSuppl 1, P215; Ertl P, 2000, J MED CHEM, V43, P3714, DOI 10.1021/jm000942e; [Anonymous], EXT OP SOURC CONT IN; Biovia, VIRT BIOSPH MAT; Certara, D360 BRING YOUR DAT; Chin DN, 2004, MINI-REV MED CHEM, V4, P1053; Fernandez-Recio Juan, 2002, Pac Symp Biocomput, P552; Gerebtzoff G., 2013, RDKIT US GROUP M CAM; Guha R., 2009, PAPERS SYSTEMS YOU C; Landrum G. A., OPEN SOURCE ENTERPRI; Landrum GA, 2012, FUTURE MED CHEM, V4, P1885, DOI [10.4155/fmc.12.160, 10.4155/FMC.12.160]; Molsoft, ICM CHEM PRO; Ozawa M., PAPER IN PROCESS, DOI [10.2210/pdb3ad4/pdb, DOI 10.2210/PDB3AD4/PDB]; Raush E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007394; Totrov M., 2001, DRUG RECEPTOR THERMO, P603; Yiu CPB, 2014, METHODS MOL BIOL, V1091, P343, DOI 10.1007/978-1-62703-691-7_24	30	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1549-9596	1549-960X		J CHEM INF MODEL	J. Chem Inf. Model.	APR	2015	55	4					896	908		10.1021/ci500598e		13	Chemistry, Medicinal; Chemistry, Multidisciplinary; Computer Science, Information Systems; Computer Science, Interdisciplinary Applications	Pharmacology & Pharmacy; Chemistry; Computer Science	CG9VQ	WOS:000353668600018		
J	Homma, K; Homma, Y; Yoshida, T; Ozawa, H; Shiina, Y; Wakino, S; Hayashi, K; Itoh, H; Hori, S				Homma, Koichiro; Homma, Yasuhiko; Yoshida, Tadashi; Ozawa, Hideki; Shiina, Yutaka; Wakino, Shu; Hayashi, Koichi; Itoh, Hiroshi; Hori, Shingo			Changes in ultracentrifugally separated plasma lipoprotein subfractions in patients with polygenic hypercholesterolemia, familial combined hyperlipoproteinemia, and familial hypercholesterolemia after treatment with atorvastatin	JOURNAL OF CLINICAL LIPIDOLOGY			English	Article						Atorvastatin; Lipoprotein subfractions; LDL-receptor activity; Polygenic hypercholesterolemia; Hypercholesterolemia; Familial combined hyperlipoproteinemia; Familial hypercholesterolemia	LOW-DENSITY-LIPOPROTEIN; CHOLESTERYL ESTER TRANSFER; CORONARY-HEART-DISEASE; PRAVASTATIN TREATMENT; CHEMICAL-COMPOSITION; PRIMARY PREVENTION; APOLIPOPROTEIN-B; PARTICLE-SIZE; LDL RECEPTOR; HUMAN SERUM	BACKGROUND: Plasma levels of low-density lipoproteins (LDLs) are decreased through stimulation of their hepatic uptake by statins via an LDL receptor. However, it is unclear whether statins equally stimulate the hepatic uptake of all LDL subfractions. OBJECTIVE: We compared the effects of atorvastatin on 3 LDL subfractions, and their associations with LDL-receptor activities, in Japanese patients with polygenic hypercholesterolemia (PHC), familial combined hyperlipoproteinemia (FCHL), and familial hypercholesterolemia (FH). MATERIALS AND METHODS: Atorvastatin was administered to patients with PHC (n = 11), Fail, (n = 16), and FH (n = 13). We measured plasma levels of lipids, remnant-like particle cholesterol, apoproteins, and cholesterol in lipoprotein fractions. Sequential ultracentrifugation was performed to subfractionate the plasma lipoproteins, and lymphocyte LDL-receptor activities were estimated using flow cytometry. RESULTS: The average daily dosage of atorvastatin was 10, 27, and 40 mg in patients with PHC, FCHL, and FH, respectively; after 12 months of atorvastatin treatment, LDL cholesterol (LDL-C) plasma levels decreased by 44%, 50%, and 53%, respectively (all, P < .0001). Atorvastatin reduced low-density LDL-C plasma levels in patients with PHC (48% reduction), FCHL (53%), and FH (46%) (all, P < .0001). Plasma levels of medium-density and high-density LDL-C were also significantly reduced in the 3 patient groups (all, P <= .0147). LDL-receptor activity was negatively correlated with baseline levels of medium-density LDL-C and with the decreases in plasma md-LDL-C levels. CONCLUSION: Atorvastatin decreased the levels of the 3 LDL fractions. The md-LDL decrease appeared to be mainly because of stimulation of LDL-receptor activity. (C) 2015 National Lipid Association. All rights reserved.	[Homma, Koichiro; Wakino, Shu; Hayashi, Koichi; Itoh, Hiroshi] Keio Univ, Sch Med, Dept Internal Med, Shinjuku Ku, Tokyo 1608582, Japan; [Homma, Yasuhiko; Hori, Shingo] Keio Univ, Sch Med, Dept Emergency Med, Shinjuku Ku, Tokyo 1608582, Japan; [Homma, Yasuhiko; Shiina, Yutaka] Tokai Univ Sch Med, Dept Clin Hlth Sci, Isehara, Kanagawa, Japan; [Yoshida, Tadashi] Keio Univ, Sch Med, Apheresis & Dialysis Ctr, Shinjuku Ku, Tokyo 1608582, Japan; [Ozawa, Hideki] Tokai Univ Sch Med, Dept Internal Med, Isehara, Kanagawa, Japan	Homma, K (reprint author), Keio Univ, Sch Med, Dept Internal Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	homma@keio.jp	Homma, Koichiro/J-3146-2015				HOMMA Y, 1994, ATHEROSCLEROSIS, V106, P191, DOI 10.1016/0021-9150(94)90124-4; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; TRIBBLE DL, 1992, ATHEROSCLEROSIS, V93, P189, DOI 10.1016/0021-9150(92)90255-F; TENG B, 1986, J CLIN INVEST, V77, P663, DOI 10.1172/JCI112360; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Campos H, 2001, JAMA-J AM MED ASSOC, V286, P1468, DOI 10.1001/jama.286.12.1468; Tsimihodimos V, 2003, J CARDIOVASC PHARM, V42, P304, DOI 10.1097/00005344-200308000-00021; Galeano NF, 1998, J LIPID RES, V39, P1263; Otvos JD, 2002, ATHEROSCLEROSIS, V160, P41, DOI 10.1016/S0021-9150(01)00544-5; PEDERSEN TR, 1994, LANCET, V344, P1383; Packard CJ, 2000, J LIPID RES, V41, P305; NAKAJIMA K, 1993, CLIN CHIM ACTA, V223, P53, DOI 10.1016/0009-8981(93)90062-9; Nakamura H, 2006, LANCET, V368, P1155, DOI 10.1016/S0140-6736(06)69472-5; DEGRAAF J, 1991, ARTERIOSCLER THROMB, V11, P298; Goldstein JL, 2001, METABOLIC MOL BASES, V2, P2863; Guerin M, 2000, ARTERIOSCL THROM VAS, V20, P189; Havel RJ, 2001, METABOLIC MOL BASES, P2705; Kane JP, 2001, METABOLIC MOL BASES, V2, P2717; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; NIGON F, 1991, J LIPID RES, V32, P1741; Noma A, 1993, CLIN CHIM ACTA, V221, P147; Ranganathan S, 1995, J LAB CLIN MED, V125, P476; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Sasaki S, 2002, AM J CARDIOL, V89, P386, DOI 10.1016/S0002-9149(01)02257-3	27	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1933-2874	1876-4789		J CLIN LIPIDOL	J. Clin. Lipidol.	APR	2015	9	2					210	216		10.1016/j.jacl.2014.12.007		7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CH3KZ	WOS:000353930900008		
J	Shibayama, S				Shibayama, Sotaro			Academic commercialization and changing nature of academic cooperation	JOURNAL OF EVOLUTIONARY ECONOMICS			English	Article						Indirect reciprocity; Evolution of cooperation; Social norms; Open science; Academic commercialization; Academic Entrepreneurship; Evolutionary game theory	INDIRECT RECIPROCITY; INTELLECTUAL PROPERTY; SOCIAL NORMS; PUBLIC-GOODS; UNIVERSITIES; PUNISHMENT; EVOLUTION; DYNAMICS; SCIENCE; COMMONS	Recent economic policies emphasize the role of academic science in technological innovation and economic growth and encourage universities and individual academics to engage in commercial activities. In this trend of academic commercialization, a growing concern has been expressed that its potential incompatibility with the traditional norms of open science could undermine the cooperative climate in academia. Drawing on the framework of evolution of the cooperation, this study examines the changing nature of academic cooperation under the current policy trend. In an ideal state of open science, academics are supposed to cooperate gratis and unconditionally. However, results predict that the commercialized regime could compromise underlying mechanisms of cooperation and allow defectors to prevail. As the trend further grows, academics would become more demanding of direct reward in exchange for cooperation, and they would refrain from engaging in cooperation but would prefer to work independently. Some interventions (e.g., centralized rewarding) could mitigate the problem but require delicate system design.	Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1538904, Japan	Shibayama, S (reprint author), Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.	shibayama@00.alumni.u-tokyo.ac.jp			Konosuke Matsushita Memorial Foundation; Japan Society for the Promotion of Science [23810004]	I am grateful to Yasunori Baba, Thomas Hellmann, David N. Laband, Hisashi Ohtsuki, Nobuyuki Takahashi, John P. Walsh, and an anonymous reviewer for their critical and insightful suggestions. An earlier version of this paper was presented at the 14th International Schumpeter Society Conference, and I acknowledge Andreas Chai and Jason Potts for their review. This study is partly supported by the Konosuke Matsushita Memorial Foundation and Grant-in-Aid for Research Activity Start-up of Japan Society for the Promotion of Science (#23810004).	Sefton M, 2007, ECON INQ, V45, P671, DOI 10.1111/j.1465-7295.2007.00051.x; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Nowak MA, 2012, J THEOR BIOL, V299, P1, DOI 10.1016/j.jtbi.2012.01.014; Hauert C, 2002, J THEOR BIOL, V218, P187, DOI 10.1006/jtbi.2002.3067; Brandt H, 2005, P NATL ACAD SCI USA, V102, P2666, DOI 10.1073/pnas.0407370102; Grimaldi R, 2011, RES POLICY, V40, P1045, DOI 10.1016/j.respol.2011.04.005; Ohtsuki H, 2004, J THEOR BIOL, V231, P107, DOI 10.1016/j.jtbi.2004.06.005; Nowak MA, 1998, J THEOR BIOL, V194, P561, DOI 10.1006/jtbi.1998.0775; Furman JL, 2011, AM ECON REV, V101, P1933, DOI 10.1257/aer.101.5.1933; Shibayama S, 2011, SCI PUBL POLICY, V38, P649, DOI 10.3152/030234211X13122939587699; Frey BS, 2001, J ECON SURV, V15, P589, DOI 10.1111/1467-6419.00150; DASGUPTA P, 1994, RES POLICY, V23, P487; Thursby JG, 2011, RES POLICY, V40, P1077, DOI 10.1016/j.respol.2011.05.009; Walsh JP, 2007, RES POLICY, V36, P1184, DOI 10.1016/j.respol.2007.04.006; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Campbell EG, 2000, RES POLICY, V29, P303, DOI 10.1016/S0048-7333(99)00068-2; Nelson RR, 2004, RES POLICY, V33, P455, DOI 10.1016/j.respol.2003.09.008; Lei Z, 2009, NAT BIOTECHNOL, V27, P36, DOI 10.1038/nbt0109-36; Argyres NS, 1998, J ECON BEHAV ORGAN, V35, P427, DOI 10.1016/S0167-2681(98)00049-3; Etzkowitz H, 1998, RES POLICY, V27, P823, DOI 10.1016/S0048-7333(98)00093-6; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Friedman D, 1998, J EVOL ECON, V8, P15, DOI 10.1007/s001910050054; Haeussler C, 2011, RES POLICY, V40, P105, DOI 10.1016/j.respol.2010.08.007; Seinen I, 2006, EUR ECON REV, V50, P581, DOI 10.1016/j.euroecorev.2004.10.005; Jensen R, 2001, AM ECON REV, V91, P240, DOI 10.1257/aer.91.1.240; Sigmund K, 2001, P NATL ACAD SCI USA, V98, P10757, DOI 10.1073/pnas.161155698; Leimar O, 2001, P ROY SOC B-BIOL SCI, V268, P745; Arce DG, 1996, RATION SOC, V8, P277; AUTM, 2007, AUTM US LIC ACT SURV; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Blau P. M., 1964, EXCHANGE POWER SOCIA; Bowles S, 2011, COOPERATIVE SPECIES: HUMAN RECIPROCITY AND ITS EVOLUTION, P1; David PA, 1998, AM ECON REV, V88, P15; Gintis Herbert, 2005, MORAL SENTIMENTS MAT; Gneezy U, 2000, Q J ECON, V115, P791, DOI 10.1162/003355300554917; Merton R. K., 1973, SOCIOLOGY SCI; Murray F, 2007, J ECON BEHAV ORGAN, V63, P648, DOI 10.1016/j.jebo.2006.05.017; National Academy of Sciences, 2003, SHAR PUBL REL DAT MA; OECD, 2003, TURN SCI BUS PAT LIC; Ostrom E., 1990, GOVERNING COMMONS EV; Poyago-Theotoky J, 2002, OXFORD REV ECON POL, V18, P10, DOI 10.1093/oxrep/18.1.10; Shibayama S, 2012, AM SOCIOL REV, V77, P804, DOI 10.1177/0003122412452874; Sigmund K., 2010, CALCULUS SELFISHNESS; Sigmund K., 1998, EVOLUTIONARY GAMES P	45	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0936-9937	1432-1386		J EVOL ECON	J. Evol. Econ.	APR	2015	25	2					513	532		10.1007/s00191-014-0387-z		20	Economics	Business & Economics	CH7DX	WOS:000354196900007		
J	Riede, T; Li, ZH; Tokuda, IT; Farmer, CG				Riede, Tobias; Li, Zhiheng; Tokuda, Isao T.; Farmer, Colleen G.			Functional morphology of the Alligator mississippiensis larynx with implications for vocal production	JOURNAL OF EXPERIMENTAL BIOLOGY			English	Article						Larynx; Syrinx; Vocal production; Vocal control; Sauropsida; Extracellular matrix; Hyaluronan	FUNDAMENTAL-FREQUENCY CONTROL; PHONATION THRESHOLD PRESSURE; AMERICAN ALLIGATOR; SUBGLOTTAL PRESSURE; BEHAVIOR; CROCODILIANS; FOLD; VOCALIZATION; MODEL; COMMUNICATION	Sauropsid vocalization is mediated by the syrinx in birds and the larynx in extant reptiles; but whereas avian vocal production has received much attention, the vocal mechanism of basal reptilians is poorly understood. The American alligator (Alligator mississippiensis) displays a large vocal repertoire during mating and in parent-offspring interactions. Although vocal outputs of these behaviors have received some attention, the underlying mechanism of sound production remains speculative. Here, we investigate the laryngeal anatomy of juvenile and adult animals by macroscopic and histological methods. Observations of the cartilaginous framework and associated muscles largely corroborate earlier findings, but one muscle, the cricoarytenoideus, exhibits a heretofore unknown extrinsic insertion that has important implications for effective regulation of vocal fold length and tension. Histological investigation of the larynx revealed a layered vocal fold morphology. The thick lamina propria consists of non-homogenous extracellular matrix containing collagen fibers that are tightly packed below the epithelium but loosely organized deep inside the vocal fold. We found few elastic fibers but comparatively high proportions of hyaluronan. Similar organizational complexity is also seen in mammalian vocal folds and the labia of the avian syrinx: convergent morphologies that suggest analogous mechanisms for sound production. In tensile tests, alligator vocal folds demonstrated a linear stress-strain behavior in the low strain region and nonlinear stress responses at strains larger than 15%, which is similar to mammalian vocal fold tissue. We have integrated morphological and physiological data in a two-mass vocal fold model, providing a systematic description of the possible acoustic space that could be available to an alligator larynx. Mapping actual call production onto possible acoustic space validates the model's predictions.	[Riede, Tobias] Midwestern Univ, Dept Physiol, Glendale, AZ 85308 USA; [Li, Zhiheng] Univ Texas Austin, Dept Geol Sci, Austin, TX 78712 USA; [Tokuda, Isao T.] Ritsumeikan Univ, Dept Mech Engn, Shiga 5258577, Japan; [Farmer, Colleen G.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Riede, T (reprint author), Midwestern Univ, Dept Physiol, Glendale, AZ 85308 USA.	triede@midwestern.edu	Riede, Tobias/J-9092-2012; 	Riede, Tobias/0000-0001-6875-0017; Riede, Tobias/0000-0001-9606-0742	Japan Society for the Promotion of Science (JSPS) [25540074, 23300071]; NSF [IOS - 1055080]	I.T.T. was supported by Grant-in-Aid for Scientific Research (No. 25540074, No. 23300071) from Japan Society for the Promotion of Science (JSPS). The work was also partially funded by NSF IOS - 1055080 to C.G.F.	HERZOG HA, 1977, Z TIERPSYCHOL, V44, P294; ISHIZAKA K, 1972, AT&T TECH J, V51, P1233; Riede T, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2306; GARRICK LD, 1977, AM ZOOL, V17, P225; Wang XY, 2007, J ACOUST SOC AM, V121, P2984, DOI 10.1121/1.2714910; TITZE IR, 1989, J ACOUST SOC AM, V85, P901, DOI 10.1121/1.397562; Goller F, 2013, J PHYSIOL-PARIS, V107, P230, DOI 10.1016/j.jphysparis.2012.11.001; Bass AH, 2008, SCIENCE, V321, P417, DOI 10.1126/science.1157632; HUNT RH, 1982, J HERPETOL, V16, P235, DOI 10.2307/1563716; VLIET KA, 1989, AM ZOOL, V29, P1019; TITZE IR, 1995, J ACOUST SOC AM, V97, P3080, DOI 10.1121/1.411870; Fee MS, 2002, J COMP PHYSIOL A, V188, P829, DOI 10.1007/s00359-002-0349-z; Riede T, 2010, BRAIN LANG, V115, P69, DOI 10.1016/j.bandl.2009.11.003; HIRANO M, 1974, FOLIA PHONIATR, V26, P89; Todd NPM, 2007, J ACOUST SOC AM, V122, P2906, DOI 10.1121/1.2785811; Senter P, 2008, J HERPETOL, V42, P354, DOI 10.1670/07-150.1; Riede T, 2010, J EXP BIOL, V213, P2924, DOI 10.1242/jeb.044404; Wang XY, 2009, J ACOUST SOC AM, V126, P2082, DOI 10.1121/1.3203667; STEINECKE I, 1995, J ACOUST SOC AM, V97, P1874, DOI 10.1121/1.412061; Vergne AL, 2009, BIOL REV, V84, P391, DOI 10.1111/j.1469-185X.2009.00079.x; Brazaitis P, 2011, HIST BIOL, V23, P73, DOI 10.1080/08912963.2011.560723; Riede T, 2011, J EXP BIOL, V214, P3082, DOI 10.1242/jeb.051110; Britton ARC, 2001, CROCODILIAN BIOLOGY AND EVOLUTION, P364; CAMPBELL HW, 1973, ZOOLOGICA-NEW YORK, V58, P1; Chan RW, 2006, J ACOUST SOC AM, V119, P2351, DOI 10.1121/1.2173516; Chan RW, 2007, ANN BIOMED ENG, V35, P1471, DOI 10.1007/s10439-007-9314-x; Fraher J, 2010, J EXP BIOL, V213, P4137, DOI 10.1242/jeb.042218; Frey R, 2013, J MORPHOL, V274, P307, DOI 10.1002/jmor.20092; Goppert E., 1899, MORPH JB, V28, P1; Goppert E., 1937, HDB VERGLEICHENDEN A, V3, P797; Henle F. G. J., 1839, VERGLEICHEND ANATOMI; Honda K, 1983, VOCAL FOLD PHYSL BIO, P127; Klemuk SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027029; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; MOORE BA, 1991, J MORPHOL, V210, P227, DOI 10.1002/jmor.1052100303; Muller J., 1839, COMPENSATION PHYS KR, P1; Murry T, 1998, J VOICE, V12, P44, DOI 10.1016/S0892-1997(98)80074-X; Riede T, 2010, J MORPHOL, V271, P1, DOI 10.1002/jmor.10774; Rittenhouse DR, 1998, S AFR J ZOOL, V33, P23; Russell AP, 2000, J MORPHOL, V245, P241, DOI 10.1002/1097-4687(200009)245:3<241::AID-JMOR5>3.0.CO;2-H; Sacchi R, 2004, J MORPHOL, V261, P175, DOI 10.1002/jmor.10236; Sicuro FL, 2013, REV BIOL TROP, V61, P1401; Soller L, 1931, MORPH JB, V68, P541; Titze I. R., 2006, MYOELASTIC AERODYNAM; TITZE IR, 1988, J ACOUST SOC AM, V83, P1536, DOI 10.1121/1.395910; VANDENBERG J, 1958, J SPEECH HEAR RES, V1, P227; Watanabe M. E., 1980, THESIS NYU NY	47	4	4	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0022-0949	1477-9145		J EXP BIOL	J. Exp. Biol.	APR	2015	218	7					991	998		10.1242/jeb.117101		8	Biology	Life Sciences & Biomedicine - Other Topics	CH5YX	WOS:000354113300012		
J	Okada, Y; Sasaki, K; Miyazaki, S; Shimoji, H; Tsuji, K; Miura, T				Okada, Yasukazu; Sasaki, Ken; Miyazaki, Satoshi; Shimoji, Hiroyuki; Tsuji, Kazuki; Miura, Toru			Social dominance and reproductive differentiation mediated by dopaminergic signaling in a queenless ant	JOURNAL OF EXPERIMENTAL BIOLOGY			English	Article						Biogenic amine; Reproductive dominance; Primitively eusocial; Ponerine ant; Diacamma	PRIMITIVELY EUSOCIAL WASP; DIVISION-OF-LABOR; BEES APIS-MELLIFERA; AGE-RELATED-CHANGES; JUVENILE-HORMONE; DIACAMMA SP; HARPEGNATHOS-SALTATOR; BIOGENIC-AMINES; PONERINE ANT; STREBLOGNATHUS-PEETERSI	In social Hymenoptera with no morphological caste, a dominant female becomes an egg layer, whereas subordinates become sterile helpers. The physiological mechanism that links dominance rank and fecundity is an essential part of the emergence of sterile females, which reflects the primitive phase of eusociality. Recent studies suggest that brain biogenic amines are correlated with the ranks in dominance hierarchy. However, the actual causality between aminergic systems and phenotype (i.e. fecundity and aggressiveness) is largely unknown due to the pleiotropic functions of amines (e.g. age-dependent polyethism) and the scarcity of manipulation experiments. To clarify the causality among dominance ranks, amine levels and phenotypes, we examined the dynamics of the aminergic system during the ontogeny of dominance hierarchy in the queenless ant Diacamma sp., which undergoes rapid physiological differentiation based on dominance interactions. Brain dopamine levels differed between dominants and subordinates at day 7 after eclosion, although they did not differ at day 1, reflecting fecundity but not aggressiveness. Topical applications of dopamine to the subordinate workers induced oocyte growth but did not induce aggressiveness, suggesting the gonadotropic effect of dopamine. Additionally, dopamine receptor transcripts (dopr1 and dopr2) were elevated in the gaster fat body of dominant females, suggesting that the fat body is a potential target of neurohormonal dopamine. Based on this evidence, we suggest that brain dopamine levels are elevated in dominants as a result of hierarchy formation, and differences in dopamine levels cause the reproductive differentiation, probably via stimulation of the fat body.	[Okada, Yasukazu] Univ Tokyo, Grad Sch Arts & Sci, Dept Gen Syst Studies, Tokyo, Japan; [Okada, Yasukazu; Miyazaki, Satoshi; Shimoji, Hiroyuki; Miura, Toru] Hokkaido Univ, Grad Sch Environm Sci, Lab Ecol Genet, Sapporo, Hokkaido 0600810, Japan; [Sasaki, Ken] Tamagawa Univ, Dept Bioresource Sci, Machida, Tokyo 1948610, Japan; [Miyazaki, Satoshi] Tokyo Womens Med Univ, Dept Hyg & Publ Hlth, Shinjuku Ku, Tokyo 1628666, Japan; [Tsuji, Kazuki] Univ Ryukyus, Fac Agr, Dept Subtrop Agroenvironm Sci, Nishihara, Okinawa 9030213, Japan	Okada, Y (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Gen Syst Studies, Tokyo, Japan.	okayasukazu@gmail.com			Kakenhi [26870121, 26440181]; Research and Education Platform for Dynamic Living States;  [11J03715]	This work was supported by Kakenhi [26870121 to Y.O., 26440181 to K.S.] and by Research and Education Platform for Dynamic Living States to Y.O. H.S. is supported by Grant-in-Aid for JSPS Fellows [11J03715].	FLETCHER DJC, 1985, ANNU REV ENTOMOL, V30, P319, DOI 10.1146/annurev.en.30.010185.001535; JARVIS JUM, 1981, SCIENCE, V212, P571, DOI 10.1126/science.7209555; Monnin T, 1999, BEHAV ECOL, V10, P323, DOI 10.1093/beheco/10.3.323; Sasaki K, 2012, GEN COMP ENDOCR, V178, P46, DOI 10.1016/j.ygcen.2012.04.006; Hartfelder K, 2000, BRAZ J MED BIOL RES, V33, P157, DOI 10.1590/S0100-879X2000000200003; Okada Y, 2010, J INSECT PHYSIOL, V56, P288, DOI 10.1016/j.jinsphys.2009.10.013; Cuvillier-Hot V, 2001, J INSECT PHYSIOL, V47, P485, DOI 10.1016/S0022-1910(00)00137-2; Miczek KA, 2002, PSYCHOPHARMACOLOGY, V163, P434, DOI 10.1007/s00213-002-1139-6; Vergoz V, 2012, INSECT MOL BIOL, V21, P21, DOI 10.1111/j.1365-2583.2011.01106.x; Shimoji H, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0599; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; Penick CA, 2014, J EXP BIOL, V217, P1496, DOI 10.1242/jeb.098301; Huber R, 1997, P NATL ACAD SCI USA, V94, P5939, DOI 10.1073/pnas.94.11.5939; Tsuji K, 1999, ANIM BEHAV, V58, P337, DOI 10.1006/anbe.1999.1161; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; Kikuchi T, 2008, ANIM BEHAV, V76, P2069, DOI 10.1016/j.anbehav.2008.08.029; Blenau W, 2001, ARCH INSECT BIOCHEM, V48, P13, DOI 10.1002/arch.1055; WINBERG S, 1993, COMP BIOCHEM PHYS C, V106, P597, DOI 10.1016/0742-8413(93)90216-8; ITO F, 1991, NATURWISSENSCHAFTEN, V78, P80, DOI 10.1007/BF01206263; Penick CA, 2011, J COMP PHYSIOL A, V197, P1063, DOI 10.1007/s00359-011-0667-0; Premnath S, 1996, BEHAV ECOL SOCIOBIOL, V39, P125, DOI 10.1007/s002650050274; Reeve HK, 2001, ANNU REV ENTOMOL, V46, P347, DOI 10.1146/annurev.ento.46.1.347; Hoyer SC, 2008, CURR BIOL, V18, P159, DOI 10.1016/j.cub.2007.12.052; SHERMAN PW, 1995, BEHAV ECOL, V6, P102, DOI 10.1093/beheco/6.1.102; NAKATA K, 1995, J ETHOL, V13, P113, DOI 10.1007/BF02352570; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Liebig J, 2000, P NATL ACAD SCI USA, V97, P4124, DOI 10.1073/pnas.97.8.4124; ADAMO SA, 1995, J EXP BIOL, V198, P1691; BAILEY L, 1952, J EXP BIOL, V29, P310; Barron AB, 2007, J INSECT PHYSIOL, V53, P187, DOI 10.1016/j.jinsphys.2006.11.009; BARTH RH, 1975, EXPERIENTIA, V31, P691, DOI 10.1007/BF01944632; Bloch G, 2000, J COMP PHYSIOL A, V186, P261, DOI 10.1007/s003590050426; Bloch G, 1996, PHYSIOL ENTOMOL, V21, P257, DOI 10.1111/j.1365-3032.1996.tb00863.x; BOHM MK, 1972, J INSECT PHYSIOL, V18, P1875, DOI 10.1016/0022-1910(72)90158-8; Brent C, 2006, J COMP PHYSIOL A, V192, P315, DOI 10.1007/s00359-005-0065-6; Brent CS, 2003, J INSECT PHYSIOL, V49, P967, DOI 10.1016/S0022-1910(03)00166-5; Cuvillier-Hot V, 2002, P ROY SOC B-BIOL SCI, V269, P1295, DOI 10.1098/rspb.2002.1991; Cuvillier-Hot V, 2006, NATURWISSENSCHAFTEN, V93, P149, DOI 10.1007/s00114-006-0086-1; Dombroski TCD, 2003, APIDOLOGIE, V34, P281, DOI 10.1051/apido:2003024; DREWS C, 1993, BEHAVIOUR, V125, P283, DOI 10.1163/156853993X00290; EMLEN ST, 1992, NATURE, V356, P331, DOI 10.1038/356331a0; Evans P.D., 1980, Advances in Insect Physiology, V15, P317, DOI 10.1016/S0065-2806(08)60143-5; Fuchikawa T, 2014, BEHAV ECOL SOCIOBIOL, V68, P1843, DOI 10.1007/s00265-014-1793-9; FUKUMOTO Y, 1989, Physiology and Ecology Japan, V26, P55; GADAGKAR R, 1991, J GENET, V70, P1, DOI 10.1007/BF02923575; HARRIS JW, 1995, COMP BIOCHEM PHYS C, V111, P271, DOI 10.1016/0742-8413(95)00048-S; Heming B. S., 2003, INSECT DEV EVOLUTION; HIGASHI S, 1994, ANIM BEHAV, V47, P179, DOI 10.1006/anbe.1994.1020; Kamhi JF, 2013, BRAIN BEHAV EVOLUT, V82, P220, DOI 10.1159/000356091; KEANE B, 1994, ANIM BEHAV, V47, P65, DOI 10.1006/anbe.1994.1008; Kikuchi T, 2010, PHYSIOL ENTOMOL, V35, P93, DOI 10.1111/j.1365-3032.2009.00710.x; Kravitz EA, 2003, CURR OPIN NEUROBIOL, V13, P736, DOI 10.1016/j.conb.2003.10.003; Mezawa R, 2013, GEN COMP ENDOCR, V186, P108, DOI 10.1016/j.ygcen.2013.02.039; Monnin T, 1999, BEHAV ECOL SOCIOBIOL, V46, P413, DOI 10.1007/s002650050637; Monnin T, 2006, ANN ZOOL FENN, V43, P515; Nakata K, 1996, ETHOL ECOL EVOL, V8, P147; Neckameyer WS, 1996, DEV BIOL, V176, P209, DOI 10.1006/dbio.1996.0128; Nelson R., 2006, BIOL AGGRESSION; Nievergelt CM, 2000, INT J PRIMATOL, V21, P1, DOI 10.1023/A:1005411227810; Nijhout H. F., 1998, INSECT HORMONES; Okada Y, 2010, NATURWISSENSCHAFTEN, V97, P971, DOI 10.1007/s00114-010-0713-8; PASTOR D, 1991, BIOGENIC AMINES, V8, P109; PEETERS C, 1989, NATURWISSENSCHAFTEN, V76, P177, DOI 10.1007/BF00366404; PEETERS C, 1993, INSECT SOC, V40, P119, DOI 10.1007/BF01240701; PEETERS C, 1991, BIOL J LINN SOC, V44, P141, DOI 10.1111/j.1095-8312.1991.tb00612.x; Peeters Christian, 1993, P234; Pendleton RG, 1996, LIFE SCI, V59, P2083, DOI 10.1016/S0024-3205(96)00562-0; RAIKHEL AS, 2005, COMPREHENSIVE MOL IN, V3, P433; ROBINSON GE, 1991, J INSECT PHYSIOL, V37, P929, DOI 10.1016/0022-1910(91)90008-N; ROBINSON GE, 1992, GEN COMP ENDOCR, V87, P471, DOI 10.1016/0016-6480(92)90055-O; Sasaki K, 2009, NATURWISSENSCHAFTEN, V96, P625, DOI 10.1007/s00114-009-0510-4; Sasaki K, 2007, J INSECT PHYSIOL, V53, P940, DOI 10.1016/j.jinsphys.2007.03.006; Schulz DJ, 1999, J COMP PHYSIOL A, V184, P481, DOI 10.1007/s003590050348; Schulz DJ, 2001, J COMP PHYSIOL A, V187, P53, DOI 10.1007/s003590000177; Seid MA, 2008, DEV NEUROBIOL, V68, P1325, DOI 10.1002/dneu.20663; Seid MA, 2005, NATURWISSENSCHAFTEN, V92, P198, DOI 10.1007/s00114-005-0610-8; SOMMER K, 1993, ETHOLOGY, V94, P162; STRASSMANN JE, 1983, ANIM BEHAV, V31, P431, DOI 10.1016/S0003-3472(83)80063-3; Tsuji K, 1998, ETHOLOGY, V104, P633; Tsuji K, 2005, BEHAV ECOL SOCIOBIOL, V58, P517, DOI 10.1007/s00265-005-0929-3; Turillazzi S, 1996, NATURAL HIST EVOLUTI; West-Eberhard M.J., 1981, P3; WESTEBERHARD MJ, 1979, P AM PHILOS SOC, V123, P222; Wilson EO, 1971, INSECT SOC, P548; WINBERG S, 1992, NEUROREPORT, V3, P243, DOI 10.1097/00001756-199203000-00006; Wnuk A, 2011, PHYSIOL ENTOMOL, V36, P54, DOI 10.1111/j.1365-3032.2010.00762.x	86	2	2	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0022-0949	1477-9145		J EXP BIOL	J. Exp. Biol.	APR	2015	218	7					1091	1098		10.1242/jeb.118414		8	Biology	Life Sciences & Biomedicine - Other Topics	CH5YX	WOS:000354113300025		
J	Dyakonova, VE; Hernadi, L; Ito, E; Dyakonova, TL; Chistopolsky, IA; Zakharov, IS; Sakharov, DA				Dyakonova, Varvara E.; Hernadi, Laszlo; Ito, Etsuro; Dyakonova, Taisia L.; Chistopolsky, Ilya A.; Zakharov, Igor S.; Sakharov, Dmitri A.			The activity of isolated neurons and the modulatory state of an isolated nervous system represent a recent behavioural state	JOURNAL OF EXPERIMENTAL BIOLOGY			English	Article						Serotonergic neuron; Extrasynaptic release; Volume transmission; Neuromodulation; Lymnaea stagnalis; Neurotransmitter synthesis	CENTRAL PATTERN GENERATOR; CEREBRAL GIANT-CELLS; LYMNAEA-STAGNALIS L; SEROTONERGIC MODULATION; TRANSMITTER RELEASE; ESCAPE CIRCUIT; SNAIL; OCTOPAMINE; TRANSMISSION; EXPERIENCE	Behavioural/motivational state is known to influence nearly all aspects of physiology and behaviour. The cellular basis of behavioural state control is only partially understood. Our investigation, performed on the pond snail Lymnaea stagnalis whose nervous system is useful for work on completely isolated neurons, provided several results related to this problem. First, we demonstrated that the behavioural state can produce long-term changes in individual neurons that persist even after neuron isolation from the nervous system. Specifically, we found that pedal serotonergic neurons that control locomotion show higher activity and lower membrane potential after being isolated from the nervous systems of hungry animals. Second, we showed that the modulatory state (the chemical neuroactive microenvironment of the central ganglia) changes in accordance with the nutritional state of an animal and produces predicted changes in single isolated locomotor neurons. Third, we report that observed hunger-induced effects can be explained by the increased synthesis of serotonin in pedal serotonergic neurons, which has an impact on the electrical activity of isolated serotonergic neurons and the intensity of extrasynaptic serotonin release from the pedal ganglia.	[Dyakonova, Varvara E.; Dyakonova, Taisia L.; Chistopolsky, Ilya A.; Zakharov, Igor S.; Sakharov, Dmitri A.] Russian Acad Sci, Inst Dev Biol, Moscow 119334, Russia; [Hernadi, Laszlo] MTA Ctr Ecol Res, Balaton Limnol Inst, H-8237 Tihany, Hungary; [Ito, Etsuro] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Shido, Sanuki 7692193, Japan	Dyakonova, VE (reprint author), Russian Acad Sci, Inst Dev Biol, Moscow 119334, Russia.	dyakonova.varvara@gmail.com			Russian Foundation for Basic Research (RFBR) [14-04-00537, 14-04-00875]; Japan Society for the Promotion of Science (JSPS) [25291074]	This work was supported by Russian Foundation for Basic Research (RFBR) grants 14-04-00537 to D.A.S. and 14-04-00875 to I.S.Z., and by Grants-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science (JSPS; no. 25291074) to E.I.	Alania M, 2004, ACTA BIOL HUNG, V55, P195, DOI 10.1556/ABiol.55.2004.1-4.24; Whitaker KW, 2011, J NEUROPHYSIOL, V106, P127, DOI 10.1152/jn.01126.2010; Hirayama K, 2012, CURR BIOL, V22, P118, DOI 10.1016/j.cub.2011.10.055; Bunin MA, 1998, J NEUROSCI, V18, P4854; Mita K, 2014, NEUROBIOL LEARN MEM, V107, P1, DOI 10.1016/j.nlm.2013.10.013; Agnati LF, 2006, ACTA PHYSIOL, V187, P329, DOI 10.1111/j.1748-1716.2006.01579.x; De-Miguel FF, 2005, CELL MOL NEUROBIOL, V25, P297, DOI 10.1007/s10571-005-3061-z; Dash MB, 2009, J NEUROSCI, V29, P580, DOI 10.1523/JNEUROSCI.5486-08.2009; YEOMAN MS, 1994, J NEUROPHYSIOL, V72, P1372; SYED NI, 1991, J COMP PHYSIOL A, V169, P557; Stevenson PA, 2005, J NEUROSCI, V25, P1431, DOI 10.1523/JNEUROSCI.4258-04.2005; Bargmann CI, 2012, BIOESSAYS, V34, P458, DOI 10.1002/bies.201100185; Chen XW, 2008, J NEUROSCI, V28, P3202, DOI 10.1523/JNEUROSCI.4426-07.2008; Dyakonova VE, 2009, J COMP PHYSIOL A, V195, P515, DOI 10.1007/s00359-009-0428-5; Yeh SR, 1996, SCIENCE, V271, P366, DOI 10.1126/science.271.5247.366; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; SYED NI, 1990, SCIENCE, V250, P282, DOI 10.1126/science.2218532; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; LENT CM, 1988, SCI AM, V258, P98; Taylor BE, 2000, RESP PHYSIOL, V122, P197, DOI 10.1016/S0034-5687(00)00159-6; Hatcher NG, 2008, J NEUROCHEM, V104, P1358, DOI 10.1111/j.1471-4159.2007.05084.x; CHEN GY, 1995, J NEUROSCI, V15, P7747; ADAMO SA, 1995, J EXP BIOL, V198, P1691; O'Connell LA, 2012, SCIENCE, V336, P1154, DOI 10.1126/science.1218889; Vizi ES, 2004, NEUROCHEM INT, V45, P443, DOI 10.1016/j.neuint.2003.11.016; Chistopol'skii I A, 2003, Neurosci Behav Physiol, V33, P295, DOI 10.1023/A:1022163701311; Donnelly JL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001529; D'yakonova V E, 1995, Neurosci Behav Physiol, V25, P247, DOI 10.1007/BF02360213; D'yakonova V. E., 2001, Doklady Akademii Nauk, V376, P267; Dyakonova V E, 2001, Dokl Biol Sci, V378, P230, DOI 10.1023/A:1019258523049; Dyakonova V. E., 2014, NEUROSCI BEHAV PHYSL, V44, P256; Dyakonova VE, 2010, J COMP PHYSIOL A, V196, P529, DOI 10.1007/s00359-010-0541-5; Edwards DH, 2002, BRAIN BEHAV EVOLUT, V60, P360, DOI 10.1159/000067789; ELLIOTT CJH, 1991, J EXP BIOL, V157, P391; Gillette Rhanor, 2006, Integr Comp Biol, V46, P838, DOI 10.1093/icb/icl024; GLOVER JC, 1991, COMP BIOCHEM PHYS C, V99, P437, DOI 10.1016/0742-8413(91)90268-X; HAYDON PG, 1981, J EXP BIOL, V94, P149; Hernadi L, 2004, ACTA BIOL HUNG, V55, P185, DOI 10.1556/ABiol.55.2004.1-4.23; Hirayama K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102240; Jaffe EH, 1998, J NEUROSCI, V18, P3548; KABOTYANSKY EA, 1991, BIOL MEMBRANY, V8, P1158; KABOTYANSKI EA, 1990, COMP BIOCHEM PHYS C, V95, P39, DOI 10.1016/0742-8413(90)90080-S; Kabotyanskii E A, 1991, Neurosci Behav Physiol, V21, P422, DOI 10.1007/BF01200277; LENT CM, 1991, J COMP PHYSIOL A, V168, P191; Maimon G, 2011, CURR OPIN NEUROBIOL, V21, P559, DOI 10.1016/j.conb.2011.05.001; MCCROHAN CR, 1987, COMP BIOCHEM PHYS A, V87, P969, DOI 10.1016/0300-9629(87)90022-3; Palmer CR, 2011, CURR OPIN NEUROBIOL, V21, P520, DOI 10.1016/j.conb.2011.05.003; SAKHAROV D A, 1990, Zhurnal Evolyutsionnoi Biokhimii i Fiziologii, V26, P733; Sakharov D. A., 1990, THE EARLY BRAIN, P73; SATTERLIE RA, 1995, J EXP BIOL, V198, P905; Sem'yanov A V, 2005, Neurosci Behav Physiol, V35, P253, DOI 10.1007/s11055-005-0051-z; SLADE CT, 1981, COMP BIOCHEM PHYS A, V69, P789, DOI 10.1016/0300-9629(81)90173-0; Spencer GE, 2000, J NEUROSCI, V20, P8077; SYED NI, 1989, COMP BIOCHEM PHYS A, V93, P633, DOI 10.1016/0300-9629(89)90024-8	54	3	3	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0022-0949	1477-9145		J EXP BIOL	J. Exp. Biol.	APR	2015	218	8					1151	1158		10.1242/jeb.111930		8	Biology	Life Sciences & Biomedicine - Other Topics	CH5ZM	WOS:000354114900009		
J	Kasuga, J; Charrier, G; Uemura, M; Ameglio, T				Kasuga, Jun; Charrier, Guillaume; Uemura, Matsuo; Ameglio, Thierry			Characteristics of ultrasonic acoustic emissions from walnut branches during freeze-thaw-induced embolism formation	JOURNAL OF EXPERIMENTAL BOTANY			English	Article						Embolism formation; freezing stress; loss of hydraulic conductivity; ultrasonic acoustic emission; vessel; walnut; xylem parenchyma	RAY PARENCHYMA CELLS; XYLEM CAVITATION; NORWAY SPRUCE; HYDRAULIC CONDUCTIVITY; FIELD-MEASUREMENTS; ALPINE TIMBERLINE; WATER RELATIONS; WOODY-PLANTS; PICEA-ABIES; LEAF WATER	Ultrasonic acoustic emission (UAE) methods have been applied for the detection of freeze-thaw-induced embolism formation in water conduits of tree species. Until now, however, the exact source(s) of UAE has not been identified especially in angiosperm species, in which xylem tissues are composed of diverse types of cells. In this study, UAE was recorded from excised branches of walnut (Juglans regia cv. Franquette) during freeze-thaw cycles, and attempts were made to characterize UAEs generated by cavitation events leading to embolism formation according to their properties. During freeze-thaw cycles, a large number of UAEs were generated from the sample segments. However, the cumulative numbers of total UAE during freeze-thawing were not correlated with the percentage loss of hydraulic conductivity after thawing, suggesting that the sources of UAE were not only cavitation leading to embolism formation in vessels. Among the UAEs, cumulative numbers of UAEs with absolute energy >10.0 fJ strongly correlated with the increase in percentage loss of hydraulic conductivity. The high absolute energy of the UAEs might reflect the formation of large bubbles in the large lumen of vessels. Therefore, UAEs generated by cavitation events in vessels during freeze-thawing might be distinguished from other signals according to their magnitudes of absolute energy. On the other hand, the freezing of xylem parenchyma cells was followed by a certain number of UAEs. These results indicate the possibility that UAE methods can be applied to the detection of both freeze-thaw-induced embolism and supercooling breakdown in parenchyma cells in xylem.	[Kasuga, Jun; Charrier, Guillaume; Ameglio, Thierry] INRA, UMR 547, PIAF, F-63100 Clermont Ferrand, France; [Kasuga, Jun; Charrier, Guillaume; Ameglio, Thierry] Univ Clermont Ferrand, Clermont Univ, UMR 547, PIAF, F-63100 Clermont Ferrand, France; [Kasuga, Jun] Obihiro Univ Agr & Vet Med, Dept Agroenvironm Sci, Obihiro, Hokkaido 0808555, Japan; [Charrier, Guillaume] Univ Innsbruck, Dept Bot, A-6020 Innsbruck, Austria; [Uemura, Matsuo] Iwate Univ, Cryobiofrontier Res Ctr, Fac Agr, Morioka, Iwate 0208550, Japan	Ameglio, T (reprint author), INRA, UMR 547, PIAF, F-63100 Clermont Ferrand, France.	Thierry.Ameglio@clermont.inra.fr	AMEGLIO, THIERRY/E-1535-2011		Institut National de la Recherche Agronomique (INRA)-Department of Agronomy and Environment from Blaise Pascal University; Japan Society for the Promotion of Science [22-5901]; French research agency (ANR) [I826-B25]; Austrian research agency (FWF) [I826-B25]	This work was partly supported by the Institut National de la Recherche Agronomique (INRA)-Department of Agronomy and Environment, a post-doctoral grant from Blaise Pascal University (Clermont II), and a Grant-in-Aid from the Japan Society for the Promotion of Science (22-5901 to JK). This project was also funded by the French and Austrian research agencies (ANR and FWF) in the project I826-B25 'Acoufreeze'. The authors thank Mr C. Bodet and Mr C. Serre (INRA UMR-PIAF) for technical assistance. We would like to thank the two anonymous reviewers for their comments and suggestions on the first draft that greatly improved this manuscript.	Domec JC, 2002, J EXP BOT, V53, P2369, DOI 10.1093/jxb/erf100; Rockwell FE, 2014, PLANT PHYSIOL, V164, P1649, DOI 10.1104/pp.113.233817; Ameglio T, 2002, TREE PHYSIOL, V22, P1211; Charra-Vaskou K, 2012, TREE PHYSIOL, V32, P1161, DOI 10.1093/treephys/tps071; Mayr S, 2011, TREE PHYSIOL, V31, P59, DOI 10.1093/treephys/tpq099; Mayr S, 2003, PLANT PHYSIOL, V131, P780, DOI 10.1104/pp.011452; Cruiziat P, 2002, ANN FOREST SCI, V59, P723, DOI 10.1051/forest:2002060; Rosner S, 2006, NEW PHYTOL, V171, P105, DOI 10.1111/j.1469-8137.2006.01736.x; Utsumi Y, 1998, PLANT PHYSIOL, V117, P1463, DOI 10.1104/pp.117.4.1463; Wolkerstorfer SV, 2012, PHYSIOL PLANTARUM, V146, P184, DOI 10.1111/j.1399-3054.2012.01605.x; HACKE U, 1995, J EXP BOT, V46, P1177, DOI 10.1093/jxb/46.9.1177; Mayr S, 2006, AGR FOREST METEOROL, V137, P81, DOI 10.1016/j.agrformet.2006.02.013; Utsumi Y, 1999, PLANT PHYSIOL, V121, P897, DOI 10.1104/pp.121.3.897; Kikuta SB, 2003, PLANT CELL ENVIRON, V26, P383, DOI 10.1046/j.1365-3040.2003.00969.x; Mayr S, 2007, PLANT PHYSIOL, V143, P60, DOI 10.1104/pp.106.085704; LOGULLO MA, 1993, PLANT CELL ENVIRON, V16, P511; Langan SJ, 1997, PLANT CELL ENVIRON, V20, P425, DOI 10.1046/j.1365-3040.1997.d01-94.x; Holtta T, 2005, TREE PHYSIOL, V25, P237; Kikuta SB, 2003, PHYTON-ANN REI BOT A, V43, P161; Brodersen CR, 2013, PLANT PHYSIOL, V161, P1820, DOI 10.1104/pp.112.212712; Davis SD, 1999, AM J BOT, V86, P1367, DOI 10.2307/2656919; Neuner G, 2010, TREE PHYSIOL, V30, P1037, DOI 10.1093/treephys/tpq059; Ball MC, 2006, PLANT CELL ENVIRON, V29, P729, DOI 10.1111/j.1365-3040.2005.01426.x; Fujikawa S, 2000, MICRON, V31, P669, DOI 10.1016/S0968-4328(99)00103-1; Charrier G, 2013, TREE PHYSIOL, V33, P891, DOI 10.1093/treephys/tpt062; SPERRY JS, 1988, AM J BOT, V75, P1212, DOI 10.2307/2444104; Pockman WT, 1997, OECOLOGIA, V109, P19, DOI 10.1007/s004420050053; Johnson DM, 2009, PLANT CELL ENVIRON, V32, P828, DOI 10.1111/j.1365-3040.2009.01961.x; Hacke UG, 2001, PERSPECT PLANT ECOL, V4, P97, DOI 10.1078/1433-8319-00017; Yamazaki T, 2008, PLANT CELL, V20, P3389, DOI 10.1105/tpc.108.062679; Xin Z, 2000, PLANT CELL ENVIRON, V23, P893, DOI 10.1046/j.1365-3040.2000.00611.x; SPERRY JS, 1992, PLANT PHYSIOL, V100, P605, DOI 10.1104/pp.100.2.605; Holbrook NM, 2001, PLANT PHYSIOL, V126, P27, DOI 10.1104/pp.126.1.27; Mayr S, 2003, PLANT CELL ENVIRON, V26, P1365, DOI 10.1046/j.0016-8025.2003.01060.x; McCulloh KA, 2011, AM J BOT, V98, P1007, DOI 10.3732/ajb.1000503; Wheeler JK, 2013, PLANT CELL ENVIRON, V36, P1938, DOI 10.1111/pce.12139; Pittermann J, 2003, TREE PHYSIOL, V23, P907; Charrier G, 2014, PLANT PHYSIOL, V164, P992, DOI 10.1104/pp.113.228403; Mayr S, 2010, NEW PHYTOL, V185, P1016, DOI 10.1111/j.1469-8137.2009.03133.x; Mayr S, 2014, PLANT PHYSIOL, V164, P1731, DOI 10.1104/pp.114.236646; Pratt RB, 2005, AM J BOT, V92, P1102, DOI 10.3732/ajb.92.7.1102; Canny MJ, 1997, AM J BOT, V84, P1223, DOI 10.2307/2446046; Charra-Vaskou K, 2012, ANN FOREST SCI, V69, P325, DOI 10.1007/s13595-011-0160-5; Cochard H, 1997, J EXP BOT, V48, P655; Dixon HH, 1914, TRANSPIRATION ASCENT, P81; EWERS FW, 1985, IAWA BULL, V6, P309; Fukami R, 2011, CRYOBIOLOGY CRYOTECH, V57, P71; HANSEN J, 1988, BOT ACTA, V101, P76; Hietz P, 2008, ANN FOREST SCI, V65, DOI 10.1051/forest:2008023; IKEDA T, 1992, ECOL RES, V7, P391, DOI 10.1007/BF02347106; Jackson GE, 1996, J EXP BOT, V47, P1643, DOI 10.1093/jxb/47.11.1643; Jackson GE, 1999, PLANT ECOL, V140, P3, DOI 10.1023/A:1009781225506; Kuroda K, 1999, CRYOBIOLOGY, V38, P81, DOI 10.1006/cryo.1998.2149; Larcher W, 1995, PHYSL PLANT ECOLOGY; Lemoine D, 1999, TREES-STRUCT FUNCT, V13, P206, DOI 10.1007/s004680050234; LEVITT J., 1972, RESPONSES PLANTS ENV; LOGULLO MA, 1991, ANN BOT-LONDON, V67, P417; Mayr S, 2010, J PLANT PHYSIOL, V167, P34, DOI 10.1016/j.jplph.2009.07.010; Ogaya R, 2007, ACTA PHYSIOL PLANT, V29, P407, DOI 10.1007/s11738-007-0048-z; PARKER J, 1963, BOT REV, V29, P123, DOI 10.1007/BF02860820; Perks MP, 2004, ANN FOREST SCI, V61, P1, DOI 10.1051/forest.2003079; Ponomarenko A, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0480; RASCHI A, 1989, AGR ECOSYST ENVIRON, V27, P411, DOI 10.1016/0167-8809(89)90101-1; RISTIC Z, 1994, PLANT PHYSIOL, V104, P737; Sakai A, 1987, FROST SURVIVAL PLANT; Sevanto S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00107; Suuronen JP, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-11; TYREE MT, 1989, PLANT CELL ENVIRON, V12, P371, DOI 10.1111/j.1365-3040.1989.tb01953.x; Vogt KU., 2001, J EXPT BOT, V52, P1527, DOI DOI 10.1093/JEXBOT/52.360.1527; WEISER RL, 1988, J AM SOC HORTIC SCI, V113, P636	70	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0957	1460-2431		J EXP BOT	J. Exp. Bot.	APR	2015	66	7					1965	1975		10.1093/jxb/eru543		11	Plant Sciences	Plant Sciences	CH2ZG	WOS:000353894100021		
J	Feng, BF; Maruno, K; Ohta, Y				Feng, Bao-Feng; Maruno, Ken-ichi; Ohta, Yasuhiro			Integrable semi-discretization of a multi-component short pulse equation	JOURNAL OF MATHEMATICAL PHYSICS			English	Article							ULTRA-SHORT PULSES; NONLINEAR MEDIA; PROPAGATION	In the present paper, we mainly study the integrable semi-discretization of a multicomponent short pulse equation. First, we briefly review the bilinear equations for a multi-component short pulse equation proposed by Matsuno [J. Math. Phys. 52, 123702 (2011)] and reaffirm its N-soliton solution in terms of pfaffians. Then by using a Backlund transformation of the bilinear equations and defining a discrete hodograph (reciprocal) transformation, an integrable semi-discrete multi-component short pulse equation is constructed. Meanwhile, its N-soliton solution in terms of pfaffians is also proved. (C) 2015 AIP Publishing LLC.	[Feng, Bao-Feng] Univ Texas Pan Amer, Dept Math, Edinburg, TX 78541 USA; [Maruno, Ken-ichi] Waseda Univ, Dept Appl Math, Tokyo 1698050, Japan; [Ohta, Yasuhiro] Kobe Univ, Dept Math, Kobe, Hyogo 6578501, Japan	Feng, BF (reprint author), Univ Texas Pan Amer, Dept Math, Edinburg, TX 78541 USA.				National Natural Science Foundation of China [11428102]; CREST, JST	The work of BF is partially supported by the National Natural Science Foundation of China (No. 11428102). The work of KM is partially supported by CREST, JST.	Agrawal G. P., 2001, NONLINEAR FIBER OPTI; Kuetche VK, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.024004; HIROTA R, 1991, J PHYS SOC JPN, V60, P798, DOI 10.1143/JPSJ.60.798; Matsuno Y, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.084003; Schafer T, 2004, PHYSICA D, V196, P90, DOI 10.1016/j.physd.2004.04.007; Chung Y, 2005, NONLINEARITY, V18, P1351, DOI 10.1088/0951-7715/18/3/021; Iwao M, 1997, J PHYS SOC JPN, V66, P577, DOI 10.1143/JPSJ.66.577; Pietrzyk M, 2008, J NONLINEAR MATH PHY, V15, P162, DOI 10.2991/jnmp.2008.15.2.4; Sakovich A, 2005, J PHYS SOC JPN, V74, P239, DOI 10.1143/JPSJ.74.239; Sakovich A, 2006, J PHYS A-MATH GEN, V39, pL361, DOI 10.1088/0305-4470/39/22/L03; Brunelli JC, 2005, J MATH PHYS, V46, DOI 10.1063/1.2146189; BEALS R, 1989, STUD APPL MATH, V81, P125; Boyd R.W., 1992, NONLINEAR OPTICS; Brunelli JC, 2006, PHYS LETT A, V353, P475, DOI 10.1016/j.physleta.2006.01.009; Brunelli JC, 2013, J MATH PHYS, V54, DOI 10.1063/1.4773363; Dimakis A, 2010, SYMMETRY INTEGR GEOM, V6, DOI 10.3842/SIGMA.2010.055; Feng B. F., 2014, PAC J MATH IND, V6, P8; Feng BF, 2012, J PHYS A-MATH THEOR, V45, DOI 10.1088/1751-8113/45/8/085202; Feng BF, 2010, J COMPUT APPL MATH, V235, P229, DOI 10.1016/j.cam.2010.05.044; Feng BF, 2011, J PHYS A-MATH THEOR, V44, DOI 10.1088/1751-8113/44/39/395201; Feng BF, 2015, PHYSICA D, V297, P62, DOI 10.1016/j.physd.2014.12.002; Feng BF, 2010, J PHYS A-MATH THEOR, V43, DOI 10.1088/1751-8113/43/8/085203; Hirota R, 2004, DIRECT METHOD SOLITO; JIMBO M, 1983, PUBL RES I MATH SCI, V19, P943, DOI 10.2977/prims/1195182017; Kartashov DV, 2003, JETP LETT+, V78, P276, DOI 10.1134/1.1625724; Kodama Y., 1995, SOLITONS OPTICAL COM; Matsuno Y, 2011, J MATH PHYS, V52, DOI 10.1063/1.3664904; Matsuno Y., 2004, HDB SOLITONS RES TEC, P541; Ohta Y, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/35/355205; Robelo M.L., 1989, STUD APPL MATH, V81, P221; ROTHENBERG JE, 1992, OPT LETT, V17, P1340, DOI 10.1364/OL.17.001340; Yao YQ, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.064004; Yariv A., 1983, OPTICAL WAVES CRYSTA; ZAKHAROV VE, 1972, SOV PHYS JETP-USSR, V34, P62	34	1	1	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	0022-2488	1089-7658		J MATH PHYS	J. Math. Phys.	APR	2015	56	4							043502	10.1063/1.4916895		15	Physics, Mathematical	Physics	CH2CV	WOS:000353833400034		
J	Miyazawa, T				Miyazawa, Toru			Formulation of a unified method for low- and high-energy expansions in the analysis of reflection coefficients for one-dimensional Schrodinger equation	JOURNAL OF MATHEMATICAL PHYSICS			English	Article							FOKKER-PLANCK EQUATION; SCATTERING MATRIX; GREEN-FUNCTION; LINE; ASYMPTOTICS; POTENTIALS; OPERATORS	We study low-energy expansion and high-energy expansion of reflection coefficients for one-dimensional Schrodinger equation, from which expansions of the Green function can be obtained. Making use of the equivalent Fokker-Planck equation, we develop a generalized formulation of a method for deriving these expansions in a unified manner. In this formalism, the underlying algebraic structure of the problem can be clearly understood, and the basic formulas necessary for the expansions can be derived in a natural way. We also examine the validity of the expansions for various asymptotic behaviors of the potential at spatial infinity. (C) 2015 AIP Publishing LLC.	Gakushuin Univ, Dept Phys, Tokyo 1718588, Japan	Miyazawa, T (reprint author), Gakushuin Univ, Dept Phys, Tokyo 1718588, Japan.	toru.miyazawa@gakushuin.ac.jp					Aktosun T, 2001, INVERSE PROBL, V17, P619, DOI 10.1088/0266-5611/17/4/304; HARRIS BJ, 1986, P ROY SOC EDINB A, V102, P243; ATKINSON FV, 1981, P ROY SOC EDINB A, V88, P345; BENNEWITZ C, 1989, P LOND MATH SOC, V59, P294; BOLLE D, 1985, J OPERAT THEOR, V13, P3; CARDY JL, 1987, PHASE TRANSITIONS CR, V11, P55; Costin O, 2012, ANN HENRI POINCARE, V13, P1371, DOI 10.1007/s00023-011-0155-7; Danielyan A, 1991, MATH USSR IZV, V36, P487, DOI 10.1070/IM1991v036n03ABEH002031; DEIFT P, 1979, COMMUN PUR APPL MATH, V32, P121, DOI 10.1002/cpa.3160320202; Everitt W. N., 1972, J LONDON MATH SOC S, Vs2-4, P443, DOI 10.1112/jlms/s2-4.3.443; Harris B. J., 1984, J LONDON MATH SOC S, Vs2-30, P110, DOI 10.1112/jlms/s2-30.1.110; Hinton D. B., 1989, DIFFERENTIAL INTEGRA, V2, P419; HINTON DB, 1989, INVERSE PROBL, V5, P1049, DOI 10.1088/0266-5611/5/6/011; KLAUS M, 1988, J MATH PHYS, V29, P148, DOI 10.1063/1.528167; Miyazawa T, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/44/445305; Miyazawa T, 2006, J PHYS A-MATH GEN, V39, P10871, DOI 10.1088/0305-4470/39/34/018; Miyazawa T, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/31/315304; Miyazawa T, 1998, J MATH PHYS, V39, P2035, DOI 10.1063/1.532276; Miyazawa T, 2006, J PHYS A-MATH GEN, V39, P7015, DOI 10.1088/0305-4470/39/22/015; Miyazawa T, 2012, J PHYS A-MATH THEOR, V45, DOI 10.1088/1751-8113/45/3/035302; Miyazawa T, 2007, J PHYS A-MATH THEOR, V40, P8683, DOI 10.1088/1751-8113/40/30/006; NEWTON RG, 1986, J MATH PHYS, V27, P2720, DOI 10.1063/1.527294; Ramond T, 1996, COMMUN MATH PHYS, V177, P221, DOI 10.1007/BF02102437; Risken H, 1984, FOKKER PLANCK EQUATI; Rybkin A, 2002, P AM MATH SOC, V130, P59, DOI 10.1090/S0002-9939-01-06014-2; Rybkin A, 2002, B LOND MATH SOC, V34, P61, DOI 10.1112/S0024609301008645; VERDE M, 1955, NUOVO CIMENTO, V2, P1001, DOI 10.1007/BF02855846; YAFAEV DR, 1982, COMMUN MATH PHYS, V85, P177, DOI 10.1007/BF01254456	28	0	0	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	0022-2488	1089-7658		J MATH PHYS	J. Math. Phys.	APR	2015	56	4							042105	10.1063/1.4918552		24	Physics, Mathematical	Physics	CH2CV	WOS:000353833400018		
J	Sasaki, R				Sasaki, Ryu			Perturbations around the zeros of classical orthogonal polynomials	JOURNAL OF MATHEMATICAL PHYSICS			English	Article							ANNIHILATION-CREATION OPERATORS; QUANTUM-MECHANICS; SYSTEMS; INTEGRABILITY	Starting from degree N solutions of a time dependent Schrodinger-like equation for classical orthogonal polynomials, a linear matrix equation describing perturbations around the N zeros of the polynomial is derived. The matrix has remarkable Diophantine properties. Its eigenvalues are independent of the zeros. The corresponding eigenvectors provide the representations of the lower degree (0,1, ... , N-1) polynomials in terms of the zeros of the degree N polynomial. The results are valid universally for all the classical orthogonal polynomials, including the Askey scheme of hypergeometric orthogonal polynomials and its q-analogues. (C) 2015 AIP Publishing LLC.	[Sasaki, Ryu] Shinshu Univ, Dept Phys, Matsumoto, Nagano 3908621, Japan; [Sasaki, Ryu] Natl Taiwan Univ, Dept Phys, Taipei 10617, Taiwan	Sasaki, R (reprint author), Shinshu Univ, Dept Phys, Matsumoto, Nagano 3908621, Japan.						Andrews G., 1999, ENCY MATH ITS APPL, V71; Odake S, 2009, PHYS LETT B, V679, P414, DOI 10.1016/j.physletb.2009.08.004; AHMED S, 1979, NUOVO CIMENTO B, V49, P173, DOI 10.1007/BF02737517; Odake S, 2011, J PHYS A-MATH THEOR, V44, DOI 10.1088/1751-8113/44/35/353001; Gomez-Ullate D, 2009, J MATH ANAL APPL, V359, P352, DOI 10.1016/j.jmaa.2009.05.052; INFELD L, 1951, REV MOD PHYS, V23, P21, DOI 10.1103/RevModPhys.23.21; Odake S, 2012, J PHYS A-MATH THEOR, V45, DOI 10.1088/1751-8113/45/38/385201; Van Diejen JF, 2005, J NONLINEAR MATH PHY, V12, P689; Calogero F, 2015, J MATH PHYS, V56, DOI 10.1063/1.4915291; CALOGERO F, 1977, LETT NUOVO CIMENTO, V19, P505; Odake S, 2010, J MATH PHYS, V51, DOI 10.1063/1.3458866; Bihun O., ARXIV14100549MATHPH; Bihun O, 2014, LETT MATH PHYS, V104, P1571, DOI 10.1007/s11005-014-0728-8; CALOGERO F, 1977, LETT NUOVO CIMENTO, V20, P251, DOI 10.1007/BF02785163; CALOGERO F, 1981, J MATH PHYS, V22, P919, DOI 10.1063/1.525022; Calogero F., 2001, LECT NOTES PHYS MO M, Vm66; BRUSCHI M, 1979, LETT NUOVO CIMENTO, V24, P601, DOI 10.1007/BF02815968; Chihara T., 1978, INTRO ORTHOGONAL POL; Cooper F., 1995, Physics Reports, V251, DOI 10.1016/0370-1573(94)00080-M; Corrigan E, 2002, J PHYS A-MATH GEN, V35, P7017, DOI 10.1088/0305-4470/35/33/306; Ismail M, 2005, ENCY MATH ITS APPL; Koekoek R., ARXIVMATHCA9602214; Koekoek R, 2010, SPRINGER MONOGR MATH, P1, DOI 10.1007/978-3-642-05014-5; Nikiforov A.F., 1991, CLASSICAL ORTHOGONAL; Odake S, 2006, J MATH PHYS, V47, DOI 10.1063/1.2349485; Odake S, 2011, PHYS LETT B, V702, P164, DOI 10.1016/j.physletb.2011.06.075; Odake S, 2006, PHYS LETT B, V641, P112, DOI 10.1016/j.physletb.2006.08.017; Odake S, 2008, PROG THEOR PHYS, V119, P663, DOI 10.1143/PTP.119.663; Odake S, 2013, J PHYS A-MATH THEOR, V46, DOI 10.1088/1751-8113/46/4/045204; Odake S, 2004, J PHYS A-MATH GEN, V37, P11841, DOI 10.1088/0305-4470/37/49/006; Odake S, 2008, J MATH PHYS, V49, DOI 10.1063/1.2898695; Odake S, 2008, PHYS LETT B, V663, P141, DOI 10.1016/j.physletb.2008.03.043; Odake S, 2005, J MATH PHYS, V46, DOI 10.1063/1.1927080; Quesne C, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/39/392001; Ragnisco O, 2004, J PHYS A-MATH GEN, V37, P469, DOI 10.1088/0305-4470/37/2/015; Sasaki R, 2009, J MATH PHYS, V50, DOI 10.1063/1.3215983; Stieltjes T. J., 1918, OUVRES COMPLETES, V2; Szego G., 1975, ORTHOGONAL POLYNOMIA	38	1	1	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	0022-2488	1089-7658		J MATH PHYS	J. Math. Phys.	APR	2015	56	4							042106	10.1063/1.4918707		22	Physics, Mathematical	Physics	CH2CV	WOS:000353833400019		
J	Han, C; Furukawa, H; Tomura, T; Fudou, R; Kaida, K; Choi, BK; Imokawa, G; Ojika, M				Han, Chunguang; Furukawa, Hiroyuki; Tomura, Tomohiko; Fudou, Ryosuke; Kaida, Kenichi; Choi, Bong-Keun; Imokawa, Genji; Ojika, Makoto			Bioactive Maleic Anhydrides and Related Diacids from the Aquatic Hyphomycete Tricladium castaneicola	JOURNAL OF NATURAL PRODUCTS			English	Article							CYCLIC DEPSIPEPTIDE ANTIBIOTICS; CLAVARIOPSIS-AQUATICA; DERIVATIVES; ACIDS	Four maleic anhydride derivatives, tricladolides A-D (1-4), and three alkylidene succinic acid derivatives, tricladic acids A-C (5-7), were isolated from the aquatic hyphomycete Tricladium castaneicola. The structures of these compounds were determined by spectroscopic analysis, and all were found to be novel. The compounds exhibited inhibitory activity against fungi, particularly Phytophthora sp., a plant pathogen of oomycetes. The inhibitory activity of these metabolites revealed the importance of the cyclic anhydride structure and the lipophilicity of the alkyl side chain. On the other hand, the cytotoxicity of the compounds against B16 melanoma cells indicated that the cyclic anhydride structure was not essential.	[Han, Chunguang] Nagoya Univ, Res Ctr Mat Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Furukawa, Hiroyuki; Tomura, Tomohiko; Ojika, Makoto] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Fudou, Ryosuke] Ajinomoto Co Inc, R&D Planning Dept, Chuo Ku, Tokyo 1048315, Japan; [Kaida, Kenichi] Ajinomoto Co Inc, Inst Innovat, Kawasaki, Kanagawa 2108681, Japan; [Choi, Bong-Keun] Myongji Univ, Ctr Nutraceut & Pharmaceut Mat, Yongin 449728, Gyeonggi Do, South Korea; [Imokawa, Genji] Chubu Univ, Res Inst Biol Funct, Kasugai, Aichi 4878501, Japan	Ojika, M (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	ojika@agr.nagoya-u.ac.jp					Reddy CR, 2012, SYNTHESIS-STUTTGART, V44, P1663, DOI 10.1055/s-0031-1290986; Mudur SV, 2006, ORG LETT, V8, P3191, DOI 10.1021/ol060916w; von Delius M, 2012, J AM CHEM SOC, V134, P15022, DOI 10.1021/ja305593y; EVIDENTE A, 1986, J NAT PROD, V49, P593, DOI 10.1021/np50046a006; Krauss GJ, 2011, FEMS MICROBIOL REV, V35, P620, DOI 10.1111/j.1574-6976.2011.00266.x; Chan S. Y., 2000, Fungal Diversity, V5, P89; GALINIS DL, 1993, J ORG CHEM, V58, P7804, DOI 10.1021/jo00079a026; HARRIGAN GG, 1995, J NAT PRODUCTS, V58, P1467, DOI 10.1021/np50123a022; HUFF RK, 1972, J CHEM SOC PERK T 1, P2584, DOI 10.1039/p19720002584; Kaida K, 2001, J ANTIBIOT, V54, P17; MORI K, 1987, LIEBIGS ANN CHEM, P863; Nakajima H, 2014, ARCH DERMATOL RES, V306, P37, DOI 10.1007/s00403-013-1376-z; Oh H, 1999, J NAT PROD, V62, P580, DOI 10.1021/np980496m; Pankiw T, 1996, J CHEM ECOL, V22, P605, DOI 10.1007/BF02033573; PAWAR AS, 1995, TETRAHEDRON-ASYMMETR, V6, P2219, DOI 10.1016/0957-4166(95)00296-2; SINGH SB, 1993, TETRAHEDRON, V49, P5917, DOI 10.1016/S0040-4020(01)87178-7; Suberkropp K, 1981, MYCOL SER, V2, P761; SUTTON BC, 1975, T BRIT MYCOL SOC, V64, P405; Suzuki Y, 2001, J ANTIBIOT, V54, P22	19	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0163-3864	1520-6025		J NAT PROD	J. Nat. Prod.	APR	2015	78	4					639	644		10.1021/np500773s		6	Plant Sciences; Chemistry, Medicinal; Pharmacology & Pharmacy	Plant Sciences; Pharmacology & Pharmacy	CG9UH	WOS:000353665100006		
J	Fukuda, T; Sudoh, Y; Tsuchiya, Y; Okuda, T; Matsuura, N; Motojima, A; Oikawa, T; Igarashi, Y				Fukuda, Takao; Sudoh, Yuri; Tsuchiya, Yuki; Okuda, Toru; Matsuura, Nobuyasu; Motojima, Atsuko; Oikawa, Tsutomu; Igarashi, Yasuhiro			Hikiamides A-C, Cyclic Pentadepsipeptides from Fusarium sp TAMA 456	JOURNAL OF NATURAL PRODUCTS			English	Article							ADIPONECTIN SECRETION; N-METHYLSANSALVAMIDE; GENUS FUSARIUM; MARINE FUNGUS; DEPSIPEPTIDE; PEPTIDE	Three new cyclic pentadepsipeptides, hikiamides A-C (1-3), were isolated from the culture extract of Fusarium sp. TAMA 456. The structures were determined by spectroscopic analysis using NMR and MS, and the absolute configurations were established by using Marfeys method and chiral HPLC analysis. Hikiamides induced the differentiation of murine ST-13 preadipocytes into mature adipocytes at 2 mu M and adiponectin mRNA expression (5- to 13-fold higher than control). They also induced PPAR-gamma-dependent gene expression at a concentration from 0.63 to 10 mu M in a gene reporter assay.	[Fukuda, Takao; Igarashi, Yasuhiro] Toyama Prefectural Univ, Biotechnol Res Ctr, Imizu, Toyama 9390398, Japan; [Fukuda, Takao; Igarashi, Yasuhiro] Toyama Prefectural Univ, Dept Biotechnol, Imizu, Toyama 9390398, Japan; [Sudoh, Yuri; Tsuchiya, Yuki] Hyphagenesis Inc, Machida, Tokyo 1940041, Japan; [Okuda, Toru] Univ Tokyo, Bot Gardens, Bunkyo Ku, Tokyo 1120001, Japan; [Matsuura, Nobuyasu] Okayama Univ Sci, Fac Sci, Dept Life Sci, Kita Ku, Okayama 7000005, Japan; [Motojima, Atsuko; Oikawa, Tsutomu] Kanagawa Univ Human Serv, Sch Nutr & Dietet, Dept Nutr Biochem, Yokosuka, Kanagawa 2388522, Japan	Igarashi, Y (reprint author), Toyama Prefectural Univ, Biotechnol Res Ctr, 5180 Kurokawa, Imizu, Toyama 9390398, Japan.	yas@pu-toyama.ac.jp			JSPS [25252037]	This work was partly supported by a Grant-in-Aid for Scientific Research (A) (25252037) from JSPS to T. Oikawa.	Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Cueto M, 2000, PHYTOCHEMISTRY, V55, P223, DOI 10.1016/S0031-9422(00)00280-6; Inzucchi SE, 2012, DIABETOLOGIA, V55, P1577, DOI 10.1007/s00125-012-2534-0; Hino K, 2012, VITAM HORM, V90, P125, DOI 10.1016/B978-0-12-398313-8.00005-1; Belofsky GN, 1999, TETRAHEDRON LETT, V40, P2913, DOI 10.1016/S0040-4039(99)00393-7; Igarashi Y, 2012, J ANTIBIOT, V65, P157, DOI 10.1038/ja.2011.132; Igarashi Y, 2012, J NAT PROD, V75, P986, DOI 10.1021/np200742c; Ikeda M, 2011, MED CHEM, V7, P250; Indananda C., 2013, J ANTIBIOT, V66, P1; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Kim MY, 2009, J NAT PROD, V72, P2065, DOI 10.1021/np900464p; Kunimasa K, 2009, BIOORG MED CHEM LETT, V19, P2062, DOI 10.1016/j.bmcl.2009.02.002; Lee HS, 2012, J AGR FOOD CHEM, V60, P4342, DOI 10.1021/jf205217v; Mutalik M., 2011, INT J CUR BIOMED PHA, V1, P141; Oh DC, 2006, TETRAHEDRON LETT, V47, P8625, DOI 10.1016/j.tetlet.2006.08.113; Schernthaner G., 2013, DIABETES CARE, V36, P5155; Song HH, 2011, FOOD CHEM, V126, P472, DOI 10.1016/j.foodchem.2010.11.023; Yu L., 2014, J ANTIBIOT, V67, P1	18	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0163-3864	1520-6025		J NAT PROD	J. Nat. Prod.	APR	2015	78	4					797	802		10.1021/np501047a		6	Plant Sciences; Chemistry, Medicinal; Pharmacology & Pharmacy	Plant Sciences; Pharmacology & Pharmacy	CG9UH	WOS:000353665100026		
J	Fuentes, RG; Toume, K; Arai, MA; Sadhu, SK; Ahmed, F; Ishibashi, M				Fuentes, Rolly G.; Toume, Kazufumi; Arai, Midori A.; Sadhu, Samir K.; Ahmed, Firoj; Ishibashi, Masami			Scopadulciol, Isolated from Scoparia dulcis, Induces beta-Catenin Degradation and Overcomes Tumor Necrosis Factor-Related Apoptosis Ligand Resistance in AGS Human Gastric Adenocarcinoma Cells	JOURNAL OF NATURAL PRODUCTS			English	Article							TRAIL-INDUCED APOPTOSIS; CANCER-CELLS; COLON-CANCER; PATHWAY; TARGET; P53; CLEAVAGE; EXPRESSION; INHIBITORS; MECHANISM	Scopadulciol (1), a scopadulan-type diterpenoid, was isolated from Scoparia dulcis along with three other compounds (2-4) by an activity-guided approach using the TCF reporter (TOP) luciferase-based assay system. A fluorometric microculture cytotoxicity assay (FMCA) revealed that compound 1 was cytotoxic to AGS human gastric adenocarcinoma cells. The treatment of AGS cells with 1 decreased beta-catenin levels and also inhibited its nuclear localization. The pretreatment of AGS cells with a proteasome inhibitor, either MG132 or epoxomicin, protected against the degradation of beta-catenin induced by 1. The 1-induced degradation of beta-catenin was also abrogated in the presence of pifithrin-alpha, an inhibitor of p53 transcriptional activity. Compound 1 inhibited TOP activity in AGS cells and downregulated the protein levels of cyclin D1, c-myc, and survivin. Compound 1 also sensitized AGS cells to tumor necrosis factor-related apoptosis ligand (TRAIL)-induced apoptosis by increasing the levels of the death receptors, DR4 and DR5, and decreasing the level of the antiapoptotic protein Bcl-2. Collectively, our results demonstrated that 1 induced the p53- and proteasome-dependent degradation of beta-catenin, which resulted in the inhibition of TCF/beta-catenin transcription in AGS cells. Furthermore, 1 enhanced apoptosis in TRAIL-resistant AGS when combined with TRAIL.	[Fuentes, Rolly G.; Toume, Kazufumi; Arai, Midori A.; Ishibashi, Masami] Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Chiba 2608675, Japan; [Sadhu, Samir K.] Khulna Univ, Sch Life Sci, Pharm Discipline, Khulna 9208, Bangladesh; [Ahmed, Firoj] Univ Dhaka, Dept Pharmaceut Chem, Dhaka 1000, Bangladesh; [Fuentes, Rolly G.] Univ Philippines, Visayas Tacloban Coll, Tacloban City 6500, Philippines	Ishibashi, M (reprint author), Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, 1-8-1 Inohana, Chiba 2608675, Japan.	mish@chiba-u.jp	Ishibashi, Masami /E-5328-2015; Arai, Midori/O-4613-2015; Toume, Kazufumi/A-2632-2012	Ishibashi, Masami /0000-0002-2839-1045; Toume, Kazufumi/0000-0002-3315-145X	KAKENHI from MEXT [23102008]; JSPS [26305001, 25870128]; Cosmetology Research Foundation; Hamaguchi Foundation for the Advancement of Biochemistry; Uehara Memorial Foundation	This study was supported by KAKENHI Grant Number 23102008 from MEXT, Grant Numbers 26305001 and 25870128 from JSPS, the Cosmetology Research Foundation, the Hamaguchi Foundation for the Advancement of Biochemistry, and the Uehara Memorial Foundation. We thank Prof. J. Nathans (John Hopkins University School of Medicine) for providing the STF/293 cells and Prof. R. T. Moon (University of Washington) for the SuperFOPflash plasmid.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Benetti R, 2005, J BIOL CHEM, V280, P22070, DOI 10.1074/jbc.M501810200; Bodmer JL, 2000, NAT CELL BIOL, V2, P241; Zhang LD, 2005, CANCER GENE THER, V12, P228, DOI 10.1038/sj.cgt.7700792; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Ikenoue T, 2002, JPN J CANCER RES, V93, P1213; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; Kisselev AF, 2012, CHEM BIOL, V19, P99, DOI 10.1016/j.chembiol.2012.01.003; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Ashkenazi A, 2008, J CLIN ONCOL, V26, P3621, DOI 10.1200/JCO.2007.15.7198; Toume K, 2013, ORG LETT, V15, P6106, DOI 10.1021/ol4029995; Kolligs FT, 2002, DIGESTION, V66, P131, DOI 10.1159/000066755; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Ahsan M, 2003, J NAT PROD, V66, P958, DOI 10.1021/np020356j; Lindhagen E, 2008, NAT PROTOC, V3, P1364, DOI 10.1038/nprot.2008.114; Deng YB, 2002, GENE DEV, V16, P33, DOI 10.1101/gad.949602; Steinhusen U, 2000, J BIOL CHEM, V275, P16345, DOI 10.1074/jbc.M001458200; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Park HY, 2014, CHEMBIOCHEM, V15, P872, DOI 10.1002/cbic.201300786; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Zhang T, 2001, CANCER RES, V61, P8664; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; De Toni EN, 2008, CLIN CANCER RES, V14, P4713, DOI 10.1158/1078-0432.CCR-07-5019; Li XF, 2009, CHEM-ASIAN J, V4, P540, DOI 10.1002/asia.200800354; Choi WY, 2009, ANTICANCER RES, V29, P4457; HAYASHI T, 1993, PHYTOCHEMISTRY, V32, P349, DOI 10.1016/S0031-9422(00)94992-6; HAYASHI T, 1991, J NAT PROD, V54, P802, DOI 10.1021/np50075a008; Horinaka M, 2005, ONCOGENE, V24, P7180, DOI 10.1038/sj.onc.1208874; Jalving M, 2014, CARCINOGENESIS, V35, P1092, DOI 10.1093/carcin/bgt484; Minakawa T, 2013, PHYTOCHEMISTRY, V96, P299, DOI 10.1016/j.phytochem.2013.08.015; Murphy PJM, 2004, J BIOL CHEM, V279, P30195, DOI 10.1074/jbc.M403539200; Senthivinayagam S, 2009, J BIOL CHEM, V284, P13577, DOI 10.1074/jbc.M900248200; Van de Craen M, 1999, FEBS LETT, V458, P167, DOI 10.1016/S0014-5793(99)01153-9	38	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0163-3864	1520-6025		J NAT PROD	J. Nat. Prod.	APR	2015	78	4					864	872		10.1021/np500933v		9	Plant Sciences; Chemistry, Medicinal; Pharmacology & Pharmacy	Plant Sciences; Pharmacology & Pharmacy	CG9UH	WOS:000353665100034		
J	Iwasaki, A; Ohno, O; Sumimoto, S; Matsubara, T; Shimada, S; Sato, T; Suenaga, K				Iwasaki, Arihiro; Ohno, Osamu; Sumimoto, Shinpei; Matsubara, Teruhiko; Shimada, Satoshi; Sato, Toshinori; Suenaga, Kiyotake			Mebamamides A and B, Cyclic Lipopeptides Isolated from the Green Alga Derbesia marina	JOURNAL OF NATURAL PRODUCTS			English	Article							MOLLUSK ELYSIA-RUFESCENS; CYANOBACTERIAL ASSEMBLAGE; BRYOPSIS SP; LYNGBYA SP; IN-VITRO; KAHALALIDES; DEPSIPEPTIDE	Mebamamides A and B, new lipopeptides with four d-amino acid residues and a 3,8-dihydroxy-9-methyldecanoic acid residue, were isolated from the green alga Derbesia marina. Their gross structures were elucidated by spectroscopic and ESI-ITMS analyses. The absolute configurations except for the two leucines were revealed based on chiral-phase HPLC analyses of the acid hydrolysate and a modified Mosher's method. A distinction between d-Leu and l-Leu in the sequence was established by the application of a dansyl-Edman method to the partial acid hydrolysate. Mebamamide A did not exhibit any growth inhibitory activity against HeLa and HL60 cells at 10 mu M, and mebamamide B did not exhibit any growth inhibitory activity against those cells at 100 mu M. Additionally, it was suggested that mebamamide B induced the differentiation of HL60 cells into macrophage-like cells at 100 mu M.	[Iwasaki, Arihiro; Ohno, Osamu; Sumimoto, Shinpei; Suenaga, Kiyotake] Keio Univ, Dept Chem, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan; [Matsubara, Teruhiko; Sato, Toshinori] Keio Univ, Dept Biosci & Informat, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan; [Shimada, Satoshi] Ochanomizu Univ, Dept Biol, Bunkyo Ku, Tokyo 1120012, Japan	Suenaga, K (reprint author), Keio Univ, Dept Chem, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	suenaga@chem.keio.ac.jp	Suenaga, Kiyotake/F-7632-2014		Ministry of Education, Culture, Sports, Science and Technology of Japan [24310160, 20436992]; Shimadzu Science Foundation; Novartis Foundation (Japan) for the Promotion of Science; Keio Gijuku Fukuzawa Memorial Fund for the Advancement of Education and Research	This work was supported in part by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (24310160 and 20436992), the Shimadzu Science Foundation, the Novartis Foundation (Japan) for the Promotion of Science, and the Keio Gijuku Fukuzawa Memorial Fund for the Advancement of Education and Research.	MARFEY P, 1984, CARLSBERG RES COMMUN, V49, P591, DOI 10.1007/BF02908688; HAMANN MT, 1993, J AM CHEM SOC, V115, P5825, DOI 10.1021/ja00066a061; ROVERA G, 1979, P NATL ACAD SCI USA, V76, P2779, DOI 10.1073/pnas.76.6.2779; Hamann MT, 1996, J ORG CHEM, V61, P6594, DOI 10.1021/jo960877+; Iwasaki A, 2014, RSC ADV, V4, P12840, DOI 10.1039/c4ra00132j; OHTANI I, 1991, J AM CHEM SOC, V113, P4092, DOI 10.1021/ja00011a006; Blunt JW, 2014, NAT PROD REP, V31, P160, DOI 10.1039/c3np70117d; Goetz G, 1997, J NAT PROD, V60, P562, DOI 10.1021/np970045m; Hamann M. T., 2011, J CHEM REV, V111, P3208; Iwasaki A, 2014, TETRAHEDRON LETT, V55, P4126, DOI 10.1016/j.tetlet.2014.05.099; Iwasaki A, 2010, TETRAHEDRON LETT, V51, P959, DOI 10.1016/j.tetlet.2009.12.041; Iwasaki A, 2014, B CHEM SOC JPN, V87, P609, DOI 10.1246/bcsj.20140008; Iwasaki A., 2015, K ORG LETT, V17, P652; Kan Y, 1999, J NAT PROD, V62, P1169, DOI 10.1021/np990053y; Lee HJ, 2006, BIOTECHNOL BIOPROC E, V11, P80, DOI 10.1007/BF02931873; Rao KV, 2008, J NAT PROD, V71, P772, DOI 10.1021/np070508g; Seo Y, 2006, BIOTECHNOL BIOPROC E, V11, P160, DOI 10.1007/BF02931901; Walker J M, 1984, Methods Mol Biol, V1, P213, DOI 10.1385/0-89603-062-8:213	18	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0163-3864	1520-6025		J NAT PROD	J. Nat. Prod.	APR	2015	78	4					901	908		10.1021/acs.jnatprod.5b00168		8	Plant Sciences; Chemistry, Medicinal; Pharmacology & Pharmacy	Plant Sciences; Pharmacology & Pharmacy	CG9UH	WOS:000353665100039		
J	Nakajima, E; Ishigouoka, T; Yoshida, T; Sato, T; Miyamoto, T; Shirai, M; Sengoku, K				Nakajima, E.; Ishigouoka, T.; Yoshida, T.; Sato, T.; Miyamoto, T.; Shirai, M.; Sengoku, K.			Prenatal diagnosis of congenital imperforate hymen with hydrocolpos	JOURNAL OF OBSTETRICS AND GYNAECOLOGY			English	Article							HYDROMETROCOLPOS; SECONDARY		[Nakajima, E.; Miyamoto, T.; Sengoku, K.] Asahikawa Med Univ, Dept Obstet & Gynecol, Asahikawa, Hokkaido 0788510, Japan; [Nakajima, E.; Ishigouoka, T.; Yoshida, T.] Asahikawa Kohsei Hosp, Dept Obstet & Gynecol, Asahikawa, Hokkaido, Japan; [Sato, T.; Shirai, M.] Asahikawa Kohsei Hosp, Dept Pediat, Asahikawa, Hokkaido, Japan	Miyamoto, T (reprint author), Asahikawa Med Univ, Dept Obstet & Gynecol, Midorigaokahigashi 2-1-1-1, Asahikawa, Hokkaido 0788510, Japan.	toshim@asahikawa-med.ac.jp					Adaletli I, 2007, AM J ROENTGENOL, V189, pW23, DOI 10.2214/AJR.05.1560; MCCANN J, 1990, PEDIATRICS, V86, P428; Odibo AO, 1997, ULTRASOUND OBST GYN, V9, P419, DOI 10.1046/j.1469-0705.1997.09060419.x; MOR N, 1986, EUR J OBSTET GYN R B, V22, P225, DOI 10.1016/0028-2243(86)90069-9; REED MH, 1973, AM J ROENTGENOL, V118, P1; Tseng JJ, 2008, J CHIN MED ASSOC, V71, P325, DOI 10.1016/S1726-4901(08)70132-1; WESTERHO.FC, 1964, AM J OBSTET GYNECOL, V89, P957; WINDERL LM, 1995, OBSTET GYNECOL, V85, P857, DOI 10.1016/0029-7844(94)00405-3	8	0	0	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	0144-3615			J OBSTET GYNAECOL	J. Obstet. Gynaecol.	APR	2015	35	3					311	313		10.3109/01443615.2014.951608		3	Obstetrics & Gynecology	Obstetrics & Gynecology	CH3IP	WOS:000353924500026		
J	Yoshida, A; Nii, S; Matsushita, H; Morii, Y; Watanabe, K; Wakatsuki, A				Yoshida, A.; Nii, S.; Matsushita, H.; Morii, Y.; Watanabe, K.; Wakatsuki, A.			Parasitic myoma in women after laparoscopic myomectomy: A late sequela of morcellation?	JOURNAL OF OBSTETRICS AND GYNAECOLOGY			English	Article									[Yoshida, A.; Nii, S.; Matsushita, H.; Morii, Y.; Watanabe, K.; Wakatsuki, A.] Aichi Med Univ, Sch Med, Dept Obstet & Gynecol, Nagakute, Aichi 4801195, Japan	Matsushita, H (reprint author), Aichi Med Univ, Dept Obstet & Gynecol, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan.	hirosm@aichi-med-u.ac.jp					Cucinella G, 2011, FERTIL STERIL, V96, pE90, DOI 10.1016/j.fertnstert.2011.05.095; Nezhat C, 2010, J MINIM INVAS GYN, V17, P544, DOI 10.1016/j.jmig.2010.04.004; Epstein J, 2009, FERTIL STERIL, V91, P932; Hill DJ, 1997, J AM ASSOC GYN LAP, V4, P277, DOI 10.1016/S1074-3804(97)80024-2; Niroumand N, 1994, J AM ASS GYNECOL L 2, V1, pS26, DOI 10.1016/S1074-3804(05)80953-3; Rajab KE, 2000, INT J GYNECOL OBSTET, V68, P271, DOI 10.1016/S0020-7292(99)00203-9; Takeda A, 2012, EUR J OBSTET GYN R B, V162, P117, DOI 10.1016/j.ejogrb.2012.01.015	7	0	0	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	0144-3615			J OBSTET GYNAECOL	J. Obstet. Gynaecol.	APR	2015	35	3					322	U166		10.3109/01443615.2014.948404		2	Obstetrics & Gynecology	Obstetrics & Gynecology	CH3IP	WOS:000353924500033		
J	Hashimoto, A; Chiba, N; Tsuno, H; Komiya, A; Furukawa, H; Matsui, T; Nishino, J; Tohma, S				Hashimoto, Atsushi; Chiba, Noriyuki; Tsuno, Hirotaka; Komiya, Akiko; Furukawa, Hiroshi; Matsui, Toshihiro; Nishino, Jinju; Tohma, Shigeto			Incidence of Malignancy and the Risk of Lymphoma in Japanese Patients with Rheumatoid Arthritis Compared to the General Population	JOURNAL OF RHEUMATOLOGY			English	Article						CANCER; EPIDEMIOLOGY; LYMPHOMA; METHOTREXATE; RHEUMATOID ARTHRITIS	EPSTEIN-BARR-VIRUS; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; INFLAMMATORY-BOWEL-DISEASE; LYMPHOPROLIFERATIVE DISORDERS; COLORECTAL-CANCER; AMERICAN-COLLEGE; REVISED CRITERIA; METHOTREXATE; METAANALYSIS; THERAPY	Objective. Recent advances in the management of patients with rheumatoid arthritis (RA) increased the rates of disease remission and patient life expectancy, while malignancy has become a more common cause of death. Here, we report the incidence of malignancy in a nationwide survey of Japanese patients with RA compared to the general population, focusing on the risk of lymphoma, which often arises in patients with RA. Methods. Data on the occurrence of malignancy were collected from patients registered in a nationwide Japanese cohort database, the National Database of Rheumatic Diseases by iR-net in Japan, from 2003 to 2012. To adjust for different population composition and to compare the incidence of malignancy with the general population, standardized incidence rates (SIR) were calculated. To identify risk factors for lymphoma, individual patient data were obtained for multivariate analysis for the year before lymphoma diagnosis. Results. In 10 years, the cohort composed of 66,953 patient-years yielded 559 malignancies, most frequently lung cancer, followed by gastric cancer, breast cancer, and lymphoma. The overall incidence of malignancies in patients with RA was slightly lower than in the general population (SIR 0.89, 95% CI 0.82-0.97). However, lymphoma risk was significantly higher (SIR 3.43, 95% CI 2.59-4.28), whereas risk of colon, rectal, or liver cancer was lower. Significant risk factors for lymphoma were the use of methotrexate or tacrolimus, and higher age. Conclusion. Patients with RA had no higher overall incidence of malignancies, but lymphoma was significantly more frequent than in the general population.	Natl Hosp Org, Sagamihara Natl Hosp, Dept Rheumatol, Dept Clin Lab, Sagamihara, Kanagawa 2520392, Japan; Natl Hosp Org, Sagamihara Natl Hosp, Clin Res Ctr Allergy Rheumatol, Sagamihara, Kanagawa 2520392, Japan; Morioka Natl Hosp, Dept Rheumatol, Morioka, Iwate, Japan; Nishino Orthoped Clin, Tokyo, Japan	Hashimoto, A (reprint author), Natl Hosp Org, Sagamihara Natl Hosp, Dept Rheumatol, Minami Ku, 18-1 Sakuradai, Sagamihara, Kanagawa 2520392, Japan.	a-hashimoto@sagamihara-hosp.gr.jp			Ministry of Health, Labor and Welfare of Japan	Supported in part by Grants-in-Aid for Scientific Research from the Ministry of Health, Labor and Welfare of Japan.	Mercer LK, 2013, RHEUMATOLOGY, V52, P91, DOI 10.1093/rheumatology/kes350; Niitsu N, 2010, CANCER SCI, V101, P1309, DOI 10.1111/j.1349-7006.2010.01517.x; GRIDLEY G, 1993, J NATL CANCER I, V85, P307, DOI 10.1093/jnci/85.4.307; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Askling J, 2005, ANN RHEUM DIS, V64, P1421, DOI 10.1136/ard.2004.033993; Nakajima A, 2010, SCAND J RHEUMATOL, V39, P360, DOI 10.3109/03009741003604542; KAMEL OW, 1993, NEW ENGL J MED, V328, P1317, DOI 10.1056/NEJM199305063281806; Rickinson AB, 1997, ANNU REV IMMUNOL, V15, P405, DOI 10.1146/annurev.immunol.15.1.405; WEISS LM, 1991, AM J PATHOL, V139, P1259; Pasternak B, 2013, AM J EPIDEMIOL, V177, P1296, DOI 10.1093/aje/kws375; Franklin J, 2006, ANN RHEUM DIS, V65, P617, DOI 10.1136/ard.2005.044784; Chen YJ, 2011, ARTHRITIS RHEUM-US, V63, P352, DOI 10.1002/art.30134; Secretan B, 2009, LANCET ONCOL, V10, P1033, DOI 10.1016/S1470-2045(09)70326-2; Smith MA, 2010, ALIMENT PHARM THER, V32, P119, DOI 10.1111/j.1365-2036.2010.04330.x; WOLFE F, 1994, ARTHRITIS RHEUM, V37, P481, DOI 10.1002/art.1780370408; Johnston A, 2005, CLIN IMMUNOL, V114, P154, DOI 10.1016/j.clim.2004.09.001; Zintzaras E, 2005, ARCH INTERN MED, V165, P2337, DOI 10.1001/archinte.165.20.2337; Hoshida Y, 2007, J RHEUMATOL, V34, P322; Salloum E, 1996, J CLIN ONCOL, V14, P1943; Feng WH, 2004, J NATL CANCER I, V96, P1691, DOI 10.1093/jnci/djh313; Stolt P, 2003, ANN RHEUM DIS, V62, P835, DOI 10.1136/ard.62.9.835; Baecklund E, 2006, ARTHRITIS RHEUM, V54, P692, DOI 10.1002/art.21675; Pandurangan AK, 2013, ASIAN PAC J CANCER P, V14, P2201, DOI 10.7314/APJCP.2013.14.4.2201; Rostom A, 2007, ANN INTERN MED, V146, P376; STEINBROCKER O, 1949, JAMA-J AM MED ASSOC, V140, P659; Ichikawa A, 2013, EUR J HAEMATOL, V91, P20, DOI 10.1111/ejh.12116; HOCHBERG MC, 1992, ARTHRITIS RHEUM, V35, P498, DOI 10.1002/art.1780350502; SILMAN AJ, 1988, ANN RHEUM DIS, V47, P988, DOI 10.1136/ard.47.12.988; Lopez-Olivo MA, 2012, JAMA-J AM MED ASSOC, V308, P898, DOI 10.1001/2012.jama.10857; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Berkel HJ, 1996, EPIDEMIOL REV, V18, P205; Cibere J, 1997, ARTHRITIS RHEUM, V40, P1580, DOI 10.1002/art.1780400906; HAKULINEN T, 1985, AM J MED, V78, P29, DOI 10.1016/0002-9343(85)90242-6; Hemminki K, 2008, RHEUMATOLOGY, V47, P698, DOI 10.1093/rheumatology/ken130; Huang DS, 2005, WORLD J GASTROENTERO, V11, P204; Huang WK, 2014, RHEUMATOL INT, V34, P1379, DOI 10.1007/s00296-014-2982-6; ISOMAKI HA, 1978, J CHRON DIS, V31, P691, DOI 10.1016/0021-9681(78)90071-1; Kim YJ, 2012, J RHEUMATOL, V39, P226, DOI 10.3899/jrheum.110704; Matsuda A, 2013, JPN J CLIN ONCOL, V43, P328, DOI 10.1093/jjco/hys233; Ozkan EA, 2014, EXP CLIN TRANSPLANT, V12, P142, DOI 10.6002/ect.25Liver.P30; PRIOR P, 1984, ANN RHEUM DIS, V43, P128, DOI 10.1136/ard.43.2.128; Saeki Y, 2012, EXPERT REV CLIN IMMU, V8, P455, DOI [10.1586/eci.12.35, 10.1586/ECI.12.35]; Sekiguchi Yasunobu, 2012, J Clin Exp Hematop, V52, P211; Shinomiya F, 2008, MOD RHEUMATOL, V18, P165, DOI 10.1007/s10165-008-0031-6; Smitten AL, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2404; SYMMONS DPM, 1985, AM J MED, V78, P22, DOI 10.1016/0002-9343(85)90241-4; Wong AK, 2012, CLIN RHEUMATOL, V31, P631, DOI 10.1007/s10067-011-1895-y; Yamada T, 2011, RHEUMATOL INT, V31, P1487, DOI 10.1007/s00296-010-1524-0	48	1	2	J RHEUMATOL PUBL CO	TORONTO	365 BLOOR ST E, STE 901, TORONTO, ONTARIO M4W 3L4, CANADA	0315-162X	1499-2752		J RHEUMATOL	J. Rheumatol.	APR	2015	42	4					564	571		10.3899/jrheum.140533		8	Rheumatology	Rheumatology	CH1IQ	WOS:000353775400003		
J	Takeuchi, T; Miyasaka, N; Inui, T; Yano, T; Yoshinari, T; Abe, T; Koike, T				Takeuchi, Tsutomu; Miyasaka, Nobuyuki; Inui, Takashi; Yano, Toshiro; Yoshinari, Toru; Abe, Tohru; Koike, Takao			Prediction of Clinical Response After 1 Year of Infliximab Therapy in Rheumatoid Arthritis Based on Disease Activity at 3 Months: Posthoc Analysis of the RISING Study	JOURNAL OF RHEUMATOLOGY			English	Article						INFLIXIMAB; RHEUMATOID ARTHRITIS; CLINICAL RESPONSE; DISEASE ACTIVITY; PREDICTION; RISING STUDY	MODIFYING ANTIRHEUMATIC DRUGS; PLUS METHOTREXATE; EULAR RECOMMENDATIONS; DOSE-ESCALATION; DOUBLE-BLIND; TRIAL; MANAGEMENT; REMISSION; PATTERNS; EFFICACY	Objective. To investigate the probability of clinical remission (REM) or low disease activity (LDA) after 1 year of infliximab (IFX) therapy based on disease activity at 3 months in patients with rheumatoid arthritis (RA). Methods. Methotrexate-refractory patients with RA received 3 mg/kg of IFX at weeks 0, 2, and 6, followed by 3 mg/kg, 6 mg/kg, or 10 mg/kg every 8 weeks from Week 14 (W14) to Week 46. Correlation of disease activity at W14 with disease activity at W54 and probability of REM/LDA at W54 were analyzed in each dosing group. Results. Disease activities at W14 were significantly correlated with both disease activity at W54 and probability of REM/LDA at W54 in patients continuing 3 mg/kg as well as in those receiving 6 mg/kg or 10 mg/kg therapy from W14. Results showed that, if approximate REM or LDA had not been achieved by W14, > 50% of patients continuing 3 mg/kg therapy would not be able to achieve REMor LDAatW54. However, even in patients with high or moderate disease activity at W14, dose escalation to 6 mg/kg or 10 mg/kg enabled many to achieve REM/LDA. Conclusion. Disease activity at W14 in standard-dose IFX therapy enabled the prediction of longterm clinical response at continued standard dose, as well as subsequent escalated-dose regimens. Disease activity at W14 was hypothesized to be an important index for IFX treatment strategy.	[Takeuchi, Tsutomu] Keio Univ, Sch Med, Dept Internal Med, Div Rheumatol, Tokyo 1608582, Japan; [Miyasaka, Nobuyuki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Tokyo, Japan; [Inui, Takashi; Yano, Toshiro; Yoshinari, Toru] Mitsubishi Tanabe Pharma Corp, Osaka, Japan; [Abe, Tohru] Saitama Med Univ, Saitama Med Ctr, Saitama, Japan; [Koike, Takao] Sapporo Med Ctr NTT EC, Sapporo, Hokkaido, Japan	Takeuchi, T (reprint author), Keio Univ, Sch Med, Dept Internal Med, Div Rheumatol,Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	tsutake@z5.keio.jp	Takeuchi, Tsutomu/L-2327-2013	Takeuchi, Tsutomu/0000-0003-1111-8218	Mitsubishi Tanabe Pharma Corporation; Mitsubishi Tanabe Pharma	Mitsubishi Tanabe Pharma Corporation sponsored this clinical trial and was responsible for the collection and analysis of data. T. Takeuchi and T. Koike have received lecture fees from Mitsubishi Tanabe Pharma. N. Miyasaka has received grant support from Mitsubishi Tanabe Pharma. T. Inui, T. Yano, and T. Yoshinari are employees of Mitsubishi Tanabe Pharma.	Smolen JS, 2005, ARTHRITIS RHEUM, V52, P1020, DOI 10.1002/art.20982; Yazici Y, 2009, J RHEUMATOL, V36, P907, DOI 10.3899/jrheum.080592; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Felson DT, 2011, ANN RHEUM DIS, V70, P404, DOI 10.1136/ard.2011.149765; Genovese MC, 2005, NEW ENGL J MED, V353, P1114, DOI 10.1056/NEJMoa050524; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; Cohen SB, 2006, ARTHRITIS RHEUM, V54, P2793, DOI 10.1002/art.22025; Takeuchi T, 2009, MOD RHEUMATOL, V19, P478, DOI 10.1007/s10165-009-0195-8; Westhovens R, 2006, ARTHRITIS RHEUM, V54, P1075, DOI 10.1002/art.21734; Rahman MU, 2007, ANN RHEUM DIS, V66, P1233, DOI 10.1136/ard.2006.065995; Nam JL, 2010, ANN RHEUM DIS, V69, P976, DOI 10.1136/ard.2009.126573; Smolen JS, 2009, LANCET, V374, P210, DOI 10.1016/S0140-6736(09)60506-7; Aletaha D, 2007, ARTHRITIS RHEUM, V56, P3226, DOI 10.1002/art.22943; van der Bijl AE, 2007, ARTHRITIS RHEUM, V56, P2129, DOI 10.1002/art.22718; Smolen JS, 2009, ANN RHEUM DIS, V68, P823, DOI 10.1136/ard.2008.090019; van Tuyl LHD, 2010, ARTHRIT CARE RES, V62, P108, DOI 10.1002/acr.20021; Inoue E, 2007, ANN RHEUM DIS, V66, P407, DOI 10.1136/ard.2006.054205; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Curtis JR, 2012, ARTHRIT CARE RES, V64, P658, DOI 10.1002/acr.21600; van Schouwenburg PA, 2013, NAT REV RHEUMATOL, V9, P164, DOI 10.1038/nrrheum.2013.4; Pavelka K, 2009, ANN RHEUM DIS, V68, P1285, DOI 10.1136/ard.2008.090860; SHARP JT, 1971, ARTHRITIS RHEUM, V14, P706, DOI 10.1002/art.1780140605; Bolge SC, 2012, CLIN THER, V34, P2286, DOI 10.1016/j.clinthera.2012.10.010; Dougados MR, 2014, J RHEUMATOL, V41, P1922, DOI 10.3899/jrheum.131238; St Clair E William, 2002, Arthritis Rheum, V46, P1451, DOI 10.1002/art.10302; St Clair E William, 2004, Arthritis Rheum, V50, P3432, DOI 10.1002/art.20568; Takeuchi T, 2011, ANN RHEUM DIS, V70, P1208, DOI 10.1136/ard.2011.153023	27	2	2	J RHEUMATOL PUBL CO	TORONTO	365 BLOOR ST E, STE 901, TORONTO, ONTARIO M4W 3L4, CANADA	0315-162X	1499-2752		J RHEUMATOL	J. Rheumatol.	APR	2015	42	4					599	607		10.3899/jrheum.140572		9	Rheumatology	Rheumatology	CH1IQ	WOS:000353775400008		
J	Yamazaki, H; Sakai, R; Koike, R; Miyazaki, Y; Tanaka, M; Nanki, T; Watanabe, K; Yasuda, S; Kurita, T; Kaneko, Y; Tanaka, Y; Nishioka, Y; Takasaki, Y; Nagasaka, K; Nagasawa, H; Tohma, S; Dohi, M; Sugihara, T; Sugiyama, H; Kawaguchi, Y; Inase, N; Ochi, S; Hagiyama, H; Kohsaka, H; Miyasaka, N; Harigai, M				Yamazaki, Hayato; Sakai, Ryoko; Koike, Ryuji; Miyazaki, Yasunari; Tanaka, Michi; Nanki, Toshihiro; Watanabe, Kaori; Yasuda, Shinsuke; Kurita, Takashi; Kaneko, Yuko; Tanaka, Yoshiya; Nishioka, Yasuhiko; Takasaki, Yoshinari; Nagasaka, Kenji; Nagasawa, Hayato; Tohma, Shigeto; Dohi, Makoto; Sugihara, Takahiko; Sugiyama, Haruhito; Kawaguchi, Yasushi; Inase, Naohiko; Ochi, Sae; Hagiyama, Hiroyuki; Kohsaka, Hitoshi; Miyasaka, Nobuyuki; Harigai, Masayoshi		PREVENT Study Grp	Assessment of Risks of Pulmonary Infection During 12 Months Following Immunosuppressive Treatment for Active Connective Tissue Diseases: A Large-scale Prospective Cohort Study	JOURNAL OF RHEUMATOLOGY			English	Article						CONNECTIVE TISSUE DISEASES; IMMUNOSUPPRESSIVE AGENTS; INFECTION; COHORT STUDIES; CORTICOSTEROIDS	SYSTEMIC-LUPUS-ERYTHEMATOSUS; COMMUNITY-ACQUIRED PNEUMONIA; PNEUMOCYSTIS-CARINII-PNEUMONIA; RHEUMATOID-ARTHRITIS; SERIOUS INFECTION; GLUCOCORTICOID THERAPY; AEROSOLIZED PENTAMIDINE; WEGENERS-GRANULOMATOSIS; PROGNOSTIC INFLUENCE; JAPANESE PATIENTS	Objective. Pulmonary infections (PI) are leading causes of death in patients with connective tissue diseases (CTD). The PREVENT study (Pulmonary infections in patients REceiving immunosuppressiVE treatmeNT for CTD) assessed risk of PI in patients with active CTD in the contemporary era of advanced immunosuppressive therapy. Methods. In patients who started corticosteroids (n = 763), conventional immunosuppressants or biologics for active CTD were enrolled. Clinical and laboratory data, usage of drugs, and occurrence of PI were collected for 12 months. Baseline risk factors were investigated using Cox regression analysis. A nested case-control (NCC) study was performed with 1: 2 matched case-control pairs to assess the risk for each drug category. Results. During the observation period, 32 patients died (4.2%) and 66 patients were lost to followup (8.6%). Patients with PI (n = 61, 8%) had a significantly worse accumulated survival rate than patients without (p < 0.01). Cox hazard regression analysis using baseline data showed that these factors were significantly associated with PI: age >= 65 years (HR 3.87, 95% CI 2.22-6.74), >= 20 pack-years of smoking (2.63, 1.37-5.04), higher serum creatinine level (1.21, 1.05-1.41 per 1.0 mg/dl increase), and maximum prednisolone (PSL) dose during the first 2 weeks of treatment (2.81, 1.35-5.86 per 1.0 mg/kg/day increase). Logistic regression analysis by an NCC study revealed that maximum PSL dose within 14 days before PI (OR 4.82, 95% CI 1.36-17.01 per 1.0 mg/dl increase; 2.57, 1.28-5.16 if >= 0.5 mg/kg/day) was significantly associated with the events, while other immunosuppressants were not. Conclusion. Physicians should be aware of the higher risks for corticosteroids of PI than other immunosuppressants and assess these risk factors before immunosuppressive treatment, to prevent PI.	Tokyo Med & Dent Univ, Dept Med & Rheumatol, Dept Pharmacovigilance, Tokyo, Japan; Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Clin Res Ctr, Dept Integrated Pulmonol, Tokyo, Japan; Tokyo Med & Dent Univ, Global Ctr Excellence GCOE Program, Tokyo, Japan; Tokyo Med & Dent Univ, Int Res Ctr Mol Sci Tooth & Bone Dis, Tokyo, Japan; Keio Univ, Sch Med, Div Rheumatol, Tokyo, Japan; Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan; Juntendo Univ, Sch Med, Dept Internal Med & Rheumatol, Tokyo 113, Japan; Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan; Tokyo Metropolitan Geriatr Hosp, Dept Rheumatol, Tokyo 173, Japan; Natl Ctr Global Hlth & Med, Dept Resp Med, Tokyo, Japan; Tokyo Med & Dent Univ, Inst Rheumatol, Tokyo, Japan; Tokyo Metropolitan Bokutoh Hosp, Dept Rheumatol, Tokyo TOKYO;, Japan; Hokkaido Univ, Grad Sch Med, Dept Med 2, Sapporo, Hokkaido, Japan; Univ Occupat & Environm Hlth, Dept Internal Med 1, Kitakyushu, Fukuoka 807, Japan; Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Resp Med & Rheumatol, Tokushima 770, Japan; Ome Municipal Gen Hosp, Dept Rheumatol, Ome, Japan; Saitama Med Univ, Saitama Med Ctr, Dept Rheumatol Clin Immunol, Kawagoe, Saitama, Japan; Natl Hosp Org, Sagamihara Natl Hosp, Clin Res Ctr Allergy & Rheumatol, Dept Rheumatol, Sagamihara, Kanagawa, Japan; Yokohama City Minato Red Cross Hosp, Dept Rheumatol, Yokohama, Kanagawa, Japan	Harigai, M (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Pharmacovigilance, Bunkyo Ku, 1-5-45 Yushima, Tokyo, Japan.	mharigai.mpha@tmd.ac.jp			Ministry of Health, Labor and Welfare, Japan [H23-meneki-sitei-016, H19-meneki-ippan-009]; Japan Society for the Promotion of Science [24890057, 19590530, 26590171, 20390158]; Abbvie G. K.; Astellas Co. Ltd.; Bristol-Myers Squibb Japan; Chugai Pharmaceutical Co. Ltd.; Eisai Co. Ltd.; Mitsubishi Tanabe Pharma Corp.; Takeda Pharmaceutical Co. Ltd.; Japanese Ministry of Education, Global Center of Excellence Program, International Research Center for Molecular Science in Tooth and Bone Diseases; Takeda Pharmaceutical Co.	Supported by a grant-in-aid from the Ministry of Health, Labor and Welfare, Japan (H23-meneki-sitei-016 and H19-meneki-ippan-009 to N. Miyasaka), and by grants-in-aid for scientific research from the Japan Society for the Promotion of Science (#24890057 to R. Sakai, #19590530 to R. Koike, #26590171 to M. Tanaka, and #20390158 to M. Harigai). Also supported by grants for pharmacovigilance research on biologics from Abbvie G. K., Astellas Co. Ltd., Bristol-Myers Squibb Japan, Chugai Pharmaceutical Co. Ltd., Eisai Co. Ltd., Mitsubishi Tanabe Pharma Corp., and Takeda Pharmaceutical Co. Ltd. (to M. Harigai), and by a grant from the Japanese Ministry of Education, Global Center of Excellence Program, International Research Center for Molecular Science in Tooth and Bone Diseases. TMDU received unrestricted research grants from Abbvie G. K., Astellas Co. Ltd., Bristol-Myers Squibb Japan, Chugai Pharmaceutical Co. Ltd., Eisai Co. Ltd., Mitsubishi Tanabe Pharma Corp., and Takeda Pharmaceutical Co. for the Department of Pharmacovigilance, with which TMDU paid salaries for H. Yamazaki, R. Sakai, R. Koike, M. Tanaka, T. Nanki, K. Watanabe, and M. Harigai.	Dixon WG, 2012, ANN RHEUM DIS, V71, P1128, DOI 10.1136/annrheumdis-2011-200702; Takeuchi T, 2008, ANN RHEUM DIS, V67, P189, DOI 10.1136/ard.2007.072967; James MT, 2009, AM J KIDNEY DIS, V54, P24, DOI 10.1053/j.ajkd.2009.04.005; Marie I, 2011, SEMIN ARTHRITIS RHEU, V41, P48, DOI 10.1016/j.semarthrit.2010.08.003; Bosch X, 2006, LUPUS, V15, P584, DOI 10.1177/0961203306071919; Duru N, 2013, ANN RHEUM DIS, V72, P1905, DOI 10.1136/annrheumdis-2013-203249; Nakajima A, 2010, SCAND J RHEUMATOL, V39, P360, DOI 10.3109/03009741003604542; Jackson ML, 2004, CLIN INFECT DIS, V39, P1642, DOI 10.1086/425615; Baik I, 2000, ARCH INTERN MED, V160, P3082, DOI 10.1001/archinte.160.20.3082; SULLIVAN KM, 1988, BLOOD, V72, P546; LEVINE SJ, 1991, AM REV RESPIR DIS, V144, P760; Almirall J, 2008, EUR RESPIR J, V31, P1274, DOI 10.1183/09031936.00095807; Noel V, 2001, ANN RHEUM DIS, V60, P1141, DOI 10.1136/ard.60.12.1141; Wolfe F, 2006, ARTHRITIS RHEUM, V54, P628, DOI 10.1002/art.21568; Sakai R, 2012, ARTHRIT CARE RES, V64, P1125, DOI 10.1002/acr.21666; Widdifield J, 2013, ARTHRIT CARE RES, V65, P353, DOI 10.1002/acr.21812; GODEAU B, 1992, ANN RHEUM DIS, V51, P627, DOI 10.1136/ard.51.5.627; Kato S, 2008, CLIN J AM SOC NEPHRO, V3, P1526, DOI 10.2215/CJN.00950208; Green H, 2007, MAYO CLIN PROC, V82, P1052; Dall'Era M, 2011, CURR RHEUMATOL REP, V13, P308, DOI 10.1007/s11926-011-0186-6; Dixon WG, 2011, ANN RHEUM DIS, V70, P956, DOI 10.1136/ard.2010.144741; MILLER LG, 1982, CHEST, V82, P526, DOI 10.1378/chest.82.5.526; Loeb M, 2009, J AM GERIATR SOC, V57, P1036, DOI 10.1111/j.1532-5415.2009.02259.x; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Crowson CS, 2012, ARTHRITIS RHEUM-US, V64, P2847, DOI 10.1002/art.34530; Goldblatt F, 2009, LUPUS, V18, P682, DOI 10.1177/0961203308101019; Ward MM, 1999, ARTHRITIS RHEUM, V42, P780, DOI 10.1002/1529-0131(199904)42:4<780::AID-ANR23>3.0.CO;2-M; Teh CL, 2013, LUPUS, V22, P106, DOI 10.1177/0961203312465780; Marie I, 2011, AUTOIMMUN REV, V11, P6, DOI 10.1016/j.autrev.2011.06.007; JONES JG, 1980, LANCET, V1, P66; Guillevin L, 1997, ARTHRITIS RHEUM, V40, P2187, DOI 10.1002/art.1780401213; Farr BM, 2000, RESP MED, V94, P954, DOI 10.1053/rmed.2000.0865; Bligny D, 2004, ARTHRIT RHEUM-ARTHR, V51, P83, DOI 10.1002/art.20082; Breedveld FC, 2011, ARTHRITIS RES THER, V13, DOI [10.1186/1478-6354-13-S1-S3, 10.1186/ar3093]; Chan M, 2009, EXPERT OPIN PHARMACO, V10, P1273, DOI 10.1517/14656560902946401; HARDY WD, 1989, AM J MED, V87, P329; Harigai M, 2007, NEW ENGL J MED, V357, P1874, DOI 10.1056/NEJMc070728; Kadoya A, 1996, J RHEUMATOL, V23, P1186; Kanik KS, 1997, RHEUM DIS CLIN N AM, V23, P955, DOI 10.1016/S0889-857X(05)70368-9; Komano Y, 2009, ARTHRIT RHEUM-ARTHR, V61, P305, DOI 10.1002/art.24283; MARCY TW, 1987, CLIN CHEST MED, V8, P381; Pryor BD, 1996, ARTHRITIS RHEUM, V39, P1475, DOI 10.1002/art.1780390906; Ruiz-Irastorza G, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2764; Schimmer B, 2011, GOODMAN GILMANS PHAR, V12th, P1209; Yamazaki H, 2011, J RHEUMATOL, V38, P777, DOI 10.3899/jrheum.100858	45	0	0	J RHEUMATOL PUBL CO	TORONTO	365 BLOOR ST E, STE 901, TORONTO, ONTARIO M4W 3L4, CANADA	0315-162X	1499-2752		J RHEUMATOL	J. Rheumatol.	APR	2015	42	4					614	622		10.3899/jrheum.140778		9	Rheumatology	Rheumatology	CH1IQ	WOS:000353775400011		
J	Yokota, S; Itoh, Y; Morio, T; Sumitomo, N; Daimaru, K; Minota, S				Yokota, Shumpei; Itoh, Yasuhiko; Morio, Tomohiro; Sumitomo, Naokata; Daimaru, Kaori; Minota, Seiji			Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis under Treatment with Tocilizumab	JOURNAL OF RHEUMATOLOGY			English	Article						JUVENILE IDIOPATHIC ARTHRITIS; POSTMARKETING PRODUCT SURVEILLANCE; TOCILIZUMAB; MACROPHAGE ACTIVATION SYNDROME; INFECTION-ASSOCIATED HEMOPHAGOCYTIC SYNDROME; INTERLEUKINS	STEM-CELL TRANSPLANTATION; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; RHEUMATOID-ARTHRITIS; CHILDREN; INFLAMMATION; INTERLEUKIN-6; DYSFUNCTION; DISORDERS; THERAPY; ENDOTHELIUM	Objective. To identify macrophage activation syndrome (MAS) in patients with systemic juvenile idiopathic arthritis (sJIA) undergoing tocilizumab (TCZ) treatment, and to confirm laboratory marker changes and responses to treatment in patients with MAS receiving TCZ. Methods. In Japan, 394 patients with sJIA were registered in an all-patient registry surveillance of TCZ as of January 15, 2012. TCZ (8 mg/kg) was administered every 2 weeks to patients with sJIA. MAS, hemophagocytic lymphohistiocytosis, or Epstein-Barr virus-associated hemophagocytic syndrome (EB-VAHS) was reported in 23 of these patients (25 events). The Safety Evaluation Committee of Tocilizumab for JIA reviewed these cases and clinically evaluated the data and laboratory findings using their own therapeutic experience. Events were categorized into 4 groups: definitive MAS, probable MAS, EB-VAHS, and non-MAS. Results. The committee's review revealed 3 events of definitive MAS in 3 patients, 12 events of probable MAS in 11 patients, 2 events of EB-VAHS in 2 patients, and 8 events of non-MAS in 8 patients. There were 2 patients who developed 2 events: 2 events in 1 patient were classified into definitive MAS and probable MAS, and 2 events in another patient were classified into probable MAS. In patients with definitive or probable MAS, common clinical manifestations and laboratory findings of MAS were observed. Changes in laboratory data observed in patients with EB-VAHS were similar to those observed in patients with MAS. Conclusion. These results suggest that the clinical/laboratory features in the course of MAS appear to be similar among patients regardless of whether TCZ is administered. Similarities in the pathophysiological background of MAS and EB-VAHS were also suggested.	[Itoh, Yasuhiko] Nippon Med Sch, Dept Pediat, Tokyo, Japan; [Morio, Tomohiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Pediat & Dev Biol, Tokyo, Japan; [Daimaru, Kaori] Chugai Pharmaceut Co Ltd, Tokyo, Japan; [Yokota, Shumpei] Yokohama City Univ, Sch Med, Dept Pediat, Yokohama, Kanagawa 2360004, Japan; [Sumitomo, Naokata] Saitama Med Univ, Int Med Ctr, Dept Pediat Cardiol, Saitama, Japan; [Minota, Seiji] Jichi Med Sch, Div Rheumatol & Clin Immunol, Shimotsuke, Tochigi, Japan	Yokota, S (reprint author), Yokohama City Univ, Sch Med, Dept Pediat, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	syokota@med.yokohama-cu.ac.jp			Chugai Pharmaceutical Co. Ltd.	Supported by Chugai Pharmaceutical Co. Ltd. S. Yokota has received royalties involving tocilizumab from Chugai.	Jennewein C, 2011, MOL MED, V17, P568, DOI 10.2119/molmed.2010.00146; Levi M, 2005, CRIT CARE CLIN, V21, P449, DOI 10.1016/j.ccc.2005.02.001; Bradham CA, 1998, MOL CELL BIOL, V18, P6353; Grom AA, 2003, CURR OPIN RHEUMATOL, V15, P587, DOI 10.1097/00002281-200309000-00011; Ravelli A, 2012, GENES IMMUN, V13, P289, DOI 10.1038/gene.2012.3; Zeft A, 2009, JCR-J CLIN RHEUMATOL, V15, P161, DOI 10.1097/RHU.0b013e3181a4f459; Grom AA, 2004, ARTHRITIS RHEUM, V50, P689, DOI 10.1002/art.20198; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Davi S, 2011, J RHEUMATOL, V38, P764, DOI 10.3899/jrheum.100996; Milner JD, 2010, BLOOD, V116, P2476, DOI 10.1182/blood-2009-11-255174; Ruperto N, 2012, NEW ENGL J MED, V367, P2396, DOI 10.1056/NEJMoa1205099; Behrens EM, 2007, J RHEUMATOL, V34, P1133; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Zoller EE, 2011, J EXP MED, V208, P1203, DOI 10.1084/jem.20102538; Sawhney S, 2001, ARCH DIS CHILD, V85, P421, DOI 10.1136/adc.85.5.421; Levi M, 2002, CRIT CARE MED, V30, pS220, DOI 10.1097/00003246-200205001-00008; Wulffraat NM, 2003, RHEUMATOLOGY, V42, P375, DOI 10.1093/rheumatology/keg074; Shuvaev VV, 2011, J CONTROL RELEASE, V153, P56, DOI 10.1016/j.jconrel.2011.03.022; Kounami S, 2005, ACTA HAEMATOL-BASEL, V113, P124, DOI 10.1159/000083450; Mouy R, 1996, J PEDIATR-US, V129, P750, DOI 10.1016/S0022-3476(96)70160-9; Yokota S, 2008, LANCET, V371, P998, DOI 10.1016/S0140-6736(08)60454-7; Nigrovic PA, 2011, ARTHRITIS RHEUM-US, V63, P545, DOI 10.1002/art.30128; Yoshizaki K, 1998, SPRINGER SEMIN IMMUN, V20, P247, DOI 10.1007/BF00832010; Prakken B, 2011, LANCET, V377, P2138, DOI 10.1016/S0140-6736(11)60244-4; DEBENEDETTI F, 1991, ARTHRITIS RHEUM, V34, P1158, DOI 10.1002/art.1780340912; Jordan MB, 2004, BLOOD, V104, P735, DOI 10.1182/blood-2003-10-3413; Stephan JL, 2001, RHEUMATOLOGY, V40, P1285, DOI 10.1093/rheumatology/40.11.1285; Castillo L, 2009, PEDIATR CRIT CARE ME, V10, P387, DOI 10.1097/PCC.0b013e3181a1ae08; Cassidy JT, 2011, TXB PEDIAT RHEUMATOL, P211; De Benedetti F, 2012, NEW ENGL J MED, V367, P2385, DOI 10.1056/NEJMoa1112802; De Benedetti F, 2009, CURR OPIN RHEUMATOL, V21, P533, DOI 10.1097/BOR.0b013e32832f1445; Demirkol D, 2012, CRIT CARE, V16, DOI 10.1186/cc11256; European Medicines Agency, ROACTEMRA EPAR PROD; Harden LM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-22; Imagawa T, 1997, Ryumachi, V37, P487; Moradinejad MH, 2011, MINERVA PEDIATR, V63, P459; Nádia Emi Aikawa, 2009, Isr Med Assoc J, V11, P635; Nakajima S, 2009, MOD RHEUMATOL, V19, P42, DOI 10.1007/s10165-008-0115-3; Nishiwaki S, 2012, INT J HEMATOL, V95, P428, DOI 10.1007/s12185-012-1023-z; Pharmaceuticals and Medical Devices Agency Japan, ACT INTR INF JAP PRO; Sawar Haroon, 2004, J Rheumatol, V31, P623; US Food and Drug Administration, PRESCR INF ACTEMRA T; Yanagimachi M, 2011, J RHEUMATOL, V38, P769, DOI 10.3899/jrheum.100655; Yokota S, 2005, CLIN REV ALLERG IMMU, V28, P231, DOI 10.1385/CRIAI:28:3:231; Yokota S, 2010, EXPERT REV CLIN IMMU, V6, P735, DOI [10.1586/eci.10.41, 10.1586/ECI.10.41]	45	1	1	J RHEUMATOL PUBL CO	TORONTO	365 BLOOR ST E, STE 901, TORONTO, ONTARIO M4W 3L4, CANADA	0315-162X	1499-2752		J RHEUMATOL	J. Rheumatol.	APR	2015	42	4					712	722		10.3899/jrheum.140288		11	Rheumatology	Rheumatology	CH1IQ	WOS:000353775400023		
J	Taki, H; Nagatani, Y; Matsukawa, M; Mizuno, K; Sato, T				Taki, Hirofumi; Nagatani, Yoshiki; Matsukawa, Mami; Mizuno, Katsunori; Sato, Toru			Fast characterization of two ultrasound longitudinal waves in cancellous bone using an adaptive beamforming technique	JOURNAL OF THE ACOUSTICAL SOCIETY OF AMERICA			English	Article							BAYESIAN PROBABILITY-THEORY; HUMAN PROXIMAL FEMUR; IN-VIVO MEASUREMENTS; QUANTITATIVE ULTRASOUND; SLOW WAVES; NEGATIVE DISPERSION; FAILURE LOADS; PROPAGATION; ATTENUATION; SIMULATION	The received signal in through-transmission ultrasound measurements of cancellous bone consists of two longitudinal waves, called the fast and slow waves. Analysis of these fast and slow waves may reveal characteristics of the cancellous bone that would be good indicators of osteoporosis. Because the two waves often overlap, decomposition of the received signal is an important problem in the characterization of bone quality. This study proposes a fast and accurate decomposition method based on the frequency domain interferometry imaging method with a modified wave transfer function that uses a phase rotation parameter. The proposed method accurately characterized the fast and slow waves in the experimental study, and the residual intensity, which was normalized with respect to the received signal intensity, was less than -20 dB over the bone specimen thickness range from 6 to 15 mm. In the simulation study, the residual intensity was less than -20 dB over the specimen thickness range from 3 to 8 mm. Decomposition of a single received signal takes only 5 s using a lap-top personal computer with a single central processing unit. The proposed method has great potential to provide accurate and rapid measurements of indicators of osteoporosis in cancellous bone. (C) 2015 Acoustical Society of America.	[Taki, Hirofumi] Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 9808579, Japan; [Nagatani, Yoshiki] Kobe City Coll Technol, Dept Elect, Kobe, Hyogo 6512194, Japan; [Matsukawa, Mami] Doshisha Univ, Fac Sci & Engn, Kyotanabe 6100321, Japan; [Mizuno, Katsunori] Univ Tokyo, Inst Ind Sci, Tokyo 1138654, Japan; [Sato, Toru] Kyoto Univ, Grad Sch Informat, Kyoto 6068501, Japan	Taki, H (reprint author), Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 9808579, Japan.	taki@ecei.tohoku.ac.jp	Sato, Toru/F-3818-2012		Innovative Techno-Hub for Integrated Medical Bio-imaging Project of the Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; MEXT/JSPS KAKENHI [25870345, 25871038]	This work was partly supported by the Innovative Techno-Hub for Integrated Medical Bio-imaging Project of the Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, and by MEXT/JSPS KAKENHI through Grant Nos. 25870345 and 25871038.	Hoffman JJ, 2012, J ACOUST SOC AM, V132, P1830, DOI 10.1121/1.4739455; Njeh CF, 1997, OSTEOPOROSIS INT, V7, P471, DOI 10.1007/s001980050035; Laugier P, 2008, IEEE T ULTRASON FERR, V55, P1179, DOI 10.1109/TUFFC.2008.782; Blake GM, 2007, J CLIN DENSITOM, V10, P102, DOI 10.1016/j.jocd.2006.11.001; Wear KA, 2014, J ACOUST SOC AM, V135, P2102, DOI 10.1121/1.4868473; Haiat G, 2009, J BIOMECH, V42, P2033, DOI 10.1016/j.jbiomech.2009.06.008; Waters KR, 2005, IEEE T ULTRASON FERR, V52, P822, DOI 10.1109/TUFFC.2005.1503968; Anderson CC, 2010, J ACOUST SOC AM, V128, P2940, DOI 10.1121/1.3493441; Marutyan KR, 2007, J ACOUST SOC AM, V121, pEL8, DOI 10.1121/1.2401198; Hosokawa A, 1998, J ACOUST SOC AM, V103, P2718, DOI 10.1121/1.422790; Fellah ZEA, 2004, J ACOUST SOC AM, V116, P61, DOI 10.1121/1.1755239; Mizuno K, 2009, J ACOUST SOC AM, V125, P3460, DOI 10.1121/1.3111107; CAPON J, 1969, P IEEE, V57, P1408, DOI 10.1109/PROC.1969.7278; Hughes ER, 1999, ULTRASOUND MED BIOL, V25, P811, DOI 10.1016/S0301-5629(99)00034-4; Barkmann R, 2008, IEEE T ULTRASON FERR, V55, P1197, DOI 10.1109/TUFFC.2008.783; Nelson AM, 2011, J ACOUST SOC AM, V130, P2233, DOI 10.1121/1.3625241; Haiat G, 2007, J BONE MINER RES, V22, P665, DOI 10.1359/JBMR.070209; Taki H, 2012, IEEE T MED IMAGING, V31, P417, DOI 10.1109/TMI.2011.2170847; Hosokawa A, 1997, J ACOUST SOC AM, V101, P558, DOI 10.1121/1.418118; Hosokawa A, 2009, IEEE T ULTRASON FERR, V56, P738, DOI 10.1109/TUFFC.2009.1096; Anderson CC, 2008, J ACOUST SOC AM, V124, P1781, DOI 10.1121/1.2953309; Barkmann R, 2008, ULTRASOUND MED BIOL, V34, P1186, DOI 10.1016/j.ultrasmedbio.2007.12.008; BOUXSEIN ML, 1995, CALCIFIED TISSUE INT, V56, P99, DOI 10.1007/BF00296338; Cardoso L, 2003, J BONE MINER RES, V18, P1803, DOI 10.1359/jbmr.2003.18.10.1803; Dencks S, 2013, IEEE T ULTRASON FERR, V60, P1884, DOI 10.1109/TUFFC.2013.2773; Genant HK, 2006, ANN NY ACAD SCI, V1068, P410, DOI 10.1196/annals.1346.038; Han S, 1997, CALCIFIED TISSUE INT, V60, P21; Hughes ER, 2007, J ACOUST SOC AM, V121, P568, DOI 10.1121/1.2387132; Kaczmarek M, 2002, ULTRASONICS, V40, P95, DOI 10.1016/S0041-624X(02)00097-5; Langton C M, 1984, Eng Med, V13, P89; Lochmuller EM, 1999, ULTRASOUND OBST GYN, V14, P125, DOI 10.1046/j.1469-0705.1999.14020125.x; Marutyan KR, 2006, J ACOUST SOC AM, V120, pEL55, DOI 10.1121/1.2357187; Mizuno K, 2008, IEEE T ULTRASON FERR, V55, P1480, DOI 10.1109/TUFFC.2008.823; Nagatani Y, 2008, ULTRASONICS, V48, P607, DOI 10.1016/j.ultras.2008.04.011; Njeh CF, 1999, QUANTITATIVE ULTRASOUND: ASSESSMENT OF OSTEOPOROSIS AND BONE STA TUS, P1; Wear KA, 2013, J ACOUST SOC AM, V133, P2490, DOI 10.1121/1.4792935	36	0	0	ACOUSTICAL SOC AMER AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0001-4966	1520-8524		J ACOUST SOC AM	J. Acoust. Soc. Am.	APR	2015	137	4					1683	1692		10.1121/1.4916276		10	Acoustics; Audiology & Speech-Language Pathology	Acoustics; Audiology & Speech-Language Pathology	CG9QV	WOS:000353653500025		
J	Yamamoto, M; Hashimoto, A; Aoyama, T; Sakai, T				Yamamoto, Masafumi; Hashimoto, Atsushi; Aoyama, Takashi; Sakai, Takeharu			A unified approach to an augmented Burgers equation for the propagation of sonic booms	JOURNAL OF THE ACOUSTICAL SOCIETY OF AMERICA			English	Article							SOUND; WAVES	Nonlinear propagation through a relaxing atmosphere of pressure disturbances extracted from a computational fluid dynamics (CFD) solution of the flow around a supersonic aircraft is simulated using an augmented Burgers equation. The effects of nonlinearity, geometrical spreading, atmospheric inhomogeneity, thermoviscous attenuation, and molecular vibration relaxation are taken into account. The augmented Burgers equation used for sonic boom propagation calculations is often solved by the operator splitting method, but numerical difficulties arise with this approach when dissipation is not effective. By re-examining the solution algorithms for the augmented Burgers equation, a stable method for handling the relaxation effect has been developed. This approach can handle the Burgers equation in a unified manner without operator splitting and, therefore, the resulting scheme is twice as fast as the original one. The approach is validated by comparing it with an analytical solution and a detailed CFD of dispersed plane wave propagation. In addition, a rise time prediction of low-boom supersonic aircraft is demonstrated. (c) 2015 Acoustical Society of America.	[Yamamoto, Masafumi] Res Ctr Computat Mech Inc, Shinagawa Ku, Tokyo 1420041, Japan; [Hashimoto, Atsushi; Aoyama, Takashi] Japan Aerosp Explorat Agcy, Chofu, Tokyo 1828522, Japan; [Sakai, Takeharu] Nagoya Univ, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Yamamoto, M (reprint author), Res Ctr Computat Mech Inc, Shinagawa Ku, 1-7-1 Togoshi, Tokyo 1420041, Japan.	yamamoto@rccm.co.jp					Cleveland RO, 1996, J ACOUST SOC AM, V99, P3312, DOI 10.1121/1.414983; BASS HE, 1995, J ACOUST SOC AM, V97, P680, DOI 10.1121/1.412989; Averiyanov M, 2011, J ACOUST SOC AM, V129, P1760, DOI 10.1121/1.3557034; Brandt S. A., 2004, INTRO AERONAUTICS DE, V2nd; CLARKE JF, 1965, J FLUID MECH, V21, P591, DOI 10.1017/S0022112065000356; Cleveland RO, 1996, J ACOUST SOC AM, V100, P3017, DOI 10.1121/1.417113; Darden C. M., 1979, TP1348 NASA; Hayes W. D., 1969, CR1299 NASA; Holzapfel G. A., 2000, NONLINEAR SOLID MECH, P288; Honda M., 2012, P 28 C INT COUNC AER; Howe D. C., 2008, 46 AIAA AER SCI M EX; Ishikawa H., 2009, 27 AIAA APPL AER C S; Makino Y., 2003, J AIRCRAFT, V41, P1413; Marchiano R, 2003, J ACOUST SOC AM, V114, P1758, DOI 10.1121/1.1610459; Murakami A., 2006, P 25 C INT COUNC AER; Pawlowski J. W., 2005, 43 AIAA AER SCI M EX; Pestorius F. M., 1973, APLTR7323; Pierce A. D., 1989, ACOUSTICS INTRO ITS, P587; Pilon A. R., 2011, 17 AIAA CEAS AER C 3; Plotkin K. J., 2013, 51 AIAA AER SCI M IN; Rallabhandi S. K., 2012, 30 AIAA APPL AER C N; Sakai T., 2010, 48 AIAA AER SCI M IN; Salamone JA, 2013, AIAA J, V51, P1745, DOI 10.2514/1.J052171; SEEBASS R, 1972, J ACOUST SOC AM, V51, P686, DOI 10.1121/1.1912902; Taylor A. D., 1980, ARL87 NOAA ERL; Thomas C. L., 1971, NASA, P205; Thomas C. L., 1972, D6832 NASA TN; Yamamoto M., 2012, 44 FLUID DYN C AER N	28	1	1	ACOUSTICAL SOC AMER AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0001-4966	1520-8524		J ACOUST SOC AM	J. Acoust. Soc. Am.	APR	2015	137	4					1857	1866		10.1121/1.4916833		10	Acoustics; Audiology & Speech-Language Pathology	Acoustics; Audiology & Speech-Language Pathology	CG9QV	WOS:000353653500042		
J	Berry, E; Hernandez-Anzaldo, S; Ghomashchi, F; Lehner, R; Murakami, M; Gelb, MH; Kassiri, Z; Wang, X; Fernandez-Patron, C				Berry, Evan; Hernandez-Anzaldo, Samuel; Ghomashchi, Farideh; Lehner, Richard; Murakami, Makoto; Gelb, Michael H.; Kassiri, Zamaneh; Wang, Xiang; Fernandez-Patron, Carlos			Matrix Metalloproteinase-2 Negatively Regulates Cardiac Secreted Phospholipase A(2) to Modulate Inflammation and Fever	JOURNAL OF THE AMERICAN HEART ASSOCIATION			English	Article						heart; inflammation; matrix metalloproteinases; PLA(2)	EXACERBATES MYOCARDIAL INFLAMMATION; TARGETED DELETION; MICE; ACTIVATION; TRIAL; PROSTAGLANDIN-E-2; ATHEROSCLEROSIS; CARDIOMYOPATHY; DEGRADATION; VARESPLADIB	Background-Matrix metalloproteinase (MMP)-2 deficiency makes humans and mice susceptible to inflammation. Here, we reveal an MMP-2-mediated mechanism that modulates the inflammatory response via secretory phospholipase A(2) (sPLA(2)), a phospholipid hydrolase that releases fatty acids, including precursors of eicosanoids. Methods and Results-Mmp2(-/-) (and, to a lesser extent, Mmp7(-/-) and Mmp9(-/-)) mice had between 10- and 1000-fold elevated sPLA(2) activity in plasma and heart, increased eicosanoids and inflammatory markers (both in the liver and heart), and exacerbated lipopolysaccharide-induced fever, all of which were blunted by adenovirus-mediated MMP-2 overexpression and varespladib (pharmacological sPLA(2) inhibitor). Moreover, Mmp2 deficiency caused sPLA(2)-mediated dysregulation of cardiac lipid metabolic gene expression. Compared with liver, kidney, and skeletal muscle, the heart was the single major source of the Ca2+-dependent, approximate to 20-kDa, varespladib-inhibitable sPLA(2) that circulates when MMP-2 is deficient. PLA2G5, which is a major cardiac sPLA(2) isoform, was proinflammatory when Mmp2 was deficient. Treatment of wild-type (Mmp2(+/+)) mice with doxycycline (to inhibit MMP-2) recapitulated the Mmp2(-/-) phenotype of increased cardiac sPLA(2) activity, prostaglandin E-2 levels, and inflammatory gene expression. Treatment with either indomethacin (to inhibit cyclooxygenase-dependent eicosanoid production) or varespladib (which inhibited eicosanoid production) triggered acute hypertension in Mmp2(-/-) ice, revealing their reliance on eicosanoids for blood pressure homeostasis. Conclusions-A heart-centric MMP-2/sPLA(2) axis may modulate blood pressure homeostasis, inflammatory and metabolic gene expression, and the severity of fever. This discovery helps researchers to understand the cardiovascular and systemic effects of MMP-2 inhibitors and suggests a disease mechanism for human MMP-2 gene deficiency.	[Berry, Evan; Hernandez-Anzaldo, Samuel; Wang, Xiang; Fernandez-Patron, Carlos] Univ Alberta, Dept Biochem, Fac Med & Dent, Edmonton, AB, Canada; [Lehner, Richard] Univ Alberta, Dept Pediat, Fac Med & Dent, Edmonton, AB, Canada; [Kassiri, Zamaneh] Univ Alberta, Dept Physiol, Fac Med & Dent, Edmonton, AB, Canada; [Lehner, Richard] Univ Alberta, Grp Mol & Cell Biol Lipids, Fac Med & Dent, Edmonton, AB, Canada; [Kassiri, Zamaneh; Fernandez-Patron, Carlos] Univ Alberta, Cardiovasc Res Grp, Fac Med & Dent, Edmonton, AB, Canada; [Kassiri, Zamaneh; Fernandez-Patron, Carlos] Univ Alberta, Mazankowski Alberta Heart Inst, Fac Med & Dent, Edmonton, AB, Canada; [Ghomashchi, Farideh; Gelb, Michael H.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Murakami, Makoto] Tokyo Metropolitan Inst Med Sci, Metab Project, Setagaya Ku, Tokyo 113, Japan; [Murakami, Makoto] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan	Fernandez-Patron, C (reprint author), 3-19 Med Sci Bldg,114th St & 85th Ave, Edmonton, AB T6G 2H7, Canada.	cf2@ualberta.ca			Queen Elizabeth II Graduate Scholarship Program from the Faculty of Medicine and Dentistry of the University of Alberta; Alberta Innovates Health Solutions; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada	Dr Berry was supported by the Queen Elizabeth II Graduate Scholarship Program from the Faculty of Medicine and Dentistry of the University of Alberta, and Dr Wang was supported by a graduate studentship award from Alberta Innovates Health Solutions. This study was supported by operating grants from the Canadian Institutes of Health Research and Natural Sciences and Engineering Research Council of Canada (to Dr Fernandez-Patron).	Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; Ivanov AI, 2004, FRONT BIOSCI, V9, P1977, DOI 10.2741/1383; Lijnen HR, 1999, THROMB HAEMOSTASIS, V82, P837; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Zankl A, 2007, J BONE MINER RES, V22, P329, DOI 10.1359/JBMR.061013; Ait-Oufella H, 2013, ARTERIOSCL THROM VAS, V33, P466, DOI 10.1161/ATVBAHA.112.300309; Fraser H, 2009, J CARDIOVASC PHARM, V53, P60, DOI 10.1097/FJC.0b013e318195bfbc; Montuschi P, 2004, FASEB J, V18, P1791, DOI 10.1096/fj.04-2330rev; Ou JF, 2001, P NATL ACAD SCI USA, V98, P6027, DOI 10.1073/pnas.111138698; Greenlee KJ, 2007, PHYSIOL REV, V87, P69, DOI 10.1152/physrev.00022.2006; Ma KL, 2008, HEPATOLOGY, V48, P770, DOI 10.1002/hep.22423; Nicholls SJ, 2014, JAMA-J AM MED ASSOC, V311, P252, DOI 10.1001/jama.2013.282836; Oslund RC, 2008, J MED CHEM, V51, P4708, DOI 10.1021/jm800422v; Tuysuz B, 2009, EUR J HUM GENET, V17, P565, DOI 10.1038/ejhg.2008.204; Matsumura S, 2005, J CLIN INVEST, V115, P599, DOI 10.1172/JCI200522304; Sato H, 2014, CELL METAB, V20, P119, DOI 10.1016/j.cmet.2014.05.002; Rosenson RS, 2009, LANCET, V373, P649, DOI 10.1016/S0140-6736(09)60403-7; Mosig RA, 2007, HUM MOL GENET, V16, P1113, DOI 10.1093/hmg/ddm060; Van Hul M, 2008, J THROMB HAEMOST, V6, P1198, DOI 10.1111/j.1538-7836.2008.02988.x; Rosengren B, 2006, ARTERIOSCL THROM VAS, V26, P1579, DOI 10.1161/01.ATV.0000221231.56617.67; Westermann D, 2011, CIRCULATION, V124, P2082, DOI 10.1161/CIRCULATIONAHA.111.035964; Choi YA, 2004, J BIOL CHEM, V279, P36579, DOI 10.1074/jbc.M314235200; Miki Y, 2013, J EXP MED, V210, P1217, DOI 10.1084/jem.20121887; Matsusaka H, 2005, AM J PHYSIOL-HEART C, V289, pH1858, DOI 10.1152/ajpheart.00216.2005; Boilard E, 2010, EMBO MOL MED, V2, P172, DOI 10.1002/emmm.201000072; Engelking LJ, 2004, J CLIN INVEST, V113, P1168, DOI 10.1172/JCI200420978; FERNANDEZPATRON C, 1992, BIOTECHNIQUES, V12, P564; Hristovska AM, 2007, HYPERTENSION, V50, P525, DOI 10.1161/HYPERTENSIONAHA.107.088948; Matsusaka H, 2006, HYPERTENSION, V47, P711, DOI 10.1161/01.HYP.0000208840.30778.00; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Rosenson RS, 2011, EUR HEART J, V32, P999, DOI 10.1093/eurheartj/ehq374; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Shaposhnik Z, 2009, J LIPID RES, V50, P623, DOI 10.1194/jlr.M800361-JLR200	33	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2047-9980			J AM HEART ASSOC	J. Am. Heart Assoc.	APR	2015	4	4							e001868	10.1161/JAHA.115.001868		27	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CH6HN	WOS:000354137300030		
J	Iwanami, J; Mogi, M; Tsukuda, K; Wang, XL; Nakaoka, H; Kan-no, H; Chisaka, T; Bai, HY; Shan, BS; Kukida, M; Horiuchi, M				Iwanami, Jun; Mogi, Masaki; Tsukuda, Kana; Wang, Xiao-Li; Nakaoka, Hirotomo; Kan-no, Harumi; Chisaka, Toshiyuki; Bai, Hui-Yu; Shan, Bao-Shuai; Kukida, Masayoshi; Horiuchi, Masatsugu			Direct angiotensin II type 2 receptor stimulation by compound 21 prevents vascular dementia	JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION			English	Article						Cerebral blood flow; cognitive function; inflammation; renin-angiotensin system	CHRONIC CEREBRAL HYPOPERFUSION; LONG-TERM POTENTIATION; WHITE-MATTER LESIONS; BLOOD-BRAIN-BARRIER; NITRIC-OXIDE; COGNITIVE IMPAIRMENT; AGONIST; STROKE; ANGIOGENESIS; ACTIVATION	Angiotensin II type 2 (AT(2)) receptor activation has been reported to play a role in cognitive function, although its detailed mechanisms and pathologic significance are not fully understood. We examined the possibility that direct AT(2) receptor stimulation by compound 21 (C2I) could prevent cognitive decline associated with hypoperfusion in the brain. We employed a bilateral common carotid artery stenosis (BCAS) model in mice as a model of vascular dementia. The Morris water maze task was performed 6 weeks after BCAS operation. Azilsartan (0.1 mg/kg/day) or C2I (10 Ag/kg/day) was administered from I week before BCAS. Cerebral blood flow (CBF) and inflammatory cytokine levels were also determined. Wild type (WT) mice showed significant prolongation of escape latency after BCAS, and this cognitive impairment was attenuated by pretreatment with azilsartan. Cognitive impairment was more marked in AT(2) receptor knockout (AT(2)KO) mice, and the preventive effect of azilsartan on cognitive decline was weaker in AT(2)KO mice than in WT mice, suggesting that the improvement of cognitive decline by azilsartan may involve stimulation of the AT(2) receptor. The significant impairment of spatial learning after BCAS in WT mice was attenuated by C2I treatment. The decrease in CBF in the BCAS treated group was blunted by C2I treatment, and the increase in TNF-alpha and MCP-1 mRNA expression after BCAS was attenuated by C2I treatment. These findings indicate that direct AT(2) receptor stimulation attenuates ischemic vascular dementia induced by hypoperfusion at least in part through an increase in CBF, and a reduction of inflammation. (C) 2015 American Society of Hypertension. All rights reserved.	[Iwanami, Jun; Mogi, Masaki; Tsukuda, Kana; Wang, Xiao-Li; Nakaoka, Hirotomo; Kan-no, Harumi; Chisaka, Toshiyuki; Bai, Hui-Yu; Shan, Bao-Shuai; Kukida, Masayoshi; Horiuchi, Masatsugu] Ehime Univ, Grad Sch Med, Dept Mol Cardiovasc Biol & Pharmacol, Tohon, Ehime 7910295, Japan	Horiuchi, M (reprint author), Ehime Univ, Grad Sch Med, Dept Mol Cardiovasc Biol & Pharmacol, Tohon, Ehime 7910295, Japan.	horiuchi@m.ehime-u.ac.jp			JSPS KAKENHI [25293310, 25462220, 24791506]; Astellas Pharma Inc; Bayer Yakuhin, Ltd; Daiichi-Sankyo Pharmaceutical Co, Ltd; Nippon Boehringer Ingelheim Co, Ltd; Takeda Pharmaceutical Co, Ltd	This study was supported by JSPS KAKENHI Grant Numbers 25293310 (MH), 25462220 (MM), and 24791506 (JI), and research grants from pharmaceutical companies: Astellas Pharma Inc, Bayer Yakuhin, Ltd, Daiichi-Sankyo Pharmaceutical Co, Ltd, Nippon Boehringer Ingelheim Co, Ltd, Novartis Pharma KK, Shionogi & Co., Ltd., and Takeda Pharmaceutical Co, Ltd.	Alhusban A, 2015, J HYPERTENS, V33, P170, DOI 10.1097/HJH.0000000000000364; Nakaji K, 2006, STROKE, V37, P2816, DOI 10.1161/01.STR.0000244808.17972.55; Washida K, 2010, STROKE, V41, P1798, DOI 10.1161/STROKEAHA.110.583948; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Horiuchi M, 2011, BRIT J PHARMACOL, V163, P1122, DOI 10.1111/j.1476-5381.2010.01167.x; Davies NM, 2011, J ALZHEIMERS DIS, V26, P699, DOI 10.3233/JAD-2011-110347; Shibata M, 2004, STROKE, V35, P2598, DOI 10.1161/01.STR.0000143725.19053.60; Rosenberg GA, 2012, J CEREBR BLOOD F MET, V32, P1139, DOI 10.1038/jcbfm.2011.197; Munk VC, 2007, HYPERTENSION, V49, P1178, DOI 10.1161/HYPERTENSIONAHA.106.080242; Bon CLM, 2003, J NEUROSCI, V23, P1941; Namsolleck P, 2013, NEUROBIOL DIS, V51, P177, DOI 10.1016/j.nbd.2012.11.008; Li P, 2008, HYPERTENSION, V51, P252, DOI 10.1161/HYPERTENSIONAHA.107.097394; Unger T, 2010, J RENIN-ANGIO-ALDO S, V11, P75, DOI 10.1177/1470320309347792; Yang Y, 2011, STROKE, V42, P3323, DOI 10.1161/STROKEAHA.110.608257; Wan YQ, 2004, J MED CHEM, V47, P5995, DOI 10.1021/jm049715t; Fuentes B, 2010, J HYPERTENS, V28, P575, DOI 10.1097/HJH.0b013e3283350f50; Hopper RA, 2006, J NEUROSCI, V26, P11513, DOI 10.1523/JNEUROSCI.2259-06.2006; Ihara M, 2011, J AGING RES, V2011, DOI DOI 10.4061/2011/978761; Jing F, 2012, J CEREBR BLOOD F MET, V32, P248, DOI 10.1038/jcbfm.2011.133; Li NC, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5465; Roh Jee Hoon, 2014, J Stroke, V16, P18, DOI 10.5853/jos.2014.16.1.18; Sakata A, 2009, BRAIN RES, V1300, P14, DOI 10.1016/j.brainres.2009.08.068; Shraim N, 2011, J NEUROSCI METH, V202, P137, DOI 10.1016/j.jneumeth.2011.06.009	23	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1933-1711	1878-7436		J AM SOC HYPERTENS	J. Am. Soc. Hypertens.	APR	2015	9	4					250	256		10.1016/j.jash.2015.01.010		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CG9XG	WOS:000353672800002		
J	McMullan, CJ; Yano, Y; Bakris, GL; Kario, K; Phillips, RA; Forman, JP				McMullan, Ciaran J.; Yano, Yuichiro; Bakris, George L.; Kario, Kazuomi; Phillips, Robert A.; Forman, John P.			Racial impact of diurnal variations in blood pressure on cardiovascular events in chronic kidney disease	JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION			English	Article						Ambulatory blood pressure; African Americans; coronary artery disease; Japanese; stroke	MORNING SURGE; PROGNOSTIC VALUE; DIPPING STATUS; HYPERTENSION; MORTALITY; HEART; COMMUNITIES; POPULATIONS; AMERICAN; OUTCOMES	Ambulatory blood pressure parameters, nocturnal dipping and morning surge, are associated with cardiovascular outcomes in several populations. While significant variation exists between racial groups in ambulatory blood pressure measurements and the incidence of cardiovascular disease, the effect of race on the associations of dipping and morning surge with cardiovascular outcomes is unknown. In a prospective analysis of 197 African American and 197 Japanese individuals with non-diabetic chronic kidney disease matched by age and renal function, we analyzed the associations of dipping and morning surge with cardiovascular events for both races and assessed whether these relations differed by race. Higher sleep-trough morning surge was independently associated with cardiovascular events in Japanese (hazard ratio, 1.93 per 10 mm Hg; 95% confidence interval, 1.20-3.10) but not in African American participants, with race an effect modifier (P-value <.01). Dipping was not associated with cardiovascular events in either racial group. In individuals with chronic kidney disease, the association between morning surge and cardiovascular events appears to be dependent upon race, with higher morning surge a risk factors in Japanese but not in African Americans. (C) 2015 American Society of Hypertension. All rights reserved.	[McMullan, Ciaran J.; Forman, John P.] Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02115 USA; [McMullan, Ciaran J.; Forman, John P.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Yano, Yuichiro; Bakris, George L.] Univ Chicago Med, ASH Comprehens Hypertens Ctr, Dept Med, Chicago, IL USA; [Yano, Yuichiro; Kario, Kazuomi] Jichi Med Univ, Sch Med, Dept Med, Div Cardiovasc Med, Shimotsuke, Tochigi, Japan; [Phillips, Robert A.] Houston Methodist, Dept Med, Houston, TX USA; [Phillips, Robert A.] Weill Cornell Coll Med, Houston, TX USA	McMullan, CJ (reprint author), Brigham & Womens Hosp, 41 Ave Louis Pasteur,Ste 121, Boston, MA 02115 USA.	cmcmullan1@partners.org			National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Office of Research in Minority Health; ASN Research Fellowship [2012D000333]; Foundation for the Development of the Community; Manpei Suzuki Diabetes Foundation	The African American Study of Kidney Disease and Hypertension (AASK) Cohort study trial was conducted by the AASK Investigators with support from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). In addition, AASK was supported by the Office of Research in Minority Health. King Pharmaceuticals, Pfizer, AstraZeneca Pharmaceuticals, GlaxoSmithKline, Forest Laboratories, Pharmacia, and Upjohn donated antihypertensive medications. The data from the AASK trial reported here were supplied by the NIDDK Central Repositories. This work does not necessarily reflect the opinions of the AASK study or the NIDDK. Dr McMullan was funded by the ASN Research Fellowship - 2012D000333. Dr Yano was supported by a grant-in-aid from the Foundation for the Development of the Community, and a research grant from Manpei Suzuki Diabetes Foundation.	Amici A, 2009, Arch Gerontol Geriatr, V49, pe105, DOI 10.1016/j.archger.2008.10.003; Ding JZ, 2003, AM HEART J, V146, P459, DOI 10.1016/S0002-8703(03)00228-X; Gabbai FB, 2012, CLIN J AM SOC NEPHRO, V7, P1770, DOI 10.2215/CJN.11301111; Eguchi K, 2008, AM J HYPERTENS, V21, P443, DOI 10.1038/ajh.2008.4; Kario K, 2003, CIRCULATION, V107, P1401, DOI 10.1161/01.CIR.0000056521.67546.AA; Li Y, 2010, HYPERTENSION, V55, P1040, DOI 10.1161/HYPERTENSIONAHA.109.137273; Israel S, 2011, AM J HYPERTENS, V24, P796, DOI 10.1038/ajh.2011.58; Lip GYH, 1997, STROKE, V28, P31; Dolan E, 2005, HYPERTENSION, V46, P156, DOI 10.1161/01.HYP.0000170138.56903.7a; Levey AS, 2009, ANN INTERN MED, V150, P604; Verdecchia P, 2012, HYPERTENSION, V60, P34, DOI 10.1161/HYPERTENSIONAHA.112.191858; Andersen MJ, 2005, AM J KIDNEY DIS, V45, P994, DOI 10.1053/j.ajkd.2005.02.015; Profant J, 1999, HYPERTENSION, V33, P1099; Bouhanick B, 2008, DIABETES METAB, V34, P560, DOI 10.1016/j.diabet.2008.05.005; Suh M, 2014, J CARDIOVASC NURS, V29, pE10, DOI 10.1097/JCN.0b013e318291ee43; Howard VJ, 2005, NEUROEPIDEMIOLOGY, V25, P135, DOI 10.1159/000086678; Kario K, 2010, HYPERTENSION, V56, P765, DOI 10.1161/HYPERTENSIONAHA.110.157149; Yano Y, 2011, AM J HYPERTENS, V24, P437, DOI 10.1038/ajh.2010.263; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; BECKER LB, 1993, NEW ENGL J MED, V329, P600, DOI 10.1056/NEJM199308263290902; CHATURVEDI N, 1994, J AM COLL CARDIOL, V24, P1499; Dolan E, 2010, HYPERTENSION, V56, P179, DOI 10.1161/HYPERTENSIONAHA.110.154708; FUMO MT, 1992, AM J HYPERTENS, V5, P111; Haas DC, 2005, J CLIN HYPERTENS GRE; Haas Donald C, 2005, J Clin Hypertens (Greenwich), V7, P205, DOI 10.1111/j.1524-6175.2005.03503.x; Ishikawa J, 2008, J CLIN HYPERTENS, V10, P787, DOI 10.1111/j.1751-7176.2008.00018.x; KASTRUP J, 1993, SCAND J CLIN LAB INV, V53, P577, DOI 10.3109/00365519309092556; Mayet J, 1998, HYPERTENSION, V31, P1190; Me Causland FR, 2014, AM J HYPERTENS, V27, P530; Mizuno M, 2012, BLOOD PRESS MONIT, V17, P20, DOI 10.1097/MBP.0b013e32835026c6; MURPHY MB, 1991, J HYPERTENS, V9, pS45; Norris K, 2006, AM J KIDNEY DIS, V48, P739, DOI 10.1053/j.ajkd.2006.08.004; Osei K, 1996, AM J HYPERTENS, V9, P1157, DOI 10.1016/S0895-7061(96)00248-8; Ross AJ, 2014, AM J PHYSIOL-REG I, V307, pR888, DOI 10.1152/ajpregu.00211.2014; Sasaki N, 2013, CLIN EXP HYPERTENS, V35, P250, DOI 10.3109/10641963.2013.780069; WHO MONICA Project Principal Investigators, 1988, J CLIN EPIDEMIOL, V41, P105, DOI DOI 10.1016/0895-4356(88)90084-4; Wild Sarah H., 1995, Annals of Epidemiology, V5, P432, DOI 10.1016/1047-2797(95)00058-5; Yano Y, 2013, AM J NEPHROL, V38, P195, DOI 10.1159/000354232; GIFFORD RW, 1993, ARCH INTERN MED, V153, P154	39	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1933-1711	1878-7436		J AM SOC HYPERTENS	J. Am. Soc. Hypertens.	APR	2015	9	4					299	306		10.1016/j.jash.2015.02.005		8	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CG9XG	WOS:000353672800008		
J	Okada, T; Sugihara, K; Chinen, S; Noguchi, T				Okada, Tatsuya; Sugihara, Kouya; Chinen, Satoshi; Noguchi, Takashi			Crystallization of a-Si films with smooth surfaces by using Blue Multi-Laser Diode Annealing	JOURNAL OF THE KOREAN PHYSICAL SOCIETY			English	Article						Blue multi-laser diode annealing; Crystallization; Si; TFT	AMORPHOUS-SILICON; PLASTIC SUBSTRATE; TEMPERATURE; TRANSISTOR	Crystallization of similar to 50-nm-thick amorphous Si (a-Si) with a smooth surface was achieved by using Blue Multi-Laser Diode Annealing (BLDA). The a-Si films were deposited by using RF sputtering with Ne gas or by using plasma enhanced chemical vapor deposition (PE-CVD) and were annealed by using BLDA with CW scanning. After the films had been annealed a relatively low laser power below 4 W, the root-mean-square (RMS) roughness deduced from the atomic force microscopy (AFM) results for the surfaces of the Si films was slightly increased, but smoothness was within 3 nm despite the conditions under which the films had been crystallized. BLDA has a potential to realize next-generation poly-Si thin film transistors (TFTs).	[Okada, Tatsuya; Sugihara, Kouya; Chinen, Satoshi; Noguchi, Takashi] Univ Ryukyus, Fac Engn, Nishihara, Okinawa 90301, Japan	Okada, T (reprint author), Univ Ryukyus, Fac Engn, Nishihara, Okinawa 90301, Japan.	tokada@tec.u-ryukyu.ac.jp			Strategic Core Technology Advancement Program	The authors thank Mr. Y. Ogino and Mr. H. Matsushima at Hitachi Information & Telecommunication Engineering, Ltd., for their encouragement and analysis and Prof. J. Jang at Kyung-Hee University for the support with the CVD films. This research was partially supported by the Strategic Core Technology Advancement Program.	PHILIPP HR, 1960, PHYS REV, V120, P37, DOI 10.1103/PhysRev.120.37; CHELIKOWSKY JR, 1974, PHYS REV B, V10, P5095, DOI 10.1103/PhysRevB.10.5095; Gosain DP, 2000, JPN J APPL PHYS 2, V39, pL179, DOI 10.1143/JJAP.39.L179; Camargo SS, 2002, DIAM RELAT MATER, V11, P1091, DOI 10.1016/S0925-9635(01)00603-3; CSEPREGI L, 1977, J APPL PHYS, V48, P4234, DOI 10.1063/1.323408; Hatano M., 2002, SID 02, P158; Ishihara R, 2008, SOLID STATE ELECTRON, V52, P353, DOI 10.1016/j.sse.2007.10.055; Kanzaki K., 2001, AM LCD 01, P71; Kim DY, 2006, J KOREAN PHYS SOC, V48, pS61; KOSTER U, 1978, PHYS STATUS SOLIDI A, V48, P313, DOI 10.1002/pssa.2210480207; Koswaththage CJ, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.03CB02; Kuo CC, 2008, LASER PHYS, V18, P464, DOI 10.1134/S1054660X0804021X; Matsuo T., 2004, SID, P856; Nishibe T., 2007, P 14 IDW SAPP JAP DE, P495; Nishinohara T., 2011, P INT DISPL WORKSH N, P1649; Noguchi T., 2012, SID S, P1129; Noguchi T., 2011, P IMID 11 SEOUL KOR, P286; Noguchi T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.03CA10; Ogino Y., 2009, P IMID 09, P945; Okada T., 2013, 9 INT THIN FILM TRAN, P38; Okada T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.03CA02; Okada T., 2012, P AWAD 12, P85; Shirai K, 2010, IEICE T ELECTRON, VE93C, P1499, DOI [10.1587/transele.E93.C1499, 10.1587/transele.E93.C.1499]; Shirai K, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.021402; Suga K., 2002, IEICE T ELECTRON, VJ85-C, P630; Sugihara K., 2013, P INT DISPL WORKSH K, P423; Voutsas T, 1997, P SOC PHOTO-OPT INS, V3014, P112, DOI 10.1117/12.270284; ZELLAMA K, 1979, J APPL PHYS, V50, P6995, DOI 10.1063/1.325856	28	0	0	KOREAN PHYSICAL SOC	SEOUL	635-4, YUKSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	0374-4884	1976-8524		J KOREAN PHYS SOC	J. Korean Phys. Soc.	APR	2015	66	8					1265	1269		10.3938/jkps.66.1265		5	Physics, Multidisciplinary	Physics	CH5AZ	WOS:000354047700016		
J	Tsubokawa, N; Miyata, Y; Mimae, T; Sasada, S; Yoshiya, T; Mimura, T; Arihiro, K; Okada, M				Tsubokawa, Norifumi; Miyata, Yoshihiro; Mimae, Takahiro; Sasada, Shinsuke; Yoshiya, Tomoharu; Mimura, Takeshi; Arihiro, Koji; Okada, Morihito			Histologic changes associated with the use of fibrinogen- and thrombin-impregnated collagen in the prevention of pulmonary air leakage	JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY			English	Article							FLEECE TACHOCOMB((R)); HEMOSTATIC FLEECE; RANDOMIZED-TRIAL; LUNG RESECTION; LOBECTOMY; MYOFIBROBLAST; ADHESIONS; TACHOSIL(R); EFFICACY; SAFETY	Objective: Although fibrinogen-and thrombin-impregnated collagen (TachoSil; Takeda GmbH, Linz, Austria) can be applied to prevent air leakage, the impact of its use on lung healing is unknown. Therefore, we histologically evaluated the long-term healing process associated with the use of TachoSil to prevent air leakage in a canine model. Methods: Via left thoracotomy, visceral pleural defects of 10 3 10 mm were created on each lung lobe of female beagles. After air leakage was confirmed, each pleural defect was covered with TachoSil. The repair sites were histologically evaluated on postoperative days 0, 4, 7, 14, 28, and 56. Results: All animals survived, and none developed pneumothorax. Histologically, inflammatory cells infiltrated the TachoSil from the pleural defect, and pleural mesothelium comprised the regenerated outermost layer of the TachoSil soon after the surgery. Inflammatory cells, myofibroblasts, and neovascular vessels subsequently spread over the entire TachoSil. The number of inflammatory cells decreased, and myofibroblast and neovascular vessels replaced the entire TachoSil. In addition, the elastic layer started to regenerate from both edges and completely repaired the pleural defect. The lung parenchyma around the pleural defects was not influenced throughout the observational period, because these healing processes occurred only inside the TachoSil. Conclusions: TachoSil provided a mechanical scaffold on which healing could proceed, followed by biodegradation over the long term. TachoSil safely repaired the pleural defects without affecting lung parenchyma.	[Tsubokawa, Norifumi; Miyata, Yoshihiro; Mimae, Takahiro; Sasada, Shinsuke; Yoshiya, Tomoharu; Mimura, Takeshi; Okada, Morihito] Hiroshima Univ, Dept Surg Oncol, Hiroshima 7348551, Japan; [Arihiro, Koji] Hiroshima Univ, Dept Pathol, Hiroshima 7348551, Japan	Okada, M (reprint author), Hiroshima Univ, Dept Surg Oncol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	morihito1217@hiroshima-u.ac.jp					Lang G, 2004, EUR J CARDIO-THORAC, V25, P160, DOI 10.1016/j.ejcts.2003.11.018; Wain JC, 2001, ANN THORAC SURG, V71, P1623, DOI 10.1016/S0003-4975(01)02537-1; Stephan F, 2000, CHEST, V118, P1263, DOI 10.1378/chest.118.5.1263; Filosso PL, 2013, INTERACT CARDIOV TH, V16, P661, DOI 10.1093/icvts/ivs571; Marta GM, 2010, EUR J CARDIO-THORAC, V38, P683, DOI 10.1016/j.ejcts.2010.03.061; [Anonymous], 1996, GUIDE CARE USE LAB A; Cerfolio RJ, 1998, ANN THORAC SURG, V66, P1726, DOI 10.1016/S0003-4975(98)00958-8; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Anegg U, 2007, EUR J CARDIO-THORAC, V31, P198, DOI 10.1016/j.ejcts.2006.11.033; Brunelli A, 2004, ANN THORAC SURG, V77, P1205, DOI 10.1016/j.athoracsur.2003.10.082; Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x; Kuschel TJ, 2013, ANN THORAC SURG, V95, P183, DOI 10.1016/j.athoracsur.2012.08.057; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Dickneite G, 2006, J INT MED RES, V34, P505; Droghetti A, 2008, J THORAC CARDIOV SUR, V136, P383, DOI 10.1016/j.jtcvs.2008.04.014; Getman Vladyslav, 2006, Interact Cardiovasc Thorac Surg, V5, P243, DOI 10.1510/icvts.2005.121129; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Ikeda T, 2012, EUR J CARDIO-THORAC, V41, P926, DOI 10.1093/ejcts/ezr128; Komatsu K, 2007, THORAC CARDIOV SURG, V55, P385, DOI 10.1055/s-2007-965174; Matsutani N, 2011, SURG TODAY, V41, P1234, DOI 10.1007/s00595-010-4468-9; Okereke Ikenna, 2005, Ann Thorac Surg, V79, P1167, DOI 10.1016/j.athoracsur.2004.08.069; Rena Ottavio, 2009, Interact Cardiovasc Thorac Surg, V9, P973, DOI 10.1510/icvts.2009.202770; Schneider A, 2006, DIGEST DIS SCI, V51, P566, DOI 10.1007/s10620-006-3171-6; Venuta F, 1998, EUR J CARDIO-THORAC, V13, P361, DOI 10.1016/S1010-7940(98)00038-4	25	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5223	1097-685X		J THORAC CARDIOV SUR	J. Thorac. Cardiovasc. Surg.	APR	2015	149	4					982	988		10.1016/j.jtcvs.2014.12.058		7	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CG5QG	WOS:000353347600019		
J	Nomori, H; Cong, Y; Abe, M; Sugimura, H; Kato, Y				Nomori, Hiroaki; Cong, Yue; Abe, Masaru; Sugimura, Hiroshi; Kato, Yoshiaki			Diffusion-weighted magnetic resonance imaging in preoperative assessment of non-small cell lung cancer	JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY			English	Article							POSITRON-EMISSION-TOMOGRAPHY; 3 CM; STAGE; SIZE; MRI	Background: Diffusion-weighted magnetic resonance imaging (DWI) frequently shows heterogeneity of signal intensity (SI) in non-small cell lung cancer (NSCLC). The purpose of our study was to examine the association of SI and DWI patterns with histology, tumor invasiveness, lymph node metastasis, and 18 F-fluorodeoxyglucose positron emission tomography (FDG-PET) uptake in NSCLC. Methods: One hundred forty-five patients with NSCLC underwent preoperative DWI and FDG-PET. DWI patterns were visually classified as homogenous (HOM) (n = 81) or heterogeneous (HET) (n = 64). The former was further classified as faint (faint-HOM) (n = 27) or dark (dark-HOM) (n = 54) according to a cutoff value of SI. Associations of SI and DWI patterns with tumor histology, lymphatic or vascular invasion, pleural invasion, lymph node metastasis, and FDG uptake were evaluated. Results: All faint-HOM tumors were well-differentiated adenocarcinoma, whereas dark-HOM and HET tumors were less-differentiated adenocarcinoma or nonadenocarcinoma. Although the dark areas in HET tumors showed a dense aggregation of tumor cells, their faint areas showed abundant fibrovascular stroma or necrosis, or a well-differentiated part of adenocarcinoma. Tumor size and the frequencies of lymphatic or vascular invasion, pleural invasion, and nodal metastasis were highest in HET tumors, followed by dark-HOM and faint-HOM (P = .1-P < .001) tumors. Sixty-five tumors having at least 1 of the invasions or metastasis showed significantly higher SI than the 81 tumors without (P < .001). HET tumors had the highest FDG uptake, followed by dark-HOM and faint-HOM tumors; differences between the groups were significant (P < .01 to P < .001). Conclusions: The SI and heterogeneity of DWI reflect the histologic heterogeneity, tumor aggressiveness, and FDG-PET uptake in NSCLC.	[Nomori, Hiroaki; Cong, Yue; Abe, Masaru; Sugimura, Hiroshi] Kameda Med Ctr, Dept Thorac Surg, Chiba, Japan; [Kato, Yoshiaki] Kameda Med Ctr, Dept Diagnost Radiol, Chiba, Japan	Nomori, H (reprint author), Kameda Med Ctr, Dept Gen Thorac Surg, 929 Higashi Cho, Kamogawa City, Chiba 2968602, Japan.	hnomori@qk9.so-net.ne.jp					Ohba Y, 2009, J THORAC CARDIOV SUR, V138, P439, DOI 10.1016/j.jtcvs.2008.12.026; Reinsberg SA, 2007, AM J ROENTGENOL, V188, P91, DOI 10.2214/AJR.05.2198; Nasu K, 2004, JPN J CLIN ONCOL, V34, P620, DOI 10.1093/jjco/hyh108; Vansteenkiste JF, 1999, J CLIN ONCOL, V17, P3201; Nomori H, 2005, ANN THORAC SURG, V79, P984, DOI 10.1016/j.athoracsur.2004.07.072; Ohba Y, 2009, ANN THORAC SURG, V87, P886, DOI 10.1016/j.athoracsur.2008.09.081; Sumi M, 2002, AM J ROENTGENOL, V178, P959; Mori T, 2008, J THORAC ONCOL, V3, P358, DOI 10.1097/JTO.0b013e318168d9ed; Cerfolio RJ, 2005, J THORAC CARDIOV SUR, V130, P151, DOI 10.1016/j.jtcvs.2004.11.007; Ohtsuka T, 2006, CANCER, V107, P2468, DOI 10.1002/cncr.22268; Wang JC, 2001, RADIOLOGY, V220, P621, DOI 10.1148/radiol.2202010063; Nomori H, 2008, J THORAC CARDIOV SUR, V135, P816, DOI 10.1016/j.jtcvs.2007.10.035; Hayashida Y, 2006, EUR RADIOL, V16, P2637, DOI 10.1007/s00330-006-0342-y; Dzik-Jurasz A, 2002, LANCET, V360, P307, DOI 10.1016/S0140-6736(02)09520-X; Matoba M, 2007, RADIOLOGY, V243, P570, DOI 10.1148/radiol.2432060131; Goldstraw P, 2009, STAGING MANUAL THORA, P85; Takahara Taro, 2004, Radiat Med, V22, P275; Woodhams Reiko, 2005, Magn Reson Med Sci, V4, P35, DOI 10.2463/mrms.4.35	18	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5223	1097-685X		J THORAC CARDIOV SUR	J. Thorac. Cardiovasc. Surg.	APR	2015	149	4					991	996		10.1016/j.jtcvs.2015.01.019		6	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CG5QG	WOS:000353347600021		
J	Watanabe, T; Arai, H; Mizuno, T				Watanabe, Taiju; Arai, Hirokuni; Mizuno, Tomohiro			Intraoperative ultrasound imaging of coronary artery ostial stenosis	JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY			English	Editorial Material									[Watanabe, Taiju; Arai, Hirokuni; Mizuno, Tomohiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc Surg, Tokyo 1138519, Japan	Arai, H (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc Surg, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	hiro.cvsg@tmd.ac.jp						0	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5223	1097-685X		J THORAC CARDIOV SUR	J. Thorac. Cardiovasc. Surg.	APR	2015	149	4					1206	1207		10.1016/j.jtcvs.2014.12.005		2	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CG5QG	WOS:000353347600073		
J	Matsuura, Y; Mun, M; Nakagawa, K; Okumura, S				Matsuura, Yosuke; Mun, Mingyon; Nakagawa, Ken; Okumura, Sakae			Efficacy and feasibility of a novel and noninvasive computed tomography-guided marking technique for peripheral pulmonary nodules	JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY			English	Editorial Material							LUNG NODULES; RESECTION		[Matsuura, Yosuke; Mun, Mingyon; Nakagawa, Ken; Okumura, Sakae] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Thorac Surg Oncol, Tokyo 1358550, Japan	Mun, M (reprint author), Japanese Fdn Canc Res, Canc Inst Hosp, Dept Thorac Surg Oncol, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan.	mingyon.mun@jfcr.or.jp					Wicky S, 2002, J THORAC CARDIOV SUR, V124, P401, DOI 10.1067/mtc.2002.124257; Sakiyama S, 2003, J THORAC CARDIOV SUR, V126, P1207, DOI 10.1016/S0022-5223(03)00821-3; Sato M, 2014, J THORAC CARDIOV SUR, V147, P1813, DOI 10.1016/j.jtcvs.2013.11.046; Kawada M, 2013, INTERACT CARDIOV TH, V16, P381, DOI 10.1093/icvts/ivs521; Nishida T, 2013, EUR J CARDIO-THORAC, V44, P1131, DOI 10.1093/ejcts/ezt285	5	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5223	1097-685X		J THORAC CARDIOV SUR	J. Thorac. Cardiovasc. Surg.	APR	2015	149	4					1208	1209		10.1016/j.jtcvs.2014.11.040		2	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CG5QG	WOS:000353347600074		
J	Zeng, Y; Chen, HS; Ni, T; Ruan, RP; Feng, L; Nie, C; Cheng, LG; Li, Y; Tao, W; Gu, J; Land, KC; Yashin, A; Tan, QH; Yang, Z; Bolund, L; Yang, HM; Hauser, E; Willcox, DC; Willcox, BJ; Tian, XL; Vaupel, JW				Zeng, Yi; Chen, Huashuai; Ni, Ting; Ruan, Rongping; Feng, Lei; Nie, Chao; Cheng, Lingguo; Li, Yang; Tao, Wei; Gu, Jun; Land, Kenneth C.; Yashin, Anatoli; Tan, Qihua; Yang, Ze; Bolund, Lars; Yang, Huanming; Hauser, Elizabeth; Willcox, D. Craig; Willcox, Bradley J.; Tian, Xiao-Li; Vaupel, James W.			GxE Interactions between FOXO Genotypes and Tea Drinking Are Significantly Associated with Cognitive Disability at Advanced Ages in China	JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES			English	Article						FOXO genotypes; Tea drinking; GxE interactions; Cognitive disability; Oldest old	OLDEST-OLD CHINESE; GREEN TEA; HUMAN LONGEVITY; CONSUMPTION; CANCER; RISK; SINGAPORE; CELLS	Logistic regression analysis based on data from 822 Han Chinese oldest old aged 92+ demonstrated that interactions between carrying FOXO1A-266 or FOXO3-310 or FOXO3-292 and tea drinking at around age 60 or at present time were significantly associated with lower risk of cognitive disability at advanced ages. Associations between tea drinking and reduced cognitive disability were much stronger among carriers of the genotypes of FOXO1A-266 or FOXO3-310 or FOXO3-292 compared with noncarriers, and it was reconfirmed by analysis of three-way interactions across FOXO genotypes, tea drinking at around age 60, and at present time. Based on prior findings from animal and human cell models, we postulate that intake of tea compounds may activate FOXO gene expression, which in turn may positively affect cognitive function in the oldest old population. Our empirical findings imply that the health benefits of particular nutritional interventions, including tea drinking, may, in part, depend upon individual genetic profiles.	[Zeng, Yi; Chen, Huashuai] Duke Univ, Ctr Study Aging & Human Dev, Sch Med, Durham, NC 27708 USA; [Zeng, Yi; Chen, Huashuai] Duke Univ, Div Geriatr, Sch Med, Durham, NC 27708 USA; [Zeng, Yi] Peking Univ, Natl Sch Dev, Ctr Hlth Aging & Dev Studies, Beijing 100871, Peoples R China; [Chen, Huashuai] Xiangtan Univ, Business Sch, Xiangtan, Hunan, Peoples R China; [Ni, Ting] Fudan Univ, State Key Lab Genet Engn, Sch Life Sci, Shanghai 200433, Peoples R China; [Ni, Ting] Fudan Univ, MOE Key Lab Contemporary Anthropol, Sch Life Sci, Shanghai 200433, Peoples R China; [Ruan, Rongping] Renmin Univ China, Beijing, Peoples R China; [Feng, Lei] Natl Univ Singapore, Singapore 117548, Singapore; [Nie, Chao; Bolund, Lars; Yang, Huanming] BGI Shenzhen, Shenzhen, Peoples R China; [Cheng, Lingguo] Nanjing Univ, Sch Business, Nanjing, Peoples R China; [Li, Yang; Tian, Xiao-Li] Peking Univ, Inst Mol Med, Dept Human Populat Genet, Beijing 100871, Peoples R China; [Tao, Wei; Gu, Jun] Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China; [Land, Kenneth C.; Yashin, Anatoli] Duke Univ, Populat Res Inst, Durham, NC 27708 USA; [Tan, Qihua] Univ Southern Denmark, Inst Publ Hlth, Unit Epidemiol Biostat & Biodemog, Odense, Denmark; [Yang, Ze] Beijing Hosp, Minist Hlth China, Natl Inst Geriatr, Beijing, Peoples R China; [Bolund, Lars] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark; [Yang, Huanming] James D Watson Inst Genome Sci, Hangzhou, Zhejiang, Peoples R China; [Yang, Huanming] King Abdulaziz Univ, Princess Al Jawhara Ctr Excellence Res Hereditary, Jeddah 21413, Saudi Arabia; [Hauser, Elizabeth] Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27708 USA; [Willcox, Bradley J.] Okinawa Int Univ, Dept Human Welf, Ginowan, Japan; [Willcox, D. Craig; Willcox, Bradley J.] Univ Hawaii, Kuakini Med Ctr, Dept Res, Honolulu, HI 96822 USA; [Willcox, D. Craig; Willcox, Bradley J.] Univ Hawaii, John A Burns Sch Med, Dept Geriatr Med, Honolulu, HI 96822 USA; [Vaupel, James W.] Max Planck Inst Demog Res, Rostock, Germany	Zeng, Y (reprint author), Duke Univ, Ctr Study Aging & Human Dev, Sch Med, Durham, NC 27708 USA.	zengyi68@gmail.com			National Natural Science Foundation of China [71233001]; National Key Basic Research Program of China [2013CB530700]; NIA/NIH [R01 AG023627, R01AG027060, R01AG038707]; KERRY GROUP KUOK FOUNDATION; NIH Pepper Center [P30AG028716]	This study is supported by the National Natural Science Foundation of China (71233001) (Y.Z.), National Key Basic Research Program of China (2013CB530700) (X.-L.T.), NIA/NIH (R01 AG023627) (Y.Z.), KERRY GROUP KUOK FOUNDATION (Y.Z.), NIH Pepper Center Grant (P30AG028716) (E.R.H.), and NIA/NIH (R01AG027060 and R01AG038707) (B.J.W. and D.C.W.).	Aiken L. S., 1991, MULTIPLE REGRESSION; Feng L, 2010, J NUTR HEALTH AGING, V14, P433; Li Y, 2009, HUM MOL GENET, V18, P4897, DOI 10.1093/hmg/ddp459; Yeo H, 2013, EMBO J, V32, P2589, DOI 10.1038/emboj.2013.186; Shankar S, 2013, MOL CELL BIOCHEM, V372, P83, DOI 10.1007/s11010-012-1448-y; Ruan RP, 2013, J AM GERIATR SOC, V61, P1937, DOI 10.1111/jgs.12498; Park SK, 2011, J MED FOOD, V14, P334, DOI 10.1089/jmf.2009.1374; Reiter CEN, 2010, ENDOCRINOLOGY, V151, P103, DOI 10.1210/en.2009-0997; Belguise K, 2007, CANCER RES, V67, P5763, DOI 10.1158/0008-5472.CAN-06-4327; Bartholome A, 2010, ARCH BIOCHEM BIOPHYS, V501, P58, DOI 10.1016/j.abb.2010.05.024; Anselmi CV, 2009, REJUV RES, V12, P95, DOI 10.1089/rej.2008.0827; Cui GH, 2011, ACTA NEUROL SCAND, V124, P361, DOI 10.1111/j.1600-0404.2010.01484.x; Flachsbart F, 2009, P NATL ACAD SCI USA, V106, P2700, DOI 10.1073/pnas.0809594106; Pawlikowska L, 2009, AGING CELL, V8, P460, DOI 10.1111/j.1474-9726.2009.00493.x; Cameron AR, 2008, AGING CELL, V7, P69, DOI 10.1111/j.1474-9726.2007.00353.x; Arab L, 2009, STROKE, V40, P1786, DOI 10.1161/STROKEAHA.108.538470; Anton S, 2007, CELL SIGNAL, V19, P378, DOI 10.1016/j.cellsig.2006.07.008; Bonner MR, 2005, MUTAT RES-GEN TOX EN, V582, P53, DOI 10.1016/j.mrgentox.2004.12.008; Eagleton M., 2014, LIFE EXTENSION, V1, P66; Feng L, 2012, J NUTR HEALTH AGING, V16, P754, DOI 10.1007/s12603-012-0077-1; Feng L, 2013, J AM GERIATR SOC, V61, P1943, DOI 10.1111/jgs.12496; Feng L, 2013, TEA IN HEALTH AND DISEASE PREVENTION, P1325, DOI 10.1016/B978-0-12-384937-3.00111-7; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goodkind D., 2009, POP STUD, V63, P1; Gu D, 2008, HLTH LONGEVITY CHINA, P39; Helm R, 2012, REV MANAG SCI, V6, P307, DOI 10.1007/s11846-010-0057-y; Hernandez LM, 2006, GEN BEH SOC ENV MOV, pp68; Lardner AL, 2014, NUTR NEUROSCI, V17, P145, DOI 10.1179/1476830513Y.0000000079; Lin IH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030951; Moll Lorna, 2012, CURR GERONTOL GERIAT, V2012, P1; Rothman KJ, 2002, EPIDEMIOLOGY INTRO; Shankar S., 2008, J MOL SIGNALING, V3, P1; Vaupel J. W., 2002, J SOC ISSUES, V58, P733; vB Hjelmborg Jacob, 2006, Hum Genet, V119, P312; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Xu WH, 2007, AM J EPIDEMIOL, V166, P1420, DOI 10.1093/aje/kwm242; Yang CS, 2010, NUTR CANCER, V62, P931, DOI 10.1080/01635581.2010.509536; Yuan JM, 2005, CARCINOGENESIS, V26, P1389, DOI 10.1093/carcin/bgi080; Zeng Y, 2011, J GERONTOL A-BIOL, V66, P1054, DOI 10.1093/gerona/glr106; Zeng Y, 2008, HLTH LONGEVITY CHINA, V20; Zeng Y, 2010, J GERONTOL A-BIOL, V65, P1285, DOI 10.1093/gerona/glq156; Zeng Y., 2010, SAGE HDB SOCIAL GERO, P420	42	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1079-5006	1758-535X		J GERONTOL A-BIOL	J. Gerontol. Ser. A-Biol. Sci. Med. Sci.	APR	2015	70	4					426	433		10.1093/gerona/glu060		8	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CH2ZW	WOS:000353896100004		
J	Makizako, H; Liu-Ambrose, T; Shimada, H; Doi, T; Park, H; Tsutsumimoto, K; Uemura, K; Suzuki, T				Makizako, Hyuma; Liu-Ambrose, Teresa; Shimada, Hiroyuki; Doi, Takehiko; Park, Hyuntae; Tsutsumimoto, Kota; Uemura, Kazuki; Suzuki, Takao			Moderate-Intensity Physical Activity, Hippocampal Volume, and Memory in Older Adults With Mild Cognitive Impairment	JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES			English	Article						Physical activity; Brain; Memory	OF-SPORTS-MEDICINE; ALZHEIMER-DISEASE; PUBLIC-HEALTH; EXERCISE; POPULATION; RECOMMENDATION; PERFORMANCE; PREVALENCE; DEMENTIA; SCIENCE	Background. Greater physical activity (PA) is associated with better memory performance and greater hippocampal volume in older adults. However, most studies to date assessed PA via questionnaires and thereby lacked objective characterization of PA (eg, intensity, duration, etc.). Thus, we currently do not have a comprehensive understanding of PA characteristics that are important for neuroprotection, especially among older adults with mild cognitive impairment (MCI). Thus, using triaxial accelerometers, we examined the association between light-and moderate-intensity PA, total duration of PA, hippocampal volume, and memory in older adults with MCI. Methods. This cross-sectional study involved 310 older adults with MCI who completed neuropsychological tests of memory, and structural magnetic resonance imaging. Participants were instructed to wear the accelerometer on an elastic band on their hip at all times for 2 weeks. Average daily duration of light, moderate, and total PA (min/day) was calculated. Results. Moderate PA was associated with hippocampal volume (beta =.167, p =.003) after controlling for age, but light PA (beta = -. 021, p =.713) and total PA (beta =.011, p =.844) were not. Both light and moderate PAs were not associated with memory performance. Structural equation modeling demonstrated that moderate PA was not directly associated with memory but significantly contributed to hippocampal volume; hippocampal volume loss was significantly and directly associated with poor memory performance. Conclusions. Our results suggest that the benefits of moderate PA on memory among older adults with MCI are mediated by hippocampal volume. Furthermore, light PA may not reduce dementia risk among older adults with MCI.	[Makizako, Hyuma; Shimada, Hiroyuki; Doi, Takehiko; Tsutsumimoto, Kota; Uemura, Kazuki] Natl Ctr Geriatr & Gerontol, Dept Res & Dev Support Independent Life Elderly, Ctr Gerontol & Social Sci, Obu, Aichi 4748511, Japan; [Makizako, Hyuma; Doi, Takehiko; Uemura, Kazuki] Japan Soc Promot Sci, Tokyo, Japan; [Makizako, Hyuma; Liu-Ambrose, Teresa] Univ British Columbia, Dept Phys Therapy, Aging Mobil & Cognit Neurosci Lab, Vancouver, BC V5Z 1M9, Canada; [Liu-Ambrose, Teresa] Univ British Columbia, Vancouver Coastal Hlth Res Inst, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC V5Z 1M9, Canada; [Liu-Ambrose, Teresa] Univ British Columbia, Vancouver Coastal Hlth Res Inst, Ctr Hip Hlth & Mobil, Vancouver, BC V5Z 1M9, Canada; [Park, Hyuntae] Natl Ctr Geriatr & Gerontol, Ctr Gerontol & Social Sci, Dept Functioning Activat, Obu, Aichi 4748511, Japan; [Suzuki, Takao] Natl Ctr Geriatr & Gerontol, Res Inst, Obu, Aichi 4748511, Japan	Makizako, H (reprint author), Natl Ctr Geriatr & Gerontol, Dept Res & Dev Support Independent Life Elderly, Ctr Gerontol & Social Sci, Sect Hlth Promot, 35 Gengo,Morioka Machi, Obu, Aichi 4748511, Japan.	makizako@ncgg.go.jp			Japanese Ministry of Health, Labour and Welfare [B-3]; National Center for Geriatrics and Gerontology [22-16]; Japan Society for the Promotion of Science [23-9862]	This study was funded by a grant from the Japanese Ministry of Health, Labour and Welfare (Project for optimising long-term care) (grant number B-3) and a grant from the National Center for Geriatrics and Gerontology (Research Funding for Longevity Sciences) (grant number 22-16). This study was also supported in part by a grant-in-aid for JSPS Fellows (23-9862) from the Japan Society for the Promotion of Science.	Almeida OP, 2014, BRIT J SPORT MED, V48, P220, DOI 10.1136/bjsports-2013-092814; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Daviglus ML, 2010, ANN INTERN MED, V153, P176, DOI 10.7326/0003-4819-153-3-201008030-00260; Ohkawara K, 2011, BRIT J NUTR, V105, P1681, DOI 10.1017/S0007114510005441; Wilbur J, 2012, J GERONTOL B-PSYCHOL, V67, P525, DOI 10.1093/geronb/gbr137; Hagstromer M, 2010, J PHYS ACT HEALTH, V7, P541; Angevaren M, 2007, EUR J CARDIOV PREV R, V14, P825; Burdette JH, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00023; Shimada H, 2013, J AM MED DIR ASSOC, V14, P518, DOI 10.1016/j.jamda.2013.03.010; Petersen RC, 2001, NEUROLOGY, V56, P1133; Oshima Y, 2010, GAIT POSTURE, V31, P370, DOI 10.1016/j.gaitpost.2010.01.005; Makizako H, 2013, GERIATR GERONTOL INT, V13, P860, DOI 10.1111/ggi.12014; Steiger JH, 2007, PERS INDIV DIFFER, V42, P893, DOI 10.1016/j.paid.2006.09.017; Yaffe K, 2011, ARCH NEUROL-CHICAGO, V68, P631, DOI 10.1001/archneurol.2011.82; Buchman AS, 2008, AM J GERIAT PSYCHIAT, V16, P697, DOI 10.1097/JGP.0b013e31817945f6; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Hamer M, 2009, PSYCHOL MED, V39, P3, DOI 10.1017/S0033291708003681; Hanninen T, 2002, ACTA NEUROL SCAND, V106, P148, DOI 10.1034/j.1600-0404.2002.01225.x; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI 10.1249/mss.0b013e3180616aa2; Snowden M, 2011, J AM GERIATR SOC, V59, P704, DOI 10.1111/j.1532-5415.2011.03323.x; Kerr J, 2013, J AM GERIATR SOC, V61, P1927, DOI 10.1111/jgs.12524; Devanand DP, 2007, NEUROLOGY, V68, P828, DOI 10.1212/01.wnl.0000256697.20968.d7; Unick JL, 2012, OBES SURG, V22, P347, DOI 10.1007/s11695-011-0491-1; Apostolova LG, 2006, ARCH NEUROL-CHICAGO, V63, P693, DOI 10.1001/archneur.63.5.693; Erickson KI, 2010, NEUROLOGY, V75, P1415, DOI 10.1212/WNL.0b013e3181f88359; Head D, 2012, NEUROPSYCHOLOGY, V26, P133, DOI 10.1037/a0027108; Barrett P, 2007, PERS INDIV DIFFER, V42, P815, DOI 10.1016/j.paid.2006.09.018; Brown BM, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.118; Buchman AS, 2014, ARCH GERONTOL GERIAT, V58, P74, DOI 10.1016/j.archger.2013.08.001; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gates N, 2013, AM J GERIAT PSYCHIAT, V21, P1086, DOI 10.1016/j.jagp.2013.02.018; Lezak M, 2004, NEUROPSYCHOLOGICAL A; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Sachdev PS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059649; Wechsler D., 1987, WECHSLER MEMORY SCAL	39	8	8	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1079-5006	1758-535X		J GERONTOL A-BIOL	J. Gerontol. Ser. A-Biol. Sci. Med. Sci.	APR	2015	70	4					480	486		10.1093/gerona/glu136		7	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CH2ZW	WOS:000353896100010		
J	Sato, K; Semboshi, S; Konno, TJ				Sato, Kazuhisa; Semboshi, Satoshi; Konno, Toyohiko J.			Three-Dimensional Imaging of Dislocations in a Ti-35mass%Nb Alloy by Electron Tomography	MATERIALS			English	Article							MICROSCOPY; RESOLUTION; TRANSFORMATION; CONTRAST	We have studied three-dimensional (3D) configurations of dislocations in the beta phase of a Ti-35mass%Nb alloy by means of single-axis tilt tomography using bright-field scanning transmission electron microscopy (BF-STEM). To visualize dislocations, the hh0 systematic reflections were excited throughout tilt-series acquisition with the maximum tilt angle of 70 degrees. Dislocations in the beta grains were clearly reconstructed by the weighted back-projection algorithm. The slip planes of the dislocations were deduced by rotating the reconstructed volumes with the aid of selected area electron diffraction patterns. It was found that BF-STEM images with relatively low contrasts, taken along low-order zone axes, are capable to reproduce and preserve the quality of reconstructed image of dislocations. We also found that tilt angles as low as 40 degrees are practically acceptable to visualize 3D configurations of dislocations, while there exists limitation in resolution due to the existence of a large missing wedge.	[Sato, Kazuhisa; Semboshi, Satoshi; Konno, Toyohiko J.] Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan	Sato, K (reprint author), Tohoku Univ, Inst Mat Res, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	ksato@imr.tohoku.ac.jp; semboshi@imr.tohoku.ac.jp; tjkonno@imr.tohoku.ac.jp	Sato, Kazuhisa/C-1510-2011	Sato, Kazuhisa/0000-0001-9078-2541	Ministry of Education, Culture, Sports, Science, and Technology [25102703]; Japan Science Technology Agency "Development of systems and technology for advanced measurement and analysis" program; General Sekiyu R & D Encouragement Assistance Foundation	The authors wish to thank Hiroaki Matsumoto of Kagawa University for invaluable comments, Kenta Aoyagi of Nagoya University for his help in 3D reconstruction, Eiji Aoyagi, and Yuichiro Hayasaka of Tohoku University for their help using TEM. This study was partly supported by the Grant-in-Aid for Scientific Research on Innovative Area, "Bulk Nanostructured Metals" (No. 25102703) from the Ministry of Education, Culture, Sports, Science, and Technology, and Japan Science Technology Agency "Development of systems and technology for advanced measurement and analysis" program. Kazuhisa Sato appreciates financial supports from the General Sekiyu R & D Encouragement Assistance Foundation.	Akanuma T, 2012, SCRIPTA MATER, V67, P21, DOI 10.1016/j.scriptamat.2012.03.011; Midgley PA, 2003, ULTRAMICROSCOPY, V96, P413, DOI 10.1016/S0304-3991(03)00105-0; Semboshi S, 2008, METALL MATER TRANS A, V39A, P2820, DOI 10.1007/s11661-008-9674-3; Liu GS, 2011, J MATER RES, V26, P514, DOI 10.1557/jmr.2010.83; Scott MC, 2012, NATURE, V483, P444, DOI 10.1038/nature10934; Matsumoto H, 2005, MATER TRANS, V46, P1070, DOI 10.2320/matertrans.46.1070; Hata S, 2011, ULTRAMICROSCOPY, V111, P1168, DOI 10.1016/j.ultramic.2011.03.021; Tanaka M, 2008, SCRIPTA MATER, V59, P901, DOI 10.1016/j.scriptamat.2008.06.042; Barnard JS, 2006, SCIENCE, V313, P319, DOI 10.1126/science.1125783; Kawase N, 2007, ULTRAMICROSCOPY, V107, P8, DOI 10.1016/j.ultramic.2006.04.007; Chen CC, 2013, NATURE, V496, P74, DOI 10.1038/nature12009; Kacher J, 2012, MICRON, V43, P1099, DOI 10.1016/j.micron.2012.01.017; Barnard JS, 2006, PHILOS MAG, V86, P4901, DOI 10.1080/14786430600798839; Hirsch P. B., 1977, ELECT MICROSCOPY THI, P169; Imura T., 1974, HIGH VOLTAGE ELECTRO, P179; Kacher JP, 2011, SCRIPTA MATER, V64, P677, DOI 10.1016/j.scriptamat.2010.12.020; Zuo J.M., 2004, MICROSC MICROANAL, V10, P1000	17	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1996-1944			MATERIALS	Materials	APR	2015	8	4					1924	1933		10.3390/ma8041924		10	Materials Science, Multidisciplinary	Materials Science	CH5RD	WOS:000354092100036		
J	Matsueda, M; Nakazawa, T				Matsueda, Mio; Nakazawa, Tetsuo			Early warning products for severe weather events derived from operational medium-range ensemble forecasts	METEOROLOGICAL APPLICATIONS			English	Article						THORPEX; TIGGE; operational medium-range ensemble forecast; multicentre grand ensemble; severe weather events; probabilistic forecast	HEMISPHERE EXTRATROPICAL CYCLONES; PREDICTION SYSTEM; TIGGE MULTIMODEL; GLOBAL ENSEMBLE; ECMWF ENSEMBLE; PAKISTAN	Accurate predictions of severe weather events are important for the society, economy, and environment in regions affected by such events. In the present study, the development and testing of a suite of prototype ensemble-based early warning products for severe weather events, which are now routinely available at , are reported. The early warning products are based on operational medium-range ensemble forecasts from four of the leading global numerical weather centres: the European Centre for Medium-Range Weather Forecasts, the Japan Meteorological Agency, the UK Meteorological Office, and the National Centers for Environmental Prediction in USA. In these products, the forecast probability of the occurrence of severe weather events, including heavy rainfall, strong surface winds, and high/low surface temperatures, is defined based on each model's climatological probabilistic density function. Several case studies have demonstrated the ability of the products to successfully predict severe events, including the Russian heatwave in 2010, the 2010 Pakistan floods, and Hurricane Sandy in 2012. The construction of a grand ensemble by combining four single-centre ensembles can improve the probabilistic skills of forecasts of severe events, up to a lead time of +360h. The improvements in forecast skills are more pronounced for severe surface temperature and precipitation. The grand ensemble provides more reliable forecasts than single-centre ensembles, particularly with respect to strong wind speeds and severe temperature, aiding the advance detection of severe weather events to help mitigate the associated catastrophic damage, especially in developing countries.	[Matsueda, Mio] Univ Oxford, Dept Phys, Oxford OX1 3PU, England; [Matsueda, Mio; Nakazawa, Tetsuo] Meteorol Res Inst, Typhoon Res Dept, Ibaraki, Japan; [Nakazawa, Tetsuo] World Meteorol Org, World Weather Res Div, Geneva, Switzerland	Matsueda, M (reprint author), Univ Oxford, Dept Phys, Clarendon Lab, Parks Rd, Oxford OX1 3PU, England.	matsueda@atm.ox.ac.uk			Japan Society for the Promotion of Science (JSPS)	The authors thank two anonymous reviewers for their valuable comments. The authors also thank the THORPEX TIGGE project team for constructing useful and user-friendly portal sites and for routinely providing operational medium-range ensemble forecast data. Mio Matsueda was supported by a Postdoctoral Fellowship for Research Abroad from the Japan Society for the Promotion of Science (JSPS).	Akthar S., 2011, J BASIC APPL SCI, V7, P101; Yamaguchi M, 2012, Q J ROY METEOR SOC, V138, P2019, DOI 10.1002/qj.1937; Hagedorn R, 2012, Q J ROY METEOR SOC, V138, P1814, DOI 10.1002/qj.1895; Buizza R, 2007, Q J ROY METEOR SOC, V133, P681, DOI 10.1002/qj.75; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Hong CC, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047583; Barriopedro D, 2011, SCIENCE, V332, P220, DOI 10.1126/science.1201224; Aonashi K, 2009, J METEOROL SOC JPN, V87A, P119, DOI 10.2151/jmsj.87A.119; Froude LSR, 2010, WEATHER FORECAST, V25, P819, DOI 10.1175/2010WAF2222326.1; Johnson C, 2009, Q J ROY METEOR SOC, V135, P777, DOI 10.1002/qj.383; Martius O, 2013, Q J ROY METEOR SOC, V139, P1780, DOI 10.1002/qj.2082; Bowler NE, 2008, Q J ROY METEOR SOC, V134, P703, DOI 10.1002/qj.234; Frame THA, 2011, Q J ROY METEOR SOC, V137, P1288, DOI 10.1002/qj.829; Pappenberger F, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033837; Matsueda M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046557; Charron M, 2010, MON WEATHER REV, V138, P1877, DOI 10.1175/2009MWR3187.1; Bougeault P, 2010, B AM METEOROL SOC, V91, P1059, DOI 10.1175/2010BAMS2853.1; Hamill TM, 2013, B AM METEOROL SOC, V94, P1553, DOI 10.1175/BAMS-D-12-00014.1; Froude LSR, 2011, WEATHER FORECAST, V26, P388, DOI 10.1175/2010WAF2222457.1; Lau WKM, 2012, J HYDROMETEOROL, V13, P392, DOI 10.1175/JHM-D-11-016.1; Park YY, 2008, Q J ROY METEOR SOC, V134, P2029, DOI 10.1002/qj.334; Cui B, 2012, WEATHER FORECAST, V27, P396, DOI 10.1175/WAF-D-11-00011.1; Galarneau TJ, 2012, MON WEATHER REV, V140, P1639, DOI 10.1175/MWR-D-11-00191.1; Gilbert N., 2010, NAT NEWS        0812, DOI [10.1038/news.2010.404, DOI 10.1038/NEWS.2010.404]; Hamill TM, 2012, MON WEATHER REV, V140, P2232, DOI 10.1175/MWR-D-11-00220.1; IPCC (Intergovernmental Panel on Climate Change), 2007, PHYS SCI BASISCONTRI; Japan Meteorological Agency, 2007, OUTL OP NUM WEATH PR; Matsueda M, 2009, SOLA, V5, P113, DOI 10.2151/sola.2009-029; Matsueda M, 2008, SOLA, V4, P77, DOI 10.2151/sola.2008-020; Matsueda M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047480; Matsueda M, 2011, MON WEATHER REV, V139, P2455, DOI 10.1175/2010MWR3551.1; Murphy A. H., 1973, Journal of Applied Meteorology, V12, DOI 10.1175/1520-0450(1973)012<0595:ANVPOT>2.0.CO;2; WILKS D. S., 2011, STAT METHODS ATMOSPH; WMO, 2005, THORPEX	34	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1350-4827	1469-8080		METEOROL APPL	Meteorol. Appl.	APR	2015	22	2					213	222		10.1002/met.1444		10	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CH4EZ	WOS:000353987300008		
J	Deditius, AP; Utsunomiya, S; Sanchez-Alfaro, P; Reich, M; Ewing, RC; Kesler, SE				Deditius, Artur P.; Utsunomiya, Satoshi; Sanchez-Alfaro, Pablo; Reich, Martin; Ewing, Rodney C.; Kesler, Stephen E.			Constraints on Hf and Zr mobility in high-sulfidation epithermal systems: formation of kosnarite, KZr2(PO4)(3), in the Chaquicocha gold deposit, Yanacocha district, Peru	MINERALIUM DEPOSITA			English	Article						Kosnarite; Chaquicocha; Yanacocha; Hafnium; Zirconium; Phosphate	GROWTH-RATE; MINERALS; SECTOR; WYCHEPROOF; AUSTRALIA; PHOSPHATE; ZIRCONIUM; VICTORIA	We report the first occurrence of Hf-rich kosnarite [K(Hf,Zr)(2)(PO4)(3)], space group R-3c, Z = 6, in the giant Chaquicocha high-sulfidation epithermal gold deposit in the Yanacocha mining district, Peru. Kosnarite crystals are small (< 100 mu m) and occur in 2-3-mm-thick veins that cut intensively silicified rocks. The paragenesis includes a first stage of As-free pyrite and quartz (plus gratonite and rutile), followed by trace metal-rich pyrite [(Fe,As,Pb,Au)S-2] and secondary Fe sulfates. Kosnarite is associated with quartz and is clearly late within the paragenetic sequence. Electron microprobe analyses (EMPA) of kosnarite show relatively high concentrations of HfO2 and Rb2O (7.61 and 1.05 wt.%, respectively). The re-calculated chemical formulas of kosnarite vary from K-I 1.00(Zr1.93Na0.01Hf0.01Mn0.01)(I pound 1.96)(P3.04O4)(I pound 3) pound to (K0.92Rb0.05Na0.03)(I 1.00)(Zr1.81Hf0.19)(I pound 2.00) pound [(P2.98Si0.02As0.01)(I 3.01)O-4](I pound 3) pound, where Hf and Rb are most likely incorporated according to a coupled substitution of Hf4+ + Rb+ a double dagger" Zr4+ + K+. Back-scattered electron (BSE) images and elemental mapping of kosnarite reveal that Hf and Rb are enriched in 2-10-mu m-wide oscillatory and/or sector zones. High-angle annular dark-field scanning transmission electron microscopy (HAADF-STEM) observations of such zones reveal a pattern of alternating, 5-50-nm-thick, Hf-rich and Zr-rich nanozones. These high-resolution observations indicate that the incorporation of Hf does not appear to cause significant distortion in the kosnarite structure. Semiquantitative TEM-energy-dispersive X-ray spectrometry (EDS) analyses of the nano-layers show up to 22 wt.% of HfO2, which corresponds to 31 mol% of the hypothetical, KHf2(PO4)(3), end-member. The presence of kosnarite in the advanced argillic alteration zone at Yanacocha is indicative of Hf and Zr mobility under highly acidic conditions and points towards an unforeseen role of phosphates as sinks of Zr and Hf in high-sulfidation epithermal environments. Finally, potentially new geochronological applications of highly insoluble vein kosnarite, including Rb-Sr dating, may provide further age constraints in pervasively altered areas where other isotopic systems might have been reset.	[Deditius, Artur P.] Murdoch Univ, Sch Engn & Informat Technol, Murdoch, WA 6150, Australia; [Utsunomiya, Satoshi] Kyushu Univ, Dept Chem, Higashi Ku, Fukuoka 8108560, Japan; [Sanchez-Alfaro, Pablo; Reich, Martin] Univ Chile, Dept Geol, Santiago, Chile; [Sanchez-Alfaro, Pablo; Reich, Martin] Univ Chile, Andean Geothermal Ctr Excellence CEGA, Santiago, Chile; [Ewing, Rodney C.] Stanford Univ, Dept Geol & Earth Sci, Stanford, CA 94305 USA; [Kesler, Stephen E.] Univ Michigan, Dept Earth & Environm Sci, Ann Arbor, MI 48109 USA	Deditius, AP (reprint author), Murdoch Univ, Sch Engn & Informat Technol, 90 South St, Murdoch, WA 6150, Australia.	A.Deditius@murdoch.edu.au			NSF [EAR 052093]; Japan Society of the Promotion of Science (JSPS); FONDAP [246 15090013]; FONDECYT [1130030]; MSI grant Millennium Nucleus for Metal Tracing Along Subduction [NC130065]	The authors are grateful to Carl Henderson for the help with EMPA analyses conducted at the Electron Microbeam Analysis Laboratory (EMAL) at the University of Michigan. The comments by Atanas Hikov, Anthony Longo, Pietro Vignola, and Robert Linnen (Associate Editor) greatly improved the quality of the manuscript. Support for this study was provided by NSF EAR 052093 to Utsunomiya and Kesler. Financial support was provided by Japan Society of the Promotion of Science (JSPS) to Utsunomiya. Martin Reich acknowledges support from FONDAP project 246 15090013, FONDECYT grant 1130030, and MSI grant Millennium Nucleus for Metal Tracing Along Subduction (NC130065).	Aja SU, 1995, APPL GEOCHEM, V10, P603, DOI 10.1016/0883-2927(95)00026-7; Longo AA, 2010, ECON GEOL, V105, P1191, DOI 10.2113/econgeo.105.7.1191; RUBIN JN, 1993, CHEM GEOL, V110, P29, DOI 10.1016/0009-2541(93)90246-F; Watson EB, 1995, AM MINERAL, V80, P1179; Huminicki DMC, 2002, REV MINERAL GEOCHEM, V48, P123, DOI 10.2138/rmg.2002.48.5; Deditius AP, 2008, GEOCHIM COSMOCHIM AC, V72, P2919, DOI 10.1016/j.gca.2008.03.014; Dill HG, 2003, J S AM EARTH SCI, V16, P301, DOI 10.1016/S0895-9811(03)00099-3; Shore M, 1996, CAN MINERAL, V34, P1111; Bethke C.M., 1996, GEOCHEMICAL REACTION; BIRCH WD, 1995, CAN MINERAL, V33, P55; BIRCH WD, 1994, MINERAL MAG, V58, P635, DOI 10.1180/minmag.1994.058.393.13; Brown P. L., 2005, CHEM THERMODYNAMICS, V8; BROWNFIELD ME, 1993, AM MINERAL, V78, P653; Chouinard A, 2005, ECON GEOL, V100, P463, DOI 10.2113/100.3.463; JOHNSON JW, 1992, COMPUT GEOSCI, V18, P899, DOI 10.1016/0098-3004(92)90029-Q; Linnen R.L., 2014, TREATISE GEOCHEMISTR, V13, P543; Longo AA, 2000, GEOL ORE DEPOSIT+, V1, P201; Magdisov AA, 2011, GEOCHIM COSMOCHIM AC, V75, P7426; More PB, 1983, AM MINERAL, V68, P1022; Peterson EC, 2014, GEOLOGY, V42, P383, DOI 10.1130/G35286.1; PUTNIS A, 1992, NATURE, V358, P743, DOI 10.1038/358743a0; Shtukenberg AG, 2009, MINERAL MAG, V73, P385, DOI 10.1180/minmag.2009.073.3.385; Simmons S.F., 2005, ECON GEOL, V100, P485; Stowell H, 2011, AM MINERAL, V96, P1354, DOI 10.2138/am.2011.3759; Teal L, 2010, ECON GEOL, V105, P1173, DOI 10.2113/econgeo.105.7.1173	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0026-4598	1432-1866		MINER DEPOSITA	Miner. Depos.	APR	2015	50	4					429	436		10.1007/s00126-015-0586-z		8	Geochemistry & Geophysics; Mineralogy	Geochemistry & Geophysics; Mineralogy	CI0CN	WOS:000354403500002		
J	Azuma, K; Tamaki, K; Lo, HK				Azuma, Koji; Tamaki, Kiyoshi; Lo, Hoi-Kwong			All-photonic quantum repeaters	NATURE COMMUNICATIONS			English	Article							LINEAR OPTICS; ATOMIC ENSEMBLES; COMMUNICATION; COMPUTATION; OPERATIONS; STATE	Quantum communication holds promise for unconditionally secure transmission of secret messages and faithful transfer of unknown quantum states. Photons appear to be the medium of choice for quantum communication. Owing to photon losses, robust quantum communication over long lossy channels requires quantum repeaters. It is widely believed that a necessary and highly demanding requirement for quantum repeaters is the existence of matter quantum memories. Here we show that such a requirement is, in fact, unnecessary by introducing the concept of all-photonic quantum repeaters based on flying qubits. In particular, we present a protocol based on photonic cluster-state machine guns and a loss-tolerant measurement equipped with local high-speed active feedforwards. We show that, with such all-photonic quantum repeaters, the communication efficiency scales polynomially with the channel distance. Our result paves a new route towards quantum repeaters with efficient single-photon sources rather than matter quantum memories.	[Azuma, Koji; Tamaki, Kiyoshi] NTT Corp, NTT Basic Res Labs, Atsugi, Kanagawa 2430198, Japan; [Lo, Hoi-Kwong] Univ Toronto, Dept Phys, Ctr Quantum Informat & Quantum Control, Toronto, ON M5S 3G4, Canada; [Lo, Hoi-Kwong] Univ Toronto, Dept Elect & Comp Engn, Toronto, ON M5S 3G4, Canada	Azuma, K (reprint author), NTT Corp, NTT Basic Res Labs, 3-1 Morinosato Wakamiya, Atsugi, Kanagawa 2430198, Japan.	azuma.koji@lab.ntt.co.jp			MEXT [21102008]; Japan Society for the Promotion of Science (JSPS); NSERC; CRC program	We thank K. Fujii, D. Gottesman, R. Jozsa, G. Kato, M. Koashi, M. Owari, K. Shimizu, H. Takesue and S. Tani for valuable discussions, N. Matsuda for presenting an excellent thumbnail image and especially M. Curty and W. J. Munro for fruitful discussions in the early stage of this study. This research is in part executed under the Project UQCC by the National Institute of Information and Communications Technology (NICT). K.A. thanks support from a MEXT Grant-in-Aid for Scientific Research on Innovative Areas 21102008, and K.T. acknowledges support from the Japan Society for the Promotion of Science (JSPS) through its Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program). H.-K.L. thanks financial support from NSERC and CRC program.	Aaronson S., 2011, P 43 ANN ACM S THEOR, P333; EKERT AK, 1991, PHYS REV LETT, V67, P661, DOI 10.1103/PhysRevLett.67.661; van Loock P, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.240501; Knill E, 2001, NATURE, V409, P46, DOI 10.1038/35051009; Kent A, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.012326; Vaidman L, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.010402; Sangouard N, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.042340; Munro WJ, 2012, NAT PHOTONICS, V6, P777, DOI [10.1038/nphoton.2012.243, 10.1038/NPHOTON.2012.243]; Lo HK, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.130503; Tanzilli S, 2005, NATURE, V437, P116, DOI 10.1038/nature04009; Briegel HJ, 1998, PHYS REV LETT, V81, P5932, DOI 10.1103/PhysRevLett.81.5932; ZUKOWSKI M, 1993, PHYS REV LETT, V71, P4287, DOI 10.1103/PhysRevLett.71.4287; WOOTTERS WK, 1982, NATURE, V299, P802, DOI 10.1038/299802a0; Raussendorf R, 2001, PHYS REV LETT, V86, P5188, DOI 10.1103/PhysRevLett.86.5188; Nielsen MA, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.040503; Lau HK, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.012322; Ladd TD, 2010, NATURE, V464, P45, DOI 10.1038/nature08812; Lindner NH, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.113602; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Prevedel R, 2007, NATURE, V445, P65, DOI 10.1038/nature05346; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; Northup TE, 2014, NAT PHOTONICS, V8, P356, DOI 10.1038/nphoton.2014.53; Varnava M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.060502; Jiang L, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.032325; Azuma K, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.062309; Sangouard N, 2011, REV MOD PHYS, V83, P33, DOI 10.1103/RevModPhys.83.33; Varnava M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.120501; Shacham A, 2008, IEEE T COMPUT, V57, P1246, DOI 10.1109/TC.2008.78; BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Simon C, 2010, EUR PHYS J D, V58, P1, DOI 10.1140/epjd/e2010-00103-y; Clark SR, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/8/083034; Childress L, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.070504; WEINFURTER H, 1994, EUROPHYS LETT, V25, P559, DOI 10.1209/0295-5075/25/8/001; Gottesman D, 1999, NATURE, V402, P390; Bennett C. H., 1984, P IEEE INT C COMP SY, P175; Buhrman H., 2011, LNCS, V6841, P429; de Riedmatten H, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.047904; DiVincenzo D. P., PREPRINT; Grudka A., 2014, PHYS REV A, V90; Ikuta R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1544; Jacobs BC, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.052307; Kok P, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.022301; Li Y, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/2/023012; Lundskog A, 2014, LIGHT-SCI APPL, V3, DOI 10.1038/lsa.2014.20; Munro WJ, 2010, NAT PHOTONICS, V4, P792, DOI [10.1038/nphoton.2010.213, 10.1038/NPHOTON.2010.213]; Razavi M, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.032301; Simon C, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.190503; Varnava M, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/203; Waks E., 2002, PHYS REV A, V65, DOI DOI 10.1103/PHYSREVA.65.052310; Wang TJ, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.062311; Zwerger M, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.062326	51	4	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6787	10.1038/ncomms7787		7	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0IH	WOS:000353702500027		
J	Dai, S; Ma, Q; Andersen, T; Mcleod, AS; Fei, Z; Liu, MK; Wagner, M; Watanabe, K; Taniguchi, T; Thiemens, M; Keilmann, F; Jarillo-Herrero, P; Fogler, MM; Basov, DN				Dai, S.; Ma, Q.; Andersen, T.; Mcleod, A. S.; Fei, Z.; Liu, M. K.; Wagner, M.; Watanabe, K.; Taniguchi, T.; Thiemens, M.; Keilmann, F.; Jarillo-Herrero, P.; Fogler, M. M.; Basov, D. N.			Subdiffractional focusing and guiding of polaritonic rays in a natural hyperbolic material	NATURE COMMUNICATIONS			English	Article							DER-WAALS HETEROSTRUCTURES; HEXAGONAL BORON-NITRIDE; NEGATIVE REFRACTION; DIFFRACTION LIMIT; GRAPHENE PLASMONS; PHONON POLARITONS; OPTICAL HYPERLENS; RESONANCE CONES; METAMATERIALS; SUPERLENS	Uniaxial materials whose axial and tangential permittivities have opposite signs are referred to as indefinite or hyperbolic media. In such materials, light propagation is unusual leading to novel and often non-intuitive optical phenomena. Here we report infrared nano-imaging experiments demonstrating that crystals of hexagonal boron nitride, a natural mid-infrared hyperbolic material, can act as a 'hyper-focusing lens' and as a multi-mode waveguide. The lensing is manifested by subdiffractional focusing of phonon-polaritons launched by metallic disks underneath the hexagonal boron nitride crystal. The waveguiding is revealed through the modal analysis of the periodic patterns observed around such launchers and near the sample edges. Our work opens new opportunities for anisotropic layered insulators in infrared nanophotonics complementing and potentially surpassing concurrent artificial hyperbolic materials with lower losses and higher optical localization.	[Dai, S.; Mcleod, A. S.; Fei, Z.; Liu, M. K.; Wagner, M.; Fogler, M. M.; Basov, D. N.] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Ma, Q.; Andersen, T.; Jarillo-Herrero, P.] MIT, Dept Phys, Cambridge, MA 02215 USA; [Liu, M. K.] SUNY Stony Brook, Dept Phys, Stony Brook, NY 11794 USA; [Watanabe, K.; Taniguchi, T.] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan; [Thiemens, M.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Keilmann, F.] Univ Munich, D-80539 Munich, Germany; [Keilmann, F.] Ctr Nanosci, D-80539 Munich, Germany	Basov, DN (reprint author), Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA.	dbasov@physics.ucsd.edu	WATANABE, Kenji/H-2825-2011; Fei, Zhe/E-6475-2015	WATANABE, Kenji/0000-0003-3701-8119; Fei, Zhe/0000-0002-7940-5566	DOE-BES [DE-FG02-00ER45799]; Gordon and Betty Moore Foundation's EPiQS initiative [GBMF4533]; Office of Naval Research; AFOSR [FA9550-11-1-0225]; NASA; University of California Office of the President; Office of Science Graduate Research Fellowship from U.S. Department of Energy	D.N.B. acknowledges support from DOE-BES grant DE-FG02-00ER45799 and the Gordon and Betty Moore Foundation's EPiQS initiative through Grant GBMF4533; research on polariton focusing is supported by AFOSR. Work at UCSD is supported by the Office of Naval Research, AFOSR, NASA and The University of California Office of the President. A.S.M. acknowledges support from an Office of Science Graduate Research Fellowship from U.S. Department of Energy. P.J-H acknowledges support from AFOSR grant number FA9550-11-1-0225.	Smith DR, 2004, APPL PHYS LETT, V84, P2244, DOI 10.1063/1.1690471; Atkin JM, 2012, ADV PHYS, V61, P745, DOI 10.1080/00018732.2012.737982; Yang XD, 2012, NAT PHOTONICS, V6, P450, DOI 10.1038/NPHOTON.2012.124; Lindell IV, 2001, MICROW OPT TECHN LET, V31, P129, DOI 10.1002/mop.1378; Boltasseva A, 2011, SCIENCE, V331, P290, DOI 10.1126/science.1198258; Yao J, 2008, SCIENCE, V321, P930, DOI 10.1126/science.1157566; Argyropoulos C, 2013, OPT EXPRESS, V21, P15037, DOI 10.1364/OE.21.015037; Zhang X, 2008, NAT MATER, V7, P435, DOI 10.1038/nmat2141; Ishii S, 2013, LASER PHOTONICS REV, V7, P265, DOI 10.1002/lpor.201200095; Salandrino A, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.075103; Jacob Z, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4710548; FISHER RK, 1969, PHYS REV LETT, V22, P1093, DOI 10.1103/PhysRevLett.22.1093; Fei Z, 2012, NATURE, V487, P82, DOI 10.1038/nature11253; Watanabe K, 2004, NAT MATER, V3, P404, DOI 10.1038/nmat1134; Tassin P, 2012, NAT PHOTONICS, V6, P259, DOI 10.1038/nphoton.2012.27; Poddubny A, 2013, NAT PHOTONICS, V7, P948, DOI [10.1038/nphoton.2013.243, 10.1038/NPHOTON.2013.243]; Ishii S, 2012, OPT COMMUN, V285, P3368, DOI 10.1016/j.optcom.2012.01.042; Hoffman AJ, 2007, NAT MATER, V6, P946, DOI 10.1038/nmat2033; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; Liu ZW, 2007, SCIENCE, V315, P1686, DOI 10.1126/science.1137368; Guo Y, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4754616; Chen JN, 2012, NATURE, V487, P77, DOI 10.1038/nature11254; Noginov MA, 2010, OPT LETT, V35, P1863, DOI 10.1364/OL.35.001863; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Taubner T, 2006, SCIENCE, V313, P1595, DOI 10.1126/science.1131025; Biehs SA, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.104301; Fang N, 2005, SCIENCE, V308, P534, DOI 10.1126/science.1108759; Dai S, 2014, SCIENCE, V343, P1125, DOI 10.1126/science.1246833; Khurgin JB, 2012, MRS BULL, V37, P768, DOI 10.1557/mrs.2012.173; Jacob Z, 2006, OPT EXPRESS, V14, P8247, DOI 10.1364/OE.14.008247; Smith DR, 2003, APPL PHYS LETT, V82, P1506, DOI 10.1063/1.1554779; Caldwell JD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6221; Chaves J., 2008, INTRO NONIMAGING OPT; Fogler MM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5555; Guo Y., 2012, ADV OPTOELECTRON, V2012, DOI DOI 10.1155/2012/452502; Kehr SC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1249; Keilmann F, 2012, J INFRARED MILLIM TE, V33, P479, DOI 10.1007/s10762-012-9894-x; LEVINE B, 1978, PHYS FLUIDS, V21, P1116, DOI 10.1063/1.862351; Li P., 2015, HYPERBOLIC PHONON PO; Lu D., 2012, NAT COMMUN, V2, P1205; Novotny L, 2006, PRINCIPLES NANOOPTIC; Rho J, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1148; Siddiqui O, 2004, APPL PHYS LETT, V85, P1292, DOI 10.1063/1.1781360; Smith D. R., 2003, PHYS REV LETT, V90, P77405, DOI DOI 10.1103/PHYSREVLETT.90.077405; Smolyaninov II, 2007, SCIENCE, V315, P1699, DOI 10.1126/science.1138746; Tarkhanyan R., 2006, RADIOWAVES POLARITON; Thongrattanasiri S, 2009, OPT LETT, V34, P890, DOI 10.1364/OL.34.000890; Vinogradov A.P., 2010, METAMATERIALS, V4, P181, DOI 10.1016/j.metmat.2010.09.002; Woessner A., 2015, NAT MATER, V487, P82; Xu XJG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5782	50	11	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6963	10.1038/ncomms7963		7	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0JC	WOS:000353704700015		
J	Fukushima, T; Yoshihara, H; Furuta, H; Kamei, H; Hakuno, F; Luan, J; Duan, CM; Saeki, Y; Tanaka, K; Iemura, SI; Natsume, T; Chida, K; Nakatsu, Y; Kamata, H; Asano, T; Takahashi, SI				Fukushima, Toshiaki; Yoshihara, Hidehito; Furuta, Haruka; Kamei, Hiroyasu; Hakuno, Fumihiko; Luan, Jing; Duan, Cunming; Saeki, Yasushi; Tanaka, Keiji; Iemura, Shun-Ichiro; Natsume, Tohru; Chida, Kazuhiro; Nakatsu, Yusuke; Kamata, Hideaki; Asano, Tomoichiro; Takahashi, Shin-Ichiro			Nedd4-induced monoubiquitination of IRS-2 enhances IGF signalling and mitogenic activity	NATURE COMMUNICATIONS			English	Article							GROWTH-FACTOR-I; RECEPTOR SUBSTRATES IRSS; UBIQUITIN LIGASE; FRTL-5 CELLS; NEGATIVE REGULATOR; E3 LIGASE; INSULIN; CANCER; PTEN; DEGRADATION	Insulin-like growth factors (IGFs) induce proliferation of various cell types and play important roles in somatic growth and cancer development. Phosphorylation of insulin receptor substrate (IRS)-1/2 by IGF-I receptor tyrosine kinase is essential for IGF action. Here we identify Nedd4 as an IRS-2 ubiquitin ligase. Nedd4 monoubiquitinates IRS-2, which promotes its association with Epsin1, a ubiquitin-binding protein. Nedd4 recruits IRS-2 to the membrane, probably through promoting Epsin1 binding, and enhances IGF-I receptor-induced IRS-2 tyrosine phosphorylation. In thyroid FRTL-5 cells, activation of the cyclic AMP pathway increases the association of Nedd4 with IRS-2, thereby enhancing IRS-2-mediated signalling and cell proliferation induced by IGF-I. The Nedd4 and IRS-2 association is also required for maximal activation of IGF-I signalling and cell proliferation in prostate cancer PC-3 cells. Nedd4 overexpression accelerates zebrafish embryonic growth through IRS-2 in vivo. We conclude that Nedd4-induced monoubiquitination of IRS-2 enhances IGF signalling and mitogenic activity.	[Fukushima, Toshiaki; Yoshihara, Hidehito; Furuta, Haruka; Kamei, Hiroyasu; Hakuno, Fumihiko; Chida, Kazuhiro; Takahashi, Shin-Ichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Sci & Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; [Fukushima, Toshiaki; Nakatsu, Yusuke; Kamata, Hideaki; Asano, Tomoichiro] Hiroshima Univ, Grad Sch Med, Dept Med Sci, Minami Ku, Hiroshima, Hiroshima 7348553, Japan; [Yoshihara, Hidehito; Saeki, Yasushi; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Prot Metab, Setagaya Ku, Tokyo 1568506, Japan; [Luan, Jing] Ocean Univ China, Chinese Minist Educ, Key Lab Marine Drugs, Qingdao 266003, Shandong, Peoples R China; [Duan, Cunming] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Iemura, Shun-Ichiro] Fukushima Med Univ, Translat Res Ctr, Fukushima, Fukushima 9608031, Japan; [Natsume, Tohru] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery Molprof, Koto Ku, Tokyo 1350064, Japan	Takahashi, SI (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Sci & Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	atkshin@mail.ecc.u-tokyo.ac.jp			Japan Society for the Promotion of Science (JSPS) [22780249, 24790928]; Japan Science and Technology Agency [AS232Z02241G]; Tsuchiya Memorial Medical Foundation; JSPS [13J07852, 24112008, 21000012, 23390242, 16208028, 22248030, 25221204]; Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; JSPS	We thank Dr Leonard Girnita (Karolinska Hospital, Stockholm, Sweden), Dr Ignacio Torres-Aleman (Cajal Institute, Madrid, Spain), Dr Yusuke Higashi (Tulane University, New Orleans, LA, USA), Dr Robert J. Smith (Brown University, Providence, RI, USA) and Dr Yoshihiro Tsuchiya (Hiroshima University) for helpful discussions. We thank Dr Ohkuma, Dr Kumar, Dr Imamura, Dr Nakae, Dr Iwaki, Dr Suzuki and Dr Matsubara for kind donations of IGF-I, cDNAs, plasmids and cells. We also acknowledge the help of Dr Susan Hall (The University of North Carolina at Chapel Hill) and Mr John Allard in proof-reading the manuscript. A part of this work was carried out at the Analysis Center of Life Science, Natural Science Center for Basic Research and Development, Hiroshima University. This work was partially supported by the following grants: Grant-in-Aid for Young Scientists (B)#22780249 and (B)#24790928 from the Japan Society for the Promotion of Science (JSPS), A-STEP Feasibility Study Stage #AS232Z02241G from Japan Science and Technology Agency and Grant from Tsuchiya Memorial Medical Foundation to TF; Grant-in-Aid for JSPS Fellows #13J07852 to H.Y.; Grant-in-Aid for Scientific Research on Innovative Areas #24112008 from JSPS to Y.S.; Grant-in-Aid for Specially Promoted Research #21000012 from JSPS to K.T.; Grant-in-Aid for Scientific Research (B)#23390242 from JSPS to T.A.; Grant-in-Aid for Scientific Research (A)(2)#16208028, (A)#22248030 and (S)#25221204; Core-to-core programme from JSPS and Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry to S.-I.T.	Anan T, 1998, GENES CELLS, V3, P751, DOI 10.1046/j.1365-2443.1998.00227.x; ANGELLOZNICOUD P, 1995, ENDOCRINOLOGY, V136, P5485, DOI 10.1210/en.136.12.5485; Tsuchiya H, 2013, BIOCHEM BIOPH RES CO, V436, P223, DOI 10.1016/j.bbrc.2013.05.080; Takeuchi T, 2011, INT J EXP PATHOL, V92, P79, DOI 10.1111/j.1365-2613.2010.00740.x; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Kimura T, 2001, ENDOCR REV, V22, P631, DOI 10.1210/er.22.5.631; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Xu XS, 2008, MOL CELL, V30, P403, DOI 10.1016/j.molcel.2008.03.009; Fan CD, 2013, J BIOL CHEM, V288, P1674, DOI 10.1074/jbc.M112.416339; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Kwak YD, 2012, J NEUROSCI, V32, P10971, DOI 10.1523/JNEUROSCI.1836-12.2012; Nakao R, 2009, MOL CELL BIOL, V29, P4798, DOI 10.1128/MCB.01347-08; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; THISSEN JP, 1994, ENDOCR REV, V15, P80, DOI 10.1210/er.15.1.80; Yang B, 2010, CELL DEATH DIFFER, V17, P68, DOI 10.1038/cdd.2009.84; Persad S, 2000, P NATL ACAD SCI USA, V97, P3207; Chan B, 2008, J MAMMARY GLAND BIOL, V13, P415, DOI 10.1007/s10911-008-9101-9; Clemmons DR, 2007, NAT REV DRUG DISCOV, V6, P821, DOI 10.1038/nrd2359; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Amodio N, 2010, AM J PATHOL, V177, P2622, DOI 10.2353/ajpath.2010.091075; Song RS, 2013, NATURE, V494, P375, DOI 10.1038/nature11834; Kim SS, 2008, APMIS, V116, P779, DOI 10.1111/j.1600-0463.2008.00999.x; Maspero E, 2011, EMBO REP, V12, P342, DOI 10.1038/embor.2011.21; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; TAKAHASHI S, 1990, ENDOCRINOLOGY, V126, P736; Ariga M, 2000, BIOCHEM J, V348, P409, DOI 10.1042/0264-6021:3480409; Haglund K, 2012, J CELL SCI, V125, P265, DOI 10.1242/jcs.091280; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Eide PW, 2013, CELL SIGNAL, V25, P12, DOI 10.1016/j.cellsig.2012.08.012; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Butler AA, 2001, ENDOCRINOLOGY, V142, P1685, DOI 10.1210/en.142.5.1685; Cao XR, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160940; Chan S. J., 2000, INTEGR COMP BIOL, V40, P213, DOI DOI 10.1093/ICB/40.2.213; Dupont J., 2001, Molecular Pathology, V54, P149, DOI 10.1136/mp.54.3.149; Fukushima T, 2011, BIOCHEM BIOPH RES CO, V404, P767, DOI 10.1016/j.bbrc.2010.12.045; Fukushima T, 2011, MOL CELL ENDOCRINOL, V344, P81, DOI 10.1016/j.mce.2011.06.029; Fukushima T, 2008, ENDOCRINOLOGY, V149, P3729, DOI 10.1210/en.2007-1443; Higashi Y, 2008, AM J PHYSIOL-HEART C, V295, pH1684, DOI 10.1152/ajpheart.00548.2008; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Kabuta T, 2002, J BIOL CHEM, V277, P6846, DOI 10.1074/jbc.M107058200; KIMMEL CB, 1995, DEV DYNAM, V203, P253; Maures T, 2002, ENDOCRINOLOGY, V143, P1858, DOI 10.1210/en.143.5.1858; Monami G, 2008, J CELL PHYSIOL, V216, P426, DOI 10.1002/jcp.21405; Muller K, 2011, MOL ENDOCRINOL, V25, P1867, DOI 10.1210/me.2011-0065; PIETRZKOWSKI Z, 1993, CANCER RES, V53, P1102; Schlueter PJ, 2007, CELL DEATH DIFFER, V14, P1095, DOI 10.1038/sj.cdd.4402109; Sen A, 2012, BIOMOL CONCEPTS, V3, P117; Shi Y, 2014, INT J INF TECH DECIS, V13, P1, DOI 10.1142/S0219622014010019; TRAMONTANO D, 1988, ENDOCRINOLOGY, V122, P127; Van Wyk J. J., 1990, DEV ENDOCRINOL; Yoshihara H, 2012, BIOCHEM BIOPH RES CO, V423, P122, DOI 10.1016/j.bbrc.2012.05.093	55	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6780	10.1038/ncomms7780		14	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0IH	WOS:000353702500020		
J	Madan, I; Kurosawa, T; Toda, Y; Oda, M; Mertelj, T; Mihailovic, D				Madan, I.; Kurosawa, T.; Toda, Y.; Oda, M.; Mertelj, T.; Mihailovic, D.			Evidence for carrier localization in the pseudogap state of cuprate superconductors from coherent quench experiments	NATURE COMMUNICATIONS			English	Article							HIGH-T-C; COPPER-OXIDE SUPERCONDUCTORS; PHASE COHERENCE; QUASI-PARTICLE; MOTT INSULATOR; JAHN-TELLER; DYNAMICS; BI2SR2CACU2O8+DELTA; CONDENSATION; SPECTROSCOPY	A 'pseudogap' was introduced by Mott to describe a state of matter that has a minimum in the density of states at the Fermi level, deep enough for states to become localized. It can arise either from Coulomb repulsion between electrons, and/or incipient charge or spin order. Here we employ ultrafast spectroscopy to study dynamical properties of the normal to pseudogap state transition in the prototype high-temperature superconductor Bi2Sr2CaCu2O8+delta. We perform a systematic temperature and doping dependence study of the pseudogap photodestruction and recovery in coherent quench experiments, revealing marked absence of critical behaviour of the elementary excitations, which implies an absence of collective electronic ordering beyond a few coherence lengths on short timescales. The data imply ultrafast carrier localization into a textured polaronic state arising from a competing Coulomb interaction and lattice strain, enhanced by a Fermi surface instability.	[Madan, I.; Mertelj, T.; Mihailovic, D.] Jozef Stefan Inst, SI-1000 Ljubljana, Slovenia; [Madan, I.; Mertelj, T.; Mihailovic, D.] Int Postgrad Sch, SI-1000 Ljubljana, Slovenia; [Kurosawa, T.; Oda, M.] Hokkaido Univ, Dept Phys, Sapporo, Hokkaido 0600810, Japan; [Toda, Y.] Hokkaido Univ, Dept Appl Phys, Sapporo, Hokkaido 0608628, Japan	Mihailovic, D (reprint author), Jozef Stefan Inst, Jamova 39, SI-1000 Ljubljana, Slovenia.	Dragan.Mihailovic@ijs.si					Agrestini S, 2003, J PHYS A-MATH GEN, V36, P9133, DOI 10.1088/0305-4470/36/35/302; Stojchevska L, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.180507; Parker CV, 2010, NATURE, V468, P677, DOI 10.1038/nature09597; Comin R, 2014, SCIENCE, V343, P390, DOI 10.1126/science.1242996; Devereaux TP, 2007, REV MOD PHYS, V79, P175, DOI 10.1103/RevModPhys.79.175; Cortes R, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.097002; He RH, 2011, SCIENCE, V331, P1579, DOI 10.1126/science.1198415; Kusar P, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.227001; Quijada MA, 1999, PHYS REV B, V60, P14917, DOI 10.1103/PhysRevB.60.14917; Pogrebna A, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.165131; Lee PA, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.031017; Zhao GM, 1998, J PHYS-CONDENS MAT, V10, P9055, DOI 10.1088/0953-8984/10/40/010; Yusupov R, 2010, NAT PHYS, V6, P681, DOI 10.1038/NPHYS1738; Torchinsky DH, 2013, NAT MATER, V12, P387, DOI [10.1038/nmat3571, 10.1038/NMAT3571]; Ghiringhelli G, 2012, SCIENCE, V337, P821, DOI 10.1126/science.1223532; Smallwood CL, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.115126; Mannella N, 2005, NATURE, V438, P474, DOI 10.1038/nature04273; Kabanov VV, 1999, PHYS REV B, V59, P1497, DOI 10.1103/PhysRevB.59.1497; Zhao GM, 1997, NATURE, V385, P236, DOI 10.1038/385236a0; Mertelj T, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.147003; Vishik IM, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.207002; Toda Y, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.174516; ALEXANDROV AS, 1994, REP PROG PHYS, V57, P1197, DOI 10.1088/0034-4885/57/12/001; Efetov KB, 2013, NAT PHYS, V9, P442, DOI [10.1038/nphys2641, 10.1038/NPHYS2641]; Keimer B, 2015, NATURE, V518, P179, DOI 10.1038/nature14165; Porer M, 2014, NAT MATER, V13, P857, DOI [10.1038/nmat4042, 10.1038/NMAT4042]; Sakai S, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.107001; Stojchevska L, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.024519; Kohsaka Y, 2008, NATURE, V454, P1072, DOI 10.1038/nature07243; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; Damascelli A, 2003, REV MOD PHYS, V75, P473, DOI 10.1103/RevModPhys.75.473; Kivelson SA, 1998, NATURE, V393, P550; Norman MR, 2005, ADV PHYS, V54, P715, DOI 10.1080/00018730500489906; Cilento F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5353; Coslovich G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3643; Neto EHD, 2014, SCIENCE, V343, P393, DOI 10.1126/science.1243479; DEMSAR J, 2001, PHYS REV B, V63; Demsar J, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.041101; Dvorsek D, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.020510; Gadermaier C, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.011056; Gay P, 1999, J LOW TEMP PHYS, V117, P1025, DOI 10.1023/A:1022561904373; Kabanov VV, 2006, J SUPERCOND NOV MAGN, V19, P67, DOI 10.1007/s10948-005-0096-9; Keller H, 2008, MATER TODAY, V11, P38, DOI 10.1016/S1369-7021(08)70178-0; Krasnov VM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3970; Kusar P., 2008, PREPRINT; Loram JW, 2000, PHYSICA C, V341, P831, DOI 10.1016/S0921-4534(00)00706-1; Madan I, 2014, SCI REP-UK, V4, DOI 10.1038/srep05656; Mertelj T, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.054523; Mihailovic D, 2005, STRUCT BOND, V114, P331, DOI 10.1007/b101024; Mihailovic D, 2002, EUROPHYS LETT, V57, P254, DOI 10.1209/epl/i2002-00569-0; Mishchenko AS, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.036402; Oda M, 1997, PHYSICA C, V281, P135, DOI 10.1016/S0921-4534(97)00505-4; Patashinski A., 1979, FLUCTIATION THEORY P; Sacepe B, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1140; Timusk T, 1999, REP PROG PHYS, V62, P61, DOI 10.1088/0034-4885/62/1/002; Stojchevska L, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.012505; Toda Y, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.094513	57	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6958	10.1038/ncomms7958		6	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0JC	WOS:000353704700010		
J	Minocha, S; Valloton, D; Ypsilanti, AR; Fiumelli, H; Allen, EA; Yanagawa, Y; Marin, O; Chedotal, A; Hornung, JP; Lebrand, C				Minocha, Shilpi; Valloton, Delphine; Ypsilanti, Athena R.; Fiumelli, Hubert; Allen, Elizabeth A.; Yanagawa, Yuchio; Marin, Oscar; Chedotal, Alain; Hornung, Jean-Pierre; Lebrand, Cecile			Nkx2.1-derived astrocytes and neurons together with Slit2 are indispensable for anterior commissure formation	NATURE COMMUNICATIONS			English	Article							RADIAL GLIAL-CELLS; CORPUS-CALLOSUM; CEREBRAL-CORTEX; AXON GUIDANCE; MAMMALIAN FOREBRAIN; IN-VIVO; GANGLIONIC EMINENCES; MOUSE TELENCEPHALON; MOLECULAR TUNNELS; GROWING AXONS	Guidepost cells present at and surrounding the midline provide guidance cues that orient the growing axons through commissures. Here we show that the transcription factor Nkx2.1 known to control the specification of GABAergic interneurons also regulates the differentiation of astroglia and polydendrocytes within the mouse anterior commissure (AC). Nkx2.1-positive glia were found to originate from three germinal regions of the ventral telencephalon. Nkx2.1-derived glia were observed in and around the AC region by E14.5. Thereafter, a selective cell ablation strategy showed a synergistic role of Nkx2.1-derived cells, both GABAergic interneurons and astroglia, towards the proper formation of the AC. Finally, our results reveal that the Nkx2.1-regulated cells mediate AC axon guidance through the expression of the repellent cue, Slit2. These results bring forth interesting insights about the spatial and temporal origin of midline telencephalic glia, and highlight the importance of neurons and astroglia towards the formation of midline commissures.	[Minocha, Shilpi; Valloton, Delphine; Hornung, Jean-Pierre; Lebrand, Cecile] Univ Lausanne, Dept Fundamental Neurosci, CH-1005 Lausanne, Switzerland; [Ypsilanti, Athena R.; Chedotal, Alain] INSERM, Inst Vis, UMR S968, F-75012 Paris, France; [Ypsilanti, Athena R.; Chedotal, Alain] Univ Paris 06, Univ Paris 04, Inst Vis, UMR S 968, F-75012 Paris, France; [Ypsilanti, Athena R.; Chedotal, Alain] CNRS, UMR 7210, F-75012 Paris, France; [Fiumelli, Hubert] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Thuwal 23955, Saudi Arabia; [Allen, Elizabeth A.] Ecole Polytech Fed Lausanne, Stn 19, CH-1015 Lausanne, Switzerland; [Yanagawa, Yuchio] Gunma Univ, Grad Sch Med, Dept Genet & Behav Neurosci, Maebashi, Gumma 3718511, Japan; [Yanagawa, Yuchio] Japan Sci & Technol Agcy, CREST, Maebashi, Gumma 3718511, Japan; [Marin, Oscar] CSIC, Inst Neurociencias, Sant Joan dAlacant 03550, Spain; [Marin, Oscar] Univ Miguel Hernandez, Sant Joan dAlacant 03550, Spain	Lebrand, C (reprint author), Univ Lausanne, Dept Fundamental Neurosci, CH-1005 Lausanne, Switzerland.	cecile.lebrand@unil.ch	Lebrand, Cecile/G-1394-2015; Marin, Oscar/F-3856-2012; Hornung, Jean-Pierre/O-7505-2015; 	Lebrand, Cecile/0000-0002-2750-3164; Marin, Oscar/0000-0001-6264-7027; Hornung, Jean-Pierre/0000-0002-9229-7520; Chedotal, Alain/0000-0001-7577-3794	Fondation Pierre Mercier pour la science; Ecole des Neurosciences de Paris; Swiss National Foundation [31003A-122550]; French State programme 'Investissements d'Avenir' [LIFESENSES: ANR 10 LABX 65]; fondation pour la recherche medicale (Programme equipe FRM); ANR [ANR2011 BSV4 0091]; MEXT, Japan; Takeda Science Foundation	We are particularly grateful to Christiane Devenoges for technical assistance. We would like to thank Fanny Thevenaz and Alain Gnecchi for mouse care, plugs and genotyping. We thank Jean-Yves Chatton from the Cellular Imaging Facility (University of Lausanne, Switzerland) and Nicolas Liaudet for imaging assistance. We thank Pr D. Riethmacher for the gift of the Rosa-DTA mice (Zentrum fur Molekulare Neurobiologie, University of Hamburg, Germany) and Shigeyoshi Itohara (RIKEN Brain Science Instituta, Japan) for the gift of the NSE-DTA mice. S.M. was supported by a postdoctoral fellowship of the Fondation Pierre Mercier pour la science. A.R.Y. was a recipient of a doctoral fellowship of the Ecole des Neurosciences de Paris. The work in the laboratories of C.L. and J.-P.H. was supported by funds from Swiss National Foundation Grant no. 31003A-122550. The work in the laboratory of A.C. was supported by grants from the French State programme 'Investissements d'Avenir' managed by the Agence Nationale de la Recherche [LIFESENSES: ANR 10 LABX 65], the fondation pour la recherche medicale (Programme equipe FRM) and the ANR (grant ANR2011 BSV4 0091). Work in the laboratory of Y.Y. was supported by funds for Scientific Research from the MEXT, Japan and Takeda Science Foundation.	Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Shu TZ, 2003, J NEUROSCI, V23, P8176; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895; Brose K, 2000, CURR OPIN NEUROBIOL, V10, P95, DOI 10.1016/S0959-4388(99)00066-5; Pinto L, 2007, PROG NEUROBIOL, V83, P2, DOI 10.1016/j.pneurobio.2007.02.010; Magnani D, 2014, CEREB CORTEX, V24, P186, DOI 10.1093/cercor/bhs303; Ge WP, 2012, NATURE, V484, P376, DOI 10.1038/nature10959; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Falk J, 2005, NEURON, V48, P63, DOI 10.1016/j.neuron.2005.08.033; LAZZARO D, 1991, DEVELOPMENT, V113, P1093; Andrews WD, 2007, J ANAT, V211, P188, DOI 10.1111/j.1469-7580.2007.00750.x; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; Cai J, 2007, DEVELOPMENT, V134, P1887, DOI 10.1242/dev.02847; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; SILVER J, 1993, J COMP NEUROL, V328, P415, DOI 10.1002/cne.903280308; Sahay A, 2003, J NEUROSCI, V23, P6671; Shu TZ, 2001, J NEUROSCI, V21, P2749; Pires-Neto MA, 1998, J COMP NEUROL, V399, P176, DOI 10.1002/(SICI)1096-9861(19980921)399:2<176::AID-CNE3>3.0.CO;2-Y; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; Shu TZ, 2003, J NEUROBIOL, V57, P81, DOI 10.1002/neu.10252; Cancedda L, 2007, J NEUROSCI, V27, P5224, DOI 10.1523/JNEUROSCI.5169-06.2007; Anderson SA, 2001, DEVELOPMENT, V128, P353; Lent R, 2005, J COMP NEUROL, V483, P375, DOI 10.1002/cne.20427; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; Islam SM, 2009, SCIENCE, V323, P388, DOI 10.1126/science.1165187; Casarosa S, 1999, DEVELOPMENT, V126, P525; Marshall CAG, 2002, J NEUROSCI, V22, P9821; Xu Q, 2008, J COMP NEUROL, V506, P16, DOI 10.1002/cne.21529; SMITH GM, 1986, J COMP NEUROL, V251, P23, DOI 10.1002/cne.902510103; CAMERON RS, 1991, GLIA, V4, P124, DOI 10.1002/glia.440040204; Sussel L, 1999, DEVELOPMENT, V126, P3359; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Bradford J, 2009, P NATL ACAD SCI USA, V106, P22480, DOI 10.1073/pnas.0911503106; Bagri A, 2002, NEURON, V33, P233, DOI 10.1016/S0896-6273(02)00561-5; Lopez-Bendito G, 2007, J NEUROSCI, V27, P3395, DOI 10.1523/JNEUROSCI.4605-06.2007; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; Chen H, 2000, NEURON, V25, P43, DOI 10.1016/S0896-6273(00)80870-3; GUAZZI S, 1990, EMBO J, V9, P3631; Giger RJ, 2000, NEURON, V25, P29, DOI 10.1016/S0896-6273(00)80869-7; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; SCHMECHEL DE, 1979, ANAT EMBRYOL, V156, P115, DOI 10.1007/BF00300010; Hildebrandt H, 2009, BRAIN, V132, P2831, DOI 10.1093/brain/awp117; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Niquille M, 2013, DEV NEUROBIOL, V73, P647, DOI 10.1002/dneu.22075; Benadiba C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002606; Braga-de-Souza S, 2004, J COMP NEUROL, V468, P217, DOI 10.1002/cne.10947; Brockschniedier D, 2006, GENESIS, V44, P322, DOI 10.1002/dvg.20218; Chedotal A, 2011, CURR OPIN NEUROBIOL, V21, P68, DOI 10.1016/j.conb.2010.07.008; Cho IH, 2011, EXP MOL MED, V43, P462, DOI 10.3858/emm.2011.43.8.052; Corbin JG, 2001, NAT NEUROSCI, V4, P1177, DOI 10.1038/nn749; Guillemot F, 2007, PROG NEUROBIOL, V83, P37, DOI 10.1016/j.penurobio.2007.02.009; Ho SKY, 2009, NEUROSCIENCE, V160, P784, DOI 10.1016/j.neuroscience.2009.03.013; Jovanov-Milosevic N, 2010, EUR J NEUROSCI, V32, P1423, DOI 10.1111/j.1460-9568.2010.07400.x; MISSON JP, 1991, GLIA, V4, P138, DOI 10.1002/glia.440040205; Niquille M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000230; Nishiyama A, 2002, J NEUROCYTOL, V31, P437, DOI 10.1023/A:1025783412651; PIXLEY SKR, 1984, DEV BRAIN RES, V15, P201, DOI 10.1016/0165-3806(84)90097-X; SCHAMBRA UB, 1991, EXP NEUROL, V114, P145, DOI 10.1016/0014-4886(91)90034-A; Schroeter ML, 2010, CARDIOVASC PSYCHIAT, V2010, DOI DOI 10.1155/2010/780645; SILVER J, 1983, SCIENCE, V220, P1067, DOI 10.1126/science.6844928; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Yang ZS, 2006, J NEUROSCI, V26, P3829, DOI 10.1523/JNEUROSCI.4247-05.2006	66	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6887	10.1038/ncomms7887		15	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0IR	WOS:000353703600009		
J	Sohmen, D; Chiba, S; Shimokawa-Chiba, N; Innis, CA; Berninghausen, O; Beckmann, R; Ito, K; Wilson, DN				Sohmen, Daniel; Chiba, Shinobu; Shimokawa-Chiba, Naomi; Innis, C. Axel; Berninghausen, Otto; Beckmann, Roland; Ito, Koreaki; Wilson, Daniel N.			Structure of the Bacillus subtilis 70S ribosome reveals the basis for species-specific stalling	NATURE COMMUNICATIONS			English	Article							PARTICLE ELECTRON CRYOMICROSCOPY; TRANSLATION TERMINATION; MESSENGER-RNA; CRYO-EM; STRUCTURE PREDICTION; MOLECULAR-DYNAMICS; NASCENT PEPTIDE; EXIT TUNNEL; RESOLUTION; SEQUENCE	Ribosomal stalling is used to regulate gene expression and can occur in a species-specific manner. Stalling during translation of the MifM leader peptide regulates expression of the downstream membrane protein biogenesis factor YidC2 (YqjG) in Bacillus subtilis, but not in Escherichia coli. In the absence of structures of Gram-positive bacterial ribosomes, a molecular basis for species-specific stalling has remained unclear. Here we present the structure of a Gram-positive B. subtilis MifM-stalled 70S ribosome at 3.5-3.9 angstrom, revealing a network of interactions between MifM and the ribosomal tunnel, which stabilize a non-productive conformation of the PTC that prevents aminoacyl-tRNA accommodation and thereby induces translational arrest. Complementary genetic analyses identify a single amino acid within ribosomal protein L22 that dictates the species specificity of the stalling event. Such insights expand our understanding of how the synergism between the ribosome and the nascent chain is utilized to modulate the translatome in a species-specific manner.	[Sohmen, Daniel; Berninghausen, Otto; Beckmann, Roland; Wilson, Daniel N.] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Sohmen, Daniel; Berninghausen, Otto; Beckmann, Roland; Wilson, Daniel N.] Univ Munich, Dept Biochem, D-81377 Munich, Germany; [Chiba, Shinobu; Shimokawa-Chiba, Naomi; Ito, Koreaki] Kyoto Sangyo Univ, Fac Life Sci, Kita Ku, Kyoto 6038555, Japan; [Innis, C. Axel] Univ Bordeaux, Inst Europeen Chim & Biol, Pessac, France; [Innis, C. Axel] INSERM, U869, Bordeaux, France; [Beckmann, Roland; Wilson, Daniel N.] Univ Munich, Ctr Integrated Prot Sci Munich CiPSM, D-81377 Munich, Germany	Wilson, DN (reprint author), Univ Munich, Gene Ctr, Feodor Lynen St 25, D-81377 Munich, Germany.	wilson@lmb.uni-muenchen.de		Innis, Axel/0000-0003-3153-9490	Deutsche Forschungsgemeinschaft [WI3285/3-1, FOR1805, GRK1721]; European Research Council; MEXT; JSPS [20523517, 25291006, 26116008, 20247020]; Private University Strategic Research Foundation Support Program from MEXT [S1101029]; Fondation pour la Recherche Medicale [AJE201133]; Conseil Regional d'Aquitaine [2012 13 01 009]; European Union [PCIG14-GA-2013-631479]	This research was supported by grants from the Deutsche Forschungsgemeinschaft (WI3285/3-1 to D.W.; FOR1805 and GRK1721 to D.N.W. and R.B.), European Research Council (to R.B.), MEXT and JSPS Grant-in-Aid for Scientific Research (20523517, 25291006, 26116008 to S.C. and 20247020 to K.I.), the Private University Strategic Research Foundation Support Program from MEXT (S1101029 to K.I.), the Fondation pour la Recherche Medicale (AJE201133 to C.A.I) and the Conseil Regional d'Aquitaine (2012 13 01 009 to C.A.I) and the European Union (PCIG14-GA-2013-631479 to C.A.I). We thank Rishi Matadeen and Sacha DeCarlo for EM data collection, Naoka Kagatsume and Shiori Yamamoto for preliminary data collection, Tomoe Takino and Chika Tsutsumi, for technical support and Andreas Anger for help with molecular modelling of the 30S subunit.	Gong F, 2002, SCIENCE, V297, P1864, DOI 10.1126/science.1073997; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; Schmeing TM, 2005, MOL CELL, V20, P437, DOI 10.1016/j.molcel.2005.09.006; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Korostelev A, 2008, P NATL ACAD SCI USA, V105, P19684, DOI 10.1073/pnas.0810953105; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; YOUNGMAN P, 1984, MOL GEN GENET, V195, P424, DOI 10.1007/BF00341443; Voorhees RM, 2013, ANNU REV BIOCHEM, V82, P203, DOI 10.1146/annurev-biochem-113009-092313; Gumbart J, 2012, BIOPHYS J, V103, P331, DOI 10.1016/j.bpj.2012.06.005; Seidelt B, 2009, SCIENCE, V326, P1412, DOI 10.1126/science.1177662; Schmeing TM, 2005, NATURE, V438, P520, DOI 10.1038/nature04152; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Voorhees RM, 2009, NAT STRUCT MOL BIOL, V16, P528, DOI 10.1038/nsmb.1577; Polacek N, 2003, MOL CELL, V11, P103, DOI 10.1016/S1097-2765(02)00825-0; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Butkus ME, 2003, J BACTERIOL, V185, P6719, DOI 10.1128/JB.185.22.6719-6722.2003; Loerke J, 2010, METHOD ENZYMOL, V483, P161, DOI 10.1016/S0076-6879(10)83008-3; Chou FC, 2013, NAT METHODS, V10, P74, DOI [10.1038/nmeth.2262, 10.1038/NMETH.2262]; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Yusupova G, 2006, NATURE, V444, P391, DOI 10.1038/nature05281; Weixlbaumer A, 2008, SCIENCE, V322, P953, DOI 10.1126/science.1164840; Vazquez-Laslop N, 2008, MOL CELL, V30, P190, DOI [10.1016/j.molcel.2008.02.026, 10.1016/j.moicel.2008.02.026]; Chiba S, 2009, EMBO J, V28, P3461, DOI 10.1038/emboj.2009.280; Kim TW, 2006, J BIOTECHNOL, V126, P554, DOI 10.1016/j.jbiotec.2006.05.014; Kaminishi T, 2007, STRUCTURE, V15, P289, DOI 10.1016/j.str.2006.12.008; Becker T, 2012, NATURE, V482, P501, DOI 10.1038/nature10829; Pulk A, 2013, SCIENCE, V340, P1544, DOI 10.1126/science.1235970; Peil L, 2013, P NATL ACAD SCI USA, V110, P15265, DOI 10.1073/pnas.1310642110; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Chiba S, 2012, MOL CELL, V47, P863, DOI 10.1016/j.molcel.2012.06.034; Fernandez JJ, 2008, J STRUCT BIOL, V164, P170, DOI 10.1016/j.jsb.2008.05.010; Wen JD, 2008, NATURE, V452, P598, DOI 10.1038/nature06716; Chen JZ, 2007, J STRUCT BIOL, V157, P168, DOI 10.1016/j.jsb.2006.06.001; Korostelev AA, 2011, RNA, V17, P1409, DOI 10.1261/rna.2733411; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Dalbey RE, 2011, ANNU REV BIOCHEM, V80, P161, DOI 10.1146/annurev-biochem-060409-092524; Arenz S, 2014, MOL CELL, V56, P446, DOI 10.1016/j.molcel.2014.09.014; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Bhushan S, 2010, NAT STRUCT MOL BIOL, V17, P313, DOI 10.1038/nsmb.1756; Schmeing TM, 2002, NAT STRUCT BIOL, V9, P225, DOI 10.1038/nsb758; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Laurberg M, 2008, NATURE, V454, P852, DOI 10.1038/nature07115; Arenz S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4501; Bhushan S., 2011, PLOS BIOL, V19; Bischoff L, 2014, CELL REP, V9, P469, DOI 10.1016/j.celrep.2014.09.011; Borg A., 2014, J MOL BIOL; Chiba S., 2014, J BACTERIOL, V197, P99; Chiba S, 2011, P NATL ACAD SCI USA, V108, P6073, DOI 10.1073/pnas.1018343108; Ismail N, 2012, NAT STRUCT MOL BIOL, V19, P1018, DOI 10.1038/nsmb.2376; Jossinet F, 2005, BIOINFORMATICS, V21, P3320, DOI 10.1093/bioinformatics/bti504; Kim T.-W., 2009, BIOTECHNOL BIOPROC E, V13, P464; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Rubio A, 2005, J BACTERIOL, V187, P5000, DOI 10.1128/JB.187.14.5000-5002.2005; Sawano A, 2000, Nucleic Acids Res, V28, pE78, DOI 10.1093/nar/28.16.e78; Starosta AL, 2014, NUCLEIC ACIDS RES, V42, P10711, DOI 10.1093/nar/gku768; Wilson D. N., 2011, CURR OPIN STRUC BIOL, V21, P1	60	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6941	10.1038/ncomms7941		10	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0JA	WOS:000353704500004		
J	Son, BK; Sawaki, D; Tomida, S; Fujita, D; Aizawa, K; Aoki, H; Akishita, M; Manabe, I; Komuro, I; Friedman, SL; Nagai, R; Suzuki, T				Son, Bo-Kyung; Sawaki, Daigo; Tomida, Shota; Fujita, Daishi; Aizawa, Kenichi; Aoki, Hiroki; Akishita, Masahiro; Manabe, Ichiro; Komuro, Issei; Friedman, Scott L.; Nagai, Ryozo; Suzuki, Toru			Granulocyte macrophage colony-stimulating factor is required for aortic dissection/intramural haematoma	NATURE COMMUNICATIONS			English	Article							SMOOTH-MUSCLE-CELLS; E-DEFICIENT MICE; ACTIVATED MOUSE MACROPHAGES; ANGIOTENSIN-II; ATHEROSCLEROTIC LESIONS; MARFAN-SYNDROME; ANEURYSMS; DISSECTION; GROWTH; INTERLEUKIN-6	Aortic dissection and intramural haematoma comprise an aortopathy involving separation of the aortic wall. Underlying mechanisms of the condition remain unclear. Here we show that granulocyte macrophage colony-stimulating factor (GM-CSF) is a triggering molecule for this condition. Transcription factor Kruppel-like factor 6 (KLF6)-myeloid-specific conditional deficient mice exhibit this aortic phenotype when subjected to aortic inflammation. Mechanistically, KLF6 downregulates expression and secretion of GM-CSF. Administration of neutralizing antibody against GM-CSF prevents the condition in these mice. Conversely, administration of GM-CSF in combination with aortic inflammation to wild-type mice is sufficient to induce the phenotype, suggesting the general nature of effects. Moreover, patients with this condition show highly increased circulating levels of GM-CSF, which is also locally expressed in the dissected aorta. GM-CSF is therefore a key regulatory molecule causative of this aortopathy, and modulation of this cytokine might be an exploitable treatment strategy for the condition.	[Son, Bo-Kyung; Sawaki, Daigo; Tomida, Shota; Fujita, Daishi; Aizawa, Kenichi; Manabe, Ichiro; Komuro, Issei; Suzuki, Toru] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo 1138655, Japan; [Aizawa, Kenichi; Nagai, Ryozo; Suzuki, Toru] Jichi Med Univ, Shimotsuke, Tochigi 3290498, Japan; [Aoki, Hiroki] Kurume Univ, Cardiovasc Res Inst, Kurume, Fukuoka 8300011, Japan; [Akishita, Masahiro] Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Tokyo 1138655, Japan; [Friedman, Scott L.] Icahn Sch Med Mt Sinai, Dept Med, Div Liver Dis, New York, NY 10029 USA; [Suzuki, Toru] Univ Leicester, Glenfield Hosp, BHF Cardiovasc Res Ctr, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Suzuki, Toru] Glenfield Hosp, Natl Inst Hlth Res, Leicester Cardiovasc Biomed Res Unit, Leicester LE3 9QP, Leics, England	Suzuki, T (reprint author), Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, 7-3-1 Bunkyo Ku, Tokyo 1138655, Japan.	ts263@le.ac.uk			Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science through its Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program); National Institutes of Health National Cancer Institute [DK37340]	Klf6 floxed mice were provided by Genentech. We thank Yasushi Imai for human samples and Naoko Sato for technical assistance. This research was funded in part by the Ministry of Health, Labour and Welfare of Japan; Grants-in Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan and the Japan Society for the Promotion of Science through its Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program). This study was also supported by the National Institutes of Health National Cancer Institute (DK37340).	Hamilton JA, 2004, GROWTH FACTORS, V22, P225, DOI 10.1080/08977190412331279881; Starkel P, 2003, J HEPATOL, V39, P538, DOI 10.1016/S0168-8278(03)00360-X; Atreya R, 2000, NAT MED, V6, P583; Haghighat A, 2007, CIRCULATION, V115, P2049, DOI 10.1161/CIRCULATIONAHA.106.665570; Milewicz DM, 2010, J THORAC CARDIOV SUR, V140, pS2, DOI 10.1016/j.jtcvs.2010.07.027; Tarocchi M, 2011, HEPATOLOGY, V54, P522, DOI 10.1002/hep.24413; Treska V, 2000, CLIN CHEM LAB MED, V38, P1161, DOI 10.1515/CCLM.2000.178; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Brocheriou I, 2011, ATHEROSCLEROSIS, V214, P316, DOI 10.1016/j.atherosclerosis.2010.11.023; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Saraff K, 2003, ARTERIOSCL THROM VAS, V23, P1621, DOI 10.1161/01.ATV.0000085631.76095.64; Tsai TT, 2005, CIRCULATION, V112, P3802, DOI 10.1161/CIRCULATIONAHA.105.534198; Dawson J, 2006, ANN NY ACAD SCI, V1085, P320, DOI 10.1196/annals.1383.009; EZEKOWITZ RAB, 1982, J EXP MED, V155, P1623; Dawson J, 2007, J VASC SURG, V45, P350, DOI 10.1016/j.jvs.2006.09.049; Ju XX, 2013, ARTERIOSCL THROM VAS, V33, P1612, DOI 10.1161/ATVBAHA.112.301049; Wright HL, 2010, RHEUMATOLOGY, V49, P1618, DOI 10.1093/rheumatology/keq045; Ye P, 2013, J CLIN INVEST, V123, P2317, DOI 10.1172/JCI67356; Date D, 2014, J BIOL CHEM, V289, P10318, DOI 10.1074/jbc.M113.526749; Hagan PG, 2000, JAMA-J AM MED ASSOC, V283, P897, DOI 10.1001/jama.283.7.897; von Kodolitsch Y, 2003, CIRCULATION, V107, P1158, DOI 10.1161/01.CIR.0000052628.77047.EA; Li W, 2014, J CLIN INVEST, V124, P755, DOI 10.1172/JCI69942; Kessel A, 2014, AUTOIMMUN REV, V13, P351, DOI 10.1016/j.autrev.2014.01.002; Milewicz DM, 2008, ANNU REV GENOM HUM G, V9, P283, DOI 10.1146/annurev.genom.8.080706.092303; Babamusta F, 2006, ATHEROSCLEROSIS, V186, P282, DOI 10.1016/j.atherosclerosis.2005.08.006; Zhu SN, 2009, J EXP MED, V206, P2141, DOI 10.1084/jem.20090866; Hiratzka LF, 2010, J AM COLL CARDIOL, V55, pE27, DOI 10.1016/j.jacc.2010.02.015; Habashi JP, 2011, SCIENCE, V332, P361, DOI 10.1126/science.1192152; Holm TM, 2011, SCIENCE, V332, P358, DOI 10.1126/science.1192149; Cavalcante JL, 2011, J AM COLL CARDIOL, V57, P1511, DOI 10.1016/j.jacc.2010.12.017; JOHNSTON KW, 1991, J VASC SURG, V13, P452; Nagasawa A, 2013, J SURG RES, V183, P472, DOI 10.1016/j.jss.2012.12.012; Nienaber CA, 2012, EUR HEART J, V33, P26, DOI 10.1093/eurheartj/ehr186; Lindsay ME, 2012, NAT GENET, V44, P922, DOI 10.1038/ng.2349; Cheuk BLY, 2008, WORLD J SURG, V32, P55, DOI 10.1007/s00268-007-9279-9; Clough R. E., 2014, NAT REV CARDIOL, V12, P103; Dietz HC, 2010, J CLIN INVEST, V120, P403, DOI 10.1172/JCI42014; EZEKOWITZ RAB, 1981, J EXP MED, V154, P60, DOI 10.1084/jem.154.1.60; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; FILONZI EL, 1993, ATHEROSCLEROSIS, V99, P241, DOI 10.1016/0021-9150(93)90026-Q; Holian J, 2008, AM J PHYSIOL-RENAL, V295, pF1388, DOI 10.1152/ajprenal.00055.2008; Kimura T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04051; Plenz G, 1997, ARTERIOSCL THROM VAS, V17, P2489; Sakai M, 1999, ARTERIOSCL THROM VAS, V19, P1726; Sawaki D, 2013, CIRC J, V77, P898, DOI 10.1253/circj.CJ-13-0183; Shindo J, 1999, CIRCULATION, V99, P2150; Song JK, 2011, HERZ, V36, P488, DOI 10.1007/s00059-011-3501-0; Suzuki T, 2013, AM HEART J, V165, P15, DOI 10.1016/j.ahj.2012.10.006; Suzuki T, 2010, CURR OPIN CARDIOL, V25, P541, DOI 10.1097/HCO.0b013e32833e6e13; Weissen-Plenz G, 2010, J CARDIOTHORAC SURG, V5, DOI 10.1186/1749-8090-5-66	51	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6994	10.1038/ncomms7994		12	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0JJ	WOS:000353705400003		
J	Tomita, S; Abdalla, MOA; Fujiwara, S; Matsumori, H; Maehara, K; Ohkawa, Y; Iwase, H; Saitoh, N; Nakao, M				Tomita, Saori; Abdalla, Mohamed Osama Ali; Fujiwara, Saori; Matsumori, Haruka; Maehara, Kazumitsu; Ohkawa, Yasuyuki; Iwase, Hirotaka; Saitoh, Noriko; Nakao, Mitsuyoshi			A cluster of noncoding RNAs activates the ESR1 locus during breast cancer adaptation	NATURE COMMUNICATIONS			English	Article							ESTROGEN-RECEPTOR-ALPHA; ENDOCRINE THERAPY; HUMAN GENOME; INTERPHASE CHROMOSOMES; GENE AMPLIFICATION; X-INACTIVATION; MCF-7 CELLS; TRANSCRIPTION; CHROMATIN; TERM	Estrogen receptor-alpha (ER)-positive breast cancer cells undergo hormone-independent proliferation after deprivation of oestrogen, leading to endocrine therapy resistance. Up-regulation of the ER gene (ESR1) is critical for this process, but the underlying mechanisms remain unclear. Here we show that the combination of transcriptome and fluorescence in situ hybridization analyses revealed that oestrogen deprivation induced a cluster of noncoding RNAs that defined a large chromatin domain containing the ESR1 locus. We termed these RNAs as Eleanors (ESR1 locus enhancing and activating noncoding RNAs). Eleanors were present in ER-positive breast cancer tissues and localized at the transcriptionally active ESR1 locus to form RNA foci. Depletion of one Eleanor, upstream (u)-Eleanor, impaired cell growth and transcription of intragenic Eleanors and ESR1 mRNA, indicating that Eleanors cis-activate the ESR1 gene. Eleanor-mediated gene activation represents a new type of locus control mechanism and plays an essential role in the adaptation of breast cancer cells.	[Tomita, Saori; Abdalla, Mohamed Osama Ali; Fujiwara, Saori; Matsumori, Haruka; Saitoh, Noriko; Nakao, Mitsuyoshi] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Med Cell Biol, Kumamoto 8600811, Japan; [Tomita, Saori; Fujiwara, Saori; Iwase, Hirotaka] Kumamoto Univ, Grad Sch Med Sci, Dept Breast & Endocrine Surg, Kumamoto 8608556, Japan; [Maehara, Kazumitsu; Ohkawa, Yasuyuki] Kyushu Univ, Fac Med, Dept Adv Initiat Med, Fukuoka 8128582, Japan; [Nakao, Mitsuyoshi] Kumamoto Univ, Program Leading Grad Sch, HIGO Hlth life Sci Interdisciplinary & Glocal Ori, Kumamoto 8608556, Japan; [Nakao, Mitsuyoshi] Japan Sci & Technol Agcy, CREST, Tokyo 1020076, Japan	Saitoh, N (reprint author), Kumamoto Univ, Inst Mol Embryol & Genet, Dept Med Cell Biol, Kumamoto 8600811, Japan.	norikos@kumamoto-u.ac.jp; mnakao@gpo.kumamoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency (CREST)	We thank all the members of our laboratory for discussions and technical assistance, Takumi Takizawa (Gunma University), Hideyuki Tanabe (The Graduate University for Advanced Studies), Sui Huang (Northwestern University), Christian Lanctot (Charles University in Prague), Gary Felsenfeld, Takashi Ideue (Kumamoto University) and Masahiko Harata (Tohoku University) for valuable advice, and Sakura Aoki (CTC Laboratory Systems) and Takehiko Oka (World Fusion) for helping with the bioinformatic analyses of the sequencing data. This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan and the Japan Science and Technology Agency (CREST; M.N. and N.S.).	Aguilar H, 2010, ONCOGENE, V29, P6071, DOI 10.1038/onc.2010.333; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ellis MJ, 2009, JAMA-J AM MED ASSOC, V302, P774, DOI 10.1001/jama.2009.1204; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Guil S, 2012, NAT STRUCT MOL BIOL, V19, P664, DOI 10.1038/nsmb.2315; Vallot C, 2013, NAT GENET, V45, P239, DOI 10.1038/ng.2530; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Jensen TH, 2013, MOL CELL, V52, P473, DOI 10.1016/j.molcel.2013.10.032; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Geisler S, 2013, NAT REV MOL CELL BIO, V14, P699, DOI 10.1038/nrm3679; Iwase H, 2013, BRIT J CANCER, V109, P1537, DOI 10.1038/bjc.2013.520; Yaswen P, 2002, INT J BIOCHEM CELL B, V34, P1382, DOI 10.1016/S1357-2725(02)00047-X; Miller TW, 2010, J CLIN INVEST, V120, P2406, DOI 10.1172/JCI41680; KOPCZYNSKI CC, 1992, J CELL BIOL, V119, P503, DOI 10.1083/jcb.119.3.503; Martin LA, 2005, ENDOCR-RELAT CANCER, V12, pS75, DOI 10.1677/erc.1.0123; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Lonning PE, 2001, BREAST CANCER RES TR, V67, P111, DOI 10.1023/A:1010619225209; STALDER J, 1980, CELL, V20, P451, DOI 10.1016/0092-8674(80)90631-5; Ooi A, 2012, J PATHOL, V227, P8, DOI 10.1002/path.3974; Gehm BD, 1997, P NATL ACAD SCI USA, V94, P14138, DOI 10.1073/pnas.94.25.14138; Solier S, 2013, CANCER RES, V73, P4830, DOI 10.1158/0008-5472.CAN-12-3504; Santen RJ, 2005, ENDOCR-RELAT CANCER, V12, pS61, DOI 10.1677/erc.01018; Tomita S, 2009, CANCER SCI, V100, P1012, DOI 10.1111/j.1349-7006.2009.01145.x; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; King IF, 2013, NATURE, V501, P58, DOI 10.1038/nature12504; Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Ellison-Zelski SJ, 2009, MOL CELL BIOL, V29, P4949, DOI 10.1128/MCB.00383-09; Sotiriou C, 2007, NAT REV CANCER, V7, P545, DOI 10.1038/nrc2173; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Jeng MH, 1998, ENDOCRINOLOGY, V139, P4164, DOI 10.1210/en.139.10.4164; Reid G, 2002, CELL MOL LIFE SCI, V59, P821, DOI 10.1007/s00018-002-8470-2; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Ravasi T, 2006, GENOME RES, V16, P11, DOI 10.1101/gr.4200206; Nora EP, 2013, BIOESSAYS, V35, P818, DOI 10.1002/bies.201300040; Chan CMW, 2002, J STEROID BIOCHEM, V81, P333, DOI 10.1016/S0960-0760(02)00074-2; Jia H, 2010, RNA, V16, P1478, DOI 10.1261/rna.1951310; HEBBES TR, 1994, EMBO J, V13, P1823; Kos M, 2001, MOL ENDOCRINOL, V15, P2057, DOI 10.1210/me.15.12.2057; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Gardner EJ, 2012, GENE DEV, V26, P2550, DOI 10.1101/gad.202184.112; Holst F, 2007, NAT GENET, V39, P655, DOI 10.1038/ng2006; Bickmore WA, 2013, CELL, V152, P1270, DOI 10.1016/j.cell.2013.02.001; Martin LA, 2003, J BIOL CHEM, V278, P30458, DOI 10.1074/jbc.M305226200; Castles CG, 1997, J STEROID BIOCHEM, V62, P155, DOI 10.1016/S0960-0760(97)00023-X; Dunbier AK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001382; Hall LL, 2014, CELL, V156, P907, DOI 10.1016/j.cell.2014.01.042; HU XF, 1993, INT J CANCER, V55, P873, DOI 10.1002/ijc.2910550529; KATZENELLENBOGEN BS, 1987, CANCER RES, V47, P4355; Magnani L, 2013, P NATL ACAD SCI USA, V110, pE1490, DOI 10.1073/pnas.1219992110; Nwachukwu JC, 2014, ELIFE, V3, DOI DOI 10.7554/ELIFE.02057; rMay D., 2012, NAT GENET, V44, P89; Saitoh N, 2000, EMBO J, V19, P2315, DOI 10.1093/emboj/19.10.2315; Schubert T, 2012, MOL CELL, V48, P434, DOI 10.1016/j.molcel.2012.08.021; WELSHONS WV, 1987, EUR J CANCER CLIN ON, V23, P1935, DOI 10.1016/0277-5379(87)90062-9; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Yoon DS, 2002, AM J PATHOL, V161, P391, DOI 10.1016/S0002-9440(10)64194-6	68	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6966	10.1038/ncomms7966		15	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0JC	WOS:000353704700018		
J	Tokuno, H; Watson, C; Roberts, A; Sasaki, E; Okano, H				Tokuno, Hironobu; Watson, Charles; Roberts, Angela; Sasaki, Erika; Okano, Hideyuki			Marmoset neuroscience	NEUROSCIENCE RESEARCH			English	Editorial Material									[Tokuno, Hironobu] Tokyo Metropolitan Inst Med Sci, Lab Brain Struct, Setagaya Ku, Tokyo 1568506, Japan; [Watson, Charles] Curtin Univ, Perth, WA 6845, Australia; [Watson, Charles] Neurosci Res Australia, Sydney, NSW 2031, Australia; [Roberts, Angela] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England; [Roberts, Angela] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge CB2 3DY, England; [Sasaki, Erika] Cent Inst Expt Anim, Ctr Appl Dev Biol, Kawasaki, Kanagawa 2100821, Japan; [Sasaki, Erika] Keio Univ, Adv Res Ctr, Shinjuku Ku, Tokyo 1608582, Japan; [Okano, Hideyuki] RIKEN, Lab Marmoset Neural Architecture, Brain Sci Inst, Wako, Saitama 3510198, Japan; [Okano, Hideyuki] Keio Univ, Dept Physiol, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan	Tokuno, H (reprint author), Tokyo Metropolitan Inst Med Sci, Lab Brain Struct, Setagaya Ku, Tokyo 1568506, Japan.	tokuno-hr@igakuken.or.jp	Okano, Hideyuki/J-5973-2013				Bakola S., 2015, NEUROSCI RES, V93; Burkart J.M., 2015, NEUROSCI RES, V93; Hashikawa T., 2015, NEUROSCI RES, V93; Ichinohe N, 2015, NEUROSCI RES, V93; Koshiba M., 2015, NEUROSCI RES, V93; Lui L.L., 2015, NEUROSCI RES, V93; Mitchell J.F., 2015, NEUROSCI RES, V93; Moriya-Ito K., 2015, NEUROSCI RES, V93; Okano H., 2015, NEUROSCI RES, V93; Saito A., 2015, NEUROSCI RES, V93; Sasaki E., 2015, NEUROSCI RES, V93; Senoo A., 2015, NEUROSCI RES, V93; Takemoto A., 2015, NEUROSCI RES, V93; Watakabe A., 2015, NEUROSCI RES, V93; Watson C., 2015, NEUROSCI RES, V93; Yokoyama C., 2015, NEUROSCI RES, V93; Yu H.H., 2015, NEUROSCI RES, V93	17	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	APR	2015	93				SI		1	2		10.1016/j.neures.2015.03.001		2	Neurosciences	Neurosciences & Neurology	CH9GK	WOS:000354343800001		
J	Okano, H; Mitra, P				Okano, Hideyuki; Mitra, Partha			Brain-mapping projects using the common marmoset	NEUROSCIENCE RESEARCH			English	Review						Brain Mapping by Integrated; Neurotechnologies for Disease Studies (Brain/MINDS); Diffusion tensor imaging (DTI); Brain-wide connectivity maps; Macroscopic structural mapping; Mesoscopic structural mapping; Microscopic structural mapping	NEUROSCIENCE RESEARCH; SPINAL-CORD; TRACTOGRAPHY; ATLAS; PRINCIPLES; CIRCUIT; ANATOMY; PATHWAY; GENOME; FMRI	Globally, there is an increasing interest in brain-mapping projects, including the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative project in the USA, the Human Brain Project (HBP) in Europe, and the Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) project in Japan. These projects aim to map the structure and function of neuronal circuits to ultimately understand the vast complexity of the human brain. Brain/MINDS is focused on structural and functional mapping of the common marmoset (Callithrix jacchus) brain. This non-human primate has numerous advantages for brain mapping, including a well-developed frontal cortex and a compact brain size, as well as the availability of transgenic technologies. In the present review article, we discuss strategies for structural and functional mapping of the marmoset brain and the relation of the common marmoset to other animals models. (C) 2014 The Authors. Published by Elsevier Ireland Ltd.	[Okano, Hideyuki] RIKEN, Brain Sci Inst, Lab Marmoset Neural Architecture, Wako, Saitama 3510198, Japan; [Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 1608582, Japan; [Mitra, Partha] Cold Spring Harbor Lab, New York, NY 11724 USA	Okano, H (reprint author), Keio Univ, Dept Physiol, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	hidokano@a2.keio.jp	Okano, Hideyuki/J-5973-2013		Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)	This work has been supported by Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS), Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT). We would like to thank Dr. Keigo Hikishima for providing unpublished MRI data, Dr. Erika Sasaki, Dr. Atsushi Iriki, Dr. Keigo Hikishima, Dr. Tomomi Shimogori, and Dr. Akira Yoshida for valuable discussions, and Prof. Shigeo Okabe for critical advice for this project.	Anderson A., 2013, NEUROIMAGE; Helmstaedter M, 2012, CURR OPIN NEUROBIOL, V22, P162, DOI 10.1016/j.conb.2011.11.010; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/nmeth.1694, 10.1038/NMETH.1694]; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Hikishima K, 2011, NEUROIMAGE, V54, P2741, DOI 10.1016/j.neuroimage.2010.10.061; Chklovskii DB, 2010, CURR OPIN NEUROBIOL, V20, P667, DOI 10.1016/j.conb.2010.08.002; Yamada M, 2008, RADIOLOGY, V249, P855, DOI 10.1148/radiol.2493072141; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Fujiyoshi K, 2007, J NEUROSCI, V27, P11991, DOI 10.1523/JNEUROSCI.3354-07.2007; Dennis EL, 2014, NEUROPSYCHOL REV, V24, P49, DOI 10.1007/s11065-014-9249-6; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Kandel ER, 2013, NAT REV NEUROSCI, V14, P659, DOI 10.1038/nrn3578; Fujiyoshi K, 2013, EXP NEUROL, V242, P74, DOI 10.1016/j.expneurol.2012.07.015; St-Pierre F, 2014, NAT NEUROSCI, V17, P884, DOI 10.1038/nn.3709; Kishi N, 2014, DEV GROWTH DIFFER, V56, P53, DOI 10.1111/dgd.12109; Grange P, 2014, P NATL ACAD SCI USA, V111, P5397, DOI 10.1073/pnas.1312098111; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Bohland JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007200; Lein E. S., 2007, NATURE, V445, P168; Mashiko H, 2012, J NEUROSCI, V32, P5039, DOI 10.1523/JNEUROSCI.4788-11.2012; Papoti D, 2013, NMR BIOMED, V26, P1395, DOI 10.1002/nbm.2965; Paxinos G., 2012, MARMOSET BRAIN STERE; Pinsky V., 2013, COMBINING HIGH RESOL; Tokuno H, 2009, NEUROSCI RES, V65, pS225, DOI 10.1016/j.neures.2009.09.1259; Tokuno H, 2009, NEUROSCI RES, V64, P128, DOI 10.1016/j.neures.2009.02.003	29	7	7	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	APR	2015	93				SI		3	7		10.1016/j.neures.2014.08.014		5	Neurosciences	Neurosciences & Neurology	CH9GK	WOS:000354343800002		
J	Yokoyama, C; Onoe, H				Yokoyama, Chihiro; Onoe, Hirotaka			Positron emission tomography imaging of the social brain of common marmosets	NEUROSCIENCE RESEARCH			English	Review						PET; Experimental animal; Social behavior; Serotonin; Neural network; Common marmoset	MONKEY CALLITHRIX-JACCHUS; 5-HT1A RECEPTOR-BINDING; MIDDLE TEMPORAL AREA; MEDIAL BELT REGIONS; SEROTONIN TRANSPORTER; DOPAMINE TRANSPORTER; NONHUMAN-PRIMATES; VISUAL AREAS; PREFRONTAL CORTEX; AUDITORY-CORTEX	Positron emission tomography (PET) is a molecular imaging modality that can visualize functional neurochemical processes throughout the brain in the living condition, and is useful in bridging the gap between experimental animals and humans. We applied PET to common marmosets to study the brain mechanisms underlying social behaviors. Common marmosets are known for their high level of sociality within a cooperative breeding system, which is rare among non-human primates, and they could represent valuable animals for studying human-like social behaviors. PET successfully revealed a brain-molecular relationship underlying social traits and a functional brain network associated with social situations in common marmosets. Marmoset PET appears likely to prove useful in understanding the neurobiological mechanisms underpinning social behaviors in both physiological and pathological conditions, and has potential for simulating psychiatric disorders. (C) 2014 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	[Yokoyama, Chihiro; Onoe, Hirotaka] RIKEN, Ctr Life Sci Technol, Biofunct Imaging Team, Chuo Ku, Kobe, Hyogo 6500047, Japan	Yokoyama, C (reprint author), RIKEN, Ctr Life Sci Technol, Biofunct Imaging Team, Chuo Ku, 6-7-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	chihiro@riken.jp			SENSHIN Medical Research Foundation; Molecular Imaging Research Program; Ministry of Education, Culture, Sports, Science and Technology of Japan [19591388, 22500379, 25293254]	This work was supported by 2014 SENSHIN Medical Research Foundation (to C.Y.), and the Molecular Imaging Research Program and Grant-in-Aid for Scientific Research (KAKENHI (C) No. 19591388, No. 22500379 and (B) No. 25293254 to C.Y.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Alstrup AKO, 2013, LAB ANIM-UK, V47, P12, DOI 10.1258/la.2012.011173; Ando K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046371; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Wilson AA, 2002, NUCL MED BIOL, V29, P509, DOI 10.1016/S0969-8051(02)00316-5; Burman KJ, 2006, J COMP NEUROL, V495, P149, DOI 10.1002/cne.20837; aan het Rot M, 2006, J PSYCHIATR NEUROSCI, V31, P253; Adolphs R, 2010, NEURON, V65, P752, DOI 10.1016/j.neuron.2010.03.006; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Miall RC, 2001, NAT NEUROSCI, V4, P638, DOI 10.1038/88465; Burman KJ, 2011, CEREB CORTEX, V21, P1712, DOI 10.1093/cercor/bhq239; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; Miller CT, 2009, J COMP PHYSIOL A, V195, P783, DOI 10.1007/s00359-009-0456-1; Rosa MGP, 1998, J COMP NEUROL, V393, P505; Takahashi DY, 2013, CURR BIOL, V23, P2162, DOI 10.1016/j.cub.2013.09.005; de la Mothe LA, 2006, J COMP NEUROL, V496, P27, DOI 10.1002/cne.20923; Burman KJ, 2008, J COMP NEUROL, V506, P860, DOI 10.1002/cne.21580; Parsey RV, 2002, BRAIN RES, V954, P173, DOI 10.1016/S0006-8993(02)03243-2; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Lee JH, 2012, NEUROIMAGE, V62, P2244, DOI 10.1016/j.neuroimage.2012.01.116; Schweighofer N, 2007, ANN NY ACAD SCI, V1104, P289, DOI 10.1196/annals.1390.011; Palmer SM, 2006, CEREB CORTEX, V16, P1361, DOI 10.1093/cercor/bhj078; Hari R, 2010, ANN NY ACAD SCI, V1191, P89, DOI 10.1111/j.1749-6632.2010.05438.x; Wood RM, 2006, NEUROPSYCHOPHARMACOL, V31, P1075, DOI 10.1038/sj.npp.1300932; KRUBITZER LA, 1990, J NEUROSCI, V10, P952; Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Aubert Y, 2012, J SEX MED, V9, P694, DOI 10.1111/j.1743-6109.2011.02616.x; Tsukada H, 1999, BRAIN RES, V849, P85, DOI 10.1016/S0006-8993(99)02018-1; Barr CS, 2003, GENES BRAIN BEHAV, V2, P336, DOI 10.1046/j.1601-1848.2003.00051.x; Dunbar RIM, 2007, SCIENCE, V317, P1344, DOI 10.1126/science.1145463; Gautier A, 2014, NAT CHEM BIOL, V10, P533, DOI [10.1038/nchembio.1534, 10.1038/NCHEMBIO.1534]; Pearson JM, 2011, TRENDS COGN SCI, V15, P143, DOI 10.1016/j.tics.2011.02.002; Nakamura K, 2010, ARCH GEN PSYCHIAT, V67, P59, DOI 10.1001/archgenpsychiatry.2009.137; Roberts AC, 2007, J COMP NEUROL, V502, P86, DOI 10.1002/cne.21300; Frokjaer VG, 2008, BIOL PSYCHIAT, V63, P569, DOI 10.1016/j.biopsych.2007.07.009; Yokoyama C, 2013, CEREB CORTEX, V23, P2136, DOI 10.1093/cercor/bhs196; Clarke HF, 2014, J NEUROSCI, V34, P7663, DOI 10.1523/JNEUROSCI.0718-14.2014; Canli T, 2007, NAT NEUROSCI, V10, P1103, DOI 10.1038/nn1964; Tauscher J, 2001, AM J PSYCHIAT, V158, P1326, DOI 10.1176/appi.ajp.158.8.1326; Rosa MGP, 2000, J COMP NEUROL, V422, P621, DOI 10.1002/1096-9861(20000710)422:4<621::AID-CNE10>3.0.CO;2-E; de la Mothe LA, 2006, J COMP NEUROL, V496, P72, DOI 10.1002/cne.20924; Itier RJ, 2009, NEUROSCI BIOBEHAV R, V33, P843, DOI 10.1016/j.neubiorev.2009.02.004; Yokoyama C, 2010, SYNAPSE, V64, P594, DOI 10.1002/syn.20766; Carver CS, 2006, PSYCHIAT RES, V144, P1, DOI 10.1016/j.psychres.2006.03.013; Wendland JR, 2006, BEHAV GENET, V36, P163, DOI 10.1007/s10519-005-9017-8; Lou HC, 1999, HUM BRAIN MAPP, V7, P98; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Uher J, 2011, DEV PSYCHOBIOL, V53, P521, DOI 10.1002/dev.20544; Barrett L, 2005, P ROY SOC B-BIOL SCI, V272, P1865, DOI 10.1098/rspb.2005.3200; Gerretsen P, 2010, SOC NEUROSCI-UK, V5, P375, DOI 10.1080/17470911003589309; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Hariri AR, 2006, TRENDS COGN SCI, V10, P182, DOI 10.1016/j.tics.2006.02.011; Burkart JM, 2009, EVOL ANTHROPOL, V18, P175, DOI 10.1002/evan.20222; Burman KJ, 2009, J COMP NEUROL, V514, P11, DOI 10.1002/cne.21976; DEWAAL FBM, 1986, Q REV BIOL, V61, P459, DOI 10.1086/415144; Krakowski M, 2003, J NEUROPSYCH CLIN N, V15, P294, DOI 10.1176/appi.neuropsych.15.3.294; Barrett L, 2007, PHILOS T R SOC B, V362, P561, DOI 10.1098/rstb.2006.1995; Cappe C, 2005, EUR J NEUROSCI, V22, P2886, DOI 10.1111/j.1460-9568.2005.04462.x; Rousset OG, 1998, J NUCL MED, V39, P904; Tsukada H, 2001, SYNAPSE, V42, P273, DOI 10.1002/syn.10012; Crockett MJ, 2010, P NATL ACAD SCI USA, V107, P17433, DOI 10.1073/pnas.1009396107; Barros M, 2003, EUR J PHARMACOL, V482, P197, DOI 10.1016/j.ejphar.2003.09.064; Burkart JM, 2009, ANIM BEHAV, V77, P1291, DOI 10.1016/j.anbehav.2009.02.006; Converse AK, 2012, NEUROIMAGE, V60, P447, DOI 10.1016/j.neuroimage.2011.12.065; Ferrari PF, 2005, EUR J PHARMACOL, V526, P259, DOI 10.1016/j.ejphar.2005.10.002; Galley HF, 2005, PHARMACOGENOMICS, V6, P849, DOI 10.2217/14622416.6.8.849; Grandjean J, 2014, J NEUROSCI, V34, P13780, DOI 10.1523/JNEUROSCI.4762-13.2014; KENNETT GA, 1995, PSYCHOPHARMACOLOGY, V118, P178, DOI 10.1007/BF02245837; Kinnally EL, 2006, AM J PRIMATOL, V68, P812, DOI 10.1002/ajp.20281; Klein RL, 2009, BRAIN RES, V1259, P113, DOI 10.1016/j.brainres.2009.01.063; Konvalinka I, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00215; Kung MP, 2005, NUCL MED BIOL, V32, P673, DOI 10.1016/j.nucmedbio.2005.04.002; Lartizien C, 2007, PHYS MED BIOL, V52, P4845, DOI 10.1088/0031-9155/52/16/009; Lehnert W, 2006, PHYS MED BIOL, V51, P4003, DOI 10.1088/0031-9155/51/16/008; Lesch KP, 2007, EMBO REP, V8, pS24, DOI 10.1038/sj.embor.7401008; Lyon DC, 2001, J NEUROSCI, V21, P249; McCowan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022350; Mitchell JF, 2014, J NEUROSCI, V34, P1183, DOI 10.1523/JNEUROSCI.3899-13.2014; Nakazawa S, 2013, PSYCHOPHARMACOLOGY, V225, P329, DOI 10.1007/s00213-012-2815-9; ONOE H, 1994, BRAIN RES, V663, P191, DOI 10.1016/0006-8993(94)91263-7; REIVICH M, 1979, CIRC RES, V44, P127; Sooksawate T, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00162; Tsukada H, 2011, SYNAPSE, V65, P84, DOI 10.1002/syn.20845; Vandeputte C, 2011, J NUCL MED, V52, P1102, DOI 10.2967/jnumed.110.084426; WAGNER HN, 1988, BIOCHEM PHARMACOL, V37, P51, DOI 10.1016/0006-2952(88)90754-X; Yao Rutao, 2012, J Nucl Med Technol, V40, P157, DOI 10.2967/jnmt.111.098632; Yokoyama C, 2005, CEREB CORTEX, V15, P796, DOI 10.1093/cercor/bhh180	88	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	APR	2015	93				SI		82	90		10.1016/j.neures.2014.12.006		9	Neurosciences	Neurosciences & Neurology	CH9GK	WOS:000354343800008		
J	Koshiba, M; Senoo, A; Karino, G; Ozawa, S; Tanaka, I; Honda, Y; Usui, S; Kodama, T; Mimura, K; Nakamura, S; Kunikata, T; Yamanouchi, H; Tokuno, H				Koshiba, Mamiko; Senoo, Aya; Karino, Genta; Ozawa, Simpei; Tanaka, Ikuko; Honda, Yoshiko; Usui, Setsuo; Kodama, Tohru; Mimura, Koki; Nakamura, Shun; Kunikata, Tetsuya; Yamanouchi, Hideo; Tokuno, Hironobu			Susceptible period of socio-emotional development affected by constant exposure to daylight	NEUROSCIENCE RESEARCH			English	Review						A susceptible period learning; Circadian rhythm; Socio-emotional behavior; Alert call and whole body motion; Multivariate analysis; Social sensory cues	MARMOSET CALLITHRIX-JACCHUS; COMMON MARMOSET; CIRCADIAN-RHYTHMS; SUPRACHIASMATIC NUCLEUS; MULTIVARIATE-ANALYSIS; ATTACHMENT FORMATION; NONHUMAN PRIMATE; CLOCK NEURONS; LIGHT; SLEEP	As a diurnal experimental primate, the common marmoset (Callithrix jacchus) has recently contributed to numerous kinds of studies of neurobiological psychiatry as an essential pre-clinical model. The marmoset matures sexually within one or two years after birth. Thus, we can observe how the primate learns and develops psycho-cognitive functions through experiences in experimental environment for a much shorter period compared to that of humans. Longer daylight exposure may affect psychological development of children. In our research, we focus on raising marmosets under constant daylight from birth until various ages. In order to quantitatively evaluate the development of higher-ordered psychological functions, we designed a system of socio-behavioral tests and multivariate correlation analysis methods based on principal component analysis. With reference to the call and typical body movement expressed during a particular social context, we statistically inferred the emotional features of the subjects. In the current literature, we review our published results showing increased alert behaviors by constant light, and then, attempted to extend our additional analysis to seek age-dependent susceptibility to constant light. We then present the neurobiological mechanisms with reference to previous research reports. The current review suggests possible existence of a susceptible period earlier than three to five month-old in the environment-included developmental disorder model, supposedly like attention deficit hyperactive disorders (ADHD) or oppositional defiant disorder (ODD). (C) 2014 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	[Koshiba, Mamiko; Senoo, Aya; Karino, Genta; Ozawa, Simpei; Kunikata, Tetsuya; Yamanouchi, Hideo] Saitama Med Univ, Dept Pediat, Saitama 3500495, Japan; [Koshiba, Mamiko; Karino, Genta] Saitama Med Univ, Dept Biochem, Saitama 3500495, Japan; [Senoo, Aya; Karino, Genta; Ozawa, Simpei; Mimura, Koki; Nakamura, Shun] Tokyo Univ Agr & Technol, Fuchu, Tokyo 183, Japan; [Tanaka, Ikuko; Honda, Yoshiko; Usui, Setsuo; Kodama, Tohru; Tokuno, Hironobu] Tokyo Metropolitan Inst Med Sci, Tokyo, Japan; [Koshiba, Mamiko; Mimura, Koki; Nakamura, Shun] Natl Ctr Neurol & Psychiat, Tokyo, Japan	Koshiba, M (reprint author), Saitama Med Univ, 38 Morohongo Moroyama Machi, Saitama 3500495, Japan.	koshiba@saitama-med.ac.jp			MEXT; JSPS (JST-ALCA, JST-a-step) in Japan [21200017, 25119509, 25282221]	This work was partially supported by MEXT; JSPS KAKENHI Grant Number (21200017, 25119509, 25282221, JST-ALCA, JST-a-step) in Japan. We thank all members of our universities and institutes.	Kriegsfeld LJ, 1999, NEUROSCIENCE, V89, P311, DOI 10.1016/S0306-4522(98)00614-9; Carere C, 2003, HORM BEHAV, V43, P540, DOI 10.1016/S0018-506X(03)00065-5; Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; Ancoli-Israel S, 2003, SLEEP, V26, P342; Ciarleglio CM, 2011, NAT NEUROSCI, V14, P25, DOI 10.1038/nn.2699; Leppanen JM, 2009, NAT REV NEUROSCI, V10, P37, DOI 10.1038/nrn2554; Happe F, 2014, J CHILD PSYCHOL PSYC, V55, P553, DOI 10.1111/jcpp.12162; Azzi A, 2014, NAT NEUROSCI, V17, P377, DOI 10.1038/nn.3651; Klump KL, 2013, HORM BEHAV, V64, P399, DOI 10.1016/j.yhbeh.2013.02.019; Cambras T, 1998, PHYSIOL BEHAV, V63, P875, DOI 10.1016/S0031-9384(98)00006-7; Evans BE, 2012, ADDICTION, V107, P312, DOI 10.1111/j.1360-0443.2011.03568.x; Pistorio AL, 2006, J ACOUST SOC AM, V120, P1655, DOI 10.1121/1.2225899; de la Iglesia HO, 2000, SCIENCE, V290, P799, DOI 10.1126/science.290.5492.799; Bunney JN, 2008, BRIT MED BULL, V86, P23, DOI 10.1093/bmb/ldn019; Drabick DAG, 2012, J AM ACAD CHILD PSY, V51, P384, DOI 10.1016/j.jaac.2012.01.010; Ito M, 2004, BRAIN DEV-JPN, V26, P429, DOI 10.1016/j.brainrev.2004.02.001; Kasahara T, 2006, MOL PSYCHIATR, V11, P577, DOI 10.1038/sj.mp.4001824; Blakemore SJ, 2012, NAT NEUROSCI, V15, P1184, DOI 10.1038/nn.3177; Okano H, 2012, SEMIN FETAL NEONAT M, V17, P336, DOI 10.1016/j.siny.2012.07.002; Germain A, 2008, HUM PSYCHOPHARM CLIN, V23, P571, DOI 10.1002/hup.964; Mistlberger RE, 2004, BIOL REV, V79, P533, DOI 10.1017/S1464793103006353; Ciarleglio CM, 2009, J NEUROSCI, V29, P1670, DOI 10.1523/JNEUROSCI.3801-08.2009; Morishita H, 2008, CURR OPIN NEUROBIOL, V18, P101, DOI 10.1016/j.conb.2008.05.009; Corbett BA, 2009, AUTISM RES, V2, P39, DOI 10.1002/aur.64; LeSauter J, 2009, P NATL ACAD SCI USA, V106, P13582, DOI 10.1073/pnas.0906426106; Liston C, 2013, NAT NEUROSCI, V16, P698, DOI 10.1038/nn.3387; de la Iglesia HO, 2004, CURR BIOL, V14, P796, DOI 10.1016/j.cub.2004.04.034; Plante DT, 2008, AM J PSYCHIAT, V165, P830, DOI 10.1176/appi.ajp.2008.08010077; Burkart JM, 2007, P NATL ACAD SCI USA, V104, P19762, DOI 10.1073/pnas.0710310104; Cross N, 2004, DEV PSYCHOBIOL, V45, P134, DOI 10.1002/dev.20023; Wang TA, 2012, SCIENCE, V337, P839, DOI 10.1126/science.1222826; Ohta H, 2005, NAT NEUROSCI, V8, P267, DOI 10.1038/nn1395; LeGates TA, 2012, NATURE, V491, P594, DOI 10.1038/nature11673; Cross N, 2006, HORM BEHAV, V49, P237, DOI 10.1016/j.yhbeh.2005.07.007; Lesch KP, 2012, NEURON, V76, P175, DOI 10.1016/j.neuron.2012.09.013; Lewy AJ, 2007, COLD SPRING HARB SYM, V72, P623, DOI 10.1101/sqb.2007.72.055; Cambras T, 2007, P NATL ACAD SCI USA, V104, P7634, DOI 10.1073/pnas.0702424104; Connolly M.S., 1983, MED BIOL, V6, P113; DIEZNOGUERA A, 1990, PHYSIOL BEHAV, V47, P889, DOI 10.1016/0031-9384(90)90014-U; Flack JC, 2013, CURR BIOL, V23, pR967, DOI 10.1016/j.cub.2013.10.001; Kato Y, 2014, BEHAV BRAIN RES, V275, P43, DOI 10.1016/j.bbr.2014.08.047; Kohyama J, 2009, BRAIN DEV-JPN, V31, P255, DOI 10.1016/j.braindev.2008.07.006; Koshiba K., 2013, PLOS ONE, V8; Koshiba M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02630; Koshiba M, 2011, PROG NEURO-PSYCHOPH, V35, P1499, DOI 10.1016/j.pnpbp.2011.01.021; Koshiba M, 2013, OA AUTISM, V1, P18; Koshiba M, 2013, ECS TRANSACTIONS, V50, P9, DOI 10.1149/05028.0009ecst; Koshiba M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02503; Lewis A.J., 2014, BMC MED, V1, P33; LORENZ KONRAD Z., 1937, AUK, V54, P245; Machado CJ, 2003, J CHILD PSYCHOL PSYC, V44, P64, DOI 10.1111/1469-7610.00103; Mashiko H, 2012, J NEUROSCI, V32, P5039, DOI 10.1523/JNEUROSCI.4788-11.2012; Mimura K, 2013, NEUROSCI LETT, V547, P70, DOI 10.1016/j.neulet.2013.05.009; Mimura K, 2013, J CLIN TOXICOL, V3, P158, DOI DOI 10.4172/2161-0495.1000158; MINEMATSU S, 1991, Journal of Toxicological Sciences, V16, P61; Pantazatos S.P., 2013, NEUROIMAGE, V16, P61; Roybal K., P NATL ACAD SCI A, V104, P6406; Schelstraete I., 1992, PHYSIOL BEHAV, V42, P189; Senoo A, 2011, PROG NEURO-PSYCHOPH, V35, P1493, DOI 10.1016/j.pnpbp.2011.01.008; Shirakawa Y, 2013, J CLIN TOXICOL, V3, P2; Shirakawa Y, 2013, J CLIN TOXICOL, V3, P161; Suchecki D, 1998, J SLEEP RES, V7, P276, DOI 10.1046/j.1365-2869.1998.00122.x; Toki S., EUR J NEUROSCI, V25, P815; Tokuno H, 2009, NEUROSCI RES, V65, P312, DOI 10.1016/j.neures.2009.08.004; Tokuno H, 2009, NEUROSCI RES, V64, P128, DOI 10.1016/j.neures.2009.02.003; Tokuno H, 2012, EXP ANIM TOKYO, V61, P389; Tononi G, 2001, NEUROPSYCHOPHARMACOL, V25, pS28, DOI 10.1016/S0893-133X(01)00322-0; Touchette E, 2009, SLEEP MED REV, V13, P355, DOI 10.1016/j.smrv.2008.12.001; Watson Charles R, 2010, Front Hum Neurosci, V4, P13, DOI 10.3389/neuro.09.013.2010; Weinstock M, 2010, ISR J PSYCHIATR REL, V47, P36; Yamaguchi C., 2010, AM J PRIMATOL, V71, P1; Yerushalmi S, 2006, J EXP BIOL, V209, P1044, DOI 10.1242/jeb.02125	72	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	APR	2015	93				SI		91	98		10.1016/j.neures.2014.09.011		8	Neurosciences	Neurosciences & Neurology	CH9GK	WOS:000354343800009		
J	Saito, A				Saito, Atsuko			The marmoset as a model for the study of primate parental behavior	NEUROSCIENCE RESEARCH			English	Review						Marmoset; Tamarin; Callitrichid; Parental behavior; Endocrinology; Macaque monkey	COTTON-TOP TAMARINS; MOTHER-INFANT INTERACTIONS; FEMALE COMMON MARMOSETS; NEW-WORLD PRIMATE; CALLITHRIX-JACCHUS; SAGUINUS-OEDIPUS; MATERNAL-BEHAVIOR; JAPANESE MACAQUES; RHESUS MACAQUES; NONHUMAN-PRIMATES	Parental behavior is important for the development of mammalian offspring. Research on the mechanisms underlying parental behavior, however, has been largely restricted to rodent models. As a consequence, although research on parent-infant relationships has been conducted using macaque monkeys for more than half a century, little is known about the neural mechanisms and brain regions associated with such behaviors in primates. This article reviews parental behavior and its endocrinological mechanisms in marmosets and tamarins, both cooperative breeders in the callitrichid family, and compares these findings with studies of macaque monkeys. The paper examines the similarities and differences between marmosets and humans, and suggests the possibility that marmosets can be a model for future studies of the neural underpinnings and endocrinology underlying human parental behavior. (C) 2015 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	[Saito, Atsuko] Univ Tokyo, Dept Cognit & Behav Sci, Grad Sch Arts & Sci, Tokyo 1538902, Japan	Saito, A (reprint author), 3-8-1 Komaba,Meguro Ku, Tokyo 1538902, Japan.	casaito@mail.ecc.u-tokyo.ac.jp			JSPS [25118003]	This study was supported by JSPS KAKENHI Grant Number 25118003.	Achenbach GG, 2002, INT J PRIMATOL, V23, P179, DOI 10.1023/A:1013210226793; Almond REA, 2008, AM J PRIMATOL, V70, P560, DOI 10.1002/ajp.20529; Almond REA, 2006, HORM BEHAV, V49, P673, DOI 10.1016/j.yhbeh.2005.12.009; EPPLE G, 1968, FOLIA PRIMATOL, V8, P1, DOI 10.1159/000155129; DEGEEST K, 1985, J PERINAT MED, V13, P3, DOI 10.1515/jpme.1985.13.1.3; FERRARI SF, 1989, FOLIA PRIMATOL, V52, P132, DOI 10.1159/000156392; Tachikawa KS, 2013, J NEUROSCI, V33, P5120, DOI 10.1523/JNEUROSCI.2364-12.2013; LOVEJOY CO, 1981, SCIENCE, V211, P341, DOI 10.1126/science.211.4480.341; Kondo M, 2003, ZOO BIOL, V22, P65, DOI 10.1002/zoo.10073; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; MARTIN RD, 1985, NATURE, V313, P220, DOI 10.1038/313220a0; Feldman R, 2007, PSYCHOL SCI, V18, P965, DOI 10.1111/j.1467-9280.2007.02010.x; ZIEGLER TE, 1995, HORM BEHAV, V29, P407, DOI 10.1006/hbeh.1995.1028; Glocker ML, 2009, ETHOLOGY, V115, P257, DOI 10.1111/j.1439-0310.2008.01603.x; Tardif SD, 2003, COMPARATIVE MED, V53, P364; ZIEGLER TE, 1993, ANIM BEHAV, V45, P313, DOI 10.1006/anbe.1993.1036; Nunes S, 2001, HORM BEHAV, V39, P70, DOI 10.1006/hbeh.2000.1631; Nunes S, 2000, ANIM BEHAV, V60, P857, DOI 10.1006/anbe.2000.1524; Strathearn L, 2008, PEDIATRICS, V122, P40, DOI 10.1542/peds.2007-1566; HARLOW HF, 1958, AM PSYCHOL, V13, P673, DOI 10.1037/h0047884; Repetti RL, 2002, PSYCHOL BULL, V128, P330, DOI 10.1037//0033-2909.128.2.330; Kozorovitskiy Y, 2006, NAT NEUROSCI, V9, P1094, DOI 10.1038/nn1753; Mota MTD, 2006, HORM BEHAV, V49, P293, DOI 10.1016/j.yhbeh.2005.07.012; FERRARI SF, 1992, AM J PRIMATOL, V26, P109, DOI 10.1002/ajp.1350260205; Saltzman W, 2011, PROG NEURO-PSYCHOPH, V35, P1192, DOI 10.1016/j.pnpbp.2010.09.017; Kuroda KO, 2011, PROG NEURO-PSYCHOPH, V35, P1205, DOI 10.1016/j.pnpbp.2011.02.008; Lee AG, 2011, BIOL LETTERS, V7, P584, DOI 10.1098/rsbl.2011.0107; Maestripieri D, 2008, HORM BEHAV, V53, P170, DOI 10.1016/j.yhbeh.2007.09.013; Tardif S, 1998, LAB ANIM SCI, V48, P264; Boccia ML, 2007, HORM BEHAV, V52, P344, DOI 10.1016/j.yhbeh.2007.05.009; Woller MJ, 2012, J NEUROENDOCRINOL, V24, P413, DOI 10.1111/j.1365-2826.2011.02252.x; Freeman ME, 2000, PHYSIOL REV, V80, P1523; Zahed SR, 2008, AM J PRIMATOL, V70, P84, DOI 10.1002/ajp.20460; Berg SJ, 2002, HORM BEHAV, V42, P424, DOI 10.1006/hbeh.2002.1841; ABBOTT DH, 1978, J REPROD FERTIL, V53, P155; HINDE RA, 1967, ANIM BEHAV, V15, P169, DOI 10.1016/S0003-3472(67)80029-0; Maestripieri D, 2009, PHYSIOL BEHAV, V96, P613, DOI 10.1016/j.physbeh.2008.12.016; DIXSON AF, 1982, NATURE, V299, P551, DOI 10.1038/299551a0; Ziegler TE, 2011, HORM BEHAV, V59, P265, DOI 10.1016/j.yhbeh.2010.12.001; Saito A, 2011, J COMP PHYSIOL A, V197, P329, DOI 10.1007/s00359-010-0617-2; Takemoto A, 2011, J NEUROSCI METH, V199, P82, DOI 10.1016/j.jneumeth.2011.04.029; Bales KL, 2005, AM J PRIMATOL, V67, P25, DOI 10.1002/ajp.20167; Bardi M, 2003, AM J PHYS ANTHROPOL, V120, P298, DOI 10.1002/ajpa.10150; Bardi M, 2004, BIOL PSYCHIAT, V55, P724, DOI 10.1016/j.biopsych.2004.01.002; Bardi M, 2003, PHYSIOL BEHAV, V80, P185, DOI 10.1016/j.physbeh.2003.07.004; Bardi M, 2003, GEN COMP ENDOCR, V133, P323, DOI 10.1016/S0016-6480(03)00193-X; Bardi M, 2001, INT J PRIMATOL, V22, P647, DOI 10.1023/A:1010793719669; BERMAN CM, 1980, ANIM BEHAV, V28, P860, DOI 10.1016/S0003-3472(80)80146-1; BIELERT C, 1976, J REPROD FERTIL, V46, P179; Burkart JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5747; Delahunty KM, 2007, HORM BEHAV, V51, P213, DOI 10.1016/j.yhbeh.2006.10.004; DIXSON AF, 1987, PHYSIOL BEHAV, V41, P577, DOI 10.1016/0031-9384(87)90314-3; Fairbanks L. A., 1996, ADV STUD BEHAV, V25, P579; Fite JE, 2005, J HUM EVOL, V49, P122, DOI 10.1016/j.jhevol.2005.04.003; Fite JE, 2000, HORM BEHAV, V38, P1, DOI 10.1006/hbeh.2000.1607; Fite JE, 2005, HORM BEHAV, V47, P39, DOI 10.1016/j.yhbeh.2004.08.005; Gilad Y, 2004, PLOS BIOL, V2, P120, DOI 10.1371/journal.pbio.0020005; Harvey P.H., 1987, P181; HIRAIWA M, 1981, Primates, V22, P309, DOI 10.1007/BF02381573; Hoffman CL, 2010, AM J PRIMATOL, V72, P559, DOI 10.1002/ajp.20793; HOLMAN SD, 1995, MOTHERHOOD IN HUMAN AND NONHUMAN PRIMATES, P87; Hrdy SB, 2005, ATTACHMENT BONDING N, P9; INGRAM JC, 1977, ANIM BEHAV, V25, P811, DOI 10.1016/0003-3472(77)90035-5; JENSEN GD, 1965, J COMP PHYSIOL PSYCH, V59, P305, DOI 10.1037/h0021832; Kawamura Shoji, 2012, P93; KHOLKUTE S D, 1984, Primates, V25, P538, DOI 10.1007/BF02381675; Kikusui T., 2010, ETHOLOGY BRAIN HORMO, P112; Krasnegor N.A., 1990, MAMMALIAN PARENTING; Leutenegger C.M., 1973, FOLIA PRIMATOL, V20, P280; Levine Ari, 2007, Peptides, V28, P1162, DOI 10.1016/j.peptides.2007.04.016; LUNN SF, 1982, FOLIA PRIMATOL, V37, P99, DOI 10.1159/000156023; Maestripieri D, 1998, ETHOLOGY, V104, P379; MAESTRIPIERI D, 1995, PHYSIOL BEHAV, V57, P353, DOI 10.1016/0031-9384(94)00222-Q; Maestripieri D, 2005, P ROY SOC B-BIOL SCI, V272, P1243, DOI 10.1098/rspb.2005.3059; Maestripieri D, 1999, NEUROSCI BIOBEHAV R, V23, P411, DOI 10.1016/S0149-7634(98)00042-6; Maestripieri Dario, 2009, P1; Maestripieri D, 1998, HORM BEHAV, V34, P223, DOI 10.1006/hbeh.1998.1470; Maestripieri Dario, 1996, Advances in the Study of Behavior, V25, P613; Maestripieri D, 2000, PHYSIOL BEHAV, V71, P43, DOI 10.1016/S0031-9384(00)00338-3; MCNEILLY AS, 1981, J REPROD FERTIL, V62, P353; Melnick D.J., 1987, P121; Mills DA, 2004, PRIMATES, V45, P259, DOI 10.1007/s10329-004-0095-7; Mitchell JF, 2014, J NEUROSCI, V34, P1183, DOI 10.1523/JNEUROSCI.3899-13.2014; MORO M, 1995, PRIMATES, V36, P249, DOI 10.1007/BF02381350; Mota MT, 2000, FOLIA PRIMATOL, V71, P22, DOI 10.1159/000021727; NAKAMICHI M, 1989, ANIM BEHAV, V38, P737, DOI 10.1016/S0003-3472(89)80106-X; Nguyen N, 2008, ANIM BEHAV, V75, P1747, DOI 10.1016/j.anbehav.2007.09.035; Parker KJ, 2010, BEHAV NEUROSCI, V124, P428, DOI 10.1037/a0019576; Paxinos G., 2012, MARMOSET BRAIN STERE; Prudom SL, 2008, BIOL LETTERS, V4, P603, DOI 10.1098/rsbl.2008.0358; Pryce Christopher R., 1996, Advances in the Study of Behavior, V25, P423; PRYCE CR, 1993, J COMP PSYCHOL, V107, P99, DOI 10.1037//0735-7036.107.1.99; PRYCE CR, 1995, MOTHERHOOD IN HUMAN AND NONHUMAN PRIMATES, P78; PRYCE CR, 1988, PHYSIOL BEHAV, V44, P717, DOI 10.1016/0031-9384(88)90052-2; Roberts RL, 2001, PHYSIOL BEHAV, V72, P713, DOI 10.1016/S0031-9384(01)00430-9; Roberts RL, 2001, HORM BEHAV, V39, P106, DOI 10.1006/hbeh.2000.1639; ROTHE H, 1993, INT J PRIMATOL, V14, P79, DOI 10.1007/BF02196504; Rowe N, 1996, PICTORIAL GUIDE LIVI; Saito A, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00217; Saito A., 2011, MONKEYS BIOL BEHAV D, P77; Saito A, 2011, BEHAVIOUR, V148, P1199, DOI 10.1163/000579511X596598; Saltzman W., 2003, SEXUAL SELECTION REP, P197; Saltzman W, 2009, PSYCHONEUROENDOCRINO, V34, P1222, DOI 10.1016/j.psyneuen.2009.03.012; Saltzman W, 2011, J NEUROENDOCRINOL, V23, P1139, DOI 10.1111/j.1365-2826.2011.02153.x; Saltzman W, 2005, HORM BEHAV, V47, P151, DOI 10.1016/j.yhbeh.2004.10.001; Sanchez S, 1999, AM J PRIMATOL, V48, P99, DOI 10.1002/(SICI)1098-2345(1999)48:2<99::AID-AJP2>3.0.CO;2-6; Sato A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038387; SCHINO G, 1995, ANIM BEHAV, V49, P151, DOI 10.1016/0003-3472(95)80162-6; Schradin C, 2004, HORM BEHAV, V46, P670, DOI 10.1016/j.yhbeh.2004.04.010; Schradin C, 2001, ANIM BEHAV, V62, P289, DOI 10.1006/anbe.2001.1767; Schradin C, 2003, J HUM EVOL, V45, P389, DOI 10.1016/j.jhevol.2003.08.008; SIMPSON MJA, 1986, ANIM BEHAV, V34, P1528, DOI 10.1016/S0003-3472(86)80222-6; Smith TE, 1998, AM J PRIMATOL, V46, P265; Takemoto A., 2015, NEUROSCI RE IN PRESS; TANAKA I, 1989, PRIMATES, V30, P477, DOI 10.1007/BF02380875; TARDIF SD, 1994, AM J PRIMATOL, V34, P133, DOI 10.1002/ajp.1350340205; Tardif SD, 2002, ETHOLOGY, V108, P825, DOI 10.1046/j.1439-0310.2002.00815.x; Tardif SD, 2005, J CLIN ENDOCR METAB, V90, P335, DOI 10.1210/jc.2004-1064; Tokuno H, 2012, EXP ANIM TOKYO, V61, P389; Torii R, 1998, PRIMATES, V39, P407, DOI 10.1007/BF02557565; van Schaik Carel, 1996, Evolutionary Anthropology, V5, P152, DOI 10.1002/(SICI)1520-6505(1996)5:5<152::AID-EVAN3>3.0.CO;2-H; vom Saal F S, 1982, Science, V215, P1270, DOI 10.1126/science.7058349; Washabaugh KF, 2002, ANIM BEHAV, V63, P1163, DOI 10.1006/anbe.2002.3018; WEISS G, 1976, P SOC EXP BIOL MED, V151, P113; Whitten P.L., 1987, P343; Wynne-Edwards KE, 2000, TRENDS ECOL EVOL, V15, P464, DOI 10.1016/S0169-5347(00)01972-8; Ximenes MFFM, 1996, PRIMATES, V37, P175, DOI 10.1007/BF02381405; Yamamoto ME, 1997, ETHOLOGY, V103, P760; Yuasa S., 2010, STEREOTAXIC ATLAS MA; Zahed SR, 2010, AM J PRIMATOL, V72, P296, DOI 10.1002/ajp.20782; Ziegler TE, 2009, HORM BEHAV, V56, P436, DOI 10.1016/j.yhbeh.2009.07.012; ZIEGLER TE, 1990, J REPROD FERTIL, V90, P563; Ziegler TE, 2004, HORM BEHAV, V45, P84, DOI 10.1016/j.yhbeh.2003.09.003; Ziegler TE, 2004, AM J PRIMATOL, V64, P57, DOI 10.1002/ajp.20061; Ziegler TE, 2000, HORM BEHAV, V38, P159, DOI 10.1006/hbeh.2000.1617; Ziegler TE, 1996, HORM BEHAV, V30, P287, DOI 10.1006/hbeh.1996.0035	136	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	APR	2015	93				SI		99	109		10.1016/j.neures.2014.12.011		11	Neurosciences	Neurosciences & Neurology	CH9GK	WOS:000354343800010		
J	Sasaki, E				Sasaki, Erika			Prospects for genetically modified non-human primate models, including the common marmoset	NEUROSCIENCE RESEARCH			English	Review						Transgenic; Target gene KO; Genome editing; Common marmoset	CELL NUCLEAR TRANSFER; EMBRYONIC STEM-CELLS; MONKEY CALLITHRIX-JACCHUS; ZINC-FINGER NUCLEASES; SPINAL-CORD-INJURY; GENE-TRANSFER; HEPATIC HEMOSIDEROSIS; LENTIVIRAL VECTOR; VIRUS-INFECTION; STAGE EMBRYOS	Genetically modified mice have contributed much to studies in the life sciences. In some research fields, however, mouse models are insufficient for analyzing the molecular mechanisms of pathology or as disease models. Often, genetically modified non-human primate (NHP) models are desired, as they are more similar to human physiology, morphology, and anatomy. Recent progress in studies of the reproductive biology in NHPs has enabled the introduction of exogenous genes into NHP genomes or the alteration of endogenous NHP genes. This review summarizes recent progress in the production of genetically modified NHPs, including the common marmoset, and future perspectives for realizing genetically modified NHP models for use in life sciences research. (C) 2015 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	[Sasaki, Erika] Keio Univ, Adv Res Ctr, Shinjuku Ku, Tokyo 1608582, Japan; [Sasaki, Erika] Ctr Inst Expt Anim, Ctr Appl Dev Biol, Kawasaki, Kanagawa 2100821, Japan	Sasaki, E (reprint author), Ctr Inst Expt Anim, Ctr Appl Dev Biol, 3-25-12 Tonomachi, Kawasaki, Kanagawa 2100821, Japan.	esasaki@ciea.or.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	This work was supported by grants from the "Maintenance of Systems for Creation and Spread of Primate Model Animals" under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.	Nunomura S, 2012, INT IMMUNOL, V24, P593, DOI 10.1093/intimm/dxs070; Kurita R, 2006, STEM CELLS, V24, P2014, DOI 10.1634/stemcells.2005-0499; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Niu YY, 2010, P NATL ACAD SCI USA, V107, P17663, DOI 10.1073/pnas.1006563107; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; Izawa K, 2004, EXP HEMATOL, V32, P843, DOI 10.1016/j.exphem.2004.06.007; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Hikishima K, 2011, NEUROIMAGE, V54, P2741, DOI 10.1016/j.neuroimage.2010.10.061; Iwanami A, 2005, J NEUROSCI RES, V80, P182, DOI 10.1002/jnr.20436; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Miller MT, 1999, TERATOLOGY, V60, P306, DOI 10.1002/(SICI)1096-9926(199911)60:5<306::AID-TERA11>3.0.CO;2-Y; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Kametani Y, 2009, EXP HEMATOL, V37, P1318, DOI 10.1016/j.exphem.2009.08.003; Yang SH, 2008, NATURE, V453, P921, DOI 10.1038/nature06975; Hikishima K, 2013, NEUROSCIENCE, V230, P102, DOI 10.1016/j.neuroscience.2012.09.053; Sasaki E, 2005, STEM CELLS, V23, P1304, DOI 10.1634/stemcells.2004-0366; Kim JH, 2011, TOXICOL SCI, V122, P1, DOI 10.1093/toxsci/kfr088; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Liu HL, 2014, CELL STEM CELL, V14, P323, DOI 10.1016/j.stem.2014.01.018; Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006; Dropulic LK, 2012, EXPERT REV VACCINES, V11, P1429, DOI [10.1586/erv.12.129, 10.1586/ERV.12.129]; Ma SD, 2012, J VIROL, V86, P7976, DOI 10.1128/JVI.00770-12; Chan AWS, 2001, SCIENCE, V291, P309, DOI 10.1126/science.291.5502.309; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Iwanami A, 2005, J NEUROSCI RES, V80, P172, DOI 10.1002/jnr.20435; Chung YG, 2014, CELL STEM CELL, V14, P777, DOI 10.1016/j.stem.2014.03.015; Hattori F, 2010, NAT METHODS, V7, P61, DOI [10.1038/nmeth.1403, 10.1038/NMETH.1403]; AVILA MM, 1985, J MED VIROL, V15, P93; AVILA MM, 1987, J MED VIROL, V21, P67, DOI 10.1002/jmv.1890210109; Berges B., 2014, J GEN VIROL; Bulte JWM, 1997, MAGN RESON MED, V37, P530, DOI 10.1002/mrm.1910370409; Byrne JA, 2007, NATURE, V450, P497, DOI 10.1038/nature06357; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen H, 2008, BIOCHEM BIOPH RES CO, V369, P801, DOI 10.1016/j.bbrc.2008.02.141; Cox C, 1996, J GEN VIROL, V77, P1173, DOI 10.1099/0022-1317-77-6-1173; Datson NA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-190; Hart B.A., 2013, FRONT IMMUNOL, V4, P145; HEARN JP, 1975, J ENDOCRINOL, V65, pP1; Hearn J P, 1978, Primates Med, V10, P40; Hibino H, 2001, EUR J HAEMATOL, V66, P272, DOI 10.1034/j.1600-0609.2001.066004272.x; Howard MK, 1998, GENE THER, V5, P1137, DOI 10.1038/sj.gt.3300700; Ishibashi H, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.109165; Ishibashi H, 2013, REPROD BIOL, V13, P139, DOI 10.1016/j.repbio.2013.02.002; Jagessar SA, 2013, EXP ANIM TOKYO, V62, P159; Kobune F, 1996, LAB ANIM SCI, V46, P315; Kwon DN, 2013, SCI REP-UK, V3, DOI 10.1038/srep01981; Lillico SG, 2013, SCI REP-UK, V3, DOI 10.1038/srep02847; LOPATA A, 1988, FERTIL STERIL, V50, P503; Marshall VS, 1997, J MED PRIMATOL, V26, P241; Miller GF, 1997, LAB ANIM SCI, V47, P138; Moncla LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078750; Mueller T, 2007, J Stem Cells Regen Med, V2, P81; Muller T, 2009, HUM REPROD, V24, P1359, DOI 10.1093/humrep/dep012; Pinto MA, 2002, EXP TOXICOL PATHOL, V53, P413, DOI 10.1078/0940-2993-00212; POSWILLO DE, 1972, NATURE, V239, P460, DOI 10.1038/239460a0; Sawada K, 2014, NEUROSCIENCE, V257, P158, DOI 10.1016/j.neuroscience.2013.10.067; Shimada H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049469; Sparman M, 2009, STEM CELLS, V27, P1255, DOI 10.1002/stem.60; SUMMERS PM, 1985, J REPROD FERTIL, V73, P133; Takahashi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095560; Tatsumoto S, 2013, DNA RES, V20, P255, DOI 10.1093/dnares/dst007; Worley KC, 2014, NAT GENET, V46, P850, DOI 10.1038/ng.3042; Thomson JA, 1996, BIOL REPROD, V55, P254, DOI 10.1095/biolreprod55.2.254; THOMSON JA, 1994, J MED PRIMATOL, V23, P333; Tomioka I, 2010, GENES CELLS, V15, P959, DOI 10.1111/j.1365-2443.2010.01437.x; Tomioka I, 2012, THERIOGENOLOGY, V78, P1487, DOI 10.1016/j.theriogenology.2012.06.024; Wiedemann A, 2012, CELL REPROGRAM, V14, P485, DOI 10.1089/cell.2012.0036; Wolfgang MJ, 2001, P NATL ACAD SCI USA, V98, P10728, DOI 10.1073/pnas.181336098; WRIGHT J, 1977, J NATL CANCER I, V59, P1475; Wu Y, 2012, STEM CELLS INT, V2012; Yamamori T, 2011, PROG NEUROBIOL, V94, P201, DOI 10.1016/j.pneurobio.2011.04.008; Yang DS, 2013, JOVE-J VIS EXP, DOI 10.3791/50957; Zhang CF, 2014, MOL BIOL REP, V41, P209, DOI 10.1007/s11033-013-2853-3	74	2	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	APR	2015	93				SI		110	115		10.1016/j.neures.2015.01.011		6	Neurosciences	Neurosciences & Neurology	CH9GK	WOS:000354343800011		
J	Hashikawa, T; Nakatomi, R; Iriki, A				Hashikawa, Tsutomu; Nakatomi, Reiko; Iriki, Atsushi			Current models of the marmoset brain	NEUROSCIENCE RESEARCH			English	Review						Common marmoset; Cytoarchitecture; Stereotaxic atlas; Brain models; Volume rendering; MRI	GENE-EXPRESSION ATLAS; COMMON MARMOSET; CALLITHRIX-JACCHUS; MOUSE-BRAIN	Since the availability of the common marmoset monkey as a primate model in neuroscience research has recently increased, much effort has been made to develop a reliable guide of the brain structures of this species. In this article, we review the development of the marmoset brain atlas and discuss a newly developed brain model, which was reconstructed from histological sections under volume-rendering technology. This kind of brain model allows virtual sections to be constructed on any axis, with nomenclatural annotations to structures in situ. This model is also applicable for the identification of structures revealed in magnetic resonance imaging studies. The brain model is accessible at the following web address: http://brainatlas.brain.riken.jp/marmoset/modules/xoonips/listitem.php?indexid=66. (C) 2015 The Authors. Published by Elsevier Ireland Ltd.	[Hashikawa, Tsutomu; Nakatomi, Reiko; Iriki, Atsushi] RIKEN, Lab Symbol Cognit Dev, Brain Sci Inst, Wako, Saitama 3510198, Japan	Iriki, A (reprint author), RIKEN, Lab Symbol Cognit Dev, Brain Sci Inst, Wako, Saitama 3510198, Japan.	iriki@brain.riken.jp			MEXT Japan	This study was supported by grants FIRST and Brain/MINDS from MEXT Japan.	Newman JD, 2009, BRAIN RES REV, V62, P1, DOI 10.1016/j.brainresrev.2009.09.001; Norscia I, 2011, PRIMATES, V52, P101, DOI 10.1007/s10329-010-0228-0; Hikishima K, 2011, NEUROIMAGE, V54, P2741, DOI 10.1016/j.neuroimage.2010.10.061; Martin RF, 1996, NEUROIMAGE, V4, P119, DOI 10.1006/nimg.1996.0036; Dorr AE, 2008, NEUROIMAGE, V42, P60, DOI 10.1016/j.neuroimage.2008.03.037; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Ma Y, 2005, NEUROSCIENCE, V135, P1203, DOI 10.1016/j.neuroscience.2005.07.014; Hikishima K, 2013, NEUROSCIENCE, V230, P102, DOI 10.1016/j.neuroscience.2012.09.053; Sasaki E, 2005, STEM CELLS, V23, P1304, DOI 10.1634/stemcells.2004-0366; Ng L, 2009, NAT NEUROSCI, V12, P356, DOI 10.1038/nn.2281; Kishi N, 2014, DEV GROWTH DIFFER, V56, P53, DOI 10.1111/dgd.12109; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Ash H, 2014, AM J PRIMATOL, V76, P1062, DOI 10.1002/ajp.22293; Berman A L, 1982, THALAMUS BASAL TELEN; Berman AL, 1968, BRAIN STEM CAT CYTOA; Carson JP, 2005, PLOS COMPUT BIOL, V1, P289, DOI 10.1371/journal.pcbi.0010041; Hardman C.D., 2012, STEREOTAXIC CHEMOARC; Hawrylycz M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001065; Heig D., 1999, AM J PRIMATOL, V49, P285; Hevner RF, 2007, J NEUROPATH EXP NEUR, V66, P101, DOI 10.1097/nen.0b013e3180301c06; Hjornevik T, 2007, FRONT NEUROINFORM, V1, P1, DOI DOI 10.3389/NEURO.11.004.2007; Iriki A., 3D STEREOTAXIC BRAIN; Jessberger S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100122; Kumazawa-Manita N, 2013, EXP BRAIN RES, V231, P65, DOI 10.1007/s00221-013-3667-1; MANO MT, 1987, J NEUROL SCI, V79, P287, DOI 10.1016/0022-510X(87)90236-X; Palazzi X., 2008, MARMOSET BRAIN STERE; Paxinos G., 2012, MARMOSET BRAIN STERE; Power RA, 2001, COMPARATIVE MED, V51, P218; Saleem KS, 2012, COMBINED MRI HISTOLO; Sasaki T., 2014, BRAIN STRUCT FUNCT; Sawada K., 2014, NEUROSCIENCE, P158; Stephan H., 2009, BRAIN COMMON MARMOSE; STEVENSON MF, 1976, J HUM EVOL, V5, P365, DOI 10.1016/0047-2484(76)90041-5; Worley KC, 2014, NAT GENET, V46, P850, DOI 10.1038/ng.3042; Tokuno H, 2009, NEUROSCI RES, V64, P128, DOI 10.1016/j.neures.2009.02.003; Yuasa S., 2010, STEREOTAXIC ATLAS MA	36	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	APR	2015	93				SI		116	127		10.1016/j.neures.2015.01.009		12	Neurosciences	Neurosciences & Neurology	CH9GK	WOS:000354343800012		
J	Senoo, A; Tokuno, H; Watson, C				Senoo, Aya; Tokuno, Hironobu; Watson, Charles			Mini-atlas of the marmoset brain	NEUROSCIENCE RESEARCH			English	Review						Common marmoset; Rat; Mini-atlas; Neuroanatomy; Brain organization; Neuroscience education		A mini-atlas of the brain is designed to help students and young researchers who are not familiar with neuroanatomy. In the mini-atlas, a limited number of important nuclei and fiber tracts are shown on a small number of brain sections from posterior end to the anterior end of the brain. The first mini-atlas was introduced for the rat brain (Watson et al., 2010). Here we present a mini-atlas of the common marmoset (Callithrix jaccus), which is one of representative experimental primates for modern neuroscience. We further discuss the differences of brain structures between rodents and primates. (C) 2015 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	[Senoo, Aya] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Koganei, Tokyo 1848588, Japan; [Senoo, Aya; Tokuno, Hironobu] Tokyo Metropolitan Inst Med Sci, Lab Brain Struct, Setagaya Ku, Tokyo 1568506, Japan; [Watson, Charles] Curtin Univ, Perth, WA 6845, Australia; [Watson, Charles] Neurosci Res Australia, Sydney, NSW 2031, Australia; [Watson, Charles] Univ New S Wales, Sydney, NSW 2052, Australia	Tokuno, H (reprint author), Tokyo Metropolitan Inst Med Sci, Lab Brain Struct, Setagaya Ku, Tokyo 1568506, Japan.	tokuno-hr@igakuken.or.jp			JSPS KAKENHI [258053, 23500423]	We thank I. Tanaka and Y. Umitsu for their help. This work was partly supported by JSPS KAKENHI Grant Numbers 258053 and 23500423 to H.T.	Moriya-Ito K, 2015, NEUROSCI RES, V93, P158, DOI 10.1016/j.neures.2014.12.007; Paxinos G., 2012, MARMOSET BRAIN STERE; Paxinos G., 2014, RAT BRAIN STEREOTAXI; Tokuno H, 2009, NEUROSCI RES, V64, P128, DOI 10.1016/j.neures.2009.02.003; Watson C., 2010, BRAIN INTRO FUNCTION	5	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	APR	2015	93				SI		128	135		10.1016/j.neures.2014.12.014		8	Neurosciences	Neurosciences & Neurology	CH9GK	WOS:000354343800013		
J	Takemoto, A; Miwa, M; Koba, R; Yamaguchi, C; Suzuki, H; Nakamura, K				Takemoto, Atsushi; Miwa, Miki; Koba, Reiko; Yamaguchi, Chieko; Suzuki, Hiromi; Nakamura, Katsuki			Individual variability in visual discrimination and reversal learning performance in common marmosets	NEUROSCIENCE RESEARCH			English	Article						Marmoset; Visual discrimination learning; Reversal learning; Learning set; Family	PREFRONTAL SEROTONIN DEPLETION; ORBITOFRONTAL CORTEX; COGNITIVE INFLEXIBILITY; MEDIAL STRIATUM; BASAL NUCLEUS; MONKEYS; DISSOCIATION; IMPAIRMENTS; DOPAMINE; PRIMATES	Detailed information about the characteristics of learning behavior in marmosets is useful for future marmoset research. We trained 42 marmosets in visual discrimination and reversal learning. All marmosets could learn visual discrimination, and all but one could complete reversal learning, though some marmosets failed to touch the visual stimuli and were screened out. In 87% of measurements, the final percentage of correct responses was over 95%. We quantified performance with two measures: onset trial and dynamic interval. Onset trial represents the number of trials that elapsed before the marmoset started to learn. Dynamic interval represents the number of trials from the start before reaching the final percentage of correct responses. Both measures decreased drastically as a result of the formation of discrimination learning sets. In reversal learning, both measures worsened, but the effect on onset trial was far greater. The effects of age and sex were not significant as far as we used adolescent or young adult marmosets. Unexpectedly, experimental circumstance (in the colony or isolator) had only a subtle effect on performance. However, we found that marmosets from different families exhibited different learning process characteristics, suggesting some family effect on learning. (C) 2014 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	[Takemoto, Atsushi; Miwa, Miki; Koba, Reiko; Yamaguchi, Chieko; Suzuki, Hiromi; Nakamura, Katsuki] Kyoto Univ, Primate Res Inst, Cognit Neurosci Sect, Inuyama, Aichi 4848506, Japan	Nakamura, K (reprint author), Kyoto Univ, Primate Res Inst, Cognit Neurosci Sect, 41-2 Kanrin, Inuyama, Aichi 4848506, Japan.	nakamura.katsuki.4z@kyoto-u.ac.jp					Clarke HF, 2011, J NEUROSCI, V31, P4290, DOI 10.1523/JNEUROSCI.5066-10.2011; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Mansfield K, 2003, COMPARATIVE MED, V53, P383; Rygula R, 2010, J NEUROSCI, V30, P14552, DOI 10.1523/JNEUROSCI.2631-10.2010; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; HARLOW HF, 1949, PSYCHOL REV, V56, P51, DOI 10.1037/h0062474; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; Harder JA, 1998, BRAIN RES BULL, V45, P319, DOI 10.1016/S0361-9230(97)00381-X; Schweighofer N, 2003, NEURAL NETWORKS, V16, P5, DOI 10.1016/S0893-6080(02)00228-9; Braun DA, 2010, BEHAV BRAIN RES, V206, P157, DOI 10.1016/j.bbr.2009.08.031; ROBERTS AC, 1988, Q J EXP PSYCHOL-B, V40, P321; Fine A, 1997, NEUROSCIENCE, V81, P331, DOI 10.1016/S0306-4522(97)00208-X; Pryce CR, 2004, BIOL PSYCHIAT, V56, P72, DOI 10.1016/j.biopsych.2004.05.002; Clarke HF, 2005, J NEUROSCI, V25, P532, DOI 10.1523/JNEUROSCI.3690-04.2005; Clarke HF, 2007, CEREB CORTEX, V17, P18, DOI 10.1093/cercor/bhj120; Clarke HF, 2004, SCIENCE, V304, P878, DOI 10.1126/science.1094987; Gilmour G, 2013, NEUROSCI BIOBEHAV R, V37, P2125, DOI 10.1016/j.neubiorev.2012.04.006; Clarke HF, 2008, J NEUROSCI, V28, P10972, DOI 10.1523/JNEUROSCI.1521-08.2008; Kishi N, 2014, DEV GROWTH DIFFER, V56, P53, DOI 10.1111/dgd.12109; Horner AE, 2013, NAT PROTOC, V8, P1961, DOI 10.1038/nprot.2013.122; Izquierdo A, 2012, PSYCHOPHARMACOLOGY, V219, P607, DOI 10.1007/s00213-011-2579-7; 't Hart BA, 2012, DRUG DISCOV TODAY, V17, P1160, DOI 10.1016/j.drudis.2012.06.009; Man MS, 2009, CEREB CORTEX, V19, P899, DOI 10.1093/cercor/bhn137; Smith AC, 2004, J NEUROSCI, V24, P447, DOI 10.1523/JNEUROSCI.2908-03.2004; Takemoto A, 2011, J NEUROSCI METH, V199, P82, DOI 10.1016/j.jneumeth.2011.04.029; Gallistel CR, 2004, P NATL ACAD SCI USA, V101, P13124, DOI 10.1097/pnas.0404965101; COTTERMAN TE, 1956, J COMP PHYSIOL PSYCH, V49, P539, DOI 10.1037/h0048341; Klanker M., 2013, FRONT NEUROSCI, V7, P1; MILES RC, 1956, J COMP PHYSIOL PSYCH, V49, P219, DOI 10.1037/h0045088; RIDLEY RM, 1981, PSYCHOPHARMACOLOGY, V75, P283, DOI 10.1007/BF00432439; RIDLEY RM, 1986, BRAIN RES, V376, P108, DOI 10.1016/0006-8993(86)90904-2; RIDLEY RM, 1993, NEUROSCIENCE, V52, P595, DOI 10.1016/0306-4522(93)90409-9; ROBERTS AC, 1992, NEUROSCIENCE, V47, P251, DOI 10.1016/0306-4522(92)90241-S; SCHRIER A M, 1984, Primates, V25, P95, DOI 10.1007/BF02382299; Smith AG, 1999, PHARMACOL BIOCHEM BE, V63, P201, DOI 10.1016/S0091-3057(98)00230-5; Yokoyama C, 2004, BEHAV BRAIN RES, V152, P221, DOI 10.1016/j.bbr.2003.10.005	36	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	APR	2015	93				SI		136	143		10.1016/j.neures.2014.10.001		8	Neurosciences	Neurosciences & Neurology	CH9GK	WOS:000354343800014		
J	Watakabe, A; Ohtsuka, M; Kinoshita, M; Takaji, M; Isa, K; Mizukami, H; Ozawa, K; Isa, T; Yamamori, T				Watakabe, Akiya; Ohtsuka, Masanari; Kinoshita, Masaharu; Takaji, Masafumi; Isa, Kaoru; Mizukami, Hiroaki; Ozawa, Keiya; Isa, Tadashi; Yamamori, Tetsuo			Comparative analyses of adeno-associated viral vector serotypes 1, 2, 5, 8 and 9 in marmoset, mouse and macaque cerebral cortex	NEUROSCIENCE RESEARCH			English	Article						rAAV; Tropism; Viral vector; Monkey; Non-human primate; Neuron	GENE-TRANSFER; TRANSDUCTION EFFICIENCY; VIRUS; BRAIN; PRIMATE; NEURONS; SYSTEM; OPTOGENETICS; EXPRESSION; LENTIVIRUS	Here we investigated the transduction characteristics of adeno-associated viral vector (AAV) serotypes 1, 2, 5, 8 and 9 in the marmoset cerebral cortex. Using three constructs that each has hrGFP under ubiquitous (CMV), or neuron-specific (CaMKII and Synapsin I (SynI)) promoters, we investigated (1) the extent of viral spread, (2) cell type tropism, and (3) neuronal transduction efficiency of each serotype. AAV2 was clearly distinct from other serotypes in small spreading and neuronal tropism. We did not observe significant differences in viral spread among other serotypes. Regarding the cell tropism, AAV1, 5, 8 and 9 exhibited mostly glial expression for CMV construct. However, when the CaMKII construct was tested, cortical neurons were efficiently transduced (>similar to 70% in layer 3) by all serotypes, suggesting that glial expression obscured neuronal expression for CMV construct. For both SynI and CaMKII constructs, we observed generally high-level expression in large pyramidal cells especially in layer 5, as well as in parvalbumin-positive interneurons. The expression from the CaMKII construct was more uniformly observed in excitatory cells compared with SynI construct. Injection of the same viral preparations in mouse and macaque cortex resulted in essentially the same result with some species-specific differences. (C) 2014 The Authors. Published by Elsevier Ireland Ltd.	[Watakabe, Akiya; Ohtsuka, Masanari; Takaji, Masafumi; Yamamori, Tetsuo] Natl Inst Basic Biol, Div Brain Biol, Okazaki, Aichi 444, Japan; [Watakabe, Akiya; Isa, Tadashi; Yamamori, Tetsuo] Grad Univ Adv Studies SOKENDAI, Okazaki, Aichi, Japan; [Kinoshita, Masaharu; Isa, Kaoru; Isa, Tadashi] Natl Inst Physiol Sci, Dept Dev Physiol, Okazaki, Aichi 444, Japan; [Mizukami, Hiroaki; Ozawa, Keiya] Jichi Med Univ, Ctr Mol Med, Div Genet Therapeut, Shimotsuke, Tochigi, Japan	Watakabe, A (reprint author), 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.	watakabe@nibb.ac.jp	Mizukami, Hiroaki/D-7674-2013	Mizukami, Hiroaki/0000-0001-8954-874X	Scientific Research on Innovative Areas (Neocortical Organization) [22123009, 23123510]; JSPS (Japan Society for the Promotion of Science) [40290910, 22500300];  [20240030]	We thank Drs. Ryosuke Matsui and Dai Watanabe, Kyoto University for CaMKII promoter DNA. We thank Ms. Ohsawa for help with histology and confocal microscope imaging. Confocal images were acquired at Spectrography and Bioimaging Facility, NIBB Core Research Facilities. Some of the monkeys used in this study were provided by the National BioResource Project 'Japanese Monkeys' of the Ministry of Education, Culture, Sports, Science and Technology, Japan. This study is the result of "Highly creative animal model development for brain sciences" carried out under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan. Also supported by Scientific Research on Innovative Areas (Neocortical Organization) (22123009 to TY and 23123510 to HH) and the grant from the JSPS (Japan Society for the Promotion of Science) to AW (KAKENHI 40290910 and 22500300), and Grants-in-Aid for Scientific Research A (20240030) to TY.	Dodiya HB, 2010, MOL THER, V18, P579, DOI 10.1038/mt.2009.216; Lock M, 2010, HUM GENE THER, V21, P1273, DOI 10.1089/hum.2009.223; Sanchez CE, 2011, J NEUROSURG, V114, P672, DOI 10.3171/2010.8.JNS091583; Diester I, 2011, NAT NEUROSCI, V14, P387, DOI 10.1038/nn.2749; Han X, 2012, PROG BRAIN RES, V196, P215, DOI 10.1016/B978-0-444-59426-6.00011-2; Wu ZJ, 2006, MOL THER, V14, P316, DOI 10.1016/j.ymthe.2006.05.009; Cearley CN, 2006, MOL THER, V13, P528, DOI 10.1016/j.ymthe.2005.11.015; Klein RL, 2008, MOL THER, V16, P89, DOI 10.1038/sj.mt.6300331; Masamizu Y, 2010, NEUROREPORT, V21, P447, DOI 10.1097/WNR.0b013e328338ba00; Wang QX, 2014, J COMP NEUROL, V522, P1989, DOI 10.1002/cne.23567; Markakis EA, 2010, MOL THER, V18, P588, DOI 10.1038/mt.2009.286; Bendor D, 2005, NATURE, V436, P1161, DOI 10.1038/nature03867; Okano H, 2012, SEMIN FETAL NEONAT M, V17, P336, DOI 10.1016/j.siny.2012.07.002; Clarke HF, 2004, SCIENCE, V304, P878, DOI 10.1126/science.1094987; Kinoshita M, 2012, NATURE, V487, P235, DOI 10.1038/nature11206; Hutson TH, 2012, GENE THER, V19, P49, DOI 10.1038/gt.2011.71; Nathanson JL, 2009, NEUROSCIENCE, V161, P441, DOI 10.1016/j.neuroscience.2009.03.032; Hioki H, 2009, NEUROSCI RES, V63, P149, DOI 10.1016/j.neures.2008.10.010; Taymans JM, 2007, HUM GENE THER, V18, P195, DOI 10.1089/hum.2006.178; Rabinowitz JE, 2002, J VIROL, V76, P791, DOI 10.1128/JVI.76.2.791-801.2002; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Betley JN, 2011, HUM GENE THER, V22, P669, DOI 10.1089/hum.2010.204; Masamizu Y, 2011, NEUROSCIENCE, V193, P249, DOI 10.1016/j.neuroscience.2011.06.080; Burger C, 2004, MOL THER, V10, P302, DOI 10.1016/j.ymthe.2004.05.024; Klein RL, 2006, MOL THER, V13, P517, DOI 10.1016/j.ymthe.2005.10.008; Aschauer DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076310; Blits B, 2010, J NEUROSCI METH, V185, P257, DOI 10.1016/j.jneumeth.2009.10.009; Holehonnur R, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-28; McFarland NR, 2009, J NEUROCHEM, V109, P838, DOI 10.1111/j.1471-4159.2009.06010.x; Wallace LM, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.16; Watakabe A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046157; Yagi H, 2011, J GENE MED, V13, P114, DOI 10.1002/jgm.1543; Yamamori T, 2006, NEUROSCI RES, V55, P11, DOI 10.1016/j.neures.2006.02.006	33	4	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	APR	2015	93				SI		144	157		10.1016/j.neures.2014.09.002		14	Neurosciences	Neurosciences & Neurology	CH9GK	WOS:000354343800015		
J	Moriya-Ito, K; Tanaka, I; Umitsu, Y; Ichikawa, M; Tokuno, H				Moriya-Ito, Keiko; Tanaka, Ikuko; Umitsu, Yoshitomo; Ichikawa, Masumi; Tokuno, Hironobu			The olfactory bulb and the number of its glomeruli in the common marmoset (Callithrix jacchus)	NEUROSCIENCE RESEARCH			English	Article						Nonhuman primate; Glomerulus; Accessory olfactory bulb; Olfactory receptor gene	MAMMALS; ORGANIZATION; INFORMATION; OPINION; MAP	The olfactory system has been well studied in mammals such as mice and rats. However, few studies have focused on characterizing this system in diurnal primates that rely on their sense of smell to a lesser extent due to their ecological environment. In the present study, we determined the histological organization of the olfactory bulb in the common marmoset (Callithrix jacchus). We then constructed 3-dimensional models of the glomeruli of the olfactory bulb, and estimated the number of glomeruli. Olfactory glomeruli are the functional units of olfactory processing, and have been investigated in detail using mice. There are approximately 1800 glomeruli in a mouse hemibulb, and olfactory sensory neurons expressing one selected olfactory receptor converge onto one or two glomemli. Because mice have about 1000 olfactory receptor genes, it is proposed that the number of glomeruli in mammals is nearly double that of olfactory receptor genes. The common marmoset carries only about 400 intact olfactory receptor genes. The present study revealed that the number of glomeruli in a marmoset hemibulb was approximately 1500-1800. This result suggests that the number of glomeruli is not positively correlated with the number of intact olfactory receptor genes in mammals. (C) 2015 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	[Moriya-Ito, Keiko; Tanaka, Ikuko; Umitsu, Yoshitomo; Tokuno, Hironobu] Tokyo Metropolitan Inst Med Sci, Lab Brain Struct, Tokyo, Tokyo 1568502, Japan; [Ichikawa, Masumi; Tokuno, Hironobu] Tokyo Metropolitan Inst Med Sci, Ctr Basic Technol Res, Tokyo, Tokyo 1568502, Japan	Moriya-Ito, K (reprint author), Tokyo Metropolitan Inst Med Sci, Lab Brain Struct, 2-1-6 Kamikitazawa, Tokyo, Tokyo 1568502, Japan.	moriya-kk@igakuken.or.jp					Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Niimura Y, 2014, GENOME RES, V24, P1485, DOI 10.1101/gr.169532.113; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; SMITH RL, 1991, BRAIN RES, V548, P140, DOI 10.1016/0006-8993(91)91115-H; Smith T, 2006, AM J PRIMATOL, V68, P585, DOI 10.1002/ajp.20254; Zou DJ, 2009, NAT REV NEUROSCI, V10, P611, DOI 10.1038/nrn2666; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Bendesky A, 2011, NAT REV GENET, V12, P809, DOI 10.1038/nrg3065; CLARK G, 1979, STAIN TECHNOL, V54, P337; Gould E, 2007, NAT REV NEUROSCI, V8, P481, DOI 10.1038/nrn2147; HARDY H, 1976, NEUROSCI LETT, V3, P1, DOI 10.1016/0304-3940(76)90090-2; Kosaka K, 2005, NEUROSCI RES, V53, P353, DOI 10.1016/j.neures.2005.08.004; Kosaka K, 2004, J COMP NEUROL, V472, P1, DOI 10.1002/cne.20004; Ohara H, 2013, J VET MED SCI, V75, P85, DOI 10.1292/jvms.12-0245; PAGE KATHLEEN M., 1965, J MED LAB TECHNOL, V22, P224; Paxinos G., 2012, MARMOSET BRAIN STERE; Paxinos G., 2014, RAT BRAIN STEREOTAXI; Royet JP, 1998, BRAIN RES, V788, P35, DOI 10.1016/S0006-8993(97)01504-7; ROYET JP, 1988, J COMP NEUROL, V270, P559, DOI 10.1002/cne.902700409; Sawamoto K, 2011, J COMP NEUROL, V519, P690, DOI 10.1002/cne.22543; Shepherd GM, 1998, SYNAPTIC ORG BRAIN, P159; SMITH RL, 1993, J COMP NEUROL, V333, P519, DOI 10.1002/cne.903330405; Tokuno H, 2009, NEUROSCI RES, V64, P128, DOI 10.1016/j.neures.2009.02.003; Watson C., 2010, CHEMOARCHITECTONIC A; Yang Z, 2008, J COMP NEUROL, V506, P347, DOI 10.1002/cne.21557	25	2	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	APR	2015	93				SI		158	163		10.1016/j.neures.2014.12.007		6	Neurosciences	Neurosciences & Neurology	CH9GK	WOS:000354343800016		
J	Watson, C; Sengul, G; Tanaka, I; Rusznak, Z; Tokuno, H				Watson, Charles; Sengul, Gulgun; Tanaka, Ikuko; Rusznak, Zoltan; Tokuno, Hironobu			The spinal cord of the common marmoset (Callithrix jacchus)	NEUROSCIENCE RESEARCH			English	Article						Spinal cord; Anatomy; Marmoset	MOTOR-NEURONS; CYTOARCHITECTONIC ORGANIZATION; MUSCULOTOPIC ORGANIZATION; LINEAGE RESTRICTIONS; HINDLIMB MUSCLES; POOL IDENTITY; HOX GENES; MOUSE; SEGMENTATION; MOTONEURONS	The marmoset spinal cord possesses all the characteristic features of a typical mammalian spinal cord, but with some interesting variation in the levels of origin of the limb nerves. In our study Nissl and ChAT sections of the each segment of the spinal cord in two marmosets (Ma5 and Ma8), we found that the spinal cord can be functionally and anatomically divided into six regions: the prebrachial region (C1 to C3); the brachial region (C4 to C8) - segments supplying the upper limb; the post-brachial region (T1 to L1) - containing the sympathetic outflow, and supplying the hypaxial muscles of the body wall; the crural region (L2 to L5) - segments supplying the lower limb; the postcrural region (L6) - containing the parasympathetic outflow; and the caudal region (L7 to Co4) - supplying the tail. In the rat, mouse, and rhesus monkey, the prebrachial region consists of segments C1 to C4 (with the phrenic nucleus located at the C4 segment), and the brachial region extends from C5 to T1 inclusive. The prefixing of the upper limb outflow in these two marmosets mirrors the finding in the literature that a large C4 contribution to the brachial plexus is common in humans. (C) 2015 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	[Watson, Charles] Curtin Univ, Perth, WA 6845, Australia; [Watson, Charles; Rusznak, Zoltan] Neurosci Res Australia, Sydney, NSW, Australia; [Watson, Charles] Univ New S Wales, Sydney, NSW, Australia; [Sengul, Gulgun] Ege Univ, Sch Med, Izmir, Turkey; [Tanaka, Ikuko; Tokuno, Hironobu] Tokyo Metropolitan Inst Med Sci, Tokyo 113, Japan	Watson, C (reprint author), Curtin Univ, Perth, WA 6845, Australia.	c.watson@curtin.edu.au					Mikula S, 2007, NEUROIMAGE, V35, P9, DOI 10.1016/j.neuroimage.2006.11.053; Philippidou P, 2012, NAT NEUROSCI, V15, P1636, DOI 10.1038/nn.3242; REXED B, 1954, J COMP NEUROL, V100, P297, DOI 10.1002/cne.901000205; Watson C, 2009, SPINAL CORD: A CHRISTOPHER AND DANA REEVE FOUNDATION TEXT AND ATLAS, P168, DOI 10.1016/B978-0-12-374247-6.50015-8; Wu Y, 2008, DEVELOPMENT, V135, P171, DOI 10.1242/dev.009225; Bacskai T, 2014, BRAIN STRUCT FUNCT, V219, P303, DOI 10.1007/s00429-012-0501-7; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; GIBSON SJ, 1984, J NEUROSCI, V4, P3101; Lin AW, 2003, J NEUROBIOL, V56, P328, DOI 10.1002/neu.10239; Dasen JS, 2003, NATURE, V425, P926, DOI 10.1038/nature02051; Watson C, 2012, ANAT REC, V295, P1692, DOI 10.1002/ar.22549; MOLANDER C, 1984, J COMP NEUROL, V230, P133, DOI 10.1002/cne.902300112; JENNY AB, 1983, J NEUROSCI, V3, P567; Philippidou P, 2013, NEURON, V80, P12, DOI 10.1016/j.neuron.2013.09.020; Chiken S, 2001, NEUROSCI LETT, V307, P143, DOI 10.1016/S0304-3940(01)01918-8; GIBSON SJ, 1984, J COMP NEUROL, V227, P78, DOI 10.1002/cne.902270109; Fu YH, 2012, NEUROSCI LETT, V518, P161, DOI 10.1016/j.neulet.2012.05.002; Bacskai T, 2013, BRAIN STRUCT FUNCT, V218, P221, DOI 10.1007/s00429-012-0396-3; Bruce A., 1901, TOPOGRAPHICAL ATLAS; Carpenter EM, 2002, DEV NEUROSCI-BASEL, V24, P24, DOI 10.1159/000064943; Fahandejsaadi A, 2004, NEUROREPORT, V15, P443, DOI 10.1097/01.wnr.000010520773882.ad; FRASER S, 1990, NATURE, V344, P431, DOI 10.1038/344431a0; GIBSON SJ, 1984, PEPTIDES, V5, P201, DOI 10.1016/0196-9781(84)90207-9; Guthrie S, 2004, CURR BIOL, V14, pR166, DOI 10.1016/j.cub.2004.01.050; Heise C, 2009, SPINAL CORD: A CHRISTOPHER AND DANA REEVE FOUNDATION TEXT AND ATLAS, P64, DOI 10.1016/B978-0-12-374247-6.50010-9; Kayalioglu G, 2009, SPINAL CORD: A CHRISTOPHER AND DANA REEVE FOUNDATION TEXT AND ATLAS, P148; Lance-Jones C, 2001, DEVELOPMENT, V128, P2255; Langley J.N., 1921, AUTONOMIC NERVOUS 1, P1; LIM TM, 1991, DEVELOPMENT, V113, P227; Matejcik V., 2003, ROZHLEDY CHIRURG, V82, P456; McHanwell S, 2009, SPINAL CORD: A CHRISTOPHER AND DANA REEVE FOUNDATION TEXT AND ATLAS, P94; MCHANWELL S, 1981, PHILOS T ROY SOC B, V293, P477, DOI 10.1098/rstb.1981.0082; MOLANDER C, 1989, J COMP NEUROL, V289, P375, DOI 10.1002/cne.902890303; Nicolopoulos-Stournaras S., 1983, J COMP NEUROL, V217, P27; Noback C.R., 1971, PRIMATOLOGIA HDB P 2, VII; REXED B, 1952, J Comp Neurol, V96, P414; Ryan JM, 1998, BRAIN BEHAV EVOLUT, V51, P90; Sengul G, 2014, RAT NERVOUS SYSTEM, P87; Sengul G., 2013, ATLAS SPINAL CORD RA; Sengul G, 2012, MOUSE NERVOUS SYSTEM, P424, DOI 10.1016/B978-0-12-369497-3.10013-5; Sengul G., 2012, HUMAN NERVOUS SYSTEM, P186; STERN CD, 1991, DEVELOPMENT, V113, P239; Tokuno H, 2009, NEUROSCI RES, V64, P128, DOI 10.1016/j.neures.2009.02.003; Tokuno H, 2011, NEUROSCI RES, V70, P128, DOI 10.1016/j.neures.2011.01.016; Uysal II, 2003, NEUROSURGERY, V53, P676, DOI 10.1227/01.NEU.0000079485.24016.70; Uzun A., 1999, TURK J MED SCI, V29, P573; Vanderhorst VGJM, 1997, J COMP NEUROL, V382, P46; Watson C, 2009, SPINAL CORD: A CHRISTOPHER AND DANA REEVE FOUNDATION TEXT AND ATLAS, P380, DOI 10.1016/B978-0-12-374247-6.50021-3; Watson C, 2009, SPINAL CORD: A CHRISTOPHER AND DANA REEVE FOUNDATION TEXT AND ATLAS, P308, DOI 10.1016/B978-0-12-374247-6.50020-1; Watson C, 2009, SPINAL CORD: A CHRISTOPHER AND DANA REEVE FOUNDATION TEXT AND ATLAS, P238, DOI 10.1016/B978-0-12-374247-6.50019-5; Watson C, 2009, SPINAL CORD: A CHRISTOPHER AND DANA REEVE FOUNDATION TEXT AND ATLAS, P1	51	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	APR	2015	93				SI		164	175		10.1016/j.neures.2014.12.012		12	Neurosciences	Neurosciences & Neurology	CH9GK	WOS:000354343800017		
J	Ichinohe, N				Ichinohe, Noritaka			On-going elucidation of mechanisms of primate specific synaptic spine development using the common marmoset (Callithrix jacchus)	NEUROSCIENCE RESEARCH			English	Article						Primate; Synaptogenesis; Pruning; Overshoot-type development of spines; Psychiatry model; Pathophysiology	POTENTIAL MOLECULAR-MECHANISMS; DENDRITIC SPINES; POSTNATAL-DEVELOPMENT; CORTEX; NEOCORTEX; PROFILES; CORTICES; INFANCY; SYSTEM	Recently, pathophysiology of human psychiatry originates from abnormal numbers of synapses/spines. There are generally two-types of development of spines from birth depending on species. One is, after birth, synaptogenesis occurs, and there is a clear peak of spines, and then rapidly pruning occurring, which are called "overshoot-type" of development of synapses/spines. Primates including human belong to this type. In other type including rodents, even after a peak, general number of spines does not decrease so much. Although these differences, most of human psychiatric models have been genetic modified rodents. Now, transgenic primate (the common marmoset) became available. In near future, we can, examine pathophysiology of psychiatric disorders using this animal model, which is closer to human being. To begin with this endeavor, we should know how synapses/spines of normal marmosets developed, and molecular mechanisms of "overshoot-type" of spine development, which human being also shows. Here, we will present our recent effort to explore these questions, and future experiments will be discussed. (C) 2014 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	[Ichinohe, Noritaka] NCNP, Natl Inst Neurosci, Lab Ultrastruct Res, Kodaira, Tokyo 1878502, Japan; [Ichinohe, Noritaka] RIKEN, Brain Sci Inst, Khinohe Neural Syst Grp, Lab Mol Anal Higher Cognit Funct, Wako, Saitama 3510198, Japan	Ichinohe, N (reprint author), NCNP, Natl Inst Neurosci, Lab Ultrastruct Res, 4-1-1 Ogawa Higashi, Kodaira, Tokyo 1878502, Japan.	nichino@ncnp.go.jp			National Center of Neurology and Psychiatry [23-7]; Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program); Strategic Research Program for Brain Science; Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan [22135007, 25110740, 25117001, 26118717]	This work was supported by an Intramural Research Grant (grant number 23-7) for Neurological and Psychiatric Disorders from the National Center of Neurology and Psychiatry, by a Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program), by the Strategic Research Program for Brain Science, by a Grant-in-Aid for Scientific Research on Innovative Areas "Shitsukan" (No. 22135007), "Foundation of Synapse Neurocircuit Pathology" (No. 25110740), "Glia-Assembly" (No. 25117001), and "Seishun-no" (No. 26118717) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan (to N.I.). We thank Takako Suzuki, Tomoko Manabe, and Dr. Taku Banno of the NationalCenter of Neurology and Psychiatry for their technical assistance. We also thank Dr. Keiko Nakagaki of the National Center of Neurology and Psychiatry and Yu Nabeshima and Ryoichi Saito of CLEA Japan, Inc. for their support in the conduct of experiments.	Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; Arellano JI, 2007, NEUROSCIENCE, V145, P464, DOI 10.1016/j.neuroscience.2006.12.015; DeFelipe J, 2002, J NEUROCYTOL, V31, P299, DOI 10.1023/A:1024130211265; Weible AP, 2013, BEHAV BRAIN RES, V245, P63, DOI 10.1016/j.bbr.2013.02.010; Sasaki T, 2014, BIOCHEM BIOPH RES CO, V444, P302, DOI 10.1016/j.bbrc.2014.01.024; Macedo DS, 2012, BRAZ J MED BIOL RES, V45, P179; Sasaki T, 2014, BIOCHEM BIOPH RES CO, V444, P307, DOI 10.1016/j.bbrc.2014.01.023; HUTTENLOCHER PR, 1990, NEUROPSYCHOLOGIA, V28, P517, DOI 10.1016/0028-3932(90)90031-I; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Ebrahimi S, 2014, BBA-BIOMEMBRANES, V1838, P2391, DOI 10.1016/j.bbamem.2014.06.002; Connor CM, 2012, SCHIZOPHR RES, V140, P175, DOI 10.1016/j.schres.2012.06.037; Grabenhorst F, 2008, EUR J NEUROSCI, V28, P1930, DOI 10.1111/j.1460-9568.2008.06489.x; Tsujimoto T, 2006, J NEUROPHYSIOL, V95, P2987, DOI 10.1152/jn.00730.2005; MISSLER M, 1993, J COMP NEUROL, V333, P53, DOI 10.1002/cne.903330105; Fujita I, 2014, FRONT NEURO IN PRESS; Harris S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007272; Oga T, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00031; Sasaki T., 2014, BRAIN STRUCT FUNCT; Singh S, 2013, ANN INTERN MED, V159, DOI 10.7326/0003-4819-159-4-201308200-02013	20	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	APR	2015	93				SI		176	178		10.1016/j.neures.2014.10.019		3	Neurosciences	Neurosciences & Neurology	CH9GK	WOS:000354343800018		
J	Kamiya, T; Satoh, T; Koka, M; Kada, W				Kamiya, T.; Satoh, T.; Koka, M.; Kada, W.			Development of microbeam technology to expand applications at TIARA	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS			English	Article; Proceedings Paper	14th International Conference on Nuclear Microprobe Technology and Applications (ICNMTA) / Workshop on Proton Beam Writing	JUL 07-11, 2014	Padova, ITALY	Ist Nazl Fis Nucl		Microbeam; Ion beam analysis; Proton beam writing; Single ion hit; Diamond membrane detector	SECONDARY-ELECTRON EMISSION; SINGLE-ION DETECTION; NUCLEAR MICROPROBE; ELEMENTAL ANALYSIS; PIXE ANALYSIS; MICROSCOPY; DIAMOND; SYSTEM; SEMICONDUCTOR; IRRADIATION	Herein, we review the last half decade of progress in ion-microbeam technology and applications at the Takasaki Ion Accelerators for Advanced Radiation Applications facility. Materials were microanalysed with the light-ion-microbeam system by combining micro-particle-induced X-ray and gamma-ray emission, nuclear-reaction analysis and micro-ion-beam-induced luminescence to analyse elements, including light elements such as lithium, boron or fluoride, and also their chemical states. For microfabrication, we used particle-beam writing and techniques of maskless patterning to processes materials without etching. The goal was to develop optical, magnetic or other new types of microdevices with both light-ion and the heavy-ion microbeam systems. In addition, techniques were developed to monitor in real time every individual ion injection by using an efficient scintillator or a thin diamond particle detector in both heavy-ion and high-energy heavy-ion microbeam systems. (C) 2014 Elsevier B.V. All rights reserved.	[Kamiya, T.; Satoh, T.; Koka, M.] Japan Atom Energy Agcy, Takasaki Adv Radiat Res Inst, Tokai, Ibaraki, Japan; [Kada, W.] Gunma Univ, Fac Sci & Technol, Maebashi, Gunma, Japan	Kamiya, T (reprint author), Japan Atom Energy Agcy, Takasaki Adv Radiat Res Inst, Tokai, Ibaraki, Japan.						Grilj V, 2013, NUCL INSTRUM METH B, V306, P191, DOI 10.1016/j.nimb.2012.12.034; Satoh T, 2009, NUCL INSTRUM METH B, V267, P2125, DOI 10.1016/j.nimb.2009.03.067; Mima K, 2012, NUCL INSTRUM METH B, V290, P79, DOI 10.1016/j.nimb.2012.08.016; Mokuno Y, 1999, NUCL INSTRUM METH B, V150, P109, DOI 10.1016/S0168-583X(98)00921-5; Fournier C, 2009, RADIAT RES, V171, P530, DOI 10.1667/RR1457.1; COOKSON JA, 1979, NUCL INSTRUM METHODS, V165, P477, DOI 10.1016/0029-554X(79)90631-1; Kada W, 2014, NUCL INSTRUM METH B, V318, P42, DOI 10.1016/j.nimb.2013.06.057; Cholewa M, 1998, DIAM RELAT MATER, V7, P510, DOI 10.1016/S0925-9635(97)00249-5; COOTE GE, 1991, NUCL INSTRUM METH B, V54, P144, DOI 10.1016/0168-583X(91)95504-7; Grilj V., 2013, APPL PHYS LETT, V103; Hirao T, 2009, NUCL INSTRUM METH B, V267, P2216, DOI 10.1016/j.nimb.2009.03.051; Ishii K, 2001, NUCL INSTRUM METH B, V181, P448, DOI 10.1016/S0168-583X(01)00623-1; Iwamoto N, 2013, J APPL PHYS, V113, DOI 10.1063/1.4801797; JAKSIC M, 1993, NUCL INSTRUM METH B, V77, P49; Jamieson D.N., 1991, NUCL INSTRUM METH B, VB54, P1; Kada W, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.06FB07; Kada W., 2013, T MAT RES SOC JPN, V38, P279; Kada Wataru, 2013, NUCL INSTRUM METH B, VB306, P94; KAMIYA T, 1992, NUCL INSTRUM METH B, V64, P362, DOI 10.1016/0168-583X(92)95495-D; Kamiya T., 1995, NUCL INSTRUM METH B, VB118, P423; Kamiya T, 2004, NUCL INSTRUM METH B, V219, P1010, DOI 10.1016/j.nimb.2004.01.205; Kamiya T, 1997, APPL PHYS LETT, V71, P1875, DOI 10.1063/1.120190; Kamiya T, 1996, NUCL INSTRUM METH B, V118, P447, DOI 10.1016/0168-583X(96)00251-0; Kamiya T, 2011, NUCL INSTRUM METH B, V269, P2184, DOI 10.1016/j.nimb.2011.02.043; Kamiya T, 2009, APPL RADIAT ISOTOPES, V67, P488, DOI 10.1016/j.apradiso.2008.06.021; Kitamura A, 2013, NUCL INSTRUM METH B, V307, P610, DOI 10.1016/j.nimb.2013.01.017; Kitamura A, 2013, NUCL INSTRUM METH B, V306, P288, DOI 10.1016/j.nimb.2012.11.033; Kitamura A, 2013, NUCL INSTRUM METH B, V314, P82, DOI 10.1016/j.nimb.2013.05.040; Komatsu H, 2011, NUCL INSTRUM METH B, V269, P2274, DOI 10.1016/j.nimb.2011.02.042; Kurashima S, 2009, NUCL INSTRUM METH B, V267, P2024, DOI 10.1016/j.nimb.2009.03.083; LEGGE GJF, 1984, NUCL INSTRUM METH B, V3, P561, DOI 10.1016/0168-583X(84)90439-7; Li X, 2013, NUCL INSTRUM METH B, V308, P1, DOI 10.1016/j.nimb.2013.04.047; LINDH U, 1991, NUCL INSTRUM METH B, V54, P160, DOI 10.1016/0168-583X(91)95507-A; MCMILLAN JW, 1988, NUCL INSTRUM METH B, V30, P474, DOI 10.1016/0168-583X(88)90044-4; Miura K, 2014, KEY ENG MATER, V596, P134, DOI 10.4028/www.scientific.net/KEM.596.134; Miyawaki N, 2013, NUCL INSTRUM METH A, V715, P126, DOI 10.1016/j.nima.2013.03.033; Miyawaki N, 2011, NUCL INSTRUM METH A, V636, P41, DOI 10.1016/j.nima.2011.01.174; Kashiwagi H, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4858175; Nagamine T., 14 INT C NUCL MICR T; Ohshima T., 2012, RAD RESPONSE SILICON, P379; Ohshima T., TO BE PRESENTED IN I; Onoda S, 2009, IEEE T NUCL SCI, V56, P3218, DOI 10.1109/TNS.2009.2032395; Onoda S, 2005, NUCL INSTRUM METH B, V231, P497, DOI 10.1016/j.nimb.2005.01.106; RYAN CG, 1993, NUCL INSTRUM METH B, V77, P381, DOI 10.1016/0168-583X(93)95570-U; Satoh T, 2014, NUCL INSTRUM METH B, V332, P242, DOI 10.1016/j.nimb.2014.02.070; SEKIGUCHI H, 1991, NUCL INSTRUM METH B, V54, P225, DOI 10.1016/0168-583X(91)95517-H; Shimizu Y, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-88; SIE SH, 1993, NUCL INSTRUM METH B, V75, P403, DOI 10.1016/0168-583X(93)95685-X; SWANN CP, 1995, NUCL INSTRUM METH B, V104, P576, DOI 10.1016/0168-583X(95)00394-0; Vizkelethy G, 2005, NUCL INSTRUM METH B, V231, P467, DOI 10.1016/j.nimb.2005.01.102; Watt F, 1997, NUCL INSTRUM METH B, V130, P1, DOI 10.1016/S0168-583X(97)00164-X; WATT F, 1993, NUCL INSTRUM METH B, V77, P249, DOI 10.1016/0168-583X(93)95552-G; Yamazaki A., ICNMTA 2014	53	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-583X	1872-9584		NUCL INSTRUM METH B	Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms	APR 1	2015	348						4	7		10.1016/j.nimb.2014.12.047		4	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical; Physics, Nuclear	Instruments & Instrumentation; Nuclear Science & Technology; Physics	CH6IS	WOS:000354140900002		
J	Abo, S; Hamada, Y; Seidl, A; Wakaya, F; Takai, M				Abo, Satoshi; Hamada, Yasuhisa; Seidl, Albert; Wakaya, Fujio; Takai, Mikio			Improvement of depth resolution and detection efficiency by control of secondary-electrons in single-event three-dimensional time-of-flight Rutherford backscattering spectrometry	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS			English	Article; Proceedings Paper	14th International Conference on Nuclear Microprobe Technology and Applications (ICNMTA) / Workshop on Proton Beam Writing	JUL 07-11, 2014	Padova, ITALY	Ist Nazl Fis Nucl		Nuclear nanoprobe; RBS; Time-of-flight (TOF); Focused ion beam (FIB); Three-dimensional analysis	SEMICONDUCTOR PROCESS ANALYSIS; BEAM-ASSISTED PROCESS; TOF-RBS; NANOPROBE; NANOSTRUCTURES; SYSTEM; FABRICATION; MICROPROBE; DEPOSITION; PROBE	An improvement of a depth resolution and a detection efficiency in single-event three-dimensional time-of-flight (TOF) Rutherford backscattering spectrometry (RBS) is discussed on both simulation and experiment by control of secondary electron trajectories using sample bias voltage. The secondary electron, used for a start signal in single-event TOF-RBS, flies more directly to a secondary electron detector with the positive sample bias voltage of several tens of volt than that without sample bias voltage in the simulation. The simulated collection efficiency of the secondary electrons also increases with the positive sample bias voltage of several tens of volt. These simulation results indicate the possibility of a smaller depth resolution and a shorter measurement time in single-event TOF-RBS with positive sample bias voltage. The measurement time for the Pt-stripe sample using single-event three-dimensional TOF-RBS with the sample bias voltage of +100 V is 65% shorter than that without sample bias voltage, resulting in a less sample damage by a probe beam. The depth resolution for the Pt stripes under the 50-nm-thick SiO2 cover-layer with the sample bias voltage of +100 V is 4 nm smaller than that without sample bias voltage. Positive sample bias voltage improves the depth resolution and the detection efficiency in single-event three-dimensional TOF-RBS without an influence on the beam focusing. (C) 2014 Elsevier B.V. All rights reserved.	[Abo, Satoshi; Hamada, Yasuhisa; Seidl, Albert; Wakaya, Fujio; Takai, Mikio] Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan; [Seidl, Albert] Magdeburg Stendal Univ Appl Sci, Engn Sci & Ind Design, D-39114 Magdeburg, Germany	Abo, S (reprint author), Osaka Univ, Grad Sch Engn Sci, 1-3 Machikaneyama, Toyonaka, Osaka 5608531, Japan.	s-abo@stec.es.osaka-u.ac.jp					Abo S, 2011, NUCL INSTRUM METH B, V269, P2233, DOI 10.1016/j.nimb.2011.02.062; Abo S, 2012, NUCL INSTRUM METH B, V273, P266, DOI 10.1016/j.nimb.2011.07.091; Abo S, 2010, NUCL INSTRUM METH B, V268, P2019, DOI 10.1016/j.nimb.2010.02.122; Zolnai Z, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.233302; Kodzuka M, 2009, ULTRAMICROSCOPY, V109, P644, DOI 10.1016/j.ultramic.2008.11.011; Kometani R, 2004, J VAC SCI TECHNOL B, V22, P257, DOI 10.1116/1.1643056; Huszank R, 2009, NUCL INSTRUM METH B, V267, P2132, DOI 10.1016/j.nimb.2009.03.065; Gault B, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2194089; Gustafson J, 2011, SURF SCI, V605, P220, DOI 10.1016/j.susc.2010.10.022; Hajnal Z, 1996, NUCL INSTRUM METH B, V118, P617, DOI 10.1016/0168-583X(96)00245-5; Hayashi K, 2004, NUCL INSTRUM METH B, V219, P589, DOI 10.1016/j.nimb.2004.01.125; Iwasaki K, 2002, NUCL INSTRUM METH B, V190, P296, DOI 10.1016/S0168-583X(01)01319-2; Koops HWP, 2001, MICROELECTRON ENG, V57-8, P995, DOI 10.1016/S0167-9317(01)00565-2; LAKITS G, 1989, REV SCI INSTRUM, V60, P3151, DOI 10.1063/1.1140546; Mimura R, 2003, NUCL INSTRUM METH B, V210, P104, DOI 10.1016/S0168-583X(03)01044-9; Murakami K, 2003, JPN J APPL PHYS 1, V42, P4037, DOI 10.1143/JJAP.42.4037; Murakami K, 2004, J VAC SCI TECHNOL B, V22, P1266, DOI 10.1116/1.1669652; Nguyen NV, 2007, NUCL INSTRUM METH B, V260, P105, DOI 10.1016/j.nimb.2007.01.229; Sorica M.A., 2009, J APPL PHYS, V106; Sortica MA, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4734686; Tajima J, 2001, NUCL INSTRUM METH B, V181, P44, DOI 10.1016/S0168-583X(01)00553-5; Takai M, 2007, NUCL INSTRUM METH B, V261, P466, DOI 10.1016/j.nimb.2007.04.249; Takayama H, 2003, NUCL INSTRUM METH B, V210, P108, DOI 10.1016/S0168-583X(03)01049-8; Thompson K, 2007, SEMICOND SCI TECH, V22, pS127, DOI 10.1088/0268-1242/22/1/S30; Zolnai Z, 2010, NUCL INSTRUM METH B, V268, P79, DOI 10.1016/j.nimb.2009.09.039; Zolnai Z, 2013, APPL SURF SCI, V281, P17, DOI 10.1016/j.apsusc.2013.04.081	26	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-583X	1872-9584		NUCL INSTRUM METH B	Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms	APR 1	2015	348						29	33		10.1016/j.nimb.2014.12.052		5	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical; Physics, Nuclear	Instruments & Instrumentation; Nuclear Science & Technology; Physics	CH6IS	WOS:000354140900007		
J	Ishii, Y; Ohkubo, T; Kamiya, T; Saitoh, Y				Ishii, Yasuyuki; Ohkubo, Takeru; Kamiya, Tomihiro; Saitoh, Yuichi			Beam size reduction of a several hundred-keV compact ion microbeam system by improving the extraction condition in an ion source	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS			English	Article; Proceedings Paper	14th International Conference on Nuclear Microprobe Technology and Applications (ICNMTA) / Workshop on Proton Beam Writing	JUL 07-11, 2014	Padova, ITALY	Ist Nazl Fis Nucl		Ion microbeam; Compact microbeam system; Three-stage acceleration lens	NUCLEAR MICROPROBE; 300 KV; DESIGN; LENS	A several hundred-key compact ion microbeam system with a three-stage acceleration lens has been developed to form an ion beam of several micrometers in diameter. In a previous study of the Ohkubo et al. (2013) and Ishii et al. (2014), a hydrogen beam of 143 keV having 17 mu m diameter was experimentally formed using such a microbeam system. It was demonstrated that a three-stage acceleration lens functioned as a focusing lens and indicated that the beam diameter (hereinafter referred to as the "beam size") depended on the extraction voltage to generate the ion beam and the vacuum pressure in the extraction space in a plasma-type ion source. In this study, the hydrogen beam sizes were experimentally measured at 130 keV as functions of the extraction voltage and vacuum pressure to form the beam size With several micrometers in diameter. These two relationships showed that beam sizes were reduced in the extraction voltage range of 400-500 V and when the vacuum pressure was lowered to a minimum value of 5.33 x 10(-5) Pa. In addition, the result showed that the beam size was dominantly influenced by the vacuum pressure. Consequently, a hydrogen beam 5.8 mu m in diameter was formed experimentally-the smallest beam yet obtained. (C) 2014 Elsevier B.V. All rights reserved.	[Ishii, Yasuyuki; Ohkubo, Takeru; Kamiya, Tomihiro; Saitoh, Yuichi] Japan Atom Energy Agcy, Takasaki, Gunma 3701292, Japan	Ishii, Y (reprint author), Japan Atom Energy Agcy, 1233 Watanuki Machi, Takasaki, Gunma 3701292, Japan.						Ignat'ev IG, 2005, NUCL INSTRUM METH B, V231, P94, DOI 10.1016/j.nimb.2005.01.040; Ishibashi K., 1993, NUCL INSTR METH B, V75, P526; Ishii Y, 2014, NUCL INSTRUM METH B, V332, P156, DOI 10.1016/j.nimb.2014.02.051; Ishii Y, 2011, NUCL INSTRUM METH B, V269, P2193, DOI 10.1016/j.nimb.2011.02.029; KAMIYA T, 1995, NUCL INSTRUM METH B, V104, P43, DOI 10.1016/0168-583X(95)00399-1; Ohkubo T, 2013, AIP CONF PROC, V1525, P370, DOI 10.1063/1.4802353; Takai M, 1996, NUCL INSTRUM METH B, V118, P418, DOI 10.1016/0168-583X(96)00250-9; van der Veen J.F., 1985, SURF SCI REP, V5, P199; van Kan JA, 2011, MICROSYST TECHNOL, V17, P1519, DOI 10.1007/s00542-011-1321-z; van Kan JA, 2007, NUCL INSTRUM METH B, V260, P353, DOI 10.1016/j.nimb.2007.02.046	10	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-583X	1872-9584		NUCL INSTRUM METH B	Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms	APR 1	2015	348						79	82		10.1016/j.nimb.2014.12.011		4	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical; Physics, Nuclear	Instruments & Instrumentation; Nuclear Science & Technology; Physics	CH6IS	WOS:000354140900016		
J	Matsuyama, S; Hamada, N; Ishii, K; Nozawa, Y; Ohkura, S; Terakawa, A; Hatori, Y; Fujiki, K; Fujiwara, M; Toyama, S				Matsuyama, Shigeo; Hamada, Naoki; Ishii, Keizo; Nozawa, Yuichiro; Ohkura, Satoru; Terakawa, Atsuki; Hatori, Yoshinobu; Fujiki, Kota; Fujiwara, Mitsuhiro; Toyama, Sho			In vivo 3D PIXE-micron-CT imaging of Drosophila melanogaster using a contrast agent	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS			English	Article; Proceedings Paper	14th International Conference on Nuclear Microprobe Technology and Applications (ICNMTA) / Workshop on Proton Beam Writing	JUL 07-11, 2014	Padova, ITALY	Ist Nazl Fis Nucl		3D PIXE-micron-CT; Contrast agent; Living Drosophila; Abdominal image		In this study, we developed a three-dimensional (3D) computed tomography (CT) in vivo imaging system for imaging small insects with micrometer resolution. The 3D CT imaging system, referred to as 3D PIXE-micron-CT (PIXE mu CT), uses characteristic X-rays produced by ion microbeam bombardment of a metal target. PIXE mu CT was used to observe the body organs and internal structure of a living Drosophila melanogaster. Although the organs of the thorax were clearly imaged, the digestive organs in the abdominal cavity could not be clearly discerned initially, with the exception of the rectum and the Malpighian tubule. To enhance the abdominal images, a barium sulfate powder radiocontrast agent was added. For the first time, 3D images of the ventriculus of a living D. melanogaster were obtained. Our results showed that PIXE mu CT can provide in vivo 3D-CT images that reflect correctly the structure of individual living organs, which is expected to be very useful in biological research. (C) 2014 Elsevier B.V. All rights reserved.	[Matsuyama, Shigeo; Hamada, Naoki; Ishii, Keizo; Nozawa, Yuichiro; Ohkura, Satoru; Terakawa, Atsuki; Hatori, Yoshinobu; Fujiki, Kota; Fujiwara, Mitsuhiro; Toyama, Sho] Tohoku Univ, Dept Quantum Sci & Energy Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan	Matsuyama, S (reprint author), Tohoku Univ, Dept Quantum Sci & Energy Engn, Aoba Ku, Aramaki Aza Aoba 01, Sendai, Miyagi 9808579, Japan.						Calhoun PS, 1999, RADIOGRAPHICS, V19, P745; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; Ishii K, 2007, NUCL INSTRUM METH A, V571, P64, DOI 10.1016/j.nima.2006.10.030; Ishii K., 2005, INT J PIXE, V15, P111, DOI 10.1142/S0129083505000416; Ishii K, 2006, NUCL INSTRUM METH B, V249, P726, DOI 10.1016/j.nimb.2006.03.127; Kawamura Y., 2009, INT J PIXE, V19, P29; Kawamura Y., 2007, INT J PIXE, V17, P29; Matsuyama S., 2011, INT J PIXE, V21, P87; Matsuyama S., 2005, INT J PIXE, V15, P41, DOI 10.1142/S0129083505000283; Matsuyama S., 2004, INT J PIXE, V14, P1, DOI 10.1142/S0129083504000033; Matsuyama S, 2003, NUCL INSTRUM METH B, V210, P59, DOI 10.1016/S0168-583X(03)01014-0; Matsuyama S, 2007, NUCL INSTRUM METH B, V260, P55, DOI 10.1016/j.nimb.2007.01.277; Ohkura S, 2011, X-RAY SPECTROM, V40, P191, DOI 10.1002/xrs.1306; Okura S., 2005, INT J PIXE, V18, P167; Paarashar V., 2008, RADIAT RES, V169, P707; WALLIS JW, 1989, IEEE T MED IMAGING, V8, P297, DOI 10.1109/42.41482; Yamaguchi T., 2005, INT J PIXE, V15, P195, DOI 10.1142/S0129083505000519	17	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-583X	1872-9584		NUCL INSTRUM METH B	Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms	APR 1	2015	348						123	126		10.1016/j.nimb.2014.11.039		4	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical; Physics, Nuclear	Instruments & Instrumentation; Nuclear Science & Technology; Physics	CH6IS	WOS:000354140900025		
J	Puttaraksa, N; Mackel, V; Kobayashi, T; Kojima, TM; Hamagaki, M; Imamoto, N; Yamazaki, Y				Puttaraksa, Nitipon; Maeckel, Volkhard; Kobayashi, Tomohiro; Kojima, Takao M.; Hamagaki, Manabu; Imamoto, Naoko; Yamazaki, Yasunori			Irradiation of Fucci-expressing HeLa cells using a tapered glass capillary microbeam	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS			English	Article; Proceedings Paper	14th International Conference on Nuclear Microprobe Technology and Applications (ICNMTA) / Workshop on Proton Beam Writing	JUL 07-11, 2014	Padova, ITALY	Ist Nazl Fis Nucl		Microbeam; Tapered glass capillary; Cell irradiation; Fucci-expressing HeLa cells	LIVING CELLS; ION; SYSTEM	Fluorescent, ubiquitination-based cell cycle indicator-expressing HeLa cells have been irradiated with a microbeam set-up at RIKEN for examining the effect to cell cycle after bombarding with protons of 1 MeV incident energy. Here, single cells were exposed in their nucleus with different doses (100, 1000, 10,000 and 100,000 protons). Subsequently, the cells were monitored using time-lapse microscopy after irradiation. In this paper, we present the preliminary results for such irradiation for 8 cells. The irradiated cells with up to 10,000 protons. showed the change in fluorescence from red to green. This indicates that the transformation from G(1) to S/G(2) in cell cycle seemed not to be affected by the irradiation up to 10,000 protons. However, the irradiated cell with 100,000 protons died in red fluorescence at similar to 4 h after the irradiation. (C) 2014 Elsevier B.V. All rights reserved.	[Puttaraksa, Nitipon; Maeckel, Volkhard; Kobayashi, Tomohiro; Kojima, Takao M.; Hamagaki, Manabu; Yamazaki, Yasunori] RIKEN, Atom Phys Lab, Wako, Saitama 3510198, Japan; [Imamoto, Naoko] RIKEN, Cellular Dynam Lab, Wako, Saitama 3510198, Japan	Puttaraksa, N (reprint author), RIKEN, Atom Phys Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	nitipon.puttaraksa@riken.jp					Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Hable V, 2009, NUCL INSTRUM METH B, V267, P2090, DOI 10.1016/j.nimb.2009.03.071; Konishi T, 2013, J RADIAT RES, V54, P736, DOI 10.1093/jrr/rrs132; Nebiki T, 2003, J VAC SCI TECHNOL A, V21, P1671, DOI 10.1116/1.1597889; Hauptner A, 2004, RADIAT ENVIRON BIOPH, V42, P237, DOI 10.1007/s00411-003-0222-7; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Heiss M, 2006, RADIAT RES, V165, P231, DOI 10.1667/RR3495.1; Barberet P, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1823551; Greif KD, 2004, NUCL INSTRUM METH B, V217, P505, DOI 10.1016/j.nimb.2003.11.082; Iwai Y, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2834695; Kirkby KJ, 2007, NUCL INSTRUM METH B, V260, P97, DOI 10.1016/j.nimb.2007.01.281; Kobayashi Y, 2009, J RADIAT RES, V50, pA29, DOI 10.1269/jrr.09009S; Mackel V, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4859499; Moretto P, 2001, NUCL INSTRUM METH B, V181, P104, DOI 10.1016/S0168-583X(01)00624-3; Randers-Pehrson G, 2009, NUCL INSTRUM METH A, V609, P294, DOI 10.1016/j.nima.2009.08.041; Reinert T, 2004, NUCL INSTRUM METH B, V219, P77, DOI 10.1016/j.nimb.2004.01.031; Salmon ED, 2007, METHOD CELL BIOL, V81, P335, DOI 10.1016/S0091-679X(06)81016-2; Scholz M, 1989, Adv Space Res, V9, P91, DOI 10.1016/0273-1177(89)90426-2; Ziegler J. F., SRIM 2013	19	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-583X	1872-9584		NUCL INSTRUM METH B	Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms	APR 1	2015	348						127	130		10.1016/j.nimb.2014.11.037		4	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical; Physics, Nuclear	Instruments & Instrumentation; Nuclear Science & Technology; Physics	CH6IS	WOS:000354140900026		
J	Yamamoto, H; Iwami, Y; Yagi, K; Hayashi, M; Komatsu, H; Okuyama, K; Matsuda, Y; Yasuda, K				Yamamoto, H.; Iwami, Y.; Yagi, K.; Hayashi, M.; Komatsu, H.; Okuyama, K.; Matsuda, Y.; Yasuda, K.			Evaluation of caries progression in dentin treated by fluoride-containing materials using an in-air micro-PIGE and micro-PIXE measurement system	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS			English	Article; Proceedings Paper	14th International Conference on Nuclear Microprobe Technology and Applications (ICNMTA) / Workshop on Proton Beam Writing	JUL 07-11, 2014	Padova, ITALY	Ist Nazl Fis Nucl		PIGE; PIXE; Fluoride; Human tooth; Caries progression	HUMAN ENAMEL; VIVO	It is well-known that fluorine (F) is involved in the progression of caries. The evaluation of caries progression has conventionally been based on the change in mineral content using transverse microradiography (TMR). The purpose of this study was to evaluate the progression of dentinal caries by the change in calcium (Ca) content using Particle-Induced Gamma-ray Emission/Particle-Induced X-ray Emission (PIGE/PIXE) techniques at the Wakasa Wan Energy Research Center. We also assessed the relationship between caries progression rate and the concentration of F penetration into dentin from dental fluoride-containing materials (FCMs). Dentin sections of six extracted human teeth were prepared to obtain various amounts of F uptake using three types of FCMs. F and Ca distribution of specimens were obtained using PIGE/PIXE techniques. After evaluation, the specimens were immersed in 10 ml of demineralizing solution (pH 4.5) to simulate caries attack. To estimate caries progression rates, the same portions of the specimens were evaluated after caries attack treatment using PIGE/PIXE. A negative correlation between the F uptake in dentin and the rate of caries progression was observed. Therefore, caries progression in dentin was reduced by increasing the amount of F uptake from FCMs. This demonstrates that PIGE/PIXE techniques are valuable for estimating caries progression rates. (C) 2015 Elsevier B.V. All rights reserved.	[Yamamoto, H.; Iwami, Y.; Yagi, K.; Hayashi, M.] Osaka Univ, Dept Restorat Dent & Endodontol, Grad Sch Dent, Suita, Osaka 5650871, Japan; [Komatsu, H.; Okuyama, K.; Matsuda, Y.] Hokkaido Univ, Grad Sch Dent Med, Kita Ku, Sapporo, Hokkaido 0608586, Japan; [Yasuda, K.] Wakasa Wan Energy Res Ctr, Tsuruga, Fukui 9140192, Japan	Yamamoto, H (reprint author), Osaka Univ, Dept Restorat Dent & Endodontol, Grad Sch Dent, 1-8 Yamada Oka, Suita, Osaka 5650871, Japan.	yhiroko@dent.osaka-u.ac.jp					Fejerskov O, 2004, CARIES RES, V38, P182, DOI 10.1159/000077753; Yamazaki H, 2007, ARCH ORAL BIOL, V52, P110, DOI 10.1016/j.archoralbio.2006.08.012; Burke FM, 2006, INT DENT J, V56, P33; Komatsu H, 2007, NUCL INSTRUM METH B, V260, P201, DOI 10.1016/j.nimb.2007.02.068; Komatsu H, 2009, NUCL INSTRUM METH B, V267, P2136, DOI 10.1016/j.nimb.2009.03.081; Komatsu H., 2011, JAEAI REV, V2011-043, P85; Matsuda Y, 2006, DENT MATER J, V25, P280; Matsuda Y, 2007, DENT MATER J, V26, P414; MUKAI M, 1993, ARCH ORAL BIOL, V38, P1093; SKARTVEIT L, 1990, J DENT CHILD, V57, P97; PHILLIPS R W, 1957, J Am Dent Assoc, V54, P623; ten Cate JM, 2004, CARIES RES, V38, P254, DOI 10.1159/000077763; Wang NJ, 1999, ACTA ODONTOL SCAND, V57, P342, DOI 10.1080/000163599428599; Yamamoto H, 2000, OPER DENT, V25, P104; Yamamoto H, 2001, CARIES RES, V35, P111, DOI 10.1159/000047441; Yamamoto H., 2009, INT J PIXE, V21, P31; Yasuda K, 2007, NUCL INSTRUM METH B, V260, P207, DOI 10.1016/j.nimb.2007.02.109; Yasuda K, 2011, NUCL INSTRUM METH B, V269, P2180, DOI 10.1016/j.nimb.2011.02.026	18	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-583X	1872-9584		NUCL INSTRUM METH B	Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms	APR 1	2015	348						152	155		10.1016/j.nimb.2015.01.068		4	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical; Physics, Nuclear	Instruments & Instrumentation; Nuclear Science & Technology; Physics	CH6IS	WOS:000354140900031		
J	Yasuhiro, M; Katsushi, O; Hiroko, Y; Hisanori, K; Masashi, K; Takahiro, S; Naoki, H; Saiko, O; Chiharu, K; Hidehiko, S				Yasuhiro, Matsuda; Katsushi, Okuyama; Hiroko, Yamamoto; Hisanori, Komatsu; Masashi, Koka; Takahiro, Sato; Naoki, Hashimoto; Saiko, Oki; Chiharu, Kawamoto; Hidehiko, Sano			Fluorine uptake into the human enamel surface from fluoride-containing sealing materials during cariogenic pH cycling	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS			English	Article; Proceedings Paper	14th International Conference on Nuclear Microprobe Technology and Applications (ICNMTA) / Workshop on Proton Beam Writing	JUL 07-11, 2014	Padova, ITALY	Ist Nazl Fis Nucl		Fluoride uptake; Fluoride containing materials; Microbeam; PIGE/PIXE system	DEMINERALIZATION; SYSTEM	To prevent the formation of caries and reduce dentin hypersensitivity, sealing materials, either with or without fluoride, are generally applied on the tooth in clinical practice. Application of-fluoride-free sealing materials results in the formation of an acid-resistant layer on the tooth surface. On the other hand, fluoride-containing sealing materials might not only form an acid-resistant layer but could possibly further provide fluoride to enhance remineralization and reduce demineralization. In this study, the demineralization prevention ability and fluorine uptake rate in human enamel of fluoride-containing sealing materials ["MS coats F" (MSF)] and fluoride-free sealing materials ("hybrid coats 2" [HI]) were evaluated using an automatic pH cycling system. Each material was applied to the original tooth surface, the cut surfaces were covered with sticky wax, and the automatic pH-cycling system simulated daily acid changes (pH 6.8-4.5) occurring in the oral cavity for 4 weeks. Caries progresion was analyzed using transverse microradiography (TMR) taken pre and post the 4 weeks of pH cycling. The fluorine and calcium distributions in the carious lesion in each specimen were evaluated using the proton-induced gamma emission (PIGE) and proton-induced X-ray (PIXE) techniques, respectively. TMR analysis showed that both MSF and HI had a caries-preventing effect after 4 weeks of pH cycling. PIGE/PIXE analysis demonstrated that only MSF resulted in fluoride uptake in the enamel surface. Therefore, MSF can help to form an acid-resistant layer and provide fluoride to the enamel surface. The presence of fluoride on the enamel surface suggested that MSF could prevent demineralization, even if the acid-resistant layer was removed, in clinical settings. The data obtained using the PIGE and PIXE techniques are useful for understanding the benefits of the use of a fluoride-containing sealing material for preventing caries. (C) 2015 Elsevier B.V. All rights reserved.	[Yasuhiro, Matsuda; Katsushi, Okuyama; Hisanori, Komatsu; Naoki, Hashimoto; Saiko, Oki; Chiharu, Kawamoto; Hidehiko, Sano] Hokkaido Univ, Grad Sch Dent Med, Dept Restorat Dent, Sapporo, Hokkaido 0608586, Japan; [Hiroko, Yamamoto] Osaka Univ, Grad Sch Dent, Suita, Osaka 565, Japan; [Masashi, Koka; Takahiro, Sato] JAEA, Takasaki Adv Radiat Res Inst, Tokai, Ibaraki, Japan	Yasuhiro, M (reprint author), Hokkaido Univ, Grad Sch Dent Med, Dept Restorat Dent, Div Oral Hlth Sci,Kita Ku, Kita 13,Nishi 7, Sapporo, Hokkaido 0608586, Japan.	matsuda@den.hokudai.ac.jp	matsuda, yasuhiro/A-4832-2012	matsuda, yasuhiro/0000-0002-8358-9089			ALMQVIST H, 1993, CARIES RES, V27, P100; ANGMAR B, 1963, J ULTRA MOL STRUCT R, V8, P12, DOI 10.1016/S0022-5320(63)80017-9; ARENDS J, 1992, J DENT RES, V71, P924; Wendell S, 2010, J DENT RES, V89, P1198, DOI 10.1177/0022034510381502; Komatsu H, 2007, NUCL INSTRUM METH B, V260, P201, DOI 10.1016/j.nimb.2007.02.068; Komatsu H, 2009, NUCL INSTRUM METH B, V267, P2136, DOI 10.1016/j.nimb.2009.03.081; Komatsu H, 2011, NUCL INSTRUM METH B, V269, P2274, DOI 10.1016/j.nimb.2011.02.042; Matsuda Y, 2006, DENT MATER J, V25, P280; Matsuda Y, 2007, DENT MATER J, V26, P414; Oki S., 2013, J DENT RES, V92, P140; Sakai T, 2002, NUCL INSTRUM METH B, V190, P271, DOI 10.1016/S0168-583X(02)00469-X; STEPHAN R. M., 1940, JOUR AMER DENTAL ASSOC, V27, P718	12	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-583X	1872-9584		NUCL INSTRUM METH B	Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms	APR 1	2015	348						156	159		10.1016/j.nimb.2015.01.062		4	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical; Physics, Nuclear	Instruments & Instrumentation; Nuclear Science & Technology; Physics	CH6IS	WOS:000354140900032		
J	Kada, W; Miura, K; Kato, H; Saruya, R; Kubota, A; Satoh, T; Koka, M; Ishii, Y; Kamiya, T; Nishikawa, H; Hanaizumi, O				Kada, W.; Miura, K.; Kato, H.; Saruya, R.; Kubota, A.; Satoh, T.; Koka, M.; Ishii, Y.; Kamiya, T.; Nishikawa, H.; Hanaizumi, O.			Development of embedded Mach-Zehnder optical waveguide structures in polydimethylsiloxane thin films by proton beam writing	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS			English	Article; Proceedings Paper	14th International Conference on Nuclear Microprobe Technology and Applications (ICNMTA) / Workshop on Proton Beam Writing	JUL 07-11, 2014	Padova, ITALY	Ist Nazl Fis Nucl		Proton beam writing; Polydimethylsiloxane; Mach-Zehnder optical waveguide; Interferometer; Embedded structures	RESIST MATERIALS; ION-BEAM; FABRICATION; PDMS; RESOLUTION; SYSTEM	A focused 750 key proton microbeam was used to fabricate an embedded Mach-Zehnder (MZ) optical waveguide in a polydimethylsiloxane (PDMS) film for interferometer application. The sample position was precisely controlled by a mechanical stage together with scanning microbeam to form an embedded MZ waveguide structure within an area of 0.3 mm x 40 mm. The MZ waveguides with core size of 8 mu m was successfully embedded in PDMS film at a depth of 18 mu m by 750 keV proton microbeam with fluences from 10 to 100 nC/mm(2). The MZ waveguides were coupled with an IR fiber-laser with a center wavelength of 1550 nm and evaluated by using the transmitted intensity images from an IR vidicon camera. The results indicate that the embedded MZ waveguide structure in PDMS achieved single spot light propagation, which is necessary for building optical switching circuits based on polymer MZ waveguides. (C) 2014 Elsevier B.V. All rights reserved.	[Kada, W.; Miura, K.; Saruya, R.; Kubota, A.; Hanaizumi, O.] Gunma Univ, Grad Sch Sci & Technol, Kiryu, Gumma 3768515, Japan; [Kato, H.; Nishikawa, H.] Shibaura Inst Technol, Dept Elect Engn, Koto Ku, Tokyo 1358548, Japan; [Satoh, T.; Koka, M.; Ishii, Y.; Kamiya, T.] Japan Atom Energy Agcy, Takasaki Adv Radiat Res Inst, Takasaki, Gumma 3701292, Japan	Kada, W (reprint author), Gunma Univ, Grad Sch Sci & Technol, 1-5-1 Tenjincho, Kiryu, Gumma 3768515, Japan.	kada.wataru@gunma-u.acjp					SELIGER RL, 1979, J VAC SCI TECHNOL, V16, P1610, DOI 10.1116/1.570253; van Kan JA, 2003, APPL PHYS LETT, V83, P1629, DOI 10.1063/1.1604468; Bettiol AA, 2006, J CRYST GROWTH, V288, P209, DOI 10.1016/j.jcrysgro.2005.12.053; Dutta RK, 2007, NUCL INSTRUM METH B, V260, P464, DOI 10.1016/j.nimb.2007.02.064; Hanaizumi O, 2011, KEY ENG MATER, V459, P153, DOI 10.4028/www.scientific.net/KEM.459.153; Hiratani Y., 2005, IEICE TECH REP, V104, P13; Huszank R, 2010, OPT COMMUN, V283, P176, DOI 10.1016/j.optcom.2009.09.066; Kada W, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.06FB07; KAMIYA T, 1995, NUCL INSTRUM METH B, V104, P43, DOI 10.1016/0168-583X(95)00399-1; Kamiya T, 2009, APPL RADIAT ISOTOPES, V67, P488, DOI 10.1016/j.apradiso.2008.06.021; Miura K, 2014, KEY ENG MATER, V596, P134, DOI 10.4028/www.scientific.net/KEM.596.134; Miura K, 2012, KEY ENG MATER, V497, P147, DOI 10.4028/www.scientific.net/KEM.497.147; Miura K, 2013, KEY ENG MATER, V534, P158, DOI 10.4028/www.scientific.net/KEM.534.158; Nishikawa H, 2009, J PHOTOPOLYM SCI TEC, V22, P239, DOI 10.2494/photopolymer.22.239; Saito K, 2013, NUCL INSTRUM METH B, V306, P284, DOI 10.1016/j.nimb.2012.12.032; Sakai T, 2013, NUCL INSTRUM METH B, V306, P299, DOI 10.1016/j.nimb.2012.10.030; Sakai T, 1998, NUCL INSTRUM METH B, V136, P390, DOI 10.1016/S0168-583X(97)00862-8; Sum TC, 2003, NUCL INSTRUM METH B, V210, P266, DOI 10.1016/S0168-583X(03)01028-0; Szilasi Szabolcs Zoltan, 2011, Applied Surface Science, V257, DOI 10.1016/j.apsusc.2010.12.095; Szilasi SZ, 2011, MATER CHEM PHYS, V131, P370, DOI 10.1016/j.matchemphys.2011.09.058; Szilasi SZ, 2011, MICROELECTRON ENG, V88, P2885, DOI 10.1016/j.mee.2011.03.007; Uchiya N, 2007, NUCL INSTRUM METH B, V260, P405, DOI 10.1016/j.nimb.2007.02.053; Uchiya N, 2008, MICROSYST TECHNOL, V14, P1537, DOI 10.1007/s00542-007-0549-0; Udalagama C. N. B., 2008, P SOC PHOTO-OPT INS, V6882; van Kan J. A., 2012, BIOMICROFLUIDICS, V6; van Kan JA, 1999, NUCL INSTRUM METH B, V158, P179, DOI 10.1016/S0168-583X(99)00392-4; van Kan JA, 2014, APPL SURF SCI, V310, P100, DOI 10.1016/j.apsusc.2014.04.147; Watanabe K., 2010, NTT TECH REV, V8, P1; Watt F., 2005, INT J NANOSCI, V4, P269, DOI 10.1142/S0219581X05003139; Ziegler J. F., 1985, STOPPING RANGE IONS	30	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-583X	1872-9584		NUCL INSTRUM METH B	Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms	APR 1	2015	348						218	222		10.1016/j.nimb.2014.12.041		5	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical; Physics, Nuclear	Instruments & Instrumentation; Nuclear Science & Technology; Physics	CH6IS	WOS:000354140900045		
J	Pastuovic, Z; Capan, I; Cohen, DD; Forneris, J; Iwamoto, N; Ohshima, T; Siegele, R; Hoshino, N; Tsuchida, H				Pastuovic, Zeljko; Capan, Ivana; Cohen, David D.; Forneris, Jacopo; Iwamoto, Naoya; Ohshima, Takeshi; Siegele, Rainer; Hoshino, Norihiro; Tsuchida, Hidekazu			Radiation hardness of n-type SiC Schottky barrier diodes irradiated with MeV He ion microbeam	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS			English	Article; Proceedings Paper	14th International Conference on Nuclear Microprobe Technology and Applications (ICNMTA) / Workshop on Proton Beam Writing	JUL 07-11, 2014	Padova, ITALY	Ist Nazl Fis Nucl		Silicon carbide; CCE; Ion radiation effects; Radiation hardness; Deep defects	DEEP-LEVEL DEFECTS; 4H SILICON-CARBIDE; ELECTRON-IRRADIATION; ADVANCED POWER; SOLAR-CELLS; DEVICES; PROTON; TEMPERATURE; BEHAVIOR; LAYERS	We studied the radiation hardness of 4H-SiC Schottky barrier diodes (SBD) for the light ion detection and spectroscopy in harsh radiation environments. n-Type SBD prepared on nitrogen-doped (similar to 4 x 10(14) cm(-3)) epitaxial grown 4H-SiC thin wafers have been irradiated by a raster scanning alpha particle microbeam (2 and 4 MeV He2+ ions separately) in order to create patterned damage structures at different depths within a sensitive volume of tested diodes. Deep Level Transient Spectroscopy (DLTS) analysis revealed the formation of two deep electron traps in the irradiated and not thermally treated 4H-SiC within the ion implantation range (E1 and E2). The E2 state resembles the well-known Z(1/2) center, while the E1 state could not be assigned to any particular defect reported in the literature. Ion Beam Induced Charge (IBIC) microscopy with multiple He ion probe microbeams (1-6 MeV) having different penetration depths in tested partly damaged 4H-SiC SBD has been used to determine the degradation of the charge collection efficiency (CCE) over a wide fluence range of damaging alpha particle. A non-linear behavior of the CCE decrease and a significant degradation of the spectroscopic performance with increasing He ion fluence were observed above the value of 10(11) cm(-2). (C) 2015 Published by Elsevier B.V.	[Pastuovic, Zeljko; Cohen, David D.; Siegele, Rainer] Australian Nucl Sci & Technol Org, Kirrawee Dc, NSW 2232, Australia; [Capan, Ivana] Inst Rudjer Boskov, Div Mat Phys, Zagreb 10000, Croatia; [Forneris, Jacopo] Univ Torino, Dept Phys, I-10125 Turin, Italy; [Forneris, Jacopo] Univ Torino, NIS Excellence Ctr, I-10125 Turin, Italy; [Iwamoto, Naoya; Ohshima, Takeshi] Japan Atom Energy Agcy, Takasaki, Gunma 3701292, Japan; [Hoshino, Norihiro; Tsuchida, Hidekazu] Cent Res Inst Elect Power Ind, Yokosuka, Kanagawa 2400196, Japan	Pastuovic, Z (reprint author), Australian Nucl Sci & Technol Org, Locked Bag 2001, Kirrawee Dc, NSW 2232, Australia.	zkp@ansto.gov.au	Forneris, Jacopo/K-6294-2013; 	Forneris, Jacopo/0000-0003-2583-7424; Cohen, David/0000-0002-1209-9234			Castaldini A, 2005, J APPL PHYS, V98, DOI 10.1063/1.2014941; Wondrak W, 2001, IEEE T IND ELECTRON, V48, P307, DOI 10.1109/41.915409; Nava F, 2008, MEAS SCI TECHNOL, V19, DOI 10.1088/0957-0233/19/10/102001; Alfieri G, 2005, J APPL PHYS, V98, DOI 10.1063/1.2009816; Son NT, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.187603; Chason E, 1997, J APPL PHYS, V81, P6513, DOI 10.1063/1.365193; Ito M, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.015001; Lovlie LS, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3531755; Nava F, 2006, IEEE T NUCL SCI, V53, P2977, DOI 10.1109/TNS.2006.882777; Itoh A, 1997, PHYS STATUS SOLIDI A, V162, P389, DOI 10.1002/1521-396X(199707)162:1<389::AID-PSSA389>3.0.CO;2-X; Hemmingsson C, 1997, J APPL PHYS, V81, P6155, DOI 10.1063/1.364397; Nava F, 2003, NUCL INSTRUM METH A, V505, P645, DOI 10.1016/S0168-9002(02)01558-9; Dobaczewski L, 2004, J APPL PHYS, V96, P4689, DOI 10.1063/1.1794897; Storasta L, 2004, J APPL PHYS, V96, P4909, DOI 10.1063/1.1778819; Brown D.M., 1996, SOLID STATE ELECT, V39, P1541; Dalibor T, 1997, DIAM RELAT MATER, V6, P1333, DOI 10.1016/S0925-9635(97)00108-8; Dharmarasu N, 2002, APPL PHYS LETT, V81, P64, DOI 10.1063/1.1491005; Hazdra P, 2013, MATER SCI FORUM, V740-742, P661, DOI 10.4028/www.scientific.net/MSF.740-742.661; Iwamoto N, 2013, J APPL PHYS, V113, DOI 10.1063/1.4801797; Izzo G, 2010, NUCL INSTRUM METH B, V268, P2964, DOI 10.1016/j.nimb.2010.05.018; Kawahara K, 2014, J APPL PHYS, V115, DOI 10.1063/1.4871076; Lee KK, 2003, NUCL INSTRUM METH B, V210, P489, DOI 10.1016/S0168-583X(03)01096-6; Leroy C, 2007, REP PROG PHYS, V70, P493, DOI 10.1088/0034-4885/70/4/R01; Moore T, 1997, EPRI J, V22, P30; Ohshima T, 2013, SOL ENERG MAT SOL C, V108, P263, DOI 10.1016/j.solmat.2012.09.027; Pastuovic Z, 2009, IEEE T NUCL SCI, V56, P2457, DOI 10.1109/TNS.2009.2023123; Pastuovic Z, 2014, NUCL INSTRUM METH B, V332, P298, DOI 10.1016/j.nimb.2014.02.082; Pastuovic Z, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3559000; Pelaz L, 2009, EUR PHYS J B, V72, P323, DOI 10.1140/epjb/e2009-00378-9; Roccaforte F, 2006, J APPL PHYS, V99, DOI 10.1063/1.2158501; Ryu SH, 2001, IEEE ELECTR DEVICE L, V22, P127, DOI 10.1109/55.910618; Siegele R, 2009, NUCL INSTRUM METH B, V267, P2054, DOI 10.1016/j.nimb.2009.03.020; Strokan NB, 2006, NUCL INSTRUM METH A, V569, P758, DOI 10.1016/j.nima.2006.08.077; Vittone E., 2013, MAT SCI, V2013; Vittone E., F11016 IAEA CRP; Zamboni I, 2013, DIAM RELAT MATER, V31, P65, DOI 10.1016/j.diamond.2012.11.002	36	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-583X	1872-9584		NUCL INSTRUM METH B	Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms	APR 1	2015	348						233	239		10.1016/j.nimb.2014.12.064		7	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical; Physics, Nuclear	Instruments & Instrumentation; Nuclear Science & Technology; Physics	CH6IS	WOS:000354140900048		
J	Kada, W; Kambayashi, Y; Iwamoto, N; Onoda, S; Makino, T; Koka, M; Kamiya, T; Hoshino, N; Tsuchida, H; Kojima, K; Hanaizumi, O; Ohshima, T				Kada, Wataru; Kambayashi, Yuya; Iwamoto, Naoya; Onoda, Shinobu; Makino, Takahiro; Koka, Masashi; Kamiya, Tomihiro; Hoshino, Norihiro; Tsuchida, Hidekazu; Kojima, Kazutoshi; Hanaizumi, Osamu; Ohshima, Takeshi			Development of diagnostic method for deep levels in semiconductors using charge induced by heavy ion microbeams	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS			English	Article; Proceedings Paper	14th International Conference on Nuclear Microprobe Technology and Applications (ICNMTA) / Workshop on Proton Beam Writing	JUL 07-11, 2014	Padova, ITALY	Ist Nazl Fis Nucl		Heavy Ion Charge Transient Spectroscopy (HIQTS); Heavy ion microbeams; Deep levels; Silicon Carbide (SiC)	TRANSIENT SPECTROSCOPY; ELECTRON-IRRADIATION; SOLAR-CELLS; GAAS; DEFECTS; LAYERS; TIARA	In order to study defects that create deep energy levels in semiconductors which act as carrier traps, Charge Transient Spectroscopy using heavy ion microbeams (HIQTS) was developed at JAEA Takasaki. The HIQTS system was connected with the heavy ion microbeam line of the 3 MV Tandem accelerator. Using the HIQTS system, deep levels in 4H-SiC Schottky barrier diodes irradiated with 3 MeV-protons were studied. As a result, a HIQTS peak with an activation energy of 0.73 eV was observed. In addition, local damage in 6H-SiC pn diodes partially irradiated with 12 MeV-O ion microbeams was studied using HIQTS. With increasing 12 MeV-O ion fluence, charge collection efficiency in locally damaged areas decreased and HIQTS signals increased. (C) 2015 Elsevier B.V. All rights reserved.	[Kada, Wataru; Kambayashi, Yuya; Hanaizumi, Osamu] Gunma Univ, Fac Sci & Technol, Kiryu, Gunma 3768515, Japan; [Kambayashi, Yuya; Iwamoto, Naoya; Onoda, Shinobu; Makino, Takahiro; Koka, Masashi; Kamiya, Tomihiro; Ohshima, Takeshi] Japan Atom Energy Agcy, Takasaki, Gunma 3701292, Japan; [Hoshino, Norihiro; Tsuchida, Hidekazu] Cent Res Inst Elect Power Ind, Yokosuka, Kanagawa 2400196, Japan; [Kojima, Kazutoshi] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan	Ohshima, T (reprint author), Japan Atom Energy Agcy, 1233 Watanuki, Takasaki, Gunma 3701292, Japan.	ohshima.takeshi20@jaea.go.jp					Sasaki S, 2011, J APPL PHYS, V109, DOI 10.1063/1.3528124; Yamaguchi M, 2001, SOL ENERG MAT SOL C, V68, P31, DOI 10.1016/S0927-0248(00)00344-5; Alfieri G, 2005, J APPL PHYS, V98, DOI 10.1063/1.2009816; Son NT, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.187603; Khanna SM, 2004, IEEE T NUCL SCI, V51, P3585, DOI 10.1109/TNS.2004.839105; Dalibor T, 1997, PHYS STATUS SOLIDI A, V162, P199, DOI 10.1002/1521-396X(199707)162:1<199::AID-PSSA199>3.0.CO;2-0; LANG DV, 1974, J APPL PHYS, V45, P3023, DOI 10.1063/1.1663719; Negoro Y, 2004, J APPL PHYS, V96, P224, DOI 10.1063/1.1756213; Hemmingsson C, 1997, J APPL PHYS, V81, P6155, DOI 10.1063/1.364397; Storasta L, 2004, J APPL PHYS, V96, P4909, DOI 10.1063/1.1778819; Beyer FC, 2010, PHYS STATUS SOLIDI-R, V4, P227, DOI 10.1002/pssr.201004249; Beyer F.C., 2012, J PHYS D, V45; Borsuk J.A., 1980, IEEE T ELECTRON DEV, V17, P2217; Chow T.P., 2000, MAT RES SOC S, V622; Danno K., 2006, J APPL PHYS, V100; Friedrich P., 2010, SILICON CARBIDE, V2; HURTES C, 1978, APPL PHYS LETT, V32, P821, DOI 10.1063/1.89929; Ito M., 2008, APPL PHYS EXPRESS, V1; Iwamoto N, 2013, J APPL PHYS, V113, DOI 10.1063/1.4801797; Iwamoto N, 2011, IEEE T NUCL SCI, V58, P3328, DOI 10.1109/TNS.2011.2167631; Kamiya T, 2004, NUCL INSTRUM METH B, V219, P1010, DOI 10.1016/j.nimb.2004.01.205; Kamiya T, 1997, NUCL INSTRUM METH B, V130, P285, DOI 10.1016/S0168-583X(97)00221-8; Laird JS, 1999, NUCL INSTRUM METH B, V158, P464, DOI 10.1016/S0168-583X(99)00329-8; Laird JS, 2006, J PHYS D APPL PHYS, V39, P1342, DOI 10.1088/0022-3727/39/7/003; Laird JS, 2006, J PHYS D APPL PHYS, V39, P1352, DOI 10.1088/0022-3727/39/7/004; LANG DV, 1976, J APPL PHYS, V47, P3587, DOI 10.1063/1.323161; Ohshima T., 2012, RAD RESPONSE SILICON, P379; Ohshima T, 2013, SOL ENERG MAT SOL C, V108, P263, DOI 10.1016/j.solmat.2012.09.027; Onoda S, 2009, IEEE T NUCL SCI, V56, P3218, DOI 10.1109/TNS.2009.2032395; Sakai T, 1997, NUCL INSTRUM METH B, V130, P498, DOI 10.1016/S0168-583X(97)00240-1; Ziegler J.F., 2008, STOPPING RANGE IONS	31	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-583X	1872-9584		NUCL INSTRUM METH B	Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms	APR 1	2015	348						240	245		10.1016/j.nimb.2014.12.054		6	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical; Physics, Nuclear	Instruments & Instrumentation; Nuclear Science & Technology; Physics	CH6IS	WOS:000354140900049		
J	Nishimuro, H; Ohnishi, H; Sato, M; Ohnishi-Kameyama, M; Matsunaga, I; Naito, S; Ippoushi, K; Oike, H; Nagata, T; Akasaka, H; Saitoh, S; Shimamoto, K; Kobori, M				Nishimuro, Haruno; Ohnishi, Hirofumi; Sato, Midori; Ohnishi-Kameyama, Mayumi; Matsunaga, Izumi; Naito, Shigehiro; Ippoushi, Katsunari; Oike, Hideaki; Nagata, Tadahiro; Akasaka, Hiroshi; Saitoh, Shigeyuki; Shimamoto, Kazuaki; Kobori, Masuko			Estimated Daily Intake and Seasonal Food Sources of Quercetin in Japan	NUTRIENTS			English	Article							ONION ALLIUM-CEPA; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; DIETARY FLAVONOIDS; GENE-EXPRESSION; MICE; MORTALITY; OBESITY; CANCER; COHORT	Quercetin is a promising food component, which can prevent lifestyle related diseases. To understand the dietary intake of quercetin in the subjects of a population-based cohort study and in the Japanese population, we first determined the quercetin content in foods available in the market during June and July in or near a town in Hokkaido, Japan. Red leaf lettuce, asparagus, and onions contained high amounts of quercetin derivatives. We then estimated the daily quercetin intake by 570 residents aged 20-92 years old in the town using a food frequency questionnaire (FFQ). The average and median quercetin intakes were 16.2 and 15.5 mg day(-1), respectively. The quercetin intakes by men were lower than those by women; the quercetin intakes showed a low correlation with age in both men and women. The estimated quercetin intake was similar during summer and winter. Quercetin was mainly ingested from onions and green tea, both in summer and in winter. Vegetables, such as asparagus, green pepper, tomatoes, and red leaf lettuce, were good sources of quercetin in summer. Our results will help to elucidate the association between quercetin intake and risks of lifestyle-related diseases by further prospective cohort study and establish healthy dietary requirements with the consumption of more physiologically useful components from foods.	[Nishimuro, Haruno; Ohnishi-Kameyama, Mayumi; Matsunaga, Izumi; Naito, Shigehiro; Ippoushi, Katsunari; Oike, Hideaki; Kobori, Masuko] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan; [Nishimuro, Haruno; Nagata, Tadahiro] Seitoku Univ, Dept Human Nutr, Matsudo, Chiba 2718555, Japan; [Ohnishi, Hirofumi; Akasaka, Hiroshi] Sapporo Med Univ, Sch Med, Sapporo, Hokkaido 0608556, Japan; [Saitoh, Shigeyuki] Sapporo Med Univ, Sch Hlth Sci, Sapporo, Hokkaido 0608556, Japan; [Shimamoto, Kazuaki] Sapporo Med Univ, Sapporo, Hokkaido 0608556, Japan	Kobori, M (reprint author), Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan.	hn130901@as.seitoku.ac.jp; hohnishi@sapmed.ac.jp; sato.midori@town.sobetsu.lg.jp; kameyama@affrc.go.jp; izm@affrc.go.jp; naito@affrc.go.jp; Ippoushi@affrc.go.jp; oike@affrc.go.jp; nagata@seitoku.ac.jp; akasaka@sapmed.ac.jp; ssaitoh@sapmed.ac.jp; simamoto@sapmed.ac.jp; kobori@affrc.go.jp			Ministry of Agriculture, Forestry and Fisheries (MAFF), Japan	This work was financially supported in part by a grant from the Ministry of Agriculture, Forestry and Fisheries (MAFF) research project for the new demand and creation of agricultural products, Japan.	Dong J, 2014, J LIPID RES, V55, P363, DOI 10.1194/jlr.M038786; Edwards RL, 2007, J NUTR, V137, P2405; Terao J, 2008, ASIA PAC J CLIN NUTR, V17, P291; Slimestad R, 2007, J AGR FOOD CHEM, V55, P10067, DOI 10.1021/jf0712503; Kobori M, 2011, MOL NUTR FOOD RES, V55, P530, DOI 10.1002/mnfr.201000392; Kobori M, 2009, MOL NUTR FOOD RES, V53, P859, DOI 10.1002/mnfr.200800310; Knekt P, 1996, BRIT MED J, V312, P478; Yoo YJ, 2011, J FOOD SCI, V76, pC1355, DOI 10.1111/j.1750-3841.2011.02429.x; Arai Y, 2000, J NUTR, V130, P2243; Arranz S, 2012, NUTRIENTS, V4, P759, DOI 10.3390/nu4070759; Hollman PCH, 1999, FOOD CHEM TOXICOL, V37, P937, DOI 10.1016/S0278-6915(99)00079-4; Hooper L, 2008, AM J CLIN NUTR, V88, P38; Egert S, 2010, J NUTR, V140, P278, DOI 10.3945/jn.109.117655; Otaki N, 2009, J CLIN BIOCHEM NUTR, V44, P231, DOI 10.3164/jcbn.08-231; Ioku K, 2001, J NUTR SCI VITAMINOL, V47, P78; Lagoa R, 2011, BBA-BIOENERGETICS, V1807, P1562, DOI 10.1016/j.bbabio.2011.09.022; Formica JV, 1995, FOOD CHEM TOXICOL, V33, P1061, DOI 10.1016/0278-6915(95)00077-1; Egert S, 2009, BRIT J NUTR, V102, P1065, DOI 10.1017/S0007114509359127; Nakamura T, 2014, MOL NUTR FOOD RES, V58, P310, DOI 10.1002/mnfr.201300234; Mahesh T, 2004, PHYTOTHER RES, V18, P123, DOI 10.1002/ptr.1374; Peterson JJ, 2012, NUTR REV, V70, P491, DOI 10.1111/j.1753-4887.2012.00508.x; Yoo YJ, 2013, FOOD QUAL PREFER, V28, P531, DOI 10.1016/j.foodqual.2013.01.001; Arts ICW, 2005, AM J CLIN NUTR, V81, p317S; Boesch-Saadatmandi C, 2012, PHARMACOL RES, V65, P523, DOI 10.1016/j.phrs.2012.02.007; Ioku K., 2008, OSAKA KYOIKU U REP 2, V56, P1; Ishisaka A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080843; Jin J, 2009, J AGR FOOD CHEM, V57, P5227, DOI 10.1021/jf9002973; Kelly Gregory S, 2011, Altern Med Rev, V16, P172; Mitsumata K, 2012, HYPERTENSION, V60, P1124, DOI 10.1161/HYPERTENSIONAHA.112.201129; Morales J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040548; Murota Kaeko, 2007, J Med Invest, V54, P370, DOI 10.2152/jmi.54.370; Ohnishi H, 2006, DIABETES CARE, V29, P1128, DOI 10.2337/dc06-0222; Okamoto D, 2006, J JPN SOC HORTIC SCI, V75, P100, DOI 10.2503/jjshs.75.100; Watanabe J, 2012, ANAL SCI, V28, P1179; Zamora-Ros R, 2011, BRIT J NUTR, V106, P1915, DOI 10.1017/S000711451100239X	35	1	1	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2072-6643			NUTRIENTS	Nutrients	APR	2015	7	4					2345	2358		10.3390/nu7042345		14	Nutrition & Dietetics	Nutrition & Dietetics	CH0KY	WOS:000353709800017		
J	Yokoyama, S				Yokoyama, Shinji			Unique Features of High-Density Lipoproteins in the Japanese: In Population and in Genetic Factors	NUTRIENTS			English	Review							ESTER TRANSFER PROTEIN; CORONARY-HEART-DISEASE; LIPID TRANSFER PROTEIN; INTRON-14 SPLICING DEFECT; LOW-DOSE SIMVASTATIN; CHOLESTERYL-ESTER; CETP GENE; HDL-CHOLESTEROL; CARDIOVASCULAR-DISEASE; SCHISTOSOMA-JAPONICUM	Despite its gradual increase in the past several decades, the prevalence of atherosclerotic vascular disease is low in Japan. This is largely attributed to difference in lifestyle, especially food and dietary habits, and it may be reflected in certain clinical parameters. Plasma high-density lipoprotein (HDL) levels, a strong counter risk for atherosclerosis, are indeed high among the Japanese. Accordingly, lower HDL seems to contribute more to the development of coronary heart disease (CHD) than an increase in non-HDL lipoproteins at a population level in Japan. Interestingly, average HDL levels in Japan have increased further in the past two decades, and are markedly higher than in Western populations. The reasons and consequences for public health of this increase are still unknown. Simulation for the efficacy of raising HDL cholesterol predicts a decrease in CHD of 70% in Japan, greater than the extent by reducing low-density lipoprotein cholesterol predicted by simulation or achieved in a statin trial. On the other hand, a substantial portion of hyperalphalipoproteinemic population in Japan is accounted for by genetic deficiency of cholesteryl ester transfer protein (CETP), which is also commonly unique in East Asian populations. It is still controversial whether CETP mutations are antiatherogenic. Hepatic Schistosomiasis is proposed as a potential screening factor for historic accumulation of CETP deficiency in East Asia.	[Yokoyama, Shinji] Chubu Univ, Nutr Hlth Sci Res Ctr, Kasugai, Aichi 4878501, Japan; [Yokoyama, Shinji] Chubu Univ, Biosci & Biotechnol, Kasugai, Aichi 4878501, Japan	Yokoyama, S (reprint author), Chubu Univ, Nutr Hlth Sci Res Ctr, Kasugai, Aichi 4878501, Japan.	syokoyam@isc.chubu.ac.jp			MEXT [S1201007]; MEXT Japan [24614018]	This work was supported by the MEXT-Supported Program for Strategic Founding of Research in Private Universities (S1201007) and by Grant-in-aid from MEXT Japan (24614018).	Andersson C, 2014, AM HEART J, V168, P878, DOI 10.1016/j.ahj.2014.08.007; Sekikawa A, 2008, J AM COLL CARDIOL, V52, P417, DOI 10.1016/j.jacc.2008.03.047; Carroll MD, 2012, JAMA-J AM MED ASSOC, V308, P1545, DOI 10.1001/jama.2012.13260; WILSON PWF, 1988, ARTERIOSCLEROSIS, V8, P737; Sasaki J, 2006, CIRC J, V70, P810, DOI 10.1253/circj.70.810; Qiu XY, 2007, NAT STRUCT MOL BIOL, V14, P106, DOI 10.1038/nsmb1197; SUGIUCHI H, 1995, CLIN CHEM, V41, P717; Czarnecka H, 1996, J BIOL CHEM, V271, P2023; Thompson A, 2008, JAMA-J AM MED ASSOC, V299, P2777, DOI 10.1001/jama.299.23.2777; Nissen SE, 2007, NEW ENGL J MED, V356, P1304, DOI 10.1056/NEJMoa070635; Arai H, 2005, J ATHEROSCLER THROMB, V12, P98; Miida T, 2014, ATHEROSCLEROSIS, V233, P253, DOI 10.1016/j.atherosclerosis.2013.12.033; OHNISHI T, 1994, BIOCHEMISTRY-US, V33, P4533, DOI 10.1021/bi00181a014; Matsuzaki M, 2002, CIRC J, V66, P1087, DOI 10.1253/circj.66.1087; Calabresi L, 2009, ATHEROSCLEROSIS, V205, P506, DOI 10.1016/j.atherosclerosis.2009.01.006; WORTH RM, 1975, AM J EPIDEMIOL, V102, P481; Carroll MD, 2005, JAMA-J AM MED ASSOC, V294, P1773, DOI 10.1001/jama.294.14.1773; Kit BK, 2012, JAMA-J AM MED ASSOC, V308, P591, DOI 10.1001/jama.2012.9136; INAZU A, 1994, J CLIN INVEST, V94, P1872, DOI 10.1172/JCI117537; Nakamura H, 2006, LANCET, V368, P1155, DOI 10.1016/S0140-6736(06)69472-5; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; YAMASHITA S, 1990, J CLIN INVEST, V86, P688, DOI 10.1172/JCI114764; Arkhipova N. S., 2013, ADV GERONTOL, V3, P277; BISGAIER CL, 1991, J LIPID RES, V32, P21; BROWN ML, 1989, NATURE, V342, P448, DOI 10.1038/342448a0; Cefalu AB, 2009, ATHEROSCLEROSIS, V204, P202, DOI 10.1016/j.atherosclerosis.2008.08.031; Chantepie S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049336; Chen DW, 2008, BRAIN RES, V1187, P52, DOI 10.1016/j.brainres.2007.10.054; Curb JD, 2004, J LIPID RES, V45, P948, DOI 10.1194/jlr.M300520-JLR200; Dixit Manjusha, 2005, BMC Endocr Disord, V5, P7, DOI 10.1186/1472-6823-5-7; Foger B, 1996, ARTERIOSCL THROM VAS, V16, P1430; GORDON T, 1981, ARCH INTERN MED, V141, P1128, DOI 10.1001/archinte.141.9.1128; Goto A, 2001, ATHEROSCLEROSIS, V159, P153, DOI 10.1016/S0021-9150(01)00476-2; Hill SA, 1997, CLIN BIOCHEM, V30, P413, DOI 10.1016/S0009-9120(97)00009-X; Hirano K, 1997, ARTERIOSCL THROM VAS, V17, P1053; Hsu LA, 2002, HUM GENET, V110, P57, DOI 10.1007/s00439-001-0640-z; Hui Shu-Ping, 1997, Hokkaido Journal of Medical Science, V72, P319; INAZU A, 1990, NEW ENGL J MED, V323, P1234, DOI 10.1056/NEJM199011013231803; Jap TS, 2002, METABOLISM, V51, P394, DOI 10.1053/meta.2002.30527; KO KWS, 1994, J BIOL CHEM, V269, P28206; KOIZUMI J, 1985, ATHEROSCLEROSIS, V58, P175, DOI 10.1016/0021-9150(85)90064-4; KURASAWA T, 1985, J BIOCHEM-TOKYO, V98, P1499; Ma YQ, 2001, CLIN GENET, V59, P287, DOI 10.1034/j.1399-0004.2001.590413.x; Maruyama Takao, 2004, J Atheroscler Thromb, V11, P131; Moriyama Y, 1998, PREV MED, V27, P659, DOI 10.1006/pmed.1998.0340; Nagano M, 2002, J LIPID RES, V43, P1011, DOI 10.1194/jlr.M200024-JLR200; Nagano Makoto, 2004, J Atheroscler Thromb, V11, P110; Nakamura M, 2015, CLIN CHIM ACTA, V439, P185, DOI 10.1016/j.cca.2014.10.039; Okumura-Noji K, 2013, FASEB J, V27, P1236, DOI 10.1096/fj.12-219816; Okumura-Noji K, 2001, BIOCHEM BIOPH RES CO, V286, P305, DOI 10.1006/bbrc.2001.5386; Plengpanich W, 2009, METABOLISM, V58, P1178, DOI 10.1016/j.metabol.2009.03.020; Preis SR, 2013, DIABETES CARE, V36, P1590, DOI 10.2337/dc12-1121; Rhyne J, 2006, J MOL MED-JMM, V84, P647, DOI 10.1007/s00109-005-0070-4; Ritsch A, 1997, ARTERIOSCL THROM VAS, V17, P3433; SAKAI N, 1995, ATHEROSCLEROSIS, V114, P139, DOI 10.1016/0021-9150(94)05477-Z; SAKAI N, 1991, ARTERIOSCLER THROMB, V11, P71; Sasai K, 1998, CLIN CHEM, V44, P1466; Song GJ, 1997, MOL CELLS, V7, P615; TALL A, 1995, ANNU REV BIOCHEM, V64, P235; Teh EM, 1998, J LIPID RES, V39, P442; Thompson JF, 2009, ATHEROSCLEROSIS, V202, P241, DOI 10.1016/j.atherosclerosis.2008.03.013; Thu NN, 2005, PEDIATR RES, V58, P1249, DOI 10.1203/01.pdr.0000183782.57705.fc; van der Steeg WA, 2007, J LIPID RES, V48, P674, DOI 10.1194/jlr.M600405-JLR200; Yamamoto A., 1996, J ATHEROSCLER THROMB, V2, P122; Yamashita S, 1997, CURR OPIN LIPIDOL, V8, P101, DOI 10.1097/00041433-199704000-00008; Yamashita S, 2000, BBA-MOL CELL BIOL L, V1529, P257, DOI 10.1016/S1388-1981(00)00164-5; YAMASHITA S, 1991, METABOLISM, V40, P756, DOI 10.1016/0026-0495(91)90097-G; YAMASHITA S, 1990, BIOCHEM BIOPH RES CO, V170, P1346, DOI 10.1016/0006-291X(90)90542-U; Yokoyama S, 2012, J ATHEROSCLER THROMB, V19, P207; Yokoyama S, 2014, J ATHEROSCLER THROMB, V21, P151; Yokoyama S, 2014, BBA-MOL CELL BIOL L, V1841, P495, DOI [10.1016/j.bbalip.2013.12.014, 10.1016/j.jbbalip.2013.12.014]	71	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2072-6643			NUTRIENTS	Nutrients	APR	2015	7	4					2359	2381		10.3390/nu7042359		23	Nutrition & Dietetics	Nutrition & Dietetics	CH0KY	WOS:000353709800018		
J	Kasubuchi, M; Hasegawa, S; Hiramatsu, T; Ichimura, A; Kimura, I				Kasubuchi, Mayu; Hasegawa, Sae; Hiramatsu, Takero; Ichimura, Atsuhiko; Kimura, Ikuo			Dietary Gut Microbial Metabolites, Short-chain Fatty Acids, and Host Metabolic Regulation	NUTRIENTS			English	Review							PROTEIN-COUPLED RECEPTOR; INSULIN SENSITIVITY; ENERGY-METABOLISM; OBESITY; BUTYRATE; ACTIVATION; GPR41; BACTERIA; ACETATE; INFLAMMATION	During feeding, the gut microbiota contributes to the host energy acquisition and metabolic regulation thereby influencing the development of metabolic disorders such as obesity and diabetes. Short-chain fatty acids (SCFAs) such as acetate, butyrate, and propionate, which are produced by gut microbial fermentation of dietary fiber, are recognized as essential host energy sources and act as signal transduction molecules via G-protein coupled receptors (FFAR2, FFAR3, OLFR78, GPR109A) and as epigenetic regulators of gene expression by the inhibition of histone deacetylase (HDAC). Recent evidence suggests that dietary fiber and the gut microbial-derived SCFAs exert multiple beneficial effects on the host energy metabolism not only by improving the intestinal environment, but also by directly affecting various host peripheral tissues. In this review, we summarize the roles of gut microbial SCFAs in the host energy regulation and present an overview of the current understanding of its physiological functions.	[Kasubuchi, Mayu; Hasegawa, Sae; Kimura, Ikuo] Tokyo Univ Agr & Technol, Grad Sch Agr, Dept Appl Biol Sci, Fuchu, Tokyo 1838509, Japan; [Hiramatsu, Takero] Kyoto Univ, Dept Biochem Genet, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan; [Ichimura, Atsuhiko; Kimura, Ikuo] Kyoto Univ, Dept Pharmacogen, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan	Kimura, I (reprint author), Tokyo Univ Agr & Technol, Grad Sch Agr, Dept Appl Biol Sci, Fuchu, Tokyo 1838509, Japan.	50012152019@st.tuat.ac.jp; 50012152057@st.tuat.ac.jp; hiramatsu.takerou.88v@st.kyoto-u.ac.jp; ichimura.atsuhiko.2r@kyoto-u.ac.jp; ikimura@cc.tuat.ac.jp					Ahmed K, 2009, TRENDS PHARMACOL SCI, V30, P557, DOI 10.1016/j.tips.2009.09.001; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Greiner T, 2011, TRENDS ENDOCRIN MET, V22, P117, DOI 10.1016/j.tem.2011.01.002; Singh V, 2012, CELL HOST MICROBE, V12, P669, DOI 10.1016/j.chom.2012.09.012; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Delzenne NM, 2005, CURR OPIN CLIN NUTR, V8, P636, DOI 10.1097/01.mco.0000171124.06408.71; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Lukasova M, 2011, J CLIN INVEST, V121, P1163, DOI 10.1172/JCI41651; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Topping DL, 2001, PHYSIOL REV, V81, P1031; Yamashita H, 2007, BIOSCI BIOTECH BIOCH, V71, P1236, DOI 10.1271/bbb.60668; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/nature4441022a; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Binder HJ, 2010, ANNU REV PHYSIOL, V72, P297, DOI 10.1146/annurev-physiol-021909-135817; COUSENS LS, 1979, J BIOL CHEM, V254, P1716; Sanz Y, 2010, P NUTR SOC, V69, P434, DOI 10.1017/S0029665110001813; Hong YH, 2005, ENDOCRINOLOGY, V146, P5092, DOI 10.1210/en.2005-0545; Ge HF, 2008, ENDOCRINOLOGY, V149, P4519, DOI 10.1210/en.2008-0059; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Delzenne NM, 2011, NAT REV ENDOCRINOL, V7, P639, DOI 10.1038/nrendo.2011.126; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; WOLEVER TMS, 1989, AM J GASTROENTEROL, V84, P1027; Khan MT, 2014, CELL METAB, V20, P753, DOI 10.1016/j.cmet.2014.07.006; Remely M, 2014, GENE, V537, P85, DOI 10.1016/j.gene.2013.11.081; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Cresci GA, 2010, J GASTROINTEST SURG, V14, P449, DOI 10.1007/s11605-009-1045-x; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Blad CC, 2012, NAT REV DRUG DISCOV, V11, P603, DOI 10.1038/nrd3777; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; Kimura I, 2011, P NATL ACAD SCI USA, V108, P8030, DOI 10.1073/pnas.1016088108; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Galisteo M, 2008, J NUTR BIOCHEM, V19, P71, DOI 10.1016/j.jnutbio.2007.02.009; Tazoe H, 2009, BIOMED RES-TOKYO, V30, P149; Inoue D, 2012, FEBS LETT, V586, P1547, DOI 10.1016/j.febslet.2012.04.021; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; HARIG JM, 1989, NEW ENGL J MED, V320, P23, DOI 10.1056/NEJM198901053200105; De Vadder F, 2014, CELL, V156, P84, DOI 10.1016/j.cell.2013.12.016; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Bourlioux P, 2003, AM J CLIN NUTR, V78, P675; Chambers E. S., 2014, GUT, P1, DOI [DOI 10.1136/GUTJNL-2014-307913, 10.1136/gutjnl-2014-307913]; Di Sabatino A, 2005, ALIMENT PHARM THERAP, V22, P789, DOI 10.1111/j.1365-2036.2005.02639.x; Feingold KR, 2014, J LIPID RES, V55, P2501, DOI 10.1194/jlr.M050955; Frost G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4611; Greenwood Hannah C, 2011, Rev Diabet Stud, V8, P355, DOI 10.1900/RDS.2011.8.355; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240; Liou AP, 2013, SCI TRANSL MED, V5, P178, DOI DOI 10.1126/SCITRANSLMED.3005687; Natarajan N, 2014, AM J PHYSIOL-CELL PH, V307, pC979, DOI 10.1152/ajpcell.00228.2014; Offermanns S, 2014, ANNU REV PHARMACOL, V54, P407, DOI 10.1146/annurev-pharmtox-011613-135945; Pliznick J. L., 2013, P NATL ACAD SCI USA, V110, P4410, DOI [10.1073/pnas.121592711023401498, DOI 10.1073/PNAS.121592711023401498]; Pluznick Jennifer, 2014, Gut Microbes, V5, P202, DOI 10.4161/gmic.27492	59	6	6	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2072-6643			NUTRIENTS	Nutrients	APR	2015	7	4					2839	2849		10.3390/nu7042839		11	Nutrition & Dietetics	Nutrition & Dietetics	CH0KY	WOS:000353709800045		
J	Chiba, T; Sato, Y; Suzuki, S; Umegaki, K				Chiba, Tsuyoshi; Sato, Yoko; Suzuki, Sachina; Umegaki, Keizo			Concomitant Use of Dietary Supplements and Medicines in Patients due to Miscommunication with Physicians in Japan	NUTRIENTS			English	Article							ALTERNATIVE MEDICINE; HEALTH CHARACTERISTICS; DRUG-INTERACTIONS; CANCER INCIDENCE; COMPLEMENTARY; CYTOCHROME-P450; ADULTS; POPULATION; MORTALITY; VITAMIN	We previously reported that some patients used dietary supplements with their medication without consulting with physicians. Dietary supplements and medicines may interact with each other when used concomitantly, resulting in health problems. An Internet survey was conducted on 2109 people who concomitantly took dietary supplements and medicines in order to address dietary supplement usage in people who regularly take medicines in Japan. A total of 1508 patients (two admitted patients and 1506 ambulatory patients) and 601 non-patients, who were not consulting with physicians, participated in this study. Purpose for dietary supplement use was different among ages. Dietary supplements were used to treat diseases in 4.0% of non-patients and 11.9% of patients, while 10.8% of patients used dietary supplements to treat the same diseases as their medication. However, 70.3% of patients did not declare dietary supplement use to their physicians or pharmacists because they considered the concomitant use of dietary supplements and medicines to be safe. A total of 8.4% of all subjects realized the potential for adverse effects associated with dietary supplements. The incidence of adverse events was higher in patients who used dietary supplements to treat their disease. Communication between patients and physicians is important for avoiding the adverse effects associated with the concomitant use of dietary supplements and medicines.	[Chiba, Tsuyoshi; Sato, Yoko; Suzuki, Sachina; Umegaki, Keizo] Natl Inst Hlth & Nutr, Informat Ctr, Shinjuku Ku, Tokyo 1628636, Japan	Chiba, T (reprint author), Natl Inst Hlth & Nutr, Informat Ctr, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628636, Japan.	tyschiba@nih.go.jp; satoyoko@nih.go.jp; sachina-s@nih.go.jp; umegaki@nih.go.jp			Health and Labour Sciences Research Grants (Research on Food Safety)	This work was supported in part by Health and Labour Sciences Research Grants (Research on Food Safety). The authors thank the pharmacies, hospitals and autonomous communities that cooperated with this study.	Madabushi R, 2006, EUR J CLIN PHARMACOL, V62, P225, DOI 10.1007/s00228-006-0096-0; Hermann R, 2012, PLANTA MED, V78, P1458, DOI 10.1055/s-0032-1315117; Bjelakovic G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007749.pub2; Kimura Y, 2010, FOOD CHEM TOXICOL, V48, P429, DOI 10.1016/j.fct.2009.10.041; Izzo AA, 2009, DRUGS, V69, P1777, DOI 10.2165/11317010-000000000-00000; Detampel P, 2012, DRUG METAB REV, V44, P253, DOI 10.3109/03602532.2012.700715; Hyodo I, 2005, J CLIN ONCOL, V23, P2645; Chen Y, 2009, CLIN EXP PHARMACOL P, V36, P828, DOI 10.1111/j.1440-1681.2009.05158.x; Paul M, 2013, J CANCER RES CLIN, V139, P1515, DOI 10.1007/s00432-013-1460-y; Lyle BJ, 1998, J NUTR, V128, P2355; Singendonk M, 2013, EUR J PEDIATR, V172, P31, DOI 10.1007/s00431-012-1821-6; Ashar BH, 2007, ARCH INTERN MED, V167, P966, DOI 10.1001/archinte.167.9.966; Qiao YL, 2009, J NATL CANCER I, V101, P507, DOI 10.1093/jnci/djp037; Velicer CM, 2008, J CLIN ONCOL, V26, P665, DOI 10.1200/JCO.2007.13.5905; Messerer M, 2001, EUR J CLIN NUTR, V55, P1104, DOI 10.1038/sj.ejcn.1601272; Bailey RL, 2013, JAMA INTERN MED, V173, P355, DOI 10.1001/jamainternmed.2013.2299; Alexander DD, 2013, J AM COLL NUTR, V32, P339, DOI 10.1080/07315724.2013.839909; Teschke R, 2012, LIVER INT, V32, P1543, DOI 10.1111/j.1478-3231.2012.02864.x; Wu CH, 2011, CLIN THER, V33, P1749, DOI 10.1016/j.clinthera.2011.09.024; Ohama H, 2006, TOXICOLOGY, V221, P95, DOI 10.1016/j.tox.2006.01.015; Shord SS, 2009, INTEGR CANCER THER, V8, P208, DOI 10.1177/1534735409340900; Pawar RS, 2013, ANAL BIOANAL CHEM, V405, P4373, DOI 10.1007/s00216-012-6691-2; Nakajima M, 2006, J CLIN PHARMACOL, V46, P337, DOI 10.1177/0091270005285199; Archer JRH, 2015, DRUG TEST ANAL, V7, P433, DOI 10.1002/dta.1764; Bamba Y, 2011, J NAT MED-TOKYO, V65, P583, DOI 10.1007/s11418-011-0507-0; Binkowska-Bury M, 2013, J CLIN NURS, V22, P559, DOI 10.1111/j.1365-2702.2012.04166.x; Block G, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-30; Cellini M, 2013, MED SCI SPORT EXER, V45, P23, DOI 10.1249/MSS.0b013e318269904f; Chiba T, 2014, NUTRIENTS, V6, P5392, DOI 10.3390/nu6125392; Cohen PA, 2014, JAMA-J AM MED ASSOC, V312, P1691, DOI 10.1001/jama.2014.10308; Cohen PA, 2012, ARCH INTERN MED, V172, P1038, DOI 10.1001/archinternmed.2012.1677; Frenkel M, 2014, CURR ONCOL REP, V16, DOI 10.1007/s11912-014-0411-3; Gardiner P., 2015, ED COUNS, V98, P512, DOI [10.1016/j.pec.2014.12.01025636694, DOI 10.1016/J.PEC.2014.12.01025636694]; Hara A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-540; Hirayama F, 2008, ASIA PAC J CLIN NUTR, V17, P280; Ikuyama S, 2009, MOD RHEUMATOL, V19, P253, DOI 10.1007/s10165-009-0156-2; Ishihara J, 2001, EUR J CLIN NUTR, V55, P360, DOI 10.1038/sj.ejcn.1601164; Ishihara J, 2003, INT J EPIDEMIOL, V32, P546, DOI 10.1093/ije/dyg091; Kemper K. J., 2006, BMC COMPLEMENT ALTER, V6, DOI 10.1186/1472-6882-6-15; Klafke N, 2012, ANN ONCOL, V23, P1571, DOI 10.1093/annonc/mdr521; LI JY, 1993, J NATL CANCER I, V85, P1492, DOI 10.1093/jnci/85.18.1492; Mehta DH, 2008, J ALTERN COMPLEM MED, V14, P1263, DOI 10.1089/acm.2008.0290; Messina Barbara Ann M, 2006, J Perianesth Nurs, V21, P268, DOI 10.1016/j.jopan.2006.05.004; Muto S, 2001, MUTAT RES-FUND MOL M, V479, P197, DOI 10.1016/S0027-5107(01)00204-4; Park SY, 2008, J AM DIET ASSOC, V108, P529, DOI 10.1016/j.jada.2007.12.011; Pilkington K, 2012, COMPLEMENT THER MED, V20, P73, DOI 10.1016/j.ctim.2011.10.002; Sadovsky R, 2008, CURR MED RES OPIN, V24, P1209, DOI 10.1185/030079908X280743 ; Samuels N, 2012, PATIENT EDUC COUNS, V89, P392, DOI 10.1016/j.pec.2012.07.005; Virgona N, 2012, FOOD CHEM TOXICOL, V50, P750, DOI 10.1016/j.fct.2011.11.054; Yamada K., 2008, J NUTR, V138, P1192; Yokotani K, 2012, J PHARM PHARMACOL, V64, P1793, DOI 10.1111/j.2042-7158.2012.01563.x; Young C, 2012, MIL MED, V177, P1450, DOI 10.7205/MILMED-D-11-00342	52	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2072-6643			NUTRIENTS	Nutrients	APR	2015	7	4					2947	2960		10.3390/nu7042947		14	Nutrition & Dietetics	Nutrition & Dietetics	CH0KY	WOS:000353709800051		
J	Ganeev, RA				Ganeev, R. A.			Laser harmonic enhancement using the quasi-phase-matching in laser plasma	OPTICS AND SPECTROSCOPY			English	Article							ATTOSECOND PULSE GENERATION; COUNTERPROPAGATING LIGHT; SILVER PLASMA; FIELDS; OPTIMIZATION; IONIZATION; FREQUENCY; CUTOFF	The recently developed quasi-phase-matching techniques for the high-order harmonics generating in the multiple plasma jets produced on the surfaces of various targets are reviewed. The achievement of 40x enhancement of the quasi-phase-matched harmonics of 804 nm radiation in the range of 35th harmonic in the cases of metal plasmas is analyzed. We demonstrate various approaches in formation of the multi-jet structures during laser ablation by applying the perforated targets and multi-slit shields.	Saitama Med Univ, Ophthalmol & Adv Laser Med Ctr, Saitama 3500495, Japan	Ganeev, RA (reprint author), Saitama Med Univ, Ophthalmol & Adv Laser Med Ctr, Saitama 3500495, Japan.	rashid_ganeev@mail.ru					Andreev AV, 2013, EUR PHYS J D, V67, DOI 10.1140/epjd/e2012-30527-0; Ganeev RA, 2005, PHYS LETT A, V339, P103, DOI 10.1016/j.physleta.2005.02.073; Pfeifer T, 2006, OPT LETT, V31, P975, DOI 10.1364/OL.31.000975; Willner A, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.175002; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; Kan C, 1997, PHYS REV LETT, V79, P2971, DOI 10.1103/PhysRevLett.79.2971; Ganeev RA, 2014, JETP LETT+, V99, P368, DOI 10.1134/S0021364014070078; Ganeev RA, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.033838; LEWENSTEIN M, 1994, PHYS REV A, V49, P2117, DOI 10.1103/PhysRevA.49.2117; Zhang XH, 2007, NAT PHYS, V3, P270, DOI 10.1038/nphys541; Mauritsson J, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.013001; Ozaki T, 2007, LASER PART BEAMS, V25, P321, DOI 10.1017/S0263034607000201; Ganeev RA, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.023832; Ganeev RA, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.023831; Ganeev RA, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.033845; Seres J, 2007, NAT PHYS, V3, P878, DOI 10.1038/nphys775; Bahabad A, 2010, NAT PHOTONICS, V4, P570, DOI 10.1038/NPHOTON.2010.122; Sheinfux AH, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3578407; Paul A, 2003, NATURE, V421, P51, DOI 10.1038/nature01222; Ganeev RA, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1898428; TELNOV DA, 1995, PHYS REV A, V52, P3988, DOI 10.1103/PhysRevA.52.3988; Ganeev RA, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.033821; Ganeev RA, 2012, OPT EXPRESS, V20, P90, DOI 10.1364/OE.20.000090; Ganeev RA, 2014, J PHYS B-AT MOL OPT, V47, DOI 10.1088/0953-4075/47/10/105401; Ganeev RA, 2014, J NONLINEAR OPT PHYS, V23, DOI 10.1142/S0218863514500131; Ganeev RA, 2007, APPL PHYS B-LASERS O, V87, P243, DOI 10.1007/s00340-007-2583-0; Cormier E, 2000, EUR PHYS J D, V12, P227, DOI 10.1007/s100530070017; Tosa V, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/2/025016; SCHAFER KJ, 1993, PHYS REV LETT, V70, P1599, DOI 10.1103/PhysRevLett.70.1599; Auguste T, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.011802; Ganeev RA, 2013, HIGH-ORDER HARMONIC GENERATION IN LASER PLASMA PLUMES, P1; Ganeev RA, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.053831; Bom LBE, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.033804; Kim IJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.243901; Kim IJ, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2836252; Lambert G, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/8/083033; Liu LZ, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.023810; Liu XS, 2008, J PHYS B-AT MOL OPT, V41, DOI 10.1088/0953-4075/41/1/015602; Lytle AL, 2008, OPT EXPRESS, V16, P6544, DOI 10.1364/OE.16.006544; O'Keeffe K, 2012, OPT EXPRESS, V20, P6236, DOI 10.1364/OE.20.006236; Pirri A, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.011801; Wang XW, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.021802; Yu YL, 2008, OPT EXPRESS, V16, P686, DOI 10.1364/OE.16.000686	43	1	1	MAIK NAUKA/INTERPERIODICA/SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	0030-400X	1562-6911		OPT SPECTROSC+	Opt. Spectrosc.	APR	2015	118	4					574	589		10.1134/S0030400X15040050		16	Optics; Spectroscopy	Optics; Spectroscopy	CH1VE	WOS:000353809000011		
J	Ganeev, RA				Ganeev, R. A.			Advanced Properties of Extended Laser-Produced Plasmas for Efficient Generation of the High-Order Harmonics of Ultrashort Laser Pulses	OPTICS AND SPECTROSCOPY			English	Article							ATOM CLUSTERS; SILVER PLASMA; 2-COLOR PUMP; ENHANCEMENT; FIELDS; OPTIMIZATION; IONIZATION; IONS	The review of the studies showing the advanced properties of extended plasma plumes (5 mm) for efficient high-order harmonic generation of laser radiation compared with the short lengths of plasmas (similar to 0.3-0.5 mm) used in previous studies is presented. The harmonic conversion efficiency cjuadratically increased with the growth of plasma length at the optimal conditions of plasma formation. The studies of this process using the long plasma jets produced on various metal surfaces, particularly including the resonanceenhanced harmonic generation, two-color pump, and extended nanoparticle plasma, are discussed.	Saitama Med Univ, Ophthalmol & Adv Laser Med Ctr, Saitama 3500495, Japan	Ganeev, RA (reprint author), Saitama Med Univ, Ophthalmol & Adv Laser Med Ctr, Saitama 3500495, Japan.	ganeev@saitama-med.ac.jp					Ganeev RA, 2005, PHYS LETT A, V339, P103, DOI 10.1016/j.physleta.2005.02.073; Ganeev RA, 2006, OPT LETT, V31, P1699, DOI 10.1364/OL.31.001699; Hsu H, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.115406; Pfeifer T, 2006, OPT LETT, V31, P975, DOI 10.1364/OL.31.000975; Elouga-Bom LB, 2008, J PHYS B-AT MOL OPT, V41, DOI 10.1088/0953-4075/41/21/215401; AKIYAMA Y, 1992, PHYS REV LETT, V69, P2176, DOI 10.1103/PhysRevLett.69.2176; Ganeev RA, 2008, J OPT SOC AM B, V25, P325, DOI 10.1364/JOSAB.25.000325; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; Kan C, 1997, PHYS REV LETT, V79, P2971, DOI 10.1103/PhysRevLett.79.2971; Pertot Y, 2012, J PHYS B-AT MOL OPT, V45, DOI 10.1088/0953-4075/45/7/074017; Ganeev RA, 2014, JETP LETT+, V99, P368, DOI 10.1134/S0021364014070078; Ganeev RA, 1997, OPT COMMUN, V135, P251, DOI 10.1016/S0030-4018(96)00633-5; Ganeev RA, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.013903; Ganeev RA, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4875738; Ganeev RA, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.063824; LEWENSTEIN M, 1994, PHYS REV A, V49, P2117, DOI 10.1103/PhysRevA.49.2117; Mauritsson J, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.013001; Ganeev RA, 2013, J OPT SOC AM B, V30, P7; Donnelly TD, 1996, PHYS REV LETT, V76, P2472, DOI 10.1103/PhysRevLett.76.2472; Alon OE, 1998, PHYS REV LETT, V80, P3743, DOI 10.1103/PhysRevLett.80.3743; Singhal H, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.023807; Ruf H, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.083902; Lange HR, 1998, PHYS REV LETT, V81, P1611, DOI 10.1103/PhysRevLett.81.1611; Vozzi C, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1888053; Singhal H, 2008, J APPL PHYS, V103, DOI 10.1063/1.2825570; Ganeev RA, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.023831; Tisch JWG, 1997, J PHYS B-AT MOL OPT, V30, pL709, DOI 10.1088/0953-4075/30/20/006; Ganeev RA, 2014, J OPT SOC AM B, V31, P911, DOI 10.1364/JOSAB.31.000911; Ganeev RA, 2012, OPT EXPRESS, V20, P25239, DOI 10.1364/OE.20.025239; Ganeev RA, 2008, J APPL PHYS, V103, DOI 10.1063/1.2887990; Sheinfux AH, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3578407; Stadler J, 1997, INT J MOD PHYS C, V8, P1131, DOI 10.1142/S0129183197000990; MORENO P, 1994, EUROPHYS LETT, V28, P629, DOI 10.1209/0295-5075/28/9/003; TELNOV DA, 1995, PHYS REV A, V52, P3988, DOI 10.1103/PhysRevA.52.3988; Krushelnick K, 1997, J OPT SOC AM B, V14, P1687, DOI 10.1364/JOSAB.14.001687; Ganeev RA, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.033821; Ganeev RA, 2012, OPT EXPRESS, V20, P90, DOI 10.1364/OE.20.000090; Hutchison C, 2012, OPT LETT, V37, P2064, DOI 10.1364/OL.37.002064; Rundquist A, 1998, SCIENCE, V280, P1412, DOI 10.1126/science.280.5368.1412; Ganeev RA, 2014, J PHYS B-AT MOL OPT, V47, DOI 10.1088/0953-4075/47/10/105401; Ganeev RA, 2014, J NONLINEAR OPT PHYS, V23, DOI 10.1142/S0218863514500131; Ganeev RA, 2007, APPL PHYS B-LASERS O, V87, P243, DOI 10.1007/s00340-007-2583-0; Ganeev RA, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.033803; Cormier E, 2000, EUR PHYS J D, V12, P227, DOI 10.1007/s100530070017; Ganeev RA, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.015807; Ganeev RA, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.023805; SCHAFER KJ, 1993, PHYS REV LETT, V70, P1599, DOI 10.1103/PhysRevLett.70.1599; Ganeev RA, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.013820; Bahari A, 2009, CARBON, V47, P457, DOI 10.1016/j.carbon.2008.10.025; Balcou P, 2002, APPL PHYS B-LASERS O, V74, P509, DOI 10.1007/s003400200797; Charalambidis D, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/2/025018; Ciappina MF, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.063405; Ciappina MF, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.063406; Duffy D., 2001, J PHYS B ATOM MOL PH, V34, pL173; Ganeev RA, 2007, J PHYS B-AT MOL OPT, V40, pR213, DOI 10.1088/0953-4075/40/22/R01; Ganeev RA, 2014, J PHYS B-AT MOL OPT, V47, DOI 10.1088/0953-4075/47/13/135401; Ganeev RA, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.023832; Ganeev RA, 2014, J APPL PHYS, V115, DOI 10.1063/1.4875681; Ganeev RA, 2008, J PHYS B-AT MOL OPT, V41, DOI 10.1088/0953-4075/41/4/045603; Ganeev RA, 2009, J PHYS B-AT MOL OPT, V42, DOI 10.1088/0953-4075/42/5/055402; Kim IJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.243901; Kim IJ, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2836252; Kjeldsen H, 2004, J PHYS B-AT MOL OPT, V37, P1321, DOI 10.1088/0953-4075/37/6/014; Lambert G, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/8/083033; Liu XS, 2008, J PHYS B-AT MOL OPT, V41, DOI 10.1088/0953-4075/41/1/015602; Oujja M, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.043841; Redkin PV, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.063825; Singhal H, 2010, J PHYS B-AT MOL OPT, V43, DOI 10.1088/0953-4075/43/2/025603; Slepyan GY, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.053808; Sun J, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.195438; Tosa V, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.063817; Veniard V., 2002, Physical Review A (Atomic, Molecular, and Optical Physics), V65, DOI 10.1103/PhysRevA.65.013202; Yu YL, 2008, OPT EXPRESS, V16, P686, DOI 10.1364/OE.16.000686; Zhang GP, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.047401	74	1	1	MAIK NAUKA/INTERPERIODICA/SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	0030-400X	1562-6911		OPT SPECTROSC+	Opt. Spectrosc.	APR	2015	118	4					639	654		10.1134/S0030400X15030133		16	Optics; Spectroscopy	Optics; Spectroscopy	CH1VE	WOS:000353809000022		
J	Togami, S; Sasajima, Y; Kasamatsu, T; Oda-Otomo, R; Okada, S; Ishikawa, M; Ikeda, S; Kato, T; Tsuda, H				Togami, Shinichi; Sasajima, Yuko; Kasamatsu, Takahiro; Oda-Otomo, Rie; Okada, Satoshi; Ishikawa, Mitsuya; Ikeda, Shun-ichi; Kato, Tomoyasu; Tsuda, Hitoshi			Immunophenotype and Human Papillomavirus Status of Serous Adenocarcinoma of the Uterine Cervix	PATHOLOGY & ONCOLOGY RESEARCH			English	Article						Serous adenocarcinoma; Uterine cervix; Immunohistochemical features; Human papillomavirus	DIFFERENT HISTOLOGICAL SUBTYPES; P53 EXPRESSION; FALLOPIAN-TUBE; HPV-DNA; CARCINOMA; CANCER; OVEREXPRESSION; GRADE; AMPLIFICATION; ENDOMETRIUM	Serous adenocarcinoma of the cervix (SACC) is a very rare tumor. Our study aimed to characterize the immune profile and human papillomavirus (HPV) status of SACC, in comparison with other serous adenocarcinomas arising in the female genital tract. The pathological specimens obtained from 81 patients with serous carcinoma of the uterine cervix (n = 12), 29 endometrium, 20 ovary and 20 patients with mucinous carcinoma of the uterine cervix were reviewed. We assessed the expression of WT-1, p53, p16, HER2, CEA, and CA125 by immunohistochemistry and HPV DNA by PCR in 12 SACC samples. Their immune profile was compared with that of uterine papillary serous carcinoma (UPSC), ovarian serous adenocarcinoma (OSA), and mucinous endocervical adenocarcinoma (MEA). WT-1 and HER2 were expressed in very few SACC samples (0 and 0 %, respectively), but p16, CA125, CEA and p53 were present in 100, 92, 58 and 50 %, respectively. The difference in WT-1 expression between SACC and UPSC, MEA is not significant, but SACC differ significantly from OSA (p < 0.01). HPV DNA (type 16 or 18) was detected in 4 of the 12 SACC. The immunophenotype of SACC was similar to UPSC, whereas the frequency of expression of WT-1 was significantly lower in SACC than OSA. It appeared that p53 expression was associated with worse clinical outcome in patients with SACC, and that HPV infection was related to its occurrence.	[Togami, Shinichi; Kasamatsu, Takahiro; Okada, Satoshi; Ishikawa, Mitsuya; Ikeda, Shun-ichi; Kato, Tomoyasu] Natl Canc Ctr, Dept Gynecol, Chuo Ku, Tokyo 1040045, Japan; [Togami, Shinichi] Kagoshima Univ, Fac Med, Dept Obstet & Gynecol, Dept Mol & Cellular Pathol,Field Oncol, Kagoshima 890, Japan; [Sasajima, Yuko; Oda-Otomo, Rie; Tsuda, Hitoshi] Natl Canc Ctr, Dept Pathol & Clin Labs, Chuo Ku, Tokyo, Japan; [Sasajima, Yuko] Teikyo Univ, Sch Med, Dept Pathol, Itabashi Ku, Tokyo 173, Japan	Togami, S (reprint author), Natl Canc Ctr, Dept Gynecol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	togami@m3.kufm.kagoshima-u.ac.jp					Acs G, 2004, INT J GYNECOL PATHOL, V23, P110, DOI 10.1097/01.pgp.0000116627.23685.b2; Alkushi A, 2003, VIRCHOWS ARCH, V442, P271, DOI 10.1007/s00428-002-0752-4; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2; Pirog EC, 2000, AM J PATHOL, V157, P1055, DOI 10.1016/S0002-9440(10)64619-6; [Anonymous], 2001, DEV BIOL BASEL; Santin AD, 2005, CANCER, V104, P1391, DOI 10.1002/cncr.21308; Andersson S, 2001, EUR J CANCER, V37, P246, DOI 10.1016/S0959-8049(00)00376-2; Slomovitz BM, 2004, J CLIN ONCOL, V22, P3126, DOI 10.1200/JCO.2004.11.154; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; Olawaiye AB, 2008, GYNECOL ONCOL, V110, P293, DOI 10.1016/j.ygyno.2008.05.027; Broker T R, 2001, Dev Biol (Basel), V106, P443; Hunt CR, 1996, J CLIN PATHOL, V49, P971, DOI 10.1136/jcp.49.12.971; Swan DC, 1999, J CLIN MICROBIOL, V37, P1030; Baalbergen A, 2007, INT J CANCER, V121, P106, DOI 10.1002/ijc.22678; Batistatou A, 2000, INT J GYNECOL CANCER, V10, P336, DOI 10.1046/j.1525-1438.2000.010004336.x; Bocker W, 2002, VERH DEUT G, V86, P116; Broker TR, 2001, DEV BIOL BASEL, V106, P465; Chiesa-Vottero AG, 2007, INT J GYNECOL PATHOL, V26, P328, DOI 10.1097/01.pgp.0000235065.31301.3e; De Roda Husman Ana-Maria, 1995, Journal of General Virology, V76, P1057, DOI 10.1099/0022-1317-76-4-1057; Deavers MT, 2003, INT J GYNECOL CANCER, V13, P567, DOI 10.1046/j.1525-1438.2003.13387.x; Fontaine J, 2005, AIDS, V19, P785, DOI 10.1097/01.aids.0000168972.65304.6b; Franco EL, 1999, J NATL CANCER I, V91, P506, DOI 10.1093/jnci/91.6.506; Hadzisejdic I, 2007, COLLEGIUM ANTROPOL, V31, P97; Hashi A, 2003, INT J GYNECOL PATHOL, V22, P374, DOI 10.1097/01.pgp.0000092130.10100.88; Hylander B, 2006, GYNECOL ONCOL, V101, P12, DOI 10.1016/j.ygyno.2005.09.052; Lin XQ, 2008, APPL IMMUNOHISTO M M, V16, P453, DOI 10.1097/PAI.0b013e3181672574; Missaoui N, 2006, VIRCHOWS ARCH, V448, P597, DOI 10.1007/s00428-005-0141-x; Nofech-Mozes S, 2010, APPL IMMUNOHISTO M M, V18, P80, DOI 10.1097/PAI.0b013e3181ae7240; Nofech-Mozes S, 2008, MODERN PATHOL, V21, P1147, DOI 10.1038/modpathol.2008.108; Nofech-Mozes S, 2006, INT J GYNECOL CANCER, V16, P286, DOI 10.1111/j.1525-1438.2006.00514.x; Riethdorf L, 2002, HUM PATHOL, V33, P899, DOI 10.1053/hupa.2002.127442; Togami S, 2012, GYNECOL OBSTET INVES, V73, P26, DOI 10.1159/000329319; Togami S, 2012, CANCER SCI, V103, P926, DOI 10.1111/j.1349-7006.2012.02240.x; TSUDA H, 1995, JPN J CANCER RES, V86, P1049; Zhou C, 1998, AM J SURG PATHOL, V22, P113, DOI 10.1097/00000478-199801000-00015	35	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1219-4956	1532-2807		PATHOL ONCOL RES	Pathol. Oncol. Res.	APR	2015	21	2					487	494		10.1007/s12253-014-9854-y		8	Oncology; Pathology	Oncology; Pathology	CH8DG	WOS:000354265700031		
J	Izumi, M; Hidema, J; Wada, S; Kondo, E; Kurusu, T; Kuchitsu, K; Makino, A; Ishida, H				Izumi, Masanori; Hidema, Jun; Wada, Shinya; Kondo, Eri; Kurusu, Takamitsu; Kuchitsu, Kazuyuki; Makino, Amane; Ishida, Hiroyuki			Establishment of Monitoring Methods for Autophagy in Rice Reveals Autophagic Recycling of Chloroplasts and Root Plastids during Energy Limitation	PLANT PHYSIOLOGY			English	Article							GATEWAY BINARY VECTORS; ORYZA-SATIVA-L; ARABIDOPSIS-THALIANA; LEAF SENESCENCE; PLANT-CELLS; DEGRADATION; RUBISCO; PROTEINS; LEAVES; FUSION	Autophagy is an intracellular process leading to vacuolar or lysosomal degradation of cytoplasmic components in eukaryotes. Establishment of proper methods to monitor autophagy was a key step in uncovering its role in organisms, such as yeast (Saccharomyces cerevisiae), mammals, and Arabidopsis (Arabidopsis thaliana), in which chloroplastic proteins were found to be recycled by autophagy. Chloroplast recycling has been predicted to function in nutrient remobilization for growing organs or grain filling in cereal crops. Here, to develop our understanding of autophagy in cereals, we established monitoring methods for chloroplast autophagy in rice (Oryza sativa). We generated transgenic rice-expressing fluorescent protein (FP) OsAuTophaGy8 (OsATG8) fusions as autophagy markers. FP-ATG8 signals were delivered into the vacuolar lumen in living cells of roots and leaves mainly as vesicles corresponding to autophagic bodies. This phenomenon was not observed upon the addition of wortmannin, an inhibitor of autophagy, or in an ATG7 knockout mutant. Markers for the chloroplast stroma, stromal FP, and FP-labeled Rubisco were delivered by a type of autophagic body called the Rubisco-containing body (RCB) in the same manner. RCB production in excised leaves was suppressed by supply of external sucrose or light. The release of free FP caused by autophagy-dependent breakdown of FP-labeled Rubisco was induced during accelerated senescence in individually darkened leaves. In roots, nongreen plastids underwent both RCB-mediated and entire organelle types of autophagy. Therefore, our newly developed methods to monitor autophagy directly showed autophagic degradation of leaf chloroplasts and root plastids in rice plants and its induction during energy limitation.	[Izumi, Masanori] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Sendai, Miyagi 9808578, Japan; [Izumi, Masanori; Hidema, Jun] Tohoku Univ, Grad Sch Life Sci, Dept Environm Life Sci, Sendai, Miyagi 9808577, Japan; [Wada, Shinya; Kondo, Eri; Makino, Amane; Ishida, Hiroyuki] Tohoku Univ, Grad Sch Agr Sci, Dept Appl Plant Sci, Sendai, Miyagi 9818555, Japan; [Kurusu, Takamitsu; Kuchitsu, Kazuyuki] Tokyo Univ Sci, Dept Appl Biol Sci, Chiba 2788510, Japan; [Kurusu, Takamitsu; Kuchitsu, Kazuyuki] Tokyo Univ Sci, Res Inst Sci & Technol, Chiba 2788510, Japan; [Kurusu, Takamitsu] Tokyo Univ Technol, Sch Biosci & Biotechnol, Tokyo 1920982, Japan; [Makino, Amane] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo 1020076, Japan	Ishida, H (reprint author), Tohoku Univ, Grad Sch Agr Sci, Dept Appl Plant Sci, Sendai, Miyagi 9818555, Japan.	hiroyuki@biochem.tohoku.ac.jp			KAKENHI [26506001, 25120702, 24380037, 25119703, 26660286]; Frontier Research Institute for Interdisciplinary Sciences, Tohoku University (Program for Creation of Interdisciplinary Research); Ministry of Education, Culture, Sports, Science and Technology, Japan (GRENE/NC-CARP Project)	This work was supported, in part, by KAKENHI (grant nos. 26506001 to M.I., 25120702 to J.H., 24380037 to H.I., 25119703 to H.I., and 26660286 to H.I.); the Frontier Research Institute for Interdisciplinary Sciences, Tohoku University (Program for Creation of Interdisciplinary Research to M.I.); and the Ministry of Education, Culture, Sports, Science and Technology, Japan (GRENE/NC-CARP Project to A.M.).	NAKANO H, 1995, PLANT CELL PHYSIOL, V36, P653; Izumi M, 2010, PLANT PHYSIOL, V154, P1196, DOI 10.1104/pp.110.158519; Kim J, 2013, PLANT CELL, V25, P4956, DOI 10.1105/tpc.113.117960; Cheong H, 2008, METHOD ENZYMOL, V451, P1, DOI 10.1016/S0076-6879(08)03201-1; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Toyooka K, 2006, AUTOPHAGY, V2, P96; Yoshimoto K, 2004, PLANT CELL, V16, P2967, DOI 10.1105/tpc.104.025395; Suzuki Y, 2009, PLANT CELL PHYSIOL, V50, P1851, DOI 10.1093/pcp/pcp120; Takatsuka C, 2011, PLANT CELL PHYSIOL, V52, P2074, DOI 10.1093/pcp/pcr137; Kurusu T, 2014, AUTOPHAGY, V10, P878, DOI 10.4161/auto.28279; Guiboileau A, 2012, NEW PHYTOL, V194, P732, DOI 10.1111/j.1469-8137.2012.04084.x; Ishida H, 2008, PLANT PHYSIOL, V148, P142, DOI 10.1104/pp.108.122770; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Suttangkakul A, 2011, PLANT CELL, V23, P3761, DOI 10.1105/tpc.111.090993; Izumi M, 2013, PLANT PHYSIOL, V161, P1682, DOI 10.1104/pp.113.215632; Brouwer B, 2012, PLANT CELL ENVIRON, V35, P1084, DOI 10.1111/j.1365-3040.2011.02474.x; Phillips AR, 2008, GENETICS, V178, P1339, DOI 10.1534/genetics.107.086199; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Xia KF, 2011, DNA RES, V18, P363, DOI 10.1093/dnares/dsr024; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Ono Y, 2013, PLANT CELL ENVIRON, V36, P1147, DOI 10.1111/pce.12049; Wada S, 2009, PLANT PHYSIOL, V149, P885, DOI 10.1104/pp.108.130013; Hanaoka H, 2002, PLANT PHYSIOL, V129, P1181, DOI 10.1104/pp.011024; Weaver LM, 2001, PLANT PHYSIOL, V127, P876, DOI 10.1104/pp.127.3.876; Li FQ, 2014, PLANT CELL, V26, P788, DOI 10.1105/tpc.113.120014; Ghiglione HO, 2008, PLANT J, V55, P1010, DOI 10.1111/j.1365-313X.2008.03570.x; Shibata M, 2013, PLANT CELL, V25, P4967, DOI 10.1105/tpc.113.116947; Fujiki Y, 2007, PLANT PHYSIOL, V143, P1132, DOI 10.1104/pp.106.093864; Xiong Y, 2005, PLANT J, V42, P535, DOI 10.1111/j.1365-313X.2005.02397.x; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Thompson AR, 2005, PLANT PHYSIOL, V138, P2097, DOI 10.1104/pp.105.060673; Yoshimoto K, 2012, PLANT CELL PHYSIOL, V53, P1355, DOI 10.1093/pcp/pcs099; Li FQ, 2012, TRENDS PLANT SCI, V17, P526, DOI 10.1016/j.tplants.2012.05.006; Bampton ETW, 2005, AUTOPHAGY, V1, P23; Ishida H, 1997, PLANT CELL PHYSIOL, V38, P471; Makino A, 2003, PLANT CELL PHYSIOL, V44, P952, DOI 10.1093/pcp/pcg113; MAE T, 1981, PLANT CELL PHYSIOL, V22, P1067; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Masclaux C, 2001, ANN APPL BIOL, V138, P69, DOI 10.1111/j.1744-7348.2001.tb00086.x; Ishida H, 2014, BBA-BIOENERGETICS, V1837, P512, DOI 10.1016/j.bbabio.2013.11.009; Merkulova EA, 2014, PLANT CELL PHYSIOL, V55, P715, DOI 10.1093/pcp/pcu041; Liu YM, 2012, ANNU REV PLANT BIOL, V63, P215, DOI 10.1146/annurev-arplant-042811-105441; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Doelling JH, 2002, J BIOL CHEM, V277, P33105, DOI 10.1074/jbc.M204630200; Chung T, 2010, PLANT J, V62, P483, DOI 10.1111/j.1365-313X.2010.04166.x; Takahashi S, 2014, PLANT J, V79, P951, DOI 10.1111/tpj.12598; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Suzuki Y, 2007, PLANT CELL PHYSIOL, V48, P626, DOI 10.1093/pcp/pcm035; Yoshimoto K, 2009, PLANT CELL, V21, P2914, DOI 10.1105/tpc.109.068635; Chung T, 2009, PLANT PHYSIOL, V149, P220, DOI 10.1104/pp.108.126714; Hanson MR, 2008, PLANT CELL ENVIRON, V31, P646, DOI 10.1111/j.1365-3040.2007.01768.x; FRIEDRICH JW, 1980, PLANT PHYSIOL, V65, P1103, DOI 10.1104/pp.65.6.1103; Nakagawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P2095, DOI 10.1271/bbb.70216; MAE T, 1983, PLANT CELL PHYSIOL, V24, P1079; Munch D, 2014, AUTOPHAGY, V10, P1579, DOI 10.4161/auto.29406; Nakayama M, 2012, PLANTA, V236, P999, DOI 10.1007/s00425-012-1655-5; Yoshimoto K, 2014, J CELL SCI, V127, P1161, DOI 10.1242/jcs.139709; Zhou J, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00174	59	4	4	AMER SOC PLANT BIOLOGISTS	ROCKVILLE	15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA	0032-0889	1532-2548		PLANT PHYSIOL	Plant Physiol.	APR	2015	167	4					1307	U316		10.1104/pp.114.254078		22	Plant Sciences	Plant Sciences	CI0PC	WOS:000354438500010		
J	Morita, R; Sugino, M; Hatanaka, T; Misoo, S; Fukayama, H				Morita, Ryutaro; Sugino, Miho; Hatanaka, Tomoko; Misoo, Shuji; Fukayama, Hiroshi			CO2-Responsive CONSTANS, CONSTANS-Like, and Time of Chlorophyll a/b Binding Protein Expression1 Protein Is a Positive Regulator of Starch Synthesis in Vegetative Organs of Rice	PLANT PHYSIOLOGY			English	Article							ADP-GLUCOSE PYROPHOSPHORYLASE; ARABIDOPSIS CIRCADIAN CLOCK; ELEVATED CARBON-DIOXIDE; GENE-EXPRESSION; TRANSCRIPTION FACTOR; SIGNALING PATHWAYS; SHOOT GRAVITROPISM; HEADING PERIOD; SMALL-SUBUNIT; SUGAR	A unique CO2-Responsive CONSTANS, CONSTANS-like, and Time of Chlorophyll a/b Binding Protein1 (CCT) Protein (CRCT) containing a CCT domain but not a zinc finger motif is described, which is up-regulated under elevated CO2 in rice (Oryza sativa). The expression of CRCT showed diurnal oscillation peaked at the end of the light period and was also increased by sugars such as glucose and sucrose. Promoter beta-glucuronidase analysis showed that CRCT was highly expressed in the phloem of various tissues such as leaf blade and leaf sheath. Overexpression or RNA interference knockdown of CRCT had no appreciable effect on plant growth and photosynthesis except that tiller angle was significantly increased by the overexpression. More importantly, starch content in leaf sheath, which serves as a temporary storage organ for photoassimilates, was markedly increased in overexpression lines and decreased in knockdown lines. The expressions of several genes related to starch synthesis, such as ADP-glucose pyrophospholylase and a-glucan phospholylase, were significantly changed in transgenic lines and positively correlated with the expression levels of CRCT. Given these observations, we suggest that CRCT is a positive regulator of starch accumulation in vegetative tissues, regulating coordinated expression of starch synthesis genes in response to the levels of photoassimilates.	[Morita, Ryutaro; Sugino, Miho; Hatanaka, Tomoko; Misoo, Shuji; Fukayama, Hiroshi] Kobe Univ, Grad Sch Agr Sci, Lab Crop Sci, Kobe, Hyogo 6578501, Japan	Fukayama, H (reprint author), Kobe Univ, Grad Sch Agr Sci, Lab Crop Sci, Kobe, Hyogo 6578501, Japan.	fukayama@people.kobe-u.ac.jp			Ministry of Education, Culture, Sport, Science, and Technology of Japan [20580014, 22114511]	This work was supported by the Ministry of Education, Culture, Sport, Science, and Technology of Japan (Scientific Research Grants-in-Aid nos. 20580014 and 22114511 to H.F.).	Akihiro T, 2005, PLANT CELL PHYSIOL, V46, P937, DOI 10.1093/pcp/pci101; Scheible WR, 1997, PLANT CELL, V9, P783; Crevillen P, 2005, J BIOL CHEM, V280, P8143, DOI 10.1074/jbc.M411713200; Fukayama H, 2009, PLANT SCI, V177, P203, DOI 10.1016/j.plantsci.2009.05.014; Weise SE, 2011, J EXP BOT, V62, P3109, DOI 10.1093/jxb/err035; Dauvillee D, 2006, PLANT J, V48, P274, DOI 10.1111/j.1365-313X.2006.02870.x; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Cheng WG, 2009, AGR FOREST METEOROL, V149, P51, DOI 10.1016/j.agrformet.2008.07.006; Yoshihara T, 2007, PLANT CELL PHYSIOL, V48, P678, DOI 10.1093/pcp/pcm042; Stitt M, 1999, PLANT CELL ENVIRON, V22, P583, DOI 10.1046/j.1365-3040.1999.00386.x; Fukayama H, 2011, FIELD CROP RES, V121, P195, DOI 10.1016/j.fcr.2010.11.018; Rolland F, 2001, TRENDS BIOCHEM SCI, V26, P310, DOI 10.1016/S0968-0004(01)01805-9; Hirano T, 2005, PLANT PROD SCI, V8, P122, DOI 10.1626/pps.8.122; Vitha S, 2007, AM J BOT, V94, P590, DOI 10.3732/ajb.94.4.590; Li PJ, 2007, CELL RES, V17, P402, DOI 10.1038/cr.2007.38; Fu FF, 2010, PLANT PHYSIOL, V154, P927, DOI 10.1104/pp.110.159517; Ishikawa R, 2011, PLANT J, V65, P798, DOI 10.1111/j.1365-313X.2010.04466.x; Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Zhu Y, 2003, J BIOL CHEM, V278, P47803, DOI 10.1074/jbc.M302806200; Tiwari SB, 2010, NEW PHYTOL, V187, P57, DOI 10.1111/j.1469-8137.2010.03251.x; Tallis MJ, 2010, NEW PHYTOL, V186, P415, DOI 10.1111/j.1469-8137.2010.03184.x; An HL, 2004, DEVELOPMENT, V131, P3615, DOI 10.1242/dev.01231; Rook F, 2001, PLANT J, V26, P421, DOI 10.1046/j.1365-313X.2001.2641043.x; Leakey ADB, 2009, P NATL ACAD SCI USA, V106, P3597, DOI 10.1073/pnas.0810955106; Ishikawa C, 2011, PLANT PHYSIOL, V156, P1603, DOI 10.1104/pp.111.177030; Solfanelli C, 2006, PLANT PHYSIOL, V140, P637, DOI 10.1104/pp.105.072579; Morita K, 2014, PLANT PHYSIOL, V164, P69, DOI 10.1104/pp.113.228015; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; Wang JC, 2013, J EXP BOT, V64, P3453, DOI 10.1093/jxb/ert187; Xiao WY, 2000, PLANT MOL BIOL, V44, P451, DOI 10.1023/A:1026501430422; Flugge UI, 2011, J EXP BOT, V62, P2381, DOI 10.1093/jxb/erq361; Li PH, 2008, PLANT CELL ENVIRON, V31, P1673, DOI 10.1111/j.1365-3040.2008.01874.x; Saeed AI, 2003, BIOTECHNIQUES, V34, P374; Yu BS, 2007, PLANT J, V52, P891, DOI 10.1111/j.1365-313X.2007.03284.x; Meehl GA, 2007, CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Gendron JM, 2012, P NATL ACAD SCI USA, V109, P3167, DOI 10.1073/pnas.1200355109; Wu XR, 2013, PLANT PHYSIOL, V161, P317, DOI 10.1104/pp.112.208496; Cook JH, 1972, P CROP SCI SOC JPN, V41, P226; Dian WM, 2003, PLANTA, V218, P261, DOI 10.1007/s00425-003-1101-9; Hirose T, 2006, PHYSIOL PLANTARUM, V128, P425, DOI 10.1111/j.1399-3054.2006.00758.x; Kaczorowski KA, 2003, PLANT CELL, V15, P2654, DOI 10.1105/tpc.015065; Kaplan F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043583; Masaki T, 2005, PLANT J, V43, P142, DOI 10.1111/j.1365-313X.2005.02439.x; MATSUOKA M, 1991, MOL GEN GENET, V228, P143; Okamura M, 2013, FUNCT PLANT BIOL, V40, P1137, DOI 10.1071/FP13105; Para A, 2007, PLANT CELL, V19, P3462, DOI 10.1105/tpc.107.054775; Rook F, 2006, PLANT J, V46, P1045, DOI 10.1111/j.1365-313X.2006.02765.x; Satoh H, 2008, PLANT CELL, V20, P1833, DOI 10.1105/tpc.107.054007; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Tiessen A, 2003, PLANT J, V35, P490, DOI 10.1046/j.1365-313X.2003.01823.x	50	0	0	AMER SOC PLANT BIOLOGISTS	ROCKVILLE	15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA	0032-0889	1532-2548		PLANT PHYSIOL	Plant Physiol.	APR	2015	167	4					1321	U345		10.1104/pp.15.00021		29	Plant Sciences	Plant Sciences	CI0PC	WOS:000354438500011		
J	Kolb, C; Nagel, MK; Kalinowska, K; Hagmann, J; Ichikawa, M; Anzenberger, F; Alkofer, A; Sato, MH; Braun, P; Isono, E				Kolb, Cornelia; Nagel, Marie-Kristin; Kalinowska, Kamila; Hagmann, Joerg; Ichikawa, Mie; Anzenberger, Franziska; Alkofer, Angela; Sato, Masa H.; Braun, Pascal; Isono, Erika			FYVE1 Is Essential for Vacuole Biogenesis and Intracellular Trafficking in Arabidopsis	PLANT PHYSIOLOGY			English	Article							DEUBIQUITINATING ENZYME AMSH3; DOMAIN-CONTAINING PROTEINS; SEED STORAGE PROTEINS; PLANT-GROWTH; PREVACUOLAR COMPARTMENT; FLUORESCENT PROTEIN; POSITIVE REGULATOR; VESICLE FORMATION; SORTING MUTANTS; SHORT READS	The plant vacuole is a central organelle that is involved in various biological processes throughout the plant life cycle. Elucidating the mechanism of vacuole biogenesis and maintenance is thus the basis for our understanding of these processes. Proper formation of the vacuole has been shown to depend on the intracellular membrane trafficking pathway. Although several mutants with altered vacuole morphology have been characterized in the past, the molecular basis for plant vacuole biogenesis has yet to be fully elucidated. With the aim to identify key factors that are essential for vacuole biogenesis, we performed a forward genetics screen in Arabidopsis (Arabidopsis thaliana) and isolated mutants with altered vacuole morphology. The vacuolar fusion defective1 (vfd1) mutant shows seedling lethality and defects in central vacuole formation. VFD1 encodes a Fab1, YOTB, Vac1, and EEA1 (FYVE) domain-containing protein, FYVE1, that has been implicated in intracellular trafficking. FYVE1 localizes on late endosomes and interacts with Src homology-3 domain-containing proteins. Mutants of FYVE1 are defective in ubiquitin-mediated protein degradation, vacuolar transport, and autophagy. Altogether, our results show that FYVE1 is essential for plant growth and development and place FYVE1 as a key regulator of intracellular trafficking and vacuole biogenesis.	[Kolb, Cornelia; Nagel, Marie-Kristin; Kalinowska, Kamila; Anzenberger, Franziska; Alkofer, Angela; Braun, Pascal; Isono, Erika] Tech Univ Munich, Plant Syst Biol, D-85354 Freising Weihenstephan, Germany; [Hagmann, Joerg] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany; [Ichikawa, Mie; Sato, Masa H.] Kyoto Prefectural Univ, Dept Life & Environm Sci, Sakyo Ku, Kyoto 6068522, Japan	Isono, E (reprint author), Tech Univ Munich, Plant Syst Biol, D-85354 Freising Weihenstephan, Germany.	erika.isono@wzw.tum.de	Braun, Pascal/B-9669-2013	Braun, Pascal/0000-0003-2012-6746	Deutsche Forschungsgemeinschaft [SFB924, A06, A10]; Ministry of Education, Culture, Sports, Science, and Technology, Japan [25119720]	This work was supported by the Deutsche Forschungsgemeinschaft SFB924 (grant no. A06 to E.I.) and SFB924 (grant no. A10 to P.B.) and the Ministry of Education, Culture, Sports, Science, and Technology, Japan (Scientific Research on Innovative Areas Grant-in-Aid no. 25119720 to M.H.S.).	Reyes FC, 2011, CURR OPIN PLANT BIOL, V14, P666, DOI 10.1016/j.pbi.2011.07.009; Cui Y, 2014, PLANT CELL, V26, P2080, DOI 10.1105/tpc.114.123141; Svenning S, 2011, AUTOPHAGY, V7, P993, DOI 10.4161/auto.7.9.16389; Isono E, 2010, PLANT CELL, V22, P1826, DOI 10.1105/tpc.110.075952; Uemura T, 2004, CELL STRUCT FUNCT, V29, P49, DOI 10.1247/csf.29.49; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Yoshimoto K, 2004, PLANT CELL, V16, P2967, DOI 10.1105/tpc.104.025395; Zhuang XH, 2013, PLANT CELL, V25, P4596, DOI 10.1105/tpc.113.118307; Shimada T, 2006, PLANT CELL PHYSIOL, V47, P1187, DOI 10.1093/pcp/pcj103; Ito E, 2012, PLANT J, V69, P204, DOI 10.1111/j.1365-313X.2011.04782.x; Hofius D, 2009, CELL, V137, P773, DOI 10.1016/j.cell.2009.02.036; Dreze M, 2010, METHOD ENZYMOL, V470, P281, DOI 10.1016/S0076-6879(10)70012-4; Shahriari M, 2010, PLANT J, V64, P71, DOI 10.1111/j.1365-313X.2010.04310.x; Phillips AR, 2008, GENETICS, V178, P1339, DOI 10.1534/genetics.107.086199; Drakakaki G, 2013, PLANT SCI, V203, P74, DOI 10.1016/j.plantsci.2012.12.017; Balderhaar HJK, 2013, J CELL SCI, V126, P1307, DOI 10.1242/jcs.107805; Shimada T, 2003, J BIOL CHEM, V278, P32292, DOI 10.1074/jbc.M305740200; Wickner W, 2010, ANNU REV CELL DEV BI, V26, P115, DOI 10.1146/annurev-cellbio-100109-104131; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389; Scheuring D, 2011, PLANT CELL, V23, P3463, DOI 10.1105/tpc.111.086918; Spitzer C, 2009, PLANT CELL, V21, P749, DOI 10.1105/tpc.108.064865; Kulich I, 2013, TRAFFIC, V14, P1155, DOI 10.1111/tra.12101; Rojo E, 2001, DEV CELL, V1, P303, DOI 10.1016/S1534-5807(01)00024-7; Yamazaki M, 2008, PLANT CELL PHYSIOL, V49, P142, DOI 10.1093/pcp/pcn006; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Katsiarimpa A, 2011, PLANT CELL, V23, P3026, DOI 10.1105/tpc.111.087254; Katsiarimpa A, 2013, PLANT CELL, V25, P2236, DOI 10.1105/tpc.113.113399; BANTA LM, 1988, J CELL BIOL, V107, P1369, DOI 10.1083/jcb.107.4.1369; Singh MK, 2014, CURR BIOL, V24, P1383, DOI 10.1016/j.cub.2014.05.005; Sanmartin M, 2007, P NATL ACAD SCI USA, V104, P3645, DOI 10.1073/pnas.0611147104; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Cai Y, 2014, PLANT PHYSIOL, V165, P1328, DOI 10.1104/pp.114.238378; Haas TJ, 2007, PLANT CELL, V19, P1295, DOI 10.1105/tpc.106.049346; Thompson AR, 2005, PLANT PHYSIOL, V138, P2097, DOI 10.1104/pp.105.060673; Hirano T, 2011, PLANT PHYSIOL, V155, P797, DOI 10.1104/pp.110.167981; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Schneeberger K, 2009, NAT METHODS, V6, P550, DOI 10.1038/nmeth0809-550; Ebine K, 2014, CURR BIOL, V24, P1375, DOI 10.1016/j.cub.2014.05.004; Ueda T, 2004, PLANT J, V40, P783, DOI 10.1111/j.1365-313X.2004.02249.x; Viotti C, 2013, PLANT CELL, V25, P3434, DOI 10.1105/tpc.113.114827; Geldner N, 2009, PLANT J, V59, P169, DOI 10.1111/j.1365-313X.2009.03851.x; Katsiarimpa A, 2014, PLANT CELL PHYSIOL, V55, P727, DOI 10.1093/pcp/pcu019; Liu YM, 2012, ANNU REV PLANT BIOL, V63, P215, DOI 10.1146/annurev-arplant-042811-105441; Barberon M, 2014, P NATL ACAD SCI USA, V111, P8293, DOI 10.1073/pnas.1402262111; Lam BCH, 2001, PLANT CELL, V13, P2499, DOI 10.1105/tpc.13.11.2499; Ebine K, 2008, PLANT CELL, V20, P3006, DOI 10.1105/tpc.107.057711; Winter V, 2006, TRENDS PLANT SCI, V11, P115, DOI 10.1016/j.tplants.2006.01.006; Serrazina S, 2014, NEW PHYTOL, V203, P784, DOI 10.1111/nph.12836; Ossowski S, 2008, GENOME RES, V18, P2024, DOI 10.1101/gr.080200.108; WADA Y, 1992, J BIOL CHEM, V267, P18671; Grefen C, 2010, PLANT J, V64, P355, DOI 10.1111/j.1365-313X.2010.04322.x; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Bassham DC, 2008, SECRETORY SYSTEM ARA; Fuji K, 2007, PLANT CELL, V19, P597, DOI 10.1105/tpc.106.045997; Gao CJ, 2014, CURR BIOL, V24, P2556, DOI 10.1016/j.cub.2014.09.014; Nishizawa K, 2003, PLANT J, V34, P647, DOI 10.1046/j.1365-313X.2003.01754.x; Sanderfoot AA, 2003, SECRETORY SYSTEM ARA; Schneeberger K, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r98; van Leeuwen W, 2004, TRENDS PLANT SCI, V9, P378, DOI 10.1016/j.tplants.2004.06.008; Vermeer JEM, 2006, PLANT J, V47, P687, DOI 10.1111/j.1365-313X.2006.02830.x; Weigel D, 2001, ARABIDOPSIS LAB MANU; Wessling R, 2014, CELL HOST MICROBE, V16, P364, DOI 10.1016/j.chom.2014.08.004; Wywial E, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-157; Zhang CH, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00476; Zouhar J, 2009, PLANT PHYSIOL, V149, P1668, DOI 10.1104/pp.108.134361	67	3	3	AMER SOC PLANT BIOLOGISTS	ROCKVILLE	15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA	0032-0889	1532-2548		PLANT PHYSIOL	Plant Physiol.	APR	2015	167	4					1361	U414		10.1104/pp.114.253377		19	Plant Sciences	Plant Sciences	CI0PC	WOS:000354438500014		
J	Xue, HD; Tokutsu, R; Bergner, SV; Scholz, M; Minagawa, J; Hippler, M				Xue, Huidan; Tokutsu, Ryutaro; Bergner, Sonja Verena; Scholz, Martin; Minagawa, Jun; Hippler, Michael			PHOTOSYSTEM II SUBUNIT R Is Required for Efficient Binding of LIGHT-HARVESTING COMPLEX STRESS-RELATED PROTEIN3 to Photosystem II-Light-Harvesting Supercomplexes in Chlamydomonas reinhardtii	PLANT PHYSIOLOGY			English	Article							OXYGEN-EVOLVING COMPLEX; PHOSPHOPROTEOME PROFILING REVEALS; 10 KDA POLYPEPTIDE; IRON-DEFICIENCY; GENOME REVEALS; SUPRAMOLECULAR ORGANIZATION; SUBCELLULAR-LOCALIZATION; ARABIDOPSIS-THALIANA; PSBQ PROTEINS; GREEN PLANTS	In Chlamydomonas reinhardtii, the LIGHT-HARVESTING COMPLEX STRESS-RELATED PROTEIN3 (LHCSR3) protein is crucial for efficient energy-dependent thermal dissipation of excess absorbed light energy and functionally associates with photosystem II-light-harvesting complex II (PSII-LHCII) supercomplexes. Currently, it is unknown how LHCSR3 binds to the PSII-LHCII supercomplex. In this study, we investigated the role of PHOTOSYSTEM II SUBUNIT R (PSBR) an intrinsic membrane-spanning PSII subunit, in the binding of LHCSR3 to PSII-LHCII supercomplexes. Down-regulation of PSBR expression diminished the efficiency of oxygen evolution and the extent of nonphotochemical quenching and had an impact on the stability of the oxygen-evolving complex as well as on PSII-LHCII-LHCSR3 supercomplex formation. Its down-regulation destabilized the PSII-LHCII supercomplex and strongly reduced the binding of LHCSR3 to PSII-LHCII supercomplexes, as revealed by quantitative proteomics. PHOTOSYSTEM II SUBUNIT P deletion, on the contrary, destabilized PHOTOSYSTEM II SUBUNIT Q binding but did not affect PSBR and LHCSR3 association with PSII-LHCII. In summary, these data provide clear evidence that PSBR is required for the stable binding of LHCSR3 to PSII-LHCII supercomplexes and is essential for efficient energy-dependent quenching and the integrity of the PSII-LHCII-LHCSR3 supercomplex under continuous high light.	[Xue, Huidan; Bergner, Sonja Verena; Scholz, Martin; Hippler, Michael] Univ Munster, Inst Plant Biol & Biotechnol, D-48143 Munster, Germany; [Tokutsu, Ryutaro; Minagawa, Jun] Natl Inst Basic Biol, Div Environm Photobiol, Okazaki, Aichi 4448585, Japan	Hippler, M (reprint author), Univ Munster, Inst Plant Biol & Biotechnol, D-48143 Munster, Germany.	mhippler@uni-muenster.de			Deutsche Forschungsgemeinschaft [HI 739/8.1]; Chinese Scholarship Council; Japan Society for the Promotion of Science [26251033]	This work was supported by the Deutsche Forschungsgemeinschaft (grant no. HI 739/8.1 to M.H.), the Chinese Scholarship Council (to H.X.), and the Japan Society for the Promotion of Science (grant no. 26251033 to J.M.).	Petroutsos D, 2011, PLANT CELL, V23, P2950, DOI 10.1105/tpc.111.087973; KINDLE KL, 1989, J CELL BIOL, V109, P2589, DOI 10.1083/jcb.109.6.2589; Peers G, 2009, NATURE, V462, P518, DOI 10.1038/nature08587; Boekema EJ, 1999, BIOCHEMISTRY-US, V38, P2233, DOI 10.1021/bi9827161; Naumann B, 2005, J BIOL CHEM, V280, P20431, DOI 10.1074/jbc.M414486200; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; Tokutsu R, 2012, J BIOL CHEM, V287, P31574, DOI 10.1074/jbc.M111.331991; Reiland S, 2011, P NATL ACAD SCI USA, V108, P12955, DOI 10.1073/pnas.1104734108; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Ido K, 2014, J BIOL CHEM, V289, P20150, DOI 10.1074/jbc.M114.574822; Turkina MV, 2006, MOL CELL PROTEOMICS, V5, P1412, DOI 10.1074/mcp.M600066-MCP200; Prochnik SE, 2010, SCIENCE, V329, P223, DOI 10.1126/science.1188800; Naumann B, 2007, PROTEOMICS, V7, P3964, DOI 10.1002/pmic.200700407; Blanc G, 2010, PLANT CELL, V22, P2943, DOI 10.1105/tpc.110.076406; Reiland S, 2009, PLANT PHYSIOL, V150, P889, DOI 10.1104/pp.109.138677; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; Nakagami H, 2010, PLANT PHYSIOL, V153, P1161, DOI 10.1104/pp.110.157347; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Alboresi A, 2010, P NATL ACAD SCI USA, V107, P11128, DOI 10.1073/pnas.1002873107; Stauber EJ, 2003, EUKARYOT CELL, V2, P978, DOI 10.1128/EC.2.5.978-994.2003; Allahverdiyeva Y, 2007, BBA-BIOENERGETICS, V1767, P677, DOI 10.1016/j.bbabio.2007.01.011; Molnar A, 2009, PLANT J, V58, P165, DOI 10.1111/j.1365-313X.2008.03767.x; Busch A, 2011, BBA-BIOENERGETICS, V1807, P864, DOI 10.1016/j.bbabio.2010.09.009; LJUNGBERG U, 1986, EUR J BIOCHEM, V158, P477, DOI 10.1111/j.1432-1033.1986.tb09779.x; Pagliano C, 2014, BBA-BIOENERGETICS, V1837, P1454, DOI 10.1016/j.bbabio.2013.11.004; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Elrad D, 2002, PLANT CELL, V14, P1801, DOI 10.1005/tpc.002154; Tardif M, 2012, MOL BIOL EVOL, V29, P3625, DOI 10.1093/molbev/mss178; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Tokutsu R, 2013, P NATL ACAD SCI USA, V110, P10016, DOI 10.1073/pnas.1222606110; Caffarri S, 2009, EMBO J, V28, P3052, DOI 10.1038/emboj.2009.232; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Allahverdiyeva Y, 2013, PLANT J, V75, P671, DOI 10.1111/tpj.12230; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; WHATLEY FR, 1963, P NATL ACAD SCI USA, V49, P266, DOI 10.1073/pnas.49.2.266; Thingholm TE, 2008, MOL CELL PROTEOMICS, V7, P661, DOI 10.1074/mcp.M700362-MCP200; Allorent G, 2013, PLANT CELL, V25, P545, DOI 10.1105/tpc.112.108274; Pagliano C, 2013, PHOTOSYNTH RES, V116, P167, DOI 10.1007/s11120-013-9803-8; Takahashi H, 2006, P NATL ACAD SCI USA, V103, P477, DOI 10.1073/pnas.0509952103; BOEKEMA EJ, 1995, P NATL ACAD SCI USA, V92, P175, DOI 10.1073/pnas.92.1.175; DEVITRY C, 1989, J CELL BIOL, V109, P991, DOI 10.1083/jcb.109.3.991; GILGOMEZ G, 1991, PLANT MOL BIOL, V17, P517, DOI 10.1007/BF00040648; Harris E.H, 1989, CHLAMYDOMONAS SOURCE, P780; Hohner R, 2013, MOL CELL PROTEOMICS, V12, P2774, DOI 10.1074/mcp.M113.029991; Ifuku K, 2011, J PHOTOCH PHOTOBIO B, V104, P158, DOI 10.1016/j.jphotobiol.2011.02.006; KUCHKA MR, 1989, CELL, V58, P869, DOI 10.1016/0092-8674(89)90939-2; LAUTNER A, 1988, J BIOL CHEM, V263, P10077; Liu HJ, 2009, ARCH BIOCHEM BIOPHYS, V489, P34, DOI 10.1016/j.abb.2009.07.014; Pan JM, 2011, J PROTEOME RES, V10, P3830, DOI 10.1021/pr200428n; Redding K, 1998, EMBO J, V17, P50, DOI 10.1093/emboj/17.1.50; Rivalta I, 2011, BIOCHEMISTRY-US, V50, P6312, DOI 10.1021/bi200685w; ROVA M, 1994, PHOTOSYNTH RES, V39, P75, DOI 10.1007/BF00027145; Schmollinger S, 2010, CURR GENET, V56, P383, DOI 10.1007/s00294-010-0304-4; Suorsa M, 2006, J BIOL CHEM, V281, P145, DOI 10.1074/jbc.M510600200; WEBBER AN, 1989, FEBS LETT, V242, P435, DOI 10.1016/0014-5793(89)80517-4	57	2	2	AMER SOC PLANT BIOLOGISTS	ROCKVILLE	15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA	0032-0889	1532-2548		PLANT PHYSIOL	Plant Physiol.	APR	2015	167	4					1566	1578		10.1104/pp.15.00094		13	Plant Sciences	Plant Sciences	CI0PC	WOS:000354438500029		
J	Miyao, T; Reker, D; Schneider, P; Funatsu, K; Schneider, G				Miyao, Tomoyuki; Reker, Daniel; Schneider, Petra; Funatsu, Kimito; Schneider, Gisbert			Chemography of Natural Product Space	PLANTA MEDICA			English	Article						computational chemistry; drug discovery; generative topographic map; machine learning; polypharmacology	SELF-ORGANIZING MAP; DRUG DISCOVERY; CHEMICAL SPACE; MACROMOLECULAR TARGETS; LIBRARY DESIGN; RECEPTOR; IDENTIFICATION; VISUALIZATION; PREDICTION; SEARCH	We present the application of the generative topographic map algorithm to visualize the chemical space populated by natural products and synthetic drugs. Generative topographic maps may be used for nonlinear dimensionality reduction and probabilistic modeling. For compound mapping, we represented the molecules by two-dimensional pharmacophore features (chemically advanced template search descriptor). The results obtained suggest a close resemblance of synthetic drugs with natural products in terms of their pharmacophore features, despite pronounced differences in chemical structure. Generative topographic map-based cluster analysis revealed both known and new potential activities of natural products and drug-like compounds. We conclude that the generative topographic map method is suitable for inferring functional similarities between these two classes of compounds and predicting macromolecular targets of natural products.	[Miyao, Tomoyuki; Funatsu, Kimito] Univ Tokyo, Sch Engn, Dept Chem Syst Engn, Tokyo, Japan; [Miyao, Tomoyuki; Reker, Daniel; Schneider, Petra; Schneider, Gisbert] ETH, Dept Chem & Appl Biosci, Inst Pharmaceut Sci, CH-8093 Zurich, Switzerland	Schneider, G (reprint author), ETH, Swiss Fed Inst Technol, Inst Pharmaceut Sci, Dept Chem & Appl Biosci, Vladimir Prelog Weg 4, CH-8093 Zurich, Switzerland.	gisbert.schneider@pharma.ethz.ch			ETH Zurich; OPO Foundation Zurich	ETH Zurich and the OPO Foundation Zurich funded this research study.	Wesolowska A, 2006, J ETHNOPHARMACOL, V107, P254, DOI 10.1016/j.jep.2006.03.003; Newman DJ, 2003, J NAT PROD, V66, P1022, DOI 10.1021/np030096l; GUAN XM, 1992, MOL PHARMACOL, V41, P695; Harvey AL, 2008, DRUG DISCOV TODAY, V13, P894, DOI 10.1016/j.drudis.2008.07.004; Hirata T, 2007, J PHARMACOL SCI, V104, P263, DOI 10.1254/jphs.FP0070620; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Frey BJ, 2005, IEEE T PATTERN ANAL, V27, P1392, DOI 10.1109/TPAMI.2005.169; Oprea TI, 2001, J COMB CHEM, V3, P157, DOI 10.1021/cc0000388; Kireeva N, 2012, MOL INFORM, V31, P301, DOI 10.1002/minf.201100163; Schneider G, 1999, ANGEW CHEM INT EDIT, V38, P2894, DOI 10.1002/(SICI)1521-3773(19991004)38:19<2894::AID-ANIE2894>3.0.CO;2-F; Zhang Q, 2012, J MED CHEM, V55, P8757, DOI 10.1021/jm301064b; Wetzel S, 2007, CHIMIA, V61, P355, DOI 10.2533/chimia.2007.355; Lachance H, 2012, J MED CHEM, V55, P5989, DOI 10.1021/jm300288g; Berthold MR, 2008, STUD CLASS DATA ANAL, P319, DOI 10.1007/978-3-540-78246-9_38; Grabowski K, 2008, NAT PROD REP, V25, P892, DOI 10.1039/b715668p; Lee ML, 2001, J COMB CHEM, V3, P284, DOI 10.1021/cc0000971; Reutlinger M, 2014, ANGEW CHEM INT EDIT, V53, P4244, DOI 10.1002/anie.201310864; Norman AW, 2006, ENDOCRINOLOGY, V147, P5542, DOI 10.1210/en.2006-0946; Ganesan A, 2008, CURR OPIN CHEM BIOL, V12, P306, DOI 10.1016/j.cbpa.2008.03.016; Hufsky F, 2014, NAT PROD REP, V31, P807, DOI 10.1039/c3np70101h; Grienke U, 2011, BIOORGAN MED CHEM, V19, P6779, DOI 10.1016/j.bmc.2011.09.039; Paterson I, 2005, SCIENCE, V310, P451, DOI 10.1126/science.1116364; Rollinger JM, 2009, PLANTA MED, V75, P195, DOI 10.1055/s-0028-1088397; Bishop CM, 1997, ADV NEUR IN, V9, P354; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Maniyar DM, 2006, J CHEM INF MODEL, V46, P1806, DOI 10.1021/ci050471a; Reker D, 2014, P NATL ACAD SCI USA, V111, P4067, DOI 10.1073/pnas.1320001111; Bishop CM, 1998, NEURAL COMPUT, V10, P215, DOI 10.1162/089976698300017953; Rosen J, 2009, J MED CHEM, V52, P1953, DOI 10.1021/jm801514w; Aursand M, 2007, J AGR FOOD CHEM, V55, P38, DOI 10.1021/jf061754l; Basmadjian Christine, 2014, Front Chem, V2, P20, DOI 10.3389/fchem.2014.00020; Bikle DD, 2014, CHEM BIOL, V21, P319, DOI 10.1016/j.chembiol.2013.12.016; BIRCH AJ, 1963, J CHEM SOC, P2762, DOI 10.1039/jr9630002762; Chen KS, 2003, PLANTA MED, V69, P654, DOI 10.1055/s-2003-41112; Gaulton A., 2012, NUCLEIC ACIDS RES, V40, P1100, DOI DOI 10.1093/NAR/GKR777; Hasegawa K, 2014, MOL INFORM, V33, P65, DOI 10.1002/minf.201300137; Ivanenkov YA, 2009, DRUG DISCOV TODAY, V14, P767, DOI 10.1016/j.drudis.2009.05.016; KOO JYM, 2000, DRUG THERAPY DERMATO, V18, P305; Olah M, 2005, METH PRIN MED CHEM, V22, P223; Ovchinnikova SI, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-20; Owen JR, 2011, J CHEM INF MODEL, V51, P1552, DOI [10.1021/ci1004042, 10.1021/CI1004042]; Palomer A, 2007, ANNU REP MED CHEM, V42, P63, DOI 10.1016/S0065-7743(07)42005-X; Picket S., 2003, PROTEIN LIGAND INTER, P73; Reker D, 2014, NAT CHEM, V6, P1072, DOI [10.1038/nchem.2095, 10.1038/NCHEM.2095]; Reutlinger M, 2013, MOL INFORM, V32, P133, DOI 10.1002/minf.201200141; Reutlinger M, 2012, J MOL GRAPH MODEL, V34, P108, DOI 10.1016/j.jmgm.2011.12.006; RINALDICARMONA M, 1992, J PHARMACOL EXP THER, V262, P759; Schneider P, 2003, QSAR COMB SCI, V22, P713, DOI 10.1002/qsar.200330825; Svensen M., 1999, GTM TOOLBOX USERS GU; Todeschini R., 2009, MOL DESCRIPTORS CHEM	50	3	3	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0032-0943	1439-0221		PLANTA MED	Planta Med.	APR	2015	81	6			SI		429	435		10.1055/s-0034-1396322		7	Plant Sciences; Chemistry, Medicinal; Pharmacology & Pharmacy	Plant Sciences; Pharmacology & Pharmacy	CH5XA	WOS:000354108000002		
J	Li, KC; Nishida, K; Ogata, Y; Shi, BL				Li, Kuichun; Nishida, Keiya; Ogata, Youichi; Shi, Baolu			Effect of flat-wall impingement on diesel spray combustion	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART D-JOURNAL OF AUTOMOBILE ENGINEERING			English	Article						Diesel combustion; impingement; OH* chemiluminescence; two-colour pyrometry; injection pressure; impinging distance	OH-ASTERISK; SOOT; CHEMILUMINESCENCE; TEMPERATURE; ENGINE	The effect of spray-flat-wall interaction on the diesel combustion characteristics in a constant-volume vessel was investigated. A flat wall was fixed perpendicular to the nozzle hole axis. Three injection pressures of 100 MPa, 150 MPa and 200 MPa and a single nozzle hole with a diameter of 0.133mm were employed. Mie scattering was adopted to detect the spray formation process; OH* chemiluminescence and natural colour luminosity were conducted to analyse the combustion process. The two-colour method was applied to calculate the soot emissions and the temperature distribution. The results reveal that, in comparison with a free spray flame, flat-wall impingement causes diesel combustion to deteriorate when the liquid phase-wall interaction occurs; however, when an appropriate impinging distance (longer than liquid-phase penetration) is selected, combustion is observed to be enhanced. As for the impinging spray flame, when the injection pressure is increased, soot formation decreases; however, combustion is not linearly enhanced by increasing the injection pressure, and the OH* chemiluminescence intensity achieves the highest value with an injection pressure of 150 MPa.	[Li, Kuichun; Nishida, Keiya; Ogata, Youichi; Shi, Baolu] Hiroshima Univ, Dept Mech Syst Engn, Higashihiroshima 7398527, Japan	Li, KC (reprint author), Hiroshima Univ, Dept Mech Syst Engn, 1-4-1 Kagamiyama, Higashihiroshima 7398527, Japan.	likuichun@hiroshima-u.ac.jp					Ahn S, 1981, 810183 SAE; Hardalupas Y, 2004, COMBUST FLAME, V139, P188, DOI 10.1016/j.combustflame.2004.08.003; Tinaut FV, 2011, ENERG FUEL, V25, P119, DOI 10.1021/ef1013456; Wang XG, 2011, APPL ENERG, V88, P1620, DOI 10.1016/j.apenergy.2010.11.035; Panoutsos CS, 2009, COMBUST FLAME, V156, P273, DOI 10.1016/j.combustflame.2008.11.008; Zhao H, 1998, PROG ENERG COMBUST, V24, P221, DOI 10.1016/S0360-1285(97)00033-6; Pickett LM, 2004, COMBUST FLAME, V138, P114, DOI 10.1016/j.combustflame.2004.04.006; Klein-Douwel RJH, 2009, P COMBUST INST, V32, P2817, DOI 10.1016/j.proci.2008.06.140; Arcoumanis C, 1994, 940678 SAE; Arcoumanis C, 1994, P I MECH ENG D-J AUT, V208, P191, DOI 10.1243/PIME_PROC_1994_208_182_02; Bruneaux G, 2011, 2011011828 SAE; Bruneaux G., 2005, 2005012097 SAE; Cossali GE, 1993, 930920 SAE; Dec JE, 1998, 982685 SAE; Dec JE, 1997, 970873 SAE; Dec JE, 2001, 2001011295 SAE; Jakob M, 2012, COMBUST FLAME, V159, P2516, DOI 10.1016/j.combustflame.2012.03.004; Kato T, 1989, 890265 SAE; Katsura N., 1989, 890264 SAE; Kosaka H., 2005, International Journal of Engine Research, V6, DOI 10.1243/146808705X7347; Li KC, 2013, 2013329021 SAE; Matsui Y, 1986, JSAE REV, V7, P4; Mohammadi A, 2002, 2002010497 SAE; Moon S, 2009, 2009010849 SAE; Moon S, 2008, 2008012469 SAE; Pastor JV, 2005, 200524012 SAE; Pickett LM, 2005, 2005010921 SAE; Rao KK, 1992, IMECHE INT C, P117; Rao KK, 1992, 922203 SAE; Senda J, 1992, 920578 SAE; Speret V, 2010, EXPL FLUIDS, V49, P1293; Stojkovic BD, 2005, P COMBUST INST, V30, P2657, DOI 10.1016/j.proci.2004.08.021; Tomonaga T, 1996, 960028 SAE; XIONG TY, 1991, INT J HEAT MASS TRAN, V34, P1881, DOI 10.1016/0017-9310(91)90162-8; Zhang W, 2008, P I MECH ENG D-J AUT, V222, P1731, DOI 10.1243/09544070JAUTO858; Zurlo JR, 1991, ATOMIZATION SPRAY, V1, P303	36	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0954-4070	2041-2991		P I MECH ENG D-J AUT	Proc. Inst. Mech. Eng. Part D-J. Automob. Eng.	APR	2015	229	5					535	549		10.1177/0954407014547242		15	Engineering, Mechanical; Transportation Science & Technology	Engineering; Transportation	CH4ES	WOS:000353986400001		
J	Yamashima, T				Yamashima, Tetsumori			Dual effects of the non-esterified fatty acid receptor 'GPR40' for human health	PROGRESS IN LIPID RESEARCH			English	Review						Adult neurogenesis; BDNF; Brain-lipid sensing; Insulin; Pancreas; PUFA	CONJUGATED LINOLEIC-ACID; PANCREATIC BETA-CELLS; INDUCED INSULIN-SECRETION; TRANS-ARACHIDONIC ACIDS; SIGNAL-REGULATED KINASE; ENZYME GENE-EXPRESSION; CENTRAL-NERVOUS-SYSTEM; MAMMARY-TUMOR CELLS; FOOD-INTAKE; OLEIC-ACID	G protein-coupled receptor 40 (GPR40), a receptor for diverse non-esterified fatty acids, is expressed predominantly in the wide variety of neurons of the central nervous system and beta-cells in the pancreatic islets. Since deorphanization of GPR40 in 2003, the past decade has seen major advances in our understanding of its role in the insulin secretion. However, there is still a great deal to be elucidated about the role of GPR40 in the brain, because the latter shows the most abundant GPR40 mRNA expression among the human tissues. Since a substantial expression of GPR40 is also seen in the hypothalamus, 'brain-lipid sensing' might be involved in the control of insulin secretion and energy balance. The preceding experiments using monkeys after transient global brain ischemia, have highlighted implication of GPR40 for amplifying adult hippocampal neurogenesis. Although GPR40-mediated intracellular signaling was recently found to result in phosphorylation of CAMP response element-binding protein (CREB) necessary for the neuronal differentiation and synaptic plasticity, the signaling cascade is still incompletely understood. Furthermore, in response to conjugated linoleic acids or trans isomers of arachidonic acid, GPR40 was recently demonstrated in rodents to mediate lipotoxicity to beta-cells, neurons, or microvessels, which result in diabetes, retinopathy, stroke, etc. However, it still remains undetermined in humans whether and how oxidized, conjugated, or excessive fatty acids evoke lipotoxicity. Although literature about GPR40 is limited especially about the brain or the brain-pancreas interaction, this review aims at summarizing beneficial as well as detrimental effects of this receptor in the brain and pancreas in response to diverse fatty acids. (C) 2015 Elsevier Ltd. All rights reserved.	[Yamashima, Tetsumori] Kanazawa Univ, Grad Sch Med Sci, Dept Restorat Neurosurg, Kanazawa, Ishikawa 9208641, Japan; [Yamashima, Tetsumori] Kanazawa Univ, Grad Sch Med Sci, Dept Psychiat & Neurobiol, Kanazawa, Ishikawa 9208641, Japan	Yamashima, T (reprint author), Kanazawa Univ, Grad Sch Med Sci, Dept Restorat Neurosurg, Takara Machi 13-1, Kanazawa, Ishikawa 9208641, Japan.	yamashima215@gmail.com			Japanese Ministry of Education, Culture, Sports, Science and Technology [18390392, 22390273]	This work was supported by a grant (Kiban-Kennkyu (B):18390392, 22390273) from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Almaguel FG, 2009, J NEUROSCI RES, V87, P1207, DOI 10.1002/jnr.21918; Almaguel FG, 2010, BRAIN RES, V1318, P133, DOI 10.1016/j.brainres.2009.12.038; Alquier T, 2009, DIABETES, V58, P1035, DOI 10.2337/db09-0215; Vettor R, 2008, J CLIN ENDOCR METAB, V93, P3541, DOI 10.1210/jc.2007-2680; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Edmond J, 2001, J MOL NEUROSCI, V16, P181, DOI 10.1385/JMN:16:2-3:181; Kotarsky K, 2003, BIOCHEM BIOPH RES CO, V301, P406, DOI 10.1016/S0006-291X(02)03064-4; Nagao K, 2005, J BIOSCI BIOENG, V100, P152, DOI 10.1263/jbb.100.152; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Rapoport SI, 2001, J LIPID RES, V42, P678; Elmquist JK, 2003, NAT MED, V9, P645, DOI 10.1038/nm0603-645; Unger RH, 2001, FASEB J, V15, P312, DOI 10.1096/fj.00-0590; Obici S, 2003, NAT MED, V9, P756, DOI 10.1038/nm873; Yamashima T, 2009, PROG NEUROBIOL, V89, P343, DOI 10.1016/j.pneurobio.2009.09.003; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Adibhatla Rao Muralikrishna, 2008, V49, P241, DOI 10.1007/978-1-4020-8831-5_9; Carpentier A, 1999, AM J PHYSIOL-ENDOC M, V276, pE1055; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; Lindqvist A, 2006, EUR J NEUROL, V13, P1385, DOI 10.1111/j.1468-1331.2006.01500.x; Farr SA, 2008, ENDOCRINOLOGY, V149, P2628, DOI 10.1210/en.2007-1722; Poirier H, 2006, DIABETES, V55, P1634, DOI 10.2337/db06-0036; Gehrmann W, 2010, DIABETES OBES METAB, V12, P149, DOI 10.1111/j.1463-1326.2010.01265.x; Kelly A, 2003, J NEUROSCI, V23, P5354; Ahren B, 2009, EUR J CLIN NUTR, V63, P778, DOI 10.1038/ejcn.2008.45; Mancini AD, 2013, TRENDS ENDOCRIN MET, V24, P398, DOI 10.1016/j.tem.2013.03.003; Kennedy A, 2010, J NUTR BIOCHEM, V21, P171, DOI 10.1016/j.jnutbio.2009.08.003; NEURINGER M, 1988, ANNU REV NUTR, V8, P517; Ma D, 2007, NEUROSCI RES, V58, P394, DOI 10.1016/j.neures.2007.05.001; Jiang HL, 1999, J BIOL CHEM, V274, P16235, DOI 10.1074/jbc.274.23.16235; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Unger RH, 2002, BBA-MOL CELL BIOL L, V1585, P202, DOI 10.1016/S1388-1981(02)00342-6; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042; Boneva NB, 2012, HIPPOCAMPUS, V22, P896, DOI 10.1002/hipo.20951; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Fujiwara K, 2005, AM J PHYSIOL-ENDOC M, V289, pE670, DOI 10.1152/ajpendo.00035.2005; Sandoval DA, 2009, NAT REV DRUG DISCOV, V8, P386, DOI 10.1038/nrd2874; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Ferdaoussi M, 2012, DIABETOLOGIA, V55, P2682, DOI 10.1007/s00125-012-2650-x; Feldstein AE, 2004, HEPATOLOGY, V40, P185, DOI 10.1002/hep.20283; Obici S, 2002, DIABETES, V51, P271; Migrenne S, 2011, DIABETES METAB, V37, P83, DOI 10.1016/j.diabet.2010.11.001; Unger RH, 2003, ANNU REV PHYSIOL, V65, P333, DOI 10.1146/annurev.physiol.65.092101.142622; Stranahan AM, 2008, HIPPOCAMPUS, V18, P1085, DOI 10.1002/hipo.20470; Hsu YC, 2010, CELL SIGNAL, V22, P590, DOI 10.1016/j.cellsig.2009.11.011; Feng DD, 2006, ENDOCRINOLOGY, V147, P674, DOI 10.1210/en.2005-0225; Ma DX, 2010, BRAIN RES, V1330, P1, DOI 10.1016/j.brainres.2010.03.002; Wu XD, 2008, HEPATOLOGY, V47, P1905, DOI 10.1002/hep.22239; OOMURA Y, 1975, PHYSIOL BEHAV, V14, P483, DOI 10.1016/0031-9384(75)90015-3; SAKO Y, 1990, ENDOCRINOLOGY, V127, P1580; Atkins CM, 1998, NAT NEUROSCI, V1, P602; Poitout V, 2013, DRUG DISCOV TODAY, V18, P1301, DOI 10.1016/j.drudis.2013.09.003; Schwartz MW, 2000, NATURE, V404, P661; Salvati S, 2006, MINI-REV MED CHEM, V6, P1201, DOI 10.2174/138955706778742740; AHREN B, 1986, DIABETOLOGIA, V29, P827, DOI 10.1007/BF00870137; Yamashima T, 2000, PROG NEUROBIOL, V62, P273, DOI 10.1016/S0301-0082(00)00006-X; Winzell MS, 2006, AM J PHYSIOL-ENDOC M, V290, pE347, DOI 10.1152/ajpendo.00163.2005; Iwayama Y, 2010, AM J MED GENET B, V153B, P484, DOI 10.1002/ajmg.b.31004; Berman DE, 1998, J NEUROSCI, V18, P10037; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Schafe GE, 2000, J NEUROSCI, V20, P8177; Nakamoto K, 2012, BRAIN RES, V1432, P74, DOI 10.1016/j.brainres.2011.11.012; Davis S, 2006, GENES BRAIN BEHAV, V5, P61, DOI 10.1111/j.1601-183X.2006.00230.x; Selcher JC, 1999, LEARN MEMORY, V6, P478, DOI 10.1101/lm.6.5.478; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Luchsinger JA, 2002, ARCH NEUROL-CHICAGO, V59, P1258, DOI 10.1001/archneur.59.8.1258; Balazy M, 2008, PHARMACOL THERAPEUT, V119, P275, DOI 10.1016/j.pharmthera.2008.05.003; Balazy Michael, 2004, Current Vascular Pharmacology, V2, P81, DOI 10.2174/1570161043476465; Boneva NB, 2011, J PHARMACOL SCI, V116, P163, DOI 10.1254/jphs.10R34FM; Cruciani-Guglielmacci C, 2004, DIABETOLOGIA, V47, P2032, DOI 10.1007/s00125-004-1569-2; Dhayal S, 2008, BRIT J PHARMACOL, V153, P1718, DOI 10.1038/bjp.2008.43; Duvarci S, 2005, EUR J NEUROSCI, V21, P283, DOI 10.1111/j.1460-9568.2004.03824.x; Honore JC, 2013, ARTERIOSCL THROM VAS, V33, P954, DOI 10.1161/ATVBAHA.112.300943; Hsu YC, 2011, CELL SIGNAL, V23, P2013, DOI 10.1016/j.cellsig.2011.07.015; Itoh Y, 2005, HEPATOL RES, V33, P171, DOI 10.1016/j.hepres.2005.09.028; Kan I, 2007, J LIPID RES, V48, P513, DOI 10.1194/jlr.C600022-JLR200; Kang L, 2006, DIABETES, V55, P412, DOI 10.2337/diabetes.55.02.06.db05-1229; Kermorvant-Duchemin E, 2005, NAT MED, V11, P1339, DOI 10.1038/nm1336; Languille S, 2009, EUR J NEUROSCI, V30, P1923, DOI 10.1111/j.1460-9568.2009.06971.x; Ma D, 2008, HIPPOCAMPUS, V18, P326, DOI 10.1002/hipo.20393; Medina-Gomez G, 2005, NAT MED, V11, P602, DOI 10.1038/nm0605-602; Moon HS, 2009, J NUTR BIOCHEM, V20, P187, DOI 10.1016/j.jnutbio.2008.02.001; Morgan NG, 2009, BIOCHEM PHARMACOL, V78, P1419, DOI 10.1016/j.bcp.2009.07.020; Moulle VSF, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00385; Ou LH, 2008, J LIPID RES, V49, P985, DOI 10.1194/jlr.M700465-JLR200; Pariza MW, 2004, AM J CLIN NUTR, V79, p1132S; Poirier H, 2005, DIABETOLOGIA, V48, P1059, DOI 10.1007/s00125-005-1765-8; Rapoport SI, 2001, J MOL NEUROSCI, V16, P243, DOI 10.1385/JMN:16:2-3:243; Ryder JW, 2001, DIABETES, V50, P1149, DOI 10.2337/diabetes.50.5.1149; Sawzdargo M, 1997, BIOCHEM BIOPH RES CO, V239, P543, DOI 10.1006/bbrc.1997.7513; Schmidt J, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.C110.200477; Steneberg Par, 2005, Cell Metabolism, V1, P245, DOI 10.1016/j.cmet.2005.03.007; Wang R, 2006, J NEUROPHYSIOL, V95, P1491, DOI 10.1152/jn.00697.2005; Watanabe A, 2007, PLOS BIOL, V5, P2469, DOI 10.1371/journal.pbio.0050297; Yamashima, 2012, PROG LIPID RES, V51, P221; Yamashima T, 2008, PROG NEUROBIOL, V84, P105, DOI 10.1016/j.pneurobio.2007.11.002; Zamarbide M, 2014, HIPPOCAMPUS, V24, P733, DOI 10.1002/hipo.22263	97	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0163-7827			PROG LIPID RES	Prog. Lipid Res.	APR	2015	58						40	50		10.1016/j.plipres.2015.01.002		11	Biochemistry & Molecular Biology; Nutrition & Dietetics	Biochemistry & Molecular Biology; Nutrition & Dietetics	CH6JH	WOS:000354142400004		
J	Zha, WS; Zhou, SR; Zheng, H; Wu, KX; Yuan, Q; Zhao, XW				Zha Wusheng; Zhou Shurong; Zheng Hao; Wu Kaixia; Yuan Qiang; Zhao Xinwei			Effects of Dy on Magnetic Properties and Microstructure of Nanocomposite (Nd,Pr)(10.5-x)DyxFe83.5B6 Alloys	RARE METAL MATERIALS AND ENGINEERING			English	Article						nanocomposite alloy; melt-spun; Dy element; thermal stability; microstructure	NDFEB ALLOYS; CO; NANOCRYSTALLINE; CRYSTALLIZATION; RIBBONS; PHASE; ZR	A series of bonded magnets of (Nd,Pr)(10.5-x)DyxFe83.5B6 (x=0.0, 0.5, 1.0, 1.5, 2.0, 2.5) alloys were prepared by a melt-spun method. The effects of Dy substitution on the thermal stability of as-spun ribbons, the magnetic properties and microstructures of alloys were investigated. Dy addition will enhance the intrinsic coercivity H-cj greatly, but reduce the remanence B-r, because Dy2Fe14B has a higher magnetocrystalline anisotropy field H-A and a lower saturation magnetic polarization J(s) compared to those of Nd2Fe14B. The Dy substitution for Nd/Pr enhances the thermal stability and increases the crystallization annealing temperature. The higher annealing temperature leads the fine crystallites existing in as-spun ribbons to easily growing, resulting in appearance of some bigger grains and deterioration of the bonded magnet property. The bonded magnet of (Nd,Pr)(9.5)Dy1Fe83.5B6 alloy with 1.0at% Dy has optimal magnetic properties, i.e (BH)(max)=71.6 kJ/m(3), B-r=0.638 T, and H-cj= 611 kA/m.	[Zha Wusheng; Zhou Shurong; Wu Kaixia; Yuan Qiang] Xihua Univ, Chengdu 610039, Peoples R China; [Zhou Shurong; Zheng Hao] Sichuan Vocat & Tech Coll, Suining 629000, Peoples R China; [Zhao Xinwei] Tokyo Univ Sci, Tokyo 1628601, Japan	Zha, WS (reprint author), Xihua Univ, Coll Mat Sci & Engn, Chengdu 610039, Peoples R China.	zhawusheng684@hotmail.com			Spring Sunshine Plan of the Ministry of Education of China [Z2010095]; Key Laboratory of Special Materials and Preparation in Sichuan Province [SZJJ2011-013]	Spring Sunshine Plan of the Ministry of Education of China (Z2010095); Key Laboratory of Special Materials and Preparation in Sichuan Province (SZJJ2011-013)	Liu ZW, 2005, J MAGN MAGN MATER, V290, P1230, DOI 10.1016/j.jmmm.2004.11.409; KNELLER EF, 1991, IEEE T MAGN, V27, P3588, DOI 10.1109/20.102931; HIROSAWA S, 1986, J APPL PHYS, V59, P873, DOI 10.1063/1.336611; Bao XQ, 2009, J MAGN MAGN MATER, V321, P1832, DOI 10.1016/j.jmmm.2008.11.088; Chang HW, 2006, J MAGN MAGN MATER, V304, pE216, DOI 10.1016/j.jmmm.2006.01.200; Davies HA, 2001, SCRIPTA MATER, V44, P1337, DOI 10.1016/S1359-6462(01)00707-2; Hirosawa S, 2001, IEEE T MAGN, V37, P2558, DOI 10.1109/20.951234; Inoue A, 1995, MAT T JIM, V36, P963; Li F, 2012, RARE METAL MAT ENG, V41, P1611; Liu ZW, 2007, J MAGN MAGN MATER, V313, P337, DOI 10.1016/j.jmmm.2007.02.078; Neu V, 1998, J MAGN MAGN MATER, V189, P391, DOI 10.1016/S0304-8853(98)00295-9; Yamasaki M, 2001, SCRIPTA MATER, V44, P1375, DOI 10.1016/S1359-6462(01)00709-6; Yang CJ, 2006, J MAGN MAGN MATER, V301, P220, DOI 10.1016/j.jmmm.2005.06.031; Zha WS, 2004, RARE METAL MAT ENG, V33, P75; Zhang W, 2000, J APPL PHYS, V87, P6122, DOI 10.1063/1.372629	15	0	0	NORTHWEST INST NONFERROUS METAL RESEARCH	SHAANXI	C/O RARE METAL MATERIAL ENGINEERING PRESS, PO BOX 51, XIAN, SHAANXI 710016, PEOPLES R CHINA	1002-185X			RARE METAL MAT ENG	Rare Metal Mat. Eng.	APR	2015	44	4					813	816				4	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CH6JN	WOS:000354143000008		
J	Aizawa, N; Dobrev, VK				Aizawa, N.; Dobrev, V. K.			INTERTWINING OPERATOR REALIZATION OF ANTI-DE SITTER HOLOGRAPHY	REPORTS ON MATHEMATICAL PHYSICS			English	Article						anti-de Sitter holography; spin representations of so(3,2); boundary-to-bulk intertwining operators	CONFORMAL FIELD-THEORIES; ADS-CFT CORRESPONDENCE; ADS/CFT CORRESPONDENCE; NONCOMMUTATIVE GEOMETRY; BOUNDARY-CONDITIONS; PRIMARY SUPERFIELDS; SPACE PROPAGATORS; STRING THEORY; GAUGE-FIELDS; SUPERGRAVITY	We give a group-theoretic interpretation of relativistic holography as equivalence between representations of the anti-de Sitter algebra describing bulk fields and boundary fields. Our main result is the explicit construction of the boundary-to-bulk operators for arbitrary integer spin in the framework of representation theory. Further we show that these operators and the bulk-to-boundary operators are intertwining operators. In analogy to the de Sitter case, we show that each bulk field has two boundary (shadow) fields with conjugated conformal weights. These fields are related by another intertwining operator given by a two-point function on the boundary.	[Aizawa, N.] Osaka Prefecture Univ, Grad Sch Sci, Dept Math & Informat Sci, Sakai, Osaka 5998531, Japan; [Dobrev, V. K.] Bulgarian Acad Sci, Inst Nucl Res & Nucl Energy, BU-1784 Sofia, Bulgaria	Aizawa, N (reprint author), Osaka Prefecture Univ, Grad Sch Sci, Dept Math & Informat Sci, Nakamozu Campus, Sakai, Osaka 5998531, Japan.	aizawa@mi.s.osakafu-u.ac.jp; dobrev@inrne.bas.bg					Aizawa N, 2010, NUCL PHYS B, V828, P581, DOI 10.1016/j.nuclphysb.2009.10.019; Aizawa N., UNPUB; Andrianopoli L, 1998, LETT MATH PHYS, V46, P265, DOI 10.1023/A:1007529330007; Andrianopoli L, 1998, PHYS LETT B, V430, P248, DOI 10.1016/S0370-2693(98)00553-X; Andrianopoli L, 1999, LETT MATH PHYS, V48, P145, DOI 10.1023/A:1007550823624; ANGELOPOULOS E, 1981, PHYS REV D, V23, P1278, DOI 10.1103/PhysRevD.23.1278; Aros R, 2010, J PHYS A-MATH THEOR, V43, DOI 10.1088/1751-8113/43/20/205402; Kabat D, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.066010; Kabat D, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.026004; Gubser SS, 1998, PHYS LETT B, V428, P105, DOI 10.1016/S0370-2693(98)00377-3; Dobrev VK, 1999, NUCL PHYS B, V553, P559, DOI 10.1016/S0550-3213(99)00284-9; FERRARA S, 1972, LETT NUOVO CIMENTO, V4, P115, DOI 10.1007/BF02907130; BREITENLOHNER P, 1982, PHYS LETT B, V115, P197, DOI 10.1016/0370-2693(82)90643-8; Klebanov IR, 1999, NUCL PHYS B, V556, P89, DOI 10.1016/S0550-3213(99)00387-9; l'Yi WS, 1999, PHYS LETT B, V448, P218, DOI 10.1016/S0370-2693(99)00009-X; Bekaert X, 2013, J PHYS A-MATH THEOR, V46, DOI 10.1088/1751-8113/46/21/214008; Freedman DZ, 1999, NUCL PHYS B, V546, P96, DOI 10.1016/S0550-3213(99)00053-X; Kabat D, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.106009; D'Hoker E, 1999, NUCL PHYS B, V550, P261, DOI 10.1016/S0550-3213(99)00169-8; Bayntun A, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/3/035012; De Haro S, 2007, PHYS REV D, V76, DOI 10.1103/PhysRevD.76.106008; Leonhardt T, 2003, NUCL PHYS B, V667, P413, DOI 10.1016/j.nuclphysb.2003.07.007; Kabat D, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.086004; Henningson M, 1998, PHYS LETT B, V431, P63, DOI 10.1016/S0370-2693(98)00559-0; Leonhardt T, 2004, J PHYS A-MATH GEN, V37, P7051, DOI 10.1088/0305-4470/37/27/013; Samani KA, 2005, ANN PHYS-NEW YORK, V316, P466, DOI 10.1016/j.aop.2004.11.002; Balasubramanian V, 1999, PHYS REV D, V59, DOI 10.1103/PhysRevD.59.046003; Rehren KH, 2000, ANN HENRI POINCARE, V1, P607, DOI 10.1007/PL00001009; Yee HU, 2004, PHYS LETT B, V598, P139, DOI 10.1016/j.physletb.2004.05.082; Metsaev RR, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.106010; Berenstein D, 1999, PHYS REV D, V59, DOI 10.1103/PhysRevD.59.105023; Bianchi M, 1999, PHYS LETT B, V468, P102, DOI 10.1016/S0370-2693(99)01211-3; Bonelli G, 1999, PHYS LETT B, V450, P363, DOI 10.1016/S0370-2693(99)00153-7; Chalmers G, 1999, NUCL PHYS B, V540, P247, DOI 10.1016/S0550-3213(98)00758-5; Corley S, 1999, PHYS REV D, V59; Deser S, 2003, NUCL PHYS B, V662, P379, DOI 10.1016/S0550-3213(03)00348-1; D'Hoker E, 1999, NUCL PHYS B, V544, P612, DOI 10.1016/S0550-3213(98)00852-9; Diaz D.E., 2008, J HIGH ENERGY PHYS, V0807, P103; Diaz D.E., 2007, J HIGH ENERGY PHYS, V0705, P46; Diaz D.E., 2006, J HIGH ENERGY PHYS, V0607, P022; Dobrev V. K., 1988, REP MATH PHYS, V25, P159, DOI 10.1016/0034-4877(88)90050-X; Dobrev VK, 2006, J PHYS A-MATH GEN, V39, P5995, DOI 10.1088/0305-4470/39/20/024; Dobrev V. K., 1977, LECT NOTES PHYS, V63; Dobrev V. K., 1986, IC86393; DOBREV VK, 1994, FORTSCHR PHYS, V42, P339, DOI 10.1002/prop.2190420403; Erdelyi A., 1954, TABLES INTEGRAL TRAN, V1; Ferrara S, 1998, LETT MATH PHYS, V46, P157, DOI 10.1023/A:1007569031648; Ferrara S, 1999, LETT MATH PHYS, V47, P255, DOI 10.1023/A:1007592711262; Ferrara S, 1998, PHYS REV D, V58, DOI 10.1103/PhysRevD.58.105029; Ferrara S, 1998, CLASSICAL QUANT GRAV, V15, P2153, DOI 10.1088/0264-9381/15/8/004; FLATO M, 1981, J MATH PHYS, V22, P1100, DOI 10.1063/1.524993; Freedman DZ, 1999, PHYS LETT B, V452, P61, DOI 10.1016/S0370-2693(99)00229-4; FRONSDAL C, 1982, PHYS REV D, V26, P1988, DOI 10.1103/PhysRevD.26.1988; Gao X., 2012, J HIGH ENERGY PHYS, V1211, P112; Ghezelbash AM, 1999, INT J MOD PHYS A, V14, P2581, DOI 10.1142/S0217751X99001287; Ghezelbash AM, 1998, PHYS LETT B, V435, P291, DOI 10.1016/S0370-2693(98)00815-6; Gottschalk H, 2008, COMMUN MATH PHYS, V277, P83, DOI 10.1007/s00220-007-0358-4; HOTTA R, 1971, J MATH SOC JPN, V23, P384; Hu S., ARXIV13121545HEPTH; Kaviani K, 1999, PHYS LETT B, V469, P81, DOI 10.1016/S0370-2693(99)01275-7; Kaviani K, 2000, INT J MOD PHYS B, V14, P2355, DOI 10.1142/S0217979200001874; Kerimov GA, 2007, MOD PHYS LETT A, V22, P2287, DOI 10.1142/S0217732307022487; KNAPP AW, 1982, ANN MATH, V116, P389, DOI 10.2307/2007066; Langlands R. P., 1988, MATH SURVEYS MONOGRA, V31; Lee S., 1998, ADV THEOR MATH PHYS, V2, P697; Leigh R.G., 2003, JHEP, V0306, P011; Leigh R.G., 2003, JHEP, V0312, P020; Liu H, 1999, PHYS REV D, V60, DOI 10.1103/PhysRevD.60.106005; Liu H, 1999, PHYS REV D, V59, DOI 10.1103/PhysRevD.59.086002; Maldacena J M, 1998, ADV THEOR MATH PHYS, V2, P231, DOI DOI 10.1023/A:1026654312961; Manvelyan R, 2005, PHYS LETT B, V613, P197, DOI 10.1016/j.physletb.2005.03.061; Manvelyan R, 2005, NUCL PHYS B, V717, P3, DOI 10.1016/j.nuclphysb.2005.03.038; Minces P, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.025011; Moroz S, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.066002; Muck W, 1998, PHYS REV D, V58, DOI 10.1103/PhysRevD.58.106006; Muck W, 1998, PHYS REV D, V58; Muck W, 1999, PHYS REV D, V60, DOI 10.1103/PhysRevD.60.081901; Nicolai H., 1984, PHYS LETT B, V143 B, P103; Nolland D, 2004, PHYS LETT B, V584, P192, DOI 10.1016/j.physletb.2004.01.037; Ohya S., 2013, J HIGH ENERGY PHYS, V1312, P011; O'Loughlin MJ, 1999, NUCL PHYS B, V543, P170, DOI 10.1016/S0550-3213(98)00872-4; Oz Y, 1998, NUCL PHYS B, V532, P163, DOI 10.1016/S0550-3213(98)00454-4; POLYAKOV AM, 1970, JETP LETT-USSR, V12, P381; Rashkov RC, 1999, PHYS LETT B, V466, P190, DOI 10.1016/S0370-2693(99)01112-0; Rehren K.-H., 2005, 18 SFIN A, VA1, P95; Dutsch M, 2002, LETT MATH PHYS, V62, P171, DOI 10.1023/A:1021601215141; Dutsch M, 2003, ANN HENRI POINCARE, V4, P613, DOI 10.1007/s00023-003-0141-9; Ruehl W., 2012, PHYS ATOM NUCL, V75, P1279; Ruehl W., 2005, PHYS LETT B, V605, P413; Ruehl W., 2005, NUCL PHYS B, V705, P437; Schmid W., 1970, RICE U STUD, V56, P99; Volovich A, 1998, J HIGH ENERGY PHYS; Witten E., 1998, ADV THEOR MATH PHYS, V2, P253, DOI DOI 10.1016/S0370-1573(99)00083-6; Witten E., 2004, FIELDS STRINGS, V2, P1173; Zoubos K., 2002, J HIGH ENERGY PHYS, V0212, P037; Zoubos K., 2005, J HIGH ENERGY PHYS, V0501, P031	96	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0034-4877			REP MATH PHYS	Rep. Math. Phys.	APR	2015	75	2					179	197				19	Physics, Mathematical	Physics	CH7PD	WOS:000354228200002		
J	Tane, N; Okuda, N; Imanaka, H; Nishimura, M				Tane, Natsuki; Okuda, Nao; Imanaka, Hideaki; Nishimura, Masaji			Neurally Adjusted Ventilatory Assist Improves Patient-Ventilator Synchrony in a Patient With Tetanus and Unstable Diaphragmatic Electrical Activity	RESPIRATORY CARE			English	Article						tetanus; periodic breathing; diaphragmatic electrical activity		A 79-y-old man with generalized tetanus was admitted to the ICU. A left-forearm wound was surgically debrided, and the wound was closed. On postoperative day 1, after the patient experienced opisthotonos and convulsions, endotracheal intubation was performed. Propofol and diazepam were infused but failed to stop the convulsions. Morphine, midazolam, dantrolene, and rocuronium were used to ameliorate the muscle spasms. Magnesium sulfate was also infused. On postoperative day 15, patient-ventilator asynchrony was apparent. The patient showed recurrent tachypnea and bradypnea, which seemed typical of Cheyne-Stokes respiration. A neurally adjusted ventilatory assist (NAVA) catheter was inserted transnasally, and electrical activity of the diaphragm (E-di) was monitored. Readings showed regular attempts to breathe at 40-50 breaths/min with periodic changes in Edi amplitude. NAVA mode improved patient-ventilator synchrony. Periodic breathing continued for 2 weeks. We stopped monitoring E-di on postoperative day 39. He began respiratory rehabilitation and was transferred to a hospital for rehabilitation on postoperative day 80. We encountered periodic respiration in a patient with tetanus. E-di monitoring revealed periodic amplitude change. The cause of the periodic breathing pattern in this patient could not be determined but may be attributable to side effects of the pharmacologic interventions or the natural history of the disease itself. NAVA mode improved patient-ventilator synchrony.	[Tane, Natsuki; Okuda, Nao; Nishimura, Masaji] Tokushima Univ Hosp, Emergency & Crit Care Med, Tokushima, Tokushima, Japan; [Imanaka, Hideaki] Tokushima Univ Hosp, Emergency & Disaster Med, Tokushima, Tokushima, Japan	Nishimura, M (reprint author), Univ Tokushima, Grad Sch, Emergency & Crit Care Med, 3-18-15 Kuramoto, Tokushima, Tokushima, Japan.	nmasaji@tokushima-u.ac.jp					Sinderby C, 2001, AM J RESP CRIT CARE, V163, P1637; Thwaites CL, 2006, LANCET, V368, P1436, DOI 10.1016/S0140-6736(06)69444-0; Bunch TJ, 2002, CHEST, V122, P1488, DOI 10.1378/chest.122.4.1488; Brandom BW, 2011, ANESTH ANALG, V112, P1115, DOI 10.1213/ANE.0b013e31820b5f1f; Beck J, 2009, PEDIATR RES, V65, P663, DOI 10.1203/PDR.0b013e31819e72ab; Mathew Preethy Joseph, 2010, Acta Anaesthesiol Taiwan, V48, P152, DOI 10.1016/S1875-4597(10)60049-5; Nakatsuka Hideki, 2008, Masui, V57, P853; Navalesi Paolo, 2003, Curr Opin Crit Care, V9, P51, DOI 10.1097/00075198-200302000-00010; Sparr HJ, 1997, BRIT J ANAESTH, V78, P267	9	0	0	DAEDALUS ENTERPRISES INC	IRVING	9425 N MAC ARTHUR BLVD, STE 100, IRVING, TX 75063-4706 USA	0020-1324	1943-3654		RESP CARE	Respir. Care	APR	2015	60	4					E76	E79		10.4187/respcare.03527		4	Critical Care Medicine; Respiratory System	General & Internal Medicine; Respiratory System	CH7BQ	WOS:000354191000005		
J	Chu, AC; Cozzi, G; Furukawa, Y				Chu, Angus C.; Cozzi, Guido; Furukawa, Yuichi			Effects of economic development in China on skill-biased technical change in the US	REVIEW OF ECONOMIC DYNAMICS			English	Article						Economic growth; Skill-biased technical change; Offshoring	INTELLECTUAL PROPERTY-RIGHTS; TECHNOLOGICAL-CHANGE; PATENT PROTECTION; INNOVATION; GROWTH; TASKS; MODEL	In this study, we explore the effects of a change in unskilled labor in China on the direction of innovation in the US by incorporating production offshoring into a North-South model of directed technical change. We find that intellectual property rights (IPRs) and offshoring are different ways for the labor endowment of the South to affect the size of the market for innovations in the North. Absent offshoring and lacking IPRs in the South - as in China in the early 1980s - an increase in Southern unskilled labor should lead to skill-biased technical change. If instead offshoring is present and/or IPRs are better enforced (as in China in more recent times), then a decrease in unskilled labor in the South should lead to skill-biased technical change. Furthermore, an increase in Southern per capita stock of capital reduces offshoring and also leads to skill-biased technical change. Calibrating the model to China-US data, we find that under a moderate elasticity of substitution between skill-intensive and labor-intensive goods, the decrease in unskilled labor and the increase in capital in China can explain about one-third of the recent increase in the skill premium in China through skill-biased technical change in the US. (C) 2014 Elsevier Inc. All rights reserved.	[Chu, Angus C.] Univ Liverpool, Sch Management, Liverpool L69 3BX, Merseyside, England; [Cozzi, Guido] Univ St Gallen, Dept Econ, St Gallen, Switzerland; [Furukawa, Yuichi] Chukyo Univ, Sch Econ, Nagoya, Aichi, Japan	Cozzi, G (reprint author), Univ St Gallen, Dept Econ, St Gallen, Switzerland.	angusccc@gmail.com; guido.cozzi@unisg.ch; you.furukawa@gmail.com					Acemoglu D, 1998, Q J ECON, V113, P1055, DOI 10.1162/003355398555838; Acemoglu D., 2012, 18595 NBER; Acemoglu D, 2001, Q J ECON, V116, P563, DOI 10.1162/00335530151144104; ROMER PM, 1990, J POLIT ECON, V98, pS71, DOI 10.1086/261725; Chu AC, 2011, J ECON DYN CONTROL, V35, P876, DOI 10.1016/j.jedc.2010.11.003; Acemoglu D, 2003, REV ECON STUD, V70, P199, DOI 10.1111/1467-937X.00242; Gancia G, 2008, J INT ECON, V76, P276, DOI 10.1016/j.jinteco.2008.03.010; Acemoglu D, 2002, REV ECON STUD, V69, P781, DOI 10.1111/1467-937X.00226; GROSSMAN GM, 1991, ECON J, V101, P1214, DOI 10.2307/2234437; Acemoglu D, 2011, HBK ECON, V4, P1043, DOI 10.1016/S0169-7218(11)02410-5; Ge SQ, 2014, J EUR ECON ASSOC, V12, P300, DOI 10.1111/jeea.12072; Lai ELC, 1998, J DEV ECON, V55, P133, DOI 10.1016/S0304-3878(97)00059-X; Park WG, 2008, RES POLICY, V37, P761, DOI 10.1016/j.respol.2008.01.006; Luo CY, 2010, CHINA WORLD ECON, V18, P1, DOI 10.1111/j.1749-124X.2010.01217.x; Bai CE, 2006, BROOKINGS PAP ECO AC, P61; Grossman GA, 2008, AM ECON REV, V98, P1978, DOI 10.1257/aer.98.5.1978; AGHION P, 1992, ECONOMETRICA, V60, P323, DOI 10.2307/2951599; Gancia G, 2009, ANNU REV ECON, V1, P93, DOI 10.1146/annurev.economics.050708.143333; Gancia G, 2005, HANDB ECON, V22, P111; Goh AT, 2002, INT ECON REV, V43, P1191, DOI 10.1111/1468-2354.t01-1-00053; GROSSMAN GM, 1991, REV ECON STUD, V58, P43, DOI 10.2307/2298044; HELPMAN E, 1993, ECONOMETRICA, V61, P1247, DOI 10.2307/2951642; Iwaisako T, 2013, ECON THEOR, V52, P631, DOI 10.1007/s00199-011-0658-y; Li CW, 2001, ECON J, V111, pC164; SEGERSTROM PS, 1990, AM ECON REV, V80, P1077	25	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1094-2025	1096-6099		REV ECON DYNAM	Rev. Econ. Dyn.	APR	2015	18	2					227	242		10.1016/j.red.2014.04.001		16	Economics	Business & Economics	CH6KF	WOS:000354144800005		
J	Akagi, T; Araki, S; Funahashi, Y; Honda, Y; Miyoshi, S; Okugi, T; Omori, T; Shimizu, H; Sakaue, K; Takahashi, T; Tanaka, R; Terunuma, N; Uesugi, Y; Urakawa, J; Washio, M; Yoshitama, H				Akagi, T.; Araki, S.; Funahashi, Y.; Honda, Y.; Miyoshi, S.; Okugi, T.; Omori, T.; Shimizu, H.; Sakaue, K.; Takahashi, T.; Tanaka, R.; Terunuma, N.; Uesugi, Y.; Urakawa, J.; Washio, M.; Yoshitama, H.			Demonstration of the stabilization technique for nonplanar optical resonant cavities utilizing polarization	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article							LASER-COMPTON SCATTERING; PHASE	Based on our previously developed scheme to stabilize nonplanar optical resonant cavities utilizing polarization caused by a geometric phase in electromagnetic waves traveling along a twisted path, we report an application of the technique for a cavity installed in the Accelerator Test Facility, a 1.3-GeV electron beam accelerator at KEK, in which photons are generated by laser-Compton scattering. We successfully achieved a power enhancement of 1200 with 1.4% fluctuation, which means that the optical path length of the cavity has been controlled with a precision of 14 pm under an accelerator environment. In addition, polarization switching utilizing a geometric phase of the nonplanar cavity was demonstrated. (C) 2015 AIP Publishing LLC.	[Akagi, T.; Araki, S.; Funahashi, Y.; Honda, Y.; Okugi, T.; Omori, T.; Shimizu, H.; Terunuma, N.; Urakawa, J.] High Energy Accelerator Res Org KEK, Tsukuba, Ibaraki 3050801, Japan; [Miyoshi, S.; Takahashi, T.; Tanaka, R.; Uesugi, Y.; Yoshitama, H.] AdSM Hiroshima Univ, Hiroshima 7398530, Japan; [Sakaue, K.; Washio, M.] Waseda Univ, Res Inst Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan	Takahashi, T (reprint author), AdSM Hiroshima Univ, 1-3-1 Kagamiyama, Hiroshima 7398530, Japan.	tohru-takahashi@hiroshima-u.ac.jp			Quantum Beam Technology Program of the Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT); JSPS KAKENHI [23226020, 24654076]	The authors would like to thank the members of the ATF-KEK group and collaborators at the LAL Orsay, France, for their helpful support and discussions. This research has been supported by the Quantum Beam Technology Program of the Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT). This work was also supported by JSPS KAKENHI Grant Nos. 23226020 and 24654076.	Akagi T, 2013, NUCL INSTRUM METH A, V724, P63, DOI 10.1016/j.nima.2013.04.066; DREVER RWP, 1983, APPL PHYS B-PHOTO, V31, P97, DOI 10.1007/BF00702605; BERRY MV, 1984, P ROY SOC LOND A MAT, V392, P45, DOI 10.1098/rspa.1984.0023; Galvez E. J., 2002, RECENT RES DEV OPTIC, V165; Honda Y, 2009, OPT COMMUN, V282, P3108, DOI 10.1016/j.optcom.2009.04.043; Miyoshi S, 2010, NUCL INSTRUM METH A, V623, P576, DOI 10.1016/j.nima.2010.03.075; Simizu H., 2009, J PHYS SOC JPN, V78; Ziegler J. G., 1942, ASME T, P759	8	0	0	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	APR	2015	86	4							043303	10.1063/1.4918653		7	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	CH2EE	WOS:000353837700018		
J	Albertazzi, B; d'Humieres, E; Lancia, L; Dervieux, V; Antici, P; Bocker, J; Bonlie, J; Breil, J; Cauble, B; Chen, SN; Feugeas, JL; Nakatsutsumi, M; Nicolai, P; Romagnani, L; Shepherd, R; Sentoku, Y; Swantusch, M; Tikhonchuk, VT; Borghesi, M; Willi, O; Pepin, H; Fuchs, J				Albertazzi, B.; d'Humieres, E.; Lancia, L.; Dervieux, V.; Antici, P.; Boecker, J.; Bonlie, J.; Breil, J.; Cauble, B.; Chen, S. N.; Feugeas, J. L.; Nakatsutsumi, M.; Nicolai, P.; Romagnani, L.; Shepherd, R.; Sentoku, Y.; Swantusch, M.; Tikhonchuk, V. T.; Borghesi, M.; Willi, O.; Pepin, H.; Fuchs, J.			A compact broadband ion beam focusing device based on laser-driven megagauss thermoelectric magnetic fields	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article							ACCELERATED PROTON-BEAMS; PLASMAS; SIMULATIONS; TARGETS	Ultra-intense lasers can nowadays routinely accelerate kiloampere ion beams. These unique sources of particle beams could impact many societal (e.g., proton-therapy or fuel recycling) and fundamental (e.g., neutron probing) domains. However, this requires overcoming the beam angular divergence at the source. This has been attempted, either with large-scale conventional setups or with compact plasma techniques that however have the restriction of short (<1 mm) focusing distances or a chromatic behavior. Here, we show that exploiting laser-triggered, long-lasting (>50 ps), thermoelectric multi-megagauss surface magnetic (B)-fields, compact capturing, and focusing of a diverging laser-driven multi-MeV ion beam can be achieved over a wide range of ion energies in the limit of a 5 degrees acceptance angle. (C) 2015 AIP Publishing LLC.	[Albertazzi, B.; Dervieux, V.; Chen, S. N.; Nakatsutsumi, M.; Romagnani, L.; Fuchs, J.] UPMC, Ecole Polytech, CNRS, LULI,CEA, F-91128 Palaiseau, France; [Albertazzi, B.; Pepin, H.] INRS EMT, Varennes, PQ J3X 1S2, Canada; [Albertazzi, B.] Osaka Univ, Grad Sch Engn, Suita, Osaka 565087, Japan; [d'Humieres, E.; Breil, J.; Feugeas, J. L.; Nicolai, P.; Tikhonchuk, V. T.] Univ Bordeaux, CELIA, F-33405 Talence, France; [d'Humieres, E.; Sentoku, Y.] Univ Nevada, Dept Phys, Reno, NV 89557 USA; [Lancia, L.; Antici, P.] Univ Roma La Sapienza, Dipartimento SBAI, I-00161 Rome, Italy; [Boecker, J.; Swantusch, M.; Willi, O.] Univ Dusseldorf, Inst Laser & Plasmaphys, D-40225 Dusseldorf, Germany; [Bonlie, J.; Cauble, B.; Chen, S. N.; Shepherd, R.] Lawrence Livermore Natl Lab, Livermore, CA 94551 USA; [Borghesi, M.] Queens Univ Belfast, Sch Phys & Astron, Belfast BT7 1NN, Antrim, North Ireland	Albertazzi, B (reprint author), UPMC, Ecole Polytech, CNRS, LULI,CEA, F-91128 Palaiseau, France.	bruno.albertazzi@polytechnique.edu; Julien.fuchs@polytechnique.fr			Region Ile-de-France [E1127]; National Science Foundation [1064468]; ELAM grant from the Triangle de la Physique RTRA network; ULIMAC grant from the Triangle de la Physique RTRA network; NSERC from Canada [26558-2007 RGPIN]; Agence Nationale de la Recherche [ANR-11-IDEX-0004-02]; LASERLAB-EUROPE (EC's Seventh Framework Programme) [284464]; EPSRC [EP/K022415/1]; EURATOM; Aquitaine Regional Council;  [001528]	We acknowledge the expert support of the LLNL teams. This work was supported by grant E1127 from Region Ile-de-France, by the National Science Foundation, Grant No. 1064468, ELAM and ULIMAC grants from the Triangle de la Physique RTRA network, and by NSERC Discovery Grant No. 26558-2007 RGPIN from Canada. O.W. would like to acknowledge DFG Programme GRK 1203. This work was partly done within the LABEX Plas@Par project and received financial state aid managed by the Agence Nationale de la Recherche, as part of the program "Investissements d'avenir" under the reference ANR-11-IDEX-0004-02. The research leading to these results has also received funding from LASERLAB-EUROPE (Grant Agreement No. 284464, EC's Seventh Framework Programme), Grant No. 001528, and from EPSRC, Grant No. EP/K022415/1. This work is also partly supported by the EURATOM within the "Keep-in-Touch" activities and the Aquitaine Regional Council.	Albertazzi B., PHYS PLASMAS UNPUB; Malka V, 2004, MED PHYS, V31, P1587, DOI 10.1118/1.1747751; Haines MG, 1997, PHYS REV LETT, V78, P254, DOI 10.1103/PhysRevLett.78.254; Sarri G, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.205002; Bulanov SV, 2002, PHYS LETT A, V299, P240, DOI 10.1016/S0375-9601(02)00521-2; Robinson APL, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/1/013021; Doumy G, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.026402; Kar S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.185006; WILKS SC, 1992, PHYS REV LETT, V69, P1383, DOI 10.1103/PhysRevLett.69.1383; Sentoku Y, 2008, J COMPUT PHYS, V227, P6846, DOI 10.1016/j.jcp.2008.03.043; Santala MIK, 2001, APPL PHYS LETT, V78, P19, DOI 10.1063/1.1335849; Bolton PR, 2014, PHYS MEDICA, V30, P255, DOI 10.1016/j.ejmp.2013.09.002; Mancic A, 2010, HIGH ENERG DENS PHYS, V6, P21, DOI 10.1016/j.hedp.2009.06.008; Fritzler S, 2003, APPL PHYS LETT, V83, P3039, DOI 10.1063/1.1616661; Antici P, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.105004; Davis SP, 2013, HIGH ENERG DENS PHYS, V9, P231, DOI 10.1016/j.hedp.2012.11.009; Schollmeier M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.055004; STAMPER JA, 1991, LASER PART BEAMS, V9, P841; Spitkovsky A, 2008, ASTROPHYS J LETT, V673, pL39, DOI 10.1086/527374; Jung D, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/2/023007; Maire PH, 2007, SIAM J SCI COMPUT, V29, P1781, DOI 10.1137/050633019; Chen H, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.105001; Busold S, 2014, PHYS REV SPEC TOP-AC, V17, DOI 10.1103/PhysRevSTAB.17.031302; Toncian T, 2006, SCIENCE, V312, P410, DOI 10.1126/science.1124412; Borghesi M, 1998, PHYS REV LETT, V81, P112, DOI 10.1103/PhysRevLett.81.112; Jung D, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4817287; Bartal T, 2012, NAT PHYS, V8, P139, DOI [10.1038/nphys2153, 10.1038/NPHYS2153]; Daido H, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/5/056401; Roth M, 2001, PHYS REV LETT, V86, P436, DOI 10.1103/PhysRevLett.86.436; Patel PK, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.125004; Antici P, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4833618; Aurand B., 2013, J NEW PHYS, V15; Bin JH, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4816031; Braginskii S.I., 1965, REV PLASMA PHYS, V1; Brambrink E, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.154801; Cecchetti CA, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3097899; Chen SN, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.055001; Fuchs J, 2009, CR PHYS, V10, P176, DOI 10.1016/j.crhy.2009.03.011; Kar S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.225003; KOLODNER P, 1976, PHYS REV LETT, V37, P1754, DOI 10.1103/PhysRevLett.37.1754; Kruer W. L., 1985, PLASMA PHYS CONTROLL, V9, P63; Lancia L, 2013, LASER PART BEAMS, V31, P653, DOI 10.1017/S0263034613000451; Li CK, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.015001; Nurnberg F, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3086424; Renk TJ, 2003, FUSION ENG DES, V65, P399, DOI 10.1016/S0920-3796(03)00009-7; Teng J, 2013, NUCL INSTRUM METH A, V729, P399, DOI 10.1016/j.nima.2013.07.048	46	0	0	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	APR	2015	86	4							043502	10.1063/1.4917273		6	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	CH2EE	WOS:000353837700024		
J	Goto, T; Nakamori, H; Kimura, T; Sano, Y; Kohmura, Y; Tamasaku, K; Yabashi, M; Ishikawa, T; Yamauchi, K; Matsuyama, S				Goto, Takumi; Nakamori, Hiroki; Kimura, Takashi; Sano, Yasuhisa; Kohmura, Yoshiki; Tamasaku, Kenji; Yabashi, Makina; Ishikawa, Tetsuya; Yamauchi, Kazuto; Matsuyama, Satoshi			Hard X-ray nanofocusing using adaptive focusing optics based on piezoelectric deformable mirrors	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article							METROLOGY; LENSES	An adaptive Kirkpatrick-Baez mirror focusing optics based on piezoelectric deformable mirrors was constructed at SPring-8 and its focusing performance characteristics were demonstrated. By adjusting the voltages applied to the deformable mirrors, the shape errors (compared to a target elliptical shape) were finely corrected on the basis of the mirror shape determined using the pencil-beam method, which is a type of at-wavelength figure metrology in the X-ray region. The mirror shapes were controlled with a peak-to-valley height accuracy of 2.5 nm. A focused beam with an intensity profile having a full width at half maximum of 110 x 65 nm (V x H) was achieved at an X-ray energy of 10 keV. (C) 2015 AIP Publishing LLC.	[Goto, Takumi; Nakamori, Hiroki; Sano, Yasuhisa; Yamauchi, Kazuto; Matsuyama, Satoshi] Osaka Univ, Grad Sch Engn, Dept Precis Sci & Technol, Suita, Osaka 5650871, Japan; [Kimura, Takashi] Hokkaido Univ, Res Inst Elect Sci, Kita Ku, Sapporo, Hokkaido 0010021, Japan; [Kohmura, Yoshiki; Tamasaku, Kenji; Yabashi, Makina; Ishikawa, Tetsuya] SPring 8 RIKEN, Sayo, Hyogo 6795198, Japan; [Yamauchi, Kazuto] Osaka Univ, Grad Sch Engn, Ctr Ultraprecis Sci & Technol, Suita, Osaka 5650871, Japan; [Yamauchi, Kazuto] JST, CREST, Suita, Osaka 5650871, Japan	Matsuyama, S (reprint author), Osaka Univ, Grad Sch Engn, Dept Precis Sci & Technol, 2-1 Yamada Oka, Suita, Osaka 5650871, Japan.	matsuyama@prec.eng.osaka-u.ac.jp	Yabashi, Makina/A-2832-2015; Tamasaku, Kenji/N-7907-2015	Yabashi, Makina/0000-0002-2472-1684; 	JST CREST project; JSPS KAKENHI [23226004]; MEXT Global COE program [H08]; RIKEN	This research was supported by the JST CREST project. It was partially supported by JSPS KAKENHI (Grant No. 23226004) and the MEXT Global COE program (H08). The use of the BL29XUL beamline at SPring-8 was supported by RIKEN. We would like to acknowledge the JTEC Corporation for assistance with substrate processing.	Kimura T, 2013, OPT EXPRESS, V21, P9267, DOI 10.1364/OE.21.009267; Chen TY, 2011, OPT EXPRESS, V19, P19919, DOI 10.1364/OE.19.019919; Yan HF, 2011, OPT EXPRESS, V19, P15069, DOI 10.1364/OE.19.015069; Martin T, 2006, J SYNCHROTRON RADIAT, V13, P180, DOI 10.1107/S0909049506000550; Yamauchi K, 2002, REV SCI INSTRUM, V73, P4028, DOI 10.1063/1.1510573; KIRKPATRICK P, 1948, J OPT SOC AM, V38, P766, DOI 10.1364/JOSA.38.000766; Hignette O, 1997, P SOC PHOTO-OPT INS, V3152, P188, DOI 10.1117/12.295559; Idir M, 2010, NUCL INSTRUM METH A, V616, P162, DOI 10.1016/j.nima.2009.10.168; Kimura T, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.07GJ07; Matsuyama S, 2012, PROC SPIE, V8503, DOI 10.1117/12.930276; Merthe DJ, 2013, OPT ENG, V52, DOI 10.1117/1.OE.52.3.033603; Mimura H., 2009, NAT PHYS, V6, P122, DOI DOI 10.1038/NPHYS1457; Mimura H, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2436469; Nakamori H, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4709499; Nakamori H, 2013, NUCL INSTRUM METH A, V710, P93, DOI 10.1016/j.nima.2012.11.059; Schroer CG, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2053350; Signorato R, 1998, J SYNCHROTRON RADIAT, V5, P797, DOI 10.1107/S0909049597012843; SUSINI J, 1995, REV SCI INSTRUM, V66, P2229, DOI 10.1063/1.1145715; Sutter J, 2012, J SYNCHROTRON RADIAT, V19, P960, DOI 10.1107/S090904951203662X; Yuan S., 2010, XRAY OPT INSTRUM	20	0	0	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	APR	2015	86	4							043102	10.1063/1.4916617		5	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	CH2EE	WOS:000353837700003		
J	Hu, XK; Yamamoto, A; Ohta, M; Nishiate, H				Hu, Xiaokai; Yamamoto, Atsushi; Ohta, Michihiro; Nishiate, Hirotaka			Measurement and simulation of thermoelectric efficiency for single leg	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article							PERFORMANCE; GENERATORS; MODULES; SYSTEMS; POWER; HEAT	Thermoelectric efficiency measurements were carried out on n-type bismuth telluride legs with the hot-side temperature at 100 and 150 degrees C. The electric power and heat flow were measured individually. Water coolant was utilized to maintain the cold-side temperature and to measure heat flow out of the cold side. Leg length and vacuum pressure were studied in terms of temperature difference across the leg, open-circuit voltage, internal resistance, and heat flow. Finite-element simulation on thermoelectric generation was performed in COMSOL Multiphysics, by inputting two-side temperatures and thermoelectric material properties. The open-circuit voltage and resistance were in good agreement between the measurement and simulation. Much larger heat flows were found in measurements, since they were comprised of conductive, convective, and radiative contributions. Parasitic heat flow was measured in the absence of bismuth telluride leg, and the conductive heat flow was then available. Finally, the maximum thermoelectric efficiency was derived in accordance with the electric power and the conductive heat flow. (C) 2015 AIP Publishing LLC.	[Hu, Xiaokai; Yamamoto, Atsushi; Ohta, Michihiro; Nishiate, Hirotaka] Natl Inst Adv Ind Sci & Technol, Energy Technol Res Inst, Tsukuba, Ibaraki 3058568, Japan	Yamamoto, A (reprint author), Natl Inst Adv Ind Sci & Technol, Energy Technol Res Inst, 1-1-1 Umezono, Tsukuba, Ibaraki 3058568, Japan.	a.yamamoto@aist.go.jp	Ohta, Michihiro/J-8460-2015	Ohta, Michihiro/0000-0002-9093-7117	Ministry of Economy, Trade, and Industry, government of Japan under the framework of international cooperation project for research and standardization of Clean Energy Technologies	We would like to thank the funding support from Ministry of Economy, Trade, and Industry, government of Japan under the framework of international cooperation project for research and standardization of Clean Energy Technologies.	Wang H, 2014, J ELECTRON MATER, V43, P2274, DOI 10.1007/s11664-014-3044-2; Bell LE, 2008, SCIENCE, V321, P1457, DOI 10.1126/science.1158899; LaLonde AD, 2011, MATER TODAY, V14, P526, DOI 10.1016/S1369-7021(11)70278-4; Rauscher L, 2005, MEAS SCI TECHNOL, V16, P1054, DOI 10.1088/0957-0233/16/5/002; SHERMAN B, 1960, J APPL PHYS, V31, P1, DOI 10.1063/1.1735380; Ebling D, 2009, J ELECTRON MATER, V38, P1456, DOI 10.1007/s11664-009-0825-0; Faraji AY, 2013, J ELECTRON MATER, V42, P1535, DOI 10.1007/s11664-012-2314-0; Biswas K, 2012, NATURE, V489, P414, DOI 10.1038/nature11439; Carmo JP, 2011, MEASUREMENT, V44, P2194, DOI 10.1016/j.measurement.2011.07.015; Guo JQ, 2012, J ELECTRON MATER, V41, P1036, DOI 10.1007/s11664-012-1958-0; Hu X., J ELECT MAT; Ioffe A.F., 1957, SEMICONDUCTOR THERMO; Kraemer D., ENERGY ENV SCI; Sandoz-Rosado E, 2010, J ELECTRON MATER, V39, P1848, DOI 10.1007/s11664-010-1077-8	14	1	1	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	APR	2015	86	4							045103	10.1063/1.4916545		7	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	CH2EE	WOS:000353837700060		
J	Miake, Y; Mukaiyama, T; O'Hara, KM; Gensemer, S				Miake, Yudai; Mukaiyama, Takashi; O'Hara, Kenneth M.; Gensemer, Stephen			A self-injected, diode-pumped, solid-state ring laser for laser cooling of Li atoms	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article							FERMI GAS; 671 NM	We have constructed a solid-state light source for experiments with laser cooled lithium atoms based on a Nd:YVO4 ring laser with second-harmonic generation. Unidirectional lasing, an improved mode selection, and a high output power of the ring laser were achieved by weak coupling to an external cavity which contained the lossy elements required for single frequency operation. Continuous frequency tuning is accomplished by controlling two piezoelectric transducers (PZTs) in the internal and the external cavities simultaneously. The light source has been utilized to trap and cool fermionic lithium atoms into the quantum degenerate regime. (C) 2015 AIP Publishing LLC.	[Miake, Yudai; Mukaiyama, Takashi] Univ Electrocommun, Inst Laser Sci, Chofu, Tokyo 1828585, Japan; [O'Hara, Kenneth M.] Penn State Univ, Dept Phys, University Pk, PA 16802 USA; [Gensemer, Stephen] CSIRO Mfg Flagship, Lindfield, NSW 2070, Australia	Miake, Y (reprint author), Univ Electrocommun, Inst Laser Sci, 1-5-1 Chofugaoka, Chofu, Tokyo 1828585, Japan.	muka@ils.uec.ac.jp					Abitan H, 2005, APPL OPTICS, V44, P7802, DOI 10.1364/AO.44.007802; Eismann U, 2013, OPT EXPRESS, V21, P9091, DOI 10.1364/OE.21.009091; O'Hara KM, 2002, SCIENCE, V298, P2179, DOI 10.1126/science.1079107; Camargo FA, 2010, IEEE J QUANTUM ELECT, V46, P804, DOI 10.1109/JQE.2009.2038496; Chin C, 2004, SCIENCE, V305, P1128, DOI 10.1126/science.1100818; Zwierlein MW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.120403; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Eismann U, 2012, APPL PHYS B-LASERS O, V106, P25, DOI 10.1007/s00340-011-4693-y; Tiecke TG, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.013409; FAXVOG FR, 1980, OPT LETT, V5, P285, DOI 10.1364/OL.5.000285; Bourdel T, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.020402; FAXVOG FR, 1974, APPL PHYS LETT, V25, P306, DOI 10.1063/1.1655484; Haze S, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4793613; Inada Y, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.180406; Shardlow PC, 2009, APPL PHYS B-LASERS O, V97, P257, DOI 10.1007/s00340-009-3641-6; Zheng Y., 2011, IEEE J QUANTUM ELECT, V48, P67	16	0	0	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	APR	2015	86	4							043113	10.1063/1.4917558		3	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	CH2EE	WOS:000353837700014		
J	Mizuno, T; Nakao, S; Mizutani, Y; Iwata, T				Mizuno, T.; Nakao, S.; Mizutani, Y.; Iwata, T.			Photon-counting 1.0 GHz-phase-modulation fluorometer	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article							FLUORESCENCE-LIFETIME MEASUREMENTS; VARIABLE-FREQUENCY PHASE; GAIN PHOTOMULTIPLIER TUBE; CROSS-CORRELATION METHOD; EXCITATION LIGHT-SOURCE; MODE-LOCKED LASERS; AUTOREGRESSIVE-MODEL; DOMAIN FLUOROMETER; PULSED-EXCITATION; EMITTING DIODE	We have constructed an improved version of a photon-counting phase-modulation fluorometer (PC-PMF) with a maximum modulation frequency of 1.0 GHz, where a phase domain measurement is conducted with a time-correlated single-photon-counting electronics. While the basic concept of the PC-PMF has been reported previously by one of the authors, little attention has been paid to its significance, other than its weak fluorescence measurement capability. Recently, we have recognized the importance of the PC-PMF and its potential for fluorescence lifetime measurements. One important aspect of the PC-PMF is that it enables us to perform high-speed measurements that exceed the frequency bandwidths of the photomultiplier tubes that are commonly used as fluorescence detectors. We describe the advantages of the PC-PMF and demonstrate its usefulness based on fundamental performance tests. In our new version of the PC-PMF, we have used a laser diode (LD) as an excitation light source rather than the light-emitting diode that was used in the primary version. We have also designed a simple and stable LD driver to modulate the device. Additionally, we have obtained a sinusoidal histogram waveform that has multiple cycles within a time span to be measured, which is indispensable for precise phase measurements. With focus on the fluorescence intensity and the resolution time, we have compared the performance of the PC-PMF with that of a conventional PMF using the analogue light detection method. (C) 2015 AIP Publishing LLC.	[Mizuno, T.; Nakao, S.; Mizutani, Y.; Iwata, T.] Univ Tokushima, Inst Sci & Technol, Div Energy Syst, Tokushima 7708506, Japan	Iwata, T (reprint author), Univ Tokushima, Inst Sci & Technol, Div Energy Syst, 2-1 Minami Jyosanjima, Tokushima 7708506, Japan.	iwata@tokushima-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [26289066]	This work was supported in part by a Grant-in-Aid for Scientific Research B (No. 26289066) from the Japan Society for the Promotion of Science (JSPS). We also thank an unknown reviewer for valuable comments and suggestions for improving the quality of this paper.	GRATTON E, 1984, BIOPHYS J, V46, P479; LAKOWICZ JR, 1984, BIOPHYS J, V46, P463; Nad S, 2003, J PHYS CHEM A, V107, P4808, DOI 10.1021/jp021543t; GRATTON E, 1983, BIOPHYS J, V44, P315; GADELLA TWJ, 1993, BIOPHYS CHEM, V48, P221, DOI 10.1016/0301-4622(93)85012-7; BARCELLONA ML, 1990, EUR BIOPHYS J, V17, P315; BRIGHT FV, 1987, APPL OPTICS, V26, P3526, DOI 10.1364/AO.26.003526; Burden DL, 1997, ANAL CHEM, V69, P1936, DOI 10.1021/ac961130m; Harms P, 1999, REV SCI INSTRUM, V70, P1535, DOI 10.1063/1.1149620; Herman, 2008, ANN NY ACAD SCI, V1130, P56; IDE G, 1983, REV SCI INSTRUM, V54, P841, DOI 10.1063/1.1137488; Iwata T, 2003, OPT REV, V10, P31, DOI 10.1007/s10043-003-0031-x; IWATA T, 1985, APPL SPECTROSC, V39, P101, DOI 10.1366/0003702854249150; Iwata T, 2000, OPT REV, V7, P495, DOI 10.1007/s10043-000-0495-x; Iwata T, 2001, OPT REV, V8, P326, DOI 10.1007/s10043-001-0326-8; Iwata T, 2008, MEAS SCI TECHNOL, V19, DOI 10.1088/0957-0233/19/1/015601; Iwata T, 2003, APPL SPECTROSC, V57, P1145, DOI 10.1366/00037020360696017; Iwata T, 2010, OPT REV, V17, P513, DOI 10.1007/s10043-010-0092-6; Iwata T, 2004, OPT REV, V11, P19, DOI 10.1007/s10043-004-0019-1; Iwata T, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/6/065901; Iwata T, 2009, APPL SPECTROSC, V63, P1256, DOI 10.1366/000370209789806911; Iwata T, 2005, MEAS SCI TECHNOL, V16, P2351, DOI 10.1088/0957-0233/16/11/029; Iwata T, 2007, MEAS SCI TECHNOL, V18, P288, DOI 10.1088/0957-0233/18/1/035; Iwata T, 2007, APPL SPECTROSC, V61, P950, DOI 10.1366/000370207781745892; Kang DY, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.1.015002; Lacowicz J. R., 1991, REV SCI INSTRUM, V62, P1727; LACZKO G, 1990, REV SCI INSTRUM, V61, P2331, DOI 10.1063/1.1141360; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE; LAKOWICZ JR, 1985, BIOPHYS CHEM, V21, P61, DOI 10.1016/0301-4622(85)85007-9; MENZEL ER, 1978, REV SCI INSTRUM, V49, P39, DOI 10.1063/1.1135248; MERKELO H, 1969, SCIENCE, V164, P301, DOI 10.1126/science.164.3877.301; Miyata T, 2012, MEAS SCI TECHNOL, V23, DOI 10.1088/0957-0233/23/3/035501; Miyata T, 2003, IEEE J QUANTUM ELECT, V39, P919, DOI 10.1109/JQE.2003.813185; Mizuno T, 2012, OPT REV, V19, P222, DOI 10.1007/s10043-012-0033-7; PINSKY BG, 1994, P SOC PHOTO-OPT INS, V2137, P794, DOI 10.1117/12.182706; RAMSEY JM, 1979, APPL OPTICS, V18, P1913, DOI 10.1364/AO.18.001913; RUSSO RE, 1982, APPL SPECTROSC, V36, P92, DOI 10.1366/0003702824638791; Sipior J, 1997, REV SCI INSTRUM, V68, P2666, DOI 10.1063/1.1148177; SPENCER RD, 1969, ANN NY ACAD SCI, V158, P361, DOI 10.1111/j.1749-6632.1969.tb56231.x; WANG X F, 1989, Applied Spectroscopy, V43, P840, DOI 10.1366/0003702894202364; WANG XF, 1991, APPL SPECTROSC, V45, P360, DOI 10.1366/0003702914337182; WIRTH MJ, 1988, APPL SPECTROSC, V42, P483, DOI 10.1366/0003702884428031; Yuan BH, 2010, AM J PHYS, V78, P28, DOI 10.1119/1.3224765	43	0	0	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	APR	2015	86	4							043110	10.1063/1.4917196		9	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	CH2EE	WOS:000353837700011		
J	Sharov, IA; Sergeev, VY; Miroshnikov, IV; Tamura, N; Kuteev, BV; Sudo, S				Sharov, I. A.; Sergeev, V. Yu; Miroshnikov, I. V.; Tamura, N.; Kuteev, B. V.; Sudo, S.			Imaging polychromator for density measurements of polystyrene pellet cloud on the Large Helical Device	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article							ABLATION CLOUDS; HYDROGEN; PLASMA; LINE	Experimental data on spatial distributions of a pellet cloud electron density are necessary for the development of many applications of pellet injection, namely, plasma fuelling, discharge control, and plasma diagnostics. An improved approach of electron density measurements inside the cloud of a polystyrene pellet ablating in hot plasma of the large helical device is described. Density values of (1-30) x 10(16) cm(-3) depending on the background plasma parameters and distance from the solid pellet were measured. (C) 2015 AIP Publishing LLC.	[Sharov, I. A.; Sergeev, V. Yu; Miroshnikov, I. V.] St Petersburg State Polytech Univ, St Petersburg, Russia; [Tamura, N.; Sudo, S.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Kuteev, B. V.] Kurchatov Inst, Russian Sci Ctr, Moscow, Russia	Sharov, IA (reprint author), St Petersburg State Polytech Univ, St Petersburg, Russia.	i.sharov@spbstu.ru			Japan Society for the Promotion of Science [19340179]; MEXT Japan [19740349]; NIFS [NIFS09ULHH510]; NIFS/NINS [NIFS09KEIN1018]; Russian Foundation for Basic Research [13-02-01409a, 12-02-01100a, 14-02-00697a]; Ministry of Education and Science of Russian Federation [1014, 3.200.2014]	Authors thank the Large Helical Device team and Professor M. Goto for helpful discussion. This work was supported in part by a Grant-in-Aid for Scientific Research (B) (No. 19340179) from Japan Society for the Promotion of Science, a Grant-in-Aid for Young Scientist (B) (No. 19740349) from MEXT Japan, a budgetary Grant-in-Aid (No. NIFS09ULHH510) from NIFS, and a project of Formation of International Network for Scientific Collaborations (No. NIFS09KEIN1018) of NIFS/NINS. The work is partially supported by the Russian Foundation for Basic Research (Project Nos. 13-02-01409a, 12-02-01100a, and 14-02-00697a) and by the Ministry of Education and Science of Russian Federation under order No. 1014 and Project No. 3.200.2014.	Stehle C, 1999, ASTRON ASTROPHYS SUP, V140, P93, DOI 10.1051/aas:1999118; Goto M, 2007, PLASMA PHYS CONTR F, V49, P1163, DOI 10.1088/0741-3335/49/8/005; Bakhareva O. A., 2011, 38 EPS C PLASM PHYS; Egorov S. M., 1990, P 13 INT C PLASM PHY, V1, P599; EGOROV SM, 1994, PLASMA PHYS REP, V20, P143; Griem HR, 1964, PLASMA SPECTROSCOPY; Kaneko O, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/10/104015; MCNEILL DH, 1991, PHYS FLUIDS B-PLASMA, V3, P1994, DOI 10.1063/1.859668; Morozov DK, 2004, NUCL FUSION, V44, P252, DOI 10.1088/0029-5515/44/2/005; Motojima Gen, 2010, Plasma and Fusion Research, V5, DOI 10.1585/pfr.5.S1033; Motojima O, 1999, PHYS PLASMAS, V6, P1843, DOI 10.1063/1.873443; Pegourie B, 2007, PLASMA PHYS CONTR F, V49, pR87, DOI 10.1088/0741-3335/49/8/R01; Sharov I. A., 2012, 22 INT TOK C TOK; Sharov I. A., 2011, IEEE T PLASMA SCI, V39, P11; Sharov IA, 2014, TECH PHYS LETT+, V40, P361, DOI 10.1134/S1063785014040257; Tamura N, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2957928; Tikhonov A. N., 1977, SOLUTIONS ILL POSED; Van Loan C. F., 1996, MATRIX COMPUTATIONS	18	0	0	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	APR	2015	86	4							043505	10.1063/1.4919001		6	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	CH2EE	WOS:000353837700027		
J	Suzuki, Y				Suzuki, Yoshio			Interaction between periodic structures of object and X-ray standing wave generated by wavefront-division interferometer	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article							PRISM OPTICS	An x-ray imaging method that utilizes interaction between standing wave and periodic structure of object is proposed. When a periodic object is placed in a standing wave field, the interaction is modulated by relation between the periodic structure of object and the standing wave period. Then, the structure of object can be observed as a modulation of transmission image, and the existence of fine periodic structures can be detected with an imaging detector of low spatial resolution. Feasibility studies have been performed using a standing wave generated by a wavefront-division x-ray interferometer with refractive prism optics. (C) 2015 AIP Publishing LLC.	SPring 8, Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan	Suzuki, Y (reprint author), SPring 8, Japan Synchrotron Radiat Res Inst, 1-1-1 Kouto, Sayo, Hyogo 6795198, Japan.	yoshio@spring8.or.jp					Suzuki Y, 2004, REV SCI INSTRUM, V75, P1026, DOI 10.1063/1.1651640; BEDZYK MJ, 1989, PHYS REV LETT, V62, P1376, DOI 10.1103/PhysRevLett.62.1376; Cash W, 2000, NATURE, V407, P160, DOI 10.1038/35025009; Evans-Lutterodt K, 2003, OPT EXPRESS, V11, P919, DOI 10.1364/OE.11.000919; Suzuki Y, 2004, AIP CONF PROC, V705, P344; Snigirev A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.064801; BATTERMA.BW, 1969, PHYS REV LETT, V22, P703, DOI 10.1103/PhysRevLett.22.703; COWAN PL, 1980, PHYS REV LETT, V44, P1680, DOI 10.1103/PhysRevLett.44.1680; Isakovic AF, 2010, J SYNCHROTRON RADIAT, V17, P451, DOI 10.1107/S0909049510012823; Koyama T, 2004, JPN J APPL PHYS 2, V43, pL421, DOI 10.1143/JJAP.43.L421; Lang AR, 1999, J SYNCHROTRON RADIAT, V6, P59, DOI 10.1107/S0909049599001041; Stutman D, 2010, APPL OPTICS, V49, P4677, DOI 10.1364/AO.49.004677; Suzuki Y, 2004, JPN J APPL PHYS 1, V43, P7311, DOI 10.1143/JJAP.43.7311; Suzuki Y, 2002, JPN J APPL PHYS 2, V41, pL1019, DOI 10.1143/JJAP.41.L1019; Suzuki Y, 2008, JPN J APPL PHYS, V47, P8595, DOI 10.1143/JJAP.47.8595; Wen H, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4788910	16	0	0	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	APR	2015	86	4							043701	10.1063/1.4916735		5	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	CH2EE	WOS:000353837700029		
J	Tsuchiya, K; Shioya, T				Tsuchiya, K.; Shioya, T.			Practical method using superposition of individual magnetic fields for initial arrangement of undulator magnets	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article							INSERTION DEVICES; RADIATION; DESIGN	We have developed a practical method for determining an excellent initial arrangement of magnetic arrays for a pure-magnet Halbach-type undulator. In this method, the longitudinal magnetic field distribution of each magnet is measured using a moving Hall probe system along the beam axis with a high positional resolution. The initial arrangement of magnetic arrays is optimized and selected by analyzing the superposition of all distribution data in order to achieve adequate spectral quality for the undulator. We applied this method to two elliptically polarizing undulators (EPUs), called U#16-2 and U#02-2, at the Photon Factory storage ring (PF ring) in the High Energy Accelerator Research Organization (KEK). The measured field distribution of the undulator was demonstrated to be excellent for the initial arrangement of the magnet array, and this method saved a great deal of effort in adjusting the magnetic fields of EPUs. (C) 2015 AIP Publishing LLC.	[Tsuchiya, K.; Shioya, T.] Accelerator Lab High Energy Accelerator Res Org K, Tsukuba, Ibaraki, Japan	Tsuchiya, K (reprint author), Accelerator Lab High Energy Accelerator Res Org K, 1-1 Oho, Tsukuba, Ibaraki, Japan.						SASAKI S, 1993, NUCL INSTRUM METH A, V331, P763, DOI 10.1016/0168-9002(93)90153-9; CARR R, 1991, NUCL INSTRUM METH A, V306, P391, DOI 10.1016/0168-9002(91)90346-R; Chavanne J., 1995, SYNCHROTRON RAD NEWS, V8, P18, DOI 10.1080/08940889508602784; COVER RA, 1995, IEEE J QUANTUM ELECT, V31, P664, DOI 10.1109/3.371941; Cox A., 1985, P SOC PHOTO-OPT INS, V0582, P91; Diviacco B., 1993, P 1993 PART ACC C IE, V19, P1590; Hara T, 1998, J SYNCHROTRON RADIAT, V5, P426, DOI 10.1107/S0909049597015719; Honda T, 2007, AIP CONF PROC, V879, P87; HUMPHRIES D, 1994, IEEE T MAGN, V30, P2431, DOI 10.1109/20.305768; Hwang CS, 1999, NUCL INSTRUM METH A, V420, P29, DOI 10.1016/S0168-9002(98)01138-3; Schmidt T, 2007, AIP CONF PROC, V879, P404; Tanaka T, 2000, REV SCI INSTRUM, V71, P3010, DOI 10.1063/1.1304878; Tsuchiya K, 2013, J PHYS CONF SER, V425, DOI 10.1088/1742-6596/425/13/132017; YAMAMOTO S, 1995, REV SCI INSTRUM, V66, P1996, DOI 10.1063/1.1145780	14	0	0	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	APR	2015	86	4							043305	10.1063/1.4918793		7	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	CH2EE	WOS:000353837700020		
J	Yamada, S; Minami, Y; Sohgawa, M; Abe, T				Yamada, S.; Minami, Y.; Sohgawa, M.; Abe, T.			Thermal reactive ion etching technique involving use of self-heated cathode	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article							GAS-MIXTURES; PLASMA; FILM	In this work, the thermal reactive ion etching (TRIE) technique for etching hard-to-etch materials is presented. The TRIE technique employs a self-heated cathode and a thermally insulated aluminum plate is placed on the cathode of a regular reactive ion etching (RIE) system. By optimizing the beam size to support the sample stage, the temperature of the stage can be increased to a desired temperature without a cathode heater. The technique was used to etch a bulk titanium plate. An etch rate of 0.6 mu m/min and an etch selectivity to nickel of 100 were achieved with SF6 plasma. The proposed technique makes a regular RIE system a more powerful etcher without the use of chlorine gas, a cathode heater, and an inductively coupled plasma source. (C) 2015 AIP Publishing LLC.	[Yamada, S.; Minami, Y.; Sohgawa, M.; Abe, T.] Niigata Univ, Grad Sch Sci & Technol, Niigata 9502181, Japan	Abe, T (reprint author), Niigata Univ, Grad Sch Sci & Technol, Niigata 9502181, Japan.	memsabe@eng.niigata-u.ac.jp					Aimi F., 2004, NAT MATER, V3, P103; Parker ER, 2005, J ELECTROCHEM SOC, V152, pC675, DOI 10.1149/1.2006647; LEGTENBERG R, 1995, J ELECTROCHEM SOC, V142, P2020, DOI 10.1149/1.2044234; Ayon AA, 1999, J ELECTROCHEM SOC, V146, P339; DEMIC CP, 1992, J VAC SCI TECHNOL B, V10, P1105, DOI 10.1116/1.586085; Haynes W.M., 2014, HDB CHEM PHYS; Ikegami N, 1996, JPN J APPL PHYS 1, V35, P2505, DOI 10.1143/JJAP.35.2505; Li XH, 2001, SENSOR ACTUAT A-PHYS, V87, P139, DOI 10.1016/S0924-4247(00)00482-9; Rao M. P., 2013, BIOMED NANOSENS, V3, P307; VIJAY DP, 1993, J ELECTROCHEM SOC, V140, P2635, DOI 10.1149/1.2220876; Yamada S., 2014, IEEJ T SENS MICROMAC, V134, P96; YOKOYAMA S, 1995, JPN J APPL PHYS 1, V34, P767, DOI 10.1143/JJAP.34.767	12	0	0	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	APR	2015	86	4							045001	10.1063/1.4917193		4	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	CH2EE	WOS:000353837700054		
J	Agawa, Y; Tanaka, H; Torisu, S; Endo, S; Tsujimoto, A; Gonohe, N; Malgras, V; Aldalbahi, A; Alshehri, SM; Kamachi, Y; Li, CL; Yamauchi, Y				Agawa, Yoshiaki; Tanaka, Hiroyuki; Torisu, Shigemitsu; Endo, Satoshi; Tsujimoto, Akihiro; Gonohe, Narishi; Malgras, Victor; Aldalbahi, Ali; Alshehri, Saad M.; Kamachi, Yuichiro; Li, Cuiling; Yamauchi, Yusuke			Preparation of a platinum electrocatalyst by coaxial pulse arc plasma deposition	SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS			English	Article						Pt nanoparticles; electrocatalysts; methanol oxidation	OXYGEN REDUCTION REACTION; HIGH-INDEX FACETS; CORE-SHELL NANOPARTICLES; METHANOL OXIDATION; FUEL-CELLS; ALLOY NANOCRYSTALS; TAILORED DESIGN; CATALYSTS; SURFACTANT; FILMS	We have developed a new method of preparing Pt electrocatalysts through a dry process. By coaxial pulse arc plasma deposition (CAPD), highly ionized metal plasma can be generated from a target rod without any discharged gases, and Pt nanoparticles can be deposited on a carbon support. The small-sized Pt nanoparticles are distributed over the entire carbon surface. From transmission electron microscopy (TEM), the average size of the deposited Pt nanoparticles is estimated to be 2.5 nm, and their size distribution is narrow. Our electrocatalyst shows considerably improved catalytic activity and stability toward methanol oxidation reaction (MOR) compared with commercially available Pt catalysts such as Pt black and Pt/carbon (PtC). Inspired by its very high efficiency toward MOR, we also measured the catalytic performance for oxygen reduction reaction (ORR). Our PtC catalyst shows a better performance with half-wave potential of 0.87 V, which is higher than those of commercially available Pt catalysts. The higher performance is also supported by a right-shifted onset potential. Our preparation is simple and could be applied to other metallic nanocrystals as a novel platform in catalysis, fuel cells and biosensors.	[Agawa, Yoshiaki; Tanaka, Hiroyuki; Torisu, Shigemitsu; Endo, Satoshi; Tsujimoto, Akihiro; Gonohe, Narishi] ULVAC RIKO Inc, Arc Plasma Deposit Syst Business Promot Div, Yokohama, Kanagawa 2240053, Japan; [Malgras, Victor; Kamachi, Yuichiro; Li, Cuiling; Yamauchi, Yusuke] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton MANA, Tsukuba, Ibaraki 3050044, Japan; [Aldalbahi, Ali; Alshehri, Saad M.; Yamauchi, Yusuke] King Saud Univ, Coll Sci, Dept Chem, Riyadh 11451, Saudi Arabia	Agawa, Y (reprint author), ULVAC RIKO Inc, Arc Plasma Deposit Syst Business Promot Div, 4388 Ikonobe Cho, Yokohama, Kanagawa 2240053, Japan.	yoshiaki_agawa@ulvac.com; Li.Cuiling@nims.go.jp; Yamauchi.Yusuke@nims.go.jp	Malgras, Victor/A-8221-2015; Yamauchi, Yusuke/D-2780-2015	Malgras, Victor/0000-0002-5667-9118; 	Japan Society for the Promotion of Science (JSPS) [26708028]; Japanese-Taiwanese Cooperative Program of the Japan Science and Technology Agency (JST); Canon Foundation; Deanship of Scientific Research, King Saud University	This research is partially supported by the Grants-in-Aid for Young Scientists (A) (Research Project Number: 26708028) of the Japan Society for the Promotion of Science (JSPS), the Japanese-Taiwanese Cooperative Program of the Japan Science and Technology Agency (JST) and The Canon Foundation. The authors extend their appreciation to the Visiting Professor Program (VPP) supported by the Deanship of Scientific Research, King Saud University.	Agawa Y., 2006, ULVAC TECHNICAL J E, V65E, P1; Agawa Y, 2012, 222 EL SOC M; Tang J, 2014, NANO TODAY, V9, P305, DOI 10.1016/j.nantod.2014.05.003; Wang DL, 2010, J AM CHEM SOC, V132, P17664, DOI 10.1021/ja107874u; Arico AS, 2001, FUEL CELLS, V1, P133; Tian N, 2007, SCIENCE, V316, P732, DOI 10.1126/science.1140484; Wang JJ, 2007, J POWER SOURCES, V171, P331, DOI 10.1016/j.jpowsour.2007.06.084; Lv HF, 2012, J MATER CHEM, V22, P9155, DOI 10.1039/c2jm30538k; Li CL, 2013, ANGEW CHEM INT EDIT, V52, P8050, DOI 10.1002/anie.201303035; Liu ZL, 2005, J POWER SOURCES, V139, P73, DOI 10.1016/j.jpowsour.2004.07.012; Yao T, 2012, J AM CHEM SOC, V134, P9410, DOI 10.1021/ja302642x; Li CL, 2014, CHEM-EUR J, V20, P3277, DOI 10.1002/chem.201303250; Zhou WP, 2009, J AM CHEM SOC, V131, P12755, DOI 10.1021/ja9039746; Jia YY, 2014, J AM CHEM SOC, V136, P3748, DOI 10.1021/ja413209q; Kuai L, 2011, CHEM COMMUN, V47, P6093, DOI 10.1039/c0cc05429a; Tang J, 2015, ANGEW CHEM INT EDIT, V54, P588, DOI 10.1002/anie.201407629; Wu JB, 2012, J AM CHEM SOC, V134, P11880, DOI 10.1021/ja303950v; Shao YY, 2008, APPL CATAL B-ENVIRON, V79, P89, DOI 10.1016/j.apcatb.2007.09.047; Zheng SF, 2007, J PHYS CHEM C, V111, P11174, DOI 10.1021/jp0727042; Wang GW, 2014, J AM CHEM SOC, V136, P9643, DOI 10.1021/ja503315s; Wang L, 2009, J AM CHEM SOC, V131, P9152, DOI 10.1021/ja902485x; Wei L, 2013, CHEM COMMUN, V49, P11152, DOI 10.1039/c3cc46473c; Wang L, 2012, ACS APPL MATER INTER, V4, P2865, DOI 10.1021/am300574e; van Drunen J, 2014, ACS APPL MATER INTER, V6, P12046, DOI 10.1021/am501097t; Lim B, 2009, SCIENCE, V324, P1302, DOI 10.1126/science.1170377; GASTEIGER HA, 1993, J PHYS CHEM-US, V97, P12020, DOI 10.1021/j100148a030; Zhao X, 2011, ENERG ENVIRON SCI, V4, P2736, DOI 10.1039/c1ee01307f; Bing YH, 2010, CHEM SOC REV, V39, P2184, DOI 10.1039/b912552c; Zhang J, 2007, SCIENCE, V315, P220, DOI 10.1126/science.1134569; Li CL, 2014, CHEM COMMUN, V50, P15337, DOI 10.1039/c4cc07071b; Ariga K, 2014, CHEM LETT, V43, P36, DOI 10.1246/cl.130987; Wang HJ, 2012, CHEM MATER, V24, P1591, DOI 10.1021/cm300054b; Liu HS, 2006, J POWER SOURCES, V155, P95, DOI 10.1016/j.jpowsour.2006.01.030; Ariga K, 2012, B CHEM SOC JPN, V85, P1, DOI 10.1246/bcsj.20110162; Guo SJ, 2012, J AM CHEM SOC, V134, P2492, DOI 10.1021/ja2104334; Sun SH, 2011, ANGEW CHEM INT EDIT, V50, P422, DOI 10.1002/anie.201004631; Oveisi H, 2011, CHEM LETT, V40, P420, DOI 10.1246/cl.2011.420; Zhang WM, 2010, ENERG ENVIRON SCI, V3, P1286, DOI 10.1039/c0ee00139b; Wang L, 2010, J AM CHEM SOC, V132, P13636, DOI 10.1021/ja105640p; Ruan LY, 2013, ANGEW CHEM INT EDIT, V52, P12577, DOI 10.1002/anie.201304658; Lee H, 2006, ANGEW CHEM INT EDIT, V45, P7824, DOI 10.1002/anie.200603068; Cui ZM, 2014, J AM CHEM SOC, V136, P10206, DOI 10.1021/ja504573a; Huang XQ, 2011, J AM CHEM SOC, V133, P4718, DOI 10.1021/ja1117528; Jager R, 2014, J ELECTROCHEM SOC, V161, pF861, DOI 10.1149/2.0491409jes; Jung Kim S M, 2013, CHEM MATER, V25, P1526; Li CL, 2015, CHEM-ASIAN J, V10, P316, DOI 10.1002/asia.201403181; Martinez-Rodriguez RA, 2014, J AM CHEM SOC, V136, P1280, DOI 10.1021/ja411939d; Sen F, 2007, J PHYS CHEM C, V111, P1467, DOI 10.1021/jp065809y; Shao YY, 2006, J ELECTROCHEM SOC, V153, pA1261, DOI 10.1149/1.2195878	49	4	4	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1468-6996	1878-5514		SCI TECHNOL ADV MAT	Sci. Technol. Adv. Mater.	APR	2015	16	2							024804	10.1088/1468-6996/16/2/024804		7	Materials Science, Multidisciplinary	Materials Science	CG9MY	WOS:000353641100007		
J	Belik, AA				Belik, Alexei A.			Magnetic properties of solid solutions between BiCrO3 and BiGaO3 with perovskite structures	SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS			English	Article						perovskites; multiferroics; high-pressure; BiCrO3; magnetic properties	CRYSTAL; POLAR; POLARIZATION	Magnetic properties of BiCr1-xGaxO3 perovskite-type solid solutions are reported, and a magnetic phase diagram is established. As-synthesized BiCrO3 and BiCr0.9Ga0.1O3 crystallize in a monoclinic (m) C2/c structure. The Neel temperature (T-N) decreases from 111 K in BiCrO3 to 98 K in BiCr0.9Ga0.1O3, and spin-reorientation transition temperature increases from 72 K in BiCrO3 to 83 K in BiCr0.9Ga0.1O3. o-BiCr0.9Ga0.1O3 with a PbZrO3-type orthorhombic structure is obtained by heating m-BiCr0.9Ga0.1O3 up to 573 K in air; it shows similar magnetic properties with those of m-BiCr0.9Ga0.1O3. T-N of BiCr0.8Ga0.2O3 is 81 K, and T-N of BiCr0.7Ga0.3O3 is 63 K. Samples with x = 0.4, 0.5, 0.6 and 0.7 crystallize in a polar R3c structure. Long-range antiferromagnetic order with weak ferromagnetism is observed below T-N = 56 K in BiCr0.6Ga0.4O3, T-N = 36 K in BiCr0.5Ga0.5O3 and T-N = 18 K in BiCr0.4Ga0.6O3. BiCr0.3Ga0.7O3 shows a paramagnetic behaviour because the Cr concentration is below the percolation threshold of 31%.	Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton WPI MANA, Tsukuba, Ibaraki 3050044, Japan	Belik, AA (reprint author), Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton WPI MANA, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.	Alexei.BELIK@nims.go.jp			World Premier International Research Center Initiative (WPI Initiative, MEXT, Japan); Japan Society for the Promotion of Science (JSPS)	This work was supported by World Premier International Research Center Initiative (WPI Initiative, MEXT, Japan), the Japan Society for the Promotion of Science (JSPS) through its 'Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)'.	SUGAWARA F, 1968, J PHYS SOC JPN, V25, P1553, DOI 10.1143/JPSJ.25.1553; Catalan G, 2009, ADV MATER, V21, P2463, DOI 10.1002/adma.200802849; Zhang JX, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.147602; Izyumskaya N, 2009, CRIT REV SOLID STATE, V34, P89, DOI 10.1080/10408430903368401; Baettig P, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.214105; Niitaka S, 2004, SOLID STATE IONICS, V172, P557, DOI 10.1016/j.ssi.2004.01.060; Mandal P, 2010, J MATER CHEM, V20, P1646, DOI 10.1039/b914350p; Belik AA, 2007, INORG CHEM, V46, P8746, DOI 10.1021/ic701099f; Rodel J, 2009, J AM CERAM SOC, V92, P1153, DOI 10.1111/j.1551-2916.2009.03061.x; Khalyavin DD, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.174414; Goujon C, 2008, J PHYS CONF SER, V121, DOI 10.1088/1742-6596/121/2/022009; Belik AA, 2012, CHEM MATER, V24, P3056, DOI 10.1021/cm301603v; Belik AA, 2012, J SOLID STATE CHEM, V195, P32, DOI 10.1016/j.jssc.2012.01.025; Suchomel MR, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2713757; Suchomel MR, 2006, CHEM MATER, V18, P4987, DOI 10.1021/cm061085r; Belik AA, 2008, CHEM MATER, V20, P3765, DOI 10.1021/cm800375d; Arevalo-Lopez AM, 2011, INORG CHEM, V50, P7136, DOI 10.1021/ic200680u; Belik Alexei A, 2009, Journal of Physics: Conference Series, V165, DOI 10.1088/1742-6596/165/1/012035; Blasco J, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.174431; Colin CV, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.224103; Darie C, 2010, SOLID STATE SCI, V12, P660, DOI 10.1016/j.solidstatesciences.2008.12.004; Ding J, 2011, J APPL PHYS, V109, DOI 10.1063/1.3583649; Ding J, 2014, COMP MATER SCI, V96, P219; Oka K, 2012, ANGEW CHEM INT EDIT, V51, P7977, DOI 10.1002/anie.201202644; Yu R, 2015, CHEM MATER, V27, P2012, DOI 10.1021/cm504133e	25	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1468-6996	1878-5514		SCI TECHNOL ADV MAT	Sci. Technol. Adv. Mater.	APR	2015	16	2							026003	10.1088/1468-6996/16/2/026003		8	Materials Science, Multidisciplinary	Materials Science	CG9MY	WOS:000353641100022		
J	Fujigaya, T; Nakashima, N				Fujigaya, Tsuyohiko; Nakashima, Naotoshi			Non-covalent polymer wrapping of carbon nanotubes and the role of wrapped polymers as functional dispersants	SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS			English	Review						carbon nanotubes; dispersant; non-covalent functionalization; polymer wrapping	DONOR-ACCEPTOR NANOHYBRIDS; SINGLE-CHIRALITY SEPARATION; FUEL-CELL ELECTROCATALYST; OXYGEN REDUCTION REACTION; SOLAR-ENERGY CONVERSION; THIN-FILM PHOTOVOLTAICS; BAND-GAP FLUORESCENCE; NEAR-INFRARED WINDOW; CONJUGATED-POLYMER; SIDEWALL-FUNCTIONALIZATION	Carbon nanotubes (CNTs) have been recognized as a promising material in a wide range of applications from biotechnology to energy-related devices. However, the poor solubility in aqueous and organic solvents hindered the applications of CNTs. As studies have progressed, the methodology for CNT dispersion was established. In this methodology, the key issue is to covalently or non-covalently functionalize the surfaces of the CNTs with a dispersant. Among the various types of dispersions, polymer wrapping through non-covalent interactions is attractive in terms of the stability and homogeneity of the functionalization. Recently, by taking advantage of their stability, the wrapped-polymers have been utilized to support and/or reinforce the unique functionality of the CNTs, leading to the development of high-performance devices. In this review, various polymer wrapping approaches, together with the applications of the polymer-wrapped CNTs, are summarized.	[Fujigaya, Tsuyohiko; Nakashima, Naotoshi] Kyushu Univ, Grad Sch Engn, Dept Appl Chem, Fukuoka 8190395, Japan; [Fujigaya, Tsuyohiko; Nakashima, Naotoshi] Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2CNER, World Premier Int Res Ctr Initiat, Fukuoka 8190395, Japan; [Nakashima, Naotoshi] JST CREST, Chiyoda Ku, Tokyo 1020075, Japan	Fujigaya, T (reprint author), Kyushu Univ, Grad Sch Engn, Dept Appl Chem, 744 Motooka, Fukuoka 8190395, Japan.	fujigaya-tcm@mail.cstm.kyushu-u.ac.jp			Low-Carbon Research Network (LCnet); Nanotechnology Platform Project (Molecules and Materials Synthesis) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Center of Innovation Science and Technology based Radical Innovation and Entrepreneurship Program (COI Program); Advanced Low Carbon Technology Research and Development Program (ALCA) from the Japan Science and Technology Agency (JST)	The authors would like to acknowledge the funding support from Low-Carbon Research Network (LCnet); the Nanotechnology Platform Project (Molecules and Materials Synthesis) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; the Center of Innovation Science and Technology based Radical Innovation and Entrepreneurship Program (COI Program); and the Advanced Low Carbon Technology Research and Development Program (ALCA) from the Japan Science and Technology Agency (JST).	Amer MS, 2004, J CHEM PHYS, V121, P2752, DOI [10.1063/1.1768157, 10.1063/1.1768]; Adeli M, 2013, CHEM SOC REV, V42, P5231, DOI 10.1039/c3cs35431h; Zorbas V, 2005, J AM CHEM SOC, V127, P12323, DOI 10.1021/ja050747v; Staii C, 2005, NANO LETT, V5, P1774, DOI 10.1021/nl051261f; Richard C, 2003, SCIENCE, V300, P775, DOI 10.1126/science.1080848; Hirana Y, 2010, J AM CHEM SOC, V132, P13072, DOI 10.1021/ja105980a; Ou YY, 2006, J PHYS CHEM B, V110, P2031, DOI 10.1021/jp055920o; Shigeta M, 2006, CHEM PHYS LETT, V418, P115, DOI 10.1016/j.cplett.2005.10.088; Star A, 2002, MACROMOLECULES, V35, P7516, DOI 10.1021/ma0204150; Curran S, 1999, SYNTHETIC MET, V103, P2559, DOI 10.1016/S0379-6779(98)00279-3; Georgakilas V, 2005, CHEM MATER, V17, P1613, DOI 10.1021/cm0483590; Ren SQ, 2011, NANO LETT, V11, P5316, DOI 10.1021/nl202796u; Fujigaya T, 2009, CARBON, V47, P3227, DOI 10.1016/j.carbon.2009.07.038; Kim DS, 2005, SMALL, V1, P1117, DOI 10.1002/smll.200500167; Heller DA, 2006, SCIENCE, V311, P508, DOI 10.1126/science.1120792; Gigliotti B, 2006, NANO LETT, V6, P159, DOI 10.1021/nl0518775; Yuan WZ, 2006, MACROMOLECULES, V39, P8011, DOI 10.1021/ma061856c; Wang X, 2006, J POWER SOURCES, V158, P154, DOI 10.1016/j.jpowsour.2005.09.039; Rao AM, 1997, NATURE, V388, P257; Li WZ, 2002, CARBON, V40, P791, DOI 10.1016/S0008-6223(02)00039-8; Balasubramanian K, 2005, SMALL, V1, P180, DOI 10.1002/smll.200400118; Yan YH, 2010, CARBON, V48, P2603, DOI 10.1016/j.carbon.2010.03.065; Dujardin E, 1998, ADV MATER, V10, P611, DOI 10.1002/(SICI)1521-4095(199805)10:8<611::AID-ADMA611>3.0.CO;2-8; Okamoto M, 2009, SMALL, V5, P735, DOI 10.1002/smll.200801742; Tanaka T, 2009, NANO LETT, V9, P1497, DOI 10.1021/nl8034866; Baskaran D, 2005, CHEM MATER, V17, P3389, DOI 10.1021/cm047866e; Cataldo S, 2012, ENERG ENVIRON SCI, V5, P5919, DOI 10.1039/c1ee02276h; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Malarkey EB, 2007, NEURODEGENER DIS, V4, P292, DOI 10.1159/000101885; Nativ-Roth E, 2007, MACROMOLECULES, V40, P3676, DOI 10.1021/ma0705366; Zhang YJ, 2012, J MATER CHEM, V22, P6575, DOI 10.1039/c2jm00044j; Park JS, 2012, J AM CHEM SOC, V134, P14461, DOI 10.1021/ja304282j; Xu H, 2008, ELECTROCHEM COMMUN, V10, P1839, DOI 10.1016/j.elecom.2008.09.030; Liu Z, 2009, NAT PROTOC, V4, P1372, DOI 10.1038/nprot.2009.146; Badaire S, 2005, ADV MATER, V17, P1673, DOI 10.1002/adma.200401741; Malik S, 2007, COMPOS SCI TECHNOL, V67, P916, DOI 10.1016/j.compscitech.2005.11.041; Welsher K, 2009, NAT NANOTECHNOL, V4, P773, DOI [10.1038/nnano.2009.294, 10.1038/NNANO.2009.294]; Karajanagi SS, 2006, LANGMUIR, V22, P1392, DOI 10.1021/la0528201; Hirsch A, 2002, ANGEW CHEM INT EDIT, V41, P1853, DOI 10.1002/1521-3773(20020603)41:11<1853::AID-ANIE1853>3.0.CO;2-N; Liu Z, 2008, P NATL ACAD SCI USA, V105, P1410, DOI 10.1073/pnas.0707654105; Li QA, 2011, J POWER SOURCES, V196, P565, DOI 10.1016/j.jpowsour.2010.06.073; Tanaka T, 2011, PHYS STATUS SOLIDI-R, V5, P301, DOI 10.1002/pssr.201105289; D'Este M, 2006, EUR J ORG CHEM, P2517, DOI 10.1002/ejoc.200600196; Johnson RR, 2008, NANO LETT, V8, P69, DOI 10.1021/nl071909j; Chen J, 2002, J AM CHEM SOC, V124, P9034, DOI 10.1021/ja026104m; Tian FR, 2006, TOXICOL IN VITRO, V20, P1202, DOI 10.1016/j.tiv.2006.03.008; Welsher K, 2008, NANO LETT, V8, P586, DOI 10.1021/nl072949q; He DP, 2011, LANGMUIR, V27, P5582, DOI 10.1021/la2003589; Wu BH, 2012, CHEM-ASIAN J, V7, P190, DOI 10.1002/asia.201100564; Fujigaya T, 2011, NANOSCALE, V3, P4352, DOI 10.1039/c1nr10635j; Islam MF, 2003, NANO LETT, V3, P269, DOI 10.1021/nl025924u; Tu XM, 2009, NATURE, V460, P250, DOI 10.1038/nature08116; Liu J, 1999, CHEM PHYS LETT, V303, P125, DOI 10.1016/S0009-2614(99)00209-2; Steuerman DW, 2002, J PHYS CHEM B, V106, P3124, DOI 10.1021/jp014326l; Okamoto M, 2008, ADV FUNCT MATER, V18, P1776, DOI 10.1002/adfm.200701257; Li XL, 2006, ADV FUNCT MATER, V16, P2431, DOI 10.1002/adfm.200600339; Strano MS, 2003, J NANOSCI NANOTECHNO, V3, P81, DOI 10.1166/jnn.2003.194; Coleman JN, 2006, CARBON, V44, P1624, DOI 10.1016/j.carbon.2006.02.038; Thakare VS, 2010, NANOMEDICINE-UK, V5, P1277, DOI [10.2217/nnm.10.95, 10.2217/NNM.10.95]; Skakalova V, 2005, J PHYS CHEM B, V109, P7174, DOI 10.1021/jp044741o; Arnold MS, 2005, NANO LETT, V5, P713, DOI 10.1021/nl050133o; Liu L, 2003, CHEM PHYS LETT, V367, P747, DOI 10.1016/S0009-2614(02)01789-X; Ago H, 2000, PHYS REV B, V61, P2286, DOI 10.1103/PhysRevB.61.2286; Kojima C, 2010, INT J PHARMACEUT, V383, P293, DOI 10.1016/j.ijpharm.2009.09.015; Xu Y, 2007, J PHYS CHEM C, V111, P8638, DOI 10.1021/jp0709611; Bindl DJ, 2013, J PHYS CHEM C, V117, P2390, DOI 10.1021/jp310983y; Oueiny C, 2014, PROG POLYM SCI, V39, P707, DOI 10.1016/j.progpolymsci.2013.08.009; Xiong W, 2010, J AM CHEM SOC, V132, P15839, DOI 10.1021/ja104425h; Duesberg GS, 1998, CHEM COMMUN, P435, DOI 10.1039/a707465d; Nakashima N, 2005, J PHYS CHEM B, V109, P13076, DOI 10.1021/jp050958m; Zhao YC, 2010, J POWER SOURCES, V195, P4634, DOI 10.1016/j.jpowsour.2010.02.023; Bindl DJ, 2013, CHEM PHYS, V413, P29, DOI 10.1016/j.chemphys.2012.08.001; Paredes JI, 2004, LANGMUIR, V20, P5149, DOI 10.1021/la049831z; Becker ML, 2007, ADV MATER, V19, P939, DOI 10.1002/adma.200602667; Liu HP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1313; Wang YX, 2007, J PHYS CHEM B, V111, P6520, DOI 10.1021/jp0700433; Pantarotto D, 2004, CHEM COMMUN, P16, DOI 10.1039/b311254c; Tian ZQ, 2006, J PHYS CHEM B, V110, P5343, DOI 10.1021/jp056401o; Zhao W, 2002, J AM CHEM SOC, V124, P12418, DOI 10.1021/ja027861n; Meng S, 2007, NANO LETT, V7, P45, DOI 10.1021/nl0619403; Serrano MC, 2014, PROG POLYM SCI, V39, P1448, DOI 10.1016/j.progpolymsci.2014.02.004; Mistry KS, 2013, ACS NANO, V7, P2231, DOI 10.1021/nn305336x; Wang SY, 2009, J PHYS CHEM C, V113, P18935, DOI 10.1021/jp906923z; Leubner S, 2012, FARADAY DISCUSS, V155, P253, DOI 10.1039/c1fd00102g; Paloniemi H, 2006, LANGMUIR, V22, P74, DOI 10.1021/la051736i; Wang F, 2008, J AM CHEM SOC, V130, P5392, DOI 10.1021/ja710795k; Kongkanand A, 2006, LANGMUIR, V22, P2392, DOI 10.1021/la052753a; Bandaru NM, 2012, J MATER CHEM, V22, P8748, DOI 10.1039/c2jm16636d; Dieckmann GR, 2003, J AM CHEM SOC, V125, P1770, DOI 10.1021/ja029084x; Madani SY, 2011, INT J NANOMED, V6, P2963, DOI 10.2147/IJN.S16923; Hirano A, 2011, J PHYS CHEM C, V115, P21723, DOI 10.1021/jp207786g; Ebbesen TW, 1996, ADV MATER, V8, P155, DOI 10.1002/adma.19960080212; Lee HW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1545; Holt JM, 2010, NANO LETT, V10, P4627, DOI 10.1021/nl102753z; Chen RJ, 2001, J AM CHEM SOC, V123, P3838, DOI 10.1021/ja010172b; Ausman KD, 2000, J PHYS CHEM B, V104, P8911, DOI 10.1021/jp002555m; Nish A, 2007, NAT NANOTECHNOL, V2, P640, DOI 10.1038/nnano.2007.290; Holder PG, 2007, ANGEW CHEM INT EDIT, V46, P4370, DOI 10.1002/anie.200700333; Selvaraj V, 2007, APPL CATAL B-ENVIRON, V75, P129, DOI 10.1016/j.apcatb.2007.03.012; Salzmann CG, 2007, J PHYS CHEM C, V111, P18520, DOI 10.1021/jp076013h; Kam NWS, 2006, ANGEW CHEM INT EDIT, V45, P577, DOI 10.1002/anie.200503389; Boul PJ, 1999, CHEM PHYS LETT, V310, P367, DOI 10.1016/S0009-2614(99)00713-7; Akazaki K, 2012, J AM CHEM SOC, V134, P12700, DOI 10.1021/ja304244g; Ke PC, 2007, PHYS CHEM CHEM PHYS, V9, P439, DOI 10.1039/b611142d; Tasis D, 2006, CHEM REV, V106, P1105, DOI 10.1021/cr050569o; Li PX, 2014, ACS APPL MATER INTER, V6, P5228, DOI 10.1021/am500579c; Liu Z, 2009, NANO RES, V2, P85, DOI 10.1007/s12274-009-9009-8; Sharma RK, 2010, J POWER SOURCES, V195, P1256, DOI 10.1016/j.jpowsour.2009.08.093; Peng C, 2008, PROG NAT SCI, V18, P777, DOI 10.1016/j.pnsc.2008.03.002; Fukushima T, 2003, SCIENCE, V300, P2072, DOI 10.1126/science.1082289; Cui HF, 2010, CHEM RES TOXICOL, V23, P1131, DOI [10.1021/tx100050h, 10.1021/tx1000506]; Wenseleers W, 2004, ADV FUNCT MATER, V14, P1105, DOI 10.1002/adfm.200400130; Minami N, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2180870; Shaffer MSP, 1998, CARBON, V36, P1603, DOI 10.1016/S0008-6223(98)00130-4; Zheng M, 2003, NAT MATER, V2, P338, DOI 10.1038/nmat877; Coleman JN, 2006, ADV MATER, V18, P689, DOI 10.1002/adma.200501851; Mc Carthy B, 2001, SYNTHETIC MET, V121, P1225, DOI 10.1016/S0379-6779(00)00906-1; Yoo J, 2011, NANOSCALE, V3, P2517, DOI 10.1039/c1nr10079c; Zheng XL, 2010, J PHYS CHEM B, V114, P9435, DOI 10.1021/jp103932b; Lee Y, 2010, ADV MATER, V22, P4076, DOI 10.1002/adma.201000746; Banerjee S, 2005, ADV MATER, V17, P17, DOI 10.1002/adma.200401340; Zhang S, 2010, J MATER CHEM, V20, P2826, DOI 10.1039/b919494k; Sun YQ, 2013, J POLYM SCI POL PHYS, V51, P231, DOI 10.1002/polb.23226; Karajanagi SS, 2004, LANGMUIR, V20, P11594, DOI 10.1021/la047994h; Burghard M, 1998, ADV MATER, V10, P584, DOI 10.1002/(SICI)1521-4095(199805)10:8<584::AID-ADMA584>3.0.CO;2-9; Numata M, 2004, CHEM LETT, V33, P232, DOI 10.1246/cl.2004.232; Pang X, 2010, MACROMOLECULES, V43, P10376, DOI 10.1021/ma101862b; Coleman JN, 1998, PHYS REV B, V58, pR7492, DOI 10.1103/PhysRevB.58.R7492; Ogoshi T, 2007, J AM CHEM SOC, V129, P4878, DOI 10.1021/ja070457; Nakashima N, 2007, CHEM LETT, V36, P692, DOI 10.1246/cl.2007.692; Robinson JT, 2012, J AM CHEM SOC, V134, P10664, DOI 10.1021/ja303737a; Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102; Liu Z, 2011, MATER TODAY, V14, P316; Dalton AB, 2000, J PHYS CHEM B, V104, P10012, DOI 10.1021/jp002857o; Zou JH, 2008, ADV MATER, V20, P2055, DOI 10.1002/adma.200701995; Hough LA, 2006, NANO LETT, V6, P313, DOI 10.1021/nl051871f; Petrov P, 2003, CHEM COMMUN, P2904, DOI 10.1039/b307751a; Sprafke JK, 2011, ANGEW CHEM INT EDIT, V50, P2313, DOI 10.1002/anie.201007295; Stranks SD, 2011, NANO LETT, V11, P66, DOI 10.1021/nl1036484; Kang YJ, 2003, J AM CHEM SOC, V125, P5650, DOI 10.1021/ja034082d; Sidik RA, 2006, J PHYS CHEM B, V110, P1787, DOI 10.1021/jp055150g; Tanaka Y, 2009, ANGEW CHEM INT EDIT, V48, P7655, DOI 10.1002/anie.200902468; Jeng ES, 2006, NANO LETT, V6, P371, DOI 10.1021/nl051829k; Star A, 2002, ANGEW CHEM INT EDIT, V41, P2508, DOI 10.1002/1521-3773(20020715)41:14<2508::AID-ANIE2508>3.0.CO;2-A; Guldi DM, 2006, J AM CHEM SOC, V128, P2315, DOI 10.1021/ja0550733; Panhuis MIH, 2003, J PHYS CHEM B, V107, P478, DOI 10.1021/jp026470s; Chitta R, 2007, J PHYS CHEM C, V111, P6947, DOI 10.1021/jp0704416; Grzelczak M, 2007, ANGEW CHEM INT EDIT, V46, P7026, DOI 10.1002/anie.200701671; O'Connell MJ, 2001, CHEM PHYS LETT, V342, P265, DOI 10.1016/S0009-2614(01)00490-0; Guldi DM, 2005, ADV MATER, V17, P871, DOI 10.1002/adma.200400641; Ago H, 1999, ADV MATER, V11, P1281, DOI 10.1002/(SICI)1521-4095(199910)11:15<1281::AID-ADMA1281>3.0.CO;2-6; McCarthy B, 2002, J PHYS CHEM B, V106, P2210, DOI 10.1021/jp013745f; Cathcart H, 2008, J AM CHEM SOC, V130, P12734, DOI 10.1021/ja803273s; Ozawa H, 2011, J AM CHEM SOC, V133, P2651, DOI 10.1021/ja109399f; Artyukhin AB, 2004, LANGMUIR, V20, P1442, DOI 10.1021/la035699b; Zhang XK, 2009, ACS NANO, V3, P3200, DOI 10.1021/nn9006362; Guo DJ, 2005, J COLLOID INTERF SCI, V286, P274, DOI 10.1016/j.jcis.2004.12.042; Prato M, 2008, ACCOUNTS CHEM RES, V41, P60, DOI 10.1021/ar700089b; Furtado CA, 2004, J AM CHEM SOC, V126, P6095, DOI 10.1021/ja039588a; Bahr JL, 2001, CHEM COMMUN, P193, DOI 10.1039/b008042j; Sharifi S, 2012, CHEM SOC REV, V41, P2323, DOI 10.1039/c1cs15188f; Cherukuri P, 2006, P NATL ACAD SCI USA, V103, P18882, DOI 10.1073/pnas.0609265103; Ajayan PM, 2000, ADV MATER, V12, P750, DOI 10.1002/(SICI)1521-4095(200005)12:10<750::AID-ADMA750>3.0.CO;2-6; Li WZ, 2003, J PHYS CHEM B, V107, P6292, DOI 10.1021/jp022505c; Andersen AJ, 2013, ACS NANO, V7, P1108, DOI 10.1021/nn3055175; Prakash S, 2011, ADV DRUG DELIVER REV, V63, P1340, DOI 10.1016/j.addr.2011.06.013; Curran SA, 1998, ADV MATER, V10, P1091, DOI 10.1002/(SICI)1521-4095(199810)10:14<1091::AID-ADMA1091>3.0.CO;2-L; Erlanger BF, 2001, NANO LETT, V1, P465, DOI 10.1021/nl015570r; Gilmore KJ, 2007, CARBON, V45, P402, DOI 10.1016/j.carbon.2006.09.015; Niyogi S, 2002, ACCOUNTS CHEM RES, V35, P1105, DOI 10.1021/ar010155r; Wu G, 2005, ELECTROCHEM COMMUN, V7, P1237, DOI 10.1016/j.elecom.2005.07.015; Dabera GDMR, 2013, ACS NANO, V7, P556, DOI 10.1021/nn304705t; Ozawa H, 2011, J AM CHEM SOC, V133, P14771, DOI 10.1021/ja2055885; Kim TH, 2011, ACS NANO, V5, P2824, DOI 10.1021/nn103324p; Choi JH, 2007, NANO LETT, V7, P861, DOI 10.1021/nl062306v; Noguchi Y, 2008, CHEM PHYS LETT, V455, P249, DOI 10.1016/j.cplett.2008.02.089; Sada T, 2011, ACS NANO, V5, P4414, DOI 10.1021/nn2012767; Star A, 2003, MACROMOLECULES, V36, P553, DOI 10.1021/ma021417n; O'Connell MJ, 2002, SCIENCE, V297, P593, DOI 10.1126/science.1072631; Bianco A, 2005, CHEM COMMUN, P571, DOI 10.1039/b410943k; Thostenson ET, 2005, COMPOS SCI TECHNOL, V65, P491, DOI 10.1016/j.compscitech.2004.11.003; Hong GS, 2012, NAT MED, V18, P1841, DOI 10.1038/nm.2995; Zheng M, 2003, SCIENCE, V302, P1545, DOI 10.1126/science.1091911; Ferguson AJ, 2010, J PHYS CHEM LETT, V1, P2406, DOI 10.1021/jz100768f; Zhang XF, 2003, NANO LETT, V3, P1285, DOI 10.1021/nl034336t; Guldi DM, 2005, ANGEW CHEM INT EDIT, V44, P2015, DOI 10.1002/anie.200462416; Harrison BS, 2007, BIOMATERIALS, V28, P344, DOI 10.1016/j.biomaterials.2006.07.044; Ding LH, 2005, NANO LETT, V5, P2448, DOI 10.1021/nl051748o; Li CY, 2005, ADV MATER, V17, P1198, DOI 10.1002/adma.200401977; Li XM, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/2/022001; Che GL, 1999, LANGMUIR, V15, P750, DOI 10.1021/la980663i; Mountrichas G, 2007, J PHYS CHEM B, V111, P8369, DOI 10.1021/jp067500k; Lou XD, 2004, CHEM MATER, V16, P4005, DOI 10.1021/cm0492585; Arnold MS, 2013, PHYS CHEM CHEM PHYS, V15, P14896, DOI 10.1039/c3cp52752b; Hong GS, 2014, NAT PHOTONICS, V8, P723, DOI 10.1038/NPHOTON.2014.166; Boghossian AA, 2011, CHEMSUSCHEM, V4, P848, DOI 10.1002/cssc.201100070; Ehli C, 2006, J AM CHEM SOC, V128, P11222, DOI 10.1021/ja0624974; Namazi H, 2003, EUR POLYM J, V39, P1491, DOI 10.1016/S0014-3057(02)00385-3; Lu L, 2007, CARBON, V45, P2621, DOI 10.1016/j.carbon.2007.08.025; Qu LT, 2010, ACS NANO, V4, P1321, DOI 10.1021/nn901850u; Lovat V, 2005, NANO LETT, V5, P1107, DOI 10.1021/nl050637m; Murakami H, 2007, J PORPHYR PHTHALOCYA, V11, P418; Bindl DJ, 2010, ACS NANO, V4, P5657, DOI 10.1021/nn1012397; Prencipe G, 2009, J AM CHEM SOC, V131, P4783, DOI 10.1021/ja809086q; Xie H, 2005, J MATER CHEM, V15, P1734, DOI 10.1039/b413262a; Hersam MC, 2008, NAT NANOTECHNOL, V3, P387, DOI 10.1038/nnano.2008.135; Toshimitsu F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6041; Bisri SZ, 2012, ADV MATER, V24, P6147, DOI 10.1002/adma.201202699; Diao S, 2012, J AM CHEM SOC, V134, P16971, DOI 10.1021/ja307966u; Yang DQ, 2005, J PHYS CHEM B, V109, P4481, DOI 10.1021/jp044511+; Pradhan B, 2006, J PHYS CHEM B, V110, P8274, DOI 10.1021/jp060122z; Chen J, 2001, J PHYS CHEM B, V105, P2525, DOI 10.1021/jp002596i; Landi BJ, 2004, J PHYS CHEM B, V108, P17089, DOI 10.1021/jp047521j; Li L, 2008, J POWER SOURCES, V178, P75, DOI 10.1016/j.jpowsour.2007.12.002; Numata M, 2005, J AM CHEM SOC, V127, P5875, DOI 10.1021/ja044168m; Antaris AL, 2013, ACS NANO, V7, P3644, DOI 10.1021/nn4006472; Shin HI, 2005, MACROMOL RAPID COMM, V26, P1451, DOI 10.1002/marc.200500290; Besteman K, 2003, NANO LETT, V3, P727, DOI 10.1021/nl034139u; Dyke CA, 2004, J PHYS CHEM A, V108, P11151, DOI 10.1021/jp046274g; Liu ZA, 2008, J AM CHEM SOC, V130, P13540, DOI 10.1021/ja806242t; Izard N, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2939560; Kanai Y, 2008, NANO LETT, V8, P908, DOI 10.1021/nl0732777; Jeng ES, 2007, SMALL, V3, P1602, DOI 10.1002/smll.200700141; Zhao B, 2005, J AM CHEM SOC, V127, P8197, DOI 10.1021/ja042924i; Moniruzzaman M, 2006, MACROMOLECULES, V39, P5194, DOI 10.1021/ma060733p; Schipper ML, 2008, NAT NANOTECHNOL, V3, P216, DOI 10.1038/nnano.2008.68; Bianco A, 2005, CURR OPIN CHEM BIOL, V9, P674, DOI 10.1016/j.cbpa.2005.10.006; Wang ZM, 2007, CARBON, V45, P285, DOI 10.1016/j.carbon.2006.09.025; Tomonari Y, 2006, CHEM-EUR J, V12, P4027, DOI 10.1002/chem.200501176; Ortiz-Acevedo A, 2005, J AM CHEM SOC, V127, P9512, DOI 10.1021/ja050507f; Moore VC, 2003, NANO LETT, V3, P1379, DOI 10.1021/nl034524j; Arnold MS, 2006, NAT NANOTECHNOL, V1, P60, DOI 10.1038/nnano.2006.52; Geng JX, 2008, ADV FUNCT MATER, V18, P2659, DOI 10.1002/adfm.200800496; Ramesh S, 2004, J PHYS CHEM B, V108, P8794, DOI 10.1021/jp036971t; Lacerda L, 2006, ADV DRUG DELIVER REV, V58, P1460, DOI 10.1016/j.addr.2006.09.015; Asensio JA, 2010, CHEM SOC REV, V39, P3210, DOI 10.1039/b922650h; Yang R, 2006, GENE THER, V13, P1714, DOI 10.1038/sj.gt.3302808; Fukumaru T, 2014, NANOSCALE, V6, P5879, DOI 10.1039/c4nr00809j; Chao TI, 2009, BIOCHEM BIOPH RES CO, V384, P426, DOI 10.1016/j.bbrc.2009.04.157; Ozawa H, 2011, CHEM-EUR J, V17, P13438, DOI 10.1002/chem.201101669; Guldi DM, 2006, CHEM-EUR J, V12, P3975, DOI 10.1002/chem.200600114; Liu J, 1998, SCIENCE, V280, P1253, DOI 10.1126/science.280.5367.1253; Kovtyukhova NI, 2003, J AM CHEM SOC, V125, P9761, DOI 10.1021/ja0344516; Guo ZJ, 1998, ADV MATER, V10, P701, DOI 10.1002/(SICI)1521-4095(199806)10:9<701::AID-ADMA701>3.0.CO;2-4; Tezuka N, 2011, ENERG ENVIRON SCI, V4, P741, DOI 10.1039/c0ee00482k; Lisunova MO, 2006, J COLLOID INTERF SCI, V299, P740, DOI 10.1016/j.jcis.2006.03.012; Naito M, 2008, J AM CHEM SOC, V130, P16697, DOI 10.1021/ja806109z; Antiohos D, 2011, J MATER CHEM, V21, P15987, DOI 10.1039/c1jm12986d; Engel M, 2008, ACS NANO, V2, P2445, DOI 10.1021/nn800708w; Zorbas V, 2004, J AM CHEM SOC, V126, P7222, DOI 10.1021/ja049202b; Bahun GJ, 2006, J POLYM SCI POL CHEM, V44, P1941, DOI 10.1002/pola.21308; Banerjee Sarbajit, 2003, Chemistry, V9, P1898, DOI 10.1002/chem.200204618; Banerjee S, 2002, J PHYS CHEM B, V106, P12144, DOI 10.1021/jp026304k; Bindl D. J., 2010, NANO LETT, V11, P455; Buzaneva E, 2002, MAT SCI ENG C-BIO S, V19, P41, DOI 10.1016/S0928-4931(01)00425-8; Campbell JF, 2008, J AM CHEM SOC, V130, P10648, DOI 10.1021/ja801720c; Chao Gao, 2006, Nanotechnology, V17, DOI 10.1088/0957-4484/17/12/010; Chen FM, 2009, J PHYS CHEM C, V113, P14946, DOI 10.1021/jp904431u; Ciofani G, 2009, MINI-REV MED CHEM, V9, P1251; Coleman JN, 2000, CHEM COMMUN, P2001, DOI 10.1039/b006164f; Coleman JN, 1999, SYNTHETIC MET, V102, P1174, DOI 10.1016/S0379-6779(98)01065-0; Coleman JN, 2000, ADV MATER, V12, P213, DOI 10.1002/(SICI)1521-4095(200002)12:3<213::AID-ADMA213>3.0.CO;2-D; Collison CJ, 2010, J PHYS CHEM B, V114, P11002, DOI 10.1021/jp104705y; Cordella F, 2009, CARBON, V47, P1264, DOI 10.1016/j.carbon.2009.01.004; Cotiuga I, 2006, MACROMOL RAPID COMM, V27, P1073, DOI 10.1002/marc.200600163; Dalton AB, 1999, SYNTHETIC MET, V102, P1176, DOI 10.1016/S0379-6779(98)01067-4; Dalton AB, 2004, ADV FUNCT MATER, V14, P1147, DOI 10.1002/adfm.200400190; de Paula CC, 2002, CARBON, V40, P787, DOI 10.1016/S0008-6223(01)00136-1; Drury A, 2003, J MATER CHEM, V13, P485, DOI 10.1039/b208439b; Fifield LS, 2004, J PHYS CHEM B, V108, P8737, DOI 10.1021/jp0379771; Fukumaru T, 2013, MACROMOLECULES, V46, P4034, DOI 10.1021/ma4004117; Giordani S, 2006, PHYS STATUS SOLIDI B, V243, P3058, DOI 10.1002/pssb.200669217; Gomez FJ, 2003, CHEM COMMUN, P190, DOI 10.1039/b211194b; Goutam PJ, 2011, J PHYS CHEM B, V115, P919, DOI 10.1021/jp109900m; Granot E, 2006, ELECTROANAL, V18, P26, DOI 10.1002/elan.200503403; Guldi DM, 2005, CHEM COMMUN, P2038, DOI 10.1039/b418406h; Guldi DM, 2005, J AM CHEM SOC, V127, P9830, DOI 10.1021/ja050930o; Hafez IH, 2014, SCI REP-UK, V4, DOI 10.1038/srep06295; Hirsch A, 2005, TOP CURR CHEM, V245, P193; Hsu CH, 2010, J PHYS CHEM C, V114, P7933, DOI 10.1021/jp100328f; Ishibashi A, 2006, B CHEM SOC JPN, V79, P357, DOI 10.1246/bcsj.79.357; Ishibashi A, 2006, CHEM-EUR J, V12, P7595, DOI 10.1002/chem.200600326; Islam MF, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.148301; Johnson ATC, 2006, SEMICOND SCI TECH, V21, pS17, DOI 10.1088/0268-1242/21/11/S03; Jorio A., 2008, CARBON NANOTUBES ADV; Kato Y, 2012, SCI REP-UK, V2, DOI 10.1038/srep00733; Kavakka JS, 2007, CHEM COMMUN, P519, DOI 10.1039/b611461j; Keogh SM, 2006, J PHYS CHEM B, V110, P19369, DOI 10.1021/jp056321k; Kim OK, 2003, J AM CHEM SOC, V125, P4426, DOI 10.1021/ja029233b; Kim Y, 2006, J PHYS CHEM B, V110, P1541, DOI 10.1021/jp055110c; Krajcik R, 2008, BIOCHEM BIOPH RES CO, V369, P595, DOI 10.1016/j.bbrc.2008.02.072; Kymakis E, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/43/435702; Li L, 2006, J ELECTROCHEM SOC, V153, pA1823, DOI 10.1149/1.2234659; Li MH, 2011, J PHYS CHEM C, V115, P4584, DOI 10.1021/jp112330n; Li QW, 2005, CHEM COMMUN, P3283, DOI 10.1039/b419039d; Liu Z, 2007, NAT NANOTECHNOL, V2, P47, DOI 10.1038/nnano.2006.170; Lobez JM, 2013, CHEM MATER, V25, P3662, DOI 10.1021/cm401881w; Lovell CS, 2009, POLYMER, V50, P1925, DOI 10.1016/j.polymer.2009.02.016; Manna Sunil K, 2005, NANO LETT, V5, P1676; Mc Carthy B, 2001, CHEM PHYS LETT, V350, P27, DOI 10.1016/S0009-2614(01)01184-8; McCarthy B, 2001, NANOTECHNOLOGY, V12, P187, DOI 10.1088/0957-4484/12/3/301; MCKAY SF, 1964, J APPL PHYS, V35, P1992, DOI 10.1063/1.1713794; Meuer S, 2009, POLYMER, V50, P154, DOI 10.1016/j.polymer.2008.10.039; Meuer S, 2008, CHEM COMMUN, P3166, DOI 10.1039/b803099e; Mountrichas G, 2007, SMALL, V3, P404, DOI 10.1002/smll.200600476; Mulazzi E, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.155206; Murakami H, 2006, J NANOSCI NANOTECHNO, V6, P16, DOI 10.1166/jnn.2006.072; Nakashima N, 2003, CHEM LETT, V32, P456, DOI 10.1246/cl.2003.456; Nakashima N, 2002, CHEM LETT, P638, DOI 10.1246/cl.2002.638; Nakashima N., 2004, T MAT RES SOC JPN, V29, P525; Nakashima N, 2005, INT J NANOSCI, V4, P119, DOI DOI 10.1142/S0219581X05002985; Namazi H, 2007, COLLOID POLYM SCI, V285, P1527, DOI 10.1007/s00396-007-1717-6; Oh HS, 2011, INT J HYDROGEN ENERG, V36, P11564, DOI 10.1016/j.ijhydene.2011.06.079; Ozaki JI, 2006, CARBON, V44, P1324, DOI 10.1016/j.carbon.2005.12.026; Ozawa H, 2011, CHEM LETT, V40, P470, DOI 10.1246/cl.2011.470; Ozawa H, 2011, CHEM-ASIAN J, V6, P3281, DOI 10.1002/asia.201100362; Peng S., 2003, NANO LETT, V3, P347, DOI DOI 10.1021/NL034010K; Rahman GMA, 2005, J AM CHEM SOC, V127, P10051, DOI 10.1021/ja050396k; Rai PK, 2006, J AM CHEM SOC, V128, P591, DOI 10.1021/ja055847f; Romero DB, 1996, ADV MATER, V8, P899, DOI 10.1002/adma.19960081105; Santiago-Rodriguez L, 2010, ISR J CHEM, V50, P277, DOI 10.1002/ijch.201000034; Schopf E, 2009, CHEM COMMUN, P4818, DOI 10.1039/b908282d; Schuettfort T, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/2/025201; Sgobba V, 2006, ADV MATER, V18, P2264, DOI 10.1002/adma.200501493; Shao YY, 2006, J ELECTROCHEM SOC, V153, pA1093, DOI 10.1149/1.2191147; Shvartzman-Cohen R, 2004, LANGMUIR, V20, P6085, DOI 10.1021/la049344j; Slusarenko NN, 2007, CARBON, V45, P903, DOI 10.1016/j.carbon.2006.12.003; Stranks SD, 2013, ADV MATER, V25, P4365, DOI 10.1002/adma.201205250; Sun YP, 2002, ACCOUNTS CHEM RES, V35, P1096, DOI 10.1021/ar010160v; Takahashi T, 2005, CHEM LETT, V34, P1516, DOI 10.1246/cl.2005.1516; Takahashi T, 2002, CHEM LETT, P690, DOI 10.1246/cl.2002.690; Tam PD, 2011, APPL SURF SCI, V257, P9817, DOI 10.1016/j.apsusc.2011.06.028; Tanaka T, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.114001; Tanaka Y, 2009, CHEM LETT, V38, P864, DOI 10.1246/cl.2009.864; Tsang SC, 1997, ANGEW CHEM INT EDIT, V36, P2198, DOI 10.1002/anie.199721981; Valentini L, 2005, POLYMER, V46, P6715, DOI 10.1016/j.polymer.2005.05.025; Wang D, 2006, J AM CHEM SOC, V128, P6556, DOI 10.1021/ja060907i; Yan XB, 2007, J PHYS CHEM C, V111, P4125, DOI 10.1021/jp0651844; Yang C, 2003, PHYSICA B, V338, P366, DOI 10.1016/j.physb.2003.08.022; Yerushalmi-Rozen R, 2006, SOFT MATTER, V2, P24, DOI 10.1039/b513344k; Yi X, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.098003; Yoo J, 2013, NANOSCALE, V5, P7419, DOI 10.1039/c3nr01828h; Zaminpayma E, 2012, POLYM COMPOSITE, V33, P548, DOI 10.1002/pc.22182; Zhang S, 2011, APPL CATAL B-ENVIRON, V102, P372, DOI 10.1016/j.apcatb.2010.11.029; Zhao Q, 2001, APPL PHYS LETT, V78, P1748, DOI 10.1063/1.1357209; Zhao Q, 2002, POLYM ADVAN TECHNOL, V13, P759, DOI 10.1002/pat.246	346	2	2	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1468-6996	1878-5514		SCI TECHNOL ADV MAT	Sci. Technol. Adv. Mater.	APR	2015	16	2							024802	10.1088/1468-6996/16/2/024802		21	Materials Science, Multidisciplinary	Materials Science	CG9MY	WOS:000353641100005		
J	Guo, XZ; Song, J; Lvlin, YX; Nakanishi, K; Kanamori, K; Yang, H				Guo, Xingzhong; Song, Jie; Lvlin, Yixiu; Nakanishi, Kazuki; Kanamori, Kazuyoshi; Yang, Hui			Preparation of macroporous zirconia monoliths from ionic precursors via an epoxide-mediated sol-gel process accompanied by phase separation	SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS			English	Article						porous materials; zirconia monoliths; sol-gel; phase separation; heat-treatment; solvothermal treatment	WELL-DEFINED MACROPORES; MESOSTRUCTURED SKELETONS; VIBRATIONAL-SPECTRA; TIO2 MONOLITHS; SILICA; ROUTE; CERAMICS; TEMPLATE; SYSTEMS; SPHERES	Monolithic macroporous zirconia (ZrO2) derived from ionic precursors has been successfully fabricated via the epoxide-mediated sol-gel route accompanied by phase separation in the presence of propylene oxide (PO) and poly(ethylene oxide) (PEO). The addition of PO used as an acid scavenger mediates the gelation, whereas PEO enhances the polymerization-induced phase separation. The appropriate choice of the starting compositions allows the production of a macroporous zirconia monolith with a porosity of 52.9% and a Brunauer-Emmett-Teller (BET) surface area of 171.9 m(2) . g(-1). The resultant dried gel is amorphous, whereas tetragonal ZrO2 and monoclinic ZrO2 are precipitated at 400 and 600 degrees C, respectively, without spoiling the macroporous morphology. After solvothermal treatment with an ethanol solution of ammonia, tetragonal ZrO2 monoliths with smooth skeletons and well-defined mesopores can be obtained, and the BET surface area is enhanced to 583.8 m(2) . g(-1).	[Guo, Xingzhong; Song, Jie; Lvlin, Yixiu; Yang, Hui] Zhejiang Univ, Sch Mat Sci & Engn, Hangzhou 310027, Zhejiang, Peoples R China; [Nakanishi, Kazuki; Kanamori, Kazuyoshi] Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan	Guo, XZ (reprint author), Zhejiang Univ, Sch Mat Sci & Engn, Hangzhou 310027, Zhejiang, Peoples R China.	msewj01@zju.edu.cn; yanghui@zju.edu.cn	Nakanishi, Kazuki/A-1814-2012; Kanamori, Kazuyoshi/A-5561-2011		National Natural Science Foundation of China [51372225]; Zhejiang Provincial Natural Science Foundation of China [LY13B010001]	This work is supported by the National Natural Science Foundation of China (51372225) and Zhejiang Provincial Natural Science Foundation of China (LY13B010001).	NAKANISHI K, 1991, J AM CERAM SOC, V74, P2518, DOI 10.1111/j.1151-2916.1991.tb06794.x; LIANG CY, 1959, J POLYM SCI, V37, P385, DOI 10.1002/pol.1959.1203713209; Gash AE, 2001, J NON-CRYST SOLIDS, V285, P22, DOI 10.1016/S0022-3093(01)00427-6; Guo XZ, 2013, J EUR CERAM SOC, V33, P1967, DOI 10.1016/j.jeurceramsoc.2013.02.018; Prete F, 2011, J AM CERAM SOC, V94, P3587, DOI 10.1111/j.1551-2916.2011.04594.x; Byrappa K, 2007, PROG CRYST GROWTH CH, V53, P117, DOI 10.1016/j.pcrysgrow.2007.04.001; Guo XZ, 2014, J EUR CERAM SOC, V34, P817, DOI 10.1016/j.jeurceramsoc.2013.08.016; Gionco C, 2014, J PHYS CHEM LETT, V5, P447, DOI 10.1021/jz402731s; Guo XZ, 2014, NEW J CHEM, V38, P5832, DOI 10.1039/c4nj00898g; MINH NQ, 1993, J AM CERAM SOC, V76, P563, DOI 10.1111/j.1151-2916.1993.tb03645.x; Diaz-Torres LA, 2008, J SOLID STATE CHEM, V181, P75, DOI 10.1016/j.jssc.2007.09.033; Flory PI, 1942, J CHEM PHYS, V10, P51, DOI 10.1063/1.1723621; Tokudome Y, 2007, CHEM MATER, V19, P3393, DOI 10.1021/cm063051p; Huggins ML, 1942, J AM CHEM SOC, V64, P2716, DOI 10.1021/ja01263a056; Hasegawa G, 2010, J AM CERAM SOC, V93, P3110, DOI 10.1111/j.1551-2916.2010.03831.x; Konishi J, 2006, CHEM MATER, V18, P6069, DOI 10.1021/cm0617485; Nakanishi K, 1997, J POROUS MAT, V4, P67, DOI 10.1023/A:1009627216939; Ortiz-Landeros J, 2011, J SOLID STATE CHEM, V184, P1304, DOI 10.1016/j.jssc.2011.03.056; Sakka Y, 2005, SCI TECHNOL ADV MAT, V6, P915, DOI 10.1016/j.stam.2005.07.006; Huggins ML, 1942, J PHYS CHEM-US, V46, P151, DOI 10.1021/j150415a018; Bluthardt C, 2008, CATAL TODAY, V137, P132, DOI 10.1016/j.cattod.2008.04.045; CENTI G, 1996, J CATAL TODAY, V27, P265; Chuach G K, 1999, J CATAL TODAY, V49, P131; Chuach G K, 1996, J APPL CATAL A, V145, P267; DURIG JR, 1985, J PHYS CHEM-US, V89, P2877, DOI 10.1021/j100259a034; Fonseca FC, 2009, SOLID STATE IONICS, V180, P822, DOI 10.1016/j.ssi.2009.02.010; Fujita K, 2006, SCI TECHNOL ADV MAT, V7, P511, DOI 10.1016/j.stam.2006.04.014; GARVIE RC, 1978, J PHYS CHEM-US, V82, P218, DOI 10.1021/j100491a016; GASH AE, 2001, J CHEM MAT, V13, P999; Gash AE, 2004, J NON-CRYST SOLIDS, V350, P145, DOI 10.1016/j.jnoncrysol.2004.06.030; Jung W, 2009, ACTA MATER, V57, P1399, DOI 10.1016/j.actamat.2008.11.028; KIM JD, 2001, THIN SOLID FILMS, V385, P293; KONISHI J, 2008, J CHEM MAT, V20, P2165; Konishi J, 2004, MATER RES SOC SYMP P, V788, P391; Larsen G, 1997, J CATAL, V169, P67, DOI 10.1006/jcat.1997.1698; Laurent M, 2001, J EUR CERAM SOC, V21, P1495, DOI 10.1016/S0955-2219(01)00049-8; Lee H L, 1988, J KOREAN CERAM SOC, V25, P117; Li WY, 2013, SCI TECHNOL ADV MAT, V14, DOI 10.1088/1468-6996/14/4/045007; Liang XH, 2014, CERAM INT, V40, P3097, DOI 10.1016/j.ceramint.2013.10.001; MCLACHLA.RD, 1968, SPECTROCHIM ACTA A-M, VA 24, P103, DOI 10.1016/0584-8539(68)80016-9; MERCERA PDL, 1991, J APPL CATAL, V71, P363; Ortiz-Landeros J, 2009, J POROUS MAT, V16, P473, DOI 10.1007/s10934-008-9221-z; Saravanan L, 2005, J COLLOID INTERF SCI, V284, P363, DOI 10.1016/j.jcis.2004.08.188; Siffert B, 1989, J COLLOIDS SURF, V40, P207; Tanabe K, 1985, J MAT CHEM PHYS, V13, P347; WIRTH HJ, 1995, J CHROMATOGR A, V711, P223, DOI 10.1016/0021-9673(95)00421-I; Wu C H, 2013, J SOLID STATE CHEM, V200, P170; Yamaguchi T, 1994, J CATAL TODAY, V20, P199	48	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1468-6996	1878-5514		SCI TECHNOL ADV MAT	Sci. Technol. Adv. Mater.	APR	2015	16	2							025003	10.1088/1468-6996/16/2/025003		10	Materials Science, Multidisciplinary	Materials Science	CG9MY	WOS:000353641100014		
J	Itoh, M; Akatsu, T; Azuma, M; Kamata, K; Kamiya, T				Itoh, Mitsuru; Akatsu, Takashi; Azuma, Masaki; Kamata, Keigo; Kamiya, Toshio			Focus on advanced inorganic materials science: non-traditional concepts and approaches Foreword	SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS			English	Editorial Material									[Itoh, Mitsuru; Akatsu, Takashi; Azuma, Masaki; Kamata, Keigo; Kamiya, Toshio] Tokyo Inst Technol, Tokyo, Japan	Itoh, M (reprint author), Tokyo Inst Technol, Tokyo, Japan.	Mitsuru_Itoh@msl.titech.ac.jp; Takashi_Akatsu@msl.titech.ac.jp; mazuma@msl.titech.ac.jp; kamata.k.ac@m.titech.ac.jp; kamiya.t.aa@m.titech.ac.jp	Kamata, Keigo/E-6997-2014; ITOH, Mitsuru/E-3481-2014; Kamiya, Toshio/E-8615-2014	Kamata, Keigo/0000-0002-0624-8483; ITOH, Mitsuru/0000-0001-6457-9152; Kamiya, Toshio/0000-0002-8358-240X				0	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1468-6996	1878-5514		SCI TECHNOL ADV MAT	Sci. Technol. Adv. Mater.	APR	2015	16	2							020302	10.1088/1468-6996/16/2/020302		2	Materials Science, Multidisciplinary	Materials Science	CG9MY	WOS:000353641100002		
J	Kozuka, H; Ohbayashi, K; Koumoto, K				Kozuka, Hisashi; Ohbayashi, Kazushige; Koumoto, Kunihito			Electronic conduction in La-based perovskite-type oxides	SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS			English	Review						electronic conduction; electrical conductivity; carrier concentration; carrier mobility; effective mass; relaxation time	RAY-ABSORPTION-SPECTROSCOPY; DOUBLE-EXCHANGE FERROMAGNET; INSULATOR-METAL TRANSITION; TRANSPORT-PROPERTIES; THERMOELECTRIC PROPERTIES; ELECTRICAL-CONDUCTIVITY; NEUTRON-DIFFRACTION; GIANT MAGNETORESISTANCE; SEEBECK COEFFICIENT; MAGNETIC-PROPERTIES	A systematic study of La-based perovskite-type oxides from the viewpoint of their electronic conduction properties was performed. LaCo0.5Ni0.5O3 +/-delta was found to be a promising candidate as a replacement for standard metals used in oxide electrodes and wiring that are operated at temperatures up to 1173 K in air because of its high electrical conductivity and stability at high temperatures. LaCo0.5Ni0.5O3 +/-delta exhibits a high conductivity of 1.9 x 10(3) S cm(-1) at room temperature (R.T.) because of a high carrier concentration n of 2.2 x 10(22) cm(-3) and a small effective mass m* of 0.10 m(e). Notably, LaCo0.5Ni0.5O3 +/-delta exhibits this high electrical conductivity from R.T. to 1173 K, and little change in the oxygen content occurs under these conditions. LaCo0.5Ni0.5O3 +/-delta is the most suitable for the fabrication of oxide electrodes and wiring, though La1-xSrxCoO3 +/-delta and La1-xSrxMnO3 +/-delta also exhibit high electronic conductivity at R.T., with maximum electrical conductivities of 4.4 x 10(3) S cm(-1) for La0.5Sr0.5CoO3 +/-delta and 1.5 x 10(3) S cm(-1) for La0.6Sr0.4MnO3 +/-delta because oxygen release occurs in La1-xSrxCoO3 +/-delta as elevating temperature and the electrical conductivity of La0.6Sr0.4MnO3 +/-delta slightly decreases at temperatures above 400 K.	[Kozuka, Hisashi; Ohbayashi, Kazushige] NGK Spark Plug Co Ltd, Komaki Shi, Aichi 4858510, Japan; [Koumoto, Kunihito] Nagoya Univ, Grad Sch Engn, Dept Appl Chem, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Kozuka, H (reprint author), NGK Spark Plug Co Ltd, 2808 Iwasaki, Komaki Shi, Aichi 4858510, Japan.	h-kozuka@mg.ngkntk.co.jp					ANANE A, 1995, J PHYS-CONDENS MAT, V7, P7015, DOI 10.1088/0953-8984/7/35/008; CUTLER M, 1969, PHYS REV, V181, P1336, DOI 10.1103/PhysRev.181.1336; VINING CB, 1991, J APPL PHYS, V69, P331, DOI 10.1063/1.347717; Tomioka Y, 1997, APPL PHYS LETT, V70, P3609, DOI 10.1063/1.119248; Raveau B, 2000, J SOLID STATE CHEM, V149, P203, DOI 10.1006/jssc.1999.8517; Kamihara Y, 2008, J AM CHEM SOC, V130, P3296, DOI 10.1021/ja800073m; Koumoto K, 2010, ANNU REV MATER RES, V40, P363, DOI 10.1146/annurev-matsci-070909-104521; TAKEDA Y, 1987, J ELECTROCHEM SOC, V134, P2656, DOI 10.1149/1.2100267; Zhou AJ, 2008, J MATER SCI, V43, P1520, DOI 10.1007/s10853-007-2365-4; SAITOH T, 1995, PHYS REV B, V51, P13942, DOI 10.1103/PhysRevB.51.13942; Chen CH, 1997, SOLID STATE IONICS, V98, P7, DOI 10.1016/S0167-2738(97)00097-0; Wang F, 1997, J APPL PHYS, V82, P1293, DOI 10.1063/1.365901; URUSHIBARA A, 1995, PHYS REV B, V51, P14103, DOI 10.1103/PhysRevB.51.14103; Madsen GKH, 2006, COMPUT PHYS COMMUN, V175, P67, DOI 10.1016/j.cpc.2006.03.007; KURODA K, 1981, J SOLID STATE CHEM, V38, P297, DOI 10.1016/0022-4596(81)90059-1; HEIKES RR, 1964, PHYSICA, V30, P1600, DOI 10.1016/0031-8914(64)90182-X; THORNTON G, 1986, J SOLID STATE CHEM, V61, P301, DOI 10.1016/0022-4596(86)90035-6; ITOH M, 1994, J PHYS SOC JPN, V63, P1486, DOI 10.1143/JPSJ.63.1486; Asai K, 1998, J PHYS SOC JPN, V67, P290, DOI 10.1143/JPSJ.67.290; BHIDE VG, 1972, PHYS REV B, V6, P1021, DOI 10.1103/PhysRevB.6.1021; Kriener M, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.094417; MAEDA H, 1988, JPN J APPL PHYS 2, V27, pL209, DOI 10.1143/JJAP.27.L209; Zobel C, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.020402; MIZUSAKI J, 1989, J SOLID STATE CHEM, V80, P102, DOI 10.1016/0022-4596(89)90036-4; Ohtani T, 2000, J EUR CERAM SOC, V20, P2721, DOI 10.1016/S0955-2219(00)00224-7; Madsen GKH, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.195134; Mizusaki J, 2000, SOLID STATE IONICS, V132, P167, DOI 10.1016/S0167-2738(00)00662-7; Kozuka H, 2012, J MATER CHEM, V22, P11003, DOI 10.1039/c2jm31965a; Kozuka H, 2012, J MATER CHEM, V22, P20217, DOI 10.1039/c2jm34613c; Sogaard M, 2006, SOLID STATE IONICS, V177, P3285, DOI 10.1016/j.ssi.2006.09.005; Inagaki T, 2000, J POWER SOURCES, V86, P347, DOI 10.1016/S0378-7753(99)00431-0; Moritomo Y, 1996, NATURE, V380, P141, DOI 10.1038/380141a0; ABBATE M, 1992, PHYS REV B, V46, P4511, DOI 10.1103/PhysRevB.46.4511; HUANG YS, 1982, MATER RES BULL, V17, P1305, DOI 10.1016/0025-5408(82)90166-0; RACCAH PM, 1967, PHYS REV, V155, P932, DOI 10.1103/PhysRev.155.932; Sjostedt E, 2000, SOLID STATE COMMUN, V114, P15, DOI 10.1016/S0038-1098(99)00577-3; Schwarz K, 2002, COMPUT PHYS COMMUN, V147, P71, DOI 10.1016/S0010-4655(02)00206-0; Radaelli PG, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.094408; Kawada T, 1999, SOLID STATE IONICS, V121, P271, DOI 10.1016/S0167-2738(99)00046-6; RYDEN WD, 1970, PHYS REV B, V1, P1494, DOI 10.1103/PhysRevB.1.1494; Kharton VV, 1998, SOLID STATE IONICS, V110, P53, DOI 10.1016/S0167-2738(98)00116-7; Mandal P, 2000, PHYS REV B, V61, P14675, DOI 10.1103/PhysRevB.61.14675; Maignan A, 2004, EUR PHYS J B, V39, P145, DOI 10.1140/epjb/e2004-00179-8; Ohta H, 2012, ADV MATER, V24, P740, DOI 10.1002/adma.201103809; LONGO JM, 1968, J APPL PHYS, V39, P1327, DOI 10.1063/1.1656282; OKIMOTO Y, 1995, PHYS REV LETT, V75, P109, DOI 10.1103/PhysRevLett.75.109; Yamaguchi S, 1996, PHYS REV B, V53, pR2926; Mineshige A, 1999, J SOLID STATE CHEM, V142, P374, DOI 10.1006/jssc.1998.8051; ASAI K, 1977, J PHYS SOC JPN, V43, P1093, DOI 10.1143/JPSJ.43.1093; Bednorz J. G., 1986, PHYS B, V64, P189; Belik AA, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.094438; Berggold K, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.155116; CHU CW, 1987, PHYS REV LETT, V58, P405, DOI 10.1103/PhysRevLett.58.405; Hammer D, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.134407; HAMMOUCHE A, 1989, MATER RES BULL, V24, P367, DOI 10.1016/0025-5408(89)90223-7; He T, 2006, SOLID STATE SCI, V8, P467, DOI 10.1016/j.solidstatesciences.2006.01.002; Hishida T, 2013, J APPL PHYS, V113, DOI 10.1063/1.4789315; Iwasaki K, 2008, J SOLID STATE CHEM, V181, P3145, DOI 10.1016/j.jssc.2008.08.017; Izumi F., 2000, MATER SCI FORUM, V321-324, P198; JONKER GH, 1953, PHYSICA, V19, P120, DOI 10.1016/S0031-8914(53)80011-X; Kozuka H, 2012, INORG CHEM, V51, P9259, DOI 10.1021/ic301386s; Kozuka H, 2013, J MATER CHEM A, V1, P3249, DOI 10.1039/c3ta00982c; Lee HM, 2003, MATER CHEM PHYS, V77, P639, DOI 10.1016/S0254-0584(02)00091-3; Li F, 2011, CERAM INT, V37, P105, DOI 10.1016/j.ceramint.2010.08.024; MIZUSAKI J, 1989, J ELECTROCHEM SOC, V136, P2082, DOI 10.1149/1.2097187; Moon JW, 2000, J MATER CHEM, V10, P2007, DOI 10.1039/b003964k; Mori T, 2000, J ALLOY COMPD, V313, pL1, DOI 10.1016/S0925-8388(00)01135-X; MORITOMO Y, 1995, PHYS REV B, V51, P16491, DOI 10.1103/PhysRevB.51.16491; NEGAS T, 1971, J SOLID STATE CHEM, V3, P323, DOI 10.1016/0022-4596(71)90068-5; Okuda T, 1998, PHYS REV LETT, V81, P3203, DOI 10.1103/PhysRevLett.81.3203; Onose Y, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.174421; RACCAH PM, 1968, J APPL PHYS, V39, P1209, DOI 10.1063/1.1656227; Sathe VG, 1996, J PHYS-CONDENS MAT, V8, P3889, DOI 10.1088/0953-8984/8/21/014; SCHULZ WW, 1992, PHYS REV B, V46, P14001, DOI 10.1103/PhysRevB.46.14001; SENARISRODRIGUEZ MA, 1995, J SOLID STATE CHEM, V118, P323, DOI 10.1006/jssc.1995.1351; SHENG ZZ, 1988, NATURE, V332, P138, DOI 10.1038/332138a0; Sikolenko VV, 2003, J MAGN MAGN MATER, V258, P300, DOI 10.1016/S0304-8853(02)01145-9; SLEIGHT AW, 1966, SOLID STATE COMMUN, V4, P601, DOI 10.1016/0038-1098(66)90143-8; Tokura Y, 1998, PHYS REV B, V58, pR1699, DOI 10.1103/PhysRevB.58.R1699; Tsubouchi S, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.094437; Wu T, 2008, SOLID STATE COMMUN, V145, P293, DOI 10.1016/j.ssc.2007.11.001; Yanagida H, 1975, ELECT MAT CERAMICS, P7; Zhang XD, 2006, J VAC SCI TECHNOL A, V24, P914, DOI 10.1116/1.2198867	83	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1468-6996	1878-5514		SCI TECHNOL ADV MAT	Sci. Technol. Adv. Mater.	APR	2015	16	2							026001	10.1088/1468-6996/16/2/026001		16	Materials Science, Multidisciplinary	Materials Science	CG9MY	WOS:000353641100020		
J	Omata, T; Nagatani, H; Suzuki, I; Kita, M				Omata, Takahisa; Nagatani, Hiraku; Suzuki, Issei; Kita, Masao			Wurtzite-derived ternary I-III-O-2 semiconductors	SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS			English	Article						II-VI semiconductor; I-III-VI2 semiconductor; oxide semiconductor	NONLINEAR-OPTICAL PROPERTIES; GAP OXIDE SEMICONDUCTOR; SOLAR-CELLS; THIN-FILMS; PHOTOCATALYTIC PROPERTIES; ELECTRICAL-CONDUCTION; ELECTRONIC-STRUCTURES; CRYSTAL-STRUCTURES; ZINC-OXIDE; LIGAO2	Ternary zincblende-derived I-III-VI2 chalcogenide and II-IV-V-2 pnictide semiconductors have been widely studied and some have been put to practical use. In contrast to the extensive research on these semiconductors, previous studies into ternary I-III-O-2 oxide semiconductors with a wurtzite-derived beta-NaFeO2 structure are limited. Wurtzite-derived beta-LiGaO2 and beta-AgGaO2 form alloys with ZnO and the band gap of ZnO can be controlled to include the visible and ultraviolet regions. beta-CuGaO2, which has a direct band gap of 1.47 eV, has been proposed for use as a light absorber in thin film solar cells. These ternary oxides may thus allow new applications for oxide semiconductors. However, information about wurtzite-derived ternary I-III-O2 semiconductors is still limited. In this paper we review previous studies on beta-LiGaO2, beta-AgGaO2 and beta-CuGaO2 to determine guiding principles for the development of wurtzite-derived I-III-O-2 semiconductors.	[Omata, Takahisa; Nagatani, Hiraku; Suzuki, Issei] Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, Suita, Osaka 5650871, Japan; [Kita, Masao] Toyama Natl Coll Technol, Dept Mech Engn, Toyama 9398630, Japan	Omata, T (reprint author), Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	omata@mat.eng.osaka-u.ac.jp	Omata, Takahisa/C-3946-2009	Omata, Takahisa/0000-0002-6034-4935	Japan Society for the Promotion of Science [2365640, 25630283, 26289239]	HN would like to thank the organizing committee of the 8th International Conference on the Science and Technology for Advanced Ceramics (STAC8) for the First Prize Poster Award. This work was partly supported by Grants-in-Aid for Scientific Research of Challenging Exploratory Research (Nos. 2365640 and 25630283) and a Grant-in-Aid for Scientific Research (B) (No. 26289239) from the Japan Society for the Promotion of Science.	Bob B, 2012, ADV ENERGY MATER, V2, P504, DOI 10.1002/aenm.201100578; Ohkubo I, 2002, J APPL PHYS, V92, P5587, DOI 10.1063/1.1512311; MILLER RC, 1970, J APPL PHYS, V41, P3008, DOI 10.1063/1.1659354; Li QF, 2013, J APPL PHYS, V114, DOI 10.1063/1.4818582; Ouyang SX, 2008, J PHYS CHEM C, V112, P3134, DOI 10.1021/jp077127w; Maruyama Y, 2006, J PHYS CHEM B, V110, P23274, DOI 10.1021/jp063406s; Omata T, 2008, J APPL PHYS, V103, DOI 10.1063/1.2903906; Azimi H, 2014, ENERG ENVIRON SCI, V7, P1829, DOI 10.1039/c3ee43865a; Ohtomo A, 1998, APPL PHYS LETT, V72, P2466, DOI 10.1063/1.121384; Punya A, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.075302; Ouyang SX, 2006, J PHYS CHEM B, V110, P11677, DOI 10.1021/jp055924t; Ouyang SX, 2009, J PHYS CHEM C, V113, P1560, DOI 10.1021/jp806513t; Ginley DS, 2000, MRS BULL, V25, P15; Shimode M, 2000, J SOLID STATE CHEM, V151, P16, DOI 10.1006/jssc.1999.8603; Ellmer K, 2012, NAT PHOTONICS, V6, P808, DOI [10.1038/nphoton.2012.282, 10.1038/NPHOTON.2012.282]; Kim YI, 2008, INORG CHEM, V47, P8437, DOI 10.1021/ic800916a; Ouyang SX, 2011, J AM CHEM SOC, V133, P7757, DOI 10.1021/ja110691t; Miles RW, 2007, MATER TODAY, V10, P20, DOI 10.1016/S1369-7021(07)70275-4; Omata T, 2014, J AM CHEM SOC, V136, P3378, DOI 10.1021/ja501614n; SABINE TM, 1969, ACTA CRYSTALL B-STRU, VB 25, P2254, DOI 10.1107/S0567740869005528; Minami T, 2008, THIN SOLID FILMS, V516, P5822, DOI [10.1016/j.tsf.2007.10.063, 10.1016/j.tsf2007.10.063]; Chou MMC, 2011, THIN SOLID FILMS, V519, P3627, DOI 10.1016/j.tsf.2011.01.343; Johnson NW, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/44/445501; Huang TH, 2008, J CRYST GROWTH, V310, P3144, DOI 10.1016/j.jcrysgro.2008.03.037; Fortunato E, 2012, ADV MATER, V24, P2945, DOI 10.1002/adma.201103228; Omata T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.031102; SHOCKLEY W, 1961, J APPL PHYS, V32, P510, DOI 10.1063/1.1736034; Kawazoe H, 1997, NATURE, V389, P939, DOI 10.1038/40087; Ueda K, 2001, J APPL PHYS, V89, P1790, DOI 10.1063/1.1337587; Anandan S, 2010, APPL CATAL B-ENVIRON, V100, P502, DOI 10.1016/j.apcatb.2010.08.029; Tsukazaki A, 2005, NAT MATER, V4, P42, DOI 10.1038/nmat1284; APPLE EF, 1958, J ELECTROCHEM SOC, V105, P251, DOI 10.1149/1.2428818; Boonchun A, 2011, PROC SPIE, V7940, DOI 10.1117/12.879320; Boonchun A, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.235214; Chang H-C, 1966, ACTA GEOL SINICA, V46, P76; GALLARDO PG, 1992, PHYS STATUS SOLIDI A, V130, P39, DOI 10.1002/pssa.2211300105; GAN JN, 1975, PHYS REV B, V12, P5797, DOI 10.1103/PhysRevB.12.5797; Grima-Gallardo P, 2004, PHYS STATUS SOLIDI B, V241, P1795, DOI 10.1002/pssb.200402016; Halka VO, 2000, J ALLOY COMPD, V302, P173, DOI 10.1016/S0925-8388(00)00681-2; Harrison W.A., 1980, ELECT STRUCTURE PROP; Ishii T, 1998, J CRYST GROWTH, V189, P208; Kawazoe H, 2000, MRS BULL, V25, P28, DOI 10.1557/mrs2000.148; KNOLL P, 1984, PHYS REV B, V29, P2221, DOI 10.1103/PhysRevB.29.2221; Kohler B U, 1986, ALLG CHEM, V543, P73; Li J, 2004, J SOLID STATE CHEM, V177, P889, DOI 10.1016/j.jssc.2003.09.036; Limpijumnong S, 1997, MATER RES SOC SYMP P, V449, P905; Meyer BK, 2013, SEMICONDUCT SEMIMET, V88, P201, DOI 10.1016/B978-0-12-396489-2.00006-0; Misaki T., 2002, Physica Status Solidi C; Nagatani H, 2015, J SOLID STATE CHEM, V222, P66, DOI 10.1016/j.jssc.2014.11.012; Nagatani H, 2015, INORG CHEM, V54, P1698, DOI 10.1021/ic502659e; Nicholls JFH, 1996, MATER RES SOC SYMP P, V395, P535; Omata T, 2012, J SOLID STATE CHEM, V188, P92, DOI 10.1016/j.jssc.2012.01.053; Omata T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.061102; Ozgur U, 2005, J APPL PHYS, V98, DOI 10.1063/1.1992666; Rashkeev SN, 1999, J OPT SOC AM B, V16, P2217, DOI 10.1364/JOSAB.16.002217; RIEDE V, 1989, PHYS STATUS SOLIDI A, V112, pK139, DOI 10.1002/pssa.2211120274; ROBBINS M, 1972, J SOLID STATE CHEM, V5, P462, DOI 10.1016/0022-4596(72)90094-1; Rufinus J, 2011, J APPL PHYS, V109, DOI 10.1063/1.3553938; Ryoken H, 2006, J CRYST GROWTH, V287, P134, DOI 10.1016/j.jcrysgro.2005.10.056; Srinivasan R, 2008, J MATER CHEM, V18, P5647, DOI 10.1039/b810064k; Suzuki I, 2014, THIN SOLID FILMS, V559, P112, DOI 10.1016/j.tsf.2013.10.099; Suzuki I, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4836435; Vanaja K A, THIN SOLID FILMS, V516, P1426; Vanaja K A, APPL PHYS LETT, V88; Viret M, 2012, MATER RES BULL, V47, P2294, DOI 10.1016/j.materresbull.2012.05.040; Wyckoff R W G, 1964, CRYST STRUCT, V2, P336; Wyckoff R W G, 1964, CRYST STRUCT, V2, P299; Wyckoff R W G, 1964, CRYST STRUCT, V2, P291; Yanagi H, 2001, APPL PHYS LETT, V78, P1583, DOI 10.1063/1.1355673; YEH JJ, 1985, ATOM DATA NUCL DATA, V32, P1, DOI 10.1016/0092-640X(85)90016-6	70	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1468-6996	1878-5514		SCI TECHNOL ADV MAT	Sci. Technol. Adv. Mater.	APR	2015	16	2							024902	10.1088/1468-6996/16/2/024902		7	Materials Science, Multidisciplinary	Materials Science	CG9MY	WOS:000353641100011		
J	Shimizu, M; Yamada, T; Sasaki, K; Takada, A; Nomura, H; Iguchi, F; Yugami, H				Shimizu, M.; Yamada, T.; Sasaki, K.; Takada, A.; Nomura, H.; Iguchi, F.; Yugami, H.			Anisotropic multi-step etching for large-area fabrication of surface microstructures on stainless steel to control thermal radiation	SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS			English	Article						thermal radiation; wet etching; inteference lithography	HIGH-TEMPERATURE STABILITY; CERMET SELECTIVE SURFACES; INTERFERENCE LITHOGRAPHY; PHOTONIC CRYSTALS; EMISSION; SILICON; MODES	Controlling the thermal radiation spectra of materials is one of the promising ways to advance energy system efficiency. It is well known that the thermal radiation spectrum can be controlled through the introduction of periodic surface microstructures. Herein, a method for the large-area fabrication of periodic microstructures based on multi-step wet etching is described. The method consists of three main steps, i.e., resist mask fabrication via photolithography, electrochemical wet etching, and side wall protection. Using this method, high-aspect micro-holes (0.82 aspect ratio) arrayed with hexagonal symmetry were fabricated on a stainless steel substrate. The conventional wet etching process method typically provides an aspect ratio of 0.3. The optical absorption peak attributed to the fabricated micro-hole array appeared at 0.8 mu m, and the peak absorbance exceeded 0.8 for the micro-holes with a 0.82 aspect ratio. While argon plasma etching in a vacuum chamber was used in the present study for the formation of the protective layer, atmospheric plasma etching should be possible and will expand the applicability of this new method for the large-area fabrication of high-aspect materials.	[Shimizu, M.; Iguchi, F.; Yugami, H.] Tohoku Univ, Grad Sch Engn, Dept Mech Syst & Design, Sendai, Miyagi 980, Japan; [Yamada, T.; Sasaki, K.; Takada, A.; Nomura, H.] Dexerials Corp, Div Res & Dev, Business Creat Dept, Tokyo, Japan	Shimizu, M (reprint author), Tohoku Univ, Grad Sch Engn, Dept Mech Syst & Design, Sendai, Miyagi 980, Japan.	m_shimizu@energy.mech.tohoku.ac.jp					Zhang QC, 1998, SOL ENERG MAT SOL C, V52, P95, DOI 10.1016/S0927-0248(97)00274-2; Maruyama S, 2001, APPL PHYS LETT, V79, P1393, DOI 10.1063/1.1397759; Vorobyev AY, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.234301; Shimizu M, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4767903; Chen CG, 2002, P SOC PHOTO-OPT INS, V4936, P126, DOI 10.1117/12.469431; Yeng YX, 2012, P NATL ACAD SCI USA, V109, P2280, DOI 10.1073/pnas.1120149109; Nakagawa N, 2005, J EUR CERAM SOC, V25, P1285, DOI 10.1016/j.jeurceramsoc.2005.01.031; Rinnerbauer V, 2013, OPT EXPRESS, V21, P11482, DOI 10.1364/OE.21.011482; Sai H, 2003, APPL PHYS LETT, V82, P1685, DOI 10.1063/1.1560867; Si GY, 2014, MATER LETT, V128, P373, DOI 10.1016/j.matlet.2014.04.163; HESKETH PJ, 1986, NATURE, V324, P549, DOI 10.1038/324549a0; Yeom J, 2005, J VAC SCI TECHNOL B, V23, P2319, DOI 10.1116/1.2101678; Mason JA, 2010, OPT EXPRESS, V18, P25192, DOI 10.1364/OE.18.025192; Vorobyev AY, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2834902; Arpin KA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3630; Boor J.D., 2009, OPT LETT, V34, P1783; Coutts TJ, 2003, SEMICOND SCI TECH, V18, pS144, DOI 10.1088/0268-1242/18/5/302; MOHARAM MG, 1981, J OPT SOC AM, V71, P811, DOI 10.1364/JOSA.71.000811; Palik E.D., 1991, HDB OPTICAL CONSTANT, VII; Savas TA, 1996, J VAC SCI TECHNOL B, V14, P4167, DOI 10.1116/1.588613; SHIMIZU K, 1988, JPN J APPL PHYS 2, V27, pL1778; Zhang QC, 1996, SOL ENERG MAT SOL C, V40, P43, DOI 10.1016/0927-0248(95)00078-X	22	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1468-6996	1878-5514		SCI TECHNOL ADV MAT	Sci. Technol. Adv. Mater.	APR	2015	16	2							025001	10.1088/1468-6996/16/2/025001		5	Materials Science, Multidisciplinary	Materials Science	CG9MY	WOS:000353641100012		
J	Yamamoto, A; Teramura, K; Hosokawa, S; Tanaka, T				Yamamoto, Akira; Teramura, Kentaro; Hosokawa, Saburo; Tanaka, Tsunehiro			Effects of SO2 on selective catalytic reduction of NO with NH3 over a TiO2 photocatalyst	SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS			English	Article						photocatalyst; NH3-SCR; SO2	MANGANESE OXIDES; NITRIC-OXIDE; AMMONIA; SCR; TIO2(110); CHEMISTRY; SURFACES; ANATASE	The effect of SO2 gas was investigated on the activity of the photo-assisted selective catalytic reduction of nitrogen monoxide (NO) with ammonia (NH3) over a TiO2 photocatalyst in the presence of excess oxygen (photo-SCR). The introduction of SO2 (300 ppm) greatly decreased the activity of the photo-SCR at 373 K. The increment of the reaction temperature enhanced the resistance to SO2 gas, and at 553 K the conversion of NO was stable for at least 300 min of the reaction. X-ray diffraction, FTIR spectroscopy, thermogravimetry and differential thermal analysis, x-ray photoelectron spectroscopy (XPS), elemental analysis and N-2 adsorption measurement revealed that the ammonium sulfate species were generated after the reaction. There was a strong negative correlation between the deposition amount of the ammonium sulfate species and the specific surface area. Based on the above relationship, we concluded that the deposition of the ammonium sulfate species decreased the specific surface area by plugging the pore structure of the catalyst, and the decrease of the specific surface area resulted in the deactivation of the catalyst.	[Yamamoto, Akira; Teramura, Kentaro; Hosokawa, Saburo; Tanaka, Tsunehiro] Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Nishikyo Ku, Kyoto 6158510, Japan; [Teramura, Kentaro; Hosokawa, Saburo; Tanaka, Tsunehiro] Kyoto Univ, ESICB, Kyoto 6158520, Japan; [Teramura, Kentaro] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan	Yamamoto, A (reprint author), Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Nishikyo Ku, Kyoto 6158510, Japan.	teramura@moleng.kyoto-u.ac.jp			Program for Element Strategy Initiative for Catalysts & Batteries (ESICB); Japan Science and Technology Agency (JST); JSPS Research Fellowships; Precursory Research for Embryonic Science and Technology (PRESTO)	This study was partially supported by the Program for Element Strategy Initiative for Catalysts & Batteries (ESICB), commissioned by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, and the Precursory Research for Embryonic Science and Technology (PRESTO), supported by the Japan Science and Technology Agency (JST). Akira Yamamoto thanks the JSPS Research Fellowships for Young Scientists.	Haubrich J, 2010, LANGMUIR, V26, P2445, DOI 10.1021/la904141k; Li JH, 2007, CATAL COMMUN, V8, P1896, DOI 10.1016/j.catcom.2007.03.007; CHEN JP, 1993, J CATAL, V139, P277, DOI 10.1006/jcat.1993.1023; HAGUE DC, 1994, J AM CERAM SOC, V77, P1957, DOI 10.1111/j.1151-2916.1994.tb07078.x; Kijlstra WS, 1998, APPL CATAL B-ENVIRON, V16, P327; Li JH, 2011, CATAL TODAY, V175, P147, DOI 10.1016/j.cattod.2011.03.034; SINGOREDJO L, 1992, APPL CATAL B-ENVIRON, V1, P297, DOI 10.1016/0926-3373(92)80055-5; SCOFIELD JH, 1976, J ELECTRON SPECTROSC, V8, P129, DOI 10.1016/0368-2048(76)80015-1; Rodriguez JA, 2001, J AM CHEM SOC, V123, P9597, DOI 10.1021/ja011131i; KAPTEIJN F, 1994, APPL CATAL B-ENVIRON, V3, P173, DOI 10.1016/0926-3373(93)E0034-9; Tang XL, 2007, CATAL TODAY, V126, P406, DOI 10.1016/j.cattod.2007.06.013; Bosch H., 1988, CATAL TODAY, V2, P369; Busca G, 1998, APPL CATAL B-ENVIRON, V18, P1, DOI 10.1016/S0926-3373(98)00040-X; Chou YC, 2012, FRONT ENV SCI ENG, V6, P149, DOI 10.1007/s11783-010-0296-9; HALSTEAD WD, 1970, J APPL CHEM, V20, P129; Ji YF, 2014, J PHYS CHEM C, V118, P6359, DOI 10.1021/jp501427k; LINDBERG BJ, 1970, ACTA CHEM SCAND, V24, P3661, DOI 10.3891/acta.chem.scand.24-3661; Long RQ, 2002, CHEM COMMUN, P452, DOI 10.1039/b111382h; Lu YF, 2006, J ELECTROCHEM SOC, V153, pE131, DOI 10.1149/1.2205168; Teramura K, 2003, LANGMUIR, V19, P1209, DOI 10.1021/la0263918; Teramura K, 2004, APPL CATAL B-ENVIRON, V53, P29, DOI 10.1016/j.apcatb.2004.05.005; Wagner C. D., 1979, HDB XRAY PHOTOELECTR; Yamamoto A, 2015, CATAL SCI TECHNOL, V5, P556, DOI 10.1039/c4cy00598h; Yamamoto A, 2013, CATAL SCI TECHNOL, V3, P1771, DOI 10.1039/c3cy00022b; Yamazoe S, 2008, APPL CATAL B-ENVIRON, V83, P123, DOI 10.1016/j.apcatb.2008.01.032; Yamazoe S, 2006, CATAL TODAY, V111, P266, DOI 10.1016/j.cattod.2005.10.056; Yamazoe S, 2007, J PHYS CHEM C, V111, P14189, DOI 10.1021/jp075033g	27	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1468-6996	1878-5514		SCI TECHNOL ADV MAT	Sci. Technol. Adv. Mater.	APR	2015	16	2							024901	10.1088/1468-6996/16/2/024901		9	Materials Science, Multidisciplinary	Materials Science	CG9MY	WOS:000353641100010		
J	Yi, W; Presniakov, IA; Sobolev, AV; Glazkova, YS; Matsushita, Y; Tanaka, M; Kosuda, K; Tsujimoto, Y; Yamaura, K; Belik, AA				Yi, Wei; Presniakov, Igor A.; Sobolev, Alexey V.; Glazkova, Yana S.; Matsushita, Yoshitaka; Tanaka, Masahiko; Kosuda, Kosuke; Tsujimoto, Yoshihiro; Yamaura, Kazunari; Belik, Alexei A.			Structure and cation distribution in perovskites with small cations at the A site: the case of ScCoO3	SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS			English	Article						perovskites; cobaltites; high-pressure; low-spin Co3+ ions	TEMPERATURE; CHARGE	We synthesize ScCoO3 perovskite and its solid solutions, ScCo1-xFexO3 and ScCo1-xCrxO3, under high pressure (6 GPa) and high temperature (1570 K) conditions. We find noticeable shifts from the stoichiometric compositions, expressed as (Sc1-xMx)MO3 with x = 0.05-0.11 and M=Co, (Co, Fe) and (Co, Cr). The crystal structure of (Sc0.95Co0.05)CoO3 is refined using synchrotron x-ray powder diffraction data: space group Pnma (No. 62), Z=4 and lattice parameters a = 5.26766(1) angstrom, b = 7.14027(2) angstrom and c = 4.92231(1) angstrom. (Sc0.95Co0.05) CoO3 crystallizes in the GdFeO3-type structure similar to other members of the perovskite cobaltite family, ACoO(3)(A(3+) = Y and Pr-Lu). There is evidence that (Sc0.95Co0.05)CoO3 has non-magnetic low-spin Co3+ ions at the B site and paramagnetic high-spin Co3+ ions at the A site. In the iron-doped samples (Sc1-xMx)MO3 with M=(Co, Fe), Fe3+ ions have a strong preference to occupy the A site of such perovskites at small doping levels.	[Yi, Wei; Belik, Alexei A.] Natl Inst Mat, Int Ctr Mat Nanoarchitecton WPI MANA, Tsukuba, Ibaraki 3050044, Japan; [Yi, Wei] Chinese Acad Sci, Inst Phys, Beijing 100190, Peoples R China; [Yi, Wei] Chinese Acad Sci, Beijing Natl Lab Condensed Matter Phys, Beijing 100190, Peoples R China; [Presniakov, Igor A.; Sobolev, Alexey V.; Glazkova, Yana S.] Moscow MV Lomonosov State Univ, Dept Chem, Moscow 119992, Russia; [Matsushita, Yoshitaka; Tanaka, Masahiko] SPring 8, NIMS, Synchrotron Xray Stn, Sayo, Hyogo 6795148, Japan; [Matsushita, Yoshitaka; Kosuda, Kosuke] NIMS, Mat Anal Stn, Tsukuba, Ibaraki 3050047, Japan; [Tsujimoto, Yoshihiro] NIMS, Mat Proc Unit, Tsukuba, Ibaraki 3050047, Japan; [Yamaura, Kazunari] NIMS, Supercond Properties Unit, Tsukuba, Ibaraki 3050044, Japan	Yi, W (reprint author), Natl Inst Mat, Int Ctr Mat Nanoarchitecton WPI MANA, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.	Alexei.Belik@nims.go.jp	Tsujimoto, Yoshihiro/H-6034-2012; Sobolev, Alexey/C-3832-2009; Glazkova, Iana/A-7627-2015	Sobolev, Alexey/0000-0002-8085-5425; Glazkova, Iana/0000-0001-6021-3479	World Premier International Research Center Initiative (WPI Initiative, MEXT, Japan); Japan Society for the Promotion of Science (JSPS) through its 'Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)';  [25289233]	This work was supported by the World Premier International Research Center Initiative (WPI Initiative, MEXT, Japan), the Japan Society for the Promotion of Science (JSPS) through its 'Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)' and a JSPS Grant-in-Aid for Scientific Research (25289233). The synchrotron radiation experiments were performed at the SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (Proposal Numbers: 2012A4507 and 2013B4503).	Belik AA, 2013, INORG CHEM, V52, P12005, DOI 10.1021/ic401760m; Sardar K, 2011, CHEM MATER, V23, P48, DOI 10.1021/cm102925z; Thomas CI, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2013.0012; Izyumskaya N, 2009, CRIT REV SOLID STATE, V34, P89, DOI 10.1080/10408430903368401; Tanaka M, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2956972; MENIL F, 1985, J PHYS CHEM SOLIDS, V46, P763, DOI 10.1016/0022-3697(85)90001-0; Tanaka M, 2013, J CERAM SOC JPN, V121, P287, DOI 10.2109/jcersj2.121.287; Levin I, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3298369; Belik AA, 2014, J PHYS-CONDENS MAT, V26, DOI 10.1088/0953-8984/26/16/163201; Belik AA, 2006, CHEM MATER, V18, P798, DOI 10.1021/cm052334z; Choudhury D, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.127201; Markkula M, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.094450; Presniakov IA, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.214407; Knizek K, 2005, EUR PHYS J B, V47, P213, DOI 10.1140/epjb/e2005-00320-3; GIAQUINTA DM, 1994, CHEM MATER, V6, P365, DOI 10.1021/cm00040a007; Matsnev ME, 2012, AIP CONF PROC, V1489, P178, DOI 10.1063/1.4759488; Yamada I, 2008, ANGEW CHEM INT EDIT, V47, P7032, DOI 10.1002/anie.200801482; Baiker A, 2009, J ALLOY COMPD, V484, P246; Belik AA, 2010, ANGEW CHEM INT EDIT, V49, P7723, DOI 10.1002/anie.201003080; Belik AA, 2012, CHEM MATER, V24, P2197, DOI 10.1021/cm3009144; BRESE NE, 1991, ACTA CRYSTALLOGR B, V47, P192, DOI 10.1107/S0108768190011041; Castillo-Martinez E, 2011, J AM CHEM SOC, V133, P8552, DOI 10.1021/ja109376s; Gutlich P, 2011, MOSSBAUER SPECTROSCOPY AND TRANSITION METAL CHEMISTRY: FUNDAMENTALS AND APPLICATIONS, P1; Hashimoto H, 1994, J CATAL, V146, P268; Izumi F, 2000, MATER SCI FORUM, V321-3, P198; Kolodiazhnyi T, 2014, J EUR CERAM SOC, V34, P1741, DOI 10.1016/j.jeurceramsoc.2013.12.037; Lever A. B. P., 1984, INORGANIC ELECT SPEC; Li MR, 2012, J AM CHEM SOC, V134, P3737, DOI 10.1021/ja208395z; Mitchell RH, 2002, PEROVSKITES MODERN A; Meher KRSP, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.144401; Presniakov I A, UNPUB; Rusakov V. S., 2000, MOSSBAUER SPECTROSCO; Sato K, 2014, J PHYS SOC JPN, V83, DOI 10.7566/JPSJ.83.114712; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Tachibana M, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.094402; TAFT CA, 1977, J PHYS C SOLID STATE, V10, pL369, DOI 10.1088/0022-3719/10/13/001; Tomiyasu K, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.224409	37	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1468-6996	1878-5514		SCI TECHNOL ADV MAT	Sci. Technol. Adv. Mater.	APR	2015	16	2							024801	10.1088/1468-6996/16/2/024801		9	Materials Science, Multidisciplinary	Materials Science	CG9MY	WOS:000353641100004		
J	Cao, ML; Meng, QH; Wang, JY; Luo, B; Jing, YQ; Ma, SG				Cao, Meng-Li; Meng, Qing-Hao; Wang, Jia-Ying; Luo, Bing; Jing, Ya-Qi; Ma, Shu-Gen			Learning to Rapidly Re-Contact the Lost Plume in Chemical Plume Tracing	SENSORS			English	Article							MOBILE ROBOTS; ODOR; FLOW	Maintaining contact between the robot and plume is significant in chemical plume tracing (CPT). In the time immediately following the loss of chemical detection during the process of CPT, Track-Out activities bias the robot heading relative to the upwind direction, expecting to rapidly re-contact the plume. To determine the bias angle used in the Track-Out activity, we propose an online instance-based reinforcement learning method, namely virtual trail following (VTF). In VTF, action-value is generalized from recently stored instances of successful Track-Out activities. We also propose a collaborative VTF (cVTF) method, in which multiple robots store their own instances, and learn from the stored instances, in the same database. The proposed VTF and cVTF methods are compared with biased upwind surge (BUS) method, in which all Track-Out activities utilize an offline optimized universal bias angle, in an indoor environment with three different airflow fields. With respect to our experimental conditions, VTF and cVTF show stronger adaptability to different airflow environments than BUS, and furthermore, cVTF yields higher success rates and time-efficiencies than VTF.	[Cao, Meng-Li; Meng, Qing-Hao; Wang, Jia-Ying; Luo, Bing; Jing, Ya-Qi; Ma, Shu-Gen] Tianjin Univ, Sch Elect Engn & Automat, Tianjin Key Lab Proc Measurement & Control, Inst Robot & Autonomous Syst, Tianjin 300072, Peoples R China; [Ma, Shu-Gen] Ritsumeikan Univ, Dept Robot, Kusatsu 5258577, Japan	Meng, QH (reprint author), Tianjin Univ, Sch Elect Engn & Automat, Tianjin Key Lab Proc Measurement & Control, Inst Robot & Autonomous Syst, Tianjin 300072, Peoples R China.	menglicao@tju.edu.cn; qh_meng@tju.edu.cn; wjy0709@tju.edu.cn; roice@tju.edu.cn; jingyaqi@tju.edu.cn; shugen@se.ritsumei.ac.jp			National Natural Science Foundation of China [61271321, 61473207, 61401303]; Ph.D. Programs Foundation of the Ministry of Education of China [20120032110068]; Tianjin Key Technology Research and Development Program [14ZCZDSF00025]	The authors thank the anonymous referees for their valuable and constructive suggestions. This work was supported by the National Natural Science Foundation of China under Grants 61271321, 61473207, and 61401303; the Ph.D. Programs Foundation of the Ministry of Education of China under Grant 20120032110068; Tianjin Key Technology Research and Development Program under Grant 14ZCZDSF00025.	Pravin S, 2013, SENSORS-BASEL, V13, P16591, DOI 10.3390/s131216591; Lecchini D, 2010, BEHAV ECOL, V21, P599, DOI 10.1093/beheco/arq029; WATKINS CJCH, 1992, MACH LEARN, V8, P279, DOI 10.1007/BF00992698; Dunbabin M, 2012, IEEE ROBOT AUTOM MAG, V19, P24, DOI 10.1109/MRA.2011.2181683; Atkeson CG, 1997, ARTIF INTELL REV, V11, P11, DOI 10.1023/A:1006559212014; Vergassola M, 2007, NATURE, V445, P406, DOI 10.1038/nature05464; Weissburg MJ, 2002, J EXP BIOL, V205, P3387; Ishida H, 2012, IEEE SENS J, V12, P3163, DOI 10.1109/JSEN.2012.2208740; Li W, 2001, ADAPT BEHAV, V9, P143, DOI 10.1177/10597123010093003; Lilienthal AJ, 2006, SENSORS-BASEL, V6, P1616, DOI 10.3390/s6111616; Li JG, 2011, AUTON ROBOT, V30, P281, DOI 10.1007/s10514-011-9219-2; Huang L, 2009, ROBOT AUTON SYST, V57, P55, DOI 10.1016/j.robot.2008.02.005; Neumann PP, 2013, ADV ROBOTICS, V27, P725, DOI 10.1080/01691864.2013.779052; Cao ML, 2014, SENSORS-BASEL, V14, P11444, DOI 10.3390/s140711444; Carde RT, 2008, J CHEM ECOL, V34, P854, DOI 10.1007/s10886-008-9484-5; Gu D.-B., 2004, CSM404 U ESS; Gu DB, 2005, ROBOTICA, V23, P139, DOI 10.1017/S0263574704000803; Ishida H., 2008, OLFACTORY DISPLAY MU, P191; Ishida H., 2007, P IEEE INT C ROB AUT; Larionova S, 2006, AUTON ROBOT, V20, P251, DOI 10.1007/s10514-006-7099-7; Li W, 2006, IEEE T ROBOT, V22, P292, DOI 10.1109/TRO.2006.870627; Lilienthal A.J., 2004, THESIS U TUBINGEN TU; Lilienthal A.J., 2003, AUTONOME MOBILE SYST, P150; Lochmatter T., 2010, THESIS SWISS FEDERAL; Marques L, 2002, THIN SOLID FILMS, V418, P51, DOI 10.1016/S0040-6090(02)00593-X; Meng QH, 2011, SENSORS-BASEL, V11, P10415, DOI 10.3390/s111110415; Meng QH, 2012, SENSORS-BASEL, V12, P4737, DOI 10.3390/s120404737; Neumann PP, 2012, IEEE ROBOT AUTOM MAG, V19, P50, DOI 10.1109/MRA.2012.2184671; Quinn T.P., 2005, BEHAV ECOLOGY PACIFI; Sutton R. S., 1998, REINFORCEMENT LEARNI, V1; Zhang JW, 2004, ROBOT AUTON SYST, V47, P117, DOI 10.1016/j.robot.2004.03.006	31	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1424-8220			SENSORS-BASEL	Sensors	APR	2015	15	4					7512	7536		10.3390/s150407512		25	Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation	Chemistry; Electrochemistry; Instruments & Instrumentation	CH7SE	WOS:000354236100021		
J	Yamada, A; Mohri, S; Nakamura, M; Naruse, K				Yamada, Akira; Mohri, Satoshi; Nakamura, Michihiro; Naruse, Keiji			A Simple Method for Decreasing the Liquid Junction Potential in a Flow-through-Type Differential pH Sensor Probe Consisting of pH-FETs by Exerting Spatiotemporal Control of the Liquid Junction	SENSORS			English	Article							FIELD-EFFECT TRANSISTOR; REFERENCE ELECTRODES; POTASSIUM-CHLORIDE; CULTURED-CELLS; THERMODYNAMICS; POTENTIOMETRY; ELECTROLYTES; ELIMINATION; FORMULA; ISFET	The liquid junction potential (LJP), the phenomenon that occurs when two electrolyte solutions of different composition come into contact, prevents accurate measurements in potentiometry. The effect of the LJP is usually remarkable in measurements of diluted solutions with low buffering capacities or low ion concentrations. Our group has constructed a simple method to eliminate the LJP by exerting spatiotemporal control of a liquid junction (LJ) formed between two solutions, a sample solution and a baseline solution (BLS), in a flow-through-type differential pH sensor probe. The method was contrived based on microfluidics. The sensor probe is a differential measurement system composed of two ion-sensitive field-effect transistors (ISFETs) and one Ag/AgCl electrode. With our new method, the border region of the sample solution and BLS is vibrated in order to mix solutions and suppress the overshoot after the sample solution is suctioned into the sensor probe. Compared to the conventional method without vibration, our method shortened the settling time from over two min to 15 s and reduced the measurement error by 86% to within 0.060 pH. This new method will be useful for improving the response characteristics and decreasing the measurement error of many apparatuses that use LJs.	[Yamada, Akira] Aichi Inst Technol, Fac Engn, Dept Mech Engn, Toyota, Aichi 4700392, Japan; [Yamada, Akira; Mohri, Satoshi; Nakamura, Michihiro; Naruse, Keiji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Cardiovasc Physiol, Kita Ku, Okayama, Okayama 7008558, Japan; [Mohri, Satoshi] Kawasaki Med Univ, Dept Physiol 1, Kurashiki, Okayama 7010192, Japan	Yamada, A (reprint author), Aichi Inst Technol, Fac Engn, Dept Mech Engn, 1247 Yachigusa,Yakusa Cho, Toyota, Aichi 4700392, Japan.	a-yamada@aitech.ac.jp; smohri@med.kawasaki-m.ac.jp; michinak@mx4.kct.ne.jp; knaruse@md.okayama-u.ac.jp			Ministry of Education, Science, Technology, Sports and Culture [20300160, 19659451, 17390230]; Japan Society for the Promotion of Science [25820093]; Japan Science and Technology Agency [5610003472L, 12-034];  [17076006]	The authors are very grateful to T. Sekiguchi of Waseda University, T. Makino, and T. Sugiyama of Nihon Kohden Corp. for kindly providing the ISFET sensors used in the present work. The authors would like to thank S. Nomura of Horiba Ltd. for providing parts of the apparatus. Part of the present work was financially supported by a Grant-in-Aid for Scientific Research on Priority Areas, "System Cell Engineering by Multi-Scale Manipulation" (No. 17076006), Japan. This study was also partly supported by Grants-in-Aid for Scientific Research (No. 20300160, 19659451, 17390230) from the Ministry of Education, Science, Technology, Sports and Culture, (No. 25820093) from the Japan Society for the Promotion of Science, and Research for Promoting Technological Seeds (No. 5610003472L, 12-034) from the Japan Science and Technology Agency.	Stroock AD, 2002, SCIENCE, V295, P647, DOI 10.1126/science.1066238; Rius-Ruiz FX, 2011, ANAL BIOANAL CHEM, V399, P3613, DOI 10.1007/s00216-011-4689-9; Zhang TT, 2012, ANAL CHEM, V84, P7771, DOI 10.1021/ac3011507; Sia SK, 2003, ELECTROPHORESIS, V24, P3563, DOI 10.1002/elps.200305584; BERGVELD P, 1970, IEEE T BIO-MED ENG, VBM17, P70, DOI 10.1109/TBME.1970.4502688; Bergveld P, 2003, SENSOR ACTUAT B-CHEM, V88, P1, DOI 10.1016/S0925-4005(02)00301-5; Bjerrum N, 1905, Z PHYS CHEM-STOCH VE, V53, P428; Bjerrum N, 1911, Z ELKTROCHEM ANGEW P, V17, P389; Bjerrum NN, 1911, Z ELKTROCHEM ANGEW P, V17, P58; COVINGTON AK, 1983, ANALYST, V108, P1528, DOI 10.1039/an9830801528; COVINGTON AK, 1983, ION SEL ELECTRODE R, V5, P93; DOHNER RE, 1986, ANAL CHEM, V58, P2585, DOI 10.1021/ac00125a053; Fales HA, 1918, J AM CHEM SOC, V40, P1291, DOI 10.1021/ja02242a001; Guggenheim EA, 1930, J AM CHEM SOC, V52, P1315, DOI 10.1021/ja01367a004; Haber F, 1909, Z PHYS CHEM-STOCH VE, V67, P385; Helmholtz H., 1878, ANN PHYS CHEM, V3, P201, DOI 10.1002/andp.18782390204; Henderson P, 1908, Z PHYS CHEM-STOCH VE, V63, P325; Henderson P, 1907, Z PHYS CHEM-STOCH VE, V59, P118; IZUTSU K, 1991, ANAL SCI, V7, P1, DOI 10.2116/analsci.7.1; Kakiuchi T, 2011, J SOLID STATE ELECTR, V15, P1661, DOI 10.1007/s10008-011-1373-0; Lamb AB, 1920, J AM CHEM SOC, V42, P229, DOI 10.1021/ja01447a004; MacInnes DA, 1921, J AM CHEM SOC, V43, P2563, DOI 10.1021/ja01445a011; Matsuura K, 2013, SENSORS-BASEL, V13, P2484, DOI 10.3390/s130202484; Mohri S., 2007, IEEJ T SM, V127, P367, DOI 10.1541/ieejsmas.127.367; Mohri S, 2008, SENSOR ACTUAT B-CHEM, V134, P447, DOI 10.1016/j.snb.2008.05.021; Mohri S, 2006, SENSOR ACTUAT B-CHEM, V115, P519, DOI 10.1016/j.snb.2005.10.029; NAKATSUKA T, 1988, B CHEM SOC JPN, V61, P799, DOI 10.1246/bcsj.61.799; Negbauer W., 1891, ANN PHYS CHEM, V44, P737, DOI [10.1002/andp.18912801211, DOI 10.1002/ANDP.18912801211]; Nernst W., 1888, Z PHYS CHEM, V2, P613; Nernst W., 1889, Z PHYS CHEM, VIV, P129; Ogata K, 2009, MODERN CONTROL ENG, V5th, P159; PICKNETT RG, 1968, T FARADAY SOC, V64, P1059, DOI 10.1039/tf9686401059; Planck M, 1890, ANN PHYS CHEM, V39, P161, DOI DOI 10.1002/ANDP.18902750202; Planck M., 1890, ANN PHYS CHEM, V276, P561, DOI DOI 10.1002/ANDP.18902760802; Scatchard G., 1931, Journal of the American Chemical Society, V53, DOI 10.1021/ja01353a021; Scatchard G, 1925, J AM CHEM SOC, V47, P696, DOI 10.1021/ja01680a015; Shibata M, 2011, ANAL CHEM, V83, P164, DOI 10.1021/ac1021216; Shibata M, 2010, ANAL SCI, V26, P1203, DOI 10.2116/analsci.26.1203; Tower O. F., 1895, Z PHYS CHEM, V18, P17; Tower O. F., 1896, Z PHYS CHEM, V20, P198; Yamada A., 2011, IEEJ T EIS, V131, P1535, DOI [10.1541/ieejeiss.131.1535, DOI 10.1541/IEEJEISS.131.1535]; Yamada A, 2010, SENSOR ACTUAT B-CHEM, V143, P464, DOI 10.1016/j.snb.2009.09.045; Yamada Akira, 2010, J ROBOTICS MECHATRON, V22, P197	43	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1424-8220			SENSORS-BASEL	Sensors	APR	2015	15	4					7898	7912		10.3390/s150407898		15	Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation	Chemistry; Electrochemistry; Instruments & Instrumentation	CH7SE	WOS:000354236100040		
J	Akamatsu, T; Itoh, T; Izu, N; Shin, W; Sato, K				Akamatsu, Takafumi; Itoh, Toshio; Izu, Noriya; Shin, Woosuck; Sato, Kazuo			Sensing Properties of Pd-Loaded Co3O4 Film for a ppb-Level NO Gas Sensor	SENSORS			English	Article							EXHALED NITRIC-OXIDE; BREATH HYDROGEN; CHILDREN; METHANE; WO3	We prepared 0.1 wt%-30 wt% Pd-loaded Co3O4 by a colloidal mixing method and investigated the sensing properties of a Pd-loaded Co3O4 sensor element, such as the sensor response, 90% response time, 90% recovery time, and signal-to-noise (S/N) ratio, toward low nitric oxide (NO) gas levels in the range from 50 to 200 parts per billion. The structural properties of the Pd-loaded Co3O4 powder were investigated using X-ray diffraction analysis and transmission electron microscopy. Pd in the powder existed as PdO. The sensor elements with 0.1 wt%-10 wt% Pd content have higher sensor properties than those without any Pd content. The response of the sensor element with a 30 wt% Pd content decreased markedly because of the aggregation and poor dispersibility of the PdO particles. High sensor response and S/N ratio toward the NO gas were achieved when a sensor element with 10 wt% Pd content was used.	[Akamatsu, Takafumi; Itoh, Toshio; Izu, Noriya; Shin, Woosuck] Natl Inst Adv Ind Sci & Technol, Inorgan Funct Mat Res Inst, Moriyama Ku, Nagoya, Aichi 4638560, Japan; [Sato, Kazuo] Aichi Inst Technol, Dept Mech Engn, Toyota 4700392, Japan	Akamatsu, T (reprint author), Natl Inst Adv Ind Sci & Technol, Inorgan Funct Mat Res Inst, Moriyama Ku, 2266-98 Anagahora, Nagoya, Aichi 4638560, Japan.	t-akamatsu@aist.go.jp; itoh-toshio@aist.go.jp; n-izu@aist.go.jp; w.shin@aist.go.jp; sato@aitech.ac.jp	Izu, Noriya/C-5674-2014	Izu, Noriya/0000-0001-5063-1415	"Development Project for Extremely-Early Stage Diagnostics Technologies for Human Diseases" of Aichi Prefecture, Japan	This work was supported in part by the "Development Project for Extremely-Early Stage Diagnostics Technologies for Human Diseases" of Aichi Prefecture, Japan.	Slutsky AS, 1999, AM J RESP CRIT CARE, V160, P2104; Shin W, 2014, ANAL BIOANAL CHEM, V406, P3931, DOI 10.1007/s00216-013-7606-6; Wang XS, 2000, SENSOR ACTUAT B-CHEM, V66, P74, DOI 10.1016/S0925-4005(99)00410-4; Akamatsu T, 2013, SENSORS-BASEL, V13, P12467, DOI 10.3390/s130912467; Roberge MT, 2004, J CHROMATOGR A, V1027, P19, DOI 10.1016/j.chroma.2003.08.083; FONTIJN A, 1970, ANAL CHEM, V42, P575, DOI 10.1021/ac60288a034; AKIYAMA M, 1991, CHEM LETT, P1611, DOI 10.1246/cl.1991.1611; Penza M, 1998, SENSOR ACTUAT B-CHEM, V50, P52, DOI 10.1016/S0925-4005(98)00156-7; Wetchakun K, 2011, SENSOR ACTUAT B-CHEM, V160, P580, DOI 10.1016/j.snb.2011.08.032; Lin CY, 2010, SENSOR ACTUAT B-CHEM, V146, P28, DOI 10.1016/j.snb.2010.02.040; Behall KM, 1998, J NUTR, V128, P79; Fruhberger B, 2001, SENSOR ACTUAT B-CHEM, V76, P226, DOI 10.1016/S0925-4005(01)00572-X; Fucks P., 2010, INT J CANCER, V126, P2663; Grzelewski T, 2011, NITRIC OXIDE-BIOL CH, V25, P288, DOI 10.1016/j.niox.2011.05.004; ISHIHARA T, 1989, SENSOR ACTUATOR, V19, P259, DOI 10.1016/0250-6874(89)87078-7; KAISER H, 1965, Z ANAL CHEM FRESENIU, V209, P1; Itoh T, 2013, SENSOR ACTUAT B-CHEM, V187, P135, DOI 10.1016/j.snb.2012.09.097; MATSUSHIMA S, 1989, CHEM LETT, P1651, DOI 10.1246/cl.1989.1651; Saito J, 2004, J ALLERGY CLIN IMMUN, V114, P512, DOI 10.1016/j.jaci.2004.05.033; Sun CH, 2013, SENSOR ACTUAT B-CHEM, V186, P117, DOI 10.1016/j.snb.2013.05.090	20	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1424-8220			SENSORS-BASEL	Sensors	APR	2015	15	4					8109	8120		10.3390/s150408109		12	Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation	Chemistry; Electrochemistry; Instruments & Instrumentation	CH7SE	WOS:000354236100052		
J	Pan, SW; Shi, LW; Guo, SX				Pan, Shaowu; Shi, Liwei; Guo, Shuxiang			A Kinect-Based Real-Time Compressive Tracking Prototype System for Amphibious Spherical Robots	SENSORS			English	Article							VISUAL TRACKING; OBJECT TRACKING; VIDEO	A visual tracking system is essential as a basis for visual servoing, autonomous navigation, path planning, robot-human interaction and other robotic functions. To execute various tasks in diverse and ever-changing environments, a mobile robot requires high levels of robustness, precision, environmental adaptability and real-time performance of the visual tracking system. In keeping with the application characteristics of our amphibious spherical robot, which was proposed for flexible and economical underwater exploration in 2012, an improved RGB-D visual tracking algorithm is proposed and implemented. Given the limited power source and computational capabilities of mobile robots, compressive tracking (CT), which is the effective and efficient algorithm that was proposed in 2012, was selected as the basis of the proposed algorithm to process colour images. A Kalman filter with a second-order motion model was implemented to predict the state of the target and select candidate patches or samples for the CT tracker. In addition, a variance ratio features shift (VR-V) tracker with a Kalman estimation mechanism was used to process depth images. Using a feedback strategy, the depth tracking results were used to assist the CT tracker in updating classifier parameters at an adaptive rate. In this way, most of the deficiencies of CT, including drift and poor robustness to occlusion and high-speed target motion, were partly solved. To evaluate the proposed algorithm, a Microsoft Kinect sensor, which combines colour and infrared depth cameras, was adopted for use in a prototype of the robotic tracking system. The experimental results with various image sequences demonstrated the effectiveness, robustness and real-time performance of the tracking system.	[Pan, Shaowu; Shi, Liwei; Guo, Shuxiang] Beijing Inst Technol, Sch Life Sci, Inst Adv Biomed Engn Syst, Beijing 100081, Peoples R China; [Pan, Shaowu; Shi, Liwei; Guo, Shuxiang] Beijing Inst Technol, Minist Ind & Informat Technol, Key Lab Convergence Med Engn Syst & Healthcare Te, Beijing 100081, Peoples R China; [Guo, Shuxiang] Kagawa Univ, Fac Engn, Takamatsu, Kagawa 7608521, Japan	Shi, LW (reprint author), Beijing Inst Technol, Sch Life Sci, Inst Adv Biomed Engn Syst, 5 Zhongguancun South St, Beijing 100081, Peoples R China.	panshaowu.hit@gmail.com; shiliwei@bit.edu.cn; guoshuxiang@bit.edu.cn			Excellent Young Scholars Research Fund of Beijing Institute of Technology; Basic Research Fund of the Beijing Institute of Technology [3160012211405]; National Natural Science Foundation of China [61375094]; Key Research Program of the Natural Science Foundation of Tian-jin [13JCZDJC26200]; National High Tech. Research and Development Program of China [2015AA043202]	This work was supported by the Excellent Young Scholars Research Fund of Beijing Institute of Technology and the Basic Research Fund of the Beijing Institute of Technology (No. 3160012211405). This research project was also partly supported by National Natural Science Foundation of China (61375094), Key Research Program of the Natural Science Foundation of Tian-jin (13JCZDJC26200) and National High Tech. Research and Development Program of China (No.2015AA043202). Ping Guo and Yanlin He fabricated the amphibious spherical robot used in this paper and helped to conduct the experiments.	Ross DA, 2008, INT J COMPUT VISION, V77, P125, DOI 10.1007/s11263-007-0075-7; Zhang KH, 2014, IEEE T PATTERN ANAL, V36, P2002, DOI 10.1109/TPAMI.2014.2315808; Collins RT, 2005, IEEE T PATTERN ANAL, V27, P1631, DOI 10.1109/TPAMI.2005.205; Salti S, 2012, IEEE T IMAGE PROCESS, V21, P4334, DOI 10.1109/TIP.2012.2206035; Babenko B, 2011, IEEE T PATTERN ANAL, V33, P1619, DOI 10.1109/TPAMI.2010.226; Guo SX, 2012, ROBOT AUTON SYST, V60, P1472, DOI 10.1016/j.robot.2012.07.013; Wu Y, 2013, PROC CVPR IEEE, P2411, DOI 10.1109/CVPR.2013.312; Han JG, 2013, IEEE T CYBERNETICS, V43, P1318, DOI 10.1109/TCYB.2013.2265378; Avidan S, 2004, IEEE T PATTERN ANAL, V26, P1064, DOI 10.1109/TPAMI.2004.53; Shi LW, 2013, J BIONIC ENG, V10, P446, DOI 10.1016/S1672-6529(13)60248-6; Shi Q, 2013, BIOINSPIR BIOMIM, V8, DOI 10.1088/1748-3182/8/4/046002; Spinello L, 2011, IEEE INT C INT ROBOT, P3838, DOI 10.1109/IROS.2011.6048835; Bischoff B, 2012, 2012 12TH INTERNATIONAL CONFERENCE ON CONTROL, AUTOMATION, ROBOTICS & VISION (ICARCV), P347, DOI 10.1109/ICARCV.2012.6485183; Capi G., 2010, P IEEE INT WORKSH RO, V22, P1; Chen XL, 2013, PROCEEDINGS OF THE 2013 20TH IEEE INTERNATIONAL SYMPOSIUM ON THE PHYSICAL & FAILURE ANALYSIS OF INTEGRATED CIRCUITS (IPFA 2013), P504; Fabian J, 2014, IEEE-ASME T MECH, V19, P249, DOI 10.1109/TMECH.2012.2228010; Guo Shuxiang, 2012, P 2012 ICME INT C CO, P758; Gupta M., 2014, IEEE SYST J, P1; Lin R., 2013, P IEEE INT C ROB BIO, P2499; Liu JF, 2013, COMPUT MED IMAG GRAP, V37, P207, DOI 10.1016/j.compmedimag.2013.01.010; Liu Q, 2014, IET COMPUT VIS, V8, P419, DOI 10.1049/iet-cvi.2013.0134; Liu Yanfei, 2014, Advanced Materials Research, V1003, DOI 10.4028/www.scientific.net/AMR.1003.207; Oonishi S, 2013, PROC SICE ANN CONF, P2266; Pan S., 2014, P IEEE INT C MECH AU, P150; Pirzada N, 2014, PROCD SOC BEHV, V129, P422, DOI 10.1016/j.sbspro.2014.03.696; Prats M, 2012, IEEE INT C INT ROBOT, P106, DOI 10.1109/IROS.2012.6385792; Qi Y., 2011, P 3 CHIN C INT VIS S, P77; Ren HL, 2014, IEEE T AUTOM SCI ENG, V11, P921, DOI 10.1109/TASE.2013.2283775; Shi Q., 2014, IEEE-ASME T MECH, P1; Siradjuddin I., 2012, P INT JOINT C NEUR N, P1; Smisek J., 2011, P IEEE INT C COMP VI, P1154; Song S., 2013, P IEEE INT C COMP VI, P233; Tang S., 2012, P 11 AS C COMP VIS, P525; Wang HS, 2011, IEEE INT C INT ROBOT, P2959; Wang K., 2014, P IEEE RSJ INT C INT, P767; Wang K, 2014, IEEE T ROBOT, V30, P1026, DOI 10.1109/TRO.2014.2317891; Wang P., 2014, INT J MODEL SIMUL SC, V5, P13; Wang P., 2014, P IEEE 4 ANN INT C C, P55; Wirbel E, 2013, IEEE INT C NETW SENS, P678, DOI 10.1109/ICNSC.2013.6548820; XU R, 2013, P 2 IAPR AS C PATT R, P692; Yan QS, 2014, IET COMPUT VIS, V8, P305, DOI 10.1049/iet-cvi.2013.0095; Zhang K., 2012, P EUR C COMP VIS, V7574, P864; Zhang MH, 2013, NEUROCOMPUTING, V122, P163, DOI 10.1016/j.neucom.2013.05.041	43	2	2	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1424-8220			SENSORS-BASEL	Sensors	APR	2015	15	4					8232	8252		10.3390/s150408232		21	Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation	Chemistry; Electrochemistry; Instruments & Instrumentation	CH7SE	WOS:000354236100060		
J	Guo, SX; Pang, MY; Gao, BF; Hirata, H; Ishihara, H				Guo, Shuxiang; Pang, Muye; Gao, Baofeng; Hirata, Hideyuki; Ishihara, Hidenori			Comparison of sEMG-Based Feature Extraction and Motion Classification Methods for Upper-Limb Movement	SENSORS			English	Article							PATTERN-RECOGNITION; JOINT MOMENTS; EMG SIGNALS; MUSCLE; SENSOR; SYSTEM	The surface electromyography (sEMG) technique is proposed for muscle activation detection and intuitive control of prostheses or robot arms. Motion recognition is widely used to map sEMG signals to the target motions. One of the main factors preventing the implementation of this kind of method for real-time applications is the unsatisfactory motion recognition rate and time consumption. The purpose of this paper is to compare eight combinations of four feature extraction methods (Root Mean Square (RMS), Detrended Fluctuation Analysis (DFA), Weight Peaks (WP), and Muscular Model (MM)) and two classifiers (Neural Networks (NN) and Support Vector Machine (SVM)), for the task of mapping sEMG signals to eight upper-limb motions, to find out the relation between these methods and propose a proper combination to solve this issue. Seven subjects participated in the experiment and six muscles of the upper-limb were selected to record sEMG signals. The experimental results showed that NN classifier obtained the highest recognition accuracy rate (88.7%) during the training process while SVM performed better in real-time experiments (85.9%). For time consumption, SVM took less time than NN during the training process but needed more time for real-time computation. Among the four feature extraction methods, WP had the highest recognition rate for the training process (97.7%) while MM performed the best during real-time tests (94.3%). The combination of MM and NN is recommended for strict real-time applications while a combination of MM and SVM will be more suitable when time consumption is not a key requirement.	[Guo, Shuxiang; Gao, Baofeng] Beijing Inst Technol, Sch Life Sci & Technol, Inst Adv Biomed Engn Syst, Beijing 100081, Peoples R China; [Guo, Shuxiang; Gao, Baofeng] Beijing Inst Technol, Sch Life Sci & Technol, Minist Ind & Informat Technol, Key Lab Convergence Med Engn Syst & Healthcare Te, Beijing 100081, Peoples R China; [Guo, Shuxiang; Pang, Muye; Hirata, Hideyuki; Ishihara, Hidenori] Kagawa Univ, Fac Engn, Takamatsu, Kagawa 7610369, Japan	Pang, MY (reprint author), Kagawa Univ, Fac Engn, Hayashi Cho, Takamatsu, Kagawa 7610369, Japan.	guoshuxiang@hotmail.com; s12d504@stmail.eng.kagawa-u.ac.jp; gaobaofeng@bit.edu.cn; hhirata@eng.kagawa-u.ac.jp; ishihara@eng.kagawa-u.ac.jp			National Natural Science Foundation of China [61375094]; Key Research Program of the Natural Science Foundation of Tianjin [13JCZDJC26200]; National High Tech. Research and Development Program of China [2015AA043202]; SPS KAKENHI [15K2120]	This research is partly supported by National Natural Science Foundation of China (61375094), Key Research Program of the Natural Science Foundation of Tianjin (13JCZDJC26200), National High Tech. Research and Development Program of China (No. 2015AA043202), and SPS KAKENHI Grant Number 15K2120.	Fukuda O, 2003, IEEE T ROBOTIC AUTOM, V19, P210, DOI 10.1109/TRA.2003.808873; Alkan A, 2012, EXPERT SYST APPL, V39, P44, DOI 10.1016/j.eswa.2011.06.043; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; Rafiee J, 2011, EXPERT SYST APPL, V38, P4058, DOI 10.1016/j.eswa.2010.09.068; Song ZB, 2012, 2012 INTERNATIONAL SYMPOSIUM ON MICRO-NANOMECHATRONICS AND HUMAN SCIENCE (MHS), P425; Manal K, 2003, J BIOMECH, V36, P1197, DOI 10.1016/S0021-9290(03)00152-0; Chen X, 2013, BIOMED SIGNAL PROCES, V8, P184, DOI 10.1016/j.bspc.2012.08.005; Liarokapis MV, 2012, 2012 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION (ICRA), P2287, DOI 10.1109/ICRA.2012.6225047; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Zhang X, 2011, IEEE T SYST MAN CY A, V41, P1064, DOI 10.1109/TSMCA.2011.2116004; Ju ZJ, 2013, IEEE SENS J, V13, P3302, DOI 10.1109/JSEN.2013.2259051; Young AJ, 2013, IEEE T BIO-MED ENG, V60, P1250, DOI 10.1109/TBME.2012.2232293; HUXLEY AF, 1971, NATURE, V233, P533, DOI 10.1038/233533a0; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Artemiadis P.K., 2010, IEEE T SYST MAN CY B, V41, P53; Balbinot A, 2013, SENSORS-BASEL, V13, P2613, DOI 10.3390/s130202613; Bishop C.M., 2006, PATTERN RECOGN, P325; Buchanan TS, 2004, J APPL BIOMECH, V20, P367; Cavallaro E., 2005, P IEEE INT C ROB AUT, P4525; Chang C-C, 2011, ACM T INTEL SYST TEC, V2, P3, DOI DOI 10.1145/1961189.1961199; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255; Lew H.L., 2007, JOHNSONS PRACTICAL E, P156; Naik G. R., 2012, J MECH MED BIOL, V12, P1; Naik GR, 2015, IEEE J BIOMED HEALTH, V19, P478, DOI 10.1109/JBHI.2014.2326660; Naik GR, 2012, J MED SYST, V36, P841, DOI 10.1007/s10916-010-9548-2; Naik GR, 2014, EXPERT SYST, V31, P91, DOI 10.1111/exsy.12008; Pang M., 2015, J MED BIOL IN PRESS; Pang M., 2012, J ROBOTICS MECHATRON, V24, P585; Pang M., 2012, P 2012 IEEE INT C ME, P1984; Platt J.C, 1998, ADV KERNEL METHODS S, P185; Shibanoki T, 2013, IEEE T BIO-MED ENG, V60, P853, DOI 10.1109/TBME.2012.2205990; Tang XY, 2012, SENSORS-BASEL, V12, P1130, DOI 10.3390/s120201130	32	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1424-8220			SENSORS-BASEL	Sensors	APR	2015	15	4					9022	9038		10.3390/s150409022		17	Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation	Chemistry; Electrochemistry; Instruments & Instrumentation	CH7SE	WOS:000354236100103		
J	Kinoshita, T				Kinoshita, Tetsuo			Basic Characteristics of a Macroscopic Measure for Detecting Abnormal Changes in a Multiagent System	SENSORS			English	Article							NETWORKS; PATTERNS; MODELS	Multiagent application systems must deal with various changes in both the system and the system environment at runtime. Generally, such changes have undesirable negative effects on the system. To manage and control the system, it is important to observe and detect negative effects using an appropriate observation function of the system's behavior. This paper focuses on the design of this function and proposes a new macroscopic measure with which to observe behavioral characteristics of a runtime multiagent system. The proposed measure is designed as the variance of fluctuation of a macroscopic activity factor of the whole system, based on theoretical analysis of the macroscopic behavioral model of a multiagent system. Experiments are conducted to investigate basic characteristics of the proposed measure, using a test bed system. The results of experiments show that the proposed measure reacts quickly and increases drastically in response to abnormal changes in the system. Hence, the proposed measure is considered a measure that can be used to detect undesirable changes in a multiagent system.	Tohoku Univ, Elect Commun Res Inst, Aoba Ku, Sendai, Miyagi 9808577, Japan	Kinoshita, T (reprint author), Tohoku Univ, Elect Commun Res Inst, Aoba Ku, Katahira 2-1-1, Sendai, Miyagi 9808577, Japan.	kino@riec.tohoku.ac.jp					AMARI SI, 1971, PR INST ELECTR ELECT, V59, P35, DOI 10.1109/PROC.1971.8087; Kim HM, 2012, ENERGIES, V5, P3347, DOI 10.3390/en5093347; Franch X, 2006, LECT NOTES COMPUT SC, V4001, P495; Uchiya T, 2011, TRANSDISCIPLINARY ADVANCEMENTS IN COGNITIVE MECHANISMS AND HUMAN INFORMATION PROCESSING, P60, DOI 10.4018/978-1-60960-553-7.ch004; Rahimian MA, 2013, AUTOMATICA, V49, P3149, DOI 10.1016/j.automatica.2013.06.023; Mani N, 2010, INT J ARTIF INTELL T, V19, P417, DOI 10.1142/S0218213010000261; Kaindl H, 2013, IEEE T SYST MAN CY-S, V43, P164, DOI 10.1109/TSMCA.2012.2192922; Suganuma T, 2003, IEEE T SYST MAN CY A, V33, P633, DOI 10.1109/TSMCA.2003.817376; Balchanos M., 2012, Proceedings of the 2012 5th International Symposium on Resilient Control Systems (ISRCS), DOI 10.1109/ISRCS.2012.6309310; Ferguson P., 2011, QUALITY SERVICE DELI; Gutierrez C, 2011, ENG APPL ARTIF INTEL, V24, P103, DOI 10.1016/j.engappai.2010.09.004; Gutierrez C, 2011, J SYST SOFTWARE, V84, P1563, DOI 10.1016/j.jss.2011.03.023; Haken H, 1978, SYNERGETICS INTRO, V3rd; Reif F, 1965, FUNDAMENTALS STAT TH; Sasai K, 2010, Proceedings of the 2010 International Conference on Broadband, Wireless Computing, Communication and Applications (BWCCA 2010), DOI 10.1109/BWCCA.2010.172; Takahashi A., 2011, INT J WEB INTELL AGE, V9, P161; Takahashi A., 2012, P 2012 IEEE WIC ACM, P64; MING CW, 1945, REV MOD PHYS, V17, P323, DOI 10.1103/RevModPhys.17.323; Yu H., 2013, IEEE ACCESS, V1, P35; Yuan E, 2014, ACM T AUTON ADAP SYS, V8, DOI 10.1145/2555611	20	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1424-8220			SENSORS-BASEL	Sensors	APR	2015	15	4					9112	9135		10.3390/s150409112		24	Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation	Chemistry; Electrochemistry; Instruments & Instrumentation	CH7SE	WOS:000354236100107		
J	Yaku, H; Murashima, T; Miyoshi, D; Sugimoto, N				Yaku, Hidenobu; Murashima, Takashi; Miyoshi, Daisuke; Sugimoto, Naoki			A mRNA-Responsive G-Quadruplex-Based Drug Release System	SENSORS			English	Article							ALBUMIN-BOUND PACLITAXEL; G-QUARTET FORMATION; HUMAN TELOMERE; BREAST-CANCER; K+ SOLUTION; IN-VITRO; DNA; BINDING; CARCINOGENESIS; LIGANDS	G-quadruplex-based drug delivery carriers (GDDCs) were designed to capture and release a telomerase inhibitor in response to a target mRNA. Hybridization between a loop on the GDDC structure and the mRNA should cause the G-quadruplex structure of the GDDC to unfold and release the bound inhibitor, anionic copper(II) phthalocyanine (CuAPC). As a proof of concept, GDDCs were designed with a 10-30-mer loop, which can hybridize with a target sequence in epidermal growth factor receptor (EGFR) mRNA. Structural analysis using circular dichroism (CD) spectroscopy showed that the GDDCs form a (3 + 1) type G-quadruplex structure in 100 mM KCl and 10 mM MgCl2 in the absence of the target RNA. Visible absorbance titration experiments showed that the GDDCs bind to CuAPC with K-a values of 1.5 x 10(5) to 5.9 x 10(5) M-1 (K-d values of 6.7 to 1.7 mu M) at 25 degrees C, depending on the loop length. Fluorescence titration further showed that the G-quadruplex structure unfolds upon binding to the target RNA with K-a values above 1.0 x 10(8) M-1 (K-d values below 0.01 mu M) at 25 degrees C. These results suggest the carrier can sense and bind to the target RNA, which should result in release of the bound drug. Finally, visible absorbance titration experiments demonstrated that the GDDC release CuAPC in response to the target RNA.	[Yaku, Hidenobu] Panasonic Corp, Adv Res Div, Seika, Kyoto 6190237, Japan; [Murashima, Takashi; Miyoshi, Daisuke; Sugimoto, Naoki] Konan Univ, Fac Frontiers Innovat Res Sci & Technol FIRST, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Sugimoto, Naoki] Konan Univ, Frontier Inst Biomol Engn Res, Chuo Ku, Kobe, Hyogo 6500047, Japan	Miyoshi, D (reprint author), Konan Univ, Fac Frontiers Innovat Res Sci & Technol FIRST, Chuo Ku, 7-1-20 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	yaku.hidenobu@jp.panasonic.com; murasima@konan-u.ac.jp; miyoshi@center.konan-u.ac.jp; sugimoto@konan-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [2306]; "Strategic Research Foundation at Private Universities" from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Kurata Grants from the Kurata Memorial Hitachi Science and Technology Foundation	We thank Chieko Hijiriyama for measuring the CD spectra and UV melting curves of HteloDNA and the GDDCs, and conducting the binding assays between rEGFR and the GDDCs. This work was supported by Grants-in-Aid for Scientific Research, Scientific Research on Innovative Areas "Nanomedicine Molecular Science" (No. 2306), and "Strategic Research Foundation at Private Universities" from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and Kurata Grants from the Kurata Memorial Hitachi Science and Technology Foundation.	Feron O, 2009, RADIOTHER ONCOL, V92, P329, DOI 10.1016/j.radonc.2009.06.025; Georgiades SN, 2010, ANGEW CHEM INT EDIT, V49, P4020, DOI 10.1002/anie.200906363; Neidle S, 2008, BIOCHIMIE, V90, P1184, DOI 10.1016/j.biochi.2008.03.003; Nicoludis JM, 2012, J AM CHEM SOC, V134, P20446, DOI 10.1021/ja3088746; De Cian A, 2008, BIOCHIMIE, V90, P131, DOI 10.1016/j.biochi.2007.07.011; Travascio P, 1999, CHEM BIOL, V6, P779, DOI 10.1016/S1074-5521(99)80125-2; GRANDIS JR, 1993, CANCER RES, V53, P3579; Krishnan Y, 2011, ANGEW CHEM INT EDIT, V50, P3124, DOI 10.1002/anie.200907223; Collie GW, 2012, J AM CHEM SOC, V134, P2723, DOI 10.1021/ja2102423; Bazzicalupi C, 2013, NUCLEIC ACIDS RES, V41, P632, DOI 10.1093/nar/gks1001; Hofheinz RD, 2005, ANTI-CANCER DRUG, V16, P691, DOI 10.1097/01.cad.0000167902.53039.5a; Gradishar WJ, 2005, J CLIN ONCOL, V23, P7794, DOI 10.1200/JCO.2005.04.937; Chung WJ, 2013, J AM CHEM SOC, V135, P13495, DOI 10.1021/ja405843r; Mergny JL, 1998, FEBS LETT, V435, P74, DOI 10.1016/S0014-5793(98)01043-6; Phan AT, 2005, NAT CHEM BIOL, V1, P167, DOI 10.1038/nchembio723; Fang JS, 2008, SEMIN CANCER BIOL, V18, P330, DOI 10.1016/j.semcancer.2008.03.011; Desai N, 2006, CLIN CANCER RES, V12, P1317, DOI 10.1158/1078-0432.CCR-05-1634; Luu KN, 2006, J AM CHEM SOC, V128, P9963, DOI 10.1021/ja062791w; Bourdoncle A, 2006, J AM CHEM SOC, V128, P11094, DOI 10.1021/ja0608040; Brahimi-Horn MC, 2007, FEBS LETT, V581, P3582, DOI 10.1016/j.febsict.2007.06.018; Bath J, 2007, NAT NANOTECHNOL, V2, P275, DOI 10.1038/nnano.2007.104; Beissenhirtz MK, 2006, ORG BIOMOL CHEM, V4, P3392, DOI 10.1039/b607033g; Mergny JL, 2001, CHEMBIOCHEM, V2, P124, DOI 10.1002/1439-7633(20010202)2:2<124::AID-CBIC124>3.0.CO;2-L; Wei B, 2008, ANGEW CHEM INT EDIT, V47, P331, DOI 10.1002/anie.200704143; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; Collie GW, 2011, J AM CHEM SOC, V133, P2721, DOI 10.1021/ja109767y; Autexier C, 2006, ANNU REV BIOCHEM, V75, P493, DOI 10.1146/annurev.biochem.75.103004.142412; Miele E, 2009, INT J NANOMED, V4, P99; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; Dittmer WU, 2004, ANGEW CHEM INT EDIT, V43, P3550, DOI 10.1002/anie.200353537; Ou TM, 2008, CHEMMEDCHEM, V3, P690, DOI 10.1002/cmdc.200700300; Danhier F, 2010, J CONTROL RELEASE, V148, P135, DOI 10.1016/j.jconrel.2010.08.027; Ambrus A, 2006, NUCLEIC ACIDS RES, V34, P2723, DOI 10.1093/nar/gkl348; Franceschin M, 2009, EUR J ORG CHEM, P2225, DOI 10.1002/ejoc.200801196; Chen CE, 2011, NUCLEIC ACIDS RES, V39, P1638, DOI 10.1093/nar/gkq893; Theimer CA, 2006, CURR OPIN STRUC BIOL, V16, P307, DOI 10.1016/j.sbi.2006.05.005; Xu Y, 2006, BIOORGAN MED CHEM, V14, P5584, DOI 10.1016/j.bmc.2006.04.033; Balasubramanian S, 2009, CURR OPIN CHEM BIOL, V13, P345, DOI 10.1016/j.cbpa.2009.04.637; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Ho-Pun-Cheung A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037065; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Neidle S, 2009, CURR OPIN STRUC BIOL, V19, P239, DOI 10.1016/j.sbi.2009.04.001; Van Sluis R., 1999, RESON MED, V41, P743, DOI [10.1002/(SICI)1522-2594(199904)41:4<lessthan>743::AID-MRM13<greaterthan>3.0.CO;2-Z10332850, DOI 10.1002/(SICI)1522-2594(199904)41:4<743::AID-MRM13>3.0.CO;2-Z]; Wheelhouse RT, 1998, J AM CHEM SOC, V120, P3261, DOI 10.1021/ja973792e; Yaku H, 2014, J PHYS CHEM B, V118, P2605, DOI 10.1021/jp410669t; Yaku H, 2010, CHEM COMMUN, V46, P5740, DOI 10.1039/c0cc00956c; Yaku H, 2012, CHEM COMMUN, V48, P6203, DOI 10.1039/c2cc31037f; Yaku H, 2012, MOLECULES, V17, P10586, DOI 10.3390/molecules170910586; Yaku H, 2013, METHODS, V64, P19, DOI 10.1016/j.ymeth.2013.03.028; Yamauchi T, 2005, FEBS LETT, V579, P2583, DOI 10.1016/j.febslet.2005.03.074; Yu HQ, 2008, ANGEW CHEM INT EDIT, V47, P9034, DOI 10.1002/anie.200803577	51	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1424-8220			SENSORS-BASEL	Sensors	APR	2015	15	4					9388	9403		10.3390/s150409388		16	Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation	Chemistry; Electrochemistry; Instruments & Instrumentation	CH7SE	WOS:000354236100121		
J	Itoh, T; Izu, N; Akamatsu, T; Shin, W; Miki, Y; Hirose, Y				Itoh, Toshio; Izu, Noriya; Akamatsu, Takafumi; Shin, Woosuck; Miki, Yusuke; Hirose, Yasuo			Elimination of Flammable Gas Effects in Cerium Oxide Semiconductor-Type Resistive Oxygen Sensors for Monitoring Low Oxygen Concentrations	SENSORS			English	Article							THICK-FILM; ELECTRODES; LAYER; AIR; YSZ	We have investigated the catalytic layer in zirconium-doped cerium oxide, Ce0.9Zr0.1O2 (CeZr10) resistive oxygen sensors for reducing the effects of flammable gases, namely hydrogen and carbon monoxide. When the concentration of flammable gases is comparable to that of oxygen, the resistance of CeZr10 is affected by the presence of these gases. We have developed layered thick films, which consist of an oxygen sensor layer (CeZr10), an insulation layer (Al2O3), and a catalytic layer consisting of CeZr10 with 3 wt% added platinum, which was prepared via the screen printing method. The Pt-CeZr10 catalytic layer was found to prevent the detrimental effects of the flammable gases on the resistance of the sensor layer. This effect is due to the catalytic layer promoting the oxidation of hydrogen and carbon monoxide through the consumption of ambient O-2 and/or the lattice oxygen atoms of the Pt-CeZr10 catalytic layer.	[Itoh, Toshio; Izu, Noriya; Akamatsu, Takafumi; Shin, Woosuck] Natl Inst Adv Ind Sci & Technol, Moriyama Ku, Nagoya, Aichi 4638560, Japan; [Miki, Yusuke; Hirose, Yasuo] Taiyo Nippon Sanso Corp, Tsukuba, Ibaraki 3002611, Japan	Itoh, T (reprint author), Natl Inst Adv Ind Sci & Technol, Moriyama Ku, Nagoya, Aichi 4638560, Japan.	itoh-toshio@aist.go.jp; n-izu@aist.go.jp; t-akamatsu@aist.go.jp; w.shin@aist.go.jp; Yusuke.Miki@tn-sanso.co.jp; Yasuo.Hirose@tn-sanso.co.jp	Izu, Noriya/C-5674-2014	Izu, Noriya/0000-0001-5063-1415	Adaptable and Seamless Technology Transfer Program (A-STEP) through target-driven RD, JST	This work was supported in part by Adaptable and Seamless Technology Transfer Program (A-STEP) through target-driven R&D, JST. The authors thank M. Yoshimura (Taiyo Nippon Sanso) and H. Nakano (AIST) for their experimental assistances.	Plashnitsa VV, 2009, ELECTROCHIM ACTA, V54, P6099, DOI 10.1016/j.electacta.2008.12.040; Itoh T, 2015, CERAM INT, V41, P3631, DOI 10.1016/j.ceramint.2014.11.028; Nei L, 1996, SENSOR ACTUAT B-CHEM, V30, P83, DOI 10.1016/0925-4005(95)01754-J; Fadeyev G, 2013, INT J HYDROGEN ENERG, V38, P13484, DOI 10.1016/j.ijhydene.2013.07.094; Komachiya M, 2001, SENSOR ACTUAT B-CHEM, V73, P40, DOI 10.1016/S0925-4005(00)00670-5; Ivers-Tiffee E, 2001, ELECTROCHIM ACTA, V47, P807, DOI 10.1016/S0013-4686(01)00761-7; Inaba T, 2008, SENSOR ACTUAT B-CHEM, V129, P874, DOI 10.1016/j.snb.2007.09.075; Dunst K, 2014, METROL MEAS SYST, V21, P205, DOI 10.2478/mms-2014-0018; Han JX, 2013, ELECTROCHIM ACTA, V108, P763, DOI 10.1016/j.electacta.2013.07.005; Miura N, 2011, SENSOR ACTUAT B-CHEM, V152, P261, DOI 10.1016/j.snb.2010.12.018; Mori M, 2014, SENSOR ACTUAT B-CHEM, V191, P351, DOI 10.1016/j.snb.2013.10.005; Lopez-Gandara C, 2009, SENSOR ACTUAT B-CHEM, V140, P432, DOI 10.1016/j.snb.2009.04.066; Iio A, 2014, ELECTROCHEM COMMUN, V48, P134, DOI 10.1016/j.elecom.2014.09.004; International Organization for Standardization, 1975, 25331975 ISO; Ito K., 1993, YELLOW PHOSPHORUS LU, P12; Izu N, 2004, J ELECTROCERAM, V13, P703, DOI 10.1007/s10832-004-5179-7; Izu N, 2006, SENSOR ACTUAT B-CHEM, V113, P207, DOI 10.1016/j.snb.2005.02.049; Izu N, 2005, SENSOR ACTUAT B-CHEM, V108, P238, DOI 10.1016/j.snb.2004.11.064; OGINO H, 1995, TALANTA, V42, P305, DOI 10.1016/0039-9140(94)00248-Q; Sekharz P. K., 2014, ECS ELECTROCHEM LETT, V3, pB1, DOI [10.1149/2.005402eel, DOI 10.1149/2.005402EEL]; Takeuchi T, 2001, J ELECTROCHEM SOC, V148, pH132, DOI 10.1149/1.1388888	21	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1424-8220			SENSORS-BASEL	Sensors	APR	2015	15	4					9427	9437		10.3390/s150409427		11	Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation	Chemistry; Electrochemistry; Instruments & Instrumentation	CH7SE	WOS:000354236100123		
J	Tsuji, T; Mozos, OM; Chae, H; Pyo, Y; Kusaka, K; Hasegawa, T; Morooka, K; Kurazume, R				Tsuji, Tokuo; Mozos, Oscar Martinez; Chae, Hyunuk; Pyo, Yoonseok; Kusaka, Kazuya; Hasegawa, Tsutomu; Morooka, Ken'ichi; Kurazume, Ryo			An Informationally Structured Room for Robotic Assistance (dagger)	SENSORS			English	Article							PEOPLE TRACKING; SYSTEM	The application of assistive technologies for elderly people is one of the most promising and interesting scenarios for intelligent technologies in the present and near future. Moreover, the improvement of the quality of life for the elderly is one of the first priorities in modern countries and societies. In this work, we present an informationally structured room that is aimed at supporting the daily life activities of elderly people. This room integrates different sensor modalities in a natural and non-invasive way inside the environment. The information gathered by the sensors is processed and sent to a centralized management system, which makes it available to a service robot assisting the people. One important restriction of our intelligent room is reducing as much as possible any interference with daily activities. Finally, this paper presents several experiments and situations using our intelligent environment in cooperation with our service robot.	[Tsuji, Tokuo; Chae, Hyunuk; Pyo, Yoonseok; Kusaka, Kazuya; Morooka, Ken'ichi; Kurazume, Ryo] Kyushu Univ, Fac Informat Sci & Elect Engn, Fukuoka 8190395, Japan; [Mozos, Oscar Martinez] Lincoln Univ, Sch Comp Sci, Lincoln LN57PN, England; [Hasegawa, Tsutomu] Kumamoto Natl Coll Technol, Kumamoto 8611102, Japan	Mozos, OM (reprint author), Lincoln Univ, Sch Comp Sci, Lincoln LN57PN, England.	tsuji@ait.kyushu-u.ac.jp; omozos@lincoln.ac.uk; huchae@irvs.ait.kyushu-u.ac.jp; pyo@irvs.ait.kyushu-u.ac.jp; kusaka@irvs.ait.kyushu-u.ac.jp; hasegawa@kumamoto-nct.ac.jp; morooka@ait.kyushu-u.ac.jp; kurazume@ait.kyushu-u.ac.jp					Alexandre L.A., 2012, P IEEE RSJ INT C INT; Chen TL, 2013, IEEE ROBOT AUTOM MAG, V20, P30, DOI 10.1109/MRA.2012.2229950; Hu WM, 2006, IEEE T PATTERN ANAL, V28, P663; Kim M, 2009, IEEE ROBOT AUTOM MAG, V16, P34, DOI 10.1109/MRA.2008.931636; Ngo TT, 2014, PATTERN RECOGN, V47, P228, DOI 10.1016/j.patcog.2013.06.028; McColl D, 2013, IEEE ROBOT AUTOM MAG, V20, P74, DOI 10.1109/MRA.2012.2229939; Woo S, 2011, AUTOMAT CONSTR, V20, P3, DOI 10.1016/j.autcon.2010.07.009; Pyo Y, 2014, SENSORS-BASEL, V14, P7524, DOI 10.3390/s140407524; Murakami K, 2012, 2012 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION (ICRA), P2210, DOI 10.1109/ICRA.2012.6225329; Lee JH, 2002, ADV ROBOTICS, V16, P265, DOI 10.1163/156855302760121936; KAWAMURA K, 1994, IROS '94 - INTELLIGENT ROBOTS AND SYSTEMS: ADVANCED ROBOTIC SYSTEMS AND THE REAL WORLD, VOLS 1-3, P1647, DOI 10.1109/IROS.1994.407636; Mori T, 2004, IEEE SYS MAN CYBERN, P5271; Nugent CD, 2008, IEEE T AUTOM SCI ENG, V5, P1, DOI 10.1109/TASE.2007.912247; Hasegawa T., 2006, P 3 INT C UB ROB AMB, P119; Ikeda T., 2007, P IEEE RSJ INT C INT, P4147; Kayama K., 2003, Proceedings 2003 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS 2003) (Cat. No.03CH37453); Kim B., 2006, P IEEE RSJ INT C INT, P4809; Lauritzen S.L., 2002, THIELE PIONEER STAT; Linner T, 2015, AUTOMAT CONSTR, V51, P8, DOI 10.1016/j.autcon.2014.12.013; Maruyama K., 2010, P AS C COMP VIS ACCV; Mori T., 2005, P IEEE RSJ INT C INT, P1833; Mori T., 2008, ECCV WORKSH MULT MUL; Mozos O.M., 2013, NATURAL ARTIFICIAL M, V7930, P103; Murakami K., 2010, P IEEE RSJ INT C INT, P3712; Murakami K., 2009, J ROBOTICS MECHATRON, V21, P453; Murakami K., 2008, P IEEE INT C SENS, P705; Nakauchi Y., 2003, P 2003 IEEE RSJ INT, V1, P773, DOI 10.1109/IROS.2003.1250723; Nishida Y., 2003, P INT C INTELL ROBOT, V1, P785, DOI 10.1109/IROS.2003.1250725; Noguchi Hiroshi, 2011, SICE Journal of Control, Measurement, and System Integration, V4; Nohara Y., 2010, P IEEE RSJ INT C INT, P1030; Roy N., 2000, WORKSH INT ROB ENT W; Saffiotti A., 2005, P INT C SMART OBJ AM, P275; Shao X. S. X., 2007, P IEEE RSJ INT C INT, P2174; Steinhoff U., 2010, PERV COMP COMM PERCO, P162; Tombari F., 2010, P EUR C COMP VIS ECC; Tombari F., 2010, P 4 PAC RIM S IM VID; Tsuji T., 2010, J ROBOTICS MECHATRON, V22, P230; Utsumi A, 1998, INT C PATT RECOG, P597; Walker G, 1931, P R SOC LOND A-CONTA, V131, P518, DOI 10.1098/rspa.1931.0069; Whittle P., 1951, HYPOTHESIS TESTING T	40	1	1	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1424-8220			SENSORS-BASEL	Sensors	APR	2015	15	4					9438	9465		10.3390/s150409438		28	Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation	Chemistry; Electrochemistry; Instruments & Instrumentation	CH7SE	WOS:000354236100124		
J	Yamazaki, H; Iwano, T; Otsuka, S; Kagawa, Y; Hoshino, Y; Hosoya, K; Okumura, M; Takagi, S				Yamazaki, Hiroki; Iwano, Tomomi; Otsuka, Saori; Kagawa, Yumiko; Hoshino, Yuki; Hosoya, Kenji; Okumura, Masahiro; Takagi, Satoshi			SiRNA knockdown of the DEK nuclear protein mRNA enhances apoptosis and chemosensitivity of canine transitional cell carcinoma cells	VETERINARY JOURNAL			English	Article						DEK nuclear protein; Dog; Transitional cell carcinoma; SiRNA	URINARY-BLADDER CANCER; DRUG-RESISTANCE; ONCOGENE; EXPRESSION; INHIBITOR; MODEL; CHEMORESISTANCE; ONCOPROTEIN; PIROXICAM; BIOMARKER	Transitional cell carcinoma (TCC) in dogs is an aggressive malignant neoplasm, originating in the epithelium of the urinary bladder. The DEK nuclear protein is overexpressed in several types of human bladder cancer, where it is involved in chromatin reconstruction, gene transcription and apoptosis. Since DEK represents a potential therapeutic target for canine TCC, this study was designed to investigate DEK expression in canine TCC and to determine the effects of DEK mRNA silencing on TCC cells in vitro. The gene expression profiles of seven selected cancer-associated genes was assessed in four canine TCC cell lines and expression of DEK protein was evaluated in bladder tissue biopsies from healthy dogs and those affected with cystitis or TCC After transfection of four canine TCC cell lines with DEK-specific or scrambled siRNA, annexin V staining was performed to evaluate apoptosis, and methylthiazole tetrazolium assays were performed to assess both cell viability and sensitivity to carboplatin. DEK mRNA expression was relatively high in canine TCC cells and expression of the DEK protein was significantly greater in TCC tumours compared with the other tissue samples. After transfection-with DEK-specific siRNA, apoptosis, cell growth inhibition, and enhanced sensitivity to carboplatin were observed in all TCC cells assessed. These research findings suggest that DEK could be a potential therapeutic target for canine TCC. (C) 2015 Elsevier Ltd. All rights reserved.	[Yamazaki, Hiroki; Iwano, Tomomi; Hosoya, Kenji; Okumura, Masahiro] Hokkaido Univ, Grad Sch Vet Med, Dept Vet Clin Sci, Lab Vet Surg,Kita Ku, Sapporo, Hokkaido 0600818, Japan; [Otsuka, Saori] Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Lab Anat,Kita Ku, Sapporo, Hokkaido 0600818, Japan; [Kagawa, Yumiko] North Lab, Shiroishi Ku, Sapporo, Hokkaido 0030027, Japan; [Hoshino, Yuki; Takagi, Satoshi] Hokkaido Univ, Grad Sch Vet Med, Vet Teaching Hosp, Kita Ku, Sapporo, Hokkaido 0600818, Japan	Takagi, S (reprint author), Hokkaido Univ, Grad Sch Vet Med, Vet Teaching Hosp, Kita Ku, N18 W9, Sapporo, Hokkaido 0600818, Japan.	staka@vetmed.hokudai.ac.jp					Rankin WV, 2008, VET COMP ONCOL, V6, P141, DOI 10.1111/j.1476-5829.2007.00150.x; Liu KR, 2012, BIOSCIENCE REP, V32, P323, DOI 10.1042/BSR20100141; Carro MS, 2006, CELL CYCLE, V5, P1202, DOI 10.4161/cc.5.11.2801; Fung AS, 2012, NEOPLASIA, V14, P324, DOI 10.1593/neo.12346; Kim DW, 2009, J CELL BIOCHEM, V106, P1048, DOI 10.1002/jcb.22083; Sanchez-Carbayo M, 2003, AM J PATHOL, V163, P505, DOI 10.1016/S0002-9440(10)63679-6; Wang DM, 2012, CANCER BIOL THER, V13, P1522, DOI 10.4161/cbt.22252; Henry CJ, 2003, CLIN CANCER RES, V9, P906; Dhawan D, 2009, UROL ONCOL-SEMIN ORI, V27, P284, DOI 10.1016/j.urolonc.2008.02.015; Wise-Draper TM, 2006, MOL CELL BIOL, V26, P7506, DOI 10.1128/MCB.00430-06; Mohammed SI, 2002, CANCER RES, V62, P356; Kavanaugh GM, 2011, NUCLEIC ACIDS RES, V39, P7465, DOI 10.1093/nar/gkr454; Mutsaers AJ, 2003, J VET INTERN MED, V17, P136, DOI 10.1892/0891-6640(2003)017<0136:CTCC>2.3.CO;2; Tomiyasu H, 2010, J VET MED SCI, V72, P1165, DOI 10.1292/jvms.09-0575; Khodadoust MS, 2009, CANCER RES, V69, P6405, DOI 10.1158/0008-5472.CAN-09-1063; Bergman PJ, 2003, VET CLIN N AM-SMALL, V33, P651, DOI 10.1016/S0195-5616(03)00004-4; Boria P A, 2005, Vet Comp Oncol, V3, P73, DOI 10.1111/j.1476-5810.2005.00070.x; Chun R, 1997, J VET INTERN MED, V11, P279; Datta A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-234; Lin LJ, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-366; Matos Leandro Luongo de, 2006, Clinics (Sao Paulo), V61, P417, DOI 10.1590/S1807-59322006000500008; Riveiro-Falkenbach E, 2010, CLIN CANCER RES, V16, P2932, DOI 10.1158/1078-0432.CCR-09-2330; Secchiero P, 2010, CLIN CANCER RES, V16, P1824, DOI 10.1158/1078-0432.CCR-09-3031; Takagi S, 2005, J VET MED SCI, V67, P385, DOI 10.1292/jvms.67.385; Yamazaki H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079810	25	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1090-0233	1532-2971		VET J	Vet. J.	APR	2015	204	1					60	65		10.1016/j.tvjl.2015.02.009		6	Veterinary Sciences	Veterinary Sciences	CH3KN	WOS:000353929700010		
J	Lee, HS				Lee, Han Soo			General Rainfall Patterns in Indonesia and the Potential Impacts of Local Seas on Rainfall Intensity	WATER			English	Article							NINO SOUTHERN-OSCILLATION; TROPICAL INDIAN-OCEAN; EL-NINO; SURFACE-TEMPERATURE; SPATIAL COHERENCE; MONSOON ONSET; ENSO; VARIABILITY; PREDICTABILITY; THROUGHFLOW	The relationships between observed rainfall, El Nino/Southern Oscillation (ENSO) and sea surface temperature (SST) variations in the Pacific and Indian Oceans were analyzed using a 1 degrees latitude-longitude grid over Indonesia. The Global Summary of the Day rainfall records provide 26 years of rainfall data (January 1985 to August 2010) for 23 stations throughout the Indonesian islands. The ENSO and SST variations were calculated using the Multivariate ENSO Index (MEI), the Pacific Decadal Oscillation (PDO), NINO1 + 2, NINO3, NINO3.4, NINO4, the Dipole Mode Index (DMI) for the Indian Ocean Dipole (IOD), and Indian Ocean Basin-wide (IOBW) index. The results show that the rainfall in the southern Sumatra and southern Java Islands, which face the Indian Ocean, was positively correlated with the negative IOD, whereas the rainfall in northwestern Sumatra was positively correlated with the positive IOD. In eastern Indonesia, the rainfall was positively correlated with La Nina. The PDO index was also strongly correlated with the rainfall in this region. In central Indonesia, seasonal variations due to monsoons are predominant, and the rainfall exhibited strong negative and positive correlations with the MEI and NINO.WEST, respectively, indicating that high rainfall occurred during strong La Nina episodes. The highly negative and positive correlations with the MEI and NINO.WEST, respectively, in central Indonesia led us to analyze the impacts of Indonesian seas on the rainfall in the region. Using four synoptic-scale scenarios, we investigated the relative residence time of Indonesian seawater along the pathways associated with the Pacific-Indian hydraulic head difference. The results show that when both the western Pacific and eastern Indian Oceans are warm (positive NINO.WEST and negative DMI), the rainfall intensity over central Indonesia is strongest. This increase is explained by the relationship between the residence time of Indonesian seawater and the exposure to surface evaporation: a longer exposure of Indonesian seas results in greater seawater warming and evaporation and more convection-generated cumulus clouds.	[Lee, Han Soo] Saitama Univ, Grad Sch Sci & Engn, Sakura Ku, Saitama 3388570, Japan; [Lee, Han Soo] Saitama Univ, Int Inst Resilient Soc, Sakura Ku, Saitama 3388570, Japan	Lee, HS (reprint author), Saitama Univ, Grad Sch Sci & Engn, Sakura Ku, 255 Shimo Okubo, Saitama 3388570, Japan.	hslee@mail.saitama-u.ac.jp			MEXT, Japan [24760396]; Tenure-Track program at Saitama University	This research was supported by the Grant-in-Aid (24760396) from MEXT, Japan, and by the Tenure-Track program at Saitama University. The basic rainfall analysis was performed by a former graduate student at Hiroshima University, Tsuyoshi Ikeda, and was particularly appreciated.	Aldrian E, 2008, INT J CLIMATOL, V28, P435, DOI 10.1002/joc.1543; Hamada JI, 2002, J METEOROL SOC JPN, V80, P285, DOI 10.2151/jmsj.80.285; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Hendon HH, 2003, J CLIMATE, V16, P1775, DOI 10.1175/1520-0442(2003)016<1775:IRVIOE>2.0.CO;2; Haylock M, 2001, J CLIMATE, V14, P3882, DOI 10.1175/1520-0442(2001)014<3882:SCAPOI>2.0.CO;2; Cane MA, 2001, NATURE, V411, P157, DOI 10.1038/35075500; SMITH WHF, 1990, GEOPHYSICS, V55, P293, DOI 10.1190/1.1442837; Ropelewski CF, 1989, J CLIMATE, V2, P268, DOI 10.1175/1520-0442(1989)002<0268:PPAWTH>2.0.CO;2; Juneng L, 2005, CLIM DYNAM, V25, P337, DOI 10.1007/s00382-005-0031-6; Chang CP, 2004, J CLIMATE, V17, P665, DOI 10.1175/1520-0442(2004)017<0665:OTRBWM>2.0.CO;2; Hidayat R, 2010, INT J CLIMATOL, V30, P1816, DOI 10.1002/joc.2005; Aldrian E, 2007, THEOR APPL CLIMATOL, V87, P41, DOI 10.1007/s00704-006-0218-8; Saji NH, 1999, NATURE, V401, P360, DOI 10.1038/43855; Meyers G, 2007, J CLIMATE, V20, P2872, DOI 10.1175/JCLI4152.1; Du Y, 2010, DYNAM ATMOS OCEANS, V50, P233, DOI 10.1016/j.dynatmoce.2010.04.001; HALPERT MS, 1992, J CLIMATE, V5, P577, DOI 10.1175/1520-0442(1992)005<0577:STPAWT>2.0.CO;2; Aldrian E, 2003, INT J CLIMATOL, V23, P1435, DOI 10.1002/joc.950; Song Q, 2007, J CLIMATE, V20, P2434, DOI 10.1175/JCLI4133.1; McBride JL, 2003, J CLIMATE, V16, P2905, DOI 10.1175/1520-0442(2003)016<2905:RBTMCH>2.0.CO;2; ROPELEWSKI CF, 1987, MON WEATHER REV, V115, P1606, DOI 10.1175/1520-0493(1987)115<1606:GARSPP>2.0.CO;2; Gutman G, 2000, B AM METEOROL SOC, V81, P1189, DOI 10.1175/1520-0477(2000)081<1189:UNPTME>2.3.CO;2; MADDEN RA, 1972, J ATMOS SCI, V29, P1109, DOI 10.1175/1520-0469(1972)029<1109:DOGSCC>2.0.CO;2; Asnani G.C., 1993, TROPICAL METEOROLOGY, P1202; Braak C., 1919, ATMOSPHERIC VARIATIO; Bryden H., 2001, OCEAN CIRCULATION CL, V77, P455; Cheang B. K., 1987, MONSOONS, P579; Giannini A, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008519; Gordon A.L, 2005, OCEANOGRAPHY, V18, P14, DOI DOI 10.5670/0CEAN0G.2005.01; Japan Meteorological Agency (JMA), 2005, DIAGN TABL OC HLTH; MCBRIDE JL, 1983, TELLUS A, V35, P189; Moron V, 2009, J CLIMATE, V22, P840, DOI 10.1175/2008JCLI2435.1; Moron V, 2010, CLIM DYNAM, V34, P281, DOI 10.1007/s00382-009-0547-2; MURAKAMI T, 1982, J METEOROL SOC JPN, V60, P638; NICHOLLS N, 1981, MON WEATHER REV, V109, P2435, DOI 10.1175/1520-0493(1981)109<2435:ASIATP>2.0.CO;2; Pearson K., 1900, PHILOS T R SOC A, V195, P1, DOI 10.1098/rsta.1900.0022; Philander S., 1990, INT GEOPHYS, V46, P286; Rafferty J.P., 2011, STORMS VOILENT WINDS; Ramage C.S., 1971, INT GEOPHYS, V15, P285; Santoso A, 2011, J CLIMATE, V24, P585, DOI 10.1175/2010JCLI3745.1; Schell I.I., 1947, DYNAMIC PERSISTENCE, V8, P80; Shinoda T, 2012, J PHYS OCEANOGR, V42, P1099, DOI 10.1175/JPO-D-11-0120.1; Siedler G., 2001, OCEAN CIRCULATION CL, P303; Susanto RD, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC008096; Wajsowicz RC, 2001, J CLIMATE, V14, P3029, DOI 10.1175/1520-0442(2001)014<3029:TITSEO>2.0.CO;2; Wijffels S., 2001, OCEAN CIRCULATION CL, P475, DOI DOI 10.1016/S0074-6142(01)80135-2; Wolter K, 1998, WEATHER, V53, P315, DOI DOI 10.1002/J.1477-8696.1998.TB06408.X; Wolter K., 1993, P 17 CLIM DIAGN WORK, P52	47	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2073-4441			WATER-SUI	Water	APR	2015	7	4					1751	1768		10.3390/w7041751		18	Water Resources	Water Resources	CH0MS	WOS:000353715100023		
J	Tanaka, A; Katsuno, T; Ozaki, T; Sakata, F; Kato, N; Suzuki, Y; Kosugi, T; Kato, S; Tsuboi, N; Sato, W; Yasuda, Y; Mizuno, M; Ito, Y; Matsuo, S; Maruyama, S				Tanaka, Akihito; Katsuno, Takayuki; Ozaki, Takenori; Sakata, Fumiko; Kato, Noritoshi; Suzuki, Yasuhiro; Kosugi, Tomoki; Kato, Sawako; Tsuboi, Naotake; Sato, Waichi; Yasuda, Yoshinari; Mizuno, Masashi; Ito, Yasuhiko; Matsuo, Seiichi; Maruyama, Shoichi			The efficacy of tolvaptan as a diuretic for chronic kidney disease patients	ACTA CARDIOLOGICA			English	Article						Chronic kidney disease; CKD; tolvaptan; diuretic	HEART-FAILURE; V-2-RECEPTOR ANTAGONIST; CONTROLLED-TRIAL; HEPATIC EDEMA; DOUBLE-BLIND; FUROSEMIDE; RATS; RESISTANCE; OPC-41061; MECHANISM	Background Tolvaptan selectively binds to the vasopressin V2 receptor and inhibits reabsorption of free water. Although its efficacy for heart failure has been proven, its efficacy for chronic kidney disease (CKD) patients has not been assessed in detail. Methods We examined 20 CKD patients (13 men and 7 women) who presented with volume overload and who were administered tolvaptan. We assessed urine volume (UV) and blood biochemistry before administration (d0), 1 day after administration (d1), and 7 to 14 days after administration (d7-14). Results The mean age was 74.0 +/- 13.1 years. Besides CKD, there were 9, 8, and 5 patients with heart failure, liver failure or liver cirrhosis, and severe oedema, respectively. UV significantly increased from 959.0 +/- 503.8 mL/day at d0 to 1605.4 +/- 964.0 mL/day at d7-14 (P < 0.01). Serum creatinine levels were not exacerbated (3.89 +/- 3.43 mg/dL at d0 and 3.66 +/- 3.02 mg/dL at d7-14). Serum albumin (ALB) levels and urinary protein creatinine ratio (uPCR) did not correlate with UV change. Estimated glomerular filtration rate (eGFR) correlated with UV change from d0 to d1 (r = 0.6619, P < 0.01). Serum sodium elevation correlated with increased UV (r = 0.4951, P < 0.05). Conclusion Tolvaptan is useful to reduce volume overload without exacerbation of the renal function; its effect does not depend on ALB or uPCR. The eGFR correlated with the efficacy of tolvaptan. If UV increases drastically after tolvaptan administration, serum Na levels should be carefully monitored.	[Tanaka, Akihito; Katsuno, Takayuki; Ozaki, Takenori; Sakata, Fumiko; Kato, Noritoshi; Suzuki, Yasuhiro; Kosugi, Tomoki; Kato, Sawako; Tsuboi, Naotake; Sato, Waichi; Yasuda, Yoshinari; Mizuno, Masashi; Ito, Yasuhiko; Matsuo, Seiichi; Maruyama, Shoichi] Nagoya Univ, Grad Sch Med, Dept Nephrol, Nagoya, Aichi 4668550, Japan; [Sakata, Fumiko; Suzuki, Yasuhiro; Mizuno, Masashi; Ito, Yasuhiko] Nagoya Univ, Grad Sch Med, Renal Replacement Therapy, Nagoya, Aichi 4668550, Japan; [Yasuda, Yoshinari] Univ Grad Sch Med, CKD Initiat Internal Med, Nagoya, Aichi, Japan	Tanaka, A (reprint author), Nagoya Univ, Grad Sch Med, Dept Nephrol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	zhangren_at_23@yahoo.co.jp			Otsuka Pharmaceutical Co., Ltd.	Akihito Tanaka, Takayuki Katsuno, Takenori Ozaki, Noritoshi Kato, Tomoki Kosugi, Sawako Kato, Naotake Tsuboi, Waichi Sato, Seiichi Matsuo, Shoichi Maruyama received grants from Otsuka Pharmaceutical Co., Ltd.	Aditya S, 2012, INT J APPL BASIC MED, V2, P77; Felker GM, 2011, NEW ENGL J MED, V364, P797, DOI 10.1056/NEJMoa1005419; Hirano T, 2000, J PHARMACOL EXP THER, V292, P288; Eshaghian S, 2006, AM J CARDIOL, V97, P1759, DOI 10.1016/j.amjcard.2005.12.072; Sakaida I, 2013, J INT MED RES, V41, P835, DOI 10.1177/0300060513480089; Torres VE, 2012, NEW ENGL J MED, V367, P2407, DOI 10.1056/NEJMoa1205511; INOUE M, 1987, KIDNEY INT, V32, P198, DOI 10.1038/ki.1987.192; Yamamura Y, 1998, J PHARMACOL EXP THER, V287, P860; Otsuka T, 2013, CLIN EXP NEPHROL, V17, P834, DOI 10.1007/s10157-013-0788-6; Gheorghiade M, 2004, JAMA-J AM MED ASSOC, V291, P1963, DOI 10.1001/jama.291.16.1963; Peri A, 2013, J CLIN ENDOCR METAB, V98, P1321, DOI 10.1210/jc.2012-4082; Gheorghiade M, 2005, J CARD FAIL, V11, P260, DOI 10.1016/j.cardfail.2005.03.009; Costello-Boerrigter LC, 2006, AM J PHYSIOL-RENAL, V290, pF273, DOI 10.1152/ajprenal.00195.2005; KIRCHNER KA, 1990, J PHARMACOL EXP THER, V252, P1097; MATSUE Y, 2013, J CARDIOL, V61, P169; Okita K, 2014, HEPATOL RES, V44, P83, DOI 10.1111/hepr.12099	16	0	0	ACTA CARDIOLOGICA	BRUSSELS	AVENUE CIRCULAIRE 138A, 1180 BRUSSELS, BELGIUM	0001-5385	1784-973X		ACTA CARDIOL	Acta Cardiol.	APR	2015	70	2					217	223		10.2143/AC.70.2.3073514		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG9WP	WOS:000353671100013		
J	Wang, WQ; Yamaguchi, T; Nishio, K				Wang, Wen-Qin; Yamaguchi, Tomiko; Nishio, Kazumasa			Microstructure and Wear Behavior of Cermet/Iron Alloy Cladding Layers on A6061 Alloy Coated by Resistance Seam Welding Method	ACTA METALLURGICA SINICA-ENGLISH LETTERS			English	Article						Resistance seam welding; A6061; WC; Cladding layer; Wear resistance	MOLTEN ALUMINUM; COMPOSITE COATINGS; SOLID IRON; STEEL; SURFACE; WC; SI	Cermet/iron alloy cladding layers were coated on the surface of Al-Mg-Si alloy (A6061) plates by resistance seam welding method with tungsten carbide (WC) and high-carbon iron alloy (SHA) powders. The cladding layer consisted of WC reinforcement, SHA binder, A6061 and FeAl3. The effect of WC ratio (30 wt%, 50 wt% and 70 wt%) on the microstructure and wear behavior of the cladding layers was investigated in detail. Abrasive wear test was performed under two kinds of load condition by using a rubber wheel apparatus to evaluate wear resistance. The results showed that the wear resistance of the cladding layer was improved by 3.5-5 times than that of the substrate. At lower load, the wear resistances of the samples 30% and 70% WC were nearly the same, which suggested that FeAl3 played an important role in improvement of the wear resistance instead of WC. While at higher load, the amount of WC determined the wear resistance of the cladding layer. Furthermore, wear behavior of these cladding layers was explained with reference to the observed microstructure of the worn surface.	[Wang, Wen-Qin; Yamaguchi, Tomiko] Kyushu Inst Technol, Fac Engn, Fukuoka 8040015, Japan; [Nishio, Kazumasa] Nishinippon Inst Technol, Fukuoka 8030812, Japan	Yamaguchi, T (reprint author), Kyushu Inst Technol, Fac Engn, Fukuoka 8040015, Japan.	yama@tobata.isc.kyutech.ac.jp					Abouei V, 2010, MATER DESIGN, V31, P3518, DOI 10.1016/j.matdes.2010.02.015; Chuang YC, 2006, MATER TRANS, V47, P1140, DOI 10.2320/matertrans.47.1140; Chong PH, 2001, SURF COAT TECH, V145, P51, DOI 10.1016/S0257-8972(01)01286-5; Gao F, 2008, MATER CHARACT, V59, P1349, DOI 10.1016/j.matchar.2008.05.007; Basak AK, 2012, SURF COAT TECH, V206, P3508, DOI 10.1016/j.surfcoat.2012.02.030; Farid A, 2007, ACTA MATER, V55, P1467, DOI 10.1016/j.actamat.2006.10.009; Zhang WH, 2011, ISIJ INT, V51, P1870; Wang DQ, 2003, APPL SURF SCI, V214, P304, DOI 10.1016/S0169-4332(03)00505-1; Shi ZM, 2014, J NUCL MATER, V447, P77, DOI 10.1016/j.jnucmat.2013.12.027; Shahverdi HR, 2002, J MATER PROCESS TECH, V124, P345, DOI 10.1016/S0924-0136(02)00225-X; Celik ON, 2013, APPL SURF SCI, V274, P334, DOI 10.1016/j.apsusc.2013.03.057; Li CJ, 2011, J THERM SPRAY TECHN, V20, P227, DOI 10.1007/s11666-010-9545-5; Bouayad A, 2003, MAT SCI ENG A-STRUCT, V363, P53, DOI 10.1016/S0921-5093(03)00469-6; Cheng H.J., 2013, APPL SURF SCI, V277, P139; Gong JX, 2010, ACTA METALL SIN-ENGL, V23, P439, DOI 10.11890/1006-7191-106-439; He L, 2014, SURF COAT TECH, V244, P123, DOI 10.1016/j.surfcoat.2014.01.048; Lee J.W., 2005, WELD WORLD, V49, P94; Luo Y, 2013, P I MECH ENG J-J ENG, V227, P845, DOI 10.1177/1350650112471255; Man HC, 2007, MATER LETT, V61, P4058, DOI 10.1016/j.matlet.2007.01.016; Nath S, 2012, SURF COAT TECH, V206, P3333, DOI 10.1016/j.surfcoat.2012.01.038; Nazari KA, 2009, J ALLOY COMPD, V478, P523, DOI 10.1016/j.jallcom.2008.11.127; Seth S, 2013, WEAR, V302, P972, DOI 10.1016/j.wear.2013.01.075; Tanaka Y, 2010, J MATER SCI, V45, P5676, DOI 10.1007/s10853-010-4633-y; Tong X, 2012, APPL SURF SCI, V258, P3214, DOI 10.1016/j.apsusc.2011.11.066; Xiong YY, 2014, ACTA METALL SIN-ENGL, V27, P272, DOI 10.1007/s40195-014-0041-7; Xu JS, 2013, MAT SCI ENG A-STRUCT, V560, P744, DOI 10.1016/j.msea.2012.10.028; Zafarani HR, 2014, ACTA METALL SIN-ENGL, V27, P347, DOI 10.1007/s40195-014-0053-3; Zhao XQ, 2006, MAT SCI ENG A-STRUCT, V431, P290, DOI 10.1016/j.msea.2006.06.009	28	0	0	CHINESE ACAD SCIENCES, INST METAL RESEARCH	SHENYANG	72 WENHUA RD, SHENYANG, 110016, PEOPLES R CHINA	1006-7191	2194-1289		ACTA METALL SIN-ENGL	Acta Metall. Sin.-Engl. Lett.	APR	2015	28	4					414	423		10.1007/s40195-015-0210-3		10	Metallurgy & Metallurgical Engineering	Metallurgy & Metallurgical Engineering	CH2PW	WOS:000353868100002		
J	Ishikawa, H; Zhang, C; Chen, SW; Yang, ZG				Ishikawa, Hiroki; Zhang, Chi; Chen, Sheng-Wei; Yang, Zhi-Gang			Precipitate Behavior in Fe-20Cr-30Ni-2Nb Austenitic Heat-Resistant Steel	ACTA METALLURGICA SINICA-ENGLISH LETTERS			English	Article						Precipitation free zone; Grain boundary; Phase transformation; Microstructure; Fe-20Cr-30Ni-2Nb austenitic heat-resistant steel	FERRITIC STAINLESS-STEEL; GRAIN-BOUNDARY CARBIDES; FE2NB LAVES PHASE; MECHANICAL-PROPERTIES; POWER-PLANTS; CREEP; 700-DEGREES-C; ALLOYS; USC	In this study, the precipitation behavior of a new austenitic heat-resistant steel (Fe-20Cr-30Ni-2Nb, in at%) was investigated. The effects of alloying addition of boron (B) and lanthanum (La) on the microstructure of the austenitic steel were scrutinized using SEM, EPMA, TEM, and XRD. The results showed that the addition of B enhanced the precipitation of bar-type Laves phase. A small precipitate with high La concentration was observed at the grain boundary in the alloy without aging; similar precipitates without La also presented in region adjacent to the La single phase. This result indicates that La can exist independently and does not contribute to the formation of new compounds. However, in both Band La-modified alloy, B appeared in the precipitate free zone. In the alloy containing both B and La, only Fe2Nb Lavesphase precipitates, as indicated by the XRD result.	[Ishikawa, Hiroki; Zhang, Chi; Chen, Sheng-Wei; Yang, Zhi-Gang] Tsinghua Univ, Sch Mat Sci & Engn, Beijing 100084, Peoples R China; [Ishikawa, Hiroki] Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, Tokyo 1528552, Japan	Ishikawa, H (reprint author), Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, Tokyo 1528552, Japan.	hiroki.i.ab@m.titech.ac.jp					Tokairin T, 2013, MAT SCI ENG A-STRUCT, V565, P285, DOI 10.1016/j.msea.2012.12.019; Chai G, 2013, PROCEDIA ENGINEER, V55, P232, DOI 10.1016/j.proeng.2013.03.248; Zhong ZH, 2013, MATER LETT, V109, P38, DOI 10.1016/j.matlet.2013.07.060; Yamamoto Y, 2008, INTERMETALLICS, V16, P453, DOI 10.1016/j.intermet.2007.12.005; Wang LJ, 2012, MATER DESIGN, V37, P349, DOI 10.1016/j.matdes.2012.01.024; Patel SJ, 2013, PROCEDIA ENGINEER, V55, P246, DOI 10.1016/j.proeng.2013.03.250; Fujita N, 2003, ISIJ INT, V43, P1999, DOI 10.2355/isijinternational.43.1999; BENNETT MJ, 1987, MATER SCI ENG, V90, P177, DOI 10.1016/0025-5416(87)90210-2; Chen SW, 2014, MAT SCI ENG A-STRUCT, V616, P183, DOI 10.1016/j.msea.2014.07.104; ElMahallawi IS, 2001, MATER LETT, V51, P375, DOI 10.1016/S0167-577X(01)00324-X; Fujita N, 2002, METALL MATER TRANS A, V33, P3339, DOI 10.1007/s11661-002-0322-z; Fujita N, 2004, MODEL SIMUL MATER SC, V12, P273, DOI 10.1088/0965-0393/12/2/008; Hasebe Y., 2011, MATER RES SOC S P, V1295, P171; Nedjad SH, 2008, MAT SCI ENG A-STRUCT, V490, P105, DOI 10.1016/j.msea.2008.01.070; Kestenbach H.J., 1984, MATER SCI ENG, V66, P19; Lan LY, 2011, ACTA METALL SIN-ENGL, V24, P473, DOI 10.11890/1006-7191-116-473; Lin Q., 2007, J RARE EARTH, V25, P485, DOI 10.1016/S1002-0721(07)60461-X; Min KS, 2004, J ALLOY COMPD, V370, P223, DOI 10.1016/j.jallcom.2003.09.129; Noguchi Y, 2011, PROCEDIA ENGINEER, V10, P1127, DOI 10.1016/j.proeng.2011.04.186; Ogura T, 2004, SCI TECHNOL ADV MAT, V5, P491, DOI 10.1016/j.stam.2004.02.007; Tarigan I., 2011, MATER RES SOC S P, V1295, P317; Wang LM, 2006, J ALLOY COMPD, V408, P384, DOI 10.1016/j.jallcom.2005.04.090	22	0	0	CHINESE ACAD SCIENCES, INST METAL RESEARCH	SHENYANG	72 WENHUA RD, SHENYANG, 110016, PEOPLES R CHINA	1006-7191	2194-1289		ACTA METALL SIN-ENGL	Acta Metall. Sin.-Engl. Lett.	APR	2015	28	4					424	429		10.1007/s40195-015-0212-1		6	Metallurgy & Metallurgical Engineering	Metallurgy & Metallurgical Engineering	CH2PW	WOS:000353868100003		
J	Niu, XD; Hu, P; Zhang, XW; Meng, H; Yamaguchi, H; Iwamoto, Y				Niu, Xiao-Dong; Hu, Ping; Zhang, Xing-Wei; Meng, Hui; Yamaguchi, Hiroshi; Iwamoto, Yuhiro			Numerical Investigation of "Frog-Leap" Mechanisms of Three Particles Aligned Moving in an Inclined Channel Flow	ADVANCES IN APPLIED MATHEMATICS AND MECHANICS			English	Article						Frog-leap; fluid-structure interactions; inclined channel flow; lattice Boltzmann method; immersed boundary method	IMMERSED BOUNDARY METHOD; LATTICE BOLTZMANN METHOD; VISCOUS FLUID; SWIMMING MICROORGANISMS; BEHAVIOUR; CLUSTERS; SPHERES; DYNAMICS; MOTION	Intrigued by our recent experimental work (H. Yamaguchi and X. D. Niu, J. Fluids Eng., 133 (2011), 041302), the present study numerically investigate the flow-structure interactions (FSI) of three rigid circular particles aligned moving in an inclined channel flow at intermediate Reynolds numbers by using a momentum-exchanged immersed boundary-lattice Boltzmann method. A "frog-leap" phenomenon observed in the experiment is successfully captured by the present simulation and flow characteristics and underlying FSI mechanisms of it are explored by examining the effects of the channel inclined angles and Reynolds numbers. It is found that the asymmetric difference of the vorticity distributions on the particle surface is the main cause of the "frog-leap" when particle moves in the boundary layer near the lower channel boundary.	[Niu, Xiao-Dong; Hu, Ping; Zhang, Xing-Wei; Meng, Hui] Shantou Univ, Coll Engn, Shantou 515063, Peoples R China; [Niu, Xiao-Dong; Yamaguchi, Hiroshi; Iwamoto, Yuhiro] Doshisha Univ, Dept Mech Engn, Energy Convers Res Ctr, Kyoto 6300321, Japan	Zhang, XW (reprint author), Shantou Univ, Coll Engn, Shantou 515063, Peoples R China.	zhangxw@stu.edu.cn			National Natural Science Foundation of China (NSFC) [11372168]; Second-batch Leading Talent Project of Guangdong Province of China; Personal Research Starting Founding of Shantou University of China; Natural Science Foundation of Guangdong Province of China; Academic Frontier Research Project on "Next Generation Zero-emission Energy Conversion System" of Ministry of Education, Culture, Sports, Science and Technology in Japan	This study was supported by the National Natural Science Foundation of China (NSFC No. 11372168), the Second-batch Leading Talent Project of Guangdong Province of China, the Personal Research Starting Founding of Shantou University of China, the Natural Science Foundation of Guangdong Province of China and the Academic Frontier Research Project on "Next Generation Zero-emission Energy Conversion System" of Ministry of Education, Culture, Sports, Science and Technology in Japan. The financial support is gratefully acknowledged.	GRAD H, 1949, COMMUN PUR APPL MATH, V2, P331, DOI 10.1002/cpa.3160020403; Niu XD, 2006, PHYS LETT A, V354, P173, DOI 10.1016/j.physaleta.2006.01.060; Wang XD, 2004, COMPUT METHOD APPL M, V193, P1305, DOI 10.1016/j.cma.2003.12.024; Koch DL, 2011, ANNU REV FLUID MECH, V43, P637, DOI 10.1146/annurev-fluid-121108-145434; Darnton NC, 2010, BIOPHYS J, V98, P2082, DOI 10.1016/j.bpj.2010.01.053; Mucha PJ, 2004, J FLUID MECH, V501, P71, DOI 10.1017/S0022112003006967; Tornberg AK, 2004, J COMPUT PHYS, V196, P8, DOI 10.1016/j.jcp.2003.10.017; Peskin CS, 2002, ACT NUMERIC, V11, P479; PEDLEY TJ, 1992, ANNU REV FLUID MECH, V24, P313, DOI 10.1146/annurev.fluid.24.1.313; JOSEPH DD, 1992, THEORETICAL AND APPLIED RHEOLOGY, VOLS 1 AND 2, P60; Daniel WB, 2009, J FLUID MECH, V625, P371, DOI 10.1017/S002211200900620X; Ladd AJC, 2001, J STAT PHYS, V104, P1191, DOI 10.1023/A:1010414013942; Jenny M, 2004, J FLUID MECH, V508, P201, DOI 10.1017/S0022112004009164; Grigoriadis DGE, 2009, J COMPUT PHYS, V228, P903, DOI 10.1016/j.jcp.2008.10.017; FENG J, 1995, J FLUID MECH, V286, P201, DOI 10.1017/S002211209500070X; Feng ZG, 2004, J COMPUT PHYS, V195, P602, DOI 10.1016/j.jcp.2003.10.013; Gregor T, 2010, SCIENCE, V328, P1021, DOI 10.1126/science.1183415; JAYAWEERA KOL, 1964, J FLUID MECH, V20, P121, DOI 10.1017/S0022112064001069; Dutsch H, 1998, J FLUID MECH, V360, P249, DOI 10.1017/S002211209800860X; Ardekani AM, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2363351; CROWLEY JM, 1971, J FLUID MECH, V45, P151, DOI 10.1017/S0022112071003045; Ekiel-Jezewska ML, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2186692; FENG Z. G., 2008, COMPUT FLUIDS, V38, P370; HOCKING LM, 1964, J FLUID MECH, V20, P129, DOI 10.1017/S0022112064001070; ISNEROS L. H., 2007, EXP FLUIDS, V43, P737; JOSEPH D. D., 1996, P 5 WORLD C CHEM ENG; KANG S. Y., 2010, THESIS TEXAS A M U; LIU W. K., 2006, COMPUT MECH, V39, P211; JAYAWEER.KO, 1965, J FLUID MECH, V22, P709, DOI 10.1017/S002211206500109X; Soo S. L., 1967, FLUID DYNAMICS MULTI; Thiffeault JL, 2010, PHYS LETT A, V374, P3487, DOI 10.1016/j.physleta.2010.06.043; Yamaguchi H, 2011, J FLUID ENG-T ASME, V133, DOI 10.1115/1.4003856	32	0	0	GLOBAL SCIENCE PRESS	WANCHAI	ROOM 3208, CENTRAL PLAZA, 18 HARBOUR RD, WANCHAI, HONG KONG 00000, PEOPLES R CHINA	2070-0733	2075-1354		ADV APPL MATH MECH	Adv. Appl. Math. Mech.	APR	2015	7	2					207	228		10.4208/aamm.2014.m563		22	Mathematics, Applied; Mechanics	Mathematics; Mechanics	CH0DT	WOS:000353690000006		
J	Hara, K; Zhang, DZ; Matsusaki, H; Sadanaga, Y; Ikeda, K; Hanaoka, S; Hatakeyama, S				Hara, Kazutaka; Zhang, Daizhou; Matsusaki, Hiromi; Sadanaga, Yasuhiro; Ikeda, Keisuke; Hanaoka, Sayuri; Hatakeyama, Shiro			UV-Tolerant Culturable Bacteria in an Asian Dust Plume Transported over the East China Sea	AEROSOL AND AIR QUALITY RESEARCH			English	Article						Bioaerosols; Culturable bacteria; Asian dust; Long-range transport	COMMUNITY STRUCTURE; SOURCE REGION; DESERT DUST; SP NOV.; AEROSOLS; KOSA; MICROORGANISMS; PRECIPITATION; ULTRAVIOLET; ATMOSPHERE	Airborne bacteria are dispersed along with Asian dust and have various influences on atmospheric characteristics, downwind ecosystems, and public health. In this study, aircraft observations were conducted during Asian dust passage and non-dust conditions over the East China Sea in December 2010, and the composition of culturable bacteria within the dust was investigated using culture-based gene analysis. The 16S rRNA gene analysis revealed that the 34 cultured strains isolated from the transported dust could be grouped into Bacillales and Actinomycetales. Highly tolerant endospore-forming bacteria (25 isolates) were predominant in the composition. On the other hand, all non-endospore-forming bacteria (9 isolates) were gram-positive bacteria with high guanine and cytosine contents, which have substantial ultraviolet (UV) resistance. Thus, the isolated culturable bacteria were strains having some tolerance for exposure to UV radiation. Although the atmosphere is an extreme environment for bacterial survival, Asian dust can facilitate atmospheric dispersion of culturable bacteria that are resistant to the harsh ambient air environment.	[Hara, Kazutaka; Zhang, Daizhou; Matsusaki, Hiromi] Prefectural Univ Kumamoto, Fac Environm & Symbiot Sci, Kumamoto 8628502, Japan; [Sadanaga, Yasuhiro] Osaka Prefecture Univ, Grad Sch Engn, Sakai, Osaka 5998531, Japan; [Ikeda, Keisuke; Hanaoka, Sayuri; Hatakeyama, Shiro] Tokyo Univ Agr & Technol, Grad Sch Agr, Fuchu, Tokyo 1838509, Japan	Hara, K (reprint author), Tottori Univ, Arid Land Res Ctr, Tottori 6800001, Japan.	aeromicrobiology@gmail.com			Sumitomo Environmental Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan [4003]	We thank participants (from Tokyo University of Agricultural and Technology, Kanazawa University, Hiroshima University, Muroran Institute of Technology and Osaka Prefecture University) and staff (Diamond Air Service Inc., Japan) involved in the airborne observations. We acknowledge Prof. Fumihisa Kobayashi for his support with sample collections. We also acknowledge Prof. Koji Arizono and his laboratory staff for their support with sample analysis. In addition, we thank Prof. Yasunobu Iwasaka, Prof. Atsushi Matsuki, Prof. Teruya Maki, Dr. Maromu Yamada, and Dr. Yutaka Tobo for scientific discussions. This study was supported by the Sumitomo Environmental Foundation and the Grant-in-Aid for Scientific Research on Innovative Areas No. 4003 "Impacts of Aerosols in East Asia on Plants and Human Health (ASEPH)" from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	WATSON SW, 1977, APPL ENVIRON MICROB, V33, P940; Hua NP, 2007, AEROBIOLOGIA, V23, P291, DOI 10.1007/s10453-007-9076-9; Burton NC, 2005, J ENVIRON MONITOR, V7, P475, DOI 10.1039/b500056d; Andreae MO, 2008, EARTH-SCI REV, V89, P13, DOI 10.1016/j.earscirev.2008.03.001; Kellogg CA, 2006, TRENDS ECOL EVOL, V21, P638, DOI 10.1016/j.tree.2006.07.004; Hara K, 2012, ATMOS ENVIRON, V47, P20, DOI 10.1016/j.atmosenv.2011.11.050; Ichinose T, 2008, ARCH ENVIRON CON TOX, V55, P348, DOI 10.1007/s00244-007-9128-8; Satheesh SK, 2005, ATMOS ENVIRON, V39, P2089, DOI 10.1016/j.atmosenv.2004.12.029; Uno I, 2009, NAT GEOSCI, V2, P557, DOI 10.1038/NGEO583; Demidova TN, 2004, INT J IMMUNOPATH PH, V17, P245; Smith DJ, 2011, AEROBIOLOGIA, V27, P319, DOI 10.1007/s10453-011-9203-5; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; Pratt KA, 2009, NAT GEOSCI, V2, P397, DOI 10.1038/NGEO521; Jeon EM, 2013, ATMOS ENVIRON, V81, P39, DOI 10.1016/j.atmosenv.2013.08.039; Maki T, 2010, SCI TOTAL ENVIRON, V408, P4556, DOI 10.1016/j.scitotenv.2010.04.002; Ichinose T, 2005, ENVIRON TOXICOL PHAR, V20, P48, DOI 10.1016/j.etap.2004.10.009; WEISBURG WG, 1991, J BACTERIOL, V173, P697; Creamean JM, 2013, SCIENCE, V339, P1572, DOI 10.1126/science.1227279; Kwon HJ, 2002, ENVIRON RES, V90, P1, DOI 10.1006/enrs.2002.4377; Griffin DW, 2006, AEROBIOLOGIA, V22, P211, DOI 10.1007/s10453-006-9033-z; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Qin S, 2010, INT J SYST EVOL MICR, V60, P1147, DOI 10.1099/ijs.0.015792-0; Perry KD, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004979; Tong YY, 1997, ATMOS ENVIRON, V31, P897; Lighthart B, 1997, FEMS MICROBIOL ECOL, V23, P263, DOI 10.1016/S0168-6496(97)00036-6; Luksiene Z, 2005, FOOD TECHNOL BIOTECH, V43, P411; Maki T, 2008, AIR QUAL ATMOS HLTH, V1, P81, DOI 10.1007/s11869-008-0016-9; Llabres M, 2006, LIMNOL OCEANOGR, V51, P21; Bishop JKB, 2002, SCIENCE, V298, P817, DOI 10.1126/science.1074961; Arenskotter M, 2004, APPL ENVIRON MICROB, V70, P3195, DOI 10.1128/AEM.70.6.3195-3204.2004; Park DJ, 2007, INT J SYST EVOL MICR, V57, P2660, DOI 10.1099/ijs.0.65194-0; Jeon EM, 2011, ATMOS ENVIRON, V45, P4313, DOI 10.1016/j.atmosenv.2010.11.054; BAE HC, 1972, APPL MICROBIOL, V23, P637; Echigo A., 2005, SALINE SYST, V1, P1; Fujiwara H, 2014, ATMOS ENVIRON, V97, P462, DOI 10.1016/j.atmosenv.2014.01.064; Hatakeyama S, 2011, AEROSOL AIR QUAL RES, V11, P497, DOI 10.4209/aaqr.2011.06.0076; Hatakeyama S, 2014, ATMOS ENVIRON, V97, P456, DOI 10.1016/j.atmosenv.2014.02.040; Iwasaka Yosunobu, 2010, Earozoru Kenkyu, V25; Kakikawa M, 2008, AIR QUAL ATMOS HLTH, V1, P195, DOI 10.1007/s11869-008-0024-9; Kenzaka T, 2010, MICROBES ENVIRON, V25, P53, DOI 10.1264/jsme2.ME09164; Kobayshi F., 2007, EAROZORU KENKYU, V22, P218; Lim N, 2011, SCI TOTAL ENVIRON, V412, P223, DOI 10.1016/j.scitotenv.2011.10.030; Liu B, 2014, CLIN IMMUNOL, V10, P10; Maki T, 2011, AEROBIOLOGIA, V27, P277, DOI 10.1007/s10453-011-9196-0; Maki T, 2014, SCI TOTAL ENVIRON, V488, P75, DOI 10.1016/j.scitotenv.2014.04.044; Mitchell David L., 1993, P345; Nishimura Y, 2010, MICROBES ENVIRON, V25, P22, DOI 10.1264/jsme2.ME09166; Parks SR, 1996, J APPL BACTERIOL, V80, P529, DOI 10.1111/j.1365-2672.1996.tb03252.x; Pattison DI, 2006, EXP SUPPL, V96, P131; PUI DYH, 1987, AEROSOL SCI TECH, V7, P301, DOI 10.1080/02786828708959166; SINGER CE, 1970, SCIENCE, V170, P822, DOI 10.1126/science.170.3960.822; Tanaka D., 2011, Bulletin of Glaciological Research, V29, P31, DOI 10.5331/bgr.29.31; van der Linde K, 1999, NEPHROL DIAL TRANSPL, V14, P2433, DOI 10.1093/ndt/14.10.2433; Yamada Maromu, 2010, Earozoru Kenkyu, V25; Yamaguchi N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00525; Yukimura K, 2009, POLAR SCI, V3, P163, DOI 10.1016/j.polar.2009.07.002; Zhang DZ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003869	57	0	0	TAIWAN ASSOC AEROSOL RES-TAAR	TAICHUNG COUNTY	CHAOYANG UNIV TECH, DEPT ENV ENG & MGMT, PROD CTR AAQR, NO 168, JIFONG E RD, WUFONG TOWNSHIP, TAICHUNG COUNTY, 41349, TAIWAN	1680-8584	2071-1409		AEROSOL AIR QUAL RES	Aerosol Air Qual. Res.	APR	2015	15	2					591	599		10.4209/aaqr.2014.03.0067		9	Environmental Sciences	Environmental Sciences & Ecology	CG3JE	WOS:000353175300019		
J	Fujieda, S; Izuhara, K				Fujieda, Shigeharu; Izuhara, Kenji			Regulation of upper airway inflammation facilitates comfortable breathing	ALLERGOLOGY INTERNATIONAL			English	Editorial Material							PERIOSTIN		[Fujieda, Shigeharu] Univ Fukui, Fac Med Sci, Dept Sensory & Locomotor Med, Div Otorhinolaryngol Head & Neck Surg, Fukui 910, Japan; [Izuhara, Kenji] Saga Med Sch, Dept Biomol Sci, Div Med Biochem, Saga 8498501, Japan	Izuhara, K (reprint author), Saga Med Sch, Dept Biomol Sci, Div Med Biochem, 5-1-1 Nabeshima, Saga 8498501, Japan.	kizuhara@cc.saga-u.ac.jp					Takai T, 2015, ALLERGOL INT, V64, P181, DOI 10.1016/j.alit.2015.01.005; Kato A, 2015, ALLERGOL INT, V64, P121, DOI 10.1016/j.alit.2014.12.006; Okano M, 2015, ALLERGOL INT, V64, P131, DOI 10.1016/j.alit.2015.01.004; Izuhara K, 2014, ALLERGOL INT, V63, P143, DOI 10.2332/allergolint.13-RAI-0663; Matsumoto H, 2014, ALLERGOL INT, V63, P153, DOI 10.2332/allergolint.13-RAI-0678; Murakami D, 2015, ALLERGOL INT, V64, P161, DOI 10.1016/j.alit.2014.10.009; Matsusaka M, 2015, ALLERGOL INT, V64, P175, DOI 10.1016/j.alit.2014.07.003; Fokkens WJ, 2012, RHINOLOGY, V50, P1; Yamada T, 2014, J ALLERGY CLIN IMMUN, V133, P632, DOI 10.1016/j.jaci.2013.11.002	9	0	0	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	APR	2015	64	2					119	120		10.1016/j.alit.2015.02.001		2	Allergy; Immunology	Allergy; Immunology	CH0ZV	WOS:000353751800001		
J	Okano, M; Kariya, S; Ohta, N; Imoto, Y; Fujieda, S; Nishizaki, K				Okano, Mitsuhiro; Kariya, Shin; Ohta, Nobuo; Imoto, Yoshimasa; Fujieda, Shigeharu; Nishizaki, Kazunori			Association and management of eosinophilic inflammation in upper and lower airways	ALLERGOLOGY INTERNATIONAL			English	Review						Allergic rhinitis; Asthma; Chronic rhinosinusitis; Endoscopic sinus surgery; Immunotherapy	ENDOSCOPIC SINUS SURGERY; EXHALED NITRIC-OXIDE; EARLY INTERVENTIONAL TREATMENT; JAPANESE CEDAR POLLINOSIS; ALLERGIC RHINITIS; CHRONIC RHINOSINUSITIS; NASAL POLYPS; PULMONARY-FUNCTION; BRONCHIAL-ASTHMA; FOLLOW-UP	This review discussed the contribution of eosinophilic upper airway inflammation includes allergic rhinitis (AR) and chronic rhinosinusitis (CRS) to the pathophysiology and course of asthma, the representative counterpart in the lower airway. The presence of concomitant AR can affect the severity of asthma in patients who have both diseases; however, it is still debatable whether the presence of asthma affects the severity of AR. Hypersensitivity, obstruction and/or inflammation in the lower airway can be detected in patients with AR without awareness or diagnosis of asthma, and AR is known as a risk factor for the new onset of wheeze and asthma both in children and adults. Allergen immunotherapy, pharmacotherapy and surgery for AR can contribute to asthma control; however, a clear preventive effect on the new onset of asthma has been demonstrated only for immunotherapy. Pathological similarities such as epithelial shedding are also seen between asthma and CRS, especially eosinophilic CRS. Abnormal sinus findings on computed tomography are seen in the majority of asthmatic patients, and asthmatic patients with CRS show a significant impairment in Quality of Life (QOL) and pulmonary function as compared to those without CRS. Conversely, lower airway inflammation and dysfunction are seen in non-asthmatic patients with CRS. Treatments for CRS that include pharmacotherapy such as anti-leukotrienes, surgery, and aspirin desensitization show a beneficial effect on concomitant asthma. Acting as a gatekeeper of the united airways, the control of inflammation in the nose is crucial for improvement of the QOL of patients with co-existing AR/CRS and asthma. Copyright (C) 2015, Japanese Society of Allergology. Production and hosting by Elsevier B.V. All rights reserved.	[Okano, Mitsuhiro; Kariya, Shin; Nishizaki, Kazunori] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Otolaryngol Head & Neck Surg, Okayama 7008558, Japan; [Ohta, Nobuo] Yamagata Univ, Sch Med, Dept Otolaryngol, Yamagata 99023, Japan; [Imoto, Yoshimasa; Fujieda, Shigeharu] Univ Fukui, Fac Med Sci, Dept Otorhinolaryngol Head & Neck Surg, Fukui 910, Japan	Okano, M (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Otolaryngol Head & Neck Surg, 2-5-1 Shikatacho, Okayama 7008558, Japan.	mokano@cc.okayama-u.ac.jp			Japanese Ministry of Health, Labour and Welfare [H22-intractable diseases-general-208, H23-intractable diseases-general-080, H24-intractable diseases-general-080, H25-Research on measures for intractable disease-general-004, H26- intractable diseases-general-076]	The authors would like to thank Takaya Higaki, Takenori Haruna, Yasuyuki Noyama and Takahisa Koyama for valuable discussion. This work was supported by Grants-in-Aid for Scientific Research from the Japanese Ministry of Health, Labour and Welfare (H22-intractable diseases-general-208, H23, H24-intractable diseases-general-080, H25-Research on measures for intractable disease-general-004, H26- intractable diseases-general-076).	Alsamarai Abdulghani Mohamad, 2009, Allergology International, V58, P549, DOI 10.2332/allergolint.09-OA-0093; Burgess JA, 2007, J ALLERGY CLIN IMMUN, V120, P863, DOI 10.1016/j.jaci.2007.07.020; Okano M, 2011, CLIN EXP ALLERGY, V41, P171, DOI 10.1111/j.1365-2222.2010.03584.x; Shin SH, 2014, AM J RHINOL ALLERGY, V28, P95, DOI 10.2500/ajra.2014.28.4003; Okubo K, 2014, ALLERGOL INT, V63, P357, DOI 10.2332/allergolint.14-RAI-0768; Demoly P, 2006, ALLERGY, V61, P699, DOI 10.1111/j.1398-9995.01112.x; Futamura Masaki, 2011, Allergology International, V60, P509, DOI 10.2332/allergolint.10-OA-0293; Bousquet J, 2009, J ALLERGY CLIN IMMUN, V124, P428, DOI 10.1016/j.jaci.2009.06.027; Moller C, 2002, J ALLERGY CLIN IMMUN, V109, P251, DOI 10.1067/mai.2002.121317; Lin DC, 2011, AM J RHINOL ALLERGY, V25, P205, DOI 10.2500/ajra.2011.25.3613; Ohta K, 2014, ALLERGOL INT, V63, P293, DOI [10.2332/allergolint. 14-RAI-0766, 10.2332/allergolint.14-RAI-0766]; Ciprandi G, 2010, LARYNGOSCOPE, V120, P1288, DOI 10.1002/lary.20962; Higashi N, 2004, J ALLERGY CLIN IMMUN, V113, P277, DOI 10.1016/j.jaci.2003.10.068; Paramasivan S, 2014, INT FORUM ALLERGY RH, V4, P187, DOI 10.1002/alr.21264; Ohta K, 2011, ALLERGY, V66, P1287, DOI 10.1111/j.1398-9995.2011.02676.x; Takeno Sachio, 2010, Allergol Int, V59, P247, DOI 10.2332/allergolint.10-RAI-0202; Matsuwaki Y, 2008, INT ARCH ALLERGY IMM, V146, P77, DOI 10.1159/000126066; Ferreira MAR, 2014, J ALLERGY CLIN IMMUN, V133, P1564, DOI 10.1016/j.jaci.2013.10.030; Rochat MK, 2010, J ALLERGY CLIN IMMUN, V126, P1170, DOI 10.1016/j.jaci.2010.09.008; Okano M, 2011, J ALLERGY CLIN IMMUN, V127, P277, DOI 10.1016/j.jaci.2010.09.029; Gevaert P, 2013, J ALLERGY CLIN IMMUN, V131, P110, DOI 10.1016/j.jaci.2012.07.047; Akdis CA, 2013, J ALLERGY CLIN IMMUN, V131, P1479, DOI 10.1016/j.jaci.2013.02.036; Wentzel JL, 2013, AM J RHINOL ALLERGY, V27, P482, DOI 10.2500/ajra.2013.27.3976; Shirasaki H, 2013, ALLERGOL INT, V62, P223, DOI 10.2332/allergolint.12-OA-0490; Izuhara K, 2014, ALLERGOL INT, V63, P143, DOI 10.2332/allergolint.13-RAI-0663; HUXLEY EJ, 1978, AM J MED, V64, P564, DOI 10.1016/0002-9343(78)90574-0; Braunstahl GJ, 2001, J ALLERGY CLIN IMMUN, V107, P469, DOI 10.1067/mai.2001.113046; Bresciani M, 2001, J ALLERGY CLIN IMMUN, V107, P73, DOI 10.1067/mai.2001.111593; Higaki T, 2012, ANN ALLERG ASTHMA IM, V109, P458, DOI 10.1016/j.anai.2012.08.016; Proimos E, 2010, RHINOLOGY, V48, P331, DOI [10.4193/Rhin09.123, 10.4193/Rhino09.123]; Okano M, 2009, J ALLERGY CLIN IMMUN, V123, P868, DOI 10.1016/j.jaci.2009.01.047; Galli J, 2012, OTOLARYNG HEAD NECK, V147, P351, DOI 10.1177/0194599812442322; Virchow JC, 2006, RESP MED, V100, P1952, DOI 10.1016/j.rmed.2006.02.026; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Shaaban R, 2008, LANCET, V372, P1049, DOI 10.1016/S0140-6736(08)61446-4; Van Zele T, 2010, J ALLERGY CLIN IMMUN, V125, P1069, DOI 10.1016/j.jaci.2010.02.020; Sejima T, 2012, ALLERGOL INT, V61, P115, DOI 10.2332/allergolint.10-OA-0290; Yamauchi Kohei, 2009, Allergology International, V58, P55, DOI 10.2332/allergolint.08-OA-0004; Fujimura Takashi, 2010, Allergology International, V59, P21, DOI 10.2332/allergolint.09-RAI-0151; Lohia S, 2013, ALLERGY, V68, P569, DOI 10.1111/all.12124; Noda N, 2012, AM J RHINOL ALLERGY, V26, P255, DOI 10.2500/ajra.2012.26.3772; Tosca MA, 2003, ANN ALLERG ASTHMA IM, V91, P71; CORREN J, 1992, J ALLERGY CLIN IMMUN, V89, P611, DOI 10.1016/0091-6749(92)90329-Z; Jacobsen L, 2007, ALLERGY, V62, P943, DOI 10.1111/j.1398-9995.2007.01451.x; Yilmaz O, 2014, ALLERGY, V69, P652, DOI 10.1111/all.12391; Yoshimura Katsuhiro, 2011, Allergology International, V60, P491, DOI 10.2332/allergolint.10-OA-0234; de Groot EP, 2012, THORAX, V67, P582, DOI 10.1136/thoraxjnl-2011-201168; Schaper C, 2011, J INVEST ALLERG CLIN, V21, P51; SETTIPANE RJ, 1994, ALLERGY PROC, V15, P21, DOI 10.2500/108854194778816634; Burks AW, 2013, J ALLERGY CLIN IMMUN, V131, P1288, DOI 10.1016/j.jaci.2013.01.049; Antonicelli L, 2007, CLIN EXP ALLERGY, V37, P954, DOI 10.1111/j.1365-2222.2007.02729.x; Bergmann-Hug D, 2009, ALLERGY, V64, P1629; Chakir J, 1996, LAB INVEST, V75, P735; Dejima K, 2005, INT ARCH ALLERGY IMM, V138, P97, DOI 10.1159/000088430; Deliu M, 2014, ALLERGY, V69, P1515, DOI 10.1111/all.12467; Ek A, 2013, ALLERGY, V68, P1314, DOI 10.1111/all.12222; Feng CH, 2012, AM J RHINOL ALLERGY, V26, P189; Fokkens WJ, 2012, RHINOLOGY, V50, P1; Hamasaki Y, 2014, ALLERGOL INT, V63, P335, DOI 10.2332/allergolint.14-RAI-0767; Hamilos DL, 2011, J ALLERGY CLIN IMMUN, V128, P693, DOI 10.1016/j.jaci.2011.08.004; Han DH, 2009, ALLERGY, V64, P118, DOI 10.1111/j.1398-9995.2008.01841.x; Hemmerdinger SA, 2005, OTOLARYNG CLIN N AM, V38, P453, DOI 10.1016/j.otc.2004.10.024; Higashi N, 2012, ALLERGOL INT, V61, P393, DOI 10.2332/allergolint.11-RA-0403; Ikeda K, 1999, ANN OTO RHINOL LARYN, V108, P355; Incorvaia C, 2010, Int J Immunopathol Pharmacol, V23, P70; Ishitoya Junichi, 2010, Allergol Int, V59, P239, DOI 10.2332/allergolint.10-RAI-0231; Jura-Szoltys E, 2014, EUR ARCH OTO-RHINO-L, V271, P1581, DOI 10.1007/s00405-013-2762-z; Kariya S, 2014, J LARYNGOL OTOL, V128, P255, DOI 10.1017/S0022215114000450; Katotomichelakis M, 2013, AM J RHINOL ALLERGY, V27, P354, DOI 10.2500/ajra.2013.27.3922; Kern RC, 2013, J ALLERGY CLIN IMMUN, V131, P117, DOI 10.1016/j.jaci.2012.11.021; Koga Takeharu, 2007, Allergol Int, V56, P427, DOI 10.2332/allergolint.O-06-477; Leynaert Benedicte, 2004, Journal of Allergy and Clinical Immunology, V113, P86, DOI 10.1016/j.jaci.2003.10.010; Majima Y, 2012, AURIS NASUS LARYNX, V39, P38, DOI 10.1016/j.anl.2011.04.015; Makihara S, 2012, ALLERGOL INT, V61, P295, DOI 10.2332/allergolint.11-OA-0382; Mathai John, 2004, Indian J Otolaryngol Head Neck Surg, V56, P23, DOI 10.1007/BF02968766; Morjaria JB, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-013-0412-6; NISHIOKA K, 1993, ACTA MED OKAYAMA, V47, P151; Ohta N, 2014, ALLERGOL INT, V63, P171, DOI 10.2332/allergolint.13-RAI-0673; Okano M, 2014, ALLERGOL INT, V63, P563, DOI 10.2332/allergolint.14-OA-0703; Okano Mitsuhiro, 2004, Arerugi, V53, P1; Okano M, 2006, CLIN EXP ALLERGY, V36, P1028, DOI 10.1111/j.1365-2222.2006.02528.x; Okayama M, 1998, RESPIRATION, V65, P450, DOI 10.1159/000029313; Okubo Kimihiro, 2008, Allergol Int, V57, P265, DOI 10.2332/allergolint.O-07-514; Polosa R, 2004, ALLERGY, V59, P1224, DOI 10.1111/j.1398-9995.2004.00537.x; Rabenhorst A, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0423-y; REED CE, 1988, J ALLERGY CLIN IMMUN, V81, P1042, DOI 10.1016/0091-6749(88)90177-7; Rosen PL, 2013, AM J RHINOL ALLERGY, V27, P177, DOI 10.2500/ajra.2013.27.3873; Sagara Hironori, 2009, Allergology International, V58, P277, DOI 10.2332/allergolint.08-OA-0058; Shah SA, 2013, PHARMACOLOGY, V91, P158, DOI 10.1159/000346609; Smith TL, 2014, LARYNGOSCOPE, V124, P1735, DOI 10.1002/lary.24477; Swierczynska-Krepa M, 2014, J ALLERGY CLIN IMMUN, V134, P883, DOI 10.1016/j.jaci.2014.02.041; Takeno S, 2012, ALLERGOL INT, V61, P93, DOI 10.2332/allergolint.11-OA-0318; Talay F, 2008, ALLERGY ASTHMA PROC, V29, P475, DOI 10.2500/aap.2008.29.3157; Tanakau S, 2014, ALLERGOL INT, V63, P27, DOI 10.2332/allergolint.13-OA-0579; Tomita K, 2013, ALLERGY, V68, P92, DOI 10.1111/all.12066; Ueno Kana, 2002, Arerugi, V51, P565; Warmer JO, 2001, J ALLERGY CLIN IMMUN, V108, P929; Williamson PA, 2011, CLIN EXP ALLERGY, V41, P1379, DOI 10.1111/j.1365-2222.2011.03793.x; Yamada T, 2014, J ALLERGY CLIN IMMUN, V133, P632, DOI 10.1016/j.jaci.2013.11.002; Yoshimura Tsuyoshi, 2008, Allergol Int, V57, P429, DOI 10.2332 allergolint.O-08-545	100	2	2	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	APR	2015	64	2					131	138		10.1016/j.alit.2015.01.004		8	Allergy; Immunology	Allergy; Immunology	CH0ZV	WOS:000353751800003		
J	Koga, T; Tokuyama, K; Itano, A; Morita, E; Ueda, Y; Katsunuma, T				Koga, Takeshi; Tokuyama, Kenichi; Itano, Atsushi; Morita, Eiji; Ueda, Yutaka; Katsunuma, Toshio			Usefulness of modified Pulmonary Index Score (mPIS) as a quantitative tool for the evaluation of severe acute exacerbation in asthmatic children	ALLERGOLOGY INTERNATIONAL			English	Article						Asthma attack; Asthmatic children; Isoproterenol; Pediatric asthma; Receiver operating characteristic curve	CLINICAL SCORE	Background: Acute exacerbation of asthma is divided qualitatively into mild, moderate, and severe attacks and respiratory failure. This system is, however, not suitable for estimating small changes in respiratory condition with time and for determining the efficacy of treatments, because it has a qualitative, but not quantitative nature. Methods: To evaluate the usefulness of quantitative estimation of asthma exacerbation, modified Pulmonary Index Score (mPIS) values were measured in 87 asthmatic children (mean age, 5.0 + 0.4 years) during hospitalization. mPIS was calculated by adding the sum of scores for 6 items (scores of 0-3 were given for each item). These consisted of heart rate, respiratory rate, accessory muscle use, inspiratory-toexpiratory flow ratio, degree of wheezing, and oxygen saturation in room air. Measurements were made at visits and at hospitalization and were then made twice a day until discharge. Results: mPIS values were highly correlated among raters. mPIS values at visits were 9.1 +/- 0.1 and 12.6 +/- 0.4 in subjects with moderate and severe attacks, respectively (p < 0.001). mPIS values of subjects requiring continuous inhalation therapy (CIT) with isoproterenol in addition to systemic steroids were significantly higher than the values of those without CIT (12.0 +/- 0.5 and 9.3 +/- 0.2, respectively, p < 0.001). A score of 10 was suggested to be the optimal cutoff for distinguishing between subjects requiring and not requiring CIT, from the perspectives of both sensitivity and specificity. mPIS at hospitalization correlated well with the period until discharge, suggesting that this score was a useful predictor for the clinical course after hospitalization. Conclusions: mPIS could be a useful tool for several aspects during acute asthma attacks, including the determination of a treatment plan, and prediction of the period of hospitalization in admitted patients, although prospective studies would be required to establish our hypothesis. Copyright (C) 2014, Japanese Society of Allergology. Production and hosting by Elsevier B.V. All rights reserved.	[Koga, Takeshi; Tokuyama, Kenichi; Itano, Atsushi; Morita, Eiji; Ueda, Yutaka] Saitama Med Univ Hosp, Dept Pediat, Saitama, Japan; [Koga, Takeshi; Tokuyama, Kenichi; Itano, Atsushi; Morita, Eiji; Ueda, Yutaka] Saitama Med Univ, Allergy Ctr, Saitama, Japan; [Katsunuma, Toshio] Jikei Univ, Daisan Hosp, Dept Pediat, Tokyo, Japan	Tokuyama, K (reprint author), Saitama Med Univ Hosp, Dept Pediat, 38 Morohongo, Moroyama, Saitama 3500495, Japan.	kento@saitama-med.ac.jp					Greenberg S, 2012, J ALLERGY CLIN IMMUN, V130, P1071, DOI 10.1016/j.jaci.2012.07.057; Ducharme FM, 2008, J PEDIATR, V152, P476, DOI 10.1016/j.jpeds.2007.08.034; Carroll CL, 2005, ANN ALLERG ASTHMA IM, V94, P355; BECKER AB, 1984, AM J DIS CHILD, V138, P574; Birken CS, 2004, J CLIN EPIDEMIOL, V57, P1177, DOI 10.1016/j.jclinepi.2004.02.016; Buyuktiryaki AB, 2013, J EMERG MED, V44, P919, DOI 10.1016/j.jemermed.2012.10.015; Hamasaki Y, 2012, JAPANESE PEDIAT GUID; Inui H, 1988, JPN J PEDIAT ALLERGY, V2, P28; Katsunuma T, 2010, COMP CONTINUOUS INHA; Sekine K, 1998, ASTHMA, V11, P67; Takamasu T, 1998, JPN J ALLERGOL, V47, P573	11	0	0	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	APR	2015	64	2					139	144		10.1016/j.alit.2014.10.003		6	Allergy; Immunology	Allergy; Immunology	CH0ZV	WOS:000353751800004		
J	Hoshino, Y; Koya, T; Kagamu, H; Tsukioka, K; Toyama, M; Sakagami, T; Hasegawa, T; Narita, I; Arakawa, M; Suzuki, E				Hoshino, Yoshifumi; Koya, Toshiyuki; Kagamu, Hiroshi; Tsukioka, Keisuke; Toyama, Mio; Sakagami, Takuro; Hasegawa, Takashi; Narita, Ichiei; Arakawa, Masaaki; Suzuki, Eiichi			Effect of inhaled corticosteroids on bronchial asthma in Japanese athletes	ALLERGOLOGY INTERNATIONAL			English	Article						Bronchial provocation test; Fraction of exhaled NO; IgE; Inhaled corticosteroid; Pulmonary function testing	EXERCISE-INDUCED ASTHMA; AIRWAY INFLAMMATION; ELITE ATHLETE; CHILDHOOD ASTHMA; HYPERRESPONSIVENESS; METHACHOLINE; FLUTICASONE; MONTELUKAST; SPIROMETRY; OMALIZUMAB	Background: Asthma has a higher prevalence in athlete populations such as Olympic athletes than in the general population. Correct diagnosis and management of asthma in athletes is important for symptom control and avoidance of doping accusations. However, few reports are available on asthma treatment in the athlete population in clinical practice. In this study, we focused on the clinical efficacy of inhaled corticosteroid (ICS) for asthma in a Japanese athlete population. Methods: The study subjects included athletes who visited the Niigata Institute for Health and Sports Medicine, Niigata, Japan for athletic tests and who were diagnosed with asthma on the basis of respiratory symptoms and positive results in a bronchodilator or bronchial provocation test such as exercise, hypertonic saline, or methacholine provocation. The athletes received ICS alone for at least 3 months, and the clinical background, sports type, and treatment efficacy were analyzed. Results: The study population comprised 80 athletes (59 men and 21 women) with a median age of 16.0 years. Regarding sports type, 28 athletes engaged in winter sports (35%), 22 in endurance sports (27.5%), and 25 in indoor sports (31.3%). Although ICS is the primary treatment in athlete asthma, 16.3% of the athletes showed an unsatisfactory response to treatment according to the Global Evaluation of Treatment Effectiveness (GETE). These subjects were characterized by a decreased response to methacholine and lower values for FEV1/FVC and type 2 helper T cell (Th2)-associated biomarkers relative to responsive athletes. In multivariate analysis, FEV1/FVC and the logarithm to the base 10 of the IgE level were independently associated with the ICS response. Conclusions: These data suggest that ICS is effective for asthma in most athletes. However, certain asthmatic athletes are less responsive to ICS than expected. The pathogenesis in these subjects may differ from that of conventional asthma characterized by chronic allergic airway inflammation. Copyright (C) 2014, Japanese Society of Allergology. Production and hosting by Elsevier B.V. All rights reserved.	[Hoshino, Yoshifumi; Koya, Toshiyuki; Kagamu, Hiroshi; Tsukioka, Keisuke; Toyama, Mio; Sakagami, Takuro; Narita, Ichiei] Niigata Univ, Grad Sch Med & Dent Sci, Dept Homeostat Regulat & Dev, Div Resp Med,Course Biol Funct & Med Control, Niigata, Niigata 9518510, Japan; [Hasegawa, Takashi; Suzuki, Eiichi] Niigata Univ, Med & Dent Hosp, Dept Gen Med, Niigata, Niigata 9518510, Japan; [Arakawa, Masaaki] Niigata Inst Hlth & Sports Med, Niigata, Japan	Koya, T (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Homeostat Regulat & Dev, Div Resp Med,Course Biol Funct & Med Control,Chuo, 1-754 Asahimachi Dori, Niigata, Niigata 9518510, Japan.	tkoya@med.niigata-u.ac.jp					Anderson SD, 2003, CLIN REV ALLERG IMMU, V24, P27, DOI 10.1385/CRIAI:24:1:27; Anderson SD, 2002, MED J AUSTRALIA, V177, pS61; Szefler SJ, 2005, J ALLERGY CLIN IMMUN, V115, P233, DOI 10.1016/j.jaci.2004.11.014; Weiler JM, 1998, J ALLERGY CLIN IMMUN, V102, P722, DOI 10.1016/S0091-6749(98)70010-7; Rundell KW, 2001, MED SCI SPORT EXER, V33, P208; Szefler SJ, 2002, J ALLERGY CLIN IMMUN, V109, P410, DOI 10.1067/mai.2002.122635; Weiler JM, 2000, J ALLERGY CLIN IMMUN, V106, P267, DOI 10.1067/mai.2000.108605; Fitch KD, 2008, J ALLERGY CLIN IMMUN, V122, P254, DOI 10.1016/j.jaci.2008.07.003; Knuffman JE, 2009, J ALLERGY CLIN IMMUN, V123, P411, DOI 10.1016/j.jaci.2008.11.016; Alaranta A, 2004, MED SCI SPORT EXER, V36, P919, DOI 10.1249/01.MSS.0000128250.17793.47; Kippelen P, 2012, BRIT J SPORT MED, V46, P471, DOI 10.1136/bjsports-2012-091056; Sue-Chu M, 2000, RESPIRATION, V67, P417, DOI 10.1159/000029541; Crapo RO, 2000, AM J RESP CRIT CARE, V161, P309; Smith AD, 2005, AM J RESP CRIT CARE, V172, P453, DOI 10.1164/rccm.200411-1498OC; Fitch KD, 2012, BRIT J SPORT MED, V46, P413, DOI 10.1136/bjsports-2011-090814; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Rundell KW, 2002, SPORTS MED, V32, P583, DOI 10.2165/00007256-200232090-00004; Bougault V, 2010, CHEST, V138, P31; Bousquet J, 2011, ALLERGY, V66, P671, DOI 10.1111/j.1398-9995.2010.02522.x; Braunstahl GJ, 2013, RESP MED, V107, P1141, DOI 10.1016/j.rmed.2013.04.017; Fitch KD, 2008, J ALLERGY CLIN IMMUN, V122, pe1; Galant SP, 2014, PEDIATR PULM, V49, P1160, DOI 10.1002/ppul.22957; Global Initiative for Asthma (GINA), GLOB STRAT ASTHM MAN; Karjalainen EM, 2000, AM J RESP CRIT CARE, V161, P2086; Kippelen P, 2012, BRIT J SPORT MED, V46, P385, DOI 10.1136/bjsports-2011-090819; Koya T, 2009, J ASTHMA, V46, P1032, DOI 10.3109/02770900903229693; Leuppi JD, 1998, EUR RESPIR J, V12, P13, DOI 10.1183/09031936.98.12010013; Martin RJ, 2007, J ALLERGY CLIN IMMUN, V119, P73, DOI 10.1016/j.jaci.2006.10.035; McFadden Jr ER, 2003, APPROACH PATIENT EXC, P1323; Miller MG, 2005, J ATHL TRAINING, V40, P224; Price OJ, 2013, ALLERGY, V68, P1343, DOI 10.1111/all.12265; S. American Thoracic and S. European Respiratory, 2005, AM J RESP CRIT CARE, V171, P912; Zeiger RS, 2006, J ALLERGY CLIN IMMUN, V117, P45, DOI 10.1016/j.jaci.2005.10.012	33	0	0	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	APR	2015	64	2					145	149		10.1016/j.alit.2014.10.004		5	Allergy; Immunology	Allergy; Immunology	CH0ZV	WOS:000353751800005		
J	Hojo, M; Ohta, K; Iikura, M; Hirashima, J; Sugiyama, H; Takahashi, K				Hojo, Masayuki; Ohta, Ken; Iikura, Motoyasu; Hirashima, Junko; Sugiyama, Haruhito; Takahashi, Kazuhisa			The impact of co-existing seasonal allergic rhinitis caused by Japanese Cedar Pollinosis (SAR-JCP) upon asthma control status	ALLERGOLOGY INTERNATIONAL			English	Article						Allergic rhinitis; Asthma control test; Bronchial asthma; Japanese cedar pollinosis; SACRA questionnaire	BRONCHIAL-ASTHMA; PREVALENCE; GUIDELINE; DIAGNOSIS; QUESTIONNAIRE; NATIONWIDE; TRENDS	Background: Seasonal Allergic Rhinitis Caused by Japanese Cedar Pollinosis (SAR-JCP) is a most common allergic rhinitis, affecting about 40% in Japan, but the influence from SAR-JCP upon asthma is controversial. The purpose of this study is to investigate the effect of coexistence of SAR-JCP upon control status of asthma using SACRA (Self-Assessment of Allergic Rhinitis and Asthma Questionnaire). Methods: The design was prospective, single-center, observational study. Asthmatic patients were classified into 3 groups, patients without rhinitis, those with perennial rhinitis or those with SAR-JCP from the results of SACRA. The control status of asthma were evaluated by Visual Analog Scale (VAS) in SACRA and Asthma Control Test (ACT) score. They were evaluated twice, from September to January (nonpollenseason) and February to April (pollen-season) and compared. Results: 451 patients were enrolled and 325 cases (72%) were diagnosed as having comorbidity of rhinitis, among which 173 with only perennial rhinitis, while 152 with SAR-JCP. There was no significant difference in asthma control level measured by VAS and ACT score among 3 groups during nonpollenseason. The asthma control level measured by VAS (1.91-2.95) and ACT score (22.7-21.6) got worse during pollen-season among patients with SAR-JCP, even though 84% received treatment for rhinitis. Although it differed according to criteria, asthma control during pollen-season was impaired in 18-38% asthmatic patients with SAR-JCP. Conclusion: It is possible to minimize the influence of AR on asthma control by obtaining an accurate diagnosis and providing sufficient treatment for rhinitis. Copyright (C) 2014, Japanese Society of Allergology. Production and hosting by Elsevier B.V. All rights reserved.	[Hojo, Masayuki; Iikura, Motoyasu; Hirashima, Junko; Sugiyama, Haruhito] Natl Ctr Global Hlth & Med, Div Resp Med, Tokyo 1628655, Japan; [Ohta, Ken] Natl Hosp Org Tokyo Hosp, Div Resp Med, Tokyo, Japan; [Hojo, Masayuki; Takahashi, Kazuhisa] Juntendo Univ, Fac Med, Div Resp Med, Tokyo, Japan; [Hojo, Masayuki; Takahashi, Kazuhisa] Grad Sch Med, Tokyo, Japan	Hojo, M (reprint author), Natl Ctr Global Hlth & Med, Div Resp Med, Shinjuku Ku, Toyama 1-21-1, Tokyo 1628655, Japan.	mhojo@hosp.ncgm.go.jp					Adachi M, 2012, ALLERGOL IMMUNOL, V19, P1652; Fujieda S, 2012, AURIS NASUS LARYNX, V39, P553, DOI 10.1016/j.anl.2011.12.006; Schatz M, 2009, J ALLERGY CLIN IMMUN, V124, P719, DOI 10.1016/j.jaci.2009.06.053; Yoshida K, 2013, ALLERGY, V68, P757, DOI 10.1111/all.12164; Ohta K, 2011, ALLERGY, V66, P1287, DOI 10.1111/j.1398-9995.2011.02676.x; Magnan A, 2008, ALLERGY, V63, P292, DOI 10.1111/j.1398-9995.2007.01584.x; de Marco R, 2012, EUR RESPIR J, V39, P883, DOI 10.1183/09031936.00061611; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Yamauchi Kohei, 2009, Allergology International, V58, P55, DOI 10.2332/allergolint.08-OA-0004; WELSH PW, 1987, MAYO CLIN PROC, V62, P125; Okubo Kimihiro, 2011, Allergology International, V60, P171, DOI [10.2332/allergolint. 11-RAI-0334, 10.2332/allergolint.11-RAI-0334]; Bauchau V, 2004, EUR RESPIR J, V24, P758, DOI 10.1183/09031936.04.00013904; von Hertzen L, 2005, ALLERGY, V60, P283, DOI 10.1111/j.1398-9995.2005.00769.x; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Konno S, 2012, ALLERGY, V67, P653, DOI 10.1111/j.1398-9995.2012.02793.x; Global Initiative for Asthma (GINA), 2012, NHLBI WHO WORKSH REP; Hojo M, 2013, RESPIROLOGY, V18, P1016, DOI 10.1111/resp.12116; Matsuno O, 2006, J ASTHMA, V43, P165, DOI 10.1080/02770900500499053; Nakada H., 2010, JAPANESE SOC ALLERGO, V59, P688; PRIETO L, 1994, THORAX, V49, P711, DOI 10.1136/thx.49.7.711; Silkoff PE, 2004, J ALLERGY CLIN IMMUN, V114, P1241, DOI 10.1016/j.jaci.2004.08.042; Ueno K, 2002, ARERUGI, V51, P566	22	0	0	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	APR	2015	64	2					150	155		10.1016/j.alit.2014.10.002		6	Allergy; Immunology	Allergy; Immunology	CH0ZV	WOS:000353751800006		
J	Sasaki, K; Sugiura, S; Matsui, T; Nakagawa, T; Nakata, J; Kando, N; Ito, K				Sasaki, Kemal; Sugiura, Shiro; Matsui, Teruaki; Nakagawa, Tomoko; Nakata, Joon; Kando, Naoyuki; Ito, Komei			A workshop with practical training for anaphylaxis management improves the self-efficacy of school personnel	ALLERGOLOGY INTERNATIONAL			English	Article						Adrenaline auto-injector; Anaphylaxis; Food allergy; Schools; Self-efficacy	CHILD-CARE CENTERS; ALLERGIC REACTIONS; FOOD; ADOLESCENTS; PRESCHOOLS	Background: School personnel are required to guarantee a secure school environment for children suffering from severe food allergies. We organized a workshop for school personnel to learn the appropriate management of anaphylaxis that included practical training with an adrenaline auto-injector (AAI). The objective of this study was to evaluate the workshop in terms of the improvement of selfefficacy (SE) of participants to deal with anaphylaxis. Methods: All 93 school nurses, 73 schoolteachers and 110 childcare workers participating in the study completed a questionnaire before and after the workshop. The SE of the participants was evaluated using an original 15-item questionnaire. Results: Before the workshop, the SE of school nurses was the highest among the profession groups, and being involved with children prescribed an AAI was a common factor associated with a high SE. After the workshop, the SE increased in all groups, but most apparently in school nurses and those involved with children prescribed an AAI. The presence of an emergency plan was positively associated with the SE of schoolteachers only after the workshop, even though no such association existed beforehand. Conclusions: Practical instruction of school nurses and school personnel involved with children prescribed an AAI resulted in dramatic improvement of the SE. These people are expected to play a central role in the development of an anaphylaxis management plan in their schools. Copyright (C) 2014, Japanese Society of Allergology. Production and hosting by Elsevier B.V. All rights reserved.	[Sasaki, Kemal; Sugiura, Shiro; Matsui, Teruaki; Nakagawa, Tomoko; Nakata, Joon; Kando, Naoyuki; Ito, Komei] Aichi Childrens Hlth & Med Ctr, Dept Allergy, Obu City, Aichi 4748710, Japan	Ito, K (reprint author), Aichi Childrens Hlth & Med Ctr, Dept Allergy, 7-426 Morioka Cho, Obu City, Aichi 4748710, Japan.	koumei_itoh@mx.achmc.pref.aichi.jp					American Academy of Allergy Asthma and Immunology, 1998, J ALLERGY CLIN IMMUN, V102, P173; SAMPSON HA, 1992, NEW ENGL J MED, V327, P380, DOI 10.1056/NEJM199208063270603; Patel BM, 2006, ANN ALLERG ASTHMA IM, V97, P813; Fleischer DM, 2012, PEDIATRICS, V130, pE25, DOI 10.1542/peds.2011-1762; McIntyre CL, 2005, PEDIATRICS, V116, P1134, DOI 10.1542/peds.2004-1475; Ercan H, 2012, PEDIAT ALLERG IMM-UK, V23, P428, DOI 10.1111/j.1399-3038.2012.01307.x; Bock SA, 2001, J ALLERGY CLIN IMMUN, V107, P191, DOI 10.1067/mai.2001.112031; Bohlke K, 2004, J ALLERGY CLIN IMMUN, V113, P536, DOI 10.1016/j.jaci.2003.11.033; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037//0033-295X.84.2.191; Bandura A., 1995, SELF EFFICACY CHANGI; Baumgart K, 2004, J PAEDIATR CHILD H, V40, P669, DOI 10.1111/j.1440-1754.2004.00509.x; Cabana MD, 2004, PEDIATRICS, V113, P78, DOI 10.1542/peds.113.1.78; Taras HL, 2001, PEDIATRICS, V108, P1231; Ebisawa Motohiro, 2013, Arerugi, V62, P540; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Litarowsky Jean A, 2004, J Sch Nurs, V20, P279; Murai H, 2013, JPN J PEDIAT ALLERGY, V27, P566; Nowak-Wegrzyn A, 2001, ARCH PEDIAT ADOL MED, V155, P790; Sicherer SH, 2001, J PEDIATR-US, V138, P560, DOI 10.1067/mpd.2001.111821	19	0	0	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	APR	2015	64	2					156	160		10.1016/j.alit.2014.10.005		5	Allergy; Immunology	Allergy; Immunology	CH0ZV	WOS:000353751800007		
J	Murakami, D; Sawatsubashi, M; Kikkawa, S; Ejima, M; Saito, A; Kato, A; Komune, S				Murakami, Daisuke; Sawatsubashi, Motohiro; Kikkawa, Sayaka; Ejima, Masayoshi; Saito, Akira; Kato, Akio; Komune, Shizuo			Safety and efficacy of a new regimen of short-term oral immunotherapy with Cry j 1-galactomannan conjugate for Japanese cedar pollinosis: A prospective, randomized, open-label study	ALLERGOLOGY INTERNATIONAL			English	Article						Oral immunotherapy; Japanese cedar pollinosis; Cry j1-galactomannan conjugate; Clinical efficacy; Adverse effects	SEASONAL ALLERGIC RHINITIS; SUBLINGUAL IMMUNOTHERAPY; MAJOR ALLERGEN; DOUBLE-BLIND; POLLEN; RHINOCONJUNCTIVITIS; PREVALENCE; GUIDELINE; TOLERANCE; CHILDREN	Background: Short-term oral immunotherapy (OIT) using the Cry j1-galactomannan conjugate for Japanese cedar pollinosis may be effective and relatively safe. However, a treatment regimen has not been established. In the present study, we examined a new OIT regimen with a build-up phase and extended the maintenance phase of OIT to the peak period of the pollen season to enhance the therapeutic effect and safety of OIT. Methods: A prospective, randomized, open-label trial was conducted over a period of 4 months. Participants were randomly divided into two groups. The OIT group comprised 23 subjects. The build-up phase was initiated 1 month before the expected pollen season. The maintenance phase was continued for 51 days during the peak pollen season. The control group comprised 24 subjects. The symptoms and medication score, levels of allergen-specific serum antibodies throughout the pollen season, and adverse effects with OIT were evaluated. Results: Participants receiving OIT showed significant improvements in total symptom scores, medication score, and total symptom-medication scores throughout the pollen season compared with the control group. The levels of allergen-specific serum IgG4 were significantly increased in the OIT group but not in the control group throughout the cedar pollen season. Importantly, no severe adverse effects were observed with OIT. Conclusions: The new regimen of short-term OIT using the Cry j1-galactomannan conjugate for Japanese cedar pollinosis is effective, relatively safe and induces immune tolerance. Thus, OIT using allergen galactomannan conjugates may provide a rapid, effective, and thus convenient immunotherapy for pollinosis instead of SLIT or SCIT. Copyright (C) 2014, Japanese Society of Allergology. Production and hosting by Elsevier B.V. All rights reserved.	[Murakami, Daisuke; Sawatsubashi, Motohiro; Kikkawa, Sayaka; Ejima, Masayoshi; Komune, Shizuo] Kyushu Univ, Grad Sch Med Sci, Dept Otorhinolaryngol, Fukuoka 8128582, Japan; [Saito, Akira] Wako Filter Technol Co Ltd, Biobusiness Prop Div, Biobusiness Prop Grp, Ibaraki, Japan; [Kato, Akio] Yamaguchi Univ, Dept Biol Chem, Yamaguchi, Japan; [Murakami, Daisuke] Saiseikai Fukuoka Gen Hosp, Dept Otorhinolaryngol, Fukuoka, Japan; [Ejima, Masayoshi] Kitakyushu Municipal Med Ctr, Dept Otorhinolaryngol, Fukuoka, Japan; [Kikkawa, Sayaka] Saitama Med Univ Hosp, Dept Otorhinolaryngol, Saitama, Japan	Murakami, D (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Otorhinolaryngol, Maidashi 3-1-1 Higashi Ku, Fukuoka 8128582, Japan.	muradai@qent.med.kyushu-u.ac.jp			MEXT/JSPS KAKENHI [23791905]	This work was supported by MEXT/JSPS KAKENHI (23791905).	Fujieda S, 2012, AURIS NASUS LARYNX, V39, P553, DOI 10.1016/j.anl.2011.12.006; Calderon MA, 2012, ALLERGY, V67, P302, DOI 10.1111/j.1398-9995.2011.02761.x; Di Bona D, 2012, J ALLERGY CLIN IMMUN, V130, P1097, DOI 10.1016/j.jaci.2012.08.012; Dretzke J, 2013, J ALLERGY CLIN IMMUN, V131, P1361, DOI 10.1016/j.jaci.2013.02.013; Canonica GW, 2003, J ALLERGY CLIN IMMUN, V111, P437, DOI 10.1067/mai.2003.129; Jones Stacie M, 2009, J Allergy Clin Immunol, V124, P292, DOI 10.1016/j.jaci.2009.05.022; Murakami D, 2014, AURIS NASUS LARYNX, V41, P350, DOI 10.1016/j.anl.2014.02.010; Bousquet J, 1998, J ALLERGY CLIN IMMUN, V102, P558, DOI 10.1016/S0091-6749(98)70271-4; Moingeon P, 2006, ALLERGY, V61, P151, DOI 10.1111/j.1398-9995.2006.01002.x; YASUEDA H, 1983, J ALLERGY CLIN IMMUN, V71, P77, DOI 10.1016/0091-6749(83)90550-X; Sakashita M, 2010, INT ARCH ALLERGY IMM, V151, P255, DOI 10.1159/000242363; Skripak JM, 2008, J ALLERGY CLIN IMMUN, V122, P1154, DOI 10.1016/j.jaci.2008.09.030; Chehade M, 2005, J ALLERGY CLIN IMMUN, V115, P3, DOI 10.1016/j.jaci.2004.11.008; Okubo Kimihiro, 2011, Allergology International, V60, P171, DOI [10.2332/allergolint. 11-RAI-0334, 10.2332/allergolint.11-RAI-0334]; Burks AW, 2012, NEW ENGL J MED, V367, P233, DOI 10.1056/NEJMoa1200435; Aoki R, 2010, J AGR FOOD CHEM, V58, P7986, DOI 10.1021/jf100793d; BJORKSTEN B, 1986, ALLERGY, V41, P290, DOI 10.1111/j.1398-9995.1986.tb02031.x; Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891; Mailing HJ, 1993, EUROPEAN J ALLE S514, V48, P9; MOLLER C, 1986, ALLERGY, V41, P271, DOI 10.1111/j.1398-9995.1986.tb02028.x; Okamoto Y, 2014, AURIS NASUS LARYNX, V41, P1, DOI 10.1016/j.anl.2013.06.003; Oshikawa C, 2012, OTOL FUKUOKA, V58, P268; SUKO M, 1995, INT ARCH ALLERGY IMM, V107, P278; TAUDORF E, 1987, J ALLERGY CLIN IMMUN, V80, P153, DOI 10.1016/0091-6749(87)90124-2; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Usui M, 2003, BIOSCI BIOTECH BIOCH, V67, P2425, DOI 10.1271/bbb.67.2425; Vickery BP, 2011, J ALLERGY CLIN IMMUN, V127, P576, DOI 10.1016/j.jaci.2010.12.1116; WEINER HL, 1994, P NATL ACAD SCI USA, V91, P10762, DOI 10.1073/pnas.91.23.10762; Yamada T, 2014, J ALLERGY CLIN IMMUN, V133, P632, DOI 10.1016/j.jaci.2013.11.002	29	2	2	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	APR	2015	64	2					161	168		10.1016/j.alit.2014.10.009		8	Allergy; Immunology	Allergy; Immunology	CH0ZV	WOS:000353751800008		
J	Shirasaki, H; Kanaizumi, E; Seki, N; Himi, T				Shirasaki, Hideaki; Kanaizumi, Etsuko; Seki, Nobuhiko; Himi, Tetsuo			Leukotriene E-4 induces MUC5AC release from human airway epithelial NCI-H292 cells	ALLERGOLOGY INTERNATIONAL			English	Article						Allergic mucous secretion; Epithelial cells; Leukotriene E-4; MUC5AC mucin; P2Y(12) antagonist	CILIARY ACTIVITY; GENE-EXPRESSION; MUCIN SECRETION; ION-TRANSPORT; IN-VITRO; RECEPTOR; IDENTIFICATION; CYSLT(1); LIGANDS; PROTEIN	Background: Hypersecretion of mucin in the airway epithelium is an important feature of allergic airway diseases. Of the 3 cysteinyl leukotrienes (CysLTs; LTC4 LTD4 and LTE4), only LTE4 is sufficiently stable to be detectable in extracellular fluids. However, LTE4 has received little attention because it binds poorly to the CysLT(1) and CysLT(2) receptors; therefore, little is known about the effects of LTE4 on mucous secretion. Recently, studies have focused on the P2Y(12) receptor as a potential receptor for LTE4, because this receptor is required for LTE4-mediated pulmonary inflammation. In our previous study, we confirmed the expression of P2Y(12) receptor in human airway epithelial cells. To clarify the roles of LTE4 in airway epithelial cells, we investigated mucus secretion by LTE4 in vitro. Methods: Confluent NCI-H292 cells were stimulated with LTE4 (0.01-1 mu M) for 24 h. The release and production of MUC5AC protein, a gel-forming mucin, were evaluated with an enzyme-linked immunosorbent assay. Results: Western blot analysis revealed that NCI-H292 cells expressed P2Y(12) receptor protein. LTE4 significantly induced the release of MUC5AC mucin in a dose-dependent manner. Th2 cytokines such as IL-4 (10 ng/mL) and IL-13 (10 ng/mL) accelerated the LTE4-induced release of MUC5AC protein. MRS2935, a P2Y(12) receptor antagonist, partially inhibited the LTE4-induced release of MUC5AC protein in the airway. In contrast, MK571, a CysLT(1) receptor antagonist, did not affect the release of MUC5AC protein elicited by LTE4. Conclusions: These results suggest that LTE4 may play some important roles in allergic mucus secretion partially via activation of P2Y(12) receptor. Copyright (C) 2014, Japanese Society of Allergology. Production and hosting by Elsevier B.V. All rights reserved.	[Shirasaki, Hideaki; Kanaizumi, Etsuko; Seki, Nobuhiko; Himi, Tetsuo] Sapporo Med Univ, Sch Med, Dept Otolaryngol, Sapporo, Hokkaido 0608543, Japan	Shirasaki, H (reprint author), Sapporo Med Univ, Sch Med, Dept Otolaryngol, Chuo Ku, S-1 W-16, Sapporo, Hokkaido 0608543, Japan.	shira@sapmed.ac.jp			 [24592576]	This work was supported by Grants-in-Aid for Scientific Research, Japan Society for the Promotion Science, Grant Number 24592576.	Paruchuri S, 2009, J EXP MED, V206, P2543, DOI 10.1084/jem.20091240; Kanaoka Y, 2013, J BIOL CHEM, V288, P10967, DOI 10.1074/jbc.C113.453704; Beum PV, 2005, AM J PHYSIOL-LUNG C, V288, pL116, DOI 10.1152/ajplung.00370.2003; BOUCHER RC, 1994, AM J RESP CRIT CARE, V150, P271; Nonaka Y, 2005, BIOCHEM BIOPH RES CO, V337, P281, DOI 10.1016/j.bbrc.2005.09.052; Gauvreau GM, 2001, AM J RESP CRIT CARE, V164, P1495; Heise CE, 2000, J BIOL CHEM, V275, P30531, DOI 10.1074/jbc.M003490200; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; Maekawa A, 2008, P NATL ACAD SCI USA, V105, P16695, DOI 10.1073/pnas.0808993105; LAITINEN LA, 1993, LANCET, V341, P989, DOI 10.1016/0140-6736(93)91073-U; Lynch KR, 1999, NATURE, V399, P789; Kang JH, 2011, J IMMUNOL, V187, P222, DOI 10.4049/jimmunol.1003606; Laitinen A, 2005, J ALLERGY CLIN IMMUN, V115, P259, DOI 10.1016/j.jaci.2004.10.021; Bai CH, 2007, AURIS NASUS LARYNX, V34, P203, DOI 10.1016/j.anl.2006.11.006; Berger JT, 1999, AM J RESP CELL MOL, V20, P500; Conway JD, 2003, AM J PHYSIOL-LUNG C, V284, pL945, DOI 10.1152/ajplung.00410.2002; Gachet C, 2005, SEMIN THROMB HEMOST, V31, P162, DOI 10.1055/s-2005-869521; Higashi N, 2012, ALLERGOL INT, V61, P393, DOI 10.2332/allergolint.11-RA-0403; Ishinaga H, 2005, PHARMACOLOGY, V73, P89, DOI 10.1159/000081294; Kim CH, 2004, AM J PHYSIOL-LUNG C, V287, pL835, DOI 10.1152/ajplung.00285.2003; Kojima T, 1989, Adv Exp Med Biol, V247A, P379; Lee TH, 2009, J ALLERGY CLIN IMMUN, V124, P417, DOI 10.1016/j.jaci.2009.04.020; Leuba D, 1996, AM J PHYSIOL-LUNG C, V271, pL349; Morse DM, 2001, AM J PHYSIOL-CELL PH, V280, pC1485; Shirasaki H, 2013, ALLERGOL INT, V62, P239, DOI 10.2332/allergolint.12-OA-0496; Shirasaki H, 2008, EXPERT OPIN THER TAR, V12, P415, DOI 10.1517/14728222.12.4.415 ; Shirasaki H, 2004, CLIN EXP ALLERGY, V34, P945, DOI 10.1111/j.1365-2222.2004.01964.x	27	0	0	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	APR	2015	64	2					169	174		10.1016/j.alit.2014.11.002		6	Allergy; Immunology	Allergy; Immunology	CH0ZV	WOS:000353751800009		
J	Matsusaka, M; Kabata, H; Fukunaga, K; Suzuki, Y; Masaki, K; Mochimaru, T; Sakamaki, F; Oyamada, Y; Inoue, T; Oguma, T; Sayama, K; Koh, H; Nakamura, M; Umeda, A; Ono, J; Ohta, S; Izuhara, K; Asano, K; Betsuyaku, T				Matsusaka, Masako; Kabata, Hiroki; Fukunaga, Koichi; Suzuki, Yusuke; Masaki, Katsunori; Mochimaru, Takao; Sakamaki, Fumio; Oyamada, Yoshitaka; Inoue, Takashi; Oguma, Tsuyoshi; Sayama, Koichi; Koh, Hidefumi; Nakamura, Morio; Umeda, Akira; Ono, Junya; Ohta, Shoichiro; Izuhara, Kenji; Asano, Koichiro; Betsuyaku, Tomoko			Phenotype of asthma related with high serum periostin levels	ALLERGOLOGY INTERNATIONAL			English	Article						Chronic rhinosinusitis; Eosinophils; Nasal polyp; Olfactory dysfunction; T(H)2-high asthma	QUALITY-OF-LIFE; CHRONIC RHINOSINUSITIS; BIOMARKER; CORTICOSTEROIDS; INFLAMMATION; EXPRESSION; PROTEIN	Background: Asthma is a heterogeneous disease composed of various phenotypes. Periostin, a molecule inducible with interleukin (IL)-4 or IL-13 in bronchial epithelial cells, is a biomarker of "TH2-high" asthma. The objective of this study is to examine whether the serum periostin concentrations are correlated with the severity, specific phenotype(s), or comorbidity of asthma. Methods: Serum concentrations of periostin were measured in 190 Japanese asthmatic patients and 11 healthy controls. The protocol was registered under UMIN 000002980 in the clinical trial registry. Results: The serum concentrations of periostin were significantly higher (P = 0.014) in asthmatics [70.0 (54.0-93.5) ng/ml] than in healthy subjects [57.0 (39.0-63.0) ng/ml], though we found no correlation between serum periostin concentrations and treatment steps required to control asthma. To characterize "high-periostin" phenotype(s), the patients with asthma were divided among tertiles based on the serum concentrations of periostin. The high-periostin group was older at onset of asthma (P = 0.04), had a higher prevalence of aspirin intolerance (P = 0.04) or concomitant nasal disorders (P = 0.03-0.001), higher peripheral eosinophil counts (P < 0.001), and lower pulmonary function (P = 0.02-0.07). The serum concentrations of periostin were particularly high in asthmatic patients complicated by chronic rhinosinusitis with nasal polyps and olfactory dysfunction. In contrast, neither atopic status, control status of asthma, nor quality of life were related with the "high-periostin" phenotype. Conclusion: Elevated periostin concentrations in serum were correlated with a specific phenotype of eosinophilic asthma, late-onset and often complicated by obstructive pulmonary dysfunction and nasal disorders. Copyright (C) 2014, Japanese Society of Allergology. Production and hosting by Elsevier B.V. All rights reserved.	[Matsusaka, Masako; Kabata, Hiroki; Fukunaga, Koichi; Suzuki, Yusuke; Masaki, Katsunori; Mochimaru, Takao; Asano, Koichiro; Betsuyaku, Tomoko] Keio Univ, Sch Med, Dept Med, Div Pulm Med, Tokyo 160, Japan; [Kabata, Hiroki; Oguma, Tsuyoshi; Sayama, Koichi] Kawasaki Municipal Hosp, Kawasaki, Kanagawa, Japan; [Sakamaki, Fumio] Tokai Univ, Hachioji Hosp, Dept Med, Div Pulm Med, Tokyo 151, Japan; [Sakamaki, Fumio; Nakamura, Morio] Tokyo Saiseikai Cent Hosp, Dept Med, Tokyo, Japan; [Oyamada, Yoshitaka] Natl Tokyo Med Ctr, Dept Med, Tokyo, Japan; [Inoue, Takashi] Sanokousei Gen Hosp, Dept Med, Sano, Tochigi, Japan; [Oguma, Tsuyoshi; Asano, Koichiro] Tokai Univ, Sch Med, Dept Med, Div Pulm Med, Isehara, Kanagawa 2591193, Japan; [Koh, Hidefumi] Saiseikai Utsunomiya Hosp, Dept Med, Utsunomiya, Tochigi, Japan; [Koh, Hidefumi] Tachikawa Kyosai Hosp, Dept Med, Tokyo, Japan; [Nakamura, Morio] Eiju Gen Hosp, Dept Med, Tokyo, Japan; [Umeda, Akira] Int Univ Hlth & Welf, Shioya Hosp, Dept Med, Otawara, Tochigi, Japan; [Ono, Junya] Shino Test Corp, Tokyo, Japan; [Ohta, Shoichiro] Saga Med Sch, Dept Lab Med, Saga, Japan; [Izuhara, Kenji] Saga Med Sch, Dept Biomol Sci, Div Med Biochem, Saga, Japan	Asano, K (reprint author), Tokai Univ, Sch Med, Dept Med, Div Pulm Med, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	ko-asano@tokai-u.jp			Japan Society for the Promotion of Science [25461504]; Ministry of Health, Labour, and Welfare; MSD Endowed Program for Allergy Research	This study was supported in part by a Grant-in-Aid for Scientific Research (C) (25461504) from the Japan Society for the Promotion of Science to Koichiro Asano, MD, a Grant in Aid for Research on Allergic disease and Immunology from the Ministry of Health, Labour, and Welfare to Koichiro Asano, MD, and a Grant-in-aid from Glaxo-Smith-Kline, PLC.; Yusuke Suzuki is affiliated with MSD Endowed Program for Allergy Research and has received funds for research.	Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI [10.1164/rccm.200711-1754OC, 10.1164/rccm.200711-17540C]; Takayama G, 2006, J ALLERGY CLIN IMMUN, V118, P98, DOI 10.1016/j.jaci.2006.02.046; Amelink M, 2013, J ALLERGY CLIN IMMUN, V132, P336, DOI 10.1016/j.jaci.2013.04.052; Kanemitsu Y, 2013, J ALLERGY CLIN IMMUN, V132, P305, DOI 10.1016/j.jaci.2013.04.050; Lotvall J, 2011, J ALLERGY CLIN IMMUN, V127, P355, DOI 10.1016/j.jaci.2010.11.037; Stankovic KM, 2008, LARYNGOSCOPE, V118, P881, DOI 10.1097/MLG.0b013e31816b4b6f; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Jia GQ, 2012, J ALLERGY CLIN IMMUN, V130, P647, DOI 10.1016/j.jaci.2012.06.025; Matsumoto H, 2014, ALLERGOL INT, V63, P153, DOI 10.2332/allergolint.13-RAI-0678; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Chupp GL, 2007, NEW ENGL J MED, V357, P2016, DOI 10.1056/NEJMoa073600; McDonald VM, 2012, CLIN EXP ALLERGY, V42, P670, DOI 10.1111/j.1365-2222.2012.03981.x; Okamoto M, 2011, EUR RESPIR J, V37, P1119, DOI 10.1183/09031936.00059810; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Brightling CE, 2010, CLIN EXP ALLERGY, V40, P42, DOI 10.1111/j.1365-2222.2009.03383.x; JUNIPER EF, 1992, THORAX, V47, P76, DOI 10.1136/thx.47.2.76; Ohta Ken, 2011, Allergology International, V60, P115, DOI 10.2332/allergolint.11-RAI-0327; Ishida A, 2012, ALLERGOL INT, V61, P589, DOI 10.2332/allergolint.11-OA-0370; Apfelbacher CJ, 2011, ALLERGY, V66, P439, DOI 10.1111/j.1398-9995.2010.02500.x; Global Initiative for Asthma (GINA), GLOB STRAT ASTHM MAN; Hasegawa T, 2012, ALLERGOL INT, V61, P609, DOI 10.2332/allergolint.12-OA-0453; Hashimoto S, 2012, CLIN EXP ALLERGY, V42, P693, DOI 10.1111/j.1365-2222.2011.03936.x; Ishitoya Junichi, 2010, Allergol Int, V59, P239, DOI 10.2332/allergolint.10-RAI-0231; Shoda T, 2013, ALLERGY, V68, P1467, DOI 10.1111/all.12240	26	5	5	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	APR	2015	64	2					175	180		10.1016/j.alit.2014.07.003		6	Allergy; Immunology	Allergy; Immunology	CH0ZV	WOS:000353751800010		
J	Takai, T; Okamoto, Y; Okubo, K; Nagata, M; Sakaguchi, M; Fukutomi, Y; Saito, A; Yasueda, H; Masuyama, K				Takai, Toshiro; Okamoto, Yoshitaka; Okubo, Kimihiro; Nagata, Makoto; Sakaguchi, Masahiro; Fukutomi, Yuma; Saito, Akemi; Yasueda, Hiroshi; Masuyama, Keisuke			Japanese Society of Allergology task force report on standardization of house dust mite allergen vaccines - Secondary publication	ALLERGOLOGY INTERNATIONAL			English	Article						House dust mite allergen standardization; Intradermal testing; In vivo allergenic potency; Major allergen content; Surrogate in vitro assay	IMMUNOTHERAPY; EXTRACTS; GUIDELINE	Background: In the 1990s, the Japanese Society of Allergology (JSA) standardized Japanese cedar pollen allergen vaccines. In the present study, the task force for house dust mite (HDM) allergen standardization of the Committee for Allergens and Immunotherapy of JSA reports the standardization of HDM allergen vaccines in Japan. Methods: In vivo allergenic potency was determined by intradermal testing of 51 Japanese adults with positive serum specific IgE to HDM allergens. In vitro total IgE binding potency was analyzed by competition ELISA using a pooled serum, with sera obtained from 10 allergic patients. The amounts of HDM group 1 (Der 1) and group 2 major allergens in eight HDM allergen extracts were measured by sandwich ELISAs. Correlation between the in vitro total IgE binding potency and major allergen levels was analyzed. Results: We selected a JSA reference HDM extract and determined its in vivo allergenic potency. The in vitro total IgE binding potency significantly correlated with Der 1 content, group 2 allergen content, and their combined amount, indicating that measurement of major allergen contents can be used as a surrogate in vitro assay. Conclusions: The task force determined the in vivo allergenic potency (100,000 JAU/ml) and Der 1 content (38.5 mu g/ml) of the JSA reference HDM extract, selected the measurement of Der 1 content as the surrogate in vitro assay, and decided that manufacturers can label a HDM allergen extract as having a titer of 100,000 JAU/ml if it contains 22.2-66.7 mu g/ml of Der 1. Copyright (C) 2015, Japanese Society of Allergology. Production and hosting by Elsevier B.V. All rights reserved.	[Takai, Toshiro; Okamoto, Yoshitaka; Okubo, Kimihiro; Nagata, Makoto; Sakaguchi, Masahiro; Fukutomi, Yuma; Yasueda, Hiroshi; Masuyama, Keisuke] Japanese Soc Allergol, Comm Allergens & Immunotherapy, Task Force House Dust Mite Allergen Standardizat, Tokyo, Japan; [Takai, Toshiro] Juntendo Univ, Grad Sch Med, Atopy Allergy, Tokyo, Japan; [Okamoto, Yoshitaka] Chiba Univ, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Chiba, Japan; [Okubo, Kimihiro] Nippon Med Sch, Grad Sch Med, Dept Head & Neck Sensory Organ Sci Otolaryngol, Tokyo 113, Japan; [Nagata, Makoto] Saitama Med Univ, Dept Resp Med, Saitama, Japan; [Nagata, Makoto] Saitama Med Univ, Allergy Ctr, Saitama, Japan; [Sakaguchi, Masahiro] Azabu Univ, Sch Vet Med, Lab Microbiol 1, Sagamihara, Kanagawa, Japan; [Fukutomi, Yuma; Saito, Akemi; Yasueda, Hiroshi] Sagamihara Natl Hosp, Clin Res Ctr Allergy & Rheumatol, Sagamihara, Kanagawa, Japan; [Masuyama, Keisuke] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Otorhinolaryngol Head & Neck Surg, Kofu, Yamanashi 4093898, Japan	Masuyama, K (reprint author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Otorhinolaryngol Head & Neck Surg, Kofu, Yamanashi 4093898, Japan.	mkeisuke@yamanashi.ac.jp			Ministry of Heath, Labour, and Welfare of Japan [H25-General-007]; Japanese Society of Allergology	This work was financially supported by a Grant-in-Aid for Scientific Research from the Ministry of Heath, Labour, and Welfare of Japan (Immunologic and Allergic Diseases Prevention and Treatment Research Enterprise, Immunology and Allergy Research Field, H25-General-007) (Group Leader: Kimihiro Okubo) and the Japanese Society of Allergology.	Fujieda S, 2012, AURIS NASUS LARYNX, V39, P553, DOI 10.1016/j.anl.2011.12.006; Sakaguchi M, 1997, IMMUNOLOGY, V91, P161, DOI 10.1046/j.1365-2567.1997.00255.x; Okubo K, 2014, ALLERGOL INT, V63, P357, DOI 10.2332/allergolint.14-RAI-0768; [Anonymous], 1998, ARERUGI JPN J ALLERG, V47, P698; Thomas WR, 2010, TRENDS MOL MED, V16, P321, DOI 10.1016/j.molmed.2010.04.008; Esch RE, 2013, CURR ALLERGY ASTHM R, V13, P406, DOI 10.1007/s11882-013-0358-8; Bousquet J, 1998, J ALLERGY CLIN IMMUN, V102, P558, DOI 10.1016/S0091-6749(98)70271-4; Nelson HS, 2007, J ALLERGY CLIN IMMUN, V119, P769, DOI 10.1016/j.jaci.2007.01.036; Burks AW, 2013, J ALLERGY CLIN IMMUN, V131, P1288, DOI 10.1016/j.jaci.2013.01.049; BAER H, 1970, J ALLERGY, V45, P347, DOI 10.1016/0021-8707(70)90043-2; Fernández-Caldas Enrique, 2008, Clin Allergy Immunol, V21, P161; Filep S, 2012, J ALLERGY CLIN IMMUN, V129, P1408, DOI 10.1016/j.jaci.2011.12.978; Filep S, 2012, ALLERGY, V67, P235, DOI 10.1111/j.1398-9995.2011.02750.x; ISHIZAKI T, 1963, Arerugi, V12, P14; Johansson SGO, 1998, ALLERGY, V53, P1; Larenas-Linnemann D, 2011, ANN ALLERG ASTHMA IM, V107, P448, DOI 10.1016/j.anai.2011.07.001; Larenas-Linnemann D, 2011, ANN ALLERG ASTHMA IM, V107, pe3; Larsen Jørgen Nedergaard, 2008, Clin Allergy Immunol, V21, P283; LIU DT, 1994, ARB PEI GSH, V87, P7; Noon L, 1911, LANCET, V1, P1572; Okamoto Y, 2014, AURIS NASUS LARYNX, V41, P1, DOI 10.1016/j.anl.2013.06.003; Slater JE, 2008, CLIN ALLERGY IMMUNOL, V21, pe3; Slater Jay E, 2008, Clin Allergy Immunol, V21, P273; Turkeltaub PC, 1988, ALLERGY PRINCIPLES P, P388; Turkeltaub PC, 1986, OFFICE BIOL RES REV, V3rd, P1; vanRee R, 1997, ALLERGY, V52, P795; Yasue H, 1996, Arerugi, V45, P416; YASUEDA H, 1989, INT ARCH ALLER A IMM, V90, P182; Yasueda H, 1996, CLIN EXP ALLERGY, V26, P171, DOI 10.1111/j.1365-2222.1996.tb00076.x; Yasueda H, 1991, Arerugi, V40, P1218; YASUEDA H, 1994, CLIN EXP ALLERGY, V24, P1030, DOI 10.1111/j.1365-2222.1994.tb02739.x; Yasueda Hiroshi, 1997, Allergology International, V46, P135, DOI 10.2332/allergolint.46.135	32	2	3	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	APR	2015	64	2					181	186		10.1016/j.alit.2015.01.005		6	Allergy; Immunology	Allergy; Immunology	CH0ZV	WOS:000353751800011		
J	Okada, Y; Yanagida, N; Sato, S; Ogawa, A; Ogura, K; Nagakura, K; Emura, S; Asaumi, T; Unno, H; Manabe, T; Ogura, K; Iikura, K; Ebisawa, M				Okada, Yu; Yanagida, Noriyuki; Sato, Sakura; Ogawa, Ayako; Ogura, Kanako; Nagakura, Kenichi; Emura, Shigehito; Asaumi, Tomoyuki; Unno, Hirotoshi; Manabe, Tetsuharu; Ogura, Kiyotake; Iikura, Katsuhito; Ebisawa, Motohiro			Oral immunotherapy initiation for multi-nut allergy: A case report	ALLERGOLOGY INTERNATIONAL			English	Letter							PEANUT ALLERGY; IGE		[Okada, Yu; Yanagida, Noriyuki; Nagakura, Kenichi; Emura, Shigehito; Asaumi, Tomoyuki; Unno, Hirotoshi; Manabe, Tetsuharu; Iikura, Katsuhito] Sagamihara Natl Hosp, Dept Pediat, Sagamihara, Kanagawa 2520392, Japan; [Sato, Sakura; Ogawa, Ayako; Ogura, Kanako; Ogura, Kiyotake; Ebisawa, Motohiro] Sagamihara Natl Hosp, Dept Allergy, Clin Res Ctr Allergol & Rheumatol, Sagamihara, Kanagawa 2520392, Japan	Ebisawa, M (reprint author), Sagamihara Natl Hosp, Dept Allergy, Clin Res Ctr Allergol & Rheumatol, Minami Ku, 18-1 Sakuradai, Sagamihara, Kanagawa 2520392, Japan.	m-ebisawa@sagamihara-hosp.gr.jp					Eller E, 2013, ALLERGY, V68, P190, DOI 10.1111/all.12075; Jones Stacie M, 2009, J Allergy Clin Immunol, V124, P292, DOI 10.1016/j.jaci.2009.05.022; Ebisawa M, 2012, PEDIAT ALLERG IMM-UK, V23, P573, DOI 10.1111/j.1399-3038.2012.01332.x; Sato S, 2014, INT ARCH ALLERGY IMM, V164, P1, DOI 10.1159/000361025; Vickery BP, 2014, J ALLERGY CLIN IMMUN, V133, P468, DOI 10.1016/j.jaci.2013.11.007; Sicherer SH, 2007, J ALLERGY CLIN IMMUN, V120, P491, DOI 10.1016/j.jaci.2007.07.015; Begin P, 2014, ALLERGY ASTHMA CL IM, V10, DOI 10.1186/1710-1492-10-1; Bird JA, 2012, ANN ALLERG ASTHMA IM, V109, P470, DOI 10.1016/j.anai.2012.09.004	8	0	0	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	APR	2015	64	2					192	193		10.1016/j.alit.2014.09.004		2	Allergy; Immunology	Allergy; Immunology	CH0ZV	WOS:000353751800014		
J	Numata, T; Kobayashi, Y; Ito, T; Harada, K; Tsuboi, R; Okubo, Y				Numata, Takafumi; Kobayashi, Yuko; Ito, Tomonobu; Harada, Kazutoshi; Tsuboi, Ryoji; Okubo, Yukari			Two cases of allergic contact dermatitis due to skin-whitening cosmetics	ALLERGOLOGY INTERNATIONAL			English	Letter									[Numata, Takafumi; Kobayashi, Yuko; Ito, Tomonobu; Harada, Kazutoshi; Tsuboi, Ryoji; Okubo, Yukari] Tokyo Med Univ, Dept Dermatol, Tokyo 1600023, Japan	Numata, T (reprint author), Tokyo Med Univ, Dept Dermatol, Shinjuku Ku, 6-7-1 Nishi Shinjuku, Tokyo 1600023, Japan.	numata921@gmail.com					Yagami A, 2014, CONTACT DERMATITIS, V70, P376, DOI 10.1111/cod.12161; Haramoto I, 1995, NISHINIHON J DERMATO, V57, P594; Matsunaga K, 1995, AESTHETIC DERMATOLOG, V5, P81; Nishioka K, 1999, CONTACT DERMATITIS, V40, P56, DOI 10.1111/j.1600-0536.1999.tb05986.x	4	0	0	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	APR	2015	64	2					194	195		10.1016/j.alit.2014.10.007		2	Allergy; Immunology	Allergy; Immunology	CH0ZV	WOS:000353751800015		
J	Tanaka, S; Tamari, M; Nakayama, T; Ishii, H; Hatsushika, K; Hayashi, A; Watanabe, H; Kanai, M; Osano, M; Yonaga, T; Tomita, K; Fujieda, S; Sakuma, Y; Shiono, O; Ishitoya, J; Masuyama, K; Hirota, T				Tanaka, Shota; Tamari, Mayumi; Nakayama, Tsuguhisa; Ishii, Hiroki; Hatsushika, Kyosuke; Hayashi, Akira; Watanabe, Hiroyuki; Kanai, Mari; Osano, Masashi; Yonaga, Takaaki; Tomita, Kaori; Fujieda, Shigeharu; Sakuma, Yasunori; Shiono, Osamu; Ishitoya, Junichi; Masuyama, Keisuke; Hirota, Tomomitsu			Synergistic suppression of Poly(I:C)-induced CCL3 by a corticosteroid and a long acting beta 2 agonist in nasal epithelial cells	ALLERGOLOGY INTERNATIONAL			English	Letter							CHEMOKINES; ASTHMA		[Tanaka, Shota; Tamari, Mayumi; Nakayama, Tsuguhisa; Hirota, Tomomitsu] RIKEN, Inst Phys & Chem Res, Lab Resp & Allerg Dis, Ctr Integrat Med Sci, Yokohama, Kanagawa 2300045, Japan; [Tanaka, Shota; Ishii, Hiroki; Hatsushika, Kyosuke; Hayashi, Akira; Watanabe, Hiroyuki; Kanai, Mari; Osano, Masashi; Yonaga, Takaaki; Masuyama, Keisuke] Univ Yamanashi, Fac Med, Dept Otolaryngol Head & Neck Surg, Yamanashi, Japan; [Nakayama, Tsuguhisa] Jikei Univ, Sch Med, Dept Otorhinolaryngol, Tokyo, Japan; [Tomita, Kaori; Fujieda, Shigeharu] Univ Fukui, Fac Med, Dept Otorhinolaryngol Head & Neck Surg, Fukui 910, Japan; [Sakuma, Yasunori; Shiono, Osamu; Ishitoya, Junichi] Yokohama City Univ, Med Ctr, Dept Otorhinolaryngol, Yokohama, Kanagawa, Japan	Tamari, M (reprint author), RIKEN, Inst Phys & Chem Res, Lab Resp & Allerg Dis, Ctr Integrat Med Sci,Tsurumi Ku, 1-7-22 Suehiro, Yokohama, Kanagawa 2300045, Japan.	tamari@src.riken.jp	Tamari, Mayumi/N-5378-2015				Menten P, 2002, CYTOKINE GROWTH F R, V13, P455, DOI 10.1016/S1359-6101(02)00045-X; Jackson DJ, 2010, J ALLERGY CLIN IMMUN, V125, P1178, DOI 10.1016/j.jaci.2010.04.021; Proud D, 2011, IMMUNOL REV, V242, P186, DOI 10.1111/j.1600-065X.2011.01033.x; Proud D, 2006, AM J RESP CELL MOL, V35, P513, DOI 10.1165/rcmb.2006-0199TR; Harada M, 2011, AM J RESP CELL MOL, V44, P787, DOI 10.1165/rcmb.2009-0418OC; Edwards MR, 2006, AM J RESP CELL MOL, V34, P616, DOI 10.1165/rcmb.2005-0385OC; Johnson M, 1998, AM J RESP CRIT CARE, V158, pS146; DAVIS PB, 1990, AM J PHYSIOL, V258, pC71; Fokkens WJ, 2012, RHINOLOGY, V50, P1; Haeberle HA, 2001, J VIROL, V75, P878, DOI 10.1128/JVI.75.2.878-890.2001	10	0	0	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	APR	2015	64	2					196	199		10.1016/j.alit.2014.10.006		4	Allergy; Immunology	Allergy; Immunology	CH0ZV	WOS:000353751800016		
J	Ito, T; Tatsuno, K; Sakabe, J; Fujiyama, T; Tokura, Y				Ito, Taisuke; Tatsuno, Kazuki; Sakabe, Jun-ichi; Fujiyama, Toshiharu; Tokura, Yoshiki			Antihistaminic drug olopatadine downmodulates T cell chemotaxis toward CCL17 in patients with atopic dermatitis	ALLERGOLOGY INTERNATIONAL			English	Letter							ANTIALLERGIC DRUG; INTERLEUKIN-31 LEVELS; LANGERHANS CELLS; ALOPECIA-AREATA; HYDROCHLORIDE; THYMUS; CXCL10; MODEL; TARC		[Ito, Taisuke; Tatsuno, Kazuki; Sakabe, Jun-ichi; Fujiyama, Toshiharu; Tokura, Yoshiki] Hamamatsu Univ Sch Med, Dept Dermatol, Hamamatsu, Shizuoka 4313192, Japan	Ito, T (reprint author), Hamamatsu Univ Sch Med, Dept Dermatol, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	itoutai@hama-med.ac.jp					Ito T, 2013, J DERMATOL SCI, V69, P140, DOI 10.1016/j.jdermsci.2012.12.003; Ohmori K, 2002, JPN J PHARMACOL, V88, P379, DOI 10.1254/jjp.88.379; Saeki H, 2006, J DERMATOL SCI, V43, P75, DOI 10.1016/j.jdermsci.2006.06.002; Kyoya M, 2014, J DERMATOL SCI, V75, P204, DOI 10.1016/j.jdermsci.2014.06.001; Morita E, 2010, ALLERGY, V65, P1166, DOI 10.1111/j.1398-9995.2010.02361.x; Yanni JM, 1999, ARCH OPHTHALMOL-CHIC, V117, P643; Cook EB, 2000, ANN ALLERG ASTHMA IM, V84, P504; Furukawa H, 2004, J DERMATOL SCI, V36, P165, DOI 10.1016/j.jdermsci.2004.09.001; Higashi M, 2013, ALLERGOL INT, V62, P137, DOI 10.2332/allergolint.12-LE-0466; Ito T, 2013, J DERMATOL SCI, V72, P68, DOI 10.1016/j.jdermsci.2013.04.029; Murota H, 2014, ACTA DERM-VENEREOL, V94, P78, DOI 10.2340/00015555-1648; Sugita K, 2009, J DERMATOL, V36, P654, DOI 10.1111/j.1346-8138.2009.00726.x; Tokura Y, 2003, CELL IMMUNOL, V224, P47, DOI 10.1016/j.cellimm.2003.08.002	13	0	0	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	APR	2015	64	2					200	202		10.1016/j.alit.2014.10.008		3	Allergy; Immunology	Allergy; Immunology	CH0ZV	WOS:000353751800017		
J	Yokooji, T; Okamura, Y; Chinuki, Y; Morita, E; Harada, S; Hiragun, M; Hide, M; Matsuo, H				Yokooji, Tomoharu; Okamura, Yui; Chinuki, Yuko; Morita, Eishin; Harada, Susumu; Hiragun, Makiko; Hide, Michihiro; Matsuo, Hiroaki			Prevalences of specific IgE to wheat gliadin components in patients with wheat-dependent exercise-induced anaphylaxis	ALLERGOLOGY INTERNATIONAL			English	Letter							OMEGA-5 GLIADIN; FACIAL SOAP; SENSITIVITY; DIAGNOSIS; PROTEIN		[Yokooji, Tomoharu; Matsuo, Hiroaki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pathophysiol & Therapeut, Hiroshima 7348553, Japan; [Yokooji, Tomoharu; Okamura, Yui; Matsuo, Hiroaki] Hiroshima Univ, Fac Pharmaceut Sci, Hiroshima 7348553, Japan; [Chinuki, Yuko; Morita, Eishin] Shimane Univ, Fac Med, Dept Dermatol, Matsue, Shimane, Japan; [Harada, Susumu] Harada Skin Clin, Kobe, Hyogo, Japan; [Hiragun, Makiko; Hide, Michihiro] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Dermatol, Hiroshima 7348553, Japan	Matsuo, H (reprint author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pathophysiol & Therapeut, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	hmatsuo@hiroshima-u.ac.jp					Yokooji T, 2013, ALLERGOL INT, V62, P435, DOI 10.2332/allergolint.13-OA-0561; Matsuo H, 2004, J BIOL CHEM, V279, P12135, DOI 10.1074/jbc.M311340200; Takahashi H, 2012, CLIN EXP ALLERGY, V42, P1293, DOI 10.1111/j.1365-2222.2012.04039.x; Matsuo H, 2008, ALLERGY, V63, P233, DOI 10.1111/j.1398-9995.2007.01504.x; Hiragun M, 2013, ALLERGOL INT, V62, P351, DOI 10.2332/allergolint.13-OA-0553; Denery-Papini S, 2012, ALLERGY, V67, P1023, DOI 10.1111/j.1398-9995.2012.02860.x; Fukutomi Y, 2011, J ALLERGY CLIN IMMUN, V127, P531, DOI 10.1016/j.jaci.2010.09.035; Chinuki Y, 2012, ALLERGOL INT, V61, P529, DOI 10.2332/allergolint.12-RAI-0494; Morita E, 2013, J DERMATOL SCI, V71, P155, DOI 10.1016/j.jdermsci.2013.04.010	9	2	2	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	APR	2015	64	2					206	208		10.1016/j.alit.2014.11.003		3	Allergy; Immunology	Allergy; Immunology	CH0ZV	WOS:000353751800019		
J	Nakamura, Y; Nagashima, H; Ohta, S; Ono, J; Yamauchi, K; Izuhara, K				Nakamura, Yutaka; Nagashima, Hiromi; Ohta, Shoichiro; Ono, Junya; Yamauchi, Kohei; Izuhara, Kenji			Periostin in the bronchial lavage fluid of asthma patients	ALLERGOLOGY INTERNATIONAL			English	Letter							INFLAMMATION; IL-13; ROLES		[Nakamura, Yutaka; Nagashima, Hiromi; Yamauchi, Kohei] Iwate Med Univ, Sch Med, Dept Internal Med, Div Pulm Med Allergy & Rheumatol, Morioka, Iwate, Japan; [Ohta, Shoichiro] Saga Med Sch, Dept Lab Med, Saga 8498501, Japan; [Ono, Junya] Shino Test Corp, Sagamihara, Kanagawa, Japan; [Izuhara, Kenji] Saga Med Sch, Dept Biomol Sci, Div Med Biochem, Saga, Japan	Izuhara, K (reprint author), Saga Med Sch, Dept Biomol Sci, Div Med Biochem, 5-1-1 Nabeshima, Saga 8498501, Japan.	kyamauchi@iwate-med.ac.jp; kizuhara@cc.saga-u.ac.jp					Takayama G, 2006, J ALLERGY CLIN IMMUN, V118, P98, DOI 10.1016/j.jaci.2006.02.046; Kanemitsu Y, 2013, J ALLERGY CLIN IMMUN, V132, P305, DOI 10.1016/j.jaci.2013.04.050; Izuhara K, 2014, ALLERGOL INT, V63, P143, DOI 10.2332/allergolint.13-RAI-0663; Nagashima Hiromi, 2011, Allergology International, V60, P291, DOI 10.2332/allergolint.10-OA-0259; Kim MA, 2014, ANN ALLERG ASTHMA IM, V113, P314, DOI 10.1016/j.anai.2014.06.014; Sidhu SS, 2010, P NATL ACAD SCI USA, V107, P14170, DOI 10.1073/pnas.1009426107; Matsusaka M, 2015, ALLERGOL INT, V64, P175, DOI 10.1016/j.alit.2014.07.003; Nagasaki T, 2014, J ALLERGY CLIN IMMUN, V133, P1474, DOI 10.1016/j.jaci.2013.12.1084; Ohta N, 2014, ALLERGOL INT, V63, P171, DOI 10.2332/allergolint.13-RAI-0673; Shoda T, 2013, ALLERGY, V68, P1467, DOI 10.1111/all.12240	10	1	1	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	APR	2015	64	2					209	210		10.1016/j.alit.2015.01.001		2	Allergy; Immunology	Allergy; Immunology	CH0ZV	WOS:000353751800020		
J	Kobayashi, T; Ito, T; Egusa, C; Maeda, T; Numata, T; Okubo, Y; Tsuboi, R				Kobayashi, Tomoko; Ito, Tomonobu; Egusa, Chizu; Maeda, Tasuo; Numata, Takafumi; Okubo, Yukari; Tsuboi, Ryoji			A case of contact urticaria inducing anaphylaxis due to liliaceae vegetables in a hand eczema patient	ALLERGOLOGY INTERNATIONAL			English	Letter							ALLERGY		[Kobayashi, Tomoko; Ito, Tomonobu; Egusa, Chizu; Maeda, Tasuo; Numata, Takafumi; Okubo, Yukari; Tsuboi, Ryoji] Tokyo Med Univ, Dept Dermatol, Tokyo 1600023, Japan	Ito, T (reprint author), Tokyo Med Univ, Dept Dermatol, Shinjuku Ku, 6-7-1 Nishi Shinjuku, Tokyo 1600023, Japan.	tomonobu@tokyo-med.ac.jp					Anibarro B, 1997, J ALLERGY CLIN IMMUN, V100, P734, DOI 10.1016/S0091-6749(97)70266-5; AMLOT PL, 1987, CLIN ALLERGY, V17, P33, DOI 10.1111/j.1365-2222.1987.tb02317.x; Perez-Pimiento AJ, 1999, ALLERGY, V54, P626, DOI 10.1034/j.1398-9995.1999.00806.x; Arochena L, 2012, J INVEST ALLERG CLIN, V22, P441; CRONIN E, 1987, CONTACT DERMATITIS, V17, P265, DOI 10.1111/j.1600-0536.1987.tb01475.x; Jappe U, 1999, Am J Contact Dermat, V10, P37, DOI 10.1016/S1046-199X(99)90092-1; Sanchez-Hernandez MC, 2000, ALLERGY, V55, P297, DOI 10.1034/j.1398-9995.2000.00460.x; VONKROGH G, 1981, J AM ACAD DERMATOL, V5, P328, DOI 10.1016/S0190-9622(81)70099-9	8	0	0	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	APR	2015	64	2					211	213		10.1016/j.alit.2014.12.005		3	Allergy; Immunology	Allergy; Immunology	CH0ZV	WOS:000353751800021		
J	Oda, Y; Fukunaga, A; Tsujimoto, M; Hatakeyama, M; Washio, K; Nishigori, C				Oda, Yoshiko; Fukunaga, Atsushi; Tsujimoto, Mariko; Hatakeyama, Mayumi; Washio, Ken; Nishigori, Chikako			Combined cholinergic urticaria and cold-induced cholinergic urticaria with acquired idiopathic generalized anhidrosis	ALLERGOLOGY INTERNATIONAL			English	Letter							SERUM; SWEAT		[Oda, Yoshiko; Fukunaga, Atsushi; Tsujimoto, Mariko; Hatakeyama, Mayumi; Washio, Ken; Nishigori, Chikako] Kobe Univ, Grad Sch Med, Div Dermatol, Dept Internal Med, Kobe, Hyogo 6500017, Japan	Fukunaga, A (reprint author), Kobe Univ, Grad Sch Med, Div Dermatol, Dept Internal Related,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	atsushi@med.kobe-u.ac.jp					Takahagi S, 2009, BRIT J DERMATOL, V160, P426, DOI 10.1111/j.1365-2133.2008.08862.x; Duke WW, 1924, J AMER MED ASSOC, V83, P3; FARNAM J, 1986, J ALLERGY CLIN IMMUN, V78, P353, DOI 10.1016/S0091-6749(86)80089-6; Fukunaga A, 2005, J ALLERGY CLIN IMMUN, V116, P397, DOI 10.1016/j.jaci.2005.05.024; Fukunaga A, 2009, BRIT J DERMATOL, V160, P1337, DOI 10.1111/j.1365-2133.2009.09113.x; INOUE S, 1980, J ALLERGY CLIN IMMUN, V66, P299, DOI 10.1016/0091-6749(80)90025-1; KAPLAN AP, 1981, J ALLERGY CLIN IMMUN, V68, P438; ORMEROD AD, 1988, BRIT J DERMATOL, V118, P621, DOI 10.1111/j.1365-2133.1988.tb02562.x; Sawada Y, 2014, J INVEST DERMATOL, V134, P276, DOI 10.1038/jid.2013.244	9	0	0	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	APR	2015	64	2					214	215		10.1016/j.alit.2014.12.004		2	Allergy; Immunology	Allergy; Immunology	CH0ZV	WOS:000353751800022		
J	Sakurai, Y; Morioke, S; Takeda, T; Takahagi, S; Hide, M; Shima, M				Sakurai, Yoshihiko; Morioke, Satoshi; Takeda, Tomohiro; Takahagi, Shunsuke; Hide, Michihiro; Shima, Midori			Increased thrombin generation potential in patients with chronic spontaneous urticaria (vol 64, pg 96, 2015)	ALLERGOLOGY INTERNATIONAL			English	Correction									[Sakurai, Yoshihiko; Takeda, Tomohiro; Shima, Midori] Nara Med Univ, Sch Med, Dept Pediat, Nara, Japan; [Sakurai, Yoshihiko] Matsubara Tokushukai Hosp, Dept Pediat, Tokyo, Japan; [Morioke, Satoshi; Takahagi, Shunsuke; Hide, Michihiro] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Dermatol, Integrated Hlth Sci, Hiroshima 730, Japan; [Takeda, Tomohiro] Kansai Univ Hlth Sci, Dept Clin Lab Sci, Awaji, Hyogo, Japan	Sakurai, Y (reprint author), Nara Med Univ, Sch Med, Dept Pediat, Nara, Japan.	ysakurai-th@umin.ac.jp					Sakurai Y, 2015, ALLERGOL INT, V64, P96, DOI 10.1016/j.alit.2014.07.006	1	0	0	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	APR	2015	64	2					216	216		10.1016/j.alit.2015.02.002		1	Allergy; Immunology	Allergy; Immunology	CH0ZV	WOS:000353751800023		
J	Inokuchi, R; Fukuda, T; Inokuchi, R; Nakamura, K				Ebisawa, Kazutoshi; Fukuda, Tatsuma; Inokuchi, Ryota; Nakamura, Kensuke			Recombinant thrombomodulin monotherapy for secondary thrombotic thrombocytopenic purpura	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							HUMAN SOLUBLE THROMBOMODULIN; HEMOLYTIC-UREMIC SYNDROME; RITUXIMAB; MICROANGIOPATHY; PROTEIN	The use of plasma exchange for the treatment of thrombotic thrombocytopenic purpura (TTP) has reduced the mortality rate, but it remains high, at 20%. Steroids, rituximab, and eculizumab are sometimes used in addition to plasma exchange, but their use is associated with adverse effects, including immunosuppression. Several studies reported that the concomitant use of recombinant thrombomodulin (rTM) in the treatment of TTP was useful; however, no studies have reported the successful treatment of TTP with rTM alone. We present the first case of TTP successfully treated by rTM. Because previous studies showed that rTM alleviates vascular endothelial damage, this agent is also theoretically useful for the treatment of TTP. Recombinant thrombomodulinwould be significant in alleviating vascular endothelial damage and decreasing the organ's damage.	[Ebisawa, Kazutoshi; Fukuda, Tatsuma; Inokuchi, Ryota; Nakamura, Kensuke] Hitachi Gen Hosp, Dept Emergency & Crit Care Med, Ibaraki 3170077, Japan; [Fukuda, Tatsuma; Inokuchi, Ryota; Nakamura, Kensuke] Univ Tokyo, Univ Hosp, Dept Emergency & Crit Care Med, Tokyo 1138655, Japan; [Inokuchi, Ryota] JR Gen Hosp, Dept Emergency Med, Sbuya Ku, Tokyo 1518528, Japan	Inokuchi, R (reprint author), Hitachi Gen Hosp, Dept Emergency & Crit Care Med, 2-1-1 Jonan Hitachi, Ibaraki 3170077, Japan.	utmed18@live.jp					Abeyama K, 2005, J CLIN INVEST, V115, P1267, DOI 10.1172/JCI200522782; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Tsai E, 2013, BRIT J HAEMATOL, V162, P558, DOI 10.1111/bjh.12387; Nishijima Y, 2013, INTERNAL MED, V52, P1111, DOI 10.2169/internalmedicine.52.9180; Ohlin AK, 2005, J THROMB HAEMOST, V3, P976, DOI 10.1111/j.1538-7836.2005.01267.x; Sakai M, 2010, BONE MARROW TRANSPL, V45, P803, DOI 10.1038/bmt.2009.242; Inoue Y, 2011, THROMB RES, V127, P603, DOI 10.1016/j.thromres.2010.12.023; Elphick GF, 2009, BLOOD, V113, P4078, DOI 10.1182/blood-2008-09-180968; Scully M, 2007, BRIT J HAEMATOL, V136, P451, DOI 10.1111/j.1365-2141.2006.06448.x; Allford SL, 2003, BRIT J HAEMATOL, V120, P556, DOI 10.1046/j.1365-2141.2003.04049.x; Furlan M, 1998, NEW ENGL J MED, V339, P1578, DOI 10.1056/NEJM199811263392202; Asamiya Y, 2010, INTERNAL MED, V49, P1587, DOI 10.2169/internalmedicine.49.3135; Boyer A, 2004, INTENS CARE MED, V30, P1235, DOI 10.1007/s00134-004-2272-y; Kameda T, 2007, CLIN RHEUMATOL, V26, P2159, DOI 10.1007/s10067-007-0631-0; Matsumoto M, 2004, SEMIN HEMATOL, V41, P68, DOI 10.1053/j.seminhematol.2003.10.009; Okada Keiko, 2012, Rinsho Ketsueki, V53, P235; Tonooka K, 2012, J RHEUMATOL, V39, P1766, DOI 10.3899/jrheum.111137	17	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	APR	2015	33	4							599.e1	10.1016/j.ajem.2014.08.076		3	Emergency Medicine	Emergency Medicine	CG6BP	WOS:000353380800042		
J	Gonai, S; Doi, K; Noguchi, K; Kanao, K; Gommori, S; Saito, Y; Oshiro, K; Takahashi, S; Ito, S; Kiyotsugu, T				Gonai, Shiro; Doi, Kenji; Noguchi, Kei; Kanao, Kunio; Gommori, Satoshi; Saito, Yutaka; Oshiro, Kenichi; Takahashi, Shunsuke; Ito, Soichi; Kiyotsugu, Takuma			Extraoral autoreduction of temporomandibular joint dislocation: a preliminary clinical study	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Letter									[Gonai, Shiro] Higashi Totsuka Mem Hosp, Emergency Dept, Yokohama, Kanagawa, Japan; [Doi, Kenji; Noguchi, Kei; Kanao, Kunio; Gommori, Satoshi; Saito, Yutaka; Oshiro, Kenichi; Takahashi, Shunsuke; Ito, Soichi; Kiyotsugu, Takuma] Kawasaki Municipal Hosp, Emergency Dept, Kawasaki, Kanagawa, Japan	Gonai, S (reprint author), Higashi Totsuka Mem Hosp, Emergency Dept, Yokohama, Kanagawa, Japan.	gonaishiro@gmail.com; doimoimode0209@hotmail.com; tomatito_camilo@yahoo.co.jp; minnaninben.7@gmail.com; spdm4rd9@yahoo.co.jp; yutaka144@hotmail.com; ko5137@hotmail.com; sums20@live.jp; panchita@i.softbank.jp; drtakumaphd@fa2.so-net.ne.jp						0	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	APR	2015	33	4					588	589		10.1016/j.ajem.2015.01.011		3	Emergency Medicine	Emergency Medicine	CG6BP	WOS:000353380800027		
J	Ozawa, T				Ozawa, Takeaki			A SPECIAL ISSUE ON MOLECULAR IMAGING FOR BIOANALYSIS	ANALYTICAL SCIENCES			English	Editorial Material									Univ Tokyo, Sch Sci, Dept Chem, Tokyo 1138654, Japan	Ozawa, T (reprint author), Univ Tokyo, Sch Sci, Dept Chem, Tokyo 1138654, Japan.	ozawa@chem.s.u-tokyo.ac.jp						0	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	APR	2015	31	4			SI		243	243				1	Chemistry, Analytical	Chemistry	CG9TR	WOS:000353663500001		
J	Komatsu, T; Urano, Y				Komatsu, Toru; Urano, Yasuteru			Evaluation of Enzymatic Activities in Living Systems with Small-molecular Fluorescent Substrate Probes	ANALYTICAL SCIENCES			English	Review						Enzymes; fluorescent substrates; fluorescence imaging; medicinal chemistry; chemical biology	GLUTATHIONE-S-TRANSFERASE; PROTEIN-PROTEIN INTERACTIONS; BETA-GALACTOSIDASE ACTIVITY; GAMMA-GLUTAMYL-TRANSFERASE; CHEMICAL GENETICS APPROACH; RESONANCE ENERGY-TRANSFER; DIPEPTIDYL PEPTIDASE-IV; IN-VIVO; ALDEHYDE DEHYDROGENASE; 2-DIMENSIONAL ELECTROPHORESIS	In this review, we aim to present an overview of how small-molecular fluorescent substrate probes for studying enzymatic functions are developed and how they are used in biological applications, under the following four headings: (1) History of Visual Detection of Enzymatic Activities, (2) Strategies to Design Fluorescent Substrate Probes to Measure Enzymatic Activities, (3) Development of Fluorescent Substrate Probes Suitable for Biological Studies, and (4) Biological Applications of Fluorescent Substrate Probes for Studying Enzymes.	[Komatsu, Toru; Urano, Yasuteru] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Urano, Yasuteru] Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; [Komatsu, Toru] JST PRESTO, Kawaguchi, Saitama 3320012, Japan	Urano, Y (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	uranokun@m.u-tokyo.ac.jp					Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; Stockwell BR, 2000, NAT REV GENET, V1, P116, DOI 10.1038/35038557; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; Bremer C, 2001, NAT MED, V7, P743, DOI 10.1038/89126; Takakusa H, 2002, J AM CHEM SOC, V124, P1653, DOI 10.1021/ja011251q; Backes BJ, 2000, NAT BIOTECHNOL, V18, P187; Johnsson N, 2007, ACS CHEM BIOL, V2, P31, DOI 10.1021/cb6003977; Sieber SA, 2006, NAT CHEM BIOL, V2, P274, DOI 10.1038/nchembio781; Fujikawa Y, 2008, J AM CHEM SOC, V130, P14533, DOI 10.1021/ja802423n; Zhang HZ, 2004, BIOORGAN MED CHEM, V12, P3649, DOI 10.1016/j.bmc.2004.04.017; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Bachovchin DA, 2012, NAT REV DRUG DISCOV, V11, P52, DOI 10.1038/nrd3620; Chute JP, 2006, P NATL ACAD SCI USA, V103, P11707, DOI 10.1073/pnas.0603806103; Sakabe M, 2013, J AM CHEM SOC, V135, P409, DOI 10.1021/ja309688m; Edgington LE, 2011, CURR OPIN CHEM BIOL, V15, P798, DOI 10.1016/j.cbpa.2011.10.012; Chang JW, 2012, ANGEW CHEM INT EDIT, V51, P966, DOI 10.1002/anie.201107236; ROTMAN B, 1961, P NATL ACAD SCI USA, V47, P1981, DOI 10.1073/pnas.47.12.1981; Kubinyi H, 2003, NAT REV DRUG DISCOV, V2, P665, DOI 10.1038/nrd1156; MENTLEIN R, 1993, EUR J BIOCHEM, V214, P829, DOI 10.1111/j.1432-1033.1993.tb17986.x; Komatsu T, 2006, J AM CHEM SOC, V128, P15946, DOI 10.1021/ja0657307; Jessen KA, 2005, MOL CANCER THER, V4, P761, DOI 10.1158/1535-7163.MCT-04-0333; Terai T, 2006, J AM CHEM SOC, V128, P6938, DOI 10.1021/ja060729t; Saghatelian A, 2004, P NATL ACAD SCI USA, V101, P10000, DOI 10.1073/pnas.0402784101; Drag M, 2010, J BIOL CHEM, V285, P3310, DOI 10.1074/jbc.M109.060418; Nomura DK, 2010, NAT REV CANCER, V10, P630, DOI 10.1038/nrc2901; Strausberg RL, 2003, SCIENCE, V300, P294, DOI 10.1126/science.1083395; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Oushiki D, 2012, ANAL CHEM, V84, P4404, DOI 10.1021/ac300061a; Yee DJ, 2006, P NATL ACAD SCI USA, V103, P13304, DOI 10.1073/pnas.0604672103; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Saghatelian A, 2005, NAT CHEM BIOL, V1, P130, DOI 10.1038/nchembio0805-130; Kasibhatla S, 2005, P NATL ACAD SCI USA, V102, P12095, DOI 10.1073/pnas.0406731102; Frye S, 2011, NAT REV DRUG DISCOV, V10, P409, DOI 10.1038/nrd3462; Chudakov DM, 2005, TRENDS BIOTECHNOL, V23, P605, DOI 10.1016/j.tibtech.2005.10.005; Kawaguchi M, 2011, J AM CHEM SOC, V133, P12021, DOI 10.1021/ja201028t; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Storms RW, 1999, P NATL ACAD SCI USA, V96, P9118, DOI 10.1073/pnas.96.16.9118; Bollen M, 2000, CRIT REV BIOCHEM MOL, V35, P393, DOI 10.1080/10409230091169249; Blum G, 2005, NAT CHEM BIOL, V1, P203, DOI 10.1038/nchembo728; Schreiber SL, 2005, NAT CHEM BIOL, V1, P64, DOI 10.1038/nchembio0705-64; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; HORWITZ JP, 1964, J MED CHEM, V7, P574, DOI 10.1021/jm00334a044; Simon GM, 2010, J BIOL CHEM, V285, P11051, DOI 10.1074/jbc.R109.097600; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Mizukami S, 1999, FEBS LETT, V453, P356, DOI 10.1016/S0014-5793(99)00755-3; Blair JA, 2007, NAT CHEM BIOL, V3, P229, DOI 10.1038/nchembio856; Watzke A, 2008, ANGEW CHEM INT EDIT, V47, P406, DOI 10.1002/anie.200702811; Kamiya M, 2007, J AM CHEM SOC, V129, P3918, DOI 10.1021/ja067710a; Cai SX, 2003, J MED CHEM, V46, P2474, DOI 10.1021/jm0205200; Zlokarnik G, 1998, SCIENCE, V279, P84, DOI 10.1126/science.279.5347.84; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976; Urano Y, 2005, J AM CHEM SOC, V127, P4888, DOI 10.1021/ja043919h; Ueno T, 2011, NAT METHODS, V8, P642, DOI 10.1038/nmeth.1663; Whitney M, 2010, J BIOL CHEM, V285, P22532, DOI 10.1074/jbc.M110.138297; Weissleder R, 1999, NAT BIOTECHNOL, V17, P375, DOI 10.1038/7933; Yao DF, 2000, CANCER, V88, P761, DOI 10.1002/(SICI)1097-0142(20000215)88:4<761::AID-CNCR5>3.0.CO;2-5; ALAM J, 1990, ANAL BIOCHEM, V188, P245, DOI 10.1016/0003-2697(90)90601-5; Louie AY, 2000, NAT BIOTECHNOL, V18, P321; Froemming MK, 2007, J AM CHEM SOC, V129, P14518, DOI 10.1021/ja072601x; Kamiya M, 2011, J AM CHEM SOC, V133, P12960, DOI 10.1021/ja204781t; Hanaoka K, 2008, CHEM-EUR J, V14, P987, DOI 10.1002/chem.200700785; Komatsu T, 2013, J AM CHEM SOC, V135, P6002, DOI 10.1021/ja401792d; Cai SX, 2006, CURR MED CHEM, V13, P2627; PUSCHEL G, 1982, EUR J BIOCHEM, V126, P359, DOI 10.1111/j.1432-1033.1982.tb06788.x; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; Egawa T, 2011, CHEM COMMUN, V47, P4162, DOI 10.1039/c1cc00078k; Nomura DK, 2011, SCIENCE, V334, P809, DOI 10.1126/science.1209200; Shi HB, 2012, J AM CHEM SOC, V134, P17972, DOI 10.1021/ja3064588; Macarron R, 2011, NAT REV DRUG DISCOV, V10, P188, DOI 10.1038/nrd3368; Wehrman TS, 2006, NAT METHODS, V3, P295, DOI 10.1038/NMETH868; CAMPBELL DM, 1961, CLIN CHIM ACTA, V6, P307, DOI 10.1016/0009-8981(61)90055-9; Chen G, 2005, J AM CHEM SOC, V127, P4544, DOI 10.1021/ja0428457; Drucker D, 2007, NAT REV DRUG DISCOV, V6, P109, DOI 10.1038/nrd2245; FUKASAWA KM, 1981, BIOCHIM BIOPHYS ACTA, V657, P179, DOI 10.1016/0005-2744(81)90141-8; HOPSUHAV.VK, 1966, HISTOCHEMISTRY, V7, P197, DOI 10.1007/BF00577838; Gomoki G, 1939, P SOC EXP BIOL MED, V42, P23; Goto S, 2001, FASEB J, V15, P2702, DOI 10.1096/fj.01-0376com; Gounaris E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002916; HALAZY S, 1989, J AM CHEM SOC, V111, P3484, DOI 10.1021/ja00191a085; HANIGAN MH, 1994, CANCER RES, V54, P286; Harris JL, 2001, J BIOL CHEM, V276, P34941, DOI 10.1074/jbc.M102997200; Haugland R. P, 2005, HDB GUIDE FLUORESCEN; Hoffman MD, 2008, ANAL CHIM ACTA, V627, P50, DOI 10.1016/j.aca.2008.03.032; HOFMANN J, 1984, ANAL CHIM ACTA, V163, P67, DOI 10.1016/S0003-2670(00)81494-4; HUGGINS C, 1947, J BIOL CHEM, V170, P391; JAIN VK, 1991, ANAL BIOCHEM, V199, P119, DOI 10.1016/0003-2697(91)90278-2; JONES RJ, 1995, BLOOD, V85, P2742; Kaiser J, 2008, SCIENCE, V321, P764, DOI 10.1126/science.321.5890.764; Kamada K, 2004, FREE RADICAL BIO MED, V37, P1875, DOI 10.1016/j.freeradbiomed.2004.09.002; Kawaguchi M, 2010, CHEM-EUR J, V16, P13479, DOI 10.1002/chem.201001077; Kumar S, 2004, P NATL ACAD SCI USA, V101, P7943, DOI 10.1073/pnas.0402323101; LANTZ MS, 1994, METHOD ENZYMOL, V235, P563; Lawrence DS, 2003, ACCOUNTS CHEM RES, V36, P401, DOI 10.1021/ar020132s; Lomolino G, 2001, ELECTROPHORESIS, V22, P1021, DOI 10.1002/1522-2683()22:6<1021::AID-ELPS1021>3.3.CO;2-2; Manchenko G. P., 2003, HDB DETECTION ENZYME; Menten ML, 1944, J BIOL CHEM, V153, P471; NAUGHTON MA, 1961, BIOCHEM J, V78, P156; Reboud-Ravaux M. I., 2002, PROTEIN DEGRADATION; SHERMAN WR, 1968, ANAL CHEM, V40, P803, DOI 10.1021/ac60260a045; Rodriguez PC, 2010, ACS CHEM BIOL, V5, P1045, DOI 10.1021/cb100196n; ROTMAN B, 1963, P NATL ACAD SCI USA, V50, P1; Sakagami H, 2005, J BIOL CHEM, V280, P23084, DOI 10.1074/jbc.M413438200; Schafer C, 2001, ACTA ONCOL, V40, P529; SELIGMAN AM, 1951, J AM CHEM SOC, V73, P2086, DOI 10.1021/ja01149a053; Shimazaki Y, 2004, PROTEOMICS, V4, P1406, DOI 10.1002/pmic.200300702; Shimazaki Y, 2000, CLIN CHIM ACTA, V302, P221, DOI 10.1016/S0009-8981(00)00329-6; Simon GM, 2008, NAT CHEM BIOL, V4, P639, DOI 10.1038/nchembio1108-639; SZASZ G, 1967, AM J CLIN PATHOL, V47, P607; Tagore DM, 2009, NAT CHEM BIOL, V5, P23, DOI 10.1038/nchembio.126; Takakusa H, 2003, CHEM-EUR J, V9, P1479, DOI 10.1002/chem.200390167; Urano Y., 2011, SCI TRANS MED, V3; Webb E.C., 1992, ENZYME NOMENCLATURE	115	1	1	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	APR	2015	31	4			SI		257	265				9	Chemistry, Analytical	Chemistry	CG9TR	WOS:000353663500003		
J	Fujioka, Y; Nanbo, A; Nishide, SY; Ohba, Y				Fujioka, Yoichiro; Nanbo, Asuka; Nishide, Shin-ya; Ohba, Yusuke			Fluorescent Protein-based Biosensors to Visualize Signal Transduction beneath the Plasma Membrane	ANALYTICAL SCIENCES			English	Review						Fluorescent protein; FRET; biosensor; endocytosis; Ras; PI3K	PLECKSTRIN-HOMOLOGY-DOMAIN; SINGLE LIVING CELLS; ENERGY-TRANSFER; DYNAMIC-RANGE; CA2+ INDICATORS; NEURAL ACTIVITY; IN-VIVO; GREEN; ACTIVATION; SENSOR	In response to extracellular stimuli, cells display a variety of behaviors, including proliferation, differentiation, morphological changes and migration. The analysis of the spatiotemporal regulation of signal transduction in living cells is needed for a better understanding of such behaviors, and such investigations have been greatly accelerated by the development of fluorescent protein-based biosensors. Currently, by using these biosensors a range of molecular actions, including lipid metabolism, protein activation, and ion dynamics, can be visualized in living cells. We recently reported that intracellular calcium, with its relevant downstream signaling pathways consisting of the small GTPase Ras and the lipid kinase phoshoinositide-3-kinase (PI3K), can be exploited in an efficient incorporation of influenza A viruses into host cells via endocytosis using a set of biosensors based on fluorescent proteins and the principle of Forster resonance energy transfer. Here, we focus this review on fluorescent protein-based biosensors that have been utilized in our recent research reports.	[Fujioka, Yoichiro; Nanbo, Asuka; Nishide, Shin-ya; Ohba, Yusuke] Hokkaido Univ, Grad Sch Med, Dept Cell Physiol, Kita Ku, Sapporo, Hokkaido 0608638, Japan	Ohba, Y (reprint author), Hokkaido Univ, Grad Sch Med, Dept Cell Physiol, Kita Ku, N15W7, Sapporo, Hokkaido 0608638, Japan.	yohba@med.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; Japan Science and Technology Agency; Naito Foundation; Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care	We thank M. Matsuda, J. Miyazaki, A. Miyawaki, and T. Nagai for the expression plasmids, S. Darmanin and T. Mizutani for their dedicated efforts in developing Pickles, M. Fujioka, M. Saito, and A. Kikuchi for their technical assistance, and members of the Ohba laboratory for helpful discussions. This work was supported in part by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan and from the Japan Society for the Promotion of Science as well as by a grant from the Japan Science and Technology Agency, the Naito Foundation, and the Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care.	Akerboom J, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00002; Ananthanarayanan B, 2005, P NATL ACAD SCI USA, V102, P15081, DOI 10.1073/pnas.0502889102; Kuner T, 2000, NEURON, V27, P447, DOI 10.1016/S0896-6273(00)00056-8; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/nmeth.2171, 10.1038/NMETH.2171]; Vinkenborg JL, 2009, NAT METHODS, V6, P737, DOI [10.1038/nmeth.1368, 10.1038/NMETH.1368]; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; MORISE H, 1974, BIOCHEMISTRY-US, V13, P2656, DOI 10.1021/bi00709a028; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Mank M, 2008, NAT METHODS, V5, P805, DOI [10.1038/nmeth.1243, 10.1038/NMETH.1243]; Kitano M, 2008, NATURE, V453, P241, DOI 10.1038/nature06857; Miyawaki A, 1997, NATURE, V388, P882; Varnai P, 1999, J BIOL CHEM, V274, P10983, DOI 10.1074/jbc.274.16.10983; Sato M, 2003, NAT CELL BIOL, V5, P1016, DOI 10.1038/ncb1054; Sakai R, 2001, EUR J NEUROSCI, V13, P2314, DOI 10.1046/j.0953-816x.2001.01617.x; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Klarlund JK, 2000, J BIOL CHEM, V275, P32816, DOI 10.1074/jbc.M002435200; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Ellson CD, 2001, NAT CELL BIOL, V3, P679, DOI 10.1038/35083076; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592; Shcherbo D, 2010, NAT METHODS, V7, P827, DOI [10.1038/nmeth.1501, 10.1038/NMETH.1501]; Palmer AE, 2011, TRENDS BIOTECHNOL, V29, P144, DOI 10.1016/j.tibtech.2010.12.004; Tantama M, 2011, J AM CHEM SOC, V133, P10034, DOI 10.1021/ja202902d; Yoshizaki H, 2007, MOL BIOL CELL, V18, P119, DOI 10.1091/mbc.E06-05-0467; Takao K, 2005, J NEUROSCI, V25, P3107, DOI 10.1523/JNEUROSCI.0085-05.2005; Hancock JF, 2005, BIOCHEM J, V389, P1, DOI 10.1042/BJ20050231; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Tomosugi W, 2009, NAT METHODS, V6, P351, DOI [10.1038/nmeth.1317, 10.1038/NMETH.1317]; Venkateswarlu K, 1998, BIOCHEM J, V335, P139; Takanaga H, 2008, BBA-BIOMEMBRANES, V1778, P1091, DOI 10.1016/j.bbamem.2007.11.015; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; Komatsu N, 2011, MOL BIOL CELL, V22, P4647, DOI 10.1091/mbc.E11-01-0072; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049; Watton SJ, 1999, CURR BIOL, V9, P433, DOI 10.1016/S0960-9822(99)80192-4; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Zhang J, 2005, NATURE, V437, P569, DOI 10.1038/nature04140; Mizutani T, 2010, CLIN CANCER RES, V16, P3964, DOI 10.1158/1078-0432.CCR-10-0548; Wang L, 2004, P NATL ACAD SCI USA, V101, P16745, DOI 10.1073/pnas.0407752101; Cicchetti G, 2004, BIOCHEMISTRY-US, V43, P1939, DOI 10.1021/bi035480w; Craske ML, 2005, J CELL BIOL, V170, P1147, DOI 10.1083/jcb.200503118; Fujioka Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016324; Fujioka Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3763; Hanakam F, 1996, EMBO J, V15, P2935; Horikawa K, 2010, NAT METHODS, V7, P729, DOI 10.1038/nmeth.1488; Kawase K, 2006, DEV CELL, V11, P411, DOI 10.1016/j.devcel.2006.07.008; Kimber WA, 2002, BIOCHEM J, V361, P525, DOI 10.1042/0264-6021:3610525; Sato M, 2000, ANAL CHEM, V72, P5918, DOI 10.1021/ac0006167; Sato M, 2005, ANAL CHEM, V77, P4751, DOI 10.1021/ac040195j; Seth A, 2003, BIOCHEMISTRY-US, V42, P3997, DOI 10.1021/bi026881z; Skwarek LC, 2009, DEV CELL, V16, P12, DOI 10.1016/j.devcel.2008.12.006; Sokac AM, 2003, NAT CELL BIOL, V5, P727, DOI 10.1038/ncb1025; Souslova EA, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-37; Takaya A, 2004, MOL BIOL CELL, V15, P2549, DOI 10.1091/mbc.E03-11-0857; Tsutsumi K, 2009, CELL SIGNAL, V21, P1672, DOI 10.1016/j.cellsig.2009.07.004	64	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	APR	2015	31	4			SI		267	274				8	Chemistry, Analytical	Chemistry	CG9TR	WOS:000353663500004		
J	Nakabayashi, T; Ohta, N				Nakabayashi, Takakazu; Ohta, Nobuhiro			Sensing of Intracellular Environments by Fluorescence Lifetime Imaging of Exogenous Fluorophores	ANALYTICAL SCIENCES			English	Review						Fluorescence lifetime imaging; fluorescence decay; exogenous fluorophore; intracellular environment; intracellular pH; oxygen sensor; ion sensor; apoptosis; acid-base equilibrium	LIVING CELLS; LIVE CELLS; MOLECULAR ROTORS; SINGLE-CELL; REFRACTIVE-INDEX; ELECTRIC-FIELDS; PH MEASUREMENTS; ENHANCED CYAN; QUANTUM DOTS; PROTEIN	Fluorescence lifetime imaging (FLIM) has been recognized as a powerful microscopy technique to examine environments in living systems. The fluorescence lifetime does not depend on the photobleaching and optical conditions, which allows us to obtain quantitative information on intracellular environments by analyzing the fluorescence lifetime. A variety of exogenous fluorophores have been applied in FLIM measurements to examine cellular processes. Information on the correlation between the fluorescence lifetime and the physiological parameters is essential to elucidate the cellular environments from the fluorescence lifetime measurements of exogenous fluorophores. In this review, exogenous fluorophores used for lifetime-based sensing are summarized, with the expectation that it becomes a basis for selecting the fluorophore used to investigate the intracellular environment with FLIM. Experimental results of the intracellular sensing of pH, metal ions, oxygen, viscosity, and other physiological parameters on the basis of the FLIM measurements are described along with a brief explanation of the mechanism of the change in the fluorescence lifetime.	[Nakabayashi, Takakazu] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan; [Ohta, Nobuhiro] Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido 0010020, Japan	Nakabayashi, T (reprint author), Tohoku Univ, Grad Sch Pharmaceut Sci, 6-3 Aoba, Sendai, Miyagi 9808578, Japan.	takan@m.tohoku.ac.jp; nohta@es.hokudai.ac.jp					VERKMAN AS, 1989, ANAL BIOCHEM, V178, P355, DOI 10.1016/0003-2697(89)90652-0; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; Zhang SJ, 2010, CANCER RES, V70, P4490, DOI 10.1158/0008-5472.CAN-09-3948; Nakabayashi T, 2008, CHEM PHYS LETT, V457, P408, DOI 10.1016/j.cplett.2008.04.018; Zhong W, 2003, J PHYS D APPL PHYS, V36, P1689, DOI 10.1088/0022-3727/36/14/306; Regulacio MD, 2010, ACCOUNTS CHEM RES, V43, P621, DOI 10.1021/ar900242r; Wu YL, 2013, PHYS CHEM CHEM PHYS, V15, P14986, DOI 10.1039/c3cp51953h; Chang CC, 2006, ANAL CHEM, V78, P2810, DOI 10.1021/ac052218f; Hille C, 2009, PHOTOCH PHOTOBIO SCI, V8, P319, DOI 10.1039/b813797h; Liu YX, 2006, J PHYS CHEM B, V110, P24138, DOI 10.1021/jp062164t; Kuimova MK, 2008, J AM CHEM SOC, V130, P6672, DOI 10.1021/ja800570d; Peng XJ, 2011, J AM CHEM SOC, V133, P6626, DOI 10.1021/ja1104014; Ruedas-Rama MJ, 2012, ANALYST, V137, P1500, DOI 10.1039/c2an15851e; Wilms CD, 2006, CELL CALCIUM, V40, P73, DOI 10.1016/j.ceca.2006.03.006; Levitt JA, 2009, J PHYS CHEM C, V113, P11634, DOI 10.1021/jp9013493; Suhling K, 2002, BIOPHYS J, V83, P3589; SZMACINSKI H, 1995, SENSOR ACTUAT B-CHEM, V29, P16, DOI 10.1016/0925-4005(95)01658-9; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Alvarez-Pez JM, 2001, J PHYS CHEM A, V105, P6320, DOI 10.1021/jp010372+; Paredes JM, 2013, J PHYS CHEM B, V117, P8143, DOI 10.1021/jp405041c; Chen M, 2013, BIOMATERIALS, V34, P4284, DOI 10.1016/j.biomaterials.2013.02.032; Dean KM, 2014, NAT CHEM BIOL, V10, P512, DOI [10.1038/nchembio.1556, 10.1038/NCHEMBIO.1556]; Haidekker MA, 2007, ORG BIOMOL CHEM, V5, P1669, DOI 10.1039/b618415d; Ormo M, 1996, SCIENCE, V273, P1392; Bouccara S, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.5.051208; Hotzer B, 2011, J FLUORESC, V21, P2143, DOI 10.1007/s10895-011-0916-1; Bizzarri R, 2006, BIOPHYS J, V90, P3300, DOI 10.1529/biophysj.105.074708; Wang HP, 2007, CHEM PHYS LETT, V442, P441, DOI 10.1016/j.cplett.2007.06.034; Agronskaia AV, 2004, J BIOMED OPT, V9, P1230, DOI 10.1117/1.1806472; Marcu L, 2012, ANN BIOMED ENG, V40, P304, DOI 10.1007/s10439-011-0495-y; Borst JW, 2005, J FLUORESC, V15, P153, DOI 10.1007/s10895-005-2523-5; STRICKLER SJ, 1962, J CHEM PHYS, V37, P814, DOI 10.1063/1.1733166; SZMACINSKI H, 1993, ANAL CHEM, V65, P1668, DOI 10.1021/ac00061a007; Shang L, 2011, SMALL, V7, P2614, DOI 10.1002/smll.201100746; Mohanty J, 2013, J AM CHEM SOC, V135, P367, DOI 10.1021/ja309588h; Ruedas-Rama MJ, 2011, CHEM COMMUN, V47, P2898, DOI 10.1039/c0cc05252c; Gerritsen HC, 2002, J MICROSC-OXFORD, V206, P218, DOI 10.1046/j.1365-2818.2002.01031.x; Lin HJ, 2003, CYTOM PART A, V52A, P77, DOI 10.1002/cyto.a.10028; Hanson KM, 2002, BIOPHYS J, V83, P1682; Tantama M, 2011, J AM CHEM SOC, V133, P10034, DOI 10.1021/ja202902d; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Pliss A, 2012, ACS CHEM BIOL, V7, P1385, DOI 10.1021/cb300065w; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Dahan M, 2001, OPT LETT, V26, P825, DOI 10.1364/OL.26.000825; Berezin MY, 2010, CHEM REV, V110, P2641, DOI 10.1021/cr900343z; Suhling K, 2005, PHOTOCH PHOTOBIO SCI, V4, P13, DOI 10.1039/b412924p; SANDERS R, 1995, ANAL BIOCHEM, V227, P302, DOI 10.1006/abio.1995.1285; Ogikubo S, 2011, J PHYS CHEM B, V115, P10385, DOI 10.1021/jp2058904; Levitt JA, 2009, CURR OPIN BIOTECH, V20, P28, DOI 10.1016/j.copbio.2009.01.004; Netzel TL, 1995, J PHYS CHEM-US, V99, P17936, DOI 10.1021/j100051a019; Berezin MY, 2011, BIOPHYS J, V100, P2063, DOI 10.1016/j.bpj.2011.02.050; Chorvat D, 2009, LASER PHYS LETT, V6, P175, DOI 10.1002/lapl.200810132; Becker W, 2012, J MICROSC-OXFORD, V247, P119, DOI 10.1111/j.1365-2818.2012.03618.x; Zrazhevskiy P, 2010, CHEM SOC REV, V39, P4326, DOI 10.1039/b915139g; Battisti A, 2012, CHEM COMMUN, V48, P5127, DOI 10.1039/c2cc30373f; Kuimova MK, 2009, NAT CHEM, V1, P69, DOI [10.1038/nchem.120, 10.1038/NCHEM.120]; Tsuji T, 2013, ANAL CHEM, V85, P9815, DOI 10.1021/ac402128f; Medintz IL, 2005, NAT MATER, V4, P435, DOI 10.1038/nmat1390; Orte A, 2013, ACS NANO, V7, P6387, DOI 10.1021/nn402581q; Borst JW, 2010, MEAS SCI TECHNOL, V21, DOI 10.1088/0957-0233/21/10/102002; Awasthi K, 2012, J PHYS CHEM B, V116, P11159, DOI 10.1021/jp306550v; Bahaidarah E, 2014, PHOTOCH PHOTOBIO SCI, V13, P1397, DOI 10.1039/c4pp00204k; Boens N, 2006, J PHYS CHEM A, V110, P9334, DOI 10.1021/jp0615712; CODY CW, 1993, BIOCHEMISTRY-US, V32, P1212, DOI 10.1021/bi00056a003; Douma K, 2007, MICROSC RES TECHNIQ, V70, P467, DOI 10.1002/jemt.20424; Goiffon RJ, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3095800; Heikal AA, 2001, CHEM PHYS, V274, P37, DOI 10.1016/S0301-0104(01)00486-4; Hotzer B, 2012, FEBS J, V279, P410, DOI 10.1111/j.1742-4658.2011.08434.x; Ito T, 2009, PHOTOCH PHOTOBIO SCI, V8, P763, DOI 10.1039/b902341k; Jose M, 2007, BIOPHYS J, V92, P2237, DOI 10.1529/biophysj.106.092841; Kawski A, 2002, Z NATURFORSCH A, V57, P716; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE; LAKOWICZ JR, 1993, SENSOR ACTUAT B-CHEM, V11, P133, DOI 10.1016/0925-4005(93)85248-9; LAKOWICZ JR, 1992, CELL CALCIUM, V13, P131, DOI 10.1016/0143-4160(92)90041-P; Lakowicz J R, 1992, J Fluoresc, V2, P47, DOI 10.1007/BF00866388; Li X, 2007, ANAL BIOCHEM, V367, P219, DOI 10.1016/j.ab.2007.04.032; Loison P, 2013, BBA-BIOMEMBRANES, V1828, P2436, DOI 10.1016/j.bbamem.2013.06.028; McCranor BJ, 2014, METALLOMICS, V6, P1034, DOI 10.1039/c3mt00305a; Nakabayashi T, 2008, PHOTOCH PHOTOBIO SCI, V7, P668, DOI 10.1039/b800391b; Nakabayashi T, 2007, CHEM LETT, V36, P206, DOI 10.1246/cl.2007.206; Nakabayashi T, 2012, J PHOTOCH PHOTOBIO A, V235, P65, DOI 10.1016/j.jphotochem.2012.02.016; Nakabayashi T, 2008, CHEM LETT, V37, P522, DOI 10.1246/cl.2008.522; Nakabayashi T, 2011, J PHYS CHEM B, V115, P8622, DOI 10.1021/jp203090e; Nakabayashi T, 2008, PHOTOCH PHOTOBIO SCI, V7, P671, DOI 10.1039/b805032e; Nakabayashi T, 2009, BUNSEKI KAGAKU, V58, P473; Niesner R, 2005, PHARM RES, V22, P1079, DOI 10.1007/s11095-005-5304-6; Ohshima R, 2011, J PHYS CHEM C, V115, P15274, DOI 10.1021/jp204660m; Ohta N., 2014, NATURAL BIOMARKERS C, P41; Ohta N., 2009, MOL NANODYNAMICS, P607, DOI 10.1002/9783527627820.ch31; Okabe K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1714; Peter M, 2004, BIOL CELL, V96, P231, DOI 10.1016/j.biolcel.2003.12.006; Poea-Guyon S, 2013, ANAL BIOANAL CHEM, V405, P3983, DOI 10.1007/s00216-013-6860-y; Richmond TA, 2000, BIOCHEM BIOPH RES CO, V268, P462, DOI 10.1006/bbrc.1999.1244; Saxl T, 2009, BIOSENS BIOELECTRON, V24, P3229, DOI 10.1016/j.bios.2009.04.003; Shonat RD, 2003, ANN BIOMED ENG, V31, P1084, DOI 10.1114/1.1603256; Sud D, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3116714; Suhling K, 2002, J FLUORESC, V12, P91, DOI 10.1023/A:1015323606154; Sutter JU, 2012, MEAS SCI TECHNOL, V23, DOI 10.1088/0957-0233/23/5/055103; Svensson FR, 2011, J PHYS CHEM LETT, V2, P397, DOI 10.1021/jz101580e; SZMACINSKI H, 1995, CELL CALCIUM, V18, P64, DOI 10.1016/0143-4160(95)90046-2; Szmacinski H, 1996, J Fluoresc, V6, P83, DOI 10.1007/BF00732047; Szmacinski H, 1997, ANAL BIOCHEM, V250, P131, DOI 10.1006/abio.1997.2203; Szmacinski H, 1996, BIOPHYS J, V70, P547; Thompson RB, 2002, J NEUROSCI METH, V118, P63, DOI 10.1016/S0165-0270(02)00144-9; THOMPSON RB, 1993, ANAL CHEM, V65, P853, DOI 10.1021/ac00055a005; Treanor B, 2005, J MICROSC-OXFORD, V217, P36, DOI 10.1111/j.0022-2720.2005.01430.x; van Manen HJ, 2008, BIOPHYS J, V94, pL67, DOI 10.1529/biophysj.107.127837; Villoing A, 2008, BIOCHEMISTRY-US, V47, P12483, DOI 10.1021/bi801400d; Wawrzinek R, 2012, BIOORG MED CHEM LETT, V22, P5367, DOI 10.1016/j.bmcl.2012.07.056	109	1	1	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	APR	2015	31	4			SI		275	285				11	Chemistry, Analytical	Chemistry	CG9TR	WOS:000353663500005		
J	Minoshima, M; Kikuchi, K				Minoshima, Masafumi; Kikuchi, Kazuya			Chemical Tools for Probing Histone Deacetylase (HDAC) Activity	ANALYTICAL SCIENCES			English	Review						Histone deacetylase; fluorogenic probes; activity-based probes; positron emission tomography	POSITRON-EMISSION-TOMOGRAPHY; ACTIVITY-BASED PROBES; FRIEDREICHS-ATAXIA; FLUOROGENIC PROBE; MASS-SPECTROMETRY; IN-VIVO; INHIBITORS; COMPLEXES; REVEALS; LYSINE	Histone deacetylase's (HDACs) enzymes are responsible for removing epigenetic markers on histone proteins, which results in chromatin inactivation and gene repression. An evaluation of HDAC activity is essential for not only determining the physiological function of HDACs, but also for developing HDAC-targeting drugs. This review focuses on the chemical tools used to detect HDAC activity. We highlight activity-based probes and positron emission tomography probes based on the chemical structure of the inhibitors. We also summarize fluorogenic probes used in single-step methods for HDAC detection. These fluorogenic probes are designed based on the nucleophilicity of the amino group, aggregation via electrostatic interactions, and changes in the DNA binding properties. These fluorogenic systems may enable facile and rapid screening to evaluate HDAC inhibitors, which will contribute to the development of epigenetic drugs.	[Minoshima, Masafumi; Kikuchi, Kazuya] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Minoshima, Masafumi] Osaka Univ, Inst Acad Initiat, Suita, Osaka 5650871, Japan; [Kikuchi, Kazuya] Osaka Univ, Immunol Frontier Res Ctr IFReC, Suita, Osaka 5650871, Japan	Kikuchi, K (reprint author), Osaka Univ, Grad Sch Engn, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	kkikuchi@mls.eng.osaka-u.ac.jp			Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [24108724, 25220207, 25242072, 25620133, 26750371]; Funding Program for World-Leading Innovative R&D on Science and Technology from the Japan Society for the Promotion of Science (JSPS); CREST from JST; Asahi Glass Foundation	This work was supported by the Japan Science and Technology Agency (JST), the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (Grants 24108724, 25220207, 25242072, and 25620133 to K. K. 26750371 to M. M.), the Funding Program for World-Leading Innovative R&D on Science and Technology from the Japan Society for the Promotion of Science (JSPS), CREST from JST, and the Asahi Glass Foundation.	Abel Ted, 2008, Curr Opin Pharmacol, V8, P57, DOI 10.1016/j.coph.2007.12.002; Allefrey V. G., 1964, P NATL ACAD SCI USA, V51, P786; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Finnin MS, 1999, NATURE, V401, P188; Minoshima M, 2014, ANAL CHEM, V86, P7925, DOI 10.1021/ac501881s; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Diyabalanage HVK, 2014, ACS CHEM BIOL, V9, P1257, DOI 10.1021/cb500248r; Chen Y, 2012, MOL CELL PROTEOMICS, V11, P1048, DOI 10.1074/mcp.M112.019547; Salisbury CM, 2008, J AM CHEM SOC, V130, P2184, DOI 10.1021/ja074138u; Garcia BA, 2007, NAT PROTOC, V2, P933, DOI 10.1038/nprot.2007.106; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Strahl BD, 2000, NATURE, V403, P41; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Egelhofer TA, 2011, NAT STRUCT MOL BIOL, V18, P91, DOI 10.1038/nsmb.1972; Wegener D, 2003, CHEM BIOL, V10, P61, DOI 10.1016/S1074-5521(02)00305-8; Sowa Y, 1997, BIOCHEM BIOPH RES CO, V241, P142, DOI 10.1006/bbrc.1997.7786; Imai S, 2000, NATURE, V403, P795; Jiang H, 2013, NATURE, V496, P110, DOI 10.1038/nature12038; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Hendricks JA, 2011, J MED CHEM, V54, P5576, DOI 10.1021/jm200620f; Reid AE, 2009, NUCL MED BIOL, V36, P247, DOI 10.1016/j.nucmedbio.2008.12.005; de Silva AP, 1997, CHEM REV, V97, P1515, DOI 10.1021/cr960386p; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Jessani N, 2004, P NATL ACAD SCI USA, V101, P13756, DOI 10.1073/pnas.0404727101; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Luger K, 1997, NATURE, V389, P251; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Baba R, 2012, J AM CHEM SOC, V134, P14310, DOI 10.1021/ja306045j; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Selvin PR, 2000, NAT STRUCT BIOL, V7, P730, DOI 10.1038/78948; Dhara K, 2012, CHEM COMMUN, V48, P11534, DOI 10.1039/c2cc36591j; Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759; Salisbury CM, 2007, P NATL ACAD SCI USA, V104, P1171, DOI 10.1073/pnas.0608659104; Xu CP, 2009, CHEM BIOL, V16, P980, DOI 10.1016/j.chembiol.2009.07.010; Bieliauskas AV, 2008, CHEM SOC REV, V37, P1402, DOI 10.1039/b703830p; Cohen MS, 2005, SCIENCE, V308, P1318, DOI 10.1126/science1108367; Sasaki K, 2009, P NATL ACAD SCI USA, V106, P16257, DOI 10.1073/pnas.0902150106; Greenbaum D, 2000, CHEM BIOL, V7, P569, DOI 10.1016/S1074-5521(00)00014-4; Eberl HC, 2011, CHEMBIOCHEM, V12, P224, DOI 10.1002/cbic.201000429; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Hooker JM, 2010, ACS CHEM NEUROSCI, V1, P65, DOI 10.1021/cn9000268; Merrill AE, 2013, CURR OPIN CHEM BIOL, V17, P779, DOI 10.1016/j.cbpa.2013.06.011; Phelps ME, 2000, P NATL ACAD SCI USA, V97, P9226, DOI 10.1073/pnas.97.16.9226; Seo YJ, 2014, ACS CHEM NEUROSCI, V5, P588, DOI 10.1021/cn500021p; Yu M, 2006, J AM CHEM SOC, V128, P15356, DOI 10.1021/ja066298w	48	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	APR	2015	31	4			SI		287	292				6	Chemistry, Analytical	Chemistry	CG9TR	WOS:000353663500006		
J	Segawa, H; Okuno, M; Leproux, P; Couderc, V; Ozawa, T; Kano, H				Segawa, Hiroki; Okuno, Masanari; Leproux, Philippe; Couderc, Vincent; Ozawa, Takeaki; Kano, Hideaki			Multimodal Imaging of Living Cells with Multiplex Coherent Anti-stokes Raman Scattering (CARS), Third-order Sum Frequency Generation (TSFG) and Two-photon Excitation Fluorescence (TPEF) Using a Nanosecond White-light Laser Source	ANALYTICAL SCIENCES			English	Article						CARS; two-photon excitation fluorescence; microscopy; multiphoton; spectroscopic imaging	PHOTONIC CRYSTAL FIBER; SUPERCONTINUUM GENERATION; FLOW-CYTOMETRY; MICROSCOPY; CONTINUUM; SPECTROSCOPY; TOMOGRAPHY; RESOLUTION; 3-PHOTON; PULSES	The subnanosecond "white-light laser" source has been applied to multimodal, multiphoton, and multiplex spectroscopic imaging (M-3 spectroscopic imaging) with coherent anti-Stokes Raman scattering (CARS), third-order sum frequency generation (TSFG), and two-photon excitation fluorescence (TPEF). As the proof-of-principle experiment, we performed simultaneous imaging of polystyrene beads with TSFG and TPEF. This technique is then applied to live cell imaging. Mouse L929 fibroblastic cells are clearly visualized by CARS, TSFG, and TPEF processes. M3 spectroscopic imaging provides various and unique cellular information with different image contrast based on each multiphoton process.	[Segawa, Hiroki; Ozawa, Takeaki] Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Okuno, Masanari] Univ Tsukuba, Grad Sch Pure & Appl Sci, Dept Chem, Tsukuba, Ibaraki 3058571, Japan; [Leproux, Philippe; Couderc, Vincent] Univ Limoges, CNRS, Xlim Res Inst, F-87060 Limoges, France; [Kano, Hideaki] Univ Tsukuba, Inst Appl Phys, Tsukuba, Ibaraki 3058573, Japan; [Kano, Hideaki] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan	Kano, H (reprint author), Univ Tsukuba, Inst Appl Phys, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058573, Japan.	hkano@bk.tsukuba.ac.jp			JSPS bilateral joint research project (SAKURA program); NOVARTIS Foundation (Japan) for the Promotion of Science	This work was supported by the JSPS bilateral joint research project (SAKURA program) and The NOVARTIS Foundation (Japan) for the Promotion of Science. The authors thank Prof. Hiro-o Hamaguchi for his guidance, support, discussion, and encouragement throughout the present study. The authors thank the LEUKOS company for technical support with the dual-output supercontinuum light source. The authors gratefully acknowledge J. Ukon, UKON CRAFT SCIENCE, Ltd. for assisting with a fruitful collaboration between Japanese and French labs.	Travers JC, 2008, OPT EXPRESS, V16, P14435, DOI 10.1364/OE.16.014435; Ranka JK, 2000, OPT LETT, V25, P25, DOI 10.1364/OL.25.000025; Pezacki JP, 2011, NAT CHEM BIOL, V7, P137, DOI [10.1038/nchembio.525, 10.1038/NCHEMBIO.525]; Dudley JM, 2006, REV MOD PHYS, V78, P1135, DOI 10.1103/RevModPhys.78.1135; Povazay B, 2002, OPT LETT, V27, P1800, DOI 10.1364/OL.27.001800; Okuno M, 2010, ANGEW CHEM INT EDIT, V49, P6773, DOI 10.1002/anie.201001560; Hashimoto T, 2012, J CELL SCI, V125, P6127, DOI 10.1242/jcs.113084; PRESCOTT B, 1984, BIOPOLYMERS, V23, P235, DOI 10.1002/bip.360230206; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Zheng QD, 2013, NAT PHOTONICS, V7, P234, DOI 10.1038/NPHOTON.2012.344; Coen S, 2001, OPT LETT, V26, P1356, DOI 10.1364/OL.26.001356; Kano H, 2005, APPL PHYS LETT, V86, DOI [10.1063/1.1883714, 10.1063/1.1887314]; Maiti S, 1997, SCIENCE, V275, P530, DOI 10.1126/science.275.5299.530; Saar BG, 2010, SCIENCE, V330, P1368, DOI 10.1126/science.1197236; Kudlinski A, 2009, OPT LETT, V34, P3631, DOI 10.1364/OL.34.003631; Kee TW, 2004, OPT LETT, V29, P2701, DOI 10.1364/OL.29.002701; Provino L, 2001, ELECTRON LETT, V37, P558, DOI 10.1049/el:20010395; Nishizawa N, 2004, OPT LETT, V29, P2846, DOI 10.1364/OL.29.002846; Toyama A, 1999, J RAMAN SPECTROSC, V30, P623, DOI 10.1002/(SICI)1097-4555(199908)30:8<623::AID-JRS407>3.3.CO;2-0; Vartiainen EM, 2006, OPT EXPRESS, V14, P3622, DOI 10.1364/OE.14.003622; Wildanger D, 2008, OPT EXPRESS, V16, P9614, DOI 10.1364/OE.16.009614; van Manen HJ, 2004, J PHYS CHEM B, V108, P18762, DOI 10.1021/jp046955b; Camp CH, 2009, OPT EXPRESS, V17, P22879, DOI 10.1364/OE.17.022879; Champert PA, 2004, OPT EXPRESS, V12, P4366, DOI 10.1364/OPEX.12.004366; Hiramatsu K., 2014, P 4 INT C RAM SPECTR; Kapoor V, 2007, NAT METHODS, V4, P678, DOI 10.1038/nmeth0907-678; Labruyere A, 2012, OPT FIBER TECHNOL, V18, P375, DOI 10.1016/j.yofte.2012.08.003; Lindfors K, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.037401; Matsuda H, 2006, J PHYS CHEM B, V110, P1091, DOI 10.1021/jp0561165; Ozeki Y, 2010, OPT EXPRESS, V18, P13708, DOI 10.1364/OE.18.013708; Ozeki Y, 2012, NAT PHOTONICS, V6, P844, DOI [10.1038/nphoton.2012.263, 10.1038/NPHOTON.2012.263]; Segawa H, 2015, J BIOPHOTONICS, V8, P705, DOI 10.1002/jbio.201400059; Segawa H, 2012, OPT EXPRESS, V20, DOI 10.1364/OE.20.009551; Segawa H, 2014, OPT EXPRESS, V22, P10416, DOI 10.1364/OE.22.010416; Shi KB, 2004, OPT EXPRESS, V12, P2096, DOI 10.1364/OPEX.12.002096; Telford WG, 2009, CYTOM PART A, V75A, P450, DOI 10.1002/cyto.a.20687; Tombelaine V, 2005, OPT EXPRESS, V13, P7399, DOI 10.1364/OPEX.13.007399	37	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	APR	2015	31	4			SI		299	305				7	Chemistry, Analytical	Chemistry	CG9TR	WOS:000353663500008		
J	Otomo, K; Hibi, T; Murata, T; Watanabe, H; Kawakami, R; Nakayama, H; Hasebe, M; Nemoto, T				Otomo, Kohei; Hibi, Terumasa; Murata, Takashi; Watanabe, Hirotaka; Kawakami, Ryosuke; Nakayama, Hiroshi; Hasebe, Mitsuyasu; Nemoto, Tomomi			Multi-point Scanning Two-photon Excitation Microscopy by Utilizing a High-peak-power 1042-nm Laser	ANALYTICAL SCIENCES			English	Article						Two-photon excitation microscopy; multi-point laser scanning method; confocal microscopy; Yb-based laser	TOBACCO BY-2 CELLS; FLUORESCENCE MICROSCOPY; MECHANISM; MICROLENS; PROTEINS; GFP	The temporal resolution of a two-photon excitation laser scanning microscopy (TPLSM) system is limited by the excitation laser beam's scanning speed. To improve the temporal resolution, the TPLSM system is equipped with a spinning-disk confocal scanning unit. However, the insufficient energy of a conventional Ti:sapphire laser source restricts the field of view (FOV) for TPLSM images to a narrow region. Therefore, we introduced a high-peak-power Yb-based laser in order to enlarge the FOV. This system provided three-dimensional imaging of a sufficiently deep and wide region of fixed mouse brain slices, clear four-dimensional imaging of actin dynamics in live mammalian cells and microtubule dynamics during mitosis and cytokinesis in live plant cells.	[Otomo, Kohei; Hibi, Terumasa; Watanabe, Hirotaka; Kawakami, Ryosuke; Nemoto, Tomomi] Hokkaido Univ, Res Inst Elect Sci, Kita Ku, Sapporo, Hokkaido 0010020, Japan; [Hibi, Terumasa; Watanabe, Hirotaka; Kawakami, Ryosuke; Nemoto, Tomomi] Hokkaido Univ, Grad Sch Informat Sci & Technol, Kita Ku, Sapporo, Hokkaido 0600814, Japan; [Murata, Takashi; Hasebe, Mitsuyasu] Natl Inst Basic Biol, Div Evolutionary Biol, Okazaki, Aichi 4448585, Japan; [Murata, Takashi; Hasebe, Mitsuyasu] Grad Univ Adv Studies, SOKENDAI, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi 4448585, Japan; [Nakayama, Hiroshi] Yokogawa Elect Corp, Kanazawa, Ishikawa 9200177, Japan	Nemoto, T (reprint author), Hokkaido Univ, Res Inst Elect Sci, Kita Ku, Kita 20 Nishi 10, Sapporo, Hokkaido 0010020, Japan.	tn@es.hokudai.ac.jp	Nemoto, Tomomi /B-4412-2012		JSPS KAKENHI of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [25840044, 25560411, 22300131, 22113005, 26242082]; Okazaki Institute for Integrative Bioscience; National Institute for Basic Biology; Nano-Macro Materials, Devices and System Research Alliance (MEXT); Network Joint Research Center for Materials and Devices (MEXT)	We thank Dr. Y. Kozawa and Professor S. Sato of Institute of Multidisciplinary Research for Advanced Materials, Tohoku University for providing the program that numerically calculates the intensity distributions around an ideal light focal pattern, Dr. K. Kobayashi and Dr. Y. Matsu of the Nikon Imaging Center at Hokkaido University for providing their technical support, and Dr. H. Yasuhara of Kansai University for providing EYFP-beta-tubulin expressing plasmid. We are also grateful for the technical assistance provided by Ms. E. Ito, Ms. M. Oguro, Ms. S. Ipponjima, Mr. H. Osanai and Mr. R. Kitamura as well as the helpful advice of Dr. K. Iijima of the Laboratory of Molecular and Cellular Biophysics in the Research Institute for Electronic Science, Hokkaido University. This study was supported by JSPS KAKENHI (Grants Numbers 25840044, 25560411, 22300131, 22113005 and 26242082) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; by Orion research project (Okazaki Institute for Integrative Bioscience); by National Institute for Basic Biology; by the Nano-Macro Materials, Devices and System Research Alliance (MEXT) and by the Network Joint Research Center for Materials and Devices (MEXT).	Drobizhev M, 2011, NAT METHODS, V8, P393, DOI [10.1038/nmeth.1596, 10.1038/NMETH.1596]; Fujita K, 2000, OPT COMMUN, V174, P7, DOI 10.1016/S0030-4018(99)00662-8; Bewersdorf J, 1998, OPT LETT, V23, P655, DOI 10.1364/OL.23.000655; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; NAGATA T, 1992, INT REV CYTOL, V132, P1; Hirata E, 2012, J CELL SCI, V125, P858, DOI 10.1242/jcs.089995; AN GH, 1985, PLANT PHYSIOL, V79, P568, DOI 10.1104/pp.79.2.568; Fan GY, 1999, BIOPHYS J, V76, P2412; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Shimozawa T, 2013, P NATL ACAD SCI USA, V110, P3399, DOI 10.1073/pnas.1216696110; Yasuhara H, 2011, PROTOPLASMA, V248, P493, DOI 10.1007/s00709-010-0189-6; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Aoyagi Y., PLOS ONE IN PRESS; Bewersdorf J., 2006, HDB BIOL CONFOCAL MI, P550, DOI 10.1007/978-0-387-45524-2_29; Fujita K, 1999, J MICROSC-OXFORD, V194, P528; Hama T, 1998, CELL SIGNAL, V10, P331, DOI 10.1016/S0898-6568(97)00136-8; Kawakami R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01014; Koga S, 2014, CANCER SCI, V105, P1299, DOI 10.1111/cas.12500; Kumagai F, 2001, PLANT CELL PHYSIOL, V42, P723, DOI 10.1093/pcp/pce091; Murata T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2967; Murata T., 2013, METHOD MOL BIOL, V1136, P47; Nemoto T, 2008, MOL CELLS, V26, P113; Nemoto T, 2001, NAT CELL BIOL, V3, P253, DOI 10.1038/35060042; Ogata S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037048; Saito K, 2011, CELL STRUCT FUNCT, V36, P237	28	2	2	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	APR	2015	31	4			SI		307	313				7	Chemistry, Analytical	Chemistry	CG9TR	WOS:000353663500009		
J	Sato, T; Sato, Y; Iwai, K; Kuge, S; Teramae, N; Nishizawa, S				Sato, Takaya; Sato, Yusuke; Iwai, Kenta; Kuge, Shusuke; Teramae, Norio; Nishizawa, Seiichi			Fluorescence Imaging of siRNA Delivery by Peptide Nucleic Acid-based Probe	ANALYTICAL SCIENCES			English	Article						Small interfering RNA (siRNA); RNA interference (RNAi); peptide nucleic acid; thiazole orange; fluorescence microscopy; siRNA delivery; delivery carrier; affinity-labeling	RNA INTERFERENCE; ENDOSOMAL ESCAPE; GENE DELIVERY; IN-VIVO; CELLS; THERAPEUTICS; FORMULATIONS; CANCER	We report on the use of a peptide nucleic acid (PNA)-based fluorescent probe for the analysis of siRNA delivery to living cells. The probe, Py-AA-TO, possesses thiazole orange (TO) and pyrene moieties in the C- and N-termini of PNA, and can function as a light-up probe capable of selective binding to 3'-overhanging nucleotides of target siRNAs. The affinity-labeling of the siRNAs with Py-AA-TO facilitates fluorescence imaging of cellular uptake of polymer-based carriers encapsulating the siRNAs (polyplexes) through endocytosis and subsequent sequestration into lysosome. In addition, flow cytometric measurements reveal that the monitoring of Py-AA-TO fluorescence inside the cells is successfully applicable to the analysis of the polyplex disassembly. These promising functions of Py-AA-TO are presented and discussed as a basis for the design of molecular probes for fluorescent imaging and quantitative analysis of the siRNA delivery process.	[Sato, Takaya; Sato, Yusuke; Teramae, Norio; Nishizawa, Seiichi] Tohoku Univ, Grad Sch Sci, Dept Chem, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Iwai, Kenta; Kuge, Shusuke] Tohoku Pharmaceut Univ, Dept Microbiol, Aoba Ku, Sendai, Miyagi 9818558, Japan	Sato, Y (reprint author), Tohoku Univ, Grad Sch Sci, Dept Chem, Aoba Ku, Sendai, Miyagi 9808578, Japan.	satoyuu@m.tohoku.ac.jp; nishi@m.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [24350033, 25620102]; Yamada Science Foundation	We thank Prof. Hidetoshi Oikawa and Dr. Tsunenobu Onodera for measurements of physicochemical parameters, and Prof. Tomokazu Matsue and Dr. Hitoshi Shiku for flow cytometric experiments. This work was supported by Grants-in-Aid for Scientific Research (B) (No. 24350033), Challenging Exploratory Research (No. 25620102) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and by a grant from the Yamada Science Foundation.	Kwok A, 2011, NANOMED-NANOTECHNOL, V7, P210, DOI 10.1016/j.nano.2010.07.005; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; McLendon PM, 2010, MOL PHARMACEUT, V7, P738, DOI 10.1021/mp900282e; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; Burnett JC, 2012, CHEM BIOL, V19, P60, DOI 10.1016/j.chembiol.2011.12.008; Martens TF, 2014, NANO TODAY, V9, P344, DOI 10.1016/j.nantod.2014.04.011; Resnier P, 2013, BIOMATERIALS, V34, P6429, DOI 10.1016/j.biomaterials.2013.04.060; Frigault MM, 2009, J CELL SCI, V122, P753, DOI 10.1242/jcs.033837; Morrissey DV, 2005, NAT BIOTECHNOL, V23, P1002, DOI 10.1038/nbt1122; Lee H, 2010, BIOCONJUGATE CHEM, V21, P289, DOI 10.1021/bc900342p; Sakurai Y, 2011, BIOMATERIALS, V32, P5733, DOI 10.1016/j.biomaterials.2011.04.047; Gallas A, 2013, CHEM SOC REV, V42, P7983, DOI 10.1039/c3cs35520a; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Pecot CV, 2011, NAT REV CANCER, V11, P59, DOI 10.1038/nrc2966; Akita H, 2010, J CONTROL RELEASE, V143, P311, DOI 10.1016/j.jconrel.2010.01.012; Shen H, 2012, CANCER GENE THER, V19, P367, DOI 10.1038/cgt.2012.22; Breunig M, 2007, P NATL ACAD SCI USA, V104, P14454, DOI 10.1073/pnas.0703882104; Alabi CA, 2012, ACS NANO, V6, P6133, DOI 10.1021/nn3013838; Buyens K, 2010, J CONTROL RELEASE, V141, P38, DOI 10.1016/j.jconrel.2009.08.026; Okumura A, 2008, P NATL ACAD SCI USA, V105, P3974, DOI 10.1073/pnas.0710629105; Holzerny P, 2012, J CONTROL RELEASE, V157, P297, DOI 10.1016/j.jconrel.2011.08.023; Ziegler A, 2008, BIOPHYS J, V94, P2142, DOI 10.1529/biophysj.107.113472; Jones CH, 2013, MOL PHARMACEUT, V10, P4082, DOI 10.1021/mp400467x; Xiong XB, 2009, BIOMATERIALS, V30, P242, DOI 10.1016/j.biomaterials.2008.09.025; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Tamura A, 2009, BIOMACROMOLECULES, V10, P1818, DOI 10.1021/bm900252d; Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956; Breunig M, 2005, J GENE MED, V7, P1287, DOI 10.1002/jgm.775; Chiu YL, 2002, MOL CELL, V10, P549, DOI 10.1016/S1097-2765(02)00652-4; ur Rehman Zia, 2013, ACS Nano, V7, P3767, DOI 10.1021/nn3049494; Sato T, 2015, CHEM COMMUN, V51, P1421, DOI 10.1039/c4cc08800j; Vader P, 2010, J CONTROL RELEASE, V148, P106, DOI 10.1016/j.jconrel.2010.06.019	32	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	APR	2015	31	4			SI		315	320				6	Chemistry, Analytical	Chemistry	CG9TR	WOS:000353663500010		
J	Tanaka, K; Shoji, A; Sugawara, M				Tanaka, Kazuhisa; Shoji, Atushi; Sugawara, Masao			An Enzyme-entrapped Agarose Gel for Visualization of Ischemia-induced L-Glutamate Fluxes in Hippocampal Slices in a Flow System	ANALYTICAL SCIENCES			English	Article						Enzyme-entrapped agarose gel; imaging of L-glutamate; hippocampal slice; ischemia	MOUSE-BRAIN SLICES; CAPILLARY-ELECTROPHORESIS; REAL-TIME; RELEASE; ELECTRODE; MEMBRANE; SENSOR	An agarose gel slip containing L-glutamate oxidase (GluOx), horseradish peroxidase (HRP) and a dye DA-64 is proposed as a tool for visualizing ischemia-induced L-glutamate release in hippocampal slices in a flow system. The agarose slip with a detection limit of 6.0 +/- 0.8 mu mol L-1 for L-glutamate enabled us to visualize L-glutamate fluxes in a flow system. The leak of a dye from the agarose gel was negligible and a diffusion blur due to spreading of Bindshedler's Green (BG) within the gel was suppressed. Monitoring the time-dependent change of ischemia-induced L-glutamate fluxes at neuronal regions CA1, DG and CA3 of hippocampal slices is demonstrated.	[Tanaka, Kazuhisa; Sugawara, Masao] Nihon Univ, Coll Humanities & Sci, Dept Chem, Setagaya Ku, Tokyo 1568550, Japan; [Shoji, Atushi] Tokyo Univ Pharm & Life Sci, Hachioji, Tokyo 1920329, Japan	Sugawara, M (reprint author), Nihon Univ, Coll Humanities & Sci, Dept Chem, Setagaya Ku, Tokyo 1568550, Japan.	sugawara@chs.nihon-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [21350045]	The authors thank Mr. N. Tamura for his experimental help. This work was supported in part by Grants-in-Aid for Scientific Research (No. 21350045) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	ALBERY WJ, 1992, J CHEM SOC CHEM COMM, P900, DOI 10.1039/c39920000900; Innocenti B, 2000, J NEUROSCI, V20, P1800; Okubo Y, 2011, J PHYSIOL-LONDON, V589, P481, DOI 10.1113/jphysiol.2010.199539; ALBERY WJ, 1987, PHILOS T ROY SOC B, V316, P107, DOI 10.1098/rstb.1987.0021; HU YB, 1994, BRAIN RES, V659, P117, DOI 10.1016/0006-8993(94)90870-2; Namiki S, 2007, EUR J NEUROSCI, V25, P2249, DOI 10.1111/j.1460-9568.2007.05511.x; Dulla C, 2008, J NEUROSCI METH, V168, P306, DOI 10.1016/j.jneumeth.2007.10.017; Hires SA, 2008, P NATL ACAD SCI USA, V105, P4411, DOI 10.1073/pnas.0712008105; Nakajima K, 2003, ANAL SCI, V19, P55, DOI 10.2116/analsci.19.55; ZHOU SY, 1995, ANAL CHEM, V67, P594, DOI 10.1021/ac00099a017; Day BK, 2006, J NEUROCHEM, V96, P1626, DOI 10.1111/j.1471-4159.2006.03673.x; Ayoub GS, 1998, VISION RES, V38, P2909, DOI 10.1016/S0042-6989(98)00103-5; Sugawara M, 2007, CHEM REC, V7, P317, DOI 10.1002/tcr.20126; Oldenziel WH, 2007, J NEUROSCI METH, V160, P37, DOI 10.1016/j.jneumeth.2006.08.003; Hirano A, 2006, MINI-REV MED CHEM, V6, P1091, DOI 10.2174/138955706778560102; Okumoto S, 2005, P NATL ACAD SCI USA, V102, P8740, DOI 10.1073/pnas.0503274102; Nakamura N, 2005, ANAL BIOANAL CHEM, V383, P660, DOI 10.1007/s00216-005-0033-6; Ayoub GS, 1998, J NEUROSCI METH, V81, P113, DOI 10.1016/S0165-0270(98)00038-7; Hirano A, 2000, ANAL SCI, V16, P25, DOI 10.2116/analsci.16.25; Hirano A, 2003, ANAL CHEM, V75, P3775, DOI 10.1021/ac030088+; Ka-Ming E, 2013, METHOD MOL BIOL, V979, P65; Lada MW, 1996, ANAL CHEM, V68, P2790, DOI 10.1021/ac960178x; MITANI A, 1991, NEUROSCI LETT, V122, P167, DOI 10.1016/0304-3940(91)90849-O; Okubo J., 2010, P NATL ACAD SCI USA, V107, P6526; Okubo J., 2005, P NATL ACAD SCI USA, V102, P8740; Okumura W, 2009, ANAL BIOCHEM, V385, P326, DOI 10.1016/j.ab.2008.10.047; Tohda C, 1996, NEUROSCI RES, V24, P183, DOI 10.1016/0168-0102(95)00983-3; Uchino S, 2001, EUR J NEUROSCI, V13, P670, DOI 10.1046/j.1460-9568.2001.01430.x	28	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	APR	2015	31	4			SI		321	325				5	Chemistry, Analytical	Chemistry	CG9TR	WOS:000353663500011		
J	Hattori, M; Ozawa, T				Hattori, Mitsuru; Ozawa, Takeaki			High-throughput Live Cell Imaging and Analysis for Temporal Reaction of G Protein-coupled Receptor Based on Split Luciferase Fragment Complementation	ANALYTICAL SCIENCES			English	Article						GPCR; bioluminescence; luciferase; imaging; protein complementation assay	BIOLUMINESCENCE	For the design of therapeutic drugs, G protein coupled receptors (GPCRs) are notable targets. Many screening methods have been developed to identify effective agents for GPCR signaling. However, analyses of temporal variations of GPCR activity with specific ligands remain insufficient because of monitoring method limitations and difficulties. We previously developed a high-throughput bioluminescence measuring system to detect interactions of GPCR with P-arrestin based on split luciferase fragment complementation. By newly introducing a bioluminescence imaging technique into the system, we demonstrate a method for the temporal monitoring of GPCR-P-arrestin interactions in living cells during stimulation by different ligands.	[Hattori, Mitsuru; Ozawa, Takeaki] Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan	Hattori, M (reprint author), Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	mitsuru@chem.s.u-tokyo.ac.jp			Japan Society for the Promotion of Science (JSPS); Japan Science and Technology (JST); MEXT, Japan	We thank Molecular Devices Corp. for advice and support related to the technical side of imaging. This work was supported financially by the Japan Society for the Promotion of Science (JSPS), Japan Science and Technology (JST), and MEXT, Japan.	Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Zhang R, 2012, ACTA PHARMACOL SIN, V33, P372, DOI 10.1038/aps.2011.173; Paley MA, 2014, MEDCHEMCOMM, V5, P255, DOI 10.1039/c3md00288h; Yasunaga M, 2014, ANAL BIOANAL CHEM, V406, P5735, DOI 10.1007/s00216-014-7981-7; Foord SM, 2005, PHARMACOL REV, V57, P279, DOI 10.1124/pr.57.2.5; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Musnier A, 2010, CELL SIGNAL, V22, P707, DOI 10.1016/j.cellsig.2009.10.012; Misawa N, 2010, ANAL CHEM, V82, P2552, DOI 10.1021/ac100104q; Stevens RC, 2013, NAT REV DRUG DISCOV, V12, P25, DOI 10.1038/nrd3859; Takakura H, 2012, ACS CHEM BIOL, V7, P901, DOI 10.1021/cb200360z; Grisshammer R, 2013, EXPERT REV PROTEOMIC, V10, P1, DOI [10.1586/epr.12.76, 10.1586/EPR.12.76]; Hattori M, 2013, MOL BIOSYST, V9, P957, DOI 10.1039/c2mb25443c; Hida N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005868; Kafi AKM, 2011, PHARMACEUTICALS, V4, P457, DOI 10.3390/ph4030457	14	1	1	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	APR	2015	31	4			SI		327	330				4	Chemistry, Analytical	Chemistry	CG9TR	WOS:000353663500012		
J	Nonaka, H; An, Q; Sugihara, F; Doura, T; Tsuchiya, A; Yoshioka, Y; Sando, S				Nonaka, Hiroshi; An, Qi; Sugihara, Fuminori; Doura, Tomohiro; Tsuchiya, Akira; Yoshioka, Yoshichika; Sando, Shinsuke			Phenylboronic Acid-based F-19 MRI Probe for the Detection and Imaging of Hydrogen Peroxide Utilizing Its Large Chemical-Shift Change	ANALYTICAL SCIENCES			English	Article						F-19 NMR; F-19 MRI; imaging; molecular probe; H2O2	PEROXYNITRITE; CELLS; NMR	Herein, we report on a new F-19 MRI probe for the detection and imaging of H2O2. Our designed 2-fluorophenylboronic acid-based F-19 probe promptly reacted with H2O2 to produce 2-fluorophenol via boronic acid oxidation. The accompanying F-19 chemical-shift change reached 31 ppm under our experimental conditions. Such a large chemical-shift change allowed for the imaging of H2O2 by F-19 chemical-shift-selective MRI.	[Nonaka, Hiroshi; An, Qi; Doura, Tomohiro; Tsuchiya, Akira; Sando, Shinsuke] Kyushu Univ, INAMORI Frontier Res Ctr, Nishi Ku, Fukuoka 8190395, Japan; [Sugihara, Fuminori; Yoshioka, Yoshichika] Osaka Univ, Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan	Sando, S (reprint author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	ssando@chembio.t.u-tokyo.ac.jp			Funding Program for Next Generation World-Leading Researchers (NEXT); JSPS [25620135]; CREST, Japan Science and Technology Agency (JST)	We thank Dr. T. Ishimoto of Kyushu University for discussions and Prof. T. Matsuda (Kyoto University) for their help in the <SUP>19</SUP>F MRI experiments. This work was supported by the Funding Program for Next Generation World-Leading Researchers (NEXT), partly by Grants-in-Aid No. 25620135 (H. N.) from JSPS, and partly by CREST, Japan Science and Technology Agency (JST). T. A. thanks JSPS for a fellowship.	Murphy MP, 2011, CELL METAB, V13, P361, DOI 10.1016/j.cmet.2011.03.010; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Tu CQ, 2011, ANN BIOMED ENG, V39, P1335, DOI 10.1007/s10439-011-0270-0; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Van de Bittner GC, 2010, P NATL ACAD SCI USA, V107, P21316, DOI 10.1073/pnas.1012864107; Lee D, 2007, NAT MATER, V6, P765, DOI 10.1038/nmat1983; Miller EW, 2005, J AM CHEM SOC, V127, P16652, DOI 10.1021/ja054474f; Lippert AR, 2011, ACCOUNTS CHEM RES, V44, P793, DOI 10.1021/ar200126t; Peng T, 2014, J AM CHEM SOC, V136, P11728, DOI 10.1021/ja504624q; Yu JX, 2013, PROG NUCL MAG RES SP, V70, P25, DOI 10.1016/j.pnmrs.2012.10.001; James ML, 2012, PHYSIOL REV, V92, P897, DOI 10.1152/physrev.00049.2010; Bobko AA, 2005, BIOCHEM BIOPH RES CO, V330, P367, DOI 10.1016/j.bbrc.2005.02.166; Bruemmer KJ, 2014, CHEM COMMUN, V50, P12311, DOI 10.1039/c4cc04292a; Doura T, 2011, CHEM LETT, V40, P1357, DOI 10.1246/cl.2011.1357; Giorgio Marco, 2007, Nat Rev Mol Cell Biol, V8, P722, DOI 10.1038/nrm2240; Habibi-Yangjeh A, 2006, J MOL MODEL, V12, P338, DOI 10.1007/s00894-005-0050-6; Hernanz Raquel, 2004, Cardiovasc Res, V62, P202, DOI 10.1016/j.cardiores.2004.01.014; Silla JM, 2013, BEILSTEIN J ORG CHEM, V9, P1127, DOI 10.3762/bjoc.9.125; Tirotta I, 2015, CHEM REV, V115, P1106, DOI 10.1021/cr500286d; WEISS SJ, 1981, J CLIN INVEST, V68, P714, DOI 10.1172/JCI110307	20	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	APR	2015	31	4			SI		331	335				5	Chemistry, Analytical	Chemistry	CG9TR	WOS:000353663500013		
J	Maeda, H; Kurokawa, T				Maeda, H.; Kurokawa, T.			Reply to the letter to the editor 'Surrogate end points for overall survival. Festina lente (more haste, less speed)' by Braillon	ANNALS OF ONCOLOGY			English	Letter							APPROVAL		[Maeda, H.; Kurokawa, T.] Keio Univ, Grad Sch Pharmaceut Sci, Tokyo, Japan; [Maeda, H.] Astellas Pharma Inc, Clin Dev, Tokyo, Japan	Maeda, H (reprint author), Keio Univ, Grad Sch Pharmaceut Sci, Tokyo, Japan.	hideki.maeda@astellas.com					Johnson JR, 2011, J NATL CANCER I, V103, P636, DOI 10.1093/jnci/djr062; Broglio KR, 2009, JNCI-J NATL CANCER I, V101, P1642, DOI 10.1093/jnci/djp369; Ridker PM, 2006, JAMA-J AM MED ASSOC, V295, P2270, DOI 10.1001/jama.295.19.2270; Appelbaum FR, 2007, BLOOD, V109, P1810, DOI 10.1182/blood-2006-08-041152; Braillon A, 2015, ANN ONCOL, V26, P818, DOI 10.1093/annonc/mdu586; Maeda H, 2015, ANN ONCOL, V26, P211, DOI 10.1093/annonc/mdu500	6	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	APR	2015	26	4					818	819		10.1093/annonc/mdv007		3	Oncology	Oncology	CH2BI	WOS:000353828700033		
J	Hirai, D; Matsuno, J; Takagi, H				Hirai, Daigorou; Matsuno, Jobu; Takagi, Hidenori			Fabrication of (111)-oriented Ca0.5Sr0.5IrO3/SrTiO3 superlattices-A designed playground for honeycomb physics	APL MATERIALS			English	Article							OXIDE HETEROSTRUCTURES; INTERFACE; SRIRO3; FILMS	We report the fabrication of (111)-oriented superlattice structures with alternating 2m-layers (m = 1, 2, and 3) of Ca0.5Sr0.5IrO3 perovskite and two layers of SrTiO3 perovskite on SrTiO3(111) substrates. In the case of m = 1 bilayer films, the Ir sub-lattice is a buckled honeycomb, where a topological state may be anticipated. The successful growth of superlattice structures on an atomic level along the [111] direction was clearly demonstrated by superlattice reflections in x-ray diffraction patterns and by atomically resolved transmission electron microscope images. The ground states of the superlattice films were found to be magnetic insulators, which may suggest the importance of electron correlations in Ir perovskites in addition to the much discussed topological effects. (C) 2015 Author(s).	[Hirai, Daigorou; Takagi, Hidenori] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Matsuno, Jobu] RIKEN, CEMS, Wako, Saitama 3510198, Japan; [Takagi, Hidenori] Max Plank Inst Solid State Res, D-70569 Stuttgart, Germany	Hirai, D (reprint author), Univ Tokyo, Dept Phys, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.		Matsuno, Jobu/C-1737-2008; Takagi, Hidenori/B-2935-2010; Hirai, Daigorou/E-6087-2013	Matsuno, Jobu/0000-0002-3018-8548; Hirai, Daigorou/0000-0003-2883-4376	MEXT, Japan [24224010, 25103724]	The authors are grateful to A. S. Gibbs for valuable comments. This work was supported by a Grant-in-Aid for Scientific Research (Grant Nos. 24224010 and 25103724) from MEXT, Japan.	Zubko P, 2011, ANNU REV CONDEN MA P, V2, P141, DOI 10.1146/annurev-conmatphys-062910-140445; Middey S, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4773375; Chang J, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2913005; LONGO JM, 1971, J SOLID STATE CHEM, V3, P174, DOI 10.1016/0022-4596(71)90022-3; Chang J, 2010, J CRYST GROWTH, V312, P621, DOI 10.1016/j.jcrysgro.2009.12.004; Okamoto S, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.195121; Gray B, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3455323; Moon SJ, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.226402; Chakhalian J, 2012, NAT MATER, V11, P92, DOI 10.1038/nmat3225; Gao HJ, 1999, ANNU REV MATER SCI, V29, P173, DOI 10.1146/annurev.matsci.29.1.173; Stangl J, 2004, REV MOD PHYS, V76, P725, DOI 10.1103/RevModPhys.76.725; Hwang HY, 2012, NAT MATER, V11, P103, DOI [10.1038/nmat3223, 10.1038/NMAT3223]; Schlom DG, 2008, J AM CERAM SOC, V91, P2429, DOI 10.1111/j.1551-2916.2008.02556.x; Okamoto S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.066403; Gibert M, 2012, NAT MATER, V11, P195, DOI [10.1038/nmat3224, 10.1038/NMAT3224]; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Cheng JG, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.064401; Doennig D, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.126804; Herranz G, 2012, SCI REP-UK, V2, DOI 10.1038/srep00758; Hirai D., 2015, ARXIV150101433CONDMA; Jang SY, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/48/485602; Liu J., 2013, ARXIV13051732CONDMAT; Matsuno J., 2014, ARXIV14011066CONDMAT; Middey S., 2014, ARXIV14071570CONDMAT; Nie YF, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.016401; Ruegg A, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.201103; SROLOVITZ DJ, 1989, ACTA METALL MATER, V37, P621, DOI 10.1016/0001-6160(89)90246-0; Sumi A, 2005, THIN SOLID FILMS, V486, P182, DOI 10.1016/j.tsf.2004.11.244; Xiao D, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1602; Zeb MA, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.085149	30	6	6	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	2166-532X			APL MATER	APL Mater.	APR	2015	3	4							041508	10.1063/1.4913389		6	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science & Technology - Other Topics; Materials Science; Physics	CH2BH	WOS:000353828400015		
J	Hiroi, Z; Yamaura, J; Hirose, T; Nagashima, I; Okamoto, Y				Hiroi, Z.; Yamaura, J.; Hirose, T.; Nagashima, I.; Okamoto, Y.			Lifshitz metal-insulator transition induced by the all-in/all-out magnetic order in the pyrochlore oxide Cd2Os2O7	APL MATERIALS			English	Article							PRESSURE	We investigate the metal-insulator transition (MIT) of the osmium pyrochlore oxide Cd2Os2O7 through transport and magnetization measurements. The MIT and a magnetic transition to the all-in/all-out (AIAO) order occur simultaneously at 227 K. We propose a mechanism based on a Lifshitz transition induced by the AIAO magnetic order probably via strong spin-orbit couplings in the specific semimetallic band structure. It is suggested, moreover, that two observed puzzles, a finite conductivity near T = 0 and an emergence of weak ferromagnetic moments, are not bulk properties but originate at magnetic domain walls between two kinds of AIAO domains. (C) 2015 Author(s). All article content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 Unported License.	[Hiroi, Z.; Hirose, T.; Nagashima, I.; Okamoto, Y.] Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan; [Yamaura, J.] Tokyo Inst Technol, Mat Res Ctr Element Strategy, Yokohama, Kanagawa 2268503, Japan	Hiroi, Z (reprint author), Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan.	hiroi@issp.u-tokyo.ac.jp					Wan XG, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.205101; Witczak-Krempa W, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.045124; Singh DJ, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.155109; Yamaura J, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.247205; Matsuhira K, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.023706; Nakatsuji S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.087204; Matsuhira K, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.043706; Witczak-Krempa W, 2014, ANNU REV CONDEN MA P, V5, P57, DOI 10.1146/annurev-conmatphys-020911-125138; SUBRAMANIAN MA, 1983, PROG SOLID STATE CH, V15, P55, DOI 10.1016/0079-6786(83)90001-8; Yamaji Y, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.021035; Matsuda YH, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.174431; Tomiyasu K, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.034709; SLATER JC, 1951, PHYS REV, V82, P538, DOI 10.1103/PhysRev.82.538; Godwal BK, 1998, PHYS REV B, V57, P773, DOI 10.1103/PhysRevB.57.773; Nakano M, 2012, NATURE, V487, P459, DOI 10.1038/nature11296; Shinaoka H, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.247204; Padilla WJ, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.035120; Mandrus D, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.195104; Cao J, 2009, NAT NANOTECHNOL, V4, P732, DOI [10.1038/nnano.2009.266, 10.1038/NNANO.2009.266]; Matsuhira K, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.094701; Imada M, 1998, REV MOD PHYS, V70, P1039, DOI 10.1103/RevModPhys.70.1039; Harima H, 2002, J PHYS CHEM SOLIDS, V63, P1035, DOI 10.1016/S0022-3697(02)00058-6; Arima T, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.013705; Bogdanov NA, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.127206; Cavalleri A, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.237401; Chern GW, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.186403; Disseler SM, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.060403; Disseler SM, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.140413; Gurvitch M., 2009, J APPL PHYS, V106; Harima H., COMMUNICATION; Hirose T., COMMUNICATION; JEROMINEK H, 1993, OPT ENG, V32, P2092, DOI 10.1117/12.143951; LIFSHITZ IM, 1960, SOV PHYS JETP-USSR, V11, P1130; Okamoto Y, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.121102; Reading J, 2002, J MATER CHEM, V12, P646, DOI 10.1039/b109715f; Sagayama H, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.100403; SHEAHEN TP, 1966, PHYS REV, V149, P368, DOI 10.1103/PhysRev.149.368; SLEIGHT AW, 1974, SOLID STATE COMMUN, V14, P357, DOI 10.1016/0038-1098(74)90917-X; Tardif S., 2015, ARXIV14075401; Udagawa M, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.066406; Ueda K, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.075127; Yamauchi I., COMMUNICATION	42	2	2	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	2166-532X			APL MATER	APL Mater.	APR	2015	3	4							041501	10.1063/1.4907734		11	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science & Technology - Other Topics; Materials Science; Physics	CH2BH	WOS:000353828400008		
J	Ikeura, K; Sakai, H; Bahramy, MS; Ishiwata, S				Ikeura, Koji; Sakai, Hideaki; Bahramy, Mohammad Saeed; Ishiwata, Shintaro			Rich structural phase diagram and thermoelectric properties of layered tellurides Mo1-xNbxTe2	APL MATERIALS			English	Article							TRANSITION-METAL DICHALCOGENIDES; PHYSICAL-PROPERTIES; CRYSTAL STRUCTURES; TEMPERATURE; BETA-MOTE2; MOTE2; WTE2; MOLYBDENUM; CHEMISTRY; PRESSURE	MoTe2 is a rare transition-metal ditelluride having two kinds of layered polytypes, hexagonal structure with trigonal prismatic Mo coordination and monoclinic structure with octahedral Mo coordination. The monoclinic distortion in the latter is caused by anisotropic metal-metal bonding. In this work, we have examined the Nb doping effect on both polytypes of MoTe2 and clarified a structural phase diagram for Mo1-xNbxTe2 containing four kinds of polytypes. A rhombohedral polytype crystallizing in polar space group has been newly identified as a high-temperature metastable phase at slightly Nb-rich composition. Considering the results of thermoelectric measurements and the first-principles calculations, the Nb ion seemingly acts as a hole dopant in the rigid band scheme. On the other hand, the significant interlayer contraction upon the Nb doping, associated with the Te p-p hybridization, is confirmed especially for the monoclinic phase, which implies a shift of the p-band energy level. The origin of the metal-metal bonding in the monoclinic structure is discussed in terms of the d electron counting and the Te p-p hybridization. (C) 2015 Author(s).	[Ikeura, Koji; Sakai, Hideaki; Bahramy, Mohammad Saeed; Ishiwata, Shintaro] Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan; [Bahramy, Mohammad Saeed] RIKEN, CEMS, Wako, Saitama 3510198, Japan; [Ishiwata, Shintaro] JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	Ikeura, K (reprint author), Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan.	ishiwata@ap.t.u-tokyo.ac.jp	Sakai, Hideaki/G-1008-2014; Bahramy, Mohammad/B-2865-2013	Bahramy, Mohammad/0000-0001-9024-6335	Japan Society for the Promotion of Science (JSPS) [25620040, 24224009]; Thermal & Electric Energy Technology, Inc., Foundation; Iketani Science and Technology Foundation; Murata Science Foundation; JST PRESTO program	The authors thank Y. Tokura, K. Ishizaka, H. Tsuji, and Y. Iwasa for fruitful discussions. This study was partly supported by the Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (Nos. 25620040 and 24224009), the Thermal & Electric Energy Technology, Inc., Foundation, Iketani Science and Technology Foundation, the Murata Science Foundation, and JST PRESTO program (Hyper-nano-space design toward Innovative Functionality).	Ali MN, 2014, NATURE, V514, P205, DOI 10.1038/nature13763; Xu XD, 2014, NAT PHYS, V10, P343, DOI 10.1038/NPHYS2942; WHANGBO MH, 1992, J AM CHEM SOC, V114, P9587, DOI 10.1021/ja00050a044; WILSON JA, 1969, ADV PHYS, V18, P193, DOI 10.1080/00018736900101307; Xiao D, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.196802; Mak KF, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136805; Suzuki R, 2014, NAT NANOTECHNOL, V9, P611, DOI [10.1038/nnano.2014.148, 10.1038/NNANO.2014.148]; BROWN BE, 1966, ACTA CRYSTALLOGR, V20, P268, DOI 10.1107/S0365110X66000513; PUOTINEN D, 1961, ACTA CRYSTALLOGR, V14, P691, DOI 10.1107/S0365110X61002084; HUGHES HP, 1978, J PHYS C SOLID STATE, V11, pL103, DOI 10.1088/0022-3719/11/3/004; Wang QH, 2012, NAT NANOTECHNOL, V7, P699, DOI [10.1038/nnano.2012.193, 10.1038/NNANO.2012.193]; Battaglia C, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.195114; Blaha P., WIEN2K SOFTWARE PACK; Boker T, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.235305; BROWN BE, 1966, ACTA CRYSTALLOGR, V20, P264, DOI 10.1107/S0365110X66000501; CANADELL E, 1992, J SOLID STATE CHEM, V99, P189, DOI 10.1016/0022-4596(92)90304-E; CLARKE R, 1978, PHILOS MAG B, V38, P121, DOI 10.1080/13642817808245670; DAWSON WG, 1987, J PHYS C SOLID STATE, V20, P6159, DOI 10.1088/0022-3719/20/36/017; HAYASHI K, 1995, J ALLOY COMPD, V219, P161, DOI 10.1016/0925-8388(94)05030-9; He JG, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.075409; HUISMAN R, 1970, J LESS-COMMON MET, V21, P187, DOI 10.1016/0022-5088(70)90117-7; Imai H, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.241104; JOBIC S, 1992, J ALLOY COMPD, V178, P253, DOI 10.1016/0925-8388(92)90269-F; Maeda N, 2002, J ALLOY COMPD, V336, P62, DOI 10.1016/S0925-8388(01)01893-X; Podberezskaya NV, 2001, J STRUCT CHEM+, V42, P654, DOI 10.1023/A:1013106329156; REVOLINS.E, 1966, J PHYS CHEM SOLIDS, V27, P523, DOI 10.1016/0022-3697(66)90195-8; Shimakawa M, 1997, J SOLID STATE CHEM, V129, P242, DOI 10.1006/jssc.1996.7223; Shimakawa M, 1997, J ALLOY COMPD, V259, P219; SILVERMA.MS, 1967, INORG CHEM, V6, P1063, DOI 10.1021/ic50051a047; TOWLE LC, 1966, SCIENCE, V154, P895, DOI 10.1126/science.154.3751.895; Vellinga M. B., 1970, J SOLID STATE CHEM, V2, P299, DOI 10.1016/0022-4596(70)90085-X	31	1	1	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	2166-532X			APL MATER	APL Mater.	APR	2015	3	4							041514	10.1063/1.4913967		9	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science & Technology - Other Topics; Materials Science; Physics	CH2BH	WOS:000353828400021		
J	Jeong, S; Matsuishi, S; Bang, J; Hosono, H				Jeong, Sehoon; Matsuishi, Satoru; Bang, Joonho; Hosono, Hideo			Crystal structure and physical properties of new transition metal based pnictide compounds: LaTM2AsN (TM = Fe, Co, and Ni)	APL MATERIALS			English	Article							LAYERED SUPERCONDUCTOR	New 3d transition metal-based mixed-pnictide compounds, LaTM2AsN (TM = Fe, Co, and Ni) are synthesized by solid state reactions under a high pressure of 2.5 GPa. These compounds crystallize with an orthorhombic structure (space group Cmcm) containing four formula units per unit cell. The crystal structure consists of an anisotropic network of TMAs3N tetrahedra sharing As-As edges along the in-plane ac direction and N corners along the b-direction, forming a TM honeycomb lattice with a boat-shape conformation bridged by TM-N-TM linear bonds. The temperature dependences of the electrical resistivity and magnetic susceptibility indicate that these crystals are itinerant antiferromagnets exhibiting parasitic ferromagnetism with transition temperatures of 560, 260, and 410 K for TM = Fe, Co, and Ni, respectively. These compounds are expected to be parent materials for new superconductors. (C) 2015 Author(s).	[Jeong, Sehoon; Bang, Joonho; Hosono, Hideo] Tokyo Inst Technol, Mat & Struct Lab, Midori Ku, Yokohama, Kanagawa 227, Japan; [Matsuishi, Satoru; Hosono, Hideo] Tokyo Inst Technol, Mat Res Ctr Element Strategy, Midori Ku, Yokohama, Kanagawa 227, Japan	Jeong, S (reprint author), Tokyo Inst Technol, Mat & Struct Lab, Midori Ku, 4259 Nagatsuta Cho, Yokohama, Kanagawa 227, Japan.		Hosono, Hideo/J-3489-2013	Hosono, Hideo/0000-0001-9260-6728	MEXT Elements Strategy Initiative to Form Core Research Center "Tokodai Institute for Element Strategy (TIES)	This work was supported by the MEXT Elements Strategy Initiative to Form Core Research Center "Tokodai Institute for Element Strategy (TIES)."	Mandrus D, 2010, CHEM MATER, V22, P715, DOI 10.1021/cm9027397; Kamihara Y, 2008, J AM CHEM SOC, V130, P3296, DOI 10.1021/ja800073m; de la Cruz C, 2008, NATURE, V453, P899, DOI 10.1038/nature07057; Watanabe T, 2008, J SOLID STATE CHEM, V181, P2117, DOI 10.1016/j.jssc.2008.04.033; Huang Q, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.257003; McGuire MA, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.094517; Ishida K, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.062001; Matsuishi S, 2008, J AM CHEM SOC, V130, P14428, DOI 10.1021/ja806357j; Luetkens H, 2009, NAT MATER, V8, P305, DOI [10.1038/nmat2397, 10.1038/NMAT2397]; Kamihara Y, 2006, J AM CHEM SOC, V128, P10012, DOI 10.1021/ja063355c; Paglione J, 2010, NAT PHYS, V6, P645, DOI 10.1038/NPHYS1759; Zhu XY, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.024516; [Anonymous], 2009, TOPAS VERS 4 2; Guo JG, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.180520; Sefat AS, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.104505; Nakajima M, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.104710; Nomura T, 2008, SUPERCOND SCI TECH, V21, DOI 10.1088/0953-2048/21/12/125028; PAL AK, 1976, J PHYS D APPL PHYS, V9, P2261, DOI 10.1088/0022-3727/9/15/017; Shein IR, 2011, COMP MATER SCI, V50, P824, DOI 10.1016/j.commatsci.2010.10.015; Wang C, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/47002; Wang W, 2010, J APPL PHYS, V107, DOI 10.1063/1.3448233; Yan XW, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.087005	22	1	1	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	2166-532X			APL MATER	APL Mater.	APR	2015	3	4							041509	10.1063/1.4913395		6	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science & Technology - Other Topics; Materials Science; Physics	CH2BH	WOS:000353828400016		
J	Saitoh, A; Nakata, K; Tricot, G; Chen, YY; Yamamoto, N; Takebe, H				Saitoh, Akira; Nakata, Kohei; Tricot, Gregory; Chen, Yuanyuan; Yamamoto, Naoki; Takebe, Hiromichi			Zero photoelastic and water durable ZnO-SnO-P2O5-B2O3 glasses	APL MATERIALS			English	Article							TIN PHOSPHATE-GLASS; LEAD; SNO-P2O5; BEHAVIOR; FIBERS; RAMAN	We report properties of zero birefringent xZnO-(67-x) SnO-(33-y) P2O5-yB(2)O(3) glasses, within 18.5 <= x <= 22 and y = 0, 3, and 10 mol. %. These compositions of boro-phosphate glasses provide both zero photoelastic constant (PEC) and improved water durability. x = 19 and y = 3 compositions show minimum PEC of -0.002 x 10(-12) Pa-1, which can contribute to candidate material for fiber current sensor devise without lead. The structures of zero photoelastic glasses were investigated by Raman scattering and nuclear magnetic resonance spectroscopies. Compositions of zero PEC glasses are explained by the empirical model proposed by Zwanziger et al. [Chem. Mater. 19, 286-290 (2007)]. (C) 2015 Author(s).	[Saitoh, Akira; Nakata, Kohei; Yamamoto, Naoki; Takebe, Hiromichi] Ehime Univ, Grad Sch Sci & Engn, Matsuyama, Ehime 7908577, Japan; [Tricot, Gregory; Chen, Yuanyuan] Univ Lille 1, CNRS, UMR 8516, LASIR, F-59655 Villeneuve Dascq, France	Saitoh, A (reprint author), Ehime Univ, Grad Sch Sci & Engn, 3 Bunkyo Cho, Matsuyama, Ehime 7908577, Japan.				JSPS KAKENHI [25820333]; TGIR-RMN-THC Fr3050 CNRS	A.S. and H.T. thanks graduate students S. Anan and Y. Oba for experimental assistance. A. S. also appreciates Professor H. Toyota for use of micro-Raman scattering apparatus. This work was supported by JSPS KAKENHI Grant No. 25820333. Financial support from the TGIR-RMN-THC Fr3050 CNRS for conducting the research is gratefully acknowledged.	Saitoh A, 2013, PHYS CHEM GLASSES-B, V54, P177; Hudgens JJ, 1998, J NON-CRYST SOLIDS, V223, P21, DOI 10.1016/S0022-3093(97)00347-5; Raguenet B, 2011, J MATER CHEM, V21, P17693, DOI 10.1039/c1jm12350e; Stepien R, 2013, OPT MATER, V35, P1587, DOI 10.1016/j.optmat.2013.04.005; Saranti A, 2006, J NON-CRYST SOLIDS, V352, P390, DOI 10.1016/j.jnoncrysol.2006.01.042; [Anonymous], 1985, HOYA OPT GLASS TECHN; Guignard M, 2007, CHEM MATER, V19, P286, DOI 10.1021/cm062208a; MATUSITA K, 1985, J AM CERAM SOC, V68, P389, DOI 10.1111/j.1151-2916.1985.tb10149.x; Shih PY, 1999, J NON-CRYST SOLIDS, V244, P211, DOI 10.1016/S0022-3093(99)00011-3; Ehrt D, 2008, J NON-CRYST SOLIDS, V354, P546, DOI 10.1016/j.jnoncrysol.2007.07.092; Takebe H, 2013, PHYS CHEM GLASSES-B, V54, P182; Yamamoto N, 2012, OPT LETT, V37, P4203, DOI 10.1364/OL.37.004203; Brow RK, 2000, J NON-CRYST SOLIDS, V263, P1, DOI 10.1016/S0022-3093(99)00620-1; Saitoh A, 2015, MATER CHEM PHYS, V149, P648, DOI 10.1016/j.matchemphys.2014.11.021; Lim JW, 2010, J NON-CRYST SOLIDS, V356, P1379, DOI 10.1016/j.jnoncrysol.2010.02.019; Bhat MH, 2001, J NON-CRYST SOLIDS, V291, P93; Brow RK, 1996, J AM CERAM SOC, V79, P2410, DOI 10.1111/j.1151-2916.1996.tb08990.x; Cha J, 2008, J CERAM SOC JPN, V116, P1100, DOI 10.2109/jcersj2.116.1100; Guignard M, 2008, J NON-CRYST SOLIDS, V354, P79, DOI 10.1016/j.jnoncrysol.2007.06.096; Kurosawa K, 2000, IEICE T ELECTRON, VE83C, P326; Martin V, 2011, INT J APPL GLASS SCI, V2, P282, DOI 10.1111/j.2041-1294.2011.00049.x; Ray N. H., 1978, INORGANIC POLYM; SMITH AM, 1980, OPT LASER TECHNOL, V12, P25, DOI 10.1016/0030-3992(80)90109-7; TAKASAKI H, 1980, APPL OPTICS, V19, P435, DOI 10.1364/AO.19.000435; Weyl W. A., 1964, CONSTITUTION GLASSES, V2	25	2	2	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	2166-532X			APL MATER	APL Mater.	APR	2015	3	4							046102	10.1063/1.4917347		6	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science & Technology - Other Topics; Materials Science; Physics	CH2BH	WOS:000353828400033		
J	Shimakawa, K; Strizik, L; Wagner, T; Frumar, M				Shimakawa, K.; Strizik, L.; Wagner, T.; Frumar, M.			Penn gap rule in phase-change memory materials: No clear evidence for resonance bonds	APL MATERIALS			English	Article							SEMICONDUCTORS; CRYSTALLINE; NUMBER	Although a proposal of resonance bonds in crystalline phase-change materials based on the GeSbTe system has been provided, we do not find any clear evidence in favor of the proposal. The ellipsometric study demonstrates that a change in the high frequency dielectric constant epsilon(infinity) between the amorphous and crystalline phases is only scaled by the average bandgap (the Penn gap rule). Even for a pure antimony film, regarded as a prototype resonance bonding material, epsilon(infinity) was found to follow the Penn gap rule. Experimentally, we did not find any evidence of a significant change in the optical transition matrix element during the phase change, which is necessary to support the idea of resonance bonds. (C) 2015 Author(s).	[Shimakawa, K.; Strizik, L.; Wagner, T.; Frumar, M.] Univ Pardubice, Dept Gen & Inorgan Chem, Pardubice 53002, Czech Republic; [Shimakawa, K.] Gifu Univ, Dept Elect & Elect Engn, Gifu 5011193, Japan	Wagner, T (reprint author), Univ Pardubice, Dept Gen & Inorgan Chem, Pardubice 53002, Czech Republic.	tomas.wagner@upce.cz			ESF [Cz.1.07/2.3.00/20/0254]; Ministry of Education, Youth and Sports of the Czech Republic within ECOP	We would like to thank Jan Prikryl for the preparation of Sb films. We acknowledge the Grant Project No. Cz.1.07/2.3.00/20/0254 ReAdMat-Research Team for Advanced Non-Crystalline Materials realized by ESF and the Ministry of Education, Youth and Sports of the Czech Republic within ECOP for financial support.	PENN DR, 1962, PHYS REV, V128, P2093, DOI 10.1103/PhysRev.128.2093; Shportko K, 2008, NAT MATER, V7, P653, DOI 10.1038/nmat2226; LITTLEWOOD PB, 1979, J PHYS C SOLID STATE, V12, P4459, DOI 10.1088/0022-3719/12/21/013; Kolobov AV, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.165206; Jellison GE, 1996, APPL PHYS LETT, V69, P371, DOI 10.1063/1.118064; LUCOVSKY G, 1973, PHYS REV B, V8, P660, DOI 10.1103/PhysRevB.8.660; Matsunaga T, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3665067; Luo MB, 2004, ADV MATER, V16, P439, DOI 10.1002/adma.200306077; Wuttig M, 2007, NAT MATER, V6, P824, DOI 10.1038/nmat2009; Kolobov AV, 2004, NAT MATER, V3, P703, DOI 10.1038/nmat1215; Welnic W, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.236403; HARRISON WA, 1976, PHYS REV B, V14, P691, DOI 10.1103/PhysRevB.14.691; Huang B, 2012, J NON-CRYST SOLIDS, V358, P2393, DOI 10.1016/j.jnoncrysol.2011.11.017; Kolobov AV, 2014, J PHYS CHEM C, V118, P10248, DOI 10.1021/jp412412j; Orava J, 2008, J APPL PHYS, V104, DOI 10.1063/1.2970069; Phillips J. C., 1973, BOND BANDS SEMICONDU; Robertson J, 2007, THIN SOLID FILMS, V515, P7538, DOI 10.1016/j.tsf.2006.11.159; Wooten F., 1972, OPTICAL POPERTIES SO; YOKOTA R, 1989, JPN J APPL PHYS 1, V28, P1407, DOI 10.1143/JJAP.28.1407	19	0	0	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	2166-532X			APL MATER	APL Mater.	APR	2015	3	4							041801	10.1063/1.4907251		5	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science & Technology - Other Topics; Materials Science; Physics	CH2BH	WOS:000353828400028		
J	Watanabe, N; Sano, K; Tasugi, N; Yamaguchi, T; Yamamoto, A; Ueno, M; Sumiyoshi, R; Arakawa, T; Koiwa, I				Watanabe, Nobuaki; Sano, Katsuhito; Tasugi, Naoya; Yamaguchi, Taiki; Yamamoto, Akihiro; Ueno, Misa; Sumiyoshi, Rie; Arakawa, Tomiyuki; Koiwa, Ichiro			Preparation of Co2FeSn Heusler alloys by electrodeposition method	APL MATERIALS			English	Article							MAGNETIC-PROPERTIES	We propose a new method for preparing Heusler alloys on the basis of the electrodeposition. The alloy composition is controllable by the deposition potential. The composition ratio of (Co, Fe) and Sn is inversely proportional to the deposition potential. The effect of deposition potential on alloy composition, surface morphology, crystal structure, and magnetic properties of the samples was investigated. The (Co, Fe) vs. Sn alloy composition displayed an inverse dependence on the deposition potential. According to the magnetic measurement, the obtained Co2FeSn composition alloy showed ferromagnetic properties. The coercivity shows the minimum value in the stoichiometric samples. (C) 2015 Author(s).	[Watanabe, Nobuaki; Sano, Katsuhito; Tasugi, Naoya; Yamaguchi, Taiki; Yamamoto, Akihiro; Ueno, Misa; Sumiyoshi, Rie; Arakawa, Tomiyuki; Koiwa, Ichiro] Kanto Gakuin Univ, Kanazawa Ku, Yokohama, Kanagawa 2368501, Japan	Watanabe, N (reprint author), Kanto Gakuin Univ, Kanazawa Ku, 1-50-1 Mutsuurahigashi, Yokohama, Kanagawa 2368501, Japan.	nabe@kanto-gakuin.ac.jp			MEXT	This work was partially aided by the MEXT-supported Program for the Strategic Research Foundation at Private Universities.	Duan JH, 2013, J ELECTROCHEM SOC, V160, pD471, DOI 10.1149/2.089310jes; Lincot D, 2005, THIN SOLID FILMS, V487, P40, DOI 10.1016/j.tsf.2005.01.032; Sprungmann D, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.060505; Balke B, 2008, SCI TECHNOL ADV MAT, V9, DOI 10.1088/1468-6996/9/1/014102; Balke B., 2013, SPINTRONICS MAT DEVI, P1; Bard A.J., 2001, ELECTROCHEMICAL METH, P156; Brenner A., 1963, ELECTRODEPOSITION AL, V1, P77; Chisholm C, 2007, APPL SURF SCI, V253, P4348, DOI 10.1016/j.apsusc.2006.09.045; Hakimi M, 2010, J MAGN MAGN MATER, V322, P3443, DOI 10.1016/j.jmmm.2010.06.042; Kobayashi K, 2004, APPL PHYS LETT, V85, P4684, DOI 10.1063/1.1821654; Miura Y, 2006, J APPL PHYS, V99, DOI 10.1063/1.2176907; Tezuka N, 2009, J APPL PHYS, V105, DOI 10.1063/1.3072448	12	1	1	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	2166-532X			APL MATER	APL Mater.	APR	2015	3	4							041804	10.1063/1.4918639		5	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science & Technology - Other Topics; Materials Science; Physics	CH2BH	WOS:000353828400031		
J	Ilavenil, S; Kim, DH; Jeong, YI; Arasu, MV; Vijayakumar, M; Prabhu, PN; Srigopalram, S; Choi, KC				Ilavenil, Soundharrajan; Kim, Da Hye; Jeong, Young-Il; Arasu, Mariadhas Valan; Vijayakumar, Mayakrishnan; Prabhu, Ponnuraj Nagendra; Srigopalram, Srisesharam; Choi, Ki Choon			Trigonelline protects the cardiocyte from hydrogen peroxide induced apoptosis in H9c2 cells	ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE			English	Article						Trigonelline; H9c2 cells; Antioxidant; Apoptosis; Cardiovascular diseases	OXIDATIVE STRESS; HEART-FAILURE; IN-VIVO; DEATH; RATS; CARDIOMYOCYTES; MITOCHONDRIA; METABOLITES; MECHANISMS; RELEASE	Objective: To elucidate the key parameters associated with hydrogen peroxide induced oxidative stress and investigates the mechanism of trigonelline (TG) for reducing the H2O2 induced toxicity in H9c2 cells. Methods: Cytotoxicity and antioxidant activity of TG was assessed by EZ-CYTOX kit. RNA extraction and cDNA synthesized according to the kit manufacture protocol. Apoptosis was measured by the Flowcytometry, general PCR and qPCR. Results: It was found that the TO significantly rescued the morphology of the H9c2 cells. Treatment of cells with TO attenuated H2O2 induced cell deaths and improved the antioxidant activity. In addition, TG regulated the apoptotic gene caspase-3, caspase-9 and anti-apoptotic gene Bcl-2. Bcl-XL during H2O2 induced oxidative stress in H9c2 cells. These results were comparable with quercetin treatment. For evident, flow cytometer results also confirmed the TG significantly reduced the H2O2 induced necrosis and apoptosis in H9c2 cells. However, further increment of TO concentration against H2O2 could induce the necrosis and apoptosis along with H2O2. Conclusions: It is suggested that less than 125 mu M of TO could protect the cells from H2O2, induced cell damage by down regulating the caspases and up regulating the Bcl-2 and Bcl-XL expression. Therefore, we suggest the trigonelline could be useful for treatment of oxidative stress mediated cardiovascular diseases in future.	[Ilavenil, Soundharrajan; Vijayakumar, Mayakrishnan; Choi, Ki Choon] RDA, Natl Inst Anim Sci, Grassland & Forage Div, Cheonan Si 330801, Chungnam, South Korea; [Kim, Da Hye] Tottori Univ, United Grad Sch Agr Sci, Tottori 6808553, Japan; [Jeong, Young-Il] Pusan Natl Univ, Sch Med, Yangsan 626770, Gyeongnam, South Korea; [Arasu, Mariadhas Valan] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Addiriyah Chair Environm Studies, Riyadh 11451, Saudi Arabia; [Prabhu, Ponnuraj Nagendra] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Srigopalram, Srisesharam] Sunchon Natl Univ, Dept Hort, Sunchon, South Korea	Choi, KC (reprint author), RDA, Natl Inst Anim Sci, Grassland & Forage Div, Cheonan Si 330801, Chungnam, South Korea.	choiwh@korea.kr					Abe S., 1975, EIYO TO SHOKURYO, V28, P125; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Wencker D, 2003, J CLIN INVEST, V111, P1497, DOI 10.1172/JCI200317664; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P49, DOI 10.1089/ars.2007.9.49; Ilavenil S, 2014, PHYTOMEDICINE, V21, P758, DOI 10.1016/j.phymed.2013.11.007; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Yen WJ, 2005, J AGR FOOD CHEM, V53, P2658, DOI 10.1021/jf0402429; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Reed JC, 2000, AM J PATHOL, V157, P1415, DOI 10.1016/S0002-9440(10)64779-7; Gomez-Ruiz JA, 2007, J AGR FOOD CHEM, V55, P6962, DOI 10.1021/jf0710985; Kharbanda S, 1997, NATURE, V386, P732, DOI 10.1038/386732a0; Angeloni C, 2007, BIOCHIMIE, V89, P73, DOI 10.1016/j.biochi.2006.09.006; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001; Jiang BM, 2005, CELL STRESS CHAPERON, V10, P252, DOI 10.1379/CSC-124R.1; Arlt A, 2013, ONCOGENE, V32, P4825, DOI 10.1038/onc.2012.493; Yoshinari O, 2009, BIOSCI BIOTECH BIOCH, V73, P1033, DOI 10.1271/bbb.80805; Hamilton CA, 2004, CLIN SCI, V106, P219, DOI 10.1042/CS20030379; Ghule AE, 2012, INT IMMUNOPHARMACOL, V14, P740, DOI 10.1016/j.intimp.2012.10.004; ANTHONI U, 1991, COMP BIOCHEM PHYS B, V99, P1, DOI 10.1016/0305-0491(91)90002-U; Nirmala C, 1996, MOL CELL BIOCHEM, V159, P85, DOI 10.1007/BF00420910; Pryor WA, 2006, AM J PHYSIOL-REG I, V291, P491; Sugioka R, 2003, ONCOGENE, V22, P8432, DOI 10.1038/sj.onc.1207180; Xu JJ, 2008, EUR J ANAESTH, V25, P395, DOI 10.1017/S0265021508003542; YUYAMA S, 1991, ADV EXP MED BIOL, V294, P475	25	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1995-7645			ASIAN PAC J TROP MED	Asian Pac. J. Trop. Med.	APR	2015	8	4					263	268		10.1016/S1995-7645(14)60328-X		6	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CG8AY	WOS:000353530200002		
J	Pourasghar, F; Tozuka, T; Ghaemi, H; Oettli, P; Jahanbakhsh, S; Yamagata, T				Pourasghar, Farnaz; Tozuka, Tomoki; Ghaemi, Hooshang; Oettli, Pascal; Jahanbakhsh, Saeed; Yamagata, Toshio			Influences of the MJO on intraseasonal rainfall variability over southern Iran	ATMOSPHERIC SCIENCE LETTERS			English	Article						Madden-Julian Oscillation; rainfall; Iran	MADDEN-JULIAN OSCILLATION; EAST-AFRICAN RAINFALL; INDIAN-OCEAN; SUMMER PRECIPITATION; CIRCULATION; PACIFIC; MODULATION; ASSOCIATION; CONVECTION; PREDICTION	Using daily rainfall data from 183 stations, influences of the Madden-Julian Oscillation (MJO) on precipitation over southern Iran are examined. When composites of daily rainfall anomalies are constructed by introducing eight phases in the time evolution, wet conditions are observed in MJO phases 1-2 and 7-8. During these phases, atmospheric circulation anomalies favor moisture advection from the western Indian Ocean to southern Iran. In contrast, dry conditions during MJO phases 3 to 6 are associated with advection of drier air from the north.	[Pourasghar, Farnaz; Jahanbakhsh, Saeed] Univ Tabriz, Fac Geog, Dept Phys Geog, Tabriz, Iran; [Pourasghar, Farnaz; Ghaemi, Hooshang] Iran Meteorol Org, Res Dept, Tehran, Iran; [Tozuka, Tomoki] Univ Tokyo, Grad Sch Sci, Dept Earth & Planetary Sci, Tokyo 1138654, Japan; [Oettli, Pascal; Yamagata, Toshio] JAMSTEC, Applicat Lab, Yokohama, Kanagawa, Japan	Pourasghar, F (reprint author), Univ Tabriz, Fac Geog, Dept Phys Geog, Tabriz, Iran.	farnaz_pourasghar@yahoo.com	Yamagata, Toshio/A-1807-2009; Tozuka, Tomoki/A-1805-2009		Ministry of Science, Research and Technology of Iran; Japan Society for Promotion of Science [20340125]	We thank Dr T. Izumo, for useful discussions and suggestions. Helpful comments provided by two anonymous reviewers contributed to improvement of the earlier manuscript. The present research is supported by Ministry of Science, Research and Technology of Iran and Japan Society for Promotion of Science through grant-in-aid for Scientific Research (B) 20340125 for 6-month research in Japan.	Alaka GJ, 2012, J CLIMATE, V25, P3219, DOI 10.1175/JCLI-D-11-00232.1; Dezfuli AK, 2010, THEOR APPL CLIMATOL, V100, P57, DOI 10.1007/s00704-009-0157-2; Wheeler MC, 2009, J CLIMATE, V22, P1482, DOI 10.1175/2008JCLI2595.1; Maloney ED, 2003, J CLIMATE, V16, P3482, DOI 10.1175/1520-0442(2003)016<3482:TAOEPM>2.0.CO;2; Maloney ED, 2008, J CLIMATE, V21, P4149, DOI 10.1175/2007JCLI1856.1; Matthews AJ, 2004, J CLIMATE, V17, P2427, DOI 10.1175/1520-0442(2004)017<2427:IVOTAD>2.0.CO;2; Han WQ, 2001, GEOPHYS RES LETT, V28, P4215, DOI 10.1029/2001GL013701; Paegle JN, 2000, MON WEATHER REV, V128, P837, DOI 10.1175/1520-0493(2000)128<0837:IMOSAS>2.0.CO;2; Nazemosadat MJ, 2006, IRAN J SCI TECHNOL B, V30, P555; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Bond NA, 2003, WEATHER FORECAST, V18, P600, DOI 10.1175/1520-0434(2003)018<0600:TIOTMO>2.0.CO;2; Nazemosadat MJ, 2000, INT J CLIMATOL, V20, P47, DOI 10.1002/(SICI)1097-0088(200001)20:1<47::AID-JOC461>3.3.CO;2-G; Martin-Vide J, 2006, INT J CLIMATOL, V26, P1455, DOI 10.1002/joc.1388; Higgins RW, 2001, J CLIMATE, V14, P403, DOI 10.1175/1520-0442(2001)014<0403:IOTPMO>2.0.CO;2; Rao SA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020842; Liebmann B, 1996, B AM METEOROL SOC, V77, P1275; Mutai CC, 2000, J CLIMATE, V13, P3915, DOI 10.1175/1520-0442(2000)013<3915:EARATT>2.0.CO;2; Pohl B, 2006, Q J ROY METEOR SOC, V132, P2521, DOI 10.1256/qj.05.104; MADDEN RA, 1972, J ATMOS SCI, V29, P1109, DOI 10.1175/1520-0469(1972)029<1109:DOGSCC>2.0.CO;2; Goswami BN, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016734; Pai DS, 2011, CLIM DYNAM, V36, P41, DOI 10.1007/s00382-009-0634-4; Zhang CD, 2005, REV GEOPHYS, V43, DOI 10.1029/2004RG000158; Barlow M, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027738; Wheeler MC, 2004, MON WEATHER REV, V132, P1917, DOI 10.1175/1520-0493(2004)132<1917:AARMMI>2.0.CO;2; MADDEN RA, 1971, J ATMOS SCI, V28, P702, DOI 10.1175/1520-0469(1971)028<0702:DOADOI>2.0.CO;2; Azimi F, 2009, J PHYS GEOGRAPHY, V4, P47; Barlow M, 2005, MON WEATHER REV, V133, P3579, DOI 10.1175/MWR3026.1; Foltz GR, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020023; Ghasemi AR, 2008, ATMOS RES, V88, P116, DOI 10.1016/j.atmosres.2007.10.009; Han WQ, 2008, J PHYS OCEANOGR, V38, P945, DOI 10.1175/2008JPO3854.1; Jia XL, 2011, ADV ATMOS SCI, V28, P521, DOI 10.1007/s00376-010-9118-z; Julia C, 2012, J CLIMATE, V25, P7003, DOI 10.1175/JCLI-D-11-00679.1; Mo KC, 2000, MON WEATHER REV, V128, P1490, DOI 10.1175/1520-0493(2000)128<1490:IMOSPO>2.0.CO;2; Nazemosadat MJ, 2010, J CLIMATE, V23, P887, DOI 10.1175/2009JCLI2141.1; Pohl B, 2005, CLIM RES, V29, P111, DOI 10.3354/cr029111; Pourasghar F, 2012, CLIM DYNAM, V39, P2329, DOI 10.1007/s00382-012-1357-5; Rao SA, 2009, CLIM DYNAM, V33, P751, DOI 10.1007/s00382-008-0498-z; Rybeck AV, 2013, J CLIMATE, V26, P3575; Shinoda T, 2005, J CLIMATE, V18, P3891, DOI 10.1175/JCLI3510.1; Wheeler MC, 2005, S-P B ENVIRON SCI, P125, DOI 10.1007/3-540-27250-X_5; Whitaker JS, 2001, J CLIMATE, V14, P3279, DOI 10.1175/1520-0442(2001)014<3279:SVOTCA>2.0.CO;2; Zhang CD, 2001, J CLIMATE, V14, P1309, DOI 10.1175/1520-0442(2001)014<1309:IPISST>2.0.CO;2	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1530-261X			ATMOS SCI LETT	Atmos. Sci. Lett.	APR-JUN	2015	16	2					110	118		10.1002/asl2.531		9	Geochemistry & Geophysics; Meteorology & Atmospheric Sciences	Geochemistry & Geophysics; Meteorology & Atmospheric Sciences	CH3HI	WOS:000353920000004		
J	Chowdary, JS; Bandgar, AB; Gnanaseelan, C; Luo, JJ				Chowdary, Jasti S.; Bandgar, Arti B.; Gnanaseelan, C.; Luo, Jing-Jia			Role of tropical Indian Ocean air-sea interactions in modulating Indian summer monsoon in a coupled model	ATMOSPHERIC SCIENCE LETTERS			English	Article						Indian Ocean; air-sea interactions; Indian summer monsoon; El Nino and Southern Oscillation (ENSO)	EL-NINO; INTERANNUAL VARIABILITY; DIPOLE MODE; CLIMATE; RAINFALL; ENSO; ENSEMBLE; IMPACT; CGCM	While the importance of El Nino to the Indian summer monsoon (ISM) rainfall variability has been widely recognized, the role of tropical Indian Ocean (TIO) is still unclear. Present results based on coupled model sensitivity experiments revealed that the TIO air-sea interaction trims down suppressed rainfall locally over the ISM region by opposing the influence of tropical Pacific Ocean (TPO) during El Nino developing summers. Besides, El Nino-induced TIO basin-wide warming supports positive rainfall anomalies over the ISM region by maintaining local convection. TIO local air-sea interaction opposes the Pacific impact even in the absence of Indian Ocean Dipole.	[Chowdary, Jasti S.; Bandgar, Arti B.; Gnanaseelan, C.] Indian Inst Trop Meteorol, TS Div, Pune 411008, Maharashtra, India; [Bandgar, Arti B.] Univ Pune, Dept Atmospher & Space Sci, Pune, Maharashtra, India; [Bandgar, Arti B.] Indian Meteorol Dept, Pune, Maharashtra, India; [Luo, Jing-Jia] Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa 2370061, Japan; [Luo, Jing-Jia] Ctr Australian Weather & Climate Res, Melbourne, Vic, Australia	Chowdary, JS (reprint author), Indian Inst Trop Meteorol, Dr Homi Bhabha Rd, Pune 411008, Maharashtra, India.	jasti@tropmet.res.in	Jasti, Sriranga Chowdary/C-6225-2014				Izumo T, 2008, J CLIMATE, V21, P5603, DOI 10.1175/2008JCLI2158.1; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Luo JJ, 2010, J CLIMATE, V23, P726, DOI 10.1175/2009JCLI3104.1; WEBSTER PJ, 1992, Q J ROY METEOR SOC, V118, P877, DOI 10.1002/qj.49711850705; Chowdary Jasti Sriranga, 2011, Climate Dynamics, V36, DOI 10.1007/s00382-009-0686-5; Liu L, 2014, CLIM DYNAM, V43, P1715, DOI 10.1007/s00382-013-2000-9; Saji NH, 1999, NATURE, V401, P360, DOI 10.1038/43855; Gualdi S, 2003, CLIM DYNAM, V20, P567, DOI 10.1007/s00382-002-0295-z; Du Y, 2010, DYNAM ATMOS OCEANS, V50, P233, DOI 10.1016/j.dynatmoce.2010.04.001; Luo JJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032793; Xie PP, 1997, B AM METEOROL SOC, V78, P2539, DOI 10.1175/1520-0477(1997)078<2539:GPAYMA>2.0.CO;2; Xie SP, 2009, J CLIMATE, V22, P730, DOI 10.1175/2008JCLI2544.1; Ashok K, 2001, GEOPHYS RES LETT, V28, P4499, DOI 10.1029/2001GL013294; Webster PJ, 1999, NATURE, V401, P356, DOI 10.1038/43848; Du Y, 2009, J CLIMATE, V22, P2023, DOI 10.1175/2008JCLI2590.1; Xie SP, 2002, J CLIMATE, V15, P864, DOI 10.1175/1520-0442(2002)015<0864:SAMOSI>2.0.CO;2; Luo JJ, 2005, J CLIMATE, V18, P4474, DOI 10.1175/JCLI3526.1; Luo JJ, 2008, J CLIMATE, V21, P84, DOI 10.1175/2007JCLI1412.1; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Behera SK, 2005, J CLIMATE, V18, P4514, DOI 10.1175/JCLI3541.1; Du Y, 2013, J CLIMATE, V26, P7240, DOI 10.1175/JCLI-D-12-00678.1; Goswami BN, 1999, Q J ROY METEOR SOC, V125, P611, DOI 10.1256/smsqj.55411; Slingo JM, 2000, MON WEATHER REV, V128, P1778, DOI 10.1175/1520-0493(2000)128<1778:TENOOT>2.0.CO;2; Krishna Kumar K., 1999, Science, V284; Sahai AK, 2003, CLIM DYNAM, V20, P855, DOI 10.1007/s00382-003-0306-8; SHUKLA J, 1975, J ATMOS SCI, V32, P503, DOI 10.1175/1520-0469(1975)032<0503:EOASST>2.0.CO;2; Yang JL, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028571; Yuan DL, 2011, J CLIMATE, V24, P3593, DOI 10.1175/2011JCLI3649.1	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1530-261X			ATMOS SCI LETT	Atmos. Sci. Lett.	APR-JUN	2015	16	2					170	176		10.1002/asl2.561		7	Geochemistry & Geophysics; Meteorology & Atmospheric Sciences	Geochemistry & Geophysics; Meteorology & Atmospheric Sciences	CH3HI	WOS:000353920000012		
J	Kakinoki, S; Yamaoka, T				Kakinoki, Sachiro; Yamaoka, Tetsuji			Single-Step Immobilization of Cell Adhesive Peptides on a Variety of Biomaterial Substrates via Tyrosine Oxidation with Copper Catalyst and Hydrogen Peroxide	BIOCONJUGATE CHEMISTRY			English	Article							PLASMA FIBRONECTIN; MYTILUS-EDULIS; SURFACE; MUSSEL; PROTEINS; DOPA; 3,4-DIHYDROXYPHENYLALANINE; POLYMERIZATION; MECHANISMS	Immobilization of biologically active peptides which were isolated from extracellular matrix proteins is a powerful strategy for the design and functionalization of biomaterial substrates. However, the method of peptide immobilization was restricted, that is, peptide is often immobilized through the reactive groups inherent in substrates with multistep reactions. Here, we report a single-step immobilization of fibronectin-derived cell adhesive peptide (Arg-Glu-Asp-Val; REDV) onto polymer materials by use of tyrosine oxidation with copper catalyst and hydrogen peroxide. REDV peptide was successfully immobilized on tissue culture polystyrene, poly(ethylene terephthalate), poly(vinyl chloride), expanded-poly(tetrafluoroethylene), and poly(l-lactic acid), resulting in enhanced adhesion of human umbilical vein endothelial cells. This method is a single-step reaction under very mild conditions and is available for the biological functionalization of various medical devices.	[Kakinoki, Sachiro; Yamaoka, Tetsuji] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Biomed Engn, Suita, Osaka 5658565, Japan	Kakinoki, S (reprint author), Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Biomed Engn, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	sachiro@ncvc.go.jp; yamtet@ncvc.go.jp			Intramural Research Fund of National Cerebral and Cardiovascular Center [25-6-18]; S-Innovation Project of JST	This work was supported by the Intramural Research Fund of National Cerebral and Cardiovascular Center (25-6-18) and the S-Innovation Project of JST.	Ali FE, 2004, J INORG BIOCHEM, V98, P173, DOI 10.1016/j.jinorgbio.2003.10.002; Fan XW, 2005, J AM CHEM SOC, V127, P15843, DOI 10.1021/ja0532638; Sever MJ, 2001, TETRAHEDRON, V57, P6139, DOI 10.1016/S0040-4020(01)00601-9; Vert M, 2007, PROG POLYM SCI, V32, P755, DOI 10.1016/j.progpolymsci.2007.05.006; Yu ME, 1999, J AM CHEM SOC, V121, P5825, DOI 10.1021/ja990469y; Waite JH, 2008, NAT MATER, V7, P8, DOI 10.1038/nmat2087; Kang SM, 2012, ADV FUNCT MATER, V22, P2949, DOI 10.1002/adfm.201200177; Ooka AA, 2000, BIOPOLYMERS, V57, P92; Lee BP, 2011, ANNU REV MATER RES, V41, P99, DOI 10.1146/annurev-matsci-062910-100429; Kobayashi S, 2003, PROG POLYM SCI, V28, P1015, DOI 10.1016/S0079-6700(03)00014-5; Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9; HUMPHRIES MJ, 1987, J BIOL CHEM, V262, P6886; Lin Q, 2007, P NATL ACAD SCI USA, V104, P3782, DOI 10.1073/pnas.0607852104; Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002; DEKKER A, 1991, BIOMATERIALS, V12, P130, DOI 10.1016/0142-9612(91)90191-C; Park KM, 2011, J MATER CHEM, V21, P15906, DOI 10.1039/c1jm13869c; ALI SAM, 1994, J APPL POLYM SCI, V51, P1389, DOI 10.1002/app.1994.070510805; MASSIA SP, 1992, J BIOL CHEM, V267, P14019; Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; FRYE AH, 1959, J POLYM SCI, V40, P419, DOI 10.1002/pol.1959.1204013712; Hu BH, 2000, TETRAHEDRON LETT, V41, P5795, DOI 10.1016/S0040-4039(00)00957-6; Kakinoki S, 2010, ACTA BIOMATER, V6, P1925, DOI 10.1016/j.actbio.2009.12.001; Seth R, 2004, TOXICOL IN VITRO, V18, P501, DOI 10.1016/j.tiv.2004.01.006; WAITE JH, 1990, INT J BIOL MACROMOL, V12, P139, DOI 10.1016/0141-8130(90)90065-I; WAITE JH, 1983, J BIOL CHEM, V258, P2911	26	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1043-1802			BIOCONJUGATE CHEM	Bioconjugate Chem.	APR	2015	26	4					639	644		10.1021/acs.bioconjchem.5b00032		6	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Multidisciplinary; Chemistry, Organic	Biochemistry & Molecular Biology; Chemistry	CG3JU	WOS:000353177300004		
J	Hara, D; Komatsu, H; Son, A; Nishimoto, S; Tanabe, K				Hara, Daiki; Komatsu, Hirokazu; Son, Aoi; Nishimoto, Sei-ichi; Tanabe, Kazuhito			Water-Soluble Phosphorescent Ruthenium Complex with a Fluorescent Coumarin Unit for Ratiometric Sensing of Oxygen Levels in Living Cells	BIOCONJUGATE CHEMISTRY			English	Article							TRANSITION-METAL-COMPLEXES; TRIPLET EXCITED-STATES; IN-VIVO; VISIBLE-LIGHT; IMAGING AGENT; TUMOR HYPOXIA; PROBE; CONJUGATE; SENSORS; NANOPARTICLES	Dual emission was applied to a molecular probe for the ratiometric sensing of oxygen concentration in a living system. We prepared ruthenium complexes possessing a coumarin unit (Ru-Cou), in which the (MLCT)-M-3 phosphorescence of the ruthenium complex was efficiently quenched by molecular oxygen, whereas the coumarin unit emitted constant fluorescence independent of the oxygen concentration. The oxygen status could be determined precisely from the ratio of phosphorescence to fluorescence. We achieved the molecular imaging of cellular oxygen levels using Ru-Cou possessing an alkyl chain, which provided appropriate lipophilicity to increase cellular uptake.	[Hara, Daiki; Komatsu, Hirokazu; Son, Aoi; Nishimoto, Sei-ichi; Tanabe, Kazuhito] Kyoto Univ, Grad Sch Engn, Dept Energy & Hydrocarbon Chem, Nishikyo Ku, Kyoto 6158510, Japan	Tanabe, K (reprint author), Kyoto Univ, Grad Sch Engn, Dept Energy & Hydrocarbon Chem, Nishikyo Ku, Katsura Campus, Kyoto 6158510, Japan.	tanabeka@scl.kyoto-u.ac.jp			Innovative Techno-Hub for Integrated Medical Bioimaging Project of the Special Coordination Funds for Promoting Science and Technology; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	This work is partly supported by the Innovative Techno-Hub for Integrated Medical Bioimaging Project of the Special Coordination Funds for Promoting Science and Technology and by Grant-in-Aid for Scientific Research, from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Komatsu H, 2013, CHEM-EUR J, V19, P1971, DOI 10.1002/chem.201202809; RASEY JS, 1989, INT J RADIAT ONCOL, V17, P985; Zhang SJ, 2010, CANCER RES, V70, P4490, DOI 10.1158/0008-5472.CAN-09-3948; Dmitriev RI, 2012, ANAL CHEM, V84, P2930, DOI 10.1021/ac3000144; Kozhevnikov DN, 2011, INORG CHEM, V50, P3804, DOI 10.1021/ic200210e; VAUPEL P, 1989, CANCER RES, V49, P6449; Semenza GL, 2001, TRENDS MOL MED, V7, P345, DOI 10.1016/S1471-4914(01)02090-1; Okuda K, 2012, BIOCONJUGATE CHEM, V23, P324, DOI 10.1021/bc2004704; Liu Y, 2006, BIOORGAN MED CHEM, V14, P2935, DOI 10.1016/j.bmc.2005.12.012; Lincoln R, 2013, J AM CHEM SOC, V135, P17161, DOI 10.1021/ja408426z; Komatsu H, 2010, MEDCHEMCOMM, V1, P50, DOI 10.1039/c0md00024h; Yoshihara T, 2012, ANGEW CHEM INT EDIT, V51, P4148, DOI 10.1002/anie.201107557; Tanabe K, 2008, CHEMBIOCHEM, V9, P426, DOI 10.1002/cbic.200700458; Liu YF, 2011, CHEM COMMUN, V47, P11471, DOI 10.1039/c1cc14582g; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Ceroni P, 2011, PHOTOCH PHOTOBIO SCI, V10, P1056, DOI 10.1039/c0pp00356e; Fujibayashi Y, 1997, J NUCL MED, V38, P1155; Lo KKW, 2014, RSC ADV, V4, P10560, DOI 10.1039/c3ra47611a; Aragones J, 2009, CELL METAB, V9, P11, DOI 10.1016/j.cmet.2008.10.001; Ji SM, 2010, J MATER CHEM, V20, P1953, DOI 10.1039/b916468e; Wu WH, 2011, DALTON T, V40, P11550, DOI 10.1039/c1dt11001b; Smith CS, 2012, J AM CHEM SOC, V134, P8786, DOI 10.1021/ja302807s; Semenza GL, 2003, ANNU REV MED, V54, P17, DOI 10.1146/annurev.med.54.101601.152418; Fercher A, 2011, ACS NANO, V5, P5499, DOI 10.1021/nn200807g; Xu KH, 2013, CHEM COMMUN, V49, P2554, DOI 10.1039/c3cc38980d; Zhao JZ, 2012, RSC ADV, V2, P1712, DOI 10.1039/c1ra00665g; Horobin RW, 2006, HISTOCHEM CELL BIOL, V126, P165, DOI 10.1007/s00418-006-0156-7; Nakata E, 2009, BIOORGAN MED CHEM, V17, P6952, DOI 10.1016/j.bmc.2009.08.037; Kiyose K, 2010, J AM CHEM SOC, V132, P15846, DOI 10.1021/ja105937q; Choi NW, 2012, BIOMATERIALS, V33, P2710, DOI 10.1016/j.biomaterials.2011.11.048; Fernandez-Moreira V, 2010, CHEM COMMUN, V46, P186, DOI 10.1039/b917757d; Flasik R, 2009, MOLECULES, V14, P4838, DOI 10.3390/molecules14124838; Guo HM, 2010, ANALYST, V135, P2832, DOI 10.1039/c0an00404a; Ishida H, 2010, COORDIN CHEM REV, V254, P2449, DOI 10.1016/j.ccr.2010.04.006; Ji J, 2002, J BIOMED OPT, V7, P404, DOI 10.1117/1.1483082; Mardoch C., 2005, J IMMUNOL, V175, P6257; Semenza Gregg L., 2001, Pediatric Research, V49, P614, DOI 10.1203/00006450-200105000-00002; Son A, 2015, CHEM-EUR J, V21, P2527, DOI 10.1002/chem.201404979; Ziemer LS, 2005, J APPL PHYSIOL, V98, P1503, DOI 10.1152/japplphysiol.01140.2004	39	3	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1043-1802			BIOCONJUGATE CHEM	Bioconjugate Chem.	APR	2015	26	4					645	649		10.1021/acs.bioconjchem.5b00093		5	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Multidisciplinary; Chemistry, Organic	Biochemistry & Molecular Biology; Chemistry	CG3JU	WOS:000353177300005		
J	Egawa, D; Itoh, T; Yamamoto, K				Egawa, Daichi; Itoh, Toshimasa; Yamamoto, Keiko			Characterization of Covalent Bond Formation between PPAR gamma and Oxo-Fatty Acids	BIOCONJUGATE CHEMISTRY			English	Article							ALPHA/GAMMA DUAL AGONISTS; ACTIVATED-RECEPTOR-GAMMA; LIGAND-BINDING DOMAIN; DOCOSAHEXAENOIC ACID; ANTIDIABETIC AGENTS; ALPHA; DERIVATIVES; PHOSPHORYLATION; DESIGN; SYSTEM	Covalent modification of proteins is important for normal cellular regulation. Here, we report on the covalent modification of peroxisome proliferator-activated receptor gamma (PPAR gamma), an important drug target, by oxo-fatty acids. In this study, ESI mass spectroscopy showed that the reactivities of oxo-fatty acids with PPAR gamma are different from one another and that these behaviors are related to the structure of the fatty acids. X-ray crystallography showed that three oxo-fatty acids all bound to the same residue of PPAR? (Cys285), but displayed different hydrogen bonding modes. Moreover, fatty acids formed covalent bonds with both PPAR? moieties in the homodimer, one in an active conformation and the other in an alternative conformation. These two conformations may explain why covalently bound fatty acids show partial rather than full agonist activity.	[Egawa, Daichi; Itoh, Toshimasa; Yamamoto, Keiko] Showa Pharmaceut Univ, Lab Drug Design & Med Chem, Machida, Tokyo 1948543, Japan	Yamamoto, K (reprint author), Showa Pharmaceut Univ, Lab Drug Design & Med Chem, 3-3165 Higashi Tamagawagakuen, Machida, Tokyo 1948543, Japan.	yamamoto@ac.shoyaku.ac.jp			Platform for Drug Discovery, Informatics, and Structural Life Science; Ministry of Education, Culture, Sports, Science and Technology, Japan [22790116, 25860090]; MEXT; Takeda Science Foundation, Japan	This work was supported by the Platform for Drug Discovery, Informatics, and Structural Life Science and by a Grant-in-Aid for Scientific Research (no. 22790116 and 25860090) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. We also thank the MEXT-Supported Program for the Strategic Research Foundation at Private Universities (2013-2017) and the Takeda Science Foundation, Japan, for financial support. Synchrotron-radiation experiments were performed at the Photon Factory (Proposal No. 2009G647, 2011G685), and we are grateful for the assistance provided by the beamline scientists there.	Ohashi M, 2013, BIOORGAN MED CHEM, V21, P2319, DOI 10.1016/j.bmc.2013.02.003; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Anami Y, 2014, J MED CHEM, V57, P4351, DOI 10.1021/jm500392t; Pochetti G, 2007, J BIOL CHEM, V282, P17314, DOI 10.1074/jbc.M702316200; Einstein M, 2008, MOL PHARMACOL, V73, P62, DOI 10.1124/mol.107.041202; Bloom J, 2003, CELL, V115, P71, DOI 10.1016/S0092-8674(03)00755-4; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Yamamoto K, 2000, P NATL ACAD SCI USA, V97, P1467, DOI 10.1073/pnas.020522697; Sauerberg P, 2002, J MED CHEM, V45, P789, DOI 10.1021/jm010964g; Johnson LN, 2009, BIOCHEM SOC T, V37, P627, DOI 10.1042/BST0370627; Leesnitzer LM, 2002, BIOCHEMISTRY-US, V41, P6640, DOI 10.1021/bi0159581; Rossi A, 2000, NATURE, V403, P103; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Pinelli A, 2005, J MED CHEM, V48, P5509, DOI 10.1021/jm0502844; Bruning JB, 2010, NAT CHEM BIOL, V6, P837, DOI [10.1038/nchembio.451, 10.1038/NCHEMBIO.451]; Montanari R, 2008, J MED CHEM, V51, P7768, DOI 10.1021/jm800733h; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Itoh T, 2008, NAT STRUCT MOL BIOL, V15, P924, DOI 10.1038/nsmb.1474; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Waku T, 2009, FEBS LETT, V583, P320, DOI 10.1016/j.febslet.2008.12.017; Waku T, 2009, J MOL BIOL, V385, P188, DOI 10.1016/j.jmb.2008.10.039; Laghezza A, 2013, J MED CHEM, V56, P60, DOI 10.1021/jm301018z; Nolte RT, 1998, NATURE, V395, P137; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Schopfer FJ, 2011, CHEM REV, V111, P5997, DOI 10.1021/cr200131e; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953; Casimiro-Garcia A, 2008, BIOORGAN MED CHEM, V16, P4883, DOI 10.1016/j.bmc.2008.03.043; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Ebdrup S, 2003, J MED CHEM, V46, P1306, DOI 10.1021/jm021027r; Fracchiolla G, 2009, J MED CHEM, V52, P6382, DOI 10.1021/jm900941b; Groeger A. L., 2009, NAT CHEM BIOL, V6, P433; Itoh T, 2010, HETEROCYCLES, V80, P689, DOI 10.3987/COM-09-S(S)90; Itoh T, 2006, BIOORGAN MED CHEM, V14, P98, DOI 10.1016/j.bmc.2005.07.074; Itoh T, 2011, LIPIDS, V46, P455, DOI 10.1007/s11745-011-3541-5; KANG T, 1993, J BIOL CHEM, V268, P9629; Kim WJ, 2007, EMBO J, V26, P5020, DOI 10.1038/sj.emboj.7601920; Kuwabara N, 2012, J MED CHEM, V55, P893, DOI 10.1021/jm2014293; Liberato MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036297; Liu Guei-Sheung, 2012, Cells, V1, P976, DOI 10.3390/cells1040976; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Shi GQ, 2005, J MED CHEM, V48, P4457, DOI 10.1021/jm0502135; Srinivasan S, 2013, NAT CHEM BIOL, V9, P326, DOI [10.1038/nchembio.1214, 10.1038/NCHEMBIO.1214]; Yamamoto K, 2005, BIOORG MED CHEM LETT, V15, P517, DOI 10.1016/j.bmcl.2004.11.053	44	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1043-1802			BIOCONJUGATE CHEM	Bioconjugate Chem.	APR	2015	26	4					690	698		10.1021/acs.bioconjchem.5b00021		9	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Multidisciplinary; Chemistry, Organic	Biochemistry & Molecular Biology; Chemistry	CG3JU	WOS:000353177300010		
J	Kettisen, K; Bulow, L; Sakai, H				Kettisen, Karin; Bulow, Leif; Sakai, Hiromi			Potential Electron Mediators to Extract Electron Energies of RBC Glycolysis for Prolonged in Vivo Functional Lifetime of Hemoglobin Vesicles	BIOCONJUGATE CHEMISTRY			English	Article							NADPH-FLAVIN REDUCTASE; RED-BLOOD-CELLS; METHYLENE-BLUE; HUMAN-ERYTHROCYTES; METHEMOGLOBIN REDUCTION; SUPEROXIDE-DISMUTASE; OXYGEN CARRIERS	Developing a functional blood substitute as an alternative to donated blood for clinical use is believed to relieve present and future blood shortages, and to reduce the risks of infection and blood type mismatching. Hemoglobin vesicle (HbV) encapsulates a purified and concentrated human-derived Hb solution in a phospholipid vesicle (liposome). The in vivo safety and efficacy of HbV as a transfusion alternative have been clarified. Auto-oxidation of ferrous Hb in HbV gradually increases the level of ferric methemoglobin (metHb) and impairs the oxygen transport capabilities. The extension of the functional half-life of HbV has recently been proposed using an electron mediator, methylene blue (MB), which acts as a shuttle between red blood cells (RBC) and HbV. MB transfers electron energies of NAD(P)H, produced by RBC glycolysis, to metHb in HbV. Work presented here focuses on screening of 15 potential electron mediators, with appropriate redox potential and water solubility, for electron transfer from RBC to HbV. The results are assessed with regard to the chemical properties of the candidates. The compounds examined in this study were dimethyl methylene blue (DMB), methylene green, azure A, azure B, azure C, toluidine blue (TDB), thionin acetate, phenazine methosulfate, brilliant cresyl blue, cresyl violet, gallocyanine, toluylene blue, indigo carmine, indigotetrasulfonate, and MB. Six candidates were found to be unsuitable because of their insufficient diffusion across membranes, or overly high or nonexistent reactivity with relevant biomolecules. However, 9 displayed favorable metHb reduction. Among the suitable candidates, phenothiazines DMB and TDB exhibited effectiveness like MB did. In comparison to MB, they showed faster reduction by electron-donating NAD(P)H, coupled with showing a lower rate of reoxidation in the presence of molecular oxygen. Ascertaining the best electron mediator can provide a pathway for extending the lifetime and efficiency of potential blood substitutes.	[Kettisen, Karin; Sakai, Hiromi] Nara Med Univ, Dept Chem, Kashihara, Nara 6348521, Japan; [Kettisen, Karin; Bulow, Leif] Lund Univ, Dept Pure & Appl Biochem, S-22100 Lund, Sweden	Sakai, H (reprint author), Nara Med Univ, Dept Chem, Kashihara, Nara 6348521, Japan.	hirosakai@naramed-u.ac.jp			Japan Society for the Promotion of Sciences (JSPS) [25282136]; Health and Labour Sciences Grants (Health Science Research Including Drug Innovation) from the Ministry of Health, Labour and Welfare, Japan; Scandinavia-Japan Sasakawa Foundation; Angpanneforeningens Forskningsstiftelse; Lundabygdens sparbanks stiftelse mm resestipendiefond for studerande	This research was supported by a Grant-in-Aid for Scientific Research (Kiban B, No. 25282136) from the Japan Society for the Promotion of Sciences (JSPS), and partly by Health and Labour Sciences Grants (Health Science Research Including Drug Innovation) from the Ministry of Health, Labour and Welfare, Japan. Karin Kettisen was recipient of scholarships from the Scandinavia-Japan Sasakawa Foundation, Angpanneforeningens Forskningsstiftelse, and Lundabygdens sparbanks stiftelse mm resestipendiefond for studerande. The authors acknowledge Ms. Tomoko Kure, Ms. Yumika Iga, Dr. Takashi Matsuhira, and Dr. Keizo Yamamoto (Nara Medical University) for their assistance in the experiments.	May JM, 2001, BBA-GEN SUBJECTS, V1528, P159, DOI 10.1016/S0304-4165(01)00188-X; Wright RO, 1999, ANN EMERG MED, V34, P646, DOI 10.1016/S0196-0644(99)70167-8; Wongsrikeao P, 2006, THERIOGENOLOGY, V66, P366, DOI 10.1016/j.theriogenology.2005.12.001; BENDICH A, 1986, ADV FREE RADICAL BIO, V2, P419, DOI 10.1016/S8755-9668(86)80021-7; Alayash AI, 2014, TRENDS BIOTECHNOL, V32, P177, DOI 10.1016/j.tibtech.2014.02.006; Sakai H, 2009, ARTIF ORGANS, V33, P139, DOI 10.1111/j.1525-1594.2008.00698.x; Wainwright M, 2000, INT J ANTIMICROB AG, V16, P381, DOI 10.1016/S0924-8579(00)00207-7; Atamna H, 1996, BIOCHEM PHARMACOL, V51, P693, DOI 10.1016/S0006-2952(95)02258-9; Barron ESG, 1930, J GEN PHYSIOL, V13, P483, DOI 10.1085/jgp.13.4.483; BEUTLER E, 1963, BLOOD, V22, P323; Bradberry Sally M., 2003, Toxicological Reviews, V22, P13, DOI 10.2165/00139709-200322010-00003; Bunn HF, 1986, HEMOGLOBIN MOL GENET; Chang TMS, 2012, ARTIF CELL BLOOD SUB, V40, P197, DOI 10.3109/10731199.2012.662408; FULTZ ML, 1982, ANAL CHIM ACTA, V140, P1, DOI 10.1016/S0003-2670(01)95447-9; KIESE M, 1972, EUR J CLIN PHARMACOL, V4, P115, DOI 10.1007/BF00562507; Kubota LT, 1999, ELECTROANAL, V11, P719, DOI 10.1002/(SICI)1521-4109(199907)11:10/11<719::AID-ELAN719>3.0.CO;2-S; MARIDONNEAUPARINI I, 1986, TOXICOL LETT, V31, P175, DOI 10.1016/0378-4274(86)90012-3; May JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1390, DOI 10.1152/ajpcell.00512.2003; MCCORD JM, 1970, J BIOL CHEM, V245, P1374; NAGAI M, 1980, J BIOL CHEM, V255, P4599; O'Neil M.J., 2001, MERCK INDEX ENCY CHE; ROBINSON J, 1970, ANAL BIOCHEM, V33, P390, DOI 10.1016/0003-2697(70)90310-6; Ruiz-Haas P, 2007, GEOMICROBIOL J, V24, P365, DOI 10.1080/01490450701459226; Sakai H, 2014, BIOCONJUGATE CHEM, V25, P1301, DOI 10.1021/bc500153x; STREHLITZ B, 1994, FRESEN J ANAL CHEM, V349, P676, DOI 10.1007/BF00323479; TOMODA A, 1979, J BIOL CHEM, V254, P3119; Tsuchida E., 2009, BIOCONJUGATE CHEM, V20, P1429; TURRENS JF, 1984, J CLIN INVEST, V73, P87, DOI 10.1172/JCI111210; Winslow RM, 2006, BLOOD SUBSTITUTES; YUBISUI T, 1979, J BIOCHEM-TOKYO, V85, P719	30	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1043-1802			BIOCONJUGATE CHEM	Bioconjugate Chem.	APR	2015	26	4					746	754		10.1021/acs.bioconjchem.5b00076		9	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Multidisciplinary; Chemistry, Organic	Biochemistry & Molecular Biology; Chemistry	CG3JU	WOS:000353177300016		
J	Ikeda, K; Ichihara, K; Hashiguchi, T; Hidaka, Y; Kang, DC; Maekawa, M; Matsumoto, H; Matsushita, K; Okubo, S; Tsuchiya, T; Furuta, K				Ikeda, Katsuyoshi; Ichihara, Kiyoshi; Hashiguchi, Teruto; Hidaka, Yoh; Kang, Dongchon; Maekawa, Masato; Matsumoto, Hiroyuki; Matsushita, Kazuyuki; Okubo, Shigeo; Tsuchiya, Tatsuyuki; Furuta, Koh		JSLM	Evaluation of the Short-Term Stability of Specimens for Clinical Laboratory Testing	BIOPRESERVATION AND BIOBANKING			English	Article							TISSUE SPECIMENS; PHASE-DIAGRAM; BLOOD; TEMPERATURE; SAMPLES	Background: A major concern in both the laboratory-medicine and research communities is the quality of human specimens for analysis. However, there is insufficient scientific evidence regarding optimal conditions for handling and storing routine specimens, especially those in liquid form. Thus, we investigated the stability of clinically relevant samples stored under various conditions. Materials and Methods: Ten clinical laboratories in Japan conducted analyses of the stability of post-clinical (left over after analysis) test samples in relation to temperature and storage duration. We examined serum, whole blood, and urine samples submitted to each laboratory for routine testing. In this study, at least 5 samples for each of 35 tests were analyzed at each laboratory. After completion of routine testing, specimens with sufficient residual volume and values between LL-R/2 (lower limit of reference interval) and UL+R/2 (upper limit) were divided into 300 mu L aliquots, where R=UL - LL. Aliquots of serum specimens were stored at either room temperature (23 degrees C), 4 degrees C, -20 degrees C, or -80 degrees C without light exposure. Aliquots of whole blood and urine specimens were stored at either 23 degrees C or 4 degrees C. The storage time was either 1, 3, or 7 days. Average differences between pre- and post-storage test results were evaluated for each laboratory test by two-way ANOVA. F-values for between-day variations were used for judging the statistical significance of storage-related changes in test values, whereas the ratio of between-day SD to between-individual SD (one-fourth of reference interval) was used to indicate the practical significance of the change. Results and Conclusion: Sample denaturation is clearly temperature- and storage-duration dependent for almost all analytes. In general, specimens were most susceptible to denaturation at 23 degrees C, then 4 degrees C, -20 degrees C, and -80 degrees C. This study confirmed the accumulated routine, practice-based, detailed knowledge regarding specimen stability and will help to ensure the reliability of laboratory test results.	[Ikeda, Katsuyoshi] Kumamoto Univ Hosp, Fac Hlth Sci, Dept Clin Lab, Kumamoto, Japan; [Ichihara, Kiyoshi] Yamaguchi Univ, Grad Sch Med, Dept Clin Lab Sci, Yamaguchi, Japan; [Hashiguchi, Teruto] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Lab & Vasc Med, Kagoshima 890, Japan; [Hidaka, Yoh] Osaka Univ, Grad Sch Med, Dept Lab Med, Osaka, Japan; [Kang, Dongchon] Kyushu Univ, Grad Sch Med Sci, Dept Clin Chem & Lab Med, Fukuoka 812, Japan; [Maekawa, Masato] Hamamatsu Univ Sch Med, Dept Lab Med, Hamamatsu, Shizuoka 4313192, Japan; [Matsumoto, Hiroyuki] Nagoya Univ Hosp, Dept Med Tech, Nagoya, Aichi, Japan; [Matsushita, Kazuyuki] Chiba Univ, Grad Sch Med, Dept Mol Diag, Chiba, Japan; [Matsushita, Kazuyuki] Chiba Univ, Grad Sch Med, Div Clin Genet & Prote, Chiba, Japan; [Okubo, Shigeo] Tokyo Univ Hosp, Dept Clin Lab, Tokyo 113, Japan; [Tsuchiya, Tatsuyuki] Keiyu Hosp, Dept Lab Med, Yokohama, Kanagawa, Japan; [Furuta, Koh] Natl Canc Ctr, Div Clin Labs, Tokyo 1040045, Japan	Furuta, K (reprint author), Natl Canc Ctr, Div Clin Labs, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	kfuruta@ncc.go.jp		Matsushita, Kazuyuki/0000-0001-6742-0761	National Cancer Center Research and Development Fund, Japan [26-A-1]	This study was supported in part by the National Cancer Center Research and Development Fund (26-A-1), Japan.	Scott KL, 2005, TRANSFUS MED REV, V19, P127, DOI 10.1016/j.tmrv.2004.11.004; Dunn WB, 2008, INT J EPIDEMIOL, V37, P23, DOI 10.1093/ije/dym281; Hubel A, 2014, BIOPRESERV BIOBANK, V12, P165, DOI 10.1089/bio.2013.0084; Breier M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089728; Burtis CA, 2008, FUNDAMENTALS CLIN CH, P202; Clark S, 2004, INT J EPIDEMIOL, V33, P518, DOI 10.1093/ije/dyh064; COCKS FH, 1974, CRYOBIOLOGY, V11, P340, DOI 10.1016/0011-2240(74)90011-X; Furuta K, 2011, BIOPRESERV BIOBANK, V9, P99; Gaye A, 2014, INT J EPIDEMIOL, V43, P1633, DOI 10.1093/ije/dyu127; Ichihara K, 2011, PRACTICAL MANUAL EVI; Kang HJ, 2013, BIOPRESERV BIOBANK, V11, P94, DOI 10.1089/bio.2012.0051; Kushnir MM, 2013, AM J CLIN PATHOL, V140, P287, DOI 10.1309/AJCPFZYY7BBKK9JE; Lim MD, 2010, ANAL CHEM, V83, P8; Ragoonanan V, 2013, CRYOBIOLOGY, V66, P96, DOI 10.1016/j.cryobiol.2012.10.008; RASMUSSE.DH, 1968, NATURE, V220, P1315, DOI 10.1038/2201315a0; Sapre N, 2013, BIOPRESERV BIOBANK, V11, P166, DOI 10.1089/bio.2012.0062; Unhale SA, 2012, BIOPRESERV BIOBANK, V10, P493, DOI 10.1089/bio.2012.0031; Yamauchi A, 1995, JAP J MED TECHNOL, V44, P907	18	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1947-5535	1947-5543		BIOPRESERV BIOBANK	Biopreserv. Biobank.	APR 1	2015	13	2					135	143		10.1089/bio.2014.0072		9	Cell Biology; Chemistry, Applied; Medical Laboratory Technology	Cell Biology; Chemistry; Medical Laboratory Technology	CG1DE	WOS:000353012400011		
J	Nosaka, N; Ichiba, S; Tsukahara, K; Knaup, E; Hayashi, K; Kasahara, S; Kobayashi, Y; Oka, M; Kobayashi, K; Yoshinaga, H; Ujike, Y				Nosaka, Nobuyuki; Ichiba, Shingo; Tsukahara, Kohei; Knaup, Emily; Hayashi, Kumiko; Kasahara, Shingo; Kobayashi, Yoshinori; Oka, Makio; Kobayashi, Katsuhiro; Yoshinaga, Harumi; Ujike, Yoshihito			Acute respiratory distress syndrome in a child with severe epileptic disorder treated successfully by extracorporeal membrane oxygenation: a case report	BMC PEDIATRICS			English	Article						Acute respiratory distress syndrome (ARDS); Extracorporeal membrane oxygenation (ECMO); Severe epileptic disorder; Pediatrics	HIGH-FREQUENCY OSCILLATION; 2009 INFLUENZA A(H1N1); EXOGENOUS SURFACTANT; FAILURE SECONDARY; LUNG INJURY; MORTALITY; H1N1; VENTILATION; INFECTION; REGISTRY	Background: Extracorporeal membrane oxygenation (ECMO) is now a candidate therapy for children with acute respiratory failure. Case presentation: We report our experience of using central ECMO therapy for acute respiratory distress syndrome followed by seizure in a 15-month-old girl with a severe epileptic disorder. Her respiratory distress was refractory to standard medical treatment and mechanical ventilatory support. Her condition was complicated by development of a pneumothorax. The patient was successfully weaned off ECMO and discharged without deterioration of her neurological status. Conclusion: The successful outcome in this case resulted from the central ECMO, which enabled "lung rest" and adequate cerebral blood flow. In skilled ECMO facilities, early implementation of ECMO would give some advantages to patients such as the one presented here. Given the invasiveness and the ease of the procedure, introduction of dual-lumen catheters adequately sized for pediatric patients in Japan is required.	[Nosaka, Nobuyuki; Ichiba, Shingo; Tsukahara, Kohei; Knaup, Emily; Hayashi, Kumiko; Ujike, Yoshihito] Okayama Univ Hosp, Adv Emergency & Crit Care Med Ctr, Okayama, Japan; [Nosaka, Nobuyuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pediat, Okayama, Japan; [Ichiba, Shingo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Community & Emergency Med, Okayama, Japan; [Kasahara, Shingo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Surg, Okayama, Japan; [Kobayashi, Yoshinori; Oka, Makio; Kobayashi, Katsuhiro; Yoshinaga, Harumi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Child Neurol, Okayama, Japan	Ichiba, S (reprint author), Okayama Univ Hosp, Adv Emergency & Crit Care Med Ctr, Okayama, Japan.	ecmoshingo@gmail.com					Akiyama M, 2012, ACTA MED OKAYAMA, V66, P369; Terra VC, 2011, ARQ NEURO-PSIQUIAT, V69, P766, DOI 10.1590/S0004-282X2011000600008; Forsgren L, 2005, EPILEPSIA, V46, P18, DOI 10.1111/j.1528-1167.2005.00403.x; Goffi A, 2014, CURR OPIN CRIT CARE, V20, P77, DOI 10.1097/MCC.0000000000000060; Paden ML, 2013, ASAIO J, V59, P202, DOI 10.1097/MAT.0b013e3182904a52; Willson DF, 2011, RESP CARE, V56, P1369, DOI 10.4187/respcare.01306; Young D, 2013, NEW ENGL J MED, V368, P806, DOI 10.1056/NEJMoa1215716; Noah MA, 2011, JAMA-J AM MED ASSOC, V306, P1659, DOI 10.1001/jama.2011.1471; Ferguson ND, 2013, NEW ENGL J MED, V368, P795, DOI 10.1056/NEJMoa1215554; Brower RG, 2000, NEW ENGL J MED, V342, P1301; Fallon SC, 2013, PEDIATR CRIT CARE ME, V14, P366, DOI 10.1097/PCC.0b013e31828a70dc; Buckley E, 2010, BRIT J ANAESTH, V104, P326, DOI 10.1093/bja/aep396; Davies A, 2009, JAMA-J AM MED ASSOC, V302, P1888; Extracorporeal Life Support Organization (ELSO), GEN GUID ALL ECLS CA; Extracorporeal Life Support Organization (ELSO), 2009, GUID PED RESP FAIL V; Extracorporeal Life Support Organization (ELSO), 2013, GUID PED RESP FAIL V; Fan E, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-85; Freed DH, 2010, CAN J ANAESTH, V57, P240, DOI 10.1007/s12630-009-9253-0; Kula R, 2011, BRATISL MED J, V112, P218; Lhatoo SD, 2005, EPILEPSIA, V46, P36, DOI 10.1111/j.1528-1167.2005.00406.x; Maslach-Hubbard Anna, 2013, World J Crit Care Med, V2, P29, DOI 10.5492/wjccm.v2.i4.29; Peek GJ, 1997, BRIT MED BULL, V53, P745; Peris A, 2010, SCAND J TRAUMA RESUS, V21, P18; Tokuhira N, 2012, PEDIATR CRIT CARE ME, V13, pE294, DOI 10.1097/PCC.0b013e31824fbb10; Turner DA, 2011, RESP CARE, V56, P941, DOI 10.4187/respcare.01066	25	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2431			BMC PEDIATR	BMC Pediatr.	APR 1	2015	15								29	10.1186/s12887-015-0348-1		4	Pediatrics	Pediatrics	CH3PW	WOS:000353943700001		
J	Baets, J; Duan, XH; Wu, YH; Smith, G; Seeley, WW; Mademan, I; McGrath, NM; Beadell, NC; Khoury, J; Botuyan, MV; Mer, G; Worrell, GA; Hojo, K; DeLeon, J; Laura, M; Liu, YT; Senderek, J; Weis, J; Van den Bergh, P; Merrill, SL; Reilly, MM; Houlden, H; Grossman, M; Scherer, SS; De Jonghe, P; Dyck, PJ; Klein, CJ				Baets, Jonathan; Duan, Xiaohui; Wu, Yanhong; Smith, Gordon; Seeley, William W.; Mademan, Ines; McGrath, Nicole M.; Beadell, Noah C.; Khoury, Julie; Botuyan, Maria-Victoria; Mer, Georges; Worrell, Gregory A.; Hojo, Kaori; DeLeon, Jessica; Laura, Matilde; Liu, Yo-Tsen; Senderek, Jan; Weis, Joachim; Van den Bergh, Peter; Merrill, Shana L.; Reilly, Mary M.; Houlden, Henry; Grossman, Murray; Scherer, Steven S.; De Jonghe, Peter; Dyck, Peter J.; Klein, Christopher J.			Defects of mutant DNMT1 are linked to a spectrum of neurological disorders	BRAIN			English	Article						protein aggregation; sensory neuropathy; narcolepsy; REM sleep behaviour disorder; neurodegeneration	MARIE-TOOTH-DISEASE; AUTONOMIC NEUROPATHY; DNA METHYLATION; CEREBELLAR-ATAXIA; HEARING-LOSS; MUTATION; REPLICATION; NARCOLEPSY; METHYLTRANSFERASE; NEURODEGENERATION	Baets et al. expand the clinical spectrum of hereditary sensory and autonomic neuropathy type 1E (HSAN1E) by studying nine newly identified kinships, and reveal a potential pathogenic mechanism for causative DNMT1 mutations. Mutant DNMT1 proteins form aggresomes in the cytoplasm, suggesting that aggresome-induced autophagy may contribute to disease pathogenesis.We report a broader than previously appreciated clinical spectrum for hereditary sensory and autonomic neuropathy type 1E (HSAN1E) and a potential pathogenic mechanism for DNA methyltransferase (DNMT1) mutations. The clinical presentations and genetic characteristics of nine newly identified HSAN1E kinships (45 affected subjects) were investigated. Five novel mutations of DNMT1 were discovered; p.C353F, p.T481P, p.P491L, p.Y524D and p.I531N, all within the target-sequence domain, and two mutations (p.T481P, p.P491L) arising de novo. Recently, HSAN1E has been suggested as an allelic disorder of autosomal dominant cerebellar ataxia, deafness and narcolepsy. Our results indicate that all the mutations causal for HSAN1E are located in the middle part or N-terminus end of the TS domain, whereas all the mutations causal for autosomal dominant cerebellar ataxia, deafness and narcolepsy are located in the C-terminus end of the TS domain. The impact of the seven causal mutations in this cohort was studied by cellular localization experiments. The binding efficiency of the mutant DNMT proteins at the replication foci and heterochromatin were evaluated. Phenotypic characterizations included electromyography, brain magnetic resonance and nuclear imaging, electroencephalography, sural nerve biopsies, sleep evaluation and neuropsychometric testing. The average survival of HSAN1E was 53.6 years. [standard deviation = 7.7, range 43-75 years], and mean onset age was 37.7 years. (standard deviation = 8.6, range 18-51 years). Expanded phenotypes include myoclonic seizures, auditory or visual hallucinations, and renal failure. Hypersomnia, rapid eye movement sleep disorder and/or narcolepsy were identified in 11 subjects. Global brain atrophy was found in 12 of 14 who had brain MRI. EEGs showed low frequency (delta waves) frontal-predominant abnormality in five of six patients. Marked variability in cognitive deficits was observed, but the majority of patients (89%) developed significant cognitive deficit by the age of 45 years. Cognitive function decline often started with personality changes and psychiatric manifestations. A triad of hearing loss, sensory neuropathy and cognitive decline remains as the stereotypic presentation of HSAN1E. Moreover, we show that mutant DNMT1 proteins translocate to the cytoplasm and are prone to form aggresomes while losing their binding ability to heterochromatin during the G2 cell cycle. Our results suggest mutations in DNMT1 result in imbalanced protein homeostasis through aggresome-induced autophagy. This mechanism may explain why mutations in the sole DNA maintenance methyltransferase lead to selective central and peripheral neurodegeneration.	[Baets, Jonathan; Mademan, Ines; De Jonghe, Peter] Univ Antwerp, Neurogenet Grp, VIB Det Mol Genet, B-2020 Antwerp, Belgium; [Baets, Jonathan; Mademan, Ines; De Jonghe, Peter] Univ Antwerp, Neurogenet Lab, Inst Born Bunge, B-2020 Antwerp, Belgium; [Baets, Jonathan; De Jonghe, Peter] Univ Antwerp Hosp, Dept Neurol, Antwerp, Belgium; [Duan, Xiaohui; Dyck, Peter J.; Klein, Christopher J.] Mayo Clin, Peripheral Neuropathy Res Lab, Rochester, MN 55905 USA; [Duan, Xiaohui] China Japan Friendship Hosp, Dept Neurol, Beijing, Peoples R China; [Wu, Yanhong; Klein, Christopher J.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Smith, Gordon] Univ Utah, Dept Neurol, Salt Lake City, UT 84112 USA; [Seeley, William W.; DeLeon, Jessica] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Seeley, William W.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [McGrath, Nicole M.] Whangarei Hosp, Dept Med, Whangarei, New Zealand; [Beadell, Noah C.; Khoury, Julie] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Botuyan, Maria-Victoria; Mer, Georges] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA; [Worrell, Gregory A.] Mayo Clin, Epilepsy Res Lab, Dept Neurol, Rochester, MN USA; [Hojo, Kaori] Harima Sanat, Div Neuropsychiat, Kobe, Hyogo, Japan; [Laura, Matilde; Liu, Yo-Tsen; Reilly, Mary M.; Houlden, Henry] UCL Inst Neurol, MRC Ctr Neuromuscular Dis, London, England; [Laura, Matilde; Liu, Yo-Tsen; Reilly, Mary M.; Houlden, Henry] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England; [Laura, Matilde; Liu, Yo-Tsen; Reilly, Mary M.; Houlden, Henry] UCL Inst Neurol, Dept Mol Neurosci, London, England; [Liu, Yo-Tsen] Taipei Vet Gen Hosp, Neurol Inst, Dept Neurol, Taipei, Taiwan; [Liu, Yo-Tsen] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Senderek, Jan] Univ Munich, Dept Neurol, Friedrich Baur Inst, D-80539 Munich, Germany; [Weis, Joachim] RWTH Aachen Univ Hosp, Inst Neuropathol, Aachen, Germany; [Van den Bergh, Peter] Univ Louvain, Ctr Reference Neuromusculaire, Clin Univ St Luc, Brussels, Belgium; [Merrill, Shana L.; Grossman, Murray; Scherer, Steven S.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Klein, Christopher J.] Mayo Clin, Dept Med Genet, Rochester, MN USA	Klein, CJ (reprint author), Mayo Clin, Peripheral Neuropathy Res Lab, Rochester, MN 55905 USA.	klein.christopher@mayo.edu	Senderek, Jan/F-8405-2015; Weis, Joachim/G-1984-2014	Senderek, Jan/0000-0002-8263-1783; Weis, Joachim/0000-0003-3280-6773	National Institute of Health (NIH) [NS065007, DP3DK104394, R01DK064814, U10NS077305]; American Diabetes Association (ADA) of USA [7-11-AEC-23]; University of Antwerp (UA); Association Belge contre les Maladies Neuromusculaires (ABMM); Medical Foundation Queen Elisabeth (GSKE); agency for Innovation by Science and Technology (IWT); EU [2012-305121]; Judy Seltzer Levenson Memorial Fund for CMT Research; Medical Research Council (MRC), MRC Centre grant [G0601943]; National Institutes of Neurological Diseases and Stroke and office of Rare Diseases [U54NS065712]; Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme; German Research Council [DFG WE1406/13-1]; Association Belge contre les Maladies Neuro-Musculaires, Medical Foundation Queen Elisabeth; EU; MRC UK; Wellcome Trust; NIHR UCL/UCLH BRC; National Institute of Aging; John D. French Alzheimer's Disease Foundation; Consortium for Frontotemporal Dementia Research; James S. McDonnell Foundation; Alzheimer's Drug Discovery Foundation; National Institute of Neurological Disorders and Stroke	This study was supported by the National Institute of Health (NIH) (NS065007, DP3DK104394, R01DK064814, U10NS077305), and American Diabetes Association (ADA) 7-11-AEC-23 of USA, the University of Antwerp (UA), the Association Belge contre les Maladies Neuromusculaires (ABMM), the Medical Foundation Queen Elisabeth (GSKE), the agency for Innovation by Science and Technology (IWT) and the EU FP7/2007-2013 under grant agreement number 2012-305121 (NEUROMICS) and Judy Seltzer Levenson Memorial Fund for CMT Research. MMR and ML are grateful to the Medical Research Council (MRC), MRC Centre grant (G0601943), and the National Institutes of Neurological Diseases and Stroke and office of Rare Diseases (U54NS065712) for their support. Part of this work was undertaken at University College London Hospitals/University College London, which received a proportion of funding from the Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme. J.W. is supported by the German Research Council (DFG WE1406/13-1). Dr Baets receives research grant from Association Belge contre les Maladies Neuro-Musculaires, Medical Foundation Queen Elisabeth and EU 7th Framework Programme (FP7, 'NEUROMICS'); Dr Grossman sits on the board of International FTD Society; Dr Dyck receives an honorarium for serving as an Associate Editor of Diabetes, and receives support for teaching of neuropathy examinations from Alnylam and ISIS Pharmaceutical companies; Dr Houlden receives research grant from MRC UK, The Wellcome Trust and NIHR UCL/UCLH BRC; Dr Seeley receives research grant from National Institute of Aging, John D. French Alzheimer's Disease Foundation, Consortium for Frontotemporal Dementia Research, James S. McDonnell Foundation, Alzheimer's Drug Discovery Foundation and serves as a consultant for Bristol-Myers Squibb. Dr Klein, Dr Smith and Dr Scherer receive research grants from National Institute of Neurological Disorders and Stroke. Other co-authors have nothing to disclose.	Zimon M, 2012, NAT GENET, V44, P1080, DOI 10.1038/ng.2406; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Easwaran HP, 2004, EMBO REP, V5, P1181, DOI 10.1038/sj.embor.7400295; Klein CJ, 2005, J NEUROL NEUROSUR PS, V76, P1022, DOI 10.1136/jnnp.2004.050062; Klein CJ, 2011, NAT GENET, V43, P595, DOI 10.1038/ng.830; Spada F, 2007, J CELL BIOL, V176, P565, DOI 10.1083/jcb.200610062; Schermelleh L, 2007, NUCLEIC ACIDS RES, V35, P4301, DOI 10.1093/nar/gkm432; Jin BL, 2013, ADV EXP MED BIOL, V754, P3, DOI 10.1007/978-1-4419-9967-2_1; Rotthier A, 2012, NAT REV NEUROL, V8, P73, DOI 10.1038/nrneurol.2011.227; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; Knaevelsrud H, 2010, FEBS LETT, V584, P2635, DOI 10.1016/j.febslet.2010.04.041; Frauer C, 2011, P NATL ACAD SCI USA, V108, P8919, DOI 10.1073/pnas.1105804108; Rotthier A, 2009, BRAIN, V132, P2699, DOI 10.1093/brain/awp198; Sun ZF, 2014, EPIGENETICS-US, V9, P1184, DOI 10.4161/epi.29676; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Rossor AM, 2013, NAT REV NEUROL, V9, P562, DOI 10.1038/nrneurol.2013.179; Winkelmann J, 2012, HUM MOL GENET, V21, P2205, DOI 10.1093/hmg/dds035; Klein CJ, 2013, MUSCLE NERVE, V48, P604, DOI 10.1002/mus.23775; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI 10.1056/NEJMra1205406; Davidson GL, 2012, J NEUROL, V259, P1673, DOI 10.1007/s00415-011-6397-y; Klein CJ, 2013, NEUROLOGY, V80, P824, DOI 10.1212/WNL.0b013e318284076d; Klein CJ, 2014, NEUROLOGY, V82, P1833, DOI 10.1212/WNL.0000000000000440; Margot JB, 2000, J MOL BIOL, V297, P293, DOI 10.1006/jmbi.2000.3588; Marques SCF, 2011, PROG NEURO-PSYCHOPH, V35, P348, DOI 10.1016/j.pnpbp.2010.08.008; Moghadam KK, 2014, BRAIN, V137, P1643, DOI 10.1093/brain/awu069; Pedroso JL, 2013, SLEEP, V36, P1257, DOI 10.5665/sleep.2898; Saifi GM, 2003, J INVEST MED, V51, P261, DOI 10.2310/6650.2003.3716; Takalo Mari, 2013, Am J Neurodegener Dis, V2, P1; Yamamoto A, 2011, NEUROBIOL DIS, V43, P17, DOI 10.1016/j.nbd.2010.08.015; Yuan JH, 2013, J PERIPHER NERV SYST, V18, P89, DOI 10.1111/jns5.12012	32	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	APR 1	2015	138		4				845	861		10.1093/brain/awv010		17	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CG7XZ	WOS:000353522100014		
J	Belsanti, L; Ogihara, H; Mahanty, S; Luciano, G				Belsanti, L.; Ogihara, H.; Mahanty, S.; Luciano, G.			Electrochemical behaviour of superhydrophobic coating fabricated by spraying a carbon nanotube suspension	BULLETIN OF MATERIALS SCIENCE			English	Article						Al alloy; surface coating; superhydrophobicity; potentiodynamic polarization	CERIUM OXIDE-FILM; CORROSION-RESISTANCE; SURFACES; ALUMINUM; STABILITY	In this study, superhydrophobic films were prepared through a spraying process of carbon nanotube (CNT) suspension on aluminium alloy substrate and characterized by scanning electronic microscope (SEM) contact angles (CAs) and potentiodynamic polarization tests in 0.1 M NaCl solution. Results indicate the positive effect of superhydrophobic film on the CA (> 160A degrees) in comparison with the bare metal due to the high porosity density at the surface caused by the presence of CNTs. The electrochemical observations indicate the presence of a positive shift of E (corr) that confers a better corrosion resistance of the coated samples.	[Belsanti, L.; Luciano, G.] CNR ISMAR, Ist Sci Marine, I-16149 Genoa, Italy; [Ogihara, H.] Tokyo Inst Technol, Dept Chem & Mat Sci, Tokyo 1528552, Japan; [Mahanty, S.] Indian Inst Technol, Kanpur 208016, Uttar Pradesh, India	Belsanti, L (reprint author), CNR ISMAR, Ist Sci Marine, I-16149 Genoa, Italy.	lucrezia.belsanti@ge.ismar.cnr.it			Mazda Foundation; Flagship Project RITMARE-The Italian Research for the Sea; Italian Ministry of Education, University and Research	This study is supported by a research grant from The Mazda Foundation and has been partially funded by the Flagship Project RITMARE-The Italian Research for the Sea-coordinated by the Italian National Research Council and funded by the Italian Ministry of Education, University and Research within the National Research Program 2011-2013. We would like to thank Dr Giuliano Greco for providing useful suggestions on the writing of the present paper.	Rao AV, 2009, J COLLOID INTERF SCI, V332, P484, DOI 10.1016/j.jcis.2009.01.012; Su B, 2009, LANGMUIR, V25, P3640, DOI 10.1021/la803948m; Ogihara H, 2011, LANGMUIR, V27, P9069, DOI 10.1021/la200898z; Zhang L, 2006, LANGMUIR, V22, P8576, DOI 10.1021/la061400o; Badawy WA, 1999, CORROS SCI, V41, P709, DOI 10.1016/S0010-938X(98)00145-0; Nakajima A, 2000, THIN SOLID FILMS, V376, P140, DOI 10.1016/S0040-6090(00)01417-6; Ogihara H, 2012, LANGMUIR, V28, P4605, DOI 10.1021/la204492q; Yin B, 2011, APPL SURF SCI, V258, P580, DOI 10.1016/j.apsusc.2011.08.063; Hu YW, 2012, APPL SURF SCI, V258, P7460, DOI 10.1016/j.apsusc.2012.04.061; Roach P, 2008, SOFT MATTER, V4, P224, DOI 10.1039/b712575p; Li XM, 2007, CHEM SOC REV, V36, P1350, DOI 10.1039/b602486f; Ishizaki T, 2010, LANGMUIR, V26, P9749, DOI 10.1021/la100474x; Li M, 2003, J PHYS CHEM B, V107, P9954, DOI 10.1021/jp035562u; Qian BT, 2005, LANGMUIR, V21, P9007, DOI 10.1021/la051308c; Feng XJ, 2006, ADV MATER, V18, P3063, DOI 10.1002/adma.200501961; Zhao N, 2005, LANGMUIR, V21, P4713, DOI 10.1021/la0469194; Abdel-Gaber AM, 2006, MATER CHEM PHYS, V98, P291, DOI 10.1016/j.matchemphys.2005.09.023; Burkarter E, 2007, J PHYS D APPL PHYS, V40, P7778, DOI 10.1088/0022-3727/40/24/027; Ishizaki T, 2011, LANGMUIR, V27, P4780, DOI 10.1021/la2002783; Liang J, 2013, J NANOMATER, V2013, P6; Meng LY, 2010, J COLLOID INTERF SCI, V342, P559, DOI 10.1016/j.jcis.2009.10.022; Ogihara H, 2014, J MATER SCI, V49, P3183, DOI 10.1007/s10853-014-8021-x	22	0	0	INDIAN ACAD SCIENCES	BANGALORE	C V RAMAN AVENUE, SADASHIVANAGAR, P B #8005, BANGALORE 560 080, INDIA	0250-4707	0973-7669		B MATER SCI	Bull. Mat. Sci.	APR	2015	38	2					579	582		10.1007/s12034-015-0866-3		4	Materials Science, Multidisciplinary	Materials Science	CH2CD	WOS:000353831200038		
J	Ko, H; Takenaka, S; Kim, K				Ko, Hyunjun; Takenaka, Shigeori; Kim, Kyuwon			Thrombin-induced Sensitivity Enhancement in Impedemetric Detection of Hg2+ Ion	BULLETIN OF THE KOREAN CHEMICAL SOCIETY			English	Article						Mercury; Thrombin; Electrochemical impedance; Aptamer	MERCURY(II); APTAMERS; SENSOR; HEALTH		[Ko, Hyunjun; Kim, Kyuwon] Incheon Natl Univ, Dept Chem, Inchon 406772, South Korea; [Takenaka, Shigeori] Kyushu Inst Technol, Dept Appl Chem, Fukuoka 8048550, Japan	Kim, K (reprint author), Incheon Natl Univ, Dept Chem, Inchon 406772, South Korea.	kyuwon_kim@incheon.ac.kr			Incheon National University Research Grant	This work was supported by Incheon National University Research Grant in 2011.	Ono A, 2004, ANGEW CHEM INT EDIT, V43, P4300, DOI 10.1002/anie.200454172; Hylander LD, 2006, SCI TOTAL ENVIRON, V368, P352, DOI 10.1016/j.scitotenv.2005.11.029; Miyake Y, 2006, J AM CHEM SOC, V128, P2172, DOI 10.1021/ja056354d; Famulok M, 2007, CHEM REV, V107, P3715, DOI 10.1021/cr0306743; Li D, 2007, J AM CHEM SOC, V129, P5804, DOI 10.1021/ja070180d; Hansen JA, 2006, J AM CHEM SOC, V128, P2228, DOI 10.1021/ja060005h; Zheng N, 2007, SCI TOTAL ENVIRON, V387, P96, DOI 10.1016/j.scitotenv.2007.07.044; Dong ZM, 2012, SENSORS-BASEL, V12, P7080, DOI 10.3390/s120607080; Shangguan D, 2006, P NATL ACAD SCI USA, V103, P11838, DOI 10.1073/pnas.0602615103; Zahir F, 2005, ENVIRON TOXICOL PHAR, V20, P351, DOI 10.1016/j.etap.2005.03.007; Lee J., 2008, CHEM COMMUN, V45, P6005; Liu J.W., 2007, ANGEW CHEM, V119, P7731, DOI 10.1002/ange.200702006; Shi L, 2012, ANAL METHODS-UK, V4, P1036, DOI 10.1039/c2ay05758a; Willner I, 2007, ANGEW CHEM INT EDIT, V46, P6408, DOI 10.1002/anie.200604524	14	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0253-2964	1229-5949		B KOREAN CHEM SOC	Bull. Korean Chem. Soc.	APR	2015	36	4					1285	1288		10.1002/bkcs.10229		4	Chemistry, Multidisciplinary	Chemistry	CG8RJ	WOS:000353577900041		
J	Tokushima, T; Horikawa, Y				Tokushima, Takashi; Horikawa, Yuka			Electronic Structure of Liquids and Solutions Observed by Soft X-ray Spectroscopy	BUNSEKI KAGAKU			Japanese	Article						electronic structure; liquids; solutions; soft X-rays; synchrotron radiation	EMISSION-SPECTROSCOPY; AQUEOUS-SOLUTIONS; WATER MIXTURES; SCATTERING; 3-METHYLPYRIDINE; SPECTROMETER; SPECTRUM; ICE	Soft X-ray spectroscopies that utilize the electronic transition of core electrons are known as powerful tools for observing electronic structures, and are extensively applied to solid and gaseous samples in a vacuum. However experimenting on a liquid sample is not easy. While soft X-rays require a vacuum because of low penetration ability, one cannot hold liquid-phase samples in vacuum due to the vaporization of liquids. Recently, extensive developments in experimental techniques have enabled the application of X-ray emission and absorption spectroscopy to liquid and solution samples. We have also developed a liquid flow cell and X-ray emission spectrometers dedicated to the research of liquid and solution samples at BL17SU in the third-generation synchrotron facility, SPring-8. Here, we will present our recent developments and aspects on electronic-state studies of liquids and solutions concerning the liquid structure of water, the molecular interaction of water molecules in solution and electronic state selective observations of solute molecules.	[Tokushima, Takashi; Horikawa, Yuka] RIKEN, SPring Ctr 8, Soft Xray Spect Instrumentat Unit, Sayo Cho, Hyogo 6795148, Japan	Tokushima, T (reprint author), RIKEN, SPring Ctr 8, Soft Xray Spect Instrumentat Unit, 1-1-1 Kouto, Sayo Cho, Hyogo 6795148, Japan.	toku@spring8.or.jp					Almasy L, 2002, J MOL LIQ, V101, P89, DOI 10.1016/S0167-7322(02)00084-3; Nagasaka M, 2010, J ELECTRON SPECTROSC, V177, P130, DOI 10.1016/j.elspec.2009.11.001; Pylkkanen T, 2010, J PHYS CHEM B, V114, P3804, DOI 10.1021/jp912208v; Horikawa Y, 2009, PHYS CHEM CHEM PHYS, V11, P8676, DOI 10.1039/b910039c; Takamuku T, 1998, J PHYS CHEM B, V102, P8880, DOI 10.1021/jp9824297; Odelius M, 2009, J PHYS CHEM A, V113, P8176, DOI 10.1021/jp903096k; Tokushima T, 2014, PHYS CHEM CHEM PHYS, V16, P10753, DOI 10.1039/c4cp00762j; Arai H, 2012, PHYS CHEM CHEM PHYS, V14, P1576, DOI 10.1039/c2cp23276f; Sellberg JA, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4890035; Horikawa Y, 2010, PHYS CHEM CHEM PHYS, V12, P9165, DOI 10.1039/c003644g; Nishikawa K, 2002, J PHYS CHEM B, V106, P693, DOI 10.1021/jp011964v; Tokushima T, 2008, CHEM PHYS LETT, V460, P387, DOI 10.1016/j.cplett.2008.04.077; Huang C, 2009, P NATL ACAD SCI USA, V106, P15214, DOI 10.1073/pnas.0904743106; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Harada Y, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.193001; Weinhardt L, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3702644; NORDGREN J, 1989, REV SCI INSTRUM, V60, P1690, DOI 10.1063/1.1140929; Wernet P, 2004, SCIENCE, V304, P995, DOI 10.1126/science.1096205; Odelius M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.227401; Guo JH, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.137402; BRADY GW, 1971, ACCOUNTS CHEM RES, V4, P367, DOI 10.1021/ar50047a002; Fuchs O, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.027801; GILBERG E, 1982, J CHEM PHYS, V76, P5093, DOI 10.1063/1.442858; Gubskaya AV, 2004, J PHYS CHEM A, V108, P7165, DOI 10.1021/jp048921+; Marczak W, 2003, J CHEM THERMODYN, V35, P269, DOI 10.1016/S0021-9614(02)00363-4; Myneni S, 2002, J PHYS-CONDENS MAT, V14, pL213, DOI 10.1088/0953-8984/14/8/106; NISHIKAWA K, 1987, J PHYS CHEM-US, V91, P3694, DOI 10.1021/j100297a047; NORDGREN J, 1975, J PHYS B-AT MOL OPT, V8, pL18, DOI 10.1088/0022-3700/8/2/003; Stohr J., 1992, NEXAFS SPECTROSCOPY; Tokushima T, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3610454; Tokushima T, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2204623; Tokushima T, 2002, SURF REV LETT, V9, P503, DOI 10.1142/S0218625X02002567; Winter B, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2710792	33	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0525-1931			BUNSEKI KAGAKU	Bunseki Kagaku	APR	2015	64	4					237	245				9	Chemistry, Analytical	Chemistry	CG9TT	WOS:000353663700001		
J	Hojo, M; Chen, XH				Hojo, Masashi; Chen, Xiaohui			Elucidation of Coordination Phenomena of Alkaline Earth Metal Ions with Aromatic Sulfonate Ions in Protic Solvents and Binary Solvent Systems between Acetonitrile-Alcohols	BUNSEKI KAGAKU			Japanese	Article						specific coordination; solvent donicity; solubility product; tripe ion formation	AQUEOUS NITRIC-ACID; THERMODYNAMIC BEHAVIOR; TRIPLE-ION; PURE GOLD; ELECTROLYTES; ASSOCIATION; PERMITTIVITY; PERCHLORATES; INDICATORS; MIXTURES	The specific interactions between alkaline earth metal (Mg2+, Ca2+, or Ba2+) and p-toluenesulfonate (L-), 1,5-naphthalenedisulfonate (L2-), or 1,3,6-naphthalenetrisulfonate (L3-) ions (from the tetraethylammnonium salt of L-, L2-, or L3-) have been examined by means of UV-visible spectroscopy in primary alcohols (from methanol to hexanol) as well as in binary acetonitrile-alcohols (MeCN-MeOH, MeCN-EtOH), ethanol-methanol (EtOH-MeOH) and methanol-water (MeOH-H2O) solvents. The precipitation of non-charged species (e.g. ML0) and the successive re-dissolution of the precipitates, with increasing concentration of M(ClO4)(2), have revealed the formation of cationic charged species or "reverse coordinated" species, M2L2+, even in protic media as well as the aprotic solvent MeCN. The solubility products (K-sp) and the "reverse coordination" constants (2M(2+) + L2- reversible arrow M2L2+ K2(-2)=[M2L2+] / [M2+](2) [L2-]) have been evaluated. In ethanol, both phenomena concerning the precipitation of ML0 and the successive re-dissolution to produce M2L2+ are observed for Ca2+ or Ba2+, but not for Mg2+. In butanol, the interaction between Mg2+ and the L2- causes the complete precipitation of MgL0 (pK(sp) = 10.39) as well as the successive re-dissolution of Mg2L2+ (log K2(- 2) = 8.08). Even in methanol, the interaction between Ba2+ and L2- results the precipitation (pK(sp) = 8.28) and the "reverse coordinated" species, Ba2L2+ (log K2(-2) = 5.58). The interaction of Ba2+ with L- or L3- causes no precipitation in methanol, however, in all the other alcohols, it results in both precipitation (BaL2 or Ba3L2) and "reverse coordinated" species, BaL+ or Ba2L+. The formulation for the formation constants (K2(-3)) for M2+ and L3- is newly presented, and the constants (2Ba(2+) +L3- reversible arrow Ba2L+, K2(-3)= [Ba2L+]/([Ba2+](2) [L3-]) are evaluated in ethanol and propanol as well as the binary EtOH-MeOH solvents, up to 70 % (v/v) MeOH. The donicities towards M2+ of the media have been related to the pK(sp) and "reverse coordination" constants for L-, L2-, and L3-.	[Hojo, Masashi; Chen, Xiaohui] Kochi Univ, Fac Sci, Dept Chem, Kochi, Kochi 7808520, Japan	Hojo, M (reprint author), Kochi Univ, Fac Sci, Dept Chem, 2-5-1 Akebono Cho, Kochi, Kochi 7808520, Japan.	mhojo@kochi-u.ac.jp					Fromm KM, 2008, COORDIN CHEM REV, V252, P856, DOI 10.1016/j.ccr.2007.10.032; Nikitin AM, 2007, J COMPUT CHEM, V28, P2020, DOI 10.1002/JCC.20721; Fraenkel D, 2011, J PHYS CHEM B, V115, P14634, DOI 10.1021/jp207878f; Debye P, 1923, PHYS Z, V24, P185; Bakshi MS, 1996, J CHEM ENG DATA, V41, P1459, DOI 10.1021/je960180l; Covington A.K., 1973, PHYS CHEM ORGANIC SO; Eberspaecher P, 2006, J MOL LIQ, V129, P3, DOI 10.1016/j.molliq.2006.08.007; Gutmann V., 1978, DONOR ACCEPTOR APPRO; Hojo M., 2009, J MOL LIQ, V149, P24; Hojo M, 2008, PURE APPL CHEM, V80, P1539, DOI 10.1351/pac200880071539; Hojo M, 2000, J CHEM SOC PERK T 2, P1735, DOI 10.1039/b001034k; Hojo M, 1999, J PHYS CHEM B, V103, P8965, DOI 10.1021/jp9910441; Hojo M, 1999, ANAL SCI, V15, P303, DOI 10.2116/analsci.15.303; Hojo M, 2014, BUNSEKI KAGAKU, V63, P715; HOJO M, 1983, B CHEM SOC JPN, V56, P1963, DOI 10.1246/bcsj.56.1963; Hojo M, 2009, J MOL LIQ, V145, P152, DOI 10.1016/j.molliq.2008.06.004; HOJO M, 1991, J CHEM SOC FARADAY T, V87, P3847, DOI 10.1039/ft9918703847; Hojo M, 2011, J MOL LIQ, V163, P161, DOI 10.1016/j.molliq.2011.08.013; Hojo M, 2014, J MOL LIQ, V194, P68, DOI 10.1016/j.molliq.2014.01.014; HOJO M, 1989, J PHYS CHEM-US, V93, P955, DOI 10.1021/j100339a079; Hojo M, 2000, B CHEM SOC JPN, V73, P347, DOI 10.1246/bcsj.73.347; Hojo M, 2014, B CHEM SOC JPN, V87, P98, DOI 10.1246/bcsj.20130176; Hojo M., 1994, J CHEM SOC PERK T, V2, P1855; Izutsu K., 1990, ACID BASE DISSOCIATI; Kolthoff I.M., 1979, TREATISE ANAL CHEM 1, P239; Manege LC, 1998, B CHEM SOC JPN, V71, P589, DOI 10.1246/bcsj.71.589; MARCUS Y, 1984, J SOLUTION CHEM, V13, P599, DOI 10.1007/BF00650369; Marcus Y., 1985, ION SOLVATION; Nagayama H, 2001, ANAL SCI, V17, P1413, DOI 10.2116/analsci.17.1413; Pitzer K. S., 1991, ACTIVITY COEFFICIENT; Reichardt C, 2001, EUR J ORG CHEM, P2343; Riddick J.A., 1986, ORGANIC SOLVENTS PHY, VII	32	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0525-1931			BUNSEKI KAGAKU	Bunseki Kagaku	APR	2015	64	4					247	260				14	Chemistry, Analytical	Chemistry	CG9TT	WOS:000353663700002		
J	Tsukahara, T; Morikawa, K; Mawatari, K; Kitamori, T				Tsukahara, Takehiko; Morikawa, Kyojiro; Mawatari, Kazuma; Kitamori, Takehiko			Structure and Dynamics of Water and Nonaqueous Solvents Confined in Extended Nanospaces Characterized by NMR Spectroscopy	BUNSEKI KAGAKU			Japanese	Article						extended nanospace; structure; dynamics; NMR; proton transfer	LIQUID WATER; RELAXATION; TEMPERATURE; CELL; NANOCHANNELS; FLUORESCENCE; ENHANCEMENT; DEPENDENCE; CONDUCTION; MOTION	An extended nanospace (10-100 nm scale) makes it possible to induce unique physicochemical properties, because scientific and technological concepts in this region are shifted from the bulk condensed phase to single molecule, and from microfluidic technology to conventional nanotechnology, respectively. In this study, the molecular structure and dynamics of water and nonaqueous solvents confined in extended nanospaces on a fused-silica substrate were examined by using NMR chemical spectra, relaxation times, and so on. The results showed that the collective properties of molecular clusters with a size range from 10 to 100 nm in a liquid phase were characterized due to the effects of charged surface SiOH groups, and that unique properties differing from bulk water and surface-adsorbing water could appear in extended nanospaces. In particular, we found that (1) inhibition of molecular translational motions, (2) localization of proton charge distribution along a linear O center dot center dot center dot H-O hydrogen bonding chain, and (3) an enhancement of proton transfer of water due to the Grotthuss mechanism; ( SiO- center dot center dot center dot H+ center dot center dot center dot H2O) + H2O -> SiO- +(H3O+ +H2O) -> SiO- + (H2O + H3O+), were induced in extended nanospaces. Such changes appeared for sizes smaller than 800 nm. These results suggested that a proton transfer phase, in which water molecules are loosely coupled within about 50 nm from the surface, exists in extended nanospaces. This model could be qualitatively supported by a three-phase theory invoking the bulk, proton transfer, and surface-adsorbing phases.	[Tsukahara, Takehiko; Morikawa, Kyojiro] Tokyo Inst Technol, Nucl Reactors Res Lab, Meguro Ku, Tokyo 1528550, Japan; [Mawatari, Kazuma; Kitamori, Takehiko] Univ Tokyo, Sch Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan	Tsukahara, T (reprint author), Tokyo Inst Technol, Nucl Reactors Res Lab, Meguro Ku, 2-12-1-N1-6 Ookayama, Tokyo 1528550, Japan.	ptsuka@nr.titech.ac.jp					Agmon N, 1996, J PHYS CHEM-US, V100, P1072, DOI 10.1021/jp9516295; Li LX, 2012, J PHYS CHEM LETT, V3, P2447, DOI 10.1021/jz3009198; Matubayasi N, 2001, J CHEM PHYS, V114, P4107, DOI 10.1063/1.1336571; Hummer G, 2001, NATURE, V414, P188, DOI 10.1038/35102535; Tsukahara T, 2007, ANGEW CHEM INT EDIT, V46, P1180, DOI 10.1002/anie.200604502; Farrer RA, 2003, ACCOUNTS CHEM RES, V36, P605, DOI 10.1021/ar0200302; Tas NR, 2004, APPL PHYS LETT, V85, P3274, DOI 10.1063/1.1804602; Morikawa K, 2010, LAB CHIP, V10, P871, DOI 10.1039/b916776e; Cohen B, 2003, J PHYS CHEM A, V107, P3598, DOI 10.1021/jp026053f; Tsukahara T, 2009, J PHYS CHEM B, V113, P10808, DOI 10.1021/jp903275t; Ishida T, 1999, J CHEM PHYS, V110, P3938, DOI 10.1063/1.478249; EMSLEY J, 1987, J MOL STRUCT, V161, P193, DOI 10.1016/0022-2860(87)85074-3; Hibara A, 2002, ANAL CHEM, V74, P6170, DOI 10.1021/ac025808b; Xu Y, 2013, LAB CHIP, V13, P1048, DOI 10.1039/c3lc41345d; Kornyshev AA, 2003, J PHYS CHEM B, V107, P3351, DOI 10.1021/jp020857d; Chinen H, 2012, ANGEW CHEM INT EDIT, V51, P3573, DOI 10.1002/anie.201104883; Ball P, 2008, CHEM REV, V108, P74, DOI 10.1021/cr068037a; Liu SR, 2005, NANO LETT, V5, P1389, DOI 10.1021/nl050712t; Tsukahara T, 2010, CHEM SOC REV, V39, P1000, DOI 10.1039/b822557p; Kazoe Y, 2011, ANAL CHEM, V83, P8152, DOI 10.1021/ac201654r; Bruni F, 1998, J CHEM PHYS, V109, P1478, DOI 10.1063/1.476698; Buch V., 2003, WATER CONFINING GEOM; Farrar T. C., 1971, PULSE FOURIER TRANSF; Goto M, 2007, ANAL SCI, V23, P245, DOI 10.2116/analsci.23.245; GRAF V, 1980, J CHEM PHYS, V72, P861, DOI 10.1063/1.439240; Holly R, 1998, J CHEM PHYS, V108, P4183, DOI 10.1063/1.475816; Israelachvili J. N., 1992, INTERMOLECULAR SURFA; Kap N., 2006, ANAL BIOANAL CHEM, V386, P759; Knispel R. R., 1975, CHEM PHYS LETT, V35, P238; LAMB WJ, 1981, J PHYS CHEM-US, V85, P3883, DOI 10.1021/j150625a034; LUDWIG R, 1995, J CHEM PHYS, V103, P6941, DOI 10.1063/1.470371; Morikawa K, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3644481; Yoshida K, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2961029	33	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0525-1931			BUNSEKI KAGAKU	Bunseki Kagaku	APR	2015	64	4					261	271				11	Chemistry, Analytical	Chemistry	CG9TT	WOS:000353663700003		
J	Yui, H; Suzuki, A; Morisaku, T				Yui, Hiroharu; Suzuki, Akira; Morisaku, Toshinori			Creation of Nanospaces with Polarized Inner Surfaces by Using Organic Molecular Self-assemblies and the Inducement of Anomalous Structures and Properties of the Confined Water	BUNSEKI KAGAKU			Japanese	Article						water; ice; lipid nanotube; AOT reverse micelle; hydrogen bond	AOT REVERSE MICELLES; AEROSOL-OT; TEMPERATURE-DEPENDENCE; SUPERCOOLED WATER; INFRARED-SPECTRA; HOLLOW CYLINDER; LIPID NANOTUBE; DYNAMICS; MICROEMULSIONS; BEHAVIOR	Water confined in nanospaces with diameters of 1-10 nm is ubiquitous in natural materials, such as intracellular organic space and interlayers in inorganic minerals (e.g., clay and zeolite). The confined water in those nanospaces plays a crucial role in the expression of their structure, properties, and functions. For this reason, the thermodynamic properties of the confined water have been intensively studied, especially in inorganic minerals, due to their easy controllability of the space sizes. On the other hand, few studies have been reported concerning the structure and properties of water confined in organic molecular self-assemblies composed of small organic molecules, especially lipids, in the human body. This is because regulation of the size distribution is generally difficult for such organic self-assemblies. Here, we focus on glycolipid nanotubes and AOT reverse micelles as organic self-assemblies due to good controllability of their sizes. The inner surface of a glycolipid nanotube is covered with hydrophilic hydroxyl groups, while that of an AOT reverse micelle is composed of hydrophilic ionic groups and their corresponding counter ions. Since both inner surfaces have a strongly polarized structure, they strongly interact with water molecules, which have large dipole moments. Our current study using spectroscopic techniques, especially infrared spectroscopy, reveals the anomaly on the structure and phase transition temperature of the water confined in the nanotubes and micelles. We clarified and anomalous structure and thermal properties of the water confined in the nanotubes and micelles, which are crucially different from those of bulk water at the same temperature and under the same pressure.	[Yui, Hiroharu; Suzuki, Akira; Morisaku, Toshinori] Tokyo Univ Sci, Fac Sci, Dept Chem, Shinjuku Ku, Tokyo 1628601, Japan	Yui, H (reprint author), Tokyo Univ Sci, Fac Sci, Dept Chem, Shinjuku Ku, 1-3 Kagurazaka, Tokyo 1628601, Japan.	yui@rs.kagu.tus.ac.jp					Silber JJ, 1999, ADV COLLOID INTERFAC, V82, P189, DOI 10.1016/S0001-8686(99)00018-4; Yui H, 2005, CHEM LETT, V34, P232, DOI 10.1246/cl.2005.232; Bhattacharyya K, 2000, J PHYS CHEM A, V104, P10603, DOI 10.1021/jp001878f; Moilanen DE, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3159779; Kameta N, 2008, SOFT MATTER, V4, P1681, DOI 10.1039/b803742f; Tadokoro M, 2014, CHEM-EUR J, V20, P13698, DOI 10.1002/chem.201402900; ZULAUF M, 1979, J PHYS CHEM-US, V83, P480, DOI 10.1021/j100467a011; Kameta N, 2010, CHEM-EUR J, V16, P4217, DOI 10.1002/chem.200903413; ROWLAND B, 1995, J CHEM PHYS, V102, P8328, DOI 10.1063/1.468825; Kameta N, 2009, CHEM MATER, V21, P5892, DOI 10.1021/cm903108h; Mikami F, 2009, ACS NANO, V3, P1279, DOI 10.1021/nn900221t; Sasmal DK, 2013, LANGMUIR, V29, P2289, DOI 10.1021/la3043473; Marry V, 2013, J PHYS CHEM C, V117, P15106, DOI 10.1021/jp403501h; Liu DZ, 2007, P NATL ACAD SCI USA, V104, P9570, DOI 10.1073/pnas.0701352104; Eijkel JCT, 2005, MICROFLUID NANOFLUID, V1, P249, DOI 10.1007/s10404-004-0012-9; Zhou B, 2011, J AM CHEM SOC, V133, P5736, DOI 10.1021/ja200978u; ONORI G, 1993, J PHYS CHEM-US, V97, P5430, DOI 10.1021/j100122a040; John G, 2001, ADV MATER, V13, P715, DOI 10.1002/1521-4095(200105)13:10<715::AID-ADMA715>3.0.CO;2-Z; Shimizu T, 2005, CHEM REV, V105, P1401, DOI 10.1021/cr030072j; Chen SH, 2006, P NATL ACAD SCI USA, V103, P12974, DOI 10.1073/pnas.0603253103; Simorellis AK, 2006, J AM CHEM SOC, V128, P5082, DOI 10.1021/ja0568401; Banno M., UNPUB; CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.physiol.54.1.579; DARRIGO G, 1981, J CHEM PHYS, V75, P4264, DOI 10.1063/1.442629; Das S, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.042716; Furusho H, 2008, JPN J APPL PHYS, V47, P394, DOI 10.1143/JJAP.47.394; GonzalezBlanco C, 1997, LANGMUIR, V13, P1938, DOI 10.1021/la960451q; Guo YL, 2005, LANGMUIR, V21, P4610, DOI 10.1021/la046906q; HORNIG DF, 1958, SPECTROCHIM ACTA, V12, P338, DOI 10.1016/0371-1951(58)80060-0; Jelassi J, 2010, PHYS CHEM CHEM PHYS, V12, P2838, DOI 10.1039/b908400b; Kameta N, 2012, ACS NANO, V6, P5249, DOI 10.1021/nn301041y; Levinger NE, 2009, ANNU REV PHYS CHEM, V60, P385, DOI 10.1146/annurev.physchem.040808.090438; Morishige K, 2010, J PHYS CHEM C, V114, P4028, DOI 10.1021/jp910759n; Nucci NV, 2005, J PHYS CHEM B, V109, P18301, DOI 10.1021/jp051068+; O'Connor TF, 2004, J AM CHEM SOC, V126, P11794, DOI 10.1021/ja0481777; Reiter GF, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.036803; Kameta N, 2007, CHEM MATER, V19, P3553, DOI 10.1021/cm070626p; Suzuki A, 2015, J COLLOID INTERF SCI, V443, P188, DOI 10.1016/j.jcis.2014.12.017; Suzuki A, 2014, LANGMUIR, V30, P7274, DOI 10.1021/la501210t; Van Horn WD, 2005, J AM CHEM SOC, V127, P13553, DOI 10.1021/ja052805i; WHALLEY E, 1977, CAN J CHEM, V55, P3429, DOI 10.1139/v77-481; Yui H, 2005, LANGMUIR, V21, P721, DOI 10.1021/la040109a; Zhou GW, 2002, LANGMUIR, V18, P4566, DOI 10.1021/la0116241	43	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0525-1931			BUNSEKI KAGAKU	Bunseki Kagaku	APR	2015	64	4					273	282				10	Chemistry, Analytical	Chemistry	CG9TT	WOS:000353663700004		
J	Yoshida, K; Yamaguchi, T				Yoshida, Koji; Yamaguchi, Toshio			Investigation of Protein Hydration with Quantum Beams	BUNSEKI KAGAKU			Japanese	Article						quantum beams; scattering experiment; hydrated protein; fast sound; protein aggregation	INELASTIC NEUTRON-SCATTERING; X-RAY-DIFFRACTION; COLLECTIVE DYNAMICS; BETA-LACTOGLOBULIN; MASS-SPECTROMETRY; WATER; SPECTROSCOPY; SOUND	Quantum beams (e.g. synchrotron X-rays and neutrons) are powerful tools used to investigate the structure and dynamics of hydrated proteins and protein hydration water. Inelastic X-ray scattering can reveal the collective dynamics of hydrated proteins on the sub-femtosecond time scale since X-rays are coherent and their energy exchange with a sample corresponds to the excitation energy of the atomic vibrations of the sample. Incoherent quasi-elastic neutron scattering can be used to investigate the single-particle dynamics of protons, since the incoherent cross section of a proton is larger by similar to 40 than that of other atoms. The time scale is in the range from picosecond to nanosecond. Small-angle scattering can characterize the nanoscale structure of protein aggregates (e.g., size, shape, and fractal dimension of the protein aggregate). From this review, IXS revealed the collective dynamics of hydrated beta-lactoglobulin (beta-LG) and antifreeze proteins. A dispersion relation of collective excitation energy vs. Q was found for the hydrated proteins, but it was not for dry ones. The fast sound velocity obtained from the dispersion relation at 180 K was found to be higher than that at higher temperatures, implying a kind of dynamic transition of the hydrated proteins, as can be seen in the single-particle dynamic observed by incoherent neutron scattering. The structure of the aggregate and dynamic properties of beta-LG were revealed as a function of the alcohol concentration in alcohol-water mixtures with small-angle and quasi-elastic neutron scatterings. The beta-LG in the alcohol-water solutions undergoes aggregation and gelation at specific alcohol concentrations. With increasing the alcohol concentration, the fraction of mobile protons, accompanied with increasing the sphere radius where hydrogen atoms in hydrophobic residues of the protein move around. A possible mechanism of the protein aggregation process would be as follows: the addition of alcohol makes the embedded amino acid residues be exposed to the solvent. The protein is more molten globule-like, i.e. disordered in the aggregation.	[Yoshida, Koji; Yamaguchi, Toshio] Fukuoka Univ, Fac Sci, Dept Chem, Jonan Ku, Fukuoka, Fukuoka 8140180, Japan	Yoshida, K (reprint author), Fukuoka Univ, Fac Sci, Dept Chem, Jonan Ku, 8-19-1 Nanakuma, Fukuoka, Fukuoka 8140180, Japan.	kyoshida@fukuoka-u.ac.jp					Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1; Yoshida K, 2003, J CHEM PHYS, V119, P6132, DOI 10.1063/1.1602070; FARSACI F, 1989, PHYS CHEM LIQ, V20, P205, DOI 10.1080/00319108908028451; LIN MY, 1989, NATURE, V339, P360, DOI 10.1038/339360a0; Orecchini A, 2009, J AM CHEM SOC, V131, P4664, DOI 10.1021/ja807957p; Hong DP, 1999, J AM CHEM SOC, V121, P8427, DOI 10.1021/ja990833t; Chen SH, 2006, P NATL ACAD SCI USA, V103, P9012, DOI 10.1073/pnas.0602474103; Tachibana M, 2000, CHEM PHYS LETT, V332, P259, DOI 10.1016/S0009-2614(00)01267-7; DOSTER W, 1989, NATURE, V337, P754, DOI 10.1038/337754a0; TEIXEIRA J, 1985, PHYS REV LETT, V54, P2681, DOI 10.1103/PhysRevLett.54.2681; Krisch M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.125502; RAHMAN A, 1974, PHYS REV A, V10, P368, DOI 10.1103/PhysRevA.10.368; Barteri M, 1998, BBA-PROTEIN STRUCT M, V1383, P317, DOI 10.1016/S0167-4838(97)00225-2; Bee M., 1998, QUASIELASTIC NEUTRON; Bellissent-Funel MC, 2011, WATER: THE FORGOTTEN BIOLOGICAL MOLECULE, P23; Changeux Jean-Pierre, 2011, F1000 Biol Rep, V3, P19, DOI 10.3410/B3-19; Cui Q, 2006, NORMAL MODE ANAL THE; Glatter O., 1982, SMALL ANGLE XRAY SCA; Jia Z., 2002, TRENDS BIOCHEM SCI, V227, P101; Joti Y, 2005, J AM CHEM SOC, V127, P8705, DOI 10.1021/ja0425886; Kamiyama T, 2004, J PHYS SOC JPN, V73, P1615, DOI 10.1143/JPSJ.73.1615; Kataoka M, 2011, WATER: THE FORGOTTEN BIOLOGICAL MOLECULE, P49; Kawakita Y, 2003, J PHYS SOC JPN, V72, P1603, DOI 10.1143/JPSJ.72.1603; LIN MY, 1990, J COLLOID INTERF SCI, V137, P263, DOI 10.1016/0021-9797(90)90061-R; Liu D, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.135501; MATSUMOTO M, 1995, B CHEM SOC JPN, V68, P1775, DOI 10.1246/bcsj.68.1775; Nakagawa H, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.083801; Santucci SC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.225701; SETTE F, 1995, PHYS REV LETT, V75, P850, DOI 10.1103/PhysRevLett.75.850; Sivia D. S., 2011, ELEMENTARY SCATTERIN; Tarek M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.275501; Yoshida K, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3484238; Yoshida K., 2006, CHEM PHYS LETT, V440, P210; Yoshida K, 2012, BBA-PROTEINS PROTEOM, V1824, P502, DOI 10.1016/j.bbapap.2011.12.011	34	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0525-1931			BUNSEKI KAGAKU	Bunseki Kagaku	APR	2015	64	4					283	293				11	Chemistry, Analytical	Chemistry	CG9TT	WOS:000353663700005		
J	Yamaguchi, T; Lee, K; Yamauchi, M; Fukuyama, N; Yoshida, K				Yamaguchi, Toshio; Lee, Kosei; Yamauchi, Mikio; Fukuyama, Nami; Yoshida, Koji			Visualization of 3D Structure of a Subcritical Aqueous Magnesium Nitrate Solution as Revealed by Raman Scattering, X-ray Diffraction and Empirical Potential Structure Refinement Modeling	BUNSEKI KAGAKU			Japanese	Article						structure; ion hydration; high temperature; X-ray diffraction; Raman spectrosocpy	SUPERCRITICAL WATER; MOLECULAR-DYNAMICS; HYDRATION; DIFFRACTOMETRY; LIQUIDS; IONS; MG2+	Raman scattering measurements were conducted at 25-350 degrees C and 40 MPa on a 1 mol dm(-3) Mg(NO3)(2) aqueous solution. Along with elevating temperature, the N-O nu(1) band of the nitrate ion at 1050 cm(-1) to a lower wave number, whereas the O-D nu(1) band of a water molecule does to a higher wave number at 2540 cm(-1). For the both bands, an inflection point was observed at around 200 degrees C, suggesting a structure change in the hydration shell of nitrate ion and the solvent water hydrogen network. Energy-dispersive X-ray diffraction measurements were also performed at 25-210 degrees C and 40 MPa on a 1 mol dm(-3) Mg(NO3)(2) aqueous solution. The experimental structure factors were subjected to empirical potential structure refinement (EPSR) modeling to reveal 3D structures of solvent water, ion hydration and ion-pairs. For solvent water, there was no significant structure change in the first coordination shell of a water molecule, but the number of the second coordination shell decreased from 10.5 at 25 degrees C and 0.1 MPa to 8.5 at 210 degrees C and 40 MPa. A Mg2+ ion is surrounded by six water molecules in an octahedral manner at 25 degrees C and 0.1 MPa. At 210 degrees C and 40 MPa one nitrate ion enters the first coordination shell of Mg2+ to form a contact ion pair in a monodentate fashion with a Mg-O-N-N bond angle of about 150 degrees. About 11 water molecules surround a central nitrate ion without specific coordination sites over the measured temperature range, except for a slight decrease in the coordination number of the nitrate ion at 210 degrees C and 40 MPa, probably due to the formation of a Mg2+ -NO3- ion pair.	[Yamaguchi, Toshio; Lee, Kosei; Yamauchi, Mikio; Fukuyama, Nami; Yoshida, Koji] Fac Sci, Dept Chem, Jonan Ku, Fukuoka, Fukuoka 8140180, Japan	Yamaguchi, T (reprint author), Fac Sci, Dept Chem, Jonan Ku, 8-19-1 Nanakuma, Fukuoka, Fukuoka 8140180, Japan.	yamaguch@fukuoka-u.ac.jp					[Anonymous], 1974, INT TABLES CRYSTALLO, VIV; Megyes T, 2009, J PHYS CHEM B, V113, P4054, DOI 10.1021/jp806411c; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Vchirawongkwin V, 2011, J PHYS CHEM B, V115, P12527, DOI 10.1021/jp204809f; Mamatkulov S, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4772808; Sako T, 1997, J CHEM ENG JPN, V30, P744, DOI 10.1252/jcej.30.744; PAALMAN HH, 1962, J APPL PHYS, V33, P2635, DOI 10.1063/1.1729034; OHTAKI H, 1993, CHEM REV, V93, P1157, DOI 10.1021/cr00019a014; Bhattacharjee A, 2012, CHEM PHYS LETT, V536, P39, DOI 10.1016/j.cplett.2012.03.049; CAMINITI R, 1977, CHEM PHYS LETT, V47, P275, DOI 10.1016/0009-2614(77)80016-X; da Silva J. R. F., 1991, BIOL CHEM LIFE; de Siqueira AV, 1999, J PHYS-CONDENS MAT, V11, P9179, DOI 10.1088/0953-8984/11/47/305; Dudev T, 2013, J AM CHEM SOC, V135, P17200, DOI 10.1021/ja4087769; Funakoshi K., 1997, THESIS TOKYO I TECH; Ibers J. A., 1962, INT TABLES XRAY CRYS, VIV; JOHANSSO.G, 1973, CHEM SCRIPTA, V4, P195; MacGillavry C. H., 1962, INT TABLES XRAY CRYS, V3; Mitsuhashi T., 1982, ANN M CRYST SOC JAP; NISHIKAWA K, 1984, B CHEM SOC JPN, V57, P1750, DOI 10.1246/bcsj.57.1750; Ohara S, 2008, J MATER SCI, V43, P2393, DOI 10.1007/s10853-007-1823-3; Soper A. K., 1996, CHEM PHYS, V202, P298; Soper A. K., 2009, EMPIRICAL POTENTIAL; Subramanian H, 2013, CORROS SCI, V70, P127, DOI 10.1016/j.corsci.2013.01.021; Sutton M. A., 2011, NATURE, V427, P159; SZASZ GI, 1982, CHEM PHYS LETT, V92, P388, DOI 10.1016/0009-2614(82)83434-9; XCYLABS, PROGR ABS SAMPL CYL; YAMANAKA K, 1994, J CHEM PHYS, V101, P9830, DOI 10.1063/1.467948; Yamasaki N., 1995, ENERGY RESOURCE, V16, P187	28	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0525-1931			BUNSEKI KAGAKU	Bunseki Kagaku	APR	2015	64	4					295	308				14	Chemistry, Analytical	Chemistry	CG9TT	WOS:000353663700006		
J	Bao, XF; Zheng, WJ; Sugi, NH; Agarwala, KL; Xu, QL; Wang, ZC; Tendyke, K; Lee, WN; Parent, L; Li, W; Cheng, HS; Shen, YC; Taylor, N; Dezso, Z; Du, H; Kotake, Y; Zhao, ND; Wang, J; Postema, M; Woodall-Jappe, M; Takase, Y; Uenaka, T; Kingston, DGI; Nomoto, K				Bao, Xingfeng; Zheng, Wanjun; Sugi, Naoko Hata; Agarwala, Kishan L.; Xu, Qunli; Wang, Zichun; Tendyke, Karen; Lee, Winnie; Parent, Lana; Li, Wei; Cheng, Hongsheng; Shen, Yongchun; Taylor, Noel; Dezso, Zoltan; Du, Hong; Kotake, Yoshihiko; Zhao, Nanding; Wang, John; Postema, Maarten; Woodall-Jappe, Mary; Takase, Yasutaka; Uenaka, Toshimitsu; Kingston, David G. I.; Nomoto, Kenichi			Small molecule schweinfurthins selectively inhibit cancer cell proliferation and mTOR/AKT signaling by interfering with trans-Golgi-network trafficking	CANCER BIOLOGY & THERAPY			English	Article						diffuse large B cell lymphoma; natural compounds; mTOR-AKT signaling; schweinfurthins; trans-Golgi-network	OXYSTEROL-BINDING PROTEINS; NATURAL-PRODUCTS; PLASMA-MEMBRANE; LYMPHOMA; ANALOGS; GROWTH; IDENTIFICATION; CYTOTOXICITY; PATHOGENESIS; MECHANISMS	Natural compound schweinfurthins are of considerable interest for novel therapy development because of their selective anti-proliferative activity against human cancer cells. We previously reported the isolation of highly active schweinfurthins E-H, and in the present study, mechanisms of the potent and selective anti-proliferation were investigated. We found that schweinfurthins preferentially inhibited the proliferation of PTEN deficient cancer cells by indirect inhibition of AKT phosphorylation. Mechanistically, schweinfurthins and their analogs arrested trans-Golgi-network trafficking, an intracellular vesicular trafficking system, resulting in the induction of endoplasmic reticulum stress and the suppression of both lipid raft-mediated PI3K activation and mTOR/RheB complex formation, which collectively led to an effective inhibition of mTOR/AKT signaling. The trans-Golgi-network traffic arresting effect of schweinfurthins was associated with their in vitro binding activity to oxysterol-binding proteins that are known to regulate intracellular vesicular trafficking. Moreover, schweinfurthins were found to be highly toxic toward PTEN-deficient B cell lymphoma cells, and displayed 2orders of magnitude lower activity toward normal human peripheral blood mononuclear cells and primary fibroblasts in vitro. These results revealed a previously unrecognized role of schweinfurthins in regulating trans-Golgi-network trafficking, and linked mechanistically this cellular effect with mTOR/AKT signaling and with cancer cell survival and growth. Our findings suggest the schweinfurthin class of compounds as a novel approach to modulate oncogenic mTOR/AKT signaling for cancer treatment.	[Bao, Xingfeng; Zheng, Wanjun; Xu, Qunli; Wang, Zichun; Tendyke, Karen; Lee, Winnie; Parent, Lana; Li, Wei; Cheng, Hongsheng; Shen, Yongchun; Taylor, Noel; Dezso, Zoltan; Du, Hong; Zhao, Nanding; Wang, John; Postema, Maarten; Woodall-Jappe, Mary; Uenaka, Toshimitsu; Nomoto, Kenichi] Eisai Inc, Andover, MA 01810 USA; [Sugi, Naoko Hata; Agarwala, Kishan L.; Kotake, Yoshihiko; Takase, Yasutaka] Eisai Co, Tsukuba Res Lab, Ibaraki, Japan; [Kingston, David G. I.] Virginia Tech, Dept Chem, Blacksburg, VA USA; [Kingston, David G. I.] Virginia Tech, Virginia Tech Ctr Drug Discovery, Blacksburg, VA USA; [Xu, Qunli] Takeda Oncol, Cambridge, MA USA; [Lee, Winnie] Mersana Therapeut, Cambridge, MA USA; [Parent, Lana] Norvartis Inst Biomed Res, Cambridge, MA USA; [Wang, John] H3 Biomed Inc, Cambridge, MA USA; [Uenaka, Toshimitsu] Morphotek Inc, Exton, PA USA	Bao, XF (reprint author), Eisai Inc, Andover, MA 01810 USA.	Xingfeng_Bao@eisai.com			NIH [U01 TW000313]	The isolation of natural schweinfurthins in Dr. Kingston's lab was supported by the NIH under Cooperative Agreement U01 TW000313 with the International Cooperative Biodiversity Groups.	Hoeller D, 2005, CURR OPIN CELL BIOL, V17, P107, DOI 10.1016/j.ceb.2005.01.001; Bao XF, 2009, P NATL ACAD SCI USA, V106, P12109, DOI 10.1073/pnas.0904515106; Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398; Raychaudhuri S, 2006, J CELL BIOL, V173, P107, DOI 10.1083/jcb.200510084; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hung DT, 1996, CHEM BIOL, V3, P623, DOI 10.1016/S1074-5521(96)90129-5; Kloo B, 2011, P NATL ACAD SCI USA, V108, P272, DOI 10.1073/pnas.1008969108; Holstein SA, 2011, LIPIDS, V46, P907, DOI 10.1007/s11745-011-3572-y; Beutler JA, 1998, J NAT PROD, V61, P1509, DOI 10.1021/np980208m; Du XM, 2011, J CELL BIOL, V192, P121, DOI 10.1083/jcb.201004142; Neighbors JD, 2006, BIOORGAN MED CHEM, V14, P1771, DOI 10.1016/j.bmc.2005.10.025; Pfeifer M, 2013, P NATL ACAD SCI USA, V110, P12420, DOI 10.1073/pnas.1305656110; Raychaudhuri S, 2010, ANNU REV CELL DEV BI, V26, P157, DOI 10.1146/annurev.cellbio.042308.113334; Burgett AWG, 2011, NAT CHEM BIOL, V7, P639, DOI 10.1038/nchembio.625; Santiago-Tirado FH, 2011, TRENDS CELL BIOL, V21, P515, DOI 10.1016/j.tcb.2011.05.005; Nagy P, 2002, J CELL SCI, V115, P4251, DOI 10.1242/jcs.00118; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Wood CS, 2009, J CELL BIOL, V187, P967, DOI 10.1083/jcb.200909063; Pfeffer SR, 2013, CURR OPIN CELL BIOL, V25, P414, DOI 10.1016/j.ceb.2013.04.002; Burd CG, 2011, TRAFFIC, V12, P948, DOI 10.1111/j.1600-0854.2011.01188.x; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Smith DF, 2010, METHOD ENZYMOL, V480, P417, DOI 10.1016/S0076-6879(10)80033-3; Kodet JG, 2013, J ORG CHEM, V78, P9291, DOI 10.1021/jo4014244; Yoder BJ, 2007, J NAT PROD, V70, P342, DOI 10.1021/np060484y; Hill MM, 2002, CURR BIOL, V12, P1251, DOI 10.1016/S0960-9822(02)00973-9; Cheung LWT, 2011, CANCER DISCOV, V1, P170, DOI 10.1158/2159-8290.CD-11-0039; Kuder CH, 2012, MOL PHARMACOL, V82, P9, DOI 10.1124/mol.111.077107; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109; Topczewski JJ, 2010, BIOORGAN MED CHEM, V18, P6734, DOI 10.1016/j.bmc.2010.07.056; Turbyville TJ, 2010, MOL CANCER THER, V9, P1234, DOI 10.1158/1535-7163.MCT-09-0834; Kuppers R, 2005, NAT REV CANCER, V5, P251, DOI 10.1038/nrc1589; James MF, 2009, MOL CELL BIOL, V29, P4250, DOI 10.1128/MCB.01581-08; El-Battari A, 2003, GLYCOBIOLOGY, V13, P941, DOI 10.1093/glycob/cwg117; Gonnord P, 2011, SEMIN CELL DEV BIOL, V23, P154; Huo HR, 2003, J BIOL CHEM, V278, P11561, DOI 10.1074/jbc.M211785200; Isotani S, 1999, J BIOL CHEM, V274; Kobuna H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001055; Mousley CJ, 2012, CELL, V148, P702, DOI 10.1016/j.cell.2011.12.026; R Development Core Team, 2010, R LANG ENV STAT COMP; Xu QL, 2011, ANTICANCER RES, V31, P2773; Yung HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017894	45	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-4047	1555-8576		CANCER BIOL THER	Cancer Biol. Ther.	APR	2015	16	4					589	U37		10.1080/15384047.2015.1019184		33	Oncology	Oncology	CH3QO	WOS:000353945600011		
J	Okuno, Y; Small, M; Gotoda, H				Okuno, Yuta; Small, Michael; Gotoda, Hiroshi			Dynamics of self-excited thermoacoustic instability in a combustion system: Pseudo-periodic and high-dimensional nature	CHAOS			English	Article							TIME-SERIES; COMPLEX NETWORK; PREMIXED FLAME; OSCILLATIONS	We have examined the dynamics of self-excited thermoacoustic instability in a fundamentally and practically important gas-turbine model combustion system on the basis of complex network approaches. We have incorporated sophisticated complex networks consisting of cycle networks and phase space networks, neither of which has been considered in the areas of combustion physics and science. Pseudo-periodicity and high-dimensionality exist in the dynamics of thermoacoustic instability, including the possible presence of a clear power-law distribution and small-world-like nature. (C) 2015 AIP Publishing LLC.	[Okuno, Yuta; Gotoda, Hiroshi] Ritsumeikan Univ, Dept Mech Engn, Kyoto, Shiga 5258577, Japan; [Okuno, Yuta; Small, Michael] Univ Western Australia, Sch Math & Stat, Crawley, WA 6009, Australia	Gotoda, H (reprint author), Tokyo Univ Sci, Dept Mech Engn, Katsushika Ku, 6-3-1 Niijuku, Tokyo 1258585, Japan.	gotoda@rs.tus.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); JGC-S Scholarship Foundation; Australian Research Council [FT110100876, DP140100203]	H.G. was partially supported by a Grant-in-Aid for Young Scientists (A) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), and by the JGC-S Scholarship Foundation. M.S. was supported by an Australian Research Council Future Fellowship (FT110100876) and Discovery Project (DP140100203). The authors thank Taku Kuriyama and Shuya Sawada for helping in the implementation of our experiments, and Shohei Domen for estimating the pseudo-Rayleigh index.	Amigo JM, 2007, EPL-EUROPHYS LETT, V79, DOI 10.1209/0295-5075/79/50001; Bandt C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.174102; Yoshida T, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3187546; Xu XK, 2008, P NATL ACAD SCI USA, V105, P19601, DOI 10.1073/pnas.0806082105; Gotoda H, 2012, CHAOS, V22, DOI 10.1063/1.4731267; Zhang J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.238701; Gotoda H, 2012, CHAOS, V22, DOI 10.1063/1.4766589; Nair V, 2014, J FLUID MECH, V756, P470, DOI 10.1017/jfm.2014.468; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Balusamy S, 2015, P COMBUST INST, V35, P3229, DOI 10.1016/j.proci.2014.05.029; Kabiraj L, 2012, CHAOS, V22, DOI 10.1063/1.4718725; Gotoda H, 2013, J APPL PHYS, V113, DOI 10.1063/1.4795264; Balasubramanian K, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.2895634; Jegadeesan V, 2013, P COMBUST INST, V34, P3175, DOI 10.1016/j.proci.2012.05.003; Hatori H, 2012, J APPL PHYS, V111, DOI 10.1063/1.3700244; Biwa T, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066304; Nair V, 2014, J FLUID MECH, V747, P635, DOI 10.1017/jfm.2014.171; Gotoda H, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.022910; Tachibana S, 2009, P COMBUST INST, V32, P1795, DOI 10.1016/j.proci.2008.06.206; Donges JF, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.046105; Donner RV, 2011, EUR PHYS J B, V84, P653, DOI 10.1140/epjb/e2011-10899-1; Candel S, 2002, P COMBUST INST, V29, P1, DOI 10.1016/S1540-7489(02)80007-4; Biwa T, 2007, J APPL PHYS, V101, DOI 10.1063/1.2713360; Donner RV, 2011, INT J BIFURCAT CHAOS, V21, P1019, DOI 10.1142/S0218127411029021; Biwa T, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3464554; Nair V, 2013, CHAOS, V23, DOI 10.1063/1.4821475; Gotoda H, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.026211; Small M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.188101; Domen S., 2015, P COMBUST INST, V35, P3295; JUDD K, 1992, PHYSICA D, V56, P216, DOI 10.1016/0167-2789(92)90025-I; Kashinath K., 2013, THESIS U CAMBRIDGE; Kashinath K, 2014, J FLUID MECH, V761, DOI 10.1017/jfm.2014.601; Lieuwen TC, 2012, UNSTEADY COMBUSTOR PHYSICS, P1, DOI 10.1017/CBO9781139059961; Newman M E J, 2010, NETWORKS INTRO; Small M., 2005, APPL NONLINEAR TIME; Takens F., 1981, LECT NOTES MATH, V898, P366, DOI DOI 10.1007/BFB0091924	36	2	2	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	1054-1500	1089-7682		CHAOS	Chaos	APR	2015	25	4							043107	10.1063/1.4914358		5	Mathematics, Applied; Physics, Mathematical	Mathematics; Physics	CH2BR	WOS:000353829800007		
J	Nakamura, I; Terada, M				Nakamura, Itaru; Terada, Masahiro			Copper-Catalyzed Skeletal Rearrangements of O-Propargylic Oximes via Cleavage of a Carbon-Oxygen Bond	CHEMICAL RECORD			English	Article						alkynes; cascade reactions; copper; heterocycles; rearrangement	4-MEMBERED CYCLIC NITRONES; ELECTROCYCLIC RING-CLOSURE; DIELS-ALDER CYCLOADDITION; C-N BOND; PLATINUM CATALYSIS; CHIRALITY TRANSFER; ORGANIC-REACTIONS; CASCADE REACTIONS; ALLYL ETHERS; GOLD	In this account, we describe recent developments in copper-catalyzed skeletal 2,3-rearrangement reactions of O-propargylic oximes to form four-membered cyclic nitrones, pyridine N-oxides, and amidodienes via N-allenylnitrone intermediates. The sequence of events leading up to our encounter with O-propargylic oximes is also presented.	[Nakamura, Itaru; Terada, Masahiro] Tohoku Univ, Grad Sch Sci, Res & Analyt Ctr Giant Mol, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Terada, Masahiro] Tohoku Univ, Dept Chem, Grad Sch Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan	Nakamura, I (reprint author), Tohoku Univ, Grad Sch Sci, Res & Analyt Ctr Giant Mol, Aoba Ku, 6-3 Aramaki Aza Aoba, Sendai, Miyagi 9808578, Japan.	itaru-n@m.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Molecular Activation Directed toward Straightforward Synthesis" from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Furstner A, 2005, J AM CHEM SOC, V127, P15024, DOI 10.1021/ja055659p; Aubert C, 2002, CHEM REV, V102, P813, DOI 10.1021/cr980054f; Nakamura I, 2006, ANGEW CHEM INT EDIT, V45, P4473, DOI 10.1002/anie.200601178; Zhang LM, 2006, ADV SYNTH CATAL, V348, P2271, DOI 10.1002/adsc.200600368; Xiao J, 2011, ANGEW CHEM INT EDIT, V50, P7226, DOI 10.1002/anie.201100148; Huang H, 2011, BEILSTEIN J ORG CHEM, V7, P897, DOI 10.3762/bjoc.7.103; Miki K, 2003, J ORG CHEM, V68, P8505, DOI 10.1021/jp034841a; Nakamura I, 2014, ORG LETT, V16, P2562, DOI 10.1021/ol5009608; Hashmi ASK, 2007, CHEM REV, V107, P3180, DOI 10.1021/cr000436x; TROST BM, 1988, J AM CHEM SOC, V110, P1636, DOI 10.1021/ja00213a054; Nakamura I, 2012, ANGEW CHEM INT EDIT, V51, P10816, DOI 10.1002/anie.201205285; Correa A, 2008, ANGEW CHEM INT EDIT, V47, P718, DOI 10.1002/anie.200703769; Nakamura I, 2010, ORG LETT, V12, P2453, DOI 10.1021/ol100581m; Momiyama N, 2011, J AM CHEM SOC, V133, P19294, DOI 10.1021/ja2081444; Shu XZ, 2012, CHEM SOC REV, V41, P7698, DOI 10.1039/c2cs35235d; Michelet V, 2008, ANGEW CHEM INT EDIT, V47, P4268, DOI 10.1002/anie.200701589; Nakamura I, 2011, ORG LETT, V13, P3616, DOI 10.1021/ol2012583; Furstner A, 2007, ANGEW CHEM INT EDIT, V46, P3410, DOI 10.1002/anie.200604335; Nakamura I, 2011, J AM CHEM SOC, V133, P6862, DOI 10.1021/ja201076c; Nakamura I, 2007, ANGEW CHEM INT EDIT, V46, P2284, DOI 10.1002/anie.200604038; Furstner A, 2001, J AM CHEM SOC, V123, P11863, DOI 10.1021/ja0109343; GRIGG R, 1991, TETRAHEDRON LETT, V32, P279, DOI 10.1016/0040-4039(91)80875-7; CHATANI N, 1994, J AM CHEM SOC, V116, P6049, DOI 10.1021/ja00092a098; Nakamura I, 2005, J AM CHEM SOC, V127, P15022, DOI 10.1021/ja055202f; Furstner A, 2009, CHEM SOC REV, V38, P3208, DOI 10.1039/b816696j; Jimenez-Nunez E, 2008, CHEM REV, V108, P3326, DOI 10.1021/cr0684319; Nakamura I, 2008, ORG LETT, V10, P2649, DOI 10.1021/ol8007556; Shimada T, 2004, J AM CHEM SOC, V126, P10546, DOI 10.1021/ja047542r; Nakamura I, 2007, ORG LETT, V9, P4081, DOI 10.1021/ol701951n; Nakamura I, 2013, ANGEW CHEM INT EDIT, V52, P7536, DOI 10.1002/anie.201302751; Krause N, 2011, CHEM REV, V111, P1994, DOI 10.1021/cr1004088; Anorbe L, 2004, CHEM-EUR J, V10, P4938, DOI 10.1002/chem.200400089; Nakamura I, 2010, J AM CHEM SOC, V132, P7884, DOI 10.1021/ja102436z; Nakamura I, 2014, TETRAHEDRON LETT, V55, P1178, DOI 10.1016/j.tetlet.2013.12.105; Tobisu M, 2008, CHEM SOC REV, V37, P300, DOI 10.1039/b702940n; Hayashi R, 2010, ORG LETT, V12, P1152, DOI 10.1021/ol902821w; Corma A, 2011, CHEM REV, V111, P1657, DOI 10.1021/cr100414u; OVERMAN LE, 1981, J AM CHEM SOC, V103, P2807, DOI 10.1021/ja00400a053; TROFIMOV BA, 1995, TETRAHEDRON LETT, V36, P9181, DOI 10.1016/0040-4039(95)01935-B; Furstner A, 2000, J AM CHEM SOC, V122, P6785, DOI 10.1021/ja001034+; Fang LC, 2013, ORG LETT, V15, P4842, DOI 10.1021/ol402254p; Nakamura I, 2009, TETRAHEDRON LETT, V50, P2075, DOI 10.1016/j.tetlet.2009.02.108; Diver ST, 2004, CHEM REV, V104, P1317, DOI 10.1021/cr020009e; RAUTENSTRAUCH V, 1984, J ORG CHEM, V49, P950, DOI 10.1021/jo00179a044; Yamamoto Y, 2007, J ORG CHEM, V72, P7817, DOI 10.1021/jo070579k; Bruneau C., 2005, ANGEW CHEM, V117, P2380, DOI 10.1002/ange.200462568; Bruneau C, 2005, ANGEW CHEM INT EDIT, V44, P2328, DOI 10.1002/anie.200462568; Correa A., 2008, ANGEW CHEM, V120, P730, DOI 10.1002/ange.200703769; Fehr C, 2012, SYNLETT, P990, DOI 10.1055/s-0031-1290657; Furstner A., 2007, ANGEW CHEM, V119, P3478, DOI 10.1002/ange.200604335; Hayashi R, 2011, BEILSTEIN J ORG CHEM, V7, P410, DOI 10.3762/bjoc.7.53; Hayashi R, 2009, ORG LETT, V11, P2125, DOI 10.1021/ol900647s; Hummel S, 2011, BEILSTEIN J ORG CHEM, V7, DOI 10.3762/bjoc.7.97; Lopez S, 1996, J AM CHEM SOC, V118, P1881, DOI 10.1021/ja9522241; Marion N, 2007, ANGEW CHEM INT EDIT, V46, P2750, DOI 10.1002/anie.200604773; Marion N., 2007, ANGEW CHEM, V119, P2806, DOI 10.1002/ange.200604773; Martynoff M., 1937, ANN CHIM, V11, P424; Michelet V., 2008, ANGEW CHEM, V120, P4338, DOI 10.1002/ange.200701589; Nakamura I, 2012, SYNTHESIS-STUTTGART, V44, P1542, DOI 10.1055/s-0031-1290819; Nakamura I, 2014, ORG CHEM FRONT, V1, P914, DOI 10.1039/c4qo00156g; Nakamura I., 2006, ANGEW CHEM, V118, P4585, DOI 10.1002/ange.200601178; Nakamura I, 2009, J AM CHEM SOC, V131, P2804, DOI 10.1021/ja900133m; Nakamura I, 2012, ORG LETT, V14, P206, DOI 10.1021/ol203001w; Nakamura I, 2009, J AM CHEM SOC, V131, P4198, DOI 10.1021/ja900174t; Nakamura I., 2007, ANGEW CHEM, V119, P2334, DOI 10.1002/ange.200604038; Nakamura I., 2013, ANGEW CHEM, V125, P7684; Nakamura I., 2012, ANGEW CHEM, V124, P10974; Nakamura I, 2011, J AM CHEM SOC, V133, P6861, DOI 10.1021/ja201074e; Nakamura I., 2014, CHEM-EUR J, P10214; Nakamura I., 2011, TETRAHEDRON LETT, V52, P6470; Nakamura I, 2014, HETEROCYCLES, V89, P845, DOI 10.3987/REV-13-791; de Haro T, 2011, SYNTHESIS-STUTTGART, P2530, DOI 10.1055/s-0030-1260122; OVERMAN LE, 1976, J AM CHEM SOC, V98, P2352, DOI 10.1021/ja00424a068; PENNINGS MLM, 1983, J ORG CHEM, V48, P4043, DOI 10.1021/jo00170a034; Pradal A, 2011, SYNTHESIS-STUTTGART, P1501, DOI 10.1055/s-0030-1258465; RANGANAT.S, 1973, TETRAHEDRON LETT, P3577; Reddy CR, 2011, EUR J ORG CHEM, P5967, DOI 10.1002/ejoc.201100797; Sato T, 2009, EUR J ORG CHEM, P5509, DOI 10.1002/ejoc.200900894; Shapiro ND, 2010, SYNLETT, P675, DOI 10.1055/s-0029-1219369; Wang SZ, 2010, SYNLETT, P692, DOI 10.1055/s-0029-1219527; Xiao J., 2011, ANGEW CHEM, V123, P7364; Yeom HS, 2007, SYNLETT, P2292, DOI 10.1055/s-2007-985571	82	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1527-8999	1528-0691		CHEM REC	Chem. Rec.	APR	2015	15	2					429	444		10.1002/tcr.201402088		16	Chemistry, Multidisciplinary	Chemistry	CH3HB	WOS:000353919100001		
J	Hirai, G				Hirai, Go			Mimicking/Extracting Structure and Functions of Natural Products: Synthetic Approaches that Address Unexplored Needs in Chemical Biology	CHEMICAL RECORD			English	Article						bioorganic chemistry; C-glycosides; inhibitors; natural products; structure-activity relationships	PROTEIN-TYROSINE PHOSPHATASES; IRELAND-CLAISEN REARRANGEMENT; DUAL-SPECIFICITY PHOSPHATASE; CF2-LINKED GANGLIOSIDE GM4; N-ACETYLNEURAMINIC ACID; ALKEKENGI VAR FRANCHETI; ISOBENZOFURANONE LIGANDS; BITTER PRINCIPLES; POTENT INHIBITOR; C-DISACCHARIDE	Natural products are often attractive and challenging targets for synthetic chemists, and many have interesting biological activities. However, synthetic chemists need to be more than simply suppliers of compounds to biologists. Therefore, we have been seeking ways to actively apply organic synthetic methods to chemical biology studies of natural products and their activities. In this personal review, I would like to introduce our work on the development of new biologically active compounds inspired by, or extracted from, the structures of natural products, focusing on enhancement of functional activity and specificity and overcoming various drawbacks of the parent natural products.	[Hirai, Go] RIKEN, Synthet Organ Chem Lab, Wako, Saitama 3510198, Japan; [Hirai, Go] RIKEN, Ctr Sustainable Resource Sci, Wako, Saitama 3510198, Japan	Hirai, G (reprint author), RIKEN, Synthet Organ Chem Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	gohirai@riken.jp			 [26102744];  [24102534];  [22603014];  [19710195];  [16710152]	All of the work introduced herein was conducted in the Synthetic Organic Chemistry Laboratory at RIKEN. I would like to express my sincere appreciation for the continued support and supervision of Prof. Mikiko Sodeoka. I would also like to thank all my colleagues and graduate students, whose names will be found in the publications listed in the reference section, for their tremendous contributions. I also thank Dr. Ayako Miyazaki for assisting me in writing this personal account. The work described was partially supported by Grants-in-Aid for Scientific Research (nos. 26102744, 24102534, 22603014, 19710195, and 16710152).	Contour-Galcera MO, 2007, PHARMACOL THERAPEUT, V115, P1, DOI 10.1016/j.pharmthera.2007.03.009; Watanabe T, 2008, ORG LETT, V10, P4167, DOI [10.1021/ol801519j, 10.1021/o1801519j]; Bazin HG, 1999, J ORG CHEM, V64, P7254, DOI 10.1021/jo990564p; Morita M, 2012, ORG LETT, V14, P3434, DOI 10.1021/ol301394b; Notz W, 2001, J ORG CHEM, V66, P4250, DOI 10.1021/jo015543l; Miljan EA, 2002, J BIOL CHEM, V277, P10108, DOI 10.1074/jbc.M111669200; Patterson DM, 2014, ACS CHEM BIOL, V9, P592, DOI 10.1021/cb400828a; Bialy L, 2005, ANGEW CHEM INT EDIT, V44, P3814, DOI 10.1002/anie.200461517; Burke TR, 2006, CURR TOP MED CHEM, V6, P1465, DOI 10.2174/156802606777951091; Hirai G, 2007, J AM CHEM SOC, V129, P15420, DOI 10.1021/ja075738w; Lang K, 2014, ACS CHEM BIOL, V9, P16, DOI 10.1021/cb4009292; Sodeoka M, 2001, J MED CHEM, V44, P3216, DOI 10.1021/jm0100741; Terai T, 2008, CURR OPIN CHEM BIOL, V12, P515, DOI 10.1016/j.cbpa.2008.08.007; Vlahov IR, 1997, J AM CHEM SOC, V119, P1480, DOI 10.1021/ja962703f; Nodwell MB, 2012, TOP CURR CHEM, V324, P1, DOI 10.1007/128_2011_302; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; ITO Y, 1989, J CARBOHYD CHEM, V8, P285, DOI 10.1080/07328308908048010; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Wang Q, 2000, BIOORG MED CHEM LETT, V10, P941, DOI 10.1016/S0960-894X(00)00132-3; Ohkubo M, 2009, ANGEW CHEM INT EDIT, V48, P3862, DOI 10.1002/anie.200900634; Ueda M, 2012, CHEM LETT, V41, P658, DOI 10.1246/cl.2012.658; Fukuda I, 2009, CHEM BIOL, V16, P133, DOI 10.1016/j.chembiol.2009.01.009; McCluskey A, 2002, J MED CHEM, V45, P1151, DOI 10.1021/jm010066k; Sodeoka M, 2009, PURE APPL CHEM, V81, P205, DOI 10.1351/PAC-CON-08-09-14; Baba Y, 2004, BIOORG MED CHEM LETT, V14, P2963, DOI 10.1016/j.bmcl.2004.02.097; Baba Y, 2004, BIOORG MED CHEM LETT, V14, P2969, DOI 10.1016/j.bmcl.2004.02.098; Bergnes G, 1999, BIOORG MED CHEM LETT, V9, P2849, DOI 10.1016/S0960-894X(99)00497-7; Cebula RE, 1997, BIOORG MED CHEM LETT, V7, P2015, DOI 10.1016/S0960-894X(97)00357-0; HAMAGUCHI T, 1995, FEBS LETT, V372, P54, DOI 10.1016/0014-5793(95)00953-7; Hirai G, 2007, CHEMMEDCHEM, V2, P1006, DOI 10.1002/cmdc.200700080; Hirai G, 2011, CHEMMEDCHEM, V6, P617, DOI 10.1002/cmdc.201100107; Hirai G, 2011, BIOORG MED CHEM LETT, V21, P3587, DOI 10.1016/j.bmcl.2011.04.108; Hirai G, 2009, TETRAHEDRON LETT, V50, P3609, DOI 10.1016/j.tetlet.2009.03.069; Hirai G, 2012, YAKUGAKU ZASSHI, V132, P117; Ishida K, 2004, MOL CANCER THER, V3, P1069; Jacobo-Herrera NJ, 2006, J NAT PROD, V69, P328, DOI 10.1021/np050225t; Kato M, 2011, CHEM LETT, V40, P877, DOI 10.1246/cl.2011.877; Kawai M, 2002, PHARMAZIE, V57, P348; Lyon MA, 2002, NAT REV DRUG DISCOV, V1, P961, DOI 10.1038/nrd963; MATSUURA T, 1969, TETRAHEDRON LETT, P1765; MATSUURA T, 1969, TETRAHEDRON LETT, P1083; Monti E., 2012, TOP CURR CHEM, P1; Ozawa M, 2013, ACS MED CHEM LETT, V4, P730, DOI 10.1021/ml400144e; Shi Z, 2007, CHEMBIOCHEM, V8, P2092, DOI 10.1002/cbic.200700397; Thuaud F, 2014, BIOORGAN MED CHEM, V22, P2771, DOI 10.1016/j.bmc.2014.03.012; Trabocchi A., 2013, DIVERSITY ORIENTED S; Tsuchiya A, 2012, ACS MED CHEM LETT, V3, P294, DOI 10.1021/ml2002778; Ueda K, 2002, FEBS LETT, V525, P48, DOI 10.1016/S0014-5793(02)03065-X; Waldmann H., 2009, CHEM BIOL; Wu SD, 2009, J MED CHEM, V52, P6716, DOI 10.1021/jm901016k; Yu RK, 2007, COMPREHENSIVE GLYCOS, V1, P73	51	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1527-8999	1528-0691		CHEM REC	Chem. Rec.	APR	2015	15	2					445	456		10.1002/tcr.201402074		12	Chemistry, Multidisciplinary	Chemistry	CH3HB	WOS:000353919100002		
J	Oyama, HT				Oyama, Hideko Tamaru			Setsuro Tamaru and Fritz Haber: Links between Japan and Germany in Science and Technology	CHEMICAL RECORD			English	Article							7 NOTICES; 7TH ANNOUNCEMENT; FORMATION HEAT; AMMONIAC; TEMPERATURES; EQUILIBRIUM; PRESSURE	Setsuro Tamaru was my grandfather. He worked with Fritz Haber in Germany on researching the ammonia synthesis process and contributed substantially to the development of scientific research and education in Japan. Although I had never met him, I felt his existence while I grew up, since our house was built by him and had many artifacts brought back from Germany by my grandfather; e.g., a Bechstein upright piano upon which I practiced piano every day and Fritz Haber's portrait with his handwritten message hung on the wall. This is an account of my grandfather's life, concentrating on his relationship with Fritz Haber. This story goes back to a time more than a century ago.	Rikkyo Univ, Dept Chem, Toshima Ku, Tokyo 1718501, Japan	Oyama, HT (reprint author), Rikkyo Univ, Dept Chem, Toshima Ku, 3-34-1 Nishi Ikebukuro, Tokyo 1718501, Japan.	hideko-oyama@rikkyo.ac.jp					[Anonymous], 1915, YOMIURI         0906, P4; [Anonymous], 1920, ASAHI           0223, P6; [Anonymous], 1920, ASAHI           0309, P3; Auer P., 2004, DAHLEM NACH HIROSHIM; Badino M, 2013, PHYS PERSPECT, V15, P295, DOI 10.1007/s00016-013-0110-8; Crookes W., 1898, CHEM NEWS, V78, P125; Ekstrand A. G., 1920, COMMUNICATION; Ertl G., 2007, NOB LECT REACT SURF; Haber F., 1907, Z ELEKTROCHEM, V14, P513; Haber F, 1915, Z ELKTROCHEM ANGEW P, V21, P241; Haber F, 1915, Z ELKTROCHEM ANGEW P, V21, P128; Haber F, 1915, Z ELKTROCHEM ANGEW P, V21, P228; Haber F, 1915, Z ELKTROCHEM ANGEW P, V21, P89; Haber F, 1914, Z ELKTROCHEM ANGEW P, V20, P597; Haber F, 1915, Z ELKTROCHEM ANGEW P, V21, P191; Haber F., 1920, NOB LECT SYNTH AMM I; Haber F, 1915, Z ELKTROCHEM ANGEW P, V21, P206; Haber Fritz, 1931, HABERS LECT SERIES N; Herschbach DR, 2014, ANGEW CHEM INT EDIT, V53, P13982, DOI 10.1002/anie.201407464; Hoshi S., 1978, WEAK CITIZENS STRONG; James J, 2011, ONE HUNDRED YEARS AT THE INTERSECTION OF CHEMISTRY AND PHYSICS: THE FRITZ HABER INSTITUTE OF THE MAX PLANCK SOCIETY 1911-2011, P1, DOI 10.1515/9783110239546; Kenkyujo Rikagaku, 1980, REC 60 YEAR RIK KENK, P36; Morinaka K., 1988, B OSAKA PREFECTURAL, V24, P13; Osaka Prefectural Library, 1963, CLASS CAT BOOKS SC 1; Saito K., 1964, KAGAKU, V19, P132; Sakurai J., 1940, FULL MEMORIES POSTHU; Sato K., 1969, MAGOKORO, P110; Smil V., 2001, ENRICHING THE EARTH; Stoltzenberg D., 2003, F HABER CHEM NOBEL L; Tamaru K., 2012, KAGAKU TO KOGYOU, V65, P536; Tamaru K., 1912, GEN NOGI HIS PERSONA; Tamaru S., 1934, KAGAKU, V4, P167; Tamaru S., 1914, FOUNDING K WILHELM I; Tamaru S., 1931, K WILHELM SOC GERMAN; Tamaru S., 1938, KAGAKU, V8, P185	35	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1527-8999	1528-0691		CHEM REC	Chem. Rec.	APR	2015	15	2					535	549		10.1002/tcr.201402086		15	Chemistry, Multidisciplinary	Chemistry	CH3HB	WOS:000353919100008		
J	Iida, N; Tanaka, K; Tokunaga, E; Takahashi, H; Shibata, N				Iida, Norihito; Tanaka, Kenta; Tokunaga, Etsuko; Takahashi, Hiromi; Shibata, Norio			Regioisomer-Free C-4h beta-Tetrakis(tert-butyl)metallo-phthalocyanines: Regioselective Synthesis and Spectral Investigations	CHEMISTRYOPEN			English	Article						aggregation; phthalocyanines; protecting groups; regioselectivity; silicon; synthesis	TETRA-SUBSTITUTED PHTHALOCYANINE; ONE STRUCTURAL ISOMER; COMPLEX; DERIVATIVES; PORPHYRINS; SEPARATION	Metal beta-tetrakis(tert-butyl)phthalocyanines are the most commonly used phthalocyanines due to their high solubility, stability, and accessibility. They are commonly used as a mixture of four regioisomers, which arise due to the tert-butyl substituent on the beta-position, and to the best of our knowledge, their regioselective synthesis has yet to be reported. Herein, the C-4h-selective synthesis of beta-tetrakis(tert-butyl) metallophthalocyanines is disclosed. Using tetramerization of alpha-trialkylsilyl phthalonitriles with metal salts following acid-mediated desilylation, the desired metallophthalocyanines were obtained in good yields. Upon investigation of regioisomer-free zinc beta-tetrakis(tert-butyl) phthalocyanine using spectroscopy, the C-4h single isomer described here was found to be distinct in the solid state to zinc beta-tetrakis(tert-butyl) phthalocyanine obtained by a conventional method.	[Iida, Norihito; Tanaka, Kenta; Shibata, Norio] Nagoya Inst Technol, Dept Frontier Mat, Showa Ku, Nagoya, Aichi 4668555, Japan; [Tokunaga, Etsuko; Shibata, Norio] Nagoya Inst Technol, Dept Nanopharmaceut Sci, Showa Ku, Nagoya, Aichi 4668555, Japan; [Takahashi, Hiromi] Syst Instruments Co Ltd, Hachioji, Tokyo 1920031, Japan	Iida, N (reprint author), Nagoya Inst Technol, Dept Frontier Mat, Showa Ku, Nagoya, Aichi 4668555, Japan.	nozshiba@nitech.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Society for the Promotion of Science (JSPS) [25288045, 25670055]; Hori Science and Arts Foundation (Japan)	This research was financially supported in part by the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) through their Platform for Drug Discovery, Informatics, & Structural Life Science, and the Japan Society for the Promotion of Science (JSPS) through their Scientific Research (B) grant 25288045 and Exploratory Research grant 25670055. N.I. thanks the Hori Science and Arts Foundation (Japan) for support.	Okada S, 2003, J AM CHEM SOC, V125, P2792, DOI 10.1021/ja017768j; KOBAYASHI N, 1987, J AM CHEM SOC, V109, P7433, DOI 10.1021/ja00258a030; Eguchi M, 2014, TETRAHEDRON LETT, V55, P2662, DOI 10.1016/j.tetlet.2014.03.027; Bottari G, 2010, CHEM REV, V110, P6768, DOI 10.1021/cr900254z; Eguchi M, 2007, B CHEM SOC JPN, V80, P1350, DOI 10.1246/bcsj.80.1350; Kobayashi N, 2003, CHEM-EUR J, V9, P5123, DOI 10.1002/chem.200304834; Sommerauer M, 1996, J AM CHEM SOC, V118, P10085, DOI 10.1021/ja961009x; Hu M, 1998, J MED CHEM, V41, P1789, DOI 10.1021/jm970336s; Sorokin AB, 2013, CHEM REV, V113, P8152, DOI 10.1021/cr4000072; Perry JW, 1996, SCIENCE, V273, P1533, DOI 10.1126/science.273.5281.1533; BRAUN A, 1907, CHEM BER, V40, P2709; CHEN MJ, 1990, J MACROMOL SCI CHEM, VA27, P1415; de la Torre G, 2007, CHEM COMMUN, P2000, DOI 10.1039/b614234f; de la Torre G, 2000, EUR J ORG CHEM, P2821; Gorlach B, 2001, CHEM-EUR J, V7, P2459, DOI 10.1002/1521-3765(20010601)7:11<2459::AID-CHEM24590>3.0.CO;2-4; GREENBERG S, 1988, CAN J CHEM, V66, P1059, DOI 10.1139/v88-175; Isago H, 1998, B CHEM SOC JPN, V71, P1039, DOI 10.1246/bcsj.71.1039; Isago H, 2003, CHEM COMMUN, P1864, DOI 10.1039/b304089e; Kadish KM, 2010, HANDB PORPHYR SCI, V3, P1; Kasha M., 1965, Eighth European Congress on Molecular Spectroscopy, DOI 10.1351/pac196511030371; Kasuga K, 1996, CHEM LETT, P867, DOI 10.1246/cl.1996.867; Kasuga K, 1997, B CHEM SOC JPN, V70, P1859, DOI 10.1246/bcsj.70.1859; KOBAYASHI N, 1993, J AM CHEM SOC, V115, P10994, DOI 10.1021/ja00076a069; Leznoff CC, 1996, CHEM COMMUN, P1245, DOI 10.1039/cc9960001245; Leznoff C.C., 1989, PHTHALOCYANINES PROP, V1, P27; Lim B, 2013, ORG LETT, V15, P784, DOI 10.1021/ol303436q; NEVIN WA, 1987, CAN J CHEM, V65, P855; Palomares E, 2004, CHEM COMMUN, P2112, DOI 10.1039/b407860h; Rager C, 1999, CHEM-EUR J, V5, P280, DOI 10.1002/(SICI)1521-3765(19990104)5:1<280::AID-CHEM280>3.0.CO;2-0; Sugimori T, 2000, CHEM LETT, P1200, DOI 10.1246/cl.2000.1200	30	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	2191-1363			CHEMISTRYOPEN	ChemistryOpen	APR	2015	4	2					102	106		10.1002/open.201402093		5	Chemistry, Multidisciplinary	Chemistry	CG9QX	WOS:000353653800003		
J	Ichinose, K; Arima, K; Ushigusa, T; Nishino, A; Nakashima, Y; Suzuki, T; Horai, Y; Nakajima, H; Kawashiri, S; Iwamoto, N; Tamai, M; Nakamura, H; Origuchi, T; Motomura, M; Kawakami, A				Ichinose, Kunihiro; Arima, Kazuhiko; Ushigusa, Takeshi; Nishino, Ayako; Nakashima, Yoshikazu; Suzuki, Takahisa; Horai, Yoshiro; Nakajima, Hideki; Kawashiri, Shin-ya; Iwamoto, Naoki; Tamai, Mami; Nakamura, Hideki; Origuchi, Tomoki; Motomura, Masakatsu; Kawakami, Atsushi			Distinguishing the cerebrospinal fluid cytokine profile in neuropsychiatric systemic lupus erythematosus from other autoimmune neurological diseases	CLINICAL IMMUNOLOGY			English	Article						Neuropsychiatric systemic lupus erythematosus; Cytokine profiles; Cerebrospinal fluid; Weighted-voting algorithm	BLOOD-BRAIN-BARRIER; NEUROMYELITIS-OPTICA; MURINE LUPUS; NITRIC-OXIDE; T-CELLS; EXPRESSION; SCLEROSIS; IL-2; MANIFESTATIONS; CLASSIFICATION	Neuropsychiatric systemic lupus erythematosus (NPSLE) is a serious complication in SLE. Although the mechanism of NPSLE remains unclear, cytokines and chemokines are considered to be involved in their pathogenesis. Here we used Bio-Plex Pro assays to examine 27 types of cytokines and chemokines in the cerebrospinal fluid (CSF) of 32 NPSLE patients. We used the CSF of 20 patients with multiple sclerosis (MS) and 22 patients with neuromyelitis optica (NMO) as a disease control group. Fourteen of 27 cytokines/chemokines were significantly higher in the NPSLE patients compared to the MS/NMO patients. We could identify six "minimum predictive markers" by using a weighted-voting algorithm that could distinguish NPSLE from MS and NMO: interleukin (IL)-17, IL-2, interferon (IFN)-gamma, IL-5, basic fibroblast growth factor (FGF) -basic and IL-15. The determination of various types of CSF cytokine profiles may contribute to the diagnosis of NPSLE and may help elucidate the mechanisms underlying this disease. (C) 2015 Elsevier Inc. All rights reserved.	[Ichinose, Kunihiro; Ushigusa, Takeshi; Nishino, Ayako; Nakashima, Yoshikazu; Suzuki, Takahisa; Horai, Yoshiro; Iwamoto, Naoki; Tamai, Mami; Nakamura, Hideki; Kawakami, Atsushi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Immunol & Rheumatol, Nagasaki 8528501, Japan; [Arima, Kazuhiko; Kawashiri, Shin-ya] Nagasaki Univ, Grad Sch Biomed Sci, Dept Publ Hlth, Nagasaki 8528501, Japan; [Origuchi, Tomoki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Rehabil Sci, Nagasaki 8528501, Japan; [Nakajima, Hideki; Motomura, Masakatsu] Nagasaki Univ, Grad Sch Biomed Sci, Dept Clin Neurosci & Neurol, Nagasaki 8528501, Japan	Ichinose, K (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Immunol & Rheumatol, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	kichinos@nagasaki-u.ac.jp			Japan Intractable Diseases Research Foundation [24790999]; Nagao Memorial Foundation	This work was supported by a Grant-in-Aid for Scientific Research (to K. I.; no. 24790999), Japan Intractable Diseases Research Foundation and Nagao Memorial Foundation.	Liang MH, 1999, ARTHRITIS RHEUM-US, V42, P599; Humrich JY, 2010, P NATL ACAD SCI USA, V107, P204, DOI 10.1073/pnas.0903158107; Hirohata S, 2009, CLIN RHEUMATOL, V28, P1319, DOI 10.1007/s10067-009-1226-8; Nalbandian A, 2009, CLIN EXP IMMUNOL, V157, P209, DOI 10.1111/j.1365-2249.2009.03944.x; Lieberman LA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/740619; Mitchell RM, 2009, NEUROLOGY, V72, P14, DOI 10.1212/01.wnl.0000333251.36681.a5; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Dimitrijevic OB, 2007, STROKE, V38, P1345, DOI 10.1161/01.STR.0000259709.16654.8f; Iwao-Koizumi K, 2005, J CLIN ONCOL, V23, P422, DOI 10.1200/JCO.2005.09.078; Hopia L, 2011, SCAND J RHEUMATOL, V40, P363, DOI 10.3109/03009742.2010.550900; Mizui M, 2014, J IMMUNOL, V193, P2168, DOI 10.4049/jimmunol.1400977; Jadidi-Niaragh F, 2011, SCAND J IMMUNOL, V74, P1, DOI 10.1111/j.1365-3083.2011.02536.x; Stamatovic SM, 2005, J CEREBR BLOOD F MET, V25, P593, DOI 10.1038/sj.jcbfm.9600055; Matsumoto T, 1997, LAB INVEST, V77, P119; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Uzawa A, 2014, BRAIN PATHOL, V24, P67, DOI 10.1111/bpa.12097; Fragoso-Loyo H, 2007, ARTHRITIS RHEUM, V56, P1242, DOI 10.1002/art.22451; Wong D, 2004, EXP NEUROL, V190, P446, DOI 10.1016/j.expneurol.2004.08.008; Aringer M, 2001, RHEUMATOLOGY, V40, P876, DOI 10.1093/rheumatology/40.8.876; Trysberg E, 2004, ARTHRITIS RES THER, V6, pR551, DOI 10.1186/ar1228; Gilad R, 1997, BRIT J RHEUMATOL, V36, P190; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Efthimiou P, 2009, MOD RHEUMATOL, V19, P457, DOI 10.1007/s10165-009-0198-5; ARMITAGE RJ, 1995, J IMMUNOL, V154, P483; Bertsias GK, 2010, NAT REV RHEUMATOL, V6, P358, DOI 10.1038/nrrheum.2010.62; Fragoso-Loyo H, 2013, RHEUMATOLOGY, V52, P2218, DOI 10.1093/rheumatology/ket294; Crispin JC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/943254; Dellalibera-Joviliano R, 2003, J RHEUMATOL, V30, P485; Kira Jun-Ichi, 2011, Pathophysiology, V18, P69, DOI 10.1016/j.pathophys.2010.04.008; Lima I, 2007, JCR-J CLIN RHEUMATOL, V13, P85, DOI 10.1097/01.rhu.0000260637.95695.40; Matsushita T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061835; Carneiro JRM, 2011, CLINICS, V66, P77, DOI 10.1590/S1807-59322011000100014; Svenungsson E, 2001, ANN RHEUM DIS, V60, P372, DOI 10.1136/ard.60.4.372; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Wen XS, 2004, EUR J IMMUNOL, V34, P2740, DOI 10.1002/eji.200425267; Zhou L, 2014, BIOMED RES INT, V2014	36	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1521-6616	1521-7035		CLIN IMMUNOL	Clin. Immunol.	APR	2015	157	2					114	120		10.1016/j.clim.2015.01.010		7	Immunology	Immunology	CH2FS	WOS:000353841700002		
J	Shiina, A; Kanahara, N; Sasaki, T; Oda, Y; Hashimoto, T; Hasegawa, T; Yoshida, T; Iyo, M; Hashimoto, K				Shiina, Akihiro; Kanahara, Nobuhisa; Sasaki, Tsuyoshi; Oda, Yasunori; Hashimoto, Tasuku; Hasegawa, Tadashi; Yoshida, Taisuke; Iyo, Masaomi; Hashimoto, Kenji			An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients with Schizophrenia	CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE			English	Article						Schizophrenia; Sulforafan; Executive function; Clinical trial; CogState	PLACEBO-CONTROLLED TRIAL; COGSTATE BRIEF BATTERY; SUPEROXIDE-DISMUTASE ACTIVITY; CONSENSUS COGNITIVE BATTERY; ETHYL-EICOSAPENTAENOIC ACID; DOUBLE-BLIND; OXIDATIVE STRESS; NEUROTROPHIC FACTOR; IMPROVE COGNITION; BIPOLAR DISORDER	Objective: Schizophrenia is a mental disorder characterized by severe cognitive impairment. Accumulating evidence suggests a role for oxidative stress in the pathophysiology of schizophrenia. Sulforaphane (SFN) extracted from broccoli sprout is an agent with potent anti oxidant and anti inflammatory activity. In this study, we attempted to evaluate the effect of SFN on cognitive impairment in medicated patients with schizophrenia. Methods: We recruited a total of 10 outpatients with schizophrenia, all of whom gave informed consent. Participants took 3 tablets of SFN, consisting of 30 mg of SFN glucosinolate per day, for 8 weeks. Clinical symptoms using the Positive and Negative. Syndrome Scale (PANSS) and cognitive function using the Japanese version of CogState battery were evaluated at the beginning of the study and at week 8. Results: A total of 7 patients completed the trial. The mean score in the Accuracy component of the One Card Learning Task increased significantly after the trial. However, we detected no other significant changes in participants. Conclusion: This result suggests that SFN has the potential to improve cognitive function in patients with schizophrenia,	[Shiina, Akihiro; Sasaki, Tsuyoshi; Iyo, Masaomi] Chiba Univ Hosp, Dept Child Psychiat, Chiba 2608670, Japan; [Shiina, Akihiro] Chiba Univ, Ctr Forens Mental Hlth, Div Law & Psychiat, Chiba, Japan; [Kanahara, Nobuhisa] Chiba Univ, Ctr Forens Mental Hlth, Div Med Treatment & Rehabil, Chiba, Japan; [Oda, Yasunori; Hashimoto, Tasuku; Iyo, Masaomi] Chiba Univ, Grad Sch Med, Dept Psychiat, Chiba, Japan; [Hasegawa, Tadashi; Iyo, Masaomi] Chiba Univ Hosp, Dept Psychiat, Chiba 2608670, Japan; [Yoshida, Taisuke] Kisarazu Hosp, Chiba, Japan; [Iyo, Masaomi] Chiba Univ, Ctr Forens Mental Hlth, Chiba, Japan; [Hashimoto, Kenji] Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba, Japan	Shiina, A (reprint author), Chiba Univ Hosp, Dept Child Psychiat, Chuoh Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	shiina-akihiro@faculty.chiba-u.jp					American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Niitsu T, 2012, CURR PHARM DESIGN, V18, P875; Hammers D, 2011, AM J ALZHEIMERS DIS, V26, P326, DOI 10.1177/1533317511411907; Fredrickson J, 2010, NEUROEPIDEMIOLOGY, V34, P65, DOI 10.1159/000264823; Hashimoto K, 2013, PROG NEUROBIOL, V100, P15, DOI 10.1016/j.pneurobio.2012.09.001; Reddy R, 2011, ANTIOXID REDOX SIGN, V15, P2047, DOI 10.1089/ars.2010.3571; Yao JK, 2011, ANTIOXID REDOX SIGN, V15, P2011, DOI 10.1089/ars.2010.3603; Fahey JW, 2002, P NATL ACAD SCI USA, V99, P7610, DOI 10.1073/pnas.112203099; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261; Nuechterlein KH, 2008, AM J PSYCHIAT, V165, P203, DOI 10.1176/appi.ajp.2007.07010042; Chengappa KNR, 2012, SCHIZOPHR RES, V142, P145, DOI 10.1016/j.schres.2012.10.001; Wild K, 2008, ALZHEIMERS DEMENT, V4, P428, DOI 10.1016/j.jalz.2008.07.003; Saruwatari J, 2013, NEUROPSYCH DIS TREAT, V9, P1683, DOI 10.2147/NDT.S52585; Bitanihirwe BKY, 2011, NEUROSCI BIOBEHAV R, V35, P878, DOI 10.1016/j.neubiorev.2010.10.008; Lim YY, 2012, J CLIN EXP NEUROPSYC, V34, P345, DOI 10.1080/13803395.2011.643227; Falleti MG, 2006, J CLIN EXP NEUROPSYC, V28, P1095, DOI 10.1080/13803390500205718; Emsley R, 2002, AM J PSYCHIAT, V159, P1596, DOI 10.1176/appi.ajp.159.9.1596; Elvevag B, 2000, CRIT REV NEUROBIOL, V14, P1; Green MF, 2006, J CLIN PSYCHIAT, V67, P3; Juge N, 2007, CELL MOL LIFE SCI, V64, P1105, DOI 10.1007/s00018-007-6484-5; Llorca PM, 2008, PSYCHIAT RES, V161, P235, DOI 10.1016/j.psychres.2007.07.012; Chen HX, 2012, PSYCHOPHARMACOLOGY, V222, P37, DOI 10.1007/s00213-011-2619-3; Gubert C, 2013, J PSYCHIATR RES, V47, P1396, DOI 10.1016/j.jpsychires.2013.06.018; Pietrzak RH, 2009, HUM PSYCHOPHARM CLIN, V24, P113, DOI 10.1002/hup.998; Peet M, 2002, J PSYCHIAT RES, V36, P7, DOI 10.1016/S0022-3956(01)00048-6; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; Kern RS, 2008, AM J PSYCHIAT, V165, P214, DOI 10.1176/appi.ajp.2007.07010043; Yao JK, 2001, CNS DRUGS, V15, P287, DOI 10.2165/00023210-200115040-00004; Peet M, 2001, SCHIZOPHR RES, V49, P243, DOI 10.1016/S0920-9964(00)00083-9; Barch DM, 2012, TRENDS COGN SCI, V16, P27, DOI 10.1016/j.tics.2011.11.015; Berk M, 2008, BIOL PSYCHIAT, V64, P361, DOI [10.1016/j.biopsych.2008.03.004, 10.1016/j.biopsych.2008.03-004]; Harvey PD, 2001, AM J PSYCHIAT, V158, P176, DOI 10.1176/appi.ajp.158.2.176; Pietrzak RH, 2009, J CLIN EXP NEUROPSYC, V31, P848, DOI 10.1080/13803390802592458; Green MJ, 2011, MOL PSYCHIATR, V16, P960, DOI 10.1038/mp.2010.88; Robinson DG, 2002, SCHIZOPHR RES, V57, P209, DOI 10.1016/S0920-9964(01)00312-7; Lim YY, 2013, ARCH CLIN NEUROPSYCH, V28, P320, DOI 10.1093/arclin/act021; Zhang XY, 2012, SCHIZOPHR RES, V139, P66, DOI 10.1016/j.schres.2012.04.009; Fenton WS, 2001, AM J PSYCHIAT, V158, P2071, DOI 10.1176/appi.ajp.158.12.2071; Carlino D, 2013, NEUROSCIENTIST, V19, P345, DOI 10.1177/1073858412469444; Lieberman JA, 2013, NEUROPSYCHOPHARMACOL, V38, P968, DOI 10.1038/npp.2012.259; Mahadik SP, 2001, PROG NEURO-PSYCHOPH, V25, P463, DOI 10.1016/S0278-5846(00)00181-0; Hashimoto K, 2010, PSYCHIAT CLIN NEUROS, V64, P341, DOI 10.1111/j.1440-1819.2010.02113.x; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Darby DG, 2012, ALZHEIMERS DEMENT, V8, P95, DOI 10.1016/j.jalz.2010.12.009; Do KQ, 2010, WORLD REV NUTR DIET, V101, P131, DOI 10.1159/000314518; Huerta-Ramos E, 2014, EUR NEUROPSYCHOPHARM, V24, P223, DOI 10.1016/j.euroneuro.2013.11.012; Ibrahim BM, 2012, CURR PHARM BIOTECHNO, V13, P1587; Ichimura S, 2010, NEUROL MED-CHIR, V50, P441; Keefe RSE, 2013, SCHIZOPHRENIA BULL, V39, P417, DOI 10.1093/schbul/sbr153; Lane BY, 2013, JAMA PSYCHIAT, V70, P1267; Mas S, 2012, FUND CLIN PHARMACOL, V26, P712, DOI 10.1111/j.1472-8206.2011.00988.x; Meltzer HY, 1999, SCHIZOPHR B, V25, P233; Murthy NV, 2012, SCHIZOPHR RES, V139, P87, DOI 10.1016/j.schres.2012.01.042; Niitsu T, 2012, J CLIN PSYCHOPHARM, V32, P593, DOI 10.1097/JCP.0b013e3182664cfc; Nurjono Milawaty, 2012, Clin Psychopharmacol Neurosci, V10, P61, DOI 10.9758/cpn.2012.10.2.61; Pandya Chirayu D, 2013, Asian J Psychiatr, V6, P22, DOI 10.1016/j.ajp.2012.08.010; Shiina A, 2010, ANN GEN PSYCHIATR, V9, DOI 10.1186/1744-859X-9-27; Shirai Yumi, 2012, Clin Psychopharmacol Neurosci, V10, P94, DOI 10.9758/cpn.2012.10.2.94; Sumiyoshi T., 2013, FRONT BEHAV NEUROSCI, V16, P140; Busner Joan, 2007, Psychiatry (Edgmont), V4, P28; Wu JQ, 2014, SCHIZOPHR RES, V152, P210, DOI 10.1016/j.schres.2013.11.010; Yoshida T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020469; Yoshida T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042676; Zbang XY, 2001, J CLIN PSYCHIAT, V62, P878; Zhang XY, 2013, J PSYCHIATR RES, V47, P1049, DOI 10.1016/j.jpsychires.2013.03.014	65	2	2	KOREAN COLL NEUROPSYCHOPHARMACOLOGY	SEOUL	RN 1003 OFFICETEL 40, 63-RO YEONGDEUNGPO-GU, SEOUL, 150-731, SOUTH KOREA	1738-1088	2093-4327		CLIN PSYCHOPHARM NEU	Clin. Psychopharmacol. Neurosci.	APR	2015	13	1					62	67		10.9758/cpn.2015.13.1.62		6	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	CG9UB	WOS:000353664500007		
J	Takeuchi, I; Suzuki, T; Kishi, T; Kanamori, D; Hanya, M; Uno, J; Fujita, K; Kamei, H				Takeuchi, Ippei; Suzuki, Tatsuyo; Kishi, Taro; Kanamori, Daisuke; Hanya, Manako; Uno, Junji; Fujita, Kiyoshi; Kamei, Hiroyuki			Effect of Scopolamine Butylbromide on Clozapine-induced Hypersalivafion in Schizophrenic Patients: A Case Series	CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE			English	Article						Clozapine; Schizophrenia; Hypersalivation; Sialorrhea; Scopolamine butylbromide	N-DESMETHYLCLOZAPINE; TRIHEXYPHENIDYL; OLANZAPINE; DRUGS	Clozapine has been demonstrated to be useful for treating refractory schizophrenia. However, hypersalivation occurs in 31.0-97.4% of the patients treated with clozapine. Accordingly, some patients who are disturbed by their hypersalivation refuse to continue with clozapine treatment. This study investigated the efficacy of the anticholinergic agent scopolamine butylbromide against clozapine-induced hypersalivation. Five schizophrenia patients were coadministered scopolamine butylbromide (30-60 mg/day) for 4 weeks. At the baseline and after 4 weeks' treatment, we subjectively evaluated hypersalivation using a visual analog scale and objectively assessed it using the Drooling Severity Scale and Drooling Frequency Scale. As a result, improvements in the patients' Drooling Severity Scale and Drooling Frequency Scale scores, but no improvements in their visual analog scale scores, were observed after scopolamine butylbromide treatment. These results indicate that at least some schizophrenic patients with clozapine-induced hypersalivation would benefit from scopolamine butylbromide treatment. We conclude that clozapine-induced hypersalivation is one factor of stress to patients. Subjective hypersalivation was not improved, but objective hypersalivation was, by scopolamine butylbromide treatment. However, scopolamine butylbromide and clozapine possess anticholinergic effects so clinicians should closely monitor patients who take scopolamine butylbromide.	[Takeuchi, Ippei; Suzuki, Tatsuyo; Kishi, Taro; Kanamori, Daisuke; Uno, Junji; Fujita, Kiyoshi] Okehazama Hosp, Dept Psychiat, Toyoake, Aichi 4701168, Japan; [Takeuchi, Ippei; Hanya, Manako; Kamei, Hiroyuki] Meijo Univ, Fac Pharm, Off Clin Pharm Practice & Hlth Care Management, Nagoya, Aichi 468, Japan	Takeuchi, I (reprint author), Okehazama Hosp, Dept Psychiat, Minamiyakata 3-879,Sakae Cho, Toyoake, Aichi 4701168, Japan.	134331503@ccalumni.meijo-u.ac.jp					ZORN SH, 1994, EUR J PHARM-MOLEC PH, V269, pR1, DOI 10.1016/0922-4106(94)90047-7; Raufman JP, 2011, CARCINOGENESIS, V32, P1396, DOI 10.1093/carcin/bgr118; Weiner DM, 2004, PSYCHOPHARMACOLOGY, V177, P207, DOI 10.1007/s00213-004-1940-5; Tollefson GD, 2001, BIOL PSYCHIAT, V49, P52, DOI 10.1016/S0006-3223(00)01026-X; Bymaster FP, 1996, NEUROPSYCHOPHARMACOL, V14, P87, DOI 10.1016/0893-133X(94)00129-N; Nielsen J, 2010, J PSYCHOPHARMACOL, V24, P965, DOI 10.1177/0269881108100320; Ancelin ML, 2006, BRIT MED J, V332, P455, DOI 10.1136/bmj.38740.439664.DE; Calderon J, 2000, INT CLIN PSYCHOPHARM, V15, P49, DOI 10.1097/00004850-200015010-00008; Davydov L, 2000, ANN PHARMACOTHER, V34, P662, DOI 10.1345/aph.19259; Kishi Taro, 2013, Asian J Psychiatr, V6, P200, DOI 10.1016/j.ajp.2012.10.007; Leung Jonathan G, 2011, Ann Pharmacother, V45, pe45, DOI 10.1345/aph.1Q270; Li Z, 2005, NEUROPSYCHOPHARMACOL, V30, P1986, DOI 10.1038/sj.npp.1300768; McKane JP, 2001, PSYCHIAT B, V25, P277, DOI 10.1192/pb.25.7.277-c; Praharaj SK, 2010, PSYCHOPHARMACOL BULL, V43, P73; Schneider B, 2004, PHARMACOPSYCHIATRY, V37, P43; Spivak B, 1997, INT CLIN PSYCHOPHARM, V12, P213, DOI 10.1097/00004850-199707000-00005; Zeng XP, 1997, EUR J PHARMACOL, V321, P349, DOI 10.1016/S0014-2999(96)00956-9	17	0	0	KOREAN COLL NEUROPSYCHOPHARMACOLOGY	SEOUL	RN 1003 OFFICETEL 40, 63-RO YEONGDEUNGPO-GU, SEOUL, 150-731, SOUTH KOREA	1738-1088	2093-4327		CLIN PSYCHOPHARM NEU	Clin. Psychopharmacol. Neurosci.	APR	2015	13	1					109	112		10.9758/cpn.2015.13.1.109		4	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	CG9UB	WOS:000353664500012		
J	Yang, C; Hashimoto, K				Yang, Chun; Hashimoto, Kenji			Combination of Nitrous Oxide with Isoflurane or Scopolamine for Treatment-resistant Major Depression	CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE			English	Letter							KETAMINE; NEURONS		[Yang, Chun; Hashimoto, Kenji] Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba 2608670, Japan	Hashimoto, K (reprint author), Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, 1-8-1 Inohana, Chiba 2608670, Japan.	hashimoto@faculty.chiba-u.jp					Sanders RD, 2008, ANESTHESIOLOGY, V109, P707, DOI 10.1097/ALN.0b013e3181870a17; Drevets WC, 2013, BIOL PSYCHIAT, V73, P1156, DOI 10.1016/j.biopsych.2012.09.031; Petrenko AB, 2014, EUR J PHARMACOL, V723, P29, DOI 10.1016/j.ejphar.2013.11.039; OLNEY JW, 1989, SCIENCE, V244, P1360, DOI 10.1126/science.2660263; Hashimoto K, 2014, CLIN PSYCHOPHARM NEU, V12, P72, DOI 10.9758/cpn.2014.12.1.72; Yang C, 2014, PSYCHOPHARMACOLOGY, V231, P2041, DOI 10.1007/s00213-014-3543-0; Murrough JW, 2013, AM J PSYCHIAT, V170, P1134, DOI 10.1176/appi.ajp.2013.13030392; OLNEY JW, 1991, SCIENCE, V254, P1515, DOI 10.1126/science.1835799; Krystal JH, 2013, BIOL PSYCHIAT, V73, P1133, DOI 10.1016/j.biopsych.2013.03.026; Jevtovic-Todorovic V, 2003, NEUROSCIENCE, V122, P609, DOI 10.1016/j.neuroscience.2003.07.012; Kuhlmann L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056434; Nagele P, 2014, BIOL PSYCHIAT, DOI [10.1016/1biopsych.2014.11.016, DOI 10.1016/1BI0PSYCH.2014.11.016.LEPUB]; Shah A, 2014, CLIN PSYCHOPHARM NEU, V12, P83, DOI 10.9758/cpn.2014.12.2.83; Weeks HR, 2013, PLOS ONE, V8	14	0	0	KOREAN COLL NEUROPSYCHOPHARMACOLOGY	SEOUL	RN 1003 OFFICETEL 40, 63-RO YEONGDEUNGPO-GU, SEOUL, 150-731, SOUTH KOREA	1738-1088	2093-4327		CLIN PSYCHOPHARM NEU	Clin. Psychopharmacol. Neurosci.	APR	2015	13	1					118	120		10.9758/cpn.2015.13.1.118		3	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	CG9UB	WOS:000353664500015		
J	Pu, LLQ; Yoshimura, K; Coleman, SR				Pu, Lee L. Q.; Yoshimura, Kotaro; Coleman, Sydney R.			Fat Grafting: Current Concept, Clinical Application, and Regenerative Potential, Part 1 Preface	CLINICS IN PLASTIC SURGERY			English	Editorial Material									[Pu, Lee L. Q.] Univ Calif Davis, Sacramento, CA 95817 USA; [Yoshimura, Kotaro] Univ Tokyo, Tokyo, Japan; [Coleman, Sydney R.] NYU, New York, NY USA; [Coleman, Sydney R.] Univ Pittsburgh, Pittsburgh, PA USA	Pu, LLQ (reprint author), Univ Calif Davis, Sacramento, CA 95817 USA.	lee.pu@ucdmc.ucdavis.edu; kotaro-yoshimura@umin.ac.jp; sydcoleman@me.com						0	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0094-1298	1558-0504		CLIN PLAST SURG	Clin. Plast. Surg.	APR	2015	42	2					IX	X		10.1016/j.cps.2015.02.001		2	Surgery	Surgery	CG9AR	WOS:000353607300001		
J	Mashiko, T; Yoshimura, K				Mashiko, Takanobu; Yoshimura, Kotaro			How Does Fat Survive and Remodel After Grafting?	CLINICS IN PLASTIC SURGERY			English	Article						Fat grafting; Adipose-derived stem/stromal cell; Tissue regeneration; Macrophages; Vascular endothelial cells	ADIPOSE-TISSUE; GROWTH-FACTOR; CELLS; TRANSPLANTATION; REGENERATION; SURGERY	Autologous fat grafting has become an important procedure for volumization and revitalization, although clinical outcomes depend greatly on technique. It was revealed recently how grafted fat tissue survives, regenerates, or dies. Experimental results provided the underlying mechanism and clinical implications for therapeutic strategies to maximize the effects of fat grafting, minimize necrosis, and avoid oil cyst formation.	[Mashiko, Takanobu; Yoshimura, Kotaro] Univ Tokyo, Sch Med, Dept Plast Surg, Bunkyo Ku, Tokyo 1138655, Japan	Yoshimura, K (reprint author), Univ Tokyo, Sch Med, Dept Plast Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kotaro-yoshimura@umin.ac.jp					Ogura F, 2014, STEM CELLS DEV, V23, P717, DOI 10.1089/scd.2013.0473; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61; Eto H, 2009, PLAST RECONSTR SURG, V124, P1087, DOI 10.1097/PRS.0b013e3181b5a3f1; Suga H, 2009, BRIT J DERMATOL, V161, P819, DOI 10.1111/j.1365-2133.2009.09272.x; SMAHEL J, 1986, ANN PLAS SURG, V16, P444; Eto H, 2012, PLAST RECONSTR SURG, V129, P1081, DOI 10.1097/PRS.0b013e31824a2b19; Suga H, 2009, STEM CELLS, V27, P238, DOI 10.1634/stemcells.2008-0261; Eto H, 2011, AM J PATHOL, V178, P2322, DOI 10.1016/j.ajpath.2011.01.032; BILLINGS E, 1989, PLAST RECONSTR SURG, V83, P368, DOI 10.1097/00006534-198902000-00033; Mineda K, 2014, PLAST RECONSTR SURG, V133, P1064, DOI 10.1097/PRS.0000000000000097; Cortese A, 2000, J ORAL MAXIL SURG, V58, P164, DOI 10.1016/S0278-2391(00)90331-8; Doi K, PLAST RECON IN PRESS; Kato H, 2010, TISSUE ENG PT A, V16, P2029, DOI 10.1089/ten.TEA.2009.0551; Kato H, 2014, PLAST RECONSTR SURG, V134, P951, DOI 10.1097/PRS.0000000000000600; Kato H, 2014, PLAST RECONSTR SURG, V133, p303E, DOI 10.1097/PRS.0000000000000066; Khouri RK, 2000, PLAST RECONSTR SURG, V105, P2500, DOI 10.1097/00006534-200006000-00032; Yoshimura Kotaro, 2011, Regen Med, V6, P33, DOI 10.2217/rme.11.62	18	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0094-1298	1558-0504		CLIN PLAST SURG	Clin. Plast. Surg.	APR	2015	42	2					181	+		10.1016/j.cps.2014.12.008		11	Surgery	Surgery	CG9AR	WOS:000353607300005		
J	Kuno, S; Yoshimura, K				Kuno, Shinichiro; Yoshimura, Kotaro			Condensatiion of Tissue and Stem Cells for Fat Grafting	CLINICS IN PLASTIC SURGERY			English	Article						Fat grafting; Cell assisted lipotransfer; Adipose-derived stem/stromal cell; Tissue regeneration; Macrophages; Vascular endothelial cells	STROMAL-VASCULAR FRACTION; ADIPOSE-TISSUE; ASSISTED LIPOTRANSFER; BREAST RECONSTRUCTION; SUPPORTIVE USE; TRANSPLANTATION; AUGMENTATION; CENTRIFUGATION; LIPOINJECTION; FIBROGENESIS	Aspirated fat contains unnecessary components such as water, oil, and blood cells. For better outcomes, tissue purification and condensation are useful, especially when injection volume to the recipient site is limited. Because aspirated fat is relatively poor in adipose-derived stem/stromal cells (ASCs), ASC condensation seems important for obtaining better regeneration and retention. Reducing tissue volume by removing some adipocytes or supplementation of stromal vascular fraction or ASCs can increase the ASC/adipocyte ratio in the graft. Clinical results of ASC supplementation remain controversial, but ASC condensation seems to lead to expanding applications of fat grafting into revitalization of stem cell-depleted tissue.	[Kuno, Shinichiro; Yoshimura, Kotaro] Univ Tokyo, Sch Med, Dept Plast Surg, Bunkyo Ku, Tokyo 1138655, Japan	Yoshimura, K (reprint author), Univ Tokyo, Sch Med, Dept Plast Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kotaro-yoshimura@umin.ac.jp					Salgarello M, 2012, PLAST RECONSTR SURG, V129, P317, DOI 10.1097/PRS.0b013e31822b6619; Chang Q, 2013, DERMATOL SURG, V39, P1465, DOI 10.1111/dsu.12310; Kurita M, 2008, PLAST RECONSTR SURG, V121, P1033, DOI 10.1097/01.prs.0000299384.53131.87; Caviggioli F, 2011, PLAST RECONSTR SURG, V128, P349, DOI 10.1097/PRS.0b013e31821e70e7; Yoshimura K, 2008, AESTHET PLAST SURG, V32, P48, DOI 10.1007/s00266-007-9019-4; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859; Yoshimura K, 2010, BREAST J, V16, P169, DOI 10.1111/j.1524-4741.2009.00873.x; Tiryaki T, 2011, AESTHET PLAST SURG, V35, P965, DOI 10.1007/s00266-011-9716-x; Tanikawa DYS, 2013, PLAST RECONSTR SURG, V132, P141, DOI 10.1097/PRS.0b013e3182910a82; Yoshimura K, 2009, REGEN MED, V4, P265, DOI 10.2217/17460751.4.2.265; Sterodimas A, 2011, AESTHET SURG J, V31, P682, DOI 10.1177/1090820X11415976; Eto H, 2012, PLAST RECONSTR SURG, V129, P1081, DOI 10.1097/PRS.0b013e31824a2b19; Suga H, 2009, STEM CELLS, V27, P238, DOI 10.1634/stemcells.2008-0261; Kolle SFT, 2013, LANCET, V382, P1113, DOI 10.1016/S0140-6736(13)61410-5; Gentile P, 2014, J CRANIOFAC SURG, V25, P267, DOI 10.1097/01.scs.0000436746.21031.ba; Gentile P, 2012, STEM CELL TRANSL MED, V1, P341, DOI 10.5966/sctm.2011-0065; Peltoniemi HH, 2013, J PLAST RECONSTR AES, V66, P1494, DOI 10.1016/j.bjps.2013.06.002; Matsumoto D, 2006, TISSUE ENG, V12, P3375, DOI 10.1089/ten.2006.12.3375; Yoshimura K, 2008, TRANSPLANTATION, V85, P1868, DOI 10.1097/TP.0b013e3181775136; Yoshimura K, 2008, DERMATOL SURG, V34, P1178, DOI 10.1111/j.1524-4725.2008.34256.x; Kuroda Y, 2010, P NATL ACAD SCI USA, V107, P8639, DOI 10.1073/pnas.0911647107; Yoshimura K, 2006, J CELL PHYSIOL, V208, P64, DOI 10.1002/jcp.20636; De Miguel MP, 2012, CURR MOL MED, V12, P574; Kim IH, 2009, AESTHET SURG J, V29, P35, DOI 10.1016/j.asj.2008.09.004; Castro-Govea Yanko, 2012, Arch Plast Surg, V39, P659, DOI 10.5999/aps.2012.39.6.659; Doi K, PLAST RECON IN PRESS; Kato H, 2014, PLAST RECONSTR SURG, V133, p303E, DOI 10.1097/PRS.0000000000000066; Rigotti G, 2007, PLAST RECONSTR SURG, V119, P1409, DOI 10.1097/01.prs.0000256047.47909.71; Wang L, 2014, ANN PLAST SURG	29	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0094-1298	1558-0504		CLIN PLAST SURG	Clin. Plast. Surg.	APR	2015	42	2					191	+		10.1016/j.cps.2014.12.006		9	Surgery	Surgery	CG9AR	WOS:000353607300006		
J	Hashimoto, H; Takabatake, S; Miyaguchi, H; Nakanishi, H; Naitou, Y				Hashimoto, Hiroko; Takabatake, Shinichi; Miyaguchi, Hideki; Nakanishi, Hajime; Naitou, Yasuo			Effects of dance on motor functions, cognitive functions, and mental symptoms of Parkinson's disease: A quasi-randomized pilot trial	COMPLEMENTARY THERAPIES IN MEDICINE			English	Article						Parkinson's disease; Dance; Motor functions; Cognitive functions; Mental symptoms; Rehabilitation	QUALITY-OF-LIFE; INDIVIDUALS; MOVEMENT; MOBILITY; THERAPY; BALANCE; IMAGERY; SCALE; TANGO; GO	Objective: To examine the effectiveness of dance on motor functions, cognitive functions, and mental symptoms of Parkinson's disease (PD). Design: This study employed a quasi-randomised, between-group design. Setting: Dance, PD exercise, and all assessments were performed in community halls in different regions of Japan. Participants: Forty-six mild-moderate PD patients participated. Intervention: Six PD patient associations that agreed to participate in the study were randomly assigned to a dance group, PD exercise group, or non-intervention group. The dance and PD exercise groups performed one 60-min session per week for 12 weeks. Control group patients continued with their normal lives. All groups were assessed before and after the intervention. Main outcome measures: We used the Timed Up-and-Go Test (TUG) and Berg Balance Scale (BBS) to assess motor function, the Frontal Assessment Battery at bedside (FAB) and Mental Rotation Task (MRT) to assess cognitive function, and the Apathy Scale (AS) and Self-rating Depression Scale (SDS) to assess mental symptoms of PD. The Unified Parkinson's Disease Rating Scale (UPDRS) was used for general assessment of PD. Results: When comparing results before and after intervention, the dance group showed a large effect in TUG time (ES = 0.65, p = 0.006), TUG step number (ES = 0.66, p = 0.005), BBS (ES = 0.75, p = 0.001), FAB (ES = 0.77, p = 0.001), MRT response time (ES = 0.79, p < 0.001), AS (ES = 0.78, p < 0.001), SDS (ES = 0.66, p = 0.006) and UPDRS (ES = 0.88, p < 0.001). Conclusions: Dance was effective in improving motor function, cognitive function, and mental symptoms in PD patients. General symptoms in PD also improved. Dance is an effective method for rehabilitation in PD patients. (C) 2015 Elsevier Ltd. All rights reserved.	[Hashimoto, Hiroko] Aino Univ, Sch Nursing & Rehabil, Dept Occupat Therapy, Ibaraki, Osaka 5670012, Japan; [Hashimoto, Hiroko; Takabatake, Shinichi; Naitou, Yasuo] Osaka Prefecture Univ, Grad Sch Comprehens Rehabil, Osaka, Japan; [Miyaguchi, Hideki] Hiroshima Univ, Grad Sch Hlth Sci, Hiroshima, Japan; [Nakanishi, Hajime] Hiroshima Univ Hosp, Dept Clin Support, Hiroshima, Japan	Hashimoto, H (reprint author), Aino Univ, Fac Hlth Sci, Dept Occupat Therapy, 4-5-4 Higashiohta, Ibaraki, Osaka 5670012, Japan.	h-hashimoto@ot-u.aino.ac.jp					Helmich RC, 2007, NEUROPSYCHOLOGIA, V45, P2201, DOI 10.1016/j.neuropsychologia.2007.02.024; Cross ES, 2006, NEUROIMAGE, V31, P1257, DOI 10.1016/j.neuroimage.2006.01.033; Schrag A, 2000, MOVEMENT DISORD, V15, P1112, DOI 10.1002/1531-8257(200011)15:6<1112::AID-MDS1008>3.0.CO;2-A; Hackney ME, 2009, COMPLEMENT THER MED, V17, P203, DOI 10.1016/j.ctim.2008.10.005; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V13, P508; Hackney ME, 2009, PARKINSONISM RELAT D, V15, P644, DOI 10.1016/j.parkreldis.2009.03.003; Schrag A, 2000, J NEUROL NEUROSUR PS, V69, P308, DOI 10.1136/jnnp.69.3.308; Earhart GM, 2009, EUR J PHYS REHAB MED, V45, P231; Dubois B, 2000, NEUROLOGY, V55, P1621; KARVONEN MJ, 1957, ANN MED EXP BIOL FEN, V35, P307; Westheimer O, 2008, TOP GERIATR REHABIL, V24, P127; Sacco K, 2006, NEUROIMAGE, V32, P1441, DOI 10.1016/j.neuroimage.2006.05.018; Okada K, 1997, STROKE, V28, P2437; Hackney ME, 2009, J REHABIL MED, V41, P475, DOI 10.2340/16501977-0362; Hackney ME, 2010, NEUROREHAB NEURAL RE, V24, P384, DOI 10.1177/1545968309353329; Keus SHJ, 2007, MOVEMENT DISORD, V22, P451, DOI 10.1002/mds.21244; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; BERG K, 1995, SCAND J REHABIL MED, V27, P27; Brown S, 2008, SCI AM, V299, P78; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Fahn S, 1987, RECENT DEV PARKINSON, V2, P153; Hackney ME, 2010, DISABIL REHABIL, V32, P672; Hackney Madeleine E, 2007, J Neurol Phys Ther, V31, P173, DOI 10.1097/NPT.0b013e31815ce78b; Harris J., 2008, WORKSH HELD ENGL NAT; Hashimoto H, 2014, NEURODANCE EXERCISE, P68; Heiberger L, 2011, FRONT AGING NEUROSCI, V3, DOI 10.3389/fnagi.2011.00014; Kattenstroth JC, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00031; Kim EunBi, 2014, Japanese Journal of Sport Psychology, V41, P19; LESTE A, 1984, PERCEPT MOTOR SKILL, V58, P767; Lewis C, 2014, J HLTH PSYCHOL, V21; Marchant D, 2010, COMPLEMENT THER MED, V18, P184, DOI 10.1016/j.ctim.2010.07.004; Marin R.S., 1991, PSYCHIAT RES, V38, P143; Nadasen K, 2008, J WOMEN AGING, V20, P329, DOI 10.1080/08952840801985060; Nakanishi H, 2014, NEURODANCE EXERCISE, P61; Oota H., 2011, REHABILITATION PHYS, P76; Palo-Bengtsson L, 1997, Sch Inq Nurs Pract, V11, P101; Peyton JL, 2005, J CHILD NEUROL, V20, P817, DOI 10.1177/08830738050200100701; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142; Stegemoller EL, 2014, ARCH PHYS MED REHAB, V95, P649, DOI 10.1016/j.apmr.2013.10.031; Takabatake S, 2009, JPN J OSAKA OCCUP TH, V23, P57; Takakusaki K., 2009, CLIN NEUROL, V49, P325	41	2	2	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0965-2299	1873-6963		COMPLEMENT THER MED	Complement. Ther. Med.	APR	2015	23	2					210	219		10.1016/j.ctim.2015.01.010		10	Integrative & Complementary Medicine	Integrative & Complementary Medicine	CH0TE	WOS:000353734500009		
J	Matsuoka, S; Yamashiro, T; Kotoku, A; Matsushita, S; Fujikawa, A; Yagihashi, K; Kurihara, Y; Nakajima, Y				Matsuoka, Shin; Yamashiro, Tsuneo; Kotoku, Akiyuki; Matsushita, Shoichiro; Fujikawa, Atsuko; Yagihashi, Kunihiro; Kurihara, Yasuyuki; Nakajima, Yasuo			Changes in the Superior Vena Cava Area During Inspiration and Expiration in Relation to Emphysema	COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE			English	Article						Computed tomography; hyperinflation; hemodynamics; intrathoracic pressure; venous return; expiration	OBSTRUCTIVE PULMONARY-DISEASE; VOLUME REDUCTION SURGERY; VENOUS RETURN; BLOOD-FLOW; DOPPLER-ECHOCARDIOGRAPHY; HEMODYNAMIC-RESPONSE; EXERCISE; COPD; HYPERINFLATION; HYPERTENSION	Background: In patients with emphysema, increased intrathoracic pressure is closely related to hyperinflation and leads to hemodynamic impairments. Both intrathoracic pressure and hemodynamics such as venous return are affected by the respiratory phase. Therefore, respiratory variations in hemodynamics may be associated with the extent of emphysema that causes increased intrathoracic pressure. The current study was designed to evaluate the relationship between respiratory phasic variations in the area of the superior vena cava (SVC) and the extent of emphysema. Methods: We measured the SVC area and calculated the ratio of the SVC area in inspiratory and expiratory scans (i/e-SVC ratio) in 101 patients with emphysema who underwent both inspiratory and expiratory CT. The correlation of the i/e-SVC ratio with the extent of emphysema (%LAA) obtained by CT images was evaluated. Multiple linear regression analysis using i/e-SVC ratio as the dependent variable was performed. Results: The i/e-SVC ratio had a significant positive correlation with %LAA (rho = 0.582, p < 0.0001). The i/e-SVC ratio was significantly higher in patients with severe emphysema (0.86 +/- 0.13) than in patients with mild-moderate emphysema (0.69 +/- 0.13) ( p < 0.0001). Multiple linear regression analysis showed that %LAA was the only independent predictors of the i/e-SVC ratio (r(2) = 0.471, p = 0.0006). Conclusion: Respiratory phasic variations in the SVC area are significantly correlated with the extent of emphysema.	[Matsuoka, Shin; Yamashiro, Tsuneo; Kotoku, Akiyuki; Matsushita, Shoichiro; Fujikawa, Atsuko; Yagihashi, Kunihiro; Kurihara, Yasuyuki; Nakajima, Yasuo] St Marianna Univ, Sch Med, Dept Radiol, Kawasaki, Kanagawa 2168511, Japan; [Yamashiro, Tsuneo] Univ Ryukyus, Grad Sch Med Sci, Dept Radiol, Nishihara, Okinawa 90301, Japan; [Yagihashi, Kunihiro] Univ Colorado, Sch Med, Natl Jewish Hlth, Dept Radiol, Denver, CO 80202 USA	Matsuoka, S (reprint author), St Marianna Univ, Sch Med, Dept Radiol, Miyamae Ku, 2-16-1 Sugao, Kawasaki, Kanagawa 2168511, Japan.	shin4114@mac.com					Barr RG, 2007, AM J RESP CRIT CARE, V176, P1200, DOI 10.1164/rccm.200707-980OC; Bogaard HJ, 1998, EUR RESPIR J, V12, P374, DOI 10.1183/09031936.98.12020374; Kubo K, 2000, RESP PHYSIOL, V120, P71, DOI 10.1016/S0034-5687(00)00090-6; GRANT E, 1980, AM J ROENTGENOL, V135, P335; Peinado VI, 1999, AM J RESP CRIT CARE, V159, P1605; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Watz H, 2010, CHEST, V138, P32, DOI 10.1378/chest.09-2810; Yamashiro T, 2010, ACAD RADIOL, V17, P489, DOI 10.1016/j.acra.2009.11.004; Ferguson Gary T, 2006, Proc Am Thorac Soc, V3, P176, DOI 10.1513/pats.200508-094DO; GUYTON AC, 1957, AM J PHYSIOL, V189, P609; NATORI H, 1979, AM REV RESPIR DIS, V120, P421; Peinado VI, 1998, AM J PHYSIOL-LUNG C, V274, pL908; BARBERA JA, 1994, AM J RESP CRIT CARE, V149, P423; Jellinek H, 2000, CRIT CARE MED, V28, P672, DOI 10.1097/00003246-200003000-00012; Jorgensen K, 2007, CHEST, V131, P1050, DOI 10.1378/chest.06-2245; Kuzo RS, 2007, AM J ROENTGENOL, V188, P839, DOI 10.2214/AJR.06.5035; Jorgensen K, 2003, CHEST, V124, P1863, DOI 10.1378/chest.124.5.1863; Matsuoka S, 2010, AM J RESP CRIT CARE, V181, P218, DOI 10.1164/rccm.200908-1189OC; WEXLER L, 1968, CIRC RES, V23, P349; Barr RG, 2010, NEW ENGL J MED, V362, P217, DOI 10.1056/NEJMoa0808836; APPLETON CP, 1987, J AM COLL CARDIOL, V10, P1032; BLAUSTEIN AS, 1986, J AM COLL CARDIOL, V8, P529; Boerrigter B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030208; BRECHER GA, 1955, CIRC RES, V3, P210; BRECHER GA, 1953, AM J PHYSIOL, V172, P457; CHERIYAN AF, 1995, AM J RESP CRIT CARE, V151, P851; COURNAND A, 1948, AM J PHYSIOL, V152, P162; Falk JA, 2007, CHEST, V132, P1476, DOI 10.1378/chest.07-0041; Guyton AC, 1973, CARDIAC OUTPUT ITS R, V2nd, P178; IZUMI S, 1994, INTERNAL MED, V33, P326, DOI 10.2169/internalmedicine.33.326; Kimura BJ, 2011, EUR J ECHOCARDIOGR, V12, DOI 10.1093/ejechocard/jeq157; NAKHJAVA.FK, 1966, CIRCULATION, V33, P8; ROBOTHAM JL, 1980, AM REV RESPIR DIS, V121, P677; SANTAMORE WP, 1994, AM J PHYSIOL-HEART C, V267, pH2163; Smith BM, 2013, CIRCULATION, V127, P1503, DOI 10.1161/CIRCULATIONAHA.113.001653; Tschernko EM, 1998, AM J RESP CRIT CARE, V158, P1424	36	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1541-2555	1541-2563		COPD	COPD-J. Chronic Obstr. Pulm. Dis.	APR	2015	12	2					168	174		10.3109/15412555.2014.922171		7	Respiratory System	Respiratory System	CH3JB	WOS:000353925900008		
J	Noguchi, Y; Kimijima, S; Kakigi, R				Noguchi, Yasuki; Kimijima, Shintaro; Kakigi, Ryusuke			Direct behavioral and neural evidence for an offset-triggered conscious perception	CORTEX			English	Article						Continuous flash suppression; Magnetoencephalography; Psychophysics; Subliminal stimuli; Ventral visual pathway	MOTION-INDUCED BLINDNESS; LATERAL GENICULATE-NUCLEUS; PRIMARY VISUAL-CORTEX; TEMPORAL DYNAMICS; BINOCULAR-RIVALRY; OBJECT RECOGNITION; VENTRAL STREAM; AWARENESS; MASKING; INTEGRATION	Many previous theories of perceptual awareness assume that a conscious representation of a stimulus is created from sensory information carried by an onset (appearance) of the stimulus. In contrast, here we provide behavioral and neural evidence for a new phenomenon in which conscious perception is directly triggered by an offset (disappearance) of a stimulus. When a stimulus made invisible by inter-ocular suppression physically disappeared from a screen, subjects reported an appearance (not disappearance) of that stimulus, correctly reporting a color of the disappeared stimulus. Measurements of brain activity further confirmed that the physical offset of an invisible stimulus evoked neural activity reflecting conscious perception of that stimulus. Those results indicate a new role of a stimulus offset to facilitate (rather than inhibit) an emergence of consciousness. (C) 2015 Elsevier Ltd. All rights reserved.	[Noguchi, Yasuki; Kimijima, Shintaro] Kobe Univ, Dept Psychol, Kobe, Hyogo 6578501, Japan; [Kakigi, Ryusuke] Natl Inst Physiol Sci, Dept Integrat Physiol, Okazaki, Aichi 444, Japan	Noguchi, Y (reprint author), Kobe Univ, Dept Psychol, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.	ynoguchi@lit.kobe-u.ac.jp			Japan Society for the Promotion of Science (JSPS) for Young Scientists [22680022, 26700011]	This work was supported by KAKENHI Grants (grant numbers: 22680022 and 26700011) from the Japan Society for the Promotion of Science (JSPS) for Young Scientists to Y.N. We thank Mr Y. Takeshima (National Institute for Physiological Sciences, Japan) for his technical supports.	Altmann CF, 2008, CEREB CORTEX, V18, P1350, DOI 10.1093/cercor/bhm166; de Graaf TA, 2012, NEUROSCI BIOBEHAV R, V36, P191, DOI 10.1016/j.neubiorev.2011.05.012; Enns JT, 2000, TRENDS COGN SCI, V4, P345, DOI 10.1016/S1364-6613(00)01520-5; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Lee SH, 2005, NAT NEUROSCI, V8, P22, DOI 10.1038/nn1365; Tsuchiya N, 2005, NAT NEUROSCI, V8, P1096, DOI 10.1038/nn1500; Schlag J, 2002, NAT REV NEUROSCI, V3, P191, DOI 10.1038/nrn750; Koivisto M, 2010, NEUROSCI BIOBEHAV R, V34, P922, DOI 10.1016/j.neubiorev.2009.12.002; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Tononi G, 2008, ANN NY ACAD SCI, V1124, P239, DOI 10.1196/annals.1440.004; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Cichy RM, 2014, NAT NEUROSCI, V17, P455, DOI 10.1038/nn.3635; COLTHEART M, 1980, PERCEPT PSYCHOPHYS, V27, P183, DOI 10.3758/BF03204258; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Noguchi Y, 2006, CEREB CORTEX, V16, P1797, DOI 10.1093/cercor/bhj117; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; Block N, 2005, TRENDS COGN SCI, V9, P46, DOI 10.1016/j.tics.2004.12.006; Fisch L, 2009, NEURON, V64, P562, DOI 10.1016/j.neuron.2009.11.001; Francis G, 2008, J EXP PSYCHOL HUMAN, V34, P1116, DOI 10.1037/0096-1523.34.5.1116; Wunderlich K, 2005, NAT NEUROSCI, V8, P1595, DOI 10.1038/nn1554; Crick F, 2003, NAT NEUROSCI, V6, P119, DOI 10.1038/nn0203-119; Wu CT, 2009, CURR BIOL, V19, P2003, DOI 10.1016/j.cub.2009.10.017; Kinoshita M, 2001, J NEUROPHYSIOL, V86, P2559; Lin ZC, 2009, PROG NEUROBIOL, V87, P195, DOI 10.1016/j.pneurobio.2008.09.002; Aru J, 2012, NEUROSCI BIOBEHAV R, V36, P737, DOI 10.1016/j.neubiorev.2011.12.003; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Haynes JD, 2005, NATURE, V438, P496, DOI 10.1038/nature04169; Lamme VAF, 2003, TRENDS COGN SCI, V7, P12, DOI 10.1016/S1364-6613(02)00013-X; IRWIN DE, 1986, J EXP PSYCHOL HUMAN, V12, P343, DOI 10.1037//0096-1523.12.3.343; Kouider S, 2013, SCIENCE, V340, P376, DOI 10.1126/science.1232509; NIJHAWAN R, 1994, NATURE, V370, P256, DOI 10.1038/370256b0; Baars BJ, 2005, PROG BRAIN RES, V150, P45, DOI 10.1016/S0079-6123(05)50004-9; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Nishitani N, 2002, NEURON, V36, P1211, DOI 10.1016/S0896-6273(02)01089-9; DILOLLO V, 1980, J EXP PSYCHOL GEN, V109, P75, DOI 10.1037/0096-3445.109.1.75; Eagleman DM, 2000, SCIENCE, V287, P2036, DOI 10.1126/science.287.5460.2036; Francis G, 2004, SPATIAL VISION, V17, P163, DOI 10.1163/1568568041865962; Greene E, 2007, PERCEPT PSYCHOPHYS, V69, P772, DOI 10.3758/BF03193778; KAHNEMAN D, 1967, PERCEPT PSYCHOPHYS, V2, P577, DOI 10.3758/BF03210272; Klotz W, 2007, PSYCHOL RES-PSYCH FO, V71, P694, DOI 10.1007/s00426-006-0058-2; Kramer P, 2013, BEHAV RES METHODS, V45, P267, DOI 10.3758/s13428-012-0246-5; Krekelberg B, 2000, Science, V289, P1107; Lleras A, 2006, PSYCHOL SCI, V17, P876, DOI 10.1111/j.1467-9280.2006.01797.x; Macknik SL, 2006, PROG BRAIN RES, V155, P177, DOI 10.1016/S0079-6123(06)55011-3; Mitroff SR, 2004, PERCEPTION, V33, P1267, DOI 10.1068/p5341; Montaser-Kouhsari L, 2004, PERCEPTION, V33, P249, DOI 10.1068/p5174; Noguchi Y, 2004, J NEUROSCI, V24, P6283, DOI 10.1523/JNEUROSCI.0655-04.2004; Noguchi Y, 2012, J COGNITIVE NEUROSCI, V24, P1983, DOI 10.1162/jocn_a_00262; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1; Suzuki M, 2014, CORTEX, V50, P100, DOI 10.1016/j.cortex.2013.09.005; Tarkiainen A, 2003, NEUROIMAGE, V19, P1194, DOI 10.1016/S1053-8119(03)00161-7; Tononi Giulio, 2004, BMC Neurosci, V5, P42, DOI 10.1186/1471-2202-5-42	53	0	0	ELSEVIER MASSON	MILANO	VIA PALEOCAPA 7, 20121 MILANO, ITALY	0010-9452	1973-8102		CORTEX	Cortex	APR	2015	65						159	172		10.1016/j.cortex.2015.01.017		14	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	CH0VA	WOS:000353739300014		
J	Ogawa, M; Kanbe, T; Kano, A; Kubota, F; Makiguchi, T; Miyazaki, H; Yokoo, S				Ogawa, Masaru; Kanbe, Tomoyuki; Kano, Akio; Kubota, Fumitaka; Makiguchi, Takaya; Miyazaki, Hidetaka; Yokoo, Satoshi			Conservative reduction by lever action of chronic bilateral mandibular condyle dislocation	CRANIO-THE JOURNAL OF CRANIOMANDIBULAR PRACTICE			English	Article						Long-standing dislocation of the temporomandibular joint; Lever action; Conservative reduction		Aims: The treatment of long-standing dislocation of the temporomandibular joint is broadly classified into open reduction and closed reduction. The current study presents a case of long-standing dislocation of the temporomandibular joint treated 3 years after dislocation. In this study, the authors evaluated the long-term outcome of conservative reduction by lever action of chronic bilateral mandibular condyle dislocation. Methodology: Manual repositioning of temporomandibular joint dislocation lasting for 3 years in a 31-year-old woman was attempted without success; therefore, conservative reduction by lever action was carried out because the patient declined treatment under general anesthesia. Results: The treatment was discontinued after 6 days because of the subluxation of the retaining tooth. The retainer was changed from tooth to screw for intermaxillary fixation, and treatment was reinstituted. Fifteen days later, reduction was achieved and retention was started and continued for 2 months. The outcome was good, with no recurrent dislocation within 24 months of the treatment. Conclusions: Conservative reduction by lever action, involving minimally invasive treatment and little dysfunction, should be considered an optional conservative treatment.	[Ogawa, Masaru; Kanbe, Tomoyuki; Kubota, Fumitaka; Makiguchi, Takaya; Miyazaki, Hidetaka; Yokoo, Satoshi] Gunma Univ, Grad Sch Med, Dept Stomatol & Maxillofacial Surg, Maebashi, Gumma 3718511, Japan; [Kano, Akio] Kano Dent & Oral Surg Off, Gunma, Japan	Ogawa, M (reprint author), Gunma Univ, Grad Sch Med, Dept Stomatol & Maxillofacial Surg, 3-39-22 Showa Machi, Maebashi, Gumma 3718511, Japan.	masar-u0523@gunma-u.ac.jp					Compbell J, 1952, DENT REC, V72, P230; Fordyce GL, 1965, BRIT J ORAL SURG, V2, P222; GOTTLIEB O, 1952, J Oral Surg (Chic), V10, P25; Hogan N, 1964, IRISH DENT REV, V10, P40; ISHIZUKA T, 1992, Japanese Journal of Allergology, V41, P504; Kawamura H, 1980, J JPN STOMATOL SOC, V29, P341; Kowaka S, 1987, J ORAL MAXILLOFAC SU, V33, P59; Lewis JB, 1961, N Y STATE DENT J, V27, P29; Mizutani H, 2000, J JPN SOC TMJ, V12, P52; MULLER GM, 1946, BRIT MED J, V1, P572; Sakamoto A, 1977, JPN J ORAL MAXILLOFA, V23, P422; Sugisaki M, 1981, J ORAL MAXILLOFAC SU, V27, P283; TOPAZIAN RG, 1967, J TRAUM, V7, P257, DOI 10.1097/00005373-196703000-00008; Yao M, 2007, J JPN SOC TMJ, V19, P171	14	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0886-9634	2151-0903		CRANIO	Cranio-J. Craniomandib. Pract.	APR	2015	33	2					142	147		10.1179/0886963414Z.00000000041		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CG9RZ	WOS:000353658600010		
J	Roose, J; Fagarasan, S				Roose, Jeroen; Fagarasan, Sidonia			Editorial overview: Lymphocyte development and activation: Lymphocytes, integrators of information	CURRENT OPINION IN IMMUNOLOGY			English	Editorial Material									[Roose, Jeroen] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Fagarasan, Sidonia] RIKEN Yokohama Inst, Lab Mucosal Immun, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan	Roose, J (reprint author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	jeroen.roose@ucsf.edu; sidonia.fagarasan@riken.jp						0	0	0	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0952-7915	1879-0372		CURR OPIN IMMUNOL	Curr. Opin. Immunol.	APR	2015	33						V	VII		10.1016/j.coi.2015.03.003		3	Immunology	Immunology	CH1AT	WOS:000353754200001		
J	Kometani, K; Kurosaki, T				Kometani, Kohei; Kurosaki, Tomohiro			Differentiation and maintenance of long-lived plasma cells	CURRENT OPINION IN IMMUNOLOGY			English	Review							TRANSCRIPTION FACTOR BLIMP-1; INDUCED CYTIDINE DEAMINASE; GERMINAL CENTER RESPONSE; MEMORY B-CELLS; BONE-MARROW; ANTIBODY-RESPONSES; CUTTING EDGE; LYMPH-NODES; EXPRESSION; MICRORNA-155	Long-lived plasma cells, which mostly reside in the bone marrow have been shown to be vital for protection from recurrent infections. Recent gene-targeting and cell-ablation experiments have solidified the concept that their survival depends on both cell-intrinsic programs and extrinsic factors. The BTB transcription factor ZBTB20, which is expressed at high levels in long-lived plasma cells, is critical for their survival. On the other hand, eosinophils, megakaryocytes and monocytes function to establish a niche for long-lived plasma cells by secreting cytokines and growth factors such as APRIL and IL6.	[Kurosaki, Tomohiro] Osaka Univ, Lab Lymphocyte Differentiat, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Kometani, Kohei; Kurosaki, Tomohiro] RIKEN Ctr Integrat Med Sci IMS, Lab Lymphocyte Differentiat, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	Kurosaki, T (reprint author), Osaka Univ, Lab Lymphocyte Differentiat, WPI Immunol Frontier Res Ctr, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	kurosaki@ifrec.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology in Japan; Japan Science and Technology Agency, Core Research for Evolutional Science and Technology (CREST); Secom Science and Technology Foundation; RIKEN Special Postdoctoral Researchers Program	We thank Dr. K. Suzuki and Dr. P.D. Burrows for critical reading of our manuscript. This work was supported by grants provided by the Ministry of Education, Culture, Sports, Science, and Technology in Japan (to T.K.); Japan Science and Technology Agency, Core Research for Evolutional Science and Technology (CREST) (to T.K.); Secom Science and Technology Foundation (to T.K.); RIKEN Special Postdoctoral Researchers Program (to K.K.).	Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Uchida J, 1999, SCIENCE, V286, P300, DOI 10.1126/science.286.5438.300; Winter O, 2010, BLOOD, V116, P1867, DOI 10.1182/blood-2009-12-259457; Benson MJ, 2008, J IMMUNOL, V180, P3655; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Homig-Holzel C, 2008, J EXP MED, V205, P1317, DOI 10.1084/jem.20080238; O'Connor BP, 2004, J EXP MED, V199, P91, DOI 10.1084/jem.20031330; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; Kallies A, 2007, IMMUNITY, V26, P555, DOI 10.1016/j.immuni.2007.04.007; van Spriel AB, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003113; Wang YN, 2014, J EXP MED, V211, P841, DOI 10.1084/jem.20131821; Yasuda T, 2012, J IMMUNOL, V188, P6127, DOI 10.4049/jimmunol.1103039; Fritz JH, 2012, NATURE, V481, P199, DOI 10.1038/nature10698; Bolduc A, 2010, J IMMUNOL, V185, P220, DOI 10.4049/jimmunol.0901689; Hauser AE, 2002, J IMMUNOL, V169, P1277; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Neves P, 2010, IMMUNITY, V33, P777, DOI 10.1016/j.immuni.2010.10.016; Muehlinghaus G, 2005, BLOOD, V105, P3965, DOI 10.1182/blood-2004-08-2992; Kabashima K, 2006, J EXP MED, V203, P2683, DOI 10.1084/jem.20061289; Delogu A, 2006, IMMUNITY, V24, P269, DOI 10.1016/j.immuni.2006.01.012; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; Nera KP, 2006, IMMUNITY, V24, P283, DOI 10.1016/j.immuni.2006.02.003; Shen P, 2014, NATURE, V507, P366, DOI 10.1038/nature12979; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Shapiro-Shelef M, 2005, J EXP MED, V202, P1471, DOI 10.1084/jem.20051611; Rauch PJ, 2012, SCIENCE, V335, P597, DOI 10.1126/science.1215173; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Teng G, 2008, IMMUNITY, V28, P621, DOI 10.1016/j.immuni.2008.03.015; Fooksman DR, 2010, IMMUNITY, V33, P118, DOI 10.1016/j.immuni.2010.06.015; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jcm.20040973; Peperzak V, 2013, NAT IMMUNOL, V14, P290, DOI 10.1038/ni.2527; Rozanski CH, 2011, J EXP MED, V208, P1435, DOI 10.1084/jem.20110040; Kishi Y, 2010, J IMMUNOL, V185, P211, DOI 10.4049/jimmunol.0901694; Dorsett Y, 2008, IMMUNITY, V28, P630, DOI 10.1016/j.immuni.2008.04.002; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; Belnoue E, 2012, J IMMUNOL, V188, P1283, DOI 10.4049/jimmunol.1103169; Gatto D, 2009, IMMUNITY, V31, P259, DOI 10.1016/j.immuni.2009.06.016; Ochiai K, 2006, J BIOL CHEM, V281, P38226, DOI 10.1074/jbc.M607592200; Chevrier S, 2014, J EXP MED, V211, P827, DOI 10.1084/jem.20131831; Muto A, 2010, EMBO J, V29, P4048, DOI 10.1038/emboj.2010.257; Erickson LD, 2002, J CLIN INVEST, V109, P613, DOI 10.1172/JCI200214110; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Bermejo DA, 2013, NAT IMMUNOL, V14, P514, DOI 10.1038/ni.2569; Le Gallou S, 2012, J IMMUNOL, V189, P161, DOI 10.4049/jimmunol.1200301; Carotta S, 2014, J EXP MED, V211, P2169, DOI 10.1084/jem.20140425; Chu Van Trung, 2011, Nat Immunol, V12, P151, DOI 10.1038/ni.1981; Heise N, 2014, J EXP MED, V211, P2103, DOI 10.1084/jem.20132613; Lu D, 2014, J EXP MED, V211, P2183, DOI 10.1084/jem.20140338; Matsumoto M, 2014, IMMUNITY, V41; Mohr E, 2009, J IMMUNOL, V182, P2113, DOI 10.4049/jimmunol.0802771; Nagase H, 2000, J IMMUNOL, V164, P5935; Pabst O, 2005, J IMMUNOL, V174, P7492; Wehrli N, 2001, EUR J IMMUNOL, V31, P609, DOI 10.1002/1521-4141(200102)31:2<609::AID-IMMU609>3.0.CO;2-9; Yasuda T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001592	55	3	3	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0952-7915	1879-0372		CURR OPIN IMMUNOL	Curr. Opin. Immunol.	APR	2015	33						64	69		10.1016/j.coi.2015.01.017		6	Immunology	Immunology	CH1AT	WOS:000353754200011		
J	Nakabayashi, R; Saito, K				Nakabayashi, Ryo; Saito, Kazuki			Integrated metabolomics for abiotic stress responses in plants	CURRENT OPINION IN PLANT BIOLOGY			English	Review							RESONANCE-MASS-SPECTROMETRY; PHENYLPROPANOID METABOLISM; CATHARANTHUS-ROSEUS; HYDROGEN-PEROXIDE; GENETIC DIVERSITY; ARABIDOPSIS; SYSTEM; CELLS; IDENTIFICATION; ANTIOXIDANTS	Plants are considered to biosynthesize specialized (traditionally called secondary) metabolites to adapt to environmental stresses such as biotic and abiotic stresses. The majority of specialized metabolites induced by abiotic stress characteristically exhibit antioxidative activity in vitro, but their function in vivo is largely yet to be experimentally confirmed. In this review, we highlight recent advances in the identification of the role of abiotic stress-responsive specialized metabolites with an emphasis on flavonoids. Integrated 'omics' analysis, centered on metabolomics with a series of plant resources differing in their flavonoid accumulation, showed experimentally that flavonoids play a major role in antioxidation in vivo. In addition, the results also suggest the role of flavonoids in the vacuole. To obtain more in-depth insights, chemical and biological challenges need to be addressed for the identification of unknown specialized metabolites and their in vivo functions.	[Nakabayashi, Ryo; Saito, Kazuki] RIKEN, Ctr Sustainable Resource Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Saito, Kazuki] Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Chiba 2608675, Japan	Saito, K (reprint author), RIKEN, Ctr Sustainable Resource Sci, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	kazuki.saito@riken.jp	Saito, Kazuki/D-2670-2009		Strategic International Collaborative Research Program (SICORP), JST	We apologize to all colleagues whose relevant work we could not cite because of space limitations. This work was supported by the Strategic International Collaborative Research Program (SICORP), JST.	Afendi FM, 2012, PLANT CELL PHYSIOL, V53, DOI 10.1093/pcp/pcr165; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Hartmann T, 2007, PHYTOCHEMISTRY, V68, P2831, DOI 10.1016/j.phytochem.2007.09.017; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Kusano M, 2011, PLANT J, V67, P354, DOI 10.1111/j.1365-313X.2011.04599.x; Glaser K, 2014, PLANT J, V77, P31, DOI 10.1111/tpj.12359; Shahidi F, 2010, PHYTOCHEM REV, V9, P147, DOI 10.1007/s11101-009-9142-8; Fernie AR, 2011, PLANT CELL, V23, P2477, DOI 10.1105/tpc.111.086272; Tohge T, 2011, PLANT PHYSIOL, V157, P1469, DOI 10.1104/pp.111.185710; Sueishi Y, 2014, J CLIN BIOCHEM NUTR, V54, P67, DOI 10.3164/jcbn.13-53; Keunen E, 2013, PLANT CELL ENVIRON, V36, P1242, DOI 10.1111/pce.12061; Krueger S, 2009, PLANT CELL ENVIRON, V32, P349, DOI [10.1111/j.1365-3040.2008.01928.x, 10.1111/j.1365-3040.2009.01928.x]; Niggeweg R, 2004, NAT BIOTECHNOL, V22, P746, DOI 10.1038/nbt966; Saito K, 2013, PLANT PHYSIOL BIOCH, V72, P21, DOI 10.1016/j.plaphy.2013.02.001; Saito K, 2013, CURR OPIN PLANT BIOL, V16, P373, DOI 10.1016/j.pbi.2013.04.001; Bi XL, 2014, FOOD CHEM, V152, P205, DOI 10.1016/j.foodchem.2013.11.088; SMIRNOFF N, 1989, PHYTOCHEMISTRY, V28, P1057, DOI 10.1016/0031-9422(89)80182-7; Saito K, 2008, TRENDS PLANT SCI, V13, P36, DOI 10.1016/j.tplants.2007.10.006; Bottcher C, 2008, PLANT PHYSIOL, V147, P2107, DOI 10.1104/pp.108.117754; Peshev D, 2013, J EXP BOT, V64, P1025, DOI 10.1093/jxb/ers377; Tohge T, 2010, NAT PROTOC, V5, P1210, DOI 10.1038/nprot.2010.82; Nakabayashi R, 2014, PLANT J, V77, P367, DOI 10.1111/tpj.12388; Vickers CE, 2009, NAT CHEM BIOL, V5, P283, DOI 10.1038/nchembio.158; Mao YF, 2013, MOL PLANT, V6, P2008, DOI 10.1093/mp/sst121; Nishizawa A, 2008, PLANT PHYSIOL, V147, P1251, DOI 10.1104/pp.108.122465; Lobell DB, 2014, SCIENCE, V344, P516, DOI 10.1126/science.1251423; Pollier J, 2011, J NAT PROD, V74, P1462, DOI 10.1021/np200218r; Nutzmann HW, 2014, CURR OPIN BIOTECH, V26, P91, DOI 10.1016/j.copbio.2013.10.009; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Tohge T, 2013, CRIT REV BIOCHEM MOL, V48, P123, DOI 10.3109/10409238.2012.758083; Havaux M, 2014, PLANT J, V79, P597, DOI 10.1111/tpj.12386; Morreel K, 2014, PLANT CELL, V26, P929, DOI 10.1105/tpc.113.122242; Obata T, 2012, CELL MOL LIFE SCI, V69, P3225, DOI 10.1007/s00018-012-1091-5; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Oikawa A, 2012, PLANT J, V70, P30, DOI 10.1111/j.1365-313X.2012.04967.x; Hernandez I, 2009, TRENDS PLANT SCI, V14, P125, DOI 10.1016/j.tplants.2008.12.003; Besseau S, 2013, PLANT PHYSIOL, V163, P1792, DOI 10.1104/pp.113.222828; Vincken JP, 2007, PHYTOCHEMISTRY, V68, P275, DOI 10.1016/j.phytochem.2006.10.008; Agati G, 2013, PLANT PHYSIOL BIOCH, V72, P35, DOI 10.1016/j.plaphy.2013.03.014; Queval G, 2011, PLANT CELL ENVIRON, V34, P21, DOI 10.1111/j.1365-3040.2010.02222.x; Suzuki N, 2014, NEW PHYTOL, V203, P32, DOI 10.1111/nph.12797; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Agati G, 2012, PLANT SCI, V196, P67, DOI 10.1016/j.plantsci.2012.07.014; Signorelli S, 2014, J PHYS CHEM B, V118, P37, DOI 10.1021/jp407773u; Agerbirk N, 2012, PHYTOCHEMISTRY, V77, P16, DOI 10.1016/j.phytochem.2012.02.005; Nakabayashi R, 2013, ANAL CHEM, V85, P1310, DOI 10.1021/ac302733c; Nakabayashi R, 2013, ANAL BIOANAL CHEM, V405, P5005, DOI 10.1007/s00216-013-6869-2; Arita M, 2008, BIODATA MIN, V1, DOI 10.1186/1756-0381-1-7; Belhaj K, 2013, PLANT METHODS, P9; Bolouri-Moghaddam MR, 2010, FEBS J, V277, P2022, DOI 10.1111/j.1742-4658.2010.07633.x; Chang YC, 2007, FREE RADICAL BIO MED, V43, P1541, DOI 10.1016/j.freeradbiomed.2007.08.018; Fellenberg C, 2009, PHYTOCHEMISTRY, V70, P1392, DOI 10.1016/j.phytochem.2009.08.010; Ferreres F, 2011, J EXP BOT, V62, P2841, DOI 10.1093/jxb/erq458; Handrick V, 2010, ANAL BIOANAL CHEM, V398, P2789, DOI 10.1007/s00216-010-4129-2; Hirayama T, 2010, PLANT J, V61, P1041, DOI 10.1111/j.1365-313X.2010.04124.x; Mahfouz MM, 2014, PLANT BIOTECHNOL J, V12, P1006, DOI 10.1111/pbi.12256; Matsuda F, 2012, PLANT J, V70, P624, DOI 10.1111/j.1365-313X.2012.04903.x; Nakabayashi R, 2009, PHYTOCHEMISTRY, V70, P1017, DOI 10.1016/j.phytochem.2009.03.021; Natella F, 2014, FOOD CHEM, V149, P226, DOI 10.1016/j.foodchem.2013.10.134; Oikawa A, 2011, PLANT PHYSIOL, V157, P544, DOI 10.1104/pp.111.183772; Okubo K, 2000, BIOFACTORS, V13, P219; Oleszek WA, 2002, J CHROMATOGR A, V967, P147, DOI 10.1016/S0021-9673(01)01556-4; Sturm S, 2012, J CHROMATOGR A, V1259, P50, DOI 10.1016/j.chroma.2012.05.032; Sumner LW, 2014, METABOLOMICS, V10, P1047, DOI 10.1007/s11306-014-0739-6; Takahama U, 1997, PHYSIOL PLANTARUM, V101, P845; Velikova VB, 2007, Z NATURFORSCH C, V62, P833; Yamasaki H, 1997, PLANT PHYSIOL, V115, P1405; Yang ZG, 2014, METABOLOMICS, V10, P543, DOI 10.1007/s11306-013-0619-5; Yonekura-Sakakibara K, 2014, PLANT J, V79, P769, DOI 10.1111/tpj.12580; Yonekura-Sakakibara K, 2008, PLANT CELL, V20, P2160, DOI 10.1105/tpc.108.058040	70	6	6	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1369-5266	1879-0356		CURR OPIN PLANT BIOL	Curr. Opin. Plant Biol.	APR	2015	24						10	16		10.1016/j.pbi.2015.01.003		7	Plant Sciences	Plant Sciences	CH1AS	WOS:000353754100003		
J	Izawa, T				Izawa, Takeshi			Deciphering and prediction of plant dynamics under field conditions	CURRENT OPINION IN PLANT BIOLOGY			English	Review							ARABIDOPSIS-THALIANA; GENE-EXPRESSION; CIRCADIAN CLOCK; DIURNAL RHYTHMS; FLOWERING-TIME; RICE; TRANSCRIPTOME; PHYTOCHROME; TEMPERATURE; REGULATORS	Elucidation of plant dynamics under fluctuating natural environments is a challenging goal in plant physiology. Recently, using a computer statistics integrating a series of transcriptome data of field-grown rice leaves during an entire crop season and several corresponding environmental data such as solar radiation and ambient temperature, most parts of transcriptome have been modeled. This reveals the detailed contributions of developmental timing, circadian clocks and each environmental factor to transcriptome dynamics in the field and can predict transcriptome dynamics under given environments. Furthermore, some traits such as flowering time in natural environments have been shown to be predicted by mathematical models based on gene-networks parameterized with data obtained in the laboratory, and phenology models refined by knowledge of molecular genetics. New molecular physiology is beginning in plant science.	Natl Inst Agrobiol Sci, Funct Plant Res Unit, Tsukuba, Ibaraki 3058602, Japan	Izawa, T (reprint author), Natl Inst Agrobiol Sci, Funct Plant Res Unit, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058602, Japan.	tizawa@nias.affrc.go.jp			MAFF, Japan [RTR-0004]; Genomics-based Technology for Agricultural Improvement [PFT-1001]	I thank M. Fukata for her assistance in constructing the Figure 1 in this manuscript. My research was funded by grants from MAFF, Japan (Genomics for Agricultural Innovation, RTR-0004 (2008-2012) and Genomics-based Technology for Agricultural Improvement, PFT-1001 (2013-)) to TI.	Aikawa S, 2010, P NATL ACAD SCI USA, V107, P11632, DOI 10.1073/pnas.0914293107; Gattermann R, 2008, BIOL LETTERS, V4, P253, DOI 10.1098/rsbl.2008.0066; Kami C, 2010, CURR TOP DEV BIOL, V91, P29, DOI 10.1016/S0070-2153(10)91002-8; Salazar JD, 2009, CELL, V139, P1170, DOI 10.1016/j.cell.2009.11.029; Tagkopoulos I, 2008, SCIENCE, V320, P1313, DOI 10.1126/science.1154456; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Millar AJ, 1996, P NATL ACAD SCI USA, V93, P15491, DOI 10.1073/pnas.93.26.15491; Chew YH, 2012, NEW PHYTOL, V194, P654, DOI 10.1111/j.1469-8137.2012.04069.x; Nakagawa H, 2005, THEOR APPL GENET, V110, P778, DOI 10.1007/s00122-004-1905-4; Itoh H, 2010, NAT GENET, V42, P635, DOI 10.1038/ng.606; Quail PH, 1997, BIOESSAYS, V19, P571, DOI 10.1002/bies.950190708; Izawa T, 2002, GENE DEV, V16, P2006, DOI 10.1101/gad.999202; Shrestha R, 2014, ANN BOT-LONDON, V114, P1445, DOI 10.1093/aob/mcu032; Nagano AJ, 2012, CELL, V151, P1358, DOI 10.1016/j.cell.2012.10.048; Shinomura T, 1996, P NATL ACAD SCI USA, V93, P8129, DOI 10.1073/pnas.93.15.8129; Yang XFS, 2011, PLANT PHYSIOL, V157, P1841, DOI 10.1104/pp.111.187898; Locke JCW, 2005, J THEOR BIOL, V234, P383, DOI 10.1016/j.jtbi.2004.11.038; Troein C, 2009, CURR BIOL, V19, P1961, DOI 10.1016/j.cub.2009.09.024; Wilczek AM, 2009, SCIENCE, V323, P930, DOI 10.1126/science.1165826; Doherty CJ, 2010, ANNU REV GENET, V44, P419, DOI 10.1146/annurev-genet-102209-163432; Vanin S, 2012, NATURE, V484, P371, DOI 10.1038/nature10991; Filichkin SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016907; Izawa T, 2012, PLANT CELL ENVIRON, V35, P1729, DOI 10.1111/j.1365-3040.2012.02555.x; Izawa T, 2011, PLANT CELL, V23, P1741, DOI 10.1105/tpc.111.083238; Locke JCW, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100018; Locke JCW, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100102; Matsubara K, 2014, FRONT PLANT SCI, V13, P193, DOI DOI 10.3389/FPLS.2014.00193; Michael TP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040014; Richards CL, 2012, PLOS GENET, V8, P482, DOI 10.1371/journal.pgen.1002662; ROBERTSON G W, 1968, International Journal of Biometeorology, V12, P191, DOI 10.1007/BF01553422; Sachdeva UM, 2008, AUTOPHAGY, V4, P581; Satake A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3303; Sato Y, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-10; Sugiyama N, 2001, PLANT J, V26, P607, DOI 10.1046/j.1365-313x.2001.01063.x	34	0	1	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1369-5266	1879-0356		CURR OPIN PLANT BIOL	Curr. Opin. Plant Biol.	APR	2015	24						87	92		10.1016/j.pbi.2015.02.003		6	Plant Sciences	Plant Sciences	CH1AS	WOS:000353754100013		
J	Ochiai, N				Ochiai, Nobuo			Stir Bar Sorptive Extraction Taste on the Trail	DEUTSCHE LEBENSMITTEL-RUNDSCHAU			German	Editorial Material									Gerstel KK, Meguro Ku, Tokyo 1520031, Japan	Ochiai, N (reprint author), Gerstel KK, Meguro Ku, SMBC Torisudai Ekimae Bldg 4F,1-3-1 Nakane, Tokyo 1520031, Japan.	gerstel@gerstel.de						0	0	0	B BEHES VERLAG GMBH & CO KG	HAMBURG	AVERHOFFSTRASSE 10, HAMBURG, 22085, GERMANY	0012-0413			DEUT LEBENSM-RUNDSCH	Dtsch. Lebensm.-Rundsch.	APR	2015	111	4					161	164				4	Food Science & Technology	Food Science & Technology	CG9WZ	WOS:000353672100006		
J	Yan, CY; Gu, JW; Hou, DP; Jing, HY; Wang, J; Guo, YZ; Katsumi, H; Sakane, T; Yamamoto, A				Yan, Chengyun; Gu, Jiwei; Hou, Daping; Jing, Hongying; Wang, Jing; Guo, Yuzhi; Katsumi, Hidemasa; Sakane, Toshiyasu; Yamamoto, Akira			Improved tumor targetability of Tat-conjugated PAMAM dendrimers as a novel nanosized anti-tumor drug carrier	DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY			English	Article						Biodistribution; nanoparticles; PAMAM dendrimer; Tat peptide; tumor targeting	ARGININE-RICH PEPTIDES; N-SUCCINYL-CHITOSAN; IN-VIVO; ANTISENSE OLIGONUCLEOTIDES; POLYAMIDOAMINE DENDRIMERS; DELIVERY; NANOPARTICLES; CELLS; PROTEIN; VITRO	The generation 4-poly-amidoamine-dendrimers (PAMAM G4 dendrimer, P) was conjugated to Tat peptide (Tat, T), a cell-penetrating peptide, in search of an efficient anti-tumor drug delivery vehicle for cancer therapy. In this study, we synthesized BODIPY-labeled Tat-Conjugated PAMAM dendrimers (BPTs) as a novel nanosized anticancer drug carriers and systemically investigated their biodistribution and the tumor accumulation in Sarcoma 180-bearing mice. In addition, the uptake and the cytotoxicity to S180 cells of BPTs thereof were evaluated. The unmodified dendrimer (BP) showed a soon clearance from the blood stream and nonspecific accumulation in tumor. In contrast, the Tat-modified dendrimer, BPT(64) with appropriate particle size showed a better retention in blood and could be accumulated effectively in tumor tissue via the enhanced permeability and retention (EPR) effect. Moreover, BPTs with a high Tat modification rate was accumulated more effectively in tumor tissue. In vitro experiments, these BPTs displayed low cytotoxicity on S180 cells and high uptake to S180 cells. These findings indicate that the nanoparticulate system on the basis of Tat-conjugated PAMAM dendrimers is safer and effective in the concentration range (below 20 mu g/ml) to be used as a carrier of anti-tumor drugs for tumor targeting by intravenous administration.	[Yan, Chengyun] Guilin Med Univ, Coll Pharm, Guilin, Guangxi, Peoples R China; [Yan, Chengyun; Gu, Jiwei; Hou, Daping; Jing, Hongying; Wang, Jing; Guo, Yuzhi] Jiamusi Univ, Affiliated Hosp 1, Jiamusi, Heilongjiang, Peoples R China; [Katsumi, Hidemasa; Sakane, Toshiyasu; Yamamoto, Akira] Kyoto Pharmaceut Univ, Dept Biopharmaceut, Yamashina Ku, Kyoto 607, Japan	Yan, CY (reprint author), Jiamusi Univ, Affiliated Hosp 1, Dept Pharm, Dexiang St,Box 348, Jiamusi 154000, Peoples R China.	hademan@126.com			National Natural Science Foundation of China [81260484]; Program of Hei Longjiang and Guangxi Provincial Natural Science Foundation of China [D201054, 2013GXNSFAA019226]	This work was supported by the National Natural Science Foundation of China (NO. 81260484) and the Program of Hei Longjiang and Guangxi Provincial Natural Science Foundation of China (D201054 and 2013GXNSFAA019226).	Jang SH, 2011, DRUG DEV IND PHARM, V37, P41, DOI 10.3109/03639045.2010.489563; RUBEN S, 1989, J VIROL, V63, P1; Kojima C, 2000, BIOCONJUGATE CHEM, V11, P910, DOI 10.1021/bc0000583; Yan CY, 2006, J PHARM PHARMACOL, V58, P1177, DOI 10.1221/jpp.58.9.0003; Esfand R, 2001, DRUG DISCOV TODAY, V6, P427, DOI 10.1016/S1359-6446(01)01757-3; Juliano RL, 2005, CURR OPIN MOL THER, V7, P132; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Gaumet M, 2008, EUR J PHARM BIOPHARM, V69, P1, DOI 10.1016/j.ejpb.2007.08.001; Kitchens KM, 2007, PHARM RES, V24, P2138, DOI 10.1007/s11095-007-9415-0; Woo BH, 1999, ARCH PHARM RES, V22, P459, DOI 10.1007/BF02979153; Roberts JC, 1996, J BIOMED MATER RES, V30, P53, DOI 10.1002/(SICI)1097-4636(199601)30:1<53::AID-JBM8>3.0.CO;2-Q; DOUGLAS SJ, 1987, CRIT REV THER DRUG, V3, P233; Pooga M, 1998, NAT BIOTECHNOL, V16, P857, DOI 10.1038/nbt0998-857; Twyman LJ, 1999, TETRAHEDRON LETT, V40, P1743, DOI 10.1016/S0040-4039(98)02680-X; Astriab-Fisher A, 2000, BIOCHEM PHARMACOL, V60, P83, DOI 10.1016/S0006-2952(00)00310-5; Moulton HM, 2004, BIOCONJUGATE CHEM, V15, P290, DOI 10.1021/bc034221g; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; Barichello JM, 1999, DRUG DEV IND PHARM, V25, P471, DOI 10.1081/DDC-100102197; Lindgren M, 2000, TRENDS PHARMACOL SCI, V21, P99, DOI 10.1016/S0165-6147(00)01447-4; Moghimi SM, 2001, PHARMACOL REV, V53, P283; TOMALIA DA, 1995, SCI AM, V272, P62; YUAN F, 1995, CANCER RES, V55, P3752; Kato Y, 2000, BIOMATERIALS, V21, P1579, DOI 10.1016/S0142-9612(00)00044-2; Galeazzi S, 2010, BIOMACROMOLECULES, V11, P182, DOI 10.1021/bm901055a; Haley B, 2008, UROL ONCOL-SEMIN ORI, V26, P57, DOI 10.1016/j.urolonc.2007.03.015; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Hu JJ, 2010, J PHYS CHEM B, V114, P7148, DOI 10.1021/jp1007889; Malik N, 2000, J CONTROL RELEASE, V65, P133, DOI 10.1016/S0168-3659(99)00246-1; Yoo H, 2000, NUCLEIC ACIDS RES, V28, P4225, DOI 10.1093/nar/28.21.4225; Hobbs SK, 1998, P NATL ACAD SCI USA, V95, P4607, DOI 10.1073/pnas.95.8.4607; Emanuele AD, 2002, DENDRIMERS PHARM TEC, P1; Hawker C. J., 1993, J CHEM SOC PERK T, V12, P1287; Hussain M, 2004, J CONTROL RELEASE, V99, P139, DOI 10.1016/j.jconrel.2004.06.009; Klajnert B, 2007, NEW DEV MUTATION RES, P217; KUSUMOTO H, 1988, CANCER RES, V48, P1208; Lee CC, 2005, NAT BIOTECHNOL, V23, P1517, DOI 10.1038/nbt1171; Moghimi SM, 2003, FEBS LETT, V540, P241, DOI 10.1016/S0014-5793(03)00273-4; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Yoo H, 1999, PHARMACEUT RES, V16, P1799, DOI 10.1023/A:1018926605871; Yuan Y, 2012, ARCH PHARM RES, V35, P343	41	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0363-9045	1520-5762		DRUG DEV IND PHARM	Drug Dev. Ind. Pharm.	APR	2015	41	4					617	622		10.3109/03639045.2014.891127		6	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG9RJ	WOS:000353655600011		
J	Portugal-Pereira, J; Nakatani, J; Kurisu, KH; Hanaki, K				Portugal-Pereira, Joana; Nakatani, Jun; Kurisu, Kiyo H.; Hanaki, Keisuke			Comparative energy and environmental analysis of Jatropha bioelectricity versus biodiesel production in remote areas	ENERGY			English	Article						Jatropha; Bioelectricity; Biodiesel; Life cycle assessment; India	LIFE-CYCLE ASSESSMENT; CURCAS-L. OIL; RURAL ELECTRIFICATION; INDIA; TANZANIA; SYSTEMS; PLANT	This study presents a comparative analysis between jatropha seed production systems to generate bioelectricity versus production of biodiesel under current and optimised conditions. An LCA (life cycle assessment) has been developed, comprising both upstream and downstream processes, encompassing the farming, collection, fuel processing and usage phases. The following energy and environmental indicators were assessed: fossil depletion, GWP (global warming potential), TAP (terrestrial acidification potential), and PMF (particulate matter formation). The rural electrification based on the JCO (latropha crude oil) system is more environmentally friendly compared to generation of biodiesel, in terms of TAP and PMF indicators. Under current practices, two out of the four evaluated indicators score positive benefits, when compared to the generation of marginal diesel-based electricity. The optimisation of the expelling pressing process and the power generation engine could bring further improvements in terms of fossil depletion, GWP and PMF indicators. The biodiesel route, on the other hand, presents a limited local environmental performance, showing only gains in terms of fossil depletion and GWP. (C) 2015 Elsevier Ltd. All rights reserved.	[Portugal-Pereira, Joana] Univ Fed Rio de Janeiro, Ctr Tecnol, Grad Sch Engn, Energy Planning Program, BR-21941972 Rio De Janeiro, RJ, Brazil; [Nakatani, Jun; Kurisu, Kiyo H.; Hanaki, Keisuke] Univ Tokyo, Grad Sch Engn, Dept Urban Engn, Bunkyo Ku, Tokyo 1138656, Japan	Portugal-Pereira, J (reprint author), Univ Fed Rio de Janeiro, Ctr Tecnol, Grad Sch Engn, Energy Planning Program, Bloco C,Sala 211 Cidade Univ, BR-21941972 Rio De Janeiro, RJ, Brazil.	portugal.pereira@ppe.ufrj.br; nakatani@env.t.u-tokyo.ac.jp; kiyo@env.t.u-tokyo.ac.jp; hanaki@env.t.u-tokyo.ac.jp					Cherubini F, 2011, RESOUR CONSERV RECY, V55, P1070, DOI 10.1016/j.resconrec.2011.06.001; Basili M, 2012, ECOL ECON, V78, P1, DOI 10.1016/j.ecolecon.2012.03.010; Ajayebi A, 2013, BIORESOURCE TECHNOL, V150, P429, DOI 10.1016/j.biortech.2013.09.118; Gmunder SM, 2010, BIOMASS BIOENERG, V34, P347, DOI 10.1016/j.biombioe.2009.11.006; [Anonymous], 2006, 14040 ISO; Luo L, 2009, INT J LIFE CYCLE ASS, V14, P529, DOI 10.1007/s11367-009-0112-6; Pandey KK, 2011, APPL ENERG, V88, P4831, DOI 10.1016/j.apenergy.2011.06.026; Kumar S, 2012, RENEW SUST ENERG REV, V16, P1089, DOI 10.1016/j.rser.2011.11.014; Grimsby LK, 2012, ENERGY SUSTAIN DEV, V16, P297, DOI 10.1016/j.esd.2012.04.002; Koh MY, 2011, RENEW SUST ENERG REV, V15, P2240, DOI 10.1016/j.rser.2011.02.013; Pandey VC, 2012, RENEW SUST ENERG REV, V16, P2870, DOI 10.1016/j.rser.2012.02.004; Kumar S, 2012, BIORESOURCE TECHNOL, V110, P723, DOI 10.1016/j.biortech.2012.01.142; Openshaw K, 2000, BIOMASS BIOENERG, V19, P1, DOI 10.1016/S0961-9534(00)00019-2; Cherubini F, 2011, BIORESOURCE TECHNOL, V102, P437, DOI 10.1016/j.biortech.2010.08.010; Achten WMJ, 2008, BIOMASS BIOENERG, V32, P1063, DOI 10.1016/j.biombioe.2008.03.003; Achten WMJ, 2010, APPL ENERG, V87, P3652, DOI 10.1016/j.apenergy.2010.07.003; Urpelainen J, 2014, ENERGY SUSTAIN DEV, V19, P66, DOI 10.1016/j.esd.2013.12.008; Bouffaron P, 2012, BIOMASS BIOENERG, V37, P298, DOI 10.1016/j.biombioe.2011.11.008; Brittaine R., 2010, INTEGRATED CROP MANA, V8; Curran M. A., 2001, INT WORKSH EL DAT LI; Curran M.A., 1996, ENV LIFE CYCLE ASSES; EEA (European Environment Agency), 2009, 92009 EEA; EPA, 2010, BIOD EM; Goedkoop M, 2013, LIFE CYCLE IMPACT AS, VFirst; Goedkoop M, 2013, SIMAPRO 8 TUTORIAL P; Heller J., 1996, PROMOTING CONSERVATI; IEA, 2014, EN IND 2010; International Organization for Standardization (ISO), 2006, 14044 ISO; IPCC, 2006, GUID NAT GREENH GAS; Jain S, 2009, PROSPECTS BIODIESEL; Kaewcharoensombat U, 2011, J TAIWAN INST CHEM E, V42, P454, DOI 10.1016/j.jtice.2010.09.008; Kinawy OSE, 2009, ENERG SOURCE PART A, V31, P1089; Ministry of Environment and Forest, 2009, STAT ENV REP; Ministry of Shipping, 2013, ROAD TRANSP YB 2011; Mukherjee P, 2008, P 5 INT C BIOF NEW D; Panda H., 2007, GOVERNANCE RURAL ELE; Planning Commission, 2003, REP COMM DEV BIOF; Planning Commission, 2011, 12 5 YEAR PLAN 2012; Portugal-Pereira J, 2011, THESIS U TOKYO JAPAN; Pre Consultants, 2013, EC V 3 DAT; Prueksakorn K, 2010, ENERGY SUSTAIN DEV, V14, P1, DOI 10.1016/j.esd.2009.12.002; Qian JF, 2010, BIORESOURCE TECHNOL, V101, P7025, DOI 10.1016/j.biortech.2010.04.018; Singh B, 2013, BIOMASS BIOENERG, V48, P202; van Eijck J, 2014, BIOMASS BIOENERG, V61, P25, DOI 10.1016/j.biombioe.2013.10.005; Wani S.P., 2009, P 46 INT BIOF C NEW; Whitaker M., 2009, NRELTP6A244428; World Bank, 2013, WORLD BANK GROUP IMPACT EVALUATIONS: RELEVANCE AND EFFECTIVENESS, P1, DOI 10.1596/978-0-8213-9717-6	47	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0360-5442	1873-6785		ENERGY	Energy	APR 1	2015	83						284	293		10.1016/j.energy.2015.02.022		10	Thermodynamics; Energy & Fuels	Thermodynamics; Energy & Fuels	CH0RX	WOS:000353731200025		
J	Itazaki, M; Ito, M; Nakazawa, H				Itazaki, Masumi; Ito, Masaki; Nakazawa, Hiroshi			Synthesis, Structure, and Reactivity of Ruthenium(0) Indane Complexes fac-[Ru(NCMe)(3)(CO)(2)(InX3)] (X = Cl, Br)	EUROPEAN JOURNAL OF INORGANIC CHEMISTRY			English	Article						Indium; Ruthenium; Halides; Ligand effects; Coordination modes	COORDINATION CHEMISTRY; GROUP-13; DERIVATIVES; LIGANDS; INDIUM; RU	The first ruthenium indane complexes, fac-[Ru(NCMe)(3)(CO)(2)(InX3)] (X = Cl: 1, Br: 2), were synthesized in the reaction of triruthenium dodecacarbonyl Ru-3(CO)(12) with 3 equiv. of InX3 in acetonitrile at 80 degrees C for 30 min. Reaction of fac-[Ru(NCMe)(3)(CO)(2)(InX3)] (X = Cl: 1, Br: 2) with PPh3 at a 1:1 molar ratio in acetonitrile at 50 degrees C for 5 h afforded cis,cis,trans-[Ru(NCMe)(2)(CO)(2)(InX3)(PPh3)] (X = Cl: 3, Br: 4). The structures of 1-4 were determined by using single-crystal X-ray analysis.	[Itazaki, Masumi; Ito, Masaki; Nakazawa, Hiroshi] Osaka City Univ, Grad Sch Sci, Dept Chem, Sumiyoshi Ku, Osaka 5588585, Japan	Itazaki, M (reprint author), Osaka City Univ, Grad Sch Sci, Dept Chem, Sumiyoshi Ku, 3-3-138 Sugimoto, Osaka 5588585, Japan.	nakazawa@sci.osaka-cu.ac.jp	Itazaki, Masumi/A-2124-2009		Ministry of Education, Culture, Sports, Science and Technology (MEXT) [25410073, 25620048, 25109538]	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) with a Grant-in-Aid for Science Research Japan (C) (No. 25410073), a Challenging Exploratory Research Grant (No. 25620048), and a Grant-in Aid for Scientific Research on Innovation Area "Stimuli-responsive Chemical Species" (No. 25109538).	Aldridge S, 2005, MAIN GROUP MET CHEM, V28, P201; Amgoune A, 2011, CHEM COMMUN, V47, P859, DOI 10.1039/c0cc04109b; Derrah EJ, 2011, ORGANOMETALLICS, V30, P657, DOI 10.1021/om1011769; Asay M, 2011, CHEM REV, V111, P354, DOI 10.1021/cr100216y; Baker RJ, 2005, COORDIN CHEM REV, V249, P1857, DOI 10.1016/j.ccr.2004.12.016; Boehme C, 2000, COORDIN CHEM REV, V197, P249, DOI 10.1016/S0010-8545(99)00227-1; BRUCE MI, 1988, J ORGANOMET CHEM, V347, P181, DOI 10.1016/0022-328X(88)80281-X; CALABRESE JC, 1992, J CHEM SOC DALTON, P3525, DOI 10.1039/dt9920003525; CLARKSON LM, 1988, INORG CHEM, V27, P2653, DOI 10.1021/ic00288a019; Cokoja M, 2005, DALTON T, P44, DOI 10.1039/b411727a; Esser M, 2000, Z ANORG ALLG CHEM, V626, P915, DOI 10.1002/(SICI)1521-3749(200004)626:4<915::AID-ZAAC915>3.3.CO;2-M; Fischer R. A., 1999, ANGEW CHEM, V111, P3002, DOI 10.1002/(SICI)1521-3757(19991004)111:19<3002::AID-ANGE3002>3.0.CO;2-B; Fischer R. A., 1999, ANGEW CHEM INT EDIT, V38, P2830, DOI 10.1002/(SICI)1521-3773(19991004)38:19<2830::AID-ANIE2830>3.0.CO;2-E; Gemel C, 2004, EUR J INORG CHEM, P4161, DOI 10.1002/ejic.200400569; Gonzalez-Gallardo S, 2012, CHEM REV, V112, P3136, DOI 10.1021/cr2001146; Hieber W, 1942, Z ANORG ALLG CHEM, V249, P43, DOI 10.1002/zaac.19422490104; Hopfl Herbert, 2002, GROUP 13 CHEM 1 FUND, V103; Jones C, 2009, EUR J INORG CHEM, P3593, DOI 10.1002/ejic.200900407; Leadbeater NE, 2001, J COORD CHEM, V53, P311, DOI 10.1080/00958970108022617; Murugavel R., 1999, ANGEW CHEM, V111, P1289, DOI 10.1002/(SICI)1521-3757(19990503)111:9<1289::AID-ANGE1289>3.0.CO;2-6; Murugavel R, 1999, ANGEW CHEM INT EDIT, V38, P1211, DOI 10.1002/(SICI)1521-3773(19990503)38:9<1211::AID-ANIE1211>3.0.CO;2-O; Nakazawa H, 2005, ACTA CRYSTALLOGR E, V61, pM945, DOI 10.1107/S1600536805011992; NUBER B, 1990, Z NATURFORSCH B, V45, P508; Rutsch P, 2002, Z NATURFORSCH B, V57, P757	24	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1434-1948	1099-0682		EUR J INORG CHEM	Eur. J. Inorg. Chem.	APR	2015		12					2033	2036		10.1002/ejic.201500112		4	Chemistry, Inorganic & Nuclear	Chemistry	CG6FD	WOS:000353391700003		
J	Qian, J; Hu, JC; Yoshikawa, H; Zhang, JF; Awaga, K; Zhang, C				Qian, Jun; Hu, Jingchun; Yoshikawa, Hirofumi; Zhang, Jinfang; Awaga, Kunio; Zhang, Chi			External-Template-Assisted Formation of Octacyanometalate-Based M-V-Mn-II (M = W, Mo) Bimetallic Coordination Polymers with Magnetic Properties	EUROPEAN JOURNAL OF INORGANIC CHEMISTRY			English	Article						External-Template-Assisted; Octacyanometalates; Polymers; Structure elucidation; Magnetic properties	METAL-ORGANIC FRAMEWORKS; SECONDARY BUILDING UNITS; HIGH-SPIN MOLECULES; CRYSTAL-STRUCTURE; PHOTOINDUCED MAGNETIZATION; PLATINUM(II) COMPLEXES; DNA-BINDING; CENTER-DOT; MICROPOROUS METAL; HYDROGEN STORAGE	Three manganese-molybdenum/tungsten bimetallic coordination polymers, two 2D {{[(4)-M(CN)(8)](2)[Mn(dmf)(3)](2)[Mn(dmf)(4)]}2DMF}(n) (M = W 1, Mo 2) and a 1D {{[(4)-Mo(CN)(8)][Mn(dmf)(4)](2)}(ClO4)}(n) (3), were constructed from the reaction of the (Bu3NH)(3)[M(CN)(8)] (M = W, Mo) and Mn(ClO4)(2)6H(2)O molecular building blocks in DMF solvent in the presence (for 1 and 2) or absence (for 3) of the organic ligand bis(benzimidazol-2-yl)pyridine. Single-crystal X-ray diffraction structure analysis indicated that compounds 1 and 2 both crystallize in the monoclinic crystal system with the P2(1)/c space group and possess the same 2D network. The 2D layer structures of 1 and 2 have a (3,4)-connected 2-nodal topology with the point symbol {4(2)6(3)8}{4(2)6}. Compound 3 crystallizes in the tetragonal crystal system with the P4(2)/m space group. All three compounds are further assembled into 3D supramolecular structures through intermolecular C-HN or C-HO hydrogen bonds. The magnetic susceptibility of compounds 1 and 3 was investigated in the temperature range of 2-300 K; these compounds exhibit typical ferrimagnetic properties.	[Qian, Jun; Hu, Jingchun] Jiangsu Univ, Sci Res Acad, China Australia Joint Res Ctr Funct Mol Mat, Zhenjiang 212013, Peoples R China; [Qian, Jun; Zhang, Jinfang; Zhang, Chi] Jiangnan Univ, Sch Chem & Mat Engn, China Australia Joint Res Ctr Funct Mol Mat, Wuxi 214122, Peoples R China; [Yoshikawa, Hirofumi; Awaga, Kunio] Nagoya Univ, Grad Sch Sci, Dept Chem, Res Ctr Mat Sci,Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Zhang, Chi] Chinese Acad Sci, Ningbo Inst Mat Technol & Engn, Ningbo 315201, Peoples R China; [Zhang, Chi] Australian Natl Univ, Res Sch Chem, Canberra, ACT 2601, Australia	Zhang, C (reprint author), Jiangsu Univ, Sci Res Acad, China Australia Joint Res Ctr Funct Mol Mat, Zhenjiang 212013, Peoples R China.	chizhang@jiangnan.edu.cn			National Natural Science Foundation of China (NSFC) [51432006, 50925207, 51172100]; Ministry of Science and Technology of China for the International Science Linkages Program [2009DFA50620, 2011DFG52970]; Ministry of Education of China for the Changjiang Innovation Research Team [IRT14R23]; Ministry of Education and the State Administration of Foreign Experts Affairs for the 111 Project [B13025]; Jiangsu Innovation Research Team; Ministry of Education, Culture, Sports, Science and Technology (MEXT)	Financial support from the National Natural Science Foundation of China (NSFC) (grant numbers 51432006, 50925207 and 51172100), the Ministry of Science and Technology of China for the International Science Linkages Program (grant numbers 2009DFA50620 and 2011DFG52970), the Ministry of Education of China for the Changjiang Innovation Research Team (grant number IRT14R23), the Ministry of Education and the State Administration of Foreign Experts Affairs for the 111 Project (grant number B13025), and Jiangsu Innovation Research Team are gratefully acknowledged. H. Y. is grateful to the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan for a Grant-in-Aid for Scientific Research.	ADDISON AW, 1981, J HETEROCYCLIC CHEM, V18, P803; Korzeniak T, 2004, INORG CHEM, V43, P4811, DOI 10.1021/ic049402o; Sokol JJ, 2002, J AM CHEM SOC, V124, P7656, DOI 10.1021/ja0263846; Ohkoshi S, 2006, J AM CHEM SOC, V128, P5320, DOI 10.1021/ja060510e; Sutter JP, 2008, CR CHIM, V11, P1200, DOI 10.1016/j.crci.2008.04.015; Liu YY, 2012, CRYST GROWTH DES, V12, P3505, DOI 10.1021/cg300237e; Chandler BD, 2006, J AM CHEM SOC, V128, P10403, DOI 10.1021/ja060666e; Ohkoshi S, 2007, J AM CHEM SOC, V129, P3084, DOI 10.1021/ja069353+; Zhang JF, 2011, CRYST GROWTH DES, V11, P100, DOI 10.1021/cg1009779; Sha JQ, 2012, CRYSTENGCOMM, V14, P5053, DOI 10.1039/c2ce00025c; Li DF, 2003, INORG CHEM, V42, P6123, DOI 10.1021/ic034539k; Larionova J, 2000, ANGEW CHEM INT EDIT, V39, P1605, DOI 10.1002/(SICI)1521-3773(20000502)39:9<1605::AID-ANIE1605>3.0.CO;2-5; Umemura A, 2011, J AM CHEM SOC, V133, P15506, DOI 10.1021/ja204233q; Rowsell JLC, 2005, ANGEW CHEM INT EDIT, V44, P4670, DOI 10.1002/anie.200462786; Moulton B, 2001, CHEM REV, V101, P1629, DOI 10.1021/cr9900432; Murugavel R, 2004, ACCOUNTS CHEM RES, V37, P763, DOI 10.1021/ar040083e; Zhao H, 2007, CHEM-EUR J, V13, P6573, DOI 10.1002/chem.200700298; Arimoto Y, 2003, J AM CHEM SOC, V125, P9240, DOI 10.1021/ja030130i; Wang F, 2013, CRYST GROWTH DES, V13, P3522, DOI 10.1021/cg400486q; Chen SC, 2011, CRYST GROWTH DES, V11, P4190, DOI 10.1021/cg200785g; Perry JJ, 2009, CHEM SOC REV, V38, P1400, DOI 10.1039/b807086p; Zhang W, 2010, CRYSTENGCOMM, V12, P4045, DOI 10.1039/c0ce00178c; O'Keeffe M, 2009, CHEM SOC REV, V38, P1215, DOI 10.1039/b802802h; Zhong ZJ, 2000, J AM CHEM SOC, V122, P2952, DOI 10.1021/ja992622u; Lim JH, 2007, INORG CHEM, V46, P10578, DOI 10.1021/ic701243w; Hozumi T, 2003, J PHYS CHEM B, V107, P11571, DOI 10.1021/jp0356057; Rosi NL, 2005, J AM CHEM SOC, V127, P1504, DOI 10.1021/ja045123o; Yaghi OM, 2003, NATURE, V423, P705, DOI 10.1038/nature01650; Panda T, 2011, CHEM COMMUN, V47, P2011, DOI 10.1039/c0cc04169f; Ferey G, 2008, CHEM SOC REV, V37, P191, DOI 10.1039/b618320b; Herrera JM, 2004, ANGEW CHEM INT EDIT, V43, P5468, DOI 10.1002/anie.200460387; Bernini MC, 2011, INORG CHEM, V50, P5958, DOI 10.1021/ic102472u; Zhong ZJ, 2000, INORG CHEM, V39, P5095, DOI 10.1021/ic0005994; McManus GJ, 2004, CRYST GROWTH DES, V4, P11, DOI 10.1021/cg034199d; Eubank JF, 2011, J AM CHEM SOC, V133, P14204, DOI 10.1021/ja205658j; Podgajny R, 2010, CRYST GROWTH DES, V10, P4693, DOI 10.1021/cg100920c; Przychodzen P, 2007, INORG CHEM, V46, P8924, DOI 10.1021/ic700795q; Tam AYY, 2008, CHEM-EUR J, V14, P4562, DOI 10.1002/chem.200701914; Lin ZJ, 2007, J AM CHEM SOC, V129, P10334, DOI 10.1021/ja0737671; Nouar F, 2008, J AM CHEM SOC, V130, P1833, DOI [10.1021/ja710123s, 10.1021/ja710123sS0002-7863(71)00123-9]; Ma SL, 2008, CRYST GROWTH DES, V8, P3761, DOI 10.1021/cg800392a; O'Keeffe M, 2012, CHEM REV, V112, P675, DOI 10.1021/cr200205j; Po C, 2014, CHEM SCI, V5, P2688, DOI 10.1039/c4sc00411f; Moulton B, 2002, ANGEW CHEM INT EDIT, V41, P2821, DOI 10.1002/1521-3773(20020802)41:15<2821::AID-ANIE2821>3.0.CO;2-Y; Eddaoudi M, 2001, ACCOUNTS CHEM RES, V34, P319, DOI 10.1021/ar000034b; Chae HK, 2004, NATURE, V427, P523, DOI 10.1038/nature02311; Tranchemontagne DJ, 2009, CHEM SOC REV, V38, P1257, DOI 10.1039/b817735j; Risset ON, 2014, J AM CHEM SOC, V136, P15660, DOI [10.1021/ja5084283, 10.1021/ja50842831]; Dybtsev DN, 2004, J AM CHEM SOC, V126, P32, DOI 10.1021/ja038678c; Han Y, 2011, CRYST GROWTH DES, V11, P3448, DOI 10.1021/cg200250m; Ma LQ, 2008, J AM CHEM SOC, V130, P13834, DOI 10.1021/ja804944r; Harvey MA, 2013, J CHEM CRYSTALLOGR, V43, P275, DOI 10.1007/s10870-013-0415-0; Kesanli B, 2003, COORDIN CHEM REV, V246, P305, DOI 10.1016/j.cct.2003.08.004; Wang TW, 2010, INORG CHEM, V49, P7756, DOI 10.1021/ic100591h; Wang ZX, 2007, INORG CHEM, V46, P10990, DOI 10.1021/ic070195c; Venkatakrishnan TS, 2007, INORG CHEM, V46, P9569, DOI 10.1021/ic062383t; Wang J, 2010, DALTON T, V39, P3489, DOI 10.1039/b924203a; Wang JL, 2005, J INORG BIOCHEM, V99, P883, DOI 10.1016/j.jinorgbio.2004.12.018; Kashiwagi T, 2004, J AM CHEM SOC, V126, P5024, DOI 10.1021/ja030648m; Jing XM, 2010, CRYST GROWTH DES, V10, P492, DOI 10.1021/cg9015096; Podgajny R, 2008, CRYST GROWTH DES, V8, P3817, DOI 10.1021/cg800470e; Boca R, 2001, INORG CHEM, V40, P3025, DOI 10.1021/ic000807s; Vaidyanathan VG, 2003, J INORG BIOCHEM, V94, P121, DOI 10.1016/S0162-0134(02)00620-7; Zhou H, 2007, INORG CHEM COMMUN, V10, P940, DOI 10.1016/j.inoche.2007.04.031; Sugaya A, 2014, NEW J CHEM, V38, P1955, DOI 10.1039/c3nj01564e; Cook TR, 2013, CHEM REV, V113, P734, DOI 10.1021/cr3002824; Farha OK, 2010, ACCOUNTS CHEM RES, V43, P1166, DOI 10.1021/ar1000617; Rivera EJ, 2007, INORG CHEM, V46, P8569, DOI 10.1021/ic7006183; Lee YH, 2011, POLYHEDRON, V30, P3001, DOI 10.1016/j.poly.2011.02.015; Eubank JF, 2011, J AM CHEM SOC, V133, P17532, DOI 10.1021/ja203898s; Ruiz E, 2005, ANGEW CHEM INT EDIT, V44, P2711, DOI 10.1002/anie.200500129; Yang GS, 2011, CRYSTENGCOMM, V13, P1461, DOI 10.1039/c0ce00259c; Lim JH, 2006, ANGEW CHEM INT EDIT, V45, P7424, DOI 10.1002/anie.200601759; Halper SR, 2006, J AM CHEM SOC, V128, P15255, DOI 10.1021/ja0645483; Suh MP, 2012, CHEM REV, V112, P782, DOI 10.1021/cr200274s; Wang P, 2010, CHEM-EUR J, V16, P6900, DOI 10.1002/chem.201000167; Stock N, 2012, CHEM REV, V112, P933, DOI 10.1021/cr200304e; Bao SS, 2014, J AM CHEM SOC, V136, P9292, DOI 10.1021/ja505916c; Pan C, 2011, J AM CHEM SOC, V133, P12330, DOI 10.1021/ja2031568; Cui YJ, 2012, CHEM REV, V112, P1126, DOI 10.1021/cr200101d; Zaworotko MJ, 2007, CRYST GROWTH DES, V7, P4, DOI 10.1021/cg0680172; Mitina TG, 2013, CRYST GROWTH DES, V13, P1655; Tanase S, 2008, INORG CHIM ACTA, V361, P3548, DOI 10.1016/j.ica.2008.03.026; Li DF, 2003, CHEM MATER, V15, P2094, DOI 10.1021/cm030144n; Chen BL, 2005, ANGEW CHEM INT EDIT, V44, P4745, DOI 10.1002/anie.200462787; Ohkoshi S, 2008, CHEM MATER, V20, P3048, DOI 10.1021/cm703258n; Arimoto Y, 2002, CHEM LETT, P832, DOI 10.1246/cl.2002.832; Boca M, 2011, COORDIN CHEM REV, V255, P290, DOI 10.1016/j.ccr.2010.09.010; Boca R, 2005, INORG CHEM COMMUN, V8, P227, DOI 10.1016/j.inoche.2004.12.014; Chang F, 2002, INORG CHEM COMMUN, V5, P660, DOI 10.1016/S1387-7003(02)00518-X; Chen B., 2005, ANGEW CHEM, V117, P4823, DOI 10.1002/ange.200462787; Desiraju GR, 2002, ACCOUNTS CHEM RES, V35, P565, DOI 10.1021/ar010054t; Desiraju GR, 2005, CHEM COMMUN, P2995, DOI 10.1039/b504372g; Dietrich B., 1993, MACROCYCLIC CHEM; Dong W, 2003, NEW J CHEM, V27, P1760, DOI 10.1039/b306755f; Enamullah M, 2002, THERMOCHIM ACTA, V388, P401, DOI 10.1016/S0040-6031(02)00043-6; Ghosh S, 2002, INORG CHEM, V41, P2243, DOI 10.1021/ic010945x; Hagiwara H., 2007, INORG CHEM, V46, P336; Hayami S, 2007, POLYHEDRON, V26, P2375, DOI 10.1016/j.poly.2007.02.021; Herrera J. M., 2004, ANGEW CHEM, V116, P5584, DOI 10.1002/ange.200460387; Kim JI, 2008, EUR J INORG CHEM, P2756, DOI 10.1002/ejic.200800232; Kitagawa S, 2004, ANGEW CHEM INT EDIT, V43, P2334, DOI 10.1002/anie.200300610; Kitagawa S., 2004, ANGEW CHEM, V116, DOI 10.1002/ange.200300610; Larionova J., 2000, ANGEW CHEM, V112, P1667, DOI 10.1002/(SICI)1521-3757(20000502)112:9<1667::AID-ANGE1667>3.0.CO;2-3; Larionova J, 2003, CRYST GROWTH DES, V3, P267, DOI 10.1021/cg020048j; Li DF, 2002, J CHEM SOC DALTON, P2805, DOI 10.1039/b205197b; Li DF, 2002, NEW J CHEM, V26, P1190, DOI 10.1039/b110635j; Lim JH, 2008, EUR J INORG CHEM, P3428, DOI 10.1002/ejic.200800416; Lim J. H., 2006, ANGEW CHEM, V118, P7584, DOI 10.1002/ange.200601759; Liu BL, 2009, SCI CHINA SER B, V52, P1801, DOI 10.1007/s11426-009-0246-1; Long J, 2009, INORG CHEM, V48, P22, DOI 10.1021/ic801901j; Malecki JG, 2012, POLYHEDRON, V44, P221, DOI 10.1016/j.poly.2012.07.002; Mathoniere C, 2005, CHEM MATER, V17, P442, DOI 10.1021/cm0487851; Miller AR, 2001, EWEEK, V18, P46; Moulton B., 2002, ANGEW CHEM, V114, P2945, DOI 10.1002/1521-3757(20020802)114:15<2945::AID-ANGE2945>3.0.CO;2-4; Nowicka B, 2007, INORG CHEM, V46, P8123, DOI 10.1021/ic701168x; Podgajny R, 2003, DALTON T, P3458, DOI 10.1039/b306422k; Podgajny R, 2010, EUR J INORG CHEM, P4166, DOI 10.1002/ejic.201000280; Podgajny R, 2002, INORG CHEM, V41, P1323, DOI 10.1021/ic010679n; Podgajny R, 2006, DALTON T, P2801, DOI 10.1039/b516004a; PRIBUSH RA, 1974, INORG CHEM, V13, P2556, DOI 10.1021/ic50141a007; Przychodzen P, 2004, INORG CHEM, V43, P2967, DOI 10.1021/ic035464n; Przychodzen P, 2006, DALTON T, P625, DOI 10.1039/b511788g; Rombaut G, 2000, J CHEM SOC DALTON, P3609, DOI 10.1039/b003983g; Rowsell J. L. C., 2005, ANGEW CHEM, V117, P4748, DOI 10.1002/ange.200462786; SADABS, 1997, AR DET ABS CORR PROG; Sheldrick G M, 1997, SHELXTL VERSION 5 1; SMART and SAINT, 1997, SMART SAINT AR DET S; STRAUSS B, 1993, MONATSH CHEM, V124, P391, DOI 10.1007/BF00814135; Su YH, 2014, INORG CHEM, V53, P6042, DOI 10.1021/ic500356b; Tsunobuchi Y, 2011, CRYST GROWTH DES, V11, P5561, DOI 10.1021/c92011265; Vaidyanathan VG, 2005, EUR J INORG CHEM, P3756, DOI 10.1002/ejic.200500335; Vaidyanathan VG, 2003, EUR J INORG CHEM, P3633, DOI 10.1002/ejic.200300170; Vaidyanathan VG, 2002, J INORG BIOCHEM, V91, P405, DOI 10.1016/S0162-0134(02)00448-8; Vaidyanathan VG, 2005, DALTON T, P2842, DOI 10.1039/b502917a; Wang BW, 2007, POLYHEDRON, V26, P2054, DOI 10.1016/j.poly.2006.09.099; Wang ZX, 2009, INORG CHEM COMMUN, V12, P1179, DOI 10.1016/j.inoche.2009.09.011; Wen HM, 2010, INORG CHEM, V49, P2210, DOI 10.1021/ic902019s; Whyte AM, 2011, INORG CHEM, V50, P12867, DOI 10.1021/ic2020644; Withers JR, 2006, INORG CHEM, V45, P4307, DOI 10.1021/ic0515251; Xia J, 2013, J COORD CHEM, V66, P539, DOI 10.1080/00958972.2012.763118; Yamada R, 2012, CRYST GROWTH DES, V12, P2013, DOI 10.1021/cg201710s; Yang FL, 2015, CRYST GROWTH DES, V15, P176, DOI 10.1021/cg501128n; Yoon JH, 2007, INORG CHEM, V46, P1529, DOI 10.1021/ic0621743d; Yoon JH, 2005, INORG CHEM, V44, P7714, DOI 10.1021/ic051415u; You YS, 2005, INORG CHEM, V44, P7063, DOI 10.1021/ic050634c; You YS, 2004, INORG CHEM, V43, P6899, DOI 10.1021/ic048856i; Yuan R, 2012, J INORG ORGANOMET P, V22, P507, DOI 10.1007/s10904-011-9649-5; Zaworotko M. J, 2010, J AM CHEM SOC, V132, P7821; Zhang W, 2011, DALTON T, V40, P2735, DOI 10.1039/c0dt01213k; Zhu Y, 2013, POLYHEDRON, V61, P181, DOI 10.1016/j.poly.2013.05.041	151	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1434-1948	1099-0682		EUR J INORG CHEM	Eur. J. Inorg. Chem.	APR	2015		12					2110	2119		10.1002/ejic.201403223		10	Chemistry, Inorganic & Nuclear	Chemistry	CG6FD	WOS:000353391700014		
J	Seno, A; Maruhashi, T; Kaifu, T; Yabe, R; Fujikado, N; Ma, GY; Ikarashi, T; Kakuta, S; Iwakura, Y				Seno, Akimasa; Maruhashi, Takumi; Kaifu, Tomonori; Yabe, Rikio; Fujikado, Noriyuki; Ma, Guangyu; Ikarashi, Tetsuro; Kakuta, Shigeru; Iwakura, Yoichiro			Exacerbation of experimental autoimmune encephalomyelitis in mice deficient for DCIR, an inhibitory C-type lectin receptor	EXPERIMENTAL ANIMALS			English	Article						C-type lectin receptor; dendritic cell immunoreceptor; experimental autoimmune encephalomyelitis; multiple sclerosis	CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; T-CELL-ACTIVATION; CYTOKINE GM-CSF; MULTIPLE-SCLEROSIS; RHEUMATOID-ARTHRITIS; DENDRITIC CELLS; IFN-GAMMA; EFFECTOR PHASE	Dendritic cell immunoreceptor (DCIR) is a C-type lectin receptor containing a carbohydrate recognition domain in its extracellular portion and an immunoreceptor tyrosine-based inhibitory motif, which transduces negative signals into cells, in its cytoplasmic portion. Previously, we showed that Dcir(-/-) mice spontaneously develop autoimmune diseases such as enthesitis and sialadenitis due to excess expansion of dendritic cells (DCs), suggesting that DCIR is critically important for the homeostasis of the immune system. In this report, we analyzed the role of DCIR in the development of experimental autoimmune encephalomyelitis (EAE), an autoimmune disease model for multiple sclerosis. We found that EAE was exacerbated in Dcir(-/-) mice associated with severe demyelination of the spinal cords. The number of infiltrated CD11c(+) DCs and CD4(+) T cells into spinal cords was increased in Dcir(-/-) mice. Recall proliferative response of lymph node cells was higher in Dcir(-/-) mice compared with wild-type mice. These observations suggest that DCIR is an important negative regulator of the immune system, and Dcir(-/-) mice should be useful for analyzing the roles of DCIR in an array of autoimmune diseases.	[Seno, Akimasa; Maruhashi, Takumi; Kaifu, Tomonori; Yabe, Rikio; Fujikado, Noriyuki; Ma, Guangyu; Iwakura, Yoichiro] Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Minato Ku, Tokyo 1088639, Japan; [Seno, Akimasa; Maruhashi, Takumi; Kaifu, Tomonori; Yabe, Rikio; Iwakura, Yoichiro] Tokyo Univ Sci, Res Inst Biomed Sci, Ctr Anim Dis Models, Noda, Chiba 2780022, Japan; [Seno, Akimasa; Iwakura, Yoichiro] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, Kashiwa, Chiba 2770882, Japan; [Kaifu, Tomonori; Iwakura, Yoichiro] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Ikarashi, Tetsuro; Kakuta, Shigeru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomed Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Iwakura, Yoichiro] Chiba Univ, Med Mycol Res Ctr, Chuo Ku, Chiba 2508673, Japan	Iwakura, Y (reprint author), Tokyo Univ Sci, Res Inst Biomed Sci, Ctr Anim Dis Models, 2641 Yamazaki, Noda, Chiba 2780022, Japan.				Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry; CREST from Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan; Global COE Program "Deciphering Biosphere from Genome Big Bang", MEXT, Japan	We thank to all members of our laboratory for their kind cooperation, discussion and animal care. We thank to Prof. Masahira Hattori for valuable discussion, Dr. Shinobu Ohmi for MOG<INF>35-55</INF> synthesis, and Dr. Shinobu Saijo for critical reading of the manuscript. This work was supported by the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry (to Y. I.), CREST from Japan Science and Technology Agency (Y. I.), and Grants-in Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Y. I.). A. S. is supported by the Global COE Program "Deciphering Biosphere from Genome Big Bang", MEXT, Japan.	Komiyama Y, 2006, J IMMUNOL, V177, P566; VOORTHUIS JAC, 1990, CLIN EXP IMMUNOL, V81, P183; Litzenburger T, 1998, J EXP MED, V188, P169, DOI 10.1084/jem.188.1.169; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Furlan R, 2001, J IMMUNOL, V167, P1821; Lund FE, 2010, NAT REV IMMUNOL, V10, P236, DOI 10.1038/nri2729; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; McMahon EJ, 2005, NAT MED, V11, P335, DOI 10.1038/nm1202; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Liu JL, 1998, NAT MED, V4, P78, DOI 10.1038/nm0198-078; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Nakae S, 2001, J IMMUNOL, V167, P90; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Mills KHG, 2011, NAT REV IMMUNOL, V11, P807, DOI 10.1038/nri3095; Meyer-Wentrup F, 2008, BLOOD, V111, P4245, DOI 10.1182/blood-2007-03-081398; Ueno H, 2007, IMMUNOL REV, V219, P118, DOI 10.1111/j.1600-065X.2007.00551.x; Meyer-Wentrup F, 2009, J LEUKOCYTE BIOL, V85, P518, DOI 10.1189/jlb.0608352; Zhou D, 2006, J NEUROIMMUNOL, V178, P103; BILLIAU A, 1988, J IMMUNOL, V140, P1506; Rao P, 2004, METH MOLEC MED, V102, P363; Matsuki T, 2006, INT IMMUNOL, V18, P399, DOI 10.1093/intimm/dxh379; Willenborg DO, 1996, J IMMUNOL, V157, P3223; Bates EEM, 1999, J IMMUNOL, V163, P1973; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Matsushita T, 2008, J CLIN INVEST, V118, P3420, DOI 10.1172/JCI36030; Bailey SL, 2007, NAT IMMUNOL, V8, P172, DOI 10.1038/ni1430; Huang DR, 2001, J EXP MED, V193, P713, DOI 10.1084/jem.193.6.713; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Blass S, 1997, ANN RHEUM DIS, V56, P317; NIENHUIS RL, 1964, ANN RHEUM DIS, V23, P302, DOI 10.1136/ard.23.4.302; Dittel BN, 1999, J IMMUNOL, V163, P32; Marta M, 2009, ANN NY ACAD SCI, V1173, P458, DOI 10.1111/j.1749-6632.2009.04849.x; Lee E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-7; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Thakker P, 2007, J IMMUNOL, V178, P2589; Kroenke MA, 2008, J EXP MED, V205, P1535, DOI 10.1084/jem.20080159; Comabella M, 2010, NAT REV NEUROL, V6, P499, DOI 10.1038/nrneurol.2010.112; Fujikado N, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1985; Fujikado N., 2008, NAT MED, V14, P176; HOET RMA, 1991, ANN RHEUM DIS, V50, P611, DOI 10.1136/ard.50.9.611; Lackner KJ, 1998, BRIT J RHEUMATOL, V37, P1164; Okuda Y, 2002, J NEUROIMMUNOL, V131, P115, DOI 10.1016/S0165-5728(02)00267-9; Yonekawa A, 2014, IMMUNITY, V41, P402, DOI 10.1016/j.immuni.2014.08.005	46	1	1	INT PRESS EDITING CENTRE INC	TOKYO	1-2-3 SUGAMO, TOSHIMA-KU, TOKYO, 170 0002, JAPAN	1341-1357	1881-7122		EXP ANIM TOKYO	Exp. Anim.	APR	2015	64	2					109	119				11	Veterinary Sciences; Zoology	Veterinary Sciences; Zoology	CG9WL	WOS:000353670700002		
J	Tanaka, M; Watanabe, M; Yokomi, I; Matsumoto, N; Sudo, K; Satoh, H; Igarashi, T; Seki, A; Amano, H; Ohura, K; Ryu, K; Shibata, S; Nagayama, M; Tanuma, J				Tanaka, Masami; Watanabe, Minoru; Yokomi, Izuru; Matsumoto, Naoki; Sudo, Katsuko; Satoh, Hitoshi; Igarashi, Tsuneo; Seki, Azusa; Amano, Hitoshi; Ohura, Kiyoshi; Ryu, Kakei; Shibata, Shunichi; Nagayama, Motohiko; Tanuma, Jun-ichi			Establishment of a novel dwarf rat strain: cartilage calcification insufficient (CCI) rats	EXPERIMENTAL ANIMALS			English	Article						animal model; cartilage; calcification; dwarf; rat	GROWTH-FACTOR RECEPTOR-3; NATRIURETIC PEPTIDE; GH DEFICIENCY; HORMONE GH; ACHONDROPLASIA; MOUSE; CHONDROCYTES; MUTATION; MODEL; DIFFERENTIATION	Rats with dwarfism accompanied by skeletal abnormalities, such as shortness of the limbs, tail, and body (dwarf rats), emerged in a Jcl-derived Sprague-Dawley rat colony maintained at the Institute for Animal Experimentation, St. Marianna University Graduate School of Medicine. Since the dwarfism was assumed to be due to a genetic mutation based on its frequency, we bred the dwarf rats and investigated their characteristics in order to identify the causative factors of their phenotypes and whether they could be used as a human disease model. One male and female that produced dwarf progeny were selected, and reproduction was initiated by mating the pair. The incidence of dwarfism was 25.8% among the resultant litter, and dwarfism occurred in both genders, suggesting that it was inherited in an autosonnal recessive manner. At 12 weeks of age, the body weights of the male and female dwarf rats were 40% and 57% of those of the normal rats, respectively. In soft X-ray radiographic and histological examinations, shortening and hypoplasia of the long bones, such as the tibia and femur, were observed, which were suggestive of endochondral ossification abnormalities. An immunohistochemical examination detected an aggrecan synthesis disorder, which might have led to delayed calcification and increased growth plate thickening in the dwarf rats. We hypothesized that the principal characteristics of the dwarf rats were systemically induced by insufficient cartilage calcification in their long bones; thus, we named them cartilage calcification insufficient (CCI) rats.	[Tanaka, Masami] Univ Aizu, Dept Food & Nutr, Jr Coll Div, Fukushima 9658570, Japan; [Watanabe, Minoru] St Marianna Univ, Grad Sch Med, Inst Anim Experimentat, Kawasaki, Kanagawa 2168511, Japan; [Yokomi, Izuru; Matsumoto, Naoki] St Marianna Univ, Sch Med, Dept Pharmacol, Kawasaki, Kanagawa 2168511, Japan; [Sudo, Katsuko] Tokyo Med Univ, Anim Res Ctr, Tokyo 1608402, Japan; [Satoh, Hitoshi] Univ Tokyo, Grad Sch Frontier Sci, Lab Tumor Cell Biol, Tokyo 1088639, Japan; [Igarashi, Tsuneo] Anim Care Co Ltd, Tokyo 1640001, Japan; [Seki, Azusa] Hamri Co Ltd, Tokyo 1100005, Japan; [Amano, Hitoshi; Ohura, Kiyoshi] Osaka Dent Univ, Dept Pharmacol, Osaka 5731121, Japan; [Ryu, Kakei] Showa Univ, Sch Med, Dept Pharmacol, Tokyo 1428555, Japan; [Shibata, Shunichi] Tokyo Med & Dent Univ, Grad Sch, Maxillofacial Anat, Dept Maxillofacial Biol,Maxillofacial Neck Recons, Tokyo 1138549, Japan; [Nagayama, Motohiko; Tanuma, Jun-ichi] Asahi Univ, Sch Dent, Dept Oral Pathol, Hozumi, Gifu 5010296, Japan	Tanaka, M (reprint author), Univ Aizu, Dept Food & Nutr, Jr Coll Div, Fukushima 9658570, Japan.				JSPS KAKENHI Grant [20591792]	This study was supported by JSPS KAKENHI Grant Number 20591792.	Amano H, 1989, Shika Kiso Igakkai Zasshi, V31, P404; Koyama E, 2007, DEVELOPMENT, V134, P2159, DOI 10.1242/dev.001586; Chikuda H, 2004, GENE DEV, V18, P2418, DOI 10.1101/gad.1224204; Shibata S, 2003, ANAT EMBRYOL, V207, P35, DOI 10.1007/s00429-003-0325-6; Rousseau F, 1996, HORM RES, V45, P108; Tsuji T, 2005, J BIOL CHEM, V280, P14288, DOI 10.1074/jbc.C500024200; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Chusho H, 2001, P NATL ACAD SCI USA, V98, P4016, DOI 10.1073/pnas.071389098; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Yasoda A, 2004, NAT MED, V10, P80, DOI 10.1038/nm971; Watanabe H, 1997, P NATL ACAD SCI USA, V94, P6943, DOI 10.1073/pnas.94.13.6943; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; Wang YC, 1999, P NATL ACAD SCI USA, V96, P4455, DOI 10.1073/pnas.96.8.4455; Mackie EJ, 2011, J ENDOCRINOL, V211, P109, DOI 10.1530/JOE-11-0048; Sato T, 2011, J BIOL CHEM, V286, P5803, DOI 10.1074/jbc.M110.159244; CHARLTON HM, 1988, J ENDOCRINOL, V119, P51, DOI 10.1677/joe.0.1190051; Domowicz MS, 2009, DEV BIOL, V329, P242, DOI 10.1016/j.ydbio.2009.02.024; Michigami T, 2013, CELL MOL LIFE SCI, V70, P4213, DOI 10.1007/s00018-013-1346-9; Nagayama M, 2008, J DENT RES, V87, P244; NOGAMI H, 1992, HORM METAB RES, V24, P300, DOI 10.1055/s-2007-1003317; SHIBATA S, 1991, ARCH ORAL BIOL, V36, P541, DOI 10.1016/0003-9969(91)90149-O; Shur BD, 1998, GLYCOCONJUGATE J, V15, P537, DOI 10.1023/A:1006951407168; TAKEUCHI T, 1990, ENDOCRINOLOGY, V126, P31; Tsuchida A, 2008, COMPARATIVE MED, V58, P560; WASSARMAN PM, 1990, DEVELOPMENT, V108, P1; Yamamoto H, 1998, EXP ANIM TOKYO, V47, P131, DOI 10.1538/expanim.47.131	26	0	0	INT PRESS EDITING CENTRE INC	TOKYO	1-2-3 SUGAMO, TOSHIMA-KU, TOKYO, 170 0002, JAPAN	1341-1357	1881-7122		EXP ANIM TOKYO	Exp. Anim.	APR	2015	64	2					121	128				8	Veterinary Sciences; Zoology	Veterinary Sciences; Zoology	CG9WL	WOS:000353670700003		
J	Tsukamoto, A; Ilmuro, M; Sato, R; Yamazaki, J; Inomata, T				Tsukamoto, Atsushi; Ilmuro, Mami; Sato, Reiichiro; Yamazaki, Jumpei; Inomata, Tomo			Effect of midazolam and butorphanol premedication on inhalant isoflurane anesthesia in mice	EXPERIMENTAL ANIMALS			English	Article						balanced anesthesia; inhalant anesthesia; respiratory depression	MINIMUM ALVEOLAR CONCENTRATION; INJECTABLE ANESTHETICS; LABORATORY MICE; SEVOFLURANE; DOGS; INDUCTION; MEDETOMIDINE; HALOTHANE; KETAMINE; NOCICEPTION	lsoflurane is a representative inhalant anesthesia used in laboratory animals. However, isoflurane mediates respiratory depression and adverse clinical reactions during induction. In the present study, we established a novel balanced anesthesia method in mice that combined isoflurane anesthesia with midazolam and butorphanol (MB). Thirty-four male C57BL/6J mice received either isoflurane alone or isoflurane with an intra-peritoneal MB premedication (3 mg/kg midazolam and 4 mg/kg butorphanol). The minimum alveolar concentration (MAC) in each group was evaluated. Induction time and adverse clinical reactions were recorded in each group. Core body temperature, heart rate, respiratory rate, and oxygen saturation (SPO2) were assessed before and for 1 h after induction. Premedication with MB achieved a significant reduction in MAC compared with isoflurane monoanesthesia (isoflurane, 1.38 +/- 0.15%; isoflurane with MB, 0.78 +/- 0.10%; P<0.05). Induction time was significantly shortened with MB premedication, and adverse reactions such as excitement or incontinence were observed less frequently. Furthermore, isoflurane anesthesia with MB premedication caused increase of respiratory rates compared to isoflurane monoanesthesia. No significant decrease of SPO2 was observed in MBI anesthesia, while a decrease in SPO2 was apparent with isoflurane monoanesthesia (baseline, 98.3% +/- 1.1; 10 min after induction, 91.8 +/- 6.4%; P<0.05). In conclusion, premedication with MB was effective for the mitigation of respiratory depression induced by isoflurane in mice, with rapid induction and fewer adverse clinical reactions.	[Tsukamoto, Atsushi; Ilmuro, Mami; Inomata, Tomo] Azabu Univ, Sch Vet Med, Lab Lab Anim Sci, Chuou Ku, Sagamihara, Kanagawa 2525201, Japan; [Sato, Reiichiro] Azabu Univ, Sch Vet Med, Lab Vet Internal Med, Chuou Ku, Sagamihara, Kanagawa 2525201, Japan; [Yamazaki, Jumpei] Hokkaido Univ, Grad Sch Vet Med, Lab Mol Med, Sapporo, Hokkaido 0600818, Japan	Inomata, T (reprint author), Azabu Univ, Sch Vet Med, Lab Lab Anim Sci, Chuou Ku, 1-17-71 Fuchinobe, Sagamihara, Kanagawa 2525201, Japan.		Yamazaki, Jumpei/A-3360-2012				Kawai S, 2011, EXP ANIM TOKYO, V60, P481, DOI 10.1538/expanim.60.481; Richardson CA, 2005, ATLA-ALTERN LAB ANIM, V33, P119; Sonner JM, 1999, ANESTH ANALG, V89, P1030, DOI 10.1097/00000539-199910000-00039; Buitrago S, 2008, J AM ASSOC LAB ANIM, V47, P11; Psatha E, 2011, VET ANAESTH ANALG, V38, P24, DOI 10.1111/j.1467-2995.2010.00577.x; Gargiulo S, 2012, ILAR J, V53, pE55, DOI 10.1093/ilar.53.1.55; Cesarovic N, 2010, LAB ANIM-UK, V44, P329, DOI 10.1258/la.2010.009085; Kirihara Y, 2013, EXP ANIM TOKYO, V62, P173, DOI 10.1538/expanim.62.173; Arras M, 2001, COMPARATIVE MED, V51, P443; Muir WW, 2003, AM J VET RES, V64, P1155, DOI 10.2460/ajvr.2003.64.1155; Alves HC, 2009, LAB ANIM-UK, V43, P27, DOI 10.1258/la.2008.007036; Cesarovic N, 2012, J AM ASSOC LAB ANIM, V51, P209; Chaves AA, 2003, LIFE SCI, V72, P2401, DOI 10.1016/S0024-3205(03)00137-1; Chiba S, 2009, J PHARMACOL SCI, V109, P71, DOI 10.1254/jphs.08094FP; Constantinides Christakis, 2011, ILAR J, V52, pe21; de Jong R H, 1975, Anesthesiology, V42, P384, DOI 10.1097/00000542-197504000-00003; Diven Kinta, 2003, Lab Anim (NY), V32, P44, DOI 10.1038/laban0303-44; Doherty TJ, 1997, J VET PHARMACOL THER, V20, P408, DOI 10.1046/j.1365-2885.1997.00086.x; EBERT TJ, 1995, ANESTH ANALG, V81, pS11, DOI 10.1097/00000539-199512001-00003; Flecknell P.A., 2010, GEN ANESTHESIA, V3rd; GROSS ME, 1993, VET SURG, V22, P159, DOI 10.1111/j.1532-950X.1993.tb01692.x; Konno K, 2014, J VET MED SCI, V76, P1375, DOI 10.1292/jvms.14-0146; Mogil JS, 2005, ANESTHESIOLOGY, V103, P751, DOI 10.1097/00000542-200510000-00013; Mutoh T, 1995, J VET MED SCI, V57, P1121; Mutoh T, 2001, J VET MED A, V48, P223, DOI 10.1046/j.1439-0442.2001.00350.x; Mutoh T, 1995, J VET MED SCI, V57, P1007; Rosow C.E., 1988, ACUTE CARE S1, V12, P2; Sano T, 2003, J VET MED SCI, V65, P1141, DOI 10.1292/jvms.65.1141; Sinha Chandni, 2012, J Anaesthesiol Clin Pharmacol, V28, P32, DOI 10.4103/0970-9185.92431; SMITH W, 1993, LAB ANIM, V27, P30, DOI 10.1258/002367793781082377; Tao F, 2010, ANESTHESIOLOGY, V112, P1444, DOI 10.1097/ALN.0b013e3181dcd3dc; Tonner P H, 2005, Best Pract Res Clin Anaesthesiol, V19, P475, DOI 10.1016/j.bpa.2005.02.005; Tranquilli WJ, 2007, LUMB JONES VET ANEST; Tsukamoto A, 2015, EXP ANIM TOKYO, V64, P57, DOI 10.1538/expanim.14-0050; Wiersema AM, 1997, LAB ANIM, V31, P151, DOI 10.1258/002367797780600125; Yu DS, 2013, J ANESTH, V27, P750, DOI 10.1007/s00540-013-1609-5	36	0	0	INT PRESS EDITING CENTRE INC	TOKYO	1-2-3 SUGAMO, TOSHIMA-KU, TOKYO, 170 0002, JAPAN	1341-1357	1881-7122		EXP ANIM TOKYO	Exp. Anim.	APR	2015	64	2					139	145				7	Veterinary Sciences; Zoology	Veterinary Sciences; Zoology	CG9WL	WOS:000353670700005		
J	Hayashimoto, N; Morita, H; Ishida, T; Uchida, R; Tanaka, M; Ozawa, M; Yasuda, M; Itoh, T				Hayashimoto, Nobuhito; Morita, Hanako; Ishida, Tomoko; Uchida, Ritsuki; Tanaka, Mai; Ozawa, Midori; Yasuda, Masahiko; Itoh, Toshio			Microbiological survey of mice (Mus musculus) purchased from commercial pet shops in Kanagawa and Tokyo, Japan	EXPERIMENTAL ANIMALS			English	Article						Infectious disease; Mice; Pet shop; Zoonosis	POLYMERASE-CHAIN-REACTION; TRANSPLANTABLE TUMORS; LABORATORY MICE; CELL-LINES; HOUSE MICE; CONTAMINATION; INFECTION; VIRUSES; RATS; RNA	Information regarding the prevalence of infectious agents in mice in pet shops in Japan is scarce. This information is particularly useful for minimizing the risk of potential transmission of infections to laboratory mice. Therefore, we surveyed infectious agents in mice from pet shops in Kanagawa and Tokyo, Japan. The survey was conducted in 28 mice from 5 pet shops to screen for 47 items (17 viruses, 22 bacteria and fungi, 10 parasites) using culture tests, serology, PCR, and microscopy. The most common viral agent detected was murine norovirus (17 mice; 60.7%), followed by Theiler's murine encephalomyelitis virus (13 mice; 46.4%), and mouse hepatitis virus (12 mice; 42.8%). The most common agent amongst the bacteria and fungi was Pasteurella pneumotropica (10 mice; 35.7%), followed by Helicobacter ganmani and Pneumocystis murina (8 mice; 28.5%, for both). Tritrichomonas muris was the most common parasite (19 mice; 67.8%), followed by Spironucleus muris (13 mice; 46.4%), Aspiculuris tetraptera, and Syphacia obvelata (8 mice each; 28.5%). Remarkably, a zoonotic agent, Hymenolepis nana, was found in 7 mice (25%). Given these results, we suggest that the workers in laboratory animal facilities should recognize again the potential risks of mice outside of the laboratory animal facilities as an infectious source, and avoid keeping mice as pets or as feed for carnivorous reptiles as much as possible for risk management.	[Hayashimoto, Nobuhito; Morita, Hanako; Ishida, Tomoko; Uchida, Ritsuki; Tanaka, Mai; Ozawa, Midori] Cent Inst Expt Anim, ICLAS Monitoring Ctr, Kawasaki Ku, Kawasaki, Kanagawa 2100821, Japan; [Yasuda, Masahiko] Cent Inst Expt Anim, Pathol Anal Ctr, Kawasaki Ku, Kawasaki, Kanagawa 2100821, Japan; [Itoh, Toshio] Cent Inst Expt Anim, Marmoset Res Dept, Kawasaki Ku, Kawasaki, Kanagawa 2100821, Japan	Hayashimoto, N (reprint author), Cent Inst Expt Anim, ICLAS Monitoring Ctr, Kawasaki Ku, 3-25-12 Tonomachi, Kawasaki, Kanagawa 2100821, Japan.						Becker SD, 2007, LAB ANIM-UK, V41, P229, DOI 10.1258/002367707780378203; Hayashimoto N, 2013, EXP ANIM TOKYO, V62, P41, DOI 10.1538/expanim.62.41; BESSELSEN DG, 1995, J CLIN MICROBIOL, V33, P2859; Cho SC, 2009, GASTROINTEST ENDOSC, V70, P784, DOI 10.1016/j.gie.2009.05.024; Dammann P, 2011, LAB ANIM-UK, V45, P271, DOI 10.1258/la.2011.010183; Goto K, 1998, LAB ANIM SCI, V48, P99; Goto K, 2009, EXP ANIM TOKYO, V58, P47, DOI 10.1538/expanim.58.47; Goto K, 2009, EXP ANIM TOKYO, V58, P135, DOI 10.1538/expanim.58.135; Goto K, 2000, CURR MICROBIOL, V41, P161, DOI 10.1007/s002840010111; Hunter JAC, 1996, J EUKARYOT MICROBIOL, V43, pS24, DOI 10.1111/j.1550-7408.1996.tb04962.x; KAPLAN C, 1980, J HYG-CAMBRIDGE, V84, P285; Moro D, 1999, J WILDLIFE DIS, V35, P301; Roble GS, 2012, J AM ASSOC LAB ANIM, V51, P37; YAGAMI K, 1995, LAB ANIM SCI, V45, P326; Youn H, 2009, KOREAN J PARASITOL, V47, pS133, DOI 10.3347/kjp.2009.47.S.S133	15	2	2	INT PRESS EDITING CENTRE INC	TOKYO	1-2-3 SUGAMO, TOSHIMA-KU, TOKYO, 170 0002, JAPAN	1341-1357	1881-7122		EXP ANIM TOKYO	Exp. Anim.	APR	2015	64	2					155	160				6	Veterinary Sciences; Zoology	Veterinary Sciences; Zoology	CG9WL	WOS:000353670700007		
J	Katsuda, Y; Sasase, T; Tadaki, H; Mera, Y; Motohashi, Y; Kemmochi, Y; Toyoda, K; Kakimoto, K; Kume, S; Ohta, T				Katsuda, Yoshiaki; Sasase, Tomohiko; Tadaki, Hironobu; Mera, Yasuko; Motohashi, Yu; Kemmochi, Yusuke; Toyoda, Kaoru; Kakimoto, Kochi; Kume, Shinichi; Ohta, Takeshi			Contribution of hyperglycemia on diabetic complications in obese type 2 diabetic SDT fatty rats: effects of SGLT inhibitor phlorizin	EXPERIMENTAL ANIMALS			English	Article						diabetic complications; nephropathy; peripheral neuropathy; retinopathy; SDT fatty rat	PERIPHERAL NEUROPATHY; TORII RAT; MODEL; MICE	The spontaneously diabetic torii (SDT) fatty rat is a new model of type 2 diabetes showing overt obesity, hyperglycemia and hyperlipidemia. With early onset of diabetes mellitus, diabetic microvascular complications, including nephropathy, peripheral neuropathy and retinopathy, are observed at young ages. In the present study, blood glucose levels of female SDT fatty rats were controlled with phlorizin, a non-selective SGLT inhibitor, to examine whether and how these complications are caused by hyperglycemia. Phlorizin treatment adequately controlled plasma glucose levels during the experiment. At 29 weeks of age, urinary albumin excretion considerably increased in SOT fatty rats. Glomerulosclerosis and tubular pathological findings also indicate diabetic nephropathy. These renal parameters tended to decrease with phlorizin; however, effects were partial. Sciatic nerve conduction velocities were significantly delayed in SDT fatty rats compared with Sprague-Dawley (SD) rats. Intraepidermal nerve fiber density, an indicator of subclinical small nerve fiber neuropathy, significantly decreased in SDT fatty rats. Retinal dysfunction (prolongation of peak latency for oscillatory potential in electroretinograms) and histopathological eye abnormalities, including retinal folding and mature cataracts were also observed. Both nerve and eye disorders were prevented with phlorizin. These findings indicate that severe hyperglycemia mainly causes diabetic complications in SOT fatty rats. However, other factors, such as hyperlipidemia and hypertension, may affect diabetic nephropathy. These characteristics of diabetic complications will become helpful in evaluating new drugs for diabetic complications using SOT fatty rats.	[Katsuda, Yoshiaki; Sasase, Tomohiko; Tadaki, Hironobu; Mera, Yasuko; Motohashi, Yu; Ohta, Takeshi] Japan Tobacco Inc, Cent Pharmaceut Res Inst, Biol Pharmacol Res Labs, Takatsuki, Osaka 5691125, Japan; [Kemmochi, Yusuke; Toyoda, Kaoru; Kakimoto, Kochi] Japan Tobacco Inc, Toxicol Res Labs, Cent Pharmaceut Res Inst, Hadano, Kanagawa 2570024, Japan; [Kume, Shinichi] Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kyoto 6068502, Japan	Sasase, T (reprint author), Japan Tobacco Inc, Cent Pharmaceut Res Inst, Biol Pharmacol Res Labs, 1-1 Murasaki Cho, Takatsuki, Osaka 5691125, Japan.						Abdul-Ghani Muhammad A, 2008, Endocr Pract, V14, P782; Matsui K, 2008, EXP ANIM TOKYO, V57, P111, DOI 10.1538/expanim.57.111; Katsuda Y, 2014, EXP ANIM TOKYO, V63, P121, DOI 10.1538/expanim.63.121; Chew EY, 2010, NEW ENGL J MED, V363, P233, DOI 10.1056/NEJMoa1001288; Sun LJ, 2002, J BIOL CHEM, V277, P18919, DOI 10.1074/jbc.M110650200; Mukai E, 2014, DIABETES RES CLIN PR, V106, P303, DOI 10.1016/j.diabres.2014.08.023; Malatiali S, 2008, EXP DIABETES RES, DOI 10.1155/2008/305403; Masuyama T, 2005, EXP ANIM TOKYO, V54, P13, DOI 10.1538/expanim.54.13; Shun CT, 2004, BRAIN, V127, P1593, DOI 10.1093/brain/awh180; Himeno T, 2011, DIABETES, V60, P2397, DOI 10.2337/db10-1462; Harmon JS, 2001, DIABETES, V50, P2481, DOI 10.2337/diabetes.50.11.2481; Ehrenkranz JRL, 2005, DIABETES-METAB RES, V21, P31, DOI 10.1002/dmrr.532; Goncalves ACD, 2009, HYPERTENSION, V53, P387, DOI 10.1161/HYPERTENSIONAHA.108.124776; GUIJARRO C, 1995, AM J KIDNEY DIS, V26, P152, DOI 10.1016/0272-6386(95)90169-8; Ohta T, 2014, J DIABETES RES, DOI 10.1155/2014/841957; Ishii Y, 2010, EXP ANIM TOKYO, V59, P73; Brussee V, 2008, DIABETES, V57, P1664, DOI 10.2337/db07-1737; Fukuda S., 2011, OPEN DIABETES J, V4, P30; Hsu CY, 2000, AM J KIDNEY DIS, V36, P272, DOI 10.1053/ajkd.2000.8971; International Diabetes Federation, 2011, IDF DIABETES ATLAS; Ishii Y, 2011, J VET MED SCI, V73, P501, DOI 10.1292/jvms.10-0453; Ishii Y, 2010, EXP ANIM TOKYO, V59, P525; Kemmochi Y, 2013, J DIABETES RES, DOI 10.1155/2013/948257; Lauria G, 2010, J PERIPHER NERV SYST, V15, P79; Obrosova IG, 2007, DIABETES, V56, P2598, DOI 10.2337/db06-1176; Osorio H, 2012, OXID MED CELL LONGEV, DOI 10.1155/2012/542042; Sasase T, 2006, DIABETES OBES METAB, V8, P501, DOI 10.1111/j.1463-1326.2006.00535.x; Sasase T, 2009, DIABETES OBES METAB, V11, P1084, DOI 10.1111/j.1463-1326.2009.01082.x; Yamaguchi T, 2012, J VET MED SCI, V74, P1669, DOI 10.1292/jvms.12-0149	29	0	0	INT PRESS EDITING CENTRE INC	TOKYO	1-2-3 SUGAMO, TOSHIMA-KU, TOKYO, 170 0002, JAPAN	1341-1357	1881-7122		EXP ANIM TOKYO	Exp. Anim.	APR	2015	64	2					161	169				9	Veterinary Sciences; Zoology	Veterinary Sciences; Zoology	CG9WL	WOS:000353670700008		
J	Shoji, H; Kiniwa, Y; Okuyama, R; Yang, M; Higuchi, K; Mori, M				Shoji, Haruka; Kiniwa, Yukiko; Okuyama, Ryuhei; Yang, Mu; Higuchi, Keiichi; Mori, Masayuki			A nonsense nucleotide substitution in the oculocutaneous albinism II gene underlies the original pink-eyed dilution allele (Oca2(p)) in mice	EXPERIMENTAL ANIMALS			English	Article						mouse; nonsense mutation; oculocutaneous albinism II; pink-eyed dilution	HEREDITARY CATARACT; NAKANO MOUSE; P-GENE; MELANOCYTES; TYROSINASE; PHEOMELANIN; MELANOSOMES; EUMELANIN; LENS	The original pink-eyed dilution (p) on chromosome 7 is a very old spontaneous mutation in mice. The oculocutaneous albinism II (Oca2) gene has previously been identified as the p gene. Oca2 transcripts have been shown to be absent in the skin of SJL/J mice with the original p mutant allele (Oca2(p)); however, the molecular genetic lesion underlying the original Oca2(p) allele has never been reported. The NCT mouse (commonly known as Nakano cataract mouse) has a pink-eyed dilution phenotype, which prompted us to undertake a molecular genetic analysis of the Oca2 gene of this strain. Our genetic linkage analysis suggests that the locus for the pink-eyed dilution phenotype of NCT is tightly linked to the Oca2 locus. PCR cloning and nucleotide sequence analysis indicates that the NCT mouse has a nonsense nucleotide substitution at exon 7 of the Oca2 gene. Examination of three mouse strains (NZW/NSlc, SJL/J, and 129X1/SvJJmsSlc) with the original Oca2(p) allele revealed the presence of a nonsense nucleotide substitution identical to that in the NCT strain. RTPCR analysis revealed that the Oca2 transcripts were absent in the skin of NCT mice, suggesting intervention of the nonsense-mediated mRNA decay pathway. Collectively, the data in this study indicate that the nonsense nucleotide substitution in the Oca2 gene underlies the Oca2(p) allele. Our data also indicate that the NCT mouse can be used not only as a cataract model, but also as a model for human type II oculocutaneous albinism.	[Shoji, Haruka; Yang, Mu; Higuchi, Keiichi] Shinshu Univ, Grad Sch Med, Dept Aging Biol, Inst Pathogenesis & Dis Prevent, Matsumoto, Nagano 3908621, Japan; [Kiniwa, Yukiko; Okuyama, Ryuhei] Shinshu Univ, Sch Med, Dept Dermatol, Matsumoto, Nagano 3908621, Japan; [Higuchi, Keiichi] Shinshu Univ, Dept Biol Sci Intractable Neurol Dis, Inst Biomed Sci, Interdisciplinary Cluster Cutting Edge Res, Matsumoto, Nagano 3908621, Japan; [Mori, Masayuki] Shinshu Univ, Dept Adv Med Hlth Promot, Inst Biomed Sci, Interdisciplinary Cluster Cutting Edge Res, Matsumoto, Nagano 3908621, Japan	Mori, M (reprint author), Shinshu Univ, Dept Adv Med Hlth Promot, Inst Biomed Sci, Interdisciplinary Cluster Cutting Edge Res, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.						Brilliant MH, 2001, PIGM CELL RES, V14, P86, DOI 10.1034/j.1600-0749.2001.140203.x; ROSEMBLAT S, 1994, P NATL ACAD SCI USA, V91, P12071, DOI 10.1073/pnas.91.25.12071; Chen K, 2002, MOL BIOL CELL, V13, P1953, DOI 10.1091/mbc.02-02-0022; Ito S, 2011, PIGM CELL MELANOMA R, V24, P605, DOI 10.1111/j.1755-148X.2011.00864.x; Rosemblat S, 1998, EXP CELL RES, V239, P344, DOI 10.1006/excr.1997.3901; Hirobe T, 2002, J EXP ZOOL, V292, P351, DOI 10.1002/jez.10051; Puri N, 2000, J INVEST DERMATOL, V115, P607, DOI 10.1046/j.1523-1747.2000.00108.x; Sitaram A, 2009, MOL BIOL CELL, V20, P1464, DOI 10.1091/mbc.E08-07-0710; Uchiyama R, 2014, J DERMATOL SCI, V73, P161, DOI 10.1016/j.jdermsci.2013.09.008; GARDNER JM, 1992, SCIENCE, V257, P1121, DOI 10.1126/science.257.5073.1121; DURHAMPIERRE D, 1994, NAT GENET, V7, P176, DOI 10.1038/ng0694-176; Toyofuku K, 2002, PIGM CELL RES, V15, P217, DOI 10.1034/j.1600-0749.2002.02007.x; BRILLIANT MH, 1994, GENETICS, V138, P203; Hara A, 1999, GRAEF ARCH CLIN EXP, V237, P249, DOI 10.1007/s004170050226; Hirobe T, 2011, PIGM CELL MELANOMA R, V24, P241, DOI 10.1111/j.1755-148X.2010.00783.x; MATSUZAWA A, 1988, EXP EYE RES, V47, P705, DOI 10.1016/0014-4835(88)90038-3; Mori M, 2013, EXP EYE RES, V112, P45, DOI 10.1016/j.exer.2013.04.005; Nakano K., 1960, JPN J CLIN OPHTHAL, V14, P1772; TAKEHANA M, 1990, EXP EYE RES, V50, P671, DOI 10.1016/0014-4835(90)90112-8	19	0	0	INT PRESS EDITING CENTRE INC	TOKYO	1-2-3 SUGAMO, TOSHIMA-KU, TOKYO, 170 0002, JAPAN	1341-1357	1881-7122		EXP ANIM TOKYO	Exp. Anim.	APR	2015	64	2					171	179				9	Veterinary Sciences; Zoology	Veterinary Sciences; Zoology	CG9WL	WOS:000353670700009		
J	Fujii, E; Kato, A; Chen, YJ; Matsubara, K; Ohnishi, Y; Suzuki, M				Fujii, Etsuko; Kato, Atsuhiko; Chen, Yu Jau; Matsubara, Koichi; Ohnishi, Yasuyuki; Suzuki, Masami			The status of donor cancer tissues affects the fate of patient-derived colorectal cancer xenografts in NOG mice	EXPERIMENTAL ANIMALS			English	Article						immunoglobulin; NOG mouse; patient-derived xenograft; T lymphocyte; tumor aggressiveness	TUMOR XENOGRAFTS; MOUSE MODELS; LUNG-TUMOR; LYMPHOCYTES; CELLS; ENGRAFTMENT	Patient-derived xenografts (PDXs) of tumors are increasingly becoming important tools for translational research in oncology. The NOD.Cg-Prkdc(scid) II2rg(tm1sug)/Jic (NOG) mouse is an efficient host for PDXs. Thus as a basis for future development of methods to obtain PDXs from various disease types, we have studied the factors that affect the outcome of transplantation of human colorectal cancer in NOG mice. Of the original donor cases examined, 73% had successful engraftment. The outcome of donor-matched tissues was consistent in most cases, and was thought to show that the condition of the host did not affect engraftment. Next we analyzed the tumor aggressiveness in terms of histology grade of the original tumor and found that they were related to engraftment. Detailed histopathological examination of the transplanted tissues strongly indicated that lymphocytes engrafted with the tumor cells affect engraftment. As a factor related to transplantation of lymphocytes, we studied the human IgG concentration in the serum of tumor-bearing mice, but there was no tendency for higher concentrations to result in unsuccessful engraftment. Finally, we studied the type, density and location of T cells in the original donor tissue to determine the immune contexture and found that the unsuccessful engraftment cases tended to have an adequate or coordinated immune contexture compared to successful engraftment cases. From these results, we concluded that the aggressiveness and the T cell infiltration of the original tumor affect the outcome of transplantation in the NOG mouse.	[Fujii, Etsuko; Kato, Atsuhiko; Suzuki, Masami] Chugai Pharmaceut Co Ltd, Div Res, Kamakura, Kanagawa 2478530, Japan; [Chen, Yu Jau; Matsubara, Koichi] Chugai Pharmabody Res Pte Ltd, Singapore 138623, Singapore; [Matsubara, Koichi] PharmaLog Res Pte Ltd, Singapore 138667, Singapore; [Ohnishi, Yasuyuki] Cent Inst Expt Anim, Kawasaki, Kanagawa 2100821, Japan	Fujii, E (reprint author), Chugai Pharmaceut Co Ltd, Div Res, 200 Kajiwara, Kamakura, Kanagawa 2478530, Japan.						Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Julien S, 2012, CLIN CANCER RES, V18, P5314, DOI 10.1158/1078-0432.CCR-12-0372; Simpson-Abelson MR, 2008, J IMMUNOL, V180, P7009; Camus M, 2009, CANCER RES, V69, P2685, DOI 10.1158/0008-5472.CAN-08-2654; Masuda H, 2007, P NATL ACAD SCI USA, V104, P1925, DOI 10.1073/pnas.0604310104; Moro M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/568567; Kobayashi S, 2012, STEM CELLS, V30, P2631, DOI 10.1002/stem.1257; Decaudin D, 2011, ANTI-CANCER DRUG, V22, P827, DOI 10.1097/CAD.0b013e3283475f70; John T, 2011, CLIN CANCER RES, V17, P134, DOI 10.1158/1078-0432.CCR-10-2224; Alpdogan O, 2012, SEMIN ONCOL, V39, P629, DOI 10.1053/j.seminoncol.2012.10.001; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Ito M, 2008, CURR TOP MICROBIOL, V324, P53; Galon J, 2014, J PATHOL, V232, P199, DOI 10.1002/path.4287; Fujii E, 2014, EXP ANIM TOKYO, V63, P289; Pearson T, 2008, CURR TOP MICROBIOL, V324, P25; Williams SS, 1996, J IMMUNOL, V156, P1908; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; SATO Y, 1986, AM J PATHOL, V125, P431; Edge SB, 2010, CANC STAGING MANUAL, P1; Fridman Wolf-Herman, 2013, Cancer Microenviron, V6, P117, DOI 10.1007/s12307-012-0124-9; Fujii E, 2008, PATHOL INT, V58, P559, DOI 10.1111/j.1440-1827.2008.02271.x; Fujii E, 2014, EXP TOXICOL PATHOL, V66, P203, DOI 10.1016/j.etp.2014.01.006; Lee R.A., 2012, AM J HEALTH-SYST PH, V69, P1961; Manz Markus G, 2009, Nat Immunol, V10, P1039, DOI 10.1038/ni1009-1039; Mizukami M, 2006, ANTICANCER RES, V26, P1827; Suzuki Masami, 2002, J Toxicol Sci, V27, P165, DOI 10.2131/jts.27.165	26	0	0	INT PRESS EDITING CENTRE INC	TOKYO	1-2-3 SUGAMO, TOSHIMA-KU, TOKYO, 170 0002, JAPAN	1341-1357	1881-7122		EXP ANIM TOKYO	Exp. Anim.	APR	2015	64	2					181	190				10	Veterinary Sciences; Zoology	Veterinary Sciences; Zoology	CG9WL	WOS:000353670700010		
J	Goto, K; Kuwayama, E; Nozu, R; Ueno, M; Hayashimoto, N				Goto, Kazuo; Kuwayama, Eri; Nozu, Ryoko; Ueno, Masami; Hayashimoto, Nobuhito			Effect of hypochlorous acid solution on the eradication and prevention of Pseudomonas aeruginosa infection, serum biochemical variables, and cecum microbiota in rats	EXPERIMENTAL ANIMALS			English	Article						microbiota; Pseudomonas aeruginosa; rat; T-RFLP; weak acid hypochlorous solution	FRAGMENT-LENGTH-POLYMORPHISM	In this study, hypochlorous acid solution, a weak acid, provided as drinking water to rats, was evaluated for its ability to eradicate and prevent Pseudomonas aeruginosa infection, while monitoring its simultaneous effect on serum biochemical variables and microbiota in the rat cecum. The results suggest that the solution could not eliminate the bacteria in the experimentally infected rats; however, the administration of a 10-parts-per-million (ppm) hypochlorous acid solution as drinking water was effective in inhibiting horizontal spread of Pseudomonas aeruginosa infection among cage mates. Additionally, exposure to hypochlorous solution did not have any effect on serum biochemical variables of the rat including levels of total cholesterol, aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), albumin, total bilirubin, lipase, amylase, urea nitrogen, total protein, calcium (Ca), phosphorus (P), sodium (Na), chlorine (Cl), except for potassium (K) levels. The most frequently isolated bacteria in the rat cecum included species belonging to Bacteroidales, Lactobacillus, Clostridiales, Erysipelotrichaceae, Akkermansia, Coriobacteriales, and Firmicutes. The ratio of the terminal restriction fragment length polymorphism (T-RFLP) peaks did not differ across rats administered with 5 and 10 ppm weak acid solution as compared to the control group for any of the bacteria, except for Erysipelotrichaceae and Firmicutes, where the ratio of T-RFLP peaks was higher in the 5 ppm group for Erysipelotrichaceae and in the 10 ppm group for Firmicutes than that in the control group (P<0.01). The results suggest that the weak acid hypochlorous solution could not eradicate Pseudomonas aeruginosa completely from rats. The solution was effective in preventing infection without affecting serum biochemical variables; however, some of bacterial microbiota may have changed due to administration of the solution.	[Goto, Kazuo; Kuwayama, Eri] Teikyo Univ, Dept Clin Lab Med, Itabashi Ku, Tokyo 1738605, Japan; [Nozu, Ryoko; Ueno, Masami; Hayashimoto, Nobuhito] Cent Inst Expt Anim, Kawasaki, Kanagawa 2100821, Japan	Goto, K (reprint author), Teikyo Univ, Dept Clin Lab Med, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.						Nagashima K, 2003, APPL ENVIRON MICROB, V69, P1251, DOI 10.1128/AEM.69.2.1251-1262.2003; Kibe R, 2004, FEMS MICROBIOL LETT, V235, P139, DOI 10.1016/j.femsle.2004.04.023; Odamaki T, 2007, J INVEST ALLERG CLIN, V17, P92; NAKAMURA N, 1994, EXP ANIM TOKYO, V43, P191; Ono T, 2012, BIOCONTROL SCI, V17, P129; Slivestry-Rodriguez N., 2007, J ENV SCI HLTH A, V42, P1579; Taharaguchi M, 2014, EXP ANIM TOKYO, V63, P141, DOI 10.1538/expanim.63.141; Takimoto K, 2013, EXP ANIM TOKYO, V62, P237, DOI 10.1538/expanim.62.237; Wang L, 2007, J Burns Wounds, V6, pe5	9	1	1	INT PRESS EDITING CENTRE INC	TOKYO	1-2-3 SUGAMO, TOSHIMA-KU, TOKYO, 170 0002, JAPAN	1341-1357	1881-7122		EXP ANIM TOKYO	Exp. Anim.	APR	2015	64	2					191	197				7	Veterinary Sciences; Zoology	Veterinary Sciences; Zoology	CG9WL	WOS:000353670700011		
J	Ukaji, T; Hashimoto, M; Kai, O				Ukaji, Takao; Hashimoto, Masako; Kai, Osamu			Conditioned medium from gerbil-mouse T cell heterohybridomas improved antibody secretion	EXPERIMENTAL ANIMALS			English	Article						Conditioned medium; Heterohybridoma; Mongolian gerbil	CHAIN CONSTANT-REGION; MERIONES-UNGUICULATUS; GROWTH-FACTOR; MONOCLONAL-ANTIBODIES; HYBRIDOMA; IMMUNOGLOBULIN; CLONING; INTERLEUKIN-6; EXPRESSION; SEQUENCE	Mongolian gerbils (Meriones unguiculatus) are widely used as animal models for a variety of infectious diseases. However, immunological reagents such as cytokines have not been characterized. Two heterohybridomas, D9(E6)C2B3 and D9(E4), obtained by fusion of gerbil splenocytes with mouse myeloma cells (P3-X63-Ag8.653), expressed gerbil CD3G mRNA. These cells were suggested to be T cell heterohybridomas. They also expressed gerbil IL6 [D9(E6)C2B3] and TGFB [D9(E4) and D9(E6)C2B3] mRNAs. The addition of conditioned medium (CM) obtained from the culture of D9(E6)C2B3 significantly enhanced antibody secretion and expression of gerbil C gamma 1 and C epsilon IGHC mRNAs in the B11D2(C2) heterohybridoma, which secretes gerbil IgG1. However, the addition of CM from both heterohybridomas did not improve in proliferation of B11D2(C2) cells. These results indicate that CM from D9(E6)C2B3 improved the culture of gerbil mouse heterohybridomas, possibly by secreting gerbil IL6.	[Ukaji, Takao; Hashimoto, Masako; Kai, Osamu] Nihon Univ, Coll Bioresource Sci, Dept Anim Sci & Resources, Fujisawa, Kanagawa 2520880, Japan	Kai, O (reprint author), Nihon Univ, Coll Bioresource Sci, Kameino 1866, Fujisawa, Kanagawa 2520880, Japan.						Lengweiler S, 1999, BIOCHEM BIOPH RES CO, V262, P167, DOI 10.1006/bbrc.1999.1172; BAZIN R, 1987, J IMMUNOL, V139, P780; Chu YueFeng, 2006, Agricultural Sciences in China, V5, P873, DOI 10.1016/S1671-2927(06)60138-7; Coico Richard, 2003, IMMUNOLOGY SHORT COU; Gaucher D, 2001, CYTOKINE, V14, P177, DOI 10.1006/cyto.2001.0866; Gaucher D, 2003, GENE, V307, P159, DOI 10.1016/S0378-1119(03)00457-8; GRAVEKAMP C, 1987, HYBRIDOMA, V6, P121, DOI 10.1089/hyb.1987.6.121; HOWARD M, 1979, CELL, V18, P993, DOI 10.1016/0092-8674(79)90211-3; Imitola J, 2005, PHARMACOL THERAPEUT, V106, P163, DOI 10.1016/j.pharmthera.2004.11.007; KAI O, 1995, EXP ANIM TOKYO, V44, P307, DOI 10.1538/expanim.44.307; KOO GC, 1991, J IMMUNOL, V147, P1194; KUO MC, 1985, MOL IMMUNOL, V22, P351; Liguori MJ, 2001, HYBRIDOMA, V20, P189, DOI 10.1089/027245701750293529; MAI ZM, 1994, VET IMMUNOL IMMUNOP, V40, P63, DOI 10.1016/0165-2427(94)90015-9; MAKISHIMA F, 1992, CYTOTECHNOLOGY, V10, P15, DOI 10.1007/BF00376096; Matsubara S, 2004, CANCER SCI, V95, P798, DOI 10.1111/j.1349-7006.2004.tb02184.x; MATSUDA T, 1988, EUR J IMMUNOL, V18, P951, DOI 10.1002/eji.1830180618; Nishimichi N, 2005, VET IMMUNOL IMMUNOP, V106, P97, DOI 10.1016/j.vetimm.2005.01.006; Terada S, 1996, CYTOKINE, V8, P889, DOI 10.1006/cyto.1996.0119; Thomson A. W., 2003, CYTOKINE HDB; Ukaji T, 2012, J IMMUNOL METHODS, V386, P108, DOI 10.1016/j.jim.2012.09.001; Ukaji T, 2013, EXP ANIM TOKYO, V62, P145; Ukaji T, 2011, ANIM SCI J, V82, P713, DOI 10.1111/j.1740-0929.2011.00938.x; Ukaji T, 2012, EXP ANIM TOKYO, V61, P99; Ukaji T, 2011, J IMMUNOL METHODS, V373, P174, DOI 10.1016/j.jim.2011.08.015; VANSNICK J, 1986, P NATL ACAD SCI USA, V83, P9679; Watanabe M, 2003, VIROLOGY, V310, P245, DOI 10.1016/S0042-6822(03)0158-2	27	0	0	INT PRESS EDITING CENTRE INC	TOKYO	1-2-3 SUGAMO, TOSHIMA-KU, TOKYO, 170 0002, JAPAN	1341-1357	1881-7122		EXP ANIM TOKYO	Exp. Anim.	APR	2015	64	2					199	205				7	Veterinary Sciences; Zoology	Veterinary Sciences; Zoology	CG9WL	WOS:000353670700012		
J	Ishikawa, A; Sugiyama, M; Hondo, E; Kinoshita, K; Yamagishi, Y				Ishikawa, Akira; Sugiyama, Makoto; Hondo, Eiichi; Kinoshita, Keiji; Yamagishi, Yuki			Development of a novel pink-eyed dilution mouse model showing progressive darkening of the eyes and coat hair with aging	EXPERIMENTAL ANIMALS			English	Article						animal model; coat color; hair darkening; mouse; Oca2	OCULOCUTANEOUS ALBINISM; GENETIC-VARIANTS; PRADER-WILLI; CELLS; MICE; PIGMENTATION; MELANOCYTES; EXPRESSION; MELANOMA; MUTATION	Oca2(p-cas) (oculocutaneous albinism II; pink-eyed dilution castaneus) is a coat color mutant gene on mouse chromosome 7 that arose spontaneously in wild Mus musculus castaneus mice. Mice homozygous for Oca2(p-cas) usually exhibit pink eyes and gray coat hair on the non-agouti genetic background, and this ordinary phenotype remains unchanged throughout life. During breeding of a mixed strain carrying this gene on the C57BL/6J background, we discovered a novel spontaneous mutation that causes darkening of the eyes and coat hair with aging. In this study, we developed a novel mouse model showing this unique phenotype. Gross observations revealed that the pink eyes and gray coat hair of the novel mutant young mice became progressively darker in color by approximately 3 months after birth. Light and transmission-electron microscopic observations revealed a marked increase in melanin pigmentation of coat hair shafts and choroid of the eye in the novel mice compared to that in the ordinary mice. Sequence analysis of Oca2(p-cas) revealed a 4.1-kb deletion involving exons 15 and 16 of its wild-type gene. However, there was no sequence difference between the two types of mutant mice. Mating experiments suggested that the novel mutant phenotype was not inherited in a simple fashion, due to incomplete penetrance. The novel spontaneous mutant mouse is the first example of progressive hair darkening animals and is an essential animal model for understanding of the regulation mechanisms of melanin biosynthesis with aging.	[Ishikawa, Akira; Kinoshita, Keiji; Yamagishi, Yuki] Nagoya Univ, Grad Sch Bioagr Sci, Lab Anim Genet, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Sugiyama, Makoto; Hondo, Eiichi] Nagoya Univ, Grad Sch Bioagr Sci, Lab Anim Morphol & Funct, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Ishikawa, A (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Lab Anim Genet, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.				Japan Society for the Promotion of Science	We thank H. Miyake for guidance and technical support in transmission electron microscopic analysis. This work was supported by Grants-in-Aids for Scientific Research from the Japan Society for the Promotion of Science to A. lshikawa.	Ancans J, 2001, EXP CELL RES, V268, P26, DOI 10.1006/excr.2001.5251; Kilpinen H, 2013, SCIENCE, V342, P744, DOI 10.1126/science.1242463; Heinz S, 2013, NATURE, V503, P487, DOI 10.1038/nature12615; Eiberg H, 2008, HUM GENET, V123, P177, DOI 10.1007/s00439-007-0460-x; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; TSUJI A, 1995, EXP ANIM TOKYO, V44, P347, DOI 10.1538/expanim.44.347; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; McVicker G, 2013, SCIENCE, V342, P747, DOI 10.1126/science.1242429; Kaelin CB, 2013, ANNU REV ANIM BIOSCI, V1, P125, DOI 10.1146/annurev-animal-031412-103659; Pielberg GR, 2008, NAT GENET, V40, P1004, DOI 10.1038/ng.185; RINCHIK EM, 1993, NATURE, V361, P72, DOI 10.1038/361072a0; MORSE HC, 1985, CELL, V41, P439, DOI 10.1016/S0092-8674(85)80017-9; Kasowski M, 2013, SCIENCE, V342, P750, DOI 10.1126/science.1242510; Visser M, 2012, GENOME RES, V22, P446, DOI 10.1101/gr.128652.111; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; GARDNER JM, 1992, SCIENCE, V257, P1121, DOI 10.1126/science.257.5073.1121; Toyofuku K, 2002, PIGM CELL RES, V15, P217, DOI 10.1034/j.1600-0749.2002.02007.x; Boissy R.E., 2006, PIGMENTARY SYSTEM PH, V2nd, P91, DOI 10.1002/9780470987100.ch4; BRILLIANT MH, 1994, GENETICS, V138, P203; HIROBE T, 1984, ANAT REC, V208, P589, DOI 10.1002/ar.1092080414; Hirobe T, 2011, PIGM CELL MELANOMA R, V24, P241, DOI 10.1111/j.1755-148X.2010.00783.x; Ishikawa A, 2013, CURR GENOMICS, V14, P225, DOI 10.2174/1389202911314040001; Masson P., 1970, HUMAN TUMORS HISTOLO, V2nd; Montoliu L, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12167; Resnick JL, 2013, MAMM GENOME, V24, P165, DOI 10.1007/s00335-013-9454-2; RUSSELL L, 1977, TISSUE CELL, V9, P751, DOI 10.1016/0040-8166(77)90040-4; Searle A G, 1968, COMP GENETICS COAT C; Silvers W.K., 1979, COAT COLORS MICE; Wang JR, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S3-S13	30	1	1	INT PRESS EDITING CENTRE INC	TOKYO	1-2-3 SUGAMO, TOSHIMA-KU, TOKYO, 170 0002, JAPAN	1341-1357	1881-7122		EXP ANIM TOKYO	Exp. Anim.	APR	2015	64	2					207	220				14	Veterinary Sciences; Zoology	Veterinary Sciences; Zoology	CG9WL	WOS:000353670700013		
J	Mansour, MA; Hyodo, T; Ito, S; Kurita, K; Kokuryo, T; Uehara, K; Nagino, M; Takahashi, M; Hamaguchi, M; Senga, T				Mansour, Mohammed A.; Hyodo, Toshinori; Ito, Satoko; Kurita, Kenji; Kokuryo, Toshio; Uehara, Keisuke; Nagino, Masato; Takahashi, Masahide; Hamaguchi, Michinari; Senga, Takeshi			SATB2 suppresses the progression of colorectal cancer cells via inactivation of MEK5/ERK5 signaling	FEBS JOURNAL			English	Article						colorectal cancer; ERK5; invasion; migration; SATB2	OSTEOBLAST DIFFERENTIATION; GENE-EXPRESSION; BINDING-PROTEIN; GASTRIC-CANCER; CLEFT-PALATE; ERK5; DETERMINANT; METASTASIS; INTERACTS; 2Q32-Q33	Special AT-rich sequence binding protein2 (SATB2) is an evolutionarily conserved transcription factor that has multiple roles in neuronal development, osteoblast differentiation, and craniofacial patterning. SATB2 binds to the nuclear matrix attachment region, and regulates the expression of diverse sets of genes by altering chromatin structure. Recent studies have reported that high expression of SATB2 is associated with favorable prognosis in colorectal and laryngeal cancer; however, it remains uncertain whether SATB2 has tumor-suppressive functions in cancer cells. In this study, we examined the effects of SATB2 expression on the malignant characteristics of colorectal cancer cells. Expression of SATB2 repressed the proliferation of cancer cells invitro and invivo, and also suppressed their migration and invasion. Extracellular signal-regulated kinase5 (ERK5) is a mitogen-activated protein kinase that is associated with an aggressive phenotype in various types of cancer. SATB2 expression reduced the activity of ERK5, and constitutive activation of ERK5 restored the proliferation, anchorage-independent growth, migration and invasion of SATB2-expressing cells. Our results demonstrate the existence of a novel regulatory mechanism of SATB2-mediated tumor suppression via ERK5 inactivation.	[Mansour, Mohammed A.; Hyodo, Toshinori; Ito, Satoko; Hamaguchi, Michinari; Senga, Takeshi] Nagoya Univ, Grad Sch Med, Div Canc Biol, Nagoya, Aichi 4668550, Japan; [Mansour, Mohammed A.] Tanta Univ, Fac Sci, Dept Chem, Biochem Sect, Tanta, Gharbia, Egypt; [Kurita, Kenji; Kokuryo, Toshio; Uehara, Keisuke; Nagino, Masato] Nagoya Univ, Grad Sch Med, Dept Surg Oncol, Nagoya, Aichi 4648601, Japan; [Takahashi, Masahide] Nagoya Univ, Grad Sch Med, Dept Pathol, Nagoya, Aichi 4648601, Japan	Senga, T (reprint author), Nagoya Univ, Grad Sch Med, Div Canc Biol, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	biomansour@hotmail.com; tsenga@med.nagoya-u.ac.jp			Naito Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan [23107010]	We would like to thank the members of the Division of Cancer Biology for their helpful discussions. This research was funded by the Naito Foundation and the Ministry of Education, Culture, Sports, Science and Technology of Japan (Nanomedicine Molecular Science, grant number 23107010 to T.S.).	Balasubramanian M, 2011, J MED GENET, V48, P290, DOI 10.1136/jmg.2010.084491; Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; Barros JC, 2005, J CELL SCI, V118, P1663, DOI 10.1242/jcs.02308; Cheng C, 2010, APMIS, V118, P855, DOI 10.1111/j.1600-0463.2010.02673.x; Lochhead PA, 2012, BIOCHEM SOC T, V40, P251, DOI 10.1042/BST20110663; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Eberhard J, 2012, BRIT J CANCER, V106, P931, DOI 10.1038/bjc.2012.34; Dobreva G, 2003, GENE DEV, V17, P3048, DOI 10.1101/gad.1153003; Galande S, 2001, MOL CELL BIOL, V21, P5591, DOI 10.1128/MCB.21.16.5591-5604.2001; Gong YM, 2014, MOL CELL BIOCHEM, V387, P227, DOI 10.1007/s11010-013-1888-z; Chen HX, 2011, J DERMATOL SCI, V64, P39, DOI 10.1016/j.jdermsci.2011.06.007; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Beaty TH, 2006, HUM GENET, V120, P501, DOI 10.1007/s00439-006-0235-9; Leoyklang P, 2007, HUM MUTAT, V28, P732, DOI 10.1002/humu.20515; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Hassan MQ, 2010, P NATL ACAD SCI USA, V107, P19879, DOI 10.1073/pnas.1007698107; Savarese F, 2009, GENE DEV, V23, P2625, DOI 10.1101/gad.1815709; Britanova O, 2006, AM J HUM GENET, V79, P668, DOI 10.1086/508214; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Gyorgy AB, 2008, EUR J NEUROSCI, V27, P865, DOI 10.1111/j.1460-9568.2008.06061.x; Lu XM, 2010, ONCOL REP, V24, P981, DOI 10.3892/or_00000945; FitzPatrick DR, 2003, HUM MOL GENET, V12, P2491, DOI 10.1093/hmg/ddg248; Wang S, 2009, J PATHOL, V219, P114, DOI 10.1002/path.2575; Mehta PB, 2003, ONCOGENE, V22, P1381, DOI 10.1038/sj.onc.1206154; Kohwi-Shigematsu T, 2013, SEMIN CANCER BIOL, V23, P72, DOI 10.1016/j.semcancer.2012.06.009; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; Britanova O, 2005, EUR J NEUROSCI, V21, P658, DOI 10.1111/j.1460-9568.2005.03897.x; Docker D, 2013, EUR J HUM GENET, V22, P1034; Fromberg A, 2014, INT J CANCER, V135, P2537, DOI 10.1002/ijc.28895; Hu B, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-127; Liu T, 2012, PLOS ONE, V7, P40704; Nithianandarajah-Jones GN, 2012, CELL SIGNAL, V24, P2187, DOI 10.1016/j.cellsig.2012.07.007; Rosenfeld J, 2009, PLOS ONE, V4, P6568; Yanagisawa J, 1996, CANCER RES, V56, P457; Yang M, 2013, PLOS ONE, V8, P85353	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	APR	2015	282	8					1394	1405		10.1111/febs.13227		12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CG9SF	WOS:000353659600005		
J	Tu, TH; Kim, CS; Nam-Goong, IS; Nam, CW; Kim, YI; Goto, T; Kawada, T; Park, T; Park, JHY; Ryoo, ZY; Park, JW; Choi, HS; Yu, R				Tu, Thai H.; Kim, Chu-Sook; Nam-Goong, Il S.; Nam, Chang W.; Kim, Young-Il; Goto, Tsuyoshi; Kawada, Teruo; Park, Taesun; Park, Jung H. Yoon; Ryoo, Zae Y.; Park, Jeong W.; Choi, Hye-Seon; Yu, Rina			4-1BBL signaling promotes cell proliferation through reprogramming of glucose metabolism in monocytes/macrophages	FEBS JOURNAL			English	Article						inflammation; macrophage; metabolic reprogramming; obesity; proliferation	OBESITY-INDUCED INFLAMMATION; FATTY-ACID SYNTHASE; ADIPOSE-TISSUE; LOCAL PROLIFERATION; MONOCYTE ACTIVATION; AEROBIC GLYCOLYSIS; REVERSE SIGNALS; MYELOID CELLS; CD137; MACROPHAGES	Obesity-induced monocyte/macrophage proliferation and activation play a crucial role in various chronic inflammatory metabolic disorders, such as insulin resistance, diabetes mellitus, and atherosclerosis. 4-1BBL, a member of the tumor necrosis factor superfamily expressed on monocytes/macrophages, provides inflammatory signals to modulate their proliferation, survival, and cytokine release. Previously, we demonstrated that 4-1BBL signaling promotes adipose inflammation through enhancement of macrophage activation. Here, we show that 4-1BBL stimulation on monocytes/macrophages enhanced reprogramming of glucose metabolism in the cells, and that this was accompanied by cell proliferation. 4-1BBL stimulation on macrophages increased glucose uptake, transcript/protein levels of glucose transporter 1 and glycolytic enzymes, and lactate production. It also enhanced transcript levels of genes involved in the pentose phosphate pathway and lipogenesis. The 4-1BBL-induced metabolic reprogramming was mediated by AKT-mammalian target of rapamycin signaling. The effect of 4-1BBL-induced macrophage proliferation was completely abolished by 2-deoxyglucose, a glycolytic inhibitor. These findings suggest that 4-1BBL signaling promotes cell proliferation through reprogramming of glucose metabolism in monocytes/macrophages to support their energy demands and biomass production. The 4-1BBL signaling pathway may be a valid target for controlling macrophage-mediated chronic inflammation in obesity and metabolic diseases.	[Tu, Thai H.; Kim, Chu-Sook; Yu, Rina] Univ Ulsan, Dept Food Sci & Nutr, Ulsan 680749, South Korea; [Nam-Goong, Il S.] Univ Ulsan, Ulsan Univ Hosp, Coll Med, Dept Internal Med, Ulsan 680749, South Korea; [Nam, Chang W.] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Surg, Ulsan 680749, South Korea; [Kim, Young-Il; Goto, Tsuyoshi; Kawada, Teruo] Kyoto Univ, Grad Sch Agr, Uji, Kyoto, Japan; [Park, Taesun] Yonsei Univ, Dept Food & Nutr, Seoul 120749, South Korea; [Park, Jung H. Yoon] Hallym Univ, Dept Food Sci & Nutr, Chunchon, South Korea; [Park, Jung H. Yoon] Hallym Univ, Res Inst Biosci & Biotechnol, Chunchon, South Korea; [Ryoo, Zae Y.] Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Daegu, South Korea; [Park, Jeong W.; Choi, Hye-Seon] Univ Ulsan, Dept Biol Sci, Ulsan 680749, South Korea	Yu, R (reprint author), Univ Ulsan, Dept Food Sci & Nutr, Ulsan 680749, South Korea.	rinayu@ulsan.ac.kr			National Research Foundation of Korea (NRF) - Korean government (MEST) [2012R1A2A4A0100 2702]; NRF - Korean government (MSIP) [2008-0062618]; Bio & Medical Technology Development Program of the NRF - Korean government (MEST) [2012M3A9C3048687]	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (No. 2012R1A2A4A0100 2702), an NRF grant funded by the Korean government (MSIP) (No. 2008-0062618), and the Bio & Medical Technology Development Program of the NRF funded by the Korean government (MEST) (No. 2012M3A9C3048687).	Barata JT, 2004, J EXP MED, V200, P659, DOI 10.1084/jem.20040789; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Jadhav A, 2013, J PHARMACOL EXP THER, V345, P239, DOI 10.1124/jpet.112.200808; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Kuhajda FP, 2000, NUTRITION, V16, P202, DOI 10.1016/S0899-9007(99)00266-X; Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Ndisang JF, 2013, AM J HYPERTENS, V26, P1123, DOI 10.1093/ajh/hpt082; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Sanchez-Margalet V, 2003, CLIN EXP IMMUNOL, V133, P11, DOI 10.1046/j.1365-2249.2003.02190.x; Ricote M, 2004, ARTERIOSCL THROM VAS, V24, P230, DOI 10.1161/01.ATV.0000103951.67680.B1; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Amano SU, 2014, CELL METAB, V19, P162, DOI 10.1016/j.cmet.2013.11.017; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Porstmann T, 2009, BIOCHEM SOC T, V37, P278, DOI 10.1042/BST0370278; Rathmell JC, 2003, EUR J IMMUNOL, V33, P2223, DOI 10.1002/eji.200324048; Castrillo A, 2004, ANNU REV CELL DEV BI, V20, P455, DOI 10.1146/annurev.cellbio.20.012103.134432; Fritz V, 2010, ONCOGENE, V29, P4369, DOI 10.1038/onc.2010.182; Bauer DE, 2004, FASEB J, V18, P1303, DOI 10.1096/fj.03-1001fje; Nagareddy PR, 2014, CELL METAB, V19, P821, DOI 10.1016/j.cmet.2014.03.029; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Haschemi A, 2012, CELL METAB, V15, P813, DOI 10.1016/j.cmet.2012.04.023; Olofsson PS, 2008, CIRCULATION, V117, P1292, DOI 10.1161/CIRCULATIONAHA.107.699173; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Freemerman AJ, 2014, J BIOL CHEM, V289, P7884, DOI 10.1074/jbc.M113.522037; Gamelli RL, 1996, J LEUKOCYTE BIOL, V59, P639; Haase J, 2014, DIABETOLOGIA, V57, P562, DOI 10.1007/s00125-013-3139-y; Boros LG, 1998, MED HYPOTHESES, V50, P55, DOI 10.1016/S0306-9877(98)90178-5; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Tang QQ, 2013, EUR J IMMUNOL, V43, P1555, DOI 10.1002/eji.201243071; Tong XM, 2009, P NATL ACAD SCI USA, V106, P21660, DOI 10.1073/pnas.0911316106; Bae JS, 2012, CELL SIGNAL, V24, P2227, DOI 10.1016/j.cellsig.2012.07.021; Bae JS, 2011, INFLAMM RES, V60, P467, DOI 10.1007/s00011-010-0289-y; Biswas S, 2001, INT J IMMUNOPATH PH, V15, P183; Chang YS, 2005, J LIPID RES, V46, P2624, DOI 10.1194/jlr.M500154-JLR200; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Fujiwara Nagatoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P281, DOI 10.2174/1568010054022024; Kim CS, 2011, DIABETES, V60, P3159, DOI 10.2337/db10-1805; Kim CS, 2010, ENDOCRINOLOGY, V151, P4725, DOI 10.1210/en.2010-0346; Kim DK, 2009, EUR J IMMUNOL, V39, P2617, DOI 10.1002/eji.200939292; Langstein J, 2000, BIOCHEM BIOPH RES CO, V273, P117, DOI 10.1006/bbrc.2000.2889; Langstein J, 1999, BLOOD, V94, P3161; Langstein J, 1998, J IMMUNOL, V160, P2488; Langstein J, 1999, J LEUKOCYTE BIOL, V65, P829; Vander Heiden M G, 2011, Cold Spring Harb Symp Quant Biol, V76, P325, DOI 10.1101/sqb.2012.76.010900; Palsson-McDermott EM, 2013, BIOESSAYS, V35, P965, DOI 10.1002/bies.201300084; Park SJ, 2012, MOL CELLS, V33, P533, DOI 10.1007/s10059-012-0077-3; Söllner Liane, 2007, Cell Signal, V19, P1899, DOI 10.1016/j.cellsig.2007.04.014; Tu TH, 2014, MEDIAT INFLAMM, V2014, P10; Tu TH, 2014, INT J OBESITY, V38, P1075, DOI 10.1038/ijo.2013.222; Tu TH, 2012, MEDIAT INFLAMM, V2012, P1; Vander Heiden Matthew G, 2009, Science, V324, P1029, DOI 10.1126/science.1160809; Vander Heiden Matthew G, 2010, Science, V329, P1492, DOI 10.1126/science.1188015; Vizan P, 2009, INT J CANCER, V124, P2789, DOI 10.1002/ijc.24262; Wieman Heather L, 2007, Mol Biol Cell, V18, P1437, DOI 10.1091/mbc.E06-07-0593; World Health Organization International Association for the Study of Obesity & International Obesity Task Force, 2000, AS PAC PERSP RED OB; Zhu GF, 2001, J IMMUNOL, V167, P2671	60	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	APR	2015	282	8					1468	1480		10.1111/febs.13236		13	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CG9SF	WOS:000353659600011		
J	Hou, F; Miyakawa, T; Kitamura, N; Takeuchi, M; Park, SB; Kishino, S; Ogawa, J; Tanokura, M				Hou, Feng; Miyakawa, Takuya; Kitamura, Nahoko; Takeuchi, Michiki; Park, Si-Bum; Kishino, Shigenobu; Ogawa, Jun; Tanokura, Masaru			Structure and reaction mechanism of a novel enone reductase	FEBS JOURNAL			English	Article						crystal structure; enone reductase; fatty acid; NADH oxidase; flavin reductase family; reaction mechanism	FATTY-ACID BIOSYNTHESIS; ACYL CARRIER PROTEIN; OLD YELLOW ENZYME; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; TREPONEMA-DENTICOLA; ENOYL REDUCTASE; LIGAND; NITROREDUCTASE; SEARCH	Recently, a novel gut-bacterial fatty acid metabolism, saturation of polyunsaturated fatty acid, that modifies fatty acid composition of the host and is expected to improve our health by altering lipid metabolism related to the onset of metabolic syndrome, was discovered in Lactobacillusplantarum AKU 1009a. Enzymes constituting the pathway catalyze sequential reactions of free fatty acids without CoA or acyl carrier protein. Among these enzymes, CLA-ER was identified as an enone reductase that can saturate the C=C bond in the 10-oxo-trans-11-octadecenoic acid (KetoB) to produce 10-oxo-octadecanoic acid (KetoC). This enzyme is the sole member of the NADH oxidase/flavin reductase family that has been identified to exert an enone reduction activity. Here, we report both the structure of holo CLA-ER with cofactor FMN and the KetoC-bound structure, which elucidate the structural basis of enone group recognition of free fatty acids and provide the unique catalytic mechanism as an enone reductase in the NADH oxidase/flavin reductase family. A cap' structure of CLA-ER underwent a large conformational change upon KetoC binding. The resulting binding site adopts a sandglass shape and is positively charged at one side, which is suitable to recognize a fatty acid molecule with enone group. Based on the crystal structures and enzymatic activities of several mutants, we identified C51, F126 and Y101 as the critical residues for the reaction and proposed an alternative electron transfer pathway of CLA-ER. These findings expand our understanding of the complexity of fatty acid metabolism. DatabaseThe atomic coordinates have been deposited in the Protein Data Bank (PDB), (PDB ID , )	[Hou, Feng; Miyakawa, Takuya; Tanokura, Masaru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 1138657, Japan; [Kitamura, Nahoko; Takeuchi, Michiki; Park, Si-Bum; Kishino, Shigenobu; Ogawa, Jun] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Kyoto 6068501, Japan	Tanokura, M (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	amtanok@mail.ecc.u-tokyo.ac.jp		Kishino, Shigenobu/0000-0002-4587-2422	Targeted Proteins Research Program (TPRP) of the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Platform for Drug Discovery, Informatics, and Structural Life Science of MEXT; Bio-Oriented Technology Research Advancement Institution of Japan	We would like to thank the beamline staff at Photon Factory. The synchrotron radiation experiments were performed at AR-NE3A in the Photon Factory, Tsukuba, Japan (Proposal No. 2012G561). This work was supported by the Targeted Proteins Research Program (TPRP) of the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT), the Platform for Drug Discovery, Informatics, and Structural Life Science of MEXT, and the Bio-Oriented Technology Research Advancement Institution of Japan.	Alphey MS, 2005, J BIOL CHEM, V280, P3068, DOI 10.1074/jbc.M411069200; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Taga ME, 2007, NATURE, V446, P449, DOI 10.1038/nature05611; Race PR, 2005, J BIOL CHEM, V280, P13256, DOI 10.1074/jbc.M409652200; Parkinson GN, 2000, J MED CHEM, V43, P3624, DOI 10.1021/jm000159m; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Stuermer R, 2007, CURR OPIN CHEM BIOL, V11, P203, DOI 10.1016/j.cbpa.2007.02.025; Tvrzicka E, 2011, BIOMED PAP, V155, P117, DOI 10.5507/bp.2011.038; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Chan DI, 2010, BIOCHEM J, V430, P1, DOI 10.1042/BJ20100462; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barna T, 2002, J BIOL CHEM, V277, P30976, DOI 10.1074/jbc.M202846200; Thomas SR, 2009, J BIOL CHEM, V284, P19659, DOI 10.1074/jbc.M109.013458; Ames BD, 2012, P NATL ACAD SCI USA, V109, P11144, DOI 10.1073/pnas.1113029109; Kremmyda LS, 2011, BIOMED PAP, V155, P195, DOI 10.5507/bp.2011.052; Meah Y, 2000, P NATL ACAD SCI USA, V97, P10733, DOI 10.1073/pnas.190345597; Kishino S, 2013, P NATL ACAD SCI USA, V110, P17808, DOI 10.1073/pnas.1312937110; Bond-Watts BB, 2012, BIOCHEMISTRY-US, V51, P6827, DOI 10.1021/bi300879n; Ghisla S, 2004, EUR J BIOCHEM, V271, P494, DOI 10.1046/j.1432-1033.2003.03946.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GHISLA S, 1989, EUR J BIOCHEM, V181, P1, DOI 10.1111/j.1432-1033.1989.tb14688.x; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hu K, 2013, BIOCHEM J, V449, P79, DOI 10.1042/BJ20120871; KINDL H, 1993, BIOCHIMIE, V75, P225, DOI 10.1016/0300-9084(93)90080-C; Rafi S, 2006, J BIOL CHEM, V281, P39285, DOI 10.1074/jbc.M608758200; SCHWEIZER E, 1978, MOL CELL BIOCHEM, V21, P95; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Watkins PA, 1997, PROG LIPID RES, V36, P55, DOI 10.1016/S0163-7827(97)00004-0	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	APR	2015	282	8					1526	1537		10.1111/febs.13239		12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CG9SF	WOS:000353659600014		
J	Nakano, H; Hirakawa, K; Shoji, J				Nakano, Hikaru; Hirakawa, Koji; Shoji, Jun			Development of swimming speed and schooling behavior of juvenile white rockfish (Sebastes cheni) in relation to ambient light intensity	FISHERY BULLETIN			English	Article							STRIPED JACK; ONTOGENY; FISH; ABUNDANCE; BED; NIGHTTIME; JELLYFISH; JAPONICUS; HABITATS; INERMIS	To clarify the ontogenetic changes in antipredator behavior of juvenile white rockfish (Sebastes cheni), effects of light intensity (0.1, 1, 10, 100, 1000, and 10,000 lx) and body size (23.4, 30.3, 41.1, 49.4 and 58.6 mm in total length [TL]) on swimming (cruising [swimming] speed [CS] and burst [swimming] speed [BS]) and schooling behavior (nearest neighbor distance [NND] and separation angle [SA]) were examined under laboratory conditions. The CS was higher under higher light intensities for all length classes. The BS increased with increases in fish body size at the highest light intensity although there was no significant effect of body size at the lowest light intensity. The NND was largest for the smallest fish-size class at all light intensities. The effects of light intensity and fish body size on SA were not significant. Schooling behavior of the juvenile white rockfish was determined to begin to develop at body sizes >30 mm TL. In this study, we found the ability of juvenile white rockfish to avoid predation through schooling behavior to be minimal in comparison with other species because the instinct appears to not be well developed during the early postsettlement period (20-30 mm TL).	[Nakano, Hikaru; Shoji, Jun] Hiroshima Univ, Takehara Fisheries Res Lab, Hiroshima 7250024, Japan; [Hirakawa, Koji] Hiroshima Prefectural Sea Farming Ctr, Hiroshima 7292313, Japan	Shoji, J (reprint author), Hiroshima Univ, Takehara Fisheries Res Lab, 5-8-1 Minato Machi, Hiroshima 7250024, Japan.	jshoji@hiroshima-u.ac.jp			Global Environment Research Fund of the Ministry of the Environment, Japan [E1102]	We express our thanks to S. Iwasaki, Y. Chiba, Y. Ogino, other laboratory staff members, and students for their assistance in our experiments. This study was supported partly by the Global Environment Research Fund (E1102) of the Ministry of the Environment, Japan.	Adams PB, 1996, FISH B-NOAA, V94, P156; Laidig TE, 2007, FISH B-NOAA, V105, P39; Jones DT, 2012, FISH B-NOAA, V110, P332; Guest MA, 2003, FISH RES, V64, P185, DOI 10.1016/S0165-7836(03)00109-7; Shoji J, 2011, ICES J MAR SCI, V68, P1165, DOI 10.1093/icesjms/fsr059; [Anonymous], 2013, ESTUAR COAST SHELF S, V129, P86; [Anonymous], 2011, J FISH BIOL, V78, P1323; Masuda R, 1998, J FISH BIOL, V52, P483, DOI 10.1006/jfbi.1997.0597; BAILEY KM, 1989, ADV MAR BIOL, V25, P1, DOI 10.1016/S0065-2881(08)60187-X; BATTY RS, 1990, MAR BIOL, V107, P383, DOI 10.1007/BF01313419; BLAXTER J H S, 1968, Journal of Experimental Marine Biology and Ecology, V2, P293, DOI 10.1016/0022-0981(68)90021-X; Dauble AD, 2012, MAR ECOL PROG SER, V448, P143, DOI 10.3354/meps09504; Heck KL, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P537; Hindell JS, 2000, MAR BIOL, V136, P725, DOI 10.1007/s002270050732; Houde E.D., 1987, AM FISH SOC S, V2, P17; Kai Y, 2008, ICHTHYOL RES, V55, P238, DOI 10.1007/s10228-007-0029-7; Kamimura Y, 2011, AQUAT ECOL, V45, P367, DOI 10.1007/s10452-011-9360-1; Kamimura Y, 2009, AQUACULTURE SCI, V57, P233; Kinoshita H, 2014, ICES J MAR SCI, V71, P1022, DOI 10.1093/icesjms/fst033; Kinoshita Hikari, 2012, Bulletin of the Japanese Society of Fisheries Oceanography, V76, P24; LOVE MS, 1991, ENVIRON BIOL FISH, V30, P225, DOI 10.1007/BF02296891; Love MS, 2002, ROCKFISHES NE PACIFI; Masuda R, 2006, FISHERIES SCI, V72, P1225, DOI 10.1111/j.1444-2906.2006.01280.x; Masuda R, 2002, FISHERIES SCI, V68, P320, DOI 10.1046/j.1444-2906.2002.00428.x; Masuda R, 2003, FISHERIES SCI, V69, P772, DOI 10.1046/j.1444-2906.2003.00685.x; Miyazaki T, 2000, MAR ECOL PROG SER, V192, P267, DOI 10.3354/meps192267; Nagasawa Toru, 2001, Bulletin of the Japan Sea National Fisheries Research Institute, V51, P1; Petr T., 2000, 396 FAO; Plaza G, 2002, FISHERIES SCI, V68, P1254, DOI 10.1046/j.1444-2906.2002.00563.x; R Core Team, 2014, R LANG ENV STAT COMP; Suzuki Nobuhiro, 1999, Bulletin of Fisheries and Environment of Inland Sea, V1, P1	31	0	0	NATL MARINE FISHERIES SERVICE SCIENTIFIC PUBL OFFICE	SEATTLE	7600 SAND POINT WAY NE BIN C15700, SEATTLE, WA 98115 USA	0090-0656	1937-4518		FISH B-NOAA	Fish. Bull.	APR	2015	113	2					121	128		10.7755/FB.113.2.2		8	Fisheries	Fisheries	CH2HE	WOS:000353845500002		
J	Orr, JW; Wildes, S; Kai, Y; Raring, N; Nakabo, T; Katugin, O; Guyon, J				Orr, James W.; Wildes, Sharon; Kai, Yoshiaki; Raring, Nate; Nakabo, T.; Katugin, Oleg; Guyon, Jeff			Systematics of North Pacific sand lances of the genus Ammodytes based on molecular and morphological evidence, with the description of a new species from Japan	FISHERY BULLETIN			English	Article							PERCIFORMES AMMODYTIDAE; MITOCHONDRIAL-DNA; CONTROL REGION; MARINE FISHES; POPULATIONS; ATLANTIC; WESTERN; CANADA	The systematic status of North Pacific sand lances (genus Ammodytes) was assessed from mitochondrial DNA (cytochrome oxidase c subunit 1) sequence data and morphological data to identify the number of species in the North Pacific Ocean and its fringing seas. Although only 2 species, Ammodytes hexapterus and A. personatus, have been considered valid in the region, haplotype networks and trees constructed with maximum parsimony and genetic distance (neighbor-joining) methods revealed 4 highly divergent monophyletic clades that clearly represent 4 species of Ammodytes in the North Pacific region. On the basis of our material and comparisons with sequence data reported in online databases, A. personatus is found throughout the eastern North Pacific Ocean, Gulf of Alaska, Aleutian Islands, and the eastern Bering Sea where it co-occurs with a northwestern Arctic species, A. hexapterus, that is found throughout the North American Arctic from Hudson Bay, Canada, in the east, through the Beaufort and Chukchi seas, into the northern and western Bering Sea, and to the southern Sea of Okhotsk in the Soya Strait off Hokkaido, Japan. Two other species reside in waters around Japan: A. japonicus throughout the Sea of Japan and the Seto Inland Sea and a new species in the Sea of Japan and the North Pacific Ocean off northern Honshu. We designate neotypes for A. hexapterus and A. personatus because of the absence of type material and the close similarity of these 2 species. Ammodytes ale utensis is a junior synonym of A. japonicus, and A. alascanus is a junior synonym of A. personatus.	[Orr, James W.; Raring, Nate] NOAA, Resource Assessment & Conservat Engn Div, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA; [Wildes, Sharon; Guyon, Jeff] NOAA, Auke Bay Labs, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Juneau, AK 99801 USA; [Kai, Yoshiaki] Kyoto Univ, Maizuru Fisheries Res Stn, Field Sci Educ & Res Ctr, Maizuru, Kyoto 6250086, Japan; [Nakabo, T.] Kyoto Univ, Kyoto Univ Museum, Sakyo Ku, Kyoto 6068501, Japan; [Katugin, Oleg] TINRO Ctr, Pacific Res Inst Fisheries & Oceanog, Vladivostok 690950, Primorsky Kray, Russia	Orr, JW (reprint author), NOAA, Resource Assessment & Conservat Engn Div, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, 7600 Sand Point Way NE, Seattle, WA 98115 USA.	james.orr@noaa.gov					Allen M., 1988, 66 NOAA NMFS; Andriashev A.P., 1964, FISHES NO SEAS USSR; TAMURA K, 1993, MOL BIOL EVOL, V10, P512; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Page Lawrence M., 2013, V34, P7; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; TAJIMA F, 1989, GENETICS, V123, P585; McCusker MR, 2013, MOL ECOL RESOUR, V13, P177, DOI 10.1111/1755-0998.12043; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Kim JK, 2010, GENES GENOM, V32, P437, DOI 10.1007/s13258-010-0017-6; Furness RW, 2002, ICES J MAR SCI, V59, P261, DOI 10.1006/jmsc.2001.1155; Artedi P., 1738, ICHTHYOLOGIA SIVE OP; Briggs J., 1995, GLOBAL BIOGEOGRAPHY; Cope E. D., 1873, P AM PHILOS SOC, V13, P24; DeKay J. E., 1842, ZOOLOGY NEW YORK N 4; Duncker Georg, 1939, MITTEIL ZOOL MUS BERLIN, V24, P8; Eschmeyer WN, 2013, CATALOG FISHES; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Field L. J., 1988, SPECIES SYNOPSES LIF, P15; Gill T. N., 1861, P ACAD NATURAL SCI S, V13, P1; Girard CF, 1856, P ACAD NAT SCI PHILA, V8, P131; Hamada T., 1985, FISHERY BIOL SAND LA; Han ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037425; Hart J. L., 1973, B FISH RES BOARD CAN, V180; HASHIMOTO H, 1981, Tohoku Journal of Agricultural Research, V31, P173; HASHIMOTO H, 1984, B JPN SOC SCI FISH, V50, P1357; Hatooka K., 2013, FISHES JAPAN PICTORI, V3rd, p[1276, 2095]; Hatooka K., 2000, FISHES JAPAN PICTORI, V2nd, P1074; Hatooka K., 2002, FISHES JAPAN PICTORI, P1074; Hubbs C. L., 1958, CRANBOOK I SCI B, V26; IDA H, 1994, ZOOL STUD, V33, P251; Ida H., 1984, FISHES JAPANESE ARCH, P222; Jordan David Starr, 1906, Proceedings of the United States National Museum Smithsonian Institution Washington, V30; Kawamura T., 1940, SUISANGAKU ZASSHI, V46, P80; Kim JK, 2006, KOREAN J GENETIC, V28, P343; Kim J.K., 2008, J ICHTHYOL, V48, P904; Kitaguchi T., 1979, SCI REP HOKK FISH EX, V54, P17; Lacepede B. G. E, 1800, HIST NATURELLE POISS, V2; Ladiges W., 1958, Mitteilungen der Hamburgischen Zoologischen Museum, V56, P155; LEVITON AE, 1985, COPEIA, P802; Lindberg G. U., 1989, KEYS FAUNA USSR, V108; Lindberg G. U., 1937, B FAR E BR ACAD SCI, V27, P85; Linnaeus C., 1758, SYSTEMA NATURAE REGN; Logerwell E. A., 2005, FISH OCEANOG S1, V14, P1; Love M., 2005, 2005030 US GEOL SURV; Mecklenburg C. W., 2011, MAR BIODIVERS, V41, P19; Mecklenburg C. W., 2002, AM FISH SOC; Miller D. J., 1972, FISH B, V5, P157; Nei M., 2000, MOL EVOLUTION PHYLOG; Nelson J. S, 2004, AM FISH SOC, V6th; Nelson JS, 2006, FISHES WORLD; NIZINSKI MS, 1990, FISH B-NOAA, V88, P241; OHSHIMA Y., 1950, BULL JAPANESE SOC SCI FISH, V16, P99; OKAMOTO H, 1989, CAN J FISH AQUAT SCI, V46, P1945, DOI 10.1139/f89-244; Pallas P. S., 1814, ZOOGRAPHIA ROSSOASIA, V3; PIETSCH TW, 1984, COPEIA, P1011, DOI 10.2307/1445355; Popov A. M., 1931, ISSLED MOR SSSR, P121; Rafinesque C.S., 1810, CARATTERI ALCUNI NUO; Raitt D. S., 1934, Journal du Conseil Copenhague, V9, P365; Randall John E., 2014, Journal of the Ocean Science Foundation, V12, P1; Randall John E., 2008, Smithiana Bulletin, V9, P21; Reinhardt J. C. H., 1837, KONGELIGE DANSKE VID, V7, P83; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; SHERMAN K, 1981, NATURE, V291, P486, DOI 10.1038/291486a0; Shibukawa K., 2013, B NATL MUS NAT S A S, V7, P25; Svetovidov A. N., 1978, ZOOGRAPHIA ROSSO ASI; Turanov SV, 2014, RUSS J MAR BIOL+, V40, P447, DOI 10.1134/S1063074014060212; Walbaum J. J., 1792, IMPENSIS ANT FERDIN; Wooding S., 2004, CURR BIOL, V4, pR700	72	1	2	NATL MARINE FISHERIES SERVICE SCIENTIFIC PUBL OFFICE	SEATTLE	7600 SAND POINT WAY NE BIN C15700, SEATTLE, WA 98115 USA	0090-0656	1937-4518		FISH B-NOAA	Fish. Bull.	APR	2015	113	2					129	156		10.7755/FB.113.2.3		28	Fisheries	Fisheries	CH2HE	WOS:000353845500003		
J	Hirata, A; Kim, SY; Kobayakawa, N; Tanaka, N; Kashiwada, Y				Hirata, Ai; Kim, Sang-Yong; Kobayakawa, Natsuki; Tanaka, Naonobu; Kashiwada, Yoshiki			Miltiorins A-D, diterpenes from Radix Salviae miltiorrhizae	FITOTERAPIA			English	Article						Radix Salviae miltiorrhizae; Diterpene; Anti-influenza; Miltiorins A-D	PRENYLATED FLAVONOIDS; DESMODIUM-CAUDATUM; CONSTITUENTS; LEAVES; ROOT	Constituents of the anti-influenza A neuraminidase (NA) active extract from Radix Salviae miltiorrhizae were investigated, resulting in the isolation of four new diterpenes, miltiorins A-D (1-4), together with eight known diterpenes. The structures of 1-4 were assigned by spectroscopic analysis. Miltiorins A-C (1-3) were abietane diterpenes possessing a 2 alpha-acetoxy group and a 12-hydroxy group in common, while miltiorin D (4) was a 11,12-seco-abietane diterpene with a gamma-lactone ring. Miltiorin D (4) is the first example of a 11,12-seco-abietane diterpene from natural sources. Anti-NA activities of the isolated diterpenes were evaluated. (C) 2015 Elsevier B.V. All rights reserved.	[Hirata, Ai; Kim, Sang-Yong; Kobayakawa, Natsuki; Tanaka, Naonobu; Kashiwada, Yoshiki] Univ Tokushima, Grad Sch Pharmaceut Sci, Tokushima 7708505, Japan; [Kim, Sang-Yong] Hlth Sci Univ Hokkaido, Fac Pharmaceut Sci, Tobetsu 0610293, Japan	Kashiwada, Y (reprint author), Univ Tokushima, Grad Sch Pharmaceut Sci, Tokushima 7708505, Japan.	kasiwada@tokushima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25860074]	We thank Mr. Hitoshi Katagiri, UCHIDA WAKANYAKU Ltd. for providing Radix Salviae miltiorrhizae. This work was partly supported by a Grant-in-Aid for Scientific Research (No. 25860074) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	MICHAVILA A, 1986, PHYTOCHEMISTRY, V25, P1935, DOI 10.1016/S0031-9422(00)81178-4; Don MJ, 2006, PHYTOCHEMISTRY, V67, P497, DOI 10.1016/j.phytochem.2005.11.005; Kusumoto N, 2009, J CHEM ECOL, V35, P635, DOI 10.1007/s10886-009-9646-0; Sasaki H, 2012, PHYTOCHEMISTRY, V82, P136, DOI 10.1016/j.phytochem.2012.06.007; Lee SY, 2005, ARCH PHARM RES, V28, P909, DOI 10.1007/BF02973876; OHTANI I, 1991, J AM CHEM SOC, V113, P4092, DOI 10.1021/ja00011a006; DANHEISER RL, 1992, TETRAHEDRON LETT, V33, P1149, DOI 10.1016/S0040-4039(00)91882-3; GINDA H, 1988, TETRAHEDRON LETT, V29, P4603, DOI 10.1016/S0040-4039(00)80559-6; IKESHIRO Y, 1991, PHYTOCHEMISTRY, V30, P2791, DOI 10.1016/0031-9422(91)85147-R; Kakisawa H, 1970, J CHEM SOC CHEM COMM, P299; Kashiwada Y, 2012, J NAT MED-TOKYO, V66, P217, DOI 10.1007/s11418-011-0563-5; Kashiwada Y, 2013, PHYTOCHEMISTRY, V96, P423, DOI 10.1016/j.phytochem.2013.09.021; Kurimoto SI, 2014, FITOTERAPIA, V92, P200, DOI 10.1016/j.fitote.2013.11.004; Nasipuri D, 1973, J CHEM SOC PERK T, V1, P285; Sasaki H, 2014, J AGR FOOD CHEM, V62, P6345, DOI 10.1021/jf5020439; Shi SY, 2007, CHINESE CHEM LETT, V18, P1367, DOI 10.1016/j.cclet.2007.09.005; Ullah N, 1999, PHYTOCHEMISTRY, V51, P103, DOI 10.1016/S0031-9422(98)00724-9; Wu YB, 2012, CHEM REV, V112, P5976	18	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0367-326X	1873-6971		FITOTERAPIA	Fitoterapia	APR	2015	102						49	55		10.1016/j.fitote.2015.01.013		7	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	CH0WH	WOS:000353742600008		
J	Sato, A; Tamura, H				Sato, Akihiko; Tamura, Hirotoshi			High antiallergic activity of 5,6,4 '-trihydroxy-7,8,3 '-trimethoxyflavone and 5,6-dihydroxy-7,8,3 ',4 '-tetramethoxyflavone from eau de cologne mint (Mentha x piperita citrata)	FITOTERAPIA			English	Article						RBL-2H3; Antiallergy; Degranulation; Eau de cologne mint; Mentha x piperita citrata; Polymethoxyflavone	FREE FLAVONOID AGLYCONES; LEUKEMIA RBL-2H3 CELLS; STRUCTURAL REQUIREMENTS; ESSENTIAL OIL; SPICATA L.; TNF-ALPHA; INHIBITION; EXTRACT; LEAVES; DEGRANULATION	The following compounds with higher antiallergic activities were isolated from eau de cologne mint leaves: 5,6,4'-trihydroxy-7,8-dimethoxyflavone (6), 5,6,4'-trihydroxy-7,8,3'-timethoxyflavone (7), 5,6-dihydroxy-7,3',4'-trimethoxyflavone (8), 5,6-dihydroxy-7,8,3',4'-tetramethoxyflavone (9), and 5,6-dihydroxy-7,8,4'-trimethoxyflavone (10). The IC50 values of compounds 6-10 against RBL-2H3 cells were 6.7, 2.4, 5.6, 3.0, and 6.1 mu M. Compounds 7 and 9 (IC50 2.4 mu M and 3.0 mu M) had the highest antiallergic activities among the flavonoids previously reported. The amounts of 7, 9, and 10 isolated were fairly high, at 177.7 mg/kg, 278.0 mg/kg, and 179.7 mg/kg in the mint, respectively. LD5 value (index of toxicity) and LD5/IC50 ratio of 7 and 9 indicate that the safety is greater than that of luteolin, a typical antiallergic substance. The extract containing powerful antiallergic flavones, 6-10 with higher hydrophobicity could be selectively separated from the extract containing luteolin and other flavonoid glycosides by partition with dichloromethane and water. Therefore, compounds 7 and 9 in mint, and the dichloromethane extract would be the most potent and preventive resources against type I allergy. (C) 2015 Elsevier B.V. All rights reserved.	[Sato, Akihiko; Tamura, Hirotoshi] Ehime Univ, United Grad Sch Agr Sci, Matsuyama, Ehime 7908566, Japan; [Tamura, Hirotoshi] Kagawa Univ, Grad Sch Agr, Miki, Kagawa 7610795, Japan	Tamura, H (reprint author), Kagawa Univ, Grad Sch Agr, 2393 Ikenobe, Miki, Kagawa 7610795, Japan.	tamura@ag.kagawa-u.ac.jp					Maeda-Yamamoto M, 2007, CYTOTECHNOLOGY, V55, P135, DOI 10.1007/s10616-007-9112-1; Murata K, 2013, J NAT MED-TOKYO, V67, P643, DOI 10.1007/s11418-012-0699-y; Zhu FX, 2014, J AGR FOOD CHEM, V62, P885, DOI 10.1021/jf404318j; Kimata M, 2000, CLIN EXP ALLERGY, V30, P501, DOI 10.1046/j.1365-2222.2000.00768.x; Areias FM, 2001, FOOD CHEM, V73, P307, DOI 10.1016/S0308-8146(00)00302-2; Siriwan D, 2011, FITOTERAPIA, V82, P1093, DOI 10.1016/j.fitote.2011.07.007; Matsuda H, 2003, BIOORG MED CHEM LETT, V13, P3197, DOI 10.1016/S0960-894X(03)00710-8; Ueda H, 2002, BIOL PHARM BULL, V25, P1197, DOI 10.1248/bpb.25.1197; Asekun OT, 2007, FOOD CHEM, V101, P995, DOI 10.1016/j.foodchem.2006.02.052; Arumugam P, 2008, ENVIRON TOXICOL PHAR, V26, P92, DOI 10.1016/j.etap.2008.02.008; Kumar S, 2012, INT IMMUNOPHARMACOL, V13, P432, DOI 10.1016/j.intimp.2012.05.018; Inoue T, 2002, BIOL PHARM BULL, V25, P256, DOI 10.1248/bpb.25.256; Tassou C, 2000, FOOD RES INT, V33, P273, DOI 10.1016/S0963-9969(00)00047-8; Sato A, 2014, J AGR FOOD CHEM, V62, P7787, DOI 10.1021/jf502151b; Matsuda H, 2004, BIOORGAN MED CHEM, V12, P5891, DOI 10.1016/j.bmc.2004.08.027; Shimoda H, 2006, J AGR FOOD CHEM, V54, P2915, DOI 10.1021/jf052994o; Sugiura Y, 2009, FOOD SCI TECHNOL RES, V15, P423; Kanatt SR, 2007, FOOD CHEM, V100, P451, DOI 10.1016/j.foodchem.2005.09.066; Zaidi F, 1998, PHYTOCHEMISTRY, V48, P991, DOI 10.1016/S0031-9422(97)01042-X; Biswas AK, 2012, FOOD CHEM, V133, P467, DOI 10.1016/j.foodchem.2012.01.073; Chen BH, 2009, J NAT PROD, V72, P950, DOI 10.1021/np800555y; Izquierdo-Dominguez A, 2013, CURR ALLERGY ASTHM R, V13, P142, DOI 10.1007/s11882-012-0331-y; Kobayashi S, 2006, INT J MOL MED, V17, P511; Markham K. K., 1982, TECHNIQUES FLAVONOID, P36; Matsuda H., 2002, BIOORGAN MED CHEM, V10, P3123; Park J, 2006, IMMUNOL LETT, V103, P108, DOI 10.1016/j.imlet.2005.10.002; Saito N, 1980, PLANT PIGMENTS INTRO, P81; Setoguchi Y, 1995, Japan Kokai Tolckyo Koho, Patent No. [JP 07-033648A, 07033648]; TOMASBARBERAN FA, 1990, PLANT SYST EVOL, V173, P109, DOI 10.1007/BF00940856; Trisonthi P, 2014, MOLECULES, V19, P6838, DOI 10.3390/molecules19056838; Voirin B, 1999, PHYTOCHEMISTRY, V50, P1189, DOI 10.1016/S0031-9422(98)00672-4; Watanabe K., 2001, Japan Kokai Tolckyo Koho, Patent No. [JP 2001-348339A, 2001348339]	32	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0367-326X	1873-6971		FITOTERAPIA	Fitoterapia	APR	2015	102						74	83		10.1016/j.fitote.2015.02.003		10	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	CH0WH	WOS:000353742600012		
J	Yanagi, T; Matsumoto, M; Shimizu, S; Iwamura, T; Ogaki, M				Yanagi, Tokue; Matsumoto, Makoto; Shimizu, Sachiko; Iwamura, Tetsuro; Ogaki, Mamiko			Study on Extraction Conditions of Water-Soluble Substances -Purity Test (4) for Polyvinylpolypyrrolidone Listed in Japan's Specifications and Standards for Food Additives-	FOOD HYGIENE AND SAFETY SCIENCE			Japanese	Article						polyvinylpolypyrrolidone; water-soluble substances; hot stirrer; oil bath; polyvinylpyrrolidone; 1-vinyl-2-pyrrolidone (vinylpyrrolidone)		The food additive polyvinylpolypyrrolidone is approved for use as a filter aid. The water-soluble substances test of polyvinylpolypyrrolidone often shows poor reproducibility. The instruction "boil gently while stirring using a stirrer" was considered critical, and so this issue was examined. The results showed that the use of a combination of both an oil bath and a stirrer provided good reproducibility without decomposition or other problems.	[Yanagi, Tokue; Matsumoto, Makoto; Shimizu, Sachiko; Iwamura, Tetsuro; Ogaki, Mamiko] Japan Food Res Labs, Tama Lab, Tama Shi, Tokyo 2060025, Japan	Yanagi, T (reprint author), Japan Food Res Labs, Tama Lab, 6-11-10 Nagayama, Tama Shi, Tokyo 2060025, Japan.	yanagitok@jfrl.or.jp					Committee on Codex Specification, 2014, FOOD CHEM COD, P322; Joint FAO/WHO Expert Committee on Food Additives, COMP FOOD ADD SPEC, V4	2	0	0	FOOD HYGIENE & SAFETY	TOKYO	6-1 JINGU-MAE 2-CHOME SHIBUYA-KU, TOKYO, 150-0001, JAPAN	0015-6426			FOOD HYG SAFE SCI	Food Hyg. Saf. Sci.	APR	2015	56	2					37	41				5	Food Science & Technology	Food Science & Technology	CH3NK	WOS:000353937200001		
J	Yoshida, M; Umemura, T; Kojima, H; Inoue, K; Takahashi, M; Uramaru, N; Kitamura, S; Abe, K; Tohkin, M; Ozawa, S; Yoshinari, K				Yoshida, Midori; Umemura, Takashi; Kojima, Hiroyuki; Inoue, Kaoru; Takahashi, Miwa; Uramaru, Naoto; Kitamura, Shigeyuki; Abe, Kaori; Tohkin, Masahiro; Ozawa, Shogo; Yoshinari, Koichi			Basic Principles of Interpretation of Hepatocellular Hypertrophy in Risk Assessment in Japan	FOOD HYGIENE AND SAFETY SCIENCE			Japanese	Article						liver hypertrophy; hepatocellualr hypertrophy; drug metabolizing enzyme; homeostatsis in the whole organism; acceptable daily intake (ADI)	CONSTITUTIVE ANDROSTANE RECEPTOR; RODENT LIVER-TUMORS; HUMAN RELEVANCE; MODE; MICE; PROMOTION; CAR	This article provided a scientific basis for determining whether liver hypertrophy, a common change in the liver induced by xenobiotics in toxicological studies, is an adaptive or adverse event. To maintain homeostasis in the whole organism, the liver frequently responds to xenobiotic exposure by increasing metabolic capacity via nuclear receptor activation. The resuiting hepatic adaptive responses (hepatocellular hypertrophy and increased relative liver weight) are potentially beneficial to the organism in providing increased capacity to respond to chemical-induced stress. However, excessive responses should be recognized as adverse. Practically, hepatocellular hypertrophy leading to the following alterations should be considered adverse: 1) hepatocellular degeneration/necrosis, whether or not accompanied with inflammatory reaction, 2) changes indicating damage to biliary tracts, 3) disruption of fat metabolism, 4) pigmentation, 5) deviation from typical localization or morphological features of hypertrophied hepatocytes.	[Yoshida, Midori; Umemura, Takashi; Inoue, Kaoru; Takahashi, Miwa] Natl Inst Hlth Sci, Div Pathol, Setagaya Ku, Tokyo 1588501, Japan; [Kojima, Hiroyuki] Hokkaido Inst Publ Hlth, Food Safety Grp, Kita Ku, Sapporo, Hokkaido 0600819, Japan; [Uramaru, Naoto; Kitamura, Shigeyuki] Nihon Pharmaceut Univ, Dept Environm Sci, Ina, Saitama 3620806, Japan; [Tohkin, Masahiro] Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan; [Ozawa, Shogo] Iwate Med Univ, Fac Pharmaceut Sci, Morioka, Iwate 0283694, Japan; [Yoshinari, Koichi] Univ Shizuoka, Sch Pharmaceut Sci, Suruga Ku, Shizuoka 4228526, Japan	Yoshida, M (reprint author), Natl Inst Hlth Sci, Div Pathol, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	midoriy@nihs.go.jp					Braeuning A, 2014, TOXICOL SCI, V140, P259, DOI 10.1093/toxsci/kfu099; Holsapple MP, 2006, TOXICOL SCI, V89, P51, DOI 10.1093/toxsci/kfj001; Peffer RC, 2007, TOXICOL SCI, V99, P315, DOI 10.1093/toxsci/kfm154; Sakamoto Y, 2013, TOXICOL PATHOL, V41, P1078, DOI 10.1177/0192623313482055; Tamura K, 2013, TOXICOL LETT, V221, P47, DOI 10.1016/j.toxlet.2013.05.011; Yamamoto Y, 2004, CANCER RES, V64, P7197, DOI 10.1158/0008-5472.CAN-04-1459; Hall AP, 2012, TOXICOL PATHOL, V40, P971, DOI 10.1177/0192623312448935; Elcombe CR, 2014, CRIT REV TOXICOL, V44, P64, DOI 10.3109/10408444.2013.835786; Joint FAO/WHO Meeting on Pesticide Residues, 2006, SUMM REP ACC DAIL IN, P21; LeBaron MJ, 2014, CRIT REV TOXICOL, V44, P15, DOI 10.3109/10408444.2014.910751; Misra Parimal, 2013, Subcell Biochem, V69, P77, DOI 10.1007/978-94-007-6889-5_5; Osmitz T. G., 2009, CRIT REV TOXICOL, V39, P501; Stagg NJ, 2012, TOXICOL SCI, V128, P334, DOI 10.1093/toxsci/kfs157; US EPA, 2002, G0201 US EAP OFF PES; Yamada T, 2009, TOXICOL SCI, V108, P59, DOI 10.1093/toxsci/kfp007	15	0	0	FOOD HYGIENE & SAFETY	TOKYO	6-1 JINGU-MAE 2-CHOME SHIBUYA-KU, TOKYO, 150-0001, JAPAN	0015-6426			FOOD HYG SAFE SCI	Food Hyg. Saf. Sci.	APR	2015	56	2					42	48				7	Food Science & Technology	Food Science & Technology	CH3NK	WOS:000353937200002		
J	Uekusa, Y; Nabeshi, H; Nakamura, R; Tsutsumi, T; Hachisuka, A; Matsuda, R; Teshima, R				Uekusa, Yoshinori; Nabeshi, Hiromi; Nakamura, Rika; Tsutsumi, Tomoaki; Hachisuka, Akiko; Matsuda, Rieko; Teshima, Reiko			Surveillance of Radioactive Cesium in Domestic Foods on the Japanese Market (Fiscal Years 2012 and 2013)	FOOD HYGIENE AND SAFETY SCIENCE			Japanese	Article						radioactive cesium; screening test; NaI (Tl) scintillation spectrometer; germanium semiconductor detector		We surveyed the concentration of radioactive cesium in foods purchased at markets in areas where possible contamination has been a concern after the Fukushima accident. In fiscal years 2012 and 2013, we surveyed 1,735 and 1,674 foods, respectively, using a NaI (Tl) scintillation spectrometer for the screening test and a gamma-ray spectrometer with a germanium semiconductor detector for the final test. Only 3 and 4 samples (0.2% of our total samples) exceeded the regulatory limit (100 Bq/kg) for radioactive cesium in fiscal years 2012 and 2013, respectively. Our surveillance indicates that the pre-shipment monitoring of foods by local governments has been working effectively.	[Uekusa, Yoshinori; Nabeshi, Hiromi; Nakamura, Rika; Tsutsumi, Tomoaki; Hachisuka, Akiko; Matsuda, Rieko; Teshima, Reiko] Natl Inst Hlth Sci, Setagaya Ku, Tokyo 1588501, Japan	Uekusa, Y (reprint author), Natl Inst Hlth Sci, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	uekusa@nihs.go.jp					Kiyono Y., 2013, JPN J FOR ENV, V55, P113	1	0	0	FOOD HYGIENE & SAFETY	TOKYO	6-1 JINGU-MAE 2-CHOME SHIBUYA-KU, TOKYO, 150-0001, JAPAN	0015-6426			FOOD HYG SAFE SCI	Food Hyg. Saf. Sci.	APR	2015	56	2					49	56		10.3358/shokueishi.56.49		8	Food Science & Technology	Food Science & Technology	CH3NK	WOS:000353937200003		
J	Murakami, R; Mutsuga, M; Abe, T; Abe, Y; Ohsaka, I; Ohno, H; Ohno, H; Ohno, Y; Ozaki, A; Kakihara, Y; Kawasaki, H; Kobayashi, H; Shibata, H; Shirono, K; Sekido, H; Sonobe, H; Takasaka, N; Tajima, Y; Tanaka, A; Tanaka, H; Nomuka, C; Haneishi, N; Hikida, A; Miura, T; Watanabe, K; Akiyama, H				Murakami, Ryo; Mutsuga, Motoh; Abe, Takashi; Abe, Yutaka; Ohsaka, Ikue; Ohno, Haruka; Ohno, Hiroyuki; Ohno, Yuichiro; Ozaki, Asako; Kakihara, Yoshiteru; Kawasaki, Hiromi; Kobayashi, Hisashi; Shibata, Hiroshi; Shirono, Katsuhiro; Sekido, Haruko; Sonobe, Hironori; Takasaka, Noriko; Tajima, Yoshiyasu; Tanaka, Aoi; Tanaka, Hideyuki; Nomuka, Chie; Haneishi, Nahoko; Hikida, Akinori; Miura, Toshihiko; Watanabe, Kazunari; Akiyama, Hiroshi			Interlaboratory Study on Migration Test of Antimony and Germanium for Food-Contact Polyethylene Terephthalate	FOOD HYGIENE AND SAFETY SCIENCE			Japanese	Article						antimony; germanium; migration test; atomic absorption spectrometry; induced coupled plasma-optical emission spectrometry; induced coupled plasma-mass spectrometry; interlaboratory study		An interlaboratory study was performed to evaluate a migration test method of antimony (Sb) and germanium (Ge), based on the Japanese Food Sanitation Law for food- contact polyethylene terephthalate. Eighteen laboratories participated, and quantified Sb and Ge in three test solutions as blind duplicates using graphite furnace atomic absorption spectrometry (GF-AAS), inductively coupled plasma-optical emission spectrometry (ICP-OES) or induced coupled plasma-mass spectrometry (ICP-MS). Statistical analysis revealed that the trueness, repeatability and reproducibility were 98-107%, 1.7-7.5% and 2.0-18.8% by using GF-AAS and ICP-OES. The performance of these methods is sufficient for testing the specifications. The performance parameters of ICP-MS were 99-106%, 0.7-2.2% and 2.2-10.5%, respectively. ICP-MS is available as an alternative measuring method. However, in some laboratories, the quantitative values of Sb were higher than the addition levels. We found that Sb in working solutions is absorbed on glass vessels. Careful control of concentration in working solutions is required for Sb analysis.	[Murakami, Ryo] Japan Food Hyg Assoc, Machida, Tokyo 1940035, Japan; [Mutsuga, Motoh; Abe, Yutaka; Kawasaki, Hiromi; Akiyama, Hiroshi] Natl Inst Hlth Sci, Setagaya Ku, Tokyo 1588501, Japan; [Abe, Takashi] Japan Food Res Labs, Saito Lab, Ibaraki, Osaka 5670085, Japan; [Ohsaka, Ikue] Saitama Prefectural Inst Publ Hlth, Yoshimi, Saitama 3550133, Japan; [Ohno, Haruka] Aichi Prefectural Inst Publ Hlth, Kita Ku, Nagoya, Aichi 4628576, Japan; [Ohno, Hiroyuki] Nagoya City Publ Hlth Res Inst, Mizuho Ku, Nagoya, Aichi 4678615, Japan; [Ohno, Yuichiro] Res Ctr Chiba Pharmaceut Assoc, Midori Ku, Chiba 2670056, Japan; [Ozaki, Asako] Osaka City Inst Publ Hlth & Environm Sci, Tennouji Ku, Osaka 5430026, Japan; [Kakihara, Yoshiteru] Japan Grain Inspect Assoc, Koto Ku, Tokyo 1350043, Japan; [Kobayashi, Hisashi] Food Anal Technol Ctr SUNATEC, Yokaichi, Mie 5100826, Japan; [Shibata, Hiroshi] Tokyo Kenbikyoin Toyomi Ctr BLDG, Chuo Ku, Tokyo 1040055, Japan; [Shirono, Katsuhiro; Tanaka, Hideyuki] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058565, Japan; [Sekido, Haruko] Kanagawa Prefectural Inst Publ Hlth, Chigasaki, Kanagawa 2530087, Japan; [Sonobe, Hironori] Japan Recreat & Miscellaneous Goods Safety Lab, Sumida Ku, Tokyo 1308611, Japan; [Takasaka, Noriko] Hatano Res Inst, Food & Drug Safety Ctr, Hadano, Kanagawa 2578523, Japan; [Tajima, Yoshiyasu] Japan Inspect Assoc Food & Food Ind Environm, Koto Ku, Tokyo 1360082, Japan; [Tanaka, Aoi] Nippon Kaiji Kentei Kyokai, Kanazawa Ku, Yokohama, Kanagawa 2360003, Japan; [Nomuka, Chie] Osaka Prefectural Inst Publ Hlth, Higashinari Ku, Osaka 5370025, Japan; [Haneishi, Nahoko] Tokyo Metropolitan Inst Publ Hlth, Shinjyuku Ku, Tokyo 1690073, Japan; [Hikida, Akinori] Nagano Environm Conservat Res Inst, Nagano, Nagano 3800944, Japan; [Miura, Toshihiko] Japan Frozen Foods Inspection Corp, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Watanabe, Kazunari] Japan Chem Innovat & Inspect Inst, Koto Ku, Tokyo 1350062, Japan	Mutsuga, M (reprint author), Natl Inst Hlth Sci, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	mutsuga@nihs.go.jp					[Anonymous], 1994, 57252 ISO; Ohkado Y, 2005, J FOOD HYG SOC JPN, V46, P109; Japanese Standards Association, 1999, Z84022 JIS; Kakimoto S, 2004, J FOOD HYG SOC JPN, V45, P264; Kawamura Y., 2008, JPN J FOOD CHEM, V15, P1; Kishi E., 2013, J FOOD CHEM, V20, P105; Ohno H, 2011, FOOD HYG SAFE SCI, V52, P66, DOI 10.3358/shokueishi.52.66; Yasuno T., 2007, ANN REP TOKYO METR I, V58, P145	8	0	0	FOOD HYGIENE & SAFETY	TOKYO	6-1 JINGU-MAE 2-CHOME SHIBUYA-KU, TOKYO, 150-0001, JAPAN	0015-6426			FOOD HYG SAFE SCI	Food Hyg. Saf. Sci.	APR	2015	56	2					57	67				11	Food Science & Technology	Food Science & Technology	CH3NK	WOS:000353937200004		
J	Kriegsfeld, LJ; Ubuka, T; Bentley, GE; Tsutsui, K				Kriegsfeld, Lance J.; Ubuka, Takayoshi; Bentley, George E.; Tsutsui, Kazuyoshi			Seasonal control of gonadotropin-inhibitory hormone (GnIH) in birds and mammals	FRONTIERS IN NEUROENDOCRINOLOGY			English	Review						GnIH; RFRP-3; Photoperiod; Melatonin; RFamide-related peptide	RFAMIDE-RELATED PEPTIDE; SPARROWS PASSER-DOMESTICUS; HAMSTERS PHODOPUS-SUNGORUS; MALE SYRIAN-HAMSTERS; PHOTOPERIODIC TIME MEASUREMENT; RIBONUCLEIC-ACID EXPRESSION; INDUCED GONADAL REGRESSION; QUAIL COTURNIX-COTURNIX; MELATONIN BINDING-SITES; SHORT-DAY LENGTHS	Animals inhabiting temperate and boreal latitudes experience marked seasonal changes in the quality of their environments and maximize reproductive success by phasing breeding activities with the most favorable time of year. Whereas the specific mechanisms driving seasonal changes in reproductive function vary across species, converging lines of evidence suggest gonadotropin-inhibitory hormone (GnIH) serves as a key component of the neuroendocrine circuitry driving seasonal changes in reproduction and sexual motivation in some species. In addition to anticipating environmental change through transduction of photoperiodic information and modifying reproductive state accordingly, GnIH is also positioned to regulate acute changes in reproductive status should unpredictable conditions manifest throughout the year. The present overview summarizes the role of GnIH in avian and mammalian seasonal breeding while considering the similarities and disparities that have emerged from broad investigations across reproductively photoperiodic species. (C) 2014 Elsevier Inc. All rights reserved.	[Kriegsfeld, Lance J.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Kriegsfeld, Lance J.; Bentley, George E.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Bentley, George E.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Ubuka, Takayoshi; Tsutsui, Kazuyoshi] Waseda Univ, Ctr Med Life Sci, Dept Biol, Lab Integrat Brain Sci,Shinjuku Ku, Tokyo 1628480, Japan	Kriegsfeld, LJ (reprint author), Univ Calif Berkeley, Dept Psychol, Neurobiol Lab, 3210 Tolman Hall, Berkeley, CA 94720 USA.	kriegsfeld@berkeley.edu			NIH [R01 HD-050470]; NSF [IOS-1257638]; Ministry of Education, Science and Culture, Japan [22132004, 22227002]	Supported by NIH R01 HD-050470 and NSF IOS-1257638 (to L.J.K.) and Grants-in-Aid for Scientific Research from the Ministry of Education, Science and Culture, Japan (22132004 and 22227002 to K.T.).	Tsutsui K, 2000, BIOCHEM BIOPH RES CO, V275, P661, DOI 10.1006/bbrc.2000.3350; Chowdhury VS, 2010, ENDOCRINOLOGY, V151, P271, DOI 10.1210/en.2009-0908; Clarke IJ, 2012, NEUROENDOCRINOLOGY, V95, P305, DOI 10.1159/000332822; Gibson EM, 2008, ENDOCRINOLOGY, V149, P4958, DOI 10.1210/en.2008-0316; Paul MJ, 2008, PHILOS T R SOC B, V363, P341, DOI 10.1098/rstb.2007.2143; Tsutsui K, 2012, GEN COMP ENDOCR, V177, P305, DOI 10.1016/j.ygcen.2012.02.013; NICHOLLS TJ, 1988, PHYSIOL REV, V68, P133; Ancel C, 2012, ENDOCRINOLOGY, V153, P1352, DOI 10.1210/en.2011-1622; UNDERWOOD H, 1984, GEN COMP ENDOCR, V56, P70, DOI 10.1016/0016-6480(84)90063-7; Dawson A, 1998, IBIS, V140, P35, DOI 10.1111/j.1474-919X.1998.tb04538.x; Goodman RL, 2014, NEUROENDOCRINOLOGY, V99, P18, DOI 10.1159/000355285; Mason AO, 2007, HORM BEHAV, V52, P492, DOI 10.1016/j.yhbeh.2007.07.004; KARSCH FJ, 1984, RECENT PROG HORM RES, V40, P185; Sari IP, 2009, ENDOCRINOLOGY, V150, P5549, DOI 10.1210/en.2009-0775; Smith JT, 2007, ENDOCRINOLOGY, V148, P1150, DOI 10.1210/en.2006-1435; DOCKRAY GJ, 1983, NATURE, V305, P328, DOI 10.1038/305328a0; Hinuma S, 2000, NAT CELL BIOL, V2, P703, DOI 10.1038/35036326; Calisi RM, 2011, GENES BRAIN BEHAV, V10, P557, DOI 10.1111/j.1601-183X.2011.00693.x; Barrett P, 2007, ENDOCRINOLOGY, V148, P3608, DOI 10.1210/en.2007-0316; Ubuka T, 2012, ENDOCRINOLOGY, V153, P373, DOI 10.1210/en.2011-1110; PRICE DA, 1977, SCIENCE, V197, P670, DOI 10.1126/science.877582; Wingfield JC, 1998, AM ZOOL, V38, P191; Johnson MA, 2007, HORM BEHAV, V51, P171, DOI 10.1016/j.yhbeh.2006.09.009; TAMARKIN L, 1976, ENDOCRINOLOGY, V99, P1528; Caraty A, 2007, ENDOCRINOLOGY, V148, P5258, DOI 10.1210/en.2007-0554; Revel FG, 2006, CURR BIOL, V16, P1730, DOI 10.1016/j.cub.2006.07.025; Tsutsui K, 2010, FRONT NEUROENDOCRIN, V31, P284, DOI 10.1016/j.yfrne.2010.03.001; Dawson A, 2001, J BIOL RHYTHM, V16, P365, DOI 10.1177/074873001129002079; Greives TJ, 2007, ENDOCRINOLOGY, V148, P1158, DOI 10.1210/en.2006-1249; Wingfield JC, 2008, PHILOS T R SOC B, V363, P425, DOI 10.1098/rstb.2007.2149; Smith JT, 2008, ENDOCRINOLOGY, V149, P5770, DOI 10.1210/en.2008-0581; Tsutsui K, 2009, PROG NEUROBIOL, V88, P76, DOI 10.1016/j.pneurobio.2009.02.003; Klosen P, 2013, FASEB J, V27, P2677, DOI 10.1096/fj.13-229559; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Dardente H, 2008, J NEUROENDOCRINOL, V20, P1252, DOI 10.1111/j.1365-2826.2008.01784.x; Goldman BD, 2001, J BIOL RHYTHM, V16, P283, DOI 10.1177/074873001129001980; Shirazi MRJ, 2014, J NEUROENDOCRINOL, V26, P186, DOI 10.1111/jne.12137; CARTER DS, 1983, ENDOCRINOLOGY, V113, P1261; Clarke IJ, 2008, ENDOCRINOLOGY, V149, P5811, DOI 10.1210/en.2008-0575; Tobari Y, 2010, PEPTIDES, V31, P816, DOI 10.1016/j.peptides.2010.01.015; Ubuka T, 2005, P NATL ACAD SCI USA, V102, P3052, DOI 10.1073/pnas.0403840102; Zhao S, 2010, ENDOCRINOLOGY, V151, P617, DOI 10.1210/en.2009-0978; Goodman RL, 2010, J NEUROENDOCRINOL, V22, P674, DOI 10.1111/j.1365-2826.2010.02014.x; Tsutsui K, 2006, PEPTIDES, V27, P1121, DOI 10.1016/j.peptides.2005.06.036; Kirby ED, 2009, P NATL ACAD SCI USA, V106, P11324, DOI 10.1073/pnas.0901176106; Ubuka T, 2008, ENDOCRINOLOGY, V149, P268, DOI 10.1210/en.2007-0983; Mason AO, 2010, J BIOL RHYTHM, V25, P176, DOI 10.1177/0748730410368821; Osugi T, 2004, J ENDOCRINOL, V182, P33, DOI 10.1677/joe.0.1820033; Stevenson TJ, 2013, P NATL ACAD SCI USA, V110, P16651, DOI 10.1073/pnas.1310643110; Singh P, 2011, J MOL HISTOL, V42, P371, DOI 10.1007/s10735-011-9340-8; WOODFILL CJI, 1994, BIOL REPROD, V50, P965, DOI 10.1095/biolreprod50.4.965; Perfito N, 2011, GEN COMP ENDOCR, V173, P20, DOI 10.1016/j.ygcen.2011.04.016; Calisi RM, 2008, GEN COMP ENDOCR, V157, P283, DOI 10.1016/j.ygcen.2008.05.010; Kriegsfeld LJ, 2006, P NATL ACAD SCI USA, V103, P2410, DOI 10.1073/pnas.0511003103; Ubuka T, 2009, J COMP NEUROL, V517, P841, DOI 10.1002/cne.22191; Anjum S, 2012, J EXP ZOOL PART A, V317A, P630, DOI 10.1002/jez.1765; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Fukusumi S, 2001, BBA-MOL CELL RES, V1540, P221, DOI 10.1016/S0167-4889(01)00135-5; Revel FG, 2008, ENDOCRINOLOGY, V149, P902, DOI 10.1210/en.2007-0848; Dardente H, 2010, CURR BIOL, V20, P2193, DOI 10.1016/j.cub.2010.10.048; Kauffman AS, 2007, TRENDS NEUROSCI, V30, P504, DOI 10.1016/j.tins.2007.08.001; Pinilla L, 2012, PHYSIOL REV, V92, P1235, DOI 10.1152/physrev.00037.2010; Ikemoto T, 2005, J REPROD DEVELOP, V51, P359, DOI 10.1262/jrd.16087; Bentley GE, 2003, J NEUROENDOCRINOL, V15, P794; Tsutsui K, 2010, J NEUROENDOCRINOL, V22, P716, DOI 10.1111/j.1365-2826.2010.02018.x; Kadokawa H, 2009, DOMEST ANIM ENDOCRIN, V36, P219, DOI 10.1016/j.domaniend.2009.02.001; ROBINSON JE, 1982, PROC R SOC SER B-BIO, V215, P95, DOI 10.1098/rspb.1982.0030; Nakao N, 2008, REPRODUCTION, V136, P1, DOI 10.1530/REP-08-0041; Wood S, 2014, J ENDOCRINOL, V222, pR39, DOI 10.1530/JOE-14-0141; Satake H, 2001, BIOCHEM J, V354, P379, DOI 10.1042/0264-6021:3540379; Ukena K, 2002, FEBS LETT, V512, P255, DOI 10.1016/S0014-5793(02)02275-5; Hanon EA, 2008, CURR BIOL, V18, P1147, DOI 10.1016/j.cub.2008.06.076; Greives TJ, 2008, GEN COMP ENDOCR, V156, P552, DOI 10.1016/j.ygcen.2008.02.017; McGuire NL, 2011, ENDOCRINOLOGY, V152, P3461, DOI 10.1210/en.2011-1053; Murakami M, 2008, J ENDOCRINOL, V199, P105, DOI 10.1677/JOE-08-0197; Ansel L, 2011, REPRODUCTION, V142, P417, DOI 10.1530/REP-10-0313; Bae HH, 1999, J BIOL RHYTHM, V14, P391, DOI 10.1177/074873099129000795; BITTMAN EL, 1990, BIOL REPROD, V43, P986, DOI 10.1095/biolreprod43.6.986; Bronson F. H., 1989, MAMMALIAN REPROD BIO; BRONSON FH, 1986, ENDOCRINOLOGY, V118, P2483; BRONSON FH, 1988, AM J PHYSIOL, V254, pR616; BRONSON FH, 1985, BIOL REPROD, V33, P660, DOI 10.1095/biolreprod33.3.660; Clarke IJ, 2009, PEPTIDES, V30, P154, DOI 10.1016/j.peptides.2008.08.022; Farner D. S., 1979, HORMONES EVOLUTION, P829; Follett B.K., 1984, MARSHALLS PHYSL REPR, V1, P283; Guyomarc'h C, 2001, BEHAV PROCESS, V53, P121, DOI 10.1016/S0376-6357(01)00133-4; Harbid AA, 2013, J COMP NEUROL, V521, P3030, DOI 10.1002/cne.23328; Henson JR, 2013, J BIOL RHYTHM, V28, P193, DOI 10.1177/0748730413487974; Ikegami K, 2013, J REPROD DEVELOP, V59, P327, DOI 10.1262/jrd.2013-035; Janati A, 2013, J NEUROENDOCRINOL, V25, P402, DOI 10.1111/jne.12015; Jarjisian SG, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109587; Klingerman Candice M, 2011, Front Endocrinol (Lausanne), V2, P101, DOI 10.3389/fendo.2011.00101; Kovacs A, 2014, BRAIN RES BULL, V107, P61, DOI 10.1016/j.brainresbull.2014.07.002; Kriegsfeld L.J., 2010, PHOTOPERIODISM BIOL; LEE TM, 1991, J BIOL RHYTHM, V6, P315, DOI 10.1177/074873049100600403; LEGAN SJ, 1977, ENDOCRINOLOGY, V101, P818; Lehman MN, 2010, EUR J NEUROSCI, V32, P2152, DOI 10.1111/j.1460-9568.2010.07530.x; Leon S, 2014, ENDOCRINOLOGY, V155, P2953, DOI 10.1210/en.2014-1030; Lewis D, 2002, J NEUROENDOCRINOL, V14, P294, DOI 10.1046/j.1365-2826.2002.00779.x; Masson-Pevet Mireille, 1994, Biological Signals, V3, P63; Maywood ES, 1996, BIOL REPROD, V54, P470, DOI 10.1095/biolreprod54.2.470; MAYWOOD ES, 1995, ENDOCRINOLOGY, V136, P144, DOI 10.1210/en.136.1.144; McGuire NL, 2013, PEERJ, V1, DOI 10.7717/peerj.139; Nakane Y, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00115; OHTA M, 1989, BIOL REPROD, V40, P935, DOI 10.1095/biolreprod40.5.935; Papargiris MM, 2011, J NEUROENDOCRINOL, V23, P208, DOI 10.1111/j.1365-2826.2010.02094.x; Piekarski DJ, 2014, J BIOL RHYTHM, V29, P181, DOI 10.1177/0748730414532423; Piekarski DJ, 2013, HORM BEHAV, V64, P501, DOI [10.1016/j.yhbeh.2013.06.006, 10.1016/j.yhbeh2013.06.006]; Poling M.C., 2014, NEUROENDOCRINOLOGY; Revel FG, 2006, ENDOCRINOLOGY, V147, P4680, DOI 10.1210/en.2006-0606; Rozenboim I, 2002, POULTRY SCI, V81, P1354; SCHNEIDER JE, 1989, SCIENCE, V244, P1326, DOI 10.1126/science.2734610; Schneider JE, 2013, HORM BEHAV, V64, P702, DOI 10.1016/j.yhbeh.2013.07.005; Shahab M, 1997, LIFE SCI, V61, P1293, DOI 10.1016/S0024-3205(97)00674-7; Simonneaux V, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00022; SISK CL, 1986, BIOL REPROD, V35, P554, DOI 10.1095/biolreprod35.3.554; SKENE DJ, 1992, J NEUROENDOCRINOL, V4, P189, DOI 10.1111/j.1365-2826.1992.tb00158.x; Smith JT, 2012, DOMEST ANIM ENDOCRIN, V43, P75, DOI 10.1016/j.domaniend.2011.11.003; Son YL, 2014, ENDOCRINOLOGY, V155, P1817, DOI 10.1210/en.2013-2076; Tobari Y, 2014, J NEUROSCI, V34, P9803, DOI 10.1523/JNEUROSCI.3706-13.2014; Tsutsui K, 2012, HDB BIOL ACTIVE PEPT, P802; Tsutsui K, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00060; TUREK FW, 1977, ENDOCRINOLOGY, V101, P1210; Ubuka T, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00038; Ubuka T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008400; WEAVER DR, 1991, ENDOCRINOLOGY, V128, P1086; WILLIAMS LM, 1989, J NEUROENDOCRINOL, V1, P315, DOI 10.1111/j.1365-2826.1989.tb00122.x; WINGFIELD JC, 1993, GEN COMP ENDOCR, V92, P388, DOI 10.1006/gcen.1993.1176; Wingfield J.C., 1983, AVIAN ENDOCRINOLOGY; Wingfield J.C., 1980, PROG REPRODUCT BIOL, P62; Yoshida H, 2003, BBA-MOL CELL RES, V1593, P151, DOI 10.1016/S0167-4889(02)00389-0; Zucker I., 1991, SUPRACHIASMATIC NUCL, P246	132	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0091-3022	1095-6808		FRONT NEUROENDOCRIN	Front. Neuroendocrinol.	APR	2015	37						65	75		10.1016/j.yfrne.2014.12.001		11	Endocrinology & Metabolism; Neurosciences	Endocrinology & Metabolism; Neurosciences & Neurology	CH2HL	WOS:000353846200007		
J	Kishida, O; Tezuka, A; Ikeda, A; Takatsu, K; Michimae, H				Kishida, Osamu; Tezuka, Ayumi; Ikeda, Akiko; Takatsu, Kunio; Michimae, Hirofumi			Adaptive acceleration in growth and development of salamander hatchlings in cannibalistic situations	FUNCTIONAL ECOLOGY			English	Article						cannibalism; density dependence; escape performance; gape-limited predator; Hynobius retardatus; inducible defences; inducible offenses; phenotypic plasticity; salamander; trade-offs	LARVAL TIGER SALAMANDERS; HYNOBIUS-RETARDATUS; PREDATION RISK; TRADE-OFF; PHENOTYPIC PLASTICITY; INDUCIBLE DEFENSE; SIZE STRUCTURE; ANURAN LARVAE; EVOLUTION; POPULATIONS	In most animal species, the hatchling stage is a highly vulnerable life-history stage. In many fish and amphibian species, hatchling abundance varies substantially among sites and years, with the result that selection strength in conspecific interactions such as cannibalism is also variable. The variability of selection leads species to evolve phenotypic plasticity, and adaptive trait changes in hatchlings that depend on the density of conspecifics can therefore be expected. However, plasticity strategies in response to cannibalistic interactions in this vulnerable life-history stage have received little attention. Because cannibalism success is dependent on the size balance between predator capturing organ and prey body, and also on the prey-capturing ability of the cannibal and the escape ability of its prey, we hypothesize that hatchlings will exhibit faster growth and development in response to conspecific interactions. We performed a series of experiments to test this hypothesis, using pre-feeding larvae of a cannibalistic salamander (Hynobius retardatus). Many traits of the hatchlings reared with conspecifics were larger than the same traits in those reared alone, because the former hatchlings grew faster and were more advanced developmentally. The time to the beginning of feeding was shorter, and swimming speed as an indicator of escape performance was faster, for hatchlings reared with conspecifics. Hatchlings reared with conspecifics more successfully cannibalized small hatchlings and were also highly resistant to being cannibalized by large conspecifics, compared with hatchlings reared alone. These differences in cannibalism success and avoidance of cannibalization were well explained by differences in gape and head size, respectively, between the interacting hatchlings. Therefore, acceleration of growth and development of hatchlings in the proximate presence of conspecifics may confer significant fitness advantages on hatchlings in a high-density cannibalistic situation. Developmental and growth plasticity may thus be a powerful adaptive mechanism that allows individuals to respond to the dynamic character of salamander populations in nature.	[Kishida, Osamu; Tezuka, Ayumi] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Teshio Expt Forest, Horonobe, Hokkaido 0982943, Japan; [Tezuka, Ayumi] Kyushu Inst Technol, Dept Biosci & Bioinformat, Iizuka, Fukuoka 8208502, Japan; [Ikeda, Akiko; Takatsu, Kunio] Hokkaido Univ, Grad Sch Environm Sci, Horonobe, Hokkaido 0982943, Japan; [Michimae, Hirofumi] Kitasato Univ, Sch Pharmaceut Sci, Div Biostat, Minato Ku, Tokyo 1088641, Japan	Kishida, O (reprint author), Hokkaido Univ, Field Sci Ctr Northern Biosphere, Teshio Expt Forest, Toikanbetsu 131, Horonobe, Hokkaido 0982943, Japan.	bulgy_tadpoles@hotmail.com			Japan Society for the Promotion of Science [23247004, 70447069]	We are very grateful to two anonymous reviewers for their constructive comments on the previous version of the manuscript. Our work conforms to guidelines for the proper conduct of animal experiments in Japan. This work was supported by Grants-in-Aid for a Research Fellow of the Japan Society for the Promotion of Science to O. Kishida (no. 23247004) and to H. Michimae (no. 70447069).	Urban MC, 2007, ECOLOGY, V88, P2587, DOI 10.1890/06-1946.1; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; MORAN NA, 1992, AM NAT, V139, P971, DOI 10.1086/285369; Warkentin KM, 2000, ANIM BEHAV, V60, P503, DOI 10.1006/anbe.2000.1508; Callahan HS, 2008, ANN NY ACAD SCI, V1133, P44, DOI 10.1196/annals.1438.008; Bourdeau PE, 2012, OIKOS, V121, P1175, DOI 10.1111/j.1600-0706.2012.20235.x; WARKENTIN KM, 1995, P NATL ACAD SCI USA, V92, P3507, DOI 10.1073/pnas.92.8.3507; Dmitriew CM, 2011, BIOL REV, V86, P97, DOI 10.1111/j.1469-185X.2010.00136.x; Warkentin KM, 2011, INTEGR COMP BIOL, V51, P14, DOI 10.1093/icb/icr017; POLIS GA, 1981, ANNU REV ECOL SYST, V12, P225, DOI 10.1146/annurev.es.12.110181.001301; Kishida O, 2011, J ANIM ECOL, V80, P1278, DOI 10.1111/j.1365-2656.2011.01871.x; Warkentin KM, 2011, INTEGR COMP BIOL, V51, P111, DOI 10.1093/icb/icr046; Van Buskirk J, 2002, AM NAT, V160, P87, DOI 10.1086/340599; Ali M, 2003, FISH FISH, V4, P147, DOI 10.1046/j.1467-2979.2003.00120.x; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; MAGNUSSON WE, 1991, OECOLOGIA, V86, P310, DOI 10.1007/BF00317595; Miner BG, 2004, ECOL LETT, V7, P794, DOI 10.1111/j.1461-0248.2004.00637.x; Cowan JH, 1996, ICES J MAR SCI, V53, P23; Vonesh JR, 2000, COPEIA, P560, DOI 10.1643/0045-8511(2000)000[0560:DPOTAE]2.0.CO;2; Hoffman EA, 1999, ECOLOGY, V80, P1076, DOI 10.1890/0012-9658(1999)080[1076:PCOCPI]2.0.CO;2; Touchon JC, 2013, ECOLOGY, V94, P850; Van Buskirk J, 2001, J EVOLUTION BIOL, V14, P482, DOI 10.1046/j.1420-9101.2001.00282.x; Pfennig DW, 2010, TRENDS ECOL EVOL, V25, P459, DOI 10.1016/j.tree.2010.05.006; FUIMAN LA, 1994, REV FISH BIOL FISHER, V4, P145, DOI 10.1007/BF00044127; Ferrari MCO, 2009, BIOL LETTERS, V5, P160, DOI 10.1098/rsbl.2008.0641; Sultan SE, 2007, TRENDS ECOL EVOL, V22, P575, DOI 10.1016/j.tree.2007.06.014; Relyea RA, 2001, ECOLOGY, V82, P523, DOI 10.1890/0012-9658(2001)082[0523:MABPOL]2.0.CO;2; Mathis A, 2008, P R SOC B, V275, P2603, DOI 10.1098/rspb.2008.0754; Hangui J, 2009, ZOOL SCI, V26, P119, DOI 10.2108/zsj.26.119; Vonesh JR, 2005, OIKOS, V110, P241, DOI 10.1111/j.0030-1299.2005.13759.x; Arendt JD, 1997, Q REV BIOL, V72, P149, DOI 10.1086/419764; Kishida O, 2010, POPUL ECOL, V52, P37, DOI 10.1007/s10144-009-0182-0; Arendt JD, 2000, CAN J FISH AQUAT SCI, V57, P351, DOI 10.1139/cjfas-57-2-351; Wissinger SA, 2010, ECOLOGY, V91, P549, DOI 10.1890/08-1366.1; COLLINS JP, 1984, CAN J ZOOL, V62, P168; DeWitt T. J., 2004, PHENOTYPIC PLASTICIT; FOX LR, 1975, ANNU REV ECOL SYST, V6, P87, DOI 10.1146/annurev.es.06.110175.000511; Fujimoto S, 2012, POPUL ECOL, V54, P275, DOI 10.1007/s10144-011-0297-y; Gilbert SF, 2009, ECOLOGICAL DEV BIOL; Gosner K. L., 1960, Herpetologica, V16, P183; Harvell C. D., 1999, ECOLOGY EVOLUTION IN; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; HOUSTON AI, 1993, PHILOS T ROY SOC B, V341, P375, DOI 10.1098/rstb.1993.0123; Iwami T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001084; Johnson LJ, 2010, HEREDITY, V105, P113, DOI 10.1038/hdy.2010.25; Kishida O, 2009, ECOLOGY, V90, P1217, DOI 10.1890/08-0238.1; Kishida O., 2014, DRYAD DIGITAL REPOSI, DOI [10.5061/dryad.g8hm9, DOI 10.5061/DRYAD.G8HM9]; Kishida O, 2009, ECOLOGY, V90, P3150, DOI 10.1890/08-2158.1; Landberg T., 2009, FUNCT ECOL, V24, P576; IWASAWA H, 1991, Japanese Journal of Herpetology, V14, P39; Michimae H, 2002, EVOLUTION, V56, P2029; Michimae H, 2006, BEHAV ECOL SOCIOBIOL, V60, P205, DOI 10.1007/s00265-005-0157-x; MILLER TJ, 1988, CAN J FISH AQUAT SCI, V45, P1657, DOI 10.1139/f88-197; Nishihara-Takahashi A, 1999, ZOOL SCI, V16, P303, DOI 10.2108/zsj.16.303; Nosaka M, 2015, OIKOS, V124, P225, DOI 10.1111/oik.01662; RICKLEFS RE, 1994, EVOLUTION, V48, P1080, DOI 10.2307/2410368; SIH A, 1993, AM NAT, V142, P947, DOI 10.1086/285583; Voronezhskaya EE, 2008, ACTA BIOL HUNG, V59, P117, DOI 10.1556/ABiol.59.2008.Suppl.19; Voronezhskaya EE, 2004, DEVELOPMENT, V131, P3671, DOI 10.1242/dev.01237; Ziemba RE, 1999, OECOLOGIA, V120, P524, DOI 10.1007/s004420050886	60	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0269-8463	1365-2435		FUNCT ECOL	Funct. Ecol.	APR	2015	29	4					469	478		10.1111/1365-2435.12361		10	Ecology	Environmental Sciences & Ecology	CH0BV	WOS:000353684800004		
J	Archer, CR; Duffy, E; Hosken, DJ; Mokkonen, M; Okada, K; Oku, K; Sharma, MD; Hunt, J				Archer, C. Ruth; Duffy, Eoin; Hosken, David J.; Mokkonen, Mikael; Okada, Kensuke; Oku, Keiko; Sharma, Manmohan D.; Hunt, John			Sex-specific effects of natural and sexual selection on the evolution of life span and ageing in Drosophila simulans	FUNCTIONAL ECOLOGY			English	Article						ageing rates; evolutionary response; experimental evolution; longevity; senescence; sexual conflict	EXTRINSIC MORTALITY; OXIDATIVE STRESS; FEMALE FITNESS; HISTORY TRAITS; MALE-STERILITY; SEED BEETLE; SENESCENCE; MELANOGASTER; AGE; POPULATIONS	Variation in the strength of age-dependent natural selection shapes differences in ageing rates across species and populations. Likewise, sexual selection can promote divergent patterns of senescence across the sexes. However, the effects of these processes on the evolution of ageing have largely been considered independently, and interactions between them are poorly understood. We use experimental evolution to investigate how natural and sexual selection affect life span and ageing in Drosophila simulans. Replicate populations were evolved under lifetime monogamy (relaxed sexual selection) or lifetime polyandry (elevated sexual selection) and at one of two temperatures, 25 degrees C (relaxed natural selection) or 27 degrees C (enhanced natural selection), in a fully factorial design. We measured longevity in 150 individually housed flies taken from each of three replicate populations per selection regime. We found that natural and sexual selection affected the evolution of life span via sex-specific effects on different ageing parameters (ageing rate vs. baseline mortality): natural selection reduced the rate of ageing in both sexes but increased male baseline mortality, while sexual selection elevated baseline mortality in both sexes but particularly in males. This means that sexual and natural selection interacted to reduce male life span but acted on female life span by independently affecting particular ageing parameters. Sex-specific effects of sexual and natural selection may help explain the diverse patterns of ageing seen in nature but complicate predictions about how ageing and life span evolve across the sexes	[Archer, C. Ruth; Duffy, Eoin; Hosken, David J.; Mokkonen, Mikael; Okada, Kensuke; Oku, Keiko; Sharma, Manmohan D.; Hunt, John] Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Exeter TR10 9EZ, Devon, England; [Archer, C. Ruth] Max Planck Inst Demog Res, Max Planck Res Grp, Modelling Evolut Ageing, D-18057 Rostock, Germany; [Duffy, Eoin] Jagiellonian Univ, Inst Environm Sci, PL-30387 Krakow, Poland; [Mokkonen, Mikael] Univ Jyvaskyla, Dept Biol & Environm Sci, FI-40014 Jyvaskyla, Finland; [Okada, Kensuke] Okayama Univ, Grad Sch Environm Sci, Lab Evolutionary Ecol, Okayama 7008530, Japan; [Oku, Keiko] Wageningen Univ, Entomol Lab, NL-6700 EH Wageningen, Netherlands	Hunt, J (reprint author), Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Penryn Campus, Exeter TR10 9EZ, Devon, England.	J.Hunt@exeter.ac.uk			NERC Studentship; BBSRC; NERC; Royal Society Fellowship	RA was funded by a NERC Studentship (awarded to JH) and the BBSRC and MS, and DH and JH were supported by NERC and JH by a Royal Society Fellowship. We thank Tom Tregenza for commenting on our selection regime and Thomas Flatt for advice on interpreting the Weibull function.	KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Kokko H, 1997, BEHAV ECOL SOCIOBIOL, V41, P99, DOI 10.1007/s002650050369; Gems D, 2008, CELL METAB, V7, P200, DOI 10.1016/j.cmet.2008.01.001; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.2307/2406060; PARTRIDGE L, 1992, EVOLUTION, V46, P76, DOI 10.2307/2409806; Williams PD, 2003, EVOLUTION, V57, P1478; Archer CR, 2012, EVOLUTION, V66, P3088, DOI 10.1111/j.1558-5646.2012.01673.x; Reznick DN, 2004, NATURE, V431, P1095, DOI 10.1038/nature02936; Lorch PD, 2003, EVOL ECOL RES, V5, P867; Kokko H, 1998, EVOL ECOL, V12, P739, DOI 10.1023/A:1006541701002; Pletcher SD, 1999, J EVOLUTION BIOL, V12, P430; Bronikowski AM, 2005, TRENDS ECOL EVOL, V20, P271, DOI 10.1016/j.tree.2005.03.011; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Bonduriansky R, 2008, FUNCT ECOL, V22, P443, DOI 10.1111/j.1365-2435.2008.01417.x; Partridge L, 1996, P ROY SOC B-BIOL SCI, V263, P1365; Pletcher SD, 2000, J GERONTOL A-BIOL, V55, pB381; Lailvaux SP, 2006, ANIM BEHAV, V72, P263, DOI 10.1016/j.anbehav.2006.02.003; Promislow D, 2003, BEHAV GENET, V33, P191, DOI 10.1023/A:1022562103669; Hosken DJ, 2008, CURR BIOL, V18, pR553, DOI 10.1016/j.cub.2008.04.028; Stearns SC, 2000, P NATL ACAD SCI USA, V97, P3309, DOI 10.1073/pnas.060289597; Gasparini C, 2012, EVOLUTION, V66, P532, DOI 10.1111/j.1558-5646.2011.01455.x; Tower J, 2011, EXP GERONTOL, V46, P355, DOI 10.1016/j.exger.2010.09.002; Rohmer C, 2004, J EXP BIOL, V207, P2735, DOI 10.1242/jcb.01087; Tafani M, 2013, OECOLOGIA, V172, P427, DOI 10.1007/s00442-012-2499-1; Sharma MD, 2012, EVOLUTION, V66, P665, DOI 10.1111/j.1558-5646.2011.01468.x; Maklakov AA, 2007, AGING CELL, V6, P739, DOI 10.1111/j.1474-9726.2007.00333.x; ABRAMS PA, 1993, EVOLUTION, V47, P877, DOI 10.2307/2410191; Graves BM, 2007, EVOL ECOL, V21, P663, DOI 10.1007/s10682-006-9144-6; Chen HY, 2012, CURR BIOL, V22, P2140, DOI 10.1016/j.cub.2012.09.021; PROMISLOW DEL, 1992, P ROY SOC B-BIOL SCI, V247, P203, DOI 10.1098/rspb.1992.0030; Taylor ML, 2008, ANIM BEHAV, V76, P963, DOI 10.1016/j.anbehav.2008.05.015; Wright LI, 2008, CONSERV GENET, V9, P833, DOI 10.1007/s10592-007-9405-0; Landis G, 2012, AGING-US, V4, P768; Kokko H, 2003, ANN ZOOL FENN, V40, P207; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; Okada K, 2011, J EVOLUTION BIOL, V24, P363, DOI 10.1111/j.1420-9101.2010.02170.x; Chakir M, 2002, GENETICA, V114, P195, DOI 10.1023/A:1015154329762; Maklakov AA, 2013, BIOESSAYS, V35, P717, DOI 10.1002/bies.201300021; Rogell B, 2014, FUNCT ECOL, V28, P469, DOI 10.1111/1365-2435.12179; Nussey DH, 2008, FUNCT ECOL, V22, P393, DOI 10.1111/j.1365-2435.2008.01408.x; Archer C. R., 2014, DRYAD DIGITAL REPOSI; Arnqvist G, 2005, SEXUAL CONFLICT; Bolker B, 2009, BBMLE TOOLS GEN MAXI; Botero CA, 2009, ANIM BEHAV, V77, P701, DOI 10.1016/j.anbehav.2008.11.020; Caswell H, 2007, TRENDS ECOL EVOL, V22, P173, DOI 10.1016/j.tree.2007.01.006; Fox CW, 2003, FUNCT ECOL, V17, P619, DOI 10.1046/j.1365-2435.2003.00781.x; Hughes KA, 2010, PHILOS T R SOC B, V365, P1273, DOI 10.1098/rstb.2009.0265; Medawar P.B., 1952, UNSOLVED PROBLEM BIO; Miyo T, 2004, P ROY SOC B-BIOL SCI, V271, P2517, DOI 10.1098/rspb.2004.2879; PARTRIDGE L, 1995, EVOLUTION, V49, P538, DOI 10.2307/2410277; R Core Development Team, 2013, LANG ENV STAT COMP; Sarup P., 2013, EXPT GERONTOLOGY, V50, P34; Sisodia S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046131; Taylor ML, 2007, CURR BIOL, V17, pR959, DOI 10.1016/j.cub.2007.09.054	54	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0269-8463	1365-2435		FUNCT ECOL	Funct. Ecol.	APR	2015	29	4					562	569		10.1111/1365-2435.12369		8	Ecology	Environmental Sciences & Ecology	CH0BV	WOS:000353684800014		
J	Mizusawa, K; Kawashima, Y; Sunuma, T; Hamamoto, A; Kobayashi, Y; Kodera, Y; Saito, Y; Takahashi, A				Mizusawa, Kanta; Kawashima, Yusuke; Sunuma, Toshikazu; Hamamoto, Akie; Kobayashi, Yuki; Kodera, Yoshio; Saito, Yumiko; Takahashi, Akiyoshi			Involvement of melanin-concentrating hormone 2 in background color adaptation of barfin flounder Verasper moseri	GENERAL AND COMPARATIVE ENDOCRINOLOGY			English	Article						Background color adaptation; Barfin flounder; Hypothalamus; Melanin-concentrating hormone; Pituitary; Receptor	FOOD-INTAKE; GENE-EXPRESSION; MCH; GOLDFISH; RECEPTOR; FISH; EVOLUTIONARY; PEPTIDES; PROTEINS; APPETITE	In teleosts, melanin-concentrating hormone (MCH) plays a key role in skin color changes. MCH is released into general circulation from the neurohypophysis, which causes pigment aggregation in the skin chromatophores. Recently, a novel MCH (MCH2) precursor gene, which is orthologous to the mammalian MCH precursor gene, has been identified in some teleosts using genomic data mining. The physiological function of MCH2 remains unclear. In the present study, we cloned the cDNA for MCH2 from barfin flounder, Verasper moseri. The putative prepro-MCH2 contains 25 amino acids of MCH2 peptide region. Liquid chromatography-electrospray ionization mass spectrometry with a high resolution mass analyzer were used for confirming the amino acid sequences of MCH1 and MCH2 peptides from the pituitary extract. In vitro synthesized MCH1 and MCH2 induced pigment aggregation in a dose-dependent manner. A mammalian cell-based assay indicated that both MCH1 and MCH2 functionally interacted with both the MCH receptor types 1 and 2. Mch1 and mch2 are exclusively expressed in the brain and pituitary. The levels of brain mch2 transcript were three times higher in the fish that were chronically acclimated to a white background than those acclimated to a black background. These results suggest that in V. moseri, MCH1 and MCH2 are involved in the response to changes in background colors, during the process of chromatophore control. (C) 2014 Elsevier Inc. All rights reserved.	[Mizusawa, Kanta; Sunuma, Toshikazu; Kobayashi, Yuki; Takahashi, Akiyoshi] Kitasato Univ, Sch Marine Biosci, Minami Ku, Sagamihara, Kanagawa 2520373, Japan; [Kawashima, Yusuke; Kodera, Yoshio] Kitasato Univ, Sch Sci, Minami Ku, Sagamihara, Kanagawa 2520373, Japan; [Hamamoto, Akie; Kobayashi, Yuki; Saito, Yumiko] Hiroshima Univ, Grad Sch Integrated Arts & Sci, Hiroshima 7398521, Japan	Mizusawa, K (reprint author), Kitasato Univ, Sch Marine Biosci, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520373, Japan.	mizusawa@kitasato-u.ac.jp			Japan Society for the Promotion of Science - Japan [22248023]	The authors would like to thank the following people for their cooperation: Tadashi Andoh and Naoto Murakami at Hokkaido National Fisheries Research Institute; Takashi Sunada and Tomoaki Mikawa at Iwate Cultivating Fishery Association; Hoshito Tomizawa and Daisuke Saito at Kitasato University. This study was supported by Grants from the Japan Society for the Promotion of Science - Japan to A.T. (22248023).	Amano M, 2009, PEPTIDES, V30, P1979, DOI 10.1016/j.peptides.2009.05.022; Saito Y, 1999, NATURE, V400, P265; Wu M, 2009, P NATL ACAD SCI USA, V106, P17217, DOI 10.1073/pnas.0908200106; Sherwood A, 2012, EUR J NEUROSCI, V36, P3126, DOI 10.1111/j.1460-9568.2012.08207.x; Saito Yumiko, 2008, V46, P159, DOI 10.1007/400_2007_052; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Tuziak SM, 2012, MOL CELL ENDOCRINOL, V348, P281, DOI 10.1016/j.mce.2011.09.015; Hawes BE, 2000, ENDOCRINOLOGY, V141, P4524, DOI 10.1210/en.141.12.4524; Berman JR, 2009, J COMP NEUROL, V517, P695, DOI 10.1002/cne.22171; KAWAUCHI H, 1983, NATURE, V305, P321, DOI 10.1038/305321a0; Seidah NG, 1998, ANN NY ACAD SCI, V839, P9, DOI 10.1111/j.1749-6632.1998.tb10727.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Audinot V, 2001, J BIOL CHEM, V276, P13554; Cerda-Reverter JM, 2006, NEUROENDOCRINOLOGY, V84, P364, DOI 10.1159/000098334; Eberle A.N., 1988, THE MELANOTROPINS; Griffond B, 2002, INT REV CYTOL, V213, P233; GRONEVELD D, 1995, J MOL ENDOCRINOL, V14, P199; GRONEVELD D, 1995, J NEUROENDOCRINOL, V7, P527, DOI 10.1111/j.1365-2826.1995.tb00789.x; Hall T. A., 1999, NUCL ACIDS S SER, V4, P95, DOI DOI 10.1111/J.1469-8137.2009.02874.X; Hamamoto A, 2011, REGUL PEPTIDES, V169, P6, DOI 10.1016/j.regpep.2011.04.001; Kang DY, 2013, GEN COMP ENDOCR, V189, P74, DOI 10.1016/j.ygcen.2013.04.025; KAWAUCHI H, 1993, ANN NY ACAD SCI, V680, P64, DOI 10.1111/j.1749-6632.1993.tb19675.x; Kawauchi H, 2006, J EXP ZOOL PART A, V305A, P751, DOI 10.1002/jez.a.310; Kobayashi Y, 2009, GEN COMP ENDOCR, V161, P419, DOI 10.1016/j.ygcen.2009.02.009; Matsuda K, 2006, NEUROSCI LETT, V399, P259, DOI 10.1016/j.neulet.2006.02.005; Matsuda K, 2007, CELL TISSUE RES, V328, P375, DOI 10.1007/s00441-006-0347-5; Mizusawa K, 2009, PEPTIDES, V30, P1990, DOI 10.1016/j.peptides.2009.04.010; Mizusawa K, 2011, GEN COMP ENDOCR, V171, P75, DOI 10.1016/j.ygcen.2010.12.008; Nahon JL, 2006, CR BIOL, V329, P623, DOI 10.1016/j.crvi.2006.03.021; Siegel S., 1998, NONPARAMETRIC STAT B; Sunuma T, 2009, AQUAC RES, V40, P748, DOI 10.1111/j.1365-2109.2009.02179.x; SUZUKI M, 1995, J NEUROENDOCRINOL, V7, P319, DOI 10.1111/j.1365-2826.1995.tb00764.x; Takahashi A, 2007, GEN COMP ENDOCR, V151, P210, DOI 10.1016/j.ygcen.2007.01.011; Takahashi A, 2004, PEPTIDES, V25, P1613, DOI 10.1016/j.peptides.2004.02.022; Yamanome T, 2005, AQUACULTURE, V244, P323, DOI 10.1016/j.aquaculture.2004.11.020; Zhang C, 2010, P NATL ACAD SCI USA, V107, P20164, DOI 10.1073/pnas.1014941107	36	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0016-6480	1095-6840		GEN COMP ENDOCR	Gen. Comp. Endocrinol.	APR 1	2015	214						140	148		10.1016/j.ygcen.2014.07.008		9	Endocrinology & Metabolism	Endocrinology & Metabolism	CH2GS	WOS:000353844300018		
J	Yaji, S; Manya, H; Nakagawa, N; Takematsu, H; Endo, T; Kannagi, R; Yoshihara, T; Asano, M; Oka, S				Yaji, Shohei; Manya, Hiroshi; Nakagawa, Naoki; Takematsu, Hiromu; Endo, Tamao; Kannagi, Reiji; Yoshihara, Toru; Asano, Masahide; Oka, Shogo			Major glycan structure underlying expression of the Lewis X epitope in the developing brain is O-mannose-linked glycans on phosphacan/RPTP beta	GLYCOBIOLOGY			English	Article						Lewis X; O-mannosyl glycan; phosphacan (RPTP beta); poly-N-acetyllactosamine	PROTEIN-TYROSINE-PHOSPHATASE; POLY-N-ACETYLLACTOSAMINE; CENTRAL-NERVOUS-SYSTEM; ALPHA-DYSTROGLYCAN; NEURITE OUTGROWTH; ADHESION MOLECULES; CELL-ADHESION; GLYCOSYLATION; BINDING; MICE	Glycosylation is a major protein modification. Although proteins are glycosylated/further modulated by several glycosyltransferases during trafficking from the endoplasmic reticulum to the Golgi apparatus, a certain glycan epitope has only been detected on a limited number of proteins. Of these glycan epitopes, Lewis X is highly expressed in the early stage of a developing brain and plays important roles in cell-cell interaction. The Lewis X epitope is comprised of a trisaccharide (Gal beta 1-4 (Fuc alpha 1-3) GlcNAc), and a key enzyme for the expression of this epitope is alpha 1,3-fucosyltransferase 9. However, the scaffolding glycan structure responsible for the formation of the Lewis X epitope as well as its major carrier protein has not been fully characterized in the nervous system. Here we showed that the Lewis X epitope was mainly expressed on phosphacan/receptor protein tyrosine phosphatase beta (RPTP beta) in the developing mouse brain. Expression of the Lewis X epitope was markedly reduced in beta 1,4-galactosyltransferase 2 (beta 4GalT2) gene-deficient mice, which indicated that beta 4GalT2 is a major galactosyltransferase required for the Lewis X epitope. We also showed that the Lewis X epitope almost disappeared due to the knockout of protein O-mannose beta 1,2-N-acetylglucosaminyltransferase 1, an N-acetylglucosaminyltransferase essential for the synthesis of O-mannosylated glycans, which indicated that the O-mannosylated glycan is responsible for presenting the Lewis X epitope. Since O-mannosylated glycans on phosphacan/RPTP beta could also present human natural killer-1, another glycan epitope specifically expressed in the nervous system, our results revealed the importance of O-mannosylated glycan chains in the presentation of functional glycan epitopes in the brain.	[Yaji, Shohei; Nakagawa, Naoki; Takematsu, Hiromu; Oka, Shogo] Kyoto Univ, Grad Sch Med, Human Hlth Sci, Dept Biol Chem, Kyoto, Japan; [Manya, Hiroshi; Endo, Tamao] Tokyo Metropolitan Geriatr Hosp, Mol Glycobiol, Res Team Mech Aging, Tokyo, Japan; [Manya, Hiroshi; Endo, Tamao] Inst Gerontol, Tokyo, Japan; [Kannagi, Reiji] Aichi Med Univ, Adv Med Res Ctr, Nagakutce, Japan; [Yoshihara, Toru; Asano, Masahide] Kanazawa Univ, Adv Sci Res Ctr, Div Transgen Anim Sci, Kanazawa, Ishikawa, Japan; [Yoshihara, Toru] Kanazawa Univ, Res Ctr Child Mental Dev, Kanazawa, Ishikawa, Japan	Oka, S (reprint author), Kyoto Univ, Grad Sch Med, Human Hlth Sci, Dept Biol Chem, Kyoto, Japan.	shogo@hs.med.kyoto-u.ac.jp			MEXT of Japan [23110006, 24110523]; Japan Society for the Promotion of Science [26291021, 25293016, 24590078, 252038]; NCNP [26-8]	This work was supported by Grants-in-Aid for Scientific Research on Innovative Areas (no. 23110006 to S.O. and no. 24110523 to H.M.) from MEXT of Japan, Grants-in-Aid for Scientific Research (B) (no. 26291021 to S.O. and no. 25293016 to T.E.), Scientific Research (C) (no. 24590078 to H.T.) and JSPS Fellows (no. 252038 to N.N.) from the Japan Society for the Promotion of Science, and a Grant-in-Aid for Intramural Research Grant (26-8) for Neurological and Psychiatric Disorders of NCNP (to T.E.).	Maeda N, 2003, J BIOL CHEM, V278, P35805, DOI 10.1074/jbc.M305530200; Sakurai T, 1997, J CELL BIOL, V136, P907, DOI 10.1083/jcb.136.4.907; Miyagoe-Suzuki Y, 2009, MECH DEVELOP, V126, P107, DOI 10.1016/j.mod.2008.12.001; Hennen E, 2013, J BIOL CHEM, V288, P16538, DOI 10.1074/jbc.M112.419812; KRUSIUS T, 1986, J BIOL CHEM, V261, P8237; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Sato S, 2008, NAT NEUROSCI, V11, P923, DOI 10.1038/nn.2160; Togayachi A, 2010, METHOD ENZYMOL, V479, P185, DOI 10.1016/S0076-6879(10)79011-X; Morise J, 2014, GLYCOBIOLOGY, V24, P314, DOI 10.1093/glycob/cwt116; Chai WG, 1999, EUR J BIOCHEM, V263, P879, DOI 10.1046/j.1432-1327.1999.00572.x; Lommel M, 2013, P NATL ACAD SCI USA, V110, P21024, DOI 10.1073/pnas.1316753110; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; ALLENDOERFER KL, 1995, MOL CELL NEUROSCI, V6, P381, DOI 10.1006/mcne.1995.1029; Inatani M, 2001, INVEST OPHTH VIS SCI, V42, P1930; Nishihara S, 2003, GLYCOBIOLOGY, V13, P445, DOI 10.1093/glycob/cwg048; Shimoda Y, 2002, J BIOL CHEM, V277, P2033, DOI 10.1074/jbc.M108495200; Yagi H, 2012, J BIOL CHEM, V287, P24356, DOI 10.1074/jbc.M112.365643; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Dwyer CA, 2012, NEUROSCIENCE, V220, P47, DOI 10.1016/j.neuroscience.2012.06.026; Abbott KL, 2008, J BIOL CHEM, V283, P33026, DOI 10.1074/jbc.M803646200; Parry S, 2007, GLYCOBIOLOGY, V17, P646, DOI 10.1093/glycob/cwm024; Lieberoth A, 2009, J NEUROSCI, V29, P6677, DOI 10.1523/JNEUROSCI.4361-08.2009; Mitsuoka C, 1998, J BIOL CHEM, V273, P11225, DOI 10.1074/jbc.273.18.11225; BARNEA G, 1994, J BIOL CHEM, V269, P14349; Lamprianou S, 2011, P NATL ACAD SCI USA, V108, P17498, DOI 10.1073/pnas.1108774108; Kudo T, 2007, GLYCOBIOLOGY, V17, P1, DOI 10.1093/glycob/cwl047; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Beltrán-Valero de Bernabé Daniel, 2002, Am J Hum Genet, V71, P1033, DOI 10.1086/342975; Bleckmann C, 2009, BIOL CHEM, V390, P627, DOI 10.1515/BC.2009.044; Chang HH, 2013, CLIN CANCER RES, V19, P1705, DOI 10.1158/1078-0432.CCR-12-2367; Chiba A, 1997, J BIOL CHEM, V272, P2156; FENDERSON BA, 1984, J EXP MED, V160, P1591, DOI 10.1084/jem.160.5.1591; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Gocht A, 1996, HISTOL HISTOPATHOL, V11, P1007; HAKOMORI SI, 1992, HISTOCHEM J, V24, P771, DOI 10.1007/BF01046348; Hennen E, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201095; KRUEGER NX, 1992, P NATL ACAD SCI USA, V89, P7417, DOI 10.1073/pnas.89.16.7417; MERKLE RK, 1987, J BIOL CHEM, V262, P8179; MILEV P, 1995, J BIOL CHEM, V270, P24650; MOORE KL, 1994, J BIOL CHEM, V269, P23318; Ohmori K, 2001, LEUKOCYTE TYPING, P179; Peles E, 1998, TRENDS BIOCHEM SCI, V23, P121, DOI 10.1016/S0968-0004(98)01195-5; Sajdel-Sulkowska EM, 1998, ACTA BIOCHIM POL, V45, P781; Sasaki N, 2005, BIOCHEM BIOPH RES CO, V333, P131, DOI 10.1016/j.bbrc.2005.05.082; Smalheiser NR, 1998, J BIOL CHEM, V273, P23698, DOI 10.1074/jbc.273.37.23698; Ujita M, 1999, J BIOL CHEM, V274, P9296, DOI 10.1074/jbc.274.14.9296; Ujita M, 1998, J BIOL CHEM, V273, P34843, DOI 10.1074/jbc.273.52.34843; Vester-Christensen MB, 2013, P NATL ACAD SCI USA, V110, P21018, DOI 10.1073/pnas.1313446110; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512; Yoshihara T, 2009, J BIOL CHEM, V284, P12550, DOI 10.1074/jbc.M809188200	53	2	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658	1460-2423		GLYCOBIOLOGY	Glycobiology	APR	2015	25	4					376	385		10.1093/glycob/cwu118		10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CH3BS	WOS:000353901700004		
J	Kato, T; Takashima, A; Kasamatsu, T; Nakamura, K; Mizusawa, J; Nakanishi, T; Takeshima, N; Kamiura, S; Onda, T; Sumi, T; Takano, M; Nakai, H; Saito, T; Fujiwara, K; Yokoyama, M; Itamochi, H; Takehara, K; Yokota, H; Mizunoe, T; Takeda, S; Sonoda, K; Shiozawa, T; Kawabata, T; Honma, S; Fukuda, H; Yaegashi, N; Yoshikawa, H; Konishi, I; Kamura, T				Kato, Tomoyasu; Takashima, Atsuo; Kasamatsu, Takahiro; Nakamura, Kenichi; Mizusawa, Junki; Nakanishi, Toru; Takeshima, Nobuhiro; Kamiura, Shoji; Onda, Takashi; Sumi, Toshiyuki; Takano, Masashi; Nakai, Hidekatsu; Saito, Toshiaki; Fujiwara, Kiyoshi; Yokoyama, Masatoshi; Itamochi, Hiroaki; Takehara, Kazuhiro; Yokota, Harushige; Mizunoe, Tomoya; Takeda, Satoru; Sonoda, Kenzo; Shiozawa, Tanri; Kawabata, Takayo; Honma, Shigeru; Fukuda, Haruhiko; Yaegashi, Nobuo; Yoshikawa, Hiroyuki; Konishi, Ikuo; Kamura, Toshiharu		Japan Clinical Oncology Grp	Clinical tumor diameter and prognosis of patients with FIGO stage IB1 cervical cancer (JCOG0806-A)	GYNECOLOGIC ONCOLOGY			English	Article						Cervical cancer; FIGO stage IB1; Radical hysterectomy; Tumor diameter; MR imaging	MODIFIED RADICAL HYSTERECTOMY; COMPUTED-TOMOGRAPHY; BLADDER FUNCTION; CLASS-III; LOW-RISK; CARCINOMA; SURGERY; IDENTIFICATION; LYMPHADENECTOMY; CHEMOTHERAPY	Objective. In order to determine indications for less radical surgery such as modified radical hysterectomy, the risk of pathological parametrial involvement and prognosis of FIGO stage IB1 cervical cancer patients undergoing standard radical hysterectomy with pre-operatively assessed tumor diameter <= 2 cm were investigated. Methods. We conducted a retrospective multi-institutional chart review of patients with FIGO stage IB1 cervical cancer who underwent primary surgical treatment between 1998 and 2002. The eligibility criteria for the analyses were (i) histologically-proven squamous cell carcinoma, adenocarcinoma or, adenosquamous cell carcinoma, (ii) radical hysterectomy performed, (iii) clinical tumor diameter data available by MR imaging or specimens by cone biopsy, and (iv) age between 20 and 70. Based on the clinical tumor diameter, patients were stratified into those with the following tumors: i) 2 cm or less (cT <= 2 cm) and ii) greater than 2 cm (cT > 2 cm). We expected 5-year OS of >= 95% and parametrial involvement <2-3% for patients with cT <= 2 cm who underwent radical hysterectomy. Results. Of the 1269 patients enrolled, 604 were eligible for the planned analyses. Among these, 571 underwent radical hysterectomy (323 with cT <= 2 cm and 248 with cT > 2 cm). Parametrial involvement was present in 1.9% (6/323) with cT <= 2 cm and 12.9% (32/248) with cT > 2 cm. Five-year overall survivals were 95.8% (95% CI 92.9-97.6%) in cT <= 2 cm and 91.9% (95% Cl 87.6-94.8%) in cT > 2 cm patients. Conclusion. Patients with cT <= 2 cm had lower risk of parametrial involvement and more favorable 5-year overall survival. They could therefore be good candidates for receiving less radical surgery. (C) 2015 Elsevier Inc. All rights reserved.	[Kato, Tomoyasu; Kasamatsu, Takahiro] Natl Canc Ctr, Dept Gynecol Oncol, Tokyo 1040045, Japan; [Takashima, Atsuo; Nakamura, Kenichi; Mizusawa, Junki; Fukuda, Haruhiko] Natl Canc Ctr, Multiinst Clin Trial Support Ctr, Japan Clin Oncol Grp, Ctr Data, Tokyo, Japan; [Nakanishi, Toru] Aichi Canc Ctr, Dept Gynecol Oncol, Nagoya, Aichi, Japan; [Takeshima, Nobuhiro] Canc Inst Hosp, Dept Gynecol, Tokyo, Japan; [Kamiura, Shoji] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Gynecol, Osaka, Japan; [Onda, Takashi] Kitasato Univ, Dept Obstet & Gynecol, Minato, Tokyo, Japan; [Sumi, Toshiyuki] Osaka City Univ, Grad Sch Med, Dept Obstet & Gynecol, Osaka, Japan; [Takano, Masashi] Natl Def Med Coll, Dept Obstet & Gynecol, Tokorozawa, Saitama, Japan; [Nakai, Hidekatsu] Kinki Univ, Dept Gynecol, Higashiosaka, Osaka 577, Japan; [Saito, Toshiaki] Kyushu Natl Canc Ctr, Gynecol Serv, Yokohama, Kanagawa, Japan; [Fujiwara, Kiyoshi] Hyogo Canc Ctr, Dept Gynecol Oncol, Kobe, Hyogo, Japan; [Yokoyama, Masatoshi] Saga Univ, Dept Gynecol & Obstet, Saga, Japan; [Itamochi, Hiroaki] Tottori Univ, Dept Obstet & Gynecol, Tottori, Japan; [Takehara, Kazuhiro] Shikoku Canc Ctr, Dept Gynecol Oncol, Sapporo, Hokkaido, Japan; [Yokota, Harushige] Saitama Canc Ctr, Dept Gynecol Oncol, Saitama, Japan; [Mizunoe, Tomoya] Kure Med Ctr, Dept Gynecol Oncol, Hiroshima, Japan; [Takeda, Satoru] Juntendo Univ, Sch Med, Dept Obstet & Gynecol, Keio, Japan; [Sonoda, Kenzo] Kyushu Univ, Dept Obstet & Gynecol, Fukuoka 812, Japan; [Shiozawa, Tanri] Shinshu Univ, Dept Obstet & Gynecol, Matsumoto, Nagano, Japan; [Kawabata, Takayo] Kagoshima City Hosp, Dept Obstet & Gynecol, Kagoshima, Japan; [Honma, Shigeru] Niigata Canc Ctr Hosp, Dept Gynecol, Tokyo, Japan; [Yaegashi, Nobuo] Tohoku Univ, Dept Obstet & Gynecol, Sendai, Miyagi 980, Japan; [Yoshikawa, Hiroyuki] Univ Tsukuba, Dept Obstet & Gynecol, Tsukuba, Ibaraki 305, Japan; [Konishi, Ikuo] Kyoto Univ, Dept Gynecol & Obstet, Kyoto 6068501, Japan; [Kamura, Toshiharu] Kurume Univ, Dept Obstet & Gynecol, Kurume, Fukuoka, Japan	Kato, T (reprint author), Natl Canc Ctr, Gynecol Dept, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	tokato@ncc.go.jp			National Cancer Center Research and Development Fund from Ministry of Health, Labour and Welfare, Japan [23-A-16, 23-A-17, 26-A-4]	The authors thank the members of the JCOG Data Center and Operations Office for their support, especially Ms. H. Kaba for data management. This work was supported in part by the National Cancer Center Research and Development Fund (23-A-16, 23-A-17 and 26-A-4) from the Ministry of Health, Labour and Welfare, Japan.	SUBAK LL, 1995, OBSTET GYNECOL, V86, P43, DOI 10.1016/0029-7844(95)00109-5; Schmeler KM, 2011, GYNECOL ONCOL, V120, P321, DOI 10.1016/j.ygyno.2010.12.352; KINNEY WK, 1995, GYNECOL ONCOL, V57, P3, DOI 10.1006/gyno.1995.1091; INOUE T, 1984, CANCER, V54, P1714, DOI 10.1002/1097-0142(19841015)54:8<1714::AID-CNCR2820540838>3.0.CO;2-S; Kamimori T, 2011, INT J GYNECOL CANCER, V21, P349, DOI 10.1097/IGC.0b013e3182072eea; Fujii S, 2007, GYNECOL ONCOL, V107, P4, DOI 10.1016/j.ygyno.2007.08.076; Peters WA, 2000, J CLIN ONCOL, V18, P1606; Kenter GG, 2000, ACTA OBSTET GYN SCAN, V79, P72, DOI 10.1034/j.1600-0412.2000.079001072.x; Landoni F, 1997, LANCET, V350, P535, DOI 10.1016/S0140-6736(97)02250-2; Quinn M, 2006, INT J GYNECOL OBSTET, V95, pS43, DOI 10.1016/S0020-7292(06)60030-1; Benedetti-Panici P, 2004, CANCER, V100, P2110, DOI 10.1002/cncr.20235; PIVER MS, 1974, OBSTET GYNECOL, V44, P265; Jackson KS, 2006, INT J GYNECOL CANCER, V16, P354, DOI 10.1111/j.1525-1438.2006.00347.x; Balleyguier C, 2011, EUR RADIOL, V21, P1102, DOI 10.1007/s00330-010-1998-x; Frumovitz M, 2009, OBSTET GYNECOL, V114, P93, DOI 10.1097/AOG.0b013e3181ab474d; Covens A, 2002, GYNECOL ONCOL, V84, P145, DOI 10.1006/gyno.2001.6493; Mitchell DG, 2006, J CLIN ONCOL, V24, P5687, DOI 10.1200/JCO.2006.07.4799; Landoni F, 2001, GYNECOL ONCOL, V80, P3, DOI 10.1006/gyno.2000.6010; Sheu MH, 2001, EUR RADIOL, V11, P1828, DOI 10.1007/s003300000774; Reade CJ, 2013, GYNECOL ONCOL, V131, P222, DOI 10.1016/j.ygyno.2013.07.078; Bipat S, 2003, GYNECOL ONCOL, V91, P59, DOI 10.1016/S0090-8258(03)00409-8; Biliatis I, 2012, GYNECOL ONCOL, V126, P73, DOI 10.1016/j.ygyno.2012.03.041; Zullo MA, 2003, CRIT REV ONCOL HEMAT, V48, P287, DOI 10.1016/S1040-8428(03)00125-2; Covens A, GOG PROTOCOL 278; FARQUHARSON DIM, 1987, BRIT J OBSTET GYNAEC, V94, P351, DOI 10.1111/j.1471-0528.1987.tb03104.x; FORNEY JP, 1980, AM J OBSTET GYNECOL, V138, P374; Green J, 2005, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002225; Jung DC, 2010, GYNECOL ONCOL, V119, P426, DOI 10.1016/j.ygyno.2010.08.005; Kunieda F, 2015, JPN J CLIN ONCOL, V45, P123, DOI 10.1093/jjco/hyu168; NCT Group, 2013, RAD VERS SIMPL HYST; PHOTOPULOS GJ, 1991, GYNECOL ONCOL, V40, P21, DOI 10.1016/0090-8258(91)90078-J; RALPH G, 1991, European Journal of Gynaecological Oncology, V12, P27; Scully RE, 1996, HISTOLOGICAL TYPING; Sekido N, 1997, Int J Urol, V4, P259, DOI 10.1111/j.1442-2042.1997.tb00183.x; Yang YC, 1999, GYNECOL ONCOL, V74, P241, DOI 10.1006/gyno.1999.5434	35	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0090-8258	1095-6859		GYNECOL ONCOL	Gynecol. Oncol.	APR	2015	137	1					34	39		10.1016/j.ygyno.2015.01.548		6	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CG2BJ	WOS:000353079600007		
J	Takahashi, R; Mabuchi, S; Kawano, M; Sasano, T; Matsumoto, Y; Kuroda, H; Hisamatsu, T; Kozasa, K; Sawada, K; Hamasaki, T; Kimura, T				Takahashi, Ryoko; Mabuchi, Seiji; Kawano, Mahiru; Sasano, Tomoyuki; Matsumoto, Yuri; Kuroda, Hiromasa; Hisamatsu, Takeshi; Kozasa, Katsumi; Sawada, Kenjiro; Hamasaki, Toshimitsu; Kimura, Tadashi			Prognostic significance of systemic neutrophil and leukocyte alterations in surgically treated endometrial cancer patients: A monoinstitutional study	GYNECOLOGIC ONCOLOGY			English	Article						Neutrophilia; Endometrial cancer; Surgery; Survival	CERVICAL-CANCER; PREOPERATIVE LEUKOCYTOSIS; CARCINOMA; ADENOCARCINOMA; RECURRENCE; INDICATOR; SURVIVAL; MARKERS	Objective. The aim of this study was to investigate the prognostic significance of an elevated neutrophil count at the time of the initial diagnosis in patients with surgically treated endometrial cancer. Methods. The baseline characteristics and outcome data of patients who were diagnosed with endometrial cancer between January 2000 and December 2010 were collected and retrospectively reviewed. The patients were separated into two groups according to their neutrophil counts. The clinicopathological characteristics and overall survival rates of the two groups were compared. A Cox proportional hazard regression model was used to investigate the prognostic significance of an elevated neutrophil count among patients with surgically treated endometrial cancer. Results. An elevated neutrophil count was found to be associated with an advanced clinical stage (P < 0.0001), lymphovascular space involvement (P = 0.0003), cervical involvement (P = 0.0049), the proportion of patients that received adjuvant therapy (P = 0.0020), elevated NLR (P <0.0001), and treatment failure (P <0.0001). Multivariate analyses demonstrated that age (hazard ratio (HR) = 2.23, 95% confidence interval (95% CI) = 1.30 to 3.91; P = 0.0035), clinical stage (HR = 4.72, 95% Cl = 2.61 to 8.90; P < 0.0001), lymphovascular space involvement (HR = 3.15, 95% Cl = 1.60 to 6.68; P = 0.0007), an elevated neutrophil count (HR = 2.76, 95% Cl = 1.43 to 5.03; P = 0.0033), and an elevated white blood cell count (HR = 2.79, 95% CI = 1.50 to 4.96; P = 0.0017) were significant predictors of survival. Conclusion. The elevated neutrophil or leukocyte counts at the time of the initial diagnosis are independent prognostic factors in patients with surgically treated endometrial cancer. (C) 2015 Elsevier Inc. All rights reserved.	[Takahashi, Ryoko; Mabuchi, Seiji; Kawano, Mahiru; Sasano, Tomoyuki; Matsumoto, Yuri; Kuroda, Hiromasa; Hisamatsu, Takeshi; Kozasa, Katsumi; Sawada, Kenjiro; Kimura, Tadashi] Osaka Univ, Grad Sch Med, Dept Obstet & Gynecol, Suita, Osaka 5650871, Japan; [Hamasaki, Toshimitsu] Osaka Univ, Grad Sch Med, Dept Biomed Stat, Suita, Osaka 5650871, Japan	Mabuchi, S (reprint author), Osaka Univ, Grad Sch Med, Dept Obstet & Gynecol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	smabuchi@gyne.med.osaka-u.ac.jp	Hamasaki, Toshimitsu/N-3851-2015	Hamasaki, Toshimitsu/0000-0002-4928-1160			Granger JM, 2009, CANCER, V115, P3919, DOI 10.1002/cncr.24480; Mabuchi S, 2011, GYNECOL ONCOL, V122, P25, DOI 10.1016/j.ygyno.2011.03.037; Kim HS, 2010, EJSO-EUR J SURG ONC, V36, P691, DOI 10.1016/j.ejso.2010.05.004; Njolstad TS, 2013, GYNECOL ONCOL, V131, P410, DOI 10.1016/j.ygyno.2013.08.032; Mabuchi S, 2012, INT J GYNECOL CANCER, V22, P1545, DOI 10.1097/IGC.0b013e31826ea0eb; Lopez CM, 2012, CLIN GENITOURIN CANC, V10, P262, DOI 10.1016/j.clgc.2012.06.005; Ruka W, 2001, ANN ONCOL, V12, P1423, DOI 10.1023/A:1012527006566; Amant F, 2005, LANCET, V366, P491, DOI 10.1016/S0140-6736(05)67063-8; Lewin SN, 2010, OBSTET GYNECOL, V116, P1141, DOI 10.1097/AOG.0b013e3181f39849; Tavares-Murta BM, 2010, INT J GYNECOL CANCER, V20, P1154, DOI 10.1111/IGC.0b013e3181ef8deb; Suh DH, 2012, EUR J OBSTET GYN R B, V162, P206, DOI 10.1016/j.ejogrb.2012.02.028; Salvesen HB, 2012, LANCET ONCOL, V13, pE353, DOI 10.1016/S1470-2045(12)70213-9; Prat J, 2004, HUM PATHOL, V35, P649, DOI 10.1016/j.humpath.2004.02.007; Wang D, 2013, ONCOTARGETS THER, V6, P211, DOI 10.2147/OTT.S41711; Egawa-Takata T, 2011, CANCER CHEMOTH PHARM, V68, P1603, DOI 10.1007/s00280-011-1638-4; International Agency for Research on Cancer, 2014, GLOBACAN 2012 EST CA; Mabuchi S, 2010, INT J GYNECOL PATHOL, V29, P483, DOI 10.1097/PGP.0b013e3181d29729; Mabuchi S, 2014, JNCI-J NATL CANCER I, P106; Nagase S, 2010, INT J CLIN ONCOL, V15, P531, DOI 10.1007/s10147-010-0138-6; Santoni M, 2015, TARGET ONCOL; Tejerizo-Garcia A, 2013, ONCOTARGETS THER, V6, P1305, DOI 10.2147/OTT.S51532; Worley MJ, 2012, GYNECOL ONCOL, V125, P561, DOI 10.1016/j.ygyno.2012.03.043; Worley MJ, 2013, INT J GYNECOL CANCER, V23, P312, DOI 10.1097/IGC.0b013e31827da21b; Yamamoto K, 2013, J OBSTET GYNAECOL RE, V39, P1107, DOI 10.1111/j.1447-0756.2012.02060.x	24	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0090-8258	1095-6859		GYNECOL ONCOL	Gynecol. Oncol.	APR	2015	137	1					112	118		10.1016/j.ygyno.2015.02.006		7	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CG2BJ	WOS:000353079600020		
J	Mabuchi, S; Kuroda, H; Takahashi, R; Sasano, T				Mabuchi, Seiji; Kuroda, Hiromasa; Takahashi, Ryoko; Sasano, Tomoyuki			The PI3K/AKT/mTOR pathway as a therapeutic target in ovarian cancer	GYNECOLOGIC ONCOLOGY			English	Review						PI3K; AKT; mTOR; mTORC1; mTORC2; Ovarian cancer	CLEAR-CELL CARCINOMA; INHIBITION; MTOR; PIK3CA; PI3K; AKT; MUTATIONS; BREAST; GENE; PHOSPHORYLATION	The phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway plays a critical role in the malignant transformation of human tumors and their subsequent growth, proliferation, and metastasis. Preclinical investigations have suggested that the PI3K/AKT/mTOR pathway is frequently activated in ovarian cancer, especially in clear cell carcinoma and endometrioid adenocarcinoma. Thus, this pathway is regarded as an attractive candidate for therapeutic interventions, and inhibitors targeting different components of this pathway are in various stages of clinical development. Here, we highlight the recent progress that has been made in our understanding of the PI3K/AKT/mTOR pathway and discuss the potential of therapeutic agents that target this pathway as treatments for ovarian cancer and the obstacles to their development. (C) 2015 Elsevier Inc. All rights reserved.	[Mabuchi, Seiji; Kuroda, Hiromasa; Takahashi, Ryoko; Sasano, Tomoyuki] Osaka Univ, Grad Sch Med, Dept Obstet & Gynecol, Suita, Osaka 5650871, Japan	Mabuchi, S (reprint author), Osaka Univ, Grad Sch Med, Dept Obstet & Gynecol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	smabuchi@gyne.med.osaka-u.ac.jp					Obata K, 1998, CANCER RES, V58, P2095; Janku F, 2012, J CLIN ONCOL, V30, P777, DOI 10.1200/JCO.2011.36.1196; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Hashiguchi Y, 2006, GYNECOL ONCOL, V101, P71, DOI 10.1016/j.ygyno.2005.09.047; Mabuchi S, 2007, CANCER RES, V67, P2408, DOI 10.1158/0008-5472.CAN-06-4490; Levine DA, 2005, CLIN CANCER RES, V11, P2875, DOI 10.1158/1078-0432.CCR-04-2142; Altomare DA, 2004, ONCOGENE, V23, P5853, DOI 10.1038/sj.onc.1207721; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/JCI34739, 10.1172/jCI34739]; Kuo KT, 2009, AM J PATHOL, V174, P1597, DOI 10.2353/ajpath.2009.081000; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Hanrahan AJ, 2012, CANCER DISCOV, V2, P56, DOI 10.1158/2159-8290.CD-11-0170; CHENG JQ, 1992, P NATL ACAD SCI USA, V89, P9267, DOI 10.1073/pnas.89.19.9267; Hajjar J, 2013, EXPERT OPIN INV DRUG, V22, P1511, DOI 10.1517/13543784.2013.833604; Philp AJ, 2001, CANCER RES, V61, P7426; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Hisamatsu T, 2013, MOL CANCER THER, V12, P1367, DOI 10.1158/1535-7163.MCT-12-1185; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Santiskulvong C, 2011, CLIN CANCER RES, V17, P2373, DOI 10.1158/1078-0432.CCR-10-2289; Gewinner C, 2009, CANCER CELL, V16, P115, DOI 10.1016/j.ccr.2009.06.006; Mabuchi S, 2009, CLIN CANCER RES, V15, P5404, DOI 10.1158/1078-0432.CCR-09-0365; Ibrahim YH, 2012, CANCER DISCOV, V2, P1036, DOI 10.1158/2159-8290.CD-11-0348; Verhaak RGW, 2013, J CLIN INVEST, V123, P517, DOI 10.1172/JCI65833; Delbaldo C, 2011, TARGET ONCOL, V6, P119, DOI 10.1007/s11523-011-0177-6; Guan B, 2014, JNCI-J NATL CANCER I, P106; Vanhaesebroeck B, 2014, CANCER CELL, V25, P269, DOI 10.1016/j.ccr.2014.02.012; Mabuchi S, 2011, CURR MED CHEM, V18, P2960; Mabuchi S, 2002, J BIOL CHEM, V277, P33490, DOI 10.1074/jbc.M204042200; Rodrik-Outmezguine VS, 2011, CANCER DISCOV, V1, P248, DOI 10.1158/2159-8290.CD-11-0085; Sasano T, 2014, MOL CANC RE IN PRESS; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Takano Atsuko, 2001, Molecular and Cellular Biology, V21, P5050, DOI 10.1128/MCB.21.15.5050-5062.2001; Weigelt Britta, 2012, Front Oncol, V2, P109, DOI 10.3389/fonc.2012.00109; Yamashita Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057724; Yang HJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-212	37	9	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0090-8258	1095-6859		GYNECOL ONCOL	Gynecol. Oncol.	APR	2015	137	1					173	179		10.1016/j.ygyno.2015.02.003		7	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CG2BJ	WOS:000353079600028		
J	Kato, K; Usami, T; Takeshima, N				Kato, Kazuyoshi; Usami, Tomoka; Takeshima, Nobuhiro			Secondary debulking surgery for isolated para-aortic nodal recurrence in ovarian cancer involving the division of the left renal vein	GYNECOLOGIC ONCOLOGY			English	Editorial Material						Ovarian cancer; Para-aortic lymphadenectomy; Renal vein		Objective. To present a case that involved para-aortic lymphadenectomy in the aortocaval and retrocaval region involving the division of the left renal vein (LRV). Methods. A 36-year-old woman presented with ovarian cancer and isolated nodal recurrence located in the aortocaval and retrocaval region above and below the renal vein. Cytoreduction of para-aortic lymph nodes involving the division of the LRV was performed. Results and conclusion. Division of the LRV facilitates the separation of the lymph nodes from the renal artery or inferior vena cava under direct vision. No intra- or early postoperative complications, including renal dysfunction, occurred. Further analyses with long-term follow-up are warranted to evaluate this surgical method. (C) 2015 Elsevier Inc. All rights reserved.	[Kato, Kazuyoshi; Usami, Tomoka; Takeshima, Nobuhiro] Canc Inst Hosp, Dept Gynecol, Koutou Ku, Tokyo 1358550, Japan	Kato, K (reprint author), Canc Inst Hosp, Dept Gynecol, Koutou Ku, 3-8-31 Ariake, Tokyo 1358550, Japan.	kazuyosikato@gmail.com					Kato K, 2014, GYNECOL ONCOL, V134, P164, DOI 10.1016/j.ygyno.2014.04.054; Kato K, 2013, GYNECOL ONCOL, V130, P226, DOI 10.1016/j.ygyno.2013.03.025; Fotiou S, 2009, GYNECOL ONCOL, V114, P178, DOI 10.1016/j.ygyno.2009.04.025; MCCOMBS PR, 1979, AM J SURG, V138, P257, DOI 10.1016/0002-9610(79)90382-9; Suzuki T, 2006, J AM COLL SURGEONS, V202, P87, DOI 10.1016/j.jamcollsurg.2005.08.001	5	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0090-8258	1095-6859		GYNECOL ONCOL	Gynecol. Oncol.	APR	2015	137	1					188	189		10.1016/j.ygyno.2015.02.007		2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CG2BJ	WOS:000353079600030		
J	Wakeman, KC; Yamaguchi, A; Roy, MC; Jenke-Kodama, H				Wakeman, Kevin C.; Yamaguchi, Aika; Roy, Michael C.; Jenke-Kodama, Holger			Morphology, phylogeny and novel chemical compounds from Coolia malayensis (Dinophyceae) from Okinawa, Japan	HARMFUL ALGAE			English	Article						Coolia malayensis; Cooliatoxin; High-resolution MS; Morphology; NanoLC/MS; Molecular phylogeny	SP-NOV DINOPHYCEAE; SCANNING-ELECTRON-MICROSCOPY; MONOTIS DINOPHYCEAE; MEDITERRANEAN SEA; PROTOCERATIUM-RETICULATUM; EPIPHYTIC DINOFLAGELLATE; BENTHIC DINOFLAGELLATE; RDNA SEQUENCES; NEW-ZEALAND; CORAL-REEF	Marine benthic dinoflagellates within the genus Coolia have been reported to produce natural products, some of which are known to be toxic (i.e., cooliatoxin). To date, five species of Coolia have been reported in tropical and temperate waters around the world; however, very few studies have combined detailed morphological and molecular data with chemical analyses. In this study, a clonal culture of Coolia malayensis was isolated and mass cultivated from a coral reef on the island of Okinawa, Japan. Analysis of the thecal plate morphology and molecular phylogeny from 28S rDNA strongly supported the close relationship between this new isolate of C. malayensis from Okinawa and other isolates of C malayensis from around the world. Following methanol extraction of 250 L of Mass culture, chemical analyses using NanoLiquid chromatography mass spectrometry revealed the mass profiles of water-soluble and ethyl acetate-soluble parts. High-resolution mass spectrometry derived the molecular formulas of three novel disulphated polyether analogs of yessotoxin (C56H78O18S2 1102.4 (Compound 1), C57H80O18S2 1116.4 (Compound 2), and C57H78O19S2 1130.4 (Compound 3)); two potential homologous compounds (Compounds 4 and 5) were also observed on the high-resolution mass, albeit with low signal intensity. The five compounds in the C malayensis from Okinawa are composed of less oxygen, compared to cooliatoxin and other analogs of yessotoxin, suggesting the metabolites produced by C malayensis are unique to those previously reported from other strains of Coolia. (C) 2015 Elsevier B.V. All rights reserved.	[Wakeman, Kevin C.; Roy, Michael C.; Jenke-Kodama, Holger] Okinawa Inst Sci & Technol, Kunigami, Okinawa 9040495, Japan; [Yamaguchi, Aika] Kobe Univ, Res Ctr Inland Seas, Kobe, Hyogo 6578501, Japan	Wakeman, KC (reprint author), Okinawa Inst Sci & Technol, 1919-1 Tancha, Kunigami, Okinawa 9040495, Japan.	wakeman.kevin@gmail.com			Okinawa Institute of Science and Technology, Okinawa, Japan	This study was completed with funding provided by the Okinawa Institute of Science and Technology, Okinawa, Japan.[SS]	Akasaka K, 2000, BIOSCI BIOTECH BIOCH, V64, P1842, DOI 10.1271/bbb.64.1842; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Zingone A, 2006, HARMFUL ALGAE, V5, P321, DOI 10.1016/j.hal.2005.09.002; Miles CO, 2006, TOXICON, V47, P229, DOI 10.1016/j.toxicon.2005.11.001; Pagliara P, 2012, TOXICON, V60, P1203, DOI 10.1016/j.toxicon.2012.08.005; Rhodes LL, 2010, TOXICON, V56, P751, DOI 10.1016/j.toxicon.2009.05.017; Nunn GB, 1996, J MOL EVOL, V42, P211, DOI 10.1007/BF02198847; Faust MA, 1995, J PHYCOL, V31, P996, DOI 10.1111/j.0022-3646.1995.00996.x; YASUMOTO T, 1987, BIOL BULL, V172, P128, DOI 10.2307/1541612; YASUMOTO T, 1980, B JPN SOC SCI FISH, V46, P327; Takano Y, 2006, J PHYCOL, V42, P251, DOI 10.1111/j.1529-8817.2006.00177.x; Satake M, 1999, NAT TOXINS, V7, P147, DOI 10.1002/(SICI)1522-7189(199907/08)7:4<147::AID-NT50>3.3.CO;2-Y; Kogame K, 1999, PHYCOLOGIA, V38, P496, DOI 10.2216/i0031-8884-38-6-496.1; NAKAJIMA I, 1981, B JPN SOC SCI FISH, V47, P1029; Aligizaki K, 2006, HARMFUL ALGAE, V5, P717, DOI 10.1016/j.hal.2006.02.005; Penna A, 2005, J PHYCOL, V41, P212, DOI 10.1111/j.1529-8817.2005.04011.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Armi Z, 2010, ENVIRON MONIT ASSESS, V164, P423, DOI 10.1007/s10661-009-0903-z; Dolapsakis NP, 2006, SCI MAR, V70, P67; FAUST MA, 1992, J PHYCOL, V28, P94; Fraga S, 2008, J PHYCOL, V44, P1060, DOI 10.1111/j.1529-8817.2008.00555.x; FUKUYO Y, 1981, B JPN SOC SCI FISH, V47, P967; Holmes Michael J., 1995, Natural Toxins, V3, P355, DOI 10.1002/nt.2620030506; Howard MDA, 2009, APPL ENVIRON MICROB, V75, P54, DOI 10.1128/AEM.00818-08; Ismael A.A., 2014, EGYPT J AQUAT RES, V40, P19; Jeong HJ, 2012, J EUKARYOT MICROBIOL, V59, P114, DOI 10.1111/j.1550-7408.2012.00610.x; Laza-Martinez A, 2011, EUR J PHYCOL, V46, P45, DOI 10.1080/09670262.2010.550387; Leaw CP, 2010, J PHYCOL, V46, P162, DOI 10.1111/j.1529-8817.2009.00778.x; Liang JL, 2009, CHEM PHARM BULL, V57, P888; Maddison D.R., 2007, ALIGN MESQUITE PACKA; Meunier A., 1919, MEM MUS R HIST NAT B, V8, P116; Mohammad-Noor N, 2004, NORD J BOT, V24, P629, DOI 10.1111/j.1756-1051.2004.tb01938.x; Mohammad-Noor N, 2013, J PHYCOL, V49, P536, DOI 10.1111/jpy.12062; Momigliano P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079278; Nakayama Takeshi, 1996, Phycological Research, V44, P47, DOI 10.1111/j.1440-1835.1996.tb00037.x; Rhodes L, 2014, HARMFUL ALGAE, V34, P36, DOI 10.1016/j.hal.2014.02.004; Rhodes LL, 1997, NEW ZEAL J MAR FRESH, V31, P139; Satake Masayuki, 1997, Natural Toxins, V5, P164; Shah M.M.R., 2014, AFR J BIOTECHNOL, V13, P792; Tanaka I, 1998, J NAT PROD, V61, P685, DOI 10.1021/np970554o; Ten-Hage L, 2000, PHYCOLOGIA, V39, P377, DOI 10.2216/i0031-8884-39-5-377.1	41	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-9883	1878-1470		HARMFUL ALGAE	Harmful Algae	APR	2015	44						8	19		10.1016/j.hal.2015.02.009		12	Marine & Freshwater Biology	Marine & Freshwater Biology	CH0TJ	WOS:000353735000002		
J	Nishikawa, T; Hori, Y				Nishikawa, Tetsuya; Hori, Yutaka			Estimation of the nutrient consumption by various cell sizes of the diatom Eucampia zodiacus: A representative organism causing bleaching of aquacultured nori	HARMFUL ALGAE			English	Article						Cell quota; Coscinodiscus wailesii; Eucampia zodiacus; Diatom; Nori bleaching; Nutrient	SETO INLAND SEA; LIGHT-LIMITED GROWTH; COSCINODISCUS-WAILESII; HARIMA-NADA; PORPHYRA-THALLI; CHAETOCEROS-PSEUDOCURVISETUS; POPULATION-DYNAMICS; CAUSATIVE ORGANISM; PHOSPHORUS; JAPAN	The diatom Eucampia zodiacus is a harmful species that indirectly causes bleaching to nod (Pyropia) cultivation through competitive utilization of nutrients during its bloom, however cellular storage and changes in physiology by asexual reproduction remains unclear. In the present study, we experimentally investigated the nitrate (N), phosphate (P) and silicic acid (Si) consumption by various cell sizes of E. zodiacus strains, the apical axis length of which ranged from 10.2 to 77.3 mu m. Nutrient cell quotas of E. zodiacus ranged from 2.7 to 8.4 pM cell(-1) for N, 0.34-0.76 pM cell(-1) for P and 1.7-7.3 pM cell(-1) for Si, and they increased with cell size, in which there is a significant correlation between these two elements. The N and P quotas were estimated to be several times higher than the minimum cell quotas. In contrast, the Si cell quotas were approximately equal to those of the minimum values. Based on the present cell quotas, total nitrate consumption by E. zodiacus population when the blooms reached maximum cell density (=1000 cells ml(-1)) were estimated to be 6.5 mu M. Monthly mean concentrations of dissolved inorganic nitrogen (DIN) range from 3.5 to 8.2 mu M during the period of late nod harvest season-when E. zodiacus blooms occur, and nod bleaching is reported at the condition of DIN concentration of less than 3 mu M in Harima-Nada, eastern Seto Inland Sea, Japan. Therefore, the present results suggest that E. zodiacus causes serious damage to nod cultivation due to high levels of nutrient consumption. (C) 2015 Elsevier B.V. All rights reserved.	[Nishikawa, Tetsuya] Hyogo Prefectural Technol Ctr Agr Forestry & Fish, Tajima Fisheries Technol Inst, Mikata, Hyogo 6696541, Japan; [Hori, Yutaka] Hyogo Prefectural Technol Ctr Agr Forestry & Fish, Fisheries Technol Inst, Akashi, Hyogo 6740093, Japan	Nishikawa, T (reprint author), Hyogo Prefectural Technol Ctr Agr Forestry & Fish, Tajima Fisheries Technol Inst, Mikata, Hyogo 6696541, Japan.	tetsuya_nishikawa@pref.hyogo.lg.jp					Nishikawa Tetsuya, 2011, Plankton & Benthos Research, V6, P26; Nishikawa T, 2004, NIPPON SUISAN GAKK, V70, P31, DOI 10.2331/suisan.70.31; D'Alelio D, 2009, HARMFUL ALGAE, V8, P225, DOI 10.1016/j.hal.2008.05.004; Nishikawa T, 2007, HARMFUL ALGAE, V6, P763, DOI 10.1016/j.hal.2007.04.005; Nishikawa T, 2006, HARMFUL ALGAE, V5, P141, DOI 10.1016/j.hal.2005.06.007; Nishikawa T, 2008, HARMFUL ALGAE, V7, P561, DOI 10.1016/j.hal.2007.12.021; Tantanasarit C, 2013, J EXP MAR BIOL ECOL, V446, P67, DOI 10.1016/j.jembe.2013.05.004; Lomas MW, 2000, J PHYCOL, V36, P903, DOI 10.1046/j.1529-8817.2000.99029.x; Nishikawa T, 2009, HARMFUL ALGAE, V8, P513, DOI 10.1016/j.hal.2008.10.006; Nishikawa T, 2010, ESTUAR COAST, V33, P417, DOI 10.1007/s12237-009-9198-0; Ito Y, 2013, J OCEANOGR, V69, P467, DOI 10.1007/s10872-013-0187-3; GALLAGHER JC, 1983, J PHYCOL, V19, P539, DOI 10.1111/j.0022-3646.1983.00539.x; Hori Y., 2006, J ADV MAR SCI TECHNO, V12, P13; MANABE T, 1991, MAR POLLUT BULL, V23, P181, DOI 10.1016/0025-326X(91)90671-E; Kuwata A, 1999, MAR BIOL, V134, P471, DOI 10.1007/s002270050563; Manabe T., 1986, SEA SKY, V62, P25; Nagai S, 1998, J PLANKTON RES, V20, P1417, DOI 10.1093/plankt/20.7.1417; Nagai S., 1994, B PLANKTON SOC JPN, V40, P151; Nagata S., 2001, B HYOGO PREFECT FISH, V36, P59; Nishikawa T., 2011, B HYOGO PREF TECH CT, V42, P421; Nishikawa T, 2011, NIPPON SUISAN GAKK, V77, P876, DOI 10.2331/suisan.77.876; Nishikawa Tetsuya, 2013, Plankton & Benthos Research, V8, P166; Nishikawa T, 2004, NIPPON SUISAN GAKK, V70, P872, DOI 10.2331/suisan.70.872; OKU O, 1995, MAR BIOL, V123, P393, DOI 10.1007/BF00353630; Ueno S., 1991, J SHIMONOSEKI U FISH, V40, P23	25	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-9883	1878-1470		HARMFUL ALGAE	Harmful Algae	APR	2015	44						32	36		10.1016/j.hal.2015.02.007		5	Marine & Freshwater Biology	Marine & Freshwater Biology	CH0TJ	WOS:000353735000004		
J	Tawong, W; Yoshimatsu, T; Yamaguchi, H; Adachi, M				Tawong, Wittaya; Yoshimatsu, Takamichi; Yamaguchi, Haruo; Adachi, Masao			Effects of temperature, salinity and their interaction on growth of benthic dinoflagellates Ostreopsis spp. from Thailand	HARMFUL ALGAE			English	Article						Growth; Ostreopsis; Temperature; Thailand; Salinity; Palytoxin	SP-NOV DINOPHYCEAE; CF. OVATA; COASTAL WATERS; JEJU ISLAND; MASS-SPECTROMETRY; GENUS OSTREOPSIS; NEW-ZEALAND; COOLIA; MORPHOLOGY; KOREA	Benthic dinoflagellates Ostreopsis spp. are known as producers of palytoxin and its analogs, resulting occasionally in human health problems worldwide. Although distribution of Ostreopsis spp. along the Thai coasts has been reported, little is known about their growth characteristics. To discuss the bloom dynamics of Ostreopsis spp. in Thailand, first we tested four kinds of media to optimize growth conditions and then clarified the effects of temperature, salinity and temperature-salinity interaction on the growth of strains of the O. cf. ovata Thailand subclade, O. cf. ovata South China Sea subclade, Ostreopsis sp. 6 and Ostreopsis sp. 7. We showed that the f/2 medium was a suitable medium which gave the highest cell yields for all the strains tested. The strains of the O. cf. ovata Thailand subclade, O. cf. ovata South China Sea subclade and Ostreopsis sp. 6 grew in the temperature range 20-32.5 degrees C, whereas the strain of Ostreopsis sp. 7 grew in 20-30 degrees C. The semi-optimal temperature ranges (>= 80% of the maximal growth rate) for the former three strains were 22.7-27.4 degrees C, 27.9-30.8 degrees C and 23.5-26.4 degrees C, respectively, whereas that of the latter strain was 23-27.2 degrees C. The optimal temperature for the O. cf. ovata South China Sea subclade was 30 degrees C, whereas for the others it was 25 degrees C. All the Ostreopsis strains tested could grow in a salinity range of 20-40. The semi-optimal salinities for the O. cf. ovata Thailand subclade, O. cf. ovata South China Sea subclade Ostreopsis sp. 6 and Ostreopsis sp. 7 were 28.7-35,23.8-30.8, 29.8-36 and 2836, respectively. The optimal salinities for the O. cf. ovata Thailand subclade and O. cf. ovata South China Sea subclade were 30 and 25, respectively, whereas for Ostreopsis sp. 6 and Ostreopsis sp. 7 it was 35. In this study, our results suggested that the optimal and tolerable temperature-salinity conditions differ among the Thai Ostreopsis species/clades/subclades. Tolerances of the O. cf. ovata Thailand subclade, O. cf. ovate South China Sea subclade and Ostreopsis sp. 6 to the high temperature of 32.5 degrees C may allow these organisms to be distributed in the tropical areas, where the water temperature often reaches >30 degrees C. (C) 2015 Elsevier B.V. All rights reserved.	[Tawong, Wittaya; Yoshimatsu, Takamichi; Yamaguchi, Haruo; Adachi, Masao] Kochi Univ, Fac Agr, LAQUES Lab Aquat Environm Sci, Kochi 7838502, Japan; [Tawong, Wittaya] Ehime Univ, United Grad Sch Agr Sci, Matsuyama, Ehime 7908566, Japan	Adachi, M (reprint author), Kochi Univ, Fac Agr, LAQUES Lab Aquat Environm Sci, Kochi 7838502, Japan.	madachi@kochi-u.ac.jp			Naresuan University	This research was supported by Naresuan University. We thank D. Murphy of Ehime University for editing the English in our manuscript.[SS]	Pezzolesi L, 2012, WATER RES, V46, P82, DOI 10.1016/j.watres.2011.10.029; Pistocchi R, 2011, TOXICON, V57, P421, DOI 10.1016/j.toxicon.2010.09.013; Kim Hyung Seop, 2011, Ocean Science Journal, V46, P205, DOI 10.1007/s12601-011-0016-9; Suzuki T, 2012, HARMFUL ALGAE, V20, P81, DOI 10.1016/j.hal.2012.08.002; Fraga S, 2012, CRYPTOGAMIE ALGOL, V33, P171; YAMAGUCHI M, 1989, NIPPON SUISAN GAKK, V55, P2029; Yamaguchi H, 2012, PHYCOL RES, V60, P297, DOI 10.1111/j.1440-1835.2012.00660.x; Shears NT, 2009, HARMFUL ALGAE, V8, P916, DOI 10.1016/j.hal.2009.05.003; Faust MA, 1999, PHYCOLOGIA, V38, P92, DOI 10.2216/i0031-8884-38-2-92.1; Totti C, 2010, HARMFUL ALGAE, V9, P233, DOI 10.1016/j.hal.2009.10.006; QUOD JP, 1994, CRYPTOGAMIE ALGOL, V15, P243; Ciminiello P, 2006, ANAL CHEM, V78, P6153, DOI 10.1021/ac060250j; Rhodes L, 2000, NEW ZEAL J MAR FRESH, V34, P371; Ashton M, 2003, REV BIOL TROP, V51, P1; Ciminiello P, 2013, HARMFUL ALGAE, V23, P19, DOI 10.1016/j.hal.2012.12.002; Ciminiello P, 2010, RAPID COMMUN MASS SP, V24, P2735, DOI 10.1002/rcm.4696; Mangialajo L, 2011, TOXICON, V57, P408, DOI 10.1016/j.toxicon.2010.11.019; Parsons ML, 2007, HARMFUL ALGAE, V6, P658, DOI 10.1016/j.hal.2007.01.001; Kang NS, 2013, HARMFUL ALGAE, V27, P98, DOI 10.1016/j.hal.2013.05.006; MORTON SL, 1992, J EXP MAR BIOL ECOL, V157, P79, DOI 10.1016/0022-0981(92)90076-M; Graneli E, 2011, HARMFUL ALGAE, V10, P165, DOI 10.1016/j.hal.2010.09.002; Guerrini F, 2010, TOXICON, V55, P211, DOI 10.1016/j.toxicon.2009.07.019; Tanimoto Y, 2013, FISHERIES SCI, V79, P285, DOI 10.1007/s12562-013-0597-6; Yoshimatsu T, 2014, HARMFUL ALGAE, V35, P29, DOI 10.1016/j.hal.2014.03.007; YASUMOTO T, 1987, BIOL BULL, V172, P128, DOI 10.2307/1541612; Chang FH, 2000, NEW ZEAL J MAR FRESH, V34, P29; Ciminiello P, 2014, ENVIRON SCI TECHNOL, V48, P3532, DOI 10.1021/es405617d; Parsons ML, 2012, HARMFUL ALGAE, V14, P107, DOI 10.1016/j.hal.2011.10.017; Aligizaki K, 2006, HARMFUL ALGAE, V5, P717, DOI 10.1016/j.hal.2006.02.005; Bold H.C., 1978, INTRO ALGAE STRUCTUR, P1; BRAND L E, 1981, Journal of Plankton Research, V3, P193, DOI 10.1093/plankt/3.2.193; Eiamsa-ard M., 1997, STATUS MANAGEMENT TR, V53, P85; FAUST MA, 1995, J PHYCOL, V31, P456, DOI 10.1111/j.0022-3646.1995.00456.x; Faust Maria A., 2009, Atoll Research Bulletin, P1; FUKUYO Y, 1981, Nippon Suisan Gakkaishi, V47, P967; Guillard R. R. L., 1975, CULTURE MARINE INVER, P29; GUILLARD R.R.L., 1973, HDB PHYCOLOGICAL MET, P289; Guillard R.R.L., 2003, MANUAL HARMFUL MARIN, P77; Holmes M.J., 1988, P 6 INT COR REEF S, V3, P49; Holmes M.J., 1998, HARMFUL ALGAE, P50; Jeong HJ, 2012, J EUKARYOT MICROBIOL, V59, P114, DOI 10.1111/j.1550-7408.2012.00610.x; Krishnan P, 2011, CURR SCI INDIA, V100, P111; Laza-Martinez A, 2011, EUR J PHYCOL, V46, P45, DOI 10.1080/09670262.2010.550387; Maiphae Supiyanit, 2011, Songklanakarin Journal of Science and Technology, V33, P641; Mercado JA, 1994, TOXICON, V32, P256; Meunier F.A., 1997, BRIT J PHARMACOL, V121, P1225; Nakajima L., 1981, B JPN SOC SCI FISH, V47, P1029; Nishimura T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060882; Norris D.R., 1985, P39; Pearse I, 2001, P 9 INT C HARMF ALG, P54; Petsut Nidsaraporn, 2012, Biodivers. J., V3, P229; Piumsomboon A., 2001, BENTHIC MICROALGAE M, P1; Pocsidio GN, 2004, PHILIPP AGRIC SCI, V87, P148; Sato S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027983; Schmidt J., 1901, BOT TIDSSKRIFT, V24, P212; Selina MS, 2010, BOT MAR, V53, P243, DOI 10.1515/BOT.2010.033; Shah M.M.R., 2014, AFR J BIOTECHNOL, V13, P792; Tawong W, 2014, HARMFUL ALGAE, V37, P160, DOI 10.1016/j.hal.2014.06.003; Tindall D. R., 1998, PHYSL ECOLOGY HARMFU, VG41, P293; Wieringa A., 2014, CLIN TOXICOL, V52, P154; Yamaguchi H, 2012, FISHERIES SCI, V78, P993, DOI 10.1007/s12562-012-0530-4	61	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-9883	1878-1470		HARMFUL ALGAE	Harmful Algae	APR	2015	44						37	45		10.1016/j.hal.2015.02.611		9	Marine & Freshwater Biology	Marine & Freshwater Biology	CH0TJ	WOS:000353735000005		
J	Marshall, MR; Young, BA; Fox, SJ; Cleland, CJ; Walker, RJ; Maskane, I; Herold, AM				Marshall, Mark R.; Young, Bessie A.; Fox, Sally J.; Cleland, Calli J.; Walker, Robert J.; Maskane, Ikuto; Herold, Aaron M.			The home hemodialysis hub: Physical infrastructure and integrated governance structure	HEMODIALYSIS INTERNATIONAL			English	Article						Infrastructure; governance; home hemodialysis; dialysis	EXPERIENCE; DIALYSIS; PROGRAM; CHRISTCHURCH; BARRIERS	An effective home hemodialysis program critically depends on adequate hub facilities and support functions and on transparent and accountable organizational processes. The likelihood of optimal service delivery and patient care will be enhanced by fit-for-purpose facilities and implementation of a well-considered governance structure. In this article, we describe the required accommodation and infrastructure for a home hemodialysis program and a generic organizational structure that will support both patient-facing clinical activities and business processes.	[Marshall, Mark R.] Univ Auckland, Fac Med & Hlth Sci, Auckland 1142, New Zealand; [Marshall, Mark R.; Fox, Sally J.; Cleland, Calli J.] Counties Manukau Dist Hlth Board, Dept Renal Med, Auckland, New Zealand; [Young, Bessie A.] Univ Washington, Div Nephrol, Kidney Res Inst, Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA 98195 USA; [Walker, Robert J.] Univ Otago, Dunedin Sch Med, Dept Med, Dunedin, New Zealand; [Maskane, Ikuto] Yabuki Hosp, Kidney & Dialysis Ctr, Yamagata, Japan; [Herold, Aaron M.] Northwest Kidney Ctr, Operat Support, Seattle, WA USA	Marshall, MR (reprint author), Univ Auckland, Fac Med & Hlth Sci, Private Bag 92019, Auckland 1142, New Zealand.	mrmarsh@woosh.co.nz			Baxter; Fresenius Medical Care, Asia-Pacific; Auckland Medical Research Foundation; Gambro Pty Ltd (New Zealand); Fresenius Medical Care Australia Pty Ltd; Fresenius Medical Care Asia-Pacific Pty Ltd; Health Research Council of New Zealand; Kidney Health New Zealand; Lottery Health Research Foundation (New Zealand); Maurine and Phyllis Paykel Trust; New Zealand Ministry of Health; Royal Australasian College of Physicians Jacquot Foundation; Amgen; Ineos Healthcare Limited; Fresenius Medical Care	MM is currently employed as the Director of Medical Affairs, Asia-Pacific, by Baxter Healthcare Corporation and previously served as a paid consultant to Baxter and Fresenius Medical Care, Asia-Pacific. He has received grant support from the Auckland Medical Research Foundation, Gambro Pty Ltd (New Zealand), Fresenius Medical Care Australia Pty Ltd, Fresenius Medical Care Asia-Pacific Pty Ltd, Health Research Council of New Zealand, Kidney Health New Zealand (formerly the National Kidney Foundation, New Zealand), Lottery Health Research Foundation (New Zealand), Maurine and Phyllis Paykel Trust, New Zealand Ministry of Health, and The Royal Australasian College of Physicians Jacquot Foundation. He has been an investigator for clinical trials sponsored by Amgen, Ineos Healthcare Limited, and Fresenius Medical Care.	Agar JWM, 2008, HEMODIAL INT, V12, pS26, DOI 10.1111/j.1542-4758.2008.00292.x; Alhomayeed B, 2009, Saudi J Kidney Dis Transpl, V20, P185; Anderson C, 2001, UPTODATE WEBSITE; Irvine J, 2014, NEPHROLOGY, V19, P296, DOI 10.1111/nep.12222; ANZDATA Registry, 2012, SUMM AUSTR NZ DIAL T; Blagg C, 2010, DIALYSIS TRANSPLANT, V39, P335, DOI 10.1002/dat.20474; Cafazzo JA, 2009, CLIN J AM SOC NEPHRO, V4, P784, DOI 10.2215/CJN.05501008; Cocks J, 1973, Queens Nurs J, V16, P131; Connaughton DM, 2013, IRISH J MED SCI, V182, P91, DOI 10.1007/s11845-012-0835-4; Fortnum D, 2012, KIDNEY HLTH AUSTR WE; Golper TA, 2012, ISSUES IN DIALYSIS; Honkanen E, 2002, SCAND J UROL NEPHROL, V36, P137, DOI 10.1080/003655902753679445; Hoy Christopher, 2004, Hemodial Int, V8, P144, DOI 10.1111/j.1492-7535.2004.01088.x; Kraus Michael, 2007, Hemodial Int, V11, P468, DOI 10.1111/j.1542-4758.2007.00229.x; Kumar Victoria A, 2007, Hemodial Int, V11, P225, DOI 10.1111/j.1542-4758.2007.00173.x; Marshall MR, 2015, SEMIN DIALYSIS, V28, P176, DOI 10.1111/sdi.12327; McGregor D, 2000, NEW ZEAL MED J, V113, P27; McLaughlin R, 1981, J Am Assoc Nephrol Nurses Tech, V8, P35; Moran J, 2007, SEMIN DIALYSIS, V20, P35, DOI 10.1111/j.1525-139X.2007.00239.x; Pipkin M, 2010, CLIN J AM SOC NEPHRO, V5, P1614, DOI 10.2215/CJN.02440310; Schachter ME, 2013, HEMODIAL INT, V17, P421, DOI 10.1111/hdi.12036; Tanaka H, 2012, CONTRIB NEPHROL, V177, P133, DOI 10.1159/000337045; Tonozuka Y, 2014, DATA ON FILE; Whitlock DJ, 2014, PHYS LEADERSHIP J, V5, P8; Young BA, 2012, CLIN J AM SOC NEPHRO, V7, P2023, DOI 10.2215/CJN.07080712	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1492-7535	1542-4758		HEMODIAL INT	Hemodial. Int.	APR	2015	19			1	SI		S8	S22		10.1111/hdi.12273		15	Urology & Nephrology	Urology & Nephrology	CH3WC	WOS:000353960400003		
J	Yamaguchi, J; Noguchi-Yachide, T; Sakaguchi, Y; Shibata, C; Kanuma, S; Yoshizaki, A; Takizawa, Y; Hashimoto, Y				Yamaguchi, Jun-ichi; Noguchi-Yachide, Tomomi; Sakaguchi, Yuka; Shibata, Chiaki; Kanuma, Shinnosuke; Yoshizaki, Akiko; Takizawa, Yuka; Hashimoto, Yuichi			SYNTHESIS OF NEW HYDANTOINS BEARING GLUTARIMIDE OR SUCCINIMIDE MOIETY AND THEIR EVALUATION FOR CELL DIFFERENTIATION-INDUCING AND ANTI-ANGIOGENIC ACTIVITIES	HETEROCYCLES			English	Article						Hydantoin; Thalidomide; Glutarimide; Succinimide; Biological Activity	THALIDOMIDE; DESIGN	Several derivatives of hydantoin containing glutarimide or succinimide at the 3-position were synthesized. The new hydantoin derivatives had a structure similar to that of thalidomide, and so may possess activity similar to that of thalidomide and/or its analogs, such as effects on cell differentiation and angiogenesis. Some hydantoins showed enhancing effects on all-trans retinoic acid (ATRA)-induced cell differentiation of human leukemia cell line HL-60 and anti-angiogenic activity on human umbilical vein endothelial cells (HUVEC). These new hydantoin derivatives were more effective than thalidomide in cell differentiation-inducing activity on HL-60 and anti-angiogenic activity on HUVEC.	[Yamaguchi, Jun-ichi; Sakaguchi, Yuka; Shibata, Chiaki; Kanuma, Shinnosuke; Yoshizaki, Akiko; Takizawa, Yuka] Kanagawa Inst Technol, Fac Engn, Dept Appl Chem, Atsugi, Kanagawa 2430292, Japan; [Noguchi-Yachide, Tomomi; Hashimoto, Yuichi] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	Yamaguchi, J (reprint author), Kanagawa Inst Technol, Fac Engn, Dept Appl Chem, 1030 Shimo Ogino, Atsugi, Kanagawa 2430292, Japan.	yamagu@chem.kanagawa-it.ac.jp					Rogawski MA, 2004, NAT REV NEUROSCI, V5, P553, DOI 10.1038/nrn1430; KAGECHIKA H, 1988, J MED CHEM, V31, P2182, DOI 10.1021/jm00119a021; Meusel M, 2004, ORG PREP PROCED INT, V36, P391; Fox DJ, 2002, J MED CHEM, V45, P360, DOI 10.1021/jm010984i; Fujimoto H, 2006, CHEM PHARM BULL, V54, P855, DOI 10.1248/cpb.54.855; Hashimoto Y, 2002, BIOORGAN MED CHEM, V10, P461, DOI 10.1016/S0968-0896(01)00308-X; Li QB, 2012, BIOORG MED CHEM LETT, V22, P850, DOI 10.1016/j.bmcl.2011.12.048; Noguchi T, 2005, BIOL PHARM BULL, V28, P563, DOI 10.1248/bpb.28.563; Noguchi T, 2005, BIOORG MED CHEM LETT, V15, P5509, DOI 10.1016/j.bmcl.2005.008.086; SONDHEIMER E, 1957, J AM CHEM SOC, V79, P3767, DOI 10.1021/ja01571a041; Yamaguchi J, 2003, CHEM LETT, V32, P372; Yamaguchi J, 2005, TETRAHEDRON LETT, V46, P6411, DOI 10.1016/j.tetlet.2005.07.116	12	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0385-5414	1881-0942		HETEROCYCLES	Heterocycles	APR 1	2015	91	4					764	781		10.3987/COM-15-13184		18	Chemistry, Organic	Chemistry	CG8ZH	WOS:000353603700006		
J	Fukuda, T; Sato, D; Iwao, M				Fukuda, Tsutomu; Sato, Daichi; Iwao, Masatomo			A SYNTHESIS OF LAMELLARINS VIA REGIOSELECTIVE ASSEMBLY OF 1,2,3-DIFFERENTIALLY SUBSTITUTED 5,6-DIHYDROPYRROLO[2,1-a]ISOQUINOLINE CORE	HETEROCYCLES			English	Article						Lamellarin; Modular Synthesis; 5,6-Dihydropyrrolo[2,1-a]isoquinoline; Regioselective Bromination-Cross Coupling; Oxidative Lactonization	G TRIMETHYL ETHER; AUSTRALIAN MARINE SPONGE; ASCIDIAN DIDEMNUM-OBSCURUM; ALPHA 20-SULFATE ANALOGS; TOPOISOMERASE-I; UNNATURAL LAMELLARINS; MULTIDRUG-RESISTANCE; AROMATIC METABOLITES; EFFICIENT SYNTHESIS; MODULAR SYNTHESIS	A modular synthesis of the marine natural products lamellarins has been developed. The key reactions utilized are C3-selective Vilsmeier-Haack formylation followed by iterative bromination/cross-coupling of the 5,6-dihydropyrrolo[2,1-a]isoquinoline core. The 1,2-diaryl-5,6-dihydropyrrolo[2,1-a]isoquinoline-3-carbaldehyde thus synthesized was readily converted to the lamellarin skeleton by mean of palladium-catalyzed oxidative lactonization.	[Fukuda, Tsutomu; Sato, Daichi; Iwao, Masatomo] Nagasaki Univ, Grad Sch Engn, Div Chem & Mat Sci, Nagasaki 8528521, Japan	Fukuda, T (reprint author), Nagasaki Univ, Grad Sch Engn, Div Chem & Mat Sci, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan.	iwao@nagasaki-u.ac.jp			JSPS KAKENHI Grant from the Japan Society for the Promotion of Science (JSPS) [26293028]	This work was financially supported by a Grant-in-Aid for Scientific Research (B) (JSPS KAKENHI Grant Number 26293028) from the Japan Society for the Promotion of Science (JSPS).	Plisson F, 2012, CHEM-ASIAN J, V7, P1616, DOI 10.1002/asia.201101049; Chittchang M, 2009, CHEMMEDCHEM, V4, P457, DOI 10.1002/cmdc.200800339; Fukuda T, 2011, HETEROCYCLES, V83, P491, DOI 10.3987/REV-10-686; Ueda K, 2014, J AM CHEM SOC, V136, P13226, DOI 10.1021/ja508449y; Reddy MVR, 1997, TETRAHEDRON, V53, P3457, DOI 10.1016/S0040-4020(97)00073-2; Zhang H, 2012, ORG BIOMOL CHEM, V10, P2656, DOI 10.1039/c2ob06747a; LINDQUIST N, 1988, J ORG CHEM, V53, P4570, DOI 10.1021/jo00254a029; Ishibashi F, 2002, J NAT PROD, V65, P500, DOI 10.1021/np0104525; Ploypradith P, 2004, ANGEW CHEM INT EDIT, V43, P866, DOI 10.1002/anie.200352043; Pla D, 2006, J MED CHEM, V49, P3257, DOI 10.1021/jm0602458; Gallego MA, 2008, ONCOGENE, V27, P1981, DOI 10.1038/sj.onc.1210833; Kluza J, 2006, CANCER RES, V66, P3177, DOI 10.1158/0008-5472.CAN-05-1929; Reddy MVR, 1999, J MED CHEM, V42, P1901, DOI 10.1021/jm9806650; Facompre M, 2003, CANCER RES, V63, P7392; Marco E, 2005, J MED CHEM, V48, P3796, DOI 10.1021/jm049060w; Ploypradith P, 2006, J ORG CHEM, V71, P9440, DOI 10.1021/jo061810h; Imbri D, 2014, MAR DRUGS, V12, P6142, DOI 10.3390/md12126142; Fujikawa N, 2006, TETRAHEDRON, V62, P594, DOI 10.1016/j.tet.2005.10.014; Liermann JC, 2008, J ORG CHEM, V73, P4526, DOI 10.1021/jo800467e; ANDERSEN RJ, 1985, J AM CHEM SOC, V107, P5492, DOI 10.1021/ja00305a027; Komatsubara M, 2014, J ORG CHEM, V79, P529, DOI 10.1021/jo402181w; Heim A, 1997, ANGEW CHEM INT EDIT, V36, P155, DOI 10.1002/anie.199701551; Fan H, 2008, CHEM REV, V108, P264, DOI 10.1021/cr078199m; Pla D, 2005, J ORG CHEM, V70, P8231, DOI 10.1021/jo051083a; Ruchirawat S, 2001, TETRAHEDRON LETT, V42, P1205, DOI 10.1016/S0040-4039(00)02222-X; Zajac M, 2008, TETRAHEDRON, V64, P10605, DOI 10.1016/j.tet.2008.08.064; Urban S, 1996, AUST J CHEM, V49, P711; Handy ST, 2004, J ORG CHEM, V69, P2362, DOI 10.1021/jo0352833; Handy ST, 2005, ORG PREP PROCED INT, V37, P411; BAL BS, 1981, TETRAHEDRON, V37, P2091, DOI 10.1016/S0040-4020(01)97963-3; Ballot C, 2010, APOPTOSIS, V15, P769, DOI 10.1007/s10495-010-0471-2; Mikhaleva AI, 2006, TETRAHEDRON LETT, V47, P3693, DOI 10.1016/j.tetlet.2006.03.126; Pla D, 2011, MEDCHEMCOMM, V2, P689, DOI 10.1039/c1md00003a; Imbri D, 2013, CHEM-EUR J, V19, P15080, DOI 10.1002/chem.201303563; Ishibashi F, 1997, TETRAHEDRON, V53, P5951, DOI 10.1016/S0040-4020(97)00287-1; Li QJ, 2011, ORG LETT, V13, P312, DOI 10.1021/ol1027877; Bailly Christian, 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P363, DOI 10.2174/1568011043352939; Ballot C, 2009, MOL CANCER THER, V8, P3307, DOI 10.1158/1535-7163.MCT-09-0639; Banwell M., 1997, CHEM COMMUN, P2259; Baunbk D, 2008, MAR DRUGS, V6, P514, DOI 10.3390/md20080026; Cantrell CL, 1999, NAT PROD LETT, V14, P39, DOI 10.1080/10575639908045433; CARROLL AR, 1993, AUST J CHEM, V46, P489; Chen L, 2009, ADV SYNTH CATAL, V351, P2005, DOI 10.1002/adsc.200900287; Cironi P, 2004, PROG HET CH, V16, P1; Collins MA, 2004, BIOORG MED CHEM LETT, V14, P2185, DOI 10.1016/j.bmcl.2004.02.054; Davis RA, 1999, J NAT PROD, V62, P419, DOI 10.1021/np9803530; Deally A, 2010, POLYHEDRON, V29, P2445, DOI 10.1016/j.poly.2010.05.018; Diaz M., 2001, SYNLETT, P1164; D'Silva C, 1998, J ORG CHEM, V63, P6715, DOI 10.1021/jo971365d; Fan A.-L., 2011, J CHIN PHARM SCI, V20, P425; Flynn BL, 2012, HETEROCYCLES, V84, P1141, DOI 10.3987/COM-11-S(P)95; Gupton JT, 2009, TETRAHEDRON, V65, P4283, DOI 10.1016/j.tet.2009.03.085; Ham J, 2002, B KOR CHEM SOC, V23, P163; Hasse K., 2011, EUR J ORG CHEM, P88; Kamiyama H, 2011, BIOORGAN MED CHEM, V19, P7541, DOI 10.1016/j.bmc.2011.10.030; KASHIMA C, 1986, TETRAHEDRON LETT, V27, P2131, DOI 10.1016/S0040-4039(00)84467-6; KRAUS GA, 1980, J ORG CHEM, V45, P1175, DOI 10.1021/jo01294a058; Krishnaiah P, 2004, J NAT PROD, V67, P1168, DOI 10.1021/np030503t; Ohta T, 2009, J ORG CHEM, V74, P8143, DOI 10.1021/jo901589e; Olsen CA, 2005, TETRAHEDRON LETT, V46, P2041, DOI 10.1016/j.tetlet.2005.01.145; Peschko C, 2000, CHEM-EUR J, V6, P1147, DOI 10.1002/(SICI)1521-3765(20000403)6:7<1147::AID-CHEM1147>3.3.CO;2-T; Quesada AR, 1996, BRIT J CANCER, V74, P677, DOI 10.1038/bjc.1996.421; Reddy SM, 2005, TETRAHEDRON, V61, P9242, DOI 10.1016/j.tet.2005.07.067; Ridley CP, 2002, BIOORGAN MED CHEM, V10, P3285, DOI 10.1016/S0968-0896(02)00237-7; TAMARU Y, 1983, J ORG CHEM, V48, P1286, DOI 10.1021/jo00156a028; Tardy C, 2004, BIOORGAN MED CHEM, V12, P1697, DOI 10.1016/j.bmc.2004.01.020; URBAN S, 1994, AUST J CHEM, V47, P1919; URBAN S, 1995, AUST J CHEM, V48, P1491, DOI 10.1071/CH9951491; Zhang Y, 2005, ORG PREP PROCED INT, V8, P411	69	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0385-5414	1881-0942		HETEROCYCLES	Heterocycles	APR 1	2015	91	4					782	794		10.3987/COM-15-13188		13	Chemistry, Organic	Chemistry	CG8ZH	WOS:000353603700007		
J	Matsumoto, S; Sakamoto, K; Akazome, M				Matsumoto, Shoji; Sakamoto, Keisuke; Akazome, Motohiro			SYSTEMATIC INVESTIGATION OF FLUORESCENCE PROPERTIES OF SYMMETRIC AND ASYMMETRIC DIAZOLO[1,2-a:2 ',1 '-c]QUINOXALINE DERIVATIVES	HETEROCYCLES			English	Article						Quinoxaline; Coupling Reaction; Fluorescence; Fine Structure; Crystal Structure	OPTICAL-PROPERTIES; PHENYLENEVINYLENE POLYMERS; PHOTOPHYSICAL PROPERTIES; ENERGY-TRANSFER; AGGREGATION; DYES; LUMINESCENCE; SUBSTITUTION; EMISSION; RING	The investigation of the synthesis and optical properties of symmetric and asymmetric diazolo[1,2-a:2',1'-c]quinoxaline derivatives were systematically examined. The formation of an intramolecular carbon-carbon bond between two azole rings could be achieved by selection of the reaction depending on the type of azole. The absorption and fluorescence spectra revealed the following effects induced by structural changes: 1) introduction of a fused-benzene ring affects the peak shape and the increment of 0-0 transition in the absorption and fluorescence spectra. 2) A hypsochromic shift is induced by substitution of the CH moiety with a nitrogen atom. 3) Introduction of fused-benzene ring(s) is a promising strategy for improving the fluorescence quantum yield of these species. Furthermore, all of the compounds were fluorescent in the solid state, although no systematic trend was found. Investigation of the single crystal structures revealed a diversity of crystal packing arrangements, even in related structures.	[Matsumoto, Shoji; Sakamoto, Keisuke; Akazome, Motohiro] Chiba Univ, Grad Sch Engn, Dept Appl Chem & Biotechnol, Inage Ku, Chiba 2638522, Japan	Matsumoto, S (reprint author), Chiba Univ, Grad Sch Engn, Dept Appl Chem & Biotechnol, Inage Ku, 1-33 Yayoicho, Chiba 2638522, Japan.	smatsumo@faculty.chiba-u.jp			JSPS KAKENHI Grant [24550146]	This work was supported by JSPS KAKENHI Grant No. 24550146.	Yuan CX, 2013, J AM CHEM SOC, V135, P8842, DOI 10.1021/ja404198h; Rosch U, 2006, ANGEW CHEM INT EDIT, V45, P7026, DOI 10.1002/anie.200602286; Tateno K, 2014, ORG LETT, V16, P3212, DOI 10.1021/ol501226x; Wang XY, 2013, ORG LETT, V15, P5714, DOI 10.1021/ol402745r; Cai Q, 2010, ORG LETT, V12, P1500, DOI 10.1021/ol1002225; Hulcoop DG, 2007, ORG LETT, V9, P1761, DOI 10.1021/ol070475w; Aronoff MR, 2013, ORG LETT, V15, P5382, DOI 10.1021/ol402714k; Zophel L, 2013, ORG LETT, V15, P804, DOI 10.1021/ol303476g; Antilla JC, 2002, J AM CHEM SOC, V124, P11684, DOI 10.1021/ja027433h; Zhang JY, 2014, CHEM COMMUN, V50, P4214, DOI 10.1039/c3cc49605h; Wang LK, 2014, CHEM COMMUN, V50, P8723, DOI 10.1039/c4cc02564d; Saravanan C, 2014, ORG LETT, V16, P354, DOI 10.1021/ol403082p; Kumar S, 2014, J MATER CHEM C, V2, P6637, DOI 10.1039/c4tc00807c; Pisoni DS, 2014, J ORG CHEM, V79, P5511, DOI 10.1021/jo500657s; Jancy B, 2008, CHEM MATER, V20, P169, DOI 10.1021/cm702497y; Rothberg LJ, 1996, SYNTHETIC MET, V80, P41, DOI 10.1016/0379-6779(96)80202-5; Yao H, 2011, RSC ADV, V1, P834, DOI 10.1039/c1ra00497b; Jakubiak R, 1999, J PHYS CHEM A, V103, P2394, DOI 10.1021/jp9839450; SO YH, 1992, MACROMOLECULES, V25, P516, DOI 10.1021/ma00028a003; Matsuo K, 2014, J AM CHEM SOC, V136, P12580, DOI 10.1021/ja506980p; Hirano K, 2009, J ORG CHEM, V74, P9570, DOI 10.1021/jo902160y; Yang SJ, 2012, J AM CHEM SOC, V134, P11868, DOI 10.1021/ja304082h; Amthor S, 2006, J PHYS CHEM A, V110, P5204, DOI 10.1021/jp056728p; Lee SY, 2014, ANGEW CHEM INT EDIT, V53, P6402, DOI 10.1002/anie.201402992; Gong Y, 2007, J PHYS CHEM A, V111, P5806, DOI 10.1021/jp0705323; Cigan M, 2013, J PHYS CHEM A, V117, P4870, DOI 10.1021/jp402627a; BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; Chakraborty S, 2014, J PHOTOCH PHOTOBIO A, V293, P57, DOI 10.1016/j.jphotochem.2014.07.018; Chen JH, 2012, J ORG CHEM, V77, P3475, DOI 10.1021/jo3002722; Cho S, 2014, J PHYS CHEM A, V118, P4995, DOI 10.1021/jp505072x; Deng Y, 2014, TETRAHEDRON LETT, V55, P3792, DOI 10.1016/j.tetlet.2014.05.066; Frisch M.J., 2009, GAUSSIAN 09; Garcia-Moreno I, 2012, CHEMPHYSCHEM, V13, P3923, DOI 10.1002/cphc.201200587; Grybowski M., 2012, ORG LETT, V14, P2670; Lau V, 2010, CHEM COMMUN, V46, P3595, DOI 10.1039/c002128h; Li L, 2013, J MOL STRUCT, V1051, P23, DOI 10.1016/j.molstruc.2013.07.042; Massue J, 2012, ORG LETT, V14, P230, DOI 10.1021/ol203014e; Matsumoto S, 2011, ORG BIOMOL CHEM, V9, P5941, DOI 10.1039/c1ob06002c; Matsumoto S, 2010, HETEROCYCLES, V80, P645, DOI 10.3987/COM-09-S(S)51; Neute B., 2013, ANGEW CHEM INT EDIT, V52, P9966; Sheldrick G. M., 1997, SHELXTL VERSION 5 10; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shirai K, 1999, DYES PIGMENTS, V42, P95, DOI 10.1016/S0143-7208(99)00013-3; Wang P, 2001, J PHOTOCH PHOTOBIO A, V144, P63, DOI 10.1016/S1010-6030(01)00518-4; Wiirthner F., 2006, CHEM COMMUN, P1188; Yang LJ, 2013, TETRAHEDRON LETT, V54, P2967, DOI 10.1016/j.tetlet.2013.03.113; Yuan MS, 2012, DYES PIGMENTS, V95, P236, DOI 10.1016/j.dyepig.2012.04.008	47	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0385-5414	1881-0942		HETEROCYCLES	Heterocycles	APR 1	2015	91	4					795	814		10.3987/COM-15-13189		20	Chemistry, Organic	Chemistry	CG8ZH	WOS:000353603700008		
J	Furuta, M; Ninomiya-Baba, M; Chiba, S; Funabashi, T; Akema, T; Kunugi, H				Furuta, Miyako; Ninomiya-Baba, Midori; Chiba, Shuichi; Funabashi, Toshiya; Akema, Tatsuo; Kunugi, Hiroshi			Exposure to social defeat stress in adolescence improves the working memory and anxiety-like behavior of adult female rats with intrauterine growth restriction, independently of hippocampal neurogenesis	HORMONES AND BEHAVIOR			English	Article						Anxiety-like behavior; Working memory; Female rat; Hippocampal cellular proliferation; Hippocampal neurogenesis; Intrauterine growth restriction; Social defeat stress	SPATIAL DELAYED ALTERNATION; SYNTHETIC THROMBOXANE A(2); CELL-PROLIFERATION; FETAL-GROWTH; NEUROTROPHIC FACTORS; SEX-DIFFERENCES; DENTATE GYRUS; BRAIN; RETARDATION; DEPRESSION	Intrauterine growth restriction (IUGR) is a risk factor for memory impairment and emotional disturbance during growth and adulthood. However, this risk might be modulated by environmental factors during development. Here we examined whether exposing adolescent male and female rats with thromboxane A2-induced IUGR to social defeat stress (SOS) affected their working memory and anxiety-like behavior in adulthood. We also used BrdU staining to investigate hippocampal cellular proliferation and BrdU and NeuN double staining to investigate neural differentiation in female IUGR rats. In the absence of adolescent stress, IUGR female rats, but not male rats, scored significantly lower in the T-maze test of working memory and exhibited higher anxiety-like behavior in the elevated-plus maze test compared with controls. Adolescent exposure to SOS abolished these behavioral impairments in IUGR females. In the absence of adolescent stress, hippocampal cellular proliferation was significantly higher in IUGR females than in non-IUGR female controls and was not influenced by adolescent exposure to SDS. Hippocampal neural differentiation was equivalent in non-stressed control and IUGR females. Neural differentiation was significantly increased by adolescent exposure to SDS in controls but not in IUGR females. There was no significant difference in the serum corticosterone concentrations between non-stressed control and IUGR females; however, adolescent exposure to SOS significantly increased serum corticosterone concentration in control females but not in IUGR females. These results demonstrate that adolescent exposure to SOS improves behavioral impairment independent of hippocampal neurogenesis in adult rats with IUGR (C) 2015 Elsevier Inc. All rights reserved.	[Furuta, Miyako; Funabashi, Toshiya; Akema, Tatsuo] St Marianna Univ, Dept Physiol, Dept Physiol, Kawasaki, Kanagawa 2168511, Japan; [Furuta, Miyako; Ninomiya-Baba, Midori; Chiba, Shuichi; Kunugi, Hiroshi] Natl Ctr Psychiat & Neurosci, Dept Mental Disorder, Tokyo, Japan	Furuta, M (reprint author), St Marianna Univ, Dept Physiol, Sch Med, Miyamae Ku, Sugao 2-16-1, Kawasaki, Kanagawa 2168511, Japan.	mfuruta@marianna-u.ac.jp	Chiba, Shuichi/E-3231-2010	Chiba, Shuichi/0000-0001-7480-4827	Ministry of Education, Culture, Sports, Science and Technology [KAKEN 20790198, 22790232]	The work of MF was supported by the Ministry of Education, Culture, Sports, Science and Technology (KAKEN 20790198 and 22790232). We would like to thank Ms. Atsuko Kawahira and Ms. Chiaki Kakehashi for excellent technical assistance.	Alati R, 2009, INT J EPIDEMIOL, V38, P1390, DOI 10.1093/ije/dyp252; Liu J, 2013, NUTR NEUROSCI, V16, P282, DOI 10.1179/1476830513Y.0000000057; Weisglas-Kuperus N, 2009, ARCH DIS CHILD-FETAL, V94, pF196, DOI 10.1136/adc.2007.135095; Encinas JM, 2008, METHOD CELL BIOL, V85, P243, DOI 10.1016/S0091-679X(08)85011-X; McCormick CM, 2010, BEHAV BRAIN RES, V208, P23, DOI 10.1016/j.bbr.2009.11.003; Arancio O, 2007, CURR OPIN NEUROBIOL, V17, P325, DOI 10.1016/j.conb.2007.03.013; HOLSON RR, 1992, NEUROTOXICOL TERATOL, V14, P221, DOI 10.1016/0892-0362(92)90020-B; Samuels BA, 2011, EUR J NEUROSCI, V33, P1152, DOI 10.1111/j.1460-9568.2011.07614.x; Donner NC, 2013, PFLUG ARCH EUR J PHY, V465, P601, DOI 10.1007/s00424-013-1271-7; Westenbroek C, 2004, BRAIN RES BULL, V64, P303, DOI 10.1016/j.brainresbull.2004.08.006; Uban KA, 2010, HORM BEHAV, V58, P835, DOI 10.1016/j.yhbeh.2010.08.007; Watt MJ, 2009, BEHAV NEUROSCI, V123, P564, DOI 10.1037/a0015752; MILLER MW, 1988, BRAIN RES, V457, P44, DOI 10.1016/0006-8993(88)90055-8; Leitner Y, 2007, J CHILD NEUROL, V22, P580, DOI 10.1177/0883073807302605; ter Horst J, 2012, CELL MOL NEUROBIOL, V32, P725, DOI 10.1007/s10571-011-9774-2; Geva R, 2006, PEDIATRICS, V118, P91, DOI 10.1542/peds.2005-2343; Vasiliadis HM, 2010, DEPRESS ANXIETY, V27, P1066, DOI 10.1002/da.20739; Douglas LA, 2004, DEV PSYCHOBIOL, V45, P153, DOI 10.1002/dev.20025; Geva R, 2006, BRAIN RES, V1117, P186, DOI 10.1016/j.brainres.2006.08.004; Koolhaas JM, 1997, NEUROSCI BIOBEHAV R, V21, P775, DOI 10.1016/S0149-7634(96)00057-7; Shors TJ, 2007, BIOL PSYCHIAT, V62, P487, DOI 10.1016/j.biopsych.2006.10.033; Schoenfeld TJ, 2012, EXP NEUROL, V233, P12, DOI 10.1016/j.expneurol.2011.01.008; Gould E, 1999, BIOL PSYCHIAT, V46, P1472, DOI 10.1016/S0006-3223(99)00247-4; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Scherjon S, 2000, PEDIATRICS, V105, P385, DOI 10.1542/peds.105.2.385; Falconer EM, 2003, BRAIN RES, V975, P22, DOI 10.1016/S0006-8993(03)02542-3; O'Keeffe MJ, 2003, PEDIATRICS, V112, P301, DOI 10.1542/peds.112.2.301; Kuipers SD, 2006, NEUROPHARMACOLOGY, V50, P428, DOI 10.1016/j.neuropharm.2005.10.006; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Malberg JE, 2003, NEUROPSYCHOPHARMACOL, V28, P1562, DOI 10.1038/sj.npp.1300234; Jacobs BL, 2000, MOL PSYCHIATR, V5, P262, DOI 10.1038/sj.mp.4000712; Buwalda B, 2013, NEUROSCIENCE, V249, P258, DOI 10.1016/j.neuroscience.2012.12.050; Van Bokhoven P, 2011, EUR J NEUROSCI, V33, P1833, DOI 10.1111/j.1460-9568.2011.07668.x; Rygula R, 2005, BEHAV BRAIN RES, V162, P127, DOI 10.1016/j.bbr.2005.03.009; Bourke CH, 2011, HORM BEHAV, V60, P112, DOI 10.1016/j.yhbeh.2011.03.011; Osborn JA, 1998, ALCOHOL CLIN EXP RES, V22, P685, DOI 10.1097/00000374-199805000-00021; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Takao K, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-11; Bingham B, 2011, NEUROPSYCHOPHARMACOL, V36, P896, DOI 10.1038/npp.2010.229; DEBRABANDER JM, 1991, BEHAV BRAIN RES, V42, P67; Drago F., 1999, EUR NEUROPSYCHOPHARM; Fukami E, 2000, EARLY HUM DEV, V58, P101, DOI 10.1016/S0378-3782(00)00068-2; Furuta M, 2013, ENDOCRINOLOGY, V154, P3807, DOI 10.1210/en.2012-2136; Girotti M, 2009, AM J PHYSIOL-ENDOC M, V296, pE888, DOI 10.1152/ajpendo.90946.2008; Hayakawa M, 1999, EARLY HUM DEV, V55, P125, DOI 10.1016/S0378-3782(99)00023-7; Henn FA, 2004, BIOL PSYCHIAT, V56, P146, DOI 10.1016/j.biopsych.2004.04.011; Huang Pu, 2008, Sichuan Da Xue Xue Bao Yi Xue Ban, V39, P627; Illa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076453; Komada M., 2008, J VIS EXP; Koolhaas J M, 1997, Acta Physiol Scand Suppl, V640, P69; Kovalenko IL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091762; Luine V., 2014, BEHAV BRAIN RES; MICZEK KA, 1991, PSYCHOPHARMACOLOGY, V104, P181, DOI 10.1007/BF02244176; Ninomiya M, 2010, NEUROSCI LETT, V476, P104, DOI 10.1016/j.neulet.2010.03.082; Nolan LA, 2001, ENDOCRINOLOGY, V142, P2996, DOI 10.1210/en.142.7.2996; Novick AM, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-39; Saito A, 2009, EXP NEUROL, V219, P81, DOI 10.1016/j.expneurol.2009.04.012; Sasaki J, 2000, EARLY HUM DEV, V58, P91, DOI 10.1016/S0378-3782(00)00069-4; STAM CJ, 1989, BEHAV NEUROSCI, V103, P24, DOI 10.1037/0735-7044.103.1.24; Stoop R, 1996, J NEUROSCI, V16, P3256; Tuscher J.J., 2014, BEHAV BRAIN RES; Ver Hoeve E S, 2013, Neuroscience, V249, P63, DOI 10.1016/j.neuroscience.2013.01.073; Watson C, 2007, RAT BRAIN STEREOTAXI; Xuelan L, 2008, J MED COLL PLA, V23, P283, DOI 10.1016/S1000-1948(08)60055-6	64	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0018-506X	1095-6867		HORM BEHAV	Horm. Behav.	APR	2015	70						30	37		10.1016/j.yhbeh.2015.01.010		8	Behavioral Sciences; Endocrinology & Metabolism	Behavioral Sciences; Endocrinology & Metabolism	CH0XU	WOS:000353746500005		
J	Nagano, Y; Imamura, H; Yabe, M				Nagano, Yuki; Imamura, Hisashi; Yabe, Mamoru			A new ghost flathead (Scorpaeniformes: Hoplichthyidae) from southwestern Australia	ICHTHYOLOGICAL RESEARCH			English	Article						Hoplichthys mcgroutheri; Hoplichthyidae; New species; Australia		A new hoplichthyid species, Hoplichthys mcgroutheri, is described on the basis of six specimens (188-244 mm standard length) collected off southwestern Australia. It is clearly distinguished from its congeners by the following combination of characters: dorsal-fin rays V-14; anal-fin rays 16-17, usually 16; pectoral-fin rays 13-14 + 4-5 = 17-18, usually 14 + 4 = 18; infraorbitals mostly spineless; scales present on dorsal surface of body; vomerine tooth patch constricted medially, mostly separating teeth into bilaterally symmetrical patches; interorbit narrow [interorbital width 5.8-6.8 % of head length (HL)]; and orbit relatively large (orbital diameter 41.8-44.9 % HL). The form of the vomerine tooth patch is unique to H. mcgroutheri in this genus.	[Nagano, Yuki; Imamura, Hisashi; Yabe, Mamoru] Hokkaido Univ, Fac Fisheries Sci, Lab Marine Biol & Biodivers Systemat Ichthyol, Hakodate, Hokkaido 0418611, Japan	Nagano, Y (reprint author), Hokkaido Univ, Fac Fisheries Sci, Lab Marine Biol & Biodivers Systemat Ichthyol, 3-1-1 Minato Cho, Hakodate, Hokkaido 0418611, Japan.	yuki.ghost_flatheads@fish.hokudai.ac.jp					Cuvier G, 1829, HIST NATURELLE POISS; FOWLER HENRY W., 1938, PROC U S NATION MUS, V85, P31; Fowler HW, 1943, B US NATL MUS, V100, p[i, 53]; Fricke R., 2014, GUIDE FISH COLLECTIO; Gilbert C. H., 1905, Bulletin US Fish Comm Washington, V23, P577; Jordan DS, 1908, AM NAT, V42, P800, DOI 10.1086/279012; Jordan D. S., 1908, Proceedings of the United States National Museum Smithsonian Institution Washington, V33; Matsubara K, 1950, JPN J ICHTHYOL, V1, P82; Matsubara K., 1937, Zoological Magazine Tokyo, V49, P264; Matsubara K, 1950, JPN J ICHTHYOL, V1, P145; McCulloch AR, 1907, RECORDS AUSTR MUSEUM, V6, P345, DOI DOI 10.3853/J.0067-1975.6.1907.1019; McCulloch A. R., 1914, Biological Results Endeavour, V2; McGrouther MA, 1999, LIVING MARINE RES 2, V4, P2422; Nagano Y, 2012, ICHTHYOL RES, V59, P255, DOI 10.1007/s10228-012-0286-y; Nagano Y, 2013, ZOOTAXA, V3681, P241, DOI 10.11646/zootaxa.3681.3.3; Nagano Y, 2013, B NATL SCI MUSE A S7, V7, P1; Regan C. T., 1908, Transactions of the Linnean Society London, V12	17	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-8998	1616-3915		ICHTHYOL RES	Ichthyol. Res.	APR	2015	62	3					245	252		10.1007/s10228-014-0432-9		8	Zoology	Zoology	CH2FI	WOS:000353840700001		
J	Ishida, Y; Asaoka, R; Nakae, M; Sasaki, K				Ishida, Yusuke; Asaoka, Ryu; Nakae, Masanori; Sasaki, Kunio			The trunk lateral line system and its innervation in Mugil cephalus (Mugilidae: Mugiliformes)	ICHTHYOLOGICAL RESEARCH			English	Article						Canal neuromast; Superficial neuromast; Lateral line nerve	TETRAODONTIFORMES; NERVES; ORIGIN; FISHES	The trunk lateral line system and its innervation were examined in Mugil cephalus. Almost every scale had an open longitudinal groove that housed a superficial neuromast (SN), the total number of SNs being 550 (including 55 on the caudal fin). Grooved lateral line scales constituted 14 longitudinal rows (14 lateral lines), although each groove was independent, not forming a continuous common groove along adjacent scales. The lateral ramus of the posterior lateral line nerve gave off four characteristic ramules: the anteriormost two dorsal ramules extended strongly backward, innervating SNs on the dorsal surface of the trunk; the anteriormost ventral ramule was extensively ramified to innervate SNs on the anterior flank, passing ventrally in front of the pectoral fin base; and the fifth ventral ramule extended posteriorly close to the anal fin origin, innervating SNs on the ventral half of the middle flank. The remaining SNs were innervated by 29 dorsal, 33 lateral and 25 ventral ramules, excepting those on the caudal fin. The innervation pattern revealed that the sixth lateral line (from uppermost) was homologous with that typically found in teleosts, the others being considered as additional. The sixth lateral line was anteriorly regressive, suggesting that the high insertion of the pectoral fin on the trunk is a secondary condition.	[Ishida, Yusuke; Asaoka, Ryu; Sasaki, Kunio] Kochi Univ, Marine Biol Lab, Fac Sci, Kochi 7808520, Japan; [Nakae, Masanori] Natl Museum Nat & Sci, Dept Zool, Tsukuba, Ibaraki 3050005, Japan	Sasaki, K (reprint author), Kochi Univ, Marine Biol Lab, Fac Sci, 2-5-1 Akebono Cho, Kochi 7808520, Japan.	fishssk@cc.kochi-u.ac.jp			JSPS KAKENHI [257627, 26840132]; Kochi University Marine Science Project	G. Hardy (Ngunguru, New Zealand) read the manuscript and offered helpful comments on English. This study was partly supported by JSPS KAKENHI Grant Number 257627 (to RA) and 26840132 (to MN) and Kochi University Marine Science Project (to KS).	Asaoka R, 2011, ICHTHYOL RES, V58, P51, DOI 10.1007/s10228-010-0193-z; Tarby ML, 2003, J MORPHOL, V255, P44, DOI 10.1002/jmor.10045; FRASER TH, 1971, COPEIA, P574, DOI 10.2307/1442465; Nakae M, 2010, J MORPHOL, V271, P559, DOI 10.1002/jmor.10817; Voronina EP, 2013, ACTA ZOOL-STOCKHOLM, V94, P154, DOI 10.1111/j.1463-6395.2011.00534.x; DIJKGRAAF S, 1963, BIOL REV, V38, P51, DOI 10.1111/j.1469-185X.1963.tb00654.x; Nakae M, 2012, ICHTHYOL RES, V59, P286, DOI 10.1007/s10228-012-0274-2; Asaoka R, 2012, ICHTHYOL RES, V59, P143, DOI 10.1007/s10228-011-0263-x; Asaoka R, 2014, ICHTHYOL RES, V61, P49, DOI 10.1007/s10228-013-0373-8; Ben-Tuiva A., 1986, FISHES NE ATLANTIC M, VIII, P1197; Braun CB, 2014, LATERAL LINE SYSTEM, P281; Carpenter K, 2002, LIVING MARINE RESOUR, P1071; CARVALHO C. D. M., 2007, NEOTROP ICHTHYOL, V5, P81; FILIPSKI GT, 1984, COPEIA, P204, DOI 10.2307/1445054; Freihofer W.C., 1972, Occasional Papers of the California Academy of Sciences, VNo. 95, P1; Gunther ACLG, 1880, INTRO STUDY FISHES; Hellier T. R., 1962, Copeia, V1962, P453, DOI 10.2307/1440932; Jacot AP, 1920, TRANSACT MICROSCOPIC, V29, P199; LIU C-H, 1991, Journal of Taiwan Museum, V44, P321; Liu Chen-Hsiang, 1993, Acta Zoologica Taiwanica, V4, P21; Nakae M, 2008, J MORPHOL, V269, P674, DOI 10.1002/jmor.10611; Nelson JS, 2006, FISHES WORLD; SCHEMMEL CHRISTIAN, 1967, Z MORPHOL TIERE, V61, P255, DOI 10.1007/BF00400988; STIASSNY MLJ, 1993, B MAR SCI, V52, P197; Webb JF, 2014, LATERAL LINE SYSTEM, P17; Weber M, 1922, FISHES INDO AUSTR AR, V4; Yamanaka Y, 2010, ICHTHYOL RES, V57, P49, DOI 10.1007/s10228-009-0122-1	27	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-8998	1616-3915		ICHTHYOL RES	Ichthyol. Res.	APR	2015	62	3					253	257		10.1007/s10228-014-0433-8		5	Zoology	Zoology	CH2FI	WOS:000353840700002		
J	Nakajima, J; Onikura, N				Nakajima, Jun; Onikura, Norio			Larval and juvenile development of Pike Gudgeon, Pseudogobio esocinus (Cyprinidae: Gobioninae)	ICHTHYOLOGICAL RESEARCH			English	Article						Cypriniformes; Cyprinid fish; Larvae; Juveniles; Morphology	FISH; MORPHOLOGY; JAPAN	We describe the larval and juvenile development of Pike Gudgeon, Pseudogobio esocinus, using laboratory-reared specimens. Newly hatched larvae with a 4.2-4.6 mm body length (BL) and 22-23 + 16 = 38-39 myomeres had melanophores on their head and body. The yolk sac was completely absorbed at 5.0 mm BL. Notochord flexion was initiated at 5.0-6.0 mm BL and completed at 7.3 mm BL. The aggregate number of all fin rays was completed at 11 mm BL. Several rod-like cupulae were observed on the head and lateral side of the body at 4.2-11.0 mm BL and were completely distinguished at 11.0-14.0 mm BL. Squamation was initiated on the caudal body at approximately 11.0 mm BL and completed at 11.0-14.0 mm BL. The newly hatched larvae had well-developed eyes and large pectoral fins.	[Nakajima, Jun] Fukuoka Inst Hlth & Environm Sci, Fukuoka 8180135, Japan; [Onikura, Norio] Kyushu Univ, Fishery Res Lab, Fac Agr, Fukuoka 8113304, Japan	Nakajima, J (reprint author), Fukuoka Inst Hlth & Environm Sci, Mukaizano 39, Fukuoka 8180135, Japan.	cyprin@kyudai.jp					Yang JQ, 2006, HYDROBIOLOGIA, V553, P255, DOI 10.1007/s10750-005-1301-3; Sado T, 2005, ICHTHYOL RES, V52, P386, DOI 10.1007/s10228-005-0301-7; Banarescu PM, 1973, TIERRICH LIEFERUNG 9; Banarescu Petru M., 1992, Travaux du Museum d'Histoire Naturelle 'Grigore Antipa', V32, P303; BANARESCU P., 1965, REV ROUMAINE BIOL, V10, P301; Eschmeyer WN, 2014, CATALOGUE OF FISHES; Hosoya K, 2014, ATLAS EARLY STAGE FI, Vsecond, P125; Hosoya K, 2013, FISHES JAPAN PICTORI, Vthird, p[308, 1813]; IWAI TAMOTSU, 1967, P27; MUKAI Y, 1991, NIPPON SUISAN GAKK, V57, P1339; Nakajima J, 2006, B HOSHIZAKI GREEN FO, V9, P244; Nakajima J, 2008, FISHERIES SCI, V74, P842, DOI 10.1111/j.1444-2906.2008.01597.x; Nakamura M, 1969, SPEC PUBL RES I NAT, V4; Nelson JS, 2006, FISHES WORLD; Sado T, 2005, ICHTHYOL RES, V52, P152, DOI 10.1007/s10228-005-0266-6; Sado T, 2006, ICHTHYOL RES, V53, P34, DOI 10.1007/s10228-005-0311-5; Sado T, 2005, ICHTHYOL RES, V52, P20, DOI 10.1007/s10228-004-0249-z; Takeshita Naohiko, 1998, Journal of National Fisheries University, V47, P15; Tominaga K, 2009, ICHTHYOL RES, V56, P195, DOI 10.1007/s10228-008-0071-0; Uchida K, 1939, B FISH EXP ST GOVERN, V6, P1; Yue P.Q., 1998, FAUNA SINICA OSTEICH, P232	21	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-8998	1616-3915		ICHTHYOL RES	Ichthyol. Res.	APR	2015	62	3					268	273		10.1007/s10228-014-0436-5		6	Zoology	Zoology	CH2FI	WOS:000353840700004		
J	Hirota, K; Asaoka, R; Nakae, M; Sasaki, K				Hirota, Kyouhei; Asaoka, Ryu; Nakae, Masanori; Sasaki, Kunio			The lateral line system and its innervation in Zenarchopterus dunckeri (Beloniformes: Exocoetoidei: Zenarchopteridae): an example of adaptation to surface feeding in fishes	ICHTHYOLOGICAL RESEARCH			English	Article						Hemiramphidae; Freshwater halfbeak; Neuromasts; Lateral line nerve	CARASSIUS-AURATUS; TELEOSTEI; NEUROMASTS; GOLDFISH	Examination of the lateral line system and its innervation in a freshwater halfbeak, Zenarchopterus dunckeri (Beloniformes: Exocoetoidei: Zenarchopteridae), revealed adaptations of a surface insect feeder. Superficial neuromasts (SNs) occurred on the head (ventral surface of lower jaw, snout, cheek, supratemporal region and opercle), trunk (forming four longitudinal rows: middorsal, dorsolateral, lateral and ventrolateral rows) and caudal fin (two rows). The middorsal row was broad, involving three longitudinal scale series (middorsal and left and right adjacent series) anteriorly on the trunk and including 809 SNs (counted on the left side); up to 108 SNs formed a more or less crescentic patch on each scale. The supratemporal ramus of the posterior lateral line nerve (PLLN) extended strongly posterior to innervate the middorsal row. The lateral ramus (of PLLN) gave off an anterior dorsal ramule innervating the dorsolateral row, four short ventral ramules innervating the lateral row, and 15 long ventral ramules innervating SNs of the ventrolateral row and canal neuromasts of the trunk lateral line.	[Hirota, Kyouhei; Asaoka, Ryu; Sasaki, Kunio] Kochi Univ, Marine Biol Lab, Fac Sci, Kochi 7808520, Japan; [Nakae, Masanori] Natl Museum Nat & Sci, Dept Zool, Tsukuba, Ibaraki 3050005, Japan	Sasaki, K (reprint author), Kochi Univ, Marine Biol Lab, Fac Sci, 2-5-1 Akebono Cho, Kochi 7808520, Japan.	fishssk@cc.kochi-u.ac.jp			JSPS KAKENHI [257627, 26840132]; Kochi University Marine Science Project	G. Hardy (Ngunguru, New Zealand) read the manuscript and offered helpful comments on English. This study was partly supported by JSPS KAKENHI Grant Number 257627 (to RA) and 26840132 (to MN) and Kochi University Marine Science Project (to KS).	Akihito Sakamoto K, 2002, FISHES JAPAN PICTORI, P1139; Anderson WD, 1991, ICHTHYOL EXPLOR FRES, V2, P156; WEBB JF, 1989, BRAIN BEHAV EVOLUT, V33, P34, DOI 10.1159/000115896; Parenti LR, 2008, ZOOL J LINN SOC-LOND, V154, P494; Northcutt RG, 2000, J COMP NEUROL, V421, P570; Nakae M, 2010, J MORPHOL, V271, P559, DOI 10.1002/jmor.10817; Schmitz A, 2014, J MORPHOL, V275, P357, DOI 10.1002/jmor.20219; Schmitz A, 2008, J MORPHOL, V269, P751, DOI 10.1002/jmor.10621; Nakae M, 2012, ICHTHYOL RES, V59, P286, DOI 10.1007/s10228-012-0274-2; Asaoka R, 2012, ICHTHYOL RES, V59, P143, DOI 10.1007/s10228-011-0263-x; Aschliman NC, 2005, P BIOL SOC WASH, V118, P416, DOI 10.2988/0006-324X(2005)118[416:ROSANT]2.0.CO;2; Coates D., 1992, Ichthyological Exploration of Freshwaters, V3, P25; Collette Bruce B., 1995, Ichthyological Exploration of Freshwaters, V6, P171; Collette BB, 2004, CALF ACAD SCI ANNOTA, V22; Collette BB, 1995, ENCY FISHES, P144; FILIPSKI GT, 1984, COPEIA, P204, DOI 10.2307/1445054; Freihofer W.C., 1972, Occasional Papers of the California Academy of Sciences, VNo. 95, P1; Huylebrouck J, 2012, RAFFLES B ZOOL, V60, P477; Ishikawa Y, 1994, FISH BIOL J MEDAKA, V6, P17; Ladiges W, 1951, FISCH LANDSCHAFT; Lovejoy NR, 2004, INTEGR COMP BIOL, V44, P366, DOI 10.1093/icb/44.5.366; MEGURO K, 1972, Japanese Journal of Ichthyology, V19, P186; Meisner AD, 2001, ZOOL J LINN SOC-LOND, V133, P199, DOI 10.1006/zjls.2000.0281; Nakae M, 2006, ICHTHYOL RES, V53, P209, DOI 10.1007/s10228-006-0335-5; Nakae M, 2013, B NATN SCI MUS TOK A, V39, P39; PARIN NV, 1982, COPEIA, P276; PUZDROWSKI RL, 1989, BRAIN BEHAV EVOLUT, V34, P110, DOI 10.1159/000116496; Roberts T. R., 1989, MEMOIRS CALIFORNIA A, V14, P1; ROBERTS T.R., 1978, SMITHSONIAN CONTRIBU, V281, P1, DOI DOI 10.5479/SI.00810282.281; Schemmel C, 1967, J MORPH TIERE, V61, P255; SCHWARTZ E, 1970, J MORPH TIERE, V67, P40; Schwarz JS, 2011, J EXP BIOL, V214, P1857, DOI 10.1242/jeb.051714; Yamanaka Y, 2010, ICHTHYOL RES, V57, P49, DOI 10.1007/s10228-009-0122-1	33	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-8998	1616-3915		ICHTHYOL RES	Ichthyol. Res.	APR	2015	62	3					286	292		10.1007/s10228-014-0442-7		7	Zoology	Zoology	CH2FI	WOS:000353840700006		
J	Matsunuma, M; Motomura, H				Matsunuma, Mizuki; Motomura, Hiroyuki			A new species of scorpionfish, Ebosia saya (Scorpaenidae: Pteroinae), from the western Indian Ocean and notes on fresh coloration of Ebosia falcata	ICHTHYOLOGICAL RESEARCH			English	Article						Ebosia bleekeri; sexual dimorphism; distribution; Saya de Malha Bank	POORLY KNOWN SCORPIONFISH; PACIFIC-OCEAN; 1ST RECORDS; AUSTRALIA; COAST; REDESCRIPTION; LIONFISH; VALIDITY; JAPAN	A new scorpionfish, Ebosia saya sp. nov. (Scorpaenidae: Pteroinae), is described on the basis of 10 specimens collected from the Saya de Malha Bank in depths of 95-126 m. Comparisons with two valid Indo-Pacific species, Ebosia bleekeri (Doderlein in Steindachner and Doderlein 1884) (western Pacific Ocean) and Ebosia falcata Eschmeyer and Rama-Rao 1978 (northern and eastern Indian Ocean), showed E. saya to be most similar to the latter, with both species sharing 8 (usually) anal-fin soft rays, 17 (usually) pectoral-fin rays, the elongated parietal spine of males relatively narrow and strongly falcate posterodorsally, and the pectoral fin predominantly yellow in males, whereas E. bleekeri has 7 (usually) anal-fin soft rays, 16 (usually) pectoral-fin rays, the elongated parietal spine of males relatively broad and weakly falcate, and the pectoral fins entirely red in males. However, E. saya differs from E. falcata in having 5 scale rows above the lateral line [vs. 4 or 5 (modally 4) in E. falcata], slightly greater total numbers (5-20, mean 12.3) of preocular, supraocular, and postocular spines at 60-90 mm SL (vs. 4-18, 8.4), shorter postorbital length 18.1-19.2 (mean 18.7) % SL [vs. 19.8-23.5 (21.5) % SL], and the blotch above the pectoral-fin base and blotches on the pectoral-fin membrane all relatively smaller. Fresh coloration of E. falcata is described for the first time, based on specimens from the Andaman Sea (easternmost record for the species).	[Matsunuma, Mizuki] Seikai Natl Fisheries Res Inst, Nagasaki 8512213, Japan; [Motomura, Hiroyuki] Kagoshima Univ Museum, Kagoshima 8900065, Japan	Matsunuma, M (reprint author), Seikai Natl Fisheries Res Inst, 1551-8 Taira, Nagasaki 8512213, Japan.	k1139853@kadai.jp; motomura@kaum.kagoshima-u.ac.jp			Japan Society for the Promotion of Science, Tokyo, Japan (JSPS) [26241027, 24370041, 23580259, 26450265]; JSPS Asian Core Program "Establishment of Research and Education Network on Coastal Marine Science in Southeast Asia"; JSPS International Training Program "Protect Diversity of Bioresources in the Tropical Area"; Coastal Area Capability Enhancement in Southeast Asia Project of the Research Institute for Humanity and Nature, Kyoto, Japan; "Biological Properties of Biodiversity Hotspots in Japan" project of the National Museum of Nature and Science, Tsukuba, Japan; Mikimoto Fund for Marine Ecology	We are deeply grateful to M. McGrouther, A. Hay, and S. Reader (AMS); K.-T. Shao, Y.-C. Liao, and M.-Y. Lee (ASIZP); H. Endo, T. Yamakawa, N. Nakayama (BSKU), and E. Katayama (formerly BSKU); T. Nakabo, Y. Kai, A. Tokairin (FAKU), and N. Muto (formerly FAKU); M. Yabe, H. Imamura, and T. Kawai (HUMZ); R. Causse (MNHN); Y. Iwatsuki (MUFS), K. Hidaka, and K. Miyamoto (formerly MUFS); Z. Arifin, R. Pratiwi, M. Adrim, I. Alhakim, and K. Wibowo (NCIP); H.-C. Ho (NMMB); M. Gomon and D. Bray (NMV); K. Matsuura and G. Shinohara (NSMT); K.-Y. Wu (NTUM); T. Yoshino (formerly URM); K. Hoshino and M. Okamoto (SNFR); J. Williams (USNM); S. Morrison (WAM); R. Thiel and I. Eidus (ZMH); and K. Sakamoto (ZUMT) for their kind hospitality during the first author's visits to their institutions. We are also grateful to R. Feeney (LACM) for providing opportunities to examine specimens, H.-C. Ho (MNHB) for donating specimens, H. Endo and T. Kawai for providing photographs of fresh E. bleekeri and E. saya, respectively, and Y. Haraguchi, students, and other KAUM volunteers for curatorial assistance and sampling specimens. The first author is especially grateful to S. Chiba (NSMT) for advice with molecular analysis and M. Sakurai (The Kagoshima Immaculate Heart College) for advice with gonad examinations. G. Hardy (Ngunguru, New Zealand) read the manuscript and provided help with English. Specimens from Pakistan were donated to KAUM from Marine Fisheries Department, Government of Pakistan, and P. Psomadakis (FAO, Rome). This study was supported in part by Grants-in-Aid for Scientific Research (A: 26241027, B: 24370041, and C: 23580259 and 26450265) from the Japan Society for the Promotion of Science, Tokyo, Japan (JSPS), JSPS Asian Core Program "Establishment of Research and Education Network on Coastal Marine Science in Southeast Asia", JSPS International Training Program "Protect Diversity of Bioresources in the Tropical Area", the Coastal Area Capability Enhancement in Southeast Asia Project of the Research Institute for Humanity and Nature, Kyoto, Japan, and the "Biological Properties of Biodiversity Hotspots in Japan" project of the National Museum of Nature and Science, Tsukuba, Japan, and by the grant awarded to the first author from the Mikimoto Fund for Marine Ecology.	Miya M, 2000, MOL PHYLOGENET EVOL, V17, P437, DOI 10.1006/mpev.2000.0839; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Motomura H, 2005, ZOOTAXA, P17; Motomura H, 2008, J FISH BIOL, V72, P1761, DOI 10.1111/j.1095-8649.2008.01862.x; Motomura H, 2007, ZOOL STUD, V46, P35; Akihito, 2000, GENE, V259, P5, DOI 10.1016/S0378-1119(00)00488-1; Kuriiwa K, 2007, MOL PHYLOGENET EVOL, V45, P69, DOI 10.1016/j.ympev.2007.04.018; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Motomura H, 2004, COPEIA, P818; Motomura H, 2005, NEW ZEAL J MAR FRESH, V39, P865; Motomura H, 2011, ICHTHYOL RES, V58, P315, DOI 10.1007/s10228-011-0234-2; Bloch ME, 1787, NATURGESCHICHTE AUSL, V3; Chan WL, 1973, HONG KONG FISH B, P103; ESCHMEYER WILLIAM N., 1965, BULL MAR SCI, V15, P84; Eschmeyer WN, 1978, MATSYA, P64; Eschmeyer W.N., 1986, P463; Iwamoto T., 2014, CORAL TRIANGLE 2011, P263; Kotthaus A., 1979, Meteor Forschungsergebnisse Reihe D - Biologie, P6; Linnaeus C., 1758, SYSTEMA NATURAE; Mandrytsa S. A., 2001, LATERAL LINE SYSTEM; Mandritsa S. A., 2002, Voprosy Ikhtiologii, V42, P129; MANILO L. G., 2003, J ICHTHYOLOGY S1, V43, pS75; Matsubara K., 1943, T SIGENKAGAKU KENKYU, V2, P171; Matsunuma Mizuki, 2011, Japanese Journal of Ichthyology, V58, P27; Matsunuma M, 2013, ZOOTAXA, V3693, P401; Matsunuma Mizuki, 2013, Species Diversity, V18, P163; Motomura H, 2006, COPEIA, P445; Motomura H, 2006, COPEIA, P360, DOI 10.1643/0045-8511(2006)2006[360:NSOSWS]2.0.CO;2; Motomura H, 2006, COPEIA, P500; Motomura Hiroyuki, 2005, Stuttgarter Beitraege zur Naturkunde Serie A (Biologie), V674, P1; Motomura Hiroyuki, 2004, Indo-Pacific Fishes, V37, P1; Motomura H, 2004, ZOOL STUD, V43, P1; Oshima M., 1956, Zoological Magazine Tokyo, V65, P236; Poss S.G., 1999, SPECIES IDENTIFICA 2, V4, P2291; Quantum GIS Development Team, 2014, QUANT GIS GEOGR INF; Randall J. E., 2002, INDOPACIFIC FISH, V34, P1; Sabaj Perez M.E., 2014, STANDARD SYMBOLIC CO; Schmidt P., 1931, Transactions of the Pacific Committee Acad Sci USSR Moscow, V2, P1; Steindachner F, 1884, DENKSCHR AKAD WISS W, V49, P171; Temminck CJ, 1843, FAUNA JAPONICA 2, P21	40	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-8998	1616-3915		ICHTHYOL RES	Ichthyol. Res.	APR	2015	62	3					293	312		10.1007/s10228-014-0445-4		20	Zoology	Zoology	CH2FI	WOS:000353840700007		
J	Nakayama, N; Kimura, Y; Endo, H				Nakayama, Naohide; Kimura, Yuki; Endo, Hiromitsu			Neoepinnula minetomai, a new species of sackfish from off Kuchierabu-jima Island, southern Japan (Actinopterygii: Gempylidae)	ICHTHYOLOGICAL RESEARCH			English	Article						Deep-sea fish; Kagoshima; Satsunan Islands; East China Sea; Taxonomy	NESIARCHUS	Neoepinnula minetomai, a new species of sackfish, is described from two specimens collected from the East China Sea off Kuchierabu-jima Island, Kagoshima, Japan, at depths of about 380-420 m. The species is separable from its two congeners, Neoepinnula americana and Neoepinnula orientalis, by the following combination of characters: orbit huge, 1.0-1.1 in snout length, its upper margin forming predorsal profile in lateral view; fleshy interorbital width less than orbit diameter; posteroventral corner of preopercle forming an acute angle; distal margin of second dorsal and anal fins concave; tip of lower jaw without distinctly enlarged fangs; lower lateral line above pectoral fin base hidden behind opercle; oral cavities uniformly blackish; head length (HL) 33.5-34.8 % standard length (SL); body depth at pelvic fin base 28.2-29.0 % SL, and at anal fin origin 27.0-28.0 % SL; pectoral fin length 17.9-18.1 % SL; upper caudal fin lobe length 25.6 % SL; lower caudal fin lobe length 23.4-24.0 % SL; snout length 31.3-33.4 % HL; postorbital length 38.2-39.0 % HL; upper jaw length 40.5-41.2 % HL.	[Nakayama, Naohide; Endo, Hiromitsu] Kochi Univ, Marine Biol Lab, Fac Sci, Kochi 7808520, Japan; [Kimura, Yuki] Hiroshima Univ, Grad Sch Biosphere Sci, Lab Biol Aquat Resources, Hiroshima 7398528, Japan	Nakayama, N (reprint author), Kochi Univ, Marine Biol Lab, Fac Sci, 2-5-1 Akebono Cho, Kochi 7808520, Japan.	gadiformes@gmail.com			Japan Society for the Promotion of Science, Tokyo [24370041]; Natural Science Cluster, Science Unit, Kochi University; National Museum of Nature and Science, Tsukuba	Our sincere thanks go to Takeshi Minetoma (Kagoshima, Japan) for his generous help in collecting specimens. We also thank Gento Shinohara, Masanori Nakae, and Eri Katayama (NSMT-P) and Robert Robins (UF) for loans of specimens; Yuki Nagano (HUMZ) for providing copies of Russian literature; Taiga Naito (BSKU) for his help in taking radiographs. Fumihito Tashiro (FAKU) kindly assisted us in producing Fig. 3. Our special thanks go to Martin Gomon (NMV) who reviewed an early draft of the manuscript and provided valuable comments. This study was partly supported by a Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science, Tokyo (24370041), a Grant-in-Aid of the "Marine Science Project" of the Natural Science Cluster, Science Unit, Kochi University, and the "Kuroshio Sougou Project" of the National Museum of Nature and Science, Tsukuba.	Shinohara Gento, 2005, National Science Museum Monographs, V29, P385; Fricke R., 2014, GUIDE FISH COLLECTIO; Furuhashi Naoki, 2010, Bulletin of the Faculty of Fisheries Nagasaki University, V91, P17; Gilchrist JDF, 1924, REPORT FISHERIES MAR, V3, P1; GREY M, 1953, COPEIA, P135; Hubbs C.L., 1964, B CRANBROOK I SCI, V26, P1; MATSUBARA KIYOMATSU, 1952, PACIFIC SCI, V6, P193; Nakamura I, 1993, FAO SPECIES CATALOG, V15; NAKAMURA I, 1983, JPN J ICHTHYOL, V29, P408; Okamura O, 1985, FISHES OKINAWA ADJAC, VII; Okamura O, 1984, FISHES OKINAWA ADJAC, VI; Parin NV, 1972, T I OKEANOL, V93, P110; Roberts Clive D., 1997, Memoires du Museum National d'Histoire Naturelle, V174, P125; Yamada U, 2007, FISHES FISHERIES E C; Yamada U, 1986, FISHES E CHINA SEA Y	15	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-8998	1616-3915		ICHTHYOL RES	Ichthyol. Res.	APR	2015	62	3					320	326		10.1007/s10228-014-0446-3		7	Zoology	Zoology	CH2FI	WOS:000353840700009		
J	Matsunuma, M; Motomura, H				Matsunuma, Mizuki; Motomura, Hiroyuki			Pterois paucispinula, a new species of lionfish (Scorpaenidae: Pteroinae) from the western Pacific Ocean	ICHTHYOLOGICAL RESEARCH			English	Article						Pterois mombasae; Pteropterus; Geographic variation; Distribution	POORLY KNOWN SCORPIONFISH; 1ST RECORDS; AUSTRALIA; COAST; REDESCRIPTION; MITOCHONDRIAL; TELEOSTEI; VALIDITY; FISHES; JAPAN	A new species of lionfish (Scorpaenidae: Pteroinae), Pterois paucispinula sp. nov., is described on the basis of 37 specimens from the western Pacific Ocean. The new species is closely related to and has been previously confused with Pterois mombasae (Smith 1957), both species sharing usually XIII, 10 dorsal-fin rays, usually more than 18 pectoral-fin rays, numerous black blotches on the pectoral-fin membrane, and several bands on the posterior portion of the pectoral-fin rays (free from membrane). However, P. paucispinula differs from similarly sized P. mombasae in having a lesser body depth at the anal-fin origin, head width, postorbital length, and caudal-peduncle depth, in addition to a slightly higher number of scale rows below the lateral line. Pterois paucispinula also differs from the typical form of P. mombasae, occurring off the east coast of Africa and in the central Indian Ocean and Andaman Sea, by having usually 18 pectoral-fin rays (vs. usually 19 in the latter) and relatively long dorsal-fin spines, with the longest dorsal-fin spine length 42.9-51.7 % of standard length (SL) (vs. 35.1-44.8 % of SL). Although a Sri Lankan population of P. mombasae is similar to P. paucispinula in the above characters (usually 18 pectoral-fin rays and longest dorsal-fin spine length 37.5-51.1 % of SL), such differences among P. mombasae are regarded as intra-specific geographical variations. Additionally, young and adult P. mombasae have ctenoid scales on the pectoral-fin base, ventrolateral portion of the body (below the lateral line) and laterally on the caudal peduncle. These regions in all examined P. paucispinula usually have only cycloid or at most a few ctenoid scales, thereby providing a consistent basis for identification of both species, including the Sri Lankan population of P. mombasae. Pterois mombasae is distributed in the Indian Ocean from the east coast of Africa to the Andaman Sea, whereas P. paucispinula is recorded from the western Pacific Ocean, from northern Australia to southern Japan and eastward to the Wallis and Futuna Islands.	[Matsunuma, Mizuki] Seikai Natl Fisheries Res Inst, Nagasaki 8512213, Japan; [Motomura, Hiroyuki] Kagoshima Univ Museum, Kagoshima 8900065, Japan	Matsunuma, M (reprint author), Seikai Natl Fisheries Res Inst, 1551-8 Taira, Nagasaki 8512213, Japan.	k1139853@kadai.jp; motomura@kaum.kagoshima-u.ac.jp			Japan Society for the Promotion of Science, Tokyo, Japan (JSPS) [26241027, 24370041, 23580259, 26450265]; JSPS Asian Core Program "Establishment of Research and Education Network on Coastal Marine Science in Southeast Asia"; JSPS International Training Program "Protect Diversity of Bioresources in the Tropical Area"; Coastal Area Capability Enhancement in Southeast Asia Project of the Research Institute for Humanity and Nature, Kyoto, Japan; "Biological Properties of Biodiversity Hotspots in Japan" project of the National Museum of Nature and Science, Tsukuba, Japan; Mikimoto Fund for Marine Ecology	We are deeply grateful to M. McGrouther, A. Hay and S. Reader (AMS); K.-T. Shao, Y.-C. Liao and M.-Y. Lee (ASIZP); J. Maclaine and O. Crimmen (BMNH); H. Endo, T. Yamakawa, N. Nakayama (BSKU) and E. Katayama (formerly BSKU); T. Nakabo, Y. Kai, A. Tokairin (FAKU) and N. Muto (formerly FAKU); K. Swagel (FMNH); M. Yabe, H. Imamura, T. Kawai (HUMZ); H. Senou (KPM); R. Causse (MNHN); Z. Arifin, R. Pratiwi, M. Adrim, I. Alhakim and K. Wibowo (NCIP); H.-C. Ho (NMMB); M. Gomon and D. Bray (NMV); K. Matsuura and G. Shinohara (NSMT); I.-S. Chen (NTOU); K. Hatooka (OMNH); U. Satapoomin (PMBC); T. Alpermann, H. Zetzsche (SMF) and F. Krupp (formerly SMF); T. Yoshino (formerly URM); J. Williams (USNM); P. Bartsch and C. Lamour (ZMB); and K. Sakamoto (ZUMT) for their kind hospitality during the first author's visits to their institutions. We are indebted to D. Catania (CAS), A. Suzumoto (BPBM), T. Noichi (CMNH), R. Feeney (LACM) and R. Bills (SAIAB) for providing opportunities to examine specimens. We especially thank S. Chiba (NSMT) for instructing the first author in molecular analysis and also T. Yoshida (KAUM) for providing specimen data, Y. Sakurai (Okinawa Prefecture, Japan), S. Koizumi (URM), K. Koeda (formerly URM) and H.-C. Ho (MNHB) for donating specimens, M. Aizawa (BLIH) and H. Endo for providing photographs of fresh P. paucispinula, Y. Haraguchi, students and other KAUM volunteers for curatorial assistance and sampling specimens, and G. Hardy (Ngunguru, New Zealand) for reading the manuscript and providing help with English. We also thank the two anonymous reviewers and editors for their helpful suggestions. This study was supported in part by Grants-in-Aid for Scientific Research (A: 26241027, B: 24370041 and C: 23580259 and 26450265) from the Japan Society for the Promotion of Science, Tokyo, Japan (JSPS), JSPS Asian Core Program "Establishment of Research and Education Network on Coastal Marine Science in Southeast Asia", JSPS International Training Program "Protect Diversity of Bioresources in the Tropical Area", the Coastal Area Capability Enhancement in Southeast Asia Project of the Research Institute for Humanity and Nature, Kyoto, Japan, and the "Biological Properties of Biodiversity Hotspots in Japan" project of the National Museum of Nature and Science, Tsukuba, Japan, and by grant awarded to the first author from the Mikimoto Fund for Marine Ecology.	Allen G. R., 2012, REEF FISHES E INDIES, V1-3; Allen G. R., 1997, MARINE FISHES TROPIC; Allen GR, 2003, REEF FISH IDENTIFICA; Allen GR, 2006, ZOOLOGICAL CATALOG 1, V35, P876; Allen GR, 1989, ZOOLOGICAL CATALOGUE, V7, P438; Miya M, 2000, MOL PHYLOGENET EVOL, V17, P437, DOI 10.1006/mpev.2000.0839; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Motomura H, 2005, ZOOTAXA, P17; Motomura H, 2008, J FISH BIOL, V72, P1761, DOI 10.1111/j.1095-8649.2008.01862.x; Akihito, 2000, GENE, V259, P5, DOI 10.1016/S0378-1119(00)00488-1; Kuriiwa K, 2007, MOL PHYLOGENET EVOL, V45, P69, DOI 10.1016/j.ympev.2007.04.018; Kochzius M, 2003, MOL PHYLOGENET EVOL, V28, P396, DOI 10.1016/S1055-7903(02)00444-X; Allen GR, 2003, ZOOL STUD, V42, P1; [Anonymous], 2011, STUTTG BEITR NATUR A; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Motomura H, 2005, NEW ZEAL J MAR FRESH, V39, P865; Motomura H, 2011, ICHTHYOL RES, V58, P315, DOI 10.1007/s10228-011-0234-2; Bloch ME, 1787, NATURGESCHICHTE AUSL, V3; Cuvier G, 1829, HIST NATURELLE POISO, V4; ESCHMEYER WILLIAM N., 1965, BULL MAR SCI, V15, P84; ESCHMEYER W N, 1975, Proceedings of the California Academy of Sciences, V40, P265; Eschmeyer W.N., 1986, P463; Gloerfelt-Tarp T., 1984, TRAWLED FISHES SO IN; Herre A. W., 1952, Philippine Journal of Science, V80, P381; Hirata T, 2010, FISHES AINAN EHIME P, P34; Hutchins J. Barry, 2001, Records of the Western Australian Museum Supplement, V63, P9; Jones S, 1980, FISHES LACCADIVE ARC; Jordan DS, 1903, B US FISH COMM, V22, P161; Kotthaus A., 1979, Meteor Forschungsergebnisse Reihe D - Biologie, P6; Kubota S, 2011, J JAPAN DRIFTOLOGICA, V9, P13; Kuiter RH, 2006, WORLD ATLAS MARINE F; Kuiter RH, 1996, GUIDE SEA FISHES AUS; Mandrytsa S. A., 2001, LATERAL LINE SYSTEM; Mandrytsa SA, 2002, J ICHTHYOL, V42, P129; Masuda H., 1975, COASTAL FISHES SO JA; Matsunuma Mizuki, 2011, Japanese Journal of Ichthyology, V58, P27; Matsunuma M, 2013, ZOOTAXA, V3693, P401; Matsunuma Mizuki, 2013, Species Diversity, V18, P1, DOI 10.12782/sd.18.1.001; Matsunuma M., 2013, BIOGEOGRAPHY, V15, P49; Matsunuma M, 2011, NATURE KAGOSHIMA, V37, P3; Matsunuma Mizuki, 2013, Species Diversity, V18, P163; Motomura H, 2009, FISHES ANDAMAN SEA W, P63; Motomura H, 2006, COPEIA, P445; Motomura Hiroyuki, 2011, Journal of the Fisheries Society of Taiwan, V38, P97; Motomura H, 2006, COPEIA, P360, DOI 10.1643/0045-8511(2006)2006[360:NSOSWS]2.0.CO;2; Motomura H, 2006, COPEIA, P500; Motomura Hiroyuki, 2005, Stuttgarter Beitraege zur Naturkunde Serie A (Biologie), V674, P1; Motomura Hiroyuki, 2004, Indo-Pacific Fishes, V37, P1; Motomura H, 2004, ZOOL STUD, V43, P1; Poss S.G., 1999, SPECIES IDENTIFICA 2, V4, P2291; Poss SG, 1983, FISHING AREA 51, V4; Quantum GIS Development Team, 2014, QUANT GIS GEOGR INF; R Core Team, 2014, R LANG ENV STAT COMP; Randall J. E., 2005, REEF SHORE FISHES S; Randall J. E., 2002, INDOPACIFIC FISH, V34, P1; Randall JE, 1995, COASTAL FISHES OMAN; Randall J.E., 1997, FISHES GREAT BARRIER; Sabaj Perez M.E., 2014, STANDARD SYMBOLIC CO; Satapoomin Ukkrit, 2011, Phuket Marine Biological Center Research Bulletin, V70, P29; Shimizu T, 1984, FISHES JAPANESE ARCH, p[302, 282C]; Smith J. L. B., 1957, Ichthyological Bulletin Rhodes University, VNo. 5, P75	61	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-8998	1616-3915		ICHTHYOL RES	Ichthyol. Res.	APR	2015	62	3					327	346		10.1007/s10228-014-0451-6		20	Zoology	Zoology	CH2FI	WOS:000353840700010		
J	Ito, T; Matsumura, K; Kozawa, G; Ozawa, M; Mitsuo, Y; Maruyama, A; Yuma, M				Ito, Takuya; Matsumura, Kentaro; Kozawa, Genki; Ozawa, Maho; Mitsuo, Yoshito; Maruyama, Atsushi; Yuma, Masahide			Studying the contribution of two types of landlocked Ayu fish in Lake Biwa to the next generation using nitrogen-stable isotope ratio analysis	ICHTHYOLOGICAL RESEARCH			English	Article						Ayu egg; Life history; Plecoglossus altivelis altivelis; Ovary; Polymorphism	SALMO-TRUTTA L; BROWN TROUT; EGG SIZE; SMALL STREAMS; COHO SALMON; CARBON; SYSTEM; TISSUE; GOBY	Contribution of amphidromous (Ooayu) and lake types (Koayu) of the landlocked Ayu (Plecoglossus altivelis altivelis) fish population in Lake Biwa to the next generation was investigated by isotopic approaches. delta N-15 values of eggs in adult ovaries distinctively differed between the two types. Contribution of Koayu, calculated using delta N-15 values of spawned Ayu eggs, was much greater than that of Ooayu in general, as previously reported. Ooayu spawned more eggs in the upper area of the spawning ground and did so late in the season. These results show the potential of isotopic approaches for identifying maternal life-history types of spawned eggs of migratory animals.	[Ito, Takuya; Matsumura, Kentaro; Kozawa, Genki; Ozawa, Maho; Mitsuo, Yoshito; Maruyama, Atsushi; Yuma, Masahide] Ryukoku Univ, Fac Sci & Technol, Otsu, Shiga 5202194, Japan	Ito, T (reprint author), Ryukoku Univ, Fac Sci & Technol, Otsu, Shiga 5202194, Japan.	bettapugnax110@yahoo.co.jp					Grey J, 2001, ECOL FRESHW FISH, V10, P168, DOI 10.1034/j.1600-0633.2001.100306.x; HESSLEIN RH, 1993, CAN J FISH AQUAT SCI, V50, P2071, DOI 10.1139/f93-230; Bilby RE, 1998, CAN J FISH AQUAT SCI, V55, P1909, DOI 10.1139/cjfas-55-8-1909; HINDAR K, 1991, HEREDITY, V66, P83, DOI 10.1038/hdy.1991.11; Maruyama A, 2001, CAN J FISH AQUAT SCI, V58, P2125, DOI 10.1139/cjfas-58-11-2125; Kohzu A, 2009, ECOL RES, V24, P127, DOI 10.1007/s11284-008-0489-x; Bilby RE, 1996, CAN J FISH AQUAT SCI, V53, P164, DOI 10.1139/cjfas-53-1-164; AZUMA M, 1970, Japanese Journal of Ecology, V20, P63; AZUMA M, 1973, Japanese Journal of Ecology, V23, P126; AZUMA M, 1973, Japanese Journal of Ecology, V23, P147; AZUMA M, 1973, Japanese Journal of Ecology, V23, P255; Chelkowski Z., 1986, Acta Ichthyologica et Piscatoria, V15, P37; Iguchi K, 1999, FISHERIES SCI, V65, P790; Iguchi K, 2001, EVOLUTIONARY BIOL EG, P43; ISHIDA R., 1959, BULL JAPANESE SOC SCI FISH, V25, P259; Jonsson B, 2001, FUNCT ECOL, V15, P310, DOI 10.1046/j.1365-2435.2001.00528.x; Kato F., 2002, B FUKUI CITY MUS NAT, V49, P53; LobonCervia J, 1997, FRESHWATER BIOL, V38, P277, DOI 10.1046/j.1365-2427.1997.00217.x; Maruyama A, 2001, ECOL RES, V16, P697, DOI 10.1046/j.1440-1703.2001.00427.x; Morita Kentaro, 2007, Japanese Journal of Ecology (Otsu), V57, P13; Pakkasmaa S, 2001, EVOL ECOL, V15, P143, DOI 10.1023/A:1013873810905; Primack RB, 1997, PRIMER CONSERVATION, P164; Sakai A, 2011, B SHIGA PREF FISHER, V54, P191; SAKAI H, 1991, Bulletin of the Faculty of Fisheries Hokkaido University, V42, P39; Yamada Yoshihiro, 1996, Japanese Journal of Limnology, V57, P467; Yamamoto S, 1999, CAN J ZOOL, V77, P871, DOI 10.1139/cjz-77-6-871	26	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-8998	1616-3915		ICHTHYOL RES	Ichthyol. Res.	APR	2015	62	3					357	362		10.1007/s10228-014-0439-2		6	Zoology	Zoology	CH2FI	WOS:000353840700013		
J	Sakuma, K; Ueda, Y; Ito, M; Kojima, S				Sakuma, Kay; Ueda, Yuji; Ito, Masaki; Kojima, Shigeaki			Demographic histories of two deep-sea eelpouts, Lycodes japonicus and Lycodes ocellatus: paleoenvironmental implications of the western North Pacific deep waters	ICHTHYOLOGICAL RESEARCH			English	Article						Population history; Deep-sea fishes; Sea of Japan; Western North Pacific; Last glacial period	MITOCHONDRIAL-DNA SEQUENCES; JAPAN SEA; GLACIAL REFUGIA; DEMERSAL FISH; OKHOTSK SEA; PHYLOGENY; PHYLOGEOGRAPHY; ZOARCIDAE; MAXIMUM; RATES	We compared the population histories of two deep-sea eelpouts, Lycodes japonicus and Lycodes ocellatus, to elucidate the impacts of the last glacial period on deep-sea species in the western North Pacific area. The results of phylogenetic analyses based on the nucleotide sequences of the mitochondrial cytochrome c oxidase subunit I and cytochrome b genes revealed that the two species are closely related to each other. The results of mismatch distribution analyses, Bayesian skyline plots, and a Bayes factor test supported a constant population size of L. ocellatus in the western North Pacific during the last glacial period, but suggested a post-glacial population expansion of L. japonicus.	[Sakuma, Kay; Kojima, Shigeaki] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan; [Ueda, Yuji] Fisheries Res Agcy, Japan Sea Natl Fisheries Res Inst, Chuo Ku, Niigata 9518121, Japan; [Ito, Masaki] Fisheries Res Agcy, Tohoku Natl Fisheries Res Inst, Hachinohe Lab, Hachinohe, Aomori 0310841, Japan	Sakuma, K (reprint author), Fisheries Res Agcy, Natl Res Inst Far Seas Fisheries, 5-7-1 Orido, Shimizu, Shizuoka 4240902, Japan.	keisakuma@affrc.go.jp			Ministry of Agriculture, Forestry, and Fisheries of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan [22370032]	We thank the captains, officers, and crews of the T/S Tanshu-Maru (Kasumi High School, Hyogo Prefecture) and the R/V Wakataka-maru (Tohoku National Fishery Institute, Fisheries Research Agency) for their help with sampling. The samples were collected on behalf of the Fishery Resources Survey contracted by the Ministry of Agriculture, Forestry, and Fisheries of Japan. This study was also supported in part by a grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (no. 22370032).	Adachi T, 2009, ICHTHYOL RES, V56, P323, DOI 10.1007/s10228-009-0101-6; Amano K, 2004, PALAEOGEOGR PALAEOCL, V202, P245, DOI 10.1016/S0031-0182(03)00637-0; Anderson M. Eric, 1994, Ichthyological Bulletin of the J. L. B. Smith Institute of Ichthyology, V60, P1; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Stefanni S, 2007, MOL PHYLOGENET EVOL, V42, P38, DOI 10.1016/j.ympev.2006.05.035; McCusker MR, 2010, MOL ECOL, V19, P4852, DOI 10.1111/j.1365-294X.2010.04822.x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Suchard MA, 2005, BIOMETRICS, V61, P665, DOI 10.1111/j.1541-0420.2005.00352.x; Miya M, 2003, MOL PHYLOGENET EVOL, V26, P121, DOI 10.1016/S1055-7903(02)00332-9; TAMURA K, 1993, MOL BIOL EVOL, V10, P512; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Aboim MA, 2005, MOL ECOL, V14, P1343, DOI 10.1111/j.1365-294X.2005.02518.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Near TJ, 2012, P NATL ACAD SCI USA, V109, P13698, DOI 10.1073/pnas.1206625109; Wang PX, 1999, MAR GEOL, V156, P5, DOI 10.1016/S0025-3227(98)00172-8; Kodama Y, 2008, MOL PHYLOGENET EVOL, V49, P682, DOI 10.1016/j.ympev.2008.08.022; Burridge CP, 2008, MOL BIOL EVOL, V25, P624, DOI 10.1093/molbev/msm271; Sakuma K, 2014, ZOOL SCI, V31, P375, DOI 10.2108/zs130271; Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Moller PR, 2003, MOL PHYLOGENET EVOL, V26, P369, DOI 10.1016/S1055-7903(02)00362-7; Shirai SM, 2006, ICHTHYOL RES, V53, P357, DOI 10.1007/s10228-006-0356-0; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Makinen HS, 2008, MOL PHYLOGENET EVOL, V46, P167, DOI 10.1016/j.ympev.2007.06.011; Avise JC., 2000, PHYLOGEOGRAPHY HIST; Balanov A, 2006, J ICHTHYOL, V46, P148, DOI 10.1134/S0032945206020020; Drummond A. J., 2009, TRACER V1 5; Harada N, 2012, DEEP-SEA RES PT II, V61-64, P93, DOI 10.1016/j.dsr2.2011.12.007; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Ikeda S, 2008, ICHTHYOL RES, V55, P356, DOI 10.1007/s10228-008-0050-5; Itaki T, 2004, PALAEOGEOGR PALAEOCL, V208, P263, DOI 10.1016/j.palaeo.2004.03.010; Matarese A, 1989, 80 NOAA, V80, P490; Palumbi SR, 1996, MOL SYSTEMATICS, V2, P205; Suchard MA, 2003, J AM STAT ASSOC, V98, P427, DOI 10.1198/016214503000215; Toyoshima M, 1984, FISHES JAPANESE ARCH, P305; Varela AI, 2012, MAR BIOL, V159, P1049, DOI 10.1007/s00227-012-1885-x	38	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-8998	1616-3915		ICHTHYOL RES	Ichthyol. Res.	APR	2015	62	3					363	367		10.1007/s10228-014-0441-8		5	Zoology	Zoology	CH2FI	WOS:000353840700014		
J	Noguchi, T; Sakuma, K; Kitahashi, T; Itoh, H; Kano, Y; Shinohara, G; Hashimoto, J; Kojima, S				Noguchi, Taisuke; Sakuma, Kay; Kitahashi, Tomo; Itoh, Hajime; Kano, Yasunori; Shinohara, Gento; Hashimoto, Jun; Kojima, Shigeaki			No genetic deviation between two morphotypes of the snipefishes (Macroramphosidae: Macroramphosus) in Japanese waters	ICHTHYOLOGICAL RESEARCH			English	Article						Macroramphosus; Japanese waters; Morphotype; Molecular phylogeny	TROPHIC POLYMORPHISM; MIXED MODELS; SCOLOPAX; FISH; GASTEROSTEIFORMES; SYNGNATHIFORMES; SUBSTITUTION; CENTRISCIDAE; LARVAE; DIET	We examined morphological and molecular characteristics of individuals of Macroramphosus in Japanese waters (the East China Sea and the northwestern Pacific). Two morphotypes (M. scolopax-type and M. gracilis-type) that were differentiated based on 10 quantitative morphological characters were not supported by molecular analyses using nuclear and mitochondrial DNA markers, while a genetic deviation was observed between populations of Macroramphosus from the northwestern Pacific and the northeastern Atlantic. Macroramphosus scolopax-type and M. gracilis-type individuals are thought to be intraspecific morphotypes adapted to plankton and benthos feeding, respectively.	[Noguchi, Taisuke; Itoh, Hajime; Kojima, Shigeaki] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778563, Japan; [Sakuma, Kay] Fisheries Res Agcy, Natl Res Inst Far Seas Fisheries, Shimizu, Shizuoka 4240902, Japan; [Kitahashi, Tomo; Kano, Yasunori] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan; [Shinohara, Gento] Natl Museum Nat & Sci, Tsukuba, Ibaraki 3050005, Japan; [Hashimoto, Jun] Nagasaki Univ, Fac Fisheries, Nagasaki 8528521, Japan	Kojima, S (reprint author), Univ Tokyo, Grad Sch Frontier Sci, 1-5-1 Kashiwanoha, Kashiwa, Chiba 2778563, Japan.	kojima@aori.u-tokyo.ac.jp					Andersson J, 2003, EVOL ECOL RES, V5, P213; Chow S, 1998, MOL ECOL, V7, P1255; Kristjansson BK, 2002, BIOL J LINN SOC, V76, P247, DOI 10.1111/j.1095-8312.2002.tb02086.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Smith TB, 1996, ANNU REV ECOL SYST, V27, P111, DOI 10.1146/annurev.ecolsys.27.1.111; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Ostellari L, 1996, ANIM GENET, V27, P423; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Whiteley AR, 2007, BIOL J LINN SOC, V92, P253, DOI 10.1111/j.1095-8312.2007.00845.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Bilecenoglu M, 2006, ZOOTAXA, P55; Bleeker P, 1852, NATUURKUNDIG TIJDSCH, V3, P51; CLARKE TA, 1984, COPEIA, P595; Ehrich S., 1973, Meteor ForschErgebn (Biol), VNo. 14, P87; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Kuranaga I, 2000, ICHTHYOL RES, V47, P101, DOI 10.1007/BF02674320; Lacepede B.G.E., 1803, HIST NATURELLE POISS, V5; Linnaeus C., 1758, SYSTEMA NATURAE; Lowe RT, 1839, P ZOOL SOC LOND, V7, P76; Matthiessen B, 2003, HELGOLAND MAR RES, V57, P63, DOI 10.1007/s10152-002-0133-z; Miyazaki E, 2004, ICHTHYOL RES, V51, P256, DOI 10.1007/s10228-004-0227-5; Mohr E, 1937, DANA REP, V13, P1; Okada Y., 1951, Report of the Faculty of Fisheries Prefectural University of Mie, V1, P7; Oksanen J., 2008, VEGAN COMMUNITY ECOL; Olsson J, 2005, EVOL ECOL RES, V7, P1109; R Development Core Group, 2008, R LANG ENV STAT COMP; Robalo JI, 2009, MAR BIOL, V156, P1733, DOI 10.1007/s00227-009-1197-y; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Swanson BO, 2003, ECOLOGY, V84, P1441, DOI 10.1890/02-0353; Swofford D.L, 2002, PHYLOGENETIC ANAL US	33	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-8998	1616-3915		ICHTHYOL RES	Ichthyol. Res.	APR	2015	62	3					368	373		10.1007/s10228-014-0443-6		6	Zoology	Zoology	CH2FI	WOS:000353840700015		
J	Simanjuntak, CPH; Kinoshita, I; Fujita, S; Takeuchi, K				Simanjuntak, Charles P. H.; Kinoshita, Izumi; Fujita, Shinji; Takeuchi, Keigo			Reproduction of the endemic engraulid, Coilia nasus, in freshwaters inside a reclamation dike of Ariake Bay, western Japan	ICHTHYOLOGICAL RESEARCH			English	Article						Anadromous engraulid; Spawning; Pelagic egg; Landlocked; Isahaya inlet		To examine reproduction of Coilia nasus, an engraulid endemic fish to Ariake Bay, in the freshwaters upstream of the reclamation dike of Isahaya inlet, ichthyoplankton was collected at the surface with a larva net. Eggs and larvae of this species were captured in abundance, especially in the retention basin. All eggs had reached middle or late embryonic stages, and larvae from the preflexion with yolk to the juvenile stage (4.1-39.3 mm) were found. This suggests that the freshwaters of retention basin supply spawning and nursery grounds for C. nasus.	[Simanjuntak, Charles P. H.; Kinoshita, Izumi] Kochi Univ, Usa Inst Marine Biol, Tosa, Kochi 7811164, Japan; [Fujita, Shinji] Nishinihon Inst Technol, Kochi 7800812, Japan	Simanjuntak, CPH (reprint author), Kochi Univ, Usa Inst Marine Biol, Tosa, Kochi 7811164, Japan.	ichthyes@gmail.com					Suzuki KW, 2014, FISH OCEANOGR, V23, P157, DOI 10.1111/fog.12051; Hayashi Munenori, 1994, Suisan Zoshoku, V42, P15; Inoue N, 1980, MARINE SCI MONTHLY, V12, P116; Ishida K., 1990, Suisan Zoshoku, V38, P135; Kendall A. W., 1984, SPECIAL PUBLICATION, V1, P11; Kinoshita Izumi, 2007, Aquabiology (Tokyo), V29, P69; MATSUI S, 1986, Science Bulletin of the Faculty of Agriculture Kyushu University, V40, P221; MATSUI S, 1986, Science Bulletin of the Faculty of Agriculture Kyushu University, V40, P229; Miller BS, 2009, EARLY LIFE HISTORY OF MARINE FISHES, P1, DOI 10.1525/california/9780520249721.001.0001; NAKAI ZINZIRO, 1962, BULL TOKAI REG FISH RES LAB, V9, P109; Takita T, 1967, B FAC FISH NAGASAKI, V22, P45; Takita T., 1967, Bulletin of the Faculty of Fisheries Nagasaki University, VNo. 23, P107; Tanaka S, 1933, DOBUTSUGAKU ZASSHI, V45, P38; Uchida K., 1955, Bulletin of the Biogeographical Society of Japan, V16-19, P292; Whitehead PJP, 1988, CLUPEOID FISHES WORL; Yagi Y, 2011, ENVIRON BIOL FISH, V91, P337, DOI 10.1007/s10641-011-9790-6	16	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-8998	1616-3915		ICHTHYOL RES	Ichthyol. Res.	APR	2015	62	3					374	378		10.1007/s10228-014-0448-1		5	Zoology	Zoology	CH2FI	WOS:000353840700016		
J	Gwak, WS; Lee, YD; Nakayama, K				Gwak, Woo-Seok; Lee, Yong-Deuk; Nakayama, Kouji			Population structure and sequence divergence in the mitochondrial DNA control region of gizzard shad Konosirus punctatus in Korea and Japan	ICHTHYOLOGICAL RESEARCH			English	Article						Gizzard shad; Konosirus punctatus; mtDNA; Genetic diversity; Secondary contact	GENETIC-DIFFERENCES; ORIGIN; FISHES; MAXIMUM; GROWTH; TREES	To investigate the extent of genetic differentiation among populations, genetic polymorphism in gizzard shad Konosirus punctatus, collected from wild populations of eight locations in Korea and four locations in Japan, was examined using mitochondrial DNA (mtDNA) control region. Two distinct mitochondrial lineages were detected: Lineage A was only distributed around Korean coastal waters and dominates the western and southwestern coast group of Korea. While Japanese groups of K. punctatus were exclusively assigned to lineage B. The co-occurrence of both lineages in southeast and east coasts of Korean coastal waters indicated that the current distribution pattern of gizzard shad populations was constructed by secondary contact.	[Gwak, Woo-Seok; Lee, Yong-Deuk] Gyeongsang Natl Univ, Marine Bioeduc & Res Ctr, Tongyeong 650160, South Korea; [Nakayama, Kouji] Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Kyoto 6068502, Japan	Gwak, WS (reprint author), Gyeongsang Natl Univ, Marine Bioeduc & Res Ctr, Tongyeong 650160, South Korea.	wsgwak@gnu.ac.kr			National Research Foundation of Korea Grant - Korean Government [NRF-2013-0340]; Japan Society for the Promotion of Science [23580253, 24370036]	This work was partly supported by the National Research Foundation of Korea Grant funded by the Korean Government (NRF-2013-0340) and a grant-in-aid for scientific research from the Japan Society for the Promotion of Science (23580253, 24370036). We are grateful to Dr. Yoshiaki Kai for collecting the samples.	Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Sivasundar A, 2001, MOL ECOL, V10, P407, DOI 10.1046/j.1365-294x.2001.01194.x; IMBRIE J, 1993, PALEOCEANOGRAPHY, V8, P699, DOI 10.1029/93PA02751; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.2307/2410314; Lambeck K, 2002, QUATERNARY SCI REV, V21, P343, DOI 10.1016/S0277-3791(01)00071-3; Fu YX, 1997, GENETICS, V147, P915; TAJIMA F, 1989, GENETICS, V123, P585; Park SC, 2000, GEO-MAR LETT, V20, P64, DOI 10.1007/s003670000039; Teacher AGF, 2011, MOL ECOL RESOUR, V11, P151, DOI 10.1111/j.1755-0998.2010.02890.x; Bowen BW, 1997, EVOLUTION, V51, P1601, DOI 10.2307/2411212; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; MEYER A, 1990, NATURE, V347, P550, DOI 10.1038/347550a0; Larmuseau MHD, 2009, J BIOGEOGR, V36, P1138, DOI 10.1111/j.1365-2699.2008.02072.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Liu JX, 2007, MOL ECOL, V16, P275, DOI 10.1111/j.1365-294X.2006.03140.x; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Emery KO, 1971, LATE CENOZOIC GLACIA, P381; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Gibbard P. L., 2004, GEOLOGIC TIME SCALE, P441; Gwak WS, 2011, FISHERIES SCI, V77, P945, DOI 10.1007/s12562-011-0403-2; Kim H.-B., 1984, Bulletin of the Korean Fisheries Society, V17, P206; Kong Libo, 1998, Journal of the Tokyo University of Fisheries, V85, P97; Kong LB, 2004, FISHERIES SCI, V70, P116, DOI 10.1111/j.1444-2906.2003.00779.x; Kuroda Kazunori, 2002, Bulletin of the Japanese Society of Fisheries Oceanography, V66, P239; Lee T.-W., 1983, Journal of the Oceanological Society of Korea, V18, P161; Maggs CA, 2008, ECOLOGY, V89, P108; MOF, 2013, ANN REP OC FISH KOR; Oba T, 1983, CHIKYU, V5, P37; Park SY, 2006, KOREAN J ICHTHYOL, V18, P300; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Sato A, 2003, MOL BIOL EVOL, V20, P1448, DOI 10.1093/molbev/msg151; Takita T, 1978, B FAC FISH NAGASAKI, V45, P5; Whitehead PJP, 1985, FAO FISHERIES SYNOPS, V125; Yamada U, 2007, FISHES E CHINA SEA Y; Yokogawa K, 1997, FISHERIES SCI, V63, P332	37	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-8998	1616-3915		ICHTHYOL RES	Ichthyol. Res.	APR	2015	62	3					379	385		10.1007/s10228-014-0450-7		7	Zoology	Zoology	CH2FI	WOS:000353840700017		
J	Shinohara, G				Shinohara, Gento			Untitled	ICHTHYOLOGICAL RESEARCH			English	Editorial Material									Natl Museum Nat & Sci, Fish Sect, Dept Zool, Tsukuba, Ibaraki 3050005, Japan	Shinohara, G (reprint author), Natl Museum Nat & Sci, Fish Sect, Dept Zool, 4-1-1 Amakubo, Tsukuba, Ibaraki 3050005, Japan.	s-gento@kahaku.go.jp						0	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-8998	1616-3915		ICHTHYOL RES	Ichthyol. Res.	APR	2015	62	3					386	387		10.1007/s10228-015-0466-7		2	Zoology	Zoology	CH2FI	WOS:000353840700018		
J	Masuda, N; Maiguma, T; Komoto, A; Haruki, Y; Sugiyama, T; Kondo, S; Teshima, D				Masuda, Nobutoshi; Maiguma, Takayoshi; Komoto, Atsushi; Haruki, Yuto; Sugiyama, Tetsuhiro; Kondo, Sachiyo; Teshima, Daisuke			Impact of pharmacist intervention in preventing nephrotoxicity from vancomycin	INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS			English	Article						pharmacist intervention; trough concentration; nephrotoxicity; vancomycin	STAPHYLOCOCCUS-AUREUS BACTEREMIA; METHICILLIN-RESISTANT; RETROSPECTIVE ANALYSIS; METAANALYSIS; INFECTIONS; GUIDELINES; PNEUMONIA; MORTALITY; OUTCOMES; COHORT	Objectives: To evaluate the impact of pharmacist interventions on preventing nephrotoxicity from vancomycin. Methods: A pre- to postpharmacist intervention study was performed in the Tsuyama Central Hospital. 508 Patients admitted from May 2007 to May 2012 served as the non-pharmacist intervention group, while 102 patients admitted from June 2012 to November 2013 formed the pharmacist intervention group. Pharmacist interventions were mainly performed for the initial dosage planning, controlling vancomycin prescriptions, and real-time monitoring of medical records before routine therapeutic drug monitoring. The non- and pharmacist intervention groups were compared to evaluate the outcomes of pharmacist interventions. Results: By pharmacist interventions, initial trough concentration of vancomycin promptly tightened within the 10 - 20 mu g/mL therapeutic trough concentration range (p < 0.001), and reaching an ineffective or risky trough concentration was avoided. Also, the mean vancomycin trough concentrations of patients with and without nephrotoxicity were 23.9 and 13.9 mu g/mL, respectively. Furthermore, by multivariate logistic regression analysis, significant increased risks of nephrotoxicity in baseline creatinine clearance, and 15 - 20 and over 20 mu g/mL of initial vancomycin trough concentration were observed. Significant decreased risk of nephrotoxicity was gender (male). Although pharmacist intervention showed a trend of 45% decrease in the incidence of nephrotoxicity, there was no significant difference between the pharmacist intervention and non-intervention groups. Conclusion: Pharmacist intervention may have an impact on vancomycin therapy from the standpoint of balancing a higher vancomycin trough concentration with risk of nephrotoxicity.	[Masuda, Nobutoshi; Haruki, Yuto; Sugiyama, Tetsuhiro; Kondo, Sachiyo] Tsuyama Cent Hosp, Dept Pharm, Okayama, Japan; [Maiguma, Takayoshi; Komoto, Atsushi; Teshima, Daisuke] Shujitsu Univ, Sch Pharm, Dept Clin Pharm, Okayama 7038516, Japan; [Masuda, Nobutoshi; Maiguma, Takayoshi; Teshima, Daisuke] Shujitsu Univ, Grad Sch Pharm, Okayama 7038516, Japan	Teshima, D (reprint author), Shujitsu Univ, Sch Pharm, Dept Clin Pharm, Naka Ku, 1-6-1 Nishi Kawara, Okayama 7038516, Japan.	teshima@shujitsu.ac.jp					Lodise TP, 2008, ANTIMICROB AGENTS CH, V52, P1330, DOI 10.1128/AAC.01602-07; Liu C, 2011, CLIN INFECT DIS, V52, P285, DOI 10.1093/cid/cir034; Lodise TP, 2009, CLIN INFECT DIS, V49, P507, DOI 10.1086/600884; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Jeffres MN, 2007, CLIN THER, V29, P1107, DOI 10.1016/j.clinthera.2007.06.014; Gould FK, 2009, J ANTIMICROB CHEMOTH, V63, P849, DOI 10.1093/jac/dkp065; Bosso JA, 2011, ANTIMICROB AGENTS CH, V55, P5475, DOI 10.1128/AAC.00168-11; Kullar R, 2012, PHARMACOTHERAPY, V32, P195, DOI 10.1002/j.1875-9114.2011.01017.x; van Hal SJ, 2013, ANTIMICROB AGENTS CH, V57, P734, DOI 10.1128/AAC.01568-12; Shen WC, 2011, NEPHROLOGY, V16, P697, DOI 10.1111/j.1440-1797.2011.01488.x; Jeffres MN, 2006, CHEST, V130, P947, DOI 10.1378/chest.130.4.947; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; Horey A, 2012, ANN PHARMACOTHER, V46, P1477, DOI 10.1345/aph.1R158; McKamy S, 2011, J PEDIATR-US, V158, P422, DOI 10.1016/j.jpeds.2010.08.019; Ariano R E, 1995, Can J Hosp Pharm, V48, P284; Blot S, 2014, CRIT CARE, V18, DOI 10.1186/cc13874; deGatta MDF, 1996, CLIN PHARMACOL THER, V60, P332, DOI 10.1016/S0009-9236(96)90060-0; Han JH, 2012, ANTIMICROB AGENTS CH, V56, P5164, DOI 10.1128/AAC.00757-12; R Core Team, 2013, R LANG ENV STAT COMP; Rybak Michael, 2009, Am J Health Syst Pharm, V66, P82, DOI 10.2146/ajhp080434	20	0	0	DUSTRI-VERLAG DR KARL FEISTLE	DEISENHOFEN-MUENCHEN	BAHNHOFSTRASSE 9 POSTFACH 49, D-82032 DEISENHOFEN-MUENCHEN, GERMANY	0946-1965			INT J CLIN PHARM TH	Int. J. Clin. Pharmacol. Ther.	APR	2015	53	4					284	291		10.5414/CP202274		8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CH2PG	WOS:000353866500002		
J	Shiozaki, T; Ueno, T; Nagashima, H; Yamahira, N; Hiraoka, M; Eley, T; Bifano, M; Bertz, RJ				Shiozaki, Tomomi; Ueno, Takayo; Nagashima, Hirotaka; Yamahira, Naomi; Hiraoka, Masaki; Eley, Tim; Bifano, Marc; Bertz, Richard J.			Single- and multiple-ascending dose studies to evaluate the safety, tolerability, and pharmacokinetics of daclatasvir and asunaprevir in healthy male Japanese subjects	INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS			English	Article						hepatitis C; antiviral; daclatasvir; asunaprevir; pharmacokinetic; Japanese; healthy	PROTEASE INHIBITOR ASUNAPREVIR; GENOTYPE 1B INFECTION; VIRUS NS3 PROTEASE; HEPATITIS-C; NS5A INHIBITOR; TRANSPORTERS; MANAGEMENT; BMS-790052	Objectives: Assess the safety, tolerability, and pharmacokinetic (PK) profiles of daclatasvir (DCV) and asunaprevir (ASV) in healthy male Japanese subjects. Methods: AI444-007 and AI447-005 were phase I, double-blind, placebo-controlled, sequential, single-ascending dose (SAD), and multiple-ascending dose (MAD) studies assessing DCV or ASV, respectively. Eight subjects per panel were randomized to study drug or placebo (3 : 1). In the SAD part of each study, subjects received single oral dose DCV 1/10/50/100/200 mg or ASV 200/400/600/900/1,200 mg. In MAD, subjects received 14-day oral multiple dose DCV 1/10/100 mg once-daily or ASV 200/400/600 mg every 12 hours. Serial PK blood sampling occurred from predose to 72-hours postdose or post-last-dose. Safety and tolerability was assessed throughout. Results: 64 (SAD, n = 40; MAD, n = 24) and 65 (SAD, n = 40; MAD, n = 25) subjects were enrolled in AI444-007 and AI447-005, respectively. DCV and ASV were generally well tolerated, with no serious adverse events or clinically-relevant changes in vital signs or ECG parameters. Baseline demographic characteristics were comparable across treatment groups in both studies. DCV was readily absorbed, with median t(max) of similar to 1 - 2 hours postdose and concentrations declining in a multi-phasic manner. Exposure generally increased dose-proportionally within dose-range studied. Steady-state was achieved between days 4 and 5 of multiple dosing. ASV was readily absorbed, with median t(max) of similar to 2 - 4 hours postdose and concentrations declining in a biphasic manner. Exposure generally increased dose-proportionally within dose-range studied. Steady-state appeared to be achieved between days 3 and 5 of multiple dosing. Conclusions: Results suggest no clinically significant short-term safety signals with DCV and ASV at single or multiple doses in this population.	[Shiozaki, Tomomi; Ueno, Takayo; Yamahira, Naomi; Hiraoka, Masaki] Bristol Myers KK, Tokyo, Japan; [Nagashima, Hirotaka] Clin Res Hosp Tokyo, Tokyo Clin Trial Ctr, Tokyo, Japan; [Eley, Tim; Bifano, Marc; Bertz, Richard J.] Bristol Myers Squibb Res & Dev, Hopewell, NJ USA	Shiozaki, T (reprint author), Bristol Myers KK, Shinjuku Ku, 6-5-1 Nishi Sinjuku, Tokyo, Japan.	tomomi.shiozaki@bms.com			Bristol-Myers KK., Tokyo, Japan (BMKK)	The authors would like to acknowledge Bing He and Xiaoli You (Bristol-Myers Squibb, Hopewell, New Jersey, USA) for their contribution to this manuscript. Medical writing and editorial assistance was provided by Stephen Griffiths, PhD of Articulate Science Ltd. and was funded by Bristol-Myers KK., Tokyo, Japan (BMKK).	Eley T, 2013, CLIN PHARM DRUG DEV, V2, P316, DOI 10.1002/cpdd.52; Pasquinelli C, 2012, ANTIMICROB AGENTS CH, V56, P1838, DOI 10.1128/AAC.05854-11; McPhee F, 2012, ANTIMICROB AGENTS CH, V56, P5387, DOI 10.1128/AAC.01186-12; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Negro F, 2011, LIVER INT, V31, P1, DOI 10.1111/j.1478-3231.2011.02537.x; Scheel TKH, 2011, GASTROENTEROLOGY, V140, P1032, DOI 10.1053/j.gastro.2010.11.036; Jiang H, 2012, J CHROMATOGR A, V1245, P117, DOI 10.1016/j.chroma.2012.05.028; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Lok AS, 2014, J HEPATOL, V60, P490, DOI 10.1016/j.jhep.2013.10.019; Bronowicki JP, 2013, ANTIVIR THER, V18, P885, DOI 10.3851/IMP2660; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Nettles RE, 2011, HEPATOLOGY, V54, P1956, DOI 10.1002/hep.24609; Kumada H, 2014, HEPATOLOGY, V59, P2083, DOI 10.1002/hep.27113; Suzuki Y, 2013, J HEPATOL, V58, P655, DOI 10.1016/j.jhep.2012.09.037; Chan P, 2013, J HEPATOL, V58, pS328; Dore GJ, 2013, J HEPATOL, V58, pS570; Drafting Committee for Hepatitis Management Guidelines the Japan Society of Hepatology, 2014, HEPATOL RES SS1, V44, P59; Editors of the Drafting Committee for Hepatitis Management Guidelines: the Japan Society of Hepatology, 2013, HEPATOL RES, V43, P1; Eley T, 2012, HEPATOLOGY, V56, p1070A; Eley T, 2015, CLIN PHARMACOL THER, V97, P159, DOI 10.1002/cpt.4; Everson GT, 2013, GASTROENTEROLOGY, V146, P420; Reddy KR, 2009, EXP HEMATOL, V50, P402; World Health Organization, 2013, HEP C KEY FACTS	23	1	1	DUSTRI-VERLAG DR KARL FEISTLE	DEISENHOFEN-MUENCHEN	BAHNHOFSTRASSE 9 POSTFACH 49, D-82032 DEISENHOFEN-MUENCHEN, GERMANY	0946-1965			INT J CLIN PHARM TH	Int. J. Clin. Pharmacol. Ther.	APR	2015	53	4					292	300		10.5414/CP202186		9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CH2PG	WOS:000353866500003		
J	Li, Q; Kobayashi, M; Kawada, T				Li, Qing; Kobayashi, Maiko; Kawada, Tomoyuki			Carbamate Pesticide-Induced Apoptosis in Human T Lymphocytes	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article							NATURAL-KILLER-CELLS; CYTOCHROME-C; NECROSIS; DEATH; ZIRAM	We previously found that carbamate pesticides induced significant apoptosis in human natural killer cells. To investigate whether carbamate pesticides also induce apoptosis in human T lymphocytes, in the present study Jurkat human T cells were treated in vitro with thiram, maneb, carbaryl or ziram. Apoptosis was determined by FITC-Annexin-V/PI staining. To explore the mechanism of apoptosis, intracellular levels of active caspase 3 and mitochondrial cytochrome-c release were determined by flow cytometry. We found that thiram, ziram, maneb and carbaryl also induced apoptosis in a time- and dose-dependent manner in the human T cells. However, the strength of the apoptosis-inducing effect differed among the pesticides, with the: thiram > ziram > maneb > carbaryl. Moreover, thiram significantly increased the intracellular level of active caspase 3 and caspase inhibitors significantly inhibited apoptosis. Thiram also significantly caused mitochondrial cytochrome-c release. These findings indicate that carbamate pesticides can induce apoptosis in human T cells, and the apoptosis is mediated by the activation of caspases and the release of mitochondrial cytochrome-c.	[Li, Qing; Kobayashi, Maiko; Kawada, Tomoyuki] Nippon Med Sch, Dept Hyg & Publ Hlth, Tokyo 1138602, Japan	Li, Q (reprint author), Nippon Med Sch, Dept Hyg & Publ Hlth, Tokyo 1138602, Japan.	qing-li@nms.ac.jp; mk831111@nms.ac.jp; kawada@nms.ac.jp			Ministry of Education, Culture, Sports, Science and Technology	This work was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology. We are grateful to the staff at the Department of Hygiene and Public Health, Nippon Medical School for their assistance.	KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Goldstein JC, 2000, NAT CELL BIOL, V2, P156; McDuffie HH, 2001, CANCER EPIDEM BIOMAR, V10, P1155; Patel T, 1996, FASEB J, V10, P587; MAJNO G, 1995, AM J PATHOL, V146, P3; Stennicke HR, 1998, J BIOL CHEM, V273, P27084, DOI 10.1074/jbc.273.42.27084; Okada S, 2003, J IMMUNOL, V171, P2556; Li Q, 2014, J BIOL REG HOMEOS AG, V28, P23; Li Q, 2011, ARCH TOXICOL, V85, P355, DOI 10.1007/s00204-010-0586-9; Li Q, 2012, ARCH TOXICOL, V86, P475, DOI 10.1007/s00204-011-0771-5; Li Q., 2015, INT J IMMUNOPATHOL P; Li Q, 2012, ARCH TOXICOL, V86, P615, DOI 10.1007/s00204-011-0791-1; Li Q, 2012, INT J IMMUNOPATH PH, V25, P883; Richardson ML, 1993, DICT SUBSTANCES THEI, V2, P99; Richardson ML, 1993, DICT SUBSTANCES THEI, V7, P437; Richardson ML, 1993, DICT SUBSTANCES THEI, V5, P323; Stahnke K, 2004, APOPTOSIS, V9, P457, DOI 10.1023/B:APPT.0000031454.62937.fa; Taylor TR, 2009, CELL BIOL TOXICOL, V25, P447, DOI 10.1007/s10565-008-9098-2; VANDEKAR M, 1971, B WORLD HEALTH ORGAN, V44, P241	19	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1660-4601			INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	APR	2015	12	4					3633	3645		10.3390/ijerph120403633		13	Environmental Sciences	Environmental Sciences & Ecology	CG7MT	WOS:000353488500016		
J	Mizuno, K; Shinohara, N; Miyakoshi, J				Mizuno, Kohei; Shinohara, Naoki; Miyakoshi, Junji			In Vitro Evaluation of Genotoxic Effects under Magnetic Resonant Coupling Wireless Power Transfer	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article								Wireless power transfer (WPT) technology using the resonant coupling phenomenon has been widely studied, but there are very few studies concerning the possible relationship between WPT exposure and human health. In this study, we investigated whether exposure to magnetic resonant coupling WPT has genotoxic effects on WI38VA13 subcloned 2RA human fibroblast cells. WPT exposure was performed using a helical coil-based exposure system designed to transfer power with 85.4% efficiency at a 12.5-MHz resonant frequency. The magnetic field at the positions of the cell culture dishes is approximately twice the reference level for occupational exposure as stated in the International Commission on Non-Ionizing Radiation Protection (ICNIRP) guidelines. The specific absorption rate at the positions of the cell culture dishes matches the respective reference levels stated in the ICNIRP guidelines. For assessment of genotoxicity, we studied cell growth, cell cycle distribution, DNA strand breaks using the comet assay, micronucleus formation, and hypoxanthine-guanine phosphoribosyltransferase (HPRT) gene mutation, and did not detect any significant effects between the WPT-exposed cells and control cells. Our results suggest that WPT exposure under the conditions of the ICNIRP guidelines does not cause detectable cellular genotoxicity.	[Mizuno, Kohei; Shinohara, Naoki; Miyakoshi, Junji] Kyoto Univ, Res Inst Sustainable Humanosphere, Lab Appl Radio Engn Humanosphere, Kyoto 6110011, Japan	Mizuno, K (reprint author), Kyoto Univ, Res Inst Sustainable Humanosphere, Lab Appl Radio Engn Humanosphere, Kyoto 6110011, Japan.	mizuno.kohei.67z@st.kyoto-u.ac.jp; shino@rish.kyoto-u.ac.jp; miyakoshi@rish.kyoto-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [23310022]; Development of New Research Area in Sustainable Humanosphere	This work was supported in part by a Grant-in-Aid for Scientific Research (B) (No. 23310022) from the Japan Society for the Promotion of Science (JSPS) and a Development of New Research Area in Sustainable Humanosphere.	Kurs A, 2007, SCIENCE, V317, P83, DOI 10.1126/science.1143254; Chun Y, 2014, IEICE T COMMUN, VE97B, P416, DOI 10.1587/transcom.E97.B.416; Christ A, 2013, IEEE T ELECTROMAGN C, V55, P265, DOI 10.1109/TEMC.2012.2219870; Karalis A, 2008, ANN PHYS-NEW YORK, V323, P34, DOI 10.1016/j.aop.2007.04.017; Park SW, 2013, IEEE T MICROW THEORY, V61, P3461, DOI 10.1109/TMTT.2013.2274053; [Anonymous], 2007, EXTR LOW FREQ FIELDS, V238; FAIRBAIRN DW, 1995, MUTAT RES-REV GENET, V339, P37, DOI 10.1016/0165-1110(94)00013-3; IARC, 2002, NON RAD 1, V80; IARC (International Agency for Research on Cancer), 2013, NON RAD 2, V102; International Commission on Non- Ionizing Radiation Pro- tection (ICNIRP), 1998, HEALTH PHYS, V74, P494; International Commission on Non-Ionizing Radiation Protection (ICNIRP), 2010, HEALTH PHYS, V99, P818, DOI DOI 10.1097/HP.0B013E3181F06C86; KirschVolders M, 1997, MUTAT RES-GEN TOX EN, V392, P1, DOI 10.1016/S0165-1218(97)00039-6; Mizuno K., 2014, POWER TRANSF, V1, P97, DOI [10.1017/wpt.2014.12, DOI 10.1017/WPT.2014.12]; Shinohara N., 2013, JAP IEEE RAD WIR S, DOI [10.1109/RWS.2013.6486657, DOI 10.1109/RWS.2013.6486657]; Shinohara N, 2011, IEEE MICROW MAG, V12, pS64, DOI 10.1109/MMM.2011.942732; STOUT JT, 1985, ANNU REV GENET, V19, P127, DOI 10.1146/annurev.genet.19.1.127; World Health Organization (WHO), 1993, EL FIELDS 300HZ 300G, V137	17	1	1	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1660-4601			INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	APR	2015	12	4					3853	3863		10.3390/ijerph120403853		11	Environmental Sciences	Environmental Sciences & Ecology	CG7MT	WOS:000353488500029		
J	Song, CR; Ikei, H; Miyazaki, Y				Song, Chorong; Ikei, Harumi; Miyazaki, Yoshifumi			Elucidation of a Physiological Adjustment Effect in a Forest Environment: A Pilot Study	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article							INITIAL-VALUE; STRESS; LAW; REACTIVITY; LANDSCAPES; HUMANS; HEALTH	There is a significant positive relationship between exposure to forest environments and physical and mental health. However, there are individual differences within these responses, and this phenomenon has posed questions in various fields. Here, we show that the physiological effect of a forest environment can differ depending on a subject's initial values and that forests have a physiological adjustment effect close to an appropriate level. Subjects with high initial blood pressure and pulse rate showed a decrease in these values after walking in a forested area, whereas those with low initial values showed an increase. There was no physiological adjustment effect observed in an urban area; thus, these effects are specific to a forest environment.	[Song, Chorong; Ikei, Harumi; Miyazaki, Yoshifumi] Chiba Univ, Ctr Environm Hlth & Field Sci, Kashiwa, Chiba 2770882, Japan	Miyazaki, Y (reprint author), Chiba Univ, Ctr Environm Hlth & Field Sci, Kashiwa No Ha 6-2-1, Kashiwa, Chiba 2770882, Japan.	crsong1028@gmail.com; ikei0224@ffpri.affrc.go.jp; ymiyazaki@faculty.chiba-u.jp			Council for Science, Technology and Innovation (CSTI), Cross-ministerial Strategic Innovation Promotion Program (SIP), "Technologies for creating next-generation agriculture, forestry and fish	This work was supported by Council for Science, Technology and Innovation (CSTI), Cross-ministerial Strategic Innovation Promotion Program (SIP), "Technologies for creating next-generation agriculture, forestry and fisheries" (funding agency: Bio-oriented Technology Research Advancement Institution, NARO) We also appreciate Takahide Kagawa, Yuko Tsunetsugu, Bum-Jin Park, and Juyoung Lee for support on data collection phase of this study.	Lee J, 2011, PUBLIC HEALTH, V125, P93, DOI 10.1016/j.puhe.2010.09.005; Lederbogen F, 2011, NATURE, V474, P498, DOI 10.1038/nature10190; Park Bum-Jin, 2007, Journal of Physiological Anthropology, V26, P123, DOI 10.2114/jpa2.26.123; Tsunetsugu Yuko, 2010, Environmental Health and Preventive Medicine, V15, P27, DOI 10.1007/s12199-009-0091-z; Lee J, 2009, SCAND J FOREST RES, V24, P227, DOI 10.1080/02827580902903341; Tsunetsugu Y, 2013, LANDSCAPE URBAN PLAN, V113, P90, DOI 10.1016/j.landurbplan.2013.01.014; Gemes K, 2008, EUR J EPIDEMIOL, V23, P95, DOI 10.1007/s10654-007-9201-7; Dye C, 2008, SCIENCE, V319, P766, DOI 10.1126/science.1150198; HERBERT TB, 1993, PSYCHOSOM MED, V55, P364; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Li Q, 2008, J BIOL REG HOMEOS AG, V22, P45; Bloch J. D., 1962, ANN NY ACAD SCI, V98, P1229, DOI [10.1111/j.1749-6632.1962.tb30631.x, DOI 10.1111/J.1749-6632.1962.TB30631.X]; Brod C, 1984, TECHNOSTRESS HUMAN C; Frumkin Howard, 2001, American Journal of Preventive Medicine, V20, P234, DOI 10.1016/S0749-3797(00)00317-2; HORD DJ, 1964, PSYCHOPHYSIOLOGY, V1, P79, DOI 10.1111/j.1469-8986.1964.tb02624.x; Kaplan R., 1989, EXPERIENCE NATURE PS; Lacey J. I., 1956, ANN NY ACAD SCI, V67, P125, DOI [10.1111/j.1749-6632.1956.tb46040.x, DOI 10.1111/J.1749-6632.1956.TB46040.X]; Lee J., 2012, PUBLIC HLTH SOCIAL B; Leites S, 1936, LANCET, V1, P1348; Pronczuka J., 2008, N Y ACAD SCI, V1140, P143; ROGERS RL, 1985, J CEREBR BLOOD F MET, V5, P79; Saito O., 2011, DESIGNING OUR FUTURE, P407; SCHER H, 1985, PSYCHOPHYSIOLOGY, V22, P345, DOI 10.1111/j.1469-8986.1985.tb01612.x; Tsunetsugu Y., 2007, JPN J PHYSL ANTHR, V12, P134; ULRICH RS, 1991, J ENVIRON PSYCHOL, V11, P201, DOI 10.1016/S0272-4944(05)80184-7; Wilder J., 1967, STIMULUS RESPONSE LA	26	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1660-4601			INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	APR	2015	12	4					4247	4255		10.3390/ijerph120404247		9	Environmental Sciences	Environmental Sciences & Ecology	CG7MT	WOS:000353488500054		
J	Win-Shwe, TT; Ohtani, S; Ushiyama, A; Kunugita, N				Win-Shwe, Tin-Tin; Ohtani, Shin; Ushiyama, Akira; Kunugita, Naoki			Early Exposure to Intermediate-Frequency Magnetic Fields Alters Brain Biomarkers without Histopathological Changes in Adult Mice	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article							ELECTROMAGNETIC-FIELDS; 50 HZ; PEROMYSCUS-MANICULATUS; SEX-DIFFERENCES; DEER MICE; IN-VITRO; 20 KHZ; C-FOS; 1 MT; MEMORY	Recently we have reported that intermediate-frequency magnetic field (IF-MF) exposure transiently altered the mRNA expression levels of memory function-related genes in the hippocampi of adult male mice. However, the effects of IF-MF exposure during brain development on neurological biomarkers have not yet been clarified. In the present study, we investigated the effect of IF-MF exposure during development on neurological and immunological markers in the mouse hippocampus in 3- and 7-week-old male mice. Pregnant C57BL/6J mice were exposed to IF-MF (21 kHz, 3.8 mT) for one hour per day from organogenesis period day 7 to 17. At adolescence, some IF-MF-exposed mice were further divided into exposure, recovery, and sham-exposure groups. The adolescent-exposure groups were exposed again to IF-MF from postnatal day 27 to 48. The expression of mRNA in the hippocampi was examined using a real-time RT-PCR method, and microglia activation was examined by immunohistochemical analysis. The expression levels of NR1 and NR2B as well as transcription factors (CaMKIV, CREB1), inflammatory mediators (COX2, IL-1 beta,TNF-alpha), and the oxidative stress marker heme-oxygenase (HO)-1 were significantly increased in the IF-MF-exposed mice, compared with the control group, in the 7-week-old mice, but not in the 3-week-old mice. Microglia activation was not different between the control and other groups. This study provides the first evidence that early exposure to IF-MF reversibly affects the NMDA receptor, its related signaling pathways, and inflammatory mediators in the hippocampus of young adult mice; these changes are transient and recover after termination of exposure without histopathological changes.	[Win-Shwe, Tin-Tin] Natl Inst Environm Studies, Ctr Environm Hlth Sci, Tsukuba, Ibaraki 3058506, Japan; [Ohtani, Shin; Ushiyama, Akira; Kunugita, Naoki] Natl Inst Publ Hlth, Dept Environm Hlth, Wako, Saitama 3510197, Japan	Win-Shwe, TT (reprint author), Natl Inst Environm Studies, Ctr Environm Hlth Sci, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan.	tin.tin.win.shwe@nies.go.jp; ohtani@niph.go.jp; ushiyama@niph.go.jp; kunugita@niph.go.jp		Kunugita, Naoki/0000-0002-6516-8379	JSPS KAKENHI [25282015, 22300255]	We thank Keiji Wada, Yukihisa Suzuki and Chiyoji Ohkubo for giving their permission to use the novel in vivo exposure apparatus. This research was partly supported by a Grant-in-Aid for Scientific Research (B) from JSPS KAKENHI (25282015, 22300255) to Naoki Kunugita.	Ahmed Z, 2008, BRAIN RES, V1221, P30, DOI 10.1016/j.brainres.2008.05.007; Win-Shwe TT, 2008, NEUROTOXICOLOGY, V29, P940, DOI 10.1016/j.neuro.2008.09.007; Herbert MR, 2010, CURR OPIN NEUROL, V23, P103, DOI 10.1097/WCO.0b013e328336a01f; Hagberg H, 2012, ANN NEUROL, V71, P444, DOI 10.1002/ana.22620; Theoharides TC, 2011, J CLIN PSYCHOPHARM, V31, P685, DOI 10.1097/JCP.0b013e318239c190; Goines PE, 2013, NEUROTOXICOL TERATOL, V36, P67, DOI 10.1016/j.ntt.2012.07.006; Trimmel M, 1998, TOXICOL LETT, V96-7, P377, DOI 10.1016/S0378-4274(98)00096-4; BLACKMAN CF, 1985, BIOELECTROMAGNETICS, V6, P327, DOI 10.1002/bem.2250060402; BAWIN SM, 1978, P NATL ACAD SCI USA, V75, P6314, DOI 10.1073/pnas.75.12.6314; Floderus B, 2002, BIOELECTROMAGNETICS, V23, P568, DOI 10.1002/bem.10050; Piacentini R, 2008, J CELL PHYSIOL, V215, P129, DOI 10.1002/jcp.21293; Miyakoshi J, 2007, BIOELECTROMAGNETICS, V28, P529, DOI 10.1002/bem.20334; Che Y, 2007, BRAIN RES BULL, V74, P178, DOI 10.1016/j.brainresbull.2007.06-009; BANNERMAN DM, 1995, NATURE, V378, P182, DOI 10.1038/378182a0; Marchionni I, 2006, BBA-BIOMEMBRANES, V1758, P597, DOI 10.1016/j.bbamem.2006.03.014; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; VanElzakker M, 2008, LEARN MEMORY, V15, P899, DOI 10.1101/lm.1196508; Choleris E, 2000, PHYSIOL BEHAV, V71, P237, DOI 10.1016/S0031-9384(00)00323-1; Cui YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032196; Davanipour Zoreh, 2009, Pathophysiology, V16, P149, DOI 10.1016/j.pathophys.2009.01.005; Davanipour Z, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-13; Dawson BV, 1998, BIOELECTROMAGNETICS, V19, P162, DOI 10.1002/(SICI)1521-186X(1998)19:3<162::AID-BEM4>3.0.CO;2-#; Day HEW, 2008, BRAIN RES, V1229, P137, DOI 10.1016/j.brainres.2008.06.085; Decat G, 2006, INT J OCCUP SAF ERGO, V12, P169; DIMBERG Y, 1995, BIOELECTROMAGNETICS, V16, P263, DOI 10.1002/bem.2250160409; Hakansson N, 2003, AM J EPIDEMIOL, V158, P534, DOI 10.1093/aje/kwg197; He YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054376; Ziegelberger G, 2008, HEALTH PHYS, V94, P376; Ikehata M., 2010, P 32 ANN M BIOEL SOC, P429; KAVALIERS M, 1986, PEPTIDES, V7, P449, DOI 10.1016/0196-9781(86)90013-6; KAVALIERS M, 1987, PHYSIOL BEHAV, V40, P559, DOI 10.1016/0031-9384(87)90096-5; LOOMIS DP, 1990, BRIT J IND MED, V47, P633; Mulligan S, 1998, NEUROSCI LETT, V253, P29, DOI 10.1016/S0304-3940(98)00594-1; Nishimura I, 2011, BIRTH DEFECTS RES B, V92, P469, DOI 10.1002/bdrb.20316; Nishimura I, 2009, BIOELECTROMAGNETICS, V30, P573, DOI 10.1002/bem.20513; Nishimura I, 2012, REGUL TOXICOL PHARM, V64, P394, DOI 10.1016/j.yrtph.2012.10.005; Ohtani S., 2011, P 10 INT C EUR BIOEL; Ramundo-Orlando A, 2000, BIOELECTROMAGNETICS, V21, P499, DOI 10.1002/1521-186X(200010)21:7<499::AID-BEM3>3.0.CO;2-9; Sun HY, 2010, BIOELECTROMAGNETICS, V31, P150, DOI 10.1002/bem.20540; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Ushiyama A, 2014, INT J RADIAT BIOL, V90, P1211, DOI 10.3109/09553002.2014.930538; Wada K., 2010, P 32 ANN M BIOEL SOC, P455; Whissell PD, 2007, INT J DEV NEUROSCI, V25, P433, DOI 10.1016/j.ijdevneu.2007.09.001; Win-Shwe TT, 2013, J TOXICOL SCI, V38, P169; World Health Organization (WHO), 2007, ENV HLTH CRIT MON, V238	45	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1660-4601			INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	APR	2015	12	4					4406	4421		10.3390/ijerph120404406		16	Environmental Sciences	Environmental Sciences & Ecology	CG7MT	WOS:000353488500064		
J	Tomono, H				Tomono, H.			Development of steel continuous casting in Japan: Has Bessemer's dream come true?	IRONMAKING & STEELMAKING			English	Editorial Material									Nippon Steel & Sumitomo Met Corp, Tokyo, Japan	Tomono, H (reprint author), Nippon Steel & Sumitomo Met Corp, Tokyo, Japan.	tomono.74p.hiroshi@jp.nssmc.com					[Anonymous], 1972, J. Met., V24, P31, Patent No. 221; [Anonymous], 1857, J MET, Patent No. 221; Boylston H. M., 1936, INTRO METALLURGY IRO, P218; Brotzmann K., 1968, TECHNIK FORSCHUNG, V41, P718; Kato T., 2006, MATERIA JAPAN, V45, P45; Kawamoto M., 1998, TECH REP SUMITOMO ME, V50, P71; Kawawa T., 1974, TETSU TO HAGANE, V60, P486; Ohtsuka M., 2003, P 4 EUR OX STEELM C; Schwerdtfeger K, 2000, ISIJ INT, V40, P756, DOI 10.2355/isijinternational.40.756; Shimokawa Y., 1947, TECH REP FUSO MET SU, V1, P1; Starratt E. W., 1960, J MET, V12, P528; Sugitani Y., 1981, TETSU TO HAGANE, V67, P1508; Suzuki H.G., 1979, TETSU TO HAGANE, V65, P2038; Takeuchi T., 2002, CAMP ISIJ, V15, P209; Tani M., 2001, CAMP ISIJ, V14, P163; Tani M., 2012, TECH REP NIPPON STEE, V394, P62; Tomono H., THESIS ECOLE POLYTEC, P35; UEDA T, 1983, TETSU TO HAGANE, V69, P24; Yamanaka A, 1996, TETSU TO HAGANE, V82, P999	19	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0301-9233	1743-2812		IRONMAK STEELMAK	Ironmak. Steelmak.	APR	2015	42	4					242	251		10.1179/0301923315Z.000000000356		10	Metallurgy & Metallurgical Engineering	Metallurgy & Metallurgical Engineering	CH0KO	WOS:000353708600002		
J	Fujii, K; Hao, H; Shibuya, M; Imanaka, T; Fukunaga, M; Mild, K; Tamaru, H; Sawada, H; Naito, Y; Ohyanagi, M; Hirota, S; Masuyama, T				Fujii, Kenichi; Hao, Hiroyuki; Shibuya, Masahiko; Imanaka, Takahiro; Fukunaga, Masashi; Mild, Kojiro; Tamaru, Hiroto; Sawada, Hisashi; Naito, Yoshiro; Ohyanagi, Mitsumasa; Hirota, Seiichi; Masuyama, Tohru			Accuracy of OCT, Grayscale IVUS, and Their Combination for the Diagnosis of Coronary TCFA An Ex Vivo Validation Study	JACC-CARDIOVASCULAR IMAGING			English	Article						intravascular ultrasound; optical coherence tomography; vulnerable plaque	OPTICAL COHERENCE TOMOGRAPHY; ACUTE MYOCARDIAL-INFARCTION; THIN-CAP FIBROATHEROMA; NO-REFLOW PHENOMENON; INTRAVASCULAR ULTRASOUND; ATHEROSCLEROTIC PLAQUE; ARTERIES; INSIGHTS; RUPTURE; ACQUISITION	OBJECTIVES This study sought to assess the accuracy of optical coherence tomography (OCT), gray-scale intravascular ultrasound (IVUS), and their combination for detecting thin-cap fibroatheromas (TCFA). BACKGROUND The extent to which the imaging characteristics of OCT and IVUS correlate with histologically defined TCFA is unknown. METHODS IVUS and OCT examinations identified focal plaques in 165 coronary arteries from 60 autopsy hearts. A total of 685 pairs of images of OCT and IVUS were compared with histology. By OCT, a TCFA was defined as a signal-poor region with diffuse borders and cap thickness <65 mu m. By IVUS, a TCFA was defined by the presence of echolucent zones and/or ultrasound attenuation in areas of positive remodeling. By histology, 12 of 685 focal plaques were classified as TCFAs. RESULTS With histology as the gold standard, the sensitivity, specificity, positive predictive value, negative predictive value, and overall diagnostic accuracy for OCT-derived TCFA were 100%, 97%, 41%, 100%, and 98%, respectively. The corresponding numbers for IVUS-derived TCFA were 92%, 93%, 19%, 99%, and 93%, respectively. The histological findings underlying the false positive diagnoses of OCT for TCFA included large amounts of foam cell accumulation on the Luminal surface, Large amounts of microcalcifications at the surface, Large amounts of hemosiderin accumulation, or organized thrombus. In contrast, histological causes of mischaracterization of TCFA by IVUS were mostly TCFA. When both OCT and IVUS criteria for TCFA were required to be met, the sensitivity, specificity, positive predictive value, negative predictive value, and overall diagnostic accuracy were 92%, 99%, 69%, 99%, and 99%, respectively. CONCLUSIONS In the present study, neither OCT nor IVUS were optimal to detect TCFA. The combined use of OCT and IVUS may improve TCFA detection accuracy. (C) 2015 by the American College of Cardiology Foundation.	[Fujii, Kenichi; Shibuya, Masahiko; Imanaka, Takahiro; Fukunaga, Masashi; Mild, Kojiro; Tamaru, Hiroto; Sawada, Hisashi; Naito, Yoshiro; Masuyama, Tohru] Hyogo Coll Med, Cardiovasc Div, Nishinomiya, Hyogo 6638501, Japan; [Hao, Hiroyuki; Hirota, Seiichi] Hyogo Coll Med, Dept Surg Pathol, Nishinomiya, Hyogo 6638501, Japan; [Ohyanagi, Mitsumasa] Hyogo Coll Med, Div Coronary Heart Dis, Nishinomiya, Hyogo 6638501, Japan	Fujii, K (reprint author), Hyogo Coll Med, Cardiovasc Div, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	kfujii@hyo-med.ac.jp					Cilingiroglu M, 2006, CATHETER CARDIO INTE, V67, P915, DOI 10.1002/ccd.20717; Nakano M, 2012, JACC-CARDIOVASC IMAG, V5, P71, DOI 10.1016/j.jcmg.2011.09.015; Yamagishi M, 2000, J AM COLL CARDIOL, V35, P106, DOI 10.1016/S0735-1097(99)00533-1; Gronholdt MLM, 1999, ARTERIOSCL THROM VAS, V19, P2; Nakamura M, 2001, J AM COLL CARDIOL, V37, P63, DOI 10.1016/S0735-1097(00)01097-4; Tearney GJ, 2012, J AM COLL CARDIOL, V59, P1058, DOI 10.1016/j.jacc.2011.09.079; Fujii K, 2010, JACC-CARDIOVASC IMAG, V3, P168, DOI 10.1016/j.jcmg.2009.11.004; Cheruvu PK, 2007, J AM COLL CARDIOL, V50, P940, DOI 10.1016/j.jacc.2007.04.086; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Kotani J, 2003, CIRCULATION, V107, P2889, DOI 10.1161/01.CIR.0000072768.80031.74; Li BH, 2013, CATHETER CARDIO INTE, V81, P494, DOI 10.1002/ccd.24295; Goldstein JA, 2000, NEW ENGL J MED, V343, P915, DOI 10.1056/NEJM200009283431303; Allen TJ, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.6.061209; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Jang IK, 2005, CIRCULATION, V111, P1551, DOI 10.1161/01.CIR.0000159354.43778.69; van Soest G, 2011, JACC-CARDIOVASC IMAG, V4, P810, DOI 10.1016/j.jcmg.2011.01.022; Nissen SE, 2001, CIRCULATION, V103, P604; Yabushita H, 2002, CIRCULATION, V106, P1640, DOI 10.1161/01.CIR.0000029927.92825.F6; Brezinski ME, 1996, CIRCULATION, V93, P1206; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262; Pu J, 2014, J AM COLL CARDIOL, V63, P2220, DOI 10.1016/j.jacc.2014.02.576; Tanaka A, 2002, CIRCULATION, V105, P2148, DOI 10.1161/01.CIR.0000015697.59592.07; Kato K, 2012, CIRC-CARDIOVASC IMAG, V5, P433, DOI 10.1161/CIRCIMAGING.112.973701; Endo M, 2010, JACC-CARDIOVASC INTE, V3, P540, DOI 10.1016/j.jcin.2010.01.015; FUSTER V, 1990, CIRCULATION, V82, P47; Smits PC, 1999, CARDIOVASC RES, V41, P458, DOI 10.1016/S0008-6363(98)00320-4; Yamada Ryotaro, 2007, J Cardiol, V50, P223	27	5	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1936-878X	1876-7591		JACC-CARDIOVASC IMAG	JACC-Cardiovasc. Imag.	APR	2015	8	4					451	460		10.1016/j.jcmg.2014.10.015		10	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	CG6TI	WOS:000353434900011		
J	Negishi, K; Negishi, T; Kurosawa, K; Hristova, K; Popescu, BA; Vinereanu, D; Yuda, S; Marwick, TH				Negishi, Kazuald; Negishi, Tomoko; Kurosawa, Koji; Hristova, Krasimira; Popescu, Bogdan A.; Vinereanu, Dragos; Yuda, Satoshi; Marwick, Thomas H.			Practical Guidance in Echocardiographic Assessment of Global Longitudinal Strain	JACC-CARDIOVASCULAR IMAGING			English	Editorial Material									[Negishi, Kazuald; Negishi, Tomoko; Marwick, Thomas H.] Menzies Res Inst Tasmania, Hobart, Tas 7000, Australia; [Kurosawa, Koji] Gunma Univ, Gunma, Japan; [Hristova, Krasimira] Natl Heart Hosp, Sofia, Bulgaria; [Popescu, Bogdan A.; Vinereanu, Dragos] Univ Med & Pharm Carol Davila, Bucharest, Romania; [Yuda, Satoshi] Sapporo Med Univ, Sapporo, Hokkaido, Japan	Marwick, TH (reprint author), Menzies Res Inst Tasmania, 17 Liverpool St, Hobart, Tas 7000, Australia.	tom.marwick@utas.edu.au	Negishi, Kazuaki/J-7242-2014	Negishi, Kazuaki/0000-0002-9086-2565			Yingchoncharoen T, 2013, J AM SOC ECHOCARDIOG, V26, P185, DOI 10.1016/j.echo.2012.10.008; Bansal M, 2008, J AM SOC ECHOCARDIOG, V21, P1318, DOI 10.1016/j.echo.2008.09.021	2	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1936-878X	1876-7591		JACC-CARDIOVASC IMAG	JACC-Cardiovasc. Imag.	APR	2015	8	4					489	492		10.1016/j.jcmg.2014.06.013		4	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	CG6TI	WOS:000353434900014		
J	Saka, K; Hibi, K; Kozuma, K; Maejima, N; Okada, K; Matsuzawa, Y; Endo, M; Iwahashi, N; Tsukahara, K; Kosuge, M; Ebina, T; Umemura, S; Kimura, K				Saka, Kenichiro; Hibi, Kiyoshi; Kozuma, Ken; Maejima, Nobuhiko; Okada, Kozo; Matsuzawa, Yasushi; Endo, Mitsuaki; Iwahashi, Noriaki; Tsukahara, Kengo; Kosuge, Masami; Ebina, Toshiaki; Umemura, Satoshi; Kimura, Kazuo			Relation Between the SYNTAX Score and Culprit Vessel Vulnerability in Non-ST-Segment Elevation Acute Coronary Syndrome	JACC-CARDIOVASCULAR IMAGING			English	Letter							INTERVENTION; SURGERY; DISEASE; TRIAL		[Saka, Kenichiro; Hibi, Kiyoshi; Kozuma, Ken; Maejima, Nobuhiko; Okada, Kozo; Matsuzawa, Yasushi; Endo, Mitsuaki; Iwahashi, Noriaki; Tsukahara, Kengo; Kosuge, Masami; Ebina, Toshiaki; Umemura, Satoshi; Kimura, Kazuo] Yokohama City Univ, Med Ctr, Div Cardiol, Minami Ku, Yokohama, Kanagawa 2320024, Japan	Saka, K (reprint author), Yokohama City Univ, Med Ctr, Div Cardiol, Minami Ku, 4-57 Urafune Cho, Yokohama, Kanagawa 2320024, Japan.	hibikiyo@yokohama-cu.ac.jp					Mohr FW, 2013, LANCET, V381, P629, DOI 10.1016/S0140-6736(13)60141-5; Wykrzykowska JJ, 2010, J AM COLL CARDIOL, V56, P272, DOI 10.1016/j.jacc.2010.03.044; Glaser R, 2005, CIRCULATION, V111, P143, DOI 10.1161/01.CIR.0000150335.01285.12; Genereux P, 2012, J AM COLL CARDIOL, V59, P2165, DOI 10.1016/j.jacc.2012.03.010	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1936-878X	1876-7591		JACC-CARDIOVASC IMAG	JACC-Cardiovasc. Imag.	APR	2015	8	4					496	498		10.1016/j.jcmg.2014.07.022		3	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	CG6TI	WOS:000353434900017		
J	Miyata, A				Miyata, Akira			Neutralization method for detecting the incidence of color perception changes after cataract surgery	JOURNAL OF CATARACT AND REFRACTIVE SURGERY			English	Article							FILTERING INTRAOCULAR LENSES; CONTRAST SENSITIVITY; VISUAL FUNCTION; YELLOW; VISION; CLEAR; ULTRAVIOLET; DISCRIMINATION; TRANSMITTANCE; IMPLANTATION	PURPOSE: To evaluate and compare the incidence of cyanopsia using the neutralization method in eyes in which clear or yellow intraocular lenses (IOLs) were implanted. SETTING: Miyata Eye Clinic, Hiroshima, Japan. DESIGN: Retrospective comparative study. METHODS: Patients who had cataract surgery with the implantation of a monofocal IOL were enrolled in the study. Group 1 had implantation of a clear IOL (Acrysof SA6OAT, Sensar AR40e, N4-18B). Group 2 had implantation of a yellow IOL (AF-1 YA60BB, AN-6). A control group comprised healthy patients. The detection and degree of cyanopsia were evaluated using white gradation cards (1 white [W] and 5 white gradation cards with increasing intensity of yellow tint [Y1, Y2, Y3, Y4, and Y5]) (neutralization method). RESULTS: The study comprised 57 patients in Group 1, 96 in Group 2, and 41 in the control group. All patients in the control group selected the W, Y1, or Y2 cards as white. Cyanopsia was then defined as the perception of Y3, Y4, and Y5 as white. One month postoperatively, cyanopsia occurred significantly more frequently in Group 1 than in Group 2 (14.5% versus 4.9%) (P = .049). There was no significant difference at 3 months (9.1% versus 5.2%) (P > .05). In Group 1, cyanopsia was more frequent in eyes with monocular IOL implantation than in eyes with binocular IOL implantation (22.2% versus 2.7%; P = .035). CONCLUSION: The incidence of cyanopsia evaluated with the neutralization method was higher with clear IOLs than with yellow IOLs. In monocular implantation, yellow IOLs are recommended to avoid cyanopsia. (C) 2015 ASCRS and ESCRS	[Miyata, Akira] Miyata Eye Clin, Hiroshima 7330844, Japan	Miyata, A (reprint author), Miyata Eye Clin, Nishi Ku, 2-23-32 Inokuchidai, Hiroshima 7330844, Japan.	eyedoctor2014@gmail.com					Brockmann C, 2008, J CATARACT REFR SURG, V34, P1161, DOI 10.1016/j.jcrs.2008.03.039; Hayashi K, 2006, BRIT J OPHTHALMOL, V90, P1019, DOI 10.1136/bjo.2006.090712; Mester U, 2008, J CATARACT REFR SURG, V34, P608, DOI 10.1016/j.jcrs.2007.11.049; Kitakawa T, 2009, J OPT SOC AM A, V26, P1375, DOI 10.1364/JOSAA.26.001375; Ao MX, 2010, J CATARACT REFR SURG, V36, P389, DOI 10.1016/j.jcrs.2009.09.038; Cionni RJ, 2006, J CATARACT REFR SURG, V32, P236, DOI 10.1016/j.jcr5.2005.12.129; Ernest PH, 2004, J CATARACT REFR SURG, V30, P1755, DOI 10.1016/j.jcrs.2003.12.054; Greenstein VC, 2007, J CATARACT REFR SURG, V33, P667, DOI 10.1016/j.jcrs.2006.12.012; Ichikawa K, 1993, GANKA, V35, P575; JORDAN DR, 1986, CAN J OPHTHALMOL, V21, P140; Kara N, 2011, J CATARACT REFR SURG, V37, P2115, DOI 10.1016/j.jcrs.2011.06.024; Khokhar SK, 2011, J CATARACT REFR SURG, V37, P1598, DOI 10.1016/j.jcrs.2011.03.044; Leibovitch I, 2006, ACTA OPHTHALMOL SCAN, V84, P95, DOI 10.1111/j.1600-0420.2005.00607.x; Mainster MA, 2006, BRIT J OPHTHALMOL, V90, P784, DOI 10.1136/bjo.2005.086553; Muftuoglu O, 2007, J CATARACT REFR SURG, V33, P658, DOI 10.1016/j.jcrs.2006.12.018; Mukai K, 2009, JPN J OPHTHALMOL, V53, P47, DOI 10.1007/s10384-008-0620-0; Munoz G, 2012, EUR J OPHTHALMOL, V22, P769, DOI 10.5301/ejo.5000112; Neumaier-Ammerer B, 2010, J CATARACT REFR SURG, V36, P2073, DOI 10.1016/j.jcrs.2010.06.069; Olson MD, 2006, AM J OPHTHALMOL, V141, P957, DOI 10.1016/j.ajo.2005.11.051; Pierre A, 2007, J CATARACT REFR SURG, V33, P1248, DOI 10.1016/j.jcrs.2007.03.024; Rodriguez-Galietero A, 2005, J CATARACT REFR SURG, V31, P1736, DOI 10.1016/j.jcrs.2005.02.039; Schmidinger G, 2008, J CATARACT REFR SURG, V34, P769, DOI 10.1016/j.jcrs.2007.12.034; Shah SA, 2005, AM J OPHTHALMOL, V140, P941, DOI 10.1016/j.ajo.2005.05.043; Vuori ML, 2006, ACTA OPHTHALMOL SCAN, V84, P92, DOI 10.1111/j.1600-0420.2005.00579.x; Wang HW, 2010, J CATARACT REFR SURG, V36, P2080, DOI 10.1016/j.jcrs.2010.07.024; Wirtitsch MG, 2009, OPHTHALMOLOGY, V116, P39, DOI 10.1016/j.ophtha.2008.08.035; Yuan ZX, 2004, AM J OPHTHALMOL, V138, P138, DOI 10.1016/j.ajo.2004.02.024; ZEIMER RC, 1984, OPHTHALMIC RES, V16, P246	28	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0886-3350	1873-4502		J CATARACT REFR SURG	J. Cataract. Refract. Surg.	APR	2015	41	4					764	770		10.1016/j.jcrs.2014.07.040		7	Ophthalmology; Surgery	Ophthalmology; Surgery	CG6QS	WOS:000353427800012		
J	Ruiz-Barragan, S; Morokuma, K; Blancafort, L				Ruiz-Barragan, Sergi; Morokuma, Keiji; Blancafort, Lluis			Conical Intersection Optimization Using Composed Steps Inside the ONIOM(QM:MM) Scheme: CASSCF:UFF Implementation with Microiterations	JOURNAL OF CHEMICAL THEORY AND COMPUTATION			English	Article							POTENTIAL-ENERGY SURFACES; AGGREGATION-INDUCED EMISSION; MC-SCF; MOLECULAR-MECHANICS; AB-INITIO; GEOMETRY OPTIMIZATIONS; WOLFF REARRANGEMENT; MMVB DYNAMICS; EXTENDED SEAM; ONIOM METHOD	Three algorithms for optimization of minimum energy conical intersections (MECI) are implemented inside an ONIOM(QM:MM) scheme combined with microiterations. The algorithms follow the composed gradient (CG), composed gradient-composed steps (CG-CS), and double Newton-Raphson-composed step (DNR-CS) schemes developed previously for purely QM optimizations. The CASSCF and UFF methods are employed for the QM and MM calculations, respectively. Conical intersections are essential to describe excited state processes in chemistry, including biological systems or functional molecules, and our approach is suitable for large molecules or systems where the excitation is well localized on a fragment that can be treated at the CASSCF level. The algorithms are tested on a set of 14 large hydrocarbons composed of a medium-sized chromophore (fulvene, benzene, butadiene, and hexatriene) derivatized with alkyl substituents. Thanks to the microiteration technique, the number of steps required to optimize the MECI of the large molecules is similar to the one needed to optimize the unsubstituted chromophores at the QM level. The three tested algorithms have a similar performance, although the CG-CS implementation is the most efficient one on average. The implementation can be straightforwardly applied to ONIOM(QM:QM) schemes, and its potential is further demonstrated locating the MECI of diphenyl dibenzofulvene (DPDBF) in its crystal, which is relevant for the aggregation induced emission (AIE) of this molecule. A cluster of 12 molecules (528 atoms) is relaxed during the MECI optimization, with one molecule treated at the QM level. Our results confirm the mechanistic picture that AIE in DPDBF is due to the packing of the molecules in the crystal. Even when the molecules surrounding the excited molecule are allowed to relax, the rotation of the bulky substituents is hindered, and the conical intersection responsible for radiationless decay in solution is not accessible energetically.	[Ruiz-Barragan, Sergi; Blancafort, Lluis] Univ Girona, Inst Quim Computac & Catalisis, Girona 17071, Spain; [Ruiz-Barragan, Sergi; Blancafort, Lluis] Univ Girona, Dept Quim, Girona 17071, Spain; [Morokuma, Keiji] Kyoto Univ, Fukui Inst Fundamental Chem, Kyoto 6068103, Japan	Blancafort, L (reprint author), Univ Girona, Inst Quim Computac & Catalisis, Campus Montilivi, Girona 17071, Spain.	lluis.blancafort@udg.edu	Blancafort, Lluis/B-5679-2009	Blancafort, Lluis/0000-0002-0003-5540	Spanish Ministerio de Economia y Competividad (MINECO) [CTQ2011-26573]; Catalan Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) [2014SGR1202]; Spanish Ministerio de Ciencia e Innovacion (MICINN) [UNGI10-4E-801]; European Fund for Regional Development; Xarxa de Referencia en Quimica Teorica i Computacional de Catalunya from AGAUR; MINECO [BES-2009-029177, EEBB-I-12-04604]	This work has been supported by grant CTQ2011-26573 from the Spanish Ministerio de Economia y Competividad (MINECO), 2014SGR1202 from the Catalan Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR), UNGI10-4E-801 from the Spanish Ministerio de Ciencia e Innovacion (MICINN) and the European Fund for Regional Development, and the Xarxa de Referencia en Quimica Teorica i Computacional de Catalunya from AGAUR. S.R.-B. thanks the MINECO for grant BES-2009-029177 and a travel grant EEBB-I-12-04604.	Anglada JM, 1997, J COMPUT CHEM, V18, P992, DOI 10.1002/(SICI)1096-987X(199706)18:8<992::AID-JCC3>3.0.CO;2-L; Vreven T, 2000, J COMPUT CHEM, V21, P1419, DOI 10.1002/1096-987X(200012)21:16<1419::AID-JCC1>3.3.CO;2-3; Maeda S, 2010, J CHEM THEORY COMPUT, V6, P1538, DOI 10.1021/ct1000268; Chung LW, 2012, WIRES COMPUT MOL SCI, V2, P327, DOI 10.1002/wcms.85; Sicilia F, 2007, J PHYS CHEM A, V111, P2182, DOI 10.1021/jp067614w; Sicilia F, 2008, J CHEM THEORY COMPUT, V4, P257, DOI 10.1021/ct7002435; Horke DA, 2013, NAT CHEM, V5, P711, DOI [10.1038/nchem.1705, 10.1038/NCHEM.1705]; Cui GL, 2013, ANGEW CHEM INT EDIT, V52, P433, DOI 10.1002/anie.201207628; Yamamoto N, 1996, CHEM PHYS LETT, V250, P373, DOI 10.1016/0009-2614(96)00027-9; BERNARDI F, 1992, J AM CHEM SOC, V114, P8211, DOI 10.1021/ja00047a035; PALMER IJ, 1993, J AM CHEM SOC, V115, P673, DOI 10.1021/ja00055a042; OLIVUCCI M, 1993, J AM CHEM SOC, V115, P3710, DOI 10.1021/ja00062a042; Levine BG, 2008, J PHYS CHEM B, V112, P405, DOI 10.1021/jp0761618; Li QS, 2010, CHEM PHYS, V377, P60, DOI 10.1016/j.chemphys.2010.08.016; Li QS, 2013, CHEM COMMUN, V49, P5966, DOI 10.1039/c3cc41730a; Li QS, 2015, J CHEM THEORY COMPUT, V11, P1674, DOI 10.1021/ct5010388; Blancafort L, 2014, CHEMPHYSCHEM, V15, P3166, DOI 10.1002/cphc.201402359; [Anonymous], 1999, J MOL STRUC-THEOCHEM, DOI DOI 10.1016/S01666-1280(98)00475-8; Marian CM, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1861452; Vreven T, 2000, J CHEM PHYS, V113, P2969, DOI 10.1063/1.1287059; BEARPARK MJ, 1994, CHEM PHYS LETT, V223, P269, DOI 10.1016/0009-2614(94)00433-1; Vreven T, 2003, J COMPUT CHEM, V24, P760, DOI 10.1002/jcc.10156; Boggio-Pasqua M, 2003, J PHYS CHEM A, V107, P11139, DOI 10.1021/jp036862e; Bearpark MJ, 1996, J AM CHEM SOC, V118, P5254, DOI 10.1021/ja9542799; Blancafort L, 2006, J AM CHEM SOC, V128, P210, DOI 10.1021/ja054998f; Conti I, 2008, J AM CHEM SOC, V130, P5216, DOI 10.1021/ja710275e; Perun S, 2005, J AM CHEM SOC, V127, P6257, DOI 10.1021/ja044321c; Yarkony DR, 1996, REV MOD PHYS, V68, P985, DOI 10.1103/RevModPhys.68.985; Martinez TJ, 2006, ACCOUNTS CHEM RES, V39, P119, DOI 10.1021/ar040202q; Bernardi F, 1996, CHEM SOC REV, V25, P321, DOI 10.1039/cs9962500321; Barbatti M, 2010, P NATL ACAD SCI USA, V107, P21453, DOI 10.1073/pnas.1014982107; Tong H, 2007, J PHYS CHEM C, V111, P2287, DOI 10.1021/jp0630828; MANAA MR, 1993, J CHEM PHYS, V99, P5251, DOI 10.1063/1.465993; Martin ME, 2004, J AM CHEM SOC, V126, P5452, DOI 10.1021/ja037278m; ATCHITY GJ, 1991, J CHEM PHYS, V95, P1862, DOI 10.1063/1.461036; Bearpark MJ, 2008, J PHYS CHEM A, V112, P7286, DOI 10.1021/jp802204w; Blancafort L, 2005, MOL SUPRAM PHOTOCHEM, V13, P31; Blancafort L, 2009, SPRINGER SER CHEM PH, V97, P169; BOCK H, 1992, HELV CHIM ACTA, V75, P1816, DOI 10.1002/hlca.19920750607; Cui G., 2011, J CHEM PHYS, V134; De Vico L, 2005, J CHEM THEORY COMPUT, V1, P1029, DOI 10.1021/ct0500949; Domcke W., 2011, CONICAL INTERSECTION; Domcke W., 2004, CONICAL INTERSECTION; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Humbel S., 1996, J CHEM PHYS, P105; Klessinger M., 1995, EXCITED STATES PHOTO; Li QS, 2012, J PHYS CHEM LETT, V3, P1056, DOI 10.1021/jz300235z; Losa AM, 2007, CHEM PHYS LETT, V443, P76, DOI 10.1016/j.cplett.2007.06.037; MASERAS F, 1995, J COMPUT CHEM, V16, P1170, DOI 10.1002/jcc.540160911; Merchan M, 2006, J PHYS CHEM B, V110, P26471, DOI 10.1021/jp066874a; Minezawa N, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4899049; Mori T., 2010, J CHEM PHYS, V133; RAPPE AK, 1992, J AM CHEM SOC, V114, P10024, DOI 10.1021/ja00051a040; Ruiz-Barragan S, 2013, J CHEM THEORY COMPUT, V9, P1433, DOI 10.1021/ct301059t; SCHLEGEL HB, 1998, ENCY COMPUTATIONAL C, V2, P1136; Svensson M, 1996, J PHYS CHEM-US, V100, P19357, DOI 10.1021/jp962071j; Svensson M, 1996, J CHEM PHYS, V105, P3654, DOI 10.1063/1.472235; Teller E, 1937, J PHYS CHEM-US, V41, P109, DOI 10.1021/j150379a010; Toniolo A, 2002, J PHYS CHEM A, V106, P4679, DOI 10.1021/jp014289y	59	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1549-9618	1549-9626		J CHEM THEORY COMPUT	J. Chem. Theory Comput.	APR	2015	11	4					1585	1594		10.1021/acs.jctc.5b00004		10	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CG3JM	WOS:000353176500025		
J	Noguchi, Y; Hiyama, M; Akiyama, H; Harada, Y; Koga, N				Noguchi, Yoshifumi; Hiyama, Miyabi; Akiyama, Hidefumi; Harada, Yoshihisa; Koga, Nobuaki			First-Principles Investigation of Strong Excitonic Effects in Oxygen is X-ray Absorption Spectra	JOURNAL OF CHEMICAL THEORY AND COMPUTATION			English	Article							STATIC EXCHANGE; MOLECULES; SEMICONDUCTORS; THRESHOLDS; ENERGIES; EQUATION; XAS	We calculated the oxygen 1s X-ray absorption spectra (XAS) of acetone and acetic acid molecules in vacuum by utilizing the first-principles GW+Bethe-Salpeter method with an all-electron mixed basis. The calculated excitation energies show good agreement with the available experimental data without an artificial shift. The remaining error, which is less than 1% or 2-5 eV, is a significant improvement from those of time-dependent (TD) density functional methods (5% error or 27-29 eV for TD-LDA and 2.4-2.8% error or 13-15 eV for TD-B3LYP). Our method reproduces the first and second isolated peaks and broad peaks at higher photon energies, corresponding to Rydberg excitations. We observed a failure of the one-particle picture (or independent particle approximation) from our assignment of the five lowest exciton peaks and significant excitonic or state-hybridization effects inherent in the core electron excitations.	[Noguchi, Yoshifumi; Hiyama, Miyabi; Akiyama, Hidefumi; Harada, Yoshihisa] Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan; [Koga, Nobuaki] Nagoya Univ, Grad Sch Informat Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Noguchi, Y (reprint author), Univ Tokyo, Inst Solid State Phys, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778581, Japan.	y.noguchi@issp.u-tokyo.ac.jp			Japan Society for the Promotion of Science (JSPS) [23740288, 26400383]; KAKENHI from JSPS [23360135, 26610081]; Photon Frontier Network Program of MEXT; JST-CREST; JST-SENTSN in Japan	Y.N. was supported by a Grant-in-Aid for Young Scientist (B) (23740288) and a Grant-in-Aid for Scientific Research (C) (26400383) from the Japan Society for the Promotion of Science (JSPS). This work was partially supported by KAKENHI (23360135 and 26610081) from JSPS, the Photon Frontier Network Program of MEXT, JST-CREST, and JST-SENTSN in Japan.	Prince KC, 2003, J PHYS CHEM A, V107, P1955, DOI 10.1021/jp0219045; Coriani S, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.022507; Vinson J, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.115106; Besley NA, 2010, PHYS CHEM CHEM PHYS, V12, P12024, DOI 10.1039/c002207a; Tabayashi K, 2013, CHEM PHYS LETT, V557, P1, DOI 10.1016/j.cplett.2012.10.043; Song JW, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3010372; Vinson J, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.045101; Vinson J, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.195135; HYBERTSEN MS, 1986, PHYS REV B, V34, P5390, DOI 10.1103/PhysRevB.34.5390; de Groot F, 2001, CHEM REV, V101, P1779, DOI 10.1021/cr9900681; Rozzi CA, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.205119; Rohlfing M, 2000, PHYS REV B, V62, P4927, DOI 10.1103/PhysRevB.62.4927; Blase X, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.115103; Triguero L, 1998, PHYS REV B, V58, P8097, DOI 10.1103/PhysRevB.58.8097; SHAM LJ, 1966, PHYS REV, V144, P708, DOI 10.1103/PhysRev.144.708; Shirley EL, 2004, J ELECTRON SPECTROSC, V136, P77, DOI 10.1016/j.elspec.2004.02.134; Kolczewski C, 2001, J CHEM PHYS, V115, P6426, DOI 10.1063/1.1397797; STRINATI G, 1984, PHYS REV B, V29, P5718, DOI 10.1103/PhysRevB.29.5718; Shirley EL, 1998, PHYS REV LETT, V80, P794, DOI 10.1103/PhysRevLett.80.794; Takahashi O, 2004, J CHEM PHYS, V121, P10339, DOI 10.1063/1.1809610; Rehr JJ, 2006, RADIAT PHYS CHEM, V75, P1547, DOI 10.1016/j.radphyschem.2005.11.014; AGREN H, 1994, CHEM PHYS LETT, V222, P75, DOI 10.1016/0009-2614(94)00318-1; Castro A, 2003, CAN J PHYS, V81, P1151, DOI 10.1139/P03-078; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Hedin L., 1965, PHYS REV A, V139, pA796; Herman F., 1963, ATOMIC STRUCTURE CAL; Leetmaa M, 2010, J ELECTRON SPECTROSC, V177, P135, DOI 10.1016/j.elspec.2010.02.004; Mangione G, 2014, PHYS CHEM CHEM PHYS, V16, P19852, DOI 10.1039/c4cp02441a; Noguchi Y, 2013, J PHYS CHEM C, V117, P15362, DOI 10.1021/jp4041259; Noguchi Y., 2015, J CHEM PHYS, P142; Noguchi Y, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.045201; Noguchi Y, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.165411; Noguchi Y, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4732123; Noguchi Y., 2014, J CHEM PHYS, V141; Ohno K, 2006, CHEMPHYSCHEM, V7, P1820, DOI 10.1002/cphc.200600144; Ono S, 2015, COMPUT PHYS COMMUN, V189, P20, DOI 10.1016/j.cpc.2014.11.012; Pachucki K, 2004, CHEM PHYS LETT, V389, P209, DOI 10.1016/j.cplett.2004.03.069; ROBIN MB, 1988, J ELECTRON SPECTROSC, V47, P53, DOI 10.1016/0368-2048(88)85005-9; Rohlfing M, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.087402; Shirley EL, 2005, J ELECTRON SPECTROSC, V144, P1187, DOI 10.1016/j.elspec.2005.01.191; Stohr J, 1992, SPRINGER SER SURF, V25, P292; Sun YP, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.132202; Tabayashi K, 2011, J ELECTRON SPECTROSC, V184, P134, DOI 10.1016/j.elspec.2010.12.019; Tamenori Y, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3257962; Yang L, 1996, PHYS SCRIPTA, V54, P614, DOI 10.1088/0031-8949/54/6/011	45	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1549-9618	1549-9626		J CHEM THEORY COMPUT	J. Chem. Theory Comput.	APR	2015	11	4					1668	1673		10.1021/acs.jctc.5b00082		6	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CG3JM	WOS:000353176500033		
J	De Sancho, D; Kubas, A; Wang, PH; Blumberger, J; Best, RB				De Sancho, David; Kubas, Adam; Wang, Po-Hung; Blumberger, Jochen; Best, Robert B.			Identification of Mutational Hot Spots for Substrate Diffusion: Application to Myoglobin	JOURNAL OF CHEMICAL THEORY AND COMPUTATION			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; SPERM-WHALE MYOGLOBIN; LIGAND MIGRATION; CARBON-MONOXIDE; STRUCTURAL DYNAMICS; FOLDING KINETICS; CO DIFFUSION; PATHWAYS; BINDING; PROTEIN	The pathways by which small molecules (substrates or inhibitors) access active sites are a key aspect of the function of enzymes and other proteins. A key problem in designing or altering such proteins is to identify sites for mutation that will have the desired effect on the substrate transport properties. While specific access channels have been invoked in the past, molecular simulations suggest that multiple routes are possible, complicating the analysis. This complexity, however, can be captured by a Markov State Model (MSM) of the ligand diffusion process. We have developed a sensitivity analysis of the resulting rate matrix, which identifies the locations where mutations should have the largest effect on the diffusive on rate. We apply this method to myoglobin, which is the best characterized example both from experiment and simulation. We validate the approach by translating the sensitivity parameter obtained from this method into the CO binding rates in myoglobin upon mutation, resulting in a semi-quantitative correlation with experiments. The model is further validated against an explicit simulation for one of the experimental mutants.	[De Sancho, David] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Kubas, Adam; Wang, Po-Hung; Blumberger, Jochen] UCL, Dept Phys & Astron, London WC1E 6BT, England; [Best, Robert B.] NIDDKD, Chem Phys Lab, NIH, Bethesda, MD 20892 USA; [De Sancho, David] CIC NanoGUNE, Donostia San Sebastian 20018, Spain; [De Sancho, David] Ikerbasque, Basque Fdn Sci, Bilbao 48013, Spain; [Wang, Po-Hung] Theoret Mol Sci Lab, Wako, Saitama 3510198, Japan	Best, RB (reprint author), NIDDKD, Chem Phys Lab, NIH, Bethesda, MD 20892 USA.	robertbe@helix.nih.gov	nanoGUNE, CIC/A-2623-2015; Wang, Po-hung/G-9962-2012	Wang, Po-hung/0000-0001-6770-1918	EPSRC [EP/J016764/1, EP/J015571/1]; Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health; Royal Society; Materials Chemistry Consortium (EPSRC) [EP/F067496, EP/L000202]	D.D.S. was supported by EPSRC Grant EP/J016764/1 and A.K. by EPSRC Grant EP/J015571/1. R.B.B. was supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health. J.B. thanks the Royal Society for a University Research Fellowship. This work was carried out on the HECToR and Archer computing facilities (Edinburgh), access to which was granted through the Materials Chemistry Consortium (EPSRC Grants EP/F067496 and EP/L000202). This study utilized the high-performance computational capabilities of the Biowulf Linux cluster at the National Institutes of Health, Bethesda, MD (http://biowulf.nih.gov). The authors acknowledge the use of the UCL Legion High Performance Computing Facility (Legion@UCL) and associated support services in the completion of this work D.D. acknowledges Jacob Stevenson for useful discussions.	EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; Yeh IC, 2002, J AM CHEM SOC, V124, P6563, DOI 10.1021/ja025789n; Ostermann A, 2000, NATURE, V404, P205; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Olson JS, 2007, IUBMB LIFE, V59, P552, DOI 10.1080/15216540701230495; ELBER R, 1987, SCIENCE, V235, P318, DOI 10.1126/science.3798113; ZAMYATNIN AA, 1984, ANNU REV BIOPHYS BIO, V13, P145, DOI 10.1146/annurev.bb.13.060184.001045; Wang PH, 2011, PHYS CHEM CHEM PHYS, V13, P7708, DOI 10.1039/c0cp02098b; Lim MH, 1997, NAT STRUCT BIOL, V4, P209, DOI 10.1038/nsb0397-209; QUILLIN ML, 1995, J MOL BIOL, V245, P416, DOI 10.1006/jmbi.1994.0034; HYDE CC, 1988, J BIOL CHEM, V263, P17857; Ruscio JZ, 2008, P NATL ACAD SCI USA, V105, P9204, DOI 10.1073/pnas.0710825105; Swope WC, 2004, J PHYS CHEM B, V108, P6571, DOI 10.1021/jp037421y; Wang PH, 2012, P NATL ACAD SCI USA, V109, P6399, DOI 10.1073/pnas.1121176109; Nienhaus K, 2003, BIOCHEMISTRY-US, V42, P9647, DOI 10.1021/bi034788k; Chodera JD, 2014, CURR OPIN STRUC BIOL, V25, P135, DOI 10.1016/j.sbi.2014.04.002; Cohen J, 2007, BIOPHYS J, V93, P3591, DOI 10.1529/biophysj.107.108712; Merchant KA, 2003, J AM CHEM SOC, V125, P13804, DOI 10.1021/ja035654x; Maragliano L, 2010, J AM CHEM SOC, V132, P1010, DOI 10.1021/ja905671x; Cojocaru V, 2007, BBA-GEN SUBJECTS, V1770, P390, DOI 10.1016/j.bbagen.2006.07.005; De Sancho D, 2013, J CHEM THEORY COMPUT, V9, P1743, DOI 10.1021/ct301033r; Nutt DR, 2003, BIOPHYS J, V85, P3612, DOI 10.1016/S0006-3495(03)74779-1; Noe F, 2009, P NATL ACAD SCI USA, V106, P19011, DOI 10.1073/pnas.0905466106; Wang PH, 2013, J AM CHEM SOC, V135, P9493, DOI 10.1021/ja403110s; Baron R, 2009, P NATL ACAD SCI USA, V106, P10603, DOI 10.1073/pnas.0903809106; Bossa C, 2004, BIOPHYS J, V86, P3855, DOI 10.1529/biophysj.103.037432; Elber R, 2010, CURR OPIN STRUC BIOL, V20, P162, DOI 10.1016/j.sbi.2010.01.002; GIBSON QH, 1992, J BIOL CHEM, V267, P22022; Buchete NV, 2008, J PHYS CHEM B, V112, P6057, DOI 10.1021/jp0761665; Boechi L, 2013, J BIOL CHEM, V288, P6754, DOI 10.1074/jbc.M112.426056; Wang PH, 2011, J AM CHEM SOC, V133, P3548, DOI 10.1021/ja109712q; HUANG XH, 1994, NAT STRUCT BIOL, V1, P226, DOI 10.1038/nsb0494-226; Schotte F, 2003, SCIENCE, V300, P1944, DOI 10.1126/science.1078797; AUSTIN RH, 1975, BIOCHEMISTRY-US, V14, P5355, DOI 10.1021/bi00695a021; Baron R, 2009, CURR OPIN STRUC BIOL, V19, P672, DOI 10.1016/j.sbi.2009.10.003; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Scott EE, 1997, BIOCHEMISTRY-US, V36, P11909, DOI 10.1021/bi970719s; Harvey JN, 2004, FARADAY DISCUSS, V127, P165, DOI 10.1039/b314768a; Anselmi M, 2008, BIOPHYS J, V94, P4277, DOI 10.1529/biophysj.107.124529; Berezhkovskii A, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3139063; Bossa C, 2005, BIOPHYS J, V89, P465, DOI 10.1529/biophysj.104.055020; Bourgeois D, 2006, P NATL ACAD SCI USA, V103, P4924, DOI 10.1073/pnas.0508880103; Brunori M, 2004, J STRUCT BIOL, V147, P223, DOI 10.1016/j.jsb.2004.04.008; Carlson ML, 1996, BIOCHEMISTRY-US, V35, P1125, DOI 10.1021/bi951767k; CARVER TE, 1990, J BIOL CHEM, V265, P20007; Case D A, 1986, Ann N Y Acad Sci, V482, P222, DOI 10.1111/j.1749-6632.1986.tb20953.x; Ceccarelli M, 2008, PROTEINS, V71, P1231, DOI 10.1002/prot.21817; Goldbeck RA, 2006, P NATL ACAD SCI USA, V103, P1254, DOI 10.1073/pnas.0507840103; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kendrew J. C., 2005, J AM CHEM SOC, V127, P16961; Kubas A., 2014, ANGEW CHEM INT EDIT, V126, P4165; Meller J, 1998, BIOPHYS J, V74, P789; Mishra S, 2010, BIOPHYS J, V99, P3969, DOI 10.1016/j.bpj.2010.09.068; Nutt DR, 2004, P NATL ACAD SCI USA, V101, P5998, DOI 10.1073/pnas.0306712101; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Prinz JH, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3565032; Schutte C, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3590108; STRAUB JE, 1991, CHEM PHYS, V158, P221, DOI 10.1016/0301-0104(91)87068-7; Tarjan R., 1972, SIAM Journal on Computing, V1, DOI 10.1137/0201010; E W, 2006, J STAT PHYS, V123, P503, DOI 10.1007/s10955-005-9003-9; Vitkup D, 1997, NAT STRUCT BIOL, V4, P202, DOI 10.1038/nsb0397-202	62	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1549-9618	1549-9626		J CHEM THEORY COMPUT	J. Chem. Theory Comput.	APR	2015	11	4					1919	1927		10.1021/ct5011455		9	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CG3JM	WOS:000353176500056		
J	Lucas-Herald, AK; Kinning, E; Iida, A; Wang, Z; Miyake, N; Ikegawa, S; McNeilly, J; Ahmed, SF				Lucas-Herald, Angela K.; Kinning, Esther; Iida, Aritoshi; Wang, Zheng; Miyake, Noriko; Ikegawa, Shiro; McNeilly, Jane; Ahmed, S. Faisal			A Case of Functional Growth Hormone Deficiency and Early Growth Retardation in a Child With IFT172 Mutations	JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM			English	Article							DYSPLASIA; JEUNE	Context: Ciliopathies are a group of rare conditions that present through a wide range of manifestations. Given the relative common occurrence of defects of the GH/IGF-I axis in children with short stature and growth retardation, the association between ciliopathies and these defects needs further attention. Case: Our patient is a boy who was born atterm and noted to have early growth retardation and weight gain within the first 18 months of life. Biochemical tests demonstrated low IGF-I but a normal peak GH on stimulation and an adequate increase in IGF-I on administration of recombinant human growth hormone (rhGH). A magnetic resonance imaging scan revealed pituitary hypoplasia and an ectopic posterior pituitary. His growth responded well to rhGH therapy. Subsequently he also developed a retinopathy of his rods and cones, metaphyseal dysplasia, and hypertension with renal failure requiring renal replacement therapy. Whole-exome sequencing demonstrated compound heterozygous mutations of IFT172, thus consistent with a ciliopathy. Conclusions: This is the first reported case of a child with a mutation in IFT172 who presented with growth retardation in early childhood and was initially managed as a case of functional GH deficiency that responded to rhGH therapy. This case highlights the importance of ciliary function in pituitary development and the link between early onset growth failure and ciliopathies.	[Lucas-Herald, Angela K.; Ahmed, S. Faisal] Univ Glasgow, Royal Hosp Sick Children, Sch Med, Dev Endocrinol Res Grp, Glasgow G3 8SJ, Lanark, Scotland; [Kinning, Esther] So Gen Hosp, Dept Clin Genet, Glasgow G51 4TF, Lanark, Scotland; [Iida, Aritoshi; Wang, Zheng; Ikegawa, Shiro] RIKEN, Ctr Integrat Med Sci, Lab Bone & Joint Dis, Tokyo 1088639, Japan; [Miyake, Noriko] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 2360004, Japan; [McNeilly, Jane] So Gen Hosp, Dept Biochem, Glasgow G51 4TF, Lanark, Scotland	Ahmed, SF (reprint author), Royal Hosp Sick Children, Dev Endocrinol Res Grp, Glasgow G3 8SJ, Lanark, Scotland.	faisal.ahmed@glasgow.ac.uk			Japan Society for the Promotion of Science [25293235]; Takeda Science Foundation	A part of this work is supported by a Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (Contract No. 25293235) and a grant from the Takeda Science Foundation.	Halbritter J, 2013, AM J HUM GENET, V93, P915, DOI 10.1016/j.ajhg.2013.09.012; Lee JH, 2010, NEUROBIOL DIS, V38, P167, DOI 10.1016/j.nbd.2009.12.022; Huber C, 2012, AM J MED GENET C, V160C, P165, DOI 10.1002/ajmg.c.31336; Han JC, 2010, LANCET, V375, P1737, DOI 10.1016/S0140-6736(10)60171-7; McInerney-Leo AM, 2013, AM J HUM GENET, V93, P515, DOI 10.1016/j.ajhg.2013.06.022; Perrault I, 2012, AM J HUM GENET, V90, P864, DOI 10.1016/j.ajhg.2012.03.006; Han YG, 2010, CURR OPIN NEUROBIOL, V20, P58, DOI 10.1016/j.conb.2009.12.002; Zaghloul NA, 2011, GENESIS, V49, P231, DOI 10.1002/dvg.20728; Bujakowska KM, 2015, HUM MOL GENET, V24, P230, DOI 10.1093/hmg/ddu441; Hedera P, 2001, AM J MED GENET, V101, P142, DOI 10.1002/ajmg.1338; Isidor B, 2009, AM J MED GENET A, V149A, P788, DOI 10.1002/ajmg.a.32343	11	0	0	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0021-972X	1945-7197		J CLIN ENDOCR METAB	J. Clin. Endocrinol. Metab.	APR	2015	100	4					1221	1224		10.1210/jc.2014-3852		4	Endocrinology & Metabolism	Endocrinology & Metabolism	CG5UN	WOS:000353361500024		
J	Duparc, C; Moreau, L; Dzib, JFG; Boyer, HG; Nomigni, MT; Boutelet, I; Boulkroun, S; Mukai, K; Benecke, AG; Amar, L; Gobet, F; Meatchi, T; Plouin, PF; Zennaro, MC; Louiset, E; Lefebvre, H				Duparc, Celine; Moreau, Lucile; Dzib, Jose Felipe Golib; Boyer, Hadrien-Gael; Nomigni, Milene Tetsi; Boutelet, Isabelle; Boulkroun, Sheerazed; Mukai, Kuniaki; Benecke, Arndt G.; Amar, Laurence; Gobet, Francoise; Meatchi, Tchao; Plouin, Pierre-Francois; Zennaro, Maria-Christina; Louiset, Estelle; Lefebvre, Herve			Mast Cell Hyperplasia Is Associated With Aldosterone Hypersecretion in a Subset of Aldosterone-Producing Adenomas	JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM			English	Article							SOMATIC MUTATIONS; CHANNEL MUTATIONS; ADRENAL-CORTEX; EXPRESSION; RECEPTORS; PATIENT; TUMOR; IDENTIFICATION; PREVALENCE; SECRETION	Context: Adrenal mast cells can stimulate aldosterone secretion through the local release of serotonin (5-HT) and activation of the 5-HT4 receptor (5-HT4). In aldosterone-producing adenomas (APAs), 5-HT4 receptor is overexpressed and the administration of 5-HT4 receptor agonists to patients with APA increases plasma aldosterone levels. These data and the well-documented role of mast cells in tumorigenesis suggest that mast cells may be involved in the pathophysiology of APA. Objective: The study aimed at investigating the occurrence of mast cells in a series of APA tissues and to examine the influence of mast cells on aldosterone secretion. Design: The occurrence of mast cells in APAs was investigated by immunohistochemistry. Mast cell densities were compared with clinical data. The influence of mast cells on aldosterone production was studied by using cultures of human mast cell and adrenocortical cell lines. Results: In APA tissues, the density of mast cells was found to be increased in comparison with normal adrenals. Mast cells were primarily observed in adrenal cortex adjacent to adenomas or in the adenomas themselves, distinguishing two groups of APAs. A subset of adenomas was found to contain a high density of intratumoral mast cells, which was correlated with aldosterone synthase expression and in vivo aldosterone secretory parameters. Administration of conditioned medium from cultures of human mast cell lines to human adrenocortical cells induced a significant increase in aldosterone synthase (CYP11B2) mRNA expression and aldosterone production. Conclusion: APA tissues commonly contain numerous mast cells that may influence aldosterone secretion through the local release of regulatory factors.	[Duparc, Celine; Moreau, Lucile; Boyer, Hadrien-Gael; Nomigni, Milene Tetsi; Boutelet, Isabelle; Louiset, Estelle; Lefebvre, Herve] Normandie Univ, INSERM, Unite 982, F-76821 Mont St Aignan, France; [Duparc, Celine; Moreau, Lucile; Boyer, Hadrien-Gael; Nomigni, Milene Tetsi; Boutelet, Isabelle; Louiset, Estelle; Lefebvre, Herve] Normandie Univ, Inst Res & Innovat Biomed, F-76821 Mont St Aignan, France; [Duparc, Celine; Moreau, Lucile; Boyer, Hadrien-Gael; Nomigni, Milene Tetsi; Boutelet, Isabelle; Louiset, Estelle; Lefebvre, Herve] Univ Rouen, Lab Neuronal & Neuroendocrine Differenciat & Comm, F-76821 Mont St Aignan, France; [Moreau, Lucile; Lefebvre, Herve] Univ Hosp Rouen, Dept Endocrinol, Inst Res & Innovat Biomed, F-76031 Rouen, France; [Gobet, Francoise] Univ Hosp Rouen, Dept Pathol, Inst Res & Innovat Biomed, F-76031 Rouen, France; [Dzib, Jose Felipe Golib; Benecke, Arndt G.] CNRS, Inst Hautes Etud Sci, F-91440 Bures Sur Yvette, France; [Boulkroun, Sheerazed; Amar, Laurence; Meatchi, Tchao; Plouin, Pierre-Francois; Zennaro, Maria-Christina] Paris Cardiovasc Res Ctr, INSERM, Unite Mixte Rech Sante 970, F-75015 Paris, France; [Boulkroun, Sheerazed; Amar, Laurence; Meatchi, Tchao; Plouin, Pierre-Francois; Zennaro, Maria-Christina] Univ Paris 05, Sorbonne Paris Cite, F-75015 Paris, France; [Mukai, Kuniaki] Keio Univ, Sch Med, Dept Biochem, Tokyo 1608582, Japan; [Amar, Laurence; Meatchi, Tchao; Plouin, Pierre-Francois; Zennaro, Maria-Christina] Hop Europeen Georges Pompidou, AP HP, F-75098 Paris, France	Lefebvre, H (reprint author), Univ Hosp Rouen, Inst Res & Innovat Biomed, Dept Endocrinol, INSERM Unite 982, F-76031 Rouen, France.	herve.lefebvre@chu-rouen.fr			Institut National de la Sante et de la Recherche Medicale; Agence Nationale pour la Recherche (ANR Physio) [013-01]; Genopat Grant [08-GENO-021]; Fondation pour la Recherche sur l'Hypertension Arterielle [AO 2007]; Fondation pour la Recherche Medicale [ING20101221177]; Association Surrenales; Programme Hospitalier de Recherche Clinique [AOM95201]; INSERM; Ministere Delegue a la Recherche et aux Nouvelles Technologies	This work was supported by the Institut National de la Sante et de la Recherche Medicale, the Agence Nationale pour la Recherche (ANR Physio 2007, Grant 013-01; Genopat 2008 Grant 08-GENO-021); the Fondation pour la Recherche sur l'Hypertension Arterielle (Grant AO 2007); the Fondation pour la Recherche Medicale (Grant ING20101221177); and by a grant from the Association Surrenales. The French Cortico et Medullo-Surrenale: les Tumeurs Endocrines (COMETE) network is supported in part by the Programme Hospitalier de Recherche Clinique Grant AOM95201 and by grants from the INSERM and the Ministere Delegue a la Recherche et aux Nouvelles Technologies.	AIBA M, 1985, ARCH PATHOL LAB MED, V109, P357; Amini RM, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-165; Choi M, 2011, SCIENCE, V331, P768, DOI 10.1126/science.1198785; Soucek L, 2007, NAT MED, V13, P1211, DOI 10.1038/nm1649; Fernandes-Rosa FL, 2014, HYPERTENSION, V64, P354, DOI 10.1161/HYPERTENSIONAHA.114.03419; Marichal T, 2013, CANCER IMMUNOL RES, V1, P269, DOI 10.1158/2326-6066.CIR-13-0119; BUTTERFIELD JH, 1988, LEUKEMIA RES, V12, P345, DOI 10.1016/0145-2126(88)90050-1; Nanba K, 2013, J CLIN ENDOCR METAB, V98, P1567, DOI 10.1210/jc.2012-3726; Nishimoto K, 2010, J CLIN ENDOCR METAB, V95, P2296, DOI 10.1210/jc.2009-2010; Bassett MH, 2004, ENDOCR RES, V30, P567, DOI 10.1081/ERC-200043715; Nakamura Y, 2014, MOL CELL ENDOCRINOL, V392, P73, DOI 10.1016/j.mce.2014.05.002; Ye P, 2007, J ENDOCRINOL, V195, P39, DOI 10.1677/JOE-07-0037; Hannemann A, 2012, HORM METAB RES, V44, P157, DOI 10.1055/s-0031-1295438; Ono Y, 2014, HYPERTENSION, V64, P438, DOI 10.1161/HYPERTENSIONAHA.113.02944; Hattangady NG, 2012, MOL CELL ENDOCRINOL, V350, P151, DOI 10.1016/j.mce.2011.07.034; Boulkroun S, 2012, HYPERTENSION, V59, P592, DOI 10.1161/HYPERTENSIONAHA.111.186478; Maltby S, 2009, BBA-REV CANCER, V1796, P19, DOI 10.1016/j.bbcan.2009.02.001; Becavin C, 2011, BIOINFORMATICS, V27, P1413, DOI 10.1093/bioinformatics/btr143; Kirshenbaum AS, 2003, LEUKEMIA RES, V27, P677, DOI 10.1016/S0145-2126(02)00343-0; Yang FC, 2008, CELL, V135, P437, DOI 10.1016/j.cell.2008.08.041; Conti P, 2007, ANN CLIN LAB SCI, V37, P315; Scholl UI, 2013, NAT GENET, V45, P1050, DOI 10.1038/ng.2695; Boulkroun S, 2010, HYPERTENSION, V56, P885, DOI 10.1161/HYPERTENSIONAHA.110.158543; Louiset E, 2013, NEW ENGL J MED, V369, P2115, DOI 10.1056/NEJMoa1215245; Beuschlein F, 2013, NAT GENET, V45; Brysbaert Guillaume, 2010, Genomics Proteomics & Bioinformatics, V8, P57, DOI 10.1016/S1672-0229(10)60006-X; Cartier D, 2005, EUR J ENDOCRINOL, V153, P939, DOI 10.1530/eje.1.02051; Dahl C, 2006, ALLERGY, V61, P276, DOI 10.1111/j.1398-9995.2005.00950.x; Ehrhart-Bornstein M, 1998, ENDOCR REV, V19, P101, DOI 10.1210/er.19.2.101; Halova I, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00119; Lampron A, 2009, J CLIN ENDOCR METAB, V94, P750, DOI 10.1210/jc.2008-1340; Lefebvre H, 2001, J CLIN ENDOCR METAB, V86, P5001, DOI 10.1210/jc.86.10.5001; Lefebvre H, 2002, J CLIN ENDOCR METAB, V87, P1211, DOI 10.1210/jc.87.3.1211; Liu WL, 2009, LIFE SCI, V85, P235, DOI 10.1016/j.lfs.2009.05.018; Louiset E, 2008, ENDOCR-RELAT CANCER, V15, P1025, DOI 10.1677/ERC-08-0085; Osswald A, 2013, EUR J ENDOCRINOL, V169, P657, DOI 10.1530/EJE-13-0551; Schjerning J, 2013, AM J PHYSIOL-HEART C, V304, pH1094, DOI 10.1152/ajpheart.00524.2012; Tchitchek Nicolas, 2012, Genomics Proteomics & Bioinformatics, V10, P127, DOI 10.1016/j.gpb.2012.06.002; Xiao J, 2009, EUR J HEART FAIL, V11, P349, DOI 10.1093/eurjhf/hfp023; Xing YW, 2012, ENDOCRINOLOGY, V153, P721, DOI 10.1210/en.2011-1752; Yano H, 1999, GASTRIC CANCER, V2, P26, DOI 10.1007/s101200050017; Zwermann O, 2009, EUR J ENDOCRINOL, V160, P443, DOI 10.1530/EJE-08-0711	42	1	1	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0021-972X	1945-7197		J CLIN ENDOCR METAB	J. Clin. Endocrinol. Metab.	APR	2015	100	4					E550	E560		10.1210/jc.2014-3660		11	Endocrinology & Metabolism	Endocrinology & Metabolism	CG5UN	WOS:000353361500006		
J	Urano, T; Shiraki, M; Sasaki, N; Ouchi, Y; Inoue, S				Urano, Tomohiko; Shiraki, Masataka; Sasaki, Noriko; Ouchi, Yasuyoshi; Inoue, Satoshi			SLC25A24 as a Novel Susceptibility Gene for Low Fat Mass in Humans and Mice	JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM			English	Article							RAT-LIVER MITOCHONDRIA; BONE-MINERAL DENSITY; ATP-MG/PI CARRIER; ADENINE-NUCLEOTIDES; I CARRIER; IDENTIFICATION; TRANSPORTER; OBESITY; INDEX; LOCI	Context: Genetic factors contribute to the development of obesity. Objective: The aim of this study was to identify novel genes that regulate body fat mass. Design: We performed a search for single nucleotide polymorphisms (SNPs) associated with body fat percentage using SNP arrays and undertook a replication study and animal study. Setting and Patients: Baseline examinations were conducted in 251 (first-stage analysis), 499 (second-stage analysis), and 732 (additional analyses) Japanese postmenopausal women. The mean age (mean +/- SD) of the subjects was 66.5 +/- 9.4 years. We also analyzed the fat-related phenotypes of a candidate gene in knockout mice. Results: In the analysis of total body fat, we focused on an SNP of SLC25A24 that showed the lowest significant P value obtained from multiple comparison tests among Japanese postmenopausal women. A significant association was also found between SLC25A24 SNPs and body mass index in the 1482 Japanese postmenopausal women examined in the study. The SLC25A24 SNPs affected the mRNA expression of SLC25A24 in human preadipocytes. Compared with wild-type mice, Slc25a24-KO mice had significantly lower body weights and white adipose tissue weights. Adipocyte differentiation was inhibited in Slc25a24-KO adipose tissues and Slc25a24-knockdown adipocytes. Conclusions: Genetic analyses in human and mouse models revealed the importance of SLC25A24/Slc25a24 in the regulation of body fat mass and adipogenesis.	[Urano, Tomohiko; Sasaki, Noriko; Ouchi, Yasuyoshi; Inoue, Satoshi] Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Tokyo 1138655, Japan; [Urano, Tomohiko; Sasaki, Noriko; Inoue, Satoshi] Univ Tokyo, Grad Sch Med, Dept Antiaging Med, Tokyo 1138655, Japan; [Shiraki, Masataka] Res Inst & Practice Involut Dis, Nagano 3998101, Japan	Inoue, S (reprint author), Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.	inoue-ger@h.u-tokyo.ac.jp			Cell Innovation Program; Support Project of Strategic Research Center in Private Universities from the Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science; Ministry of Health, Labour and Welfare; Advanced Research for Medical Products Mining Programme of the National Institute of Biomedical Innovation	This study was supported by Cell Innovation Program and Support Project of Strategic Research Center in Private Universities from the Ministry of Education, Culture, Sports, Science and Technology, grants from the Japan Society for the Promotion of Science, grants-in-aid from the Ministry of Health, Labour and Welfare, and the Advanced Research for Medical Products Mining Programme of the National Institute of Biomedical Innovation.	Adamski J, 2012, GENOME MED, V4, DOI 10.1186/gm333; Akaike H, 1974, IEEE T AUTOMAT CONTR, V19, P716, DOI DOI 10.1109/TAC.1974.1100705; Dick KJ, 2014, LANCET, V383, P1990, DOI 10.1016/S0140-6736(13)62674-4; Tokuhiro S, 2003, NAT GENET, V35, P341, DOI 10.1038/ng1267; NOSEK MT, 1990, J BIOL CHEM, V265, P8444; JOYAL JL, 1992, J BIOL CHEM, V267, P19198; [Anonymous], 2000, WHO TECH REP SER, V894, p[i, 1]; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Ball RD, 2011, GENETICS, V189, P1497, DOI 10.1534/genetics.111.131698; Kilpelainen TO, 2011, NAT GENET, V43, P753, DOI 10.1038/ng.866; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Tchkonia T, 2006, DIABETES, V55, P2571, DOI 10.2337/db06-0540; Lewis CE, 2009, CIRCULATION, V119, P3263, DOI 10.1161/CIRCULATIONAHA.109.192574; Fiermonte G, 2004, J BIOL CHEM, V279, P30722, DOI 10.1074/jbc.M400445200; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Amigo I, 2013, J BIOL CHEM, V288, P7791, DOI 10.1074/jbc.M112.409144; del Arco A, 2004, J BIOL CHEM, V279, P24701, DOI 10.1074/jbc.M401417200; Traba J, 2009, BIOCHEM J, V418, P125, DOI 10.1042/BJ20081262; Kunji ERS, 2004, FEBS LETT, V564, P239, DOI 10.1016/S0014-5793(04)00242-X; Thomas L, 1997, CONSERV BIOL, V11, P276, DOI 10.1046/j.1523-1739.1997.96102.x; Traba J, 2012, CELL DEATH DIFFER, V19, P650, DOI 10.1038/cdd.2011.139; Tung YCL, 2014, CELL METAB, V20, P710, DOI 10.1016/j.cmet.2014.09.010; Okada Y, 2012, NAT GENET, V44, P302, DOI 10.1038/ng.1086; Anunciado-Koza RP, 2011, J BIOL CHEM, V286, P11659, DOI 10.1074/jbc.M110.203000; APRILLE JR, 1988, FASEB J, V2, P2547; Basile KJ, 2014, INT J ENDOCRINOL, V2014, DOI [10.1155/2014/769671, DOI 10.1155/2014/769671]; Floyd ZE, 2012, BBA-MOL BASIS DIS, V1822, P1090, DOI 10.1016/j.bbadis.2012.03.014; Hackett CA, 1995, BIOMETRICS, V51, P1252, DOI 10.2307/2533257; HAYNES RC, 1986, J BIOL CHEM, V261, P6121; Kadowaki T, 2011, Cold Spring Harb Symp Quant Biol, V76, P257, DOI 10.1101/sqb.2012.76.010587; Lu YC, 2013, GENOME MED, V5, DOI 10.1186/gm459; Mangino M, 2008, HUM MOL GENET, V17, P2518, DOI 10.1093/hmg/ddn152; Musri MM, 2012, CURR OPIN CLIN NUTR, V15, P342, DOI 10.1097/MCO.0b013e3283546fba; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; POLLAK JK, 1980, BIOCHEM J, V192, P75; Pollex RL, 2006, NAT CLIN PRACT CARD, V3, P482, DOI 10.1038/ncpcardio0638; STUNKARD AJ, 1986, JAMA-J AM MED ASSOC, V256, P51, DOI 10.1001/jama.256.1.51; Urano T, 2012, J CLIN ENDOCR METAB, V97, pE565, DOI 10.1210/jc.2011-2393; Urano T, 2010, BONE, V47, P636, DOI 10.1016/j.bone.2010.06.017	39	1	1	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0021-972X	1945-7197		J CLIN ENDOCR METAB	J. Clin. Endocrinol. Metab.	APR	2015	100	4					E655	E663		10.1210/jc.2014-2829		9	Endocrinology & Metabolism	Endocrinology & Metabolism	CG5UN	WOS:000353361500020		
J	Tokumura, T; Isaka, H; Kanou, M; Miyazaki, E; Kaneko, N; Kurita, T				Tokumura, Tadakazu; Isaka, Hitomi; Kanou, Manami; Miyazaki, Eri; Kaneko, Natsumi; Kurita, Takuro			An inclusion complex of fluticasone propionate with gamma-cyclodextrin in aqueous solution and in a solid state	JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY			English	Article						Fluticasone propionate; Dissolution rate; Inclusion complex; gamma-Cyclodextrin; Solubility; Phase solubility diagram; Powder X-ray diffractometry	INFLAMMATORY-BOWEL-DISEASE	Inclusion complex formation of fluticasone propionate (FLT) with gamma-cyclodextrin (gamma-CD) in aqueous solution and in a solid state was confirmed by the solubility method and powder X-ray diffractometry. A solid complex of FLT with gamma-CD (FLT/gamma-CD) was prepared by a coprecipitation method, and its dissolution behavior in water was examined in comparison with FLT. Phase solubility diagrams obtained for FLT/alpha-CD, FLT/beta-CD, and FLT/gamma-CD systems in water at 26 degrees C were A(p)-, A(L)-, and B-s-type phase diagrams, respectively. The apparent stability constants, K ', of FLT/beta-CD and FLT/gamma-CD from the initial straight line portion of the solubility diagram were 10,003 M-1 and 1257 M-1, respectively. The FLT content of the solid complex of FLT/gamma-CD was 16.18%. The stoichiometry of the complex was found to be 1:2 (molar ratio, FLT:gamma-CD), which is in good accordance with that based on the data in the plateau region of the solubility diagram. The solubility values for FLT in the solutions at 10 mM of alpha-, beta- and gamma-CD at 26 degrees C were 0.3,1.4, and 78.3 mu g/mL, respectively. Those values were higher than that of FLT, 0.1 mu g/mL, in water at 37 degrees C. The dissolution rate of FLT was remarkably improved by FLT/gamma-CD. (C) 2015 Elsevier B.V. All rights reserved.	[Tokumura, Tadakazu; Kurita, Takuro] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Lab Pharmaceut, Kagawa 7692193, Japan; [Isaka, Hitomi; Kanou, Manami; Miyazaki, Eri; Kaneko, Natsumi] Int Univ Hlth & Welf, Sch Pharm, Dept Pharmaceut Sci, Ohtawara, Tochigi 3248501, Japan	Tokumura, T (reprint author), Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Lab Pharmaceut, Shido 1314-1, Kagawa 7692193, Japan.	tokumura@kph.bunri-u.ac.jp					HANAUER SB, 1991, DRUG SAFETY, V6, P192, DOI 10.2165/00002018-199106030-00005; Drumond N, 2014, J INCL PHENOM MACRO, V80, P25, DOI 10.1007/s10847-014-0400-z; Higuchi T., 1965, INTERSCIENCE, P197; Dempsey OJ, 1999, THORAX, V54, P614; Löfberg R, 1995, Inflamm Bowel Dis, V1, P135, DOI 10.1002/ibd.3780010207; Meibohm B, 1998, REV CONTEMP PHARMACO, V9, P535; Thakral NK, 2013, J INCL PHENOM MACRO, V75, P175, DOI 10.1007/s10847-012-0159-z; Tokumura T., 2014, INT RES J PHARM APPL, V4, P19; Tokumura T., 2014, INT RES J PHARM APPL, V4, P1; Uekama K, 2012, YAKUGAKU ZASSHI, V132, P85	10	0	0	EDITIONS SANTE	PARIS	47 RUE GALILEE, 75116 PARIS, FRANCE	1773-2247			J DRUG DELIV SCI TEC	J. Drug Deliv. Sci. Technol.	APR	2015	26						24	27		10.1016/j.jddst.2015.02.002		4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CH0XG	WOS:000353745100004		
J	Yoshikawa, R; Takeuchi, JS; Yamada, E; Nakano, Y; Ren, FR; Tanaka, H; Munk, C; Harris, RS; Miyazawa, T; Koyanagi, Y; Sato, K				Yoshikawa, Rokusuke; Takeuchi, Junko S.; Yamada, Eri; Nakano, Yusuke; Ren, Fengrong; Tanaka, Hiroshi; Muenk, Carsten; Harris, Reuben S.; Miyazawa, Takayuki; Koyanagi, Yoshio; Sato, Kei			Vif determines the requirement for CBF-f3 in APOBEC3 degradation	JOURNAL OF GENERAL VIROLOGY			English	Article							FELINE IMMUNODEFICIENCY VIRUS; BINDING-FACTOR BETA; RESTRICTION FACTORS; GENE-EXPRESSION; HIV-1 INFECTION; RUNT DOMAIN; PROTEINS; DNA; COMPLEX; TRANSCRIPTION	APOBEC3 (apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3) proteins are cellular DNA deaminases that restrict a broad spectrum of lentiviruses. This process is counteracted by Vif (viral infectivity factor) of lentiviruses, which binds APOBEC3s and promotes their degradation. CBF-beta (core binding factor subunit)3) is an essential co-factor for the function of human immunodeficiency virus type 1 Vif to degrade human APOBEC3s. However, the requirement for CBF-beta in Vif-mediated degradation of other mammalian APOBEC3 proteins is less clear. Here, we determined the sequence of feline CBFB and performed phylogenetic analyses. These analyses revealed that mammalian CBFB is under purifying selection. Moreover, we demonstrated that CBF-beta is dispensable for feline immunodeficiency virus Vif-mediated degradation of APOBEC3s of its host. These findings suggested that primate lentiviruses have adapted to use CBF-beta, an evolutionary stable protein, to counteract APOBEC3 proteins of their hosts after diverging from other lentiviruses.	[Yoshikawa, Rokusuke; Takeuchi, Junko S.; Yamada, Eri; Nakano, Yusuke; Koyanagi, Yoshio; Sato, Kei] Kyoto Univ, Lab Viral Pathogenesis, Inst Virus Res, Kyoto 6068507, Japan; [Nakano, Yusuke] Kumamoto Univ, Dept Med Virol, Fac Life Sci, Kumamoto 8608556, Japan; [Ren, Fengrong; Tanaka, Hiroshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Bioinformat, Tokyo 1138510, Japan; [Muenk, Carsten] Univ Dusseldorf, Clin Gastroenterol Hepatol & Infectiol, Fac Med, D-40225 Dusseldorf, Germany; [Harris, Reuben S.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Inst Mol Virol, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Harris, Reuben S.] Univ Minnesota, Ctr Genome Engn, Minneapolis, MN 55455 USA; [Miyazawa, Takayuki] Kyoto Univ, Inst Virus Res, Lab Signal Transduct, Kyoto 6068507, Japan; [Miyazawa, Takayuki] Kyoto Univ, Inst Virus Res, Lab Virolut, Kyoto 6068507, Japan; [Sato, Kei] Japan Sci & Technol Agcy, CREST, Saitama 3220012, Japan	Sato, K (reprint author), Kyoto Univ, Lab Viral Pathogenesis, Inst Virus Res, Kyoto 6068507, Japan.	ksato@virus.kyoto-u.ac.jp			Aihara Innovative Mathematical Modelling Project; Japan Society for the Promotion of Science; Council for Science and Technology Policy of Japan; CREST, Japan Science and Technology Agency; Ministry of Health, Labor and Welfare of Japan [26361601]; Takeda Science Foundation; Sumitomo Foundation; Senshin Medical Research Foundation; Ichiro Kanehara Foundation; Kanae Foundation for the Promotion of Medical Science; Ansmann Foundation for AIDS Research; National Institutes of Health [R01 AI064046, P01 GM091743]; Japan Society for the Promotion of Science [B24390112, S22220007]; Ministry of Education, Culture, Sports, Science and Technology of Japan [24115008]; Research on HIV/AIDS from Ministry of Health, Labor and Welfare of Japan	We would like to thank Ms. Naoko Misawa and Mr Yuichi Kimura (Laboratory of Viral Pathogenesis, Institute for Virus Research, Kyoto University) for experimental support, Dr Tomoyuki Miura (Laboratory of Primate model, Institute for Virus Research, Kyoto University) for providing pSIVmac239, Dr Terumasa Ikeda (University of Minnesota) for helpful suggestions and Ms Kotubu Misawa for dedicated support. This study was supported in-part by grants from the following: the Aihara Innovative Mathematical Modelling Project, the Japan Society for the Promotion of Science through the 'Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST)', initiated by the Council for Science and Technology Policy of Japan (to K. S.); CREST, Japan Science and Technology Agency (to K. S.); Ministry of Health, Labor and Welfare of Japan (Health Labor Sciences Research Grant 26361601) (to K. S.); Takeda Science Foundation (to K. S.); Sumitomo Foundation Research Grant (to K. S.); Senshin Medical Research Foundation (to K. S.); Ichiro Kanehara Foundation (to K. S.); Kanae Foundation for the Promotion of Medical Science (to K. S.); Ansmann Foundation for AIDS Research (to C. M.); National Institutes of Health (R01 AI064046 and P01 GM091743) (to R. H.); Japan Society for the Promotion of Science (Grants-in-Aid for Scientific Research B24390112 and S22220007) (to Y. K.); Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant-in-Aid for Scientific Research on Innovative Areas 24115008) (to Y. K.); and Research on HIV/AIDS from Ministry of Health, Labor and Welfare of Japan (to Y. K.).	Adya N, 2000, SEMIN CELL DEV BIOL, V11, P361, DOI 10.1006/scdb.2000.0189; Ai YW, 2014, J VIROL, V88, P12112, DOI 10.1128/JVI.01924-14; Albin JS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001343; Jager S, 2012, NATURE, V481, P371, DOI 10.1038/nature10693; Zhang WY, 2014, J VIROL, V88, P12528, DOI 10.1128/JVI.02072-14; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Wang JW, 2011, J VIROL, V85, P12482, DOI 10.1128/JVI.05218-11; Tahirov TH, 2001, CELL, V104, P755, DOI 10.1016/S0092-8674(02)02053-6; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Kim DY, 2013, MOL CELL, V49, P632, DOI 10.1016/j.molcel.2012.12.012; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Stern MA, 2010, J VIROL, V84, P7378, DOI 10.1128/JVI.00584-10; Shimojima M, 2004, SCIENCE, V303, P1192, DOI 10.1126/science.1092124; Larue RS, 2010, J VIROL, V84, P8193, DOI 10.1128/JVI.00685-10; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Refsland EW, 2013, CURR TOP MICROBIOL, V371, P1, DOI 10.1007/978-3-642-37765-5_1; Guo YY, 2014, NATURE, V505, P229, DOI 10.1038/nature12884; Zielonka J, 2010, J VIROL, V84, P7312, DOI 10.1128/JVI.00209-10; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00969; Ito Y, 2008, ADV CANCER RES, V99, P33, DOI 10.1016/S0065-230X(07)99002-8; Bravo J, 2001, NAT STRUCT BIOL, V8, P371, DOI 10.1038/86264; Desimmie BA, 2014, J MOL BIOL, V426, P1220, DOI 10.1016/j.jmb.2013.10.033; Du J, 2013, J VIROL, V87, P1906, DOI 10.1128/JVI.02199-12; Feng YQ, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00450; Han X, 2014, J VIROL, V88, P3320, DOI 10.1128/JVI.03833-13; Hultquist JF, 2012, AIDS RES HUM RETROV, V28, P1543, DOI [10.1089/AID.2012.0142, 10.1089/aid.2012.0142]; Hultquist JF, 2012, J VIROL, V86, P2874, DOI 10.1128/JVI.06950-11; Kitamura S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00258; Kobayashi T, 2014, J VIROL, V88, P5881, DOI 10.1128/JVI.00062-14; Kobayashi T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05529; Munk C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r48; Munk C, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-71; Penn O, 2010, NUCLEIC ACIDS RES, V38, pW23, DOI 10.1093/nar/gkq443; de Bruijn MFTR, 2004, ONCOGENE, V23, P4238, DOI 10.1038/sj.onc.1207763; Yan JL, 2004, NAT STRUCT MOL BIOL, V11, P901, DOI 10.1038/nsmb819; Zielonka J, 2011, VIRUSES-BASEL, V3, P1986, DOI 10.3390/v3101986	37	1	1	SOC GENERAL MICROBIOLOGY	READING	MARLBOROUGH HOUSE, BASINGSTOKE RD, SPENCERS WOODS, READING RG7 1AG, BERKS, ENGLAND	0022-1317	1465-2099		J GEN VIROL	J. Gen. Virol.	APR	2015	96		4				887	892		10.1099/jgv.0.000027		6	Biotechnology & Applied Microbiology; Virology	Biotechnology & Applied Microbiology; Virology	CG9CE	WOS:000353611200018		
J	Nakai, M; Harrison, RL; Uchida, H; Ukuda, R; Hikihara, S; Ishii, K; Kunimi, Y				Nakai, Madoka; Harrison, Robert L.; Uchida, Haruaki; Ukuda, Rie; Hikihara, Shohei; Ishii, Kazuo; Kunimi, Yasuhisa			Isolation of an Adoxophyes orana granulovirus (AdorGV) occlusion body morphology mutant: biological activity, genome sequence and relationship to other isolates of AdorGV	JOURNAL OF GENERAL VIROLOGY			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; SINGLE-NUCLEOCAPSID NUCLEOPOLYHEDROVIRUS; SMALLER TEA TORTRIX; GRANULOSIS-VIRUS; MULTIPLE NUCLEOPOLYHEDROVIRUS; LEPIDOPTERA-TORTRICIDAE; INCLUSION-BODIES; VIRION OCCLUSION; PROTEIN; GENES	A granulovirus (GV) producing occlusion bodies (OBs) with an unusual appearance was isolated from Adoxophyes spp. larvae in the field. Ultrastructural observations revealed that its OBs were significantly larger and cuboidal in shape, rather than the standard ovo-cylindrical shape typical of GVs. N-terminal amino acid sequence analysis of the OB matrix protein from this virus suggested that this new isolate was a variant of Adoxophyes orana granulovirus (AdorGV). Bioassays of this GV (termed AdorGV-M) and an English isolate of AdorGV (termed AdorGV-E) indicated that the two isolates were equally pathogenic against larvae of Adoxophyes honmai. However, AdorGV-M retained more infectivity towards larvae after irradiation with UV light than did AdorGV-E. Sequencing and analysis of the AdorGV-M genome revealed little sequence divergence between this isolate and AdorGV-E. Comparison of selected genes among the two AdorGV isolates and other Japanese AdorGV isolates revealed differences that may account for the unusual OB morphology of AdorGV-M.	[Nakai, Madoka; Uchida, Haruaki; Ukuda, Rie; Hikihara, Shohei; Ishii, Kazuo; Kunimi, Yasuhisa] Tokyo Univ Agr & Technol, Fuchu, Tokyo 1838509, Japan; [Harrison, Robert L.] USDA ARS, Invas Insect Biocontrol & Behav Lab, Beltsville Agr Res Ctr, Beltsville, MD 20705 USA; [Ukuda, Rie] Okinawa Prefectural Plant Protect Ctr, Yaeyama Branch Off, Okinawa 9070003, Japan	Nakai, M (reprint author), Tokyo Univ Agr & Technol, Fuchu, Tokyo 1838509, Japan.	madoka@cc.tuat.ac.jp	NAKAI, Madoka/G-1088-2013	NAKAI, Madoka/0000-0003-1929-9543	JSPS KAKENHI [18380038, 21580064]; US Department of Agriculture	The authors sincerely acknowledge the contribution of Miku Suzuki and Kento Abe for electron microscopy and DNA isolation. This work was supported by the JSPS KAKENHI grant nos 18380038 and 21580064 and the US Department of Agriculture. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the US Department of Agriculture.	AIZAWA K., 1963, Mushi = J. Fukuoka Ent. Soc., V37, P155; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Lin GY, 2000, J INVERTEBR PATHOL, V76, P13, DOI 10.1006/jipa.2000.4934; Katsuma S, 1999, ARCH VIROL, V144, P1275, DOI 10.1007/s007050050586; VanOers MM, 1997, J INVERTEBR PATHOL, V70, P1, DOI 10.1006/jipa.1997.4675; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Nakai Madoka, 2009, Virologica Sinica, V24, P323, DOI 10.1007/s12250-009-3057-9; Harrison RL, 2008, J GEN VIROL, V89, P775, DOI 10.1099/vir.0.83566-0; Guarino LA, 1998, J VIROL, V72, P7985; CARSTENS EB, 1986, J VIROL, V58, P684; Ishii T, 2003, J INVERTEBR PATHOL, V83, P206, DOI 10.1016/S0022-2011(03)00087-9; Garavaglia MJ, 2012, J VIROL, V86, P12069, DOI 10.1128/JVI.01873-12; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Ke JH, 2008, VIROLOGY, V374, P421, DOI 10.1016/j.virol.2007.12.033; [Anonymous], 2013, ARCH VIROL; Cheng XW, 1998, J GEN VIROL, V79, P2549; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Liang ZP, 2011, ARCH VIROL, V156, P1185, DOI 10.1007/s00705-011-0977-0; ARNOTT HJ, 1968, J ULTRA MOL STRUCT R, V22, P136, DOI 10.1016/S0022-5320(68)90053-1; Behle RW, 2000, J INVERTEBR PATHOL, V76, P120, DOI 10.1006/jipa.2000.4958; BIRD FT, 1976, CAN ENTOMOL, V108, P865; DAVID WAL, 1968, J INVERTEBR PATHOL, V11, P496, DOI 10.1016/0022-2011(68)90197-3; Eason JE, 1998, J VIROL, V72, P6237; Ferrelli ML, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-548; GROSS CH, 1994, J GEN VIROL, V75, P1115, DOI 10.1099/0022-1317-75-5-1115; Hall T. A., 1999, NUCL ACIDS S SER, V4, P95, DOI DOI 10.1111/J.1469-8137.2009.02874.X; Harrison RL, 2007, VIRUS GENES, V35, P857, DOI 10.1007/s11262-007-0136-6; HARRISON RL, 1995, J GEN VIROL, V76, P1451, DOI 10.1099/0022-1317-76-6-1451; Herniou E. A., 2011, VIRUS TAXONOMY, P163; Hilton S, 2008, J GEN VIROL, V89, P2898, DOI 10.1099/vir.0.2008/002881-0; Hu ZH, 1999, J GEN VIROL, V80, P1045; IGNOFFO CM, 1989, ENVIRON ENTOMOL, V18, P177; JARVIS DL, 1991, VIROLOGY, V185, P795, DOI 10.1016/0042-6822(91)90551-L; Lopez MG, 2011, ARCH VIROL, V156, P695, DOI 10.1007/s00705-010-0885-8; LU A, 1994, J VIROL, V68, P6710; Mikhailov VS, 1998, J VIROL, V72, P3107; Nakai M, 2003, VIROLOGY, V316, P171, DOI 10.1016/S0042-6822(03)00599-3; Nakai M, 1997, BIOL CONTROL, V8, P74, DOI 10.1006/bcon.1996.0483; Rohrmann G. F., 2011, BACULOVIRUS MOL BIOL; Rowley DL, 2010, VIRUS GENES, V40, P458, DOI 10.1007/s11262-010-0462-y; Sakamaki Y, 2004, APPL ENTOMOL ZOOL, V39, P443, DOI 10.1303/aez.2004.443; SHIGA M, 1973, J INVERTEBR PATHOL, V21, P149, DOI 10.1016/0022-2011(73)90195-X; STAIRS GR, 1964, VIROLOGY, V24, P520, DOI 10.1016/0042-6822(64)90201-6; STAIRS GR, 1966, VIROLOGY, V30, P583, DOI 10.1016/0042-6822(66)90139-5; Tanada Y., 1991, ATLAS INVERTEBRATE V, P227; WATANABE H, 1972, Japanese Journal of Applied Entomology and Zoology, V16, P193; WHITT MA, 1988, VIROLOGY, V163, P33, DOI 10.1016/0042-6822(88)90231-0; Wormleaton S, 2003, VIROLOGY, V311, P350, DOI 10.1016/S0042-6822(03)00149-1; Yang Z., 2001, HDB STAT GENETICS, P327; Yasuda Tosiro, 1998, Transactions of the Lepidopterological Society of Japan, V49, P159	51	0	0	SOC GENERAL MICROBIOLOGY	READING	MARLBOROUGH HOUSE, BASINGSTOKE RD, SPENCERS WOODS, READING RG7 1AG, BERKS, ENGLAND	0022-1317	1465-2099		J GEN VIROL	J. Gen. Virol.	APR	2015	96		4				904	914		10.1099/jgv.0.000023		11	Biotechnology & Applied Microbiology; Virology	Biotechnology & Applied Microbiology; Virology	CG9CE	WOS:000353611200020		
J	Sakaguchi, S; Hombauer, M; Hassan, H; Tanaka, H; Yasmin, N; Naoe, Y; Bilic, I; Moser, MA; Hainberger, D; Mayer, H; Seiser, C; Bergthaler, A; Taniuchi, I; Ellmeier, W				Sakaguchi, Shinya; Hombauer, Matthias; Hassan, Hammad; Tanaka, Hirokazu; Yasmin, Nighat; Naoe, Yoshinori; Bilic, Ivan; Moser, Mirjam A.; Hainberger, Daniela; Mayer, Herbert; Seiser, Christian; Bergthaler, Andreas; Taniuchi, Ichiro; Ellmeier, Wilfried			A novel Cd8-cis-regulatory element preferentially directs expression in CD44(hi)CD62L(+) CD8(+) T cells and in CD8 alpha alpha(+) dendritic cells	JOURNAL OF LEUKOCYTE BIOLOGY			English	Article							TRANSGENIC MICE; MOUSE THYMUS; THYMOCYTES; ENHANCER; ITK; LYMPHOCYTES; PHENOTYPE; SUBSETS; LOCUS; CD4	CD8 coreceptor expression is dynamically regulated during thymocyte development and is tightly controlled by the activity of at least 5 different cis-regulatory elements. Despite the detailed characterization of the Cd8 loci, the regulation of the complex expression pattern of CD8 cannot be fully explained by the activity of the known Cd8 enhancers. In this study, we revisited the Cd8ab gene complex with bioinformatics and transgenic reporter gene expression approaches to search for additional Cd8 cis-regulatory elements. This led to the identification of an ECR (ECR-4), which in transgenic reporter gene expression assays, directed expression preferentially in CD44(hi)CD62L(+) CD8(+) T cells, including innate-like CD8(+) T cells. ECR-4, designated as Cd8 enhancer E8(VI), was bound by Runx/CBF beta complexes and Bcl11b, indicating that E8VI is part of the cis-regulatory network that recruits transcription factors to the Cd8ab gene complex in CD8(+) T cells. Transgenic reporter expression was maintained in LCMV-specific CD8(+) T cells upon infection, although short-term, in vitro activation led to a down-regulation of E8VI activity. Finally, E8VI directed transgene expression also in CD8 alpha alpha(+) DCs but not in CD8 alpha alpha-expressing IELs. Taken together, we have identified a novel Cd8 enhancer that directs expression in CD44hiCD62L(+) CD8(+) T cells, including innate-like and antigen-specific effector/memory CD8(+) T cells and in CD8aa(+) DCs, and thus, our data provide further insight into the cis-regulatory networks that control CD8 expression.	[Sakaguchi, Shinya; Hombauer, Matthias; Hassan, Hammad; Bilic, Ivan; Hainberger, Daniela; Ellmeier, Wilfried] Med Univ Vienna, Inst Immunol, Div Immunobiol, Ctr Pathophysiol Infectiol & Immunol, A-1090 Vienna, Austria; [Moser, Mirjam A.; Seiser, Christian] Med Univ Vienna, Max Perutz Labs, Vienna Bioctr, Dept Med Biochem, A-1090 Vienna, Austria; [Mayer, Herbert] Med Univ Vienna, Inst Vasc Biol, A-1090 Vienna, Austria; [Tanaka, Hirokazu; Yasmin, Nighat; Naoe, Yoshinori; Taniuchi, Ichiro] RIKEN Ctr Integrat Med Sci, Lab Transcript Regulat, Yokohama, Kanagawa, Japan; [Bergthaler, Andreas] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria	Ellmeier, W (reprint author), Med Univ Vienna, Inst Immunol, Div Immunobiol, Lazarettgasse 19, A-1090 Vienna, Austria.	wilfried.ellmeier@meduniwien.ac.at		Bergthaler, Andreas/0000-0003-0597-1976; Ellmeier, Wilfried/0000-0001-8192-8481	FWF [P19990, P23641, I698, P23669, P25807]; BMWFW; Schering Stiftung; RIKEN Center for Allergy and Immunology International Collaboration Award Program; Japanese Society for the Promotion of Science Joint Research Projects	This work in the laboratory of W.E. was supported by the START program (Grant Y-163) of the FWF and BMWFW; the FWF (P19990 and P23641, I698). M.H. was supported by a Ph.D. student fellowship from the Schering Stiftung. S.S. is supported by the FWF (P23669). Work in the laboratory of I.T. was supported by the RIKEN Center for Allergy and Immunology International Collaboration Award Program and Japanese Society for the Promotion of Science Joint Research Projects. C.S. was supported by the FWF (P25807). The authors thank Drs. Andrea Carpenter and Remy Bosselut for communicating unpublished results and Clemens Donner for help with sorting.	Broussard C, 2006, IMMUNITY, V25, P93, DOI 10.1016/j.immuni.2006.05.011; Surh CD, 2006, IMMUNOL REV, V211, P154, DOI 10.1111/j.0105-2896.2006.00401.x; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Ellmeier W, 2002, IMMUNITY, V16, P623, DOI 10.1016/S1074-7613(02)00309-6; Zhang SN, 2010, J EXP MED, V207, P1687, DOI 10.1084/jem.20092136; Xiong YM, 2012, CURR OPIN IMMUNOL, V24, P139, DOI 10.1016/j.coi.2012.02.002; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294; Liao XC, 1995, IMMUNITY, V3, P757, DOI 10.1016/1074-7613(95)90065-9; Vremec D, 2000, J IMMUNOL, V164, P2978; Ellmeier W, 1998, IMMUNITY, V9, P485, DOI 10.1016/S1074-7613(00)80632-9; Carpenter AC, 2010, NAT IMMUNOL, V11, P666, DOI 10.1038/ni.1887; Mucida D, 2013, NAT IMMUNOL, V14, P281, DOI 10.1038/ni.2523; Bilic I, 2006, NAT IMMUNOL, V7, P392, DOI 10.1038/ni1311; Taniuchi I, 2011, ADV IMMUNOL, V110, P71, DOI [10.1016/B978-0-12-387663-8.00003-X, 10.1016/B978-012-387663-8.00003-X]; Hassan H, 2011, P NATL ACAD SCI USA, V108, P18330, DOI 10.1073/pnas.1105835108; Boucheron N, 2014, NAT IMMUNOL, V15, P439, DOI 10.1038/ni.2864; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; Berg LJ, 2007, NAT REV IMMUNOL, V7, P479, DOI 10.1038/nri2091; Naoe Y, 2007, J EXP MED, V204, P1749, DOI 10.1084/jem.20062456; Kienzle N, 2005, J IMMUNOL, V174, P2021; Atherly Luana O, 2006, Immunity, V25, P79, DOI 10.1016/j.immuni.2006.05.012; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; Dubois S, 2006, P NATL ACAD SCI USA, V103, P12075, DOI 10.1073/pnas.0605212103; Ellmeier W, 1997, IMMUNITY, V7, P537, DOI 10.1016/S1074-7613(00)80375-1; Feik N, 2005, J IMMUNOL, V174, P1513; Festenstein R, 2000, CURR OPIN GENET DEV, V10, P199, DOI 10.1016/S0959-437X(00)00060-5; Garefalaki A, 2002, IMMUNITY, V16, P635, DOI 10.1016/S1074-7613(02)00308-4; GORMAN SD, 1988, J IMMUNOL, V140, P3646; Hostert A, 1998, IMMUNITY, V9, P497, DOI 10.1016/S1074-7613(00)80633-0; Hostert A, 1997, J IMMUNOL, V158, P4270; Hostert A, 1997, IMMUNITY, V7, P525, DOI 10.1016/S1074-7613(00)80374-X; Hu J, 2007, EUR J IMMUNOL, V37, P2892, DOI 10.1002/eji.200737311; JARRY A, 1990, EUR J IMMUNOL, V20, P1097, DOI 10.1002/eji.1830200523; Lefrançois L, 1991, Semin Immunol, V3, P99; Nardone J, 2004, NAT IMMUNOL, V5, P768, DOI 10.1038/ni0804-768; Sato T, 2005, IMMUNITY, V22, P317, DOI 10.1016/j.immuni.2005.01.012; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; Zhang XL, 1998, J IMMUNOL, V161, P2254	38	1	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0741-5400	1938-3673		J LEUKOCYTE BIOL	J. Leukoc. Biol.	APR	2015	97	4					635	644		10.1189/jlb.1HI1113-597RR		10	Cell Biology; Hematology; Immunology	Cell Biology; Hematology; Immunology	CH3BH	WOS:000353900100004		
J	Pang, MY; Guo, SX; Huang, Q; Ishihara, H; Hirata, H				Pang, Muye; Guo, Shuxiang; Huang, Qiang; Ishihara, Hidenori; Hirata, Hideyuki			Electromyography-Based Quantitative Representation Method for Upper-Limb Elbow Joint Angle in Sagittal Plane	JOURNAL OF MEDICAL AND BIOLOGICAL ENGINEERING			English	Article						Upper limb elbow joint; Electromyography (EMG); Hill-type model; State switching; Continuous representation	SURFACE ELECTROMYOGRAPHY; EMG SIGNALS; MUSCLE; ARM; CLASSIFICATION; BIOMECHANICS; INTERFACE; HAND	This paper presents a quantitative representation method for the upper-limb elbow joint angle using only electromyography (EMG) signals for continuous elbow joint voluntary flexion and extension in the sagittal plane. The dynamics relation between the musculotendon force exerted by the biceps brachii muscle and the elbow joint angle is developed for a modified musculoskeletal model. Based on the dynamics model, a quadratic-like quantitative relationship between EMG signals and the elbow joint angle is built using a Hill-type-based muscular model. Furthermore, a state switching model is designed to stabilize the transition of EMG signals between different muscle contraction motions during the whole movement. To evaluate the efficiency of the method, ten subjects performed continuous experiments during a 4-day period and five of them performed a subsequent consecutive stepping test. The results were calculated in real-time and used as control reference to drive an exoskeleton device bilaterally. The experimental results indicate that the proposed method can provide suitable prediction results with root-mean-square (RMS) errors of below 10A degrees in continuous motion and RMS errors of below 10A degrees in stepping motion with 20A degrees and 30A degrees increments. It is also easier to calibrate and implement.	[Pang, Muye] Kagawa Univ, Grad Sch Engn, Takamatsu, Kagawa 7610396, Japan; [Guo, Shuxiang; Ishihara, Hidenori; Hirata, Hideyuki] Kagawa Univ, Dept Intelligent Mech Syst Engn, Takamatsu, Kagawa 7610396, Japan; [Guo, Shuxiang; Huang, Qiang] Beijing Inst Technol, Sch Life Sci & Technol, Beijing 100081, Peoples R China	Guo, SX (reprint author), Kagawa Univ, Dept Intelligent Mech Syst Engn, Takamatsu, Kagawa 7610396, Japan.	guo@eng.kagawa-u.ac.jp			Kagawa University Characteristic Prior Research Fund	This research was supported by the Kagawa University Characteristic Prior Research Fund 2012.	Fukuda O, 2003, IEEE T ROBOTIC AUTOM, V19, P210, DOI 10.1109/TRA.2003.808873; Osu R, 1999, J NEUROPHYSIOL, V81, P1458; Ajoudani A, 2012, INT J ROBOT RES, V31, P1642, DOI 10.1177/0278364912464668; Bu N, 2009, IEEE T ROBOT, V25, P502, DOI 10.1109/TRO.2009.2019782; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; Chen X, 2013, BIOMED SIGNAL PROCES, V8, P184, DOI 10.1016/j.bspc.2012.08.005; Bitzer S, 2006, IEEE INT CONF ROBOT, P2819; De Luca CJ, 1997, J APPL BIOMECH, V13, P135; Manal K, 2002, COMPUT BIOL MED, V32, P25, DOI 10.1016/S0010-4825(01)00024-5; HUXLEY AF, 1971, NATURE, V233, P533, DOI 10.1038/233533a0; Fleischer C, 2008, IEEE T ROBOT, V24, P872, DOI 10.1109/TRO.2008.926860; Reaz MBI, 2006, BIOL PROCED ONLINE, V8, P11, DOI 10.1251/bpo115; Artemiadis P. K., 2009, IEEE T SYST MAN CY B, V41, P53; Buchanan TS, 2004, J APPL BIOMECH, V20, P367; Cavallaro E., 2005, IEEE INT C ROB AUT, P4525; Earp JE, 2013, J ELECTROMYOGR KINES, V23, P238, DOI 10.1016/j.jelekin.2012.08.015; Franklin DW, 2003, IEEE EMBS APBME 2003, P224, DOI 10.1109/APBME.2003.1302664; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255; LIAROKAPIS MV, 2012, IEEE INT C ROB AUT, P2287; Lucas L., 2004, J ROBOTICS MECHATRON, V16, P482; Pang M., 2012, J ROBOTICS MECHATRON, V24, P585; PANG MY, 2013, P ICME INT C COMPL M, P329; Phinyomark A., 2013, ENG APPL ARTIF INTEL, V27, P1681; Song Z., 2011, INT J MECHATRONICS A, V1, P19; Tang XY, 2012, SENSORS-BASEL, V12, P1130, DOI 10.3390/s120201130; Wojtczak P., 2008, ENG APPL ARTIF INTEL, V22, P608; ZAJAC FE, 1989, CRIT REV BIOMED ENG, V17, P359	27	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1609-0985	2199-4757		J MED BIOL ENG	J. Med. Biol. Eng.	APR	2015	35	2					165	177		10.1007/s40846-015-0033-8		13	Engineering, Biomedical	Engineering	CH2BF	WOS:000353828200003		
J	Syazwani, N; Azhim, A; Morimoto, Y; Furukawa, KS; Ushida, T				Syazwani, N.; Azhim, A.; Morimoto, Y.; Furukawa, K. S.; Ushida, T.			Decellularization of Aorta Tissue Using Sonication Treatment as Potential Scaffold for Vascular Tissue Engineering	JOURNAL OF MEDICAL AND BIOLOGICAL ENGINEERING			English	Article						Tissue engineering; Decellularization; Sonication treatment; Artery; Bioscaffolds	PORCINE HEART-VALVES; MECHANICAL-PROPERTIES; EXTRACTION TECHNIQUES; EXTRACELLULAR-MATRIX; CAROTID ARTERIES; CELL REMOVAL; RECELLULARIZATION; GENERATION; COLLAGEN; TRANSPLANTATION	Arterial scaffolds have potential for replacing native arteries for vascular surgery. These scaffolds are anti-thrombogenic, biocompatible, and capable of growth and repair, making them suitable for application in vascular tissue engineering. This study develops a sonication decellularization system for preparing a complete decellularized artery. The sonication decellularization efficiency on arterial tissues is investigated. Aorta samples are decellularized by sonication treatment with various treatment times and application of sodium dodecyl sulfate (SDS) detergent with and without saline. The relation between decellularization and dissolved oxygen concentration is investigated. The treated samples are evaluated using hematoxylin-eosin staining, scanning electron microscopy, diamidino-2-phenylindol (DAPI) staining, biomechanical testing, and DNA quantification. From the histological analysis, sonication treatment without saline shows complete decellularization at a specific region on the extracellular matrix. This is further confirmed by the DAPI staining, which demonstrates complete removal of DNA fragments for sonication treatment in 2 % SDS without saline. Sonication treatment without saline is thus capable of producing complete decellularized scaffolds for vascular tissue engineering.	[Syazwani, N.; Azhim, A.] Univ Teknol Malaysia, Malaysia Japan Int Inst Technol, Dept Elect Syst Engn, Kuala Lumpur 54100, Malaysia; [Morimoto, Y.] Natl Def Med Coll, Dept Internal Physiol Bionano Med, Tokorozawa, Saitama 3598513, Japan; [Furukawa, K. S.; Ushida, T.] Univ Tokyo, Dept Bioengn, Tokyo 1130033, Japan; [Azhim, A.; Ushida, T.] Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrat Med, Tokyo 1130033, Japan	Azhim, A (reprint author), Univ Teknol Malaysia, Malaysia Japan Int Inst Technol, Dept Elect Syst Engn, Kuala Lumpur 54100, Malaysia.	azhim.kl@utm.my	Azran, Azhim/O-5225-2015		Ministry of Education, Culture, Sport, Science and Technology (MEXT); Malaysia-Japan International Institute of Technology, Universiti Teknologi Malaysia; IJN-UTM Cardiovascular Engineering Center, Universiti Teknologi Malaysia	The authors are grateful to the Ministry of Education, Culture, Sport, Science and Technology (MEXT) for its financial support through a Strategic Research Foundation Grant for Private Universities. We also would like to thank Malaysia-Japan International Institute of Technology, Universiti Teknologi Malaysia and IJN-UTM Cardiovascular Engineering Center, Universiti Teknologi Malaysia, for its financial support.	Freed AD, 2005, J BIOMECH ENG-T ASME, V127, P587, DOI 10.1115/1.1934145; McFetridge PS, 2004, J BIOMED MATER RES A, V70A, P224, DOI 10.1002/jbm.a.30060; Ingram JH, 2007, TISSUE ENG, V13, P1561, DOI 10.1089/ten.2006.0362; Williams C, 2009, ACTA BIOMATER, V5, P993, DOI 10.1016/j.actbio.2008.11.028; Negishi J, 2011, J ARTIF ORGANS, V14, P223, DOI 10.1007/s10047-011-0570-z; Sawada K, 2008, J CHEM TECHNOL BIOT, V83, P943, DOI 10.1002/jctb.1899; DOBRIN PB, 1978, PHYSIOL REV, V58, P397; Mercuri JJ, 2011, J BIOMED MATER RES A, V96A, P422, DOI 10.1002/jbm.a.33001; Reing JE, 2010, BIOMATERIALS, V31, P8626, DOI 10.1016/j.biomaterials.2010.07.083; WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816; Mason TJ, 2003, ULTRASON SONOCHEM, V10, P175, DOI 10.1016/S1350-4177(03)00086-5; Nakayama KH, 2010, TISSUE ENG PT A, V16, P2207, DOI 10.1089/ten.TEA.2009.0602; Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193; Perniconi B, 2011, BIOMATERIALS, V32, P7870, DOI 10.1016/j.biomaterials.2011.07.016; Narita Y, 2008, J ARTIF ORGANS, V11, P91, DOI 10.1007/s10047-008-0407-6; Patel A, 2006, CARDIOVASC RES, V71, P40, DOI 10.1016/j.cardiores.2006.02.021; Sheridan WS, 2012, J MECH BEHAV BIOMED, V8, P58, DOI 10.1016/j.jmbbm.2011.12.003; McKee CT, 2011, TISSUE ENG PART B-RE, V17, P155, DOI [10.1089/ten.TEB.2010.0520, 10.1089/ten.teb.2010.0520]; D'Armiento J, 2003, J CLIN INVEST, V112, P1308, DOI 10.1172/JCI200320226; Gilbert Thomas W, 2009, J Surg Res, V152, P135, DOI 10.1016/j.jss.2008.02.013; Rieder E, 2004, J THORAC CARDIOV SUR, V127, P399, DOI 10.1016/j.jtcvs.2003.06.017; Edelman ER, 1999, CIRC RES, V85, P1115; Dahl SLM, 2003, CELL TRANSPLANT, V12, P659; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Sandmann GH, 2009, J BIOMED MATER RES A, V91A, P567, DOI 10.1002/jbm.a.32269; Ravi S, 2010, REGEN MED, V5, P107, DOI [10.2217/rme.09.77, 10.2217/RME.09.77]; Cleary MA, 2012, TRENDS MOL MED, V18, P394, DOI 10.1016/j.molmed.2012.04.013; Kneser U, 2006, J CELL MOL MED, V10, P7, DOI 10.1111/j.1582-4934.2006.tb00287.x; Ketchedjian A, 2005, ANN THORAC SURG, V79, P888, DOI 10.1016/j.athorascur.2004.09.033; Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016; Anssari-Benam A, 2011, J MATER SCI-MATER M, V22, P253, DOI 10.1007/s10856-010-4210-6; Campbell EM, 2012, J MECH BEHAV BIOMED, V14, P130, DOI 10.1016/j.jmbbm.2012.06.001; Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013; Woods T, 2005, BIOMATERIALS, V26, P7339, DOI 10.1016/j.biomaterials.2005.05.066; Kasimir MT, 2003, INT J ARTIF ORGANS, V26, P421; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; Elder BD, 2009, BIOMATERIALS, V30, P3749, DOI 10.1016/j.biomaterials.2009.03.050; Azar L., 2009, CONTROLLED ENV, P14; Azhim A., 2012, IFMBE P, V39, P1987; Azhim A, 2014, J BIOMATER APPL, V29, P130, DOI 10.1177/0885328213517579; Azhim A, 2010, IFMBE PROC, V31, P915; Azhim A, 2013, P IEEE ENG MED C BIO, V2013, P6953; COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602; Fitzpatrick John C, 2010, International Journal of Biomaterials, DOI 10.1155/2010/620503; Fuchs J., 2002, ULTRASONIC CLEANING; Gonzalez-Andrades M, 2011, INVEST OPHTH VIS SCI, V52, P215, DOI 10.1167/iovs.09-4773; Ha T. L. B., 2013, REGENERATIVE MED TIS, P247; Han Q., 2013, J MED BIOL ENG, V34, P130; Hay JL, 2000, ASM HDB, V8, P232; Hung SH, 2013, J VOICE, V27, P289, DOI 10.1016/j.jvoice.2013.01.018; Maier D., 2007, J ORTHOPAED RES, V12, P1598; Makino H, 1989, Nihon Jinzo Gakkai Shi, V31, P1039; Mansour J. M., 2012, J MED BIOL ENG, V33, P1; Matsumoto T, 1996, AM J PHYSIOL-HEART C, V271, pH1711; Niemczewski B, 1999, ULTRASON SONOCHEM, V6, P211, DOI 10.1016/S1350-4177(99)00008-5; O'Connor A. J., 2012, PLASTIC SURG PRINCIP, P367; Oh JY, 2009, TISSUE ENG PART C-ME, V15, P635, DOI 10.1089/ten.TEC.2009.0022; Oliveira AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066538; Olson Jennifer L, 2011, Chonnam Med J, V47, P1, DOI 10.4068/cmj.2011.47.1.1; Tosun Z., 2012, J VASC SURG, V54, P1451; Tuziuti T, 2002, ULTRASONICS, V40, P651, DOI 10.1016/S0041-624X(02)00192-0; Walter RJ, 1998, BURNS, V24, P104, DOI 10.1016/S0305-4179(97)00110-1; Wang XN, 2005, J BIOMED MATER RES A, V74A, P263, DOI 10.1002/jbm.a.30387; Weinberg EJ, 2010, BIOMECH MODEL MECHAN, V9, P373, DOI 10.1007/s10237-009-0181-2; Wilson Samantha L, 2013, J Funct Biomater, V4, P114, DOI 10.3390/jfb4030114	65	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1609-0985	2199-4757		J MED BIOL ENG	J. Med. Biol. Eng.	APR	2015	35	2					258	269		10.1007/s40846-015-0028-5		12	Engineering, Biomedical	Engineering	CH2BF	WOS:000353828200013		
J	Yamaguchi, S; Niekawa, N; Maida, K; Chiba, R; Umeda, M; Uddin, S; Taneda, A; Ito, J				Yamaguchi, Sosei; Niekawa, Nobuyuki; Maida, Keiko; Chiba, Rie; Umeda, Maki; Uddin, Shahir; Taneda, Ayano; Ito, Junichiro			Association between stigmatisation and experiences of evidence-based practice by psychiatric rehabilitation staff in Japan: a cross-sectional survey	JOURNAL OF MENTAL HEALTH			English	Article						Attitudes; evidence-based practice; professionals; social distance; stigma	MENTAL-HEALTH PROFESSIONALS; STIGMA; ILLNESS; IMPLEMENTATION; SCHIZOPHRENIA; INTERVENTIONS; ATTITUDES; RECOVERY; PEOPLE	Background: Mental health professionals are one of the groups holding harmful stigmatisation towards people with mental illness. Aims: To investigate the association between the performance of evidence-based practice (EBP) and the staff's level of stigmatisation in Japan. Methods: The study enrolled 179 staff members in psychiatric day-care, psychiatric community outreach teams, and psychiatric rehabilitation teams at 14 psychiatric hospitals. The Positive Attitudes Scale (PAS), the Japanese-language version of the Social Distance Scale (SDSJ) and the Recovery Attitude Questionnaire (RAQ) were employed as outcome measures. Scores on each scale were compared between participants who performed EBPs and those who had never performed EBPs. Results: Approximately 40% of the staff engaged in at least assertive community treatment, supported employment or family psychoeducation. The staff who performed EBPs had significantly higher scores on PAS (MD, 7.09; 95% CIs, 4.09-10.09) and RAQ (MD, 1.30; 95% CIs, 0.36-2.25) but lower scores on SDSJ (MD, -2.41; 95% CIs, -3.50 to -1.32) than those who never performed EBPs. Multivariate analyses found that EBP experience was associated with a low level of staff stigmatisation after controlling for confounders. Conclusion: The findings suggest that an individual EBP experience is associated with their reduced stigmatisation.	[Yamaguchi, Sosei; Maida, Keiko; Taneda, Ayano; Ito, Junichiro] Natl Ctr Neurol & Psychiat, Inst Mental Hlth, Dept Psychiat Rehabil, Kodaira, Tokyo 1878553, Japan; [Niekawa, Nobuyuki] Japan Coll Social Work, Social Work Res Inst, Tokyo, Japan; [Chiba, Rie] Jichi Med Univ, Sch Nursing, Shimotsuke, Tochigi, Japan; [Umeda, Maki] Univ Tokyo, Sch Med, Dept Mental Hlth, Bunkyo Ku, Tokyo 113, Japan; [Uddin, Shahir] St Bernards Hosp, West London Mental Hlth NHS Trust, London, England	Yamaguchi, S (reprint author), Natl Ctr Neurol & Psychiat, Inst Mental Hlth, Dept Psychiat Rehabil, 4-1-1 Ogawa Higashi, Kodaira, Tokyo 1878553, Japan.	sosei.yama@ncnp.go.jp			Ministry of Health, Labour and Welfare [H23-001]	This study was part of "A study on the model construction and the evaluation of community psychiatry to promote community lives" which was funded as "Research on the Applying Health Technology" by the Ministry of Health, Labour and Welfare (H23-001).	Read J, 2006, ACTA PSYCHIAT SCAND, V114, P303, DOI 10.1111/j.1600-0447.2006.00824.x; Yates I, 2012, J MENT HEALTH, V21, P105, DOI 10.3109/09638237.2011.613957; Nordt C, 2006, SCHIZOPHRENIA BULL, V32, P709, DOI 10.1093/schbul/sbj065; Corrigan PW, 2012, PSYCHIAT SERV, V63, P963, DOI [10.1176/appi.ps.201100529, 10.1176/appi.ps.005292011]; Dieterich M, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007906.pub2; Cohen AN, 2008, PSYCHIAT SERV, V59, P40, DOI 10.1176/appi.ps.59.1.40; Gearing RE, 2011, CLIN PSYCHOL REV, V31, P79, DOI 10.1016/j.cpr.2010.09.007; Xia J, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002831.pub2; Schulze B, 2007, INT REV PSYCHIATR, V19, P137, DOI 10.1080/09540260701278929; Bond GR, 2010, RES SOCIAL WORK PRAC, V20, P493, DOI 10.1177/1049731509358085; Borkin JR, 2000, PSYCHIATR REHABIL J, V24, P95; Chiba R, 2012, P 20 C JAP ASS PSYCH; CLEMENT S, 2011, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD009453; Crowther RMM, 2001, COCHRANE DB SYST REV, V2, DOI [10.1002/14651858.CD003080, DOI 10.1002/14651858.CD003080]; Iwai K, 2011, JPN B SOC PSYCHIAT, V20, P94; Makita K, 2006, JPN B SOC PSYCHIAT, V14, P231; Thornicroft G, 2009, BETTER MENTAL HLTH C; Thornicroft G., 2006, SHUNNED DISCRIMINATI; Wykes T, 2013, J MENT HEALTH, V22, P203, DOI 10.3109/09638237.2013.799269; Yamaguchi S, 2011, PSYCHIAT CLIN NEUROS, V65, P405, DOI 10.1111/j.1440-1819.2011.02239.x; Yamaguchi S, 2013, J NERV MENT DIS, V201, P490, DOI 10.1097/NMD.0b013e31829480df	21	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0963-8237	1360-0567		J MENT HEALTH	J. Ment. Heal.	APR	2015	24	2					78	82		10.3109/09638237.2014.998802		5	Psychology, Clinical	Psychology	CG8SJ	WOS:000353582100005		
J	Shen, Z; Hasegawa, H; Sato, K				Shen, Zhi-shu; Hasegawa, Hiroshi; Sato, Ken-ichi			Integrity Enhancement of Flexible/Semi-Flexible Grid Networks That Minimizes Disruption in Spectrum Defragmentation and Bitrate-Dependent Blocking	JOURNAL OF OPTICAL COMMUNICATIONS AND NETWORKING			English	Article						Flexible grid optical path network; Rerouting and spectrum defragmentation algorithm; Semi-flexible grid optical path network	OPTICAL-PATH NETWORK; TECHNOLOGIES; BENEFITS	We propose a novel disruption-minimized dynamic rerouting and spectrum defragmentation algorithm that addresses blocking ratio equalization on different bandwidth signals in flexible grid networks and our recently proposed semi-flexible grid networks. The blocking ratio inequality among channels stems from nonuniform frequency bandwidth allocation to different channels, which is unique to flexible/semi-flexible grid networks. The nonuniform assignment also causes more frequent channel setup blocking due to the severe fragmentation that is possible in the frequency domain. To resolve these issues, a dedicated bandwidth reservation technique for the broadest bandwidth paths is introduced to cope with the inequality issue, and the path blocking ratio is reduced by applying rerouting and a spectrum defragmentation technique. Numerical evaluations verify that combining these techniques can achieve a maximum improvement in the network performance including blocking ratio and equality. The results also confirm that semi-flexible grid networks can achieve almost the same performance as the currently studied flexible grid solution. Since the former have much relaxed hardware requirements, this novel approach is expected be a viable solution to realizing future flexible bandwidth networks cost-effectively.	[Shen, Zhi-shu; Hasegawa, Hiroshi; Sato, Ken-ichi] Nagoya Univ, Dept Elect Engn & Comp Sci, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Shen, Z (reprint author), Nagoya Univ, Dept Elect Engn & Comp Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.	z_shen@echo.nuee.nagoya-u.ac.jp			NICT (lambda-Reach); KAKENHI [26220905]	This work was partly supported by NICT (lambda-Reach) and KAKENHI (26220905).	Gringeri S, 2010, IEEE COMMUN MAG, V48, P40, DOI 10.1109/MCOM.2010.5496877; Wang R, 2014, OPT SWITCH NETW, V11, P83, DOI 10.1016/j.osn.2013.09.003; Jinno M, 2009, IEEE COMMUN MAG, V47, P66, DOI 10.1109/MCOM.2009.5307468; Chiu AL, 2012, J OPT COMMUN NETW, V4, P1, DOI 10.1364/JOCN.4.000001; Klekamp A, 2012, J LIGHTWAVE TECHNOL, V30, P215, DOI 10.1109/JLT.2011.2180889; Shieh W, 2008, OPT EXPRESS, V16, P841, DOI 10.1364/OE.16.000841; Woodward SL, 2013, J OPT COMMUN NETW, V5, pA19, DOI 10.1364/JOCN.5.000A19; Bosco G, 2011, J LIGHTWAVE TECHNOL, V29, P53, DOI 10.1109/JLT.2010.2091254; Cugini F., 2012, OPT FIB COMM C OFC L; Feuer M., 2012, NAT FIB OPT ENG C NF; Gerstel O., 2012, IEEE COMMUN MAG, V50, P12; Ishida H., 2014, OPT FIB COMM C OFC S; Jensen R., 2010, EUR C EXH OPT COMM E; Ono T., 2011, OPT FIB COMM C OFC L; Patel A., 2011, OPT FIB COMM C OFC L; Sato K, 2009, J OPT COMMUN NETW, V1, pA81, DOI 10.1364/JOCN.1.000A81; Scaraficci R., 2014, INT C COMM ICC SYDN; Shen Z., 2013, EUR C EXH OPT COMM E; Shen Z., 2014, PHOT SWITCH PS SAN D; Shen Z., 2014, P OPT NETW DES MOD O, P287; Shen ZS, 2014, OPT EXPRESS, V22, P3169, DOI 10.1364/OE.22.003169; Takagi T., 2010, EUR C EXH OPT COMM E; Takagi T., 2011, EUR C EXH OPT COMM E; Takashina S., 2014, OPT FIB COMM C OFC S; Tian Y., 2013, OPT FIB COMM C OFC L; Wang X., 2012, OPT FIB COMM C OFC L; Wright P., 2013, EUR C EXH OPT COMM E; Zami T., 2013, EUR C EXH OPT COMM E; Zami T., 2012, EUR C EXH OPT COMM E	29	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1943-0620	1943-0639		J OPT COMMUN NETW	J. Opt. Commun. Netw.	APR	2015	7	4					235	247		10.1364/JOCN.7.000235		13	Computer Science, Hardware & Architecture; Computer Science, Information Systems; Optics; Telecommunications	Computer Science; Optics; Telecommunications	CG8PF	WOS:000353570100004		
J	Tabata, K; Nishimura, Y; Takeda, T; Kurita, M; Uchiyama, T; Suzuki, T				Tabata, Keiichi; Nishimura, Yuki; Takeda, Taiji; Kurita, Masahiro; Uchiyama, Taketo; Suzuki, Takashi			Sesquiterpene lactones derived from Saussurea lappa induce apoptosis and inhibit invasion and migration in neuroblastoma cells	JOURNAL OF PHARMACOLOGICAL SCIENCES			English	Article						Sesquiterpenes; Neuroblastoma; Apoptosis; Invasion; Migration	ENDOPLASMIC-RETICULUM STRESS; HUMAN PROSTATE-CANCER; DEHYDROCOSTUS LACTONE; MEDICINAL-PLANT; ROS GENERATION; COSTUNOLIDE; EXPRESSION; DEATH; CYCLE; ROOT	Neuroblastoma is among the most fatal of solid tumors in the pediatric age group, even when treated aggressively. Therefore, a new effective therapeutic drug(s) for neuroblastoma is urgently needed. To clarify the anticancer effects of the sesquiterpene lactones dehydrocostus lactone and costunolide, derived from Saussurea lappa, we examined the cytotoxic and migration/invasion-inhibitory effects of these compounds against neuroblastoma cell lines. Both the compounds exerted significant cytotoxicity against the neuroblastoma cell lines IMR-32, NB-39, SK-N-SH, and LA-N-1. Evidence of cellular apoptosis, such as nuclear condensation and membrane inversion, were observed after treatment with these compounds. Both compounds induced caspase-7 activation and PARP cleavage as confirmed by Western blotting. Furthermore, the sesquiterpene lactones also suppressed invasion and migration of the neuroblastoma cells. These results suggest that dehydrocostus lactone and costunolide are promising candidates for being developed into novel anticancer drugs effective against neuroblastoma. (C) 2015 Japanese Pharmacological Society. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Tabata, Keiichi; Nishimura, Yuki; Takeda, Taiji; Kurita, Masahiro; Uchiyama, Taketo; Suzuki, Takashi] Nihon Univ, Sch Pharm, Funabashi, Chiba 2748555, Japan; [Suzuki, Takashi] Nihon Univ, Sch Med, Itabashi Ku, Tokyo 1730032, Japan	Suzuki, T (reprint author), Nihon Univ, Sch Med, Itabashi Ku, 30-1 Oyaguchikami Cho, Tokyo 1730032, Japan.	suzuki.takashi85@nihon-u.ac.jp					Lohberger B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066300; Hung JY, 2010, LUNG CANCER, V68, P355, DOI 10.1016/j.lungcan.2009.07.017; Pandey MM, 2007, J ETHNOPHARMACOL, V110, P379, DOI 10.1016/j.jep.2006.12.033; Hsu YL, 2009, J PHARMACOL EXP THER, V329, P808, DOI 10.1124/jpet.108.148395; Choi YK, 2012, MOL CELL BIOCHEM, V363, P119, DOI 10.1007/s11010-011-1164-z; Kim EJ, 2008, FOOD CHEM TOXICOL, V46, P3651, DOI 10.1016/j.fct.2008.08.038; Lamkanfi M, 2010, INT J BIOCHEM CELL B, V42, P21, DOI 10.1016/j.biocel.2009.09.013; Choi JH, 2002, JPN J CANCER RES, V93, P1327; Choi JH, 2009, BIOL PHARM BULL, V32, P1803; Jeong D, 2013, BIOL PHARM BULL, V36, P152, DOI 10.1248/bpb.b12-00871; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; REED JC, 1991, CANCER RES, V51, P6529; Yang YI, 2011, GYNECOL ONCOL, V123, P588, DOI 10.1016/j.ygyno.2011.08.031; Oh GS, 2004, IMMUNOPHARM IMMUNOT, V26, P163, DOI 10.1081/IPH-120037712; Sun CM, 2003, J NAT PROD, V66, P1175, DOI 10.1021/np030147e; Sugiura Y, 1998, CANCER RES, V58, P2209; Choi YK, 2013, EVID-BASED COMPL ALT, DOI 10.1155/2013/936257; DOLE M, 1994, CANCER RES, V54, P3253; Hsu JL, 2011, J UROLOGY, V185, P1967, DOI 10.1016/j.juro.2010.12.091; Kocak H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.84; Kretschmer N, 2012, PLANTA MED, V78, P1749, DOI 10.1055/s-0032-1315385; Kuo PL, 2009, MOL CANCER THER, V8, P1328, DOI 10.1158/1535-7163.MCT-08-0914; Rasul A, 2013, MOLECULES, V18, P1418, DOI 10.3390/molecules18021418; Ribatti D, 2004, ANN NY ACAD SCI, V1028, P133, DOI 10.1196/annals.1322.014; Tabata K, 2012, CANCER SCI, V103, P2153, DOI 10.1111/cas.12021; Teitz T, 2001, J MOL MED, V79, P428, DOI 10.1007/s001090100233; Wang CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031195	27	1	1	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	1347-8613	1347-8648		J PHARMACOL SCI	J. Pharmacol. Sci.	APR	2015	127	4					397	403		10.1016/j.jphs.2015.01.002		7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CH2TI	WOS:000353877100001		
J	Mori, A; Morita, M; Morishita, K; Sakamoto, K; Nakahara, T; Ishii, K				Mori, Asami; Morita, Masahiko; Morishita, Koji; Sakamoto, Kenji; Nakahara, Tsutomu; Ishii, Kunio			L-Citrulline dilates rat retinal arterioles via nitric oxide- and prostaglandin-dependent pathways in vivo	JOURNAL OF PHARMACOLOGICAL SCIENCES			English	Article						L-Citrulline; Cyclooxygenase; Nitric oxide; Retinal blood vessel	ORAL L-CITRULLINE; HEART-FAILURE PATIENTS; INDUCED DIABETIC-RATS; OCULAR BLOOD-FLOW; L-ARGININE; VENTRICULAR-FUNCTION; ENDOTHELIAL-CELLS; OPTIC-NERVE; SUPPLEMENTATION; ACETYLCHOLINE	L-Citrulline is an effective precursor of L-arginine produced by the L-citrulline/L-arginine cycle, and it exerts beneficial effects on the cardiovascular system by supporting enhanced nitric oxide (NO) production. NO dilates retinal blood vessels via the cyclooxygenase-mediated pathway. The purpose of this study was to examine the effects of L-citrulline on retinal circulation and to investigate the potential involvement of NO and prostaglandins in L-citrulline-induced responses in rats. L-Citrulline (10 -300 mu g kg(-1) min(-1), i.v.) increased the diameter of retinal arterioles without significantly changing mean blood pressure, heart rate, and fundus blood flow. The vasodilator response of retinal arterioles to L-citrulline was significantly diminished following treatment with N-G-nitro-L-arginine methyl ester (30 mg/kg, i.v.), an NO synthase inhibitor, or indomethacin (5 mg/kg, i.v.), a cyclooxygenase inhibitor. In addition, alpha-methyl-DL-aspartic acid (147 mg/kg, i.v.), an inhibitor of argininosuccinate synthase, the rate-limiting enzyme for the recycling of L-citrulline to L-arginine, diminished the L-citrulline-induced retinal vasodilation. These results suggest that both NO-and prostaglandin-dependent pathways contribute to the L-citrulline-induced vasodilation of rat retinal arterioles. The L-citrulline/L-arginine recycling pathway may have more importance in regulating vascular tone in retinal blood vessels than in peripheral resistance vessels. (C) 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Mori, Asami; Sakamoto, Kenji; Nakahara, Tsutomu; Ishii, Kunio] Kitasato Univ, Sch Pharmaceut Sci, Dept Mol Pharmacol, Minato Ku, Tokyo 1088641, Japan; [Morita, Masahiko; Morishita, Koji] KYOWA HAKKO BIO CO LTD, Healthcare Prod Dev Ctr, Tsukuba, Ibaraki 3050841, Japan	Mori, A (reprint author), Kitasato Univ, Sch Pharmaceut Sci, Dept Mol Pharmacol, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	moria@pharm.kitasato-u.ac.jp			Kitasato University Research Grant for Young Researchers; Ministry of Education, Culture, Sports, Science and Technology, Japan [24790261, 21590102, 24590122]	This study was supported, in part, by a Kitasato University Research Grant for Young Researchers (A.M.) and by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (No. 24790261 A.M. and No. 21590102, 24590122 K.I.).	Bahri S, 2013, NUTRITION, V29, P479, DOI 10.1016/j.nut.2012.07.002; Ogawa N, 2007, N-S ARCH PHARMACOL, V375, P323, DOI 10.1007/s00210-007-0165-7; Curis E, 2005, AMINO ACIDS, V29, P177, DOI 10.1007/s00726-005-0235-4; Solomonson LP, 2003, J EXP BIOL, V206, P2083, DOI 10.1242/jeb.00361; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Balderas-Munoz K, 2012, CARDIOL J, V19, P612, DOI 10.5603/CJ.2012.0113; Orozco-Gutierrez JJ, 2010, CARDIOL J, V17, P612; Okuno T, 2002, INVEST OPHTH VIS SCI, V43, P784; Schwedhelm E, 2008, BRIT J CLIN PHARMACO, V65, P51, DOI 10.1111/j.1365-2125.2007.02990.x; Ananthakrishnan M, 2009, AM J PHYSIOL-LUNG C, V297, pL506, DOI 10.1152/ajplung.00017.2009; Sugiyama K, 1999, INVEST OPHTH VIS SCI, V40, P3084; HECKER M, 1990, P NATL ACAD SCI USA, V87, P8612, DOI 10.1073/pnas.87.21.8612; Mori A, 2007, EUR J PHARMACOL, V570, P135, DOI 10.1016/j.ejphar.2007.05.052; HAEFLIGER IO, 1992, INVEST OPHTH VIS SCI, V33, P2340; Mori A, 2009, J PHARMACOL SCI, V110, P160, DOI 10.1254/jphs.08320FP; Hughes S, 2000, INVEST OPHTH VIS SCI, V41, P1217; Kaneko Y, 2006, J OCUL PHARMACOL TH, V22, P317, DOI 10.1089/jop.2006.22.317; Schmetterer L, 1999, DIABETOLOGIA, V42, P387, DOI 10.1007/s001250051171; Raghavan SAV, 2001, EUR J PHARMACOL, V431, P61, DOI 10.1016/S0014-2999(01)01407-8; Guerreiro JR, 2009, J BIOL CHEM, V284, P20022, DOI 10.1074/jbc.M109.021089; Ogawa N, 2009, AM J PHYSIOL-REG I, V297, pR968, DOI 10.1152/ajpregu.91005.2008; Delaey C, 2000, OPHTHALMIC RES, V32, P249, DOI 10.1159/000055622; BENEDITO S, 1991, EXP EYE RES, V52, P575, DOI 10.1016/0014-4835(91)90059-N; Chien SJ, 2014, TRANSL RES, V163, P43, DOI 10.1016/j.trsl.2013.09.008; De La Cruz MDJP, 2004, DIABETES-METAB RES, V20, P91; Grieshaber Matthias C, 2005, Curr Opin Ophthalmol, V16, P79, DOI 10.1097/01.icu.0000156134.38495.0b; Lassala A, 2008, J NUTR, V139, P660; Miwa T, 2009, EUR J PHARMACOL, V602, P112, DOI 10.1016/j.ejphar.2008.10.060; Mori A, 2011, N-S ARCH PHARMACOL, V384, P603, DOI 10.1007/s00210-011-0682-2; Nakazawa T, 2008, N-S ARCH PHARMACOL, V376, P423, DOI 10.1007/s00210-007-0233-z; Nakazawa T, 2007, VASC PHARMACOL, V46, P153, DOI 10.1016/j.vph.2006.09.002; Shiota A, 2013, J SEX MED, V10, P2423, DOI 10.1111/jsm.12260	32	1	1	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	1347-8613	1347-8648		J PHARMACOL SCI	J. Pharmacol. Sci.	APR	2015	127	4					419	423		10.1016/j.jphs.2015.02.012		5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CH2TI	WOS:000353877100004		
J	Owaki, H; Sadahiro, S; Takaki, M				Owaki, Hiroyuki; Sadahiro, Sotaro; Takaki, Miyako			Characterizations of the alpha(1)-adrenoceptor subtypes mediating contractions of the human internal anal sphincter	JOURNAL OF PHARMACOLOGICAL SCIENCES			English	Article						Human internal anal sphincter; alpha(1)-adrenoceptor; Fecal incontinence; Age-related response change; Comparison with inferior mesenteric artery; As a predictor of systemic arterial pressure	L-ERYTHRO-METHOXAMINE; FECAL INCONTINENCE; TOPICAL PHENYLEPHRINE; RESTING PRESSURE; IN-VITRO; ALPHA(1B)-ADRENOCEPTORS; PHARMACOLOGY; FISSURE; AGE	Human internal anal sphincter (IAS) is contracted by alpha(1)-adrenoceptor stimulation and thus alpha(1)-adrenoceptor agonists may be useful in treating fecal incontinence. This study characterizes the contribution of alpha(1)-adrenoceptor subtypes in contraction of human IAS and to investigate the age-related risk of patients with fecal incontinence. IAS and inferior mesenteric artery (IMA), as a predictor of systemic arterial pressure, were obtained from 11 patients. Both muscle strips were assessed by isometric-contraction experiments using phenylephrine, further in IAS, in the presence of various subtype selective alpha(1)-adrenoceptor antagonists. Immunohistochemistry and gene expression studies were performed in the same samples. The mean pEC(50) values with SEM of phenylephrine in IAS (6.30 +/- 0.13) were higher than those of IMA (5.60 +/- 0.10). Furthermore, the age-related pEC(50) change of IAS was observed between age <70 and >= 70 (6.58 +/- 0.13 and 6.07 +/- 0.16, respectively (P < 0.05)). In IAS, rightward shift of the concentration -response curves of phenylephrine was observed with three alpha(1)-adrenoceptor antagonists. Each pK(B) value of silodosin, BMY-7378 and prazosin was 9.36 +/- 0.53, 7.28 +/- 0.20 and 8.89 +/- 0.12, respectively. These pKB values and gene expression studies indicated that alpha(1A)-adrenoceptor subtypes predominantly contributed to human IAS contraction. (C) 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Owaki, Hiroyuki; Takaki, Miyako] Nara Med Univ, Sch Med, Dept Physiol 2, Kashihara, Nara 6348521, Japan; [Takaki, Miyako] Nara Med Univ, Dept Mol Pathol, Sch Med, Kashihara, Nara 6348521, Japan; [Sadahiro, Sotaro] Tokai Univ, Dept Surg, Sch Med, Isehara, Kanagawa 2591193, Japan	Owaki, H (reprint author), Nara Med Univ, Sch Med, Dept Physiol 2, 840 Shijo Cho, Kashihara, Nara 6348521, Japan.	hiroyuki-owaki@naramed-u.ac.jp					Cheetham MJ, 2001, GUT, V48, P356, DOI 10.1136/gut.48.3.356; Carapeti EA, 2000, BRIT J SURG, V87, P38, DOI 10.1046/j.1365-2168.2000.01306.x; Mills KA, 2008, BRIT J PHARMACOL, V155, P110, DOI 10.1038/bjp.2008.217; Williams TJ, 1999, BRIT J PHARMACOL, V127, P252, DOI 10.1038/sj.bjp.0702541; Nasu K, 1998, BRIT J PHARMACOL, V123, P1289, DOI 10.1038/sj.bjp.0701731; Rayment SJ, 2010, BRIT J PHARMACOL, V160, P1727, DOI 10.1111/j.1476-5381.2010.00842.x; Melville JL, 2005, AM J OBSTET GYNECOL, V193, P2071, DOI 10.1016/j.ajog.2005.07.018; Opazo A, 2013, COLORECTAL DIS, V15, P492, DOI 10.1111/codi.12095; Rudner XL, 1999, CIRCULATION, V100, P2336; Pretlove SJ, 2006, INT UROGYNECOL J, V17, P407, DOI 10.1007/s00192-005-0014-5; GOETZ AS, 1995, EUR J PHARMACOL, V272, pR5, DOI 10.1016/0014-2999(94)00751-R; Badvie S, 2005, CLIN ONCOL-UK, V17, P122, DOI 10.1016/j.clon.2004.07.011; Bhardwaj R, 2000, GUT, V46, P861, DOI 10.1136/gut.46.6.861; Bharucha AE, 2004, GASTROENTEROLOGY, V126, pS90, DOI 10.1053/j.gastro.2003.10.014; BURT RP, 1995, BRIT J PHARMACOL, V115, P467; Carapeti EA, 1999, BRIT J SURG, V86, P267; Israilova M, 2004, J PHARMACOL EXP THER, V309, P259, DOI 10.1124/jpet.103.061796; Jones OM, 2003, BRIT J SURG, V90, P872, DOI 10.1002/bjs.4120; KENNY BA, 1995, BRIT J PHARMACOL, V115, P981; Kobayashi Mamoru, 2006, Folia Pharmacologica Japonica, V128, P259, DOI 10.1254/fpj.128.259; LESTAR B, 1989, INT J COLORECTAL DIS, V4, P118, DOI 10.1007/BF01646870; Lorenzi B, 2012, DIS COLON RECTUM, V55, P465, DOI 10.1097/DCR.0b013e31824154a0; Mills K., 2009, Autonomic & Autacoid Pharmacology, V29, P85, DOI 10.1111/j.1474-8673.2009.00437.x; Moszkowicz D, 2012, DIS COLON RECTUM, V55, P473, DOI 10.1097/DCR.0b013e318245190e; Nisar PJ, 2005, BRIT J SURG, V92, P1539, DOI 10.1002/bjs.5171; Nisar PJ, 2007, BRIT J SURG, V94, P1155, DOI 10.1002/bjs.5821; OKELLY T, 1993, GUT, V34, P689, DOI 10.1136/gut.34.5.689; OKELLY TJ, 1993, BRIT J SURG, V80, P1337, DOI 10.1002/bjs.1800801041; Omar MI, 2013, COCHRANE DB SYST REV, P6; Park JS, 2007, INT J COLORECTAL DIS, V22, P1319, DOI 10.1007/s00384-007-0335-6; REGADAS FSP, 1993, BRIT J SURG, V80, P799, DOI 10.1002/bjs.1800800650; Sathi ZS, 2008, EUR J PHARMACOL, V584, P222, DOI 10.1016/j.ejphar.2008.02.003; Singh J, 2012, AM J PHYSIOL-GASTR L, V303, pG713, DOI 10.1152/ajpgi.00112.2012; SPEAKMAN CTM, 1990, BRIT J SURG, V77, P1342, DOI 10.1002/bjs.1800771208	34	0	0	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	1347-8613	1347-8648		J PHARMACOL SCI	J. Pharmacol. Sci.	APR	2015	127	4					424	429		10.1016/j.jphs.2015.02.016		6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CH2TI	WOS:000353877100005		
J	Shimizu, S; Mizuguchi, Y; Sobue, A; Fujiwara, M; Morimoto, T; Ohno, Y				Shimizu, Saki; Mizuguchi, Yuto; Sobue, Akira; Fujiwara, Mai; Morimoto, Tomoki; Ohno, Yukihiro			Interaction between anti-Alzheimer and antipsychotic drugs in modulating extrapyramidal motor disorders in mice	JOURNAL OF PHARMACOLOGICAL SCIENCES			English	Article						Anti-Alzheimer drugs; Antipsychotic drugs; Behavioral and psychological; symptoms of dementia (BPSD); Cholinesterase inhibitors; Extrapyramidal side effects	STRIATAL CHOLINERGIC INTERNEURONS; D-2 RECEPTOR ANTAGONIST; MOUSE POLE TEST; 5-HT1A RECEPTORS; SEROTONIN RECEPTORS; PARKINSONS-DISEASE; SCHIZOPHRENIA; GALANTAMINE; DONEPEZIL; DEMENTIA	Antipsychotics are often used in conjunction with anti-Alzheimer drugs to treat the behavioral and psychological symptoms of dementia (BPSD). Here, we examined the effects of cholinesterase inhibitors (ChEIs), donepezil and galantamine, on antipsychotic-induced extrapyramidal side effects (EPS) in mice. The effects of serotonergic agents on the EPS drug interaction were also evaluated. Donepezil (0.3-3 mg/kg) did not induce EPS signs by itself; however, it significantly potentiated bradykinesia induction with a low dose of haloperidol (0.5 mg/kg) in dose-dependent and synergistic manners. Galantamine (0.3 -3 mg/kg) elicited mild bradykinesia at a high dose and dose-dependently augmented haloperidol-induced bradykinesia. The EPS potentiation by galantamine was blocked by trihexyphenidyl (a muscarinic antagonist), but not by mecamylamine (a nicotinic antagonist). In addition, the bradykinesia potentiation by galantamine was significantly reduced by (+/-)-8-hydroxy-2-(di-n-propylamino)-tetralin (a 5-HT1A agonist), ritanserin (a 5-HT2 antagonist), and SB-258585 (a 5-HT6 antagonist). The present results give us a caution for the antipsychotics and ChEIs interaction in inducing EPS in the treatment of BPSD. In addition, second generation antipsychotics, which can stimulate 5-HT1A receptors or antagonize 5-HT2 and 5-HT6 receptors, seem to be favorable as an adjunctive therapy for BPSD. (C) 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Shimizu, Saki; Mizuguchi, Yuto; Sobue, Akira; Fujiwara, Mai; Morimoto, Tomoki; Ohno, Yukihiro] Osaka Univ Pharmaceut Sci, Pharmacol Lab, Takatsuki, Osaka 5691094, Japan	Ohno, Y (reprint author), Osaka Univ Pharmaceut Sci, Pharmacol Lab, 4-20-1 Nasahara, Takatsuki, Osaka 5691094, Japan.	yohno@gly.oups.ac.jp			Smoking Research Foundation	This work was partly supported by the Smoking Research Foundation. The authors are thankful to Mr. Kentaro Tokudome and Naofumi Kunisawa for their critical reading of and comments on the manuscript.	Ago Y, 2011, SYNAPSE, V65, P1373, DOI 10.1002/syn.20969; Shimizu S, 2013, AGING DIS, V4, P1; Giacobini E, 2001, DRUG AGING, V18, P891, DOI 10.2165/00002512-200118120-00001; Kapur S, 2001, ANNU REV MED, V52, P503, DOI 10.1146/annurev.med.52.1.503; Aalten P, 2007, DEMENT GERIATR COGN, V24, P457, DOI 10.1159/000110738; OHNO Y, 1994, PHARMACOL BIOCHEM BE, V49, P19, DOI 10.1016/0091-3057(94)90451-0; Shimizu S, 2010, PROG NEURO-PSYCHOPH, V34, P877, DOI 10.1016/j.pnpbp.2010.04.005; Neumaier JF, 2001, J CHEM NEUROANAT, V21, P63, DOI 10.1016/S0891-0618(00)00092-2; Samochocki M, 2003, J PHARMACOL EXP THER, V305, P1024, DOI 10.1124/jpet.102.045773; Van Dam D, 2005, PSYCHOPHARMACOLOGY, V180, P177, DOI 10.1007/s00213-004-2132-z; Ohno Y, 2011, NEUROPHARMACOLOGY, V60, P201, DOI 10.1016/j.neuropharm.2010.08.019; Ohno Y, 2008, PROG NEURO-PSYCHOPH, V32, P1302, DOI 10.1016/j.pnpbp.2008.04.005; Meltzer HY, 2003, PROG NEURO-PSYCHOPH, V27, P1159, DOI 10.1016/j.pnpbp.2003.09.010; Newman-Tancredi A, 2010, CURR OPIN INVEST DR, V11, P802; Shimizu S, 2013, CNS NEUROL DISORD-DR, V12, P861; Silva T, 2014, AGEING RES REV, V15, P116, DOI 10.1016/j.arr.2014.03.008; Ohno Y, 1997, POL J PHARMACOL, V49, P213; Ago Y, 2011, J PHARMACOL SCI, V116, P6, DOI 10.1254/jphs.11R01CR; Ohno Y, 2011, CNS NEUROSCI THER, V17, P58, DOI 10.1111/j.1755-5949.2010.00211.x; Horacek J, 2006, CNS DRUGS, V20, P389, DOI 10.2165/00023210-200620050-00004; Bonsi P, 2007, NEUROPSYCHOPHARMACOL, V32, P1840, DOI 10.1038/sj.npp.1301294; Tatara A, 2012, PROG NEURO-PSYCHOPH, V38, P252, DOI 10.1016/j.pnpbp.2012.04.008; Alex KD, 2007, PHARMACOL THERAPEUT, V113, P296, DOI 10.1016/j.pharmthera.2006.08.004; Kapur S, 1996, AM J PSYCHIAT, V153, P466; Ishibashi T, 1996, EUR J PHARMACOL, V303, P247, DOI 10.1016/0014-2999(96)00139-2; FIBIGER HC, 1991, TRENDS NEUROSCI, V14, P220, DOI 10.1016/0166-2236(91)90117-D; DAMSMA G, 1990, N-S ARCH PHARMACOL, V342, P523; DeBoer P, 1996, J PHARMACOL EXP THER, V277, P775; Gabryelewicz Tomasz, 2014, Przegl Lek, V71, P215; Hedlund PB, 2004, EUR J PHARMACOL, V487, P125, DOI 10.1016/j.ejphar.2004.01.031; Ishida K, 1996, GEN PHARMACOL, V27, P1203, DOI 10.1016/S0306-3623(96)00056-0; Koda K, 2008, PSYCHOPHARMACOLOGY, V196, P293, DOI 10.1007/s00213-007-0962-1; Kozman MN, 2006, HUM PSYCHOPHARM CLIN, V21, P1, DOI 10.1002/hup.745; Lyketsos CG, 2001, INT J GERIATR PSYCH, V16, P1043, DOI 10.1002/gps.448; MELTZER HY, 1991, SCHIZOPHRENIA BULL, V17, P263; Ohno Y, 2012, ANTIPSYCHOTIC DRUGS, P323; Salamone JD, 2001, LIFE SCI, V68, P2579, DOI 10.1016/S0024-3205(01)01055-4; Schmitt B, 2004, CNS DRUGS, V18, P827, DOI 10.2165/00023210-200418130-00001; Smith Y, 2008, MOVEMENT DISORD, V23, P534; Takeda M, 2011, PSYCHIAT CLIN NEUROS, V65, P399, DOI 10.1111/j.1440-1819.2011.02253.x	40	2	2	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	1347-8613	1347-8648		J PHARMACOL SCI	J. Pharmacol. Sci.	APR	2015	127	4					439	445		10.1016/j.jphs.2015.03.004		7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CH2TI	WOS:000353877100007		
J	Kubokura, N; Takahashi-Yanaga, F; Arioka, M; Yoshihara, T; Igawa, K; Tomooka, K; Morimoto, S; Nakatsu, Y; Tsuzuki, T; Nakabeppu, Y; Matsumoto, T; Kitazono, T; Sasaguri, T				Kubokura, Naoya; Takahashi-Yanaga, Fumi; Arioka, Masaki; Yoshihara, Tatsuya; Igawa, Kazunobu; Tomooka, Katsuhiko; Morimoto, Sachio; Nakatsu, Yoshimichi; Tsuzuki, Teruhisa; Nakabeppu, Yusaku; Matsumoto, Takayuki; Kitazono, Takanari; Sasaguri, Toshiyuki			Differentiation-inducing factor-3 inhibits intestinal tumor growth in vitro and in vivo	JOURNAL OF PHARMACOLOGICAL SCIENCES			English	Article						c-Myc; cyclin D1; DIF-3; TCF7L2; Wnt/beta-catenin signaling pathway	CATENIN SIGNALING PATHWAY; CANCER-CELL-LINES; CYCLIN D1; DICTYOSTELIUM-DISCOIDEUM; BETA-CATENIN; ADENOMATOUS POLYPOSIS; COLORECTAL-CANCER; COLON-CANCER; C-MYC; EXPRESSION	Differentiation-inducing factor-1 (DIF-1) produced by Dictyostelium discoideum strongly inhibits the proliferation of various types of cancer cells by suppression of the Wnt/beta-catenin signal transduction pathway. In the present study, we examined the effect of differentiation-inducing factor-3 (DIF-3), a monochlorinated metabolite of DIF-1 that is also produced by D. discoideum, on human colon cancer cell lines HCT-116 and DLD-1. DIF-3 strongly inhibited cell proliferation by arresting the cell cycle at the G(0)/G(1) phase. DIF-3 reduced the expression levels of cyclin D1 and c-Myc by facilitating their degradation via activation of GSK-3 beta in a time and dose-dependent manner. In addition, DIF-3 suppressed the expression of T-cell factor 7-like 2, a key transcription factor in the Wnt/beta-catenin signaling pathway, thereby reducing the mRNA levels of cyclin D1 and c-Myc. Subsequently, we examined the in vivo effects of DIF-3 in Mutyh(-/-) mice with oxidative stress-induced intestinal cancers. Repeated oral administration of DIF-3 markedly reduced the number and size of cancers at a level comparable to that of DIF-1. These data suggest that DIF-3 inhibits intestinal cancer cell proliferation in vitro and in vivo, probably by mechanisms similar to those identified in DIF-1 actions, and that DIF-3 may be a potential novel anti-cancer agent. (C) 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Kubokura, Naoya; Takahashi-Yanaga, Fumi; Arioka, Masaki; Yoshihara, Tatsuya; Morimoto, Sachio; Sasaguri, Toshiyuki] Kyushu Univ, Fac Med Sci, Dept Clin Pharmacol, Fukuoka 8128582, Japan; [Kubokura, Naoya; Kitazono, Takanari] Kyushu Univ, Dept Med & Clin Sci, Fac Med Sci, Fukuoka 8128582, Japan; [Takahashi-Yanaga, Fumi] Kyushu Univ, Global Med Sci Educ Unit, Fac Med Sci, Fukuoka 8128582, Japan; [Igawa, Kazunobu; Tomooka, Katsuhiko] Kyushu Univ, Inst Mat Chem & Engn, Dept Mol & Mat Sci, Kasuga, Fukuoka 8168580, Japan; [Nakatsu, Yoshimichi; Tsuzuki, Teruhisa] Kyushu Univ, Dept Med Biophys & Radiat Biol, Fac Med Sci, Fukuoka 8128582, Japan; [Nakabeppu, Yusaku] Kyushu Univ, Med Inst Bioregulat, Div Neurofunct Genom, Dept Immunobiol & Neurosci, Fukuoka 8128582, Japan; [Matsumoto, Takayuki] Iwate Med Univ, Sch Med, Div Gastroenterol, Dept Internal Med, Morioka, Iwate 0200023, Japan	Takahashi-Yanaga, F (reprint author), Kyushu Univ, Fac Med Sci, Dept Clin Pharmacol, Fukuoka 8128582, Japan.	yanaga@clipharm.med.kyushu-u.ac.jp	Nakabeppu, Yusaku/A-8902-2011		Japan Society for the Promotion of Science [21590284, 25460334]	This work was supported by Kakenhi grants from the Japan Society for the Promotion of Science (21590284 and 25460334 to FTY).	Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Sampson JR, 2003, LANCET, V362, P39, DOI 10.1016/S0140-6736(03)13805-6; McDonald SAC, 2006, NAT CLIN PRACT GASTR, V3, P267, DOI 10.1038/ncpgasthep0473; Takahashi-Yanaga F, 2014, BIOCHEM PHARMACOL, V89, P340, DOI 10.1016/j.bcp.2014.03.006; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; MORRIS HR, 1987, NATURE, V328, P811, DOI 10.1038/328811a0; Sieber OM, 2003, NEW ENGL J MED, V348, P791, DOI 10.1056/NEJMoa025283; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Takahashi-Yanaga F, 2009, J PHARMACOL SCI, V109, P179, DOI 10.1254/jphs.08R28FM; Barnes DM, 1998, BREAST CANCER RES TR, V52, P1, DOI 10.1023/A:1006103831990; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Matsuzaki E, 2006, J BONE MINER RES, V21, P1307, DOI 10.1359/JBMR.060512; Sakamoto K, 2007, CANCER RES, V67, P6599, DOI 10.1158/0008-5472.CAN-06-4802; Jingushi K, 2012, BIOCHEM PHARMACOL, V83, P47, DOI 10.1016/j.bcp.2011.10.001; Jingushi K, 2013, J PHARMACOL SCI, V121, P103, DOI 10.1254/jphs.12204FP; Kubohara Y, 1999, EUR J PHARMACOL, V381, P57, DOI 10.1016/S0014-2999(99)00548-8; Matsuda T, 2010, J PHARMACOL SCI, V112, P320, DOI 10.1254/jphs.09348FP; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Miwa Y, 2000, CIRC RES, V86, P68; Mori J, 2005, EXP CELL RES, V310, P426, DOI 10.1016/j.yexcr.2005.07.024; MORRIS HR, 1988, BIOCHEM J, V249, P903; Saegusa M, 2008, J PATHOL, V216, P521, DOI 10.1002/path.2404; Shimizu K, 2004, CANCER RES, V64, P2568, DOI 10.1158/0008-5472.CAN-03-3551; Takahashi-Yanaga F, 2006, J BIOL CHEM, V281, P38489, DOI 10.1074/jbc.M605205200; Takahashi-Yanaga F, 2003, J BIOL CHEM, V278, P9663, DOI 10.1074/jbc.M205768200; Utsunomiya T, 2001, ONCOLOGY-BASEL, V61, P226, DOI 10.1159/000055379; Yasmin T, 2005, BIOCHEM BIOPH RES CO, V338, P903, DOI 10.1016/j.bbrc.2005.10.018; Yoshihara T, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-245	34	0	0	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	1347-8613	1347-8648		J PHARMACOL SCI	J. Pharmacol. Sci.	APR	2015	127	4					446	455		10.1016/j.jphs.2015.03.005		10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CH2TI	WOS:000353877100008		
J	Oguma, T; Kuriyama, C; Nakayama, K; Matsushita, Y; Yoshida, K; Kiuchi, S; Ikenaga, Y; Nakamaru, Y; Hikida, K; Saito, A; Arakawa, K; Oka, K; Ueta, K; Shiotani, M				Oguma, Takahiro; Kuriyama, Chiaki; Nakayama, Keiko; Matsushita, Yasuaki; Yoshida, Kumiko; Kiuchi, Satoko; Ikenaga, Yuka; Nakamaru, Yoshinobu; Hikida, Kumiko; Saito, Akira; Arakawa, Kenji; Oka, Kozo; Ueta, Kiichiro; Shiotani, Masaharu			The effect of combined treatment with canagliflozin and teneligliptin on glucose intolerance in Zucker diabetic fatty rats	JOURNAL OF PHARMACOLOGICAL SCIENCES			English	Article						Canagliflozin; Teneligliptin; Combination treatment; Glucagon-like peptide-1; Zucker diabetic fatty rats	COTRANSPORTER INHIBITOR T-1095; INTESTINAL GLUCOSE; INCRETIN SECRETION; EFFICACY; HYPERGLYCEMIA; MELLITUS; SAFETY; ABSORPTION; SGLT1; MICE	To assess the impact of concomitant inhibition of sodium-glucose cotransporter (SGLT) 2 and dipeptidyl peptidase IV (DPP4) for the treatment of type 2 diabetes mellitus (T2DM), the effect of combined treatment with canagliflozin, a novel SGLT2 inhibitor, and teneligliptin, a DPP4 inhibitor, on glucose intolerance was investigated in Zucker diabetic fatty (ZDF) rats. Canagliflozin potently inhibited human and rat SGLT2 and moderately inhibited human and rat SGLT1 activities but did not affect DPP4 activity. In contrast, teneligliptin inhibited human and rat DPP4 activities but not SGLT activities. A single oral treatment of canagliflozin and teneligliptin suppressed plasma glucose elevation in an oral glucose tolerance test in 13 week-old ZDF rats. This combination of agents elevated plasma active GLP-1 levels in a synergistic manner, probably mediated by intestinal SGLT1 inhibition, and further improved glucose intolerance. In the combination-treated animals, there was no pharmacokinetic interaction of the drugs and no further inhibition of plasma DPP4 activity compared with that in the teneligliptin-treated animals. These results suggest that the inhibition of SGLT2 and DPP4 improves glucose intolerance and that combined treatment with canagliflozin and teneligliptin is a novel therapeutic option for glycemic control in T2DM. (C) 2015 Mitsubishi Tanabe Pharma Corporation. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Oguma, Takahiro; Kuriyama, Chiaki; Nakayama, Keiko; Matsushita, Yasuaki; Yoshida, Kumiko; Kiuchi, Satoko; Ikenaga, Yuka; Nakamaru, Yoshinobu; Hikida, Kumiko; Saito, Akira; Arakawa, Kenji; Oka, Kozo; Ueta, Kiichiro; Shiotani, Masaharu] Mitsubishi Tanabe Pharma Corp, Div Res, Toda, Saitama 3358505, Japan	Oguma, T (reprint author), Mitsubishi Tanabe Pharma Corp, Div Res, Toda, Saitama 3358505, Japan.	oguma.takahiro@mx.mt-pharma.co.jp					Powell DR, 2013, J PHARMACOL EXP THER, V345, P250, DOI 10.1124/jpet.113.203364; TOKUYAMA Y, 1995, DIABETES, V44, P1447, DOI 10.2337/diabetes.44.12.1447; CLARK JB, 1983, P SOC EXP BIOL MED, V173, P68; Toblli JE, 2009, NEPHROL DIAL TRANSPL, V24, P2384, DOI 10.1093/ndt/gfp103; Fukuda-Tsuru S, 2012, EUR J PHARMACOL, V696, P194, DOI 10.1016/j.ejphar.2012.09.024; Arakawa K, 2001, BRIT J PHARMACOL, V132, P578, DOI 10.1038/sj.bjp.0703829; Forst T, 2014, DIABETES OBES METAB, V16, P467, DOI [10.1111/dom.12273, 10.1111/dom.12244]; Powell DR, 2013, AM J PHYSIOL-ENDOC M, V304, pE117, DOI 10.1152/ajpendo.00439.2012; Abdul-Ghani MA, 2012, CURR DIABETES REP, V12, P230, DOI 10.1007/s11892-012-0275-6; Shibazaki T, 2012, J PHARMACOL EXP THER, V342, P288, DOI 10.1124/jpet.112.193045; DeFronzo RA, 1999, ANN INTERN MED, V131, P281; Oku A, 1999, DIABETES, V48, P1794, DOI 10.2337/diabetes.48.9.1794; Polidori D, 2013, DIABETES CARE, V36, P2154, DOI 10.2337/dc12-2391; Grempler R, 2012, DIABETES OBES METAB, V14, P83, DOI 10.1111/j.1463-1326.2011.01517.x; Gorboulev V, 2012, DIABETES, V61, P187, DOI 10.2337/db11-1029; Meier JJ, 2005, DIABETES-METAB RES, V21, P91, DOI 10.1002/dmrr.538; Stein SA, 2013, EXPERT OPIN DRUG SAF, V12, P153, DOI 10.1517/14740338.2013.752813; Moriya R, 2009, AM J PHYSIOL-ENDOC M, V297, pE1358, DOI 10.1152/ajpendo.00412.2009; Cefalu WT, 2013, LANCET, V382, P941, DOI 10.1016/S0140-6736(13)60683-2; Abdul-Ghani MA, 2011, ENDOCR REV, V32, P515, DOI 10.1210/er.2010-0029; KANAI Y, 1994, J CLIN INVEST, V93, P397, DOI 10.1172/JCI116972; Kinoshita S, 2015, EXPERT OPIN DRUG MET, V11, P7, DOI 10.1517/17425255.2015.982531; Kuriyama C, 2014, J PHARMACOL EXP THER, V351, P423, DOI 10.1124/jpet.114.217992; Lebovitz HE, 1994, JOSLINS DIABETES MEL, V13th, P508; Liang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030555; Oguma T, 2013, 56 ANN M JAP DIAB SO; Oku A, 2000, EUR J PHARMACOL, V391, P183, DOI 10.1016/S0014-2999(00)00016-9; Peterson R. G., 1990, ILAR NEWS, V32, P16; Szocs Z, 2008, J PHARMACOL EXP THER, V326, P323, DOI 10.1124/jpet.108.136465; Ueta K, 2005, LIFE SCI, V76, P2655, DOI 10.1016/j.lfs.2004.09.038; UK Prospective Diabetes Study (UKPDS) Group, 1998, LANCET, V352, P837, DOI DOI 10.1016/S0140-6736(98)07019-6; Watanabe Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116851; Weir MR, 2014, J CLIN HYPERTENS, V16, P875, DOI 10.1111/jch.12425	33	2	3	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	1347-8613	1347-8648		J PHARMACOL SCI	J. Pharmacol. Sci.	APR	2015	127	4					456	461		10.1016/j.jphs.2015.03.006		6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CH2TI	WOS:000353877100009		
J	Chiba, N; Furukawa, KI; Takayama, S; Asari, T; Chin, S; Harada, Y; Kumagai, G; Wada, K; Tanaka, T; Ono, A; Motomura, S; Murakami, M; Ishibashi, Y				Chiba, Noriyuki; Furukawa, Ken-Ichi; Takayama, Shohei; Asari, Toru; Chin, Shunfu; Harada, Yoshifumi; Kumagai, Gentaro; Wada, Kanichiro; Tanaka, Toshihiro; Ono, Atsushi; Motomura, Shigeru; Murakami, Manabu; Ishibashi, Yasuyuki			Decreased DNA methylation in the promoter region of the WNT5A and GDNF genes may promote the osteogenicity of mesenchymal stem cells from patients with ossified spinal ligaments	JOURNAL OF PHARMACOLOGICAL SCIENCES			English	Article						Epigenetics; Mesenchymal stem cells; Microarray analysis; WNT5A; GDNF; DNA methylation	POSTERIOR LONGITUDINAL LIGAMENT; IDIOPATHIC SKELETAL HYPEROSTOSIS; NEUROTROPHIC FACTOR; OSSIFICATION; PATHWAYS; WINGLESS; HEDGEHOG; DISEASE; LINEAGE; CANCERS	Mesenchymal stem cells (MSCs) isolated from spinal ligaments with ectopic ossification have a propensity toward the osteogenic lineage. To explore epigenetic control of the osteogenic features of MSCs, we treated MSCs obtained from the spinal ligaments of ossification of yellow ligament (OYL) patients and non-OYL patients with the DNA methyltransferase inhibitor, 5-aza-2'-deoxycytidine (5AdC). We compared the non-OYL groups (untreated and treated with 5AdC) with the OYL groups (untreated and treated with 5AdC) by genome-wide microarray analysis. Next, we used methylated DNA immunoprecipitation combined with quantitative real-time PCR to assess gene methylation. Ninety-eight genes showed expression significantly increased by 5AdC treatment in MSCs from non-OYL patients but not from OYL patients. In contrast, only two genes, GDNF and WNT5A, showed significantly higher expression in OYL MSCs compared with non-OYL MSCs without 5AdC treatment. Both genes were hypermethylated in non-OYL MSCs but not in OYL MSCs. Small interfering RNA targeted to each gene decreased expression of the target gene and also several osteogenic genes. Both small interfering RNAs also suppressed the activity of alkaline phosphatase, a typical marker of osteogenesis. These results suggest that the osteogenic features of MSCs from OYL patients are promoted by unmethylated WNT5A and GDNF genes. (C) 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Chiba, Noriyuki; Furukawa, Ken-Ichi; Takayama, Shohei; Motomura, Shigeru; Murakami, Manabu] Hirosaki Univ, Grad Sch Med, Dept Pharmacol, Hirosaki, Aomori 0368562, Japan; [Chiba, Noriyuki; Asari, Toru; Chin, Shunfu; Harada, Yoshifumi; Kumagai, Gentaro; Wada, Kanichiro; Tanaka, Toshihiro; Ono, Atsushi; Ishibashi, Yasuyuki] Hirosaki Univ, Dept Orthopaed Surg, Grad Sch Med, Hirosaki, Aomori 0368562, Japan	Furukawa, KI (reprint author), Hirosaki Univ, Grad Sch Med, Dept Pharmacol, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.	furukawa@cc.hirosaki-u.ac.jp			AOSpine Japan research grant; Investigation Committee on Ossification of the Spinal Ligaments; Public Health Bureau of the Japanese Ministry of Labour, Health, and Welfare; Ministry of Education, Culture, Sports, Science, and Technology of Japan [24590310]	This project was funded by an AOSpine Japan research grant (2013); a Grant-in-Aid from the Investigation Committee on Ossification of the Spinal Ligaments; the Public Health Bureau of the Japanese Ministry of Labour, Health, and Welfare; and by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (no. 24590310). We thank Drs. Kazumasa Ueyama, Naoki Echigoya, Akio Sannohe, Takuya Numasawa, Toru Yokoyama, Kazunari Takeuchi, Shuichi Aburakawa, Yoshihito Yamasaki, Taisuke Nitobe, Kenji Kowatari and Takashi Tomita for their contributions to sample collection. Japanese Pharmacological Society acknowledge to Dr. Taito Itabashi for his valuable comments.	LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; van Noort M, 2002, DEV BIOL, V244, P1, DOI 10.1006/dbio.2001.0566; Nakajima M, 2014, NAT GENET, V46, P1012, DOI 10.1038/ng.3045; Matsunaga S, 2002, J NEUROSURG, V96, P168, DOI 10.3171/spi.2002.96.2.0168; Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359; Choi S, 2005, J SPINAL DISORD TECH, V18, P309, DOI 10.1097/01.bsd.0000161236.94894.fc; Mohn Fabio, 2009, V507, P55, DOI 10.1007/978-1-59745-522-0_5; SUTERCRAZZOLARA C, 1994, NEUROREPORT, V5, P2486, DOI 10.1097/00001756-199412000-00020; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; Narisawa S, 2013, J BONE MINER RES, V28, P1587, DOI 10.1002/jbmr.1901; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Chin S, 2013, BIOCHEM BIOPH RES CO, V436, P698, DOI 10.1016/j.bbrc.2013.06.019; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Koyanagi I, 1998, J NEUROSURG, V88, P247, DOI 10.3171/jns.1998.88.2.0247; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Gale Z, 2012, CYTOKINE, V57, P276, DOI 10.1016/j.cyto.2011.10.023; Asari T, 2012, BIOCHEM BIOPH RES CO, V417, P1193, DOI 10.1016/j.bbrc.2011.12.106; CABRERA CV, 1987, CELL, V50, P659, DOI 10.1016/0092-8674(87)90039-0; Furukawa KI, 2008, PHARMACOL THERAPEUT, V118, P352, DOI 10.1016/j.pharmthera.2008.03.007; Harada Y, 2014, BIOCHEM BIOPH RES CO, V443, P1014, DOI 10.1016/j.bbrc.2013.12.080; Jiang J, 2010, NEUROSCI RES, V66, P344; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Min KJ, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-28; Okamoto M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04493; RESNICK D, 1975, RADIOLOGY, V115, P513; RIJSEWIJK F, 1987, CELL, V50, P649, DOI 10.1016/0092-8674(87)90038-9; UTSINGER PD, 1985, CLIN RHEUM DIS, V11, P325; Wang ZH, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-209; Yamashita S, 2008, CANCER RES, V68, P2112, DOI 10.1158/0008-5472.CAN-07-5282; Yan HC, 2013, ONCOL LETT, V6, P845, DOI 10.3892/ol.2013.1438; Yun KS, 2014, HUM MOL GENET, V23, P6807, DOI 10.1093/hmg/ddu397	33	0	0	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	1347-8613	1347-8648		J PHARMACOL SCI	J. Pharmacol. Sci.	APR	2015	127	4					467	473		10.1016/j.jphs.2015.03.008		7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CH2TI	WOS:000353877100011		
J	Yamaguchi, T; Yamazaki, T; Nakamura, Y; Shiota, M; Shimada, K; Miura, K; Iwao, H; Yoshiyama, M; Izumi, Y				Yamaguchi, Takehiro; Yamazaki, Takanori; Nakamura, Yasuhiro; Shiota, Masayuki; Shimada, Kenei; Miura, Katsuyuki; Iwao, Hiroshi; Yoshiyama, Minoru; Izumi, Yasukatsu			Percutaneous carbon dioxide mist treatment has protective effects in experimental myocardial infarction	JOURNAL OF PHARMACOLOGICAL SCIENCES			English	Article						Animal model; Carbon dioxide; Preconditioning; Mist; Myocardial infarction	ISCHEMIA-REPERFUSION INJURY; NITRIC-OXIDE; BLOOD-FLOW; CARDIAC-HYPERTROPHY; WATER; RATS; SKIN; MICROCIRCULATION; CARDIOPROTECTION; IDENTIFICATION	Percutaneous treatment with carbon dioxide (CO2) mist, CO2 gas dissolved in water, contributes to improved cardiac function after myocardial infarction (MI). In this study, we investigated the effects of repeated pretreatment with CO2 mist on cardiac dysfunction after MI. The CO2 mist was generated by a dry mist production unit. The whole body of rats below the axilla was wrapped in a polyethylene bag, which was sealed and filled with the CO2 mist in the draft cabinet for 30 min daily for 7 days. MI was induced by ligation of the coronary artery in untreated (UT), CO2 gas-pretreated (CG), and CO2 mist-pretreated (CM) rats. The infarct size and the increase in oxidative stress due to MI were significantly smaller in the CM rats than in the UT rats. Furthermore, the expression of inflammation-related genes, such as monocyte chemoattractant protein-1, and fibrosis-related genes, such as transforming growth factor-beta 1, was significantly suppressed in the CM rats. The CM rats had a better left ventricular ejection fraction than the UT rats 7 days after MI. These parameters in the CG rats were the same as in the UT group. Thus, CO2 mist preparative treatment may be potentially useful for the reduction of MI. (C) 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Yamaguchi, Takehiro; Yamazaki, Takanori; Nakamura, Yasuhiro; Shimada, Kenei; Yoshiyama, Minoru] Osaka City Univ, Dept Cardiovasc Med, Sch Med, Osaka 5458585, Japan; [Yamazaki, Takanori] Asakayama Gen Hosp, Dept Cardiol, Sakai, Osaka 5900018, Japan; [Nakamura, Yasuhiro] Izumi Municipal Hosp, Dept Cardiol, Izumi 5940071, Japan; [Shiota, Masayuki; Izumi, Yasukatsu] Osaka City Univ, Sch Med, Dept Pharmacol, Osaka 5458585, Japan; [Miura, Katsuyuki] Osaka City Univ, Sch Med, Appl Pharmacol & Therapeut, Osaka 5458585, Japan; [Iwao, Hiroshi] Shitennoji Univ, Dept Educ, Habikino 5838501, Japan	Izumi, Y (reprint author), Osaka City Univ, Sch Med, Dept Pharmacol, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.	izumi@msic.med.osaka-cu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [24591101, 26460344]; ACP JAPAN Co., Ltd.; Hoansha Foundation	This study was supported in part by Grant-in-Aid for Scientific Research (24591101 and 26460344) from the Ministry of Education, Culture, Sports, Science and Technology, ACP JAPAN Co., Ltd., and Hoansha Foundation.	ANGELIDIS CE, 1991, EUR J BIOCHEM, V199, P35, DOI 10.1111/j.1432-1033.1991.tb16088.x; Tapuria N, 2008, J SURG RES, V150, P304, DOI 10.1016/j.jss.2007.12.747; Hamilton KL, 2003, FREE RADICAL BIO MED, V34, P800, DOI 10.1016/S0891-5849(02)01431-4; MURRY CE, 1986, CIRCULATION, V74, P1124; Rudic RD, 1998, J CLIN INVEST, V101, P731, DOI 10.1172/JCI1699; Bulckaen H, 2008, AM J PHYSIOL-HEART C, V294, pH1562, DOI 10.1152/ajpheart.00241.2007; Rosenkranz S, 2002, AM J PHYSIOL-HEART C, V283, pH1253, DOI 10.1152/ajpheart.00578.2001; LOWENSTEIN CJ, 1994, ANN INTERN MED, V120, P227; Yamazaki T, 2012, HYPERTENS RES, V35, P34, DOI 10.1038/hr.2011.139; ITO T, 1989, J INVEST DERMATOL, V93, P259, DOI 10.1111/1523-1747.ep12277584; Yamazaki T, 2012, CIRC-HEART FAIL, V5, P794, DOI 10.1161/CIRCHEARTFAILURE.112.968750; Dobaczewski M, 2011, J MOL CELL CARDIOL, V51, P600, DOI 10.1016/j.yjmcc.2010.10.033; Rassaf T, 2014, CIRC RES, V114, P1601, DOI 10.1161/CIRCRESAHA.114.303822; Powers SK, 2001, MED SCI SPORT EXER, V33, P386, DOI 10.1097/00005768-200103000-00009; Toda N, 2011, EUR J PHARMACOL, V667, P41, DOI 10.1016/j.ejphar.2011.06.028; Das DK, 2006, CARDIOVASC RES, V70, P254, DOI 10.1016/j.cardiores.2006.02.023; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Hartmann BR, 1997, ANGIOLOGY, V48, P337, DOI 10.1177/000331979704800406; Irie H, 2005, CIRCULATION, V111, P1523, DOI 10.1161/01.CIR.0000159329.40098.66; Izumi Y, 2014, J ATHEROSCLER THROMB; Kazakov A, 2012, CARDIOVASC RES, V93, P397, DOI 10.1093/cvr/cvr305; Kim HK, 2012, J CARDIOL, V60, P98, DOI 10.1016/j.jjcc.2012.02.004; Kimura R, 2007, CYTOKINE, V38, P107, DOI 10.1016/j.cyto.2007.05.011; Kurokawa S, 2011, CIRC J, V75, P1386, DOI 10.1253/circj.CJ-10-1089; Nishimura N, 2002, EUR J APPL PHYSIOL, V87, P337, DOI 10.1007/s00421-002-0626-0; SCHNIZER W, 1985, INT J MICROCIRC, V4, P343; Tanaka M, 1998, JPN CIRC J, V62, P512, DOI 10.1253/jcj.62.512; Wang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098047; Yamaguchi T, 2014, J PHARMACOL SCI, V126, P168, DOI 10.1254/jphs.14171SC; Yamaguchi T, 2014, INT J CARDIOL C, V178C, P239; Yamazaki T, 2012, CIRC J, V76, P1203, DOI 10.1253/circj.CJ-11-1116	31	0	0	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	1347-8613	1347-8648		J PHARMACOL SCI	J. Pharmacol. Sci.	APR	2015	127	4					474	480		10.1016/j.jphs.2015.03.009		7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CH2TI	WOS:000353877100012		
J	Nakagawasai, O; Yamada, K; Nemoto, W; Sato, S; Ogata, Y; Miya, K; Sakurai, H; Tan-No, K				Nakagawasai, Osamu; Yamada, Kotaro; Nemoto, Wataru; Sato, Shin; Ogata, Yoshiki; Miya, Kohei; Sakurai, Hidetomo; Tan-No, Koichi			Liver hydrolysate attenuates the sickness behavior induced by concanavalin A in mice	JOURNAL OF PHARMACOLOGICAL SCIENCES			English	Article						Liver hydrolysate; Locomotor activity; Sickness behavior	ACTIVATED PROTEIN-KINASE; MODEL; RECEPTORS; DOPAMINE; NEURONS; CELLS	Liver hydrolysate (LH) is used as a pharmaceutical agent in Japan, to enhance liver function. However, the effects of LH on sickness behavior are unknown. This study investigated the effect of LH on sickness behaviors, such as concanavalin A (ConA)-induced reduction of locomotor activity. ConA treatment significantly decreased locomotor activity. The striatal tyrosine hydroxylase (TH) levels were also significantly decreased following ConA treatment. The decreased locomotor activity and TH levels were significantly reversed by LH treatment. LH may prove beneficial for preventing sickness behavior following ConA treatment, at least in part, by activating TH in the striatum. (C) 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Nakagawasai, Osamu; Nemoto, Wataru; Sato, Shin; Ogata, Yoshiki; Miya, Kohei; Tan-No, Koichi] Tohoku Pharmaceut Univ, Dept Pharmacol, Sendai, Miyagi 9818558, Japan; [Yamada, Kotaro; Sakurai, Hidetomo] Zeria Pharmaceut Co Ltd, Consumer Healthcare Prod Dev, Tokyo 1038351, Japan	Nakagawasai, O (reprint author), Tohoku Pharmaceut Univ, Dept Pharmacol, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	osamun@tohoku-pharm.ac.jp					Giri S, 2004, J NEUROSCI, V24, P479, DOI 10.1523/JNEUROSCI.4288-03.2004; Boehm S, 1998, J NEUROCHEM, V71, P2421; Mount MP, 2007, J NEUROSCI, V27, P3328, DOI 10.1523/JNEUROSCI.5321-06.2007; Huang CL, 2003, J NEUROCHEM, V86, P1247, DOI 10.1046/j.1471-4159.2003.01936.x; Hurley FM, 2004, EXP NEUROL, V185, P281, DOI 10.1016/j.expneurol.2003.10.003; Besedovsky HO, 1996, ENDOCR REV, V17, P64, DOI 10.1210/er.17.1.64; Di Chiara G, 2002, BEHAV BRAIN RES, V137, P75, DOI 10.1016/S0166-4328(02)00286-3; Fukuda T, 2007, J NEUROENDOCRINOL, V19, P621, DOI 10.1111/j.1365-2826.2007.01570.x; Inoue N, 2013, YAKUGAKU ZASSHI, V133, P117; Nader J, 2014, NEUROPHARMACOLOGY, V87, P214, DOI 10.1016/j.neuropharm.2014.03.014; Nakagawasai O, 2007, BEHAV BRAIN RES, V177, P315, DOI 10.1016/j.bbr.2006.11.024; Nakagawasai O, 2013, J PHARMACOL SCI, V123, P328, DOI 10.1254/jphs.13084FP; Nasu M, 2014, GENOME BIOL EVOL, V6, P1145, DOI 10.1093/gbe/evu072; Toth LA, 2005, SLEEP, V28, P571; Zhang M, 2012, NEUROPHARMACOLOGY, V62, P2219, DOI 10.1016/j.neuropharm.2012.01.012	15	0	0	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	1347-8613	1347-8648		J PHARMACOL SCI	J. Pharmacol. Sci.	APR	2015	127	4					489	492		10.1016/j.jphs.2015.03.007		4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CH2TI	WOS:000353877100014		
J	Ito, M; Marx, DB; Cheng, AC; Wee, AG				Ito, Masayasu; Marx, David B.; Cheng, Ansgar C.; Wee, Alvin G.			Proposed Shade Guide for Attached Gingiva-A Pilot Study	JOURNAL OF PROSTHODONTICS-IMPLANT ESTHETIC AND RECONSTRUCTIVE DENTISTRY			English	Article						Gingiva color; acrylic; pink porcelain	COVERAGE ERROR; COLOR; SYSTEMS; MUCOSA	PurposeThe purpose of this study was to evaluate the effect of race, age, and gender on Commision Internationale de l'Eclairage Lab color space (CIELAB) values of attached gingival colors. The color coordinates of an optimal proposed attached gingival shade guide were also determined. Material and MethodsParticipants (n = 120) were recruited to fulfill the following stratification of five age groups: 18-29, 30-39, 40-49, 50-59, and 60-85, with four racial categories (white, black, Asian, and others) and balanced for gender. Reflectance measurements of participants' attached gingiva were made using a spectroradiometer and Xenon arc lamp with a 45/0 optical configuration. A stepwise discriminant analysis was carried out to identify gingival color contribution from race, age, and gender. A hierarchical clustering analysis was used to identify color groups that clustered together. The coverage error of the proposed shade guide was calculated to the original gingival color. ResultsThe stepwise discriminant analysis showed a statistically significant difference in gingival color contribution from the factors evaluated. Significant influence was found for the race/gender factors (p < 0.05), but not for age. The cluster analysis results revealed three cluster centroids with mean L*a*b* as follows: (1 = 51.0 4.2, 27.7 +/- 4.7, 18.3 +/- 3.2), (2 = 61.4 +/- 4.5, 24.3 +/- 4.3, 17.6 +/- 2.3), and (3 = 36.1 +/- 4.1, 21 +/- 4.9, 16 +/- 5.2). The coverage errors to the following racial categories were: Asian (E = 6.0 +/- 4.8), black (E = 6.7 +/- 3.9), others (E = 5.8 +/- 2.9), and white (E = 4.6 +/- 2.7). ConclusionsThe study showed that L*a*b* was significantly affected by race and gender. Clustering analysis was able to identify clusters in 120 participants for three gingival tones.	[Ito, Masayasu] Nihon Univ, Sch Dent Matsudo, Dept Removable Prosthodont, Chiba, Japan; [Marx, David B.] Univ Nebraska, Dept Stat, Lincoln, NE USA; [Cheng, Ansgar C.] Mt Elizabeth Hosp, Specialist Dent Grp, Singapore, Singapore; [Cheng, Ansgar C.] Natl Univ Singapore, Grad Prosthodont, Singapore 117548, Singapore; [Wee, Alvin G.] VA Nebraska Western Iowa Healthcare Syst, Omaha, NE USA; [Wee, Alvin G.] Creighton Univ, Sch Dent, Dept Prosthodont, Omaha, NE 68178 USA	Wee, AG (reprint author), Creighton Univ, Sch Dent, Dept Prosthodont, 2500 Calif Plaza, Omaha, NE 68178 USA.	alvingwee@gmail.com			Editorial Council of the Journal of Prosthetic Dentistry Grants and Award Program;  [NIH R15 EY013527]	Supported by grant NIH R15 EY013527 (Wee AG) and a grant from The Editorial Council of the Journal of Prosthetic Dentistry Grants and Award Program (Wee AG).	Analoui M, 2004, J PROSTHET DENT, V92, P371, DOI 10.1016/j.prosdent.2004.06.028; Bayindir F, 2009, J PROSTHET DENT, V101, P46, DOI 10.1016/S0022-3913(08)60290-5; POWERS JM, 1977, J DENT RES, V56, P112, DOI 10.1177/00220345770560020301; Huang JW, 2011, J DENT, V39, pE11, DOI 10.1016/j.jdent.2011.10.001; Heydecke G, 2005, CLIN ORAL INVEST, V9, P257, DOI 10.1007/s00784-005-0006-3; Douglas RD, 2007, J PROSTHET DENT, V97, P200, DOI 10.1016/j.prosdent.2007.02.012; BOLT RA, 1994, PHYS MED BIOL, V39, P1133, DOI 10.1088/0031-9155/39/7/006; TJAN AHL, 1984, J PROSTHET DENT, V51, P24, DOI 10.1016/S0022-3913(84)80097-9; Bayindir F, 2007, J PROSTHET DENT, V98, P175, DOI 10.1016/S0022-3913(07)60053-5; Okubo SR, 1998, J PROSTHET DENT, V80, P642, DOI 10.1016/S0022-3913(98)70049-6; Commission intemationale de l'eclairage (CIE), 1978, CIE PUBL S2, V15; DUMMETT CO, 1980, J PROSTHET DENT, V43, P392, DOI 10.1016/0022-3913(80)90207-3; Gozalo-Diaz DJ, 2007, J PROSTHET DENT, V97, P45, DOI 10.1016/j.prosdent.2006.10.013; Haeberle C B, 1997, J Prosthodont, V6, P153, DOI 10.1111/j.1532-849X.1997.tb00082.x; Hendrickson EL, 2008, J DENT RES, V87, P1004; Ibusuki M, 1975, Bull Tokyo Med Dent Univ, V22, P281; Jarad FD, 2005, BRIT DENT J, V199, P43, DOI 10.1038/sj.bdj.4812559; JONES J, 1977, J PERIODONTOL, V48, P21; O'Brien W J, 1991, Int J Prosthodont, V4, P45; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wee AG, 2006, CONT FIXED PROSTHODO, P709; Zlataric DK, 2008, INT J PROSTHODONT, V21, P86	22	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1059-941X	1532-849X		J PROSTHODONT	J. Prosthodont.	APR	2015	24	3					182	187		10.1111/jopr.12195		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CH0HF	WOS:000353699700002		
J	Murakami, M; Nishi, Y; Umezono, M; Kamashita, Y; Nishimura, M				Murakami, Mamoru; Nishi, Yasuhiro; Umezono, Minoru; Kamashita, Yuji; Nishimura, Masahiro			Fabrication of a Movable Obturator Following Maxillary Reconstruction with Slit-Shaped Fenestration	JOURNAL OF PROSTHODONTICS-IMPLANT ESTHETIC AND RECONSTRUCTIVE DENTISTRY			English	Article						Obturator prosthesis; maxillectomy; maxillary reconstruction; slit-shaped fenestration	FREE TISSUE TRANSFER; FIBULA OSTEOCUTANEOUS FLAP; OSSEOINTEGRATED IMPLANTS; EDENTULOUS PATIENTS; TOTAL MAXILLECTOMY; REHABILITATION; CLASSIFICATION; PROSTHESES; DEFECTS; PATIENT	Extensive maxillary resection has generally been reconstructed with free skin flaps. Because drooping of the transferred flap causes instability of the obturator prosthesis, maxillary reconstruction often incorporates a slit-shaped oronasal fenestration. Although obturator prostheses for edentulous patients are stabilized with the help of oronasal slits, those for dentate patients are unstable because of flap mobility, resulting in a harmful lateral force exerted on the abutment teeth, causing dislodging of the denture. This report evaluates the benefits of a movable obturator prosthesis for a 60-year-old dentulous patient with maxillary sinus carcinoma. The patient underwent left-sided total maxillectomy, and the defect was reconstructed with a slit-shaped fenestration using a rectus abdominis flap. A conventional obturator prosthesis was inserted; however, drooping of the flap caused instability of the obturator, resulting in nasal regurgitation and fracture of the clasp. To solve this problem, we designed an obturator prosthesis with a movable connection consisting of a ball attachment (patrix) in the metal base and a socket (matrix) in the obturator, which acted as a stress breaker against the harmful force exerted by the flap. Application of this movable obturator prosthesis was a useful solution for a compromising situation created by the surgical procedure. No clinical disorders were observed at the 3-year follow-up.	[Murakami, Mamoru; Kamashita, Yuji] Kagoshima Univ, Med & Dent Hosp, Dept Denture Prosthodont Restorat, Kagoshima 8908544, Japan; [Nishi, Yasuhiro; Nishimura, Masahiro] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Oral & Maxillofacial Prosthodont, Kagoshima 8908544, Japan	Murakami, M (reprint author), Kagoshima Univ, Med & Dent Hosp, Dept Denture Prosthodont Restorat, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	kaku@dent.kagoshima-u.ac.jp					Okay DJ, 2001, J PROSTHET DENT, V86, P352, DOI 10.1067/mpr.2001.119524; ARAMANY MA, 1978, J PROSTHET DENT, V40, P554, DOI 10.1016/0022-3913(78)90092-6; Funk GF, 1998, HEAD NECK-J SCI SPEC, V20, P38, DOI 10.1002/(SICI)1097-0347(199801)20:1<38::AID-HED7>3.0.CO;2-4; Hirai T, 1994, Int J Prosthodont, V7, P454; Hoshiai Taiji, 2011, J Prosthodont Res, V55, P252, DOI 10.1016/j.jpor.2010.08.001; Kamashita Y, 2007, PROSTHODONTIC RES PR, V6, P93, DOI 10.2186/prp.6.93; Kazaoka Y, 1999, PLAST RECONSTR SURG, V103, P1244, DOI 10.1097/00006534-199904040-00021; Keyf F, 2001, J ORAL REHABIL, V28, P821, DOI 10.1046/j.1365-2842.2001.00754.x; Kobayashi Makio, 2002, Journal of Medical and Dental Sciences, V49, P121; Kobayashi Yoshinori, 2009, J Prosthodont Res, V53, P142, DOI 10.1016/j.jpor.2009.04.001; Koyama S, 2005, J ORAL REHABIL, V32, P635, DOI 10.1111/j.1365-2842.2005.01483.x; Leles CR, 2010, J PROSTHODONT, V19, P240, DOI 10.1111/j.1532-849X.2009.00545.x; Mukohyama H, 2005, J ORAL REHABIL, V32, P541, DOI 10.1111/j.1365-2842.2005.01463.x; Muneuchi G, 2006, MICROSURG, V26, P171, DOI 10.1002/micr.20194; Ohtsuka A, 1999, J JPN SOC ORAL IMPLA, V12, P220; Oki M, 2006, J ORAL REHABIL, V33, P43, DOI 10.1111/j.1365-2842.2006.01528.x; Peng X, 2005, PLAST RECONSTR SURG, V115, P1562, DOI 10.1097/01.PRS.000160691.63029.74; Sakuraba M, 2003, PLAST RECONSTR SURG, V111, P594, DOI 10.1097/01.PRS.0000041941.98504.B6; Santamaria E, 2006, J SURG ONCOL, V94, P522, DOI 10.1002/jso.20490; Sumita YI, 2012, GERODONTOLOGY, V29, pE645, DOI 10.1111/j.1741-2358.2011.00538.x	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1059-941X	1532-849X		J PROSTHODONT	J. Prosthodont.	APR	2015	24	3					254	259		10.1111/jopr.12199		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CH0HF	WOS:000353699700014		
J	Koike, S; Takizawa, R; Nishimura, Y; Kinou, M; Kawasaki, S; Kasai, K				Koike, Shinsuke; Takizawa, Ryu; Nishimura, Yukika; Kinou, Masaru; Kawasaki, Shingo; Kasai, Kiyoto			Reduced but broader prefrontal activity in patients with schizophrenia during n-back working memory tasks: A multi-channel near-infrared spectroscopy study (vol 47, pg 1240, 2013)	JOURNAL OF PSYCHIATRIC RESEARCH			English	Correction									[Koike, Shinsuke; Takizawa, Ryu; Nishimura, Yukika; Kinou, Masaru; Kawasaki, Shingo; Kasai, Kiyoto] Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Bunkyo Ku, Tokyo 1138655, Japan; [Nishimura, Yukika] Japan Fdn Neurosci & Mental Hlth, Tokyo 1878551, Japan; [Kawasaki, Shingo] Hitachi Med Corp, Applicat Dev Off, Kashiwa, Chiba 2770804, Japan	Koike, S (reprint author), Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	skoike-tky@umin.ac.jp					Koike S, 2013, J PSYCHIATR RES, V47, P1240, DOI 10.1016/j.jpsychires.2013.05.009	1	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3956	1879-1379		J PSYCHIATR RES	J. Psychiatr. Res.	APR	2015	63						143	143		10.1016/j.jpsychires.2014.12.014		1	Psychiatry	Psychiatry	CH0WL	WOS:000353743000019		
J	Shima, T; Inada, K; Nakashima, A; Ushijima, A; Ito, M; Yoshino, O; Saito, S				Shima, Tomoko; Inada, Kumiko; Nakashima, Akitoshi; Ushijima, Akemi; Ito, Mika; Yoshino, Osamu; Saito, Shigeru			Paternal antigen-specific proliferating regulatory T cells are increased in uterine-draining lymph nodes just before implantation and in pregnant uterus just after implantation by seminal plasma-priming in allogeneic mouse pregnancy	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Article						Chemokine receptor; Feto-maternal tolerance; Regulatory T cells; Paternal antigen; Seminal fluid	PERIPHERAL-BLOOD; SPONTANEOUS-ABORTION; MATERNAL TOLERANCE; EXPANSION; DECIDUA; POOL; ALLOANTIGENS; DISEASES; MEMORY; FETUS	Paternal antigen-specific regulatory T (PA-specific Treg) cells play an important role in feto-maternal tolerance. To detect the PA-specific Tregs, female BALB/c mice were mated with male DBA/2 mice. Mls Ia antigen on DBA/2 mice is recognized by the T-cell receptor V beta 6; thus, CD4(+)Foxp3(+)V beta 6(+) cells are recognized as PA-specific Treg cells. CD4(+)CD25(+)V beta 6(+) cells effectively suppressed the allo-reactive proliferation of lymphocytes compared with that of CD4(+)CD25(+)V beta 6(-) cells. V beta 6(+) PA-specific Treg cells expressed CCR4 and CCR5 on their surface. The frequency of Ki67(+) PA-specific Treg cells among Treg cells was significantly increased in draining lymph nodes on day 3.5 post-coitus (pc; 6.8 +/- 1.1%, p < 0.05) and day 5.5 pc (7.2 +/- 1.1%, p < 0.05) in allogeneic pregnant mice compared with that in nonpregnant mice (2.7 +/- 0.2%). The frequency of Ki67(+) PA-specific Treg cells in the uterus increased significantly after day 5.5 pc in allogeneic pregnant mice compared with that in nonpregnant mice (8.8 +/- 2.8% vs. 1.2 +/- 1.3%, p < 0.05). However, Ki67-PA-specific Tregs did not change during pregnancy. To analyze the role of seminal fluid or sperm in Treg expansion, female BALB/c mice were mated with vasectomized DBA/2 male mice (VAS) or seminal vesicle-excised DBA/2 male mice (SVX). The frequency of Ki67+ PA-specific Treg cells did not increase in draining lymph nodes or uterus in BALB/c x DBA/2 (SVX) allogeneic mating mice. These findings suggest that the priming by seminal fluid is important for the induction of proliferating PA-specific Tregs in uterine-draining lymph nodes just before implantation and pregnant uterus after implantation, resulting in successful implantation and the maintenance of allogeneic pregnancy. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Shima, Tomoko; Inada, Kumiko; Nakashima, Akitoshi; Ushijima, Akemi; Ito, Mika; Yoshino, Osamu; Saito, Shigeru] Toyama Univ, Dept Obstet & Gynecol, Toyama 9300194, Japan	Saito, S (reprint author), Toyama Univ, Dept Obstet & Gynecol, Toyama 9300194, Japan.	s30saito@med.u-toyama.ac.jp			KAKENHI [23791818, 26861316, 24791107, 26670717, 23390386]	This study was supported by KAKENHI for Young Scientists (B) 23791818, 26861316, 24791107, Exploratory Research 26670717, and Scientific Research (B) 23390386.	Sasaki Y, 2004, MOL HUM REPROD, V10, P347, DOI 10.1093/molehr/gah044; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Wang WJ, 2010, J REPROD IMMUNOL, V84, P164, DOI 10.1016/j.jri.2009.12.003; Guerin LR, 2011, BIOL REPROD, V85, P397, DOI 10.1095/biolreprod.110.088591; Zhao JX, 2007, J REPROD IMMUNOL, V75, P71, DOI 10.1016/j.jri.2007.06.052; TAFURI A, 1995, SCIENCE, V270, P630, DOI 10.1126/science.270.5236.630; Chen T, 2013, J IMMUNOL, V191, P2273, DOI 10.4049/jimmunol.1202413; Tsuda H, 2002, AM J REPROD IMMUNOL, V48, P1, DOI 10.1034/j.1600-0897.2002.01117.x; Shima T, 2010, J REPROD IMMUNOL, V85, P121, DOI 10.1016/j.jri.2010.02.006; Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Steinborn A, 2012, CLIN EXP IMMUNOL, V167, P84, DOI 10.1111/j.1365-2249.2011.04493.x; Rowe JH, 2012, NATURE, V490, P102, DOI 10.1038/nature11462; Kallikourdis M, 2007, P NATL ACAD SCI USA, V104, P594, DOI 10.1073/pnas.0604268104; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Tilburgs T, 2008, J IMMUNOL, V180, P5737; Robertson SA, 2009, BIOL REPROD, V80, P1036, DOI 10.1095/biolreprod.108.074658; Sasaki Y, 2007, CLIN EXP IMMUNOL, V149, P139, DOI 10.1111/j.1365-2249.2007.03397.x; Zenclussen ML, 2010, AM J REPROD IMMUNOL, V63, P200, DOI 10.1111/j.1600-0897.2009.00793.x; Fraccaroli L, 2009, HUM REPROD, V24, P166, DOI 10.1093/humrep/den344; Mjosberg J, 2007, IMMUNOLOGY, V120, P456, DOI 10.1111/j.1365-2567.2006.02529.x; Zenclussen AC, 2005, AM J PATHOL, V166, P811, DOI 10.1016/S0002-9440(10)62302-4; Inada K, 2013, J REPROD IMMUNOL, V97, P104, DOI 10.1016/j.jri.2012.12.001; Arruvito L, 2010, CLIN IMMUNOL, V136, P432, DOI 10.1016/j.clim.2010.05.002; Darrasse-Jèze Guillaume, 2006, Immunol Lett, V102, P106; Maldenhauer L.M., 2009, J IMMUNOL, V182, P8080; Nagahama K, 2009, INT IMMUNOL, V21, P379, DOI 10.1093/intimm/dxp005	26	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	APR	2015	108				SI		72	82		10.1016/j.jri.2015.02.005		11	Immunology; Reproductive Biology	Immunology; Reproductive Biology	CG8YV	WOS:000353602500011		
J	Takahara, EI; Yuasa, H; Nishida, M; Mantani, Y; Udayanga, KGS; Qi, WM; Takeuchi, T; Yokoyama, T; Hoshi, N; Kitagawa, H				Takahara, Ei-ichirou; Yuasa, Hideto; Nishida, Miho; Mantani, Youhei; Udayanga, Kankanam Gamage Sanath; Qi, Wang-Mei; Takeuchi, Takashi; Yokoyama, Toshifumi; Hoshi, Nobuhiko; Kitagawa, Hiroshi			Immunohistochemical and histoplanimetrical study on the endothelial receptor involved in transportation of minute chylomicrons into subepithelial portal blood in intestinal villi of the rat jejunum	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						immunohistochemistry; minute chylomicron; rat; small intestine; VLDL receptor	DENSITY-LIPOPROTEIN RECEPTOR; TRIGLYCERIDE-RICH LIPOPROTEINS; ALIMENTARY-TRACT; SPATIAL RELATIONSHIP; INDIGENOUS BACTERIA; VLDL RECEPTOR; CELLS; EXPRESSION; METABOLISM; ENDOTOXIN	A portion of the minute chylomicrons less than 75 nm in diameter are transcytosed from the extravascular tissue into the subepithelial blood capillaries (sBC) in the villous apices of the rat jejunum. However, the details of the transportation mechanism have not been clarified. In this study, the endothelial receptor involved in the transportation of minute chylomicrons into the sBC's lumina was immunohistochemically and histoplanimetrically examined in intestinal villi of the rat jejunum. Immunopositivity for very low density lipoprotein (VLDL) receptor was detected on the luminal and basal surfaces of the endothelial cells of sBC in approximately 68% of those apices of jejunal villi that possessed numerous chylomicrons in the lamina propria, while VLDL receptor was detected on the endothelial cells of sBC in only approximately 8% of intestinal villi that possessed few or no chylomicrons in the lamina propria. No immunopositivity for VLDL receptor was detected in the sBC of all intestinal villi. These findings suggest that VLDL receptor is expressed by the endothelial cells of the sBC in conjunction with the filling of the lamina propria of jejunal villi with many chylomicrons produced by the villous columnar epithelial cells and that the VLDL receptor mediates the transportation of minute chylomicrons, maybe VLDL, into the subepithelial portal blood from the extravascular tissue of the rat jejunal villi.	[Takahara, Ei-ichirou; Yuasa, Hideto; Nishida, Miho; Mantani, Youhei; Kitagawa, Hiroshi] Kobe Univ, Grad Sch Agr Sci, Dept Bioresource Sci, Lab Histophysiol,Nada Ku, Kobe, Hyogo 6578501, Japan; [Udayanga, Kankanam Gamage Sanath] Univ Tsukuba, Inst Basic Med Sci, Grad Sch Comprehens Human Sci, Lab Immunol, Tsukuba, Ibaraki 3058575, Japan; [Qi, Wang-Mei] Inner Mongolia Agr Univ, Coll Vet Med, Dept Basic Vet Med, Hohhot 010018, Inner Mongolia, Peoples R China; [Takeuchi, Takashi] Tottori Univ, Dept Vet Lab Anim Sci, Fac Agr, Minami Ku, Tottori 6808553, Japan; [Yokoyama, Toshifumi; Hoshi, Nobuhiko] Kobe Univ, Lab Mol Morphol, Dept Bioresource Sci, Grad Sch Agr Sci,Nada Ku, Kobe, Hyogo 6578501, Japan	Kitagawa, H (reprint author), Kobe Univ, Grad Sch Agr Sci, Dept Bioresource Sci, Lab Histophysiol,Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.	hkitagaw@kobe-u.ac.jp			Japan Society for the Promotion of Science [23580403]	This work was financially supported in part by a Grant-in-Aid for Scientific Research (no. 23580403) from the Japan Society for the Promotion of Science.	JACOB AI, 1977, GASTROENTEROLOGY, V72, P1268; FRIEDMAN HI, 1980, AM J CLIN NUTR, V33, P1108; MIMURA Y, 1995, GASTROENTEROLOGY, V109, P1969, DOI 10.1016/0016-5085(95)90765-3; TAKAHASHI S, 1992, P NATL ACAD SCI USA, V89, P9252, DOI 10.1073/pnas.89.19.9252; GREEN PHR, 1981, J LIPID RES, V22, P1153; Ruan XZ, 2006, ARTERIOSCL THROM VAS, V26, P1150, DOI 10.1161/01.ATV.0000217957.93135.c2; MAHLEY RW, 1984, J LIPID RES, V25, P1277; Yamamoto K, 2009, J VET MED SCI, V71, P621, DOI 10.1292/jvms.71.621; Ueno M, 2010, HISTOCHEM CELL BIOL, V133, P669, DOI 10.1007/s00418-010-0705-y; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; OCKNER RK, 1969, J CLIN INVEST, V48, P2079, DOI 10.1172/JCI106174; Ramasamy I, 2014, CLIN CHEM LAB MED, V52, P1695, DOI 10.1515/cclm-2013-0358; HARRIS HW, 1993, J CLIN INVEST, V91, P1028, DOI 10.1172/JCI116259; Niemeier A, 1996, J LIPID RES, V37, P1733; Yokoo Y, 2011, J VET MED SCI, V73, P1043, DOI 10.1292/jvms.11-0114; Mansbach CM, 2007, AM J PHYSIOL-GASTR L, V293, pG645, DOI 10.1152/ajpgi.00299.2007; Go Gwang-woong, 2012, Yale Journal of Biology and Medicine, V85, P19; HARRIS HW, 1990, J CLIN INVEST, V86, P696, DOI 10.1172/JCI114765; Cabeen MT, 2005, NAT REV MICROBIOL, V3, P601, DOI 10.1038/nrmicro1205; Dixon JB, 2010, ANN NY ACAD SCI, V1207, pE52, DOI 10.1111/j.1749-6632.2010.05716.x; Multhaupt HAB, 1996, AM J PATHOL, V148, P1985; Cooper AD, 1997, J LIPID RES, V38, P2173; TAKAHASHI S, 1995, J BIOL CHEM, V270, P15747; BRAUN JEA, 1992, BIOCHEM J, V287, P337; BARTHEL LK, 1990, J HISTOCHEM CYTOCHEM, V38, P1383; Bikhazi AB, 2001, COMP BIOCHEM PHYS C, V129, P339, DOI 10.1016/S1532-0456(01)00207-1; CARUANA JA, 1984, J SURG RES, V37, P197, DOI 10.1016/0022-4804(84)90180-X; Chappell DA, 1998, PROG LIPID RES, V37, P393, DOI 10.1016/S0163-7827(98)00017-4; CORNETTA K, 1983, EXP HEMATOL, V11, P275; Garcia-Miranda P, 2010, EXP PHYSIOL, V95, P498, DOI 10.1113/expphysiol.2009.050682; GIANTURCO SH, 1994, J LIPID RES, V35, P1674; GIANTURCO SH, 1988, J CLIN INVEST, V82, P1633, DOI 10.1172/JCI113775; HARKES L, 1989, EUR J BIOCHEM, V180, P241, DOI 10.1111/j.1432-1033.1989.tb14639.x; Jonas A., 2002, BIOCH LIPIDS LIPOPRO, V4th, P483; Mantani Y, 2011, HISTOL HISTOPATHOL, V26, P1295; Mantani Y, 2012, J VET MED SCI, V74, P1429, DOI 10.1292/jvms.12-0146; MERESSE S, 1989, J NEUROCHEM, V53, P340, DOI 10.1111/j.1471-4159.1989.tb07340.x; MJOS OD, 1975, J CLIN INVEST, V56, P603, DOI 10.1172/JCI108130; Mutoh M, 2009, INT J CANCER, V125, P2505, DOI 10.1002/ijc.24667; Nakamura Y, 2000, ARCH PATHOL LAB MED, V124, P119; OCKNER RK, 1970, J LIPID RES, V11, P284; RANDLE PJ, 1964, POSTGRAD MED J, V40, P457; RISSER TR, 1978, AM J PHYSIOL, V234, pE277; Sanada Y., 2011, HEPATOL INT, V6, P778; SCHAEFER EJ, 1978, J LIPID RES, V19, P667; Takahara E, 2013, J VET MED SCI, V75, P1563, DOI 10.1292/jvms.13-0310; TSO P, 1983, J LIPID RES, V24, P810; TSO P, 1984, AM J PHYSIOL, V247, pG599; Wyne KL, 1996, ARTERIOSCL THROM VAS, V16, P407	49	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	APR	2015	77	4					387	393		10.1292/jvms.14-0432		7	Veterinary Sciences	Veterinary Sciences	CG9US	WOS:000353666200001		
J	Mori, H; Tanaka, T; Mochizuki, M				Mori, Hiroyuki; Tanaka, Tetsuya; Mochizuki, Masami			The widely distributed hard tick, Haemaphysalis longicornis, can retain canine parvovirus, but not be infected in laboratory condition	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						canine parvovirus; experimental inoculation; feline leukemia virus; ixodid tick; vector	RHIPICEPHALUS-APPENDICULATUS; ORNITHODOROS-MOUBATA; TRANSFERRIN RECEPTOR; FELINE PARVOVIRUSES; AMBLYOMMA-HEBRAEUM; ACARI IXODIDAE; BORNE VIRUSES; SOFT TICK; TRANSMISSION; LEUKEMIA	Ticks are known to transmit various pathogens, radically threatening humans and animals. Despite the close contact between ticks and viruses, our understanding on their interaction and biology is still lacking. The aim of this study was to experimentally assess the interaction between canine parvovirus (CPV) and a widely distributed hard tick, Haemaphysalis longicornis, in laboratory condition. After inoculation of CPV into the hemocoel of the ticks, polymerase chain reaction assay revealed that CPV persisted in inoculated unfed adult female ticks for 28 days. Canine parvovirus was recovered from the inoculated ticks using a cell culture, indicating that the virus retained intact in the ticks after inoculation, but significant positive reaction indicating virus infection was not detected in the tick organs by immunofluorescence antibody test using a monoclonal antibody. In the case of ticks inoculated with feline leukemia virus, the virus had shorter persistence in the ticks compared to CPV. These findings provide significant important information on the characteristic interaction of tick with non-tick-borne virus.	[Mori, Hiroyuki; Tanaka, Tetsuya; Mochizuki, Masami] Kagoshima Univ, Joint Fac Vet Med, Infect Dis Lab, Kagoshima 8900065, Japan	Mochizuki, M (reprint author), Kagoshima Univ, Joint Fac Vet Med, Infect Dis Lab, Korimoto 1-21-24, Kagoshima 8900065, Japan.	masamimochizuki@vet.kagoshima-u.ac.jp					AGYEI AD, 1995, INT J PARASITOL, V25, P55, DOI 10.1016/0020-7519(94)00114-4; Boldbaatar D, 2010, INSECT BIOCHEM MOLEC, V40, P49, DOI 10.1016/j.ibmb.2009.12.009; Tandon R, 2005, J VIROL METHODS, V130, P124, DOI 10.1016/j.jviromet.2005.06.017; Jongejan F, 2004, PARASITOLOGY, V129, pS3, DOI 10.1017/S0031182004005967; Truyen U, 2006, VET MICROBIOL, V117, P9, DOI 10.1016/j.vetmic.2006.04.003; FUJISAKI K, 1978, NATL I ANIM HEALTH Q, V18, P27; JARRETT O, 1982, VET REC, V110, P225; Kleiboeker SB, 1999, J VIROL, V73, P8587; Bouwknegt C, 2010, EXP APPL ACAROL, V52, P183, DOI 10.1007/s10493-010-9359-7; Parker JSL, 2001, J VIROL, V75, P3896, DOI 10.1128/JVI.75.8.3896-3902.2001; Hueffer K, 2003, J VIROL, V77, P1718, DOI 10.1128/JVI.77.3.1718-1726.2003; Labuda M, 2004, PARASITOLOGY, V129, pS221, DOI 10.1017/S0031182004005220; McMullan LK, 2012, NEW ENGL J MED, V367, P834, DOI 10.1056/NEJMoa1203378; Aung KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033504; AZETAKA M, 1981, JPN J VET SCI, V43, P243; Bagshaw C, 2014, PREV VET MED, V114, P276, DOI 10.1016/j.prevetmed.2014.02.005; Buresova V, 2006, J INVERTEBR PATHOL, V93, P96, DOI 10.1016/j.jip.2006.05.006; Favoretto SR, 2013, REV SOC BRAS MED TRO, V46, P788, DOI 10.1590/0037-8682-1673-2013; Gao JL, 2007, EXP APPL ACAROL, V41, P289, DOI 10.1007/s10493-007-9065-2; Hatta T, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-263; Havlikova S, 2013, ACTA VIROL, V57, P123, DOI 10.4149/av_2013_02_123; Hoelzer K, 2010, VET RES, V41, DOI 10.1051/vetres/2010011; Hueffer K, 2003, J VIROL, V77, P10099, DOI 10.1128/JVI.77.18.10099-10105.2003; HUMPHERYSMITH I, 1993, AIDS, V7, P341, DOI 10.1097/00002030-199303000-00006; Ikadai H, 2007, AM J TROP MED HYG, V76, P694; Kaufman WR, 1996, EXP PARASITOL, V82, P316, DOI 10.1006/expr.1996.0039; Korshus JB, 2004, MED MICROBIOL IMMUN, V193, P27, DOI 10.1007/s00430-003-0178-x; Levin ML, 2009, EXP APPL ACAROL, V49, P347, DOI 10.1007/s10493-009-9268-9; Lubinga JC, 2014, EXP APPL ACAROL, V62, P67, DOI 10.1007/s10493-013-9722-6; MEUNIER PC, 1985, VET PATHOL, V22, P60; Mochizuki M, 1989, Nihon Juigaku Zasshi, V51, P264; Mochizuki M, 1996, J CLIN MICROBIOL, V34, P2101; Mori H, 2014, TICKS TICK-BORNE DIS, V5, P121, DOI 10.1016/j.ttbdis.2013.09.004; Morris SD, 1996, J S AFR VET ASSOC, V67, P148; RICKARD CG, 1969, J NATL CANCER I, V42, P987; ROBINSON WF, 1980, VET PATHOL, V17, P589, DOI 10.1177/030098588001700508; Sonenshine DE, 1991, BIOL TICKS; Uchikawa K., 1976, Japanese J Sanit Zool, V27, P207; Willett BJ, 2013, VET J, V195, P16, DOI 10.1016/j.tvjl.2012.07.004	39	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	APR	2015	77	4					405	411		10.1292/jvms.14-0199		7	Veterinary Sciences	Veterinary Sciences	CG9US	WOS:000353666200003		
J	Yamaya, Y; Watari, T				Yamaya, Yoshiki; Watari, Toshihiro			Increased proportions of CCR4(+) cells among peripheral blood CD4(+) cells and serum levels of allergen-specific IgE antibody in canine chronic rhinitis and bronchitis	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						bronchitis; canine; rhinitis	ACTIVATION-REGULATED CHEMOKINE; ATOPIC-DERMATITIS; AIRWAY; DOGS; THYMUS; RESPONSES; THERAPY; ASTHMA	Canine chronic rhinitis (CR) and bronchitis (CB) are suspected to be allergic diseases. The present study tested whether dogs diagnosed with CR or CB present an atopic predisposition based on the ratio of CC chemokine receptor 4 (CCR4)-positive cells among peripheral blood CD4-positive cells (CCR4/CD4) and the serum levels of allergen-specific IgE antibodies. We found that most dogs with CR and CB have a possibility of atopic predisposition, and macrolide therapy constitutes an alternative to corticosteroid therapy in controlling the clinical signs.	[Yamaya, Yoshiki; Watari, Toshihiro] Nihon Univ, Lab Comprehens Vet Clin Studies, Dept Vet Med, Coll Bioresource Sci, Fujisawa, Kanagawa 2520880, Japan	Yamaya, Y (reprint author), Nihon Univ, Lab Comprehens Vet Clin Studies, Dept Vet Med, Coll Bioresource Sci, Kameino 1866, Fujisawa, Kanagawa 2520880, Japan.	yamaya@brs.nihon-u.ac.jp			Nihon University College of Bioresource Sciences Research Foundation	I would like to express the deepest appreciation to the staff of Animal Medical Center in Nihon University for following up and helping our research. Part of this study was supported by the Nihon University College of Bioresource Sciences Research Foundation for 2009.	Maeda S, 2004, CLIN EXP ALLERGY, V34, P1467, DOI 10.1111/j.1365-2222.2004.02039.x; Banfield G, 2010, ALLERGY, V65, P1126, DOI 10.1111/j.1398-9995.2010.02327.x; Olivry T, 1997, AM J DERMATOPATH, V19, P477, DOI 10.1097/00000372-199710000-00008; Panina-Bordignon P, 2001, J CLIN INVEST, V107, P1357, DOI 10.1172/JCI12655; Windsor RC, 2006, CLIN TECH SMALL AN P, V21, P76, DOI 10.1053/j.ctsap.2005.12.014; Imai T, 1999, INT IMMUNOL, V11, P81, DOI 10.1093/intimm/11.1.81; Boudreau B, 2013, JAVMA-J AM VET MED A, V242, P658, DOI 10.2460/javma.242.5.658; Cervin A, 2007, RHINOLOGY, V45, P259; Booth D. M., 2004, TXB RESP DIS DOGS CA, P229, DOI 10.1016/B978-0-7216-8706-3.50036-0; Chapman RW, 2008, PULM PHARMACOL THER, V21, P731, DOI 10.1016/j.pupt.2008.01.003; Fujimura M, 2000, CLIN EXP ALLERGY, V30, P41; Fujimura Masaki, 2000, Allergology International, V49, P135, DOI 10.1046/j.1440-1592.2000.00171.x; Fujimura M, 2011, J VET MED SCI, V73, P1309, DOI 10.1292/jvms.10-0410; Funayama M., 2013, Journal of the Japan Veterinary Medical Association, V66, P52; Grossman J, 1997, CHEST, V111, pS11, DOI 10.1378/chest.111.2_Supplement.11S; Johansson SGO, 2004, J ALLERGY CLIN IMMUN, V113, P832, DOI 10.1016/j.jaci.2003.12.591; Komine M, 2005, J INVEST DERMATOL, V125, P491, DOI 10.1111/j.0022-202X.2005.23840.x; Kurata K, 2004, J VET MED SCI, V66, P25, DOI 10.1292/jvms.66.25; Leung TF, 2005, THORAX, V60, P822, DOI 10.1136/thx.2004.039321; Okayama T, 2011, VET IMMUNOL IMMUNOP, V139, P99, DOI 10.1016/j.vetimm.2010.09.002; Ozaki E., 2009, P ANN M JAP SOC VET, V12, P38; Sin Betul, 2011, Proc Am Thorac Soc, V8, P106, DOI 10.1513/pats.201008-057RN; Spergel Jonathan M., 2003, Journal of Allergy and Clinical Immunology, V112, pS118, DOI 10.1016/j.jaci.2003.09.033; Takeuchi H, 2005, J INVEST ALLERG CLIN, V15, P172; Wakugawa M, 2002, DRUG NEWS PERSPECT, V15, P175, DOI 10.1358/dnp.2002.15.3.704686; Yasuda N, 2008, J VET MED SCI, V70, P989, DOI 10.1292/jvms.70.989	26	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	APR	2015	77	4					421	425		10.1292/jvms.14-0338		5	Veterinary Sciences	Veterinary Sciences	CG9US	WOS:000353666200005		
J	Mashita, T; Kamishina, H; Nakamoto, Y; Akagi, Y; Nakanishi, A; Harasaki, Y; Ozawa, T; Uemura, T; Kobatake, Y; Shimamura, S; Kitamura, N; Maeda, S; Uzuka, Y; Shaw, G; Yasuda, J				Mashita, Tadahisa; Kamishina, Hiroaki; Nakamoto, Yuya; Akagi, Yosuke; Nakanishi, Ataru; Harasaki, Yusuke; Ozawa, Tsuyoshi; Uemura, Takashi; Kobatake, Yui; Shimamura, Shunsuke; Kitamura, Naoki; Maeda, Sadatoshi; Uzuka, Yuji; Shaw, Gerry; Yasuda, Jun			Combination of serum phosphorylated neurofilament heavy subunit and hyperintensity of intramedullary T2W on magnetic resonance imaging provides better prognostic value of canine thoracolumbar intervertebral disc herniation	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						canine; intervertebral disc herniation; MRI; neurofilament heavy subunit; T2W hyperintensity	SPINAL-CORD-INJURY; DEEP PAIN PERCEPTION; NF-H; AXONAL INJURY; DOGS; BIOMARKER; MR; DISEASE; RECOVERY; DAMAGE	The aim of this study was to evaluate the prognostic value of concurrent measurement of serum phosphorylated neurofilament heavy subunit (pNF-H) concentration and intramedullary T2W hyperintensity in paraplegic to paraplegic dogs. Our hypothesis was that concurrent measurement of these would provide a more accurate prediction of functional outcome in dogs with thoracolumbar intervertebral disc herniation (IVDH). A prospective case-control clinical study was designed using 94 dogs with acute onset of thoracolumbar IVDH. The association of serum pNF-H concentration, T2W hyperintensity on sagittal MRI (T2H/L2), deep pain perception and surgical outcome were evaluated with logistic regression analysis after three months for all 94 surgically treated dogs. Sensitivity to predict non-ambulatory outcome was compared among pNF-H and T2H/L2 and combination of both. Logistic regression analysis indicated that serum pNF-H concentration and T2H/L2 were significantly correlated with surgical outcome (P<0.05); however, deep pain perception was not (P=0.41). The results of logistic regression analysis indicated that the odds ratios of unsuccessful long-term outcome were 2.6 for serum pNF-H concentration, 1.9 for T2H/L2 and 2.3 for deep pain sensation. The sensitivity and specificity to predict non-ambulatory outcome for using serum parameter pNF-H>2.6 ng/ml, using T2H/L2 value of>0.84 and using both serum pNF-H and T2H/L2, were 95% and 75.7%, 65% and 86.5%, and 90.0% and 97.5%, respectively. Therefore, combined measurements of serum pNF-H and T2H/L2 might be useful for predicting long-term outcome in dogs with thoracolumbar IVDH.	[Mashita, Tadahisa; Akagi, Yosuke; Nakanishi, Ataru; Harasaki, Yusuke] Maizuru Anim Med Ctr, Maizuru, Kyoto 6250037, Japan; [Mashita, Tadahisa; Kamishina, Hiroaki; Kobatake, Yui; Shimamura, Shunsuke; Maeda, Sadatoshi; Uzuka, Yuji; Yasuda, Jun] Gifu Univ, United Grad Sch Vet Sci, Dept Vet Clin Sci, Gifu 5091193, Japan; [Nakamoto, Yuya; Ozawa, Tsuyoshi; Uemura, Takashi] Kyoto Anim Referral Ctr, Kyoto 6130036, Japan; [Kamishina, Hiroaki; Kobatake, Yui; Maeda, Sadatoshi] Gifu Univ, Fac Appl Biol Sci, Dept Vet Med, Gifu 5091193, Japan; [Shaw, Gerry] Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32611 USA; [Shimamura, Shunsuke; Uzuka, Yuji; Yasuda, Jun] Iwate Univ, Cooperat Dept Vet Med, Fac Agr, Morioka, Iwate 0208550, Japan; [Kitamura, Naoki] Tottori Univ, Joint Dept Vet Med, Lab Vet Physiol, Fac Agr,Minami Ku, Tottori 6808553, Japan	Mashita, T (reprint author), Maizuru Anim Med Ctr, 8-22 Hamamachi, Maizuru, Kyoto 6250037, Japan.	mashitad@gaia.eonet.ne.jp					Petzold A, 2005, J NEUROL SCI, V233, P183, DOI 10.1016/j.jns.2005.03.015; Scott HW, 1999, J SMALL ANIM PRACT, V40, P417, DOI 10.1111/j.1748-5827.1999.tb03114.x; Boldin C, 2006, SPINE, V31, P554, DOI 10.1097/01.brs.0000201274.59427.a4; Shaw G, 2005, BIOCHEM BIOPH RES CO, V336, P1268, DOI 10.1016/j.bbrc.2005.08.252; OHSHIO I, 1993, SPINE, V18, P1140, DOI 10.1097/00007632-199307000-00005; Boylan KB, 2013, J NEUROL NEUROSUR PS, V84, P467, DOI 10.1136/jnnp-2012-303768; Singh P, 2011, J NEUROL SCI, V304, P117, DOI 10.1016/j.jns.2011.01.025; Cappello R, 2006, SPINE, V31, P873, DOI 10.1097/01.brs.0000209302.00820.fd; Shimada K, 1999, SPINAL CORD, V37, P410, DOI 10.1038/sj.sc.3100858; Chavhan GB, 2009, RADIOGRAPHICS, V29, P1433, DOI 10.1148/rg.295095034; Olby N, 2003, J AM VET MED ASSOC, V222, P762, DOI 10.2460/javma.2003.222.762; Miranda P, 2008, J NEUROSURG SCI, V52, P107; Flanders AE, 1996, RADIOLOGY, V201, P649; Levine JM, 2009, J VET INTERN MED, V23, P1220, DOI 10.1111/j.1939-1676.2009.0393.x; McMichael MA, 2006, AM J VET RES, V67, P1226, DOI 10.2460/ajvr.67.7.1226; Hayakawa K, 2012, SPINAL CORD, V50, P493, DOI 10.1038/sc.2011.184; Smith PM, 2006, BRAIN PATHOL, V16, P99, DOI 10.1111/j.1750-3639.2006.00001.x; Aronowski J, 1999, J CEREBR BLOOD F MET, V19, P652; Berens SA, 2005, AM J NEURORADIOL, V26, P1612; Duval J, 1996, VET SURG, V25, P6, DOI 10.1111/j.1532-950X.1996.tb01371.x; Fukuoka M, 1998, SPINE, V23, P1540, DOI 10.1097/00007632-199807150-00008; HACKNEY DB, 1994, NEUROSURGERY, V35, P1104; HANSEN H J, 1952, Acta Orthop Scand Suppl, V11, P1; LEE VMY, 1986, J NEUROSCI, V6, P2179; Levine GJ, 2010, J VET INTERN MED, V24, P890, DOI 10.1111/j.1939-1676.2010.0531.x; Tewari MK, 2005, SURG NEUROL, V63, P204, DOI 10.1016/j.surneu.2004.05.042; Nishida H, 2014, VET SURG, V43, P289, DOI 10.1111/j.1532-950X.2014.12144.x; Rostami Elham, 2012, Front Neurol, V3, P115, DOI 10.3389/fneur.2012.00115; Scott HW, 1997, J SMALL ANIM PRACT, V38, P488, DOI 10.1111/j.1748-5827.1997.tb03303.x	29	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	APR	2015	77	4					433	438		10.1292/jvms.14-0582		6	Veterinary Sciences	Veterinary Sciences	CG9US	WOS:000353666200007		
J	Igarashi, H; Ohno, K; Fujiwara-Igarashi, A; Kanemoto, H; Fukushima, K; Goto-Koshino, Y; Uchida, K; Tsujimoto, H				Igarashi, Hirotaka; Ohno, Koichi; Fujiwara-Igarashi, Aki; Kanemoto, Hideyuki; Fukushima, Kenjiro; Goto-Koshino, Yuko; Uchida, Kazuyuki; Tsujimoto, Hajime			Functional analysis of pattern recognition receptors in miniature dachshunds with inflammatory colorectal polyps	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						inflammatory colorectal polyp; innate immunity; miniature dachshund; pattern recognition receptor; pro-inflammatory cytokine	INTESTINAL EPITHELIAL-CELLS; MESSENGER-RNA EXPRESSION; NF-KAPPA-B; CROHNS-DISEASE; BOWEL-DISEASE; DENDRITIC CELLS; TOLL; NOD2; RESPONSES; GENES	Inflammatory colorectal polyps (ICRPs) frequently occur in miniature dachshunds (MDs) in Japan. MDs with ICRPs develop multiple polyps with severe neutrophil infiltration that respond to immunosuppressive therapy. Therefore, ICRPs are thought to constitute a novel, breed-specific form of canine inflammatory bowel disease (IBD). Pattern recognition receptors (PRRs) play a key role in the distinction of pathogens from commensal bacteria and food antigens. Dysfunction resulting from genetic disorders of PRRs have been linked to human and canine IBD. Therefore, we analyzed the reactivity of PRRs in MDs with ICRPs. Twenty-six MDs with ICRPs and 16 control MDs were recruited. Peripheral blood-derived monocytes were obtained from each dog and then stimulated with PRR ligands for 6 and 24 hr; subsequently, messenger RNA (mRNA) expression levels and protein secretion of IL-1 beta were quantified using quantitative real-time PCR and ELISA, respectively. The levels of IL-1I3 mRNA and protein secretion after stimulation with a nucleotide-binding oligomerization domain 2 (NOD2) ligand were significantly greater in monocytes from ICRP-affected MDs than in those from control MDs. In addition, IL113 protein secretion induced by toll-like receptor (TLR) 1/2, TLR2 and TLR2/6 stimulation was also significantly greater in ICRP-affected MDs. These results suggest that reactivity against NOD2, TLR1/2, TLR2 and TLR2/6 signals is enhanced in ICRP-affected MDs and may play a role in the pathogenesis of ICRPs in MDs. Additional studies of the genetic background of these PRRs should be performed. KEYWORDS: inflammatory colorectal polyp, innate immunity, miniature dachshund, pattern recognition receptor, pro-inflammatory cytokine	[Igarashi, Hirotaka; Ohno, Koichi; Fujiwara-Igarashi, Aki; Kanemoto, Hideyuki; Fukushima, Kenjiro; Goto-Koshino, Yuko; Tsujimoto, Hajime] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Internal Med, Bunkyo Ku, Tokyo 1138657, Japan; [Uchida, Kazuyuki] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Pathol, Bunkyo Ku, Tokyo 1138657, Japan	Ohno, K (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Internal Med, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	aohno@mail.ecc.u-tokyo.ac.jp			Japan Society for the Promotion of Science [KAKENHI 23380182]	This work was supported by a Grant-in-Aid for Scientific Research of the Japan Society for the Promotion of Science (KAKENHI 23380182). The authors acknowledge Dr. Yohei Adachi, Dr. Mariko Suzuki, Dr. Kengo Sasaki, Dr. Noriko Teramae, Ms. Minako Imai, Ms. Megumi Kitajima and Dr. Hideki Umehara for their kind cooperation in letting their dogs participate in the present study as controls.	Sun J, 2007, AM J PHYSIOL-GASTR L, V292, pG767, DOI 10.1152/ajpgi.00447.2006; Gewirtz AT, 2006, AM J PHYSIOL-GASTR L, V290, pG1157, DOI 10.1152/ajpgi.00544.2005; Cerquetella M, 2010, WORLD J GASTROENTERO, V16, P1050, DOI 10.3748/wjg.v16.i9.1050; Peters IR, 2007, VET IMMUNOL IMMUNOP, V117, P55, DOI 10.1016/j.vetimm.2007.01.011; Strober W, 2008, MUCOSAL IMMUNOL, V1, pS5, DOI 10.1038/mi.2008.42; Tanabe T, 2004, EMBO J, V23, P1587, DOI 10.1038/sj.emboj.7600175; Cummings JRF, 2010, TISSUE ANTIGENS, V76, P48, DOI 10.1111/j.1399-0039.2010.01470.x; Dillon S, 2004, J IMMUNOL, V172, P4733; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Sfriso P, 2012, AUTOIMMUN REV, V12, P44, DOI 10.1016/j.autrev.2012.07.028; Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Cario E, 2010, INFLAMM BOWEL DIS, V16, P1583, DOI 10.1002/ibd.21282; Yamagishi C, 2007, J VET MED SCI, V69, P915, DOI 10.1292/jvms.69.915; Watanabe T, 2008, J CLIN INVEST, V118, P545, DOI [10.1172/JCI33145, 10.1172/JC133145]; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Medzhitov R, 1997, NATURE, V388, P394; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; House AK, 2008, VET IMMUNOL IMMUNOP, V124, P230, DOI 10.1016/j.vetimm.2008.03.012; Maeda S, 2009, VET IMMUNOL IMMUNOP, V131, P298, DOI 10.1016/j.vetimm.2009.04.012; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Ruland J, 2011, NAT IMMUNOL, V12, P709, DOI 10.1038/ni.2055; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Mercier E, 2012, VET IMMUNOL IMMUNOP, V145, P618, DOI 10.1016/j.vetimm.2012.01.009; Lee J, 2006, NAT CELL BIOL, V8, P1327, DOI 10.1038/ncb1500; Arbour NC, 2000, NAT GENET, V25, P187; Hedl M, 2007, P NATL ACAD SCI USA, V104, P19440, DOI 10.1073/pnas.0706097104; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Bueno R, 2005, MEM I OSWALDO CRUZ, V100, P521, DOI 10.1590/S0074-02762005000500012; Canto E, 2006, CLIN IMMUNOL, V119, P156, DOI 10.1016/j.clim.2005.12.005; de Kivit S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00060; Goto-Koshino Y, 2011, J VET MED SCI, V73, P773, DOI 10.1292/jvms.10-0470; Hooda Seema, 2012, Animal Health Research Reviews, V13, P78, DOI 10.1017/S1466252312000059; Kathrani A, 2011, TISSUE ANTIGENS, V78, P94, DOI 10.1111/j.1399-0039.2011.01707.x; Kathrani A, 2014, VET IMMUNOL IMMUNOP, V161, P32, DOI 10.1016/j.vetimm.2014.06.003; Kathrani A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015740; Kathrani A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030117; Kullberg BJ, 2008, IMMUNOLOGY, V123, P600, DOI 10.1111/j.1365-2567.2007.02735.x; Maccoux LJ, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-62; Ohmi A, 2012, J VET MED SCI, V74, P59, DOI 10.1292/jvms.11-0352; Ohta H, 2013, VET IMMUNOL IMMUNOP, V155, P259, DOI 10.1016/j.vetimm.2013.07.006; Schmitz S, 2014, SCAND J IMMUNOL, V80, P85, DOI 10.1111/sji.12186; SEILER RJ, 1979, J AM VET MED ASSOC, V174, P72; Tamura Y, 2013, VET IMMUNOL IMMUNOP, V156, P32, DOI 10.1016/j.vetimm.2013.09.017; Uematsu S, 2009, J GASTROENTEROL, V44, P803, DOI 10.1007/s00535-009-0094-y; Valerius KD, 1997, J AM ANIM HOSP ASSOC, V33, P156; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034	49	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	APR	2015	77	4					439	447		10.1292/jvms.14-0505		9	Veterinary Sciences	Veterinary Sciences	CG9US	WOS:000353666200008		
J	Okai, K; Taharaguchi, S; Orita, Y; Yokota, H; Taniyama, H				Okai, Kazuhiko; Taharaguchi, Sadao; Orita, Yasuhiro; Yokota, Hiroshi; Taniyama, Hiroyuki			Comparative endoscopic evaluation of normal and ulcerated gastric mucosae in Thoroughbred foals	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						endoscopy; equine gastric ulcer; foal	LESIONS; MARES	To contribute to early diagnosis and treatment of gastric ulcer of foals, we examined the gastric mucosa of healthy and affected foals using an endoscope. In healthy foals, the characteristic changes in the development of the squamous mucosa were seen mainly in the squamous mucosa, and maturation of the squamous mucosa in the greater curvature (GC-S) occurred more slowly than that of the squamous mucosa in the lesser curvature (LC-S). Epithelial desquamation in the LC-S and GC-S was observed between 6 and 90 days but was not observed in the LC-S at about 60 days, whereas it was observed in the GC-S until 90 days old. These findings suggest that there is a difference in the development of the gastric mucosa by region and that desquamation continues over a term longer than studies have reported in the past. In the affected foals, the minimum age at which gastric ulcer was observed was 4 days old. Gastric ulcers formed predominantly in the squamous mucosa (LC-S and GC-S) of foals with an immature mucosa before the weaning period, and the peak incidence occurred between 61 and 90 days old. The differences in the ulceration sites were considered to depend on the difference in the development (maturation) stage of the squamous mucosa. The grading score of the gastric ulcer increased with the growth of the affected foals. The gastric ulcer might be enhanced greatly by stress in the weaning period.	[Okai, Kazuhiko] Okai Vet Serv, Niikappu, Hokkaido 0592403, Japan; [Taharaguchi, Sadao] Hidaka CLC, Niikappu, Hokkaido 0592403, Japan; [Orita, Yasuhiro] AMAA, Cent Vet Clin Ctr, Niikappu, Hokkaido 0592403, Japan; [Yokota, Hiroshi; Taniyama, Hiroyuki] Rakuno Gakuen Univ, Dept Vet Pathol, Sch Vet Med, Ebetsu, Hokkaido 0698501, Japan	Taniyama, H (reprint author), Rakuno Gakuen Univ, Dept Vet Pathol, Sch Vet Med, 582 Bunkyoudai Midorimachi, Ebetsu, Hokkaido 0698501, Japan.	taniyama@rakuno.ac.jp					Andrews F., 1999, Equine Veterinary Education, V11, P262; Andrews F., 1992, EQUINE VET J, V24, P80; Andrews F. M., 1999, EQUINE VET J S, V29, P30; IMAGAWA H, 1991, J VET MED SCI, V53, P1079; MURRAY MJ, 1990, EQUINE VET J, V22, P6; MURRAY MJ, 1989, J AM VET MED ASSOC, V195, P1135; Equine Research Institute Japan Racing, 2004, JAP FEED STAND HORS, P53; Imagawa H., 1984, B EQUINE RES I, V21, P65; LeBlanc M. M., 1990, Equine clinical neonatology., P275; MALINOWSKI K, 1990, J EQUINE VET SCI, V10, P363, DOI 10.1016/S0737-0806(06)80098-5; Murray M. J., 1999, EQUINE VET J S, V31, P14; Murray M. J., 1997, EQUINE ENDOSCOPY, P159; Murray M. J., 2002, P AM ASS EQUINE PRAC, V48, P282; Murray M. J., 1997, P ANN CONV AAEP, V43, P382; Murray M. J., 2002, MANUAL EQUINE GASTRO, V48, P469; MURRAY MJ, 1992, AM J VET RES, V53, P1729; MURRAY MJ, 1993, EQUINE VET J, V25, P514; Nadeau J. A., 2003, CURRENT THERAPY EQUI, VV, P94; Rose R. J., 1993, MANUAL EQUINE PRACTI, P275; Taharaguchi S., 2004, Journal of the Japan Veterinary Medical Association, V57, P366; Taharaguchi S., 2001, Journal of the Japan Veterinary Medical Association, V54, P435; Taharaguchi S., 2007, Journal of the Japan Veterinary Medical Association, V60, P569	22	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	APR	2015	77	4					449	453		10.1292/jvms.14-0334		5	Veterinary Sciences	Veterinary Sciences	CG9US	WOS:000353666200009		
J	Niwa, T; Shirafuji, H; Ikemiyagi, K; Nitta, Y; Suzuki, M; Kato, T; Yanase, T				Niwa, Tsuyoshi; Shirafuji, Hiroaki; Ikemiyagi, Kazufumi; Nitta, Yoshiki; Suzuki, Moemi; Kato, Tomoko; Yanase, Tohru			Occurrence of bovine ephemeral fever in Okinawa Prefecture, Japan, in 2012 and development of a reverse-transcription polymerase chain reaction assay to detect bovine ephemeral fever virus gene	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						arbovirus; bovine ephemeral fever; diagnosis; molecular epidemiology; RT-PCR	NEW-SOUTH-WALES; PHYLOGENETIC-RELATIONSHIPS; TAIWAN; AUSTRALIA; EPIDEMIOLOGY; SEQUENCE; OUTBREAK; DISTANCE; TURKEY	In September 2012, several cows and a calf showed decreased activity, anorexia and fever on Ishigaki Island, Okinawa Prefecture, Japan, and the cases were diagnosed as bovine ephemeral fever (BEF). We isolated BEF virus (BEFV) from one of the affected cows and then determined the complete genome sequence of the G gene, which encodes a class I transmembrane glycoprotein of BEFV. The BEFV isolate in this case, ON-3/E/12, was sorted into the same cluster as other BEFV isolates in Japan, Taiwan and China obtained in 1996-2004 and was most closely related to a 2002 Chinese isolate, JT02L, according to the phylogenetic analysis of the complete G gene. Since inactivated vaccines for BEF available in Japan are considered effective against the ON-3/E/12 isolate as well as other isolates in East Asia from 1996-2004, annual vaccination should be conducted to prevent BEF in Okinawa. Additionally, in this study, we developed an RT-PCR assay to detect the BEFV gene in Japan and neighboring countries. Our assay was able to amplify target sequences in all of the tested BEFV isolates, including 18 isolates in Japan and another isolate in Australia. The assay was found to be useful also for testing RNA samples extracted from bovine peripheral blood mononuclear cells, and the detection limit of the assay was 10 copies per tube. We believe that our assay would be an important tool for the screening of BEFV infection and the diagnosis of BEF.	[Niwa, Tsuyoshi; Ikemiyagi, Kazufumi; Suzuki, Moemi] Okinawa Prefectural Inst Anim Hlth, Naha, Okinawa 9000024, Japan; [Shirafuji, Hiroaki; Kato, Tomoko; Yanase, Tohru] Natl Agr & Food Res Org, Natl Inst Anim Hlth, Kyushu Res Stn, Kagoshima 8910105, Japan; [Nitta, Yoshiki; Suzuki, Moemi] Okinawa Prefectural Govt, Yaeyama Livestock Hyg Serv Ctr, Ishigaki 9070022, Japan	Shirafuji, H (reprint author), Natl Agr & Food Res Org, Kyushu Res Stn, Natl Inst Anim Hlth, 2702 Chuzan, Kagoshima 8910105, Japan.	shirah@affrc.go.jp					Aizawa M., 2008, J JPN VET MED ASSOC, V63, P363; Wang FI, 2001, J VET DIAGN INVEST, V13, P462; Kato T, 2009, VET MICROBIOL, V137, P217, DOI 10.1016/j.vetmic.2009.01.021; SHIRAKAWA H, 1994, AUST VET J, V71, P50, DOI 10.1111/j.1751-0813.1994.tb06153.x; Walker PJ, 2005, CURR TOP MICROBIOL, V292, P57; Liao YK, 1998, MICROBIOL RES, V153, P289; Zheng FY, 2011, J VIROL METHODS, V171, P306, DOI 10.1016/j.jviromet.2010.10.028; Hsieh YC, 2005, J VET MED SCI, V67, P411, DOI 10.1292/jvms.67.411; Tonbak S, 2013, J VET MED SCI, V75, P1511, DOI 10.1292/jvms.13-0085; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Finlaison DS, 2010, AUST VET J, V88, P301, DOI 10.1111/j.1751-0813.2010.00596.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Blasdell KR, 2013, J VIROL METHODS, V191, P128, DOI 10.1016/j.jviromet.2013.04.011; Finlaison DS, 2014, AUST VET J, V92, P24, DOI 10.1111/avj.12139; Inaba Y., 1971, B NAT I ANIM HLTH, V62, P1; Khalil S. A., 2001, P 6 SCI C EG SOC CAT, P135; Oguzoglu T. C., 2013, TRANSBOUND EMERG DIS, DOI [10.1111/tbed.12187, DOI 10.1111/TBED.12187]; Takayoshi K., 1991, Journal of the Japan Veterinary Medical Association, V44, P591; Ting LJ, 2014, VET MICROBIOL, V173, P241, DOI 10.1016/j.vetmic.2014.07.021; Zheng FY, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-268	20	2	2	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	APR	2015	77	4					455	460		10.1292/jvms.14-0492		6	Veterinary Sciences	Veterinary Sciences	CG9US	WOS:000353666200010		
J	Sakai, T; Ishii, A; Segawa, T; Takagi, Y; Kobayashi, Y; Itou, T				Sakai, Takeo; Ishii, Ayako; Segawa, Takao; Takagi, Yukihiko; Kobayashi, Yuki; Itou, Takuya			Establishing conditions for the storage and elution of rabies virus RNA using FTA (R) cards	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						FTA card; rabies virus; storage; viral RNA	RESPIRATORY-SYNDROME-VIRUS; DISEASE VIRUS; FILTER-PAPER; MOLECULAR-DETECTION; RT-PCR; TECHNOLOGY; SAMPLES	The Flinders Technology Associates filter paper cards (FTA (R) cards) can be used to store nucleic acid from various samples and are easily portable. However, RNA is physicochemically unstable compared with DNA, and appropriate methods have not been established for storage and extraction of RNA from FTA (R) cards. The present study investigated the optimum conditions for storage and elution of viral RNA (vRNA) using rabies virus (RABV) applied to FTA (R) cards. When TB buffer was used, the elution rates of vRNA increased with the length of the elution time. When the cards were stored at 80 degrees C or 20 degrees C, vRNA Was stable over 3 months. Degradation of vRNAs occurred following storage at 4 degrees C and room temperature, suggesting that RNA should be extracted from cards as soon as possible if no freezer is available. When we tried to amplify vRNA from RABV-infected animal brains applied to FTA (R) cards and stored at 80 degrees C for 6 months, we did not detect any amplified products with the primer set for 964 bp of RABV N gene. However, we were able to detect amplified products by increasing the elution time of vRNA from FTA (R) cards from 30 min to 24 hr or by changing the primer sets to amplify 290 bp of N gene. Thus, we recommend extending the elution time for damaged or low concentration samples in FTA (R) cards.	[Sakai, Takeo; Ishii, Ayako; Segawa, Takao; Kobayashi, Yuki; Itou, Takuya] Nihon Univ, Vet Res Ctr, Fujisawa, Kanagawa 2520880, Japan; [Takagi, Yukihiko] Azabu Univ, Dept Vet Med, Sagamihara, Kanagawa 2298501, Japan	Itou, T (reprint author), Nihon Univ, Vet Res Ctr, 1866 Kameino, Fujisawa, Kanagawa 2520880, Japan.	itou.takuya@nihon-u.ac.jp			Japan Society for the Promotion of Science [24580453]; Strategic Research Base Development Program for Private Universities - Ministry of Education, Culture, Sports, Science and Technology of Japan [S0991023]	This study was supported in part by a Grant-in-Aid for Scientific Research (no. 24580453) from the Japan Society for the Promotion of Science and the Strategic Research Base Development Program for Private Universities sponsored by the Ministry of Education, Culture, Sports, Science and Technology of Japan (S0991023).	Inoue R, 2007, J VIROL METHODS, V141, P102, DOI 10.1016/j.jviromet.2006.11.030; Maw MT, 2006, AVIAN DIS, V50, P556, DOI 10.1637/7537-032806R.1; Perozo F, 2006, AVIAN PATHOL, V35, P93, DOI 10.1080/03079450600597410; Li Y, 2012, J VIROL METHODS, V186, P62, DOI 10.1016/j.jviromet.2012.08.016; Linhares DCL, 2012, J VET DIAGN INVEST, V24, P328, DOI 10.1177/1040638711429492; Muthukrishnan M, 2008, J VIROL METHODS, V151, P311, DOI 10.1016/j.jviromet.2008.05.020; Natarajan P, 2000, BIOTECHNIQUES, V29, P1328; Picard-Meyer E, 2007, J VIROL METHODS, V140, P174, DOI 10.1016/j.jviromet.2006.11.011	8	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	APR	2015	77	4					461	465		10.1292/jvms.14-0227		5	Veterinary Sciences	Veterinary Sciences	CG9US	WOS:000353666200011		
J	Yui, T; Ohmachi, T; Matsuda, K; Okamoto, M; Taniyama, H				Yui, Takeshi; Ohmachi, Tetsuo; Matsuda, Kazuya; Okamoto, Minoru; Taniyama, Hiroyuki			Histochemical and immunohistochemical characterization of chordoma in ferrets	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						brachyury; chordoma; ferret; histochemistry; immunohistochemistry	MUSTELA-PUTORIUS-FURO; MONOCLONAL-ANTIBODY; CHONDROID CHORDOMA; VERTEBRAL CHORDOMA; EXPRESSION; CYTOKERATIN; BRACHYURY; FEATURES; TISSUES; PROTEIN	Chordomas of the tip of the tail in 6 ferrets were examined using histopathological, histochemical and immunohistochemical procedures. Histopathologically, round neoplastic cells containing numerous cytoplasmic vacuoles of varying sizes, categorized as "physaliphorous cells", were observed in the amorphous eosinophilic or pale basophilic myxoid stroma. Physaliphorous cells were arranged in lobules and in a "chordoid" or "cobblestone" manner. The neoplasms were diagnosed as benign chordoma without local invasion and metastasis. Histochemically, the cytoplasm of small neoplastic cells was positive for periodic acid-Schiff stain and alcian blue (AB) pH 2.5 and pH 1.0 stains, but negative for hyaluronidase digestion-AB pH 2.5 stain. All neoplastic cells were strongly stained with colloidal ion, negative for high iron diamine AB pH 2.5 and toluidine blue pH 2.5 stains, and positive for Mayer's mucicarmine stain. Immunohistochemistry using antibodies directed against low-molecular-weight cytokeratins (CK18, CK19 and CK20), vimentin and mucin core protein (MUC5AC) revealed that neoplastic cells had both epithelial and mesenchymal elements. The expression of low-molecular-weight cytokeratins suggests that neoplastic cells acquired the properties of glandular epithelial cells and produced epithelial mucus. Furthermore, the expression of cytokeratins, vimentin, S100 protein, brachyury and epithelial membrane antigen indicates that the neoplasms were equivalent to the classic type of human chordoma. Therefore, immunohistochemistry using these antibodies can be useful for the characterization of ferret chordoma.	[Yui, Takeshi; Matsuda, Kazuya; Okamoto, Minoru; Taniyama, Hiroyuki] Rakuno Gakuen Univ, Dept Vet Pathol, Sch Vet Med, Ebetsu, Hokkaido 0698501, Japan; [Ohmachi, Tetsuo] PATHO LABO, Ito, Shizuoka 4130235, Japan	Taniyama, H (reprint author), Rakuno Gakuen Univ, Dept Vet Pathol, Sch Vet Med, 582 Bunkyoudai Midorimachi, Ebetsu, Hokkaido 0698501, Japan.	taniyama@rakuno.ac.jp					Yabe T, 2012, DEV BIOL, V370, P213, DOI 10.1016/j.ydbio.2012.07.029; Reis CA, 1997, INT J CANCER, V74, P112, DOI 10.1002/(SICI)1097-0215(19970220)74:1<112::AID-IJC19>3.0.CO;2-H; delPino EM, 1996, DEV BIOL, V177, P64, DOI 10.1006/dbio.1996.0145; HO SB, 1993, CANCER RES, V53, P641; ALLISON N, 1988, J COMP PATHOL, V98, P371, DOI 10.1016/0021-9975(88)90046-1; Packham EA, 2003, HUM MOL GENET, V12, pR37, DOI 10.1093/hmg/ddg077; Carminato A, 2008, J VET DIAGN INVEST, V20, P679; Vujovic S, 2006, J PATHOL, V209, P157, DOI 10.1002/path.1969; KISPERT A, 1995, EMBO J, V14, P4763; DUNN DG, 1991, VET PATHOL, V28, P467; Terada T, 2013, INT J CLIN EXP PATHO, V6, P613; Munday JS, 2004, J VET DIAGN INVEST, V16, P454; WILLIAMS BH, 1993, VET PATHOL, V30, P204; STOSIEK P, 1988, DIFFERENTIATION, V39, P78, DOI 10.1111/j.1432-0436.1988.tb00083.x; Flanagan AM, 2013, WHO CLASSIFICATION T, P328; Gay E, 1995, NEUROSURGERY, V36, P896; Gruber A, 2008, VET PATHOL, V45, P650, DOI 10.1354/vp.45-5-650; HADLOW WJ, 1984, VET PATHOL, V21, P533; HEIKINHEIMO K, 1991, J PATHOL, V164, P145, DOI 10.1002/path.1711640208; HERRON AJ, 1990, VET PATHOL, V27, P284; Horn KD, 2001, AM J OTOLARYNG, V22, P428, DOI 10.1053/ajot.2001.28080; KARABELABOUROPOULOU V, 1988, PATHOL RES PRACT, V183, P256; Koestner A., 2002, TUMORS DOMESTIC ANIM, V4th, P728; Lacunza E, 2009, RES VET SCI, V86, P68, DOI 10.1016/j.rvsc.2008.05.011; LECHARPENTIER Y, 1988, ANN PATHOL, V8, P25; Naka T, 1997, MODERN PATHOL, V10, P545; O'Hara BJ, 1998, HUM PATHOL, V29, P119, DOI 10.1016/S0046-8177(98)90220-9; PELFRENE A, 1976, ANN ANAT PATHOL, V21, P357; PERSSON S, 1991, PATHOL RES PRACT, V187, P828; Scolyer RA, 2004, PATHOL INT, V54, P364, DOI 10.1111/j.1440-1827.2004.01633.x; STEFANSKI SA, 1988, VET PATHOL, V25, P42; SUSTER S, 1995, HUM PATHOL, V26, P1354, DOI 10.1016/0046-8177(95)90301-1; Tarik T., 2010, PRACTICAL SURG NEURO, P231	33	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	APR	2015	77	4					467	473		10.1292/jvms.14-0488		7	Veterinary Sciences	Veterinary Sciences	CG9US	WOS:000353666200012		
J	Ito, H; Sueyoshi, M				Ito, Hiroya; Sueyoshi, Masuo			The genetic organization of the capsular polysaccharide biosynthesis region of Actinobacillus pleuropneumoniae serotype 15	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						Actinobacillus pleuropneumoniae; serotype 15 capsule	LIPOPOLYSACCHARIDE-O-CHAIN; COMPLETE GENOME SEQUENCE; MULTIPLEX PCR ASSAY; PORCINE PLEUROPNEUMONIA; NEISSERIA-MENINGITIDIS; IDENTIFICATION; RESISTANCE; STRAINS; PIGS	Nucleotide sequence determination and analysis of the cps gene involved in the capsular polysaccharide biosynthesis of Actinobacillus pleuropneumoniae serotype 15 revealed the presence of three open reading frames, designated as cps15ABC genes. At the protein level, Cps15A and Cps15B showed considerably high homology to CpsA (67.0 to 68.7%) and CpsB (31.7 to 36.8%), respectively, of A. pleuropneumoniae serotypes 1, 4 and 12, revealing the common genetic organization of the cps among serotypes 1, 4, 12 and 15. However, Cps15C showed no homology to any proteins of A. pleuropnezimoniae serotypes, indicating that cps15C may be specific to serotype 15. This study will provide the basic molecular knowledge necessary for the development of diagnostics and a vaccine for A. pleuropnewnoniae serotype 15.	[Ito, Hiroya] Natl Agr & Food Res Org, Natl Inst Anim Hlth, Tsukuba, Ibaraki 3050856, Japan; [Sueyoshi, Masuo] Miyazaki Univ, Ctr Anim Dis Control, Miyazaki 8892192, Japan	Ito, H (reprint author), Natl Inst Anim Hlth, 3-1-5 Kannondai, Tsukuba, Ibaraki 3050856, Japan.	itohiroy@affrc.go.jp			National Agriculture and Food Research Organization, Japan	This study was supported by grants from the National Agriculture and Food Research Organization, Japan. The authors thank Ms. K. Miyata for her help with the drawing in Fig. 1.	MacLean LL, 2004, INFECT IMMUN, V72, P5925, DOI 10.1128/IAI.72.10.5925-5930.2004; Ito H, 2010, J VET MED SCI, V72, P653; Jessing SG, 2008, VET MICROBIOL, V129, P350, DOI 10.1016/j.vetmic.2007.12.003; Harrison OB, 2013, EMERG INFECT DIS, V19, P566, DOI 10.3201/eid1904.111799; Angen O, 2008, VET MICROBIOL, V132, P312, DOI 10.1016/j.vetmic.2008.05.010; Koyama T, 2007, J VET MED SCI, V69, P961, DOI 10.1292/jvms.69.961; Xu ZF, 2010, J BACTERIOL, V192, P5625, DOI 10.1128/JB.00535-10; Schuchert JA, 2004, J CLIN MICROBIOL, V42, P4344, DOI 10.1128/JCM.42.9.4344-4388.2004; Blackall PJ, 2002, VET MICROBIOL, V84, P47, DOI 10.1016/S0378-1135(01)00428-X; Lo TM, 1998, J CLIN MICROBIOL, V36, P1704; Bosse JT, 2014, J CLIN MICROBIOL, V52, P2380, DOI 10.1128/JCM.00685-14; Zhou L, 2008, J CLIN MICROBIOL, V46, P800, DOI 10.1128/JCM.01787-07; Bandara AB, 2003, INFECT IMMUN, V71, P3320, DOI 10.1128/IAI.71.6.3320-3328.2003; Jessing SG, 2003, J CLIN MICROBIOL, V41, P4095, DOI 10.1128/JCM.41.9.4095-4100.2003; Perry MB, 2005, BIOCHEM CELL BIOL, V83, P61, DOI 10.1139/O04-112; Zhu HF, 2012, J CLIN MICROBIOL, V50, P46, DOI 10.1128/JCM.00918-11; Dubreuil J. Daniel, 2000, Animal Health Research Reviews, V1, P73; Gottschalk M., 2012, DIS SWINE, P653; Gottschalk M, 2014, VET REC, V174, DOI 10.1136/vr.102470; Inzana TJ, 2004, VET MICROBIOL, V104, P63, DOI 10.1016/j.vetmic.2004.08.004; Ito H, 2004, PLASMID, V51, P41, DOI 10.1016/j.plasmid.2003.10.001; ITO H, 1995, MICROB PATHOGENESIS, V18, P29; Ito H., 2013, P JPN PIG VET SOC, V61, P14; MacInnes JI, 2012, J BACTERIOL, V194, P6686, DOI 10.1128/JB.01633-12; NIELSEN R, 1984, NORD VET MED, V36, P221; PERRY MB, 1990, SERODIAG IMMUN INF D, V4, P299, DOI 10.1016/0888-0786(90)90018-J; Schroder J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-141; Tumamao JQ, 2004, AUST VET J, V82, P370, DOI 10.1111/j.1751-0813.2004.tb11108.x	28	1	1	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	APR	2015	77	4					483	486		10.1292/jvms.14-0203		4	Veterinary Sciences	Veterinary Sciences	CG9US	WOS:000353666200015		
J	Aoki, T; Sunahara, H; Sugimoto, K; Ito, T; Kanai, E; Fujii, Y				Aoki, Takuma; Sunahara, Hiroshi; Sugimoto, Keisuke; Ito, Tetsuro; Kanai, Eiichi; Fujii, Yoko			Peripheral pulmonary artery stenosis in three cats	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						atenolol; congenital heart disease; feline; patent ductus arteriosus; peripheral pulmonary artery stenosis	SUBVALVULAR AORTIC-STENOSIS; PATENT DUCTUS-ARTERIOSUS; BALLOON VALVULOPLASTY; SUBAORTIC STENOSIS; DOGS; SURVIVAL; ATENOLOL; HYPERTENSION; OBSTRUCTION; ADULT	Case 1 involved a 4-month-old intact male Somali cat in which peripheral pulmonary artery stenosis (PPS) was recognized after a cardiac murmur remained following patent ductus arteriosus ligation. Case 2, which involved a 1-year-old neutered male Norwegian Forest cat, and Case 3, which involved a 6-month-old intact female American Curl cat, were referred, because of cardiac murmurs. Grades III to IV/VI systolic heart murmurs were auscultated at the left heart base in all 3 cats. All cases showed bilateral pulmonary artery stenosis, although there were no associated clinical signs. In Cases 1 and 2, the pressure gradient through the stenosis decreased after treatment with atenolol.	[Aoki, Takuma; Sunahara, Hiroshi; Sugimoto, Keisuke; Fujii, Yoko] Azabu Univ, Lab Vet Surg 1, Sch Vet Med, Chuo Ku, Sagamihara, Kanagawa 2525201, Japan; [Ito, Tetsuro] Azabu Univ, Lab Small Anim Clin, Sch Vet Med, Chuo Ku, Sagamihara, Kanagawa 2525201, Japan; [Kanai, Eiichi] Azabu Univ, Sch Vet Med, Lab Vet Radiol, Chuo Ku, Sagamihara, Kanagawa 2525201, Japan	Aoki, T (reprint author), Azabu Univ, Lab Vet Surg 1, Sch Vet Med, Chuo Ku, 1-17-71 Fuchi Nobe, Sagamihara, Kanagawa 2525201, Japan.	t-aoki@azabu-u.ac.jp					Loureiro J, 2008, J SMALL ANIM PRACT, V49, P578, DOI 10.1111/j.1748-5827.2008.00623.x; Abbott JA, 2006, J VET INTERN MED, V20, P111, DOI 10.1892/0891-6640(2006)20[111:TEAOTF]2.0.CO;2; MacDonald KA, 2006, VET CLIN N AM-SMALL, V36, P503, DOI 10.1016/j.cvsm.2005.12.006; Kreutzer J, 1996, CIRCULATION, V93, P1417; Aoki T, 2013, J VET MED SCI, V75, P199, DOI 10.1292/jvms.12-0322; Apostolopoulou SC, 2002, AM J ROENTGENOL, V179, P1253; Bacha E A, 2001, J Interv Cardiol, V14, P367, DOI 10.1111/j.1540-8183.2001.tb00346.x; Bush DM, 2000, AM J CARDIOL, V86, P1205, DOI 10.1016/S0002-9149(00)01203-0; Eason BD, 2014, J VET INTERN MED, V28, P857, DOI 10.1111/jvim.12339; HITTINGER L, 1992, CIRC RES, V71, P423; Imanka K, 2003, J THORAC CARDIOV SUR, V126, P598, DOI 10.1016/S0022-5223(03)00128-4; Kienle R. D., 1998, SMALL ANIMAL CARDIOV, P248; Kim DH, 2004, KOREAN J RADIOL, V5, P139; Kleman ME, 2012, J VET CARDIOL, V14, P351, DOI 10.1016/j.jvc.2011.11.008; MacGregor JM, 2006, VET RADIOL ULTRASOUN, V47, P345, DOI 10.1111/j.1740-8261.2006.00151.x; McDevitt H, 2013, J VET CARDIOL, V15, P211, DOI 10.1016/j.jvc.2013.03.004; Meurs KM, 2005, JAVMA-J AM VET MED A, V227, P420, DOI 10.2460/javma.2005.227.420; Miller Matthew W, 2006, J Vet Cardiol, V8, P109, DOI 10.1016/j.jvc.2006.07.001; Orton EC, 2000, J AM VET MED ASSOC, V216, P364, DOI 10.2460/javma.2000.216.364; Ozaki K, 2008, CIRC J, V72, P2087, DOI 10.1253/circj.CJ-07-0897; Plumb D. G., 2008, PLUMBS VET DRUG HDB, P77; Scansen BA, 2008, JAVMA-J AM VET MED A, V232, P1172, DOI 10.2460/javma.232.8.1172; Schneider M, 2003, J VET INTERN MED, V17, P349, DOI 10.1892/0891-6640(2003)17<349:TEOTPD>2.0.CO;2; Schober KE, 2013, J VET CARDIOL, V15, P93, DOI 10.1016/j.jvc.2013.03.003; Schrope Donald P, 2008, J Vet Cardiol, V10, P33, DOI 10.1016/j.jvc.2008.04.001; Schrope Donald P, 2007, J Vet Cardiol, V9, P83, DOI 10.1016/j.jvc.2007.09.001; Szatmari V, 2010, J VET DIAGN INVEST, V22, P812; Yamakawa H, 1996, CIRCULATION, V94, P340	28	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	APR	2015	77	4					487	491		10.1292/jvms.14-0388		5	Veterinary Sciences	Veterinary Sciences	CG9US	WOS:000353666200016		
J	Kobayashi, T; Koie, H; Watanabe, A; Ino, A; Watabe, K; Kim, M; Kanayama, K; Otsuji, K				Kobayashi, Toyokazu; Koie, Hiroshi; Watanabe, Arisa; Ino, Arisa; Watabe, Kazuya; Kim, Mujo; Kanayama, Kiichi; Otsuji, Kazuya			Effects of food enriched with egg yolk hydrolysate (bone peptide) on bone metabolism in orchidectomized dogs	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						BAP; canine; DPD; egg yolk hydrolysate; orchidectomy	GONADECTOMY; RESORPTION; MARKERS	We examined the effects of chicken egg hydrolysate (also known as "bone peptide" or BP) on bone metabolism in 5- to 8-month-old orchidectomized dogs. The bone formation marker serum bone alkaline phosphatase (BAP) and the bone resorption marker urine deoxypyridinoline (DPD) were used as indicators to measure changes in bone metabolism. The following results were observed that Serum BAP was higher in dogs fed BP-enriched food throughout the clinical investigation. Serum BAP was statistically significantly higher in dogs fed BP-enriched food than in dogs fed non-BP-enriched food at 2 months after orchidectomy. This suggests that BP promoted bone formation immediately after orchidectomy.	[Kobayashi, Toyokazu; Koie, Hiroshi; Kanayama, Kiichi] Nihon Univ, Vet Physiol Lab, Coll Bioresource Sci, Fujisawa, Kanagawa 2520880, Japan; [Watanabe, Arisa; Ino, Arisa; Otsuji, Kazuya] Teikyo Univ Sci, Dept Anim Sci, Adachi Ku, Tokyo 1200045, Japan; [Watabe, Kazuya; Kim, Mujo] Pharma Foods Int Co LTD, Nishikyo Ku, Kyoto 6158245, Japan	Koie, H (reprint author), Nihon Univ, Vet Physiol Lab, Coll Bioresource Sci, 1866 Kameino, Fujisawa, Kanagawa 2520880, Japan.	koie.hiroshi@nihon-u.ac.jp					Spain CV, 2004, JAVMA-J AM VET MED A, V224, P380, DOI 10.2460/javma.2004.224.380; Greendale GA, 1997, J BONE MINER RES, V12, P1833, DOI 10.1359/jbmr.1997.12.11.1833; Albright F, 1941, J AMER MED ASSOC, V116, P2465; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; Kim HK, 2011, MENOPAUSE, V18, P307, DOI 10.1097/gme.0b013e3181f31b1f; Boonen S, 2007, J CLIN ENDOCR METAB, V92, P1415, DOI 10.1210/jc.2006-1404; DeLaurier A, 2002, J NUTR, V132, P1742; Fukuda S, 2000, J VET MED SCI, V62, P69, DOI 10.1292/jvms.62.69; Hori M, 1984, Nihon Yakurigaku Zasshi, V84, P91; Leem KH, 2004, BIOSCI BIOTECH BIOCH, V68, P2388, DOI 10.1271/bbb.68.2388; NOTOYA K, 1994, J BONE MINER RES, V9, P395; OHISHI T, 1994, BONE, V15, P15, DOI 10.1016/8756-3282(94)90885-0; SALMERI KR, 1991, J AM VET MED ASSOC, V198, P1193; Sanecki R. K., 1993, Veterinary Clinical Pathology, V22, P17; UEBELHART D, 1990, BONE MINER, V8, P87, DOI 10.1016/0169-6009(91)90143-N	15	2	2	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	APR	2015	77	4					503	506		10.1292/jvms.13-0421		4	Veterinary Sciences	Veterinary Sciences	CG9US	WOS:000353666200019		
J	Endo, Y; Hobo, S; Korosue, K; Ootsuka, K; Kitauchi, A; Kikkawa, R; Hidaka, Y; Hagio, M; Tsuzuki, N				Endo, Yoshiro; Hobo, Seiji; Korosue, Kenji; Ootsuka, Kenji; Kitauchi, Akira; Kikkawa, Risa; Hidaka, Yuichi; Hagio, Mitsuyoshi; Tsuzuki, Nao			Effects of low-dose G-CSF formulation on hematology in healthy horses after long-distance transportation	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						filgrastim; horse; respiratory disease	COLONY-STIMULATING FACTOR; THOROUGHBREDS; NEUTROPENIA; PNEUMONIA; FEVER	The present study evaluated the effects of single-dose filgrastim on hematology in 16 healthy horses after long-distance transportation. Horses were assigned to receive filgrastim (0.23,mu g/kg, SC, once; G-CSF group; n=8) or saline (0.9% NaCl) solution (0.3 ml, SC, once; control group; n=8) <= 1 hr before transportation. Horses were transported 2,530 km using commercial vans over the course of approximately 44 hr. Clinical examinations and hematologic analyses were performed on all horses before and after transportation. Because the post-transportation white blood cell counts and bacillary neutrophil to segmented neutrophil ratio were significantly higher in the G-CSF group, filgrastim may have promoted the mobilization of neutrophils from marrow. Filgrastim deserves a further study for efficacy in preventing horse shipping fever.	[Endo, Yoshiro; Korosue, Kenji] Japan Racing Assoc, Miyazaki Yearling Training Farm, Miyazaki 8800036, Japan; [Hobo, Seiji] Kagoshima Univ, Joint Fac Vet Med, Kagoshima 8900065, Japan; [Ootsuka, Kenji] Japan Racing Assoc, Hidaka Training & Res Ctr, Urakawa, Hokkaido 0570171, Japan; [Kitauchi, Akira; Kikkawa, Risa; Hidaka, Yuichi; Hagio, Mitsuyoshi; Tsuzuki, Nao] Miyazaki Univ, Lab Vet Surg, Fac Agr, Miyazaki 8892192, Japan	Tsuzuki, N (reprint author), Miyazaki Univ, Lab Vet Surg, Fac Agr, 1-1 Gakuen Kibanadai Nishi, Miyazaki 8892192, Japan.	tsuzuki@cc.miyazaki-u.ac.jp					Aapro MS, 2006, EUR J CANCER, V42, P2433, DOI 10.1016/j.ejca.2006.05.002; OIKAWA M, 1995, J COMP PATHOL, V113, P29, DOI 10.1016/S0021-9975(05)80066-0; Endo Yoshiro, 2014, Journal of Equine Science, V25, P79, DOI 10.1294/jes.25.79; Endo Y., 2014, J VET MED SCI, V77, P75; Ito S, 2001, J VET MED SCI, V63, P1263, DOI 10.1292/jvms.63.1263; Momoi Y, 1996, J VET MED SCI, V58, P537; Oikawa Masa-Aki, 1995, Journal of Equine Science, V6, P25, DOI 10.1294/jes.6.25; Hobo Seiji, 1995, Journal of Equine Science, V6, P135, DOI 10.1294/jes.6.135; Sveikata A, 2014, MED LITH, V50, P144, DOI 10.1016/j.medici.2014.08.001; Tsuchiya T, 2012, AM J VET RES, V73, P968, DOI 10.2460/ajvr.73.7.968; Wong DM, 2012, J VET DIAGN INVEST, V24, P219, DOI 10.1177/1040638711416850; Yoshikawa H, 2003, J VET MED SCI, V65, P787, DOI 10.1292/jvms.65.787	12	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	APR	2015	77	4					507	509		10.1292/jvms.14-0586		3	Veterinary Sciences	Veterinary Sciences	CG9US	WOS:000353666200020		
J	Yusof, NH; Kawahara, S; Yamamoto, Y; Yamamoto, O				Yusof, Nurul Hayati; Kawahara, Seiichi; Yamamoto, Yoshimasa; Yamamoto, Oraphin			Preparation of super-low Protein Natural Rubber	KGK-KAUTSCHUK GUMMI KUNSTSTOFFE			English	Article						Removal of proteins; Natural rubber latex; Urea; Polar solvent; Nitrogen content	GEL FORMATION; BIOLOGICAL-MEMBRANES; METHYL-METHACRYLATE; LATEX ALLERGY; UREA; REMOVAL	An attempt was made to remove all proteins from natural rubber in the latex stage by both denaturation of the proteins and removal of lipids, which provided free space between them for fast detachment of the proteins. The removal of proteins was carried out by incubation of natural rubber latex with surfactant, denaturing agent and polar organic solvent, followed by centrifugation. The nitrogen content of the resulting rubbers was analyzed by the Kjehdahl method. The nitrogen content depended on the amount of urea, polar organic solvent concentration, amount of metal ions in the water and gel content. The green strength of the protein free natural rubber was slightly reduced compared to untreated natural rubber.	[Kawahara, Seiichi] Nagaoka Univ Technol, Dept Mat Sci & Technol, Fac Engn, Nagaoka, Niigata 9402188, Japan	Kawahara, S (reprint author), Nagaoka Univ Technol, Dept Mat Sci & Technol, Fac Engn, Nagaoka, Niigata 9402188, Japan.	hayati@lgm.gov.my; kawahara@mst.nagaokaut.ac.jp			Japan Society for the Promotion of Science [26620176, 25288098]; JST-JICA SATREPS	This work was supported in part by a Grantin- Aid (26620176) for Challenging Exploratory Research and Grant-in-Aid (25288098) for Scientific Research (B) from Japan Society for the Promotion of Science and JST-JICA SATREPS.	Amnuaypornsri S, 2008, RUBBER CHEM TECHNOL, V81, P753, DOI 10.5254/1.3548230; Raj S, 2005, INT J BIOMETEOROL, V49, P189, DOI 10.1007/s00484-004-0222-6; Tangpakdee J, 1997, RUBBER CHEM TECHNOL, V70, P707, DOI 10.5254/1.3538454; Nakason C, 2003, J APPL POLYM SCI, V87, P68, DOI 10.1002/app.11671; Cornish K, 2001, PHYTOCHEMISTRY, V57, P1123, DOI 10.1016/S0031-9422(01)00097-8; Bennion BJ, 2003, P NATL ACAD SCI USA, V100, P5142, DOI 10.1073/pnas.0930122100; Bousquet J, 2006, J ALLERGY CLIN IMMUN, V118, P447, DOI 10.1016/j.jaci.2006.03.048; Kawahara S, 2004, POLYM ADVAN TECHNOL, V15, P181, DOI 10.1002/pat.465; REYNOLDS JA, 1970, P NATL ACAD SCI USA, V66, P1002, DOI 10.1073/pnas.66.3.1002; Yeang HY, 2002, METHODS, V27, P32, DOI 10.1016/S1046-2023(02)00049-X; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; Archer B. L, 1975, P INT RUBB C KUAL LU, P532; Chaikumpollert O., 2011, POLYM ADVAN TECHNOL, V23, P825; Eng AH, 1993, J RUBBER RES, V8, P109; HASMA H, 1987, Journal of Natural Rubber Research, V2, P129; Kanjanee N., 2010, MACROMOL S, V288, P95; Kawahara S, 2002, RUBBER CHEM TECHNOL, V75, P739, DOI 10.5254/1.3544999; Klinklai W, 2004, J APPL POLYM SCI, V93, P555, DOI 10.1002/app.20463; Ma'zam M. S, 2003, J RUBBER RES, V7, P30; Ong E. L., 1998, LATEX PROTEIN ALLERG; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; Roberts A.D., 1988, NATUREAL RUBBER SCI, P63; Sakdapipanich JT, 2007, J BIOSCI BIOENG, V103, P287, DOI 10.1263/jbb.103.287; Sussman GL, 2002, J ALLERGY CLIN IMMUN, V110, pS33, DOI 10.1067/mai.2002.124969; Tangpakdee J., 1997, J RUBBER RES, V112-119, P12; Tarachiwin L, 2003, RUBBER CHEM TECHNOL, V76, P1185, DOI 10.5254/1.3547796; Tarachiwin L, 2003, RUBBER CHEM TECHNOL, V76, P1177, DOI 10.5254/1.3547795; Tong N.Y., 1992, SMR B; Yamamoto Y, 2008, J APPL POLYM SCI, V107, P2329, DOI 10.1002/app.27236; Yeang HY, 1996, J ALLERGY CLIN IMMUN, V98, P628, DOI 10.1016/S0091-6749(96)70097-0; Yunyongwattanakorn J, 2003, RUBBER CHEM TECHNOL, V76, P1228, DOI 10.5254/1.3547799; Yusof NH, 2008, J RUBBER RES, V11, P97	32	0	0	DR ALFRED HUTHIG VERLAG GMBH	HEIDELBERG	POSTFACH 10 28 69, D-69018 HEIDELBERG, GERMANY	0948-3276			KGK-KAUT GUMMI KUNST	KGK-Kautsch. Gummi Kunstst.	APR	2015	68	4					46	51				6	Engineering, Chemical; Polymer Science	Engineering; Polymer Science	CH2NS	WOS:000353862500016		
J	Hangai, S; Nannya, Y; Kurokawa, M				Hangai, Sho; Nannya, Yasuhito; Kurokawa, Mineo			Role of procalcitonin and C-reactive protein for discrimination between tumor fever and infection in patients with hematological diseases	LEUKEMIA & LYMPHOMA			English	Article						Procalcitonin; C-reactive protein; tumor fever; infection; hematological malignancies	IN-VITRO; SEPSIS; INTERLEUKIN-6	Tumor fever is a common complication in patients with hematological malignancies. We retrospectively analyzed the levels of C-reactive protein (CRP) and procalcitonin (PCT) in patients with lymphoid malignancies and fever that was attributed to tumor (39 episodes, group I) or infection (26 episodes, group II) before chemotherapy, and bloodstream infection (26 episodes, group III) after chemotherapy. The PCT level and PCT/CRP ratio were significantly higher in groups II and III than in group I (p = 0.003, p = 0.0005, respectively for groups II and I, and p = 0.003, p = 0.00002, respectively for groups III and I). At the cut-off level of 0.071 or 0.014 for PCT/CRP, the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of PCT/CRP were 53.8% or 96.2%, 89.7% or 53.8%, 77.8% or 58.1% and 74.5% or 95.5%, respectively, for discrimination between groups land II or groups I and III. PCT/CRP ratio was the best marker for discrimination between tumor fever and infection.	[Hangai, Sho; Nannya, Yasuhito; Kurokawa, Mineo] Univ Tokyo, Grad Sch Med, Dept Hematol & Oncol, Tokyo 1138655, Japan; [Kurokawa, Mineo] Tokyo Univ Hosp, Dept Cell Therapy & Transplantat, Tokyo 113, Japan	Kurokawa, M (reprint author), Univ Tokyo, Grad Sch Med, Dept Hematol & Oncol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kurokawa-tky@umin.ac.jp					Schuetz P, 2009, JAMA-J AM MED ASSOC, V302, P1059, DOI 10.1001/jama.2009.1297; Nijsten MWN, 2000, CRIT CARE MED, V28, P458, DOI 10.1097/00003246-200002000-00028; Cosgrove SE, 2006, CLIN INFECT DIS, V42, pS82, DOI 10.1086/499406; Simon L, 2004, CLIN INFECT DIS, V39, P206, DOI 10.1086/421997; Becker KL, 2004, J CLIN ENDOCR METAB, V89, P1512, DOI 10.1210/jc.2002-021444; Gendrel D, 1999, PEDIATR INFECT DIS J, V18, P875, DOI 10.1097/00006454-199910000-00008; Limper M, 2010, J INFECTION, V60, P409, DOI 10.1016/j.jinf.2010.03.016; Oberhoffer M, 1999, J LAB CLIN MED, V134, P49, DOI 10.1016/S0022-2143(99)90053-7; Pihusch M, 2006, EUR J HAEMATOL, V76, P93, DOI 10.1111/j.0902-4441.2005.t01-1-EJH2362.x; Mancini N, 2010, CLIN MICROBIOL REV, V23, P235, DOI 10.1128/CMR.00043-09; Hirschmann JV, 1997, CLIN INFECT DIS, V24, P291; Reinhart K, 2000, INTENS CARE MED, V26, pS145, DOI 10.1007/BF02900726; Shomali W, 2012, CANCER-AM CANCER SOC, V118, P5823, DOI 10.1002/cncr.27602	13	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1042-8194	1029-2403		LEUKEMIA LYMPHOMA	Leuk. Lymphoma	APR	2015	56	4					910	914		10.3109/10428194.2014.938329		5	Oncology; Hematology	Oncology; Hematology	CG9CT	WOS:000353612700015		
J	Morishima, S; Nakamura, S; Yamamoto, K; Miyauchi, H; Kagami, Y; Kinoshita, T; Onoda, H; Yatabe, Y; Ito, M; Miyamura, K; Nagai, H; Moritani, S; Sugiura, I; Tsushita, K; Mihara, H; Ohbayashi, K; Iba, S; Emi, N; Okamoto, M; Iwata, S; Kimura, H; Kuzushima, K; Morishima, Y				Morishima, Satoko; Nakamura, Shigeo; Yamamoto, Kazuhito; Miyauchi, Hidemasa; Kagami, Yoshitoyo; Kinoshita, Tomohiro; Onoda, Hiroshi; Yatabe, Yasushi; Ito, Masafumi; Miyamura, Kouichi; Nagai, Hirokazu; Moritani, Suzuko; Sugiura, Isamu; Tsushita, Keitaro; Mihara, Hidetsugu; Ohbayashi, Kaneyuki; Iba, Sachiko; Emi, Nobuhiko; Okamoto, Masataka; Iwata, Seiko; Kimura, Hiroshi; Kuzushima, Kiyotaka; Morishima, Yasuo			Increased T-cell responses to Epstein-Barr virus with high viral load in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma	LEUKEMIA & LYMPHOMA			English	Article						EBV-positive diffuse large B-cell lymphoma; immune response; T-cell proliferation; IFN-gamma secretion; EBV-DNA load	PYOTHORAX-ASSOCIATED LYMPHOMA; LYMPHOPROLIFERATIVE DISORDERS; NASOPHARYNGEAL CARCINOMA; CD8+T CELLS; AGE; IMMUNITY; PLASMA; DNA; EXPRESSION; INFECTION	The immunological status of patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma (EBV+ DLBCL) without obvious immunodeficiency has not been elucidated. A multicenter prospective study was conducted to assess pretreatment T-cell responses to EBV, EBV-DNA load and anti-EBV antibody in these patients. The proliferative and interferon (IFN)-gamma-producing capacity of T-cells in response to autologous B-Iymphoblastoid cell lines was determined using carboxyfluorescein diacetate succinimidyl ester (CFSE)based assay. Frequencies of EBV-specific CD4+ T-cells in patients with EBV+ DLBCL (n = 13) were significantly higher than in healthy controls (HCs) (n = 16) after both ex vivo and in vitro stimulation. Frequencies of EBV-specific CD8+ T-cells in patients with EBV+ DLBCL tended to be higher than in HCs after in vitro stimulation. Patients with EBV+ DLBCL also showed increased immunoglobulin G (IgG) responses to lytic EBV-encoded antigens. Pretreatment plasma EBV-DNA level was significantly higher in patients with EBV+ DLBCL than in patients with EBV DLBCL or HCs. In conclusion, EBV-specific T-cells showed increased reactivity, accompanied by higher levels of plasma virus DNA in patients with EBV+ DLBCL.	[Morishima, Satoko; Iba, Sachiko; Emi, Nobuhiko; Okamoto, Masataka] Fujita Hlth Univ, Sch Med, Dept Hematol, Toyoake, Aichi 4701101, Japan; [Morishima, Satoko; Kuzushima, Kiyotaka] Aichi Canc Ctr, Res Inst, Div Immunol, Nagoya, Aichi 464, Japan; [Morishima, Yasuo] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 464, Japan; [Morishima, Satoko; Yamamoto, Kazuhito; Kagami, Yoshitoyo; Kinoshita, Tomohiro; Onoda, Hiroshi; Morishima, Yasuo] Aichi Canc Ctr Hosp, Dept Hematol & Cell Therapy, Nagoya, Aichi 464, Japan; [Yatabe, Yasushi] Aichi Canc Ctr Hosp, Dept Clin Pathol, Nagoya, Aichi 464, Japan; [Nakamura, Shigeo] Nagoya Univ Hosp, Dept Pathol, Nagoya, Aichi, Japan; [Nakamura, Shigeo] Nagoya Univ Hosp, Clin Labs, Nagoya, Aichi, Japan; [Miyauchi, Hidemasa] Hlth Syst Inc, Jishokai Grp, Nagoya, Aichi, Japan; [Kagami, Yoshitoyo] Toyota Kosei Hosp, Dept Hematol, Toyota, Aichi, Japan; [Kinoshita, Tomohiro] Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Nagoya, Aichi 4648601, Japan; [Iwata, Seiko; Kimura, Hiroshi] Nagoya Univ, Grad Sch Med, Dept Virol, Nagoya, Aichi 4648601, Japan; [Ito, Masafumi] Japanese Red Cross Nagoya First Hosp, Dept Pathol, Nagoya, Aichi, Japan; [Miyamura, Kouichi] Japanese Red Cross Nagoya First Hosp, Dept Hematol, Nagoya, Aichi, Japan; [Nagai, Hirokazu] Nagoya Med Ctr, Natl Hosp Org, Clin Res Ctr, Nagoya, Aichi, Japan; [Moritani, Suzuko] Nagoya Med Ctr, Natl Hosp Org, Dept Pathol, Nagoya, Aichi, Japan; [Sugiura, Isamu] Toyohashi Municipal Hosp, Dept Hematol, Toyohashi, Aichi, Japan; [Tsushita, Keitaro] Social Insurance Chukyo Hosp, Dept Hematol, Nagoya, Aichi, Japan; [Mihara, Hidetsugu] Aichi Med Univ, Sch Med, Div Hematol, Dept Internal Med, Nagakute, Aichi 48011, Japan; [Ohbayashi, Kaneyuki] Nishio Municipal Hosp, Dept Internal Med, Nishio, Japan	Morishima, S (reprint author), Fujita Hlth Univ, Sch Med, Dept Hematol, 1-98 Dengakugakubo Kutsukake Cho, Toyoake, Aichi 4701101, Japan.	smorishi@fujita-hu.ac.jp	Kimura, Hiroshi/I-2246-2012; Nakamura, Shigeo/I-1571-2012		Ministry of Health, Labor and Welfare of Japan [H22-029]; Fujita Health University (SaM)	We thank all doctors of the participating hospitals who contributed data to this publication, and Ms. Mako Hagino for technical assistance. We are grateful for the support of the following agencies: Grant-in-Aid for Cancer Research from the Ministry of Health, Labor and Welfare of Japan (Clinical Cancer Research H22-029) and Fujita Health University (SaM).	Angulo R, 1998, CYTOMETRY, V34, P143, DOI 10.1002/(SICI)1097-0320(19980615)34:3<143::AID-CYTO4>3.3.CO;2-G; Long HM, 2011, CURR OPIN IMMUNOL, V23, P258, DOI 10.1016/j.coi.2010.12.014; Oyama T, 2007, CLIN CANCER RES, V13, P5124, DOI 10.1158/1078-0432.CCR-06-2823; Ouyang Q, 2003, MECH AGEING DEV, V124, P477, DOI 10.1016/S0047-6374(03)00026-5; Raab-Traub N, 2012, CURR OPIN VIROL, V2, P453, DOI 10.1016/j.coviro.2012.07.001; Hislop AD, 2007, ANNU REV IMMUNOL, V25, P587, DOI 10.1146/annurev.immunol.25.022106.141553; Demachi-Okamura A, 2008, CANCER SCI, V99, P1633, DOI 10.1111/j.1349-7006.2008.00852.x; Takegawa S, 2008, CANCER SCI, V99, P296, DOI 10.1111/j.1349-7006.2007.00687.x; Guppy AE, 2007, TRANSPLANTATION, V84, P1534, DOI 10.1097/01.tp.0000290232.65830.e7; Kanno H, 1997, AM J PATHOL, V150, P349; Gandhi MK, 2006, CLIN CANCER RES, V12, P460, DOI 10.1158/1078-0432.CCR-05-2008; Suzuki R, 2011, BLOOD, V118, P6018, DOI 10.1182/blood-2011-05-354142; Narimatsu H, 2007, ANN ONCOL, V18, P122, DOI 10.1093/annonc/mdl349; Kimura H, 1999, J CLIN MICROBIOL, V37, P132; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Khan N, 2004, J IMMUNOL, V173, P7481; Lin JC, 2004, NEW ENGL J MED, V350, P2461, DOI 10.1056/NEJMoa032260; Dojcinov SD, 2011, BLOOD, V117, P4726, DOI 10.1182/blood-2010-12-323238; Oyama T, 2003, AM J SURG PATHOL, V27, P16, DOI 10.1097/00000478-200301000-00003; White RE, 2012, J CLIN INVEST, V122, P1487, DOI 10.1172/JCI58092; Swain SL, 2012, NAT REV IMMUNOL, V12, P136, DOI 10.1038/nri3152; Fogg MH, 2009, P NATL ACAD SCI USA, V106, P3318, DOI 10.1073/pnas.0813320106; Heller KN, 2008, INT J CANCER, V123, P2824, DOI 10.1002/ijc.23845; Long HM, 2009, BLOOD, V114, P807, DOI 10.1182/blood-2008-12-194043; Pender MP, 2012, BLOOD, V120, P5085, DOI 10.1182/blood-2012-06-437285; Swerdlow S, 2008, WHO CLASSIFICATION T	26	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1042-8194	1029-2403		LEUKEMIA LYMPHOMA	Leuk. Lymphoma	APR	2015	56	4					1072	1078		10.3109/10428194.2014.938326		7	Oncology; Hematology	Oncology; Hematology	CG9CT	WOS:000353612700039		
J	Ito, K; Okamoto, M; Ando, M; Kakumae, Y; Okamoto, A; Inaguma, Y; Tokuda, M; Yanada, M; Yamada, S; Emi, N				Ito, Kaori; Okamoto, Masataka; Ando, Maiko; Kakumae, Yukiko; Okamoto, Akinao; Inaguma, Yoko; Tokuda, Masutaka; Yanada, Masamitsu; Yamada, Shigeki; Emi, Nobuhiko			Influence of rituximab plus bendamustine chemotherapy on the immune system in patients with refractory or relapsed follicular lymphoma and mantle cell lymphoma	LEUKEMIA & LYMPHOMA			English	Letter							NON-HODGKINS-LYMPHOMA; INDOLENT B-CELL; PHASE-II MULTICENTER		[Ito, Kaori; Ando, Maiko; Kakumae, Yukiko; Yamada, Shigeki] Fujita Hlth Univ Hosp, Dept Pharm, Toyoake, Aichi, Japan; [Ito, Kaori; Okamoto, Masataka; Okamoto, Akinao; Inaguma, Yoko; Tokuda, Masutaka; Yanada, Masamitsu; Emi, Nobuhiko] Fujita Hlth Univ, Sch Med, Dept Hematol, Toyoake, Aichi 4701192, Japan	Yanada, M (reprint author), Fujita Hlth Univ, Sch Med, Dept Hematol, 1-98 Dengakugakubo,Kutsukake Cho, Toyoake, Aichi 4701192, Japan.	myanada@fujita-hu.ac.jp					Friedberg JW, 2008, J CLIN ONCOL, V26, P204, DOI 10.1200/JCO.2007.12.5070; Rummel MJ, 2013, LANCET, V381, P1203, DOI 10.1016/S0140-6736(12)61763-2; Gea-Banacloche JC, 2010, SEMIN HEMATOL, V47, P187, DOI 10.1053/j.seminhematol.2010.01.002; Kahl BS, 2010, CANCER, V116, P106, DOI 10.1002/cncr.24714; Rummel MJ, 2005, J CLIN ONCOL, V23, P3383, DOI 10.1200/JCO.2005.08.100; Robinson KS, 2008, J CLIN ONCOL, V26, P4473, DOI 10.1200/JCO.2008.17.0001; Burchardt A, 2013, HEMATOL ONCOL S1, V31; Ohmachi K, 2010, CANCER SCI, V101, P2059, DOI 10.1111/j.1349-7006.2010.01635.x	8	2	2	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1042-8194	1029-2403		LEUKEMIA LYMPHOMA	Leuk. Lymphoma	APR	2015	56	4					1123	1125		10.3109/10428194.2014.921298		3	Oncology; Hematology	Oncology; Hematology	CG9CT	WOS:000353612700046		
J	Sumi, M; Takeda, W; Kaiume, H; Kirihara, T; Kurihara, T; Sato, K; Ueki, T; Hiroshima, Y; Ueno, M; Ichikawa, N; Kobayashi, H				Sumi, Masahiko; Takeda, Wataru; Kaiume, Hiroko; Kirihara, Takehiko; Kurihara, Taro; Sato, Keijiro; Ueki, Toshimitsu; Hiroshima, Yuki; Ueno, Mayumi; Ichikawa, Naoaki; Kobayashi, Hikaru			Successful treatment with reduced-intensity cord blood transplant in a patient with relapsed refractory hepatosplenic T-cell lymphoma	LEUKEMIA & LYMPHOMA			English	Letter							LONG-TERM REMISSION; THERAPY		[Sumi, Masahiko; Takeda, Wataru; Kaiume, Hiroko; Kirihara, Takehiko; Kurihara, Taro; Sato, Keijiro; Ueki, Toshimitsu; Hiroshima, Yuki; Ueno, Mayumi; Ichikawa, Naoaki; Kobayashi, Hikaru] Nagano Red Cross Hosp, Dept Hematol, Nagano, Nagano 3808582, Japan	Sumi, M (reprint author), Nagano Red Cross Hosp, Dept Hematol, 5-22-1 Wakasato, Nagano, Nagano 3808582, Japan.	sumin@nagano-med.jrc.or.jp					Vose JM, 2008, J CLIN ONCOL, V26, P4124, DOI 10.1200/JCO.2008.16.4558; Falchook GS, 2009, ANN ONCOL, V20, P1080, DOI 10.1093/annonc/mdn751; Chanan-Khan A, 2004, LEUKEMIA LYMPHOMA, V45, P1673, DOI 10.1080/10428190310001609924; Voss MH, 2013, CL LYMPH MYELOM LEUK, V13, P8, DOI 10.1016/j.clml.2012.09.002; Kinda SB, 2013, LEUKEMIA LYMPHOMA, V54, P1334, DOI 10.3109/10428194.2012.740563; Belhadj K, 2003, BLOOD, V102, P4261, DOI 10.1182/blood-2003-05-1675; Chalmers Anna W, 2013, Clin Adv Hematol Oncol, V11, P109; Corazzelli Gaetano, 2005, Haematologica, V90, pECR14; Ferreri AJM, 2012, CRIT REV ONCOL HEMAT, V83, P283, DOI 10.1016/j.critrevonc.2011.10.001; Gaulard P, 2008, WHO CLASSIFICATION T, P292; He S, 2007, LEUKEMIA LYMPHOMA, V48, P1448, DOI 10.1080/10428190701400071; Konuma T, 2007, LEUKEMIA LYMPHOMA, V48, P630, DOI 10.1080/10428190601126941; Otrock ZK, 2008, ANN HEMATOL, V87, P1023, DOI 10.1007/s00277-008-0523-7; Sakai R, 2006, BONE MARROW TRANSPL, V37, P537, DOI 10.1038/sj.bmt.1705272; Visnyei K, 2013, CL LYMPH MYELOM LEUK, V13, P360, DOI 10.1016/j.clml.2013.03.011	15	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1042-8194	1029-2403		LEUKEMIA LYMPHOMA	Leuk. Lymphoma	APR	2015	56	4					1140	1142		10.3109/10428194.2014.947613		3	Oncology; Hematology	Oncology; Hematology	CG9CT	WOS:000353612700052		
J	Konuma, T; Kato, S; Oiwa-Monna, M; Tojo, A; Takahashi, S				Konuma, Takaaki; Kato, Seiko; Oiwa-Monna, Maki; Tojo, Arinobu; Takahashi, Satoshi			Single-unit cord blood transplant for acute lymphoblastic leukemia and lymphoma using an intensified conditioning regimen of total body irradiation, high-dose cytarabine and cyclophosphamide	LEUKEMIA & LYMPHOMA			English	Letter							STEM-CELL TRANSPLANTATION; PERIPHERAL-BLOOD; UNRELATED DONORS; ADULT PATIENTS; BONE-MARROW; MALIGNANCIES		[Konuma, Takaaki; Kato, Seiko; Oiwa-Monna, Maki; Tojo, Arinobu; Takahashi, Satoshi] Univ Tokyo, Inst Med Sci, Dept Hematol Oncol, Tokyo 1088639, Japan	Konuma, T (reprint author), Univ Tokyo, Inst Med Sci, Dept Hematol Oncol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	tkonuma@ims.u-tokyo.ac.jp					Inamoto Y, 2007, BONE MARROW TRANSPL, V39, P25, DOI 10.1038/sj.bmt.1705543; Marks DI, 2014, HAEMATOLOGICA, V99, P322, DOI 10.3324/haematol.2013.094193; Atsuta Y, 2009, BLOOD, V113, P1631, DOI 10.1182/blood-2008-03-147041; Rodrigues CA, 2014, HAEMATOLOGICA, V99, P370, DOI 10.3324/haematol.2013.088997; Kanda Y, 2005, BIOL BLOOD MARROW TR, V11, P881, DOI 10.1016/j.bbmt.2005.07.005; Kumar P, 2008, BIOL BLOOD MARROW TR, V14, P1394, DOI 10.1016/j.bbmt.2008.09.021; Takahashi S, 2007, BLOOD, V109, P1322, DOI 10.1182/blood-2006-04-020172; Mori T, 2012, AM J HEMATOL, V87, P349, DOI 10.1002/ajh.23109; Mengarelli A, 2002, HAEMATOLOGICA, V87, P52; Shigematsu A, 2008, BIOL BLOOD MARROW TR, V14, P568, DOI 10.1016/j.bbmt.2008.02.018; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Ooi J, 2009, BONE MARROW TRANSPL, V43, P455, DOI 10.1038/bmt.2008.347; Tomblyn MB, 2009, J CLIN ONCOL, V27, P3634, DOI 10.1200/JCO.2008.20.2960	13	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1042-8194	1029-2403		LEUKEMIA LYMPHOMA	Leuk. Lymphoma	APR	2015	56	4					1148	1150		10.3109/10428194.2014.949261		3	Oncology; Hematology	Oncology; Hematology	CG9CT	WOS:000353612700055		
J	Cheng, ZG; Zhang, ZC; Hou, T; Santosh, M; Zhang, DY; Ke, S				Cheng, Zhiguo; Zhang, Zhaochong; Hou, Tong; Santosh, M.; Zhang, Dongyang; Ke, Shan			Petrogenesis of nephelinites from the Tarim Large Igneous Province, NW China: Implications for mantle source characteristics and plume-lithosphere interaction	LITHOS			English	Article						Tarim large igneous province; Mantle plume; Nephelinite; Rutile geochronology; Magnesium isotope; Plume-lithosphere interaction	OCEAN ISLAND BASALTS; PALEOZOIC TECTONIC EVOLUTION; PARTIAL MELTING EXPERIMENTS; OROGENIC BELT CAOB; TRACE-ELEMENT; FLOOD-BASALT; 3 GPA; EXPERIMENTAL CONSTRAINTS; HETEROGENEOUS MANTLE; NORTHWESTERN CHINA	The nephelinite exposed in the Wajilitage area in the northwestern margin of the Tarim large igneous province (TLIP), Xinjiang, NW China display porphyritic textures with clinopyroxene, nepheline and olivine as the major phenocryst phases, together with minor apatite, sodalite and alkali feldspar. The groundmass typically has cyptocrystalline texture and is composed of crystallites of clinopyroxene, nepheline, Fe-Ti oxides, sodalite, apatite, rutile, biotite, amphibole and alkali feldspar. We report rutile SIMS U-Pb age of 268 +/- 30 Ma suggesting that the nephelinite may represent the last phase of the TLIP magmatism, which is also confirmed by the field relation. The nephelinite shows depleted Sr-Nd isotopic compositions with age-corrected Sr-87/Sr-86 and epsilon(Nd)(t) values of 0.70348-0.70371 and +3.28 to +3.88 respectively indicating asthenospheric mantle source. Based on the reconstructed primary melt composition, the depth of magma generation is estimated as 115-140 km and the temperatures of mantle melting as 1540-1575 degrees C The hotter than normal asthenospheric mantle temperature suggests the involvement of mantle thermal plume. The Mg isotope values display a limited range of delta Mg-26 from -0.35 to -0.55%, which are lower than the mantle values (-025%). The Mg isotopic compositions, combined with the Sr-Nd isotopes and major and trace element data suggest that the Wajilitage nephelinite was most likely generated by low-degree partial melting of the hybridized carbonated peridotite/eclogite source, which we correlate with metasomatism by subducted carbonates within the early-middle Paleozoic convergent regime. A plume-lithosphere model is proposed with slight thinning of the lithosphere and variable depth and degree of melting of the carbonated mantle during the plume-lithosphere interaction. This model also accounts for the variation in lithology of the TLIP. (C) 2015 Elsevier B.V. All rights reserved.	[Cheng, Zhiguo; Zhang, Zhaochong; Hou, Tong; Santosh, M.; Zhang, Dongyang; Ke, Shan] China Univ Geosci, State Key Lab Geol Proc & Mineral Resources, Beijing 100083, Peoples R China; [Santosh, M.] Kochi Univ, Div Interdisciplinary Sci, Kochi 7808520, Japan	Zhang, ZC (reprint author), China Univ Geosci, State Key Lab Geol Proc & Mineral Resources, Beijing 100083, Peoples R China.	zczhang@cugb.edu.cn	Santosh, M/B-2563-2012		National Nature Science Foundation of China [41472060, 41230209]; 305 Project of the State Science and Technology Program of China [2011BAB06B0204]; 973 Program [2012CB416806]; 111 Project [B07011]; Fundamental Research Funds for the Central Universities	We thank Ting Gao for technical support of Mg isotope analyses and Dr. He Huang and Jinchao Ye for field research. Financial support for this work was supported by the National Nature Science Foundation of China (41472060 and 41230209), 305 Project of the State Science and Technology Program of China (2011BAB06B0204), 973 Program (2012CB416806), 111 Project (B07011) and the Fundamental Research Funds for the Central Universities.	ALBAREDE F, 1992, J GEOPHYS RES-SOL EA, V97, P10997, DOI 10.1029/91JB02927; Pilet S, 2008, SCIENCE, V320, P916, DOI 10.1126/science.1156563; Kamo SL, 2003, EARTH PLANET SC LETT, V214, P75, DOI 10.1016/S0012-821X(03)00347-9; Saunders AD, 2007, CHEM GEOL, V241, P282, DOI 10.1016/j.chemgeo.2007.01.017; Dasgupta R, 2006, J PETROL, V47, P647, DOI 10.1093/petrology.egi088; Ali S, 2013, CHEM GEOL, V337, P99, DOI 10.1016/j.chemgeo.2012.12.001; Tian W, 2010, CONTRIB MINERAL PETR, V160, P407, DOI 10.1007/s00410-009-0485-3; Putirka KD, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2005GC000915; Higgins JA, 2010, GEOCHIM COSMOCHIM AC, V74, P5039, DOI 10.1016/j.gca.2010.05.019; Bracciali L, 2013, CHEM GEOL, V347, P82, DOI 10.1016/j.chemgeo.2013.03.013; Clark DJ, 2000, PRECAMBRIAN RES, V102, P155, DOI 10.1016/S0301-9268(00)00063-2; Falloon TJ, 2000, J PETROL, V41, P257, DOI 10.1093/petrology/41.2.257; BAKER MB, 1994, GEOCHIM COSMOCHIM AC, V58, P2811, DOI 10.1016/0016-7037(94)90116-3; Kerrick DM, 2001, NATURE, V411, P293, DOI 10.1038/35077056; Li QL, 2011, LITHOS, V122, P76, DOI 10.1016/j.lithos.2010.11.007; Ireland TR, 2003, REV MINERAL GEOCHEM, V53, P215, DOI 10.2113/0530215; Lassiter JC, 2000, EARTH PLANET SC LETT, V178, P269, DOI 10.1016/S0012-821X(00)00084-4; Salters VJM, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000597; FOLEY S, 1992, LITHOS, V28, P187, DOI 10.1016/0024-4937(92)90006-K; Xu YG, 2014, LITHOS, V204, P20, DOI 10.1016/j.lithos.2014.02.015; Brenot A, 2008, GEOCHIM COSMOCHIM AC, V72, P5070, DOI 10.1016/j.gca.2008.07.027; Zeng G, 2010, CHEM GEOL, V273, P35, DOI 10.1016/j.chemgeo.2010.02.009; Li ZL, 2011, J ASIAN EARTH SCI, V42, P917, DOI 10.1016/j.jseaes.2011.05.009; Mourao C, 2010, J AFR EARTH SCI, V56, P59, DOI 10.1016/j.jafrearsci.2009.06.003; Lei JS, 2007, PHYS EARTH PLANET IN, V162, P165, DOI 10.1016/j.pepi.2007.04.010; Hofmann AW, 1997, NATURE, V385, P219, DOI 10.1038/385219a0; Ito G, 2005, EARTH PLANET SC LETT, V230, P29, DOI 10.1016/j.epsl.2004.10.035; Jones AP, 2005, ELEMENTS, V1, P277, DOI 10.2113/gselements.1.5.277; Klemme S, 2002, GEOCHIM COSMOCHIM AC, V66, P3109, DOI 10.1016/S0016-7037(02)00859-1; CAMPBELL IH, 1990, EARTH PLANET SC LETT, V99, P79, DOI 10.1016/0012-821X(90)90072-6; Li ZL, 2012, J ASIAN EARTH SCI, V49, P191, DOI 10.1016/j.jseaes.2011.11.021; TATSUMI Y, 1983, J GEOPHYS RES, V88, P5815, DOI 10.1029/JB088iB07p05815; Dasgupta R, 2009, CHEM GEOL, V262, P57, DOI 10.1016/j.chemgeo.2009.02.004; Leake BE, 1997, AM MINERAL, V82, P1019; Yang W, 2012, CHEM GEOL, V328, P185, DOI 10.1016/j.chemgeo.2012.05.018; Hirschmann MM, 2003, GEOLOGY, V31, P481, DOI 10.1130/0091-7613(2003)031<0481:AMGBPM>2.0.CO;2; Korenaga J, 2000, EARTH PLANET SC LETT, V184, P251, DOI 10.1016/S0012-821X(00)00308-3; Putirka KD, 2003, AM MINERAL, V88, P1542; Charvet J, 2011, SCI CHINA EARTH SCI, V54, P166, DOI 10.1007/s11430-010-4138-1; Wei X, 2014, AM J SCI, V314, P314, DOI 10.2475/01.2014.09; Zhang DY, 2013, EARTH PLANET SC LETT, V361, P238, DOI 10.1016/j.epsl.2012.10.034; Zhang CL, 2010, LITHOS, V119, P537, DOI 10.1016/j.lithos.2010.08.007; Yu X, 2011, GONDWANA RES, V20, P485, DOI 10.1016/j.gr.2010.11.009; Li QL, 2003, CHEM GEOL, V200, P255, DOI 10.1016/S0009-2541(03)00194-3; Keller J, 2006, LITHOS, V91, P150, DOI 10.1016/j.lithos.2006.03.014; Zhang ZC, 2006, J PETROL, V47, P1997, DOI 10.1093/petrology/egl034; Campbell IH, 2007, CHEM GEOL, V241, P153, DOI 10.1016/j.chemgeo.2007.01.024; TATSUMI Y, 1989, J GEOPHYS RES-SOLID, V94, P4697, DOI 10.1029/JB094iB04p04697; Teng FZ, 2010, GEOCHIM COSMOCHIM AC, V74, P4150, DOI 10.1016/j.gca.2010.04.019; Walter MJ, 1998, J PETROL, V39, P29, DOI 10.1093/petrology/39.1.29; Teng FZ, 2007, EARTH PLANET SC LETT, V261, P84, DOI 10.1016/j.epsl.2007.06.004; Kogiso T, 2003, EARTH PLANET SC LETT, V216, P603, DOI 10.1016/S0012-821X(03)00538-7; Zhou MF, 2002, EARTH PLANET SC LETT, V196, P113, DOI 10.1016/S0012-821X(01)00608-2; Zhang CL, 2008, J GEOL, V116, P269, DOI 10.1086/587726; Thompson RN, 2000, NATURE, V407, P502, DOI 10.1038/35035058; Herzberg C, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC002057; Wang B, 2011, TECTONOPHYSICS, V497, P85, DOI 10.1016/j.tecto.2010.11.004; Hirose K, 1997, GEOPHYS RES LETT, V24, P2837, DOI 10.1029/97GL02956; Jiang CY, 2004, ACTA PETROL SIN, V20, P1433; King SD, 1995, EARTH PLANET SC LETT, V136, P269, DOI 10.1016/0012-821X(95)00205-Q; Zhou MF, 2009, LITHOS, V113, P583, DOI 10.1016/j.lithos.2009.06.027; Zhang DY, 2012, LITHOS, V146, P65, DOI 10.1016/j.lithos.2012.04.002; ZINDLER A, 1986, ANNU REV EARTH PL SC, V14, P493, DOI 10.1146/annurev.earth.14.1.493; Ge RF, 2012, LITHOS, V142, P1, DOI 10.1016/j.lithos.2012.02.010; Dasgupta R, 2007, J PETROL, V48, P2093, DOI 10.1093/petrology/egm053; Prytulak J, 2007, EARTH PLANET SC LETT, V263, P388, DOI 10.1016/j.epsl.2007.09.015; Bryan SE, 2008, EARTH-SCI REV, V86, P175, DOI 10.1016/j.earscirev.2007.08.008; Klaudius J, 2006, LITHOS, V91, P173, DOI 10.1016/j.lithos.2006.03.017; Kogiso T, 2006, EARTH PLANET SC LETT, V249, P188, DOI 10.1016/j.epsl.2006.07.016; Putirka KD, 2007, CHEM GEOL, V241, P177, DOI 10.1016/j.chemgeo.2007.01.014; Barker AK, 2012, CONTRIB MINERAL PETR, V163, P949, DOI 10.1007/s00410-011-0708-2; Storey M, 2007, CHEM GEOL, V241, P264, DOI 10.1016/j.chemgeo.2007.01.016; D'Orazio M, 2007, LITHOS, V98, P313, DOI 10.1016/j.lithos.2007.05.004; Xu Y, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000402; Arndt N, 1998, CONTRIB MINERAL PETR, V133, P297, DOI 10.1007/s004100050453; Herzberg C, 2002, J PETROL, V43, P1857, DOI 10.1093/petrology/43.10.1857; BAO PS, 2009, DIZHI XUEBAO, V83, P1276; Cao J, 2014, J ASIAN EARTH SCI, V84, P51, DOI 10.1016/j.jseaes.2013.09.014; [陈汉林 CHEN Han-lin], 2009, [新疆石油地质, Xinjiang Petroleum Geology], V30, P179; Cheng Z.G., 2014, J ASIAN EARTH SCI; Condie K.C., 2001, MANTLE PLUME GENERAT, P115; Ernst R E, 2001, GEOLOGICAL SOC AM SP, P483, DOI DOI 10.1130/0-8137-2352-3.483; Foster MD, 1960, US GEOLOGICAL SURV B, V354B, P11; Frey F. A., 2003, P OC DRILL PROGR SCI, V183, P1, DOI DOI 10.2973/ODP.PROC.SR.183.015.2003; Herzberg C, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001390; HOFMANN AW, 1986, EARTH PLANET SC LETT, V79, P33, DOI 10.1016/0012-821X(86)90038-5; Huang H, 2013, J GEOL, V121, P401, DOI 10.1086/670653; Hurai V, 2007, MINERAL MAG, V71, P63, DOI 10.1180/minmag.2007.071.1.63; Jia C.Z., 2004, STRATIGRAPHY TARIM B, P190; Kent R.W., 1992, GEOLOGY, V20, P89; Keskin M, 2003, GEOPHYS RES LETT, V30, P1, DOI 10.1029/2003GL018019; Le Mantre R.W., IGNEOUS ROCKS CLASSI, P252; LEBAS MJ, 1989, J PETROL, V30, P1299; Li DX, 2014, LITHOS, V204, P36, DOI 10.1016/j.lithos.2014.05.023; Li Y.Q., 2013, THESIS ZHEJIANG U; Li Z.L, 2008, ACTA PETROL SIN, V24, P950; Long X.P., 2011, PRECAMBRIAN RES, V180, P272; McDonough W.F., 1995, CHEM GEOL, V120, P2523; Norrish K., 1977, PHYSICAL METHODS DET, P201; Qi L, 2000, TALANTA, V51, P507, DOI DOI 10.1016/S0039-9140(99)00318-5; SCHIANO P, 1994, EARTH PLANET SC LETT, V123, P167, DOI 10.1016/0012-821X(94)90265-8; Gregory Shellnutt J, 2014, [Geoscience Frontiers, 地学前缘], V5, P369; Sisson TW, 2009, CONTRIB MINERAL PETR, V158, P803, DOI 10.1007/s00410-009-0411-8; Sun S. S., 1989, MAGMATISM OCEAN BASI, V42, P313, DOI DOI 10.1144/GSL.SP.1989.042.01.19; Turner S, 1996, J GEOPHYS RES-SOL EA, V101, P11503, DOI 10.1029/96JB00430; Vapnik Y, 2007, INT J EARTH SCI, V96, P663, DOI 10.1007/s00531-006-0131-5; Wang S.-J., 2014, NATURE COMMUNICATION; WEAVER BL, 1991, EARTH PLANET SC LETT, V104, P381, DOI 10.1016/0012-821X(91)90217-6; Yang S.F., 1996, GEOCHIMICA, V25, P121; Yang SF, 2006, ACTA PETROL SIN, V22, P1405; Yu X., 2009, THESIS ZHEJIANG U; Zhang CL, 2013, LITHOS, V172, P47, DOI 10.1016/j.lithos.2013.04.001; Zhang CL, 2013, LITHOS, V174, P15, DOI 10.1016/j.lithos.2012.11.010; Zhang D.Y., 2014, J PETROLOGY; Zhang HM, 2012, SCI CHINA EARTH SCI, V55, P1929, DOI 10.1007/s11430-012-4532-y; Zhang YT, 2010, GONDWANA RES, V18, P596, DOI 10.1016/j.gr.2010.03.006; Zhao Z.Y., 2014, GONDWANA RES; [张招崇 Zhang Zhaochong], 2003, [吉林大学学报. 地球科学版, Journal of Jilin University], V33, P130	118	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0024-4937	1872-6143		LITHOS	Lithos	APR	2015	220						164	178		10.1016/j.lithos.2015.02.002		15	Geochemistry & Geophysics; Mineralogy	Geochemistry & Geophysics; Mineralogy	CH2JM	WOS:000353851500010		
J	Green, T; Peloza, J				Green, Todd; Peloza, John			How did the Recession Change the Communication of Corporate Social Responsibility Activities?	LONG RANGE PLANNING			English	Article							CREATE VALUE; CONSUMERS; INITIATIVES; PHILANTHROPY; CITIZENSHIP; SENSEMAKING; BUSINESSES; STRATEGIES; ADVANTAGE; RETURNS	One key objective of corporate social responsibility (CSR) activities is the enhancement of relationships with stakeholders such as consumers. However, in order for firms to enhance stakeholder relationships, individuals must be made aware of firms' CSR activities. As a result, firms dedicate considerable resources to CSR-related advertisements. The current research proposes that, during recessionary periods, managers alter their CSR communications in response to perceived consumer retrenchment to purchase criteria such as price and quality. Using sensemaking as a framework, we predict that managers used cues from consumers during the recent recession, to alter their CSR communications strategies accordingly. We test our hypotheses through a content analysis of over 4000 print advertisements from 2006 to 2010. Our findings demonstrate that instead of lower levels of CSR communications during the recession, the odds of an advertisement containing CSR messages actually increased during the recession. However, the content of this advertising did change in concert with the sensemaking hypotheses. Specifically, during periods of economic decline, CSR messages were more likely to be integrated into "mainstream" advertising. We also find that the use of self-oriented appeals (e.g., cost savings due to energy efficiency) sharply increased during the period of economic decline. We highlight how managers can use these findings to increase the probability that CSR communications will deliver the expected relational benefits with consumers. (C) 2014 Elsevier Ltd. All rights reserved.	[Green, Todd] Brock Univ, Goodman Sch Business, Mkt Int Business & Strategy, St Catharines, ON L2S 3A1, Canada; [Peloza, John] Univ Kentucky, Mkt, Lexington, KY 40506 USA; [Peloza, John] IBM Corp, Hyderabad, Andhra Pradesh, India; [Peloza, John] Subaru, Tokyo, Japan; [Peloza, John] Hewlett Packard Corp, Hyderabad, Andhra Pradesh, India; [Peloza, John] Procter & Gamble, Cincinnati, OH USA	Green, T (reprint author), Brock Univ, Goodman Sch Business, Mkt Int Business & Strategy, St Catharines, ON L2S 3A1, Canada.	tgreen@brocku.ca; john.peloza@uky.edu					Ang SH, 2000, LONG RANGE PLANN, V33, P97, DOI 10.1016/S0024-6301(99)00100-4; Angus-Leppan T., 2009, J BUS ETHICS, V93, P189; Green T, 2011, J CONSUM MARK, V28, P48, DOI 10.1108/07363761111101949; Huhmann BA, 1997, J ADVERTISING, V26, P35; Maon F, 2009, J BUS ETHICS, V87, P71, DOI 10.1007/s10551-008-9804-2; Auger P, 2007, J BUS ETHICS, V76, P361, DOI 10.1007/s10551-006-9287-y; Berger IE, 2007, CALIF MANAGE REV, V49, P132; Ellen PS, 2000, J RETAILING, V76, P393, DOI 10.1016/S0022-4359(00)00032-4; Auger P, 2003, J BUS ETHICS, V42, P281, DOI 10.1023/A:1022212816261; Pracejus JW, 2003, J ADVERTISING, V32, P19; Burke L, 1996, LONG RANGE PLANN, V29, P495, DOI 10.1016/0024-6301(96)00041-6; Chou TJ, 2004, J INT MARKETING, V12, P82, DOI 10.1509/jimk.12.1.82.25650; Maignan I, 2002, J INT BUS STUD, V33, P497, DOI 10.1057/palgrave.jibs.8491028; Barnett ML, 2007, ACAD MANAGE REV, V32, P794; van der Heijden A, 2010, J CLEAN PROD, V18, P1787, DOI 10.1016/j.jclepro.2010.07.024; Weick KE, 2005, ORGAN SCI, V16, P409, DOI 10.1287/orsc.1050.0133; Srinivasan R, 2005, INT J RES MARK, V22, P109, DOI 10.1016/j.ijresmar.2004.05.002; Halme M, 2009, J BUS ETHICS, V84, P325, DOI 10.1007/s10551-008-9712-5; Dowling G, 2012, CALIF MANAGE REV, V54, P25, DOI 10.1525/cmr.2012.54.2.25; Hoeffler S, 2010, J PUBLIC POLICY MARK, V29, P78; Du SL, 2007, INT J RES MARK, V24, P224, DOI 10.1016/j.ijresmar.2007.01.001; DUTTON JE, 1987, STRATEGIC MANAGE J, V8, P279, DOI 10.1002/smj.4250080306; Flatters P, 2009, HARVARD BUS REV, V87, P106; Hillman AJ, 2001, STRATEGIC MANAGE J, V22, P125, DOI 10.1002/1097-0266(200101)22:2<125::AID-SMJ150>3.0.CO;2-H; Luo XM, 2006, J MARKETING, V70, P1, DOI 10.1509/jmkg.70.4.1; Du SL, 2010, INT J MANAG REV, V12, P8, DOI 10.1111/j.1468-2370.2009.00276.x; Bhattacharya CB, 2004, CALIF MANAGE REV, V47, P9; Margolis JD, 2003, ADMIN SCI QUART, V48, P268, DOI 10.2307/3556659; JACKSON SE, 1988, ADMIN SCI QUART, V33, P370, DOI 10.2307/2392714; Strahilevitz M, 1998, J CONSUM RES, V24, P434, DOI 10.1086/209519; Basu K, 2008, ACAD MANAGE REV, V33, P122; Bertels S., 2008, CORPORATE REPUTATION, V11, P56, DOI DOI 10.1057/CRR.2008.1; Clifford S., 2011, NY TIMES; Cone Inc, 2009, CON CAUS EV STUD; Cone Inc, 2008, CON CAUS EV STUD; Cramer J., 2006, BUSINESS ETHICS EURO, V15, P380, DOI 10.1111/j.1467-8608.2006.00459.x; Crane A., 2000, J STRATEGIC MARKETIN, V8, P277, DOI DOI 10.1080/09652540050110011; Gardberg NA, 2006, ACAD MANAGE REV, V31, P329; Gioia D. A., 1991, STRATEGIC MANAGEMENT, V12, P443, DOI [10.1002/smj.4250120604, DOI 10.1002/SMJ.4250120604]; Haanaes K, 2011, MIT SLOAN MANAGE REV, V52, P23; Hazard Owen L, 2011, 11 MAGAZINE EXPOSURE; Holbrook Morris B., 2006, SERVICE DOMINANT LOG, P208; Holt D., 2010, SUSTAIN DEV, V20, P1; Hopkins MS, 2009, MIT SLOAN MANAGE REV, V50, P87; Hosmer DW, 2000, APPL LOGISTIC REGRES; Johnson L, 2009, FINANCIAL TIMES; KASSARJIAN HH, 1977, J CONSUM RES, V4, P8, DOI 10.1086/208674; KOLBE RH, 1991, J CONSUM RES, V18, P243, DOI 10.1086/209256; Lafferty B.A., 2009, J MARKETING THEORY P, V17, P129; Luchs M.G., 2010, J MARKETING, V74, P18; Morsig M., 2006, BUSINESS ETHICS EURO, V15, P323, DOI DOI 10.1111/J.1467-8608.2006.00460.X; Obermiller C., 2009, CORPORATE REPUTATION, V12, P159, DOI DOI 10.1057/CRR.2009.11; Pater A., 2006, BUSINESS ETHICS EURO, V15, P339; Peattie K., 2005, QUALITATIVE MARKET R, V8, P357, DOI DOI 10.1108/13522750510619733; Peloza J., 2012, CALIFORNIA IN PRESS; Peloza J, 2011, J ACAD MARKET SCI, V39, P117, DOI 10.1007/s11747-010-0213-6; Quelch J., 2008, MARKETING YOUR WAY R; Ring P.S., 1989, RES MANAGEMENT INNOV, P337; Sharma A., 1978, J MARKETING, V42, P43; Smith NC, 2003, CALIF MANAGE REV, V45, P52; Trudel R., 2009, SLOAN MANAGE REV, V50, P60; VARADARAJAN PR, 1988, J MARKETING, V52, P58, DOI 10.2307/1251450; WEBB E, 1979, ADMIN SCI QUART, V24, P650, DOI 10.2307/2392370; YALE L, 1988, J ADVERTISING, V17, P12	64	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0024-6301	1873-1872		LONG RANGE PLANN	Long Range Plan.	APR	2015	48	2			SI		108	122		10.1016/j.lrp.2014.07.004		15	Business; Management; Planning & Development	Business & Economics; Public Administration	CG9UI	WOS:000353665200005		
J	Hsu, YI; Masutani, K; Yamaoka, T; Kimura, Y				Hsu, Yu-I.; Masutani, Kazunari; Yamaoka, Tetsuji; Kimura, Yoshiharu			Tuning of Sol-Gel Transition in the Mixed Polymer Micelle Solutions of Copolymer Mixtures Consisting of Enantiomeric Diblock and Triblock Copolymers of Polylactide and Poly(ethylene glycol)	MACROMOLECULAR CHEMISTRY AND PHYSICS			English	Article						polylactide; poly(ethylene glycol); stereocomplexation; sol-gel transition	BLOCK-COPOLYMERS; PEG-PLLA; HYDROGELS; STEREOCOMPLEXATION; PDLA	Poly(ethylene glycol) (PEG) is partially furanylated with different feed ratios of furfuryl isocyanate and used as the macro initiator of ring-opening polymerization of l- and d-lactides to synthesize copolymer mixtures of furan-terminated AB diblock and ABA triblock copolymers (poly(oxyethylene)-poly(l-lactide)/poly(l-lactide)-poly(oxyethylene)-poly(l-lactide) and poly(oxyethylene-poly(d-lactide)/poly(d-lactide)-poly(oxyethylene)-poly-(d-lactide)) having different diblock/triblock ratios. The mixed micelle solutions of these enantiomeric copolymer mixtures undergo sol-to-gel or gel-to-sol transition depending on the diblock/triblock ratio of the copolymer mixtures. The rheological properties of the mixed micelle solutions could also be controlled by changing the diblock/triblock ratios or the initial furanylation ratio of PEG.	[Hsu, Yu-I.; Masutani, Kazunari; Kimura, Yoshiharu] Kyoto Inst Technol, Dept Biobased Mat Sci, Kyoto 6068585, Japan; [Yamaoka, Tetsuji] Natl Cerebral & Cardiovasc Ctr, Suita, Osaka 5658565, Japan	Kimura, Y (reprint author), Kyoto Inst Technol, Dept Biobased Mat Sci, Kyoto 6068585, Japan.	ykimura@kit.ac.jp					Hiemstra C, 2006, BIOMACROMOLECULES, V7, P2790, DOI 10.1021/bm060630e; Hsu YI, 2013, MACROMOL CHEM PHYS, V214, P1559, DOI 10.1002/macp.201300230; Ifkovits JL, 2007, TISSUE ENG, V13, P2369, DOI 10.1089/ten.2007.0093; Tian HY, 2012, PROG POLYM SCI, V37, P237, DOI 10.1016/j.progpolymsci.2011.06.004; Lasprilla AJR, 2012, BIOTECHNOL ADV, V30, P321, DOI 10.1016/j.biotechadv.2011.06.019; Fujiwara T, 2001, MACROMOL BIOSCI, V1, P204, DOI 10.1002/1616-5195(20010701)1:5<204::AID-MABI204>3.0.CO;2-H; Li Y, 2013, ANGEW CHEM INT EDIT, V52, P674, DOI 10.1002/anie.201206053; Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039; Armentano I, 2010, POLYM DEGRAD STABIL, V95, P2126, DOI 10.1016/j.polymdegradstab.2010.06.007; Hiemstra C, 2007, J AM CHEM SOC, V129, P9918, DOI 10.1021/ja072113p; Chen L, 2007, J NANOPART RES, V9, P777, DOI 10.1007/s11051-006-9103-8; Abebe DG, 2012, BIOMACROMOLECULES, V13, P1828, DOI 10.1021/bm300325v; Kim M, 2012, BIOMATERIALS, V33, P668, DOI 10.1016/j.biomaterials.2011.09.074; Fujiwara T, 2000, J POLYM SCI POL CHEM, V38, P2405, DOI 10.1002/1099-0518(20000701)38:13<2405::AID-POLA130>3.0.CO;2-A; Jun YJ, 2008, MACROMOL RES, V16, P704; Lee CW, 2012, MACROMOL CHEM PHYS, V213, P2174, DOI 10.1002/macp.201200375; Nagahama K, 2008, ADV FUNCT MATER, V18, P1220, DOI 10.1002/adfm.200700587; Nouailhas H, 2011, J APPL POLYM SCI, V122, P1599, DOI 10.1002/app.33896; Ulery BD, 2011, J POLYM SCI POL PHYS, V49, P832, DOI 10.1002/polb.22259; Zhang J., 2005, MACROMOLECULES, V38, P1882	20	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1022-1352	1521-3935		MACROMOL CHEM PHYS	Macromol. Chem. Phys.	APR	2015	216	8					837	846		10.1002/macp.201400581		10	Polymer Science	Polymer Science	CH3FX	WOS:000353915300003		
J	Namba, T; Kodama, R				Namba, Takushi; Kodama, Rika			Avarol Induces Apoptosis in Pancreatic Ductal Adenocarcinoma Cells by Activating PERK-eIF2 alpha-CHOP Signaling	MARINE DRUGS			English	Article							ENDOPLASMIC-RETICULUM-STRESS; UNFOLDED PROTEIN RESPONSE; GLUCOSE-REGULATED PROTEINS; ER STRESS; CARCINOMA-CELLS; CANCER; CHOP; INDUCTION; KINASE; MITOCHONDRIA	Avarol is a sesquiterpenoid hydroquinone with potent cytotoxicity. Although resolving endoplasmic reticulum (ER) stress is essential for intracellular homeostasis, erratic or excessive ER stress can lead to apoptosis. Here, we reported that avarol selectively induces cell death in pancreatic ductal adenocarcinomas (PDAC), which are difficult to treat owing to the availability of few chemotherapeutic agents. Analyses of the molecular mechanisms of avarol-induced apoptosis indicated upregulation of ER stress marker BiP and ER stress-dependent apoptosis inducer CHOP in PDAC cells but not in normal cells, suggesting that avarol selectively induces ER stress responses. We also showed that avarol activated the PERK-eIF2 alpha pathway but did not affect the IRE1 and ATF6 pathways. Moreover, CHOP downregulation was significantly suppressed by avarol-induced apoptosis. Thus, the PERK-eIF2 alpha-CHOP signaling pathway may be a novel molecular mechanism of avarol-induced apoptosis. The present data indicate that avarol has potential as a chemotherapeutic agent for PDAC and induces apoptosis by activating the PERK-eIF2 alpha pathway.	[Namba, Takushi; Kodama, Rika] Kochi Univ, Ctr Sci Res, Nankoku, Kochi 7838505, Japan	Namba, T (reprint author), Kochi Univ, Ctr Sci Res, Oko Cho, Nankoku, Kochi 7838505, Japan.	t-namba@kochi-u.ac.jp; jm-kodamar@kochi-u.ac.jp			Japan Science and Technology agency; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research and Technology Agency; Uehara Memorial Foundation; Japan Society for the Promotion of Science	This work was partially supported by Grants-in-Aid from the Japan Science and Technology agency, Takeda Science Foundation, Mochida Memorial Foundation for Medical and Pharmaceutical Research and Technology Agency, Uehara Memorial Foundation and the Japan Society for the Promotion of Science.	KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Koong AC, 2000, INT J RADIAT ONCOL, V48, P919, DOI 10.1016/S0360-3016(00)00803-8; Lennon AM, 2014, CANCER RES, V74, P3381, DOI 10.1158/0008-5472.CAN-14-0734; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Gotoh T, 2002, J BIOL CHEM, V277, P12343, DOI 10.1074/jbc.M107988200; Rahmani M, 2007, MOL CELL BIOL, V27, P5499, DOI 10.1128/MCB.01080-06; Kim KM, 2007, CIRC RES, V101, P919, DOI 10.1161/CIRCRESAHA.107.154781; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Nawrocki ST, 2005, CANCER RES, V65, P11510, DOI 10.1158/0008-5472.CAN-05-2394; SARIN PS, 1987, J NATL CANCER I, V78, P663; Hetz C, 2013, NAT REV DRUG DISCOV, V12, P703, DOI 10.1038/nrd3976; Amigo M, 2008, LIFE SCI, V82, P256, DOI 10.1016/j.lfs.2007.11.017; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Kinoshita E, 2009, NAT PROTOC, V4, P1513, DOI 10.1038/nprot.2009.154; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Gotoh T, 2004, CELL DEATH DIFFER, V11, P390, DOI 10.1038/sj.cdd.4401369; MULLER WEG, 1987, CANCER RES, V47, P6565; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Namba T, 2013, CELL REP, V5, P331, DOI 10.1016/j.celrep.2013.09.020; Burris HA, 1997, J CLIN ONCOL, V15, P2403; CARIELLO L, 1982, COMP BIOCHEM PHYS B, V71, P281, DOI 10.1016/0305-0491(82)90254-1; Lee DY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010489; Namba T, 2010, J BIOL CHEM, V285, P37302, DOI 10.1074/jbc.M110.148882; Namba T, 2007, MOL PHARMACOL, V71, P860, DOI 10.1124/mol.106.027698; Xu WP, 2011, CANCER CELL, V20, P281, DOI 10.1016/j.ccr.2011.08.020	33	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1660-3397			MAR DRUGS	Mar. Drugs	APR	2015	13	4					2376	2389		10.3390/md13042376		14	Chemistry, Medicinal	Pharmacology & Pharmacy	CH0NA	WOS:000353715900040		
J	Tanida, Y; Ueno, T; Ralph, MAL; Saito, S				Tanida, Yuki; Ueno, Taiji; Ralph, Matthew A. Lambon; Saito, Satoru			The roles of long-term phonotactic and lexical prosodic knowledge in phonological short-term memory	MEMORY & COGNITION			English	Article						Working memory; Short-term memory; Phonotactic knowledge; Lexical prosodic knowledge; Nonwords	PROCESSING TREE MODEL; WORKING-MEMORY; SERIAL-RECALL; WORD; LANGUAGE; REPETITION; REDINTEGRATION; FREQUENCY; CHILDREN; APHASIA	Many previous studies have explored and confirmed the influence of long-term phonological representations on phonological short-term memory. In most investigations, phonological effects have been explored with respect to phonotactic constraints or frequency. If interaction between long-term memory and phonological short-term memory is a generalized principle, then other phonological characteristics-that is, suprasegmental aspects of phonology-should also exert similar effects on phonological short-term memory. We explored this hypothesis through three immediate serial-recall experiments that manipulated Japanese nonwords with respect to lexical prosody (pitch-accent type, reflecting suprasegmental characteristics) as well as phonotactic frequency (reflecting segmental characteristics). The results showed that phonotactic frequency affected the retention not only of the phonemic sequences, but also of pitch-accent patterns, when participants were instructed to recall both the phoneme sequence and accent pattern of nonwords. In addition, accent pattern typicality influenced the retention of the accent pattern: Typical accent patterns were recalled more accurately than atypical ones. These results indicate that both long-term phonotactic and lexical prosodic knowledge contribute to phonological short-term memory performance.	[Tanida, Yuki; Saito, Satoru] Kyoto Univ, Dept Cognit Psychol Educ, Grad Sch Educ, Sakyo Ku, Kyoto 6068501, Japan; [Ueno, Taiji] Japan Soc Promot Sci, Tokyo, Japan; [Ueno, Taiji] Univ York, York YO10 5DD, N Yorkshire, England; [Ralph, Matthew A. Lambon] Univ Manchester, Manchester, Lancs, England	Tanida, Y (reprint author), Kyoto Univ, Dept Cognit Psychol Educ, Grad Sch Educ, Sakyo Ku, Yoshida Honmachi, Kyoto 6068501, Japan.	tanida.yuki.54x@st.kyoto-u.ac.jp; ssaito@educ.kyoto-u.ac.jp	Lambon Ralph, Matthew/A-1695-2009	Lambon Ralph, Matthew/0000-0001-5907-2488	Ministry of Education, Culture, Sports, Science, and Technology in Japan [22530794];  [12J05341]	This work was supported by Grant-in-Aid for JSPS Fellows (No. 12J05341) to Y.T. and by a Grant-in-Aid for Scientific Research (No. 22530794) from the Ministry of Education, Culture, Sports, Science, and Technology in Japan to S.S.	Ueno T, 2014, J COGNITIVE NEUROSCI, V26, P433, DOI 10.1162/jocn_a_00467; HULME C, 1991, J MEM LANG, V30, P685, DOI 10.1016/0749-596X(91)90032-F; Gathercole SE, 1999, J EXP PSYCHOL LEARN, V25, P84, DOI 10.1037//0278-7393.25.1.84; Thorn ASC, 2005, J EXP PSYCHOL LEARN, V31, P729, DOI 10.1037/0278-7393.31.4.729; Otake T, 1999, J PHONETICS, V27, P229, DOI 10.1006/jpho.1999.0095; Jefferies E, 2006, J MEM LANG, V54, P81, DOI 10.1016/j.jml.2005.08.001; Botvinick MM, 2006, PSYCHOL REV, V113, P201, DOI 10.1037/0033-295X.113.2.201; Allen R, 2006, J MEM LANG, V55, P64, DOI 10.1016/j.jml.2006.02.002; Tamaoka K, 2004, BEHAV RES METH INS C, V36, P531, DOI 10.3758/BF03195600; Chiat S, 2007, J SPEECH LANG HEAR R, V50, P429, DOI 10.1044/1092-4388(2007/030); Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Roy P, 2004, J SPEECH LANG HEAR R, V47, P223, DOI 10.1044/1092-4388(2004/019); Sekiguchi T, 1999, J PSYCHOLINGUIST RES, V28, P439, DOI 10.1023/A:1023245216726; Ueno T, 2011, NEURON, V72, P385, DOI 10.1016/j.neuron.2011.09.013; Gupta P, 2009, PHILOS T R SOC B, V364, P3755, DOI 10.1098/rstb.2009.0132; SEIDENBERG MS, 1989, PSYCHOL REV, V96, P523, DOI 10.1037/0033-295X.96.4.523; PATTERSON K, 1994, J COGNITIVE NEUROSCI, V6, P57, DOI 10.1162/jocn.1994.6.1.57; Thorn ASC, 2005, COGNITIVE PSYCHOL, V50, P133, DOI 10.1016/j.cogpsych.2004.07.001; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A. D., 1974, PSYCHOL LEARN MOTIV, V8, P47, DOI DOI 10.1016/S0079-7421(08)60452-1; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; de Bree E, 2007, BRAIN LANG, V103, P264, DOI 10.1016/j.bandl.2007.07.003; Gupta P, 2009, J MEM LANG, V61, P481, DOI 10.1016/j.jml.2009.08.001; Minematsu N., 1995, Journal of the Acoustical Society of Japan (E), V16; Kindaichi H., 2001, NEW CLEAR JAPANESE A; Kondo T., 2000, LEXICAL PROPERTIES J, V2; Kondo T., 1999, LEXICAL PROPERTIES J, V1; Kubozono H., 1995, WORD FORMATION PHONO; McQueen JM, 2001, J MEM LANG, V45, P103, DOI 10.1006/jmla.2000.2763; Roodenrys S, 2002, J EXP PSYCHOL LEARN, V28, P1019, DOI 10.1037//0278-7393.28.6.1019; Sakono S., 2011, ASIA PACIFIC J SPEEC, V14, P51; Sato H., 1993, Journal of the Acoustical Society of Japan, V49; SCHWEICKERT R, 1993, MEM COGNITION, V21, P168, DOI 10.3758/BF03202729; Sekiguchi T, 2006, J PSYCHOLINGUIST RES, V35, P369, DOI 10.1007/s10936-006-9020-0; Thorn ASC, 2009, INTERACTIONS BETWEEN SHORT-TERM AND LONG-TERM MEMORY IN THE VERBAL DOMAIN, P198; Ueno T., 2012, THESIS U MANCHESTER; Yuzawa Miki, 2002, Shinrigaku Kenkyu, V73, P258	37	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-502X	1532-5946		MEM COGNITION	Mem. Cogn.	APR	2015	43	3			SI		500	519		10.3758/s13421-014-0482-2		20	Psychology, Experimental	Psychology	CH1XF	WOS:000353815500015		
J	Kaminaga, M; Ishida, T; Kadonosono, T; Kizaka-Kondoh, S; Omata, T				Kaminaga, Maho; Ishida, Tadashi; Kadonosono, Tetsuya; Kizaka-Kondoh, Shinae; Omata, Toru			Uniform Cell Distribution Achieved by Using Cell Deformation in a Micropillar Array	MICROMACHINES			English	Article							GROWTH-FACTOR RECEPTORS; MICROFLUIDIC CHANNELS; SEEDING DENSITY; NANOLITER SCALE; EXPRESSION; SCAFFOLDS; SYSTEM	The uniform dispersion of cells in a microchamber is important to reproduce results in cellular research. However, achieving this is difficult owing to the laminar flow caused by the small dimensions of such a chamber. In this study, we propose a technique to achieve a uniform distribution of cells using a micropillar array inside a microchamber. The cells deform when they pass through a gap between the micropillars. The deformation causes a repetitive clog-and-release process of cells at the gaps between the micropillars. The micropillar array generates random flow inside the microchamber, resulting in the uniform distribution of the cells via cell accumulation. In the experiment, the distribution of cells in the microchamber with the micropillar array is uniform from end to end, whereas that in the microchamber without the micropillar array is centered. The deviation of the cell distribution from the ideally uniform distribution in the microchamber with the micropillar array is suppressed by 63% compared with that in the microchamber without the micropillar array. The doubling time of the cells passed through the micropillar array did not change relative to that of normal N87 cells. This technique will be helpful for reproducing results in cellular research at the micro scale or for those using microfluidic devices.	[Kaminaga, Maho; Ishida, Tadashi; Omata, Toru] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Mechanomicro Engn, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Kadonosono, Tetsuya; Kizaka-Kondoh, Shinae] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biomol Engn, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Kaminaga, M (reprint author), Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Mechanomicro Engn, Midori Ku, G5-27,4259 Nagatsutacho, Yokohama, Kanagawa 2268503, Japan.	kaminaga.m.ab@m.titech.ac.jp; ishida.t.ai@m.titech.ac.jp; tetsuyak@bio.titech.ac.jp; skondoh@bio.titech.ac.jp; omata.t.aa@m.titech.ac.jp			Solutions Research Laboratory of the Tokyo Institute of Technology	This work was supported by the Solutions Research Laboratory of the Tokyo Institute of Technology.	Altman Greg, 2002, FASEB Journal, V16, P270; BENZEEV A, 1988, P NATL ACAD SCI USA, V85, P2161, DOI 10.1073/pnas.85.7.2161; Lee PJ, 2006, BIOTECHNOL BIOENG, V94, P5, DOI 10.1002/bit.20745; Vunjak-Novakovic G, 2004, ANNU REV BIOMED ENG, V6, P131, DOI 10.1146/annurev.bioeng.6.040803.140037; Kim K, 2009, BIOMACROMOLECULES, V10, P1810, DOI 10.1021/bm900240k; Andersson H, 2003, SENSOR ACTUAT B-CHEM, V92, P315, DOI 10.1016/S0925-4005(03)00266-1; Ross AM, 2012, SMALL, V8, P336, DOI 10.1002/smll.201100934; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Nilsson J, 2009, ANAL CHIM ACTA, V649, P141, DOI 10.1016/j.aca.2009.07.017; Yin HB, 2012, CURR OPIN BIOTECH, V23, P110, DOI 10.1016/j.copbio.2011.11.002; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Ges IA, 2013, LAB CHIP, V13, P4663, DOI 10.1039/c3lc50779c; Squires TM, 2005, REV MOD PHYS, V77, P977, DOI 10.1103/RevModPhys.77.977; Kim SM, 2008, LAB CHIP, V8, P1015, DOI 10.1039/b800835c; Gonzalez-Macia L, 2010, ANALYST, V135, P845, DOI 10.1039/b916888e; Khademhosseini A, 2004, ANAL CHEM, V76, P3675, DOI 10.1021/ac035415s; Zervantonakis IK, 2012, P NATL ACAD SCI USA, V109, P13515, DOI 10.1073/pnas.1210182109; Dar A, 2002, BIOTECHNOL BIOENG, V80, P305, DOI 10.1002/bit.10372; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Melchels FPW, 2010, ACTA BIOMATER, V6, P4208, DOI 10.1016/j.actbio.2010.06.012; ALDRIDGE J, 1976, NATURE, V259, P670, DOI 10.1038/259670a0; Wang ZH, 2007, LAB CHIP, V7, P740, DOI 10.1039/b618734j; Brammer KS, 2011, ACTA BIOMATER, V7, P683, DOI 10.1016/j.actbio.2010.09.022; Rozkiewicz DI, 2006, CHEM-EUR J, V12, P6290, DOI 10.1002/chem.200501554; Hui TY, 2008, BIOMATERIALS, V29, P3201, DOI 10.1016/j.biomaterials.2008.04.001; Chen X., 2013, IEEE ENG MED BIOL SO, V2013, P6228; Gage BK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082076; KUSZYNSKI CA, 1993, IN VITRO CELL DEV-AN, V29, P708; LICHTNER RB, 1990, J CELL PHYSIOL, V144, P303, DOI 10.1002/jcp.1041440217; Ma Q., 2010, J BIOMED BIOTECHNOL, V2010, DOI [10.1155/2010/38654520625484, DOI 10.1155/2010/38654520625484]; PARK JG, 1990, CANCER RES, V50, P2773; Tan WH, 2007, P NATL ACAD SCI USA, V104, P1146, DOI 10.1073/pnas.0606625104; Wang L, 2013, LAB CHIP, V13, P695, DOI 10.1039/c2lc40661f	33	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2072-666X			MICROMACHINES-BASEL	Micromachines	APR	2015	6	4					409	422		10.3390/mi6040409		14	Nanoscience & Nanotechnology; Instruments & Instrumentation	Science & Technology - Other Topics; Instruments & Instrumentation	CH1JI	WOS:000353777200001		
J	Dai, XY; Ahn, KS; Kim, C; Siveen, KS; Ong, TH; Shanmugam, MK; Li, F; Shi, JZ; Kumar, AP; Wang, LZ; Goh, BC; Magae, J; Hui, KM; Sethi, G				Dai, Xiaoyun; Ahn, Kwang Seok; Kim, Chulwon; Siveen, Kodappully Sivaraman; Ong, Tina H.; Shanmugam, Muthu K.; Li, Feng; Shi, Jizhong; Kumar, Alan Prem; Wang, Ling Zhi; Goh, Boon Cher; Magae, Junji; Hui, Kam M.; Sethi, Gautam			Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3	MOLECULAR ONCOLOGY			English	Article						Ascochlorin; HCC; STAT3; PIAS3; Invasion; Orthotopic model	CONSTITUTIVE ACTIVATION; CANCER-CELLS; TRANSCRIPTIONAL CONTROL; MYELOMA CELLS; IN-VITRO; C-MYC; INFLAMMATION; APOPTOSIS; PATHWAY; PROLIFERATION	Deregulated activation of oncogenic transcription factors such as signal transducer and activator of transcription 3 (STAT3) plays a pivotal role in proliferation and survival of hepatocellular carcinoma (HCC). Thus, agents which can inhibit STAT3 activation may have an enormous potential for treatment of HCC patients. Hence, in the present report, we investigated the effect of ascochlorin (ASC), an isoprenoid antibiotic on STAT3 activation cascade in various HCC cell lines and orthotopic mouse model. We observed that ASC could substantially inhibit both constitutive and IL-6/EGF inducible STAT3 activation as well as reduce its DNA binding ability. ASC increased the expression of protein inhibitor of activated STAT3 (PIAS3) which could bind to STAT3 DNA binding domain and thereby down-regulate STAT3 activation. Deletion of PIAS3 gene by siRNA abolished the ability of ASC to inhibit STAT3 activation and induce apoptosis in HCC cells. ASC also modulated the expression of diverse STAT3-regulated oncogenic gene products. Finally, when administered intraperitoneally, ASC also inhibited tumor growth in an orthotopic HCC mouse model and reduced STAT3 activation in tumor tissues. Overall our results indicate that ASC mediates its anti-tumor effects predominantly through the suppression of STAT3 signaling cascade, and can form the basis of novel therapy for HCC patients. (C) 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.	[Dai, Xiaoyun; Siveen, Kodappully Sivaraman; Shanmugam, Muthu K.; Li, Feng; Shi, Jizhong; Kumar, Alan Prem; Wang, Ling Zhi; Goh, Boon Cher; Sethi, Gautam] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117597, Singapore; [Ahn, Kwang Seok; Kim, Chulwon] Kyung Hee Univ, Coll Oriental Med, Seoul 130701, South Korea; [Ong, Tina H.; Hui, Kam M.] Natl Canc Ctr, Humphrey Oei Inst Canc Res, Div Cellular & Mol Res, Singapore 169610, Singapore; [Shi, Jizhong; Kumar, Alan Prem; Wang, Ling Zhi; Goh, Boon Cher] Canc Sci Inst Singapore, Ctr Translat Med, Singapore 117599, Singapore; [Kumar, Alan Prem; Sethi, Gautam] Curtin Univ, Fac Hlth Sci, Sch Biomed Sci, Bentley, WA 6009, Australia; [Kumar, Alan Prem] Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA; [Goh, Boon Cher] Natl Univ Hlth Syst, Dept Hematol Oncol, Singapore 117597, Singapore; [Magae, Junji] Magae Biosci Inst, Tsukuba, Ibaraki 3001263, Japan; [Hui, Kam M.] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore; [Hui, Kam M.] Duke Natl Univ Singapore, Canc & Stem Cell Biol Program, Grad Sch Med, Singapore, Singapore; [Hui, Kam M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore	Sethi, G (reprint author), Natl Univ Singapore, Canc Sci Inst, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117597, Singapore.	cmrhkm@nccs.com.sg; phcgs@nus.edu.sg	ASTAR, IMCB/E-2320-2012		Singapore Ministry of Health's National Medical Research Council; National Medical Research Council of Singapore; Biomedical Research Council of Singapore; Singapore Millennium Foundation; Korea Science and Engineering Foundation (KOSEF) - Korean Ministry of Education, Science and Technology (MoEST) [2011-0006220]; Singapore Ministry of Education Tier 2 [MOE2012-T2-2-139]; NUHS Bench-to-Bedside-To-Product [R-184-000-243-515]; Cancer Science Institute of Singapore, Experimental Therapeutics I Program [R-713-001-011-271]	This research work was supported by grants from Singapore Ministry of Health's National Medical Research Council to GS under its Individual research grants funding scheme. KMH was supported by grant from the National Medical Research Council of Singapore, Biomedical Research Council of Singapore, and the Singapore Millennium Foundation. KSA was supported by the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korean Ministry of Education, Science and Technology (MoEST) (No. 2011-0006220). This work was also supported by grants from the Singapore Ministry of Education Tier 2 [MOE2012-T2-2-139], NUHS Bench-to-Bedside-To-Product [R-184-000-243-515] and Cancer Science Institute of Singapore, Experimental Therapeutics I Program [R-713-001-011-271] to APK.	Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Rajendran P, 2011, CLIN CANCER RES, V17, P1425, DOI 10.1158/1078-0432.CCR-10-1123; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Rahaman SO, 2002, ONCOGENE, V21, P8404, DOI 10.1038/sj.onc.1206047; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Fan TJ, 2005, ACTA BIOCH BIOPH SIN, V37, P719, DOI 10.1111/j.1745-7270.2005.00108.x; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Calvisi DF, 2006, GASTROENTEROLOGY, V130, P1117, DOI 10.1053/j.gastro.2006.01.006; Jeong JH, 2012, J CELL BIOCHEM, V113, P1302, DOI 10.1002/jcb.24001; Zhang Q, 2002, J IMMUNOL, V168, P466; Siveen KS, 2014, BBA-REV CANCER, V1845, P136, DOI 10.1016/j.bbcan.2013.12.005; Sun BC, 2012, J HEPATOL, V56, P704, DOI 10.1016/j.jhep.2011.09.020; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20020407; Mora LB, 2002, CANCER RES, V62, P6659; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Johnston PA, 2011, MOL INTERV, V11, P18, DOI 10.1124/mi.11.1.4; Turkson J, 2004, MOL CANCER THER, V3, P261; Shuai K, 2000, ONCOGENE, V19, P2638, DOI 10.1038/sj.onc.1203522; Hong S, 2005, J BIOL CHEM, V280, P25202, DOI 10.1074/jbc.M413985200; Subramaniam A, 2013, BBA-REV CANCER, V1835, P46, DOI 10.1016/j.bbcan.2012.10.002; Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Sun S, 2002, J GEN VIROL, V83, P1651; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Huang C, 2006, CANCER SCI, V97, P1417, DOI 10.1111/j.1349-7006.2006.00340.x; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Turkson J, 2001, J BIOL CHEM, V276, P45443, DOI 10.1074/jbc.M107527200; Jeong JH, 2010, BIOCHEM BIOPH RES CO, V398, P68, DOI 10.1016/j.bbrc.2010.06.037; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183; Kiuchi N, 1999, J EXP MED, V189, P63, DOI 10.1084/jem.189.1.63; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Thomas MB, 2005, J CLIN ONCOL, V23, P2892, DOI 10.1200/JCO.2005.03.196; HOSOKAWA T, 1985, DIABETES, V34, P267, DOI 10.2337/diabetes.34.3.267; HOSOKAWA T, 1981, LIPIDS, V16, P433, DOI 10.1007/BF02535011; Jeong JH, 2009, INT J CANCER, V124, P2797, DOI 10.1002/ijc.24259; Kang J.H., 2012, J BIOL CHEM, V287, P15661; Liu LM, 2011, CLIN RES HEPATOL GAS, V35, P393, DOI 10.1016/j.clinre.2010.12.002; MAGAE J, 1986, CANCER RES, V46, P1073; Manu KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057015; Nam D, 2014, J MED FOOD, V17, P365, DOI 10.1089/jmf.2012.2628; Ramachandran L, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.388702; Saydmohammed M, 2010, J CELL BIOCHEM, V110, P447, DOI 10.1002/jcb.22558; Shanmugam MK, 2014, MOL CARCINOG; Subramaniam A, 2013, BRIT J PHARMACOL, V170, P807, DOI 10.1111/bph.12302; Svinka J., 2014, HEPATIC ONCOL, V1, P107, DOI DOI 10.2217/HEP.13.7; TAMURA G, 1968, J ANTIBIOT, V21, P539	48	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1574-7891	1878-0261		MOL ONCOL	Mol. Oncol.	APR	2015	9	4					818	833		10.1016/j.molonc.2014.12.008		16	Oncology	Oncology	CH0TK	WOS:000353735100007		
J	Yamamura, E; Muto, S; Yamada, K; Sato, Y; Iwase, Y; Uno, Y				Yamamura, Eiji; Muto, Shigeharu; Yamada, Katsuya; Sato, Yuko; Iwase, Yumiko; Uno, Yoshifumi			Chromosomal damage and micronucleus induction by MP-124, a novel poly(ADP-ribose) polymerase-1 (PARP-1) inhibitor: Evidence for a non-DNA-reactive mode of action	MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS			English	Article						Genotoxicity; Mode of action; Chromosomal damage; Micronucleus induction; Nicotinic acid	CEREBRAL-ISCHEMIA; CELL-DEATH; IN-VITRO; REPAIR; GENOTOXICITY; HOMOLOGY; VIVO	MP-124, a novel poly(ADP-ribose) polymerase-1 (PARP-1) inhibitor that competes with the binding of the PARP substrate nicotinamide adenine dinucleotide (NAD), is being developed as a neuroprotective agent against acute ischemic stroke. MP-124 increased structural chromosomal aberration in CHL/IU cells, but showed negative results in the bacterial reverse mutation test, and the rat bone marrow micronucleus (MN) and the rat liver unscheduled DNA synthesis tests after the intravenous bolus injection. Thus, MP-124 did not appear to be direct-acting mutagen. Since, PARP-1 is a key enzyme in DNA repair, the effect of continuous PARP-1 inhibition by MP-124 was further examined in the rat MN test under 24-h intravenous infusion, and an increase in micronucleated immature erythrocytes (MNIE) was observed. The increase was clearly reduced by co-treatment with nicotinic acid, which resulted in increased intracellular NAD levels. This is consistent with the established activity of MP-124 as a competitive inhibitor of PARP and provides strong evidence that the DNA-damaging effect that leads to the increase in MNIE is a secondary effect of PARP-1 inhibition. This mechanism is expected to result in a threshold for the induction of MNIE by MP-124, and allows for the establishment of a safe margin of exposure for the therapeutic use of MP-124. (C) 2015 Elsevier B.V. All rights reserved.	[Yamamura, Eiji; Muto, Shigeharu; Yamada, Katsuya; Sato, Yuko; Iwase, Yumiko; Uno, Yoshifumi] Mitsubishi Tanabe Pharma Corp, Div Res, Safety Res Labs, Kisarazu, Chiba 2920818, Japan	Yamamura, E (reprint author), Mitsubishi Tanabe Pharma Corp, Div Res, Safety Res Labs, 1-1-1 Kazusakamatari, Kisarazu, Chiba 2920818, Japan.	Yamamura.Eiji@md.mt-pharma.co.jp					Kirkland DJ, 2007, MUTAGENESIS, V22, P161, DOI 10.1093/mutage/gem006; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; [Anonymous], 2006, GUID IND REV STAFF R; Herceg Z, 2001, MUTAT RES-FUND MOL M, V477, P97, DOI 10.1016/S0027-5107(01)00111-7; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; [Anonymous], OECD GUIDELINE FOR THE TESTING OF CHEMICALS, V486, Patent No. [2004031171, WO2004/031171]; Matsuura S, 2011, BRAIN RES, V1410, P122, DOI 10.1016/j.brainres.2011.05.069; Ruf A, 1998, BIOCHEMISTRY-US, V37, P3893, DOI 10.1021/bi972383s; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Szabo C, 1998, TRENDS PHARMACOL SCI, V19, P287, DOI 10.1016/S0165-6147(98)01193-6; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; BUTTERWORTH BE, 1987, MUTAT RES, V189, P123, DOI 10.1016/0165-1218(87)90018-8; Tong WM, 2001, BBA-REV CANCER, V1552, P27, DOI 10.1016/S0304-419X(01)00035-X; LINDAHL T, 1995, TRENDS BIOCHEM SCI, V20, P405, DOI 10.1016/S0968-0004(00)89089-1; KASTENBA.MA, 1970, MUTAT RES, V9, P527, DOI 10.1016/0027-5107(70)90038-2; Egi Y, 2011, BRAIN RES, V1389, P169, DOI 10.1016/j.brainres.2011.03.031; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; Endres M, 1997, J CEREBR BLOOD F MET, V17, P1143, DOI 10.1097/00004647-199711000-00002; International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, 1995, GEN GUID SPEC ASP RE; International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, 1997, GEN STAND BATT GEN T; International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use ICH Harmonised Tripartite Guideline, 2011, GUID GEN TEST DAT IN; Kirkland James B, 2012, Subcell Biochem, V56, P21, DOI 10.1007/978-94-007-2199-9_2; Lynch A, 2003, MUTAGENESIS, V18, P345, DOI 10.1093/mutage/geg003; MIRSALIS JC, 1989, ENVIRON MOL MUTAGEN, V14, P155, DOI 10.1002/em.2850140305; Nguewa PA, 2005, PROG BIOPHYS MOL BIO, V88, P143, DOI 10.1016/j.pbiomolbio.2004.01.001; NISSELBA.JS, 1969, ANAL BIOCHEM, V27, P212, DOI 10.1016/0003-2697(69)90025-6; Nohmi T., 2008, GENES ENV, V30, P108; Rhun Y.L., 1998, BIOCHEM BIOPH RES CO, V245, P1, DOI 10.1006/bbrc.1998.8257; SCOTT D, 1991, MUTAT RES, V257, P147, DOI 10.1016/0165-1110(91)90024-P; Spronck JC, 2002, MUTAT RES-FUND MOL M, V508, P83, DOI 10.1016/S0027-5107(02)00188-4; Thybaud V, 2011, MUTAT RES-GEN TOX EN, V723, P121, DOI 10.1016/j.mrgentox.2010.09.002	31	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1383-5718	1879-3592		MUTAT RES-GEN TOX EN	Mutat. Res. Genet. Toxicol. Environ. Mutagen.	APR	2015	782						1	8		10.1016/j.mrgentox.2015.02.006		8	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	CH0XW	WOS:000353746700001		
J	Itoh, S; Igarashi, M; Nagata, M; Hattori, C				Itoh, Satoru; Igarashi, Miyuki; Nagata, Mayumi; Hattori, Chiharu			Assessment of a twice dosing regimen both before and after partial hepatectomy in the rat liver micronucleus test	MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS			English	Article						Liver; Micronucleus test; Structural chromosome aberration; Numerical chromosome aberration; Partial hepatectomy	CHROMOSOME-ABERRATION INDUCERS; CHEMICALS	The liver micronucleus test is an important method to detect in vivo genotoxicants, especially those that require metabolic activation for their genotoxicity. We have already reported that structural or numerical chromosome aberration inducers have to be given before or after partial hepatectomy, respectively, to detect their genotoxicity in the liver of rats. In the present study, we assessed a twice dosing regimen, in which the genotoxicant is dosed both before and after partial hepatectomy, using the four chromosome aberration inducers used in the previous study. Two structural chromosome aberration inducers (diethylnitrosamine and 1,2-dimethylhydrazine) and two numerical chromosome aberration inducers (colchicine and carbendazim) were used. The genotoxicant was administered to 8-week old male F344 rats one day before and again one day after the partial hepatectomy and hepatocytes were isolated 3 days after second dosing (4 days after the partial hepatectomy). As a result, all genotoxicants (structural or numerical chromosome aberration inducers) caused a dose-dependent statistically significant increase in the incidence of micronucleated hepatocytes when given both before and after partial hepatectomy. No marked difference was observed in general toxicity, relative liver weight and cell classification between single dosing regimens and twice dosing regimen of the genotoxicants. These results confirm that the twice dosing regimen, in which the test compound is dosed both before and after partial hepatectomy, can detect in vivo induction of micronucleated hepatocytes by structural or numerical chromosome aberration inducers qualitatively similar to their appropriate regimen in which the test compound is administered either before or after partial hepatectomy. (C) 2015 Elsevier B.V. All rights reserved.	[Itoh, Satoru; Igarashi, Miyuki; Nagata, Mayumi; Hattori, Chiharu] Daiichi Sankyo Co Ltd, Med Safety Res Labs, Edogawa Ku, Tokyo 1348630, Japan	Itoh, S (reprint author), Daiichi Sankyo Co Ltd, Med Safety Res Labs, Edogawa Ku, 1-16-13 Kitakasai, Tokyo 1348630, Japan.	itoh.satoru.n5@daiichisankyo.co.jp					Kirsch-Volders M, 2002, MUTAT RES-FUND MOL M, V504, P137, DOI 10.1016/S0027-5107(02)00087-8; Matsuoka A, 1999, MUTAGENESIS, V14, P385, DOI 10.1093/mutage/14.4.385; TATES AD, 1980, MUTAT RES, V74, P11, DOI 10.1016/0165-1161(80)90187-9; Parry EM, 2002, MUTAGENESIS, V17, P509, DOI 10.1093/mutage/17.6.509; Igarashi M, 1997, MUTAT RES-GEN TOX EN, V391, P49, DOI 10.1016/S0165-1218(97)00031-1; Hamada Chikuma, 1998, Journal of Toxicological Sciences, V23, P173; Igarashi M, 2007, MUTAT RES-GEN TOX EN, V632, P89, DOI 10.1016/j.mrgentox.2007.04.012; Itoh S, 2012, MUTAT RES-GEN TOX EN, V747, P98, DOI 10.1016/j.mrgentox.2012.04.007; Itoh S, 2015, J TOXICOL SCI, V40, P109, DOI 10.2131/jts.40.109; Matsuoka A., 1993, MUTAT RES, V272, P223; Tates A.D., 1987, EVALUATION SHORT TER, P1400	11	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1383-5718	1879-3592		MUTAT RES-GEN TOX EN	Mutat. Res. Genet. Toxicol. Environ. Mutagen.	APR	2015	782						18	23		10.1016/j.mrgentox.2015.03.008		6	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	CH0XW	WOS:000353746700003		
J	Kobayashi, J; Saito, Y; Okui, M; Miwa, N; Komatsu, K				Kobayashi, Junya; Saito, Yuichiro; Okui, Michiyo; Miwa, Noriko; Komatsu, Kenshi			Increased oxidative stress in AOA3 cells disturbs ATM-dependent DNA damage responses	MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS			English	Article						ATM; AOA3; Oxidative stress; Cell cycle checkpoint; Homologous recombination	OCULAR MOTOR APRAXIA; STRAND BREAK REPAIR; NEURAL STEM-CELLS; ATAXIA-TELANGIECTASIA; HOMOLOGOUS RECOMBINATION; PROTEIN APRATAXIN; DEFICIENT MICE; HISTONE H2AX; ACTIVATION; MOUSE	Ataxia telangiectasia (AT) is caused by a mutation in the ataxia-telangiectasia-mutated (ATM) gene; the condition is associated with hyper-radiosensitivity, abnormal cell-cycle checkpoints, and genomic instability. AT patients also show cerebellar ataxia, possibly due to reactive oxygen species (ROS) sensitivity in neural cells. The ATM protein is a key regulator of the DNA damage response. Recently, several AT-like disorders have been reported. The genes responsible for them are predicted to encode proteins that interact with ATM in the DNA-damage response. Ataxia with oculomotor apraxia types 1-3 (AOA1, 2, and 3) result in a neurodegenerative and cellular phenotype similar to AT; however, the basis of this phenotypic similarity is unclear. Here, we show that the cells of AOA3 patients display aberrant ATM-dependent phosphorylation and apoptosis following gamma-irradiation. The ATM-dependent response to H2O2 treatment was abrogated in AOA3 cells. Furthermore, AOA3 cells had reduced ATM activity. Our results suggest that the attenuated ATM-related response is caused by an increase in endogenous ROS in AOA3 cells. Pretreatment of cells with pyocyanin, which induces endogenous ROS production, abolished the ATM-dependent response. Moreover, AOA3 cells had decreased homologous recombination (HR) activity, and pyocyanin pretreatment reduced HR activity in HeLa cells. These results indicate that excess endogenous ROS represses the ATM-dependent cellular response and HR repair in AOA3 cells. Since the ATM-dependent cell-cycle checkpoint is an important block to carcinogenesis, such inactivation of ATM may lead to tumorigenesis as well as neurodegeneration. (C) 2015 Elsevier B.V. All rights reserved.	[Kobayashi, Junya; Saito, Yuichiro; Miwa, Noriko; Komatsu, Kenshi] Kyoto Univ, Ctr Radiat Biol, Dept Genome Repair Dynam, Kyoto 6068501, Japan; [Okui, Michiyo] Toin Univ Yokohama, Ctr Biomed Engn, Yokohama, Kanagawa 2258503, Japan	Kobayashi, J (reprint author), Kyoto Univ, Ctr Radiat Biol, Dept Genome Repair Dynam, Kyoto 6068501, Japan.	jkobayashi@house.rbc.kyoto-u.ac.jp	Kobayashi, Junjiro/J-8547-2015		Ministry of Education, Culture, Sport, Science, and Technology [21310035, 18101002, 24310041]; Health and Labor Science Research Grant	We thank Dr. Kanji Ishizaki, Dr. Maria Jasin, and Dr. Jochen Dam-Daphi for providing experimental reagents and Dr. Martin Lavin for critical discussion about this research. We also thank Yukiko Hayuka and Kae Yanagida for their excellent technical assistance in this work. This work was supported in part by grants (No. 21310035, 18101002, and 24310041) from the Ministry of Education, Culture, Sport, Science, and Technology, and by Health and Labor Science Research Grant.	AICARDI J, 1988, ANN NEUROL, V24, P497, DOI 10.1002/ana.410240404; Guo Z, 2010, CELL CYCLE, V9, P4805, DOI 10.4161/cc.9.24.14323; Date H, 2001, NAT GENET, V29, P184, DOI 10.1038/ng1001-184; Shrivastav M, 2009, DNA REPAIR, V8, P920, DOI 10.1016/j.dnarep.2009.05.006; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Rass E, 2013, J BIOL CHEM, V288, P7086, DOI 10.1074/jbc.M112.445825; Gueven N, 2004, HUM MOL GENET, V13, P1081, DOI 10.1093/hmg/ddh122; Kocher S, 2012, NUCLEIC ACIDS RES, V40, P8336, DOI 10.1093/nar/gks604; Cosentino C, 2011, EMBO J, V30, P546, DOI 10.1038/emboj.2010.330; Kim J, 2009, STEM CELLS, V27, P1987, DOI 10.1002/stem.125; Reichenbach J, 2002, ANTIOXID REDOX SIGN, V4, P465, DOI 10.1089/15230860260196254; Iijima K, 2008, DNA REPAIR, V7, P1705, DOI 10.1016/j.dnarep.2008.06.013; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189; Kass EM, 2013, P NATL ACAD SCI USA, V110, P5564, DOI 10.1073/pnas.1216824110; Stern N, 2002, J BIOL CHEM, V277, P602, DOI 10.1074/jb.M106798200; Scully R, 2013, MUTAT RES-FUND MOL M, V750, P5, DOI 10.1016/j.mrfmmm.2013.07.007; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Kamsler A, 2001, CANCER RES, V61, P1849; Ahel I, 2006, NATURE, V443, P713, DOI 10.1038/nature05164; Kobayashi J, 2004, DNA REPAIR, V3, P855, DOI 10.1016/j.dnarep.2004.03.023; Suraweera A, 2007, J CELL BIOL, V177, P969, DOI 10.1083/jcb.200701042; Becherel OJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003435; Bellini A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047987; Bhatti S, 2011, CELL MOL LIFE SCI, V68, P2977, DOI 10.1007/s00018-011-0683-9; Boder E, 1975, Birth Defects Orig Artic Ser, V11, P255; Chen P, 2003, J NEUROSCI, V23, P11453; Gueven N, 2006, CANCER RES, V66, P2907, DOI 10.1158/0008-5472.CAN-05-3428; Kim J, 2012, STEM CELL TRANSL MED, V1, P548, DOI 10.5966/sctm.2011-0063; Kobayashi J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-34; Kobayashi J, 2009, BIOCHEM BIOPH RES CO, V380, P752, DOI 10.1016/j.bbrc.2009.01.109; Kobayashi J, 2010, MECH AGEING DEV, V131, P436, DOI 10.1016/j.mad.2010.06.005; Kruger A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001959; LAVIN MF, 1995, TRENDS BIOCHEM SCI, V20, P382, DOI 10.1016/S0968-0004(00)89083-0; Lavin MF, 1996, CURR OPIN IMMUNOL, V8, P459, DOI 10.1016/S0952-7915(96)80030-6; Le Ber Isabelle, 2005, Curr Neurol Neurosci Rep, V5, P411; Le Ber I, 2004, BRAIN, V127, P759, DOI 10.1093/brain/awh080; MEREDITH MJ, 1987, CANCER RES, V47, P4576; Morita A, 2014, BIOCHEM BIOPH RES CO, V443, P1286, DOI 10.1016/j.bbrc.2013.12.139; Murad NAA, 2013, MITOCHONDRION, V13, P235, DOI 10.1016/j.mito.2012.11.006; Russo I, 2009, EUR J NEUROL, V16, P755, DOI 10.1111/j.1468-1331.2009.02600.x; Serrano MA, 2013, ONCOGENE, V32, P2452, DOI 10.1038/onc.2012.257; Takagi M, 1998, CANCER RES, V58, P4923; Wang HL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003277	46	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1383-5718	1879-3592		MUTAT RES-GEN TOX EN	Mutat. Res. Genet. Toxicol. Environ. Mutagen.	APR	2015	782						42	50		10.1016/j.mrgentox.2015.03.012		9	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	CH0XW	WOS:000353746700007		
J	Nakashima, K; Kondo, Y; Yoshimasu, K; Sono, M; Tori, M				Nakashima, Katsuyuki; Kondo, Yuzuru; Yoshimasu, Kosei; Sono, Masakazu; Tori, Motoo			Synthesis of Chiral Hexasubstituted Cyclohexanediol, a Key Intermediate for the Synthesis of Verticillol, from (+)-Dihydrocarvone, Attempted Cyclization to 12-Membered Carbocycle in Verticillol using RCM Reaction	NATURAL PRODUCT COMMUNICATIONS			English	Article						Verticillol; Synthesis; Dihydrocarvone; Ring-closing metathesis (RCM)	ABSOLUTE-CONFIGURATION; JACKIELLA-JAVANICA; DITERPENOIDS; FAMILY	A cyclohexane derivative with three chiral centers, a key intermediate for the synthesis of a diterpene verticillol, was prepared starting from (+)-dihydrocarvone. A further challenge to cyclize to a 12-membered carbocycle was attempted, although the products were dimeric derivatives presumably due to an undesirable conformation of the substrate.	[Nakashima, Katsuyuki; Kondo, Yuzuru; Yoshimasu, Kosei; Sono, Masakazu; Tori, Motoo] Tokushima Bunri Univ, Fac Pharmaceut Sci, Tokushima 7708514, Japan	Tori, M (reprint author), Tokushima Bunri Univ, Fac Pharmaceut Sci, Yamashiro Cho, Tokushima 7708514, Japan.	tori@ph.bunri-u.ac.jp					ANET FAL, 1965, J AM CHEM SOC, V87, P5250, DOI 10.1021/ja00950a048; McGrath NA, 2008, ANGEW CHEM INT EDIT, V47, P9450, DOI 10.1002/anie.200804237; Vougioukalakis GC, 2010, CHEM REV, V110, P1746, DOI 10.1021/cr9002424; GOTO H, 1989, J AM CHEM SOC, V111, P8950, DOI 10.1021/ja00206a046; BEGLEY MJ, 1990, TETRAHEDRON, V46, P4907, DOI 10.1016/S0040-4020(01)85602-7; Cerda-Garcia-Rojas CM, 2007, J NAT PROD, V70, P1167, DOI 10.1021/np0605992; Erdtman H, 1964, TETRAHEDRON LETT, V5, P2349; Goto H, 1993, J CHEM SOC P2, V2, P187; Jin YH, 2005, J AM CHEM SOC, V127, P7834, DOI 10.1021/ja050592r; KARLSSON B, 1978, TETRAHEDRON, V34, P2349, DOI 10.1016/0040-4020(78)89049-8; Kato T, 2002, TETRAHEDRON, V58, P9213, DOI 10.1016/S0040-4020(02)01192-4; Nagashima F, 1997, PHYTOCHEMISTRY, V46, P1203, DOI 10.1016/S0031-9422(97)80012-X; Nagashima F, 2008, CHEM PHARM BULL, V56, P1184, DOI 10.1248/cpb.56.1184; Tori M, 2010, MOLECULES, V15, P4242, DOI 10.3390/molecules15064242	14	0	0	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	APR	2015	10	4					551	555				5	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	CG6PS	WOS:000353424800002		
J	Negi, N; Abou-Dough, AM; Kurosawa, M; Kitaji, Y; Saito, K; Ochi, A; Ushijima, K; Kusakabe, E; Kitaguchi, Y; Yu, JGJ; Teshima, N; Ju-ichi, M; Ito, C				Negi, Naoko; Abou-Dough, Ahmad Muhamad; Kurosawa, Masumi; Kitaji, Yukako; Saito, Keiko; Ochi, Asae; Ushijima, Kaori; Kusakabe, Eri; Kitaguchi, Yoshimi; Yu Jinguji; Teshima, Naoko; Ju-ichi, Motoharu; Ito, Chihiro			Coumarins from Murraya exotica Collected in Egypt	NATURAL PRODUCT COMMUNICATIONS			English	Article						Murraya exotica; Coumarins; Isomurralonginol senecioate; Isomurralonginoic acid; Murrangatin 2 '-formate; Meranzin hydrate 2 '-palmitate	PANICULATA VAR OMPHALOCARPA; ABSOLUTE-CONFIGURATION; ROOT BARK; CONSTITUENTS; MICROMINUTIN; FLAVONOIDS; ALKALOIDS; FRUITS	Four new coumarins, isomurralonginol senecioate (1), isomurralonginoic acid (2), murrangatin 2'-formate (3), and meranzin hydrate 2'-palmitate (4), were isolated from the vegetative branches of Murraya exotica together with 33 known compounds. The structures of the new compounds were determined from chemical and spectroscopic data.	[Negi, Naoko; Kurosawa, Masumi; Kitaji, Yukako; Saito, Keiko; Ochi, Asae; Ushijima, Kaori; Kusakabe, Eri; Kitaguchi, Yoshimi; Yu Jinguji; Teshima, Naoko; Ju-ichi, Motoharu] Mzikogawa Womens Univ, Fac Pharmaceut Sci, Nishinomiya, Hyogo 6638179, Japan; [Abou-Dough, Ahmad Muhamad] South Valley Univ, Fac Sci, Dept Chem, Aswan, Egypt; [Ito, Chihiro] Meijo Univ, Fac Pharm, Tempaku Ku, Nagoya, Aichi 4688503, Japan	Ito, C (reprint author), Meijo Univ, Fac Pharm, Tempaku Ku, Nagoya, Aichi 4688503, Japan.	itochi@meijo-zt.ac.jp					ALLISON S, 1991, TETRAHEDRON, V47, P9737, DOI 10.1016/S0040-4020(01)80713-4; ITO C, 1987, CHEM PHARM BULL, V35, P4277; Passador EAP, 1997, PHYTOCHEMISTRY, V45, P1533, DOI 10.1016/S0031-9422(97)00140-4; Kinoshita T, 1996, PHYTOCHEMISTRY, V43, P125, DOI 10.1016/0031-9422(96)00255-5; BARIK BR, 1983, PHYTOCHEMISTRY, V22, P792, DOI 10.1016/S0031-9422(00)86993-9; BARIK BR, 1983, PHYTOCHEMISTRY, V22, P2273, DOI 10.1016/S0031-9422(00)80160-0; Boyd DR, 2002, CHEM COMMUN, P3070, DOI 10.1039/b208978e; Crosby PG, 1962, J ORG CHEM, V27, P3083; Ferracin RJ, 1998, PHYTOCHEMISTRY, V47, P393, DOI 10.1016/S0031-9422(97)00598-0; GRUNDON MF, 1975, PHYTOCHEMISTRY, V14, P143, DOI 10.1016/0031-9422(75)85027-8; IMAI F, 1986, CHEM PHARM BULL, V34, P3978; IMAI F, 1989, CHEM PHARM BULL, V37, P119; Ito C, 1990, J CHEM SOC PERK T, VI, P2047; ITO C, 1991, CHEM PHARM BULL, V39, P2509; JOSHI BS, 1970, PHYTOCHEMISTRY, V9, P889, DOI 10.1016/S0031-9422(00)85198-5; MAIER VP, 1967, PHYTOCHEMISTRY, V6, P1127, DOI 10.1016/S0031-9422(00)86071-9; Moore CW, 1910, J CHEM SOC, V98, P2223; Murray RDH, 1982, NATURAL COUMARINS, P27; Negi N, 2005, CHEM PHARM BULL, V53, P1180, DOI 10.1248/cpb.53.1180; QUADER MA, 1992, PHYTOCHEMISTRY, V31, P3083, DOI 10.1016/0031-9422(92)83450-D; REISCH J, 1989, PHARMAZIE, V44, P736; Takemura Y, 2004, HETEROCYCLES, V63, P115; TANTIVATANA P, 1983, J ORG CHEM, V48, P268, DOI 10.1021/jo00150a028; VAZQUEZ MM, 1988, PHYTOCHEMISTRY, V27, P3706, DOI 10.1016/0031-9422(88)80809-4; VELDHUIS MK, 1970, J AGR FOOD CHEM, V18, P590, DOI 10.1021/jf60170a009; Walter HL, 1977, MED PLANTS AFFECTING, P273; WU TS, 1988, PHYTOCHEMISTRY, V27, P2357; WU TS, 1989, PHYTOCHEMISTRY, V28, P2873, DOI 10.1016/S0031-9422(00)98115-9	28	0	0	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	APR	2015	10	4					617	620				4	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	CG6PS	WOS:000353424800020		
J	Saito, A; Igarashi, W; Furukawa, H; Hoshikawa, H; Yamada, T; Kuwahara, S; Kiyota, H				Saito, Aki; Igarashi, Wataru; Furukawa, Hiroyuki; Hoshikawa, Hiroki; Yamada, Teiko; Kuwahara, Shigefumi; Kiyota, Hiromasa			Synthetic Studies of Enacyloxins: A Series of Antibiotics Isolated from Frateuria sp W-315: C1'-C8' and C9'-C15' Fragments	NATURAL PRODUCT COMMUNICATIONS			English	Article						Enacyloxins; Antibiotics; Elongation factor Tu; Synthetic studies	GRAM-NEGATIVE BACTERIA; FACILE SYNTHESIS; STEREOCHEMISTRY; PART; RING; CONFIGURATION; REAGENT; IIA	Synthetic studies of enacyloxins (ENXs), a series of yellow-colored, polyene-polyol antibiotics produced by Frateuria sp. W-315, are described. The C1'-C8' polyene fragments were prepared using successive Wittig reactions. The C9'-C15' and C10'-C15' fragments were constructed from (S)-isopropylideneglyceraldehyde using Yamaguchi's nucleophilic substitution reaction of acetylide to epoxide, and/or Marshall's allenylindium mediated reaction as the key steps.	[Saito, Aki; Igarashi, Wataru; Furukawa, Hiroyuki; Hoshikawa, Hiroki; Yamada, Teiko; Kuwahara, Shigefumi] Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi 9818555, Japan; [Kiyota, Hiromasa] Okayama Univ, Grad Sch Environm & Life Sci, Okayama 7008530, Japan	Kiyota, H (reprint author), Okayama Univ, Grad Sch Environm & Life Sci, Okayama 7008530, Japan.	kiyota@okayama-u.ac.jp			JSPS KAKENHI [19580120, 22560112, 25450144]	We are grateful for the financial support from JSPS KAKENHI (Grant Numbers 19580120, 22560112, 25450144). Our thanks are also due to Tokyo Ohka Foundation for the Promotion of Science and Technology, the Naito Foundation, the Intelligent Cosmos Foundation and the Kuribayashi Ikuei Foundation.	Marshall JA, 2005, ORG LETT, V7, P1593, DOI 10.1021/ol050289v; Marshall JA, 2001, ORG LETT, V3, P3369, DOI 10.1021/ol016605x; KOZIKOWSKI AP, 1984, J ORG CHEM, V49, P2762, DOI 10.1021/jo00189a024; YAMAGUCHI M, 1983, TETRAHEDRON LETT, V24, P391, DOI 10.1016/S0040-4039(00)81416-1; Boyd DR, 2000, MONATSH CHEM, V131, P673, DOI 10.1007/s007060070096; El-Batta A, 2013, SYNTHETIC COMMUN, V43, P2457, DOI 10.1080/00397911.2012.714041; Fujimori T, 2001, HETEROCYCL COMMUN, V7, P327; Furukawa H, 2007, CHEM BIODIVERS, V4, P1601, DOI 10.1002/cbdv.200790140; Furukawa H, 2011, HETEROCYCL COMMUN, V17, P3, DOI 10.1515/HC.2011.007; HIROI K, 1994, CHEM PHARM BULL, V42, P786; Igarashi W, 2011, HETEROCYCL COMMUN, V17, P7, DOI 10.1515/HC.2011.008; NICOLAOU KC, 1995, J AM CHEM SOC, V117, P634, DOI 10.1021/ja00107a007; Marshall JA, 2009, ORG SYNTH, V11, P615; Montero JL, 2003, New phosphonate derivatives, their preparation method, and their use as modulators of the activity of t&gamma;9&delta;2 lymphocytes. Fr. Demande, Patent No. [FR 2833266 A1 20030613, 2833266]; OYAMA R, 1994, BIOSCI BIOTECH BIOCH, V58, P1914; Parmeggiani A, 2006, J BIOL CHEM, V281, P2893, DOI 10.1074/jbc.M505951200; Saito A, 2014, BIOSCI BIOTECH BIOCH, V78, P766, DOI 10.1080/09168451.2014.905192; Takeuchi R, 2001, J CHEM SOC PERK T 1, P2676, DOI 10.1039/b104341m; Thiot C, 2007, PCT Int. Appl, Patent No. [WO 2007048943 A1 20070503, 2007048943]; WATANABE T, 1990, AGR BIOL CHEM TOKYO, V54, P259	20	0	0	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	APR	2015	10	4					645	648				4	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	CG6PS	WOS:000353424800029		
J	Cary, SK; Vasiliu, M; Baumbach, RE; Stritzinger, JT; Green, TD; Diefenbach, K; Cross, JN; Knappenberger, KL; Liu, G; Silver, MA; DePrince, AE; Polinski, MJ; Van Cleve, SM; House, JH; Kikugawa, N; Gallagher, A; Arico, AA; Dixon, DA; Albrecht-Schmitt, TE				Cary, Samantha K.; Vasiliu, Monica; Baumbach, Ryan E.; Stritzinger, Jared T.; Green, Thomas D.; Diefenbach, Kariem; Cross, Justin N.; Knappenberger, Kenneth L.; Liu, Guokui; Silver, Mark A.; DePrince, A. Eugene; Polinski, Matthew J.; Van Cleve, Shelley M.; House, Jane H.; Kikugawa, Naoki; Gallagher, Andrew; Arico, Alexandra A.; Dixon, David A.; Albrecht-Schmitt, Thomas E.			Emergence of californium as the second transitional element in the actinide series	NATURE COMMUNICATIONS			English	Article							CRYSTAL-STRUCTURE; STRUCTURAL CHEMISTRY; ELECTRONIC-STRUCTURE; MAGNETIC-PROPERTIES; SOLID-STATE; AQUA ION; COVALENCY; COMPLEXES; SPECTRA; LIGAND	A break in periodicity occurs in the actinide series between plutonium and americium as the result of the localization of 5f electrons. The subsequent chemistry of later actinides is thought to closely parallel lanthanides in that bonding is expected to be ionic and complexation should not substantially alter the electronic structure of the metal ions. Here we demonstrate that ligation of californium(III) by a pyridine derivative results in significant deviations in the properties of the resultant complex with respect to that predicted for the free ion. We expand on this by characterizing the americium and curium analogues for comparison, and show that these pronounced effects result from a second transition in periodicity in the actinide series that occurs, in part, because of the stabilization of the divalent oxidation state. The metastability of californium(II) is responsible for many of the unusual properties of californium including the green photoluminescence.	[Cary, Samantha K.; Stritzinger, Jared T.; Green, Thomas D.; Diefenbach, Kariem; Cross, Justin N.; Knappenberger, Kenneth L.; Silver, Mark A.; DePrince, A. Eugene; Polinski, Matthew J.; House, Jane H.; Arico, Alexandra A.; Albrecht-Schmitt, Thomas E.] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA; [Vasiliu, Monica; Dixon, David A.] Univ Alabama, Dept Chem, Tuscaloosa, AL 35487 USA; [Baumbach, Ryan E.; Gallagher, Andrew] Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Liu, Guokui] Argonne Natl Lab, Chem Sci & Engn Div, Argonne, IL 60439 USA; [Van Cleve, Shelley M.] Oak Ridge Natl Lab, Nucl Mat Proc Grp, Oak Ridge, TN 37830 USA; [Kikugawa, Naoki] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan	Albrecht-Schmitt, TE (reprint author), Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA.	albrecht-schmitt@chem.fsu.edu			U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, Heavy Elements Chemistry Program [DE-FG02-13ER16414, DE-AC02-06CH11357]; Robert Ramsay Chair Fund of The University of Alabama; National Science Foundation [DMR-1157490]; State of Florida; U.S. Department of Energy	This material is based on work supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, Heavy Elements Chemistry Program, under Award Number DE-FG02-13ER16414 (TEA-S) and DE-AC02-06CH11357 (GL and DAD). We are especially grateful for the assistance and supervision by the Office of Environmental Health and Safety at FSU; specifically Jason A. Johnson and Ashley L. Gray of the Office of Radiation Safety for their facilitation of these studies. D.A.D. thanks the Robert Ramsay Chair Fund of The University of Alabama for partial support. The isotopes used in this research were supplied by the U.S. Department of Energy, Office of Science, by the Isotope Program in the Office of Nuclear Physics. The <SUP>243</SUP>Am, <SUP>248</SUP>Cm and <SUP>249</SUP>Cf were provided to Florida State University via the Isotope Development and Production for Research and Applications Program through the Radiochemical Engineering and Development Center at Oak Ridge National Laboratory. The <SUP>249</SUP>Cf was purchased via the Gregory R. Choppin Chair Endowment. Magnetization measurements using the VSM SQUID MPMS were performed at the National High Magnetic Field Laboratory, which is supported by National Science Foundation Cooperative Agreement No. DMR-1157490, the State of Florida, and the U.S. Department of Energy.	Polinski MJ, 2014, NAT CHEM, V6, P387, DOI [10.1038/nchem.1896, 10.1038/NCHEM.1896]; HUBERT S, 1993, PHYS REV B, V48, P5751, DOI 10.1103/PhysRevB.48.5751; Lindqvist-Reis P, 2007, ANGEW CHEM INT EDIT, V46, P919, DOI 10.1002/anie.200603947; Spek AL, 2003, J APPL CRYSTALLOGR, V36, P7, DOI 10.1107/S0021889802022112; Skanthakumar S, 2007, INORG CHEM, V46, P3485, DOI 10.1021/ic061798b; Fajans K, 1923, NATURWISSENSCHAFTEN, V11, P165; Jones MB, 2013, CHEM SCI, V4, P1189, DOI 10.1039/c2sc21806b; Castro-Rodriguez I, 2003, J AM CHEM SOC, V125, P4565, DOI 10.1021/ja028342n; Apostolidis C, 2010, ANGEW CHEM INT EDIT, V49, P6343, DOI 10.1002/anie.201001077; Kaltsoyannis N, 2013, INORG CHEM, V52, P3407, DOI 10.1021/ic3006025; WEAVER B, 1968, J INORG NUCL CHEM, V30, P263, DOI 10.1016/0022-1902(68)80089-2; Solomon EI, 2005, COORDIN CHEM REV, V249, P97, DOI 10.1016/j.ccr.2004.03.020; Minasian SG, 2014, CHEM SCI, V5, P351, DOI 10.1039/c3sc52030g; MALY J, 1968, SCIENCE, V160, P1114, DOI 10.1126/science.160.3832.1114; DIAMOND RM, 1954, J AM CHEM SOC, V76, P1461, DOI 10.1021/ja01635a001; Polinski MJ, 2012, J AM CHEM SOC, V134, P10682, DOI 10.1021/ja303804r; Neidig ML, 2013, COORDIN CHEM REV, V257, P394, DOI 10.1016/j.ccr.2012.04.029; CARNALL WT, 1992, J CHEM PHYS, V96, P8713, DOI 10.1063/1.462278; Liu GK, 2012, J PHYS CHEM A, V116, P855, DOI 10.1021/jp210046j; Jones MB, 2013, CHEM REV, V113, P1137, DOI 10.1021/cr300198m; Galbis E, 2010, ANGEW CHEM INT EDIT, V49, P3811, DOI 10.1002/anie.200906129; LIU GK, 1994, J CHEM PHYS, V101, P8277, DOI 10.1063/1.468093; Soderholm L, 1999, PHYS REV B, V60, P4302, DOI 10.1103/PhysRevB.60.4302; Bray TH, 2007, INORG CHEM, V46, P10959, DOI 10.1021/ic702136h; Carnall W. T., 1989, ANL8939; Choppin G. R., 2006, ACTINIDES SOLUTION C, V4, P2574; COPELAND JC, 1969, J INORG NUCL CHEM, V31, P733, DOI 10.1016/0022-1902(69)80020-5; Dieke G. H., 1968, SPECTRA ENERGY LEVEL; EDELSTEI.N, 1974, INORG CHEM, V13, P563, DOI 10.1021/ic50133a013; Edelstein N. M., 2006, CHEM ACTINIDE TRANAC, V15, P1779; Fajans K, 1924, Z PHYS, V23, P1, DOI 10.1007/BF01327574; Fields P. R., 1964, ANL6911 AEC RES DEV; Haire R. G., 2006, CHEM ACTINIDE TRANSA, P1544; Haire R. G., 1989, J RADIOANAL NUCL CHE, V143, P35; HAIRE RG, 1974, J INORG NUCL CHEM, V36, P1295, DOI 10.1016/0022-1902(74)80067-9; HAIRE RG, 1976, INORG NUCL CHEM LETT, V12, P73, DOI 10.1016/0020-1650(76)80122-5; Heathman S, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.214111; KOT WK, 1993, PHYS REV B, V47, P3412, DOI 10.1103/PhysRevB.47.3412; LAUBEREA.PG, 1970, INORG CHEM, V9, P1091, DOI 10.1021/ic50087a018; Liu G., 2006, CHEM ACTINIDE TRANSA, P2013, DOI 10.1007/1-4020-3598-5_18; MOORE JR, 1986, J LESS-COMMON MET, V121, P187, DOI 10.1016/0022-5088(86)90529-1; Newman D.J., 2000, CRYSTAL FIELD HDB, P83, DOI 10.1017/CBO9780511524295.007; PETERSON JR, 1977, RADIOCHEM RADIOA LET, V31, P277; RISEBERG LA, 1967, PHYS REV LETT, V19, P1423, DOI 10.1103/PhysRevLett.19.1423; Skanthakumar S, 2000, J ALLOY COMPD, V303, P298, DOI 10.1016/S0925-8388(00)00589-2; Sykora RE, 2006, INORG CHEM, V45, P475, DOI 10.1021/ic051667v; Sytama J., 1995, PHYS REV B, V52, P12668	47	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6827	10.1038/ncomms7827		8	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0IO	WOS:000353703200006		
J	Chikamoto, Y; Timmermann, A; Luo, JJ; Mochizuki, T; Kimoto, M; Watanabe, M; Ishii, M; Xie, SP; Jin, FF				Chikamoto, Yoshimitsu; Timmermann, Axel; Luo, Jing-Jia; Mochizuki, Takashi; Kimoto, Masahide; Watanabe, Masahiro; Ishii, Masayoshi; Xie, Shang-Ping; Jin, Fei-Fei			Skilful multi-year predictions of tropical trans-basin climate variability	NATURE COMMUNICATIONS			English	Article							SEA-SURFACE TEMPERATURE; DECADAL-SCALE CLIMATE; OCEAN HEAT UPTAKE; DATA ASSIMILATION; WARMING HIATUS; INDO-PACIFIC; EL-NINO; ATLANTIC; ENSO; CIRCULATION	Tropical Pacific sea surface temperature anomalies influence the atmospheric circulation, impacting climate far beyond the tropics. The predictability of the corresponding atmospheric signals is typically limited to less than 1 year lead time. Here we present observational and modelling evidence for multi-year predictability of coherent trans-basin climate variations that are characterized by a zonal seesaw in tropical sea surface temperature and sea-level pressure between the Pacific and the other two ocean basins. State-of-the-art climate model forecasts initialized from a realistic ocean state show that the low-frequency trans-basin climate variability, which explains part of the El Nino Southern Oscillation flavours, can be predicted up to 3 years ahead, thus exceeding the predictive skill of current tropical climate forecasts for natural variability. This low-frequency variability emerges from the synchronization of ocean anomalies in all basins via global reorganizations of the atmospheric Walker Circulation.	[Chikamoto, Yoshimitsu; Timmermann, Axel] Univ Hawaii Manoa, Int Pacific Res Ctr, Honolulu, HI 96822 USA; [Timmermann, Axel] Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA; [Luo, Jing-Jia] Bur Meteorol, Ctr Australian Weather & Climate Res, Melbourne, Vic 3001, Australia; [Mochizuki, Takashi] Japan Agcy Marine Earth Sci & Technol, Kanazawa Ku, Yokohama, Kanagawa 2360001, Japan; [Kimoto, Masahide; Watanabe, Masahiro] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778568, Japan; [Ishii, Masayoshi] Japan Meteorol Agcy, Meteorol Res Inst, Tsukuba, Ibaraki 3050052, Japan; [Xie, Shang-Ping] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Jin, Fei-Fei] Univ Hawaii Manoa, Dept Meteorol, Honolulu, HI 96822 USA	Chikamoto, Y (reprint author), Univ Hawaii Manoa, Int Pacific Res Ctr, 1680 East West Rd, Honolulu, HI 96822 USA.	chika44@hawaii.edu	Timmermann, Axel /F-4977-2011; Mochizuki, Takashi/C-7466-2013	Timmermann, Axel /0000-0003-0657-2969; 	Japanese Ministry of Education, Culture, Sports, Science and Technology, through the Program for Risk Information on Climate Change; NSF [1049219]; NOAA	This study was supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology, through the Program for Risk Information on Climate Change. The simulations were performed with the Earth Simulator at the Japan Agency for Marine-Earth Science and Technology and the NEC SX-8R at the National Institute for Environmental Studies. A.T. and Y.C. were supported by NSF (1049219); S.-P.X. by NSF and NOAA.	Wang CZ, 2004, GEOPHYS MONOGR SER, V147, P21; Bloom SC, 1996, MON WEATHER REV, V124, P1256, DOI 10.1175/1520-0493(1996)124<1256:DAUIAU>2.0.CO;2; Meehl GA, 2011, NAT CLIM CHANGE, V1, P360, DOI 10.1038/NCLIMATE1229; Luo JJ, 2012, P NATL ACAD SCI USA, V109, P18701, DOI 10.1073/pnas.1210239109; Tatebe H, 2012, J METEOROL SOC JPN, V90A, P275, DOI 10.2151/jmsj.2012-A14; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Watanabe M, 2013, GEOPHYS RES LETT, V40, P3175, DOI 10.1002/grl.50541; Ham YG, 2013, NAT GEOSCI, V6, P112, DOI [10.1038/ngeo1686, 10.1038/NGEO1686]; Miller AJ, 2004, J OCEANOGR, V60, P163, DOI 10.1023/B:JOCE.0000038325.36306.95; Chikamoto Y, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053901; Trenberth KE, 2014, NAT CLIM CHANGE, V4, P911, DOI [10.1038/nclimate2341, 10.1038/NCLIMATE2341]; Barlow M, 2001, J CLIMATE, V14, P2105, DOI 10.1175/1520-0442(2001)014<2105:EPDVAU>2.0.CO;2; Klein SA, 1999, J CLIMATE, V12, P917, DOI 10.1175/1520-0442(1999)012<0917:RSSTVD>2.0.CO;2; Xie SP, 2004, GEOPHYS MONOGR SER, V147, P121; Ashok K, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003798; Timmermann A, 2010, J CLIMATE, V23, P4429, DOI 10.1175/2010JCLI3519.1; Timmermann A, 2003, J ATMOS SCI, V60, P152, DOI 10.1175/1520-0469(2003)060<0152:ANTFEN>2.0.CO;2; McGregor S, 2014, NAT CLIM CHANGE, V4, P888, DOI [10.1038/nclimate2330, 10.1038/NCLIMATE2330]; Booth BBB, 2012, NATURE, V484, P228, DOI 10.1038/nature10946; Kug JS, 2009, J CLIMATE, V22, P1499, DOI 10.1175/2008JCLI2624.1; Huang BH, 2002, ADV ATMOS SCI, V19, P965, DOI 10.1007/s00376-002-0059-z; Chikamoto Y, 2013, CLIM DYNAM, V40, P1201, DOI 10.1007/s00382-012-1351-y; Watanabe M, 2014, NAT CLIM CHANGE, V4, P893, DOI [10.1038/nclimate2355, 10.1038/NCLIMATE2355]; England MH, 2014, NAT CLIM CHANGE, V4, P222, DOI [10.1038/nclimate2106, 10.1038/NCLIMATE2106]; Mochizuki T, 2010, P NATL ACAD SCI USA, V107, P1833, DOI 10.1073/pnas.0906531107; Power S, 1999, CLIM DYNAM, V15, P319, DOI 10.1007/s003820050284; Ishii M, 2009, J OCEANOGR, V65, P287, DOI 10.1007/s10872-009-0027-7; Tokinaga H, 2012, NATURE, V491, P439, DOI 10.1038/nature11576; Jin EK, 2008, CLIM DYNAM, V31, P647, DOI 10.1007/s00382-008-0397-3; Meehl GA, 2006, J CLIMATE, V19, P1605, DOI 10.1175/JCLI3675.1; Kosaka Y, 2013, NATURE, V501, P403, DOI 10.1038/nature12534; Chiang JCH, 2002, J CLIMATE, V15, P2616, DOI 10.1175/1520-0442(2002)015<2616:TTTVCB>2.0.CO;2; Meehl GA, 2014, B AM METEOROL SOC, V95, P243, DOI 10.1175/BAMS-D-12-00241.1; Chikamoto Y, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027238; Doblas-Reyes FJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2704; Hendon HH, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040100; Jeong HI, 2012, CLIM DYNAM, V39, P475, DOI 10.1007/s00382-012-1359-3; Jin FF, 2001, J CLIMATE, V14, P3874, DOI 10.1175/1520-0442(2001)014<3874:LFMOTO>2.0.CO;2; K-1 Model Developers, 2004, K 1 COUPL GCM MIROC, V1; Keenlyside NS, 2008, NATURE, V453, P84, DOI 10.1038/nature06921; Matei D, 2012, SCIENCE, V335, P76, DOI 10.1126/science.1210299; Merrifield MA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049576; Smith DM, 2007, SCIENCE, V317, P796, DOI 10.1126/science.1139540	43	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6869	10.1038/ncomms7869		7	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0IQ	WOS:000353703400036		
J	Doganov, RA; O'Farrell, ECT; Koenig, SP; Yeo, YT; Ziletti, A; Carvalho, A; Campbell, DK; Coker, DF; Watanabe, K; Taniguchi, T; Neto, AHC; Ozyilmaz, B				Doganov, Rostislav A.; O'Farrell, Eoin C. T.; Koenig, Steven P.; Yeo, Yuting; Ziletti, Angelo; Carvalho, Alexandra; Campbell, David K.; Coker, David F.; Watanabe, Kenji; Taniguchi, Takashi; Castro Neto, Antonio H.; Ozyilmaz, Barbaros			Transport properties of pristine few-layer black phosphorus by van der Waals passivation in an inert atmosphere	NATURE COMMUNICATIONS			English	Article							FIELD-EFFECT TRANSISTORS; HIGH-PRESSURES; GRAPHENE; ELECTRONICS; CRYSTALS; MOBILITY; MOS2	Ultrathin black phosphorus is a two-dimensional semiconductor with a sizeable band gap. Its excellent electronic properties make it attractive for applications in transistor, logic and optoelectronic devices. However, it is also the first widely investigated two-dimensional material to undergo degradation upon exposure to ambient air. Therefore a passivation method is required to study the intrinsic material properties, understand how oxidation affects the physical properties and enable applications of phosphorene. Here we demonstrate that atomically thin graphene and hexagonal boron nitride can be used for passivation of ultrathin black phosphorus. We report that few-layer pristine black phosphorus channels passivated in an inert gas environment, without any prior exposure to air, exhibit greatly improved n-type charge transport resulting in symmetric electron and hole transconductance characteristics.	[Doganov, Rostislav A.; O'Farrell, Eoin C. T.; Koenig, Steven P.; Yeo, Yuting; Carvalho, Alexandra; Castro Neto, Antonio H.; Ozyilmaz, Barbaros] Natl Univ Singapore, Ctr Adv Mat 2D, Singapore 117546, Singapore; [Doganov, Rostislav A.; O'Farrell, Eoin C. T.; Koenig, Steven P.; Yeo, Yuting; Castro Neto, Antonio H.; Ozyilmaz, Barbaros] Natl Univ Singapore, Dept Phys, Singapore 117542, Singapore; [Doganov, Rostislav A.; Castro Neto, Antonio H.; Ozyilmaz, Barbaros] Natl Univ Singapore, Grad Sch Integrat Sci & Engn NGS, Singapore 117456, Singapore; [Ziletti, Angelo; Coker, David F.] Boston Univ, Dept Chem, Boston, MA 02215 USA; [Campbell, David K.] Boston Univ, Dept Phys, Boston, MA 02215 USA; [Watanabe, Kenji; Taniguchi, Takashi] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan	Ozyilmaz, B (reprint author), Natl Univ Singapore, Ctr Adv Mat 2D, 6 Sci Dr 2, Singapore 117546, Singapore.	phyob@nus.edu.sg	WATANABE, Kenji/H-2825-2011; O'Farrell, Eoin/H-6711-2012; Carvalho, Alexandra/B-2771-2011	WATANABE, Kenji/0000-0003-3701-8119; O'Farrell, Eoin/0000-0003-2216-8958; Carvalho, Alexandra/0000-0002-2851-1887	National Research Foundation, Prime Minister's Office, Singapore under its Competitive Research Programme (CRP) [NRF-CRP9-2011-3]; SMF-NUS Research Horizons Award-Phase II; NRF-CRP award 'Novel 2D materials with tailored properties: beyond graphene'; NSF [CHE-1301157]	B.O. acknowledges support by the National Research Foundation, Prime Minister's Office, Singapore under its Competitive Research Programme (CRP Award No. NRF-CRP9-2011-3) and the SMF-NUS Research Horizons Award 2009-Phase II. A.H.C.N. acknowledges the NRF-CRP award 'Novel 2D materials with tailored properties: beyond graphene'. The calculations were performed at the GRC computing facilities. A.Z. and D.F.C. acknowledge the NSF grant CHE-1301157.	Bunch JS, 2008, NANO LETT, V8, P2458, DOI 10.1021/nl801457b; Das S, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4820408; Aguirre CM, 2009, ADV MATER, V21, P3087, DOI 10.1002/adma.200900550; Liu H, 2014, ACS NANO, V8, P4033, DOI 10.1021/nn501226z; Bao WZ, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4789365; Pradhan NR, 2014, ACS NANO, V8, P7923, DOI 10.1021/nn501693d; Mayorov AS, 2011, NANO LETT, V11, P2396, DOI 10.1021/nl200758b; Kretinin AV, 2014, NANO LETT, V14, P3270, DOI 10.1021/nl5006542; Ziletti A, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.046801; Zhang YJ, 2012, NANO LETT, V12, P1136, DOI 10.1021/nl2021575; Koenig SP, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4868132; JAMIESON JC, 1963, SCIENCE, V139, P1291, DOI 10.1126/science.139.3561.1291; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; Tan JY, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4872178; Buscema M, 2014, NANO LETT, V14, P3347, DOI 10.1021/nl5008085; Novoselov KS, 2012, NATURE, V490, P192, DOI 10.1038/nature11458; Schwierz F, 2010, NAT NANOTECHNOL, V5, P487, DOI [10.1038/nnano.2010.89, 10.1038/NNANO.2010.89]; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Li LK, 2014, NAT NANOTECHNOL, V9, P372, DOI [10.1038/nnano.2014.35, 10.1038/NNANO.2014.35]; Koenig SP, 2012, NAT NANOTECHNOL, V7, P728, DOI [10.1038/nnano.2012.162, 10.1038/NNANO.2012.162]; Chan MY, 2013, NANOSCALE, V5, P9572, DOI 10.1039/c3nr03220e; Nathan A, 2012, P IEEE, V100, P1486, DOI 10.1109/JPROC.2012.2190168; KAWAMURA H, 1984, SOLID STATE COMMUN, V49, P879, DOI 10.1016/0038-1098(84)90444-7; Tran V, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.235319; Taniguchi T, 2007, J CRYST GROWTH, V303, P525, DOI 10.1016/j.jcrysgro.2006.12.061; Castellanos-Gomez A, 2014, 2D MATER, V1, DOI 10.1088/2053-1583/1/2/025001; Island JO, 2015, 2D MATER, V2, DOI 10.1088/2053-1583/2/1/011002; Kim J., 2014, PREPRINT; MORITA A, 1986, APPL PHYS A-MATER, V39, P227, DOI 10.1007/BF00617267; Qiao JS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5475; Xia FN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5458	31	14	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6647	10.1038/ncomms7647		7	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0GF	WOS:000353696900001		
J	Fu, HQ; Martin, MM; Regairaz, M; Huang, L; You, Y; Lin, CM; Ryan, M; Kim, R; Shimura, T; Pommier, Y; Aladjem, MI				Fu, Haiqing; Martin, Melvenia M.; Regairaz, Marie; Huang, Liang; You, Yang; Lin, Chi-Mei; Ryan, Michael; Kim, RyangGuk; Shimura, Tsutomu; Pommier, Yves; Aladjem, Mirit I.			The DNA repair endonuclease Mus81 facilitates fast DNA replication in the absence of exogenous damage	NATURE COMMUNICATIONS			English	Article							INTRA-S-PHASE; HUMAN-CELLS; SACCHAROMYCES-CEREVISIAE; EUKARYOTIC CELLS; DORMANT ORIGINS; TOPOISOMERASE-I; FRAGILE SITE; FUNCTIONAL INTERACTIONS; GENOMIC INSTABILITY; MAMMALIAN-CELLS	The Mus81 endonuclease resolves recombination intermediates and mediates cellular responses to exogenous replicative stress. Here, we show that Mus81 also regulates the rate of DNA replication during normal growth by promoting replication fork progression while reducing the frequency of replication initiation events. In the absence of Mus81 endonuclease activity, DNA synthesis is slowed and replication initiation events are more frequent. In addition, Mus81-deficient cells fail to recover from exposure to low doses of replication inhibitors and cell viability is dependent on the XPF endonuclease. Despite an increase in replication initiation frequency, cells lacking Mus81 use the same pool of replication origins as Mus81-expressing cells. Therefore, decelerated DNA replication in Mus81-deficient cells does not initiate from cryptic or latent origins not used during normal growth. These results indicate that Mus81 plays a key role in determining the rate of DNA replication without activating a novel group of replication origins.	[Fu, Haiqing; Martin, Melvenia M.; Regairaz, Marie; Huang, Liang; You, Yang; Lin, Chi-Mei; Pommier, Yves; Aladjem, Mirit I.] NCI, Dev Therapeut Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Ryan, Michael; Kim, RyangGuk] InSilico Solut, Fairfax, VA 22033 USA; [Shimura, Tsutomu] Natl Inst Publ Hlth, Dept Environm Hlth, Wako, Saitama 3510197, Japan	Aladjem, MI (reprint author), NCI, Dev Therapeut Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	aladjemm@mail.nih.gov		Huang, Liang/0000-0003-1663-7025	CCR, National Cancer Institute, National Institutes of Health	We thank Drs Paul Meltzer, Chiara Conti, Hong Fang Liu, Elisabeth Leo and Kurt W. Kohn for helpful discussion. We are grateful to Dr James Doroshow and William C. Reinhold for facilitating the bioinformatics pipeline data analysis. The intramural programme of the CCR, National Cancer Institute, National Institutes of Health, funded this work.	Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Aladjem MI, 2007, NAT REV GENET, V8, P588, DOI 10.1038/nrg2143; Gari K, 2008, P NATL ACAD SCI USA, V105, P16107, DOI 10.1073/pnas.0804777105; Aggarwal BD, 2004, NATURE, V430, P372, DOI 10.1038/nature02694; Mechali M, 2010, NAT REV MOL CELL BIO, V11, P728, DOI 10.1038/nrm2976; Abdurashidova G, 2007, EMBO J, V26, P998, DOI 10.1038/sj.emboj.7601578; Hanada K, 2006, EMBO J, V25, P4921, DOI 10.1038/sj.emboj.7601344; Vogelauer M, 2002, MOL CELL, V10, P1223, DOI 10.1016/S1097-2765(02)00702-5; Martin MM, 2011, GENOME RES, V21, P1822, DOI 10.1101/gr.124644.111; Techer H, 2013, J MOL BIOL, V425, P4845, DOI 10.1016/j.jmb.2013.03.040; Shirahige K, 1998, NATURE, V395, P618; Woodward AM, 2006, J CELL BIOL, V173, P673, DOI 10.1083/jcb.200602108; Chen XB, 2001, MOL CELL, V8, P1117, DOI 10.1016/S1097-2765(01)00375-6; Dershowitz A, 2007, MOL CELL BIOL, V27, P4652, DOI 10.1128/MCB.01246-06; Shimura T, 2007, J MOL BIOL, V367, P665, DOI 10.1016/j.jmb.2007.01.018; Zhang YW, 2011, NUCLEIC ACIDS RES, V39, P3607, DOI 10.1093/nar/gkq1304; Conti C, 2007, MOL BIOL CELL, V18, P3059, DOI 10.1091/mbc.E06-08-0689; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Munoz IM, 2009, MOL CELL, V35, P116, DOI 10.1016/j.molcel.2009.06.020; Petermann E, 2006, MOL CELL BIOL, V26, P3319, DOI 10.1128/MCB.26.8.3319-3326.2006; Kang MJ, 2010, NUCLEIC ACIDS RES, V38, P7611, DOI 10.1093/nar/gkq651; Regairaz M, 2011, J CELL BIOL, V195, P739, DOI 10.1083/jcb.201104003; Matulova P, 2009, J BIOL CHEM, V284, P7733, DOI 10.1074/jbc.M806192200; Doksani Y, 2009, CELL, V137, P247, DOI 10.1016/j.cell.2009.02.016; Conti C, 2010, CANCER RES, V70, P4470, DOI 10.1158/0008-5472.CAN-09-3028; Letessier A, 2011, NATURE, V470, P120, DOI 10.1038/nature09745; Schwab RA, 2010, EMBO J, V29, P806, DOI 10.1038/emboj.2009.385; Seiler JA, 2007, MOL CELL BIOL, V27, P5806, DOI 10.1128/MCB.02278-06; Sarbajna S, 2014, GENE DEV, V28, P1124, DOI 10.1101/gad.238303.114; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Ying SM, 2013, NAT CELL BIOL, V15, P1001, DOI 10.1038/ncb2773; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; DePamphilis ML, 1993, CURR OPIN CELL BIOL, V5, P434, DOI 10.1016/0955-0674(93)90008-E; Courbet S, 2008, NATURE, V455, P557, DOI 10.1038/nature07233; Tuduri S, 2010, CELL CYCLE, V9, P1886; Ciccia A, 2008, ANNU REV BIOCHEM, V77, P259, DOI 10.1146/annurev.biochem.77.070306.102408; Neelsen KJ, 2013, J CELL BIOL, V200, P699, DOI 10.1083/jcb.201212058; Danis E, 2004, NAT CELL BIOL, V6, P721, DOI 10.1038/ncb1149; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Santocanale C, 1999, GENE DEV, V13, P2360, DOI 10.1101/gad.13.18.2360; Marheineke K, 2004, J BIOL CHEM, V279, P28071, DOI 10.1074/jbc.M401574200; Naim V, 2013, NAT CELL BIOL, V15, P1008, DOI 10.1038/ncb2793; Anglana M, 2003, CELL, V114, P385, DOI 10.1016/S0092-8674(03)00569-5; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Shimura T, 2008, J MOL BIOL, V375, P1152, DOI 10.1016/j.jmb.2007.11.006; Roseaulin L, 2008, EMBO J, V27, P1378, DOI 10.1038/emboj.2008.65; Davidson IF, 2006, MOL CELL, V24, P433, DOI 10.1016/j.molcel.2006.09.010; Demczuk A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001360; Ehmsen KT, 2009, NUCLEIC ACIDS RES, V37, P2026, DOI 10.1093/nar/gkp038; Fu H., 2014, CURR PROTOC CELL BIO, V65, p[21, 20, 17]; Gilbert DM, 2007, CHROMOSOMA, V116, P341, DOI 10.1007/s00412-007-0105-9; Herrick J, 2000, P NATL ACAD SCI USA, V97, P222, DOI 10.1073/pnas.97.1.222; Hiyama T, 2006, NUCLEIC ACIDS RES, V34, P880, DOI 10.1093/nar/gkj495; Huang DL, 2003, GENE DEV, V17, P1741, DOI 10.1101/gad.1089203; Huang L, 2011, MOL CELL BIOL, V31, P3472, DOI 10.1128/MCB.05587-11; Kikuchi K, 2013, CANCER RES, V73, P4362, DOI 10.1158/0008-5472.CAN-12-3154; Lengronne A, 2002, MOL CELL, V9, P1067, DOI 10.1016/S1097-2765(02)00513-0; McGlynn AP, 1999, CANCER RES, V59, P5912; Miao ZH, 2007, CANCER RES, V67, P8752, DOI 10.1158/0008-5472.CAN-06-4554; Pepe A, 2014, NUCLEIC ACIDS RES, V42, P3833, DOI 10.1093/nar/gkt1333; Shechter D, 2004, DNA REPAIR, V3, P901, DOI 10.1016/j.dnarep.2004.03.020; Shimada K, 2002, GENE DEV, V16, P3236, DOI 10.1101/gad.239802; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Wang LX, 2004, MOL CELL BIOL, V24, P3373, DOI 10.1128/MCB.24.8.3373-3386.2004; Wu JR, 1996, SCIENCE, V271, P1270, DOI 10.1126/science.271.5253.1270	65	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6746	10.1038/ncomms7746		14	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0IF	WOS:000353702300003		
J	Fujishiro, T; Kahnt, J; Ermler, U; Shima, S				Fujishiro, Takashi; Kahnt, Joerg; Ermler, Ulrich; Shima, Seigo			Protein-pyridinol thioester precursor for biosynthesis of the organometallic acyl-iron ligand in [Fe]-hydrogenase cofactor	NATURE COMMUNICATIONS			English	Article							ACTIVE-SITE; THIAMIN BIOSYNTHESIS; STRUCTURAL GENOMICS; CRYSTAL-STRUCTURE; SULFUR TRANSFER; HYDROGENASE; COMPLEX; MODEL; CRYSTALLOGRAPHY; ACTIVATION	The iron-guanylylpyridinol (FeGP) cofactor of [Fe]-hydrogenase contains a prominent iron centre with an acyl-Fe bond and is the only acyl-organometallic iron compound found in nature. Here, we identify the functions of HcgE and HcgF, involved in the biosynthesis of the FeGP cofactor using structure-to-function strategy. Analysis of the HcgE and HcgF crystal structures with and without bound substrates suggest that HcgE catalyses the adenylylation of the carboxy group of guanylylpyridinol (GP) to afford AMP-GP, and subsequently HcgF catalyses the transesterification of AMP-GP to afford a Cys (HcgF)-S-GP thioester. Both enzymatic reactions are confirmed by in vitro assays. The structural data also offer plausible catalytic mechanisms. This strategy of thioester activation corresponds to that used for ubiquitin activation, a key event in the regulation of multiple cellular processes. It further implicates a nucleophilic attack onto the acyl carbon presumably via an electron-rich Fe(0)-or Fe(I)-carbonyl complex in the Fe-acyl formation.	[Fujishiro, Takashi; Kahnt, Joerg; Shima, Seigo] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany; [Ermler, Ulrich] Max Planck Inst Biophys, D-60438 Frankfurt, Germany; [Shima, Seigo] Japan Sci & Technol Agcy JST, PRESTO, Saitama 3320012, Japan	Shima, S (reprint author), Max Planck Inst Terr Microbiol, Karl Von Frisch Str 10, D-35043 Marburg, Germany.	shima@mpi-marburg.mpg.de	Fujishiro, Takashi/F-4804-2013	Fujishiro, Takashi/0000-0001-7967-8380	Max Planck Society; PRESTO program from the Japan Science and Technology Agency	We thank Professor Dr Rolf Thauer for discussions and helpful suggestions, Professor Dr Hartmut Michel for continuous support and the staff of the PXII beamline at the Swiss-Light-Source (Villigen) and Ulrike Demmer for help during data collection and X-ray structure analysis. This work was supported by a grant of the Max Planck Society to R. Thauer and a grant of the PRESTO program from the Japan Science and Technology Agency (S.S.).	Afonine PV, 2010, J APPL CRYSTALLOGR, V43, P669, DOI 10.1107/S0021889810015608; Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Fontecilla-Camps JC, 2009, NATURE, V460, P814, DOI 10.1038/nature08299; Lie TJ, 2013, FEMS MICROBIOL LETT, V343, P156, DOI 10.1111/1574-6968.12141; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Shepard EM, 2014, BIOCHEMISTRY-US, V53, P4090, DOI 10.1021/bi500210x; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; Lake MW, 2001, NATURE, V414, P325, DOI 10.1038/35104586; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Burstel I, 2012, J BIOL CHEM, V287, P38845, DOI 10.1074/jbc.M112.376947; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Galeazzi L, 2011, J BIOL CHEM, V286, P40365, DOI 10.1074/jbc.M111.275818; Lehmann C, 2006, BIOCHEMISTRY-US, V45, P11, DOI 10.1021/bi051502y; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Shima S, 2004, ANGEW CHEM INT EDIT, V43, P2547, DOI 10.1002/anie.200353763; Lubitz W, 2014, CHEM REV, V114, P4081, DOI 10.1021/cr4005814; Shima S, 2008, SCIENCE, V321, P572, DOI 10.1126/science.1158978; Hiromoto T, 2009, FEBS LETT, V583, P585, DOI 10.1016/j.febslet.2009.01.017; Ragsdale SW, 2007, J INORG BIOCHEM, V101, P1657, DOI 10.1016/j.jinorgbio.2007.07.014; Shima S, 2011, EUR J INORG CHEM, P963, DOI 10.1002/ejic.201000955; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Zhang C, 2003, CURR OPIN CHEM BIOL, V7, P28, DOI 10.1016/S1367-5931(02)00015-7; Turner JA, 2004, SCIENCE, V305, P972, DOI 10.1126/science.1103197; Jenney FE, 2008, EXTREMOPHILES, V12, P39, DOI 10.1007/s00792-007-0087-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Karyakin AA, 2005, BIOCHEM SOC T, V33, P73; Shima S, 2007, CHEM REC, V7, P37, DOI 10.1002/tcr.20111; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Royer AM, 2010, J AM CHEM SOC, V132, P16997, DOI 10.1021/ja1072228; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Thauer RK, 2010, ANNU REV BIOCHEM, V79, P507, DOI 10.1146/annurev.biochem.030508.152103; Kuchenreuther JM, 2014, SCIENCE, V343, P424, DOI 10.1126/science.1246572; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Burroughs AM, 2009, PROTEINS, V75, P895, DOI 10.1002/prot.22298; Fujishiro T, 2013, ANGEW CHEM INT EDIT, V52, P12555, DOI 10.1002/anie.201306745; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Olsen SK, 2013, MOL CELL, V49, P884, DOI [10.1016/j.molcel.2013.01.013, 10.1016/j.molce1.2013.01.013]; Regni CA, 2009, EMBO J, V28, P1953, DOI 10.1038/emboj.2009.146; Sanchez-Carron G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082705; Settembre E, 2003, CURR OPIN STRUC BIOL, V13, P739, DOI 10.1016/j.sbi.2003.10.006; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Soboh B, 2012, FEBS LETT, V586, P3882, DOI 10.1016/j.febslet.2012.09.019; Tan XS, 2006, J AM CHEM SOC, V128, P12331, DOI 10.1021/ja0627702; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	51	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6895	10.1038/ncomms7895		8	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0IW	WOS:000353704100003		
J	Hausrat, TJ; Muhia, M; Gerrow, K; Thomas, P; Hirdes, W; Tsukita, S; Heisler, FF; Herich, L; Dubroqua, S; Breiden, P; Feldon, J; Schwarz, JR; Yee, BK; Smart, TG; Triller, A; Kneussel, M				Hausrat, Torben J.; Muhia, Mary; Gerrow, Kimberly; Thomas, Philip; Hirdes, Wiebke; Tsukita, Sachiko; Heisler, Frank F.; Herich, Lena; Dubroqua, Sylvain; Breiden, Petra; Feldon, Joram; Schwarz, Juergen R.; Yee, Benjamin K.; Smart, Trevor G.; Triller, Antoine; Kneussel, Matthias			Radixin regulates synaptic GABA(A) receptor density and is essential for reversal learning and short-term memory	NATURE COMMUNICATIONS			English	Article							ALPHA-5 SUBUNIT; INHIBITORY SYNAPSES; DIFFUSION DYNAMICS; GLYCINE RECEPTORS; TONIC INHIBITION; PYRAMIDAL CELLS; ERM PROTEINS; A RECEPTORS; HIPPOCAMPUS; GEPHYRIN	Neurotransmitter receptor density is a major variable in regulating synaptic strength. Receptors rapidly exchange between synapses and intracellular storage pools through endocytic recycling. In addition, lateral diffusion and confinement exchanges surface membrane receptors between synaptic and extrasynaptic sites. However, the signals that regulate this transition are currently unknown. GABA(A) receptors containing alpha 5-subunits (GABA(A)R-alpha 5) concentrate extrasynaptically through radixin (Rdx)-mediated anchorage at the actin cytoskeleton. Here we report a novel mechanism that regulates adjustable plasma membrane receptor pools in the control of synaptic receptor density. RhoA/ROCK signalling regulates an activity-dependent Rdx phosphorylation switch that uncouples GABA(A)R-alpha 5 from its extrasynaptic anchor, thereby enriching synaptic receptor numbers. Thus, the unphosphorylated form of Rdx alters mIPSCs. Rdx gene knockout impairs reversal learning and short-term memory, and Rdx phosphorylation in wild-type mice exhibits experience-dependent changes when exposed to novel environments. Our data suggest an additional mode of synaptic plasticity, in which extrasynaptic receptor reservoirs supply synaptic GABA(A)Rs.	[Hausrat, Torben J.; Muhia, Mary; Hirdes, Wiebke; Heisler, Frank F.; Breiden, Petra; Schwarz, Juergen R.; Kneussel, Matthias] Univ Med Ctr Hamburg Eppendorf, Ctr Mol Neurobiol, ZMNH, Inst Mol Neurogenet, D-20251 Hamburg, Germany; [Gerrow, Kimberly; Triller, Antoine] PSL Res Univ, Ecole Normale Super, Biol Cellulaire Synapse, Inserm U1024,CNRS,UMR8197, F-75005 Paris, France; [Thomas, Philip; Smart, Trevor G.] UCL, Neurosci Physiol & Pharmacol, London WC1E 6BT, England; [Tsukita, Sachiko] Osaka Univ, Biol Sci Lab, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Tsukita, Sachiko] Osaka Univ, Grad Sch Med, Suita, Osaka 5650871, Japan; [Herich, Lena] Univ Med Ctr Hamburg Eppendorf, Med Biometry & Epidemiol, D-20246 Hamburg, Germany; [Dubroqua, Sylvain; Feldon, Joram; Yee, Benjamin K.] Swiss Fed Inst Technol Zurich, Behav Neurobiol, CH-8603 Schwerzenbach, Switzerland	Kneussel, M (reprint author), Univ Med Ctr Hamburg Eppendorf, Ctr Mol Neurobiol, ZMNH, Inst Mol Neurogenet, Falkenried 94, D-20251 Hamburg, Germany.	matthias.kneussel@zmnh.uni-hamburg.de			University Medical Center Hamburg-Eppendorf (UKE); German Research Foundation (DFG) [KN556/4-1, KN556/4-2, KN556/6-1, GRK1459]; Chica and Heinz Schaller Foundation; Hamburg Landesforschungsforderung (LFF) program; ERC Plastinhib; ANR Synaptune; Program 'Investissements d'Avenir' [ANR-10-LABX-54 MemoLife]; EMBO fellowship; UKE fellowship Forschungsforderung Fakultatsmittel (FFM)	We thank M.C. Potier for her help in how to prepare and use alpha 5IA. This study was supported by the University Medical Center Hamburg-Eppendorf (UKE), German Research Foundation (DFG) KN556/4-1, KN556/4-2, KN556/6-1, GRK1459, Chica and Heinz Schaller Foundation and Hamburg Landesforschungsforderung (LFF) program to M.K. The Swiss Federal Institute of Technology (ETH) Zurich to J.F. This work was supported by ERC Plastinhib and ANR Synaptune and the Program 'Investissements d'Avenir': ANR-10-LABX-54 MemoLife to KG and AT. KG was supported by an EMBO fellowship. F.F.H. is supported by an UKE fellowship Forschungsforderung Fakultatsmittel (FFM).	Grieger JC, 2006, NAT PROTOC, V1, P1412, DOI 10.1038/nprot.2006.207; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; Serwanski DR, 2006, J COMP NEUROL, V499, P458, DOI 10.1002/cne.21115; John GR, 2004, J NEUROSCI, V24, P2837, DOI 10.1523/JNEUROSCI.4789-03.2004; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Jacob TC, 2008, NAT REV NEUROSCI, V9, P331, DOI 10.1038/nrn2370; Brunig I, 2002, J COMP NEUROL, V443, P43, DOI 10.1002/cne.10102; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Kneussel M, 1999, J NEUROSCI, V19, P9289; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; Dawson GR, 2006, J PHARMACOL EXP THER, V316, P1335, DOI 10.1124/jpet.105.092320; Collinson N, 2002, J NEUROSCI, V22, P5572; Granger AJ, 2013, NATURE, V493, P495, DOI 10.1038/nature11775; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Loebrich S, 2006, EMBO J, V25, P987, DOI 10.1038/sj/emboj.7600995; Zarnowska ED, 2009, J NEUROPHYSIOL, V101, P1179, DOI 10.1152/jn.91203.2008; Muir J, 2010, P NATL ACAD SCI USA, V107, P16679, DOI 10.1073/pnas.1000589107; Mortensen M, 2010, J PHYSIOL-LONDON, V588, P1251, DOI 10.1113/jphysiol.2009.182444; Grimm D, 2003, MOL THER, V7, P839, DOI 10.1016/S1525-0016(03)00095-9; Renner M, 2009, J NEUROSCI, V29, P2926, DOI 10.1523/JNEUROSCI.4445-08.2009; Schanen NC, 2006, HUM MOL GENET, V15, pR138, DOI 10.1093/hmg/ddl213; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Kasugai Y, 2010, EUR J NEUROSCI, V32, P1868, DOI 10.1111/j.1460-9568.2010.07473.x; Panzanelli P, 2009, J NEUROSCI, V29, P15039, DOI 10.1523/JNEUROSCI.3034-09.2009; Mukherjee J, 2011, J NEUROSCI, V31, P14677, DOI 10.1523/JNEUROSCI.2001-11.2011; Glykys J, 2008, J NEUROSCI, V28, P1421, DOI 10.1523/JNEUROSCI.4751-07.2008; Collinson N, 2006, PSYCHOPHARMACOLOGY, V188, P619, DOI 10.1007/s00213-006-0361-z; Caraiscos VB, 2004, P NATL ACAD SCI USA, V101, P3662, DOI 10.1073/pnas.0307231101; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Kikuchi S, 2002, NAT GENET, V31, P320, DOI 10.1038/ng905; Sanderson DJ, 2011, J EXP PSYCHOL ANIM B, V37, P189, DOI 10.1037/a0021461; PEARCE RA, 1993, NEURON, V10, P189, DOI 10.1016/0896-6273(93)90310-N; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Bannai H, 2009, NEURON, V62, P670, DOI 10.1016/j.neuron.2009.04.023; Banks MI, 2000, J NEUROSCI, V20, P937; Ehrensperger MV, 2007, BIOPHYS J, V92, P3706, DOI 10.1529/biophysj.106.095596; Heisler FF, 2011, NEURON, V70, P66, DOI 10.1016/j.neuron.2011.03.008; Takami A, 2004, BIOORGAN MED CHEM, V12, P2115, DOI 10.1016/j.bmc.2004.02.025; Ju YH, 2009, J NEUROSCI RES, V87, P1737, DOI 10.1002/jnr.21991; Kang MG, 2009, P NATL ACAD SCI USA, V106, P3549, DOI 10.1073/pnas.0812861106; Kneussel M, 2000, TRENDS NEUROSCI, V23, P429, DOI 10.1016/S0166-2236(00)01627-1; Kowalczyk S., 2012, EUR J NEUROSCI, V37, P544; Machado P, 2011, J NEUROSCI, V31, P3, DOI 10.1523/JNEUROSCI.2533-10.2011; Martin LJ, 2010, J NEUROSCI, V30, P5269, DOI 10.1523/JNEUROSCI.4209-09.2010; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Mortensen M, 2004, J PHYSIOL-LONDON, V557, P389, DOI 10.1113/jphysiol.2003.054734; Paxinos G, 2001, MOUSE BRAIN STEREOTA; Tretter V, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00023; Triller A, 2005, TRENDS NEUROSCI, V28, P133, DOI 10.1016/j.tins.2005.01.001; Vargas-Caballero M., 2009, NEUROPHARMACOLOGY, V58, P668	52	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6872	10.1038/ncomms7872		17	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0IQ	WOS:000353703400039		
J	Hayashiji, N; Yuasa, S; Miyagoe-Suzuki, Y; Hara, M; Ito, N; Hashimoto, H; Kusumoto, D; Seki, T; Tohyama, S; Kodaira, M; Kunitomi, A; Kashimura, S; Takei, M; Saito, Y; Okata, S; Egashira, T; Endo, J; Sasaoka, T; Takeda, S; Fukuda, K				Hayashiji, Nozomi; Yuasa, Shinsuke; Miyagoe-Suzuki, Yuko; Hara, Mie; Ito, Naoki; Hashimoto, Hisayuki; Kusumoto, Dai; Seki, Tomohisa; Tohyama, Shugo; Kodaira, Masaki; Kunitomi, Akira; Kashimura, Shin; Takei, Makoto; Saito, Yuki; Okata, Shinichiro; Egashira, Toru; Endo, Jin; Sasaoka, Toshikuni; Takeda, Shin'ichi; Fukuda, Keiichi			G-CSF supports long-term muscle regeneration in mouse models of muscular dystrophy	NATURE COMMUNICATIONS			English	Article							COLONY-STIMULATING FACTOR; SKELETAL-MUSCLE; STEM-CELLS; SATELLITE CELLS; P38-ALPHA/BETA MAPK; SELF-RENEWAL; PROLIFERATION; INHIBITION; GENE; MICE	Duchenne muscular dystrophy (DMD) is a chronic and life-threatening disease that is initially supported by muscle regeneration but eventually shows satellite cell exhaustion and muscular dysfunction. The life-long maintenance of skeletal muscle homoeostasis requires the satellite stem cell pool to be preserved. Asymmetric cell division plays a pivotal role in the maintenance of the satellite cell pool. Here we show that granulocyte colony-stimulating factor receptor (G-CSFR) is asymmetrically expressed in activated satellite cells. G-CSF positively affects the satellite cell population during multiple stages of differentiation in ex vivo cultured fibres. G-CSF could be important in developing an effective therapy for DMD based on its potential to modulate the supply of multiple stages of regenerated myocytes. This study shows that the G-CSF-G-CSFR axis is fundamentally important for long-term muscle regeneration, functional maintenance and lifespan extension in mouse models of DMD with varying severities.	[Hayashiji, Nozomi; Yuasa, Shinsuke; Hara, Mie; Hashimoto, Hisayuki; Kusumoto, Dai; Seki, Tomohisa; Tohyama, Shugo; Kodaira, Masaki; Kunitomi, Akira; Kashimura, Shin; Takei, Makoto; Saito, Yuki; Okata, Shinichiro; Egashira, Toru; Endo, Jin; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Shinjuku Ku, Tokyo 1608582, Japan; [Miyagoe-Suzuki, Yuko; Ito, Naoki; Takeda, Shin'ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Therapy, Tokyo 1878502, Japan; [Sasaoka, Toshikuni] Niigata Univ, Brain Res Inst, Dept Comparat & Expt Med, Niigata 9518585, Japan	Yuasa, S (reprint author), Keio Univ, Sch Med, Dept Cardiol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	yuasa@a8.keio.jp			Ministry of Education, Science and Culture, Japan; Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation; Ministry of Health Labour and Welfare; Health Labour Sciences Research Grant; Nakatomi Foundation; Japan Heart Foundation/Novartis; SENSHIN Medical Research Foundation; Kimura Memorial Heart Foundation; Japan Intractable Diseases Research Foundation, Japan; Cell Science Research Foundation; Tokyo Biochemical Research Foundation; Suzuken Memorial Foundation; Japan Foundation for Applied Enzymology	This study was supported in part by research grants from The Ministry of Education, Science and Culture, Japan; The Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation; The Ministry of Health Labour and Welfare; Health Labour Sciences Research Grant; Nakatomi Foundation; Japan Heart Foundation/Novartis Grant for Research Award on Molecular and Cellular Cardiology; SENSHIN Medical Research Foundation; Kimura Memorial Heart Foundation Research Grant; Japan Intractable Diseases Research Foundation, Japan; The Cell Science Research Foundation; The Tokyo Biochemical Research Foundation; Suzuken Memorial Foundation; and The Japan Foundation for Applied Enzymology.	Ameen Venus, 2010, Open Cardiovasc Med J, V4, P265, DOI 10.2174/1874192401004010265; SCHIAFFINO S, 1988, DEV BIOL, V127, P1, DOI 10.1016/0012-1606(88)90183-2; HOFFMAN EP, 1988, NEW ENGL J MED, V318, P1363, DOI 10.1056/NEJM198805263182104; Shi XZ, 2006, GENE DEV, V20, P1692, DOI 10.1101/gad.1419406; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007; Troy A, 2012, CELL STEM CELL, V11, P541, DOI 10.1016/j.stem.2012.05.025; Olguin HC, 2007, J CELL BIOL, V177, P769, DOI 10.1083/jcb.200608122; Alter J, 2008, J BIOL CHEM, V283, P23224, DOI 10.1074/jbc.M801379200; Shimoji K, 2010, CELL STEM CELL, V6, P227, DOI 10.1016/j.stem.2010.01.002; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Kawabe YI, 2012, CELL STEM CELL, V11, P333, DOI 10.1016/j.stem.2012.07.001; Yuasa S, 2010, CIRC RES, V106, P1083, DOI 10.1161/CIRCRESAHA.109.214130; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; Hara M, 2011, J EXP MED, V208, P715, DOI 10.1084/jem.20101059; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; Bentzinger CF, 2013, CELL STEM CELL, V12, P75, DOI 10.1016/j.stem.2012.09.015; Relaix F, 2012, DEVELOPMENT, V139, P2845, DOI 10.1242/dev.069088; Quinlan JG, 2004, NEUROMUSCULAR DISORD, V14, P491, DOI 10.1016/j.nmd.2004.04.007; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; Tanaka KK, 2009, CELL STEM CELL, V4, P217, DOI 10.1016/j.stem.2009.01.016; DRACHMAN DB, 1974, LANCET, V2, P1409; Evans NP, 2009, AM J PHYS MED REHAB, V88, P502, DOI 10.1097/PHM.0b013e3181a5a24f; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; Yuasa S, 2005, NAT BIOTECHNOL, V23, P607, DOI 10.1038/nbt1093; Muntoni F, 2007, CURR OPIN NEUROL, V20, P590; Fairclough RJ, 2011, EXP PHYSIOL, V96, P1101, DOI 10.1113/expphysiol.2010.053025; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Jones NC, 2005, J CELL BIOL, V169, P105, DOI 10.1083/jcb.200408066; Bushby K, 2004, Neuromuscul Disord, V14, P526, DOI 10.1016/j.nmd.2004.05.006; Cottler-Fox MH, 2003, HEMATOLOGY, V1, P419; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Griggs RC, 2010, LANCET NEUROL, V9, P1038, DOI 10.1016/S1474-4422(10)70210-6; Hermans MHA, 1998, BLOOD, V92, P32; Richards MK, 2003, BLOOD, V102, P3562, DOI 10.1182/blood-2003-02-0593; SHARMA KR, 1993, NEUROLOGY, V43, P527; Siegel A.L., 2011, SKELETAL MUSCLE, V2, P1; Stratos I, 2007, J APPL PHYSIOL, V103, P1857, DOI 10.1152/japplphysiol.00066.2007; Wang YX, 2014, J CELL SCI, V127, P4543, DOI 10.1242/jcs.151209; Yablonka-Reuveni Z, 2008, J Anim Sci, V86, pE207	41	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6745	10.1038/ncomms7745		14	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0IF	WOS:000353702300002		
J	Hiraoka, K; Inoue, T; Taylor, RD; Watanabe, T; Koshikawa, N; Yoda, H; Shinohara, K; Takatori, A; Sugimoto, H; Maru, Y; Denda, T; Fujiwara, K; Balmain, A; Ozaki, T; Bando, T; Sugiyama, H; Nagase, H				Hiraoka, Kiriko; Inoue, Takahiro; Taylor, Rhys Dylan; Watanabe, Takayoshi; Koshikawa, Nobuko; Yoda, Hiroyuki; Shinohara, Ken-ichi; Takatori, Atsushi; Sugimoto, Hirokazu; Maru, Yoshiaki; Denda, Tadamichi; Fujiwara, Kyoko; Balmain, Allan; Ozaki, Toshinori; Bando, Toshikazu; Sugiyama, Hiroshi; Nagase, Hiroki			Inhibition of KRAS codon 12 mutants using a novel DNA-alkylating pyrrole-imidazole polyamide conjugate	NATURE COMMUNICATIONS			English	Article							SEQUENCE-SPECIFIC ALKYLATION; COLORECTAL-CANCER; ANTITUMOR-ACTIVITY; CBI CONJUGATE; RECOGNITION; SENESCENCE; MUTATIONS; DISCOVERY	Despite extensive efforts to target mutated RAS proteins, anticancer agents capable of selectively killing tumour cells harbouring KRAS mutations have remained unavailable. Here we demonstrate the direct targeting of KRAS mutant DNA using a synthetic alkylating agent (pyrrole-imidazole polyamide indole-seco-CBI conjugate; KR12) that selectively recognizes oncogenic codon 12 KRAS mutations. KR12 alkylates adenine N3 at the target sequence, causing strand cleavage and growth suppression in human colon cancer cells with G12D or G12V mutations, thus inducing senescence and apoptosis. In xenograft models, KR12 infusions induce significant tumour growth suppression, with low host toxicity in KRAS-mutated but not wild-type tumours. This newly developed approach may be applicable to the targeting of other mutant driver oncogenes in human tumours.	[Hiraoka, Kiriko; Inoue, Takahiro; Watanabe, Takayoshi; Koshikawa, Nobuko; Yoda, Hiroyuki; Shinohara, Ken-ichi; Takatori, Atsushi; Maru, Yoshiaki; Nagase, Hiroki] Chiba Canc Ctr, Res Inst, Canc Genet Lab, Chuoh Ku, Chiba 2608717, Japan; [Taylor, Rhys Dylan; Bando, Toshikazu; Sugiyama, Hiroshi] Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan; [Sugimoto, Hirokazu; Ozaki, Toshinori] Chiba Canc Ctr, Res Inst, Lab DNA Damage Signaling, Chuoh Ku, Chiba 2608717, Japan; [Denda, Tadamichi] Chiba Canc Ctr, Dept Gastroenterol, Chuoh Ku, Chiba 2608717, Japan; [Fujiwara, Kyoko] Nihon Univ, Res Inst Med Sci, Innovat Therapy Res Grp, Sch Med,Itabashi Ku, Tokyo 1738610, Japan; [Balmain, Allan] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA	Nagase, H (reprint author), Chiba Canc Ctr, Res Inst, Canc Genet Lab, Chuoh Ku, 666-2 Nitona, Chiba 2608717, Japan.	hnagase@chiba-cc.jp	Sugiyama, Hiroshi/C-7687-2011		Ministry of Education, Culture, Sports, Science and Technology, Japan [23300344, 25134718, 13307606]	We are grateful to Mr. Y. Hirano and Mr. Y. Suzuki for technical assistance. This work was supported by a Grant-in-Aid for Scientific Research (B) #23300344 and in Innovative Areas #25134718 and by a Project for the Development of Innovative Research on Cancer Therapeutics (P-Direct) and Young Scientists (B) #13307606 from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Yang F, 2013, P NATL ACAD SCI USA, V110, P1863, DOI 10.1073/pnas.1222035110; Dervan PB, 2001, BIOORGAN MED CHEM, V9, P2215, DOI 10.1016/S0968-0896(01)00262-0; Taylor RD, 2014, CHEM-EUR J, V20, P1310, DOI 10.1002/chem.201303295; Shima F, 2013, P NATL ACAD SCI USA, V110, P8182, DOI 10.1073/pnas.1217730110; Neumann J, 2009, PATHOL RES PRACT, V205, P858, DOI 10.1016/j.prp.2009.07.010; Matsuda H, 2011, KIDNEY INT, V79, P46, DOI 10.1038/ki.2010.330; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Bando T, 2006, ACCOUNTS CHEM RES, V39, P935, DOI 10.1021/ar030287f; Bando T, 2006, BIOCONJUGATE CHEM, V17, P715, DOI 10.1021/bc060022w; Baldwin T, 2007, PARASITE IMMUNOL, V29, P501, DOI 10.1111/j.1365-3024.2007.00969.x; Tortolina L, 2012, CURR CANCER DRUG TAR, V12, P339; Wang YD, 2002, J BIOL CHEM, V277, P42431, DOI 10.1074/jbc.M207179200; Liu Y, 2006, P NATL ACAD SCI USA, V103, P976, DOI 10.1073/pnas.0510146103; Wurtz NR, 2000, CHEM BIOL, V7, P153, DOI 10.1016/S1074-5521(00)00085-5; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Lengauer C, 2005, NAT REV DRUG DISCOV, V4, P375, DOI 10.1038/nrd1722; Dickinson LA, 2004, CHEM BIOL, V11, P1583, DOI 10.1016/j.chembiol.2004.09.004; Jespersen C, 2012, BIOORG MED CHEM LETT, V22, P4068, DOI 10.1016/j.bmcl.2012.04.090; Perez R, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00053; Raskatov JA, 2014, J MED CHEM, V57, P8471, DOI 10.1021/jm500964c; Rokita M, 2013, ONCOTARGETS THER, V6, P967, DOI 10.2147/OTT.S42446; The American Cancer Society, 2013, AM CANC SOC CANC FAC; Wang XF, 2010, CANCER SCI, V101, P759, DOI 10.1111/j.1349-7006.2009.01435.x; Zimmermann G., 2013, NATURE, V497, P631	25	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6706	10.1038/ncomms7706		8	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0HK	WOS:000353700200001		
J	Horiuchi, S; Tachibana, Y; Yamashita, M; Yamamoto, K; Masai, K; Takase, K; Matsutani, T; Kawamata, S; Kurashige, Y; Yanai, T; Murahashi, T				Horiuchi, Shinnosuke; Tachibana, Yuki; Yamashita, Mitsuki; Yamamoto, Koji; Masai, Kohei; Takase, Kohei; Matsutani, Teruo; Kawamata, Shiori; Kurashige, Yuki; Yanai, Takeshi; Murahashi, Tetsuro			Multinuclear metal-binding ability of a carotene	NATURE COMMUNICATIONS			English	Article							SANDWICH COMPLEXES; IRON TRICARBONYL; PALLADIUM; CHAINS; CLUSTERS; LIGAND; ATOMS; CHEMISTRY; BONDS	Carotenes are naturally abundant unsaturated hydrocarbon pigments, and their fascinating physical and chemical properties have been studied intensively not only for better understanding of the roles in biological processes but also for the use in artificial chemical systems. However, their metal-binding ability has been virtually unexplored. Here we report that beta-carotene has the ability to assemble and align ten metal atoms to afford decanuclear homoand heterometal chain complexes. The metallo-carotenoid framework shows reversible metalation-demetalation reactivity with multiple metals, which allows us to control the size of metal chains as well as the heterobimetallic composition and arrangement of the carotene-supported metal chains.	[Horiuchi, Shinnosuke; Tachibana, Yuki; Yamashita, Mitsuki; Yamamoto, Koji; Masai, Kohei; Kawamata, Shiori; Murahashi, Tetsuro] Natl Inst Nat Sci, Inst Mol Sci, Res Ctr Integrat Mol Syst CIMoS, Okazaki, Aichi 4448787, Japan; [Tachibana, Yuki; Takase, Kohei; Matsutani, Teruo] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan; [Yamashita, Mitsuki; Yamamoto, Koji; Masai, Kohei; Murahashi, Tetsuro] Grad Univ Adv Studies, Dept Struct Mol Sci, Okazaki, Aichi 4448787, Japan; [Kurashige, Yuki; Yanai, Takeshi] Natl Inst Nat Sci, Inst Mol Sci, Dept Theoret & Computat Mol Sci, Okazaki, Aichi 4448585, Japan; [Kurashige, Yuki; Yanai, Takeshi] Grad Univ Adv Studies, Dept Funct Mol Sci, Okazaki, Aichi 4448585, Japan; [Murahashi, Tetsuro] Japan Sci & Technol Agcy JST, PRESTO, Okazaki, Aichi 4448787, Japan	Murahashi, T (reprint author), Natl Inst Nat Sci, Inst Mol Sci, Res Ctr Integrat Mol Syst CIMoS, Okazaki, Aichi 4448787, Japan.	mura@ims.ac.jp			JST through PRESTO programme; JSPS; MEXT	This work was supported by JST through PRESTO programme, JSPS and MEXT through Grants-in-aid for Scientific Research and Institute for Molecular Science. We thank Professor H. Kurosawa and Professor S. Ogoshi for discussion.	Berry JF, 2010, STRUCT BOND, V136, P1, DOI 10.1007/978-3-642-05243-9_1; Sarkar S, 2014, CHEM MATER, V26, P184, DOI 10.1021/cm4025809; Tanaka K, 2006, NAT NANOTECHNOL, V1, P190, DOI 10.1038/nnano.2006.141; Campbell MG, 2011, NAT CHEM, V3, P949, DOI [10.1038/nchem.1197, 10.1038/NCHEM.1197]; UKAI T, 1974, J ORGANOMET CHEM, V65, P253, DOI 10.1016/S0022-328X(00)91277-4; Polivka T, 2010, ACCOUNTS CHEM RES, V43, P1125, DOI 10.1021/ar100030m; Stromberg S, 1997, ORGANOMETALLICS, V16, P3165, DOI 10.1021/om970261q; Yanai T, 2004, CHEM PHYS LETT, V393, P51, DOI 10.1016/j.cplett.2004.06.011; Visoly-Fisher I, 2006, P NATL ACAD SCI USA, V103, P8686, DOI 10.1073/pnas.0600593103; Zhao QL, 2011, J AM CHEM SOC, V133, P8293, DOI 10.1021/ja2015845; Kanady JS, 2011, SCIENCE, V333, P733, DOI 10.1126/science.1206036; Murahashi T, 2006, SCIENCE, V313, P1104, DOI 10.1126/science.1125245; Ismayilov RH, 2011, ANGEW CHEM INT EDIT, V50, P2045, DOI 10.1002/anie.201006695; Diefenbach A, 2000, J AM CHEM SOC, V122, P6449, DOI 10.1021/ja000663g; Bera JK, 2002, ANGEW CHEM INT EDIT, V41, P4453, DOI 10.1002/1521-3773(20021202)41:23<4453::AID-ANIE4453>3.0.CO;2-1; Chambers A, 1998, J PHYS CHEM B, V102, P2251, DOI 10.1021/jp973462g; Polivka T, 2004, CHEM REV, V104, P2021, DOI 10.1021/cr020674n; Nakamae K, 2015, ANGEW CHEM INT EDIT, V54, P1016, DOI 10.1002/anie.201409511; Murahashi T, 2002, COORDIN CHEM REV, V231, P207, DOI 10.1016/S0010-8545(02)00121-2; BIRCH AJ, 1966, CHEM COMMUN, P613, DOI 10.1039/c19660000613; ICHIKAWA M, 1967, Z NATURFORSCH PT B, VB 22, P376; Mashima K, 2002, J ORGANOMET CHEM, V663, P5, DOI 10.1016/S0022-328X(02)01728-X; MASON R, 1970, J CHEM SOC A, P1229, DOI 10.1039/j19700001229; Mednikov EG, 2009, J CHEM EDUC, V86, P1135; Murahashi T, 2012, NAT CHEM, V4, P52, DOI 10.1038/nchem.1202; Murahashi T, 2009, J AM CHEM SOC, V131, P9888, DOI 10.1021/ja903679f; Murahashi T, 2012, CHEM-EUR J, V18, P8886, DOI 10.1002/chem.201201474; Murahashi T, 1999, J AM CHEM SOC, V121, P10660, DOI 10.1021/ja992387f; Murahashi T, 2000, CHEM COMMUN, P1689, DOI 10.1039/b004726k; NAKAMURA A, 1964, J MED CHEM, V7, P335, DOI 10.1021/jm00333a018; Sunada Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3014; Takaichi S., 2006, CAROTENOIDS BIOL FUN; Takemoto S, 2012, COORDIN CHEM REV, V256, P574, DOI 10.1016/j.ccr.2011.10.025; Tatsumi Y, 2004, CHEM COMMUN, P1430, DOI 10.1039/b403098b; Tatsumi Y, 2006, ANGEW CHEM INT EDIT, V45, P5799, DOI 10.1002/anie.200601641; Uddin J, 1999, ORGANOMETALLICS, V18, P457, DOI 10.1021/om9805842	36	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6742	10.1038/ncomms7742		8	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0ID	WOS:000353702100001		
J	Huang, LZ; Li, YJ; Xie, XF; Zhang, JJ; Cheng, CY; Yamashiro, K; Chen, LJ; Ma, XY; Cheung, CMG; Wang, YS; Zhang, CF; Bai, YJ; Hou, J; Chen, XL; Qi, Y; Li, SS; Sun, YY; Mei, JP; Cheng, Y; Yu, WZ; Hu, XB; Zhuang, FF; Fan, L; Lu, Y; Sun, XH; Zhu, XJ; Shen, DF; Chan, CC; Zhao, MW; Yoshimura, N; Pang, CP; Wong, TY; Khor, CC; Zhang, K; Zhou, P; Li, XX				Huang, Lv-Zhen; Li, Ying-Jie; Xie, Xue-Feng; Zhang, Jing-Jing; Cheng, Ching-Yu; Yamashiro, Kenji; Chen, Li-Jia; Ma, Xiao-Yun; Cheung, Chui Ming G.; Wang, Yu-Sheng; Zhang, Chun-Fang; Bai, Yu-Jing; Hou, Jing; Chen, Xiao-Li; Qi, Yun; Li, Shan-Shan; Sun, Yao-Yao; Mei, Jun-Pu; Cheng, Yong; Yu, Wen-Zhen; Hu, Xiong-Bing; Zhuang, Feng-Feng; Fan, Lei; Lu, Yi; Sun, Xing-Huai; Zhu, Xiang-Jia; Shen, De-Fen; Chan, Chi-Chao; Zhao, Ming-Wei; Yoshimura, Nagahisa; Pang, Chi Pui; Wong, Tien Yin; Khor, Chiea Chuen; Zhang, Kang; Zhou, Peng; Li, Xiao-Xin			Whole-exome sequencing implicates UBE3D in age-related macular degeneration in East Asian populations	NATURE COMMUNICATIONS			English	Article							GENOME-WIDE ASSOCIATION; UBIQUITIN-PROTEASOME-SYSTEM; ALZHEIMERS-DISEASE; CONJUGATION; EXPRESSION; GENES; LOCI; EYE	Age-related macular degeneration (AMD) is a leading cause of irreversible central blindness among the elderly worldwide. We use exome sequencing to analyse nonsynonymous single-nucleotide variants (SNVs) across the whole genome of 216 neovascular AMD cases and 1,553 controls. As a follow-up validation, we evaluate 3,772 neovascular AMD cases and 6,942 controls from five independent cohorts in the East Asian population. Here we show strong evidence of an association at a novel, missense SNV, rs7739323, which is located in the ubiquitin protein ligase E3D (UBE3D) gene (P-meta = 1.46 x 10(-9), odds ratio (OR) = 0.74, 95% confidence interval (CI): 0.63-0.88). Furthermore, ablation of the UBE3D protein lead to an abnormal amount of pigment granules deposited in retinal pigment epithelium microvilli area and an abnormal response on electroretinography (ERG) in UBE3D(+/-) heterozygous mice. Our findings indicate that the ubiquitin-proteasome system may play a role in the pathogenesis of neovascular AMD.	[Huang, Lv-Zhen; Zhang, Jing-Jing; Bai, Yu-Jing; Hou, Jing; Chen, Xiao-Li; Qi, Yun; Li, Shan-Shan; Sun, Yao-Yao; Cheng, Yong; Yu, Wen-Zhen; Zhao, Ming-Wei; Khor, Chiea Chuen; Li, Xiao-Xin] Minist Educ China, Key Lab Vis Loss & Restorat, Beijing 100044, Peoples R China; [Huang, Lv-Zhen; Zhang, Jing-Jing; Bai, Yu-Jing; Hou, Jing; Chen, Xiao-Li; Qi, Yun; Li, Shan-Shan; Sun, Yao-Yao; Cheng, Yong; Yu, Wen-Zhen; Zhao, Ming-Wei; Li, Xiao-Xin] Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing 100044, Peoples R China; [Huang, Lv-Zhen; Zhang, Jing-Jing; Bai, Yu-Jing; Hou, Jing; Chen, Xiao-Li; Qi, Yun; Li, Shan-Shan; Sun, Yao-Yao; Yu, Wen-Zhen; Hu, Xiong-Bing; Zhao, Ming-Wei; Li, Xiao-Xin] Beijing Key Lab Diag & Therapy Retinal & Choroid, Beijing 100044, Peoples R China; [Li, Ying-Jie] Chinese Acad Med Sci, Peking Union Med Coll, Canc Inst & Hosp, Dept Abdominal Surg Oncol, Beijing 100021, Peoples R China; [Xie, Xue-Feng] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Cheng, Ching-Yu; Cheung, Chui Ming G.; Mei, Jun-Pu; Wong, Tien Yin] Singapore Eye Res Inst, Singapore 169856, Singapore; [Cheng, Ching-Yu; Wong, Tien Yin] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore; [Zhang, Chun-Fang; Wong, Tien Yin] Natl Univ Singapore, Dept Ophthalmol, Singapore 119228, Singapore; [Cheng, Ching-Yu; Wong, Tien Yin] Natl Univ Hlth Syst, Singapore 119228, Singapore; [Cheng, Ching-Yu; Cheung, Chui Ming G.; Wang, Yu-Sheng; Wong, Tien Yin] Singapore Natl Eye Ctr, Singapore 168751, Singapore; [Yamashiro, Kenji; Yoshimura, Nagahisa] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto 6068507, Japan; [Chen, Li-Jia; Pang, Chi Pui] Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Hong Kong 999077, Hong Kong, Peoples R China; [Ma, Xiao-Yun] Guanghua Integrat Med Hosp, Dept Ophthalmol, Shanghai 200052, Peoples R China; [Wang, Yu-Sheng] Fourth Mil Med Univ, Xijing Hosp, Dept Ophthalmol, Xian 710032, Peoples R China; [Zhang, Chun-Fang] Peking Univ, Peoples Hosp, Dept Clin Epidemiol, Beijing 100044, Peoples R China; [Hu, Xiong-Bing; Zhuang, Feng-Feng] Beijing View Solid Biotechnol, Beijing 100034, Peoples R China; [Fan, Lei; Lu, Yi; Sun, Xing-Huai; Zhu, Xiang-Jia; Zhou, Peng] Fudan Univ, Shanghai Med Coll, Shanghai 200032, Peoples R China; [Lu, Yi; Sun, Xing-Huai; Zhu, Xiang-Jia; Zhou, Peng] Fudan Univ, Eye & ENT Hosp, Dept Ophthalmol, Shanghai 200433, Peoples R China; [Shen, De-Fen; Chan, Chi-Chao] NEI, NIH, Bethesda, MD 20892 USA; [Khor, Chiea Chuen] Genome Inst Singapore, Div Human Genet, Singapore 138672, Singapore; [Khor, Chiea Chuen] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117549, Singapore; [Khor, Chiea Chuen] Natl Univ Hlth Syst, Singapore 117549, Singapore; [Zhang, Kang] Inst Genom Med, La Jolla, CA 92093 USA; [Zhang, Kang] Shiley Eye Ctr, La Jolla, CA 92093 USA; [Zhang, Kang] Univ Calif San Diego, La Jolla, CA 92093 USA; [Zhou, Peng] Pkwy Hlth Hongqiao Med Ctr, Shanghai 201101, Peoples R China	Li, XX (reprint author), Minist Educ China, Key Lab Vis Loss & Restorat, Beijing 100044, Peoples R China.	zhaomingwei@medmail.com.cn; drzhoupeng@gmail.com; drlixiaoxin@163.com			National Basic Research Program of China (973 Program) [2011CB510200]; National Natural Science Foundation of China [81200669, 81100666, 81102003, 81270989, 81100653]; Research Fund for Science and Technology Program of Beijing [Z121100005312006]; Doctoral Program of Higher Education of China [20120071120089]; Zhuo-Xue Project of Fudan University; National Medical Research Council (NMRC) [0796/2003, IRG07nov013, IRG09nov014, NMRC 1176/2008, NIG/1003/2009, STaR/0003/2008, CG/SERI/2010, CSA/033/2012]; Biomedical Research Council in Singapore [BMRC 08/1/35/19/550, 09/1/35/19/616, 10/1/35/19/671]; BrightFocus Foundation, USA [M2011068]; NMRC, Singapore [CSA/033/2012]	This work was supported by the National Basic Research Program of China (973 Program, no. 2011CB510200), the National Natural Science Foundation of China (nos. 81200669, 81100666, 81102003, 81270989 and 81100653), and the Research Fund for Science and Technology Program of Beijing (no. Z121100005312006), the Doctoral Program of Higher Education of China (no. 20120071120089) and the Zhuo-Xue Project of Fudan University (to P.Z.). This work was also supported by the National Medical Research Council (NMRC grants 0796/2003, IRG07nov013, IRG09nov014, NMRC 1176/2008, NIG/1003/2009, STaR/0003/2008, CG/SERI/2010 and CSA/033/2012), and Biomedical Research Council (BMRC 08/1/35/19/550, 09/1/35/19/616 and 10/1/35/19/671) in Singapore; the BrightFocus Foundation (M2011068), USA. C.-Y.C. is supported by an award from NMRC (CSA/033/2012), Singapore.	Naj AC, 2013, ANN HUM GENET, V77, P215, DOI 10.1111/ahg.12011; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Cipriani V, 2012, HUM MOL GENET, V21, P4138, DOI 10.1093/hmg/dds225; Chen YH, 2010, MOL INTERV, V10, P271, DOI 10.1124/mi.10.5.4; Kaarniranta K, 2011, J ALZHEIMERS DIS, V24, P615, DOI 10.3233/JAD-2011-101908; Balastik M, 2008, P NATL ACAD SCI USA, V105, P12016, DOI 10.1073/pnas.0802261105; SOMMER T, 1993, NATURE, V365, P176, DOI 10.1038/365176a0; Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Jones A, 2011, P NATL ACAD SCI USA, V108, P14578, DOI 10.1073/pnas.1102853108; Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327; Ohno-Matsui K, 2011, PROG RETIN EYE RES, V30, P217, DOI 10.1016/j.preteyeres.2011.02.004; Takeda A, 2009, NATURE, V460, P225, DOI 10.1038/nature08151; Sommer T, 2014, BBA-MOL CELL RES, V1843, P1, DOI 10.1016/j.bbamcr.2013.09.009; Zhou P, 2011, FASEB J, V25, P3489, DOI 10.1096/fj.11-189258; Singleton AB, 2011, LANCET NEUROL, V10, P942, DOI 10.1016/S1474-4422(11)70196-X; Sobrin L, 2012, OPHTHALMOLOGY, V119, P1874, DOI 10.1016/j.ophtha.2012.03.014; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; Kiezun A, 2012, NAT GENET, V44, P623, DOI 10.1038/ng.2303; Norton N, 2011, AM J HUM GENET, V88, P273, DOI 10.1016/j.ajhg.2011.01.016; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; Hegde AN, 2004, PROG NEUROBIOL, V73, P311, DOI 10.1016/j/.pneurobio.2004.05.005; Clemons TE, 2003, ARCH OPHTHALMOL-CHIC, V121, P211; Group CR, 2011, NEW ENGL J MED, V364, P1897; Haas AL, 1997, FASEB J, V11, P1257; Holliday EG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053830; Japanese Study Group of Polypoidal Choroidal Vasculopathy, 2005, NIPPON GANKA GAKKAI, V109, P417; Lencz T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3739; Liu ZZ, 2014, ADV EXP MED BIOL, V801, P237, DOI 10.1007/978-1-4614-3209-8_31; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Nath D, 2009, NATURE, V458, P421, DOI 10.1038/458421a; Qi Y, 2014, INVEST OPHTH VIS SCI, V55, P5466, DOI 10.1167/iovs.14-14380; Sanders SS, 2011, CLIN GENET, V79, P132, DOI 10.1111/j.1399-0004.2010.01585.x	36	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6687	10.1038/ncomms7687		6	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0GU	WOS:000353698500001		
J	Ihara, T; Ohura, H; Shirahama, C; Furuzono, T; Shimada, H; Matsuura, H; Kitamura, Y				Ihara, Toshihiro; Ohura, Hiroyuki; Shirahama, Chisato; Furuzono, Tomohiro; Shimada, Hiroshi; Matsuura, Hirotaka; Kitamura, Yusuke			Metal ion-directed dynamic splicing of DNA through global conformational change by intramolecular complexation	NATURE COMMUNICATIONS			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; TRIPLE-HELIX FORMATION; NUCLEIC-ACID; PEROXIDASE-ACTIVITY; ARTIFICIAL DNA; BASE-PAIRS; SMALL MOLECULES; SILVER ION; DNAZYME; BINDING	Chemically engineered DNAs-in which global conformation can be modulated in response to specific stimuli-could be allosteric functional DNAs themselves or work as a modulator of the functional nucleic acids such as DNAzymes and aptamers. Here, we show that two terpyridines built in the DNA backbone form a stable intramolecular 1:2 complex, [M(terpy)(2)](2+), with divalent transition metal ions. Upon complexation, the DNA conjugates adopt a Omega-shape structure, in which two distal sequences located outside the terpyridines connect with each other to form a continuous segment with a specific structure or sequence. Such a DNA structure is globally controlled by local metal complexation events that can be rationally designed based on general coordination chemistry. This method is regarded as metal ion-directed dynamic sequence edition or DNA splicing. DNAzymes with peroxidase-like activity can thus be regulated by several transition metal ions through sequence edition techniques based on the Omega-motif.	[Ihara, Toshihiro; Ohura, Hiroyuki; Shirahama, Chisato; Furuzono, Tomohiro; Shimada, Hiroshi; Matsuura, Hirotaka; Kitamura, Yusuke] Kumamoto Univ, Grad Sch Sci & Technol, Dept Appl Chem & Biochem, Chuo Ku, Kumamoto 8608555, Japan; [Ihara, Toshihiro; Kitamura, Yusuke] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1020076, Japan	Ihara, T (reprint author), Kumamoto Univ, Grad Sch Sci & Technol, Dept Appl Chem & Biochem, Chuo Ku, 2-39-1 Kurokami, Kumamoto 8608555, Japan.	toshi@chem.kumamoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [2107, 24108734, 24350040]; Ministry of Health and Labor, Japan	We thank Ms M. Nishi for the assistance in the measurements of mass spectra for amidite and conjugates identification. We also thank Professor H. Ihara and Professor M. Takafuji for their support in measuring CD spectra. This work was supported by the Grant-in-Aid for Scientific Research on Innovative Areas (Coordination Programming, Area 2107) (no. 24108734 to T.I.), Scientific Research (B) (no. 24350040 to T.I.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan; and the Health Labor Sciences Research Grant (Research on Publicly Essential Drugs and Medical Devices) (to T.I.) from the Ministry of Health and Labor, Japan.	Clever GH, 2007, ANGEW CHEM INT EDIT, V46, P6226, DOI 10.1002/anie.200701185; Schwarz G, 2014, ADV COLLOID INTERFAC, V207, P107, DOI 10.1016/j.cis.2013.12.010; REDDY EP, 1982, NATURE, V300, P149, DOI 10.1038/300149a0; Tanaka K, 2006, NAT NANOTECHNOL, V1, P190, DOI 10.1038/nnano.2006.141; Nakayama S, 2009, J AM CHEM SOC, V131, P10320, DOI 10.1021/ja902951b; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; MARKY LA, 1987, BIOPOLYMERS, V26, P1601, DOI 10.1002/bip.360260911; Collins PJ, 1998, APPL ENVIRON MICROB, V64, P2026; Tanaka K, 2003, SCIENCE, V299, P1212, DOI 10.1126/science.1080587; Kolpashchikov DM, 2008, J AM CHEM SOC, V130, P2934, DOI 10.1021/ja711192e; Gramlich PME, 2008, ANGEW CHEM INT EDIT, V47, P8350, DOI 10.1002/anie.200802077; Ihara T, 2009, J AM CHEM SOC, V131, P3826, DOI 10.1021/ja809702n; Zhang HQ, 2013, CHEM REV, V113, P2812, DOI 10.1021/cr300340p; Li YF, 1997, BIOCHEMISTRY-US, V36, P5589, DOI 10.1021/bi962694n; Travascio P, 1998, CHEM BIOL, V5, P505, DOI 10.1016/S1074-5521(98)90006-0; Nishioka H, 2012, ANGEW CHEM INT EDIT, V51, P1165, DOI 10.1002/anie.201106093; Guo WW, 2014, CHEM COMMUN, V50, P4065, DOI 10.1039/c3cc49140d; Lim RKV, 2010, CHEM COMMUN, V46, P1589, DOI 10.1039/b925931g; EICHHORN GL, 1968, J AM CHEM SOC, V90, P7323, DOI 10.1021/ja01028a024; Liu JW, 2009, CHEM REV, V109, P1948, DOI 10.1021/cr030183i; He XW, 2014, ANAL CHEM, V86, P3676, DOI 10.1021/ac500590d; Cheng XH, 2009, BIOCHEMISTRY-US, V48, P7817, DOI 10.1021/bi9006786; Vinkenborg JL, 2011, NAT CHEM BIOL, V7, P519, DOI [10.1038/nchembio.609, 10.1038/NCHEMBIO.609]; Takezawa Y, 2009, ANGEW CHEM INT EDIT, V48, P1081, DOI 10.1002/anie.200804654; Urata H, 2010, ANGEW CHEM INT EDIT, V49, P6516, DOI 10.1002/anie.201002142; Ono T, 2011, CHEM COMMUN, V47, P1542, DOI 10.1039/c0cc02028a; Ono A, 2011, CHEM SOC REV, V40, P5855, DOI 10.1039/c1cs15149e; Ambrus A, 2006, NUCLEIC ACIDS RES, V34, P2723, DOI 10.1093/nar/gkl348; Graf N, 2006, ANGEW CHEM INT EDIT, V45, P4013, DOI 10.1002/anie.200504319; Chen X, 2013, P NATL ACAD SCI USA, V110, P5386, DOI 10.1073/pnas.1222807110; Scharf P, 2013, CHEMPLUSCHEM, V78, P20, DOI 10.1002/cplu.201200256; Park KS, 2014, CURR OPIN BIOTECH, V28, P17, DOI 10.1016/j.copbio.2013.10.013; Arslan P, 2010, ORG BIOMOL CHEM, V8, P4843, DOI 10.1039/c0ob00282h; Bianke G, 2004, CHEMBIOCHEM, V5, P1063, DOI 10.1002/cbic.200400030; Biver T, 2013, COORDIN CHEM REV, V257, P2765, DOI 10.1016/j.ccr.2013.04.016; Bjerrum J., 1957, COMPILED STABILITY C; Breaker R R, 1994, Chem Biol, V1, P223, DOI 10.1016/1074-5521(94)90014-0; Choi JS, 2004, J AM CHEM SOC, V126, P8606, DOI 10.1021/ja048537q; Goritz M, 2005, J AM CHEM SOC, V127, P18016, DOI 10.1021/ja056463s; Hau A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049636; Hud N. V., 2009, NUCL ACID METAL ION; Ihara T, 2001, J AM CHEM SOC, V123, P1772, DOI 10.1021/ja0027362; Ihara T, 2004, J AM CHEM SOC, V126, P8880, DOI 10.1021/ja047784r; Ihara T, 2008, NUCLEOS NUCLEOT NUCL, V27, P1084, DOI 10.1080/15257770802271813; Ihara T, 2006, J INORG BIOCHEM, V100, P1744, DOI 10.1016/j.jinorgbio.2006.06.008; Ihara T, 1997, SUPRAMOL CHEM, V8, P93, DOI 10.1080/10610279708233974; Kitamura Y, 2008, J INORG BIOCHEM, V102, P1921, DOI [10.1016/j.jinorgbio.2008.06.016, 10.1016/j,jinorgbio.2008.06.016]; Kong DM, 2010, ANALYST, V135, P321, DOI 10.1039/b920293e; Li C, 2012, CHEM COMMUN, V48, P8347, DOI 10.1039/c2cc32919k; Li Y., 2009, FUNCTIONAL NUCL ACID; Masiero S, 2010, ORG BIOMOL CHEM, V8, P2683, DOI 10.1039/c003428b; Mori K, 2011, ORG BIOMOL CHEM, V9, P5272, DOI 10.1039/c1ob05469d; Mukae M, 2009, ORG BIOMOL CHEM, V7, P1349, DOI 10.1039/b821869b; Ogino M, 2006, ANGEW CHEM INT EDIT, V45, P7223, DOI 10.1002/anie.200603161; Rotaru A, 2007, ANGEW CHEM INT EDIT, V46, P6180, DOI 10.1002/anie.200700641; Schubert US, 2006, MODERN TERPYRIDINE C; Shimada H, 2013, DALTON T, V42, P16006, DOI 10.1039/c3dt51386f; Urata S, 2014, CHEM LETT, V43, P1020, DOI 10.1246/cl.140197; Yang H, 2008, ANGEW CHEM INT EDIT, V47, P2443, DOI 10.1002/anie.200703741	59	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6640	10.1038/ncomms7640		8	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0GB	WOS:000353696500001		
J	Iino, H; Usui, T; Hanna, J				Iino, Hiroaki; Usui, Takayuki; Hanna, Jun-ichi			Liquid crystals for organic thin-film transistors	NATURE COMMUNICATIONS			English	Article							FIELD-EFFECT TRANSISTORS; CHARGE-TRANSPORT; HIGH-MOBILITY; SEMICONDUCTING POLYMERS; FABRICATION	Crystalline thin films of organic semiconductors are a good candidate for field effect transistor (FET) materials in printed electronics. However, there are currently two main problems, which are associated with inhomogeneity and poor thermal durability of these films. Here we report that liquid crystalline materials exhibiting a highly ordered liquid crystal phase of smectic E (SmE) can solve both these problems. We design a SmE liquid crystalline material, 2-decyl-7-phenyl-[1] benzothieno[3,2-b][1] benzothiophene (Ph-BTBT-10), for FETs and synthesize it. This material provides uniform and molecularly flat polycrystalline thin films reproducibly when SmE precursor thin films are crystallized, and also exhibits high durability of films up to 200 degrees C. In addition, the mobility of FETs is dramatically enhanced by about one order of magnitude (over 10 cm(2)V(-1) s(-1)) after thermal annealing at 120 degrees C in bottom-gate-bottom-contact FETs. We anticipate the use of SmE liquid crystals in solution-processed FETs may help overcome upcoming difficulties with novel technologies for printed electronics.	[Iino, Hiroaki; Usui, Takayuki; Hanna, Jun-ichi] Tokyo Inst Technol, Imaging Sci & Engn Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Iino, Hiroaki; Usui, Takayuki; Hanna, Jun-ichi] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan	Hanna, J (reprint author), Tokyo Inst Technol, Imaging Sci & Engn Lab, Midori Ku, J1-2,4259 Nagatsuta, Yokohama, Kanagawa 2268503, Japan.	hanna@isl.titech.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [18850008, B21750188, B24750178]	This study was supported in part by JST-CREST and Grants-in-Aid for Scientific Research for Young Scientists (Start-up 18850008, B21750188 and B24750178) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The authors also wish to thank the Rigaku Co., Ltd. for single-crystal XRD measurements. In addition, we gratefully acknowledge the Center for Advanced Materials Analysis at the Tokyo Institute of Technology for in-plane XRD, TOF-SIMS and high resolution mass	Sheraw CD, 2003, ADV MATER, V15, P2009, DOI 10.1002/adma.200305393; Mcculloch I, 2006, NAT MATER, V5, P328, DOI 10.1038/nmat1612; Iino H, 2011, ADV MATER, V23, P1748, DOI 10.1002/adma.201004474; Minemawari H, 2011, NATURE, V475, P364, DOI 10.1038/nature10313; Minari T, 2012, ADV MATER, V24, P299, DOI 10.1002/adma.201102554; Tseng HR, 2014, ADV MATER, V26, P2993, DOI 10.1002/adma.201305084; Bronstein H, 2011, J AM CHEM SOC, V133, P3272, DOI 10.1021/ja110619k; Cheng YC, 2003, J CHEM PHYS, V118, P3764, DOI 10.1063/1.1539090; Ebata H, 2007, J AM CHEM SOC, V129, P15732, DOI 10.1021/ja074841i; van de Craats AM, 2003, ADV MATER, V15, P495, DOI 10.1002/adma.200390114; van Breemen AJJM, 2006, J AM CHEM SOC, V128, P2336, DOI 10.1021/ja0553371; Sirringhaus H, 1999, NATURE, V401, P685, DOI 10.1038/44359; Giri G, 2011, NATURE, V480, P504, DOI 10.1038/nature10683; Garnier F, 1998, CHEM MATER, V10, P3334, DOI 10.1021/cm970704g; Tsao HN, 2011, J AM CHEM SOC, V133, P2605, DOI 10.1021/ja108861q; Uemura T, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.111501; Takimiya K, 2011, ADV MATER, V23, P4347, DOI 10.1002/adma.201102007; Coropceanu V, 2007, CHEM REV, V107, P926, DOI 10.1021/cr050140x; Pisula W, 2005, ADV MATER, V17, P684, DOI 10.1002/adma.200401171; Okamoto T, 2013, ADV MATER, V25, P6392, DOI 10.1002/adma.201302086; Iino H, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.11PD02; Iino H, 2012, J NON-CRYST SOLIDS, V358, P2516, DOI 10.1016/j.jnoncrysol.2012.03.021; Iino H, 2011, J APPL PHYS, V109, DOI 10.1063/1.3563586; Katz HE, 1998, CHEM MATER, V10, P633, DOI 10.1021/cm970628h; Podzorov V, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.086602; Yuan YB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4005	26	4	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6828	10.1038/ncomms7828		8	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0IO	WOS:000353703200007		
J	Izumi, K; Mine, K; Inoue, Y; Teshima, M; Ogawa, S; Kai, YJ; Kurafuji, T; Hirakawa, K; Miyakawa, D; Ikeda, H; Inada, A; Hara, M; Yamada, H; Akashi, K; Niho, Y; Ina, K; Kobayashi, T; Yoshikai, Y; Anzai, K; Yamashita, T; Minagawa, H; Fujimoto, S; Kurisaki, H; Shimoda, K; Katsuta, H; Nagafuchi, S				Izumi, Kenichi; Mine, Keiichiro; Inoue, Yoshitaka; Teshima, Miho; Ogawa, Shuichiro; Kai, Yuji; Kurafuji, Toshinobu; Hirakawa, Kanako; Miyakawa, Daiki; Ikeda, Haruka; Inada, Akari; Hara, Manami; Yamada, Hisakata; Akashi, Koichi; Niho, Yoshiyuki; Ina, Keisuke; Kobayashi, Takashi; Yoshikai, Yasunobu; Anzai, Keizo; Yamashita, Teruo; Minagawa, Hiroko; Fujimoto, Shuji; Kurisaki, Hironori; Shimoda, Kazuya; Katsuta, Hitoshi; Nagafuchi, Seiho			Reduced Tyk2 gene expression in beta-cells due to natural mutation determines susceptibility to virus-induced diabetes	NATURE COMMUNICATIONS			English	Article							ENCEPHALOMYOCARDITIS VIRUS; DIABETOGENIC VARIANT; INNATE IMMUNITY; MELLITUS; INFECTION; MICE; INTERFERON; MECHANISMS; INDUCTION; RESPONSES	Accumulating evidence suggests that viruses play an important role in the development of diabetes. Although the diabetogenic encephalomyocarditis strain D virus induces diabetes in restricted lines of inbred mice, the susceptibility genes to virus-induced diabetes have not been identified. We report here that novel Tyrosine kinase 2 (Tyk2) gene mutations are present in virus-induced diabetes-sensitive SJL and SWR mice. Mice carrying the mutant Tyk2 gene on the virus-resistant C57BL/6 background are highly sensitive to virus-induced diabetes. Tyk2 gene expression is strongly reduced in Tyk2-mutant mice, associated with low Tyk2 promoter activity, and leads to decreased expression of interferon-inducible genes, resulting in significantly compromised antiviral response. Tyk2-mutant pancreatic beta-cells are unresponsive even to high dose of Type I interferon. Reversal of virus-induced diabetes could be achieved by beta-cell-specific Tyk2 gene expression. Thus, reduced Tyk2 gene expression in pancreatic beta-cells due to natural mutation is responsible for susceptibility to virus-induced diabetes.	[Izumi, Kenichi; Mine, Keiichiro; Inoue, Yoshitaka; Teshima, Miho; Ogawa, Shuichiro; Kai, Yuji; Kurafuji, Toshinobu; Hirakawa, Kanako; Miyakawa, Daiki; Ikeda, Haruka; Fujimoto, Shuji; Kurisaki, Hironori; Katsuta, Hitoshi; Nagafuchi, Seiho] Kyushu Univ, Grad Sch Med Sci, Dept Med Sci & Technol, Fukuoka 8128582, Japan; [Izumi, Kenichi; Akashi, Koichi; Niho, Yoshiyuki] Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosyst Sci, Fukuoka 8128582, Japan; [Izumi, Kenichi; Anzai, Keizo] Saga Univ, Sch Med, Dept Hepatol Diabet & Endocrinol, Saga 8498501, Japan; [Inada, Akari] Kyushu Univ, Grad Sch Med Sci, Dept Diabet & Genes, Fukuoka 8128582, Japan; [Hara, Manami] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Yamada, Hisakata; Yoshikai, Yasunobu] Kyushu Univ, Med Inst Bioregulat, Res Ctr Prevent Infect Dis, Div Host Def, Fukuoka 8128582, Japan; [Ina, Keisuke] Oita Univ, Fac Med, Dept Mol Anat, Oita 8795593, Japan; [Kobayashi, Takashi] Oita Univ, Fac Med, Dept Infect Dis Control, Oita 8795593, Japan; [Yamashita, Teruo; Minagawa, Hiroko] Aichi Prefectural Inst Publ Hlth, Dept Microbiol & Med Zool, Kita Ku, Nagoya, Aichi 4628576, Japan; [Shimoda, Kazuya] Miyazaki Univ, Fac Med, Dept Internal Med, Div Gastroenterol & Hematol, Miyazaki 8891692, Japan	Nagafuchi, S (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Med Sci & Technol, Fukuoka 8128582, Japan.	nagafu_s@med.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [19209037, 21659230]; Ministry of Health, Labor, and Welfare of Japan	We thank Itsuka Matsumoto, Ai Umei, Miki Kawano, Makoto Matsuo, Hiroko Hamada, Yumi Kamada, Yasuko Kajiki, Kanade Tokuzumim, Yukari Shimoda, Takamitsu Kasagi, Airsa Moroishi and Drs Yuji Ueki, Kazunobu Amako, Kaoru Aida and Tetsuro Kobayashi for their help in conducting this research. We also thank Drs Angela Koh and Chiri Nagatsuka for their help in preparing the manuscript. We appreciate the technical support from the Research Support Center, Graduate School of Medical Sciences, Kyushu University. This work was supported by grants (19209037 and 21659230) from the Ministry of Education, Culture, Sports, Science and Technology and a grant from the Ministry of Health, Labor, and Welfare of Japan.	Dotta F, 2007, P NATL ACAD SCI USA, V104, P5115, DOI 10.1073/pnas.0700442104; Mein CA, 1998, NAT GENET, V19, P297; McCartney SA, 2011, J CLIN INVEST, V121, P1497, DOI 10.1172/JCI44005; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; TONIOLO A, 1980, NATURE, V288, P383, DOI 10.1038/288383a0; Shimoda K, 2000, IMMUNITY, V13, P561, DOI 10.1016/S1074-7613(00)00055-8; Flodstrom M, 2002, NAT IMMUNOL, V3, P373, DOI 10.1038/ni771; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Jun HS, 2001, DIABETOLOGIA, V44, P271, DOI 10.1007/s001250051614; YOON JW, 1979, NEW ENGL J MED, V300, P1173, DOI 10.1056/NEJM197905243002102; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; CLEMENTS GB, 1995, LANCET, V346, P221, DOI 10.1016/S0140-6736(95)91270-3; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; Karaghiosoff M, 2000, IMMUNITY, V13, P549, DOI 10.1016/S1074-7613(00)00054-6; Tauriainen S, 2011, SEMIN IMMUNOPATHOL, V33, P45, DOI 10.1007/s00281-010-0207-y; Kounoue E, 2008, ARCH VIROL, V153, P1223, DOI 10.1007/s00705-008-0106-x; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Jonietz E, 2012, NATURE, V485, pS10; EWEL CH, 1992, DIABETES, V41, P1016, DOI 10.2337/diabetes.41.8.1016; YOON JW, 1985, DIABETES, V34, P922, DOI 10.2337/diabetes.34.9.922; Tanaka S, 2009, DIABETES, V58, P2285, DOI 10.2337/db09-0091; DAHLQUIST GG, 1995, DIABETES, V44, P408, DOI 10.2337/diabetes.44.4.408; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; BAE YS, 1989, DIABETES, V38, P316, DOI 10.2337/diabetes.38.3.316; BOUCHER DW, 1973, J EXP MED, V137, P1226, DOI 10.1084/jem.137.5.1226; CHAMPSAUR H, 1980, LANCET, V1, P251; Coppieters K. T., 2012, COLD SPRING HARB PER, V2, P1; CRAIGHEA.JE, 1968, SCIENCE, V162, P913, DOI 10.1126/science.162.3856.913; GOULD CL, 1985, J INTERFERON RES, V5, P33, DOI 10.1089/jir.1985.5.33; Jenson B.A., 1980, LANCET, VII, P354; Jun HS, 1997, J VIROL, V71, P9782; KANG Y, 1993, J GEN VIROL, V74, P1207, DOI 10.1099/0022-1317-74-6-1207; Katsuta H, 2010, DIABETOLOGIA, V53, P128, DOI 10.1007/s00125-009-1570-x; Nagafuchi S., 2013, DIABETES VIRUSES, P37; ONODERA T, 1978, NATURE, V274, P693, DOI 10.1038/274693a0; ROSS ME, 1976, DIABETES, V25, P190, DOI 10.2337/diabetes.25.3.190; Scully Tony, 2012, Nature, V485, pS2; Tabrah Frank L, 2011, Hawaii Med J, V70, P144; Taylor K.W., 2013, DIABETES VIRUSES, P3; YOON JW, 1980, J EXP MED, V152, P878, DOI 10.1084/jem.152.4.878	40	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6748	10.1038/ncomms7748		10	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0IF	WOS:000353702300005		
J	Jang, KJ; Mano, H; Aoki, K; Hayashi, T; Muto, A; Nambu, Y; Takahashi, K; Itoh, K; Taketani, S; Nutt, SL; Igarashi, K; Shimizu, A; Sugai, M				Jang, Kyoung-Jin; Mano, Hiroto; Aoki, Koji; Hayashi, Tatsunari; Muto, Akihiko; Nambu, Yukiko; Takahashi, Katsu; Itoh, Katsuhiko; Taketani, Shigeru; Nutt, Stephen L.; Igarashi, Kazuhiko; Shimizu, Akira; Sugai, Manabu			Mitochondrial function provides instructive signals for activation-induced B-cell fates	NATURE COMMUNICATIONS			English	Article							CLASS-SWITCH RECOMBINATION; TRANSCRIPTION FACTOR BLIMP-1; SECRETING PLASMA-CELLS; ANTIBODY CLASS SWITCH; GERMINAL CENTER B; T-CELLS; GRADED EXPRESSION; REPRESSOR BACH2; GENE-EXPRESSION; FACTOR IRF4	During immune reactions, functionally distinct B-cell subsets are generated by stochastic processes, including class-switch recombination (CSR) and plasma cell differentiation (PCD). In this study, we show a strong association between individual B-cell fates and mitochondrial functions. CSR occurs specifically in activated B cells with increased mitochondrial mass and membrane potential, which augment mitochondrial reactive oxygen species (mROS), whereas PCD occurs in cells with decreased mitochondrial mass and potential. These events are consequences of initial slight changes in mROS in mitochondriahigh B-cell populations. In CSR-committed cells, mROS attenuates haeme synthesis by inhibiting ferrous ion addition to protoporphyrin IX, thereby maintaining Bach2 function. Reduced mROS then promotes PCD by increasing haeme synthesis. In PCD-committed cells, Blimp1 reduces mitochondrial mass, thereby reducing mROS levels. Identifying mROS as a haeme synthesis regulator increases the understanding of mechanisms regulating haeme homeostasis and cell fate determination after B-cell activation.	[Jang, Kyoung-Jin; Mano, Hiroto; Hayashi, Tatsunari; Nambu, Yukiko; Shimizu, Akira; Sugai, Manabu] Kyoto Univ Hosp, Inst Advancement Clin & Translat Sci, Dept Expt Therapeut, Sakyo Ku, Kyoto 6068507, Japan; [Aoki, Koji] Univ Fukui, Sch Med, Div Pharmacol, Fukui 9101193, Japan; [Muto, Akihiko; Igarashi, Kazuhiko] Tohoku Univ, Grad Sch Med, Dept Biochem, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Muto, Akihiko; Igarashi, Kazuhiko] Japan Sci & Technol Agcy, CREST, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Takahashi, Katsu] Kyoto Univ Hosp, Dept Oral & Maxillofacial Surg, Sakyo Ku, Kyoto 6068507, Japan; [Itoh, Katsuhiko] Kyoto Univ, Grad Sch Med, Dept Clin Mol Biol, Sakyo Ku, Kyoto 6068507, Japan; [Taketani, Shigeru] Kyoto Inst Technol, Dept Biotechnol, Sakyo Ku, Kyoto 6068585, Japan; [Nutt, Stephen L.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia; [Nutt, Stephen L.] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia; [Sugai, Manabu] Univ Fukui, Sch Med, Dept Biochem & Bioinformat Sci, Div Mol Genet, Fukui 9101193, Japan	Sugai, M (reprint author), Kyoto Univ Hosp, Inst Advancement Clin & Translat Sci, Dept Expt Therapeut, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	msugai@u-fukui.ac.jp	Nutt, Stephen/C-9256-2013	Nutt, Stephen/0000-0002-0020-6637	Ministry of Education, Culture, Sports, Science and Technology of Japan; Australian Research Council; Victorian State Government; Australian Government NHMRC IRIIS	We thank Drs F. Alt (Harvard University), U. Basu (Harvard University) and J. Chaudhuri (Memorial Sloan-Kettering Cancer Center) for providing AID antibody; Drs K. Iwai (Kyoto University), Y. Sasaki (Kyoto University), H. Arakawa (National Cancer Center) and Y. Yokota (Fukui University) for discussion of the findings; Drs K. Ochiai (Tohoku University) and Y. Yokota (Fukui University) for critical reading of the manuscript; Dr M. Minami (Kyoto University) for comments on mitochondrial assay; Ms K. Furuta and Mr H. Koda (Kyoto University) for technical assistance in electron microscopy; Drs Okuno (Kyoto University) and Fukuura (PRIMETECH Corp) for the XF96 assay; Dr Takatani (Kyoto University) for comments on this study; and Mr K. Yoshida (Kyoto University) for supporting experiments. We thank Enago (www.enago.jp) for English language review. This work was supported in part by grants-in-aid for Science Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan. S.L.N. was supported by an Australian Research Council Future Fellowship and Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIIS.	Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Tormos KV, 2011, CELL METAB, V14, P537, DOI 10.1016/j.cmet.2011.08.007; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Dominguez-Sola D, 2012, NAT IMMUNOL, V13, P1083, DOI 10.1038/ni.2428; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Takubo K, 2013, CELL STEM CELL, V12, P49, DOI 10.1016/j.stem.2012.10.011; Nakamura A, 2013, J EXP MED, V210, P2191, DOI 10.1084/jem.20130028; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Vinuesa CG, 2010, IMMUNOL REV, V237, P72, DOI 10.1111/j.1600-065X.2010.00937.x; Watanabe-Matsui M, 2011, BLOOD, V117, P5438, DOI 10.1182/blood-2010-07-296483; Thaunat O, 2012, SCIENCE, V335, P475, DOI 10.1126/science.1214100; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Kueh HY, 2013, SCIENCE, V341, P670, DOI 10.1126/science.1240831; Gonda H, 2003, J EXP MED, V198, P1427, DOI 10.1084/jem.20030802; Lin L, 2004, J EXP MED, V200, P115, DOI 10.1084/jem.20040612; Delogu A, 2006, IMMUNITY, V24, P269, DOI 10.1016/j.immuni.2006.01.012; Duffy KR, 2012, SCIENCE, V335, P338, DOI 10.1126/science.1213230; Shlomchik MJ, 2012, IMMUNOL REV, V247, P52, DOI 10.1111/j.1600-065X.2012.01124.x; Calado DP, 2012, NAT IMMUNOL, V13, P1092, DOI 10.1038/ni.2418; Man K, 2013, NAT IMMUNOL, V14, P1155, DOI 10.1038/ni.2710; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; Nutt SL, 2007, NAT REV IMMUNOL, V7, P923, DOI 10.1038/nri2204; Nambu Y, 2003, SCIENCE, V302, P2137, DOI 10.1126/science.1092481; Shan Y, 2006, FASEB J, V20, P2651, DOI 10.1096/fj.06-6346fje; Lin KI, 2002, MOL CELL BIOL, V22, P4771, DOI 10.1128/MCB.22.13.4771-4780.2002; Broxmeyer HE, 2012, NAT MED, V18, P1334, DOI 10.1038/nm.2917; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Roychoudhuri R, 2013, NATURE, V498, P506, DOI 10.1038/nature12199; Barnett BE, 2012, SCIENCE, V335, P342, DOI 10.1126/science.1213495; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Muto A, 2004, NATURE, V429, P566, DOI 10.1038/nature02596; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Horcher M, 2001, IMMUNITY, V14, P779, DOI 10.1016/S1074-7613(01)00153-4; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Ochiai K, 2006, J BIOL CHEM, V281, P38226, DOI 10.1074/jbc.M607592200; Muto A, 2010, EMBO J, V29, P4048, DOI 10.1038/emboj.2010.257; Omori SA, 2006, IMMUNITY, V25, P545, DOI 10.1016/j.immuni.2006.08.015; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Ochiai K, 2008, INT IMMUNOL, V20, P453, DOI 10.1093/intimm/dxn005; Ochiai K, 2013, IMMUNITY, V38, P918, DOI 10.1016/j.immuni.2013.04.009; Pearce E.L., 2013, SCIENCE, V342, DOI [DOI 10.1126/SCIENCE.1242454, 10.1126/science.1242454]; Ramiro AR, 2004, NATURE, V430, P980, DOI 10.1038/430980b; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Sugai M., 2005, CURR IMMUNOL REV, V1, P69, DOI 10.2174/1573395052952905; Tarlinton D, 2012, CURR BIOL, V22, pR235, DOI 10.1016/j.cub.2012.02.045; Yasuda T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001592	50	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6750	10.1038/ncomms7750		13	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0IF	WOS:000353702300007		
J	Kitazawa, T; Takechi, M; Hirasawa, T; Adachi, N; Narboux-Neme, N; Kume, H; Maeda, K; Hirai, T; Miyagawa-Tomita, S; Kurihara, Y; Hitomi, J; Levi, G; Kuratani, S; Kurihara, H				Kitazawa, Taro; Takechi, Masaki; Hirasawa, Tatsuya; Adachi, Noritaka; Narboux-Neme, Nicolas; Kume, Hideaki; Maeda, Kazuhiro; Hirai, Tamami; Miyagawa-Tomita, Sachiko; Kurihara, Yukiko; Hitomi, Jiro; Levi, Giovanni; Kuratani, Shigeru; Kurihara, Hiroki			Developmental genetic bases behind the independent origin of the tympanic membrane in mammals and diapsids	NATURE COMMUNICATIONS			English	Article							MIDDLE-EAR EVOLUTION; A RECEPTOR; MOLECULAR-MECHANISMS; TETRAPOD EAR; JAW; ENDOTHELIN-1; MICE; INACTIVATION; EXPRESSION; DEFICIENT	The amniote middle ear is a classical example of the evolutionary novelty. Although paleontological evidence supports the view that mammals and diapsids (modern reptiles and birds) independently acquired the middle ear after divergence from their common ancestor, the developmental bases of these transformations remain unknown. Here we show that lower-to-upper jaw transformation induced by inactivation of the Endothelin1-Dlx5/6 cascade involving Goosecoid results in loss of the tympanic membrane in mouse, but causes duplication of the tympanic membrane in chicken. Detailed anatomical analysis indicates that the relative positions of the primary jaw joint and first pharyngeal pouch led to the coupling of tympanic membrane formation with the lower jaw in mammals, but with the upper jaw in diapsids. We propose that differences in connection and release by various pharyngeal skeletal elements resulted in structural diversity, leading to the acquisition of the tympanic membrane in two distinct manners during amniote evolution.	[Kitazawa, Taro; Kume, Hideaki; Kurihara, Yukiko; Kurihara, Hiroki] Univ Tokyo, Grad Sch Med, Dept Physiol Chem & Metab, Bunkyo Ku, Tokyo 1130033, Japan; [Kitazawa, Taro; Kurihara, Yukiko; Kurihara, Hiroki] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo 1020076, Japan; [Takechi, Masaki; Hirasawa, Tatsuya; Adachi, Noritaka; Hirai, Tamami; Kuratani, Shigeru] RIKEN, Evolut Morphol Lab, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Takechi, Masaki; Hitomi, Jiro] Iwate Med Univ, Dept Anat, Div Human Embryol, Yahaba, Iwate 0283694, Japan; [Narboux-Neme, Nicolas; Levi, Giovanni] Museum Natl Hist Nat, CNRS, UMR 7221, Evolut Regulat Endocriniennes, F-75231 Paris 05, France; [Maeda, Kazuhiro; Miyagawa-Tomita, Sachiko] Tokyo Womens Med Univ, Med Res Inst, Dept Pediat Cardiol, Div Cardiovasc Dev & Differentiat,Shinjuku Ku, Tokyo 1628666, Japan; [Kurihara, Hiroki] Univ Tokyo, Inst Biol & Math Dynam Cell Proc iBMath, Tokyo 1538914, Japan	Kuratani, S (reprint author), RIKEN, Evolut Morphol Lab, Chuo Ku, 2-2-3 Minatojimaminami Machi, Kobe, Hyogo 6500047, Japan.	saizo@cdb.riken.jp	Kuratani, Shigeru/J-4146-2014		Global COE Program (Integrative Life Science based on the Study of Biosignaling Mechanisms) from the MEXT, Japan; KAKENHI from the MEXT, Japan; Platform for Dynamic Approaches to Living System from the MEXT, Japan; Ministry of Health, Labour and Welfare, Japan; CREST from JST, Japan	We express our gratitude to M. Depew, E. Allin and J. Meng for their helpful discussion. We are also grateful to A. Kuroiwa, H. Aoyama and G. Yamada for giving us materials for in situ hybridization, H. Nagashima, F. Sugahara, F. Nagao, Y. Fujisawa and S. Kushiyama for technical assistance, and R. Ladher and D. Sipp for critical reading of this manuscript. We also thank the Animal Resource Unit of, RIKEN CDB, for the gift of gecko embryos, and Katsumi Shirato for his help in catching adult sharks. Our gratitude is extended to Actelion Pharmaceuticals Ltd for the bosentan usage. T.K. is a Research Fellow of the JSPS (PD). This work was supported in part by Global COE Program (Integrative Life Science based on the Study of Biosignaling Mechanisms), KAKENHI and Platform for Dynamic Approaches to Living System from the MEXT, Japan; grants-in-aid for scientific research from the Ministry of Health, Labour and Welfare, Japan; CREST from JST, Japan.	Adachi N, 2012, EVOL DEV, V14, P234, DOI 10.1111/j.1525-142X.2012.00542.x; ALLIN EF, 1975, J MORPHOL, V147, P403, DOI 10.1002/jmor.1051470404; Beverdam A, 2002, GENESIS, V34, P221, DOI 10.1002/gene.10156; Ruest LB, 2004, DEVELOPMENT, V131, P4413, DOI 10.1242/dev.01291; Sato T, 2008, P NATL ACAD SCI USA, V105, P18806, DOI 10.1073/pnas.0807345105; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Minoux M, 2013, DEVELOPMENT, V140, P4386, DOI 10.1242/dev.098046; Ozeki H, 2004, MECH DEVELOP, V121, P387, DOI 10.1016/j.mod.2004.02.002; Thompson H, 2013, SCIENCE, V339, P1453, DOI 10.1126/science.1232862; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Depew MJ, 2002, SCIENCE, V298, P381, DOI 10.1126/science.1075703; True JR, 2001, EVOL DEV, V3, P109, DOI 10.1046/j.1525-142x.2001.003002109.x; Noro M, 2009, DEV DYNAM, V238, P100, DOI 10.1002/dvdy.21828; Medeiros DM, 2012, DEV BIOL, V371, P121, DOI 10.1016/j.ydbio.2012.08.026; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; KURIHARA Y, 1994, NATURE, V368, P703, DOI 10.1038/368703a0; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; Daeschler EB, 2006, NATURE, V440, P757, DOI 10.1038/nature04639; Anthwal N, 2013, J ANAT, V222, P147, DOI 10.1111/j.1469-7580.2012.01526.x; Takechi M, 2010, J EXP ZOOL PART B, V314B, P417, DOI 10.1002/jez.b.21347; Depew MJ, 1999, DEVELOPMENT, V126, P3831; Murakami Y, 2001, DEVELOPMENT, V128, P3521; Clouthier DE, 1998, DEVELOPMENT, V125, P813; LOMBARD RE, 1979, BIOL J LINN SOC, V11, P19, DOI 10.1111/j.1095-8312.1979.tb00027.x; Miller CT, 2003, DEVELOPMENT, V130, P1353, DOI 10.1242/dev.00339; Minoux M, 2010, DEVELOPMENT, V137, P2605, DOI 10.1242/dev.040048; YAMADA G, 1995, DEVELOPMENT, V121, P2917; Kempf H, 1998, DEVELOPMENT, V125, P4931; Arima Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2258; Asai R, 2010, DEVELOPMENT, V137, P3823, DOI 10.1242/dev.054015; Barghusen H.R., 1986, P253; Bordzilovskaya N.P., 1989, DEV BIOL AXOLOTL, P201; CARROLL R L, 1969, Journal of Paleontology, V43, P151; Clack JA, 2002, J NEUROBIOL, V53, P251, DOI 10.1002/neu.10129; Gardner NM, 2010, PALAEONTOL ELECTRON, V13; Gaupp E, 1912, ARCH ANAT S, V1, P416; Goodrich E. S., 1914, Q J MICROSCOPICAL SC, V61, P137; Goodrich E. S., 1930, STUDIES STRUCTURE DE; Hidebrand M., 2001, ANAL VERTEBRATE STRU; Laurin M, 1998, ANN SCI NAT ZOOL, V19, P1, DOI 10.1016/S0003-4339(98)80132-9; Mall F. P., 1887, Archiv fuer Anatomie und Physiologie (Anat), P1; Mallo M, 2001, DEV BIOL, V231, P410, DOI 10.1006/dbio.2001.0154; Reisz Robert R., 2007, P228; Romer A.S., 1940, GEOLOGICAL SOC AM SP, V28, P1, DOI 10.1130/SPE28-p1; Roth V.L., 1988, P1; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; SUSHKIN PETER P., 1927, PALAEONTOL ZEITSCHR, V8, P263; Theiler K., 1989, HOUSE MOUSE ATLAS EM; Tsuji LA, 2012, J VERTEBR PALEONTOL, V32, P45, DOI 10.1080/02724634.2012.626004; Tucker AS, 2004, DEVELOPMENT, V131, P1235, DOI 10.1242/dev.01017; Westoll TS, 1943, PROC R SOC SER B-BIO, V131, P393, DOI 10.1098/rspb.1943.0014	51	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6853	10.1038/ncomms7853		7	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0IQ	WOS:000353703400020		
J	Kiyoshi, M; Caaveiro, JMM; Kawai, T; Tashiro, S; Ide, T; Asaoka, Y; Hatayama, K; Tsumoto, K				Kiyoshi, Masato; Caaveiro, Jose M. M.; Kawai, Takeaki; Tashiro, Shinya; Ide, Teruhiko; Asaoka, Yoshiharu; Hatayama, Kouta; Tsumoto, Kouhei			Structural basis for binding of human IgG1 to its high-affinity human receptor Fc gamma RI	NATURE COMMUNICATIONS			English	Article							DEPENDENT CELLULAR CYTOTOXICITY; IMMUNOGLOBULIN-G; CRYSTAL-STRUCTURE; MONOCLONAL-ANTIBODIES; EFFECTOR FUNCTION; DENDRITIC CELLS; DOMAIN MOTIONS; CD64; RECOGNITION; EXPRESSION	Cell-surface Fc gamma receptors mediate innate and adaptive immune responses. Human Fc gamma receptor I (hFc gamma RI) binds IgGs with high affinity and is the only Fc gamma receptor that can effectively capture monomeric IgGs. However, the molecular basis of hFc gamma RI's interaction with Fc has not been determined, limiting our understanding of this major immune receptor. Here we report the crystal structure of a complex between hFc gamma RI and human Fc, at 1.80 angstrom resolution, revealing an unique hydrophobic pocket at the surface of hFc gamma RI perfectly suited for residue Leu235 of Fc, which explains the high affinity of this complex. Structural, kinetic and thermodynamic data demonstrate that the binding mechanism is governed by a combination of non-covalent interactions, bridging water molecules and the dynamic features of Fc. In addition, the hinge region of hFc gamma RI-bound Fc adopts a straight conformation, potentially orienting the Fab moiety. These findings will stimulate the development of novel therapeutic strategies involving hFc gamma RI.	[Kiyoshi, Masato; Caaveiro, Jose M. M.; Tsumoto, Kouhei] Univ Tokyo, Grad Sch Engn, Dept Bioengn, Tokyo 1138656, Japan; [Kawai, Takeaki; Tashiro, Shinya; Tsumoto, Kouhei] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Kashiwa, Chiba 2778562, Japan; [Ide, Teruhiko; Asaoka, Yoshiharu] Tosoh Corp, Ayase, Kanagawa 2521123, Japan; [Ide, Teruhiko; Hatayama, Kouta] Sagami Chem Res Inst, Ayase, Kanagawa 2521193, Japan; [Tsumoto, Kouhei] Univ Tokyo, Inst Med Sci, Lab Med Prote, Minato Ku, Tokyo 1088639, Japan	Caaveiro, JMM (reprint author), Univ Tokyo, Grad Sch Engn, Dept Bioengn, 7-3-1 Hongo, Tokyo 1138656, Japan.	jose@bioeng.t.u-tokyo.ac.jp; tsumoto@bioeng.t.u-tokyo.ac.jp	Caaveiro, Jose M.M./J-2790-2013	Caaveiro, Jose M.M./0000-0001-5568-2369	Ministry of Economy, Trade and Industry of Japan	Access to beamline BL-5A was granted by the Photon Factory Advisory Committee (Proposals 2009G040 and 2012G191). We thank Yuji Watanabe for expert advice with the baculovirus expression system. This work has been financed by a grant from the Ministry of Economy, Trade and Industry of Japan.	Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Guilliams M, 2014, NAT REV IMMUNOL, V14, P94, DOI 10.1038/nri3582; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; Woof JM, 2004, NAT REV IMMUNOL, V4, P89, DOI 10.1038/nri1266; INDIK ZK, 1994, EXP HEMATOL, V22, P599; Takai T, 2002, NAT REV IMMUNOL, V2, P580, DOI 10.1038/nri856; Masuda K, 2007, MOL IMMUNOL, V44, P3122, DOI 10.1016/j.molimm.2007.02.005; Radaev S, 2001, J BIOL CHEM, V276, P16469, DOI 10.1074/jbc.M100350200; Lu JH, 2011, J BIOL CHEM, V286, P40608, DOI 10.1074/jbc.M111.257550; Radaev S, 2002, MOL IMMUNOL, V38, P1073, DOI 10.1016/S0161-5890(02)00036-6; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Pincetic A, 2014, NAT IMMUNOL, V15, P707, DOI 10.1038/ni.2939; Raghavan M, 1996, ANNU REV CELL DEV BI, V12, P181, DOI 10.1146/annurev.cellbio.12.1.181; van den Bedem H, 2013, NAT METHODS, V10, P896, DOI [10.1038/nmeth.2592, 10.1038/NMETH.2592]; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; Hogarth PM, 2012, NAT REV DRUG DISCOV, V11, P311, DOI 10.1038/nrd2909; Vafa O, 2014, METHODS, V65, P114, DOI 10.1016/j.ymeth.2013.06.035; Takai T, 2005, J CLIN IMMUNOL, V25, P1, DOI 10.1007/s10875-005-0353-8; Sakamoto S, 2009, J MOL BIOL, V389, P880, DOI 10.1016/j.jmb.2009.04.050; HARRISON PT, 1994, J BIOL CHEM, V269, P24396; Fanger NA, 1997, J IMMUNOL, V158, P3090; Cleland WW, 1999, METHOD ENZYMOL, V308, P3; van der Poel CE, 2011, J IMMUNOL, V186, P2699, DOI 10.4049/jimmunol.1003526; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Asaoka Y, 2012, PROTEIN ENG DES SEL, V25, P835, DOI 10.1093/protein/gzs053; Ahmed AA, 2014, J MOL BIOL, V426, P3166, DOI 10.1016/j.jmb.2014.07.006; DUNCAN AR, 1988, NATURE, V332, P563, DOI 10.1038/332563a0; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Mimoto F, 2013, PROTEIN ENG DES SEL, V26, P589, DOI 10.1093/protein/gzt022; Mimoto F, 2014, MOL IMMUNOL, V58, P132, DOI 10.1016/j.molimm.2013.11.017; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ioan-Facsinay A, 2002, IMMUNITY, V16, P391, DOI 10.1016/S1074-7613(02)00294-7; Idusogie EE, 2000, J IMMUNOL, V164, P4178; Mizushima T, 2011, GENES CELLS, V16, P1071, DOI 10.1111/j.1365-2443.2011.01552.x; Ramsland PA, 2011, J IMMUNOL, V187, P3208, DOI 10.4049/jimmunol.1101467; DAVIS W, 1995, EMBO J, V14, P432; Lu JH, 2015, P NATL ACAD SCI USA, V112, P833, DOI 10.1073/pnas.1418812112; Teplyakov A, 2013, MOL IMMUNOL, V56, P131, DOI 10.1016/j.molimm.2013.03.018; DUCHEMIN AM, 1994, J BIOL CHEM, V269, P12111; Mimoto F, 2013, MABS-AUSTIN, V5, P229, DOI 10.4161/mabs.23452; Uciechowski P, 1998, EUR J IMMUNOL, V28, P2928, DOI 10.1002/(SICI)1521-4141(199809)28:09<2928::AID-IMMU2928>3.0.CO;2-8; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Maenaka K, 2001, J BIOL CHEM, V276, P44898, DOI 10.1074/jbc.M106819200; Sondermann P, 2001, J MOL BIOL, V309, P737, DOI 10.1006/jmbi.2001.4670; Frank M, 2014, J MOL BIOL, V426, P1799, DOI 10.1016/j.jmb.2014.01.011; Liu Z, 2014, J BIOL CHEM, V289, P3571, DOI 10.1074/jbc.M113.513366; Salmon JE, 2001, ARTHRITIS RHEUM, V44, P739; Beekman JA, 2008, IMMUNOL LETT, V116, P149, DOI 10.1016/j.imlet.2007.12.003; FRIDMAN WH, 1992, IMMUNOL REV, V125, P49, DOI 10.1111/j.1600-065X.1992.tb00625.x; GUYRE PM, 1989, J IMMUNOL, V143, P1650; Kiyoshi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087099; KOOLWIJK P, 1989, J IMMUNOL, V143, P1656; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li XR, 2014, EXPERT OPIN THER TAR, V18, P335, DOI 10.1517/14728222.2014.877891; Li Y, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3017; Li Y, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2590; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Wallace PK, 1997, J LEUKOCYTE BIOL, V62, P469	61	11	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6866	10.1038/ncomms7866		11	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0IQ	WOS:000353703400033		
J	Lin, YC; Bjorkman, T; Komsa, HP; Teng, PY; Yeh, CH; Huang, FS; Lin, KH; Jadczak, J; Huang, YS; Chiu, PW; Krasheninnikov, AV; Suenaga, K				Lin, Yung-Chang; Bjorkman, Torbjorn; Komsa, Hannu-Pekka; Teng, Po-Yuan; Yeh, Chao-Hui; Huang, Fei-Sheng; Lin, Kuan-Hung; Jadczak, Joanna; Huang, Ying-Sheng; Chiu, Po-Wen; Krasheninnikov, Arkady V.; Suenaga, Kazu			Three-fold rotational defects in two-dimensional transition metal dichalcogenides	NATURE COMMUNICATIONS			English	Article							MONOLAYER MOLYBDENUM-DISULFIDE; HEXAGONAL BORON-NITRIDE; GRAIN-BOUNDARIES; GRAPHENE; MECHANISM; LAYERS	As defects frequently govern the properties of crystalline solids, the precise microscopic knowledge of defect atomic structure is of fundamental importance. We report a new class of point defects in single-layer transition metal dichalcogenides that can be created through 60 degrees rotations of metal-chalcogen bonds in the trigonal prismatic lattice, with the simplest among them being a three-fold symmetric trefoil-like defect. The defects, which are inherently related to the crystal symmetry of transition metal dichalcogenides, can expand through sequential bond rotations, as evident from in situ scanning transmission electron microscopy experiments, and eventually form larger linear defects consisting of aligned 8-5-5-8 membered rings. First-principles calculations provide insights into the evolution of rotational defects and show that they give rise to p-type doping and local magnetic moments, but weakly affect mechanical characteristics of transition metal dichalcogenides. Thus, controllable introduction of rotational defects can be used to engineer the properties of these materials.	[Lin, Yung-Chang; Suenaga, Kazu] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058565, Japan; [Bjorkman, Torbjorn; Komsa, Hannu-Pekka] Aalto Univ, Dept Appl Phys, COMP, FI-00076 Aalto, Finland; [Teng, Po-Yuan; Yeh, Chao-Hui] Natl Tsing Hua Univ, Dept Elect Engn, Hsinchu 30013, Taiwan; [Huang, Fei-Sheng; Lin, Kuan-Hung; Huang, Ying-Sheng] Natl Taiwan Univ Sci & Technol, Dept Elect Engn, Taipei 10607, Taiwan; [Jadczak, Joanna] Wroclaw Univ Technol, Inst Phys, PL-50370 Wroclaw, Poland; [Krasheninnikov, Arkady V.] Aalto Univ, Dept Appl Phys, FI-00076 Aalto, Finland	Lin, YC (reprint author), Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058565, Japan.	yc-lin@aist.go.jp; arkady.krasheninnikov@aalto.fi	Bjorkman, Torbjorn/B-9844-2012; Suenaga, Kazu/E-2339-2014; Lin, Yung-Chang/G-1545-2015; Krasheninnikov, Arkady/M-3020-2013; Chiu, Po-Wen/N-7560-2015	Bjorkman, Torbjorn/0000-0002-1154-9846; Suenaga, Kazu/0000-0002-6107-1123; Krasheninnikov, Arkady/0000-0003-0074-7588; 	JST Research Acceleration Programme; Academy of Finland [263416]; National Science Council of Taiwan [NSC 100-2112-M-011-001-MY3, NSC 102-2811-M-011-002]; National Tsing Hua University; Taiwan Ministry of Science and Technology [MOST 103-2628-M-007-004-MY3, MOST 103-2119-M-007008-MY3, MOST 102-2633-M-007-002-]; Academy of Finland for the support through its Centres of Excellence Programme [251748]; CSC-IT Center for Science Ltd.	Y.-C.L. and K.S. acknowledge support from JST Research Acceleration Programme. A.V.K. also acknowledges financial support from the Academy of Finland through Project No. 263416 and H.-P.K. and T.B. further thank the Academy of Finland for the support through its Centres of Excellence Programme (2012-2017) under Project No. 251748. Y.-S.H. acknowledges the support of the National Science Council of Taiwan (projects NSC 100-2112-M-011-001-MY3 and NSC 102-2811-M-011-002). P.-W.C. appreciates the project support of National Tsing Hua University and of Taiwan Ministry of Science and Technology: MOST 103-2628-M-007-004-MY3; MOST 103-2119-M-007008-MY3; and MOST 102-2633-M-007-002- (P.-W.C.). We also thank CSC-IT Center for Science Ltd. for generous grants of computer time.	Najmaei S, 2013, NAT MATER, V12, P754, DOI [10.1038/nmat3673, 10.1038/NMAT3673]; Banhart F, 2011, ACS NANO, V5, P26, DOI 10.1021/nn102598m; Cretu O, 2014, NANO LETT, V14, P1064, DOI 10.1021/nl404735w; Lin YC, 2014, NAT NANOTECHNOL, V9, P391, DOI [10.1038/nnano.2014.64, 10.1038/NNANO.2014.64]; Warner JH, 2012, SCIENCE, V337, P209, DOI 10.1126/science.1217529; Zhang ZH, 2013, ACS NANO, V7, P10475, DOI 10.1021/nn4052887; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Warner JH, 2013, NANO LETT, V13, P4937, DOI 10.1021/nl402902q; Kurasch S, 2012, NANO LETT, V12, P3168, DOI 10.1021/nl301141g; Meyer JC, 2009, NANO LETT, V9, P2683, DOI 10.1021/nl9011497; Robertson AW, 2014, NANO LETT, V14, P1634, DOI 10.1021/nl500119p; Gibb AL, 2013, J AM CHEM SOC, V135, P6758, DOI 10.1021/ja400637n; Zhou W, 2013, NANO LETT, V13, P2615, DOI 10.1021/nl4007479; Jin CH, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.195505; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; van der Zande AM, 2013, NAT MATER, V12, P554, DOI [10.1038/nmat3633, 10.1038/NMAT3633]; STONE AJ, 1986, CHEM PHYS LETT, V128, P501, DOI 10.1016/0009-2614(86)80661-3; Enyashin AN, 2013, J PHYS CHEM C, V117, P10842, DOI 10.1021/jp403976d; Komsa HP, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.035301; Komsa HP, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.035503; Suenaga K, 2007, NAT NANOTECHNOL, V2, P358, DOI 10.1038/nnano.2007.141; Lahiri J, 2010, NAT NANOTECHNOL, V5, P326, DOI [10.1038/nnano.2010.53, 10.1038/NNANO.2010.53]; Dumcenco DO, 2008, MATER CHEM PHYS, V111, P475, DOI 10.1016/j.matchemphys.2008.04.052; Ghorbani-Asl M, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.245440; Kotakoski J, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.105505; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Lee GD, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.205501; Lehtinen O., 2013, NAT COMMUN, V4, P1; Liu Z., 2011, NAT COMMUN, V2, P1; Tiong K. K., 2001, J ALLOY COMPD, V317-318, P208	30	4	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6736	10.1038/ncomms7736		6	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0IB	WOS:000353701900005		
J	Macia, L; Tan, J; Vieira, AT; Leach, K; Stanley, D; Luong, S; Maruya, M; McKenzie, CI; Hijikata, A; Wong, C; Binge, L; Thorburn, AN; Chevalier, N; Ang, C; Marino, E; Robert, R; Offermanns, S; Teixeira, MM; Moore, RJ; Flavell, RA; Fagarasan, S; Mackay, CR				Macia, Laurence; Tan, Jian; Vieira, Angelica T.; Leach, Katie; Stanley, Dragana; Luong, Suzanne; Maruya, Mikako; McKenzie, Craig Ian; Hijikata, Atsushi; Wong, Connie; Binge, Lauren; Thorburn, Alison N.; Chevalier, Nina; Ang, Caroline; Marino, Eliana; Robert, Remy; Offermanns, Stefan; Teixeira, Mauro M.; Moore, Robert J.; Flavell, Richard A.; Fagarasan, Sidonia; Mackay, Charles R.			Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome	NATURE COMMUNICATIONS			English	Article							CHAIN FATTY-ACIDS; NLRP3 INFLAMMASOME; NICOTINIC-ACID; INTESTINAL MICROBIOTA; COLONIC MICROBIOTA; PUMA-G; HEALTH; ACTIVATION; BUTYRATE; OBESITY	Diet and the gut microbiota may underpin numerous human diseases. A major metabolic product of commensal bacteria are short-chain fatty acids (SCFAs) that derive from fermentation of dietary fibre. Here we show that diets deficient or low in fibre exacerbate colitis development, while very high intake of dietary fibre or the SCFA acetate protects against colitis. SCFAs binding to the 'metabolite-sensing' receptors GPR43 and GPR109A in non-haematopoietic cells mediate these protective effects. The inflammasome pathway has hitherto been reported as a principal pathway promoting gut epithelial integrity. SCFAs binding to GPR43 on colonic epithelial cells stimulates K+ efflux and hyperpolarization, which lead to NLRP3 inflammasome activation. Dietary fibre also shapes gut bacterial ecology, resulting in bacterial species that are more effective for inflammasome activation. SCFAs and metabolite receptors thus explain health benefits of dietary fibre, and how metabolite signals feed through to a major pathway for gut homeostasis.	[Macia, Laurence; Tan, Jian; Vieira, Angelica T.; Luong, Suzanne; McKenzie, Craig Ian; Wong, Connie; Binge, Lauren; Thorburn, Alison N.; Chevalier, Nina; Ang, Caroline; Marino, Eliana; Robert, Remy; Mackay, Charles R.] Monash Univ, Fac Med Nursing & Hlth Sci, Dept Immunol, Clayton, Vic 3800, Australia; [Vieira, Angelica T.; Teixeira, Mauro M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biochem & Immunol, Immunopharmacol Grp, BR-31270901 Belo Horizonte, MG, Brazil; [Leach, Katie] Monash Univ, Fac Pharm & Pharmaceut Sci, Parkville, Vic 3052, Australia; [Stanley, Dragana; Moore, Robert J.] CSIRO Anim Food & Hlth Sci, Australian Anim Hlth Labs, Geelong, Vic 3220, Australia; [Stanley, Dragana] Cent Queensland Univ, Sch Med & Appl Sci, Rockhampton, Qld 4702, Australia; [Maruya, Mikako; Hijikata, Atsushi; Fagarasan, Sidonia] RIKEN, Res Ctr Allergy & Immunol, Lab Mucosal Immun, Yokohama, Kanagawa 2300045, Japan; [Maruya, Mikako; Hijikata, Atsushi; Fagarasan, Sidonia] RIKEN, Res Ctr Allergy & Immunol, Lab Immunogenom, Yokohama, Kanagawa 2300045, Japan; [Offermanns, Stefan] Max Planck Inst Heart & Lung Res, D-61231 Bad Nauheim, Germany; [Moore, Robert J.] Monash Univ, ARC Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic 3800, Australia; [Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Flavell, Richard A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Mackay, CR (reprint author), Monash Univ, Fac Med Nursing & Hlth Sci, Dept Immunol, Wellington Rd, Clayton, Vic 3800, Australia.	charles.mackay@monash.edu	robert, remy/E-6881-2012; Moore, Robert/D-8352-2011; Marino, Eliana/C-5135-2011; Vieira, Angelica/A-6227-2015	robert, remy/0000-0003-2416-9268; Moore, Robert/0000-0002-0776-5861; Marino, Eliana/0000-0001-5371-8778; Vieira, Angelica/0000-0002-4556-7671	Australian National Health and Medical Research Council; Conselho Nacional de Pesquisa (CNPq); Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG); CRC for Asthma and Airways; RIKEN RCAI intramural fund	This work was supported by Australian National Health and Medical Research Council, Conselho Nacional de Pesquisa (CNPq), Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG), the CRC for Asthma and Airways and RIKEN RCAI intramural fund. We thank Professor Malcolm McConville at Bio21 for metabolomics measurements. We wish to thank Honglei Chen for skilled operation of the Roche/454 Genome Sequencer. We thank Linda Mason for her help with the mouse work. We thank Professor Mansell for providing gene-deficient mice.	Dupaul-Chicoine J, 2010, IMMUNITY, V32, P367, DOI 10.1016/j.immuni.2010.02.012; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Thorburn AN, 2014, IMMUNITY, V40, P833, DOI 10.1016/j.immuni.2014.05.014; Kostylina G, 2008, CELL DEATH DIFFER, V15, P134, DOI 10.1038/sj.cdd.4402238; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Shabala L, 2013, CELL BIOCHEM FUNCT, V31, P603, DOI 10.1002/cbf.2946; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Thangaraju M, 2009, CANCER RES, V69, P2826, DOI 10.1158/0008-5472.CAN-08-4466; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Murakami T, 2012, P NATL ACAD SCI USA, V109, P11282, DOI 10.1073/pnas.1117765109; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Normand S, 2011, P NATL ACAD SCI USA, V108, P9601, DOI 10.1073/pnas.1100981108; Jacobs DM, 2009, CURR DRUG METAB, V10, P41; Franchi L, 2009, J IMMUNOL, V183, P792, DOI 10.4049/jimmunol.0900173; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Galvez J, 2005, MOL NUTR FOOD RES, V49, P601, DOI 10.1002/mnfr.200500013; Hirota SA, 2011, INFLAMM BOWEL DIS, V17, P1359, DOI 10.1002/ibd.21478; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Anderson JW, 2009, NUTR REV, V67, P188, DOI 10.1111/j.1753-4887.2009.00189.x; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Maslowski KM, 2011, NAT IMMUNOL, V12, P5, DOI 10.1038/ni0111-5; Taggart AKP, 2005, J BIOL CHEM, V280, P26649, DOI 10.1074/jbc.C500213200; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Nohr MK, 2013, ENDOCRINOLOGY, V154, P3552, DOI 10.1210/en.2013-1142; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Petrilli V, 2005, CURR BIOL, V15, pR581, DOI 10.1016/j.cub.2005.07.049; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Park Y, 2011, ARCH INTERN MED, V171, P1061, DOI 10.1001/archinternmed.2011.18; Suzuki T, 2008, BRIT J NUTR, V100, P297, DOI 10.1017/S0007114508888733; Chassaing B, 2013, GUT, V63, P1069; Erridge C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009125; FISCHER H, 1992, P NATL ACAD SCI USA, V89, P1438, DOI 10.1073/pnas.89.4.1438; Fujiwara N, 2013, BBA-MOL CELL BIOL L, V1831, P1177, DOI 10.1016/j.bbalip.2013.03.008; Kanauchi O, 2001, J GASTROEN HEPATOL, V16, P160, DOI 10.1046/j.1440-1746.2001.02427.x; McKnite AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039191; Tan J, 2014, ADV IMMUNOL, V121, P91, DOI 10.1016/B978-0-12-800100-4.00003-9; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322	48	9	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6734	10.1038/ncomms7734		15	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0IB	WOS:000353701900003		
J	Matsubara, M; Schroer, A; Schmehl, A; Melville, A; Becher, C; Trujillo-Martinez, M; Schlom, DG; Mannhart, J; Kroha, J; Fiebig, M				Matsubara, Masakazu; Schroer, Alexander; Schmehl, Andreas; Melville, Alexander; Becher, Carsten; Trujillo-Martinez, Mauricio; Schlom, Darrell G.; Mannhart, Jochen; Kroha, Johann; Fiebig, Manfred			Ultrafast optical tuning of ferromagnetism via the carrier density	NATURE COMMUNICATIONS			English	Article							EUROPIUM OXIDE; EUO; SPECTRA; NICKEL; CR2O3	Interest in manipulating the magnetic order by ultrashort laser pulses has thrived since it was observed that such pulses can be used to alter the magnetization on a sub-picosecond timescale. Usually this involves demagnetization by laser heating or, in rare cases, a transient increase of magnetization. Here we demonstrate a mechanism that allows the magnetic order of a material to be enhanced or attenuated at will. This is possible in systems simultaneously possessing a low, tunable density of conduction band carriers and a high density of magnetic moments. In such systems, the thermalization time can be set such that adiabatic processes dominate the photoinduced change of the magnetic order-the three-temperature model for interacting thermalized electron, spin and lattice reservoirs is bypassed. In ferromagnetic Eu1-xGdxO, we thereby demonstrate the strengthening as well as the weakening of the magnetic order by similar to 10% and within <= 3 ps by optically controlling the magnetic exchange interaction.	[Matsubara, Masakazu] Tohoku Univ, Dept Phys, Sendai, Miyagi 9808578, Japan; [Matsubara, Masakazu; Becher, Carsten; Fiebig, Manfred] ETH, Dept Mat, CH-8093 Zurich, Switzerland; [Schroer, Alexander; Trujillo-Martinez, Mauricio; Kroha, Johann] Univ Bonn, Inst Phys, D-53115 Bonn, Germany; [Schmehl, Andreas] Univ Augsburg, Inst Phys, D-86135 Augsburg, Germany; [Melville, Alexander; Schlom, Darrell G.] Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA; [Schlom, Darrell G.] Kavli Inst Cornell Nanoscale Sci, Ithaca, NY 14853 USA; [Mannhart, Jochen] Max Planck Inst Solid State Res, D-70569 Stuttgart, Germany	Matsubara, M (reprint author), Tohoku Univ, Dept Phys, Sendai, Miyagi 9808578, Japan.	m-matsubara@m.tohoku.ac.jp			Alexander von Humboldt Foundation; SNSF [200021_147080/1]; TRR 80 of the DFG; AFOSR [FA9550-10-1-0123]	We thank T. Stollenwerk for fruitful discussions. This work was supported by the Alexander von Humboldt Foundation, by the SNSF (Grant No. 200021_147080/1), the TRR 80 of the DFG and the AFOSR (Grant No. FA9550-10-1-0123).	Ahn K., 2004, J APPL PHYS, V97; SHEN YR, 1966, PHYS REV, V143, P372, DOI 10.1103/PhysRev.143.372; Mairoser T, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.257206; SHAPIRA Y, 1973, PHYS REV B, V8, P2299, DOI 10.1103/PhysRevB.8.2299; Kirilyuk A, 2010, REV MOD PHYS, V82, P2731, DOI 10.1103/RevModPhys.82.2731; Schmehl A, 2007, NAT MATER, V6, P882, DOI 10.1038/nmat2012; Kampfrath T, 2011, NAT PHOTONICS, V5, P31, DOI [10.1038/nphoton.2010.259, 10.1038/NPHOTON.2010.259]; Matsubara M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.207401; Fiebig M, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/16/164005; OLIVER MR, 1972, PHYS REV B, V5, P1078, DOI 10.1103/PhysRevB.5.1078; Koopmans B, 2000, PHYS REV LETT, V85, P844, DOI 10.1103/PhysRevLett.85.844; Arnold M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.046404; Wang J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.217401; Radu I, 2011, NATURE, V472, P205, DOI 10.1038/nature09901; Stanciu CD, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.047601; AHN KY, 1967, IEEE T MAGN, VMAG3, P453; Beaurepaire E, 1996, PHYS REV LETT, V76, P4250, DOI 10.1103/PhysRevLett.76.4250; Carpene E, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.174437; Matsubara M, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.214447; Steeneken PG, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.047201; Koopmans B, 2010, NAT MATER, V9, P259, DOI [10.1038/nmat2593, 10.1038/NMAT2593]; Bennemann K. H, 1998, NONLINEAR OPTICS MET; Iizuka-Sakano T, 2001, J PHYS-CONDENS MAT, V13, P3031, DOI 10.1088/0953-8984/13/13/316; Kasuya T., 1972, Critical Reviews in Solid State Sciences, V3, DOI 10.1080/10408437208244863; Kimel AV, 2005, NATURE, V435, P655, DOI 10.1038/nature03S64; Liu F, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.257401; Matsubara M, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.195127; MIYATA N, 1967, PHYS REV, V157, P448, DOI 10.1103/PhysRev.157.448; MUTHUKUMAR VN, 1995, PHYS REV LETT, V75, P2766, DOI 10.1103/PhysRevLett.75.2766; Muto M, 1998, PHYS REV B, V57, P9586, DOI 10.1103/PhysRevB.57.9586; Ogasawara T, 2005, PHYS REV LETT, V94, DOI [10.1103/PhysRevLett.94.087202, 10.1103/PhysRevLett.087202]; Sutarto R, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.205318; Tsuda N., 1991, SPRINGER SERIES SOLI, V94; WANG HY, 1986, HELV PHYS ACTA, V59, P102; Wietstruk M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.127401	35	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6724	10.1038/ncomms7724		7	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0HZ	WOS:000353701700003		
J	Mikelis, CM; Simaan, M; Ando, K; Fukuhara, S; Sakurai, A; Amornphimoltham, P; Masedunskas, A; Weigert, R; Chavakis, T; Adams, RH; Offermanns, S; Mochizuki, N; Zheng, Y; Gutkind, JS				Mikelis, Constantinos M.; Simaan, May; Ando, Koji; Fukuhara, Shigetomo; Sakurai, Atsuko; Amornphimoltham, Panomwat; Masedunskas, Andrius; Weigert, Roberto; Chavakis, Triantafyllos; Adams, Ralf H.; Offermanns, Stefan; Mochizuki, Naoki; Zheng, Yi; Gutkind, J. Silvio			RhoA and ROCK mediate histamine-induced vascular leakage and anaphylactic shock	NATURE COMMUNICATIONS			English	Article							PROTEIN-COUPLED RECEPTORS; VE-CADHERIN; ENDOTHELIAL PERMEABILITY; PULMONARY-HYPERTENSION; ADHERENS JUNCTIONS; KINASE INHIBITOR; CELL-JUNCTIONS; SMOOTH-MUSCLE; MYOSIN-II; CANCER	Histamine-induced vascular leakage is an integral component of many highly prevalent human diseases, including allergies, asthma and anaphylaxis. Yet, how histamine induces the disruption of the endothelial barrier is not well defined. By using genetically modified animal models, pharmacologic inhibitors and a synthetic biology approach, here we show that the small GTPase RhoA mediates histamine-induced vascular leakage. Histamine causes the rapid formation of focal adherens junctions, disrupting the endothelial barrier by acting on H1R G alpha(q)-coupled receptors, which is blunted in endothelial G alpha(q/11) KO mice. Interfering with RhoA and ROCK function abolishes endothelial permeability, while phospholipase C beta plays a limited role. Moreover, endothelial-specific RhoA gene deletion prevents vascular leakage and passive cutaneous anaphylaxis in vivo, and ROCK inhibitors protect from lethal systemic anaphylaxis. This study supports a key role for the RhoA signalling circuitry in vascular permeability, thereby identifying novel pharmacological targets for many human diseases characterized by aberrant vascular leakage.	[Mikelis, Constantinos M.; Simaan, May; Sakurai, Atsuko; Gutkind, J. Silvio] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA; [Ando, Koji; Fukuhara, Shigetomo; Mochizuki, Naoki] CREST JST, Dept Cell Biol, Natl Cerebral & Cardiovasc Ctr, Res Inst, Suita, Osaka 5658565, Japan; [Amornphimoltham, Panomwat; Masedunskas, Andrius; Weigert, Roberto] Natl Inst Dent & Craniofacial Res, Intracellular Membrane Trafficking Unit, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA; [Chavakis, Triantafyllos] Tech Univ Dresden, Dept Clin Pathobiochem, Fac Med, D-01307 Dresden, Germany; [Adams, Ralf H.] Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, D-48149 Munster, Germany; [Adams, Ralf H.] Univ Munster, Fac Med, D-48149 Munster, Germany; [Offermanns, Stefan] Max Planck Inst Heart & Lung Res, Dept Pharmacol, D-61231 Bad Nauheim, Germany; [Zheng, Yi] Univ Cincinnati, Canc & Blood Dis Inst, Cincinnati Childrens Hosp, Coll Med, Cincinnati, OH 45229 USA	Gutkind, JS (reprint author), Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA.	sg39v@nih.gov	Zheng, Yi/J-7235-2015	Zheng, Yi/0000-0001-7089-6074			Mikelis CM, 2013, J BIOL CHEM, V288, P12232, DOI 10.1074/jbc.M112.428599; Ando K, 2013, J CELL BIOL, V202, P901, DOI 10.1083/jcb.201301115; Liu GJ, 2012, EUR J CLIN PHARMACOL, V68, P131, DOI 10.1007/s00228-011-1100-x; Hubbard KB, 2006, CELL SIGNAL, V18, P135, DOI 10.1016/j.cellsig.2005.08.004; Giannotta M, 2013, DEV CELL, V26, P441, DOI 10.1016/j.devcel.2013.08.020; Gavard J, 2008, DEV CELL, V14, P25, DOI 10.1016/j.devcel.2007.10.019; Weis SM, 2008, CURR OPIN HEMATOL, V15, P243, DOI 10.1097/MOH.0b013e3282f97d86; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Olson MF, 2008, CURR OPIN CELL BIOL, V20, P242, DOI 10.1016/j.ceb.2008.01.002; Korhonen H, 2009, J EXP MED, V206, P411, DOI 10.1084/jem.20082150; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Shibuya M, 2005, J NEUROL SCI, V238, P31, DOI 10.1016/j.jns.2005.06.003; Jonsson F, 2011, J CLIN INVEST, V121, P1484, DOI 10.1172/JCI45232; Melendez J, 2011, J BIOL CHEM, V286, P15132, DOI 10.1074/jbc.C111.229336; Haas H, 2003, NAT REV NEUROSCI, V4, P121, DOI 10.1038/nrn1034; Ishii S, 1998, J EXP MED, V187, P1779, DOI 10.1084/jem.187.11.1779; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Huveneers S, 2012, J CELL BIOL, V196, P641, DOI 10.1083/jcb.201108120; Ngok SP, 2012, J CELL BIOL, V199, P1103, DOI 10.1083/jcb.201207009; Nyqvist D, 2008, EMBO REP, V9, P742, DOI 10.1038/embor.2008.123; MILES AA, 1952, J PHYSIOL-LONDON, V118, P228; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Bouquier N, 2009, CHEM BIOL, V16, P657, DOI 10.1016/j.chembiol.2009.04.012; Kishi T, 2005, CIRCULATION, V111, P2741, DOI 10.1161/CIRCULATIONAHA.104.510248; Krey JF, 2013, NAT NEUROSCI, V16, P201, DOI 10.1038/nn.3307; Notcovich C, 2010, EXP CELL RES, V316, P401, DOI 10.1016/j.yexcr.2009.11.002; Masumoto A, 2001, HYPERTENSION, V38, P1307, DOI 10.1161/hy1201.096541; Vaque JP, 2013, MOL CELL, V49, P94, DOI 10.1016/j.molcel.2012.10.018; Seifert R, 2013, TRENDS PHARMACOL SCI, V34, P33, DOI 10.1016/j.tips.2012.11.001; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; Aittaleb M, 2010, MOL PHARMACOL, V77, P111, DOI 10.1124/mol.109.061234; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Choi EY, 2008, SCIENCE, V322, P1101, DOI 10.1126/science.1165218; Offermanns S, 1998, EMBO J, V17, P4304, DOI 10.1093/emboj/17.15.4304; Fukumoto Y, 2005, HEART, V91, P391, DOI 10.1136/hrt.2003.029470; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Bkaily G, 1997, MOL CELL BIOCHEM, V172, P171, DOI 10.1023/A:1006840228104; Brozovich FV, 2002, CIRC RES, V90, P500, DOI 10.1161/01.RES.0000014224.43774.03; Chikumi H, 2002, J BIOL CHEM, V277, P27130, DOI 10.1074/jbc.M204715200; De Bisschop MB, 2012, CURR OPIN CRIT CARE, V18, P308, DOI 10.1097/MCC.0b013e3283557a63; Doggrell SA, 2005, EXPERT OPIN INV DRUG, V14, P1157, DOI 10.1517/13543784.14.9.1157; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Hagi Akifumi, 2000, Journal of Medical Investigation, V47, P19; Huentelman MJ, 2009, BEHAV NEUROSCI, V123, P218, DOI 10.1037/a0014260; Jones N, 2001, NAT REV MOL CELL BIO, V2, P257, DOI 10.1038/35067005; Kajiwara N, 2010, J ALLERGY CLIN IMMUN, V125, P1137, DOI 10.1016/j.jaci.2010.01.056; Liao James K, 2007, J Cardiovasc Pharmacol, V50, P17, DOI 10.1097/FJC.0b013e318070d1bd; Menetry J, 2008, PROTEIN SCI, V17, P878, DOI 10.1110/ps.073398508; Pfreimer M, 2012, CELL SIGNAL, V24, P652, DOI 10.1016/j.cellsig.2011.10.014; Rabiner CA, 2005, NEUROSCIENTIST, V11, P148, DOI 10.1177/1073858404271250; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Yagi H, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002221	57	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6725	10.1038/ncomms7725		11	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0HZ	WOS:000353701700004		
J	Miyakawa, K; Matsunaga, S; Kanou, K; Matsuzawa, A; Morishita, R; Kudoh, A; Shindo, K; Yokoyama, M; Sato, H; Kimura, H; Tamura, T; Yamamoto, N; Ichijo, H; Takaori-Kondo, A; Ryo, A				Miyakawa, Kei; Matsunaga, Satoko; Kanou, Kazuhiko; Matsuzawa, Atsushi; Morishita, Ryo; Kudoh, Ayumi; Shindo, Keisuke; Yokoyama, Masaru; Sato, Hironori; Kimura, Hirokazu; Tamura, Tomohiko; Yamamoto, Naoki; Ichijo, Hidenori; Takaori-Kondo, Akifumi; Ryo, Akihide			ASK1 restores the antiviral activity of APOBEC3G by disrupting HIV-1 Vif-mediated counteraction	NATURE COMMUNICATIONS			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; INDUCED MITOCHONDRIAL TOXICITY; SIGNAL-REGULATING KINASE-1; PROTEIN-SYNTHESIS SYSTEM; CBF-BETA; INDUCED DEGRADATION; RESTRICTION FACTORS; FAMILY PROTEINS; INNATE IMMUNITY; LIGASE COMPLEX	APOBEC3G (A3G) is an innate antiviral restriction factor that strongly inhibits the replication of human immunodeficiency virus type 1 (HIV-1). An HIV-1 accessory protein, Vif, hijacks the host ubiquitin-proteasome system to execute A3G degradation. Identification of the host pathways that obstruct the action of Vif could provide a new strategy for blocking viral replication. We demonstrate here that the host protein ASK1 (apoptosis signal-regulating kinase 1) interferes with the counteraction by Vif and revitalizes A3G-mediated viral restriction. ASK1 binds the BC-box of Vif, thereby disrupting the assembly of the Vif-ubiquitin ligase complex. Consequently, ASK1 stabilizes A3G and promotes its incorporation into viral particles, ultimately reducing viral infectivity. Furthermore, treatment with the antiretroviral drug AZT (zidovudine) induces ASK1 expression and restores the antiviral activity of A3G in HIV-1-infected cells. This study thus demonstrates a distinct function of ASK1 in restoring the host antiviral system that can be enhanced by AZT treatment.	[Miyakawa, Kei; Matsunaga, Satoko; Morishita, Ryo; Kudoh, Ayumi; Ryo, Akihide] Yokohama City Univ, Dept Microbiol, Sch Med, Yokohama, Kanagawa 2360004, Japan; [Kanou, Kazuhiko; Kimura, Hirokazu] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo 1628640, Japan; [Matsuzawa, Atsushi; Ichijo, Hidenori] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Cell Signaling, Tokyo 1130033, Japan; [Morishita, Ryo] Ehime Univ Venture, CellFree Sci Co Ltd, Matsuyama, Ehime 7908577, Japan; [Shindo, Keisuke; Takaori-Kondo, Akifumi] Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto 6068507, Japan; [Yokoyama, Masaru; Sato, Hironori] Natl Inst Infect Dis, Pathogen Genom Ctr, Tokyo 2080011, Japan; [Tamura, Tomohiko] Yokohama City Univ, Dept Immunol, Sch Med, Yokohama, Kanagawa 2360004, Japan; [Yamamoto, Naoki] Natl Univ Singapore, Dept Microbiol, Singapore 117597, Singapore	Ryo, A (reprint author), Yokohama City Univ, Dept Microbiol, Sch Med, Yokohama, Kanagawa 2360004, Japan.	aryo@yokohama-cu.ac.jp			Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program; Ministry of Education, Culture, Sports, Science and Technology of Japan	HIV-1 Vif monoclonal antibody (#319) and pNLGRINFQ were obtained from Dr Michael H. Malim and from Drs Tomozumi Imamichi and H. Clifford Lane, respectively, through the NIH AIDS Reagent Program. We thank Dr Wataru Sugiura (National Hospital Organization Nagoya Medical Center) for reagents and Mayu Miyamoto for technical support. This work was supported in part by the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program and grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to A.R.).	Albin JS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001343; Geleziunas R, 2001, NATURE, V410, P834, DOI 10.1038/35071111; Jager S, 2012, NATURE, V481, P371, DOI 10.1038/nature10693; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Takeda K, 2008, ANNU REV PHARMACOL, V48, P199, DOI 10.1146/annurev.pharmtox.48.113006.094606; Sawasaki T, 2002, P NATL ACAD SCI USA, V99, P14652, DOI 10.1073/pnas.232580399; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Mehle A, 2004, GENE DEV, V18, P2861, DOI 10.1101/gad.1249904; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Kim DY, 2013, MOL CELL, V49, P632, DOI 10.1016/j.molcel.2012.12.012; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sasada A, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-32; Kakuda TN, 2000, CLIN THER, V22, P685, DOI 10.1016/S0149-2918(00)90004-3; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Nishitoh H, 1998, MOL CELL, V2, P389, DOI 10.1016/S1097-2765(00)80283-X; Yu YK, 2004, GENE DEV, V18, P2867, DOI 10.1101/gad.1250204; Nathans R, 2008, NAT BIOTECHNOL, V26, P1187, DOI 10.1038/nbt.1496; Zhang WY, 2012, NATURE, V481, P376, DOI 10.1038/nature10718; Craig EA, 2008, DEV DYNAM, V237, P3102, DOI 10.1002/dvdy.21750; Medzhitov R, 2000, NEW ENGL J MED, V343, P338; Cen S, 2010, J BIOL CHEM, V285, P16546, DOI 10.1074/jbc.M109.085308; Noguchi T, 2005, J BIOL CHEM, V280, P37033, DOI 10.1074/jbc.M506771200; Takai K, 2010, NAT PROTOC, V5, P227, DOI 10.1038/nprot.2009.207; Scruggs ER, 2008, PHARMACOLOGY, V82, P83, DOI 10.1159/000134943; Guo YY, 2014, NATURE, V505, P229, DOI 10.1038/nature12884; Khan MA, 2005, J VIROL, V79, P5870, DOI 10.1128/JVI.79.9.5870-5874.2005; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00969; Nishi H, 2011, STRUCTURE, V19, P1807, DOI 10.1016/j.str.2011.09.021; Runchel C, 2011, ANTIOXID REDOX SIGN, V15, P205, DOI 10.1089/ars.2010.3733; ADACHI A, 1986, J VIROL, V59, P284; Iwatani Y, 2007, NUCLEIC ACIDS RES, V35, P7096, DOI 10.1093/nar/gkm750; Bogerd HP, 2008, RNA, V14, P1228, DOI 10.1261/rna.964708; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Turelli P, 2004, SCIENCE, V303, P1829, DOI 10.1126/science.1092066; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Matsuzawa A, 2008, BBA-GEN SUBJECTS, V1780, P1325, DOI 10.1016/j.bbagen.2007.12.011; Matsui M, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-122; Fujino G, 2007, MOL CELL BIOL, V27, P8152, DOI 10.1128/MCB.00227-07; ULLMAN EF, 1994, P NATL ACAD SCI USA, V91, P5426, DOI 10.1073/pnas.91.12.5426; Bishop KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000231; CHAVE JP, 1992, ANTIMICROB AGENTS CH, V36, P1013; DUAN DR, 1995, SCIENCE, V269, P1402, DOI 10.1126/science.7660122; Fouchier RAM, 1996, J VIROL, V70, P8263; Hofmann H, 2013, J VIROL, V87, P11741, DOI 10.1128/JVI.02002-13; Imamichi T, 2000, J VIROL, V74, P1023, DOI 10.1128/JVI.74.2.1023-1028.2000; Imamichi T, 2000, J VIROL, V74, P10958, DOI 10.1128/JVI.74.23.10958-10964.2000; Izumi T, 2010, P NATL ACAD SCI USA, V107, P20798, DOI 10.1073/pnas.1008076107; Kim YR, 2011, CELL BIOCHEM BIOPHYS, V61, P199, DOI 10.1007/s12013-011-9189-1; Krisko JF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003242; Kumar B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067586; Malim MH, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006940; Maruoka S, 2003, BIOCHEM BIOPH RES CO, V307, P870, DOI 10.1016/S0006-291X(03)01283-X; Matsui Y, 2014, VIROLOGY, V449, P82, DOI 10.1016/j.virol.2013.11.004; Miyagi E, 2014, J VIROL, V88, P4839, DOI 10.1128/JVI.03359-13; Miyakawa K, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003212; Sato K, 2010, J VIROL, V84, P9546, DOI 10.1128/JVI.00823-10; Shindo K, 2003, J BIOL CHEM, V278, P44412, DOI 10.1074/jbc.C300376200; Simon JHM, 1997, J VIROL, V71, P5259; SIMON JHM, 1995, J VIROL, V69, P4166; Stanley DJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003085; Strebel K, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-48; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	67	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6945	10.1038/ncomms7945		10	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0JB	WOS:000353704600002		
J	Nakamoto, A; Hester, SD; Constantinou, SJ; Blaine, WG; Tewksbury, AB; Matei, MT; Nagy, LM; Williams, TA				Nakamoto, A.; Hester, S. D.; Constantinou, S. J.; Blaine, W. G.; Tewksbury, A. B.; Matei, M. T.; Nagy, L. M.; Williams, T. A.			Changing cell behaviours during beetle embryogenesis correlates with slowing of segmentation	NATURE COMMUNICATIONS			English	Article							CENTIPEDE STRIGAMIA-MARITIMA; VERTEBRATE SEGMENTATION; TRIBOLIUM EMBRYOGENESIS; PERIPLANETA-AMERICANA; EMBRYONIC-DEVELOPMENT; INSECT SEGMENTATION; DROSOPHILA EMBRYOS; AXIS ELONGATION; GERM-BAND; CLOCK	Segmented animals are found in major clades as phylogenetically distant as vertebrates and arthropods. Typically, segments form sequentially in what has been thought to be a regular process, relying on a segmentation clock to pattern budding segments and posterior mitosis to generate axial elongation. Here we show that segmentation in Tribolium has phases of variable periodicity during which segments are added at different rates. Furthermore, elongation during a period of rapid posterior segment addition is driven by high rates of cell rearrangement, demonstrated by differential fates of marked anterior and posterior blastoderm cells. A computational model of this period successfully reproduces elongation through cell rearrangement in the absence of cell division. Unlike current models of steady-state sequential segmentation and elongation from a proliferative growth zone, our results indicate that cell behaviours are dynamic and variable, corresponding to differences in segmentation rate and giving rise to morphologically distinct regions of the embryo.	[Nakamoto, A.; Hester, S. D.; Matei, M. T.; Nagy, L. M.] Life Sci South, Mol & Cellular Biol, Tucson, AZ 85721 USA; [Constantinou, S. J.; Blaine, W. G.; Tewksbury, A. B.; Williams, T. A.] Trinity Coll, Life Sci Ctr, Dept Biol, Hartford, CT 06106 USA	Nagy, LM (reprint author), Tohoku Univ, Grad Sch Life Sci, Res Ctr Marine Biol, Sakamoto 9, Asamushi, Aomori 0393501, Japan.	lnagy@mail.arizona.edu; terri.williams@trincoll.edu			NSF IOS [1024220, 1322350, 1024446, 1322298]; HHMI [52006942]	We thank R. Beeman for sharing Tribolium stocks; S. Brown for sharing the Tribolium eve clone; K. Dunlap for comments on the manuscript; A. Singh, A.J. Stangl, J. Ikpatt and J. DeSa for assistance with data analysis; D. Reuman for help with statistical analysis; and P. Jansma for assistance with image acquisition. Our work was funded by NSF IOS 1024220 and 1322350 (T.A.W.) and NSF IOS 1024446 and 1322298 (L.M.N.) and HHMI 52006942 (S.D.H.).	Anderson DT, 1973, EMBRYOLOGY PHYLOGENY, P1; El-Sherif E, 2012, DEVELOPMENT, V139, P4341, DOI 10.1242/dev.085126; Davis GK, 2002, ANNU REV ENTOMOL, V47, P669, DOI 10.1146/annurev.ento.47.091201.145251; Oates AC, 2012, DEVELOPMENT, V139, P625, DOI 10.1242/dev.063735; da Silva SM, 2007, DEVELOPMENT, V134, P3049, DOI 10.1242/dev.004911; Gomez C, 2008, NATURE, V454, P335, DOI 10.1038/nature07020; Pourquie O, 2011, CELL, V145, P650, DOI 10.1016/j.cell.2011.05.011; Stollewerk A, 2003, NATURE, V423, P863, DOI 10.1038/nature01682; Copf T, 2004, P NATL ACAD SCI USA, V101, P17711, DOI 10.1073/pnas.0407327102; Peel AD, 2005, NAT REV GENET, V6, P905, DOI 10.1038/nrg1724; Benton MA, 2013, DEVELOPMENT, V140, P3210, DOI 10.1242/dev.096271; Choe CP, 2006, P NATL ACAD SCI USA, V103, P6560, DOI 10.1073/pnas.0510440103; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; McGregor AP, 2008, BIOESSAYS, V30, P487, DOI 10.1002/bies.20744; Chipman AD, 2004, EVOL DEV, V6, P78, DOI 10.1111/j.1525-142X.2004.04016.x; Brena C, 2012, DEV BIOL, V363, P290, DOI 10.1016/j.ydbio.2011.11.006; GLAZIER JA, 1993, PHYS REV E, V47, P2128, DOI 10.1103/PhysRevE.47.2128; Aulehla A, 2004, GENE DEV, V18, P2060, DOI 10.1101/gad.1217404; Scholtz G, 2002, ORG DIVERS EVOL, V2, P197, DOI 10.1078/1439-6092-00046; IRVINE KD, 1994, DEVELOPMENT, V120, P827; FOE VE, 1989, DEVELOPMENT, V107, P1; Chipman AD, 2010, BIOESSAYS, V32, P60, DOI 10.1002/bies.200900130; Schroter C, 2008, DEV DYNAM, V237, P545, DOI 10.1002/dvdy.21458; Benazeraf B, 2010, NATURE, V466, P248, DOI 10.1038/nature09151; Liu PZ, 2005, EVOL DEV, V7, P629, DOI 10.1111/j.1525-142X.2005.05066.x; Soroldoni D, 2014, SCIENCE, V345, P222, DOI 10.1126/science.1253089; Sarrazin AF, 2012, SCIENCE, V336, P338, DOI 10.1126/science.1218256; Butler LC, 2009, NAT CELL BIOL, V11, P859, DOI 10.1038/ncb1894; Swat MH, 2012, METHOD CELL BIOL, V110, P325, DOI 10.1016/B978-0-12-388403-9.00013-8; Nakamura T, 2010, CURR BIOL, V20, P1641, DOI 10.1016/j.cub.2010.07.044; Chesebro JE, 2013, BIOL OPEN, V2, P227, DOI 10.1242/bio.20123699; Chipman AD, 2008, DEV BIOL, V319, P160, DOI 10.1016/j.ydbio.2008.02.038; Chipman AD, 2004, CURR BIOL, V14, P1250, DOI 10.1016/j.cub.2004.07.026; EDGAR BA, 1990, CELL, V62, P469, DOI 10.1016/0092-8674(90)90012-4; Handel K, 2000, DEV GENES EVOL, V210, P167, DOI 10.1007/s004270050301; HARTENSTEIN V, 1985, ROUX ARCH DEV BIOL, V194, P181; Janssen R, 2014, INT J DEV BIOL, V58, P343, DOI 10.1387/ijdb.140058rj; KIMMEL CB, 1995, DEV DYNAM, V203, P253; KRAUSE GERHARa, 1939, BIOL ZENTMLBI, V59, P495; Krause G., 1964, ROUX ARCH ENTWMECH O, V155, P451; Mayer G, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-339; NAGY L, 1994, DEV BIOL, V165, P137, DOI 10.1006/dbio.1994.1241; Nagy L. M., 1994, MOL MODEL SYSTEMS LE, P139; NAGY LM, 1994, CURR BIOL, V4, P811, DOI 10.1016/S0960-9822(00)00179-2; Nielsen C, 2001, ANIMAL EVOLUTION INT; Ozbudak EM, 2008, CURR OPIN GENET DEV, V18, P317, DOI 10.1016/j.gde.2008.06.007; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; PEARSON M, 1979, J EMBRYOL EXP MORPH, V51, P27; Pueyo JI, 2008, P NATL ACAD SCI USA, V105, P16614, DOI 10.1073/pnas.0804093105; Sander K, 1976, ADV INSECT PHYSIOL, V12, P125, DOI DOI 10.1016/S0065-2806(08)60255-6; Scholtz G, 2013, ARTHROPOD BIOL EVOLU, P63; Scholtz G, 1996, INT J DEV BIOL, V40, P211; SCHOLTZ G, 1994, INT J DEV BIOL, V38, P471; SNODGRASS R. E., 1938, SMITHSONIAN MISC COLL, V97, P1; Swat Maciej H., 2009, V500, P361, DOI 10.1007/978-1-59745-525-1_13; Williams T. A., 2011, EVOL DEV, V14, P372; Zallen J. A., 2004, J PHYS CONDENS MATT, V16, pS073	57	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6635	10.1038/ncomms7635		9	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0FY	WOS:000353696200001		
J	Ren, DN; Chen, JX; Li, Z; Yan, HW; Yin, Y; Wo, D; Zhang, JK; Ao, LQ; Chen, B; Ito, TK; Chen, YH; Liu, ZM; Li, YY; Yang, JH; Lu, XL; Peng, Y; Pan, LH; Zhao, YX; Liu, SF; Zhu, WD				Ren, Dan-Ni; Chen, Jinxiao; Li, Zhi; Yan, Hongwei; Yin, Yan; Wo, Da; Zhang, Jiankang; Ao, Luoquan; Chen, Bo; Ito, Takashi K.; Chen, Yihan; Liu, Zhongmin; Li, Yongyong; Yang, Jianhua; Lu, Xiaoling; Peng, Yi; Pan, Linghui; Zhao, Yongxiang; Liu, Shangfeng; Zhu, Weidong			LRP5/6 directly bind to Frizzled and prevent Frizzled-regulated tumour metastasis	NATURE COMMUNICATIONS			English	Article							PROTEIN-PROTEIN INTERACTIONS; WNT SIGNAL-TRANSDUCTION; MOUSE MAMMARY-TUMOR; BETA-CATENIN; BREAST-CANCER; CYCLIN D1; RECEPTOR; LRP6; PATHWAY; CELLS	How Wnt signalling including canonical and non-canonical pathways are initiated at the cell surface is not completely understood. Here we report that Wnt receptor Frizzled (Frz) and the co-receptors LRP5 and LRP6 (LRP5/6) directly interact with each other and this interaction is regulated by the LRP6 ectodomain. Importantly, through direct binding to Frz, LRP5/6 are able to prevent Frz-regulated non-canonical pathway activation and further non-canonical pathway-mediated tumour metastasis. Knockdown of endogenous LRP5/6 promotes otherwise-nonaggressive tumour cells to migrate in vitro, whereas a soluble recombinant protein of LRP6 ectodomain suppresses migration and metastasis of otherwise-aggressive tumour cells in vitro and in vivo. Furthermore, the expression level of membrane LRP5/6 correlates inversely with metastasis in mouse and human breast cancer. Our study suggests a previously unrecognized mode of receptor interaction, revealing the mechanism of LRP5/6 in inhibition of non-canonical pathway, and a possible clinical use of the LRP6 ectodomain to impede metastasis.	[Ren, Dan-Ni; Yin, Yan; Chen, Bo; Chen, Yihan; Liu, Zhongmin; Liu, Shangfeng; Zhu, Weidong] Shanghai East Hosp, Clin & Translat Res Ctr, Key Lab Arrhythmias, Minist Educ, Shanghai, Peoples R China; [Chen, Jinxiao; Yan, Hongwei; Wo, Da; Zhang, Jiankang; Ao, Luoquan; Chen, Yihan; Li, Yongyong; Yang, Jianhua; Liu, Shangfeng; Zhu, Weidong] Tongji Univ, Sch Med, Shanghai 200092, Peoples R China; [Li, Zhi; Ito, Takashi K.] Chiba Univ, Grad Sch Med, Dept Cardiovasc Sci & Med, Chiba, Japan; [Lu, Xiaoling; Peng, Yi; Zhao, Yongxiang] Guangxi Med Univ, Biol Targeting Diag & Therapy Res Ctr, Nanning, Guangxi, Peoples R China; [Pan, Linghui] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Oncol Res, Nanning, Peoples R China	Zhu, WD (reprint author), Shanghai East Hosp, Clin & Translat Res Ctr, Key Lab Arrhythmias, Minist Educ, Shanghai, Peoples R China.	yongxiang_zhao@126.com; shangfengliu@tongji.edu.cn; wzhu@tongji.edu.cn			Ministry of Science and Technology of China [2013CB945300, 2011CB964900, 2011CB966200, 2013CB967500]; International Science & Technology Cooperation Programme of China [2011DFB30010]; National Natural Science Foundation of China [81070108, 81172024]; Innovative Research Groups of the National Natural Science Foundation of China [81221001]; Shanghai Science Foundation [11PJ1408100]; Natural Scientific Foundation of China [81430055]	We thank R.T. Moon, X. He, C. Niehrs, J.C. Hsieh, S. Takada, S.S. Gambhir and B.C. Holdener for plasmids, and Y. Sun (UCLA) for critical review of the manuscript. This manuscript was revised by D.W., who is a native English speaker. This work was supported by the Ministry of Science and Technology of China (2013CB945300, 2011CB964900, 2011CB966200, 2013CB967500), International Science & Technology Cooperation Programme of China (2011DFB30010), National Natural Science Foundation of China (81070108, 81172024), Innovative Research Groups of the National Natural Science Foundation of China (81221001), Shanghai Science Foundation (11PJ1408100) and Natural Scientific Foundation of China (81430055).	NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Zhang J, 2010, ONCOGENE, V29, P539, DOI 10.1038/onc.2009.339; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Wu YL, 2007, NAT PROTOC, V2, P3278, DOI 10.1038/nprot.2007.459; Chu M, 2013, POLYM CHEM-UK, V4, P2528, DOI 10.1039/c3py21092h; Liu W, 2012, EMBO MOL MED, V4, P93, DOI 10.1002/emmm.201100190; Lindvall C, 2006, J BIOL CHEM, V281, P35081, DOI 10.1074/jbc.M607571200; Jenei V, 2009, P NATL ACAD SCI USA, V106, P19473, DOI 10.1073/pnas.0909409106; Pfleger KDG, 2006, NAT PROTOC, V1, P337, DOI 10.1038/nprot.2006.52; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003; Liu CC, 2010, P NATL ACAD SCI USA, V107, P5136, DOI 10.1073/pnas.0911220107; Tamai K, 2000, NATURE, V407, P530; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Yamabuki T, 2007, CANCER RES, V67, P2517, DOI 10.1158/0008-5472.CAN-06-3369; Hoang BH, 2004, CANCER RES, V64, P2734, DOI 10.1158/0008-5472.CAN-03-1952; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Hsieh JC, 2003, CELL, V112, P355, DOI 10.1016/S0092-8674(03)00045-X; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; Yamamoto H, 2008, DEV CELL, V15, P37, DOI 10.1016/j.devcel.2008.04.015; Tetsu O, 1999, NATURE, V398, P422; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Jessen JR, 2009, ZEBRAFISH, V6, P21, DOI 10.1089/zeb.2008.0571; Klemm F, 2011, CARCINOGENESIS, V32, P434, DOI 10.1093/carcin/bgq269; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; Chen S, 2011, DEV CELL, V21, P848, DOI 10.1016/j.devcel.2011.09.007; Ettenberg SA, 2010, P NATL ACAD SCI USA, V107, P15473, DOI 10.1073/pnas.1007428107; Goel S, 2012, J BIOL CHEM, V287, P16454, DOI 10.1074/jbc.M112.362137; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Smith SC, 2009, NAT REV CANCER, V9, P253, DOI 10.1038/nrc2594; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Badders NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006594; Gong Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012682; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Moon Randall T, 2004, Nat Rev Genet, V5, P691, DOI 10.1038/nrg1427; Wang CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069440; Wang YS, 1996, J BIOL CHEM, V271, P4468	48	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6906	10.1038/ncomms7906		13	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0IW	WOS:000353704100014		
J	Sakamoto, R; Hoshiko, K; Liu, Q; Yagi, T; Nagayama, T; Kusaka, S; Tsuchiya, M; Kitagawa, Y; Wong, WY; Nishihara, H				Sakamoto, Ryota; Hoshiko, Ken; Liu, Qian; Yagi, Toshiki; Nagayama, Tatsuhiro; Kusaka, Shinpei; Tsuchiya, Mizuho; Kitagawa, Yasutaka; Wong, Wai-Yeung; Nishihara, Hiroshi			A photofunctional bottom-up bis(dipyrrinato)zinc(II) complex nanosheet	NATURE COMMUNICATIONS			English	Article							COVALENT ORGANIC FRAMEWORKS; LAYERED DOUBLE HYDROXIDES; 2-DIMENSIONAL POLYMER; METAL COORDINATION; ROOM-TEMPERATURE; ULTRATHIN FILMS; GRAPHENE; FABRICATION; SURFACE; ARCHITECTURES	Two-dimensional polymeric nanosheets have recently gained much attention, particularly top-down nanosheets such as graphene and metal chalcogenides originating from bulk-layered mother materials. Although molecule-based bottom-up nanosheets manufactured directly from molecular components can exhibit greater structural diversity than top-down nanosheets, the bottom-up nanosheets reported thus far lack useful functionalities. Here we show the design and synthesis of a bottom-up nanosheet featuring a photoactive bis(dipyrrinato)zinc(II) complex motif. A liquid/liquid interfacial synthesis between a three-way dipyrrin ligand and zinc(II) ions results in a multi-layer nanosheet, whereas an air/liquid interfacial reaction produces a single-layer or few-layer nanosheet with domain sizes of >10 mu m on one side. The bis(dipyrrinato)zinc(II) metal complex nanosheet is easy to deposit on various substrates using the Langmuir-Schafer process. The nanosheet deposited on a transparent SnO2 electrode functions as a photoanode in a photoelectric conversion system, and is thus the first photofunctional bottom-up nanosheet.	[Sakamoto, Ryota; Hoshiko, Ken; Yagi, Toshiki; Nagayama, Tatsuhiro; Kusaka, Shinpei; Tsuchiya, Mizuho; Nishihara, Hiroshi] Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Liu, Qian; Wong, Wai-Yeung] Hong Kong Baptist Univ, Inst Mol Funct Mat, Dept Chem, Hong Kong, Hong Kong, Peoples R China; [Liu, Qian; Wong, Wai-Yeung] Hong Kong Baptist Univ, Partner State Key Lab Environm & Biol Anal, Hong Kong, Hong Kong, Peoples R China; [Kitagawa, Yasutaka] Osaka Univ, Grad Sch Engn Sci, Dept Mat Engn Sci, Div Chem Engn, Toyonaka, Osaka 5608531, Japan; [Kitagawa, Yasutaka] Osaka Univ, Grad Sch Sci, Dept Chem, Toyonaka, Osaka 5600043, Japan; [Wong, Wai-Yeung] HKBU Inst Res & Continuing Educ, Shenzhen 518057, Peoples R China	Sakamoto, R (reprint author), Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	sakamoto@chem.s.u-tokyo.ac.jp; rwywong@hkbu.edu.hk; nisihara@chem.s.u-tokyo.ac.jp	Nishihara, Hiroshi/B-4755-2012		MEXT of Japan [24750054, 25107510, 26708005, 26107510, 26620039, 21108002, 26220801, 26248017, 26110505, 26410093]; Ogasawara Foundation for the Promotion of Science and Engineering; Noguchi Institute; Tokuyama Science Foundation; Asahi Glass Foundation; Murata Science Foundation; Iketani Science and Technology Foundation; Japan Prize Foundation; Kao Foundation for Arts and Sciences; Japan Association for Chemical Innovation; MIKIYA Science and Technology Foundation; Yazaki Memorial Foundation for Science and Technology; Shorai Foundation for Science and Technology; Kurata Memorial Hitachi Science and Technology Foundation; Kumagai Foundation for Science and Technology; Japan Science Society; Hong Kong Research Grants Council [HKBU 12302114]; Areas of Excellence Scheme of HKSAR [AoE/P-03/08]; National Natural Science Foundation of China [51373145, 91333206]; Science, Technology, and Innovation Committee of Shenzhen Municipality [JCYJ20140419130507116]; Hong Kong Baptist University [FRG2/13-14/083]; Partner State Key Laboratory of Environmental and Biological Analysis [SKLP-14-15-P011]; Strategic Development Fund of HKBU; JSPS fellowship	We acknowledge Grants-in-Aid from MEXT of Japan (Nos. 24750054, 25107510, 26708005, 26107510, 26620039, 21108002, 26220801, 26248017, 26110505, 26410093, areas 2107 (Coordination Programming), 2406 (All Nippon Artificial Photosynthesis Project for Living Earth), 2506 (Science of Atomic Layers), and 2509 (Molecular Architectonics)). R.S. is grateful to Ogasawara Foundation for the Promotion of Science and Engineering, Noguchi Institute, Tokuyama Science Foundation, Asahi Glass Foundation, The Murata Science Foundation, Iketani Science and Technology Foundation, The Japan Prize Foundation, Kao Foundation for Arts and Sciences, Japan Association for Chemical Innovation, The MIKIYA Science and Technology Foundation, Yazaki Memorial Foundation for Science and Technology, Shorai Foundation for Science and Technology, The Kurata Memorial Hitachi Science and Technology Foundation, Kumagai Foundation for Science and Technology, and The Japan Science Society for financial supports. W.-Y.W. thanks the Hong Kong Research Grants Council (HKBU 12302114), Areas of Excellence Scheme of HKSAR (AoE/P-03/08), National Natural Science Foundation of China (Project Nos. 51373145 and 91333206), Science, Technology, and Innovation Committee of Shenzhen Municipality (JCYJ20140419130507116) and Hong Kong Baptist University (FRG2/13-14/083) for the financial support. This work was also supported by the Partner State Key Laboratory of Environmental and Biological Analysis (SKLP-14-15-P011) and Strategic Development Fund of HKBU. K.H. acknowledges Fostering program of human resources in chemistry conducted by Japan Chemical Industry Association. M.T. is grateful to Advanced Leading Graduate Course for Photon Science (ALPS) and the JSPS fellowship for young scientists. Y.K. expresses gratitude to Professor Mitsutaka Okumura for valuable supports and discussion on the molecular mechanics calculation. We also thank the Research Hub Advanced Nano Characterization (The University of Tokyo) and Dr Tetsuro Kusamoto (The University of Tokyo) for XPS and electrospray ionization time-of-flight spectrometry measurements, respectively.	Kissel P, 2012, NAT CHEM, V4, P287, DOI 10.1038/nchem.1265; Zeng ZY, 2011, ANGEW CHEM INT EDIT, V50, P11093, DOI 10.1002/anie.201106004; Amo-Ochoa P, 2010, CHEM COMMUN, V46, P3262, DOI 10.1039/b919647a; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Son YW, 2006, NATURE, V444, P347, DOI 10.1038/nature05180; Xu G, 2012, J AM CHEM SOC, V134, P16524, DOI 10.1021/ja307953m; Zwaneveld NAA, 2008, J AM CHEM SOC, V130, P6678, DOI 10.1021/ja800906f; Makiura R, 2010, NAT MATER, V9, P565, DOI [10.1038/nmat2769, 10.1038/NMAT2769]; Spitler EL, 2010, NAT CHEM, V2, P672, DOI [10.1038/nchem.695, 10.1038/NCHEM.695]; Tanoue R, 2011, ACS NANO, V5, P3923, DOI 10.1021/nn200393q; Berlanga I, 2011, SMALL, V7, P1207, DOI 10.1002/smll.201002264; Grill L, 2007, NAT NANOTECHNOL, V2, P687, DOI 10.1038/nnano.2007.346; Wang ZM, 2011, J MATER CHEM, V21, P5451, DOI 10.1039/c1jm10321k; Tsuchiya M, 2014, CHEM COMMUN, V50, P5881, DOI 10.1039/c4cc01573h; Kambe T, 2013, J AM CHEM SOC, V135, P2462, DOI 10.1021/ja312380b; Li BW, 2010, ACS NANO, V4, P6673, DOI 10.1021/nn102144s; Bauer T, 2011, ANGEW CHEM INT EDIT, V50, P7879, DOI 10.1002/anie.201100669; Sakamoto J, 2009, ANGEW CHEM INT EDIT, V48, P1030, DOI 10.1002/anie.200801863; Yan DP, 2011, ANGEW CHEM INT EDIT, V50, P720, DOI 10.1002/anie.201003015; Lin YM, 2010, SCIENCE, V327, P662, DOI 10.1126/science.1184289; Bunck DN, 2013, J AM CHEM SOC, V135, P14952, DOI 10.1021/ja408243n; Zheng ZK, 2014, J AM CHEM SOC, V136, P6103, DOI 10.1021/ja501849y; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Berlanga I, 2012, CHEM COMMUN, V48, P7976, DOI 10.1039/c2cc32187d; Kusaka S, 2012, CHEM-ASIAN J, V7, P907, DOI 10.1002/asia.201200131; Payamyar P, 2014, ADV MATER, V26, P2052, DOI 10.1002/adma.201304705; Splendiani A, 2010, NANO LETT, V10, P1271, DOI 10.1021/nl903868w; Schrettl S, 2014, NAT CHEM, V6, P468, DOI [10.1038/nchem.1939, 10.1038/NCHEM.1939]; Maassen J, 2011, NANO LETT, V11, P151, DOI 10.1021/nl1031919; Ida S, 2008, J AM CHEM SOC, V130, P14038, DOI 10.1021/ja804397n; Bonaccorso F, 2010, NAT PHOTONICS, V4, P611, DOI [10.1038/nphoton.2010.186, 10.1038/NPHOTON.2010.186]; Umar A, 2006, NANOTECHNOLOGY, V17, P2174, DOI 10.1088/0957-4484/17/9/016; Motoyama S, 2011, J AM CHEM SOC, V133, P5640, DOI 10.1021/ja110720f; Gutzler R, 2009, CHEM COMMUN, P4456, DOI 10.1039/b906836h; Wood TE, 2007, CHEM REV, V107, P1831, DOI 10.1021/cr050052c; Kory MJ, 2014, NAT CHEM, V6, P779, DOI [10.1038/nchem.2007, 10.1038/NCHEM.2007]; Hoshiko K, 2014, CHEM LETT, V43, P252, DOI 10.1246/cl.130882; Maeda H, 2006, J AM CHEM SOC, V128, P10024, DOI 10.1021/ja0637301; Dienstmaier JF, 2011, ACS NANO, V5, P9737, DOI 10.1021/nn2032616; Sirtl T, 2013, J AM CHEM SOC, V135, P691, DOI 10.1021/ja306834a; Tan JC, 2012, ACS NANO, V6, P615, DOI 10.1021/nn204054k; Li PZ, 2011, CHEM COMMUN, V47, P8436, DOI 10.1039/c1cc12510a; Ma RZ, 2006, J MATER CHEM, V16, P3809, DOI 10.1039/b605422f; Ma RZ, 2007, J AM CHEM SOC, V129, P5257, DOI 10.1021/ja0693035; Liu XH, 2013, J AM CHEM SOC, V135, P10470, DOI 10.1021/ja403464h; Sasaki T, 1996, J AM CHEM SOC, V118, P8329, DOI 10.1021/ja960073b; Abel M, 2011, J AM CHEM SOC, V133, P1203, DOI 10.1021/ja108628r; Yan DP, 2009, ANGEW CHEM INT EDIT, V48, P3073, DOI 10.1002/anie.200900178; Qin WW, 2005, J PHYS CHEM A, V109, P7371, DOI 10.1021/jp052626n; Kambe T, 2014, J AM CHEM SOC, V136, P14357, DOI 10.1021/ja507619d; Lee HS, 2012, SMALL, V8, P3111, DOI 10.1002/smll.201200752; Muramatsu M, 2005, LANGMUIR, V21, P6590, DOI 10.1021/la050293f; Kissel P, 2014, NAT CHEM, V6, P774, DOI 10.1038/nchem.2008; Sazanovich IV, 2004, J AM CHEM SOC, V126, P2664, DOI 10.1021/ja038763k; Coleman JN, 2011, SCIENCE, V331, P568, DOI 10.1126/science.1194975; Li Y, 2012, J AM CHEM SOC, V134, P6401, DOI 10.1021/ja300593w; Sakai N, 2004, J AM CHEM SOC, V126, P5851, DOI 10.1021/ja0394582; KARWEIK DH, 1976, INORG CHEM, V15, P2336, DOI 10.1021/ic50164a003; Michael MCL, 2002, J AM CHEM SOC, V124, P4572; Nagaoka S, 2011, J PHYS CHEM C, V115, P24215, DOI 10.1021/jp2073792; Ping JL, 2012, NANO LETT, V12, P4635, DOI 10.1021/nl301932v	61	9	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6713	10.1038/ncomms7713		9	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0HT	WOS:000353701100001		
J	Sato, S; Kawamata, Y; Takahashi, A; Imai, Y; Hanyu, A; Okuma, A; Takasugi, M; Yamakoshi, K; Sorimachi, H; Kanda, H; Ishikawa, Y; Sone, S; Nishioka, Y; Ohtani, N; Hara, E				Sato, Seidai; Kawamata, Yuka; Takahashi, Akiko; Imai, Yoshinori; Hanyu, Aki; Okuma, Atsushi; Takasugi, Masaki; Yamakoshi, Kimi; Sorimachi, Hiroyuki; Kanda, Hiroaki; Ishikawa, Yuichi; Sone, Saburo; Nishioka, Yasuhiko; Ohtani, Naoko; Hara, Eiji			Ablation of the p16(INK4a) tumour suppressor reverses ageing phenotypes of klotho mice	NATURE COMMUNICATIONS			English	Article							ACUTE KIDNEY INJURY; CELLULAR SENESCENCE; STEM-CELLS; IN-VIVO; CANCER; EXPRESSION; GENE; P19(ARF); QUIESCENCE; TUMORIGENESIS	The p16(INK4a) tumour suppressor has an established role in the implementation of cellular senescence in stem/progenitor cells, which is thought to contribute to organismal ageing. However, since p16(INK4a) knockout mice die prematurely from cancer, whether p16(INK4a) reduces longevity remains unclear. Here we show that, in mutant mice homozygous for a hypomorphic allele of the alpha-klotho ageing-suppressor gene (kl(kl/kl)), accelerated ageing phenotypes are rescued by p16(INK4a) ablation. Surprisingly, this is due to the restoration of alpha-klotho expression in kl(kl/kl) mice and does not occur when p16(INK4a) is ablated in alpha-klotho knockout mice (kl(-/-)), suggesting that p16(INK4a) is an upstream regulator of alpha-klotho expression. Indeed, p16(INK4a) represses alpha-klotho promoter activity by blocking the functions of E2Fs. These results, together with the observation that the expression levels of p16(INK4a) are inversely correlated with those of alpha-klotho throughout ageing, indicate that p16(INK4a) plays a previously unrecognized role in downregulating alpha-klotho expression during ageing.	[Sato, Seidai; Kawamata, Yuka; Takahashi, Akiko; Imai, Yoshinori; Hanyu, Aki; Okuma, Atsushi; Takasugi, Masaki; Yamakoshi, Kimi; Ohtani, Naoko; Hara, Eiji] Japanese Fdn Canc Res, Inst Canc, Div Canc Biol, Koto Ku, Tokyo 1358550, Japan; [Sato, Seidai; Sone, Saburo; Nishioka, Yasuhiko] Univ Tokushima, Grad Sch Med, Dept Resp Med & Rheumatol, Tokushima 7708503, Japan; [Sato, Seidai; Hara, Eiji] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Kawamata, Yuka; Ohtani, Naoko] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Noda, Chiba 2788510, Japan; [Sorimachi, Hiroyuki] Tokyo Metropolitan Inst Med Sci, Setagaya Ku, Tokyo 1568506, Japan; [Kanda, Hiroaki; Ishikawa, Yuichi] Japanese Fdn Canc Res, Div Pathol, Inst Canc, Koto Ku, Tokyo 1358550, Japan; [Ohtani, Naoko] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Hara, Eiji] Osaka Univ, Microbial Dis Res Inst, Dept Mol Microbiol, Suita, Osaka 5650871, Japan	Ohtani, N (reprint author), Japanese Fdn Canc Res, Inst Canc, Div Canc Biol, Koto Ku, Tokyo 1358550, Japan.	naoko.ohtani@rs.tus.ac.jp; ehara@biken.osaka-u.ac.jp			Japan Science and Technology Agency (JST); Ministry of Educations, Culture, Sports, Science and Technology of Japan (MEXT); Japan Society for Promotion of Science (JSPS)	We thank Drs Gustavo Leone and Antony Trimboli (Ohio State University) for E2F1<SUP>-/-</SUP> E2F3a<SUP>-/-</SUP> mice, Norman E. Sharpless (University of North Carolina) for p16<SUP>-/-</SUP> mice, Kimie Nomura and Tomoyo Kakita (Japanese Foundation for Cancer Research) for histology, Sachiko Noda (Japanese Foundation for Cancer Research) for animal care and Yo-ichi Nabeshima (Institute of Biomedical Research and Innovation) for valuable suggestions. This work was supported by grants from Japan Science and Technology Agency (JST), Ministry of Educations, Culture, Sports, Science and Technology of Japan (MEXT). Y.I., A.O. and M.T. were supported by post-doctoral fellowship from the Japan Society for Promotion of Science (JSPS).	Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591; Yamazaki Y, 2010, BIOCHEM BIOPH RES CO, V398, P513, DOI 10.1016/j.bbrc.2010.06.110; Esteban MA, 2006, CANCER RES, V66, P3567, DOI 10.1158/0008-5472.CAN-05-2670; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Vlahovic G, 1999, AM J RESP CRIT CARE, V160, P2086; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.11114245; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Shiraki-Iida T, 1998, FEBS LETT, V424, P6, DOI 10.1016/S0014-5793(98)00127-6; Beausejour CM, 2006, NATURE, V443, P404, DOI 10.1038/nature05221; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013; Hu MC, 2012, NAT REV NEPHROL, V8, P423, DOI 10.1038/nrneph.2012.92; Imura A, 2007, SCIENCE, V316, P1615, DOI 10.1126/science.1135901; Koh N, 2001, BIOCHEM BIOPH RES CO, V280, P1015, DOI 10.1006/bbrc.2000.4226; Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Yamakoshi K, 2009, J CELL BIOL, V186, P393, DOI 10.1083/jcb.200904105; Takahashi A, 2012, MOL CELL, V45, P123, DOI 10.1016/j.molcel.2011.10.018; Sperka T, 2012, NAT REV MOL CELL BIO, V13, P579, DOI 10.1038/nrm3420; Baker DJ, 2008, NAT CELL BIOL, V10, P825, DOI 10.1038/ncb1744; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Tsujikawa H, 2003, MOL ENDOCRINOL, V17, P2393, DOI 10.1210/me.2003-0048; Kawano KI, 2002, J BONE MINER RES, V17, P1744, DOI 10.1359/jbmr.2002.17.10.1744; Semba RD, 2011, J GERONTOL A-BIOL, V66, P794, DOI 10.1093/gerona/glr058; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Arking DE, 2002, P NATL ACAD SCI USA, V99, P856, DOI 10.1073/pnas.022484299; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Eren M, 2014, P NATL ACAD SCI USA, V111, P7090, DOI 10.1073/pnas.1321942111; Ohnishi M, 2009, KIDNEY INT, V75, P1166, DOI 10.1038/ki.2009.24; Panesso MC, 2014, KIDNEY INT, V85, P855, DOI 10.1038/ki.2013.489; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Tsai SY, 2008, NATURE, V454, P1137, DOI 10.1038/nature07066; Tomas-Loba A, 2008, CELL, V135, P609, DOI 10.1016/j.cell.2008.09.034; Melk A, 2004, KIDNEY INT, V65, P510, DOI 10.1111/j.1523-1755.2004.00438.x; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Chkhotua AB, 2003, AM J KIDNEY DIS, V41, P1303, DOI 10.1016/S0272-6386(03)00363-9; Cho EA, 1998, DEVELOPMENT, V125, P803; Imai Y, 2014, CELL REP, V7, P194, DOI 10.1016/j.celrep.2014.03.006; Jessie C., 2008, MECH AGEING DEV, V129, P467; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Kuro-o M, 2009, BBA-GEN SUBJECTS, V1790, P1049, DOI 10.1016/j.bbagen.2009.02.005; López-Otín Carlos, 2013, Cell, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Manya H, 2002, J BIOL CHEM, V277, P35503, DOI 10.1074/jbc.M206033200; Prozialeck Walter C, 2004, BMC Physiol, V4, P10, DOI 10.1186/1472-6793-4-10; Sharpless NE, 2004, ONCOGENE, V23, P379, DOI 10.1038/sj.onc.1207074; Shimoyama Y, 2009, CLIN CHIM ACTA, V406, P134, DOI 10.1016/j.cca.2009.06.011; Takeuchi S, 2010, CANCER RES, V70, P9381, DOI 10.1158/0008-5472.CAN-10-0801	54	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								7035	10.1038/ncomms8035		10	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0KB	WOS:000353707300001		
J	Shimizu, N; Maruyama, T; Yoshikawa, N; Matsumiya, R; Ma, Y; Ito, N; Tasaka, Y; Kuribara-Souta, A; Miyata, K; Oike, Y; Berger, S; Schutz, G; Takeda, S; Tanaka, H				Shimizu, Noriaki; Maruyama, Takako; Yoshikawa, Noritada; Matsumiya, Ryo; Ma, Yanxia; Ito, Naoki; Tasaka, Yuki; Kuribara-Souta, Akiko; Miyata, Keishi; Oike, Yuichi; Berger, Stefan; Schuetz, Guenther; Takeda, Shin'ichi; Tanaka, Hirotoshi			A muscle-liver-fat signalling axis is essential for central control of adaptive adipose remodelling	NATURE COMMUNICATIONS			English	Article							GROWTH-FACTOR 21; ENDOPLASMIC-RETICULUM STRESS; INSULIN-RESISTANCE; SKELETAL-MUSCLE; GLUCOCORTICOID-RECEPTOR; ALANINE AMINOTRANSFERASE; ENERGY-EXPENDITURE; LIPID-METABOLISM; PPAR-ALPHA; FGF21	Skeletal muscle has a pleiotropic role in organismal energy metabolism, for example, by storing protein as an energy source, or by excreting endocrine hormones. Muscle proteolysis is tightly controlled by the hypothalamus-pituitary-adrenal signalling axis via a glucocorticoid-driven transcriptional programme. Here we unravel the physiological significance of this catabolic process using skeletal muscle-specific glucocorticoid receptor (GR) knockout (GRmKO) mice. These mice have increased muscle mass but smaller adipose tissues. Metabolically, GRmKO mice show a drastic shift of energy utilization and storage in muscle, liver and adipose tissues. We demonstrate that the resulting depletion of plasma alanine serves as a cue to increase plasma levels of fibroblast growth factor 21 (FGF21) and activates liver-fat communication, leading to the activation of lipolytic genes in adipose tissues. We propose that this skeletal muscle-liver-fat signalling axis may serve as a target for the development of therapies against various metabolic diseases, including obesity.	[Shimizu, Noriaki; Maruyama, Takako; Yoshikawa, Noritada; Matsumiya, Ryo; Ma, Yanxia; Tasaka, Yuki; Kuribara-Souta, Akiko; Tanaka, Hirotoshi] Univ Tokyo, Inst Med Sci, IMSUT Hosp, Dept Rheumatol & Allergy,Minato Ku, Tokyo 1088639, Japan; [Ito, Naoki; Takeda, Shin'ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Therapy, Kodaira, Tokyo 1878502, Japan; [Miyata, Keishi; Oike, Yuichi] Kumamoto Univ, Grad Sch Med Sci, Dept Mol Genet, Chuo Ku, Kumamoto 8608556, Japan; [Berger, Stefan; Schuetz, Guenther] German Canc Res Ctr, Div Mol Biol Cell 1, D-69120 Heidelberg, Germany; [Tanaka, Hirotoshi] Univ Tokyo, Inst Med Sci, IMSUT Hosp, Div Rheumatol,Ctr Antibody & Vaccine,Minato Ku, Tokyo 1088639, Japan	Tanaka, H (reprint author), Univ Tokyo, Inst Med Sci, IMSUT Hosp, Dept Rheumatol & Allergy,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	hirotnk@ims.u-tokyo.ac.jp			Ministry of Health, Labour and Welfare [24390236, 24116510, 25461469, 26461375, 24930026]; Takeda Science Foundation; IMSUT Joint Research Project [139]	We thank S. Kiryu, T. Matsuhashi and M. Sano for valuable advices; T. Masuda for clerical work and all the members of the Tanaka laboratory for discussions and suggestions about this project. This work was supported by Grants-in-Aid for Scientific Research (B) to H.T. (24390236), for Scientific Research on Innovative Areas to N.S. (24116510), for Scientific Research (C) to N.Y. (25461469) and N.S. (26461375), and for Encouragement of Scientists to T. M. (24930026), grants from the Ministry of Health, Labour and Welfare to H.T., IMSUT Joint Research Project to S.T., N.I., H.T. and N.S. (139), and grants from Takeda Science Foundation to N.S. and N.Y.	Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; White PJ, 2014, NAT MED, V20, P664, DOI 10.1038/nm.3549; PAGLIARA AS, 1972, J CLIN INVEST, V51, P1440, DOI 10.1172/JCI106940; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Schaap FG, 2013, BIOCHIMIE, V95, P692, DOI 10.1016/j.biochi.2012.10.019; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Shimizu N, 2011, CELL METAB, V13, P170, DOI 10.1016/j.cmet.2011.01.001; ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857; Cornu M, 2014, P NATL ACAD SCI USA, V111, P11592, DOI 10.1073/pnas.1412047111; Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851; Lo JC, 2014, CELL, V158, P41, DOI 10.1016/j.cell.2014.06.005; Roberts LD, 2014, CELL METAB, V19, P96, DOI 10.1016/j.cmet.2013.12.003; Hong SH, 2014, DIABETOLOGIA, V57, P860, DOI 10.1007/s00125-014-3209-9; Vozarova B, 2002, DIABETES, V51, P1889, DOI 10.2337/diabetes.51.6.1889; Laeger T, 2014, J CLIN INVEST, V124, P3913, DOI 10.1172/JCI74915; Vernia S, 2014, CELL METAB, V20, P512, DOI 10.1016/j.cmet.2014.06.010; Suh JM, 2014, NATURE, V513, P436, DOI 10.1038/nature13540; Oike Y, 2005, NAT MED, V11, P400, DOI 10.1038/nm1214; Schakman O, 2013, INT J BIOCHEM CELL B, V45, P2163, DOI 10.1016/j.biocel.2013.05.036; Kim KH, 2013, NAT MED, V19, P83, DOI 10.1038/nm.3014; Jeyaraj D, 2012, CELL METAB, V15, P311, DOI 10.1016/j.cmet.2012.01.020; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Burgert TS, 2006, J CLIN ENDOCR METAB, V91, P4287, DOI 10.1210/jc.2006-1010; De Sousa-Coelho AL, 2012, BIOCHEM J, V443, P165, DOI 10.1042/BJ20111748; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Jiang S, 2014, J BIOL CHEM, V289, P29751, DOI 10.1074/jbc.M114.565960; Kuo T, 2013, MOL CELL ENDOCRINOL, V380, P79, DOI 10.1016/j.mce.2013.03.003; Newell-Price J, 2006, LANCET, V367, P1605, DOI 10.1016/S0140-6736(06)68699-6; FELIG P, 1973, METABOLISM, V22, P179, DOI 10.1016/0026-0495(73)90269-2; Ding XS, 2012, CELL METAB, V16, P387, DOI 10.1016/j.cmet.2012.08.002; Bertorini Tulio E, 2014, Handb Clin Neurol, V120, P749, DOI 10.1016/B978-0-7020-4087-0.00050-4; Piccirillo R, 2014, DEV DYNAM, V243, P201, DOI 10.1002/dvdy.24036; Izumida Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3316; Miniou P, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.19.e27; Owen BM, 2014, CELL METAB, V20, P670, DOI 10.1016/j.cmet.2014.07.012; Viscarra JA, 2013, METABOLISM, V62, P889, DOI 10.1016/j.metabol.2012.12.014	37	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6693	10.1038/ncomms7693		14	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0HA	WOS:000353699200001		
J	Sugiura, H; Yasuda, S; Katsurabayashi, S; Kawano, H; Endo, K; Takasaki, K; Iwasaki, K; Ichikawa, M; Kobayashi, T; Hino, O; Yamagata, K				Sugiura, Hiroko; Yasuda, Shin; Katsurabayashi, Shutaro; Kawano, Hiroyuki; Endo, Kentaro; Takasaki, Kotaro; Iwasaki, Katsunori; Ichikawa, Masumi; Kobayashi, Toshiyuki; Hino, Okio; Yamagata, Kanato			Rheb activation disrupts spine synapse formation through accumulation of syntenin in tuberous sclerosis complex	NATURE COMMUNICATIONS			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; GIANT-CELL ASTROCYTOMAS; RAT HIPPOCAMPAL-NEURONS; MAMMALIAN TARGET; DENDRITIC SPINES; UBIQUITIN LIGASE; MOUSE MODEL; PROTEIN; GENE; RAPAMYCIN	Rheb is a small GTP-binding protein and its GTPase activity is activated by the complex of Tsc1 and Tsc2 whose mutations cause tuberous sclerosis complex (TSC). We previously reported that cultured TSC neurons showed impaired spine synapse morphogenesis in an mTORC1-independent manner. Here we show that the PDZ protein syntenin preferentially binds to the GDP-bound form of Rheb. The levels of syntenin are significantly higher in TSC neurons than in wild-type neurons because the Rheb-GDP-syntenin complex is prone to proteasomal degradation. Accumulated syntenin in TSC neurons disrupts spine synapse formation through inhibition of the association between syndecan-2 and calcium/calmodul-independent serine protein kinase. Instead, syntenin enhances excitatory shaft synapse formation on dendrites by interacting with ephrinB3. Downregulation of syntenin in TSC neurons restores both spine and shaft synapse densities. These findings suggest that Rheb-syntenin signalling may be a novel therapeutic target for abnormalities in spine and shaft synapses in TSC neurons.	[Sugiura, Hiroko; Yasuda, Shin; Yamagata, Kanato] Tokyo Metropolitan Inst Med Sci, Neural Plast Project, Tokyo 1568506, Japan; [Katsurabayashi, Shutaro; Kawano, Hiroyuki; Takasaki, Kotaro; Iwasaki, Katsunori] Fukuoka Univ, Fac Pharmaceut Sci, Dept Neuropharmacol, Fukuoka 8140180, Japan; [Endo, Kentaro; Ichikawa, Masumi] Tokyo Metropolitan Inst Med Sci, Ctr Basic Technol Res, Tokyo 1568506, Japan; [Kobayashi, Toshiyuki; Hino, Okio] Juntendo Univ, Sch Med, Dept Pathol & Oncol, Tokyo 1138421, Japan	Yamagata, K (reprint author), Tokyo Metropolitan Inst Med Sci, Neural Plast Project, Tokyo 1568506, Japan.	yamagata-kn@igakuken.or.jp			JSPS KAKENHI [24659093, 25293239]; MEXT KAKENHI [23110525, 25110737]; Naito Foundation	We are grateful to Y. Matsumoto and K. Kohyama for the gene gun, T. Shimada for technical assistance, A. Sato and K. Ikeda for Tsc2<SUP>+/-</SUP> mice, and H. Tanaka for critical reading of the manuscript. This work was supported by JSPS KAKENHI grant number 24659093 and 25293239, MEXT KAKENHI grant number 23110525 and 25110737, and a grant from the Naito Foundation.	Goorden SMI, 2007, ANN NEUROL, V62, P648, DOI 10.1002/ana.21317; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Krueger DA, 2010, NEW ENGL J MED, V363, P1801, DOI 10.1056/NEJMoa1001671; Neuman NA, 2011, EMBO MOL MED, V3, P189, DOI 10.1002/emmm.201100131; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999; Wojcik SM, 2006, NEURON, V50, P575, DOI 10.1016/j.neuron.2006.04.016; Ethell IM, 1999, J CELL BIOL, V144, P575, DOI 10.1083/jcb.144.3.575; Lipinski MM, 2010, DEV CELL, V18, P1041, DOI 10.1016/j.devcel.2010.05.005; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; Xu NJ, 2011, NAT NEUROSCI, V14, P1421, DOI 10.1038/nn.2931; Grootjans JJ, 2000, J BIOL CHEM, V275, P19933, DOI 10.1074/jbc.M002459200; Cohen AR, 1998, J CELL BIOL, V142, P129, DOI 10.1083/jcb.142.1.129; Pyott SJ, 2002, J PHYSIOL-LONDON, V539, P523, DOI 10.1013/jphysiol.2001.013277; Biederer T, 2001, J BIOL CHEM, V276, P47869, DOI 10.1074/jbc.M105287200; Irie Y, 2000, J BIOL CHEM, V275, P2647, DOI 10.1074/jbc.275.4.2647; Chao HW, 2008, J CELL BIOL, V182, P141, DOI 10.1083/jcb.200712094; Sugiura H, 2004, J BIOL CHEM, V279, P23343, DOI 10.1074/jbc.M312607200; Okabe S, 2001, J NEUROSCI, V21, P6105; McClelland AC, 2010, P NATL ACAD SCI USA, V107, P8830, DOI 10.1073/pnas.0910644107; Franz DN, 2013, LANCET, V381, P125, DOI 10.1016/S0140-6736(12)61134-9; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Burgalossi A, 2012, NAT PROTOC, V7, P1351, DOI 10.1038/nprot.2012.074; McClelland AC, 2009, P NATL ACAD SCI USA, V106, P20487, DOI 10.1073/pnas.0811862106; Ohtahara S, 2003, J CLIN NEUROPHYSIOL, V20, P398, DOI 10.1097/00004691-200311000-00003; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Rennebeck G, 1998, P NATL ACAD SCI USA, V95, P15629, DOI 10.1073/pnas.95.26.15629; YAMAGATA K, 1994, J BIOL CHEM, V269, P16333; Meikle L, 2007, J NEUROSCI, V27, P5546, DOI 10.1523/JNEUROSCI.5540-06.2007; Alonso M, 2004, LEARN MEMORY, V11, P172, DOI 10.1101/lm.67804; Carson RP, 2012, NEUROBIOL DIS, V45, P369, DOI 10.1016/j.nbd.2011.08.024; Kobayashi T, 1999, CANCER RES, V59, P1206; Lin YL, 2007, J CELL BIOL, V177, P829, DOI 10.1083/jcb.200608121; Saitsu H, 2012, EPILEPSIA, V53, P1441, DOI 10.1111/j.1528-1167.2012.03548.x; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; Meikle L, 2008, J NEUROSCI, V28, P5422, DOI 10.1523/JNEUROSCI.0955-08.2008; Zou J, 2011, DEV CELL, V20, P97, DOI 10.1016/j.devcel.2010.11.020; Muncy J, 2009, J CHILD NEUROL, V24, P477, DOI 10.1177/0883073808324535; KANDT RS, 1992, NAT GENET, V2, P37, DOI 10.1038/ng0992-37; Hsueh YP, 1998, J CELL BIOL, V142, P139, DOI 10.1083/jcb.142.1.139; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Krueger DA, 2013, ANN NEUROL, V74, P679, DOI 10.1002/ana.23960; Zeng LH, 2008, ANN NEUROL, V63, P444, DOI 10.1002/ana.21331; Hirbec H, 2005, MOL CELL NEUROSCI, V28, P737, DOI 10.1016/j.mcn.2004.12.005; Enz R, 2003, BIOCHEM J, V372, P183, DOI 10.1042/BJ20021750; Hata Y, 1996, J NEUROSCI, V16, P2488; Casanova E, 2001, GENESIS, V31, P37, DOI 10.1002/gene.1078; Dindot SV, 2008, HUM MOL GENET, V17, P111, DOI 10.1093/hmg/ddm288; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009; Zimmermann P, 2002, MOL CELL, V9, P1215, DOI 10.1016/S1097-2765(02)00549-X; Beekman JM, 2008, J CELL SCI, V121, P1349, DOI 10.1242/jcs.026401; vanSlegtenhorst M, 1997, SCIENCE, V277, P805; Hamilton AM, 2012, NEURON, V74, P1023, DOI 10.1016/j.neuron.2012.04.031; Aoto J, 2007, J NEUROSCI, V27, P7508, DOI 10.1523/JNEUROSCI.0705-07.2007; CHEVRAY PM, 1992, P NATL ACAD SCI USA, V89, P5789, DOI 10.1073/pnas.89.13.5789; Hung AY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009842; Koroll M, 2001, J BIOL CHEM, V276, P10646, DOI 10.1074/jbc.M010647200; Long XM, 2007, J BIOL CHEM, V282, P18542, DOI 10.1074/jbc.M610736200; MACHADOSALAS JP, 1984, CLIN NEUROPATHOL, V3, P52; Niesmann K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1565; Sun Y, 2008, P NATL ACAD SCI USA, V105, P8286, DOI 10.1073/pnas.0712268105; Yasuda S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05155; Yasuda S, 2007, NEURON, V56, P456, DOI 10.1016/j.neuron.2007.08.020; YEUNG RS, 1994, P NATL ACAD SCI USA, V91, P11413, DOI 10.1073/pnas.91.24.11413	67	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6842	10.1038/ncomms7842		15	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0IQ	WOS:000353703400009		
J	Sun, ZD; Ge, MH; Zheng, YJ				Sun, Zhen-Dong; Ge, Meihua; Zheng, Yujun			Separation and conversion dynamics of nuclear-spin isomers of gaseous methanol	NATURE COMMUNICATIONS			English	Article							POPULATION TRANSFER; ORTHO-WATER; ETHYLENE; FORMALDEHYDE; COLLISIONS; PROBE; CH3OH	All symmetrical molecules with non-zero nuclear spin exist in nature as nuclear-spin isomers (NSIs). However, owing to the lack of experimental information, knowledge is rare about interconversions of NSIs of gaseous molecules with torsional symmetry. Here we report our separation and conversion observations on NSI-torsion-specific transition systems of gaseous methanol from a light-induced drift experiment involving partially spatial separation of the ortho and para isomers. We find that vibrationally excited molecules of the methanol spin isomer have a smaller collision cross-section than their ground-state counterparts. Interconversion of the enriched ortho isomer with the para isomer, which is generally considered improbable, has been quantitatively studied by sensitive detections of the spectral intensities. Rather counterintuitively, this reveals that the interconversion is inhibited with increasing pressure. Our results suggest that the spin conversion mechanism in methanol is via a quantum relaxation process with the quantum Zeno effect induced by molecular collisions.	[Sun, Zhen-Dong; Ge, Meihua; Zheng, Yujun] Shandong Univ, Sch Phys, Jinan 250100, Shandong, Peoples R China; [Sun, Zhen-Dong] Toyama Univ, Dept Phys, Toyama 9308555, Japan	Sun, ZD (reprint author), Shandong Univ, Sch Phys, 27 Shanda Nanlu, Jinan 250100, Shandong, Peoples R China.	zdsun@sdu.edu.cn			National Natural Science Foundation of China [11074147, 11174186, 11374191]; Japan Society for the Promotion of Science [L-10519]	We express sincere thanks to P.L. Chapovsky, R.M. Lees, H. Odashima and D. M. Tong for helpful discussions and critical comments, and group members for helpful discussions. This study was partially supported by the National Natural Science Foundation of China (11074147, 11174186 and 11374191) and Japan Society for the Promotion of Science (L-10519).	CHAPOVSKY PL, 1991, PHYS REV A, V43, P3624, DOI 10.1103/PhysRevA.43.3624; CURL RF, 1967, J CHEM PHYS, V46, P3220, DOI 10.1063/1.1841193; MISRA B, 1977, J MATH PHYS, V18, P756, DOI 10.1063/1.523304; Chapovsky PL, 2000, CHEM PHYS LETT, V322, P424, DOI 10.1016/S0009-2614(00)00445-0; BALL JA, 1970, ASTROPHYS J, V162, pL203, DOI 10.1086/180654; BATRLA W, 1987, NATURE, V326, P49, DOI 10.1038/326049a0; Zhivonitko VV, 2013, ANGEW CHEM INT EDIT, V52, P13251, DOI 10.1002/anie.201307389; Kravchuk T, 2011, SCIENCE, V331, P319, DOI 10.1126/science.1200433; Tielens AGGM, 2013, REV MOD PHYS, V85, P1021, DOI 10.1103/RevModPhys.85.1021; Hogerheijde MR, 2011, SCIENCE, V334, P338, DOI 10.1126/science.1208931; Dello Russo N, 2005, ASTROPHYS J, V621, P537, DOI 10.1086/427473; Lees RM, 2007, J MOL SPECTROSC, V243, P168, DOI 10.1016/j.jms.2007.02.008; Horke DA, 2014, ANGEW CHEM INT EDIT, V53, P11965, DOI 10.1002/anie.201405986; Cacciani P., 2004, PHYS REV A, V69, P1; Chapovskii P. L., 1990, Soviet Physics - JETP, V70; Dickins JE, 1999, ASTROPHYS J, V518, P733, DOI 10.1086/307317; Farkas A., 1935, ORTHOHYDROGEN PARAHY; GELMUKHANOV FK, 1979, JETP LETT+, V29, P711; HERMANS LJF, 1992, INT REV PHYS CHEM, V11, P289, DOI 10.1080/01442359209353273; Kawakita H, 2001, SCIENCE, V294, P1089, DOI 10.1126/science.1064339; Landau L.D., 1981, QUANTUM MECH, V3; LEES RM, 1995, PHYS REV LETT, V75, P3645, DOI 10.1103/PhysRevLett.75.3645; LEES RM, 1974, CAN J PHYS, V52, P2250; Moruzzi G., 1995, MICROWAVE INFRARED L; Nagels B, 1997, PHYS REV LETT, V79, P3097, DOI 10.1103/PhysRevLett.79.3097; Nagels B, 1996, PHYS REV A, V54, P2050, DOI 10.1103/PhysRevA.54.2050; Peters G, 1999, CHEM PHYS LETT, V302, P181, DOI 10.1016/S0009-2614(99)00042-1; Sun ZD, 2005, SCIENCE, V310, P1938, DOI 10.1126/science.1120037	28	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6877	10.1038/ncomms7877		7	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0IQ	WOS:000353703400044		
J	Tatebayashi, K; Yamamoto, K; Nagoya, M; Takayama, T; Nishimura, A; Sakurai, M; Momma, T; Saito, H				Tatebayashi, Kazuo; Yamamoto, Katsuyoshi; Nagoya, Miho; Takayama, Tomomi; Nishimura, Akiko; Sakurai, Megumi; Momma, Takashi; Saito, Haruo			Osmosensing and scaffolding functions of the oligomeric four-transmembrane domain osmosensor Sho1	NATURE COMMUNICATIONS			English	Article							KINASE KINASE KINASE; THIOL CROSS-LINKING; HOG1 MAPK PATHWAY; SACCHAROMYCES-CEREVISIAE; SIGNAL-TRANSDUCTION; ESCHERICHIA-COLI; LACTOSE PERMEASE; OSMOTIC-STRESS; RESPONSE PATHWAY; PBS2 MAPKK	The yeast high osmolarity glycerol (HOG) pathway activates the Hog1 MAP kinase, which coordinates adaptation to high osmolarity conditions. Here we demonstrate that the four-transmembrane (TM) domain protein Sho1 is an osmosensor in the HKR1 sub-branch of the HOG pathway. Crosslinking studies indicate that Sho1 forms planar oligomers of the dimers-of-trimers architecture by dimerizing at the TM1/TM4 interface and trimerizing at the TM2/TM3 interface. High external osmolarity induces structural changes in the Sho1 TM domains and Sho1 binding to the cytoplasmic adaptor protein Ste50, which leads to Hog1 activation. Besides its osmosensing function, the Sho1 oligomer serves as a scaffold. By binding to the TM proteins Opy2 and Hkr1 at the TM1/TM4 and TM2/TM3 interface, respectively, Sho1 forms a multi-component signalling complex that is essential for Hog1 activation. Our results illuminate how the four TM domains of Sho1 dictate the oligomer structure as well as its osmosensing and scaffolding functions.	[Tatebayashi, Kazuo; Yamamoto, Katsuyoshi; Nagoya, Miho; Takayama, Tomomi; Nishimura, Akiko; Sakurai, Megumi; Momma, Takashi; Saito, Haruo] Univ Tokyo, Inst Med Sci, Div Mol Cell Signaling, Minato Ku, Tokyo 1088639, Japan; [Tatebayashi, Kazuo; Takayama, Tomomi; Nishimura, Akiko; Sakurai, Megumi; Saito, Haruo] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan	Tatebayashi, K (reprint author), Univ Tokyo, Inst Med Sci, Div Mol Cell Signaling, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	tategone@ims.u-tokyo.ac.jp; h-saito@ims.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Salt Science Research Foundation [1218]; MEXT	We thank Dr P. O'Grady for her critical reading and editing of the manuscript. This work was supported in part by several Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (to K.T., K.Y and H.S), and by a grant from the Salt Science Research Foundation (number 1218; to K.T.). A.N. was supported by the Graduate Program for Leaders in Life Innovation from MEXT.	Adrover MA, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002204; Wu H, 2013, CELL, V153, P287, DOI 10.1016/j.cell.2013.03.013; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Ekiel I, 2009, MOL BIOL CELL, V20, P5117, DOI 10.1091/mbc.E09-07-0645; Hao N, 2007, CURR BIOL, V17, P659, DOI 10.1016/j.cub.2007.02.044; Horie T, 2008, MOL CELL BIOL, V28, P5172, DOI 10.1128/MCB.00589-08; Reiser V, 2003, J CELL BIOL, V161, P1035, DOI 10.1083/jcb.200301099; Lee J, 2013, GENE DEV, V27, P2590, DOI 10.1101/gad.229310.113; Guan L, 2002, P NATL ACAD SCI USA, V99, P3475, DOI 10.1073/pnas.052703699; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; MCCAFFREY G, 1987, MOL CELL BIOL, V7, P2680; Liang YH, 2001, GENOMICS, V72, P119, DOI 10.1006/geno.2000.6472; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Furuse M, 2006, TRENDS CELL BIOL, V16, P181, DOI 10.1016/j.tcb.2006.02.006; Tatebayashi K, 2007, EMBO J, V26, P3521, DOI 10.1038/sj.emboj.7601796; Tzvetkov N, 2006, BIOTECHNIQUES, V40, P145, DOI 10.2144/000112113; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; MAEDA T, 1995, SCIENCE, V269, P554, DOI 10.1126/science.7624781; Wood JM, 1999, MICROBIOL MOL BIOL R, V63, P230; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; Gaskova D, 1998, YEAST, V14, P1189, DOI 10.1002/(SICI)1097-0061(19980930)14:13<1189::AID-YEA320>3.3.CO;2-B; Tatebayashi K, 2003, EMBO J, V22, P3624, DOI 10.1093/emboj/cdg353; Raitt DC, 2000, EMBO J, V19, P4623, DOI 10.1093/emboj/19.17.4623; Ferreira C, 2005, MOL BIOL CELL, V16, P2068, DOI 10.1091/mbc.E04-10-0884; Pitoniak A, 2009, MOL BIOL CELL, V20, P3101, DOI 10.1091/mbc.E08-07-0760; Tatebayashi K, 2006, EMBO J, V25, P3033, DOI 10.1038/sj.emboj.7601192; Saito H, 2012, GENETICS, V192, P289, DOI 10.1534/genetics.112.140863; Kramer R, 2010, CHEM REC, V10, P217, DOI 10.1002/tcr.201000005; Vadaie N, 2008, J CELL BIOL, V181, P1073, DOI 10.1083/jcb.200704079; Studdert CA, 2004, P NATL ACAD SCI USA, V101, P2117, DOI 10.1073/pnas.0308622100; Kovalenko OV, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-11; Loo TW, 2001, J BIOL CHEM, V276, P36877, DOI 10.1074/jbc.C100467200; Macia J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000056; Miller J. H., 1972, EXPT MOL GENETICS; Murakami Y, 2008, MOL CELL BIOL, V28, P2481, DOI 10.1128/MCB.01817-07; Posas F, 1998, MOL CELL BIOL, V18, P5788; Ramezani-Rad M, 2003, CURR GENET, V43, P161, DOI 10.1007/s00294-003-0383-6; [Anonymous], 1991, METHOD ENZYMOL; Suzuki H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2731; Tanaka K, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004780; te Welscher Yvonne M, 2008, J Biol Chem, V283, P6393, DOI 10.1074/jbc.M707821200; Wu JH, 1997, J MOL BIOL, V270, P285, DOI 10.1006/jmbi.1997.1099; Wu JH, 1996, P NATL ACAD SCI USA, V93, P14498, DOI 10.1073/pnas.93.25.14498; Yamamoto K, 2010, MOL CELL, V40, P87, DOI 10.1016/j.molcel.2010.09.011	46	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6975	10.1038/ncomms7975		15	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0JF	WOS:000353705000001		
J	Terasawa, TO; Saiki, K				Terasawa, Tomo-o; Saiki, Koichiro			Radiation-mode optical microscopy on the growth of graphene	NATURE COMMUNICATIONS			English	Article							CHEMICAL-VAPOR-DEPOSITION; BIASED GRAPHENE; LARGE-AREA; COPPER; FILMS; CU; TEMPERATURE; KINETICS; EMISSIVITIES; NUCLEATION	Chemical vapour deposition (CVD) growth of graphene has attracted much attention, aiming at the mass production of large-area and high-quality specimens. To optimize the growth condition, CVD grown graphene is conventionally characterized after synthesis. Real-time observation during graphene growth enables us to understand the growth mechanism and control the growth more easily. Here we report the optical microscope observation of the CVD growth of graphene in real time by focusing the radiation emitted from the growing graphene, which we call 'radiation-mode optical microscopy'. We observe the growth and shrinkage of graphene in response to the switching on and off of the methane supply. Analysis of the growth feature reveals that the attachment and detachment of carbon precursors are the rate-determining factor in the CVD growth of graphene. We expect radiation-mode optical microscopy to be applicable to the other crystal growth at high temperatures in various atmospheres.	[Terasawa, Tomo-o; Saiki, Koichiro] Univ Tokyo, Sch Sci, Dept Chem, Kashiwa, Chiba 2778561, Japan; [Saiki, Koichiro] Univ Tokyo, Grad Sch Frontier Sci, Dept Complex Sci & Engn, Kashiwa, Chiba 2778561, Japan	Saiki, K (reprint author), Univ Tokyo, Sch Sci, Dept Chem, Kashiwa, Chiba 2778561, Japan.	saiki@k.u-tokyo.ac.jp	Saiki, Koichiro/E-4496-2011				Chae DH, 2010, NANO LETT, V10, P466, DOI 10.1021/nl903167f; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Hayashi K, 2012, J AM CHEM SOC, V134, P12492, DOI 10.1021/ja300811p; Nair RR, 2008, SCIENCE, V320, P1308, DOI 10.1126/science.1156965; Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245; Petrone N, 2012, NANO LETT, V12, P2751, DOI 10.1021/nl204481s; Terasawa T, 2012, CARBON, V50, P869, DOI 10.1016/j.carbon.2011.09.047; Choubak S, 2013, J PHYS CHEM LETT, V4, P1100, DOI 10.1021/jz400400u; Li XS, 2009, NANO LETT, V9, P4268, DOI 10.1021/nl902515k; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Reina A, 2009, NANO LETT, V9, P30, DOI 10.1021/nl801827v; Li XS, 2010, NANO LETT, V10, P4328, DOI 10.1021/nl101629g; Li QY, 2013, NANO LETT, V13, P486, DOI 10.1021/nl303879k; Sutter PW, 2008, NAT MATER, V7, P406, DOI 10.1038/nmat2166; Lu CC, 2013, ACS NANO, V7, P2587, DOI 10.1021/nn3059828; Hao YF, 2013, SCIENCE, V342, P720, DOI 10.1126/science.1243879; Patera LL, 2013, ACS NANO, V7, P7901, DOI 10.1021/nn402927q; Wofford JM, 2010, NANO LETT, V10, P4890, DOI 10.1021/nl102788f; Starodub E, 2010, J PHYS CHEM C, V114, P5134, DOI 10.1021/jp912139e; Kim KS, 2009, NATURE, V457, P706, DOI 10.1038/nature07719; Ferrari AC, 2007, SOLID STATE COMMUN, V143, P47, DOI 10.1016/j.ssc.2007.03.052; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; Bae S, 2010, NAT NANOTECHNOL, V5, P574, DOI [10.1038/nnano.2010.132, 10.1038/NNANO.2010.132]; Cui Y, 2009, J PHYS CHEM C, V113, P20365, DOI 10.1021/jp907949a; Celebi K, 2013, NANO LETT, V13, P967, DOI 10.1021/nl303934v; Wang ZJ, 2015, ACS NANO, V9, P1506, DOI 10.1021/nn5059826; Kim H, 2012, ACS NANO, V6, P3614, DOI 10.1021/nn3008965; Teyssieux D, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2714040; Wintterlin J, 2009, SURF SCI, V603, P1841, DOI 10.1016/j.susc.2008.08.037; Mizuno K, 2009, P NATL ACAD SCI USA, V106, P6044, DOI 10.1073/pnas.0900155106; Li XS, 2011, J AM CHEM SOC, V133, P2816, DOI 10.1021/ja109793s; Losurdo M, 2011, PHYS CHEM CHEM PHYS, V13, P20836, DOI 10.1039/c1cp22347j; Puretzky AA, 2013, NANOSCALE, V5, P6507, DOI 10.1039/c3nr01436c; Yu QK, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2982585; Zhang WH, 2011, J PHYS CHEM C, V115, P17782, DOI 10.1021/jp2006827; Vlassiouk I, 2013, J PHYS CHEM C, V117, P18919, DOI 10.1021/jp4047648; Piner R, 2013, ACS NANO, V7, P7495, DOI 10.1021/nn4031564; RAMANATHAN KG, 1977, J OPT SOC AM, V67, P32, DOI 10.1364/JOSA.67.000032; Loginova E, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/9/093026; Kidambi PR, 2013, NANO LETT, V13, P4769, DOI 10.1021/nl4023572; Dong GC, 2013, ACS NANO, V7, P7028, DOI 10.1021/nn402229t; Freitag M, 2010, NAT NANOTECHNOL, V5, P497, DOI [10.1038/nnano.2010.90, 10.1038/NNANO.2010.90]; HAYASHI Y, 1992, JPN J APPL PHYS 2, V31, pL193, DOI 10.1143/JJAP.31.L193; Lewis B., 1978, NUCL GROWTH THIN FIL; Liu Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5055; McClure JL, 1999, INT J THERMOPHYS, V20, P1149, DOI 10.1023/A:1022663105959; Terasawa TO, 2015, APPL PHYS EXPRESS, V8, DOI 10.7567/APEX.8.035101; TAFT EA, 1965, PHYS REV, V138, pA197, DOI 10.1103/PhysRev.138.A197; WARD L, 1956, P PHYS SOC LOND B, V69, P339, DOI 10.1088/0370-1301/69/3/308; Zhao HM, 2014, ACS NANO, V8, P10766, DOI 10.1021/nn5044959	50	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6834	10.1038/ncomms7834		6	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0IQ	WOS:000353703400001		
J	Tominaga, N; Kosaka, N; Ono, M; Katsuda, T; Yoshioka, Y; Tamura, K; Lotvall, J; Nakagama, H; Ochiya, T				Tominaga, Naoomi; Kosaka, Nobuyoshi; Ono, Makiko; Katsuda, Takeshi; Yoshioka, Yusuke; Tamura, Kenji; Lotvall, Jan; Nakagama, Hitoshi; Ochiya, Takahiro			Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrier	NATURE COMMUNICATIONS			English	Article							ENDOTHELIAL GROWTH-FACTOR; BREAST-CANCER; IN-VITRO; MICRORNAS; EXPRESSION; RECEPTOR	Brain metastasis is an important cause of mortality in breast cancer patients. A key event during brain metastasis is the migration of cancer cells through blood-brain barrier (BBB). However, the molecular mechanism behind the passage through this natural barrier remains unclear. Here we show that cancer-derived extracellular vesicles (EVs), mediators of cell-cell communication via delivery of proteins and microRNAs (miRNAs), trigger the breakdown of BBB. Importantly, miR-181c promotes the destruction of BBB through the abnormal localization of actin via the downregulation of its target gene, PDPK1. PDPK1 degradation by miR-181c leads to the downregulation of phosphorylated cofilin and the resultant activated cofilin-induced modulation of actin dynamics. Furthermore, we demonstrate that systemic injection of brain metastatic cancer cell-derived EVs promoted brain metastasis of breast cancer cell lines and are preferentially incorporated into the brain in vivo. Taken together, these results indicate a novel mechanism of brain metastasis mediated by EVs that triggers the destruction of BBB.	[Tominaga, Naoomi; Kosaka, Nobuyoshi; Ono, Makiko; Katsuda, Takeshi; Yoshioka, Yusuke; Ochiya, Takahiro] Natl Canc Ctr, Res Inst, Div Mol & Cellular Med, Chuo Ku, Tokyo 1040045, Japan; [Tominaga, Naoomi; Nakagama, Hitoshi] Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; [Tominaga, Naoomi] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1020083, Japan; [Kosaka, Nobuyoshi] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Kosaka, Nobuyoshi] Japan Soc Promot Sci, Res Abroad, Chiyoda Ku, Tokyo 1020083, Japan; [Tamura, Kenji] Natl Canc Ctr, Res Inst, Div Breast & Med Oncol, Chuo Ku, Tokyo 1040045, Japan; [Lotvall, Jan] Univ Gothenburg, Sahlgrenska Acad, Dept Internal Med, SE-40530 Gothenburg, Sweden; [Lotvall, Jan] Univ Gothenburg, Sahlgrenska Acad, Dept Resp Med & Allergol, SE-40530 Gothenburg, Sweden; [Nakagama, Hitoshi] Natl Canc Ctr, Res Inst, Div Canc Dev Syst, Chuo Ku, Tokyo 1040045, Japan	Ochiya, T (reprint author), Natl Canc Ctr, Res Inst, Div Mol & Cellular Med, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	tochiya@ncc.go.jp		Tominaga, Naoomi/0000-0003-4368-6586; Lotvall, Jan/0000-0001-9195-9249	Ministry of Education, Culture, Sports, Science and Technology; National Institute of Biomedical Innovation (NiBio); Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program); Council for Science and Technology Policy; Japanese Ministry of Education, Culture, Sports, Science and Technology; JSPS Postdoctoral Fellowship for Research Abroad	This work was supported in part by a Grant-in-Aid for the third term of a comprehensive 10-year strategy for cancer control; a Grant-in-Aid for scientific research on priority areas in cancer from the Ministry of Education, Culture, Sports, Science and Technology; the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NiBio); the Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) initiated by the Council for Science and Technology Policy; and a Grant-in-Aid for Scientific Research on Innovative Areas (functional machinery for non-coding RNAs) from the Japanese Ministry of Education, Culture, Sports, Science and Technology. N.K. is supported by the JSPS Postdoctoral Fellowship for Research Abroad. We thank Dr. Kou Furuta for providing patient serum samples. We thank Ayako Inoue for excellent technical assistance.	Wilhelm I, 2011, ACTA NEUROBIOL EXP, V71, P113; Yano S, 2000, CANCER RES, V60, P4959; Higuchi M, 2008, NAT CELL BIOL, V10, P1356, DOI 10.1038/ncb1795; Lyle AN, 2006, PHYSIOLOGY, V21, P269, DOI 10.1152/physiol.00004.2006; Gaillard PJ, 2001, EUR J PHARM SCI, V12, P215, DOI 10.1016/S0928-0987(00)00123-8; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Zhou WY, 2014, CANCER CELL, V25, P501, DOI 10.1016/j.ccr.2014.03.007; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Yang CJ, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/842849; Bos PD, 2010, CURR OPIN PHARMACOL, V10, P571, DOI 10.1016/j.coph.2010.06.003; Kosaka N, 2013, J BIOL CHEM, V288, P10849, DOI 10.1074/jbc.M112.446831; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Orr FW, 2000, J PATHOL, V190, P310, DOI 10.1002/(SICI)1096-9896(200002)190:3<310::AID-PATH525>3.0.CO;2-P; Brown H, 1999, NEUROPATH APPL NEURO, V25, P331; Lu ZM, 2010, MOL CANCER RES, V8, P421, DOI 10.1158/1541-7786.MCR-09-0179; Lee TH, 2003, J BIOL CHEM, V278, P5277, DOI 10.1074/jbc.M210063200; Bobrie A, 2012, CANCER RES, V72, P4920, DOI 10.1158/0008-5472.CAN-12-0925; Sand M, 2012, BRIT J DERMATOL, V167, P847, DOI 10.1111/j.1365-2133.2012.11022.x; NICOLSON GL, 1988, CANCER METAST REV, V7, P143, DOI 10.1007/BF00046483; Arshad F., 2010, PATHOLOG RES INT, V2011; Ji JF, 2009, HEPATOLOGY, V50, P472, DOI 10.1002/hep.22989; Kis B, 2001, NEUROREPORT, V12, P4139, DOI 10.1097/00001756-200112210-00055; Lowery AJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2257; Polimeni Manuela, 2014, Fluids Barriers CNS, V11, P1, DOI 10.1186/2045-8118-11-1; Zaru R, 2008, J BIOL CHEM, V283, P929, DOI 10.1074/jbc.M708069200	31	5	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6716	10.1038/ncomms7716		12	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0HV	WOS:000353701300001		
J	Tsukamoto, H; Senju, S; Matsumura, K; Swain, SL; Nishimura, Y				Tsukamoto, Hirotake; Senju, Satoru; Matsumura, Keiko; Swain, Susan L.; Nishimura, Yasuharu			IL-6-mediated environmental conditioning of defective Th1 differentiation dampens antitumour immune responses in old age	NATURE COMMUNICATIONS			English	Article							CD4(+) T-CELLS; IN-VIVO; FUNCTIONAL DEFECTS; TUMOR-IMMUNOTHERAPY; IFN-GAMMA; LIFE-SPAN; CANCER; MICE; IL-6; INFLAMMATION	Decline in immune function and inflammation concomitantly develop with ageing. Here we focus on the impact of this inflammatory environment on T cells, and demonstrate that in contrast to successful tumour elimination in young mice, replenishment of tumour-specific CD4(+) T cells fails to induce tumour regression in aged hosts. The impaired antitumour effect of CD4(+) T cells with their defective Th1 differentiation in an aged environment is restored by interleukin (IL)-6 blockade or IL-6 deficiency. IL-6 blockade also restores the impaired ability of CD4(+) T cells to promote CD8(+) T-cell-dependent tumour elimination in aged mice, which requires IFN-gamma. Furthermore, IL-6-stimulated production of IL-4/IL-21 through c-Maf induction is responsible for impaired Th1 differentiation. IL-6 also contributes to IL-10 production from CD4(+) T cells in aged mice, causing attenuated responses of CD8(+) T cells. These findings suggest that IL-6 serves as an extrinsic factor counteracting CD4(+) T-cell-mediated immunity against tumour in old age.	[Tsukamoto, Hirotake; Senju, Satoru; Matsumura, Keiko; Nishimura, Yasuharu] Kumamoto Univ, Grad Sch Med Sci, Dept Immunogenet, Chuo Ku, Kumamoto 8608556, Japan; [Swain, Susan L.] Univ Massachusetts, Dept Pathol, Sch Med, Worcester, MA 01655 USA	Tsukamoto, H (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Immunogenet, Chuo Ku, Honjo 1-1-1, Kumamoto 8608556, Japan.	htsukamo@kumamoto-u.ac.jp; mxnishim@kumamoto-u.ac.jp			Japanese Society for the Promotion of Science [24700994]; YASUDA Medical Foundation	We are grateful to Drs Youichiro Iwakura, Shigeo Koyasu and Akira Sibuya for the generous supply of IL-6-deficient mouse embryos, OT-II TCR Tg mouse embryos and RMA cells, respectively. We also thank Ms Michiko Teramoto for helpful secretarial assistance. This work was supported by Japanese Society for the Promotion of Science, Grants-in-Aid for Young Scientists No. 24700994 (H.T.). H.T. was also supported by The YASUDA Medical Foundation.	SANSONI P, 1993, BLOOD, V82, P2767; Groom JR, 2012, IMMUNITY, V37, P1091, DOI 10.1016/j.immuni.2012.08.016; Chung HY, 2009, AGEING RES REV, V8, P18, DOI 10.1016/j.arr.2008.07.002; Tsukamoto H, 2013, CANCER IMMUNOL RES, V1, P64, DOI 10.1158/2326-6066.CIR-13-0030; Yang Y, 2005, J IMMUNOL, V174, P2720; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Lefebvre JS, 2012, AGING CELL, V11, P732, DOI 10.1111/j.1474-9726.2012.00836.x; Goronzy JJ, 2013, NAT IMMUNOL, V14, P428, DOI 10.1038/ni.2588; Alberti S, 2006, MECH AGEING DEV, V127, P560, DOI 10.1016/j.mad.2006.01.014; Tsukamoto H, 2009, P NATL ACAD SCI USA, V106, P18333, DOI 10.1073/pnas.0910139106; Green AM, 2013, J IMMUNOL, V190, P270, DOI 10.4049/jimmunol.1200061; Bouchlaka MN, 2013, J EXP MED, V210, P2223, DOI 10.1084/jem.20131219; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Coward J, 2011, CLIN CANCER RES, V17, P6083, DOI 10.1158/1078-0432.CCR-11-0945; Wu DY, 2007, J IMMUNOL, V179, P4829; Mitchem JB, 2013, CANCER RES, V73, P1128, DOI 10.1158/0008-5472.CAN-12-2731; Ho IC, 1998, J EXP MED, V188, P1859, DOI 10.1084/jem.188.10.1859; Sakata-Kaneko S, 2000, CLIN EXP IMMUNOL, V120, P267, DOI 10.1046/j.1365-2249.2000.01224.x; Hiramatsu Y, 2010, J LEUKOCYTE BIOL, V87, P703, DOI 10.1189/jlb.0909639; Peters M, 1996, J EXP MED, V183, P1399, DOI 10.1084/jem.183.4.1399; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Vasto S, 2009, MECH AGEING DEV, V130, P40, DOI 10.1016/j.mad.2008.06.003; Bos R, 2010, CANCER RES, V70, P8368, DOI 10.1158/0008-5472.CAN-10-1322; Gardner EM, 2006, VACCINE, V24, P1609, DOI 10.1016/j.vaccine.2005.09.058; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Church SE, 2014, EUR J IMMUNOL, V44, P69, DOI 10.1002/eji.201343718; Ossendorp F, 1998, J EXP MED, V187, P693, DOI 10.1084/jem.187.5.693; Cui GW, 2014, P NATL ACAD SCI USA, V111, P1915, DOI 10.1073/pnas.1318281111; Haynes L, 1999, J EXP MED, V190, P1013, DOI 10.1084/jem.190.7.1013; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Hurez V, 2012, CANCER RES, V72, P2089, DOI 10.1158/0008-5472.CAN-11-3019; Quinn LS, 2010, EXP GERONTOL, V45, P106, DOI 10.1016/j.exger.2009.10.012; de Magalhaes JP, 2013, NAT REV CANCER, V13, P357, DOI 10.1038/nrc3497; Ho IC, 2002, CELL, V109, pS109, DOI 10.1016/S0092-8674(02)00705-5; Lages CS, 2008, J IMMUNOL, V181, P1835; Lyon MF, 2003, HUM MOL GENET, V12, P585, DOI 10.1093/hmg/ddg063; Braumuller H, 2013, NATURE, V494, P361, DOI 10.1038/nature11824; Xie Y, 2010, J EXP MED, V207, P651, DOI 10.1084/jem.20091921; Ferrucci L, 2005, BLOOD, V105, P2294, DOI 10.1182/blood-2004-07-2599; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057; Tsukamoto H, 2010, J IMMUNOL, V185, P4535, DOI 10.4049/jimmunol.1001668; Tagawa Y, 1997, J IMMUNOL, V159, P1418; Decman V, 2010, J IMMUNOL, V184, P5151, DOI 10.4049/jimmunol.0902063; Diehl S, 2000, IMMUNITY, V13, P805, DOI 10.1016/S1074-7613(00)00078-9; Falo Jr L. D., 1995, NATURE MED, V1, P649; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Haabeth OAW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1239; Li SKP, 2002, J IMMUNOL, V168, P6120; Marzetti E, 2009, MECH AGEING DEV, V130, P272, DOI 10.1016/j.mad.2008.12.008; Matsuyoshi H, 2004, J IMMUNOL, V172, P776; Norian LA, 2004, J IMMUNOL, V173, P835; Singh M, 2013, CANCER MED-US, V2, P571, DOI 10.1002/cam4.94; Tatsumi T, 2002, J EXP MED, V196, P619, DOI 10.1084/jem.20012142; Tjin E. P. M., 2014, CANCER IMMUNOL RES, V2, P1	54	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6702	10.1038/ncomms7702		15	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0HH	WOS:000353699900002		
J	Wang, X; Kajiyama, S; Iinuma, H; Hosono, E; Oro, S; Moriguchi, I; Okubo, M; Yamada, A				Wang, Xianfen; Kajiyama, Satoshi; Iinuma, Hiroki; Hosono, Eiji; Oro, Shinji; Moriguchi, Isamu; Okubo, Masashi; Yamada, Atsuo			Pseudocapacitance of MXene nanosheets for high-power sodium-ion hybrid capacitors	NATURE COMMUNICATIONS			English	Article							2-DIMENSIONAL TITANIUM CARBIDE; ELECTROCHEMICAL ENERGY-STORAGE; HIGH VOLUMETRIC CAPACITANCE; TRANSITION-METAL CARBIDES; NEGATIVE ELECTRODE; RATE CAPABILITY; LONG-LIFE; BATTERIES; ANODE; INTERCALATION	High-power Na-ion batteries have tremendous potential in various large-scale applications. However, conventional charge storage through ion intercalation or double-layer formation cannot satisfy the requirements of such applications owing to the slow kinetics of ion intercalation and the small capacitance of the double layer. The present work demonstrates that the pseudocapacitance of the nanosheet compound MXene Ti2C achieves a higher specific capacity relative to double-layer capacitor electrodes and a higher rate capability relative to ion intercalation electrodes. By utilizing the pseudocapacitance as a negative electrode, the prototype Na-ion full cell consisting of an alluaudite Na2Fe2(SO4)(3) positive electrode and an MXene Ti2C negative electrode operates at a relatively high voltage of 2.4V and delivers 90 and 40 mAh g(-1) at 1.0 and 5.0 Ag-1 (based on the weight of the negative electrode), respectively, which are not attainable by conventional electrochemical energy storage systems.	[Wang, Xianfen; Kajiyama, Satoshi; Iinuma, Hiroki; Okubo, Masashi; Yamada, Atsuo] Univ Tokyo, Sch Engn, Dept Chem Syst Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Hosono, Eiji] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan; [Oro, Shinji; Moriguchi, Isamu] Nagasaki Univ, Grad Sch Engn, Nagasaki 8528521, Japan; [Okubo, Masashi; Yamada, Atsuo] Kyoto Univ, ESICB, Nishikyo Ku, Kyoto 6158510, Japan	Yamada, A (reprint author), Univ Tokyo, Sch Engn, Dept Chem Syst Engn, Bunkyo Ku, Hongo 7-3-1, Tokyo 1138656, Japan.	yamada@chemsys.t.u-tokyo.ac.jp	Okubo, Masashi/C-6360-2011; Yamada, Atsuo/A-4920-2011; Hosono, Eiji/M-8402-2013	Yamada, Atsuo/0000-0002-7880-5701; 	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Murata Science Foundation	This work was financially supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan under the 'Elemental Strategy Initiative for Catalysts and Batteries' (ESICB). M.O. was financially supported by the Murata Science Foundation.	Dall'Agnese Y, 2014, ELECTROCHEM COMMUN, V48, P118, DOI 10.1016/j.elecom.2014.09.002; Xie Y, 2014, ACS NANO, V8, P9606, DOI 10.1021/nn503921j; Simon P, 2008, NAT MATER, V7, P845, DOI 10.1038/nmat2297; Oh SM, 2014, ACS APPL MATER INTER, V6, P11295, DOI 10.1021/am501772a; Naguib M, 2013, J AM CHEM SOC, V135, P15966, DOI 10.1021/ja405735d; Lukatskaya MR, 2013, SCIENCE, V341, P1502, DOI 10.1126/science.1241488; Qu BH, 2014, ADV MATER, V26, P3854, DOI 10.1002/adma.201306314; Momma K, 2011, J APPL CRYSTALLOGR, V44, P1272, DOI 10.1107/S0021889811038970; Augustyn V, 2013, NAT MATER, V12, P518, DOI [10.1038/nmat3601, 10.1038/NMAT3601]; Zhu YW, 2011, SCIENCE, V332, P1537, DOI 10.1126/science.1200770; Mefford JT, 2014, NAT MATER, V13, P726, DOI [10.1038/nmat4000, 10.1038/NMAT4000]; Naguib M, 2011, ADV MATER, V23, P4248, DOI 10.1002/adma.201102306; Li WJ, 2014, ADV MATER, V26, P4037, DOI 10.1002/adma.201400794; Qian JF, 2013, ANGEW CHEM INT EDIT, V52, P4633, DOI 10.1002/anie.201209689; Xie Y, 2014, J AM CHEM SOC, V136, P6385, DOI 10.1021/ja501520b; CONWAY BE, 1991, J ELECTROCHEM SOC, V138, P1539, DOI 10.1149/1.2085829; Senguttuvan P, 2011, CHEM MATER, V23, P4109, DOI 10.1021/cm202076g; Halim J, 2014, CHEM MATER, V26, P2374, DOI 10.1021/cm500641a; Naguib M, 2012, ACS NANO, V6, P1322, DOI 10.1021/nn204153h; Come J, 2012, J ELECTROCHEM SOC, V159, pA1368, DOI 10.1149/2.003208jes; Naguib M, 2012, ELECTROCHEM COMMUN, V16, P61, DOI 10.1016/j.elecom.2012.01.002; Barpanda P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5358; Barsoum MW, 2013, MAX PHASES: PROPERTIES OF MACHINABLE TERNARY CARBIDES AND NITRIDES, P1, DOI 10.1002/9783527654581; Beguin F., 2013, SUPERCAPACITORS; Conway B. E., 1999, ELECTROCHEMICAL SUPE; Daniel C, 2011, HANDBOOK OF BATTERY MATERIALS, 2ND EDITION, P1, DOI 10.1002/9783527637188; Ghidiu M, 2014, NATURE, V516, P78, DOI 10.1038/nature13970; Levi MD, 2015, ADV ENERGY MATER, V5, DOI 10.1002/aenm.201400815; Mashtalir O, 2013, MATER CHEM PHYS, V139, P147, DOI 10.1016/j.matchemphys.2013.01.008; Mashtalir O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2664; Ming J, 2015, ELECTROCHEM COMMUN, V51, P19, DOI 10.1016/j.elecom.2014.11.009; Nazri G.-A., 2009, LITHIUM BATTERIES; Ponrouch A, 2013, ELECTROCHEM COMMUN, V27, P85, DOI 10.1016/j.elecom.2012.10.038; Wang YS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3365; Wen Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5033; Wu CZ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3431; Yu DYW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3922	37	7	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6544	10.1038/ncomms7544		6	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0FA	WOS:000353693600001		
J	Yajima, T; Hikita, Y; Minohara, M; Bell, C; Mundy, JA; Kourkoutis, LF; Muller, DA; Kumigashira, H; Oshima, M; Hwang, HY				Yajima, Takeaki; Hikita, Yasuyuki; Minohara, Makoto; Bell, Christopher; Mundy, Julia A.; Kourkoutis, Lena F.; Muller, David A.; Kumigashira, Hiroshi; Oshima, Masaharu; Hwang, Harold Y.			Controlling band alignments by artificial interface dipoles at perovskite heterointerfaces	NATURE COMMUNICATIONS			English	Article							INHOMOGENEOUS SCHOTTKY BARRIERS; SELF-ASSEMBLED MONOLAYERS; THIN-FILM TRANSISTORS; ELECTRON-TRANSPORT; OXIDE INTERFACES; CHARGE INJECTION; HEIGHT; MODULATION; EPITAXY; WATER	The concept 'the interface is the device' is embodied in a wide variety of interfacial electronic phenomena and associated applications in oxide materials, ranging from catalysts and clean energy systems to emerging multifunctional devices. Many device properties are defined by the band alignment, which is often influenced by interface dipoles. On the other hand, the ability to purposefully create and control interface dipoles is a relatively unexplored degree of freedom for perovskite oxides, which should be particularly effective for such ionic materials. Here we demonstrate tuning the band alignment in perovskite metal-semiconductor heterojunctions over a broad range of 1.7 eV. This is achieved by the insertion of positive or negative charges at the interface, and the resultant dipole formed by the induced screening charge. This approach can be broadly used in applications where decoupling the band alignment from the constituent work functions and electron affinities can enhance device functionality.	[Yajima, Takeaki; Hikita, Yasuyuki; Minohara, Makoto; Bell, Christopher; Hwang, Harold Y.] Stanford Inst Mat & Energy Sci, SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA; [Yajima, Takeaki] Univ Tokyo, Dept Mat Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Minohara, Makoto; Hwang, Harold Y.] Stanford Univ, Dept Appl Phys, Geballe Lab Adv Mat, Stanford, CA 94305 USA; [Mundy, Julia A.; Kourkoutis, Lena F.; Muller, David A.] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; [Kourkoutis, Lena F.; Muller, David A.] Kavli Inst Cornell Nanoscale Sci, Ithaca, NY 14853 USA; [Kumigashira, Hiroshi] High Energy Accelerator Res Org, Photon Factory, Tsukuba, Ibaraki 3050801, Japan; [Oshima, Masaharu] Univ Tokyo, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan	Yajima, T (reprint author), Stanford Inst Mat & Energy Sci, SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA.	yajima@adam.t.u-tokyo.ac.jp; hyhwang@stanford.edu	Bell, Christopher/B-8785-2009; Minohara, Makoto/A-8841-2012; Muller, David/A-7745-2010	Bell, Christopher/0000-0003-4732-0354; Muller, David/0000-0003-4129-0473	Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-AC02-76SF00515]; U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-SC0002334]; Cornell Center for Materials Research through the National Science Foundation (NSF) Materials Research Science and Engineering Centers program [DMR 1120296]; Japan Society for the Promotion of Science (JSPS)	We acknowledge experimental support from M. Lippmaa, R. Takahashi, K. Nishio, T. Harada, S. Toyoda and T. Namiki. We acknowledge support from the Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering, under contract DE-AC02-76SF00515 (T.Y., Y.H., M.M., C.B. and H.Y.H.). Electron microscopy research (J.A.M., D.A.M.) supported by the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering, under Award No. DE-SC0002334, with microscope facility support from the Cornell Center for Materials Research through the National Science Foundation (NSF) Materials Research Science and Engineering Centers program (DMR 1120296). T.Y. also acknowledges graduate fellowship support from the Japan Society for the Promotion of Science (JSPS).	SULLIVAN JP, 1991, J APPL PHYS, V70, P7403, DOI 10.1063/1.349737; Ohtomo A, 2002, NATURE, V419, P378, DOI 10.1038/nature00977; Campbell IH, 1997, APPL PHYS LETT, V71, P3528, DOI 10.1063/1.120381; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; TUNG RT, 1991, APPL PHYS LETT, V58, P2821, DOI 10.1063/1.104747; Marmont P, 2008, ORG ELECTRON, V9, P419, DOI 10.1016/j.orgel.2008.01.004; Fowler RH, 1931, PHYS REV, V38, P45, DOI 10.1103/PhysRev.38.45; COWLEY AM, 1965, J APPL PHYS, V36, P3212, DOI 10.1063/1.1702952; Kato H, 2003, J AM CHEM SOC, V125, P3082, DOI 10.1021/ja027751g; KURTIN S, 1969, PHYS REV LETT, V22, P1433, DOI 10.1103/PhysRevLett.22.1433; ANDERSON RL, 1962, SOLID STATE ELECTRON, V5, P341, DOI 10.1016/0038-1101(62)90115-6; Hwang HY, 2012, NAT MATER, V11, P103, DOI [10.1038/nmat3223, 10.1038/NMAT3223]; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; Jang HW, 2011, SCIENCE, V331, P886, DOI 10.1126/science.1198781; Tsukazaki A, 2005, NAT MATER, V4, P42, DOI 10.1038/nmat1284; Dong YF, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2357012; HAN CC, 1988, J VAC SCI TECHNOL B, V6, P1662, DOI 10.1116/1.584426; Hikita Y, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2719157; KOYANAGI K, 1993, JPN J APPL PHYS 1, V32, P502, DOI 10.1143/JJAP.32.502; Kroemer H., 2000, NOBEL LECT; Minohara M, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2717517; NILES DW, 1985, APPL PHYS LETT, V47, P1092, DOI 10.1063/1.96339; Nomura K, 2004, NATURE, V432, P488, DOI 10.1038/nature03090; Sato HK, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3583459; SHANNON JM, 1976, SOLID STATE ELECTRON, V19, P537, DOI 10.1016/0038-1101(76)90019-8; Sze S. M., 2007, PHYS SEMICONDUCTOR D; Yu Y., 2014, NAT COMMUN, V5, P5118	27	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6759	10.1038/ncomms7759		5	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0IF	WOS:000353702300016		
J	Yamagata, A; Yoshida, T; Sato, Y; Goto-Ito, S; Uemura, T; Maeda, A; Shiroshima, T; Iwasawa-Okamoto, S; Mori, H; Mishina, M; Fukai, S				Yamagata, Atsushi; Yoshida, Tomoyuki; Sato, Yusuke; Goto-Ito, Sakurako; Uemura, Takeshi; Maeda, Asami; Shiroshima, Tomoko; Iwasawa-Okamoto, Shiho; Mori, Hisashi; Mishina, Masayoshi; Fukai, Shuya			Mechanisms of splicing-dependent trans-synaptic adhesion by PTP delta-IL1RAPL1/IL-1RAcP for synaptic differentiation	NATURE COMMUNICATIONS			English	Article							PROTEIN-TYROSINE PHOSPHATASES; PTP-SIGMA; STRUCTURAL INSIGHTS; MENTAL-RETARDATION; LAR; MOLECULES; NEUROLIGINS; COMPLEX; FAMILY; AUTISM	Synapse formation is triggered through trans-synaptic interaction between pairs of pre- and postsynaptic adhesion molecules, the specificity of which depends on splice inserts known as 'splice-insert signaling codes'. Receptor protein tyrosine phosphatase d (PTPd) can bidirectionally induce pre- and postsynaptic differentiation of neurons by trans-synaptically binding to interleukin-1 receptor accessory protein (IL-1RAcP) and IL-1RAcP-like-1 (IL1RAPL1) in a splicing-dependent manner. Here, we report crystal structures of PTPd in complex with IL1RAPL1 and IL-1RAcP. The first immunoglobulin-like (Ig) domain of IL1RAPL1 directly recognizes the first splice insert, which is critical for binding to IL1RAPL1. The second splice insert functions as an adjustable linker that positions the Ig2 and Ig3 domains of PTPd for simultaneously interacting with the Ig1 domain of IL1RAPL1 or IL-1RAcP. We further identified the IL1RAPL1-specific interaction, which appears coupled to the first-splice-insert-mediated interaction. Our results thus reveal the decoding mechanism of splice-insert signaling codes for synaptic differentiation induced by trans-synaptic adhesion between PTPd and IL1RAPL1/IL-1RAcP.	[Yamagata, Atsushi; Sato, Yusuke; Goto-Ito, Sakurako; Maeda, Asami; Shiroshima, Tomoko; Fukai, Shuya] Univ Tokyo, Synchrotron Radiat Res Org, Div Life Sci, Struct Biol Lab, Tokyo 1130032, Japan; [Yamagata, Atsushi; Sato, Yusuke; Goto-Ito, Sakurako; Maeda, Asami; Shiroshima, Tomoko; Fukai, Shuya] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; [Yamagata, Atsushi; Sato, Yusuke; Fukai, Shuya] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Chiba 2778501, Japan; [Yamagata, Atsushi; Sato, Yusuke; Uemura, Takeshi; Maeda, Asami; Shiroshima, Tomoko; Fukai, Shuya] JST, CREST, Saitama 3320012, Japan; [Yoshida, Tomoyuki; Iwasawa-Okamoto, Shiho; Mori, Hisashi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Mol Neurosci, Toyama 9300194, Japan; [Yoshida, Tomoyuki; Uemura, Takeshi; Mishina, Masayoshi] Univ Tokyo, Grad Sch Med, Dept Mol Neurobiol & Pharmacol, Tokyo 1130033, Japan; [Yoshida, Tomoyuki; Iwasawa-Okamoto, Shiho] JST, PRESTO, Saitama 3320012, Japan; [Uemura, Takeshi] Shinshu Univ, Sch Med, Dept Mol & Cellular Physiol, Nagano 3908621, Japan; [Uemura, Takeshi] Shinshu Univ, Inst Biomed Sci, Interdisciplinary Cluster Cutting Edge Res, Nagano 3908621, Japan; [Mishina, Masayoshi] Ritsumeikan Univ, Res Org Sci & Technol, Brain Sci Lab, Shiga 5258577, Japan	Yoshida, T (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Mol Neurosci, Toyama 9300194, Japan.	toyoshid@med.u-toyama.ac.jp; fukai@iam.u-tokyo.ac.jp			PRESTO, JST [22121003, 22123008, 25110708, 25121710, 21249012, 24249014, 25293057, 25290021, 24570126, 26640038, 26640039]; CREST, JST	We thank the beam-line staff at NW12A, BL-1A, BL-5A and BL17A of Photon Factory (Tsukuba, Japan) and BL32XU and BL41XU of SPring-8 (Hyogo, Japan) for technical help during data collection. This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas 22121003 (S.F.), 22123008 (M.M.), 25110708 (T.Y.), 25121710 (T.U.), Grant-in-Aid for Scientific Research (A) 21249012, 24249014 (M.M.), Grant-in-Aid for Scientific Research (B) 25293057 (T.Y), 25290021 (T.U.), Grant-in-Aid for Scientific Research (C) 24570126 (A.Y.), Grant-in-Aid for challenging Exploratory Research 26640038 (T.Y.), 26640039 (T.U.), PRESTO, JST (T.Y.) and CREST, JST (S.F. and T.U.).	Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Thomas C, 2012, NAT STRUCT MOL BIOL, V19, P455, DOI 10.1038/nsmb.2260; Coles CH, 2011, SCIENCE, V332, P484, DOI 10.1126/science.1200840; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Koehnke J, 2010, NEURON, V67, P61, DOI 10.1016/j.neuron.2010.06.001; Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010; [Anonymous], NAT NEUROSCI; Dabrowski A, 2011, J BIOCHEM, V149, P641, DOI 10.1093/jb/mvr047; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Groves JT, 2010, NAT STRUCT MOL BIOL, V17, P659, DOI 10.1038/nsmb.1844; Kwon SK, 2010, J BIOL CHEM, V285, P13966, DOI 10.1074/jbc.M109.061127; Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Carrie A, 1999, NAT GENET, V23, P25; Aricescu AR, 2007, CURR OPIN CELL BIOL, V19, P543, DOI 10.1016/j.ceb.2007.09.010; Takahashi H, 2013, TRENDS NEUROSCI, V36, P522, DOI 10.1016/j.tins.2013.06.002; Um JW, 2013, TRENDS CELL BIOL, V23, P465, DOI 10.1016/j.tcb.2013.07.004; [Anonymous], NAT NEUROSCI; Yoshida T, 2011, J NEUROSCI, V31, P13485, DOI 10.1523/JNEUROSCI.2136-11.2011; Uemura T, 2008, BIOCHEM BIOPH RES CO, V377, P1315, DOI 10.1016/j.bbrc.2008.10.170; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Takahashi H, 2011, NEURON, V69, P287, DOI 10.1016/j.neuron.2010.12.024; Yim YS, 2013, P NATL ACAD SCI USA, V110, P4057, DOI 10.1073/pnas.1209881110; Wei CH, 2012, EXP MOL MED, V44, P413, DOI 10.3858/emm.2012.44.7.050; Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035; Wang DL, 2010, NAT IMMUNOL, V11, P905, DOI 10.1038/ni.1925; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Coles CH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6209; Ferrao R, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003124; Otwinowski Z., 1997, METHOD ENZYMOL, V276, P20; Samanta D, 2015, CELL MOL LIFE SCI, V72, P645, DOI 10.1007/s00018-014-1763-4; Uemura T, 2004, MOL CELL NEUROSCI, V26, P330, DOI 10.1016/j.mcn.2004.02.007; Um JW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6423; Vagin A. T. A., 1997, J APPL CRYSTALLOGR, V30, P4; Wei ZY, 2010, NEURON, V67, P1, DOI 10.1016/j.neuron.2010.06.035; Winn M. D., 2011, ACTA CRYSTALLOGR D, V67, P8; Woo J, 2009, NAT NEUROSCI, V12, P428, DOI 10.1038/nn.2279; Yoshida T, 2012, J NEUROSCI, V32, P2588, DOI 10.1523/JNEUROSCI.4637-11.2012	40	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6926	10.1038/ncomms7926		11	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0IW	WOS:000353704100034		
J	Yamane, M; Yokoyama, Y; Abe-Ouchi, A; Obrochta, S; Saito, F; Moriwaki, K; Matsuzaki, H				Yamane, Masako; Yokoyama, Yusuke; Abe-Ouchi, Ayako; Obrochta, Stephen; Saito, Fuyuki; Moriwaki, Kiichi; Matsuzaki, Hiroyuki			Exposure age and ice-sheet model constraints on Pliocene East Antarctic ice sheet dynamics	NATURE COMMUNICATIONS			English	Article							GENERAL-CIRCULATION MODEL; PRINCE-CHARLES MOUNTAINS; ATLANTIC COASTAL-PLAIN; SEA-LEVEL FLUCTUATIONS; MID-PLIOCENE; INTERCOMPARISON PROJECT; COSMOGENIC NUCLIDES; EXPERIMENTAL-DESIGN; VICTORIA LAND; CLIMATE	The Late Pliocene epoch is a potential analogue for future climate in a warming world. Here we reconstruct Plio-Pleistocene East Antarctic Ice Sheet (EAIS) variability using cosmogenic nuclide exposure ages and model simulations to better understand ice sheet behaviour under such warm conditions. New and previously published exposure ages indicate interior-thickening during the Pliocene. An ice sheet model with mid-Pliocene boundary conditions also results in interior thickening and suggests that both the Wilkes Subglacial and Aurora Basins largely melted, offsetting increased ice volume. Considering contributions from West Antarctica and Greenland, this is consistent with the most recent IPCC AR5 estimate, which indicates that the Pliocene sea level likely did not exceed +20m on Milankovitch timescales. The inception of colder climate since similar to 3 Myr has increased the sea ice cover and inhibited active moisture transport to Antarctica, resulting in reduced ice sheet thickness, at least in coastal areas.	[Yamane, Masako; Yokoyama, Yusuke; Abe-Ouchi, Ayako; Obrochta, Stephen] Univ Tokyo, Atmosphere & Ocean Res Inst, Chiba 2778564, Japan; [Yokoyama, Yusuke; Abe-Ouchi, Ayako] Univ Tokyo, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Yokoyama, Yusuke] Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa 2370061, Japan; [Abe-Ouchi, Ayako; Saito, Fuyuki] Japan Agcy Marine Earth Sci & Technol, Kanazawa Ku, Yokosuka, Kanagawa 2360001, Japan; [Obrochta, Stephen] Akita Univ, Fac Int Resource Sci, Akita 0108502, Japan; [Moriwaki, Kiichi] Natl Inst Polar Res, Tachikawa, Tokyo 1908518, Japan; [Matsuzaki, Hiroyuki] Univ Tokyo, Univ Museum, Bunkyo Ku, Tokyo 1130033, Japan	Yokoyama, Y (reprint author), Univ Tokyo, Atmosphere & Ocean Res Inst, 5-1-5 Kashiwanoha, Chiba 2778564, Japan.	yokoyama@aori.u-tokyo.ac.jp			JSPS NEXT programme [GR031]; KAKENHI [26247085]	We thank Yosuke Miyairi for technical support during the AMS measurements. This research was partly supported by the JSPS NEXT programme (GR031 to Y.Y.) and KAKENHI (26247085 to Y.Y.).	Lunt DJ, 2008, NATURE, V454, P1102, DOI 10.1038/nature07223; Greve R, 2005, ANN GLACIOL, V42, P424, DOI 10.3189/172756405781812510; Salzmann U, 2013, NAT CLIM CHANGE, V3, P969, DOI [10.1038/nclimate2008, 10.1038/NCLIMATE2008]; Lunt DJ, 2010, NAT GEOSCI, V3, P60, DOI 10.1038/NGEO706; O'Brien PE, 2007, PALAEOGEOGR PALAEOCL, V245, P390, DOI 10.1016/j.palaeo.2006.09.002; BROWN ET, 1991, GEOCHIM COSMOCHIM AC, V55, P2269, DOI 10.1016/0016-7037(91)90103-C; Sosdian S, 2009, SCIENCE, V325, P306, DOI 10.1126/science.1169938; DOWSETT HJ, 1990, GEOLOGY, V18, P435, DOI 10.1130/0091-7613(1990)018<0435:HESLDT>2.3.CO;2; Chan WL, 2011, GEOSCI MODEL DEV, V4, P1035, DOI 10.5194/gmd-4-1035-2011; Raymo ME, 1996, MAR MICROPALEONTOL, V27, P313, DOI 10.1016/0377-8398(95)00048-8; Dowsett H, 2010, STRATIGRAPHY, V7, P123; Seki O, 2010, EARTH PLANET SC LETT, V292, P201, DOI 10.1016/j.epsl.2010.01.037; Haywood AM, 2010, GEOSCI MODEL DEV, V3, P227, DOI 10.5194/gmd-3-227-2010; Sloan LC, 1996, MAR MICROPALEONTOL, V27, P51, DOI 10.1016/0377-8398(95)00063-1; Pritchard HD, 2009, NATURE, V461, P971, DOI 10.1038/nature08471; Pagani M, 2010, NAT GEOSCI, V3, P27, DOI 10.1038/NGEO724; Davis CH, 2005, SCIENCE, V308, P1898, DOI 10.1126/science.1110662; KOHL CP, 1992, GEOCHIM COSMOCHIM AC, V56, P3583, DOI 10.1016/0016-7037(92)90401-4; Naish TR, 2009, PHILOS T R SOC A, V367, P169, DOI 10.1098/rsta.2008.0223; Pollard D, 2009, NATURE, V458, P329, DOI 10.1038/nature07809; Nishiizumi K, 2007, NUCL INSTRUM METH B, V258, P403, DOI 10.1016/j.nimb.2007.01.297; Bindschadler RA, 2013, J GLACIOL, V59, P195, DOI 10.3189/2013JoG12J125; DOWSETT HJ, 1992, SCIENCE, V258, P1133, DOI 10.1126/science.258.5085.1133; Dowsett HJ, 2012, NAT CLIM CHANGE, V2, P365, DOI [10.1038/NCLIMATE1455, 10.1038/nclimate1455]; NISHIIZUMI K, 1991, EARTH PLANET SC LETT, V104, P440, DOI 10.1016/0012-821X(91)90221-3; Abe-Ouchi A, 2013, NATURE, V500, P190, DOI 10.1038/nature12374; Dolan AM, 2011, PALAEOGEOGR PALAEOCL, V309, P98, DOI 10.1016/j.palaeo.2011.03.030; Dwyer GS, 2009, PHILOS T R SOC A, V367, P157, DOI 10.1098/rsta.2008.0222; Cook CP, 2013, NAT GEOSCI, V6, P765, DOI [10.1038/ngeo1889, 10.1038/NGEO1889]; Hill DJ, 2014, CLIM PAST, V10, P79, DOI 10.5194/cp-10-79-2014; Matsuzaki H, 2004, NUCL INSTRUM METH B, V223, P92, DOI 10.1016/j.nimb.2004.04.022; Stone JO, 2000, J GEOPHYS RES-SOL EA, V105, P23753, DOI 10.1029/2000JB900181; Krabill W, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021533; Matsuoka N, 2006, GEOMORPHOLOGY, V81, P408, DOI 10.1016/j.geomorph.2006.05.005; Fretwell P, 2013, CRYOSPHERE, V7, P375, DOI 10.5194/tc-7-375-2013; Altmaier M, 2010, POLAR SCI, V4, P42, DOI 10.1016/j.polar.2010.01.001; WEBB PN, 1984, GEOLOGY, V12, P287, DOI 10.1130/0091-7613(1984)12<287:CMSAIV>2.0.CO;2; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Haywood AM, 2013, CLIM PAST, V9, P191, DOI 10.5194/cp-9-191-2013; Crowley TJ, 1996, MAR MICROPALEONTOL, V27, P3, DOI 10.1016/0377-8398(95)00049-6; Naish T, 2009, NATURE, V458, P322, DOI 10.1038/nature07867; BROOK EJ, 1993, QUATERNARY RES, V39, P11, DOI 10.1006/qres.1993.1002; BROOK EJ, 1995, GEOLOGY, V23, P1063, DOI 10.1130/0091-7613(1995)023<1063:COAEAU>2.3.CO;2; Dolan AM, 2012, GEOSCI MODEL DEV, V5, P963, DOI 10.5194/gmd-5-963-2012; Fink D, 2006, EARTH PLANET SC LETT, V243, P229, DOI 10.1016/j.epsl.2005.12.006; Fogwill CJ, 2004, GEOLOGY, V32, P265, DOI 10.1130/G19795.1; Haywood AM, 2002, PALAEOGEOGR PALAEOCL, V182, P93; Hill D. J., 2009, THESIS U BRISTOL, P368; HOFLE HC, 1995, POLARFORSCHUNG, V0063; Huang FX, 2008, ANTARCT SCI, V20, P197, DOI 10.1017/S0954102007000910; KAUFMAN DS, 1993, QUATERNARY SCI REV, V12, P21, DOI 10.1016/0277-3791(93)90046-O; Kong P, 2010, GLOBAL PLANET CHANGE, V72, P50, DOI 10.1016/j.gloplacha.2010.03.005; KRANTZ DE, 1991, QUATERNARY SCI REV, V10, P163, DOI 10.1016/0277-3791(91)90016-N; Lilly K, 2010, GEOLOGY, V38, P703, DOI 10.1130/G31172x.1; Liu XH, 2010, EARTH PLANET SC LETT, V290, P281, DOI 10.1016/j.epsl.2009.12.008; Masson-Delmotte V., 2013, CLIMATE CHANGE 2013; McKelvey BC, 2001, ANTARCT SCI, V13, P455; Moriwaki K., 1991, P NIPR S ANT GEOSC, V5, P99; Nicola L.D., 2009, QUATERNARY RES, V71, P83; Nishiizumi K., 2003, NUCL INSTRUM METH B, V223-224, P388; Oberholzer P, 2003, ANTARCT SCI, V15, P493, DOI 10.1017/S0954102003001603; Patterson MO, 2014, NAT GEOSCI, V7, P841, DOI 10.1038/NGEO2273; Payne AJ, 1999, CLIM DYNAM, V15, P115, DOI 10.1007/s003820050271; PRENTICE ML, 1991, J GEOPHYS RES-SOLID, V96, P6811, DOI 10.1029/90JB01614; Saito F, 2010, ANN GLACIOL, V51, P41, DOI 10.3189/172756410791392808; Strasky S, 2009, ANTARCT SCI, V21, P59, DOI 10.1017/S0954102008001478; Tschudi S, 2003, ECLOGAE GEOL HELV, V96, P109, DOI 10.1007/s00015-003-1075-4; WARDLAW BR, 1991, QUATERNARY SCI REV, V10, P247, DOI 10.1016/0277-3791(91)90023-N; Weertman J., 1964, J GLACIOL, V5, P287; Williams M, 2007, DEEP-TIME PERSPECTIVES ON CLIMATE CHANGE: MARRYING THE SIGNAL FROM COMPUTER MODELS AND BIOLOGICAL PROXIES, P1	70	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								7016	10.1038/ncomms8016		8	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0JR	WOS:000353706300003		
J	Yoshimi, R; Tsukazaki, A; Kozuka, Y; Falson, J; Takahashi, KS; Checkelsky, JG; Nagaosa, N; Kawasaki, M; Tokura, Y				Yoshimi, R.; Tsukazaki, A.; Kozuka, Y.; Falson, J.; Takahashi, K. S.; Checkelsky, J. G.; Nagaosa, N.; Kawasaki, M.; Tokura, Y.			Quantum Hall effect on top and bottom surface states of topological insulator (Bi1-xSbx)(2)Te-3 films	NATURE COMMUNICATIONS			English	Article							GRAPHENE	The three-dimensional topological insulator is a novel state of matter characterized by two-dimensional metallic Dirac states on its surface. To verify the topological nature of the surface states, Bi-based chalcogenides such as Bi2Se3, Bi2Te3, Sb2Te3 and their combined/mixed compounds have been intensively studied. Here, we report the realization of the quantum Hall effect on the surface Dirac states in (Bi1-xSbx)(2)Te-3 films. With electrostatic gate-tuning of the Fermi level in the bulk band gap under magnetic fields, the quantum Hall states with filling factor +/- 1 are resolved. Furthermore, the appearance of a quantum Hall plateau at filling factor zero reflects a pseudo-spin Hall insulator state when the Fermi level is tuned in between the energy levels of the non-degenerate top and bottom surface Dirac points. The observation of the quantum Hall effect in three-dimensional topological insulator films may pave a way toward topological insulator-based electronics.	[Yoshimi, R.; Kozuka, Y.; Falson, J.; Checkelsky, J. G.; Nagaosa, N.; Kawasaki, M.; Tokura, Y.] Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan; [Yoshimi, R.; Kozuka, Y.; Falson, J.; Checkelsky, J. G.; Nagaosa, N.; Kawasaki, M.; Tokura, Y.] Univ Tokyo, QPEC, Tokyo 1138656, Japan; [Tsukazaki, A.] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Tsukazaki, A.] Japan Sci & Technol Agcy JST, PRESTO, Chiyoda Ku, Tokyo 1020075, Japan; [Takahashi, K. S.; Nagaosa, N.; Kawasaki, M.; Tokura, Y.] RIKEN, CEMS, Wako, Saitama 3510198, Japan	Yoshimi, R (reprint author), Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan.	yoshimi@cmr.t.u-tokyo.ac.jp	Kozuka, Yusuke/E-6470-2010; Kawasaki, Masashi/B-5826-2008; Tokura, Yoshinori/C-7352-2009; Takahashi, Kei/B-2498-2013; Tsukazaki, Atsushi/C-3972-2008; Nagaosa, Naoto/G-7057-2012	Kozuka, Yusuke/0000-0002-2205-2421; 	Japan Society for the Promotion of Science (JSPS); Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R & D on Science and Technology (FIRST Program); JSPS [24224009, 24226002]	R.Y. is supported by the Japan Society for the Promotion of Science (JSPS) through a research fellowship for young scientists. This research was supported by the Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R & D on Science and Technology (FIRST Program) on 'Quantum Science on Strong Correlation' initiated by the Council for Science and Technology Policy and by JSPS Grant-in-Aid for Scientific Research(S) No. 24224009 and 24226002. This work was carried out by joint research of the Cryogenic Research Center, the University of Tokyo.	Abanin DA, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.196806; Brune C, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.126803; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Chang CZ, 2013, SCIENCE, V340, P167, DOI 10.1126/science.1234414; Yu R, 2010, SCIENCE, V329, P61, DOI 10.1126/science.1187485; Analytis JG, 2010, NAT PHYS, V6, P960, DOI [10.1038/nphys1861, 10.1038/NPHYS1861]; Yang F, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4873397; Bolotin KI, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.096802; Checkelsky JG, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.206801; Nomura K, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.166802; Zhao Y, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.106804; Kim D, 2012, NAT PHYS, V8, P459, DOI 10.1038/NPHYS2286; Qu DX, 2010, SCIENCE, V329, P821, DOI 10.1126/science.1189792; Giesbers AJM, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.201403; Taskin AA, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.016801; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.146802; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Wang J, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.086803; Kong DS, 2011, NAT NANOTECHNOL, V6, P705, DOI [10.1038/nnano.2011.172, 10.1038/NNANO.2011.172]; Martin J, 2008, NAT PHYS, V4, P144, DOI 10.1038/nphys781; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235; Checkelsky JG, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.196801; Fu L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.106803; Hsieh D, 2009, NATURE, V460, P1101, DOI 10.1038/nature08234; Steinberg H, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.233101; [Anonymous], NAT PHYS; Das Sarma S, 2009, SOLID STATE COMMUN, V149, P1502, DOI 10.1016/j.ssc.2009.06.039; Nichele F, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.036802; Yoshimi R, 2014, NAT MATER, V13, P254, DOI 10.1038/NMAT3885; Zhang J., 2012, NAT COMMUN, V2, P574	30	9	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6627	10.1038/ncomms7627		6	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0FX	WOS:000353696100001		
J	Hirayama, K; Kobayashi, M; Usui, J; Arimura, Y; Sugiyama, H; Nitta, K; Muso, E; Wada, T; Matsuo, S; Yamagata, K				Hirayama, Kouichi; Kobayashi, Masaki; Usui, Joichi; Arimura, Yoshihiro; Sugiyama, Hitoshi; Nitta, Kosaku; Muso, Eri; Wada, Takashi; Matsuo, Seiichi; Yamagata, Kunihiro		Japanese RPGN Study Grp Progressiv	Pulmonary involvements of anti-neutrophil cytoplasmic autoantibody-associated renal vasculitis in Japan	NEPHROLOGY DIALYSIS TRANSPLANTATION			English	Article						alveolar hemorrhage; ANCA-associated vasculitis; interstitial lung disease; mortality	ANCA-ASSOCIATED VASCULITIS; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; POLYANGIITIS CHURG-STRAUSS; OF-THE-LITERATURE; MICROSCOPIC POLYANGIITIS; ALVEOLAR HEMORRHAGE; CLINICAL-FEATURES; EOSINOPHILIC GRANULOMATOSIS; WEGENERS-GRANULOMATOSIS; INTERSTITIAL PNEUMONIA	Pulmonary involvement is one of the hallmark lesions of anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV) as well as rapidly progressive glomerulonephritis (RPGN). However, the pulmonary involvement of AAV patients seems to differ between Europe and Japan, as does the ANCA serotype. This retrospective and prospective multicenter cohort study collected the clinical data of the features and outcomes of 1772 RPGN patients treated from 1989 to 2007 in Japan. Based on this nationwide RPGN survey, we analyzed the cases of 1147 AAV patients. We found that 52.3% of the AAV patients had pulmonary involvements: 15.4% of the AAV patients had alveolar hemorrhage (AH), 26.2% had interstitial lung disease (ILD), 2.8% had bronchial asthma, 2.4% had pulmonary granuloma and 12.8% had a chest X-ray abnormality without AH, ILD or pulmonary granuloma. Patient survival was significantly different among the following six groups: the 5-year survival rate was 41.5% in the patients with AH, 50.2% in those with ILD, 67.9% in those with bronchial asthma, 62.5% in those with pulmonary granuloma, 55.8% in those with chest X-ray abnormality and 73.3% in those without pulmonary involvement. AH was one of the predictors of 1- and 5-year mortality for patient survival in AAV, and ILD was added as one of the predictors of 5-year mortality. In these AAV patients, not only AH but also ILD was frequently observed. AH was associated with the prognosis, but ILD was associated with the long-term prognosis of AAV.	[Hirayama, Kouichi; Kobayashi, Masaki] Tokyo Med Univ, Ibaraki Med Ctr, Dept Nephrol, Ami, Ibaraki, Japan; [Usui, Joichi; Yamagata, Kunihiro] Univ Tsukuba, Dept Nephrol, Fac Med, Tsukuba, Ibaraki, Japan; [Arimura, Yoshihiro] Kyorin Univ, Sch Med, Dept Internal Med 1, Mitaka, Tokyo 181, Japan; [Sugiyama, Hitoshi] Okayama Univ, Grad Sch Med, Dent & Pharmaceut Sci, Dept Chron Kidney Dis & Peritoneal Dialysis, Okayama, Japan; [Nitta, Kosaku] Tokyo Womens Med Univ, Kidney Ctr, Dept Med, Shinjuku Ku, Tokyo, Japan; [Muso, Eri] Kitano Hosp, Tazuke Kofukai Med Inst, Div Nephrol & Dialysis, Osaka, Japan; [Wada, Takashi] Kanazawa Univ, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa, Japan; [Matsuo, Seiichi] Nagoya Univ, Grad Sch Med, Dept Nephrol, Nagoya, Aichi 4648601, Japan	Hirayama, K (reprint author), Tokyo Med Univ, Ibaraki Med Ctr, Dept Nephrol, Ami, Ibaraki, Japan.	k-hira@tokyo-med.ac.jp			Research Fund for the Special Study Group on Progressive Glomerular Disease, the Ministry of Health, Labor and Welfare, Japan	This work was part of the nationwide RPGN survey in Japan, which was supported by a grant-in-aid from the Research Fund for the Special Study Group on Progressive Glomerular Disease, the Ministry of Health, Labor and Welfare, Japan. We acknowledge all of the people who participated in this survey and the members of the RPGN Clinical Guidelines Committee of Japan as follows: Dr S. Fujimoto, Dr S. Hirawa, Dr S. Horikoshi, Dr T. Hosoya, Dr T. Itoh, Dr O. Inaguma, Dr S. Kaname, Dr T. Kawamura, Dr K. Kimura, Dr S. Maruyama, Dr N. Nakabayashi, Dr M. Ogura, Dr T. Saitoh, Dr T. Tabei, Dr Y. Taguma, Dr K. Tsuruya, Dr T. Watanabe, Dr S. Yasunaga, Dr M. Yoshida, Dr W. Yumura, Dr Y. Yuzawa and Dr K. Sada.	Ahn JK, 2012, RHEUMATOL INT, V32, P2979, DOI 10.1007/s00296-011-2079-4; AKIKUSA B, 1995, PATHOL INT, V45, P580, DOI 10.1111/j.1440-1827.1995.tb03506.x; Al Riyami BMS, 2003, CLIN RHEUMATOL, V22, P309, DOI 10.1007/s10067-003-0738-x; Hervier B, 2009, ANN RHEUM DIS, V68, P404, DOI 10.1136/ard.2008.096131; Tzelepis GE, 2010, EUR RESPIR J, V36, P116, DOI 10.1183/09031936.00110109; Furuta S, 2014, J RHEUMATOL, V41, P325, DOI 10.3899/jrheum.130602; Arulkumaran N, 2011, RHEUMATOLOGY, V50, P2035, DOI 10.1093/rheumatology/ker236; Hruskova Z, 2013, SCAND J RHEUMATOL, V42, P211, DOI 10.3109/03009742.2012.754939; Hiromura K, 2000, CLIN NEPHROL, V53, P384; Watts RA, 2008, NEPHROL DIAL TRANSPL, V23, P3928, DOI 10.1093/ndt/gfn354; GAUDIN PB, 1995, AM J CLIN PATHOL, V104, P7; Booth AD, 2003, AM J KIDNEY DIS, V41, P776, DOI 10.1016/S0272-6386(03)00025-8; Ando M, 2013, RESP MED, V107, P608, DOI 10.1016/j.rmed.2013.01.006; Gindre D, 1995, VIRCHOWS ARCH, V427, P385; West S, 2013, INTERNAL MED, V52, P5, DOI 10.2169/internalmedicine.52.8863; Gallagher H, 2002, AM J KIDNEY DIS, V39, P42, DOI 10.1053/ajkd.2002.29876; Homma S, 2004, RESPIROLOGY, V9, P190, DOI 10.1111/j.1440-1843.2004.00581.x; Kostianovsky A, 2012, CLIN EXP RHEUMATOL, V30, pS77; Ozaki S, 2012, MOD RHEUMATOL, V22, P394, DOI 10.1007/s10165-011-0525-5; Nozu T, 2009, RESPIRATION, V77, P407, DOI 10.1159/000183754; Watts Richard, 2007, Ann Rheum Dis, V66, P222, DOI 10.1136/ard.2006.054593; Guillevin L, 1999, ARTHRITIS RHEUM, V42, P421, DOI 10.1002/1529-0131(199904)42:3<421::AID-ANR5>3.0.CO;2-6; Lauque D, 2000, MEDICINE, V79, P222, DOI 10.1097/00005792-200007000-00003; Yamagata K, 2012, CLIN EXP NEPHROL, V16, P580, DOI 10.1007/s10157-012-0598-2; Comarmond C, 2013, ARTHRITIS RHEUM-US, V65, P270, DOI 10.1002/art.37721; JENNETTE JC, 1994, ARTHRITIS RHEUM, V37, P187, DOI 10.1002/art.1780370206; Weidner S, 2004, NEPHROL DIAL TRANSPL, V19, P1403, DOI 10.1093/ndt/gfh161; Becker-Merok A, 1999, SCAND J RHEUMATOL, V28, P254; Bhanji A., 2010, NDT Plus, V3, P351; Birnbaum J, 2007, ARTHRITIS RHEUM, V56, P2065, DOI 10.1002/art.22633; CAMBRIDGE G, 1994, ANN RHEUM DIS, V53, P24, DOI 10.1136/ard.53.1.24; Eleftheriou D, 2012, Monaldi Arch Chest Dis, V77, P141; Eschun GM, 2003, CHEST, V123, P297, DOI 10.1378/chest.123.1.297; Foucher P, 1999, AM J RESP CRIT CARE, V160, P987; Foulon G, 2008, RESP MED, V102, P1392, DOI 10.1016/j.rmed.2008.04.023; GAL AA, 1994, ARCH PATHOL LAB MED, V118, P1209; HAWORTH SJ, 1985, BRIT MED J, V290, P1775; Hogan SL, 1996, J AM SOC NEPHROL, V7, P23; Huang H, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-8; Lane SE, 2005, QJM-INT J MED, V98, P97, DOI 10.1093/qjmed/hci015; Little MA, 2009, AM J PATHOL, V174, P1212, DOI 10.2353/ajpath.2009.080458; Manganelli P, 2006, CLIN EXP RHEUMATOL, V24, pS48; Mansi IA, 2001, AM J MED SCI, V321, P201, DOI 10.1097/00000441-200103000-00009; NADA AK, 1990, MAYO CLIN PROC, V65, P847; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Sada KE, 2014, MOD RHEUMATOL, V24, P640, DOI 10.3109/14397595.2013.857582; Sada KE, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4550; Schnabel A, 1999, EUR RESPIR J, V14, P118, DOI 10.1034/j.1399-3003.1999.14a20.x; Souid M, 2001, CLIN NEPHROL, V55, P337; Tanaka T, 2012, RESP MED, V106, P1765, DOI 10.1016/j.rmed.2012.08.024; Thickett DR, 2006, RHEUMATOLOGY, V45, P261, DOI 10.1093/rheumatology/kei217; Uezono S, 2007, INTERNAL MED, V46, P815, DOI 10.2169/internalmedicine.46.6371	52	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0931-0509	1460-2385		NEPHROL DIAL TRANSPL	Nephrol. Dial. Transplant.	APR	2015	30			1	SI		i83	i93		10.1093/ndt/gfu385		11	Transplantation; Urology & Nephrology	Transplantation; Urology & Nephrology	CG7QU	WOS:000353500300013		
J	Qi, Y; Inoue, K; Fu, M; Inui, A; Herzog, H				Qi, Y.; Inoue, K.; Fu, M.; Inui, A.; Herzog, H.			Chronic overproduction of ghrelin in the hypothalamus leads to temporal increase in food intake and body weight	NEUROPEPTIDES			English	Article						Ghrelin; Energy homeostasis; Obesity	PRADER-WILLI-SYNDROME; RAT ARCUATE NUCLEUS; Y-CONTAINING NEURONS; NEUROPEPTIDE-Y; KNOCKOUT MICE; PANCREATIC-POLYPEPTIDE; ENERGY HOMEOSTASIS; SHORT-TERM; HORMONE; APPETITE	Ghrelin is known to be a critical stimulator of feeding behavior mainly via actions in the hypothalamus. However, its functional contribution to the control of energy homeostasis under chronic elevated conditions is unknown. Here we show that overproduction of ghrelin via an AAV viral delivery system in the hypothalamus leads to an increase in food intake associated with increases in body weight. However, this increase in food intake is only temporary and is diminished and no longer significant after 3 weeks. Analysis of brain sections of mice 6 weeks after AAV ghrelin virus injection demonstrates unaltered neuropeptide Y levels but strongly up-regulated pro-opiomelanocortin levels indicating that a compensatory mechanism has been activated to counter regulate the feeding stimulatory actions of ghrelin. This demonstrates that control mechanism exists that is activated under conditions of prolonged high ghrelin levels, which could potentially be utilized to control feeding and the development of obesity. (C) 2015 Elsevier Ltd. All rights reserved.	[Qi, Y.; Inoue, K.; Fu, M.; Herzog, H.] St Vincents Hosp, Garvan Inst Med Res, Div Neurosci, Darlinghurst, NSW 2010, Australia; [Inoue, K.; Inui, A.] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Psychosomat Internal Med, Kagoshima 890, Japan; [Herzog, H.] Univ NSW, Sch Med Sci, Sydney, NSW, Australia	Herzog, H (reprint author), St Vincents Hosp, Garvan Inst Med Res, Div Neurosci, Darlinghurst, NSW 2010, Australia.	h.herzog@garvan.org.au					Date Y, 2002, GASTROENTEROLOGY, V123, P1120, DOI 10.1053/gast.2002.35954; ZIPF WB, 1990, AM J CLIN NUTR, V51, P162; De Smet B, 2006, J PHARMACOL EXP THER, V316, P431, DOI 10.1124/jpet.105.091504; Kohno D, 2003, DIABETES, V52, P948, DOI 10.2337/diabetes.52.4.948; Dezaki K, 2004, DIABETES, V53, P3142, DOI 10.2337/diabetes.53.12.3142; Korbonits M, 2004, FRONT NEUROENDOCRIN, V25, P27, DOI 10.1016/j.yfrne.2004.03.002; Sainsbury A, 2002, P NATL ACAD SCI USA, V99, P8938, DOI 10.1073/pnas.132043299; BERNTSON GG, 1993, PEPTIDES, V14, P497, DOI 10.1016/0196-9781(93)90138-7; Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Tan TMM, 2004, J CLIN ENDOCR METAB, V89, P4162, DOI 10.1210/jc.2004-0835; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Sun YX, 2008, ENDOCRINOLOGY, V149, P843, DOI 10.1210/en.2007-0271; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Cummings DE, 2002, NAT MED, V8, P643, DOI 10.1038/nm0702-643; Cummings DE, 2006, PHYSIOL BEHAV, V89, P71, DOI 10.1016/j.physbeh.2006.05.022; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Papotti M, 2000, J CLIN ENDOCR METAB, V85, P3803, DOI 10.1210/jc.85.10.3803; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Murata M, 2002, J BIOL CHEM, V277, P5667, DOI 10.1074/jbc.M103898200; Chen HY, 2004, ENDOCRINOLOGY, V145, P2607, DOI 10.1210/en.2003-1596; Tong J, 2010, DIABETES, V59, P2145, DOI 10.2337/db10-0504; Davies JS, 2009, MOL ENDOCRINOL, V23, P914, DOI 10.1210/me.2008-0432; Guan JL, 2003, PEPTIDES, V24, P1921, DOI 10.1016/j.peptides.2003.10.017; Geliebter A, 2008, PHYSIOL BEHAV, V94, P696, DOI 10.1016/j.physbeh.2008.04.013; Bowers CY, 2001, J CLIN ENDOCR METAB, V86, P1464, DOI 10.1210/jc.86.4.1464; DelPparigi A, 2002, J CLIN ENDOCR METAB, V87, P5461, DOI 10.1210/jc.2002-020871; Guan JL, 2008, REGUL PEPTIDES, V145, P128, DOI 10.1016/j.regpep.2007.09.028; Lindgren AC, 1997, PEDIATR RES, V42, P593, DOI 10.1203/00006450-199711000-00007; Otto B, 2001, Eur J Endocrinol, V145, P669; Purtell L, 2011, NEUROPEPTIDES, V45, P301, DOI 10.1016/j.npep.2011.06.001	31	1	1	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0143-4179	1532-2785		NEUROPEPTIDES	Neuropeptides	APR	2015	50						23	28		10.1016/j.npep.2015.02.002		6	Endocrinology & Metabolism; Neurosciences	Endocrinology & Metabolism; Neurosciences & Neurology	CH0YV	WOS:000353749200004		
J	Tokuda, E; Watanabe, S; Okawa, E; Ono, S				Tokuda, Eiichi; Watanabe, Shunsuke; Okawa, Eriko; Ono, Shin-ichi			Regulation of Intracellular Copper by Induction of Endogenous Metallothioneins Improves the Disease Course in a Mouse Model of Amyotrophic Lateral Sclerosis	NEUROTHERAPEUTICS			English	Article						Amyotrophic lateral sclerosis; Copper dyshomeostasis; Dexamethasone; Metallothioneins; Superoxide dismutase-1	LIPID-PEROXIDATION; TRANSGENIC MICE; MOTOR-NEURONS; MURINE MODEL; SPINAL-CORD; PROGRESSION; ALS; EXPRESSION; ONSET; DYSREGULATION	Mutations in SOD1 cause amyotrophic lateral sclerosis (ALS), an incurable motor neuron disease. The pathogenesis of the disease is poorly understood, but intracellular copper dyshomeostasis has been implicated as a key process in the disease. We recently observed that metallothioneins (MTs) are an excellent target for the modification of copper dyshomeostasis in a mouse model of ALS (SOD1(G93A)). Here, we offer a therapeutic strategy designed to increase the level of endogenous MTs. The upregulation of endogenous MTs by dexamethasone, a synthetic glucocorticoid, significantly improved the disease course and rescued motor neurons in SOD1(G93A) mice, even if the induction was initiated when peak body weight had decreased by 10 %. Neuroprotection was associated with the normalization of copper dyshomeostasis, as well as with decreased levels of SOD1(G93A) aggregates. Importantly, these benefits were clearly mediated in a MT-dependent manner, as dexamethasone did not provide any protection when endogenous MTs were abolished from SOD1(G93A) mice. In conclusion, the upregulation of endogenous MTs represents a promising strategy for the treatment of ALS linked to mutant SOD1.	[Tokuda, Eiichi; Watanabe, Shunsuke; Okawa, Eriko; Ono, Shin-ichi] Nihon Univ, Sch Pharm, Lab Clin Med, Funabashi, Chiba 2748555, Japan; [Tokuda, Eiichi] Umea Univ, Dept Med Biosci, Clin Chem, S-90185 Umea, Sweden; [Ono, Shin-ichi] Akiru Municipal Med Ctr, Div Neurol, Tokyo 1970834, Japan	Ono, S (reprint author), Nihon Univ, Sch Pharm, Lab Clin Med, 7-7-1 Narashinodai, Funabashi, Chiba 2748555, Japan.	ono.shinichi@nihon-u.ac.jp			Japan Society for the Promotion of Science (JSPS) for Young Scientists from JSPS [08J10542]; JSPS [21659222]; Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by a Grant-in-Aid for a research fellowship of the Japan Society for the Promotion of Science (JSPS) for Young Scientists from JSPS (08J10542 to E.T.), by a Grant-in-Aid for Exploratory Research from JSPS (21659222 to S.O.), and by an Academic Frontier Project for Private Universities: matching fund subsidy from the Ministry of Education, Culture, Sports, Science and Technology of Japan (years 2007-2009 to S.O.). We thank Drs. Shin-ichi Miyairi (Laboratory of Organic Chemistry, School of Pharmacy, Nihon University, Funabashi, Chiba, Japan) and Akira Naganuma (Laboratory of Molecular and Biochemical Toxicology, School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan) for kindly providing the anti-MT-III antibody.	Ahtoniemi T, 2007, MOL PHARMACOL, V71, P30, DOI 10.1124/mol.106.028415; Amici M, 2002, J BIOL INORG CHEM, V7, P750, DOI 10.1007/s00775-002-0352-4; Czock D, 2005, CLIN PHARMACOKINET, V44, P61, DOI 10.2165/00003088-200544010-00003; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Moser JM, 2013, MOL GENET GENOMICS, V288, P207, DOI 10.1007/s00438-013-0741-0; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; Kiaei M, 2004, J NEUROSCI, V24, P7945, DOI 10.1523/JNEUROSCI.2000-04.2004; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Fidler JA, 2011, FASEB J, V25, P4369, DOI 10.1096/fj.11-190819; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Lelie HL, 2011, J BIOL CHEM, V286, P2795, DOI 10.1074/jbc.M110.186999; Alexander GM, 2004, MOL BRAIN RES, V130, P7, DOI 10.1016/j.molbrainres.2004.07.002; Wang LJ, 2009, NEUROBIOL DIS, V35, P234, DOI 10.1016/j.nbd.2009.05.002; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Friese A, 2009, P NATL ACAD SCI USA, V106, P13588, DOI 10.1073/pnas.0906809106; Wang LJ, 2011, HUM MOL GENET, V20, P286, DOI 10.1093/hmg/ddq463; West AK, 2008, NEUROTOXICOLOGY, V29, P489, DOI 10.1016/j.neuro.2007.12.006; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Li QX, 2006, AGING CELL, V5, P153, DOI 10.1111/j.1474-9726.2006.00200.x; Scheiber IF, 2013, NEUROCHEM INT, V62, P556, DOI 10.1016/j.neuint.2012.08.017; Tokuda E, 2009, J NEUROCHEM, V111, P181, DOI 10.1111/j.1471-4159.2009.06310.x; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Heiman-Patterson TD, 2011, AMYOTROPH LATERAL SC, V12, P79, DOI 10.3109/17482968.2010.550626; Patacchioli FR, 2003, J ENDOCRINOL INVEST, V26, pRC23; Goto JJ, 2000, J BIOL CHEM, V275, P1007, DOI 10.1074/jbc.275.2.1007; Bendotti C, 2012, PROG NEUROBIOL, V97, P101, DOI 10.1016/j.pneurobio.2011.10.001; MASTERS BA, 1994, P NATL ACAD SCI USA, V91, P584, DOI 10.1073/pnas.91.2.584; Arnesano F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007052; Deniselle MCG, 1996, CELL MOL NEUROBIOL, V16, P61, DOI 10.1007/BF02578387; Gong YH, 2000, EXP NEUROL, V162, P27, DOI 10.1006/exnr.2000.7323; Kelly EJ, 1997, P NATL ACAD SCI USA, V94, P10045, DOI 10.1073/pnas.94.19.10045; Ludolph Albert C, 2007, Amyotroph Lateral Scler, V8, P217, DOI 10.1080/17482960701292837; Meloni G, 2005, J BIOCHEM BIOPH METH, V64, P76, DOI 10.1016/j.jbbm.2005.05.005; Mendez-Armenta M, 2003, TOXICOL LETT, V144, P151, DOI 10.1016/S0378-4274(03)00199-1; Miller R.G., 2012, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD001447.PUB3; Nagano S, 2001, EUR J NEUROSCI, V13, P1363, DOI 10.1046/j.0953-816x.2001.01512.x; Poppe L, 2014, EXP NEUROL, V262, P138, DOI 10.1016/j.expneurol.2014.07.001; Puttaparthi K, 2002, J NEUROSCI, V22, P8790; Rotunno MS, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00253; Sillevis Smitt P. A. E., 1992, Neuroscience Letters, V144, P107, DOI 10.1016/0304-3940(92)90727-O; Tokuda E, 2008, EXP NEUROL, V213, P122, DOI 10.1016/j.expneurol.2008.05.011; Tokuda E, 2014, HUM MOL GENET, V23, P1271, DOI 10.1093/hmg/ddt517; Tokuda E, 2007, TOXICOLOGY, V229, P33, DOI 10.1016/j.tox.2006.09.011; Tokuda E, 2013, NEUROBIOL DIS, V54, P308, DOI 10.1016/j.nbd.2013.01.001	44	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1933-7213	1878-7479		NEUROTHERAPEUTICS	Neurotherapeutics	APR	2015	12	2					461	476		10.1007/s13311-015-0346-x		16	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	CG4AS	WOS:000353223000018		
J	Li, Q; Nihei, Y; Nakashima, T; Ikeda, Y				Li, Qiao; Nihei, Yasunori; Nakashima, Takuji; Ikeda, Yoshiho			A study on the performance of cascade hard sails and sail-equipped vessels	OCEAN ENGINEERING			English	Article						Sail; Hard sail; Camber; Sail-equipped vessels; Aerodynamic interaction		This study proposes a type of hard sail and investigates its potential use on commercial vessels for utilizing wind energy. We focus on the performance of cascade sails and consider the aerodynamic interaction between the sails. To obtain the lift and drag coefficients of the sails, wind tunnel testing and a two-dimensional simulation code based on the boundary element method with vortices are used. According to the change in distance and attack angle of each sail in the cascade, the best setup parameter is investigated, and the aerodynamic interaction is analyzed. From the viewpoint of the sailing performance of the vessel, our results demonstrate that cascade hard sails can significantly reduce fuel costs for commercial vessels. (C) 2015 Elsevier Ltd. All rights reserved.	[Li, Qiao; Nihei, Yasunori; Ikeda, Yoshiho] Osaka Prefecture Univ, Dept Marine Syst Engn, Sakai, Osaka 5998531, Japan; [Nakashima, Takuji] Hiroshima Univ, Div Energy & Environm Engn, Fac Engn, Hiroshima 7398511, Japan	Li, Q (reprint author), Osaka Prefecture Univ, Dept Marine Syst Engn, Sakai, Osaka 5998531, Japan.	ri_k@marine.osakafu-u.ac.jp	Nakashima, Takuji/D-5630-2011				Fujiwara T, 2005, J MAR SCI TECHNOL, V10, P82, DOI 10.1007/s00773-005-0191-4; BERGESON L, 1985, J WIND ENG IND AEROD, V19, P45, DOI 10.1016/0167-6105(85)90056-X; Fujiwara Toshifumi, 2003, P 13 INT OFFSH POL E; Fujiwara Yoshinori, 1980, SCI SHIP, V33, P36; Hitoshi Fujii, 1961, J KANSAI SOC NAV ARC, V110, P31; Ingham P., 1985, P INT S WIND SHIP B, P169; Kijima Katsuro, 1990, AUT M SOC NAV ARCH J; Matsumoto N., 1982, P 2 INT C STAB SHIPS, P141; Nakajima Tatsuo, 2011, Proceedings of the 2011 IEEE International Conference on Multimedia and Expo (ICME 2011); Nakashima Takuji, 2010, J KANSAI SOC NAV ARC, P59; Ouchi Kazuyuki, 2013, 3 INT S MAR PROP SMP; Ouchi Kazuyuki, 2009, J KANSAI SOC NAV ARC, P155; Second IMO GHG Study, 2009, MEPC59 2 IMP GHG STU; Yamashita Yoshihiro, 2011, J KANSAI SOC NAV ARC, P107	14	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0029-8018			OCEAN ENG	Ocean Eng.	APR 1	2015	98						23	31		10.1016/j.oceaneng.2015.02.005		9	Engineering, Marine; Engineering, Civil; Engineering, Ocean; Oceanography	Engineering; Oceanography	CH0YC	WOS:000353747300003		
J	Ayama, M; Yamazaki, R; Nakanoya, S; Tashiro, T; Ishikawa, T; Ohnuma, K; Shinoda, H; Araki, K				Ayama, Miyoshi; Yamazaki, Ryosuke; Nakanoya, Shin-ichi; Tashiro, Tomonori; Ishikawa, Tomoharu; Ohnuma, Kazuhiko; Shinoda, Hiroyuki; Araki, Keisuke			Estimation of straylight in the eye and its relation to visual function	OPTICAL REVIEW			English	Article						Straylight in the eye; Light scatter; Haze factor; Color LED; Psychophysical method; Legibility	NORMAL HUMAN LENS; INTRAOCULAR LIGHT SCATTER; SPECTRAL REFLECTANCE; DONOR LENSES; WAVELENGTH; DEPENDENCE; GLARE; PIGMENTATION; DISABILITY; CHARACTER	Relative amount of straylight in the eye of individual observers was estimated using a psychophysical method proposed by Shinoda et al. Asymptotic illuminance of disturbing light presented in front of observer's eye to blur different sizes of the gap in the Landolt C was measured with the haze filters of which haze factors were known. From the relation between the haze factor and the asymptotic illuminance of the disturbing light for the average observer, the relative haze factor of each observer's eye was estimated. White and colored LEDs (lambda(p) = 645, 530, and 480 nm) were used as the disturbing lights. The four different disturbing lights showed similar tendencies among nine young observers with healthy eyes. The ability to read colored characters was also examined for six observers in the same group. A negative correlation was found between the estimation of straylight in the eye and reading performance.	[Ayama, Miyoshi; Yamazaki, Ryosuke; Nakanoya, Shin-ichi; Tashiro, Tomonori; Ishikawa, Tomoharu] Utsunomiya Univ, Grad Sch Engn, Utsunomiya, Tochigi 3218585, Japan; [Ayama, Miyoshi; Tashiro, Tomonori; Ishikawa, Tomoharu; Araki, Keisuke] Utsunomiya Univ, Ctr Opt Res & Educ, Utsunomiya, Tochigi 3218585, Japan; [Ohnuma, Kazuhiko] Chiba Univ, Grad Sch Engn, Inage Ku, Chiba 2638522, Japan; [Shinoda, Hiroyuki] Ritsumeikan Univ, Coll Informat Sci & Engn, Kusatsu 5258577, Japan	Ayama, M (reprint author), Utsunomiya Univ, Grad Sch Engn, 7-1-2 Yoto, Utsunomiya, Tochigi 3218585, Japan.	miyoshi@is.utsunomiya-u.ac.jp			Center for Optical Research and Education, Utsunomiya University;  [25390091]	We acknowledge Shunji Nishimura, Naoki Tamiya, and Chie Saiki for their assistance in conducting the experiments and analyzing the data reported here. This research was supported by a research grant from the Center for Optical Research and Education, Utsunomiya University, and the Grant-in Aid for Scientific Research No. 25390091.	Vos Johannes J, 2003, Clin Exp Optom, V86, P363; van den Berg TJTP, 2009, OPHTHAL PHYSL OPT, V29, P345, DOI 10.1111/j.1475-1313.2009.00638.x; VANDENBERG TJTP, 1986, DOC OPHTHALMOL, V61, P327; BETTELHEIM FA, 1985, EXP EYE RES, V41, P1, DOI 10.1016/0014-4835(85)90089-2; [Anonymous], 2012, 9241391 ISODIS; VANNORREN D, 1986, VISION RES, V26, P313, DOI 10.1016/0042-6989(86)90028-3; Holladay LL, 1926, J OPT SOC AM REV SCI, V12, P271, DOI 10.1364/JOSA.12.000271; Franssen L, 2006, INVEST OPHTH VIS SCI, V47, P768, DOI 10.1167/iovs.05-0690; Berendschot TTJM, 2003, PROG RETIN EYE RES, V22, P171, DOI 10.1016/S1350-9462(02)00060-5; [Anonymous], 2002, MEC SOC SYS FOUND; VANDENBERG TJTP, 1991, DOC OPHTHALMOL, V78, P177; Ansari RR, 2004, J BIOMED OPT, V9, P22, DOI 10.1117/1.1626663; Ayama M, 2007, OPT REV, V14, P48, DOI 10.1007/s10043-007-0048-7; BETTELHEIM FA, 1979, BIOPHYS J, V26, P85; Bueno JM, 2004, J OPT SOC AM A, V21, P1316, DOI 10.1364/JOSAA.21.001316; Coppens JE, 2006, EXP EYE RES, V82, P688, DOI 10.1016/j.exer.2005.09.007; DELORI FC, 1989, APPL OPTICS, V28, P1061, DOI 10.1364/AO.28.001061; Gins H. S., 2013, PHYSIOL OPT, V54, P3702; Gins H. S., 2012, J VIS, V12, P20; Gins H. S., 2014, BIOMED OPT EXPRESS, V5, P3036; IJSPEERT JK, 1990, VISION RES, V30, P699, DOI 10.1016/0042-6989(90)90096-4; Mainster MA, 2003, BRIT J OPHTHALMOL, V87, P113, DOI 10.1136/bjo.87.1.113; Pireno D. P., 2010, OPTOMETRY VISION SCI, V87, pE682; Sasaki H., 2001, J JAPANESE SOC CATAR, V13, P13; Shinoda H., 2009, J ILLUM ENG I JPN, V93, P290; SIEW EL, 1981, EXP EYE RES, V33, P603, DOI 10.1016/S0014-4835(81)80100-5; Stiles W. S., 1929, J ROY SOC LOND B, V105, P131; Stiles W. S., 1929, J ROY SOC LOND B, V104, P322; Thaung J, 2002, J OPT SOC AM A, V19, P152, DOI 10.1364/JOSAA.19.000152; Van Den Berg TJ, 2010, ENCY EYE, V3, P173; VANDENBERG TJTP, 1995, VISION RES, V35, P169, DOI 10.1016/0042-6989(94)00123-4; VANDENBERG TJTP, 1991, VISION RES, V31, P1361, DOI 10.1016/0042-6989(91)90057-C; Vos J. J., 1999, CIE COLLECTION, V135, P1; WHITAKER D, 1993, OPTOMETRY VISION SCI, V70, P963, DOI 10.1097/00006324-199311000-00014; WOOTEN BR, 1987, VISION RES, V27, P1291, DOI 10.1016/0042-6989(87)90206-9; YUAN RM, 1993, OPTOMETRY VISION SCI, V70, P976, DOI 10.1097/00006324-199311000-00016	36	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	APR	2015	22	2					185	196		10.1007/s10043-015-0061-1		12	Optics	Optics	CG9JJ	WOS:000353630800001		
J	Shinoda, M; Nakatani, H				Shinoda, Masahisa; Nakatani, Hidehiko			Analysis of focusing error signals by differential astigmatic method under off-center tracking in the land-groove-type optical disk	OPTICAL REVIEW			English	Article						Land-groove-type optical disk; DVD-RAM; Focusing error signal; Differential astigmatic method; Theoretical calculation	PUSH-PULL METHODS; PHASE-CHANGE; SEGMENTED GRATINGS; DIFFRACTION THEORY; CROSS-TALK; LAND/GROOVE; DENSITY; SYSTEMS; FEEDTHROUGH; SIMULATIONS	We theoretically calculate the behavior of the focusing error signal in the land-groove-type optical disk when the objective lens traverses on out of the radius of the optical disk. The differential astigmatic method is employed instead of the conventional astigmatic method for generating the focusing error signals. The signal behaviors are compared and analyzed in terms of the gain difference of the slope sensitivity of the focusing error signals from the land and the groove. In our calculation, the format of digital versatile disc-random access memory (DVD-RAM) is adopted as the land-groove-type optical disk model, and advantageous conditions for suppressing the gain difference are investigated. The calculation method and results described in this paper will be reflected in the next generation land-groove-type optical disks.	[Shinoda, Masahisa] Mitsubishi Electr Corp, Kyoto Works, Kyoto 6178550, Japan; [Nakatani, Hidehiko] M TEC Co Ltd, Osaka 5320003, Japan	Shinoda, M (reprint author), Mitsubishi Electr Corp, Kyoto Works, Kyoto 6178550, Japan.	Shinoda.Masahisa@aj.MitsubishiElectric.co.jp					Shinoda M, 2011, IEEE T MAGN, V47, P532, DOI 10.1109/TMAG.2010.2099109; IWANAGA T, 1993, JPN J APPL PHYS 1, V32, P5449, DOI 10.1143/JJAP.32.5449; Goodman TD, 1996, APPL OPTICS, V35, P1107, DOI 10.1364/AO.35.001107; Ogawa M, 1996, JPN J APPL PHYS 1, V35, P336, DOI 10.1143/JJAP.35.336; Nishi Y, 2002, JPN J APPL PHYS 1, V41, P2931, DOI 10.1143/JJAP.41.2931; Chung KB, 1997, APPL OPTICS, V36, P1789, DOI 10.1364/AO.36.001789; BERNACKI BE, 1993, APPL OPTICS, V32, P5789, DOI 10.1364/AO.32.005789; COHEN DK, 1984, APPL OPTICS, V23, P565; MANSURIPUR M, 1986, J OPT SOC AM A, V3, P2086, DOI 10.1364/JOSAA.3.002086; Kondo K, 2007, JPN J APPL PHYS 1, V46, P229, DOI 10.1143/JJAP.46.229; Izumi K, 1999, IEEE T CONSUM ELECTR, V45, P1284, DOI 10.1109/30.809220; Shinoda M, 2011, OPT REV, V18, P367, DOI 10.1007/s10043-011-0071-6; Mieda M, 1996, JPN J APPL PHYS 1, V35, P429, DOI 10.1143/JJAP.35.429; Chung M, 2000, JPN J APPL PHYS 1, V39, P3453, DOI 10.1143/JJAP.39.3453; Shinoda M, 2010, OPT REV, V17, P360, DOI 10.1007/s10043-010-0066-8; Ohkubo A, 2001, JPN J APPL PHYS 1, V40, P1556, DOI 10.1143/JJAP.40.1556; MIYAGAWA N, 1993, JPN J APPL PHYS 1, V32, P5324, DOI 10.1143/JJAP.32.5324; Yeh WH, 2000, APPL OPTICS, V39, P316, DOI 10.1364/AO.39.000316; HOPKINS HH, 1979, J OPT SOC AM, V69, P4; Peng CB, 1998, APPL OPTICS, V37, P4425, DOI 10.1364/AO.37.004425; Fukumoto A, 1998, JPN J APPL PHYS 1, V37, P2144, DOI 10.1143/JJAP.37.2144; BERNACKI BE, 1994, APPL OPTICS, V33, P735, DOI 10.1364/AO.33.000735; Narita K, 1997, JPN J APPL PHYS 1, V36, P495, DOI 10.1143/JJAP.36.495; Yoshizawa T, 1998, JPN J APPL PHYS 1, V37, P2255, DOI 10.1143/JJAP.37.2255; Umezawa T, 2002, JPN J APPL PHYS 1, V41, P7380, DOI 10.1143/JJAP.41.7380; Morita S, 1997, JPN J APPL PHYS 1, V36, P444, DOI 10.1143/JJAP.36.444; OOKI H, 1995, OPT REV, V2, P1, DOI 10.1007/s10043-995-0001-6; Shinoda M, 2014, IEEE T MAGN, V50, DOI 10.1109/TMAG.2013.2297335; Mansuripur M., 2002, CLASSICAL OPTICS ITS, P353; MANSURIPUR M, 1989, J OPT SOC AM A, V6, P786, DOI 10.1364/JOSAA.6.000786; Miyagawa R, 1996, JPN J APPL PHYS 1, V35, P502, DOI 10.1143/JJAP.35.502; Shinoda M., JPN J APPL PHYS	32	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	APR	2015	22	2					264	270		10.1007/s10043-015-0037-1		7	Optics	Optics	CG9JJ	WOS:000353630800008		
J	Lee, MC; Konishi, N; Fujii, H				Lee, Min-Chul; Konishi, Naoki; Fujii, Hitoshi			Development of a handheld blood flow measurement system using laser speckle flowgraphy	OPTICAL REVIEW			English	Article						Laser speckle; Blood flowmetry; Medical instruments; Medical imaging; Biometric information	HEAD	A new handheld blood flow measurement system using laser speckle flowgraphy was developed for easy measurement of blood flow. The developed system features a small display unit that allows measurement results to be viewed without a PC. The system is miniaturized, integrated with a microcontroller, a line sensor, and a laser unit. Our experiment was carried out to confirm the usefulness of the developed system to measure the blood flow variation.	[Lee, Min-Chul; Konishi, Naoki] Kyushu Inst Technol, Dept Comp Sci & Elect, Iizuka, Fukuoka 8208502, Japan; [Fujii, Hitoshi] Softcare Co Ltd, Fukuoka 8113201, Japan	Lee, MC (reprint author), Kyushu Inst Technol, Dept Comp Sci & Elect, Iizuka, Fukuoka 8208502, Japan.	lee@cse.kyutech.ac.jp			JSPS KAKENHI [24500649]	This work was supported by JSPS KAKENHI Grant No. 24500649.	Tamaki Y, 1997, JPN J OPHTHALMOL, V41, P49, DOI 10.1016/S0021-5155(96)00008-1; Konishi N, 2002, OPT REV, V9, P163, DOI 10.1007/s10043-002-0163-4; Fujii H., 2006, JSAP, V75, P699; FUJII H, 1987, APPL OPTICS, V26, P5321, DOI 10.1364/AO.26.005321; Fujii H., 2007, CHIN OPT LETT, V5, pS1; Fukuoka S, 1999, J ORTHOPAED RES, V17, P80, DOI 10.1002/jor.1100170113; Isono H, 1997, J JPN OPHTHALMOL SOC, V101, P684; Konishi N., 2002, JAPANESE J OPTICS, V31, P39; Konishi N., 1995, OPT ENG, V34, P65; Lee M. C., 2007, J BME, V28, P392; Lee MC, 2003, OPT REV, V10, P562, DOI 10.1007/s10043-003-0562-1; Nillson G. E., 1984, IEEE T BIOMED ENG, V27, P311; TAMAKI Y, 1993, JPN J OPHTHALMOL, V37, P178; Yamamoto Y., 1993, PLAST RECONSTR SURG, V91, P889	14	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	APR	2015	22	2					308	314		10.1007/s10043-015-0062-0		7	Optics	Optics	CG9JJ	WOS:000353630800014		
J	Fujii, R; Nishimura, T; Ogura, Y; Tanida, J				Fujii, Ryo; Nishimura, Takahiro; Ogura, Yusuke; Tanida, Jun			Nanoscale energy-route selector consisting of multiple photo-switchable fluorescence-resonance-energy-transfer structures on DNA	OPTICAL REVIEW			English	Article						FRET; Route; Selector; Activation; DNA	FRET; LOGIC; WIRES	We report on a nanoscale energy-route selector consisting of multiple fluorescence resonance energy transfer (FRET) structures switched by external signaling with multiple wavelengths of light. In each FRET structure, a specific activator molecule is incorporated to a FRET pair of a donor and an acceptor to control the activation of the acceptor. Owing to this configuration, the FRET structures are switched independently, and an energy route is selected. Two photo-switchable FRET structures, one consists of Alexa Fluor 568 (donor), Cy5 (acceptor), and Alexa Fluor 405 (activator), and the other consists of Alexa Fluor 568 (donor), Cy5.5 (acceptor), and Cy3 (activator), were constructed using DNA strands modified with fluorescence molecules. Switching rates for the individual FRET structures were measured as 64 and 49 %, respectively. An energy-route selector was then assembled with the FRET structures which share a single donor. Experimental results demonstrate that the energy route can be changed repeatedly by activation control using three wavelengths of light.	[Fujii, Ryo; Nishimura, Takahiro; Ogura, Yusuke; Tanida, Jun] Osaka Univ, Grad Sch Informat Sci & Technol, Suita, Osaka 5650871, Japan	Ogura, Y (reprint author), Osaka Univ, Grad Sch Informat Sci & Technol, 1-5 Yamadaoka, Suita, Osaka 5650871, Japan.	ogura@ist.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [2306]; Japan Society for the Promotion of Science (JSPS) [25.6027]	This work was partially supported by a Grant-in-aid for Scientific Research on Innovative Areas "Nanomedicine Molecular Science" (No. 2306) from Ministry of Education, Culture, Sports, Science, and Technology of Japan, and by a Grant-in-aid for JSPS Fellows (Project No. 25.6027) from the Japan Society for the Promotion of Science (JSPS).	Liu HJ, 2008, J PHYS CHEM B, V112, P6893, DOI 10.1021/jp8020485; Dempsey GT, 2009, J AM CHEM SOC, V131, P18192, DOI 10.1021/ja904588g; Heilemann M, 2004, J AM CHEM SOC, V126, P6514, DOI 10.1021/ja049351u; Seeman NC, 2010, ANNU REV BIOCHEM, V79, P65, DOI 10.1146/annurev-biochem-060308-102244; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Nishimura T, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4769812; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Teo YN, 2012, CHEM REV, V112, P4221, DOI 10.1021/cr100351g; Pistol C, 2008, IEEE MICRO, V28, P7, DOI 10.1109/MM.2008.91; Vogelsang J, 2009, PHOTOCH PHOTOBIO SCI, V8, P486, DOI 10.1039/b822318c; Li YJ, 2007, J ORG CHEM, V72, P2878, DOI 10.1021/jo0624748; Stein IH, 2011, J AM CHEM SOC, V133, P4193, DOI 10.1021/ja1105464; Vyawahare S, 2004, NANO LETT, V4, P1035, DOI 10.1021/nl049660i; Aono M, 2013, LANGMUIR, V29, P7557, DOI 10.1021/la400301p; Eftekhari F, 2014, OPT LETT, V39, P2994, DOI 10.1364/OL.39.002994; Naruse M., 2014, NANOPHOTONIC INFORM; Nishimura T, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.015201; Pang J, 2014, J PARALLEL DISTR COM, V74, P2470, DOI 10.1016/j.jpdc.2013.07.006; Spillmann CM, 2014, CHEM COMMUN, V50, P7246, DOI 10.1039/c4cc01072h; Tate N, 2008, OPT EXPRESS, V16, P607, DOI 10.1364/OE.16.000607; Uphoff S, 2010, NAT METHODS, V7, P831, DOI [10.1038/nmeth.1502, 10.1038/NMETH.1502]	21	1	1	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	APR	2015	22	2					316	321		10.1007/s10043-015-0040-6		6	Optics	Optics	CG9JJ	WOS:000353630800016		
J	Tanida, J; Mima, H; Kagawa, K; Ogata, C; Umeda, M				Tanida, Jun; Mima, Hiroki; Kagawa, Keiichiro; Ogata, Chizuko; Umeda, Makoto			Application of a compound imaging system to odontotherapy	OPTICAL REVIEW			English	Article						Multi-aperture imaging; Odontotherapy; Stereo matching; Pattern projection; Spectral analysis; Polarization; Optical system	THIN OBSERVATION MODULE; BOUND OPTICS; CAMERA; EYES	A compound imaging system called thin observation module by bound optics was applied to odontotherapy, and its effectiveness and extendability were investigated. Experimental systems were constructed for the purposes of preliminary testing and hardware prototyping. Several basic odontotherapy operations were performed using the experimental systems. Promising results were obtained in the shape measurement of teeth and gingivae, as well as in spectral observation of gingival tissue.	[Tanida, Jun; Mima, Hiroki] Osaka Univ, Grad Sch Informat Sci & Technol, Dept Informat & Phys Sci, Suita, Osaka 5650871, Japan; [Kagawa, Keiichiro] Shizuoka Univ, Elect Res Inst, Hamamatsu, Shizuoka 4328011, Japan; [Ogata, Chizuko; Umeda, Makoto] Osaka Dent Univ, Dept Periodontol, Hirakata, Osaka 5400008, Japan	Tanida, J (reprint author), Osaka Univ, Grad Sch Informat Sci & Technol, Dept Informat & Phys Sci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	tanida@ist.osaka-u.ac.jp			JSPS KAKENHI [24560054]	This work was supported by JSPS KAKENHI Grant Number 24560054.	Jeong KH, 2006, SCIENCE, V312, P557, DOI 10.1126/science.1123053; Shogenji R, 2004, OPT EXPRESS, V12, P1643, DOI 10.1364/OPEX.12.001643; Nitta K, 2006, APPL OPTICS, V45, P2893, DOI 10.1364/AO.45.002893; Jacques SL, 2000, LASER SURG MED, V26, P119, DOI 10.1002/(SICI)1096-9101(2000)26:2<119::AID-LSM3>3.0.CO;2-Y; Horisaki R, 2007, OPT REV, V14, P347, DOI 10.1007/s10043-007-0347-z; Duparre J, 2005, APPL OPTICS, V44, P2949, DOI 10.1364/AO.44.002949; Tanida J, 2001, APPL OPTICS, V40, P1806, DOI 10.1364/AO.40.001806; Athale R, 2008, OPT PHOTONICS NEWS, V19, P32, DOI 10.1364/OPN.19.3.000032; Georgiev T, 2013, PROC SPIE, V8667, DOI 10.1117/12.2013581; HORRIDGE GA, 1980, PROC R SOC SER B-BIO, V207, P287, DOI 10.1098/rspb.1980.0025; Kagawa K, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.09LB04; Laganiere R, 2011, OPENCV 2 COMPUTER VI; Levoy M., 2006, IEEE COMPUT, V39, P46; Mima H., 2014, P BIOM IM SENS C BIS, P8; Ng R., 2005, STANFORD TECH REPORT; Tsumura N., 1998, JAPANESE J OPTICS, V27, P384	16	1	1	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	APR	2015	22	2					322	328		10.1007/s10043-015-0052-2		7	Optics	Optics	CG9JJ	WOS:000353630800017		
J	Nagao, R; Ishii, K; Awazu, K				Nagao, Ryo; Ishii, Katsunori; Awazu, Kunio			Optimal wavelengths for near-infrared multispectral imaging of atherosclerotic plaque	OPTICAL REVIEW			English	Article						Multispectral imaging; Near-infrared atherosclerotic plaque; Spectroscopy	OPTICAL COHERENCE TOMOGRAPHY; REFLECTION SPECTROSCOPY; VULNERABLE PLAQUE; CORONARY PLAQUES; CHOLESTEROL	Near-infrared multispectral imaging (NIRMSI) is a potentially effective technique for evaluation of atherosclerotic plaque. In the present study, the optimal wavelength combinations in the NIR wavelength range for detecting plaque were investigated. Atherosclerotic phantoms were observed using a NIR camera at different wavelengths in the range 1150-1790 nm. It was found that the plaque phantom could be detected using just three suitably chosen wavelengths in the neighborhood of absorption peaks due to the lipid at 1210 and 1730 nm. Although higher quality images could be obtained using the peak at 1730 nm due to the stronger absorption at this wavelength, the peak at 1210 nm offered the advantage of a larger optical penetration depth.	[Nagao, Ryo; Ishii, Katsunori; Awazu, Kunio] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Awazu, Kunio] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Awazu, Kunio] Osaka Univ, Ctr Adv Med Engn & Informat, Suita, Osaka 5650871, Japan	Awazu, K (reprint author), Osaka Univ, Grad Sch Frontier Biosci, Yamadaoka 1-3, Suita, Osaka 5650871, Japan.	awazu@see.eng.osaka-u.ac.jp					Gowen AA, 2007, TRENDS FOOD SCI TECH, V18, P590, DOI 10.1016/j.tifs.2007.06.001; Bezerra HG, 2009, JACC-CARDIOVASC INTE, V2, P1035, DOI 10.1016/j.jcin.2009.06.019; Kume T, 2006, AM J CARDIOL, V97, P1172, DOI 10.1016/j.amjcard.2005.11.035; Virmani R, 2002, PROG CARDIOVASC DIS, V44, P349, DOI 10.1053/pcad.2002.122475; Dennison PE, 2004, REMOTE SENS ENVIRON, V93, P359, DOI 10.1016/j.rse.2004.07.013; Maehara A, 2009, CIRC-CARDIOVASC INTE, V2, P482, DOI 10.1161/CIRCINTERVENTIONS.109.868398; Kondepati VR, 2008, ANAL BIOANAL CHEM, V390, P125, DOI 10.1007/s00216-007-1651-y; Friebel M, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3127200; Wang J, 2002, J AM COLL CARDIOL, V39, P1305, DOI 10.1016/S0735-1097(02)01767-9; Segtnan VH, 2001, ANAL CHEM, V73, P3153, DOI 10.1021/ac010102n; Gardner CM, 2008, JACC-CARDIOVASC IMAG, V1, P638, DOI 10.1016/j.jcmg.2008.06.001; DeMaria AN, 2006, J AM COLL CARDIOL, V47, pC32, DOI 10.1016/j.jacc.2005.11.047; Yonetsu T, 2011, EUR HEART J, V32, P1251, DOI 10.1093/eurheartj/ehq518; Jaross W, 1999, ATHEROSCLEROSIS, V147, P327, DOI 10.1016/S0021-9150(99)00203-8; Sethuraman S, 2008, OPT EXPRESS, V16, P3362, DOI 10.1364/OE.16.003362; Troy TL, 2001, J BIOMED OPT, V6, P167, DOI 10.1117/1.1344191; Honda N, 2012, PROC SPIE, V8221, DOI 10.1117/12.907704; Ishibashi Fumiyuki, 2006, J Interv Cardiol, V19, P17, DOI 10.1111/j.1540-8183.2006.00099.x; Jansen K., 2014, OHOTOACOUSTICS, V2, P12; Lilledahl MB, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2186332; Mann JM, 1996, CIRCULATION, V94, P928; Weinmann P, 1998, ATHEROSCLEROSIS, V140, P81, DOI 10.1016/S0021-9150(98)00119-1; Yudovsky Dmitry, 2010, J Diabetes Sci Technol, V4, P1099	23	1	1	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	APR	2015	22	2					329	334		10.1007/s10043-015-0035-3		6	Optics	Optics	CG9JJ	WOS:000353630800018		
J	Nakano, K; Satoh, R; Hoshi, A; Matsuda, R; Suzuki, H; Nishidate, I				Nakano, Kazuya; Satoh, Ryota; Hoshi, Akira; Matsuda, Ryohei; Suzuki, Hiroyuki; Nishidate, Izumi			Non-contact imaging of venous compliance in humans using an RGB camera	OPTICAL REVIEW			English	Article						Venous compliance; Skin hemodynamics; RGB image; Monte Carlo simulation; Upper-arm occlusion; Non-contact measurement	BODY NEGATIVE-PRESSURE; PULSE-WAVE; MEN; PLETHYSMOGRAPH; STIFFNESS; VELOCITY; WOMEN	We propose a technique for non-contact imaging of venous compliance that uses the red, green, and blue (RGB) camera. Any change in blood concentration is estimated from an RGB image of the skin, and a regression formula is calculated from that change. Venous compliance is obtained from a differential form of the regression formula. In vivo experiments with human subjects confirmed that the proposed method does differentiate the venous compliances among individuals. In addition, the image of venous compliance is obtained by performing the above procedures for each pixel. Thus, we can measure venous compliance without physical contact with sensors and, from the resulting images, observe the spatial distribution of venous compliance, which correlates with the distribution of veins.	[Nakano, Kazuya] Nippon Sport Sci Univ, Aoba Ku, Yokohama, Kanagawa 2270033, Japan; [Satoh, Ryota; Hoshi, Akira; Matsuda, Ryohei; Nishidate, Izumi] Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn, Koganei, Tokyo 1848588, Japan; [Suzuki, Hiroyuki] Tokyo Inst Technol, Imaging Sci & Engn Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Nakano, K (reprint author), Nippon Sport Sci Univ, Aoba Ku, 1221-1 Kamoshidacho, Yokohama, Kanagawa 2270033, Japan.	kazuya.nakano@nittai.ac.jp			JSPS KAKENHI [26820161]	This work was supported by JSPS KAKENHI (Grant No. 26820161).	WADA T, 1994, ARTERIOSCLER THROMB, V14, P479; AVOLIO AP, 1983, CIRCULATION, V68, P50; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359; HOKANSON DE, 1975, IEEE T BIO-MED ENG, VBM22, P25, DOI 10.1109/TBME.1975.324535; Hernandez JP, 2004, J APPL PHYSIOL, V97, P925, DOI 10.1152/japplphysiol.01328.2003; Laurent S, 2001, HYPERTENSION, V37, P1236; Bramwell JC, 1922, LANCET, V1, P891; Halliwill JR, 1999, J APPL PHYSIOL, V87, P1555; Buckey J C, 1992, Acta Physiol Scand Suppl, V604, P53; Hernandez JP, 2005, J APPL PHYSIOL, V99, P1070, DOI 10.1152/japplphysiol.01169.2004; Kawano H, 2010, EUR J APPL PHYSIOL, V110, P769, DOI 10.1007/s00421-010-1557-9; MELCHIOR FM, 1993, J APPL PHYSIOL, V74, P286; Monahan K.D., 2004, AM J PHYSIOL-HEART C, V286, P895; Monahan K.D., 2001, AM J PHYSIOL-HEART C, V281, P1267; Nichols W.W., 1990, MCDONALDS BLOOD FLOW, V3rd, P77; Nishidate I, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.6.061220; Nishidate I, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3613929; Nishidate I, 2008, OPT LETT, V33, P2263, DOI 10.1364/OL.33.002263; THOMSEN TA, 1977, MED INSTRUM, V11, P240; Young CN, 2006, J APPL PHYSIOL, V101, P1362, DOI 10.1152/japplphysiol.00448.2006	20	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	APR	2015	22	2					335	341		10.1007/s10043-015-0041-5		7	Optics	Optics	CG9JJ	WOS:000353630800019		
J	Watanabe, E; Hoshino, K; Takeuchi, S				Watanabe, Eriko; Hoshino, Kazuhiro; Takeuchi, Shuichi			Portable digital holographic microscope using spherical reference beam	OPTICAL REVIEW			English	Article						Digital holography; Phase-shifting; Lensless; Spherical reference beam; Microscopy; Compact	IMAGE-FORMATION	In this study, we developed and evaluated a portable digital holographic microscope (DHM) using a spherical reference beam. To reduce the size of this DHM, we replaced the objective lens with a small aspherical single lens, which produces the spherical reference beam. In addition, integrating the CCD camera and beam splitter yielded a simplified alignment along with further microscope compactness, resulting in a DHM with dimensions of 150 (W) x 470 (D) x 244.5 (H) mm(3), which is a portable size. The spatial resolution of the developed DHM was evaluated and a value of 870 nm was experimentally obtained, similar to the theoretical resolution of 851 nm. In addition, we conducted measurements on leukemia cells to evaluate the applicability of our novel microscope to cystoscopy.	[Watanabe, Eriko; Hoshino, Kazuhiro; Takeuchi, Shuichi] Univ Electrocommun, Chofu, Tokyo 1828585, Japan	Watanabe, E (reprint author), Univ Electrocommun, 1-5-1 Chofugaoka, Chofu, Tokyo 1828585, Japan.	eriko.watanabe@uec.ac.jp			JSPS KAKENHI [24760038]	This research was partly supported by the JSPS KAKENHI Grant Number 24760038.	Yamaguchi I, 2001, APPL OPTICS, V40, P6177, DOI 10.1364/AO.40.006177; Wagner C, 1999, APPL OPTICS, V38, P4812, DOI 10.1364/AO.38.004812; Watanabe E, 2013, OPT LETT, V38, P1319, DOI 10.1364/OL.38.001319; GOODMAN JW, 1967, APPL PHYS LETT, V11, P77, DOI 10.1063/1.1755043; Tahara T, 2010, BIOMED OPT EXPRESS, V1, P610; Takaki Y, 1999, APPL OPTICS, V38, P4990, DOI 10.1364/AO.38.004990; Lee M, 2011, BIOMED OPT EXPRESS, V2, P2721, DOI 10.1364/BOE.2.002721; Pavillon N, 2009, APPL OPTICS, V48, pH186, DOI 10.1364/AO.48.00H186; Memmolo P, 2011, OPT LETT, V36, P1945, DOI 10.1364/OL.36.001945; Repetto L, 2004, OPT LETT, V29, P1132, DOI 10.1364/OL.29.001132; Choi W. J., 2010, OPT LETT, V22, P23285; Goodman J. W., 2004, INTRO FOURIER OPTICS; Hoshino K., 2014, IM APPL OPT OSA; Langehanenberg P., 2008, APPL OPTICS, V44, P176; Masa D., 1999, OPT COMMUN, V164, P233; Phillips K. G., 2012, FRONT ONCOL, V2, P1; Takaki Y, 2000, APPL OPTICS, V39, P5302, DOI 10.1364/AO.39.005302; Yamaguchi I, 1997, OPT LETT, V22, P1268, DOI 10.1364/OL.22.001268	18	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	APR	2015	22	2					342	348		10.1007/s10043-015-0036-2		7	Optics	Optics	CG9JJ	WOS:000353630800020		
J	Quan, XY; Nitta, K; Matoba, O; Xia, P; Awatsuji, Y				Quan, Xiangyu; Nitta, Kouichi; Matoba, Osamu; Xia, Peng; Awatsuji, Yasuhiro			Phase and fluorescence imaging by combination of digital holographic microscopy and fluorescence microscopy	OPTICAL REVIEW			English	Article						Digital holographic microscopy; Fluorescence; Phase image	INCOHERENT	Hybrid digital holographic microscopy that combines fluorescence microscopy and digital holographic microscopy into a single system for biological applications is proposed. In the proposed system, a phase image and a fluorescence image can be obtained simultaneously by selecting the different wavelengths of the fluorescent light and the phase measurement. Especially for biological applications, the cell structure can be obtained by the phase imaging based on digital holography and nucleus of the cell can be obtained by the fluorescence imaging. The measurement of fluorescence beads and egera densa presented the feasibility of simultaneous detection of both a phase image and a fluorescence image.	[Quan, Xiangyu; Nitta, Kouichi; Matoba, Osamu] Kobe Univ, Grad Sch Syst Informat, Dept Syst Sci, Nada Ku, Kobe, Hyogo 6578501, Japan; [Xia, Peng] Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Designing Engn, Sakyo Ku, Kyoto 6068585, Japan; [Awatsuji, Yasuhiro] Kyoto Inst Technol, Grad Sch Sci & Technol, Div Elect, Sakyo Ku, Kyoto 6068585, Japan	Quan, XY (reprint author), Kobe Univ, Grad Sch Syst Informat, Dept Syst Sci, Nada Ku, Rokkodai 1-1, Kobe, Hyogo 6578501, Japan.	zen@brian.cs.kobe-u.ac.jp					Frauel Y, 2006, P IEEE, V94, P636, DOI 10.1109/JPROC.2006.870704; Rosen J, 2008, NAT PHOTONICS, V2, P190, DOI 10.1038/nphoton.2007.300; Osten W, 2014, APPL OPTICS, V53, pG44, DOI 10.1364/AO.53.000G44; Tahara T, 2012, IEEE J SEL TOP QUANT, V18, P1387, DOI 10.1109/JSTQE.2011.2178062; Brooker G, 2011, OPT EXPRESS, V19, P5047, DOI 10.1364/OE.19.005047; Park YK, 2006, OPT EXPRESS, V14, P8263, DOI 10.1364/OE.14.008263; TAKEDA M, 1982, J OPT SOC AM, V72, P156, DOI 10.1364/JOSA.72.000156; SCHNARS U, 1994, APPL OPTICS, V33, P179, DOI 10.1364/AO.33.000179; GOODMAN JW, 1967, APPL PHYS LETT, V11, P77, DOI 10.1063/1.1755043; Tahara T, 2010, BIOMED OPT EXPRESS, V1, P610; Kemper B, 2008, APPL OPTICS, V47, pA52, DOI 10.1364/AO.47.000A52; Kim M. K., 2010, SPIE REV, V1, P1, DOI DOI 10.1117/6.0000006]; Shaffer E, 2012, J MICROSC-OXFORD, V245, P49, DOI 10.1111/j.1365-2818.2011.03543.x	13	1	1	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	APR	2015	22	2					349	353		10.1007/s10043-015-0042-4		5	Optics	Optics	CG9JJ	WOS:000353630800021		
J	Inami, W; Fukuta, M; Masuda, Y; Nawa, Y; Ono, A; Lin, S; Kawata, Y; Terakawa, S				Inami, Wataru; Fukuta, Masahiro; Masuda, Yuriko; Nawa, Yasunori; Ono, Atsushi; Lin, Sheng; Kawata, Yoshimasa; Terakawa, Susumu			A plastic scintillator film for an electron beam-excitation assisted optical microscope	OPTICAL REVIEW			English	Article						High spatial resolution; Near-field; Bioimaging	RESOLUTION; LIMIT	A plastic scintillator film for use in an electron beam excitation-assisted (EXA) optical microscope is characterized. The thin film scatters an incident electron beam weakly and generates high intensity nanoscale luminescence excited by the beam spot. For high spatial resolution and signal to noise, an EXA microscope requires a thin high-efficiency scintillator film. Homogeneous plastic scintillators with thicknesses ranging from 60 to 2800 nm were fabricated on silicon nitride via spin coating. The emission intensity was examined as a function of film thickness and the accelerating voltage of the incident electron beam. The emission wavelength can be tuned by changing scintillator materials in the film matrix. To demonstrate a plastic scintillator film performance with an EXA microscope, time-lapse images of yeast cells were acquired.	[Inami, Wataru; Fukuta, Masahiro; Masuda, Yuriko; Nawa, Yasunori] Shizuoka Univ, Fac Engn, Nake Ku, Hamamatsu, Shizuoka 4328561, Japan; [Inami, Wataru; Ono, Atsushi; Lin, Sheng; Kawata, Yoshimasa] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1020075, Japan; [Ono, Atsushi; Kawata, Yoshimasa; Terakawa, Susumu] Shizuoka Univ, Elect Res Inst, Naka Ku, Hamamatsu, Shizuoka 4328011, Japan; [Terakawa, Susumu] Hamamatsu Univ, Sch Med, Photon Med Res Ctr, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan	Inami, W (reprint author), Shizuoka Univ, Fac Engn, Nake Ku, 3-5-1 Johoku, Hamamatsu, Shizuoka 4328561, Japan.	dwinami@ipc.shizuoka.ac.jp			CREST of JST (Japan Science and Technology Agency)	This work was supported by CREST of JST (Japan Science and Technology Agency).	Drouin D, 2007, SCANNING, V29, P92, DOI 10.1002/sca.20000; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Inami W, 2010, OPT EXPRESS, V18, P12897, DOI 10.1364/OE.18.012897; Fujita K, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.228105; POHL DW, 1984, APPL PHYS LETT, V44, P651, DOI 10.1063/1.94865; Synge EH, 1928, PHILOS MAG, V6, P356; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Heintzmann R, 2002, J OPT SOC AM A, V19, P1599, DOI 10.1364/JOSAA.19.001599; Inami W, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4758290; BETZIG E, 1987, APPL PHYS LETT, V51, P2088, DOI 10.1063/1.98956; Ash E. A., 1984, APPL PHYS LETT, V44, P651; Gustafsson M.G.L., 2005, J P NATL ACAD SCI, V102, P13081; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Joy D C, 1995, MONTE CARLO MODELING; Miyake A., 2014, JPN J APPL PHYS, V53; Sugita Atsushi, 2013, OPT MATER EXPRESS, V4, P155; YEE KS, 1966, IEEE T ANTENN PROPAG, VAP14, P302	17	1	1	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	APR	2015	22	2					354	358		10.1007/s10043-015-0043-3		5	Optics	Optics	CG9JJ	WOS:000353630800022		
J	Sugawa, Y; Fukuda, A; Ohmi, M				Sugawa, Yoshihiko; Fukuda, Akihiro; Ohmi, Masato			Precise measurement of volume of eccrine sweat gland in mental sweating by optical coherence tomography	OPTICAL REVIEW			English	Article						Optical coherence tomography; Eccrine sweat gland; Mental sweating; Connected component extraction process; Adaptive threshold method	BIOPSY	We have demonstrated dynamic analysis of the physiological function of eccrine sweat glands underneath skin surface by optical coherence tomography (OCT). In this paper, we propose a method for extraction of the specific eccrine sweat gland by means of the connected component extraction process and the adaptive threshold method, where the en face OCT images are constructed by the swept-source OCT. In the experiment, we demonstrate precise measurement of the volume of the sweat gland in response to the external stimulus.	[Sugawa, Yoshihiko; Fukuda, Akihiro; Ohmi, Masato] Osaka Univ, Grad Sch Med, Course Allied Hlth Sci, Suita, Osaka 5650871, Japan	Ohmi, M (reprint author), Osaka Univ, Grad Sch Med, Course Allied Hlth Sci, 1-7 Yamada Oka, Suita, Osaka 5650871, Japan.	ohmi@sahs.med.osaka-u.ac.jp			Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science (JSPS)	This research was partially supported by Japan Science and Technology Agency (JST) and Japan Society for the Promotion of Science (JSPS).	Tearney GJ, 1997, SCIENCE, V276, P2037, DOI 10.1126/science.276.5321.2037; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; SWANSON EA, 1993, OPT LETT, V18, P1864, DOI 10.1364/OL.18.001864; Brezinski ME, 1996, CIRCULATION, V93, P1206; Sauvola J, 2000, PATTERN RECOGN, V33, P225, DOI 10.1016/S0031-3203(99)00055-2; Haruna M, 2006, JPN J APPL PHYS 2, V45, pL891, DOI 10.1143/JJAP.45.L891; Kasagawa K., 1990, J INF P J, V3, P360; Kuwabara M, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.058001; Maheswari RU, 2002, OPT COMMUN, V202, P47; Ohmi M, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3079808; Ohmi M., 2013, J BIOMED SCI ENG, V6, P249; Ohmi M, 2005, JPN J APPL PHYS 2, V44, pL854, DOI 10.1143/JJAP.44.L854; Ohmi M, 2012, SKIN RES TECHNOL, V18, P378, DOI 10.1111/j.1600-0846.2011.00580.x; Saigusa H, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.098001	14	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	APR	2015	22	2					359	364		10.1007/s10043-015-0047-z		6	Optics	Optics	CG9JJ	WOS:000353630800023		
J	Yokoi, N; Aizu, Y				Yokoi, Naomichi; Aizu, Yoshihisa			Depth measurement of a blood flow region based on speckle decorrelation	OPTICAL REVIEW			English	Article						Speckle imaging; Depth measurement; Blood flow; Image processing	OPTICAL COHERENCE TOMOGRAPHY; LASER SPECKLE; VISUALIZATION; PHOTOGRAPHY; FLOWGRAPHY; INTENSITY; DOMAIN	Laser speckle technique is a useful means for imaging blood flow in living bodies and, it has been utilized for analyzing the condition of living bodies or the health state. However, depth of a blood flow region has not been measured yet by this method. In the present study, we investigate use of a decorrelation in a pair of speckle patterns in a temporal sequence for measuring depth of the blood flow region. Blood flow is also measured simultaneously by means of a spatio-temporal difference of the same pair of speckle patterns as that used for depth measurement. Experiments are conducted for reference and sample models using ground-glass plates and a silicone layer and for a human finger, to confirm the feasibility of the proposed method.	[Yokoi, Naomichi] Asahikawa Med Coll, Natl Inst Technol, Dept Mech Syst Engn, Asahikawa, Hokkaido 0718142, Japan; [Aizu, Yoshihisa] Muroran Inst Technol, Coll Design & Mfg Technol, Muroran, Hokkaido 0508585, Japan	Yokoi, N (reprint author), Asahikawa Med Coll, Natl Inst Technol, Dept Mech Syst Engn, Asahikawa, Hokkaido 0718142, Japan.	yokoi@asahikawa-nct.ac.jp			Japan Society for the Promotion of Science	Part of this work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science.	AIZU Y, 1990, OPT COMMUN, V80, P1, DOI 10.1016/0030-4018(90)90495-F; Aizu Y., 1996, Bioimaging, V4, DOI 10.1002/1361-6374(199612)4:4<254::AID-BIO4>3.3.CO;2-Z; AIZU Y, 1992, APPL OPTICS, V31, P3020, DOI 10.1364/AO.31.003020; Aizu Y, 1999, J BIOMED OPT, V4, P61, DOI 10.1117/1.429922; Aizu Y, 1998, J BIOMED OPT, V3, P227, DOI 10.1117/1.429878; Cuccia DJ, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3088140; BRIERS JD, 1982, INVEST OPHTH VIS SCI, V22, P255; YOUNGQUIST RC, 1987, OPT LETT, V12, P158, DOI 10.1364/OL.12.000158; FUJII H, 1985, OPT LETT, V10, P104, DOI 10.1364/OL.10.000104; FERCHER AF, 1981, OPT COMMUN, V37, P326, DOI 10.1016/0030-4018(81)90428-4; Stolik S, 2000, J PHOTOCH PHOTOBIO B, V57, P90, DOI 10.1016/S1011-1344(00)00082-8; Laurent A, 2007, VACCINE, V25, P6423, DOI 10.1016/j.vaccine.2007.05.046; Kamshilin AA, 2011, BIOMED OPT EXPRESS, V2, P996, DOI 10.1364/BOE.2.000996; AIZU Y, 1991, OPT LASER TECHNOL, V23, P205, DOI 10.1016/0030-3992(91)90085-3; Yang VXD, 2005, OPT LETT, V30, P1791, DOI 10.1364/OL.30.001791; Dunn AK, 2001, J CEREBR BLOOD F MET, V21, P195; Konishi N, 2002, OPT REV, V9, P163, DOI 10.1007/s10043-002-0163-4; Beiderman Y, 2011, BIOMED OPT EXPRESS, V2, P858, DOI 10.1364/BOE.2.000858; Bouma B. E., 2002, HDB OPTICAL COHERENC, P41; BRIERS JD, 1975, OPT COMMUN, V13, P324, DOI 10.1016/0030-4018(75)90111-X; FUJII H, 1987, APPL OPTICS, V26, P5321, DOI 10.1364/AO.26.005321; KONISHI N, 1995, OPT ENG, V34, P753, DOI 10.1117/12.195203; Mazhar A, 2011, BIOMED OPT EXPRESS, V2, P1553, DOI 10.1364/BOE.2.001553; Piao DQ, 2005, APPL OPTICS, V44, P348, DOI 10.1364/AO.44.000348; Yazdanfar S, 2005, OPT EXPRESS, V13, P410, DOI 10.1364/OPEX.13.000410; Yokoi N, 2008, OPT LASER TECHNOL, V40, P52, DOI 10.1016/j.optlastec.2007.03.012; Yokoi N., 2014, P BIOM IM SENS C 201; Yokoi N., 2013, INT C EXP MACH 2013, P15; Yokoi N, 2014, OPT LASER ENG, V52, P156, DOI 10.1016/j.optlaseng.2013.06.016; Yokoi N, 2014, OPT REV, V21, P345, DOI 10.1007/s10043-014-0052-7; Yokoi N, 2010, OPT REV, V17, P230, DOI 10.1007/s10043-010-0041-4	31	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	APR	2015	22	2					365	373		10.1007/s10043-015-0039-z		9	Optics	Optics	CG9JJ	WOS:000353630800024		
J	Yoshida, K; Ishizuka, T; Mizushima, C; Nishidate, I; Kawauchi, S; Sato, S; Sato, M				Yoshida, Keiichiro; Ishizuka, Tomohiro; Mizushima, Chiharu; Nishidate, Izumi; Kawauchi, Satoko; Sato, Shunichi; Sato, Manabu			In vivo multispectral imaging of the absorption and scattering properties of exposed brain using a digital red-green-blue camera	OPTICAL REVIEW			English	Article						Multi-spectral imaging; Wiener estimation method; Diffuse reflectance spectroscopy; Monte Carlo simulation; Multiple regression analysis; Reduced scattering coefficient; Absorption coefficient	TISSUE OPTICAL-PROPERTIES; CORTICAL SPREADING DEPRESSION; ACUTE EXCITOTOXIC INSULT; HIPPOCAMPAL SLICE; NONINVASIVE DETERMINATION; ANOXIC DEPOLARIZATION; DIFFUSE-REFLECTANCE; LIGHT-SCATTERING; NEURONAL DAMAGE; BLOOD-FLOW	To evaluate multi-spectral images of the absorption and scattering properties in the cerebral cortex of rat brain, we investigated spectral reflectance images estimated by the Wiener estimation method using a digital red-green-blue camera. A Monte Carlo simulation-based multiple regression analysis for the corresponding spectral absorbance images at nine wavelengths (500, 520, 540, 560, 570, 580, 600, 730, and 760 nm) was then used to specify the absorption and scattering parameters. The spectral images of absorption and reduced scattering coefficients were reconstructed from the absorption and scattering parameters. We performed in vivo experiments on exposed rat brain to confirm the feasibility of this method. The estimated images of the absorption coefficients were dominated by hemoglobin spectra. The estimated images of the reduced scattering coefficients had a broad scattering spectrum, exhibiting a larger magnitude at shorter wavelengths, corresponding to the typical spectrum of brain tissue published in the literature.	[Yoshida, Keiichiro; Ishizuka, Tomohiro; Mizushima, Chiharu; Nishidate, Izumi] Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn, Koganei, Tokyo 1848588, Japan; [Kawauchi, Satoko; Sato, Shunichi] Natl Def Med Coll, Res Inst, Div Biomed Informat Sci, Tokorozawa, Saitama 3598513, Japan; [Sato, Manabu] Yamagata Univ, Grad Sch Sci & Engn, Yonezawa, Yamagata 9928510, Japan	Nishidate, I (reprint author), Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn, Koganei, Tokyo 1848588, Japan.	inishi@cc.tuat.ac.jp			Japanese Society for the Promotion of Science	The present study was supported in part by a Grant-in-Aid for Scientific Research from the Japanese Society for the Promotion of Science.	Lin SP, 1997, APPL OPTICS, V36, P136, DOI 10.1364/AO.36.000136; Abookasis D, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3116709; FARRELL TJ, 1992, MED PHYS, V19, P879, DOI 10.1118/1.596777; WANG LH, 1995, APPL OPTICS, V34, P2362, DOI 10.1364/AO.34.002362; Utzinger U, 2003, J BIOMED OPT, V8, P121, DOI 10.1117/1.1528207; PRAHL SA, 1993, APPL OPTICS, V32, P559, DOI 10.1364/AO.32.000559; ANDERSON RR, 1981, J INVEST DERMATOL, V77, P13, DOI 10.1111/1523-1747.ep12479191; PATTERSON MS, 1989, APPL OPTICS, V28, P2331, DOI 10.1364/AO.28.002331; Obeidat AS, 2000, J CEREBR BLOOD F MET, V20, P412; Bargo PR, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1921907; Kienle A, 1996, APPL OPTICS, V35, P2304, DOI 10.1364/AO.35.002304; Polischuk TM, 1998, NEUROBIOL DIS, V4, P423, DOI 10.1006/nbdi.1998.0172; Bouchard MB, 2009, OPT EXPRESS, V17, P15670, DOI 10.1364/OE.17.015670; Zhou C, 2006, OPT EXPRESS, V14, P1125, DOI 10.1364/OE.14.001125; Mourant JR, 1998, APPL OPTICS, V37, P3586, DOI 10.1364/AO.37.003586; Shen HL, 2006, J OPT SOC AM A, V23, P1566, DOI 10.1364/JOSAA.23.001566; Jones PB, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2950312; Arnold T, 2011, PROC SPIE, V8087, DOI 10.1117/12.889940; Basiri A, 2010, OPT EXPRESS, V18, P3244, DOI 10.1364/OE.18.003244; Bonhoeffer T., 1996, BRAIN MAPPING METHOD; Chen S, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.3.030501; Cheung V, 2005, J OPT SOC AM A, V22, P1231, DOI 10.1364/JOSAA.22.001231; Fishkin JB, 1997, APPL OPTICS, V36, P10, DOI 10.1364/AO.36.000010; Hardeberg J. Y., 1999, THESIS ECOLE NATL SU; Hardeberg JY, 2002, OPT ENG, V41, P2532, DOI 10.1117/1.1503346; Ishimaru A., 1978, WAVE PROPAGATION SCA; Jacques S. L., 1993, IN VIVO MED OPTICAL, P211; Jarvis CR, 1999, NEUROIMAGE, V10, P357, DOI 10.1006/nimg.1999.0473; Jarvis CR, 2001, CEREB CORTEX, V11, P249, DOI 10.1093/cercor/11.3.249; Joshi I, 2001, J NEUROPHYSIOL, V85, P414; Kawauchi S, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.1.015003; Konig F., 1997, P IS TS 50 ANN C, P454; Lipton P., 1999, PHYSIOL REV, V79, P1432; Murakami Y, 2008, OPT EXPRESS, V16, P4106, DOI 10.1364/OE.16.004106; Nishidate I, 2010, APPL OPTICS, V49, P6617, DOI 10.1364/AO.49.006617; Prahl SA, 1999, TABULATED MOLAR EXTE; Sato S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082891; Shen HL, 2007, OPT EXPRESS, V15, P5531, DOI 10.1364/OE.15.005531; Stigell P, 2007, Pattern Recognition and Image Analysis, V17, DOI 10.1134/S1054661807020101; Tuchin V. V., 2007, TISSUE OPTICS LIGHT; WANG LH, 1995, COMPUT METH PROG BIO, V47, P131, DOI 10.1016/0169-2607(95)01640-F; Yin C, 2013, NEUROIMAGE, V76, P70, DOI 10.1016/j.neuroimage.2013.02.079	42	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	APR	2015	22	2					374	384		10.1007/s10043-015-0048-y		11	Optics	Optics	CG9JJ	WOS:000353630800025		
J	Oda, S; Manaka, K; Kakiya, K; Hozumi, Y; Fukui, Y; Omura, S; Kurashita, M; Nishiwaki, M; Takeuchi, Y; Kitamura, H				Oda, Shinichi; Manaka, Kumiko; Kakiya, Kiyoshi; Hozumi, Yasuyuki; Fukui, Yuki; Omura, Sohei; Kurashita, Makoto; Nishiwaki, Masanori; Takeuchi, Yoshiyuki; Kitamura, Hideyuki			Development of an Optimized Synthetic and Purification Process of S-2367 (Velneperit), a Novel Neuropeptide Y (NPY) Y5 Receptor Antagonist	ORGANIC PROCESS RESEARCH & DEVELOPMENT			English	Article								We developed a simple synthetic route to S-2367 (Velneperit) (1) using trans-1-ethoxycarbonyl-4-aminocyclohexane hydrochloride salt (12) as a starting material. The key step was Na2WO4/H2O2 oxidation, and we found that it was accelerated in weakly basic conditions. The finding was useful to control one of the critical impurities: 14 in 10. The new process was more efficient than the early process from the viewpoint of the number of reactions, yield, throughput, and EHS (environment, health, and safety) but a quality deviation occurred in the pilot manufacturing: 10 content in 1 was over the upper limit. The cause was presumed to be hydrolysis of 1 during the recrystallization step. After finding it, we developed two reliable purification processes. The first was slurry washing including clever polymorphic control using only acetone and water. The second was salt formation of 10 and rational building of the recrystallization procedure based on solubility to improve removal rate.	[Oda, Shinichi] Shionogi & Co Ltd, Chem Dev, Prod Technol Dept, Mfg Div, Amagasaki, Hyogo 6600813, Japan; Shionogi & Co Ltd, Chem Dev, CMC Dev Labs, Amagasaki, Hyogo 6600813, Japan	Oda, S (reprint author), Shionogi & Co Ltd, Chem Dev, Prod Technol Dept, Mfg Div, 1-3,Kuise Terajima 2 Chome, Amagasaki, Hyogo 6600813, Japan.	shinichi.oda@shionogi.co.jp					Hida T, 2009, TETRAHEDRON, V65, P270, DOI 10.1016/j.tet.2008.10.056; Prat D, 2013, ORG PROCESS RES DEV, V17, P1517, DOI 10.1021/op4002565; Kawanishi Y., [No title captured], Patent No. [WO03076374A1, 03076374]; Kawanishi Y., [No title captured], Patent No. [WO0137826A1, 0137826]; Kobayashi Y., [No title captured], Patent No. [W02013002313A1, 2013002313]; Levens Nigel R, 2003, Curr Opin Investig Drugs, V4, P1198; Masui T., [No title captured], Patent No. [WO2006106800A1, 2006106800]; Yukioka H., [No title captured], Patent No. [W02008047769, 008047769]	8	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1083-6160	1520-586X		ORG PROCESS RES DEV	Org. Process Res. Dev.	APR	2015	19	4					531	536		10.1021/acs.oprd.5b00023		6	Chemistry, Applied; Chemistry, Organic	Chemistry	CG5EW	WOS:000353314900007		
J	Iwayama, T; Murakami, S; Watanabe, T				Iwayama, T.; Murakami, S.; Watanabe, T.			Anomalous eddy viscosity for two-dimensional turbulence	PHYSICS OF FLUIDS			English	Article							GEOSTROPHIC TURBULENCE; ENERGY-SPECTRA; DIFFUSION; CASCADES	We study eddy viscosity for generalized two-dimensional (2D) fluids. The governing equation for generalized 2D fluids is the advection equation of an active scalar q by an incompressible velocity. The relation between q and the stream function psi is given by q = -(-del(2))(alpha/2)psi. Here, alpha is a real number. When the evolution equation for the generalized enstrophy spectrum Q(alpha)(k) is truncated at a wavenumber k(c), the effect of the truncation of modes with larger wavenumbers than k(c) on the dynamics of the generalized enstrophy spectrum with smaller wavenumbers than k(c) is investigated. Here, we refer to the effect of the truncation on the dynamics of Q(alpha)(k) with k < k(c) as eddy viscosity. Our motivation is to examine whether the eddy viscosity can be represented by normal diffusion. Using an asymptotic analysis of an eddy-damped quasi-normal Markovian (EDQNM) closure approximation equation for the enstrophy spectrum, we show that even if the wavenumbers of interest k are sufficiently smaller than k(c), the eddy viscosity is not asymptotically proportional to k(2)Q(alpha)(k), i.e., a normal diffusion, but to k(4-alpha)Q(alpha)(k) for alpha > 0 and k(4)Q(alpha)(k) for alpha < 0, i.e., an anomalous diffusion. This indicates that the eddy viscosity as normal diffusion is asymptotically realized only for alpha = 2 (Navier-Stokes system). The proportionality constant, the eddy viscosity coefficient, is asymptotically negative. These results are confirmed by numerical calculations of the EDQNM closure approximation equation and direct numerical simulations of the governing equation for forced and dissipative generalized 2D fluids. The negative eddy viscosity coefficient is explained using Fjortoft's theorem and a spreading hypothesis for the spectrum. (C) 2015 AIP Publishing LLC.	[Iwayama, T.; Murakami, S.] Kobe Univ, Grad Sch Sci, Dept Earth & Planetary Sci, Kobe, Hyogo 6578501, Japan; [Watanabe, T.] Nagoya Inst Technol, Grad Sch Engn, Dept Sci & Engn Simulat, Showa Ku, Nagoya, Aichi 4668555, Japan	Iwayama, T (reprint author), Kobe Univ, Grad Sch Sci, Dept Earth & Planetary Sci, Kobe, Hyogo 6578501, Japan.	iwayama@kobe-u.ac.jp; murashin@gfd-dennou.org; watanabe@nitech.ac.jp			Japanese Society for the Promotion of Science [24540472]	This study was supported by a Grant-in-Aid for Scientific Research (C) No. 24540472 from the Japanese Society for the Promotion of Science. The authors express their deep thanks to Professor T. Gotoh of Nagoya Institute of Technology for helpful comments and encouragement. T. I. would like to thank all of the members of the Atmospheric Science Group of Kobe University for helpful conversations on this topic. We would like to thank two anonymous reviewers for their constructive suggestions.	LEITH CE, 1968, PHYS FLUIDS, V11, P671, DOI 10.1063/1.1691968; PIERREHUMBERT RT, 1994, CHAOS SOLITON FRACT, V4, P1111, DOI 10.1016/0960-0779(94)90140-6; KRAICHNAN RH, 1976, J ATMOS SCI, V33, P1521, DOI 10.1175/1520-0469(1976)033<1521:EVITAT>2.0.CO;2; MALTRUD ME, 1991, J FLUID MECH, V228, P321, DOI 10.1017/S0022112091002720; RHINES PB, 1979, ANNU REV FLUID MECH, V11, P401, DOI 10.1146/annurev.fl.11.010179.002153; Smith KS, 2002, J FLUID MECH, V469, P13, DOI 10.1017/S0022112002001763; Sukhatme J, 2009, PHYS FLUIDS, V21, DOI 10.1063/1.3141499; Batchelor G. K., 1969, PHYS FLUIDS       S2, V12, P233, DOI DOI 10.1063/1.1692443; Burgess BH, 2015, J FLUID MECH, V767, P467, DOI 10.1017/jfm.2015.26; Burgess BH, 2013, J FLUID MECH, V725, P332, DOI 10.1017/jfm.2013.192; Domaradzki D. A., 1993, PHYS FLUIDS A-FLUID, V5, P1747; DOMARADZKI JA, 1987, PHYS REV LETT, V58, P547, DOI 10.1103/PhysRevLett.58.547; Fjortoft R., 1953, TELLUS, V5, P225, DOI DOI 10.1111/J.2153-3490.1953.TB01051.X; Gkioulekas E, 2007, J FLUID MECH, V576, P173, DOI 10.1017/S0022112006003934; Iwayama T, 2014, PHYS FLUIDS, V26, DOI 10.1063/1.4864103; Iwayama T, 2013, J PHYS A-MATH THEOR, V46, DOI 10.1088/1751-8113/46/6/065501; Iwayama T, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.036307; Iwayama T, 2002, J FLUID MECH, V456, P183, DOI 10.1017/S0022112001007509; KRAICHNA.RH, 1967, PHYS FLUIDS, V10, P1417, DOI 10.1063/1.1762301; Lesieur M, 2008, FLUID MECH APPL, V84, P1; LILLY DK, 1969, PHYS FLUIDS       S2, V12, P240, DOI DOI 10.1063/1.1692444; Ohkitani K, 2012, PHYS FLUIDS, V24, DOI 10.1063/1.4748350; Schorghofer N, 2000, PHYS REV E, V61, P6572, DOI 10.1103/PhysRevE.61.6572; Scott RK, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.046301; Tran CV, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.016301; Tran CV, 2004, PHYSICA D, V191, P137, DOI 10.1016/j.physd.2003.11.005; Vallis G. K., 2006, ATMOSPHERIC OCEANIC; Watanabe T, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046303; Watanabe T, 2004, J PHYS SOC JPN, V73, P3319, DOI [10.1143/JPSJ.73.3319, 10.1143/JSPJ.73.3319]	29	0	0	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	1070-6631	1089-7666		PHYS FLUIDS	Phys. Fluids	APR	2015	27	4							045104	10.1063/1.4916956		18	Mechanics; Physics, Fluids & Plasmas	Mechanics; Physics	CH2DM	WOS:000353835700026		
J	Jones, MC; Hourigan, K; Thompson, MC				Jones, M. C.; Hourigan, K.; Thompson, M. C.			A study of the geometry and parameter dependence of vortex breakdown	PHYSICS OF FLUIDS			English	Article							SWIRLING FLOW; DELTA-WINGS; MODE SELECTION; SPHERE WAKE; STABILITY; DYNAMICS; BIOREACTOR; TRANSITION; CYLINDER; JETS	The types of vortex breakdown observed in the torsionally driven cylinder (TDC) flow and in the flow through an open-ended pipe are compared. The connection between the various breakdown types is specifically addressed, and the differences in manifestation of breakdown are attributed to the different Reynolds number regimes involved. Here, in both cases, the Reynolds number is based on quantities associated with the vortex core immediately upstream of breakdown, rather than the more geometry-specific Reynolds number defined in the previous work. Thus, the relationship between the TDC flow and the flows observed in other, more open geometries, is clarified. The predominantly asymmetric breakdown observed in open high Reynolds number flows is replaced by a closed bubble form with decreasing Reynolds number in the TDC. Three-dimensional numerical simulations support this interpretation, showing that the 3D spiral type of breakdown is replaced by a TDC-type axisymmetric breakdown in an open pipe as the Reynolds number is reduced. The stability of the three-dimensional solutions indicates that spiral breakdown modes stabilise at lower Reynolds number, leading to an axisymmetric breakdown state as a stable evolved flow solution. (C )2015 AIP Publishing LLC.	[Jones, M. C.; Hourigan, K.; Thompson, M. C.] Monash Univ, Dept Mech & Aerosp Engn, Fluids Lab Aeronaut & Ind Res FLAIR, Melbourne, Vic 3004, Australia; [Hourigan, K.] Monash Univ, Biomed Engn Lab, Melbourne, Vic 3004, Australia	Jones, MC (reprint author), Equos Res Co Ltd, Anjo, Japan.		Hourigan, Kerry/B-7999-2009	Hourigan, Kerry/0000-0002-8995-1851	Australian Research Council [DP0452664]; Linkage International Grant [LX0668992]	The authors gratefully acknowledge the funding from Australian Research Council Discovery Grant (No. DP0452664) and Linkage International Grant (No. LX0668992) for supporting this research. Dr. Lachlan Graham of the Commonwealth Scientific and Industrial Research Organisation, Melbourne, is thanked for his flow visualisation photographs.	Gallaire F, 2003, J FLUID MECH, V494, P223, DOI 10.1017/S0022112003006104; Rusak Z, 1999, J AIRCRAFT, V36, P659, DOI 10.2514/2.2508; SARPKAYA T, 1971, J FLUID MECH, V45, P545, DOI 10.1017/S0022112071000181; BENJAMIN TB, 1962, J FLUID MECH, V14, P593, DOI 10.1017/S0022112062001482; Wang S, 1997, J FLUID MECH, V340, P177, DOI 10.1017/S0022112097005272; Lopez JM, 2006, J FLUID MECH, V553, P323, DOI 10.1017/S0022112006008962; Marques F, 2001, PHYS FLUIDS, V13, P1679, DOI 10.1063/1.1368849; JEONG J, 1995, J FLUID MECH, V285, P69, DOI 10.1017/S0022112095000462; Stewart BE, 2010, J FLUID MECH, V643, P137, DOI 10.1017/S0022112009992072; Goldshtik M, 1998, FLUID DYN RES, V23, P189, DOI 10.1016/S0169-5983(98)00016-1; LEIBOVICH S, 1984, AIAA J, V22, P1192, DOI 10.2514/3.8761; Gallaire F, 2004, PHYS FLUIDS, V16, P2907, DOI 10.1063/1.1758171; LOPEZ JM, 1990, J FLUID MECH, V221, P533, DOI 10.1017/S0022112090003664; Ruith MR, 2003, J FLUID MECH, V486, P331, DOI 10.1017/S0022112003004749; RANDALL JD, 1973, J FLUID MECH, V58, P495, DOI 10.1017/S0022112073002296; Gursul I, 2005, PROG AEROSP SCI, V41, P515, DOI 10.1016/j.paerosci.2005.09.002; Rusak Z, 1996, J FLUID MECH, V323, P79, DOI 10.1017/S0022112096000857; BROWN GL, 1990, J FLUID MECH, V221, P553, DOI 10.1017/S0022112090003676; Rusak Z, 1998, AIAA J, V36, P1848, DOI 10.2514/2.277; Liow KYS, 2009, MOD PHYS LETT B, V23, P121, DOI 10.1142/S0217984909017893; Billant P, 1998, J FLUID MECH, V376, P183, DOI 10.1017/S0022112098002870; Mitchell AM, 2001, PROG AEROSP SCI, V37, P385, DOI 10.1016/S0376-0421(01)00010-0; Brons M, 2007, J FLUID MECH, V578, P453, DOI 10.1017/S0022112007005101; FALER JH, 1978, J FLUID MECH, V86, P313, DOI 10.1017/S0022112078001159; HOURIGAN K, 1995, PHYS FLUIDS, V7, P3126, DOI 10.1063/1.868620; Thompson MC, 2006, APPL MATH MODEL, V30, P1356, DOI 10.1016/j.apm.2006.03.014; Thompson M, 1996, EXP THERM FLUID SCI, V12, P190, DOI 10.1016/0894-1777(95)00098-4; HARVEY JK, 1962, J FLUID MECH, V14, P585, DOI 10.1017/S0022112062001470; Brons M, 2009, J FLUID MECH, V622, P177, DOI 10.1017/S0022112008005107; Cui YD, 2009, PHYS FLUIDS, V21, DOI 10.1063/1.3093236; Darmofal D. L., 1994, 942318 AIAA; Delery JM, 1994, PROGR AEROSPACE SCI, V30, P1, DOI 10.1016/0376-0421(94)90002-7; Dusting J., 2004, P 15 AUSTR FLUID MEC; Dusting J, 2006, BIOTECHNOL BIOENG, V94, P1196, DOI 10.1002/bit.20960; ESCUDIER MP, 1984, EXP FLUIDS, V2, P189, DOI 10.1007/BF00571864; FALER JH, 1977, PHYS FLUIDS, V20, P1385, DOI 10.1063/1.862033; Gallaire FO, 2006, J FLUID MECH, V549, P71, DOI 10.1017/S0022112005007834; Griffith MD, 2009, J FLUID MECH, V622, P291, DOI 10.1017/S0022112008005338; Gutmark EJ, 2005, AIAA J, V43, P2065, DOI 10.2514/1.11326; Herrada MA, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2338065; Ismadi MZP, 2011, PHYS FLUIDS, V23, DOI 10.1063/1.3560386; KARNIADAKIS GEM, 1992, J FLUID MECH, V238, P1, DOI 10.1017/S0022112092001617; Lopez JM, 2012, PHYS FLUIDS, V24, DOI 10.1063/1.3673608; Meliga P, 2012, J FLUID MECH, V699, P216, DOI 10.1017/jfm.2012.93; Meunier P, 2013, J FLUID MECH, V731, DOI 10.1017/jfm.2013.226; Renac F, 2007, AIAA J, V45, P1942, DOI 10.2514/1.25827; Sorensen JN, 2011, J FLUID MECH, V683, P430, DOI 10.1017/jfm.2011.308; Tan BT, 2009, PHYS FLUIDS, V21, DOI 10.1063/1.3073747; Thompson MC, 2001, J FLUID STRUCT, V15, P575, DOI 10.1006/jfls.2000.0362; Thompson MC, 2003, J FLUID MECH, V496, P129, DOI 10.1017/S0022112003006438; Thouas G., 2007, J BIOMED BIOENG, P9; Vaidya H. A., 2011, J PHYS C SER, V318, P1; Yu P., 2005, FLUID DYN MAT PROCES, V1, P235; Yu P, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2387107; Yu P, 2005, MOD PHYS LETT B, V19, P1543, DOI 10.1142/S0217984905009869; Yu P, 2009, PHYS FLUIDS, V21, DOI 10.1063/1.3072090; Yu P, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2731420; Zienkiewicz OC, 1977, FINITE ELEMENT METHO	58	0	0	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	1070-6631	1089-7666		PHYS FLUIDS	Phys. Fluids	APR	2015	27	4							044102	10.1063/1.4916352		13	Mechanics; Physics, Fluids & Plasmas	Mechanics; Physics	CH2DM	WOS:000353835700017		
J	Ali, A; Li, JQ; Kishimoto, Y				Ali, A.; Li, Jiquan; Kishimoto, Y.			On the magnetic reconnection of resistive tearing mode with the dynamic flow effects	PHYSICS OF PLASMAS			English	Article							ANOMALOUS RESISTIVITY; SOLAR-FLARES; FIELD; SIMULATIONS; DIMENSIONS; EVOLUTION; VISCOSITY; SPECTRA; PLASMAS	Magnetic reconnection usually occurs in turbulent environments, which may not only provide anomalous resistivity to enhance reconnection rates but also significantly modify the reconnection process through direct nonlinear interaction with magnetic islands. This study presents numerical simulations investigating the effects of an imposed dynamic flow on magnetic reconnection, based on a two-dimensional reduced resistive MHD model. Results show that while the linear stability properties of the resistive tearing mode are moderately affected by the dynamic flow, nonlinear evolution is significantly modified by radial parity, amplitude, and frequency of the dynamic flow. After the slowly evolving nonlinear Rutherford stage, the reconnection process is found to progress in two phases by including the dynamic flow. A Sweet-Parker like current sheet is formed in the first phase. Afterwards, plasmoid instability is triggered in the second phase, where multiple plasmoids are continuously generated and ejected along the current sheet, leading to an impulsive bursty reconnection. The reconnection rate is considerably enhanced in the range of low resistivity as compared to without flow. We found that plasmoid instability onset and evolution are strongly influenced by the frequency and radial parity of the dynamic flows. The scaling of effective reconnection rates with the flow is found to be independent of resistivity. (C) 2015 AIP Publishing LLC.	[Ali, A.; Li, Jiquan; Kishimoto, Y.] Kyoto Univ, Grad Sch Energy Sci, Kyoto 6110011, Japan	Li, JQ (reprint author), Kyoto Univ, Grad Sch Energy Sci, Kyoto 6110011, Japan.	lijq@energy.kyoto-u.ac.jp			JSPS [26400531, 25287153]	This study was partially supported by Grants-in-Aid from JSPS (Nos. 26400531 and 25287153).	Samtaney R, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.105004; Ma ZW, 1996, GEOPHYS RES LETT, V23, P1673, DOI 10.1029/96GL01600; Cassak PA, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.235002; OFMAN L, 1993, PHYS FLUIDS B-PLASMA, V5, P376, DOI 10.1063/1.860523; Loureiro NF, 2009, MON NOT R ASTRON SOC, V399, pL146, DOI 10.1111/j.1745-3933.2009.00742.x; Loureiro NF, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3703318; Lazarian A, 1999, ASTROPHYS J, V517, P700, DOI 10.1086/307233; Kowal G, 2009, ASTROPHYS J, V700, P63, DOI 10.1088/0004-637X/700/1/63; SATO T, 1979, PHYS FLUIDS, V22, P1189, DOI 10.1063/1.862721; Loureiro NF, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.013102; Porcelli F, 2002, PLASMA PHYS CONTR F, V44, pB389, DOI 10.1088/0741-3335/44/12B/327; PARK W, 1984, PHYS FLUIDS, V27, P137, DOI 10.1063/1.864502; Elmegreen BG, 2004, ANNU REV ASTRON ASTR, V42, P211, DOI 10.1146/annurev.astro.41.011802.094859; Hahm TS, 1999, PHYS PLASMAS, V6, P922, DOI 10.1063/1.873331; Leamon RJ, 1998, J GEOPHYS RES-SPACE, V103, P4775, DOI 10.1029/97JA03394; Karimabadi H, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4828395; Li JQ, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/9/095007; Chepurnov A, 2010, ASTROPHYS J, V710, P853, DOI 10.1088/0004-637X/710/1/853; Huang YM, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3420208; MATTHAEUS WH, 1986, PHYS FLUIDS, V29, P2513, DOI 10.1063/1.866004; Uzdensky DA, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.235002; UGAI M, 1977, J PLASMA PHYS, V17, P337; Daughton W, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2218817; Su Y, 2013, NAT PHYS, V9, P489, DOI 10.1038/NPHYS2675; Daughton W, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2749494; Ji HT, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3647505; BISKAMP D, 1995, PHYS REV LETT, V75, P3850, DOI 10.1103/PhysRevLett.75.3850; Militello F, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2917915; Bhattacharjee A, 2001, PHYS PLASMAS, V8, P1829, DOI 10.1063/1.1353803; Ni L, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3428553; Drake JF, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025957; Bhattacharjee A, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3264103; FURTH HP, 1963, PHYS FLUIDS, V6, P459, DOI 10.1063/1.1706761; Loureiro NF, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2783986; Liang Y, 2007, NUCL FUSION, V47, pL21, DOI 10.1088/0029-5515/47/9/L02; La Haye RJ, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3333538; Ali A, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4881464; Barta M, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/1/24; Comisso L, 2014, J PHYS CONF SER, V561, DOI 10.1088/1742-6596/561/1/012004; Dere KP, 1996, ASTROPHYS J, V472, P864, DOI 10.1086/178116; Guo ZB, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/2/173; Hastie R. J., 1997, Astrophysics and Space Science, V256, DOI 10.1023/A:1001728227899; Li JQ, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3698111; Lin J, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2008JA013409; Loureiro NF, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.235003; Maeyama S, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3432121; Malyshkin LM, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.2084847; Ng CS, 2011, ASTR SOC P, V444, P124; PARKER EN, 1957, J GEOPHYS RES, V62, P509, DOI 10.1029/JZ062i004p00509; Petschek H. E., 1964, AAS NASA S PHYS SOL, P425; Retino A, 2007, NAT PHYS, V3, P235, DOI 10.1038/nphys574; RUTHERFO.PH, 1973, PHYS FLUIDS, V16, P1903, DOI 10.1063/1.1694232; Shibata K, 2011, LIVING REV SOL PHYS, V8; Sweet P. A., 1958, ELECTROMAGNETIC PHEN, P123; Uzdensky DA, 2003, ASTROPHYS J, V587, P450, DOI 10.1086/368075; Vogt C, 2005, ASTRON ASTROPHYS, V434, P67, DOI 10.1051/0004-6361:20041839; Yamada M, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3658034	57	0	0	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	1070-664X	1089-7674		PHYS PLASMAS	Phys. Plasmas	APR	2015	22	4							042102	10.1063/1.4916776		11	Physics, Fluids & Plasmas	Physics	CH2DZ	WOS:000353837200008		
J	Kawata, S; Karino, T				Kawata, S.; Karino, T.			Robust dynamic mitigation of instabilities	PHYSICS OF PLASMAS			English	Article							RAYLEIGH-TAYLOR INSTABILITY; ION-BEAMS; FUSION; TARGET; STABILIZATION; FILAMENTATION; IMPLOSION	A dynamic mitigation mechanism for instability growth was proposed and discussed in the paper [S. Kawata, Phys. Plasmas 19, 024503 (2012)]. In the present paper, the robustness of the dynamic instability mitigation mechanism is discussed further. The results presented here show that the mechanism of the dynamic instability mitigation is rather robust against changes in the phase, the amplitude, and the wavelength of the wobbling perturbation applied. Generally, instability would emerge from the perturbation of the physical quantity. Normally, the perturbation phase is unknown so that the instability growth rate is discussed. However, if the perturbation phase is known, the instability growth can be controlled by a superposition of perturbations imposed actively: If the perturbation is induced by, for example, a driving beam axis oscillation or wobbling, the perturbation phase could be controlled, and the instability growth is mitigated by the superposition of the growing perturbations. (C) 2015 AIP Publishing LLC.	[Kawata, S.; Karino, T.] Utsunomiya Univ, Grad Sch Engn, Utsunomiya, Tochigi 3218585, Japan	Kawata, S (reprint author), Utsunomiya Univ, Grad Sch Engn, Utsunomiya, Tochigi 3218585, Japan.				MEXT; JSPS; ILE/Osaka University; CORE/Utsunomiya University; Collaboration Center for Research and Development of Utsunomiya University; Japan/U.S. Fusion Research Collaboration Program	This work was partly supported by MEXT, JSPS, ILE/Osaka University, CORE/Utsunomiya University, Collaboration Center for Research and Development of Utsunomiya University, and Japan/U.S. Fusion Research Collaboration Program conducted by MEXT, Japan. The authors would like to express their appreciations to our collaborative friends, Professor Hong Qing, Professor Ronald C. Davidson, Professor I. Kaganovich, Dr. J. Barnard, Friends in U.S. HIF-VNL, Professor A. I. Ogoyski, and Professor Y. Y. Ma for their fruitful discussions on this work.	KAWATA S, 1993, LASER PART BEAMS, V11, P757; Piriz AR, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3633487; Piriz AR, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.026317; Kawata S, 2009, NUCL INSTRUM METH A, V606, P152, DOI 10.1016/j.nima.2009.03.188; Bret A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.046401; TROYON F, 1971, PHYS FLUIDS, V14, P2069, DOI 10.1063/1.1693294; EMERY MH, 1982, PHYS REV LETT, V48, P253, DOI 10.1103/PhysRevLett.48.253; WOLF GH, 1970, PHYS REV LETT, V24, P444, DOI 10.1103/PhysRevLett.24.444; KAWATA S, 1984, J PHYS SOC JPN, V53, P3416, DOI 10.1143/JPSJ.53.3416; NUCKOLLS J, 1972, NATURE, V239, P139, DOI 10.1038/239139a0; BETTI R, 1993, PHYS REV LETT, V71, P3131, DOI 10.1103/PhysRevLett.71.3131; ARNOLD RC, 1982, NUCL INSTRUM METHODS, V199, P557, DOI 10.1016/0167-5087(82)90157-0; Kawata S, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3680617; Atzeni S., 2004, PHYS INERTIAL FUSION; Bret A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.115002; HUBBARD RF, 1978, PHYS REV LETT, V41, P866, DOI 10.1103/PhysRevLett.41.866; Kawata S., 2013, PLASMA FUSION RES RE, V8; Manheimer W., 1977, Comments on Plasma Physics and Controlled Fusion, V3; OKADA T, 1980, J PLASMA PHYS, V24, P483; OKADA T, 1981, J PHYS SOC JPN, V50, P3845, DOI 10.1143/JPSJ.50.3845; Qin H, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4885076; Qin H, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.254801	22	0	0	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	1070-664X	1089-7674		PHYS PLASMAS	Phys. Plasmas	APR	2015	22	4							042106	10.1063/1.4917340		4	Physics, Fluids & Plasmas	Physics	CH2DZ	WOS:000353837200012		
J	Sato, N; Kasaoka, N; Yoshida, Z				Sato, N.; Kasaoka, N.; Yoshida, Z.			Thermal equilibrium of non-neutral plasma in dipole magnetic field	PHYSICS OF PLASMAS			English	Article							MOTION	Self-organization of a long-lived structure is one of the remarkable characteristics of macroscopic systems governed by long-range interactions. In a homogeneous magnetic field, a non-neutral plasma creates a "thermal equilibrium," which is a Boltzmann distribution on a rigidly rotating frame. Here, we study how a non-neutral plasma self-organizes in inhomogeneous magnetic field; as a typical system, we consider a dipole magnetic field. In this generalized setting, the plasma exhibits its fundamental mechanism that determines the relaxed state. The scale hierarchy of adiabatic invariants is the determinant; the Boltzmann distribution under the topological constraint by the robust adiabatic invariants (hence, the homogeneous distribution with respect to the fragile invariant) is the relevant relaxed state, which turns out to be a rigidly rotating clump of particles (just same as in a homogeneous magnetic field), while the density is no longer homogeneous. (C) 2015 AIP Publishing LLC.	[Sato, N.; Kasaoka, N.; Yoshida, Z.] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778561, Japan	Sato, N (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778561, Japan.				MEXT-Japan [23224014]	The authors acknowledge the stimulating discussions and suggestions of Professor A. Hasegawa, Professor S. M. Mahajan, and Professor R. D. Hazeltine. This work was supported by the Grant-in-Aid for Scientific Research (23224014) from MEXT-Japan.	Cary JR, 2009, REV MOD PHYS, V81, P693, DOI 10.1103/RevModPhys.81.693; Pedersen TS, 2003, J PHYS B-AT MOL OPT, V36, P1029, DOI 10.1088/0953-4075/36/5/322; Yoshida Z, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.235004; Hasegawa A, 2005, PHYS SCRIPTA, VT116, P72; Morrison PJ, 1998, REV MOD PHYS, V70, P467, DOI 10.1103/RevModPhys.70.467; Boxer AC, 2010, NAT PHYS, V6, P207, DOI 10.1038/NPHYS1510; MALMBERG JH, 1975, PHYS REV LETT, V35, P577, DOI 10.1103/PhysRevLett.35.577; Pakter R, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.200603; Yoshida Z, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/1/014018; Antoniazzi A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.040601; Dubin DHE, 1999, REV MOD PHYS, V71, P87, DOI 10.1103/RevModPhys.71.87; Lichtenberg A J, 1992, REGULAR CHAOTIC DYNA; LYNDENBE.D, 1968, MON NOT R ASTRON SOC, V138, P495; MALMBERG JH, 1980, PHYS REV LETT, V44, P654, DOI 10.1103/PhysRevLett.44.654; Pedersen TS, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.205002; Saitoh H, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3514207; Saitoh H, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.255005; Schulz M., 1974, PARTICLE DIFFUSION R; Yoshida Z, 2014, PROG THEOR EXP PHYS, DOI 10.1093/ptep/ptu104; Yoshida Z, 1999, AIP CONF PROC, V498, P397	20	0	0	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	1070-664X	1089-7674		PHYS PLASMAS	Phys. Plasmas	APR	2015	22	4							042508	10.1063/1.4917474		9	Physics, Fluids & Plasmas	Physics	CH2DZ	WOS:000353837200039		
J	Zenitani, S				Zenitani, Seiji			Loading relativistic Maxwell distributions in particle simulations	PHYSICS OF PLASMAS			English	Article							MAGNETIC-FIELD; GENERATION; PLASMAS; SHEET	Numerical algorithms to load relativistic Maxwell distributions in particle-in-cell (PIC) and Monte-Carlo simulations are presented. For stationary relativistic Maxwellian, the inverse transform method and the Sobol algorithm are reviewed. To boost particles to obtain relativistic shifted-Maxwellian, two rejection methods are proposed in a physically transparent manner. Their acceptance efficiencies are approximate to 50% for generic cases and 100% for symmetric distributions. They can be combined with arbitrary base algorithms. (C) 2015 Author(s).	Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan	Zenitani, S (reprint author), Natl Astron Observ Japan, 2-21-1 Osawa, Mitaka, Tokyo 1818588, Japan.	seiji.zenitani@nao.ac.jp	Zenitani, Seiji/D-7988-2013		 [25871054]	The author acknowledges M. Oka and A. Taktakishvili for their assistance to find out Sobol's original article and T. N. Kato for his insightful comments on the manuscript. This work was supported by Grant-in-Aid for Young Scientists (B) (Grant No. 25871054).	Alves EP, 2012, ASTROPHYS J LETT, V746, DOI 10.1088/2041-8205/746/2/L14; Melzani M, 2013, ASTRON ASTROPHYS, V558, DOI 10.1051/0004-6361/201321557; GALLANT YA, 1992, ASTROPHYS J, V391, P73, DOI 10.1086/171326; BOX GEP, 1958, ANN MATH STAT, V29, P610, DOI 10.1214/aoms/1177706645; Zenitani S, 2007, ASTROPHYS J, V670, P702, DOI 10.1086/522226; HARRIS EG, 1962, NUOVO CIMENTO, V23, P115, DOI 10.1007/BF02733547; HOH FC, 1966, PHYS FLUIDS, V9, P277, DOI 10.1063/1.1761670; Juttner F, 1911, ANN PHYS-BERLIN, V34, P856; Kennedy W.J., 1980, STAT COMPUTING; Landau L. D., 1971, CLASSICAL THEORY FIE; Pozdnyakov L. A., 1977, Soviet Astronomy, V21; Pozdnyakov L.A., 1983, ASTROPHYS SPACE PHYS, V2, P189; Sobol I. M., 1976, MONTE CARLO METHODS, P24; Swisdak M, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4812459; Synge J. L., 1957, RELATIVISTIC GAS	15	0	0	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	1070-664X	1089-7674		PHYS PLASMAS	Phys. Plasmas	APR	2015	22	4							042116	10.1063/1.4919383		6	Physics, Fluids & Plasmas	Physics	CH2DZ	WOS:000353837200022		
J	Koike, S; Yamaguchi, T; Ohmori, S; Hayashi, T; Yatou, O; Yoshida, H				Koike, Setsuo; Yamaguchi, Tomoya; Ohmori, Shinnosuke; Hayashi, Takami; Yatou, Osamu; Yoshida, Hitoshi			Cleistogamy Decreases the Effect of High Temperature Stress at Flowering in Rice	PLANT PRODUCTION SCIENCE			English	Article						Chasmogamous rice plants; Cleistogamous rice plants; Closed flowering rice; Fertility percentage; Germinated pollen grains; High temperature; spw1-cls	COOLING TREATMENT; GENE CONTAINMENT; STERILITY; PLANTS; STAGE; SUPERWOMAN1-CLEISTOGAMY; PANICLE; ANTHERS; IMPACT	Rice sterility due to a high temperature at flowering is a serious agricultural problem that has been associated with global warming. The flowering stage in rice plants is most vulnerable to high temperature stress. Closed flowering rice plants may better withstand high temperature stress. The aim of this study was to determine the role of cleistogamy (closed flowering) in avoiding high temperature-induced sterility. Cleistogamy was induced by moderate heat treatment at 30 degrees C during the panicle development stage. Both cleistogamous and chasmogamous (ordinary open flowering) rice plants, which possess the same genetic background, were subjected to 38 degrees C or 36 degrees C for 4 h just before flowering, and the percentage of fertility, number of pollen grains on a stigma, number of germinated pollen grains on a stigma, and temperatures inside and outside of the closed spikelets were examined. The cleistogamous rice plants showed a higher fertility percentage and a larger number of germinated pollen grains on a stigma than the chasmogamous rice plants. The temperature inside the closed flowering spikelets was 1.8 degrees C lower than that outside the spikelets. The cleistogamous rice plants thus showed avoidance to high temperature stress at 38 degrees C at flowering. On the basis of these results, we concluded that cleistogamy was advantageous to rice pollination and fertilization at high temperatures because of glume cooling.	[Koike, Setsuo; Hayashi, Takami] Tohoku Agr Res Ctr, Natl Agr & Food Res Org, Morioka, Iwate 0200198, Japan; [Yamaguchi, Tomoya; Ohmori, Shinnosuke; Yatou, Osamu] Hokuriku Res Ctr, Cent Agr Res Ctr, Natl Agr & Food Res Org, Joetsu 9430193, Japan; [Yoshida, Hitoshi] Natl Agr & Food Res Org, Inst Crop Sci, Tsukuba, Ibaraki 3058518, Japan	Koike, S (reprint author), Tohoku Agr Res Ctr, Natl Agr & Food Res Org, Morioka, Iwate 0200198, Japan.	mukoike@gmail.com; tomyamag@affrc.go.jp			Ministry of Education, Science, Sports and Culture, Japan [20580018]	This research was supported in part by a Grant-in- Aid for Scientific Research (No.20580018) from the Ministry of Education, Science, Sports and Culture, Japan.	Yoshimoto Mayumi, 2011, Journal of Agricultural Meteorology, V67, P233, DOI 10.2480/agrmet.67.4.8; Matsui T, 2001, PLANT PROD SCI, V4, P36; Dale PJ, 2002, NAT BIOTECHNOL, V20, P567, DOI 10.1038/nbt0602-567; SATAKE T, 1978, JPN J CROP SCI, V47, P6; Ishimaru T, 2010, ANN BOT-LONDON, V106, P515, DOI 10.1093/aob/mcq124; Matsui T, 2001, PLANT PROD SCI, V4, P90; Fukuoka M, 2012, PLANT PROD SCI, V15, P258, DOI 10.1626/pps.15.258; Hasegawa T., 2008, NIAES ANN REP, P23; Hoshikawa K, 1989, GROWING RICE PLANT A, P1; Ito N., 1980, RES B HOKKAIDO NATL, V125, P41; KOIKE S, 1987, JPN J CROP SCI, V56, P666; Matsui Tsutomu, 2000, Plant Production Science, V3, P430; Morita S., 2008, Japanese Journal of Crop Science, V77, P1, DOI 10.1626/jcs.77.1; NISHIYAMA I, 1981, JPN J CROP SCI, V50, P54; NISHIYAMA I, 1981, JPN J CROP SCI, V50, P59; Ohmori S, 2012, BREEDING SCI, V62, P124, DOI 10.1270/jsbbs.62.124; Ohmori S., 2009, BREED RES S1, V11, P86; SATAKE T, 1983, JPN J CROP SCI, V52, P207; SATAKE T, 1992, JPN J CROP SCI, V61, P454; Yoshida H, 2007, PLANT BIOTECHNOL J, V5, P835, DOI 10.1111/j.1467-7652.2007.00291.x	20	0	0	CROP SCIENCE SOC JAPAN	TOKYO	UNIV TOKYO-FACULTY AGRICULTURE BUNKYO-KU, TOKYO, 113, JAPAN	1343-943X	1349-1008		PLANT PROD SCI	Plant. Prod. Sci.	APR	2015	18	2					111	117				7	Agronomy	Agriculture	CH1XE	WOS:000353815400001		
J	Fukuda, A; Terao, T				Fukuda, Akari; Terao, Tomio			QTLs for Shoot Length and Chlorophyll Content of Rice Seedlings Grown under Low-Temperature Conditions, using a Cross between Indica and Japonica Cultivars	PLANT PRODUCTION SCIENCE			English	Article						Chlorophyll content; Chlorosis; Culm length; Low temperature; Quantitative trait locus (QTL); Rice (Oryza sativa L.); Shoot length	ORYZA-SATIVA L.; QUANTITATIVE TRAIT LOCI; SEGMENT SUBSTITUTION LINES; RECOMBINANT INBRED LINES; DIRECT-SEEDED RICE; COLD TOLERANCE; PLANT HEIGHT; INTERNODE ELONGATION; BIOMASS PRODUCTION; GREEN-REVOLUTION	Quantitative trait loci (QTLs) affecting the shoot length and chlorophyll content of seedlings grown at a low temperature (16 degrees C) for 4 weeks were analyzed using inbred lines derived from a cross between an indica rice cultivar, Habataki, and a japonica rice cultivar, Arroz da Terra. Culm length of the inbred lines, measured at the harvesting stage, was also analyzed. The QTLs linked to increased shoot length (qSL1) and culm length (qCL1) on the Arroz da Terra allele were detected in the same region of chromosome 1, where the gibberellin 20 oxidase-2 gene (identical to Semi Dwarf1: SD1) located. Other QTLs (qSL3 and qSL8) that were linked to increased shoot length on Arroz da Terra and Habataki alleles, but had no effects on the culm length, were detected on chromosomes 3 and 8, respectively. The alleles of qSL3 and qSL8 might improve early shoot growth without increasing the risk of lodging caused by a long culm length. A novel QTL (qCC1) linked to increased chlorophyll content of seedlings grown at low temperatures through the effect of an Arroz da Terra allele was detected on chromosome 1, but it differed in position from the QTLs for shoot length.	[Fukuda, Akari; Terao, Tomio] NARO, Hokuriku Res Ctr, NARO Agr Res Ctr, Joetsu 9430193, Japan	Fukuda, A (reprint author), NARO, Hokuriku Res Ctr, NARO Agr Res Ctr, 1-2-1 Inada, Joetsu 9430193, Japan.	akfukuda@affrc.go.jp			Takano Life Science Research Foundation	This work was supported in part by Takano Life Science Research Foundation.	Abe A, 2012, THEOR APPL GENET, V125, P647, DOI 10.1007/s00122-012-1857-z; Andaya VC, 2007, MOL BREEDING, V20, P349, DOI 10.1007/s11032-007-9096-8; Fujino K, 2008, P NATL ACAD SCI USA, V105, P12623, DOI 10.1073/pnas.0805303105; Zhang ZH, 2005, FIELD CROP RES, V91, P161, DOI 10.1016/j.fcr.2004.06.004; Ohsumi A, 2012, PLANT PROD SCI, V15, P32, DOI 10.1626/pps.15.32; Andaya VC, 2003, J EXP BOT, V54, P2579, DOI 10.1093/jxb/erg243; THOMSON D, 1995, BIOTECHNIQUES, V19, P394; Arite T, 2007, PLANT J, V51, P1019, DOI 10.1111/j.1365-313X.2007.03210.x; Sakamoto T, 2006, NAT BIOTECHNOL, V24, P105, DOI 10.1038/nbt1173; Zhang SH, 2014, EUPHYTICA, V195, P95, DOI 10.1007/s10681-013-0977-0; Yano K, 2012, PLANT CELL PHYSIOL, V53, P729, DOI 10.1093/pcp/pcs027; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Miura K, 2001, BREEDING SCI, V51, P293, DOI 10.1270/jsbbs.51.293; Yamamuro C, 2000, PLANT CELL, V12, P1591, DOI 10.1105/tpc.12.9.1591; Zhang ZH, 2005, ANN BOT-LONDON, V95, P423, DOI 10.1093/aob/mci039; Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Ogiwara H, 2001, PLANT PROD SCI, V4, P166; McCouch SR, 2002, DNA RES, V9, P199, DOI 10.1093/dnares/9.6.199; Kusumi K, 2011, PLANT J, V68, P1039, DOI 10.1111/j.1365-313X.2011.04755.x; Kumar M, 2010, FUNCT INTEGR GENOMIC, V10, P349, DOI 10.1007/s10142-009-0155-6; Fukuda A, 2012, PLANT PROD SCI, V15, P183, DOI 10.1626/pps.15.183; Mackill DJ, 1997, CROP SCI, V37, P1340; Wang ZF, 2011, EUPHYTICA, V181, P405, DOI 10.1007/s10681-011-0469-z; Ando T, 2008, THEOR APPL GENET, V116, P881, DOI 10.1007/s00122-008-0722-6; Asano K, 2010, P JPN ACAD B-PHYS, V86, P265, DOI 10.2183/pjab.86.265; Baruah AR, 2009, EUPHYTICA, V165, P459, DOI 10.1007/s10681-008-9753-y; Bertin P, 1996, EUPHYTICA, V89, P201, DOI 10.1007/BF00034606; WINTERMA.JF, 1965, BIOCHIM BIOPHYS ACTA, V109, P448, DOI 10.1016/0926-6585(65)90170-6; Fukuda A, 2012, PLANT PROD SCI, V15, P270, DOI 10.1626/pps.15.270; Fukuda A, 2014, PLANT PROD SCI, V17, P41, DOI 10.1626/pps.17.41; Furuhata Masami, 2010, Japanese Journal of Crop Science, V79, DOI 10.1626/jcs.79.363; Ishimaru K, 2004, PLANTA, V218, P388, DOI 10.1007/s00425-003-1119-z; Iwata N, 2010, BREEDING SCI, V60, P353, DOI 10.1270/jsbbs.60.353; Kovi M, 2011, THEOR APPL GENET, V123, P705, DOI 10.1007/s00122-011-1620-x; Lan T, 2010, CHINESE SCI BULL, V55, P3149, DOI 10.1007/s11434-010-4041-3; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Li RQ, 2014, THEOR APPL GENET, V127, P241, DOI 10.1007/s00122-013-2213-7; Liu W, 2013, J EXP BOT, V64, P4389, DOI 10.1093/jxb/ert256; Nagata K, 2002, BREEDING SCI, V52, P259, DOI 10.1270/jsbbs.52.259; Peterson M.L., 1978, RISO, V27, P269; Ranawake AL, 2008, BIOTECHNOL BIOTEC EQ, V22, P536; Redona ED, 1996, THEOR APPL GENET, V92, P395, DOI 10.1007/BF00223685; Takahashi N., 1978, REP TOHOKU BR CROP S, V20, P44; Terao T, 2010, THEOR APPL GENET, V120, P875, DOI 10.1007/s00122-009-1218-8; Wang S, 2010, WINDOWS QTL CARTOGRA; Yamaiuchi Minoru, 2012, Japanese Journal of Crop Science, V81, DOI 10.1626/jcs.81.148; Yang MF, 2013, BIOTECHNOL LETT, V35, P121, DOI 10.1007/s10529-012-1054-9; Zhang FT, 2011, GENES GENOM, V33, P25, DOI 10.1007/s13258-010-0056-z; Zhao Z, 1999, JPN J CROP SCI, V68, P379; Zhou L, 2007, FIELD CROP RES, V100, P294, DOI 10.1016/j.fcr.2006.08.003	50	0	0	CROP SCIENCE SOC JAPAN	TOKYO	UNIV TOKYO-FACULTY AGRICULTURE BUNKYO-KU, TOKYO, 113, JAPAN	1343-943X	1349-1008		PLANT PROD SCI	Plant. Prod. Sci.	APR	2015	18	2					128	136				9	Agronomy	Agriculture	CH1XE	WOS:000353815400003		
J	Ishikawa, N; Ishioka, G; Yanaka, M; Takata, K; Murakami, M				Ishikawa, Naoyuki; Ishioka, Gen; Yanaka, Mikiko; Takata, Kanenori; Murakami, Masaharu			Effects of Ammonium Chloride Fertilizer and its Application Stage on Cadmium Concentrations in Wheat (Triticum aestivum L.) Grain	PLANT PRODUCTION SCIENCE			English	Article						Ammonium chloride; Cadmium; Leaching; Wheat	SOLANUM-TUBEROSUM L; DURUM-WHEAT; SOIL SOLUTION; SWISS-CHARD; POTATO-TUBERS; ACCUMULATION; FIELD; AVAILABILITY; CULTIVARS; SALINITY	Chloride (Cl) in saline soil increases the cadmium (Cd) concentration in crops. Here, we conducted a field experiment to investigate changes in Cd concentrations in wheat grain after the application of the Cl-containing fertilizer ammonium chloride (NH4Cl), with the aim of reducing its potential health risk. Effects of the application stage of NH4Cl fertilizer and leaching treatment (i.e., heavy rainfall) were also investigated in field and pot experiments. Both field and pot experiments showed that the Cd concentration of wheat grain was higher with NH4Cl fertilizer than with ammonium sulfate or urea fertilizers. Grain Cd concentration in wheat fertilized with NH4Cl at the tillering-jointing and flowering stages in the field experiment was 0.223 mg kg(-1), which was about 1.5 times higher than that fertilized with urea. This finding is important because, in Japan, compound fertilizers containing NH4Cl are commonly used in fields for wheat cultivation. NH4Cl fertilizer application at the tillering-jointing and flowering stages had nearly equal effects on the Cd concentration in wheat grain. Basal dressing with NH4Cl fertilizer increased Cd concentrations in wheat grain to a greater extent than topdressing (at the tillering-jointing and flowering stage applications) in a pot experiment that was protected from rain. Leaching treatment (assuming two lots of 100 mm rainfall) negated the effect of NH4Cl fertilizer application on Cd concentration in wheat grain. We recommend the use of ammonium sulfate or urea preferentially as the nitrogen fertilizer because heavy rainfall rarely occurs during this period in Japan.	[Ishikawa, Naoyuki; Ishioka, Gen; Yanaka, Mikiko; Takata, Kanenori] NARO Western Reg Agr Res Ctr, Fukuyama, Hiroshima 7218514, Japan; [Murakami, Masaharu] Natl Inst Agroenvironm Sci, Tsukuba, Ibaraki 3058604, Japan	Ishikawa, N (reprint author), NARO Western Reg Agr Res Ctr, 6-12-1 Nishifukatsu, Fukuyama, Hiroshima 7218514, Japan.	ishik@affrc.go.jp			Ministry of Agriculture, Forestry, and Fisheries of Japan	This research was supported in part by a fund "Research project for ensuring food safety from farm to table" from the Ministry of Agriculture, Forestry, and Fisheries of Japan.	ADDISCOTT TM, 1978, J SOIL SCI, V29, P305; MCLAUGHLIN MJ, 1994, J ENVIRON QUAL, V23, P1013; Weggler K, 2004, J ENVIRON QUAL, V33, P496; Mitchell LG, 2000, CAN J SOIL SCI, V80, P107; Ghallab A, 2007, WATER AIR SOIL POLL, V185, P43, DOI 10.1007/s11270-007-9424-y; Ibaraki T, 2005, SOIL SCI PLANT NUTR, V51, P893, DOI 10.1111/j.1747-0765.2005.tb00124.x; MCLAUGHLIN MJ, 1995, FERT RES, V40, P63, DOI 10.1007/BF00749863; Ozkutlu F, 2007, PLANT SOIL, V290, P323, DOI 10.1007/s11104-006-9164-6; Greger M, 2004, CROP SCI, V44, P501; Li XL, 2011, CAN J SOIL SCI, V91, P521, DOI [10.4141/CJSS10061, 10.4141/cjss10061]; Wangstrand H, 2007, EUR J AGRON, V26, P209, DOI 10.1016/j.eja.2006.09.010; Smolders E, 1996, SOIL SCI SOC AM J, V60, P1443; Smolders E, 1998, J ENVIRON QUAL, V27, P426; SPARROW LA, 1994, AUST J AGR RES, V45, P243, DOI 10.1071/AR9940243; Gao XP, 2010, PLANT SOIL, V337, P341, DOI 10.1007/s11104-010-0531-y; Adams ML, 2004, J ENVIRON QUAL, V33, P532; Chan DY, 2004, J EXP BOT, V55, P2571, DOI 10.1093/jxb/erh255; Hattori H, 2006, SOIL SCI PLANT NUTR, V52, P89, DOI 10.1111/j.1747-0765.2006.00007.x; Norvell WA, 2000, SOIL SCI SOC AM J, V64, P2162; Codex Alimentarius Commission, 2005, 37 SESS COD COMM FOO, P184; Codex Alimentarius Commission, 2005, 28 SESS ROM 4 9 JUL, P115; Diaz-Zorita M, 2004, AGRON J, V96, P839; Engel RE, 1998, SOIL SCI SOC AM J, V62, P401; FIXEN PE, 1986, AGRON J, V78, P736; Gao XP, 2011, FIELD CROP RES, V122, P95, DOI 10.1016/j.fcr.2011.03.005; Harris Neil S., 2004, BMC Plant Biology, V4, P4, DOI 10.1186/1471-2229-4-4; [甲卡拉铁 Jiaka Latie], 2010, [中国生态农业学报, Chinese Journal of Eco-Agriculture], V18, P281; Kubo K, 2008, PLANT PROD SCI, V11, P243, DOI 10.1626/pps.11.243; LI YM, 1994, PLANT SOIL, V167, P275, DOI 10.1007/BF00007954; Lopez-Chuken UJ, 2012, INT J ENVIRON SCI TE, V9, P69, DOI 10.1007/s13762-011-0018-2; Matsuyama M., 2003, KINKI CHUGOKU SHIKOK, V3, P17; McLaughlin MJ, 1997, AUST J SOIL RES, V35, P183, DOI 10.1071/S96032; Ministry of Agriculture Forestry and Fisheries of Japan, 2004, SURV CADM CONC DOM A; Ohtani T, 2007, J PLANT NUTR, V30, P599, DOI 10.1080/01904160701209352; Oliver DP, 1998, AUST J SOIL RES, V36, P571, DOI 10.1071/S97106; Oyanagi A., 2011, CULTIVATION UTILIZAT, P55; Perilli P, 2010, J SCI FOOD AGR, V90, P813, DOI 10.1002/jsfa.3889; Saso JK, 2012, CAN J SOIL SCI, V92, P285, DOI 10.4141/CJSS2011-046; SINGH BR, 1995, COMMUN SOIL SCI PLAN, V26, P2123, DOI 10.1080/00103629509369434; Weggler-Beaton K, 2000, AUST J SOIL RES, V38, P37, DOI 10.1071/SR99028; WHO and FAO, 2006, WHO FOOD ADDITIVES S, V55, P191; Wu J, 2002, SOIL SCI SOC AM J, V66, P268; Zhao Jing, 2010, Chinese Journal of Applied and Environmental Biology, V16, P58, DOI 10.3724/SP.J.1145.2010.00058; Zhao Z.Q., 2003, ENVIRON INT, V29, P973	44	0	0	CROP SCIENCE SOC JAPAN	TOKYO	UNIV TOKYO-FACULTY AGRICULTURE BUNKYO-KU, TOKYO, 113, JAPAN	1343-943X	1349-1008		PLANT PROD SCI	Plant. Prod. Sci.	APR	2015	18	2					137	145				9	Agronomy	Agriculture	CH1XE	WOS:000353815400004		
J	Nakajima, T; Seino, A; Nakamura, T; Goto, Y; Kokubun, M				Nakajima, Takayuki; Seino, Akiko; Nakamura, Teiji; Goto, Yusuke; Kokubun, Makie			Does Pre-Germination Flooding-Tolerant Soybean Cultivar Germinate Better under Hypoxia Conditions?	PLANT PRODUCTION SCIENCE			English	Article						Flooding tolerance; Germination; Hypoxia; Oxygen; Seed coat; Soybean cultivars; Temperature	WATER-UPTAKE; VARIETAL DIFFERENCES; SEED-GERMINATION; PERMEABILITY; INJURY; FIELD	The germination and emergence of soybean [Glycine max (L.) Merr.] can be adversely affected by the presence of excessive water as a result of continuous rainfall. The pre-germination flooding-tolerant cultivars can be tolerant to hypoxia in the flooding field. The objective of this study was to clarify the relationship between germination under hypoxia at different temperatures and pre-germination flooding tolerance. Seeds of 6 soybean cultivars were subjected to 5 oxygen concentrations and 3 temperatures. Seeds of all 6 cultivars hardly germinated under an oxygen concentration of 20 mL L-1, but germinated with increasing oxygen concentration regardless of temperature. The pre-germination flooding-tolerant cultivar 'Peking' exhibited poorer germination under hypoxia than the other cultivars. Seed coat of 'Peking' did not dehisce when seeds did not germinate under hypoxia regardless of temperature. The pre-germination flooding-susceptible cultivar 'Nakasennari' exhibited higher seed coat dehiscence, but the dehiscence mostly occurred on the seed surface rather than micropyle under hypoxia at 25 degrees C and 30 degrees C. Seven days after termination of 3-d hypoxia treatment at 30 degrees C, the percentage of seedlings with root hairs and/or lateral roots relative to that after ambient oxygen treatment was maintained in 'Peking' but decreased in the other cultivars, especially in 'Nakasennari'. Pre-germination flooding-tolerant cultivar, especially 'Peking', is characterized by a delay in germination processes under hypoxia, and exhibits vigorous germination after release from hypoxia.	[Nakajima, Takayuki; Seino, Akiko; Nakamura, Teiji; Goto, Yusuke; Kokubun, Makie] Tohoku Univ, Grad Sch Agr Sci, Aoba Ku, Sendai, Miyagi 9818555, Japan	Nakajima, T (reprint author), Tohoku Univ, Grad Sch Agr Sci, Aoba Ku, Sendai, Miyagi 9818555, Japan.	nakajima@bios.tohoku.ac.jp					Kokubun M, 2013, FIELD CROP RES, V152, P3, DOI 10.1016/j.fcr.2012.09.022; ALANI A, 1985, PLANT PHYSIOL, V79, P885, DOI 10.1104/pp.79.3.885; Wuebker EF, 2001, CROP SCI, V41, P1857; Cosgrove DJ, 1997, PLANT CELL, V9, P1031, DOI 10.1105/tpc.9.7.1031; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; Ma FS, 2004, ANN BOT-LONDON, V94, P213, DOI 10.1093/aob/mch133; Araki H, 2006, FIELD CROP RES, V96, P98, DOI 10.1016/j.fcr.2005.05.007; Bewley J.D., 1983, PHYSL BIOCH SEEDS RE, Vfirst, P1; Brown R, 1940, ANN BOT-LONDON, V4, P379; Copeland L.O., 1995, PRINCIPLES SEED SCI, V3rd, P59; HOU FF, 1992, JPN J CROP SCI, V61, P447; HOU FF, 1991, EUPHYTICA, V57, P169, DOI 10.1007/BF00023075; Inouye C, 1953, P CROP SCI SOC JPN, V21, P276; ISTA, 1985, SEED SCI TECHNOL, V13, P299; Kato M, 2013, PLANT PROD SCI, V16, P95, DOI 10.1626/pps.16.95; Matsui M, 1996, NIPPON NOGEIK KAISHI, V70, P663; Muramatsu N, 2008, PLANT PROD SCI, V11, P434, DOI 10.1626/pps.11.434; MUTHIAH S, 1994, CROP SCI, V34, P289; Nakajima T., 2012, ASA CSSA SSSA 2012 I; Nakajima T., 2010, TOHOKU J CROP SCI, V53, P45; Nakayama N., 2004, Japanese Journal of Crop Science, V73, P323, DOI 10.1626/jcs.73.323; Nakayama N., 2005, Japanese Journal of Crop Science, V74, P325, DOI 10.1626/jcs.74.325; National Institute for Agro-Environmental Sciences, 2014, WEATH DAT ACQ SYST N; Shiraishi K., 1977, Bulletin of the Kyushu Agricultural Experiment Station, V19, P113; SPRAGG SP, 1959, J EXP BOT, V10, P409, DOI 10.1093/jxb/10.3.409; Thseng FS, 1996, JPN J CROP SCI, V65, P525; Tian X., 1998, NISSAKU KANTO SHIHOU, V13, P48; Tian XH, 2005, PLANT PROD SCI, V8, P157, DOI 10.1626/pps.8.157; WOODSTOCK LW, 1981, PHYSIOL PLANTARUM, V51, P133, DOI 10.1111/j.1399-3054.1981.tb00891.x; WOODSTOCK LW, 1981, PHYSIOL PLANTARUM, V53, P263, DOI 10.1111/j.1399-3054.1981.tb04497.x; Yagasaki K., 1994, JPN J HOKURIKU BR CR, V29, P80; YAMAMOTO RYOZO, 1959, PROC CROP SCI SOC JAPAN, V28, P77; YENTUR S, 1976, PLANT PHYSIOL, V57, P274, DOI 10.1104/pp.57.2.274	33	0	0	CROP SCIENCE SOC JAPAN	TOKYO	UNIV TOKYO-FACULTY AGRICULTURE BUNKYO-KU, TOKYO, 113, JAPAN	1343-943X	1349-1008		PLANT PROD SCI	Plant. Prod. Sci.	APR	2015	18	2					146	153				8	Agronomy	Agriculture	CH1XE	WOS:000353815400005		
J	Hara, Y				Hara, Yoshitaka			Improvement of Soybean Seedling Establishment under a Flooded Condition by Seed Coating with Molybdenum Compounds	PLANT PRODUCTION SCIENCE			English	Article						Flooding damage; Molybdenum compound; Seed coating; Seedling emergence; Seedling establishment; Soybean; Submergence	APPLIED SUBMERGED SOIL; SULFATE; MOLYBDATE	In Japan, soybeans are generally cultivated in paddy fields which often have poor drainage. West of the Kanto region, the seeds are sown in the rainy season. Therefore, the seedling establishment is prone to damage by the rain after sowing. The generation of sulfide ions in flooded and reduced soil is thought to be one factor causing this flooding damage. Since molybdate ions suppress the generation of sulfide ions, the effect of coating soybean seeds with molybdenum compounds, on the seedling establishment under a flooded condition was examined. Soybean seeds were coated with several kinds of poorly-soluble molybdenum compounds at different concentrations. The coated seeds were sown in soil and then flooded for 3 d at 25 - 30 degrees C. Seedlings were not established from seeds not coated with molybdenum compounds. Seedling establishment was appreciably improved by coating the seeds with a molybdenum compound at the rate of 0.5 - 1 mol-Mo kg(-1) seed. Seedling establishment was especially improved by coating with molybdenum trioxide. Accordingly, coating the soybean seed with molybdenum compounds could mitigate the flooding damage occurring after sowing.	Natl Agr & Food Res Org, Kyushu Okinawa Agr Res Ctr, Chikugo & Kurume Res Stn, Chikugo 8330041, Japan	Hara, Y (reprint author), Natl Agr & Food Res Org, Kyushu Okinawa Agr Res Ctr, Chikugo & Kurume Res Stn, 496 Izumi, Chikugo 8330041, Japan.	yshara@affrc.go.jp					Biswas K, 2009, BIOMETALS, V22, P131, DOI 10.1007/s10534-008-9198-8; Hara Y, 2013, PLANT PROD SCI, V16, P50; Hara Y, 2013, PLANT PROD SCI, V16, P271, DOI 10.1626/pps.16.271; Hara Y, 2013, PLANT PROD SCI, V16, P61; Hara Yoshitaka, 1999, Plant Production Science, V2, P129; Hori K., 1990, Japanese Journal of Soil Science and Plant Nutrition, V61, P647; Kato M, 2013, PLANT PROD SCI, V16, P95, DOI 10.1626/pps.16.95; Kokuryu Takuo, 2010, Japanese Journal of Crop Science, V79, DOI 10.1626/jcs.79.476; Nakayama N., 2005, Japanese Journal of Crop Science, V74, P325, DOI 10.1626/jcs.74.325; Zheng SH, 2000, JPN J CROP SCI, V69, P520	10	0	0	CROP SCIENCE SOC JAPAN	TOKYO	UNIV TOKYO-FACULTY AGRICULTURE BUNKYO-KU, TOKYO, 113, JAPAN	1343-943X	1349-1008		PLANT PROD SCI	Plant. Prod. Sci.	APR	2015	18	2					161	165				5	Agronomy	Agriculture	CH1XE	WOS:000353815400007		
J	Fujii, K; Kato, S; Sayama, T; Tanaka, Y; Nakazaki, T; Ishimoto, M; Shiraiwa, T				Fujii, Kenichiro; Kato, Shin; Sayama, Takashi; Tanaka, Yu; Nakazaki, Tetsuya; Ishimoto, Masao; Shiraiwa, Tatsuhiko			Stability Verification of the Effects of Stem Determination and Earliness of Flowering on Green Stem Disorder of Soybean against Genetic Background and Environment	PLANT PRODUCTION SCIENCE			English	Article						Flowering time; Green stem disorder; Quantitative trait locus; Recombinant inbred lines; Senescence; Soybean; Stem growth habit	DELAYED LEAF SENESCENCE; MAP-BASED CLONING; LINKAGE MAP; GROWTH HABIT; POD REMOVAL; MATURITY; LOCI; MATURATION; MARKERS; TRAITS	Green stem disorder (GSD) of soybean reduces harvesting efficiency and negatively impacts seed appearance when mechanical harvesting is employed. Two recombinant inbred populations were investigated for the effects of segregating stem determination and flowering time on GSD at two different locations, Kyoto and Akita, over two years. Although the severity of GSD of each line varied considerably with the location, the scores showed significant correlation with the environment. Quantitative trait locus (QTL) analysis revealed a strong and consistent QTL for GSD severity in one population of recombinant inbred lines (RILs) across the environments at the Dt1 locus, which governs stem growth habits, and the determinate growth genotypes showed evident symptoms of GSD. However, QTLs were not detected near the Dt1 locus in the other population. Thus, it was unclear if the responsible gene was identical to the stem determination gene. The early flowering genotype showed a more severe symptom of GSD in both populations, but this effect was dependent on the allele at the Dt1 locus. The effect of another QTL detected in the latter population also depended on the allele at the Dt1 locus. Our results indicated that the genetic factor at the Dt1 locus and the factor controlling flowering time influenced the severity of GSD at each location and year and that their effects and interaction complicated the genetic control of the occurrence of GSD.	[Fujii, Kenichiro; Tanaka, Yu; Nakazaki, Tetsuya; Shiraiwa, Tatsuhiko] Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kyoto 6068502, Japan; [Kato, Shin] Natl Agr Res Ctr Tohoku Reg, Daisen 0192112, Japan; [Sayama, Takashi; Ishimoto, Masao] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan	Fujii, K (reprint author), Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kitashirakawa Oiwakecho, Kyoto 6068502, Japan.	kenfujii@affrc.go.jp			Ministry of Agriculture, Forestry, and Fisheries of Japan (Genomics-based Technology for Agricultural Improvement) [SFC1002]	This study was supported by a grant from the Ministry of Agriculture, Forestry, and Fisheries of Japan (Genomics-based Technology for Agricultural Improvement, SFC1002).	Abdel-Haleem H, 2012, THEOR APPL GENET, V125, P837, DOI 10.1007/s00122-012-1876-9; Song QJ, 2004, THEOR APPL GENET, V109, P122, DOI 10.1007/s00122-004-1602-3; Mansur LM, 1996, CROP SCI, V36, P1327; Specht JE, 2001, CROP SCI, V41, P493; Cober ER, 1996, CROP SCI, V36, P606; Hisano H, 2007, DNA RES, V14, P271, DOI 10.1093/dnares/dsm025; Dorrance AE, 2003, PLANT DIS, V87, P308, DOI 10.1094/PDIS.2003.87.3.308; Reinprecht Y, 2006, GENOME, V49, P1510, DOI 10.1039/G06-112; Cregan PB, 1999, CROP SCI, V39, P1464; FEHR WR, 1971, CROP SCI, V11, P929; Sayama T, 2011, DNA RES, V18, P107, DOI 10.1093/dnares/dsr003; SINCLAIR TR, 1975, SCIENCE, V189, P565, DOI 10.1126/science.189.4202.565; Watanabe S, 2011, GENETICS, V188, P395, DOI 10.1534/genetics.110.125062; Abe J, 2003, CROP SCI, V43, P1300; Tasma IM, 2001, MOL BREEDING, V8, P25, DOI 10.1023/A:1011998116037; Cober ER, 2001, CROP SCI, V41, P698; CRAFTSBRANDNER SJ, 1984, PLANT PHYSIOL, V75, P311, DOI 10.1104/pp.75.2.311; BUZZELL RI, 1971, CAN J GENET CYTOL, V13, P703; Kabelka EA, 2004, CROP SCI, V44, P784; BERNARD RL, 1971, CROP SCI, V11, P242; Watanabe S, 2009, GENETICS, V182, P1251, DOI 10.1534/genetics.108.098772; Xia ZJ, 2012, P NATL ACAD SCI USA, V109, pE2155, DOI 10.1073/pnas.1117982109; BERNARD RL, 1972, CROP SCI, V12, P235; Chen QingShan, 2007, Agricultural Sciences in China, V6, P399, DOI 10.1016/S1671-2927(07)60062-5; Curtis DF, 2000, CROP SCI, V40, P1624; FOLEY TC, 1986, CROP SCI, V26, P5; FURUYA T, 1988, JPN J CROP SCI, V57, P1; FURUYA T, 1993, JPN J CROP SCI, V62, P126; Hill CB, 2006, CROP SCI, V46, P879, DOI 10.2135/cropsci2005.0207; Hobbs HA, 2006, PLANT DIS, V90, P513, DOI 10.1094/PD-90-0513; Isobe Katsunori, 2011, Japanese Journal of Crop Science, V80, DOI 10.1626/jcs.80.408; Kilgore-Norquest L, 2000, CROP SCI, V40, P83; Konaka N., 1965, JPN J CROP SCI, V34, P492; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; LEOPOLD AC, 1959, PLANT PHYSIOL, V34, P570, DOI 10.1104/pp.34.5.570; Lincoln SE, 1993, CONSTRUCTING GENETIC; Liu BH, 2010, PLANT PHYSIOL, V153, P198, DOI 10.1104/pp.109.150607; Malvick D., 2001, GREEN STEM SOYBEAN; MATSUMOTO S, 1986, JPN J CROP SCI, V55, P333; Mochizuki A., 2005, Japanese Journal of Crop Science, V74, P339, DOI 10.1626/jcs.74.339; Molnar SJ, 2003, GENOME, V46, P1024, DOI 10.1139/G03-079; Nooden L D., 1980, Senescence in plants., P219; Ogiwara H., 2002, ANNOTATED BIBLIO AGR, V27, P291; Ookawa T., 1999, Plant Production Science, V2, P51; PHILLIPS DA, 1984, CROP SCI, V24, P518; PIERCE RO, 1984, CROP SCI, V24, P515; Tanaka Y, 2009, ANN BOT-LONDON, V104, P1293, DOI 10.1093/aob/mcp240; Wang S, 2007, WINDOWS QTL CARTOGRA; WITTENBACH VA, 1982, PLANT PHYSIOL, V70, P1544, DOI 10.1104/pp.70.5.1544; Xia Z, 2007, DNA RES, V14, P257, DOI 10.1093/dnares/dsm027; Yamanaka N, 2000, BREEDING SCI, V50, P109	51	0	0	CROP SCIENCE SOC JAPAN	TOKYO	UNIV TOKYO-FACULTY AGRICULTURE BUNKYO-KU, TOKYO, 113, JAPAN	1343-943X	1349-1008		PLANT PROD SCI	Plant. Prod. Sci.	APR	2015	18	2					166	179				14	Agronomy	Agriculture	CH1XE	WOS:000353815400008		
J	Nishida, M; Sato, Y				Nishida, Mizuhiko; Sato, Yuta			Characteristics of the Relationship between Natural N-15 Abundances in Organic Rice and Soil	PLANT PRODUCTION SCIENCE			English	Article						Natural N-15 abundance; Organic farming; Organic fertilizer; Paddy soil; Rice; Synthetic fertilizer	FERTILIZER NITROGEN; CROPS; INDICATOR; JAPAN; PESTICIDES; DELTA-N-15; SIGNATURES; MARKERS; SYSTEM; REGIME	The characteristics of the relationship of natural N-15 abundances (delta N-15 values) between rice and soil in organic farming and conventional farming were examined, and the possibility of discriminating organically grown rice from conventionally (non-organically) grown rice using this relationship was explored. Organically grown rice, conventionally grown rice and soil samples were collected from farmers' fields in Daisen city and Yokote city, Akita prefecture, Japan as well as from the experimental fields of NARO Tohoku Agricultural Research Center located in Daisen from 2007 to 2009. Organic fertilizers and synthetic fertilizers available on the market in Akita prefecture were also collected. The delta N-15 values of those samples were measured. Regardless of the farming method, the delta N-15 values of rice reflected those of the soil. The delta N-15 values of the organic fertilizers available on the market were likely to be higher than those of the soil. Meanwhile the delta N-15 values of the synthetic fertilizers were negative and lower than those of the soil. The delta N-15 values of organically grown rice tended to be higher than the regression line obtained from the delta N-15 values of rice and soil without N source application. The delta N-15 values of conventionally grown rice tended to be lower than the regression line. These results indicated that the relationship of the delta N-15 values of rice and soil without an applied N source could aid in discriminating between organic rice and conventional rice.	[Nishida, Mizuhiko] NARO Tohoku Agr Res Ctr, Yotsuya, Daisen 0140102, Japan; [Sato, Yuta] Akita Prefectural Headquarters Natl Federat Agr C, Terauchi, Akita 0110901, Japan	Nishida, M (reprint author), NARO Tohoku Agr Res Ctr, Shimofurumichi 3, Yotsuya, Daisen 0140102, Japan.	mizuhiko@affrc.go.jp			Ministry of Agriculture, Forestry and Fisheries of Japan	This research was supported in part by a Grant-in-Aid (Development of evaluation and management methods for supply of safe, reliable and functional food and farm produce) from the Ministry of Agriculture, Forestry and Fisheries of Japan.	Amor F.M., 2008, J ENVIRON QUAL, V37, P182; SHEARER GB, 1974, SOIL SCI, V118, P308, DOI 10.1097/00010694-197411000-00005; Nakano A, 2003, PLANT SOIL, V255, P343, DOI 10.1023/A:1026180700963; Bateman AS, 2007, ISOT ENVIRON HEALT S, V43, P237, DOI 10.1080/10256010701550732; Chalk PM, 2013, PLANT SOIL, V362, P373, DOI 10.1007/s11104-012-1358-5; Bateman AS, 2007, J AGR FOOD CHEM, V55, P2664, DOI 10.1021/jf0627726; Yun SI, 2006, SOIL BIOL BIOCHEM, V38, P1682, DOI 10.1016/j.soilbio.2005.11.022; Rogers KM, 2008, J AGR FOOD CHEM, V56, P4078, DOI 10.1021/jf800797w; Sturm M, 2011, J SCI FOOD AGR, V91, P262, DOI 10.1002/jsfa.4179; Bateman AS, 2005, J AGR FOOD CHEM, V53, P5760, DOI 10.1021/jf050374h; BLACK AS, 1977, AUST J SOIL RES, V15, P51, DOI 10.1071/SR9770051; Camin F, 2007, J SCI FOOD AGR, V87, P1330, DOI 10.1002/jsfa.2853; Camin F, 2011, FOOD CHEM, V125, P1072, DOI 10.1016/j.foodchem.2010.09.081; FAO, 2006, WORLD REF BAS SOIL R; FREYER HD, 1974, J ENVIRON QUAL, V3, P405; Fujita M., 2003, Japanese Journal of Soil Science and Plant Nutrition, V74, P805; Hayashi N, 2011, J AGR FOOD CHEM, V59, P10317, DOI 10.1021/jf202215z; Kobayashi H, 2009, BUNSEKI KAGAKU, V58, P985; Ministry of Agriculture Forestry and Fisheries, 2014, SYST INSP CERT ORG F; Ministry of Agriculture Forestry and Fisheries, 2014, OV REC FOOD FRAUD CA; Morita A., 1999, Japanese Journal of Soil Science and Plant Nutrition, V70, P1; Nakano A., 2005, B NATL I VEG TEA SCI, V4, P9; Nakano A., 2002, JPN J SOIL SCI PLANT, V73, P307; Nakano A., 2006, B NATL I VEG TEA SCI, V5, P15; Nakano A., 2003, Japanese Journal of Soil Science and Plant Nutrition, V74, P737; Nakano A., 2010, B NATL I VEG TEA SCI, V9, P205; Nakano A., 2006, N NATL I VEG TEA SCI, V5, P7; Nakano A., 2009, B NATL I VEG TEA SCI, V8, P157; Nishida M, 2007, SOIL SCI PLANT NUTR, V53, P310, DOI 10.1111/j.1747-0765.2007.00136.x; Nishida M, 2004, SOIL SCI PLANT NUTR, V50, P225; SAS Institute, 2010, JMP 9 0; Shoji S., 1984, BIOL PHYSL CROPS, P97; Sturm M, 2011, ISOT ENVIRON HEALT S, V47, P214, DOI 10.1080/10256016.2011.570865; Suzuki Y, 2009, BUNSEKI KAGAKU, V58, P1053; Tanizawa H, 2005, J FOOD HYG SOC JPN, V46, P185; Tokunaga T., 2000, Japanese Journal of Soil Science and Plant Nutrition, V71, P447; Wada H, 1984, NEW SOIL SCI, P159; Yano K., 2012, Japanese Journal of Crop Science, V81, P460, DOI 10.1626/jcs.81.460; YONEYAMA T, 1990, SOIL SCI PLANT NUTR, V36, P667; Yoneyama T., 1996, Mass spectrometry of soils., P205	40	0	0	CROP SCIENCE SOC JAPAN	TOKYO	UNIV TOKYO-FACULTY AGRICULTURE BUNKYO-KU, TOKYO, 113, JAPAN	1343-943X	1349-1008		PLANT PROD SCI	Plant. Prod. Sci.	APR	2015	18	2					180	186				7	Agronomy	Agriculture	CH1XE	WOS:000353815400009		
J	Uchino, H; Iwama, K; Jitsuyama, Y; Yudate, T; Nakamura, S; Gopal, J				Uchino, Hiroshi; Iwama, Kazuto; Jitsuyama, Yutaka; Yudate, Toshiko; Nakamura, Satoshi; Gopal, Jai			Interseeding a Cover Crop as a Weed Management Tool is More Compatible with Soybean than with Maize in Organic Farming Systems	PLANT PRODUCTION SCIENCE			English	Article						Canopy structure; Ground cover pattern; Maize (Zea mays L.); Soybean (Glycine max Merr.); Vegetation cover ratio; Weed spatial distribution	PLACEMENT GEOMETRY; PEST-MANAGEMENT; FERTILIZER BAND; WINTER-WHEAT; GROUND COVER; SPRING WHEAT; LEAVES; SOIL; ORIENTATION; TEMPERATURE	Weeds are the most serious threat to crop production in organic farming systems. Information on the spatial distribution of weeds is important for effective weed management. The objective of this study was to evaluate the effect of the ground cover of the main crops (soybean and maize) and cover crop on the spatial distribution of weeds for two row sections, 'within the row (IR)' and 'between the rows (BR)'. The cover crop was interseeded in BR 3 - 4 weeks after sowing the main crops in two years, and weed density and vegetation cover ratio (VCR, an index of ground cover) of the main crops and cover crop were measured. There was a significant difference in the spatial distribution of weeds between the two main crops. In IR, weed density was higher in maize than in soybean, while in BR, it was higher in soybean. This means that weed suppression in IR was more important for maize, while the suppression in BR was more important for soybean. The negative relationship between VCR of the main crop plus cover crop and weed density in each row section suggests that the difference in ground cover was one of the reasons for the difference in weed density between the two main crops. The cover crop markedly increased the VCR in BR, but only slightly increased VCR in IR in both main crops. These results suggest that the cover crop was more compatible with soybean than with maize, because the high weed density in IR of maize could not be decreased sufficiently by the slight increase of VCR in BR by the cover crop.	[Uchino, Hiroshi; Iwama, Kazuto; Jitsuyama, Yutaka; Yudate, Toshiko; Nakamura, Satoshi] Hokkaido Univ, Grad Sch Agr, Dept Bot & Agron, Lab Crop Sci, Sapporo, Hokkaido 0608589, Japan; [Uchino, Hiroshi] Tohoku Agr Res Ctr, Natl Agr & Food Res Org NARO, Morioka, Iwate 0200198, Japan; [Gopal, Jai] Indian Council Agr Res, Directorate Onion & Garl Res, Pune 410505, Maharashtra, India	Iwama, K (reprint author), Hokkaido Univ, Grad Sch Agr, Dept Bot & Agron, Lab Crop Sci, Sapporo, Hokkaido 0608589, Japan.	iwama@res.agr.hokudai.ac.jp					Ramirez-Garcia J, 2012, PLANT SOIL ENVIRON, V58, P385; Drouet JL, 2008, FIELD CROP RES, V107, P62, DOI 10.1016/j.fcr.2007.12.015; Clark MS, 1998, AGR ECOSYST ENVIRON, V68, P51, DOI 10.1016/S0167-8809(97)00130-8; Guo PG, 2003, WEED SCI, V51, P869, DOI 10.1614/P2002-127; TOLLENAAR M, 1994, AGRON J, V86, P591; TEASDALE JR, 1993, WEED SCI, V41, P207; Cardina J, 1997, WEED SCI, V45, P364; Maddonni GA, 2002, PLANT PHYSIOL, V130, P1181, DOI 10.1104/pp.009738; DITOMASO JM, 1995, WEED SCI, V43, P491; Paice MER, 1998, WEED RES, V38, P373; Liebman M, 2000, WEED RES, V40, P27, DOI 10.1046/j.1365-3180.2000.00164.x; Rasmussen J, 2007, WEED RES, V47, P299, DOI 10.1111/j.1365-3180.2007.00565.x; Gerhards R, 2003, WEED RES, V43, P385, DOI 10.1046/j.1365-3180.2003.00349.x; Rasmussen K, 2002, WEED RES, V42, P287, DOI 10.1046/j.1365-3180.2002.00286.x; Sharratt BS, 2005, AGRON J, V97, P1129, DOI 10.2134/agronj2004.0292; Abdin OA, 2000, EUR J AGRON, V12, P93, DOI 10.1016/S1161-0301(99)00049-0; Mullan DJ, 2010, FUNCT PLANT BIOL, V37, P703, DOI 10.1071/FP09277; Arber A, 1925, MONOCOTYLEDONS MORPH, P1; AULD B A, 1988, Plant Protection Quarterly, V3, P81; AULD BA, 1987, AGR SYST, V25, P219, DOI 10.1016/0308-521X(87)90021-7; Bhowmik PC, 1997, WEED SCI, V45, P349; BLAD BL, 1972, AGRON J, V64, P26; COCHRAN VL, 1990, SOIL TILL RES, V18, P347, DOI 10.1016/0167-1987(90)90119-X; Drouet JL, 1997, AGR FOREST METEOROL, V88, P85, DOI 10.1016/S0168-1923(97)00047-6; Groenendael J.M., 1988, WEED RES, V28, P437, DOI 10.1111/j.1365-3180.1988.tb00825.x; IUSS Working Group, 2006, WORLD SOIL RES REP; Kobayashi Hiroyuki, 2004, Weed Biology and Management, V4, P195, DOI 10.1111/j.1445-6664.2004.00138.x; Kobayashi H., 2004, Journal of Weed Science and Technology, V49, P1; Kokubun M, 2010, FOOD CROPS, Vthird; Kumudini S, 2010, SOYBEAN: BOTANY, PRODUCTION AND USES, P48, DOI 10.1079/9781845936440.0048; MCINTOSH MS, 1983, AGRON J, V75, P153; NAKASEKO K, 1984, Memoirs of the Faculty of Agriculture Hokkaido University, V14, P103; Peachy R.E., 1999, COVER CROP WEED SUPP; Petersen J, 2002, COMMUN SOIL SCI PLAN, V33, P163, DOI 10.1081/CSS-120002385; Petersen J, 2001, NUTR CYCL AGROECOSYS, V61, P215, DOI 10.1023/A:1013756715438; Steinmaus S, 2008, WEED RES, V48, P273, DOI 10.1111/j.1365-3180.2008.00626.x; SWANTON CJ, 1993, WEED TECHNOL, V7, P537; Uchino H, 2009, FIELD CROP RES, V113, P342, DOI 10.1016/j.fcr.2009.06.013; Uchino H, 2012, FIELD CROP RES, V127, P9, DOI 10.1016/j.fcr.2011.10.007; Vincent P.L.D, 2007, HDB PLANT SCI, P734; WIESE AM, 1987, WEED SCI, V35, P177; Zimdahl R.L., 2004, WEED CROP COMPETITIO, P1	42	0	0	CROP SCIENCE SOC JAPAN	TOKYO	UNIV TOKYO-FACULTY AGRICULTURE BUNKYO-KU, TOKYO, 113, JAPAN	1343-943X	1349-1008		PLANT PROD SCI	Plant. Prod. Sci.	APR	2015	18	2					187	196				10	Agronomy	Agriculture	CH1XE	WOS:000353815400010		
J	Iijima, M; Yamane, K; Izumi, Y; Daimon, H; Motonaga, T				Iijima, Morio; Yamane, Koji; Izumi, Yasuhiro; Daimon, Hiroyuki; Motonaga, Takayuki			Continuous Application of Biochar Inoculated with Root Nodule Bacteria to Subsoil Enhances Yield of Soybean by the Nodulation Control using Crack Fertilization Technique	PLANT PRODUCTION SCIENCE			English	Article						Biochar; Crack fertilization; Glycine max Merr; Inoculation; Midterm tillage; Root nodule bacteria; Soil amendment	NITROGEN-FIXATION; NITRATE INHIBITION; SOIL COMPACTION; PHOTOSYNTHESIS; MECHANISMS; SAKUKEI-4; RESPONSES; GROWTH; TERM	Crack fertilization is a soybean cultivation technique for nodulation control in which midterm subsoiling is used to supply fertilizing materials to deep soil just before the flowering stage. This study examined the effects of fertilizing materials and the continuous application of nodulation control, on soybean yield enhancement in two field experiments. The survival of nodule bacteria in deep soil was also evaluated by a bioassay of nodule bacteria in a root box. When the nodule bacteria on biochar were continuously applied without any other chemical fertilizers for three successive years, seed weight was significantly heavier being up to 1.34 times that of the control. The application of nodulation control in the previous year but not in the experimental year did not have residual effects on seed weight. The enhancement of seed weight in a farm field converted from a paddy was much lower. This may be partly attributed to the midterm tillage practice, which destroys the crack structure after the nodulation control, together with soil water status and cultivar differences. Nodule growth and nitrogen fixation activities significantly increased in the soybean plants grown on the soil collected from the subsoil to which nodule bacteria on biochar had been applied the previous year. This suggests that nodule bacteria in the subsoil survived in the biochar habitat for at least a year after application. These results indicate that nodulation control by the crack fertilization technique leads to yield enhancement when nodule bacteria on biochar are continuously applied.	[Iijima, Morio; Yamane, Koji; Motonaga, Takayuki] Kinki Univ, Grad Sch Agr Sci, Nara 6318505, Japan; [Izumi, Yasuhiro] Univ Shiga Prefecture, Sch Environm Sci, Hikone 5228533, Japan; [Daimon, Hiroyuki] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Sakai, Osaka 5998531, Japan	Iijima, M (reprint author), Kinki Univ, Grad Sch Agr Sci, Nara 6318505, Japan.	iijimamorio@nara.kindai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [19380010, 25292016]	We thank Ogura, Y., Kono, Y. Takeuchi, K. and other members of crop science laboratory of faculty of agriculture, Kinki University, and Shibahara, T., Inoue, H. and Kadono, H. of The University of Shiga Prefecture, and Nakatani, Y. of Japan Agricultural Cooperatives for their support to the project work. This study was supported by a Grant-in-Aid for Scientific Research (No. 19380010, 25292016) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	PFEIFFER NE, 1983, PLANT PHYSIOL, V71, P797, DOI 10.1104/pp.71.4.797; ZAPATA F, 1987, AGRON J, V79, P172; STREETER JG, 1985, PLANT PHYSIOL, V77, P325, DOI 10.1104/pp.77.2.325; Atkinson CJ, 2010, PLANT SOIL, V337, P1, DOI 10.1007/s11104-010-0464-5; Salvagiotti F, 2008, FIELD CROP RES, V108, P1, DOI 10.1016/j.fcr.2008.03.001; LeCroy C, 2013, SOIL BIOL BIOCHEM, V58, P248, DOI 10.1016/j.soilbio.2012.11.023; Fuhrer T, 2005, J BACTERIOL, V187, P1581, DOI 10.1128/JB.187.5.1581-1590.2005; Denison RF, 2011, CURR BIOL, V21, pR775, DOI 10.1016/j.cub.2011.06.018; Young EG, 1942, J BIOL CHEM, V142, P839; Warnock DD, 2007, PLANT SOIL, V300, P9, DOI 10.1007/s11104-007-9391-5; BOTTOMLEY PJ, 1989, APPL ENVIRON MICROB, V55, P959; Iijima M., 2011, PLANT PROD SCI, V14, P201; IIJIMA M, 1991, JPN J CROP SCI, V60, P130; Ishii T., 1985, JPN SOC SOIL SCI PLA, V56, P43; Jung G, 2008, PLANT PROD SCI, V11, P291, DOI 10.1626/pps.11.291; Kon'no T., 1990, JPN J SOIL SCI PLANT, V61, P396; KONO Y, 1987, JPN J CROP SCI, V56, P597; Maekawa T, 2003, PLANT PROD SCI, V6, P206, DOI 10.1626/pps.6.206; Nakamura T, 2010, PLANT PROD SCI, V13, P123, DOI 10.1626/pps.13.123; NAKANO H, 1989, JPN J CROP SCI, V58, P192; OHYAMA T, 1983, SOIL SCI PLANT NUTR, V29, P133; PAAU AS, 1980, J BACTERIOL, V143, P1480; REYES VG, 1979, APPL ENVIRON MICROB, V37, P854; STREETER JG, 1985, PLANT PHYSIOL, V77, P321, DOI 10.1104/pp.77.2.321; Takahashi M, 2005, PLANT PROD SCI, V8, P412, DOI 10.1626/pps.8.412; Zegada-Lizarazu W, 2006, PLANT PROD SCI, V9, P123, DOI 10.1626/pps.9.123	26	0	0	CROP SCIENCE SOC JAPAN	TOKYO	UNIV TOKYO-FACULTY AGRICULTURE BUNKYO-KU, TOKYO, 113, JAPAN	1343-943X	1349-1008		PLANT PROD SCI	Plant. Prod. Sci.	APR	2015	18	2					197	208				12	Agronomy	Agriculture	CH1XE	WOS:000353815400011		
J	Nabeya, K; Nakamura, S; Nakamura, T; Fujii, A; Watanabe, M; Nakajima, T; Nitta, Y; Goto, Y				Nabeya, Keita; Nakamura, Satoshi; Nakamura, Teiji; Fujii, Akihiro; Watanabe, Manabu; Nakajima, Takayuki; Nitta, Youji; Goto, Yusuke			Growth Behavior of Sago Palm (Metroxylon sagu Rottb.) from Transplantation to Trunk Formation	PLANT PRODUCTION SCIENCE			English	Article						Creeping growth; Growth stage; Metroxylon sagu Rottb.; Sago palm; Transplanted sucker; Trunk formation		Because of the large amounts of starch accumulated in its trunk, the sago palm (Metroxylon sagu Rottb.) growing in tropical areas of Southeast Asia has received much attention as a starch crop mainly for use as an industrial raw material. Sago palm propagates generally by transplantation of suckers, but little agronomical knowledge is available for transplanted sucker growth. Our objectives are to clarify sago palm growth after transplantation and to assess the transition of stem growth from horizontal to vertical. The transplanted sucker stems elongate horizontally, creeping along the ground surface in the early growth stage. Subsequently, the stem elongation shifts gradually from horizontal to vertical. The creeping stem stands up, drawing a large arc and elongating vertically. The horizontal stem elongation stops at around 6.5 years after transplantation and the stem growth curve shows a sigmoidal curve. The stem growth stage of a transplanted sucker is divisible into three stages based on its elongation direction: the creeping growth stage, the trunk formation stage, and the trunk elongation stage. The creeping growth stage, which is the early growth stage after transplantation, is an important period because the standing positions of trunks are determined in the plant and in the sago palm garden. In the area we investigated, the transplanted suckers remained in the creeping growth stage for 4 - 5 years. They remained in the trunk formation stage for around 1.5 years. These suckers will probably be in a trunk elongation stage for 6 - 7-years.	[Nabeya, Keita; Nakamura, Teiji; Fujii, Akihiro; Nakajima, Takayuki; Goto, Yusuke] Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi 9818555, Japan; [Nakamura, Satoshi] Miyagi Univ, Sch Food Agr & Environm Sci, Sendai, Miyagi 9820215, Japan; [Watanabe, Manabu] Iwate Univ, Field Sci Ctr, Fac Agr, Sugo, Takizawa 0200611, Japan; [Nitta, Youji] Ibaraki Univ, Coll Agr, Ami, Ibaraki 3000393, Japan	Nakamura, S (reprint author), Miyagi Univ, Sch Food Agr & Environm Sci, Sendai, Miyagi 9820215, Japan.	nakamurs@myu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [20405017]; Miyagi University, Japan	This research was supported in part by a Grant-in-Aid for Scienctific Research (No. 20405017) from the Ministry of Education, Culture, Sports, Science and Technology, Japan and by a grant for research abroad from Miyagi University, Japan.	Flach M., 1983, 47 FAO, P85; Flach M., 1977, SAGO 76, P157; Irawan Albertus Fajar, 2012, Tropical Agriculture and Development, V56; Jones D. L., 1995, PALMS, P1; Jong F. S., 1995, SAGO PALM, V3, P13; Jong F. S., 2010, SAG PALM PLANT RESOU, P157; NAGATO I, 1979, JPN J TROP AGR, V23, P160; Nakamura S, 2004, PLANT PROD SCI, V7, P198, DOI 10.1626/pps.7.198; SATO T, 1979, JPN J TROP AGR, V23, P130; Takahashi S., 1992, B FACULTY HOME EC KY, V38, P17; Watanabe M., 2010, SAG PALM PLANT RESOU, P109; Yamamoto Y., 2003, Japanese Journal of Tropical Agriculture, V47, P250; Yamamoto Y., 2006, Japanese Journal of Tropical Agriculture, V50, P234; Yamamoto Y., 2003, Japanese Journal of Tropical Agriculture, V47, P124	14	0	0	CROP SCIENCE SOC JAPAN	TOKYO	UNIV TOKYO-FACULTY AGRICULTURE BUNKYO-KU, TOKYO, 113, JAPAN	1343-943X	1349-1008		PLANT PROD SCI	Plant. Prod. Sci.	APR	2015	18	2					209	217				9	Agronomy	Agriculture	CH1XE	WOS:000353815400012		
J	Yamaguchi, N; Kurosaki, H; Ishimoto, M; Kawasaki, M; Senda, M; Miyoshi, T				Yamaguchi, Naoya; Kurosaki, Hideki; Ishimoto, Masao; Kawasaki, Michio; Senda, Mineo; Miyoshi, Tomoaki			Early-Maturing and Chilling-Tolerant Soybean Lines Derived from Crosses between Japanese and Polish Cultivars	PLANT PRODUCTION SCIENCE			English	Article						Chilling tolerance; Early maturity; Polish cultivar; Soybean; Yield	RESIDUAL HETEROZYGOUS LINE; COLD-WEATHER TOLERANCE; MAP-BASED CLONING; FLOWERING TIME; YIELD COMPONENTS; PUBESCENCE COLOR; LOW-TEMPERATURE; LINKAGE MAP; GENE; LOCUS	Early maturity is an important trait for soybean [Glycine max (L.) Merr.] growing in Hokkaido where the growing period is restricted because of the short fall season and early snowfall. Development of an early-maturing line without decreased seed yield is difficult because of the positive correlation between days to maturity and seed yield. In this study, we developed two breeding lines, Tokei 1067 (T1067) and Toiku 251 (T251), that were derived from crosses between Japanese and Polish cultivars. T1067 and T251 had a significantly earlier maturing time than Yukihomare (YH), the standard cultivar in Hokkaido. The seed yield of T251 was similar to that of YH. Moreover, the chilling tolerance levels of the T1067 and T251 lines at the flowering stage were greater than the tolerance level of YH.	[Yamaguchi, Naoya; Miyoshi, Tomoaki] Tokachi Agr Expt Stn, Hokkaido Res Org, Memuro, Hokkaido 0820081, Japan; [Kurosaki, Hideki] Hokkaido Cent Agr Expt Stn, Hokkaido Res Org, Naganuma, Hokkaido 0691395, Japan; [Ishimoto, Masao] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan; [Kawasaki, Michio; Senda, Mineo] Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori 0368561, Japan	Yamaguchi, N (reprint author), Tokachi Agr Expt Stn, Hokkaido Res Org, Shinsei Minami 9-2, Memuro, Hokkaido 0820081, Japan.	yamaguchi-naoya@hro.or.jp			Ministry of Agriculture, Forestry, and Fisheries of Japan (Genomics-based Technology for Agricultural Improvement) [SFC1006]	This study was supported in part by a grant from the Ministry of Agriculture, Forestry, and Fisheries of Japan (Genomics-based Technology for Agricultural Improvement, SFC1006).	Yamanaka N, 2005, THEOR APPL GENET, V110, P634, DOI 10.1007/s00122-004-1886-3; Li DD, 2008, CROP SCI, V48, P571, DOI 10.2135/cropsci2007.06.0361; Kim KS, 2012, THEOR APPL GENET, V125, P1353, DOI 10.1007/s00122-012-1944-1; [Anonymous], 1966, AGR FORESTRY FISHES; Cober ER, 2010, CROP SCI, V50, P524, DOI 10.2135/cropsci2009.04.0174; Funatsuki H, 2005, THEOR APPL GENET, V111, P851, DOI 10.1007/s00122-005-0007-2; Sayama T, 2010, BREEDING SCI, V60, P380, DOI 10.1270/jsbbs.60.380; Cober ER, 1996, CROP SCI, V36, P601; Liu B, 2008, GENETICS, V180, P995, DOI 10.1534/genetics.108.092742; Hwang TY, 2009, DNA RES, V16, P213, DOI 10.1093/dnares/dsp010; Watanabe S, 2011, GENETICS, V188, P395, DOI 10.1534/genetics.110.125062; Cober ER, 2001, CROP SCI, V41, P698; MCBLAIN BA, 1987, J HERED, V78, P160; Bonato ER, 1999, GENET MOL BIOL, V22, P229, DOI 10.1590/S1415-47571999000200016; BUZZELL RI, 1971, CAN J GENET CYTOL, V13, P703; BERNARD RL, 1971, CROP SCI, V11, P242; Watanabe S, 2009, GENETICS, V182, P1251, DOI 10.1534/genetics.108.098772; Yamanaka N, 2001, DNA RES, V8, P61, DOI 10.1093/dnares/8.2.61; Buzzell R., 1980, SOYBEAN GENET NEWSL, V7, P26; Funatsuki H, 2004, PLANT BREEDING, V123, P558, DOI 10.1111/j.1439-0523.2004.01008.x; Hagihara S., 2003, REP HOKKAIDO BRANCH, V44, P39; Hudcovicová M., 2003, Czech Journal of Genetics and Plant Breeding, V39, P120; Kobayashi, 2013, REP HOKKAIDO BRANCH, V54, P69; KONIECZNY G, 1989, Journal of the Faculty of Agriculture Hokkaido University, V64, P35; Kurosaki H, 2003, PLANT PROD SCI, V6, P17, DOI 10.1626/pps.6.17; Kurosaki H, 2004, BREEDING SCI, V54, P303, DOI 10.1270/jsbbs.54.303; Kurosaki H, 2003, PLANT PROD SCI, V6, P247, DOI 10.1626/pps.6.247; Matsukawa I, 1994, MISCELLANEOUS PUBLIC, V23, P36; Ohnishi S., 2012, REP HOKKAIDO BRANCH, V53, P65; Palomeque L, 2009, THEOR APPL GENET, V119, P417, DOI 10.1007/s00122-009-1049-7; Palomeque L, 2009, THEOR APPL GENET, V119, P429, DOI 10.1007/s00122-009-1048-8; Sanbuichi T., 1979, REP HOKKAIDO PREFECT, V28, P1; Sasaki K., 1988, B HOKKAIDO PREFECT A, V57, P1; Takahashi R, 2005, CROP SCI, V45, P1387, DOI 10.2135/cropsci2004.0386; Tanaka Y., 2009, BREED RES S2, V11, P128; Tanaka Y., 2003, B HOKKAIDO PREF AGR, V84, P13; Tsubokura Y, 2013, AGRONOMY, V3, P117, DOI DOI 10.3390/AGRONOMY3010117; Xia Z., 2012, P NATL ACAD SCI USA, V109, P2155; Yamada Tetsuya, 2012, Breed Sci, V61, P653, DOI 10.1270/jsbbs.61.653; Yumoto S., 2000, B HOKKAIDO PREFECT A, V78, P19	40	0	0	CROP SCIENCE SOC JAPAN	TOKYO	UNIV TOKYO-FACULTY AGRICULTURE BUNKYO-KU, TOKYO, 113, JAPAN	1343-943X	1349-1008		PLANT PROD SCI	Plant. Prod. Sci.	APR	2015	18	2					234	239				6	Agronomy	Agriculture	CH1XE	WOS:000353815400015		
J	Shinkarev, SM; Kotenko, KV; Granovskaya, EO; Yatsenko, VN; Imanaka, T; Hoshi, M				Shinkarev, S. M.; Kotenko, K. V.; Granovskaya, E. O.; Yatsenko, V. N.; Imanaka, T.; Hoshi, M.			Estimation of the contribution of short-lived radioiodines to the thyroid dose for the public in case of inhalation intake following the Fukushima accident	RADIATION PROTECTION DOSIMETRY			English	Article							NUCLEAR-POWER-PLANT; BYELARUS; I-131; AREA	The purpose of this paper is to present (1) the method of assessing the contribution of short-lived radioiodines to the thyroid for members of the public in Fukushima and neighbouring prefectures based on available data and (2) the results of a realistic assessment of such a contribution. The estimates of that contribution for the inhalation intake that occurred on the day of the main fallout (15 March 2011) are within 15 % of the dose to the thyroid from I-131. The contribution to the thyroid dose from intake of Te-132 is higher than that from the intake of I-133 by a factor of similar to 3. The contribution of short-lived radioiodines to the thyroid dose for the public in the case of inhalation intake occurring as early as March 12 might be as great as 30-40 %.	[Shinkarev, S. M.; Kotenko, K. V.; Granovskaya, E. O.; Yatsenko, V. N.] Fed Med Biol Agcy, Burnasyan Fed Med Biophys Ctr, State Res Ctr, Moscow 123182, Russia; [Imanaka, T.] Kyoto Univ, Res Reactor Inst, Kumatori, Osaka 5900494, Japan; [Hoshi, M.] Hiroshima Univ, Res Inst Radiat Biol & Med, Minami Ku, Hiroshima 7348553, Japan	Shinkarev, SM (reprint author), Fed Med Biol Agcy, Burnasyan Fed Med Biophys Ctr, State Res Ctr, Zhivopisnaya 46, Moscow 123182, Russia.	sshinkarev@mail.ru					Amano H, 2012, J ENVIRON RADIOACTIV, V111, P42, DOI 10.1016/j.jenvrad.2011.10.019; Yasumura S, 2012, J EPIDEMIOL, V22, P375, DOI 10.2188/jea.JE20120105; Gavrilin Y, 2004, HEALTH PHYS, V86, P565, DOI 10.1097/00004032-200406000-00002; Balonov M, 2003, RADIAT PROT DOSIM, V105, P593; ETAL. ICRP-International Commission on Radiological Protection, 1995, ICRP PUBL, V71; Furuta S., 2011, 2011035 JAEAREVIEW, V1-84, P2011; Imanaka T, 2012, HEALTH PHYS, V102, P680, DOI 10.1097/HP.0b013e31824cfe18; Kurihara O., 2013, P 2 NIRS S REC EARL; Matsuda N, 2013, RADIAT RES, V179, P663, DOI 10.1667/RR3232.1; MULLER H, 1993, HEALTH PHYS, V64, P232, DOI 10.1097/00004032-199303000-00002; Nishihara K., 2012, 2012018 JAEADATACODE; Ohkura T., 2012, 2012010 JAEADATACODE; [Scientific Committee on the Effects of Atomic Radiation United Nations], 2000, SOURC EFF ION RAD UN; Shinkarev S., 2013, 2 NIRS S REC EARL IN, P17; Shinkarev SM, 2008, HEALTH PHYS, V94, P180, DOI 10.1097/01.HP.0000288044.73410.6b; Tazoe H, 2012, RADIAT PROT DOSIM, V152, P198, DOI 10.1093/rpd/ncs222; Tokonami S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00507; United Nations. Sources and effects of ionizing radiation. United Nations Scientific Committee on the Effects of Atomic Radiation, 2014, SOURC EFF ION RAD UN, V1	18	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0144-8420	1742-3406		RADIAT PROT DOSIM	Radiat. Prot. Dosim.	APR	2015	164	1-2					51	56		10.1093/rpd/ncu335		6	Environmental Sciences; Public, Environmental & Occupational Health; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	Environmental Sciences & Ecology; Public, Environmental & Occupational Health; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	CG8GU	WOS:000353546100013		
J	Seki, A; Saito, O; Nago, H; Suzuki, K; Tomishima, K; Saito, K; Takemiya, H				Seki, A.; Saito, O.; Nago, H.; Suzuki, K.; Tomishima, K.; Saito, K.; Takemiya, H.			Development of a software platform for providing environmental monitoring data for the Fukushima Daiichi nuclear accident	RADIATION PROTECTION DOSIMETRY			English	Article								In nuclear emergencies, it is especially important to carry out a wide range of environmental monitoring and provide the data immediately so as to understand the current distribution of radionuclides and investigate countermeasures. Therefore, it is indispensable for a nuclear emergency response to establish a system that supports rapid provision of these data. The authors have been developing the software platform by integrating technologies of environmental monitoring, information processing and network communication, based on the experience of the Fukushima Daiichi Nuclear Accident. It was discovered that the platform is effective in reducing the time needed to publish the monitoring data. Reducing the cost and workload for publishing the monitoring data is also important because monitoring should be continued over a few decades in the case of the Fukushima accident. The authors' platform is expected to help to mitigate the problem, too.	[Seki, A.; Saito, O.; Nago, H.; Suzuki, K.; Tomishima, K.; Saito, K.; Takemiya, H.] Japan Atom Energy Agcy, Tokai, Ibaraki 3191195, Japan	Seki, A (reprint author), Japan Atom Energy Agcy, 2-4 Shirakata, Tokai, Ibaraki 3191195, Japan.	seki.akiyuki@jaea.go.jp			Nuclear Regulation Authority	This research project was funded by the Nuclear Regulation Authority.	Nuclear Regulation Authority, 2014, ENV MON DAT DISTR RA; Nuclear Regulation Authority, 2014, 4 STUD DISTR RAD SUB; Saito K, 2014, J ENV RADIO; The Ministry of Education Culture Sports Science and Technology, 2013, 3 STUD DISTR RAD SUB; The Ministry of Education Culture Sports Science and Technology, 2014, DAT RES RAD SUBST DI; The Ministry of Education Culture Sports Science and Technology and the Ministry of Agriculture Forestry and Fisheries, 2012, 1 STUD DISTR RAD SUB	6	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0144-8420	1742-3406		RADIAT PROT DOSIM	Radiat. Prot. Dosim.	APR	2015	164	1-2					97	102		10.1093/rpd/ncu355		6	Environmental Sciences; Public, Environmental & Occupational Health; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	Environmental Sciences & Ecology; Public, Environmental & Occupational Health; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	CG8GU	WOS:000353546100022		
J	Prowle, JR; Calzavacca, P; Licari, E; Ligabo, EV; Echeverri, JE; Bagshaw, SM; Haase-Fielitz, A; Haase, M; Ostland, V; Noiri, E; Westerman, M; Devarajan, P; Bellomo, R				Prowle, John Richard; Calzavacca, Paolo; Licari, Elisa; Ligabo, E. Valentina; Echeverri, Jorge E.; Bagshaw, Sean M.; Haase-Fielitz, Anja; Haase, Michael; Ostland, Vaughn; Noiri, Eisei; Westerman, Mark; Devarajan, Prasad; Bellomo, Rinaldo			Combination of biomarkers for diagnosis of acute kidney injury after cardiopulmonary bypass	RENAL FAILURE			English	Article						Acute kidney injury; biomarkers; cardiac bypass; glutathione S-transferase; hepcidin; liver fatty acid binding protein; neutrophil gelatinase associated lipocalin	GELATINASE-ASSOCIATED LIPOCALIN; EARLY URINARY BIOMARKER; ACID-BINDING PROTEIN; ACUTE-RENAL-FAILURE; CARDIAC-SURGERY; CYSTATIN-C; CONSENSUS CONFERENCE; CRITICALLY-ILL; INTENSIVE-CARE; ROC CURVE	Novel acute kidney injury (AKI) biomarkers offer promise of earlier diagnosis and risk stratification, but have yet to find widespread clinical application. We measured urinary alpha and pi glutathione S-transferases (alpha-GST and pi-GST), urinary L-type fatty acid-binding protein (L-FABP), urinary neutrophil gelatinase-associated lipocalin (NGAL), urinary hepcidin and serum cystatin c (CysC) before surgery, post-operatively and at 24 h after surgery in 93 high risk patient undergoing cardiopulmonary bypass (CPB) and assessed the ability of these biomarkers alone and in combination to predict RIFLE-R defined AKI in the first 5 post-operative days. Twenty-five patients developed AKI. pi-GST (ROCAUC = 0.75), lower urine Hepcidin: Creatine ratio at 24 h (0.77), greater urine NGAL:Cr ratio post-op (0.73) and greater serum CysC at 24 h (0.72) best predicted AKI. Linear combinations with significant improvement in AUC were: Hepcidin: Cr 24 h + post-operative pi-GST (AUC = 0.86, p = 0.01), Hepcidin: Cr 24 h + NGAL: Cr post-op (0.84, p = 0.03) and CysC 24 h + post-operative pi-GST (0.83, p = 0.03), notably these significant biomarkers combinations all involved a tubular injury and a glomerular filtration biomarker. Despite statistical significance in receiver-operator characteristic (ROC) analysis, when assessed by ability to define patients to two groups at high and low risk of AKI, combinations failed to significantly improve classification of risk compared to the best single biomarkers. In an alternative approach using Classification and Regression Tree (CART) analysis a model involving NGAL: Cr measurement post-op followed by Hepcidin: Cr at 24 h was developed which identified high, intermediate and low risk groups for AKI. Regression tree analysis has the potential produce models with greater clinical utility than single combined scores.	[Prowle, John Richard; Calzavacca, Paolo; Licari, Elisa; Ligabo, E. Valentina; Echeverri, Jorge E.; Bellomo, Rinaldo] Austin Hosp, Dept Intens Care, Melbourne, Vic 3084, Australia; [Bagshaw, Sean M.] Univ Alberta, Fac Med & Dent, Div Crit Care Med, Edmonton, AB, Canada; [Haase-Fielitz, Anja; Haase, Michael] Univ Magdeburg, Dept Nephrol & Hypertens & Diabet & Endocrinol, D-39106 Magdeburg, Germany; [Ostland, Vaughn; Westerman, Mark] Intrins LifeSci LLC, La Jolla, CA USA; [Noiri, Eisei] Univ Tokyo, Univ Hosp, Dept Nephrol & Endocrinol, Tokyo, Japan; [Noiri, Eisei] Univ Tokyo, Univ Hosp, Dept Hemodialysis & Apheresis, Tokyo, Japan; [Devarajan, Prasad] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA	Bellomo, R (reprint author), Austin Hlth, Dept Intens Care, 145 Studley Rd, Heidelberg, Vic 3084, Australia.	rinaldo.bellomo@austin.org.au	Prowle, John/D-5014-2009	Prowle, John/0000-0002-5002-2721	Austin Health ICU Research Fund; Alere Inc.; Abbot Diagnostics Inc.	This study has been supported by Austin Health ICU Research Fund. Dr MW is a shareholder, President and CEO of Intrinsic LifeSciences, developer and distributor of an ELISA assay for hepcidin. Dr VA is a shareholder and officer of Intrinsic LifeSciences. Dr JRP and Professor RB are named in a US patent in conjunction with Dr MW and Prof PD is a co-inventor on NGAL patents for the diagnosis of acute kidney injury. SB, PD, JP and RB have received consulting/speaking fees from Alere Inc. RB has received consulting fees from Abbot Diagnostics Inc. JRP is responsible for statistical design and analysis.	Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Ho J, 2011, CLIN J AM SOC NEPHRO, V6, P2340, DOI 10.2215/CJN.01000211; Matsui K, 2012, CIRC J, V76, P213, DOI 10.1253/circj.CJ-11-0342; Ho J, 2009, AM J KIDNEY DIS, V53, P584, DOI 10.1053/j.ajkd.2008.10.037; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Bagshaw SM, 2010, CURR OPIN CRIT CARE, V16, P533, DOI 10.1097/MCC.0b013e32833e8412; Endre ZH, 2011, AM J PHYSIOL-RENAL, V301, pF697, DOI 10.1152/ajprenal.00448.2010; Wong HR, 2014, CRIT CARE MED, V42, P781, DOI 10.1097/CCM.0000000000000106; Mishra J, 2004, AM J NEPHROL, V24, P307, DOI 10.1159/000078452; Waikar SS, 2010, KIDNEY INT, V78, P486, DOI 10.1038/ki.2010.165; Westhuyzen J, 2003, NEPHROL DIAL TRANSPL, V18, P543, DOI 10.1093/ndt/18.3.543; Herget-Rosenthal S, 2004, KIDNEY INT, V66, P1115, DOI 10.1111/j.1523-1755.2004.00861.x; Uchino S, 2010, CURR OPIN CRIT CARE, V16, P562, DOI 10.1097/MCC.0b013e32833ea7f3; Glassford NJ, 2013, INTENS CARE MED, V39, P1714, DOI 10.1007/s00134-013-3040-7; Endre ZH, 2011, KIDNEY INT, V79, P1119, DOI 10.1038/ki.2010.555; Pepe MS, 2011, AM J EPIDEMIOL, V173, P1327, DOI 10.1093/aje/kwr013; Arthur JM, 2014, KIDNEY INT, V85, P431, DOI 10.1038/ki.2013.333; McIlroy DR, 2010, CLIN J AM SOC NEPHRO, V5, P211, DOI 10.2215/CJN.04240609; Pencina Michael J, 2011, Stat Med, V30, P11, DOI 10.1002/sim.4085; Katagiri D, 2012, ANN THORAC SURG, V93, P577, DOI 10.1016/j.athoracsur.2011.10.048; Pepe MS, 2006, BIOMETRICS, V62, P221, DOI 10.1111/j.1541-0420.2005.00420.x; HANLEY JA, 1982, RADIOLOGY, V143, P29; Doi K, 2009, J AM SOC NEPHROL, V20, P1217, DOI 10.1681/ASN.2008060617; Paragas N, 2011, NAT MED, V17, P216, DOI 10.1038/nm.2290; Ichimura T, 1998, J BIOL CHEM, V273, P4135, DOI 10.1074/jbc.273.7.4135; Haase M, 2010, J AM COLL CARDIOL, V55, P2024, DOI 10.1016/j.jacc.2009.12.046; Koyner JL, 2010, CLIN J AM SOC NEPHRO, V5, P2154, DOI 10.2215/CJN.00740110; McCullough PA, 2013, CONTRIB NEPHROL, V182, P13, DOI 10.1159/000349963; Mori K, 2005, J CLIN INVEST, V115, P610, DOI 10.1172/JCI200523056; Han WK, 2008, KIDNEY INT, V73, P863, DOI 10.1038/sj.ki.5002715; Ferguson MA, 2010, KIDNEY INT, V77, P708, DOI 10.1038/ki.2009.422; Haase M, 2009, AM J KIDNEY DIS, V54, P1012, DOI 10.1053/j.ajkd.2009.07.020; Han WK, 2009, CLIN J AM SOC NEPHRO, V4, P873, DOI 10.2215/CJN.04810908; Wald R, 2010, CLIN J AM SOC NEPHRO, V5, P1373, DOI 10.2215/CJN.06350909; Ralib AM, 2012, J AM SOC NEPHROL, V23, P322, DOI 10.1681/ASN.2011040325; Waikar SS, 2012, J AM SOC NEPHROL, V23, P13, DOI 10.1681/ASN.2010111124; Prowle JR, 2012, NEPHROL DIAL TRANSPL, V27, P595, DOI 10.1093/ndt/gfr387; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Nickolas TL, 2012, J AM COLL CARDIOL, V59, P246, DOI 10.1016/j.jacc.2011.10.854; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Mishra J, 2005, LANCET, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Doi K, 2010, CURR OPIN CRIT CARE, V16, P545, DOI 10.1097/MCC.0b013e32833e2fa4; Haase M, 2011, J AM COLL CARDIOL, V57, P1752, DOI 10.1016/j.jacc.2010.11.051; Haase-Fielitz A, 2011, CRIT CARE, V15, DOI 10.1186/cc10339; Kanda J, 2015, CLIN EXP NEPHROL, V19, P99, DOI 10.1007/s10157-014-0952-7; McMahon BA, 2010, CURR OPIN CRIT CARE, V16, P550, DOI 10.1097/MCC.0b013e32833fdd9a; Prowle JR, 2010, CURR OPIN CRIT CARE, V16, P540, DOI 10.1097/MCC.0b013e32833ecdcc; Prowle JR, 2012, NEPHROLOGY, V17, P215, DOI 10.1111/j.1440-1797.2011.01546.x; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Walshe CM, 2009, CRIT CARE RESUSC, V11, P204	52	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0886-022X	1525-6049		RENAL FAILURE	Ren. Fail.	APR	2015	37	3					408	416		10.3109/0886022X.2014.1001303		9	Urology & Nephrology	Urology & Nephrology	CG9RV	WOS:000353657500009		
J	Okada, T; Wada, T; Nagaoka, Y; Kanno, Y				Okada, Tomonari; Wada, Toshikazu; Nagaoka, Yume; Kanno, Yoshihiko			Association between visit-to-visit clinic blood pressure variability and home blood pressure variability in patients with chronic kidney disease	RENAL FAILURE			English	Article						Blood pressure variability; chronic kidney disease; home blood pressure measurement; visit-to-visit variability	BY-DAY VARIABILITY; HEART-RATE; DIABETIC-NEPHROPATHY; VASCULAR FUNCTION; RENAL-FUNCTION; ORGAN DAMAGE; FINN-HOME; HYPERTENSION; OHASAMA; RISK	Although both clinic blood pressure (BP) variability and home BP variability are associated with the risk of cardiovascular disease, the relationship between both BP variabilities remain unclear. We evaluated the association between visit-to-visit variability of clinic BP (VVV) and day-by-day home BP variability (HBPV) in patients with chronic kidney disease (CKD). We recruited 143 CKD patients in whom we performed HBP measurements every morning and evening over seven consecutive days. We obtained clinic BP data during 9.6 +/- 1.0 consecutive visits within 24 months. The associations between the variables of VVV and HPBV were examined. The CV values of clinic systolic BP (CSBP) was significantly correlated with the mean values of morning systolic BP (MSBP) and those of evening systolic BP (ESBP) (r = 0.23, 0.20; p = 0.007, 0.02, respectively). The CV values of CSBP was significantly correlated with the CV values of MSBP and those of ESBP (r = 0.19, 0.31; p = 0.02, <0.001, respectively). On the multivariate regression analysis, the CV values of CSBP was significantly correlated with the CV values of MSBP and those of ESBP [standardized regression coefficient (beta) = 0.19, 0.34; p = 0.03, <0.001, respectively]. In conclusion, VVV showed a weak but significant association with HBPV, especially the CV values of ESBP in CKD patients. Further studies are necessary to clarify whether these different BPV elements will be alternative marker of BPV.	[Okada, Tomonari; Wada, Toshikazu; Nagaoka, Yume; Kanno, Yoshihiko] Tokyo Med Univ, Dept Nephrol, Tokyo 1600023, Japan	Okada, T (reprint author), Tokyo Med Univ, Dept Nephrol, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	t-okada@tokyo-med.ac.jp					Kikuya M, 2008, HYPERTENSION, V52, P1045, DOI 10.1161/HYPERTENSIONAHA.107.104620; Leoncini G, 2013, J HUM HYPERTENS, V27, P663, DOI 10.1038/jhh.2013.45; Mallamaci F, 2013, KIDNEY INT, V84, P381, DOI 10.1038/ki.2013.132; Kawai T, 2012, HYPERTENS RES, V35, P239, DOI 10.1038/hr.2011.170; Okada H, 2013, DIABETES CARE, V36, P1908, DOI 10.2337/dc12-2087; Johansson JK, 2012, HYPERTENSION, V59, P212, DOI 10.1161/HYPERTENSIONAHA.111.178657; Imai Y, 1999, J HYPERTENS, V17, P889, DOI 10.1097/00004872-199917070-00004; Mancia G, 2012, HYPERTENSION, V60, P512, DOI 10.1161/HYPERTENSIONAHA.112.194340; Okada T, 2012, BLOOD PRESS MONIT, V17, P1, DOI 10.1097/MBP.0b013e32834f7125; Kilpatrick ES, 2010, DIABETES CARE, V33, P2442, DOI 10.2337/dc10-1000; Grassi G, 2010, AM J HYPERTENS, V23, P1052, DOI 10.1038/ajh.2010.154; Yokota K, 2013, HYPERTENS RES, V36, P151, DOI 10.1038/hr.2012.145; Stergiou GS, 2014, HYPERTENS RES, V37, P565, DOI 10.1038/hr.2014.2; Muntner P, 2011, HYPERTENSION, V57, P160, DOI 10.1161/HYPERTENSIONAHA.110.162255; Kawai T, 2013, J HYPERTENS, V31, P1387, DOI 10.1097/HJH.0b013e328360f796; Eguchi K, 2012, AM J HYPERTENS, V25, P962, DOI 10.1038/ajh.2012.75; Ishikura K, 2012, CLIN EXP HYPERTENS, V34, P297, DOI 10.3109/10641963.2012.681087; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Okada H, 2012, ATHEROSCLEROSIS, V220, P155, DOI 10.1016/j.atherosclerosis.2011.10.033; Neumann J, 2007, HYPERTENSION, V49, P506, DOI 10.1161/01.HYP.0000256530.39695.a3; Rothwell PM, 2011, CURR HYPERTENS REP, V13, P177, DOI 10.1007/s11906-011-0201-3; Shimbo D, 2013, AM J HYPERTENS, V26, P896, DOI 10.1093/ajh/hpt040; Kato T, 2010, AM J HYPERTENS, V23, P980, DOI 10.1038/ajh.2010.94; Diaz KM, 2012, HYPERTENS RES, V35, P55, DOI 10.1038/hr.2011.135; Imai Y, 1997, AM J HYPERTENS, V10, P1281, DOI 10.1016/S0895-7061(97)00277-X; Webb AJS, 2010, LANCET, V375, P906, DOI 10.1016/S0140-6736(10)60235-8; Johansson JK, 2010, J HYPERTENS, V28, P1836, DOI 10.1097/HJH.0b013e32833b6c8a; Matsui Y, 2012, HYPERTENSION, V59, P1132, DOI 10.1161/HYPERTENSIONAHA.111.189217; Matsui Y, 2011, HYPERTENSION, V57, P1087, DOI 10.1161/HYPERTENSIONAHA.111.171645; Japanese Society of Nephrology, 2009, CLIN EXP NEPHROL, V13, P209; Japanese Society of Nephrology, 2009, CLIN EXP NEPHROL, V13, P196; Kawamoto R, 2008, INTERNAL MED, V47, P593, DOI 10.2169/internalmedicine.47.0825; Kawano Y, 2011, HYPERTENS RES, V34, P281, DOI 10.1038/hr.2010.241; Levi-Marpillat N, 2014, HYPERTENS RES, V37, P585, DOI 10.1038/hr.2014.33; Liu ZD, 2013, BLOOD PRESS MONIT, V18, P316, DOI 10.1097/MBP.0000000000000001; Monahan KD, 2007, AM J PHYSIOL-REG I, V293, pR3, DOI 10.1152/ajpregu.00031.2007; Muntner P, 2013, HYPERTENS RES, V36, P940, DOI 10.1038/hr.2013.58; Murakami S, 2011, HYPERTENS RES, V34, P70, DOI 10.1038/hr.2010.176; Ogihara T, 2009, HYPERTENS RES, V32, P11, DOI DOI 10.1038/HR.2008.2; Ogihara T, 2009, HYPERTENS RES, V32, P33; Okada Tomonari, 2008, Nihon Jinzo Gakkai Shi, V50, P588; Smith TR, 2013, J CLIN HYPERTENS, V15, P655, DOI 10.1111/jch.12165; Ushigome E, 2011, HYPERTENS RES, V34, P1271, DOI 10.1038/hr.2011.128	43	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0886-022X	1525-6049		RENAL FAILURE	Ren. Fail.	APR	2015	37	3					446	451		10.3109/0886022X.2014.996730		6	Urology & Nephrology	Urology & Nephrology	CG9RV	WOS:000353657500014		
J	Higurashi, N; Takahashi, Y; Kashimada, A; Sugawara, Y; Sakuma, H; Tomonoh, Y; Inoue, T; Hoshina, M; Satomi, R; Ohfu, M; Itomi, K; Takano, K; Kirino, T; Hirose, S				Higurashi, Norimichi; Takahashi, Yukitoshi; Kashimada, Ayako; Sugawara, Yuji; Sakuma, Hiroshi; Tomonoh, Yuko; Inoue, Takahito; Hoshina, Megumi; Satomi, Ruri; Ohfu, Masaharu; Itomi, Kazuya; Takano, Kyoko; Kirino, Tomoko; Hirose, Shinichi			Immediate suppression of seizure clusters by corticosteroids in PCDH19 female epilepsy	SEIZURE-EUROPEAN JOURNAL OF EPILEPSY			English	Article						Blood-brain barrier; Epilepsy and mental retardation limited to females (EFMR); Inflammation; Neuronal antibody; N-methyl-D-aspartate (NMDA)-type glutamate receptor	LIMITED EPILEPSY; ANTIBODIES	Purpose: The pathomechanism and treatment of PCDH19 female epilepsy (PCDH19-FE) remain unclear. Here, we report that corticosteroids are effective for control of the seizure clusters or other acute symptoms of PCDH19-FE and argue for the possible involvement of a compromised blood-brain barrier (BBB) in its pathogenesis. Methods: The efficacy of corticosteroids was retrospectively reviewed in five Japanese patients with PCDH19-FE. The results of antibody assays against the N-methyl-D-aspartate-type glutamate receptor (abs-NR) in serum/cerebrospinal fluid were also compiled. Results: Corticosteroid treatments significantly improved the acute symptoms, including seizure clusters, in all cases, most often immediately after the initial administration. However, the effect was transient, and some seizures recurred within a few weeks, especially in association with fever. Serum and/or cerebrospinal fluid abs-NR were detected in all patients. Target sequences of the detected antibodies were multiple, and the titers tended to decrease over time. In one patient, immunohistochemical analysis using rat hippocampal slices also revealed serum antibodies targeting an unknown epitope in neuronal cytoplasm. Conclusion: Our findings imply an involvement of inflammatory processes in the pathogenesis of PCDH19-FE and therapeutic utility for corticosteroids as an adjunctive option in acute treatment. PCDH19 is well expressed in brain microvascular endothelial cells and thus its impairment may cause BBB vulnerability, which may be ameliorated by corticosteroids. The abs-NR detected in our patients may not indicate an autoimmune pathomechanism, but may rather represent non-specific sensitization to degraded neuronal components entering the general circulation, the latter process facilitated by the BBB vulnerability. (C) 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.	[Higurashi, Norimichi] Jikei Univ, Sch Med, Dept Pediat, Minami Ku, Tokyo 1058461, Japan; [Higurashi, Norimichi; Hirose, Shinichi] Fukuoka Univ, Cent Res Inst Pathomech Epilepsy, Jonan Ku, Fukuoka 8140180, Japan; [Takahashi, Yukitoshi] Shizuoka Inst Epilepsy & Neurol Disorders, Natl Epilepsy Ctr, Aoi Ku, Shizuoka 4208688, Japan; [Kashimada, Ayako; Sugawara, Yuji] Tokyo Med & Dent Univ, Dept Pediat, Bunkyo Ku, Tokyo 1138510, Japan; [Sakuma, Hiroshi] Tokyo Metropolitan Inst Med Sci, Dept Brain Dev & Neural Regenerat, Setagaya Ku, Tokyo 1568506, Japan; [Tomonoh, Yuko; Inoue, Takahito; Hirose, Shinichi] Fukuoka Univ, Sch Med, Dept Pediat, Jonan Ku, Fukuoka 8140180, Japan; [Hoshina, Megumi] Ohara Gen Hosp, Dept Pediat, Fukushima 9608611, Japan; [Satomi, Ruri] JA Toride Med Ctr, Dept Pediat, Toride, Ibaraki 3020022, Japan; [Ohfu, Masaharu] Okinawa Prefectural Southern Med Ctr, Div Child Neurol, Haebaru, Okinawa 9011193, Japan; [Ohfu, Masaharu] Childrens Med Ctr, Haebaru, Okinawa 9011193, Japan; [Itomi, Kazuya] Aichi Childrens Hlth & Med Ctr, Div Neurol, Obu, Aichi 4748710, Japan; [Takano, Kyoko] Shinshu Univ, Sch Med, Dept Med Genet, Matsumoto, Nagano 3908621, Japan; [Kirino, Tomoko] Shikoku Med Ctr Children & Adults, Dept Pediat, Zentsuji, Kagawa 7658507, Japan	Hirose, S (reprint author), Fukuoka Univ, Sch Med, Dept Pediat, Jonan Ku, 45-1 7 Chome, Fukuoka 8140180, Japan.	hirose@fukuoka-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [24249060, 21591342, 23591238, 24591537, 26461552, 25670481, 24791095]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [221S0002, 25129708]; MEXT; Ministry of Health, Labor and Welfare (MHLW) [H26-Nanji-Ippan-49 and 51]; NCNP [24-7]; Joint Usage/Research Program of Medical Research Institute, Tokyo Medical and Dental University; Mitsubishi Foundation; Takeda Scientific Foundation; Kiyokun Foundation; Japan Epilepsy Research Foundation; Kaibara Morikazu Medical Science Promotion Foundation	The authors are indebted to all members of the study family for their helpful cooperation. This work was supported by Grants-in-Aid for Scientific Research (A) (24249060) to SH, (C) (21591342, 23591238 and 24591537) to YT, and (C) (26461552) to NH, a Grant-in-aid for Challenging Exploratory Research (25670481) to SH, Bilateral Joint Research Projects to SH, and a Grant-in-aid for Young Scientists (B) (24791095) to NH from the Japan Society for the Promotion of Science (JSPS); by Grants for Scientific Research on Innovative Areas (221S0002 and 25129708) to SH from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); by a MEXT-supported Program for the Strategic Research Foundation at Private Universities 2013-2017 to SH; by a Grant-in-aid for the Research on Measures for Intractable Diseases (No. H26-Nanji-Ippan-49 and 51) to SH, and Comprehensive Research on Disability Health and Welfare and Research on Rare and Intractable Diseases to YT from the Ministry of Health, Labor and Welfare (MHLW); by an Intramural Research Grant (24-7) for Neurological and Psychiatric Disorders of NCNP to SH; by the Joint Usage/Research Program of Medical Research Institute, Tokyo Medical and Dental University to SH; by research grants from The Mitsubishi Foundation to SH, from Takeda Scientific Foundation to SH, from Kiyokun Foundation to SH, from The Japan Epilepsy Research Foundation to YT, and from Kaibara Morikazu Medical Science Promotion Foundation to NH.	Salvador E, 2014, CELL TISSUE RES, V355, P597, DOI 10.1007/s00441-013-1762-z; Marchi N, 2009, NEUROBIOL DIS, V33, P171, DOI 10.1016/j.nbd.2008.10.002; Higurashi N, 2013, EPILEPSY RES, V106, P191, DOI 10.1016/j.eplepsyres.2013.04.005; Ekizoglu E, 2014, EPILEPSIA, V55, P414, DOI 10.1111/epi.12528; Marini C, 2012, EPILEPSIA, V53, P2111, DOI 10.1111/j.1528-1167.2012.03649.x; Gupta R, 2005, ARCH DIS CHILD, V90, P379, DOI 10.1136/adc.2004.051375; Fujita K, 2012, J NEUROIMMUNOL, V251, P90, DOI 10.1016/j.jneuroim.2012.06.010; Dalmau J, 2008, LANCET NEUROL, V7, P1091, DOI 10.1016/S1474-4422(08)70224-2; Kim SY, 2011, CELL ADHES MIGR, V5, P97, DOI 10.4161/cam.5.2.14374; Dibbens LM, 2008, NAT GENET, V40, P776, DOI 10.1038/ng.149; Castro OW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046044; Daneman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013741; Eadon MT, 2014, IMMUNOLOGY, V143, P363, DOI 10.1111/imm.12314; Forster C, 2006, J PHYSIOL-LONDON, V573, P413, DOI 10.1113/jphysiol.2006.106385; Hammer C, 2014, MOL PSYCHIATR, V19, P1143, DOI 10.1038/mp.2013.110; Higurashi N, 2012, EPILEPSY RES, V99, P28, DOI 10.1016/j.eplepsyres.2011.10.014; Marchi N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018200	17	1	1	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	1059-1311	1532-2688		SEIZURE-EUR J EPILEP	Seizure	APR	2015	27						1	5		10.1016/j.seizure.2015.02.006		5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CH0XH	WOS:000353745200001		
J	Rahman, MA; Taniyama, H				Rahman, Md. Aftabur; Taniyama, Hisashi			Analysis of a buried pipeline subjected to fault displacement: A DEM and FEM study	SOIL DYNAMICS AND EARTHQUAKE ENGINEERING			English	Article						Buried pipe; Discrete element method; Fault displacement; Soil-pipe interaction; Force-displacement	DESIGN; SLIP	Buried pipelines are commonly used to transport oil, water, sewage, and natural gas and are referred as lifeline systems. The 3D discrete element method (DEM) analysis was carried out to examine the response of buried pipeline owing to fault movement. Approximately 1.8 million spherical particles, which were considered to represent soil and a hollow circular pipe, were placed at a shallow depth in the proposed numerical model. The DEM simulation was performed for the sedimentation of soil particles, and fault displacements were subsequently assigned to the model. The force-displacement relation between pipes and particles is important in the modeling and design of buried pipes in the vicinity of faults. The present study discusses the force-displacement relation between pipes and particles in the axial and vertical directions for fault movement. This relation reveals the strain softening behavior of particles near the fault crossing point. The interaction between soil particles and pipe elements can be understood from this numerical simulation. Particles push the pipes and have a greater effect near the rupture point Finally, a parametric study was performed using different pipe properties, and the responses were analyzed. (C) 2015 Elsevier Ltd. All rights reserved.	[Rahman, Md. Aftabur; Taniyama, Hisashi] Saitama Univ, Grad Sch Sci & Engn, Dept Civil & Environm Engn, Saitama, Japan; [Rahman, Md. Aftabur] Chittagong Univ Engn & Technol, Dept Civil Engn, Chittagong, Bangladesh	Rahman, MA (reprint author), Saitama Univ, Grad Sch Sci & Engn, Dept Civil & Environm Engn, Saitama, Japan.	aftabur028@gmail.com		Rahman, Md Aftabur/0000-0002-3970-8941	Asian Development Bank-Japan Scholarship Program (ADB-JSP)	The first author would like to thank the Asian Development Bank-Japan Scholarship Program (ADB-JSP) for its financial support of the present research. The authors would also like to thank the Earthquake Information Center of the Earthquake Research Institute, University of Tokyo for the use of their computer facilities.	Abdoun Tarek H., 2008, P 12 INT C INT ASS C; Datta TK, 1999, NUCL ENG DES, V192, P271, DOI 10.1016/S0029-5493(99)00113-2; Pascal C, 2002, TECTONOPHYSICS, V356, P307, DOI 10.1016/S0040-1951(02)00413-4; Anastasopoulos I, 2007, J GEOTECH GEOENVIRON, V133, P943, DOI 10.1061/(ASCE)1090-0241(2007)133:8(943); CUNDALL PA, 1979, GEOTECHNIQUE, V29, P47; Soroush A, 2011, POWDER TECHNOL, V212, P1, DOI 10.1016/j.powtec.2011.04.007; Vazouras P, 2010, SOIL DYN EARTHQ ENG, V30, P1361, DOI 10.1016/j.soildyn.2010.06.011; Joshi S, 2011, SOIL DYN EARTHQ ENG, V31, P930, DOI 10.1016/j.soildyn.2011.02.003; [Anonymous], 1995, KONE EARTHQUAKE; Karamitros DK, 2007, SOIL DYN EARTHQ ENG, V27, P200, DOI 10.1016/j.solidyn.2006.08.001; Takada S, 2001, EARTHQUAKE ENG STRUC, V30, P1243, DOI 10.1002/eqe.62; WANG LRL, 1985, EARTHQUAKE ENG STRUC, V13, P75, DOI 10.1002/eqe.4290130109; Bakhshi Ali, 2010, P 14 ECEE; Guo Endong, 2004, P 13 WCEE; Hamzeh Shakib, 2004, P 13 WCEE; Jin Liu, 2008, P 14 WCEE; JSchiff Anshel, 1995, NORTHRIDGE EARTHQUAK; Kennedy RP, 1985, FAULT CROSSING DESIG, P3; Liu Ai-wen, 2004, P 13 WCEE; Liu Ai-wen, 2004, ACTA SEISMOLOGICA SI, V17, P150, DOI 10.1007/s11589-004-0078-1; McCaffrey MA, 1983, BURIED PIPELINE RESP, P151; Newmark N. M., 1975, P US NAT C EARTHQ EN, P416; Iwashita K, 1998, J ENG MECH-ASCE, V124, P285, DOI 10.1061/(ASCE)0733-9399(1998)124:3(285); Ohama Hiroyasu, 2003, P 3 US JAP WORKSH WA; Radan vanov, 2004, P 13 WCEE; Sim WW, 2012, SOIL DYN EARTHQ ENG, V35, P59, DOI 10.1016/j.soildyn.2011.11.005; Takada S, 1998, J STRUCT ENG A, V44A, P1637; Takashi Sakanoue, 2008, P 14 WCEE; Trifonov OV, 2010, SOIL DYN EARTHQ ENG, V30, P1298, DOI 10.1016/j.soildyn.2010.06.002; Wang Ping-Hsin, 2003, P 3 US JAP WORKSH WA; Yasuo Ogawa, 2004, P 13 WCEE; Yoshizaki Koji, 2003, J STRUCT MECH EARTHQ, V724, P1	32	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0267-7261	1879-341X		SOIL DYN EARTHQ ENG	Soil Dyn. Earthq. Eng.	APR	2015	71						49	62		10.1016/j.soildyn.2015.01.011		14	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CG6QE	WOS:000353426200006		
J	Tang, XW; Zhang, XW; Uzuoka, R				Tang, X. W.; Zhang, X. W.; Uzuoka, R.			Novel adaptive time stepping method and its application to soil seismic liquefaction analysis	SOIL DYNAMICS AND EARTHQUAKE ENGINEERING			English	Article						Adaptive time stepping; Soil liquefaction; Earthquake; Embankment; Subway station; Uplift	BIOT CONSOLIDATION ANALYSIS; TRUNCATION ERROR CONTROL; DYNAMIC-ANALYSIS; LIQUEFIABLE SOILS; STRUCTURAL DYNAMICS; INTEGRATION ALGORITHM; EMBANKMENT FOUNDATION; EARTH EMBANKMENT; ESTIMATOR; FLOW	In solid-fluid coupled and dynamic analysis, the temporal discretization error related to the time step size is unavoidable. To improve the calculation efficiency, a novel adaptive time stepping procedure based on a finite element and finite difference (FEM-FDM) coupled method is proposed for soil seismic liquefaction analysis. The core concept of this adaptive stepping method is the mixed displacement and pore water pressure error estimation, which is obtained by an embedded error estimator, and a time stepping strategy, which is operated according to the relation between the current mixed error and the prescribed error tolerance. Two numerical examples were performed to validate the proposed method. It is shown that under the same condition of mesh size and other numerical parameters, the time step size obviously affects the calculation results; using adaptive stepping method is economical, robust and has the same degree of accuracy as compared with the fixed stepping method in the soil earthquake liquefaction analysis. (C) 2015 Elsevier Ltd. All rights reserved.	[Tang, X. W.; Zhang, X. W.] Dalian Univ Technol, Inst Geotech Engn, Dalian 116024, Liaoning Provin, Peoples R China; [Zhang, X. W.; Uzuoka, R.] Univ Tokushima, Inst Geotech Engn, Tokushima 7708506, Japan	Zhang, XW (reprint author), Dalian Univ Technol, Inst Geotech Engn, 2 Linggong Rd, Dalian 116024, Liaoning Provin, Peoples R China.	zhangzw_11@163.com			China 973 Project [2011CB013605-2]; China NSFC [51079062]	The authors are grateful for the technical and financial support provided by the China 973 Project (No. 2011CB013605-2) and China NSFC (No. 51079062).	Akai K., 1978, P JSCE, V269, P95; Oka F, 1999, GEOTECHNIQUE, V49, P661; Huang Y, 2010, NAT HAZARDS, V54, P839, DOI 10.1007/s11069-010-9509-6; CHUNG J, 1993, J APPL MECH-T ASME, V60, P371, DOI 10.1115/1.2900803; Youd TL, 2001, J GEOTECH GEOENVIRON, V127, P817, DOI 10.1061/(ASCE)1090-0241(2001)127:10(817); Cheuk CY, 2007, CAN GEOTECH J, V44, P977, DOI 10.1139/T07-037; Sloan SW, 1999, INT J NUMER ANAL MET, V23, P467, DOI 10.1002/(SICI)1096-9853(199905)23:6<467::AID-NAG949>3.0.CO;2-R; Liu HB, 2005, COMPUT GEOTECH, V32, P223, DOI 10.1016/j.compgeo.2005.02.002; Finn WDL, 2002, SOIL DYN EARTHQ ENG, V22, P731, DOI 10.1016/S0267-7261(02)00094-5; ZIENKIEWICZ OC, 1987, INT J NUMER METH ENG, V24, P337, DOI 10.1002/nme.1620240206; Tang XW, 2013, SOIL DYN EARTHQ ENG, V49, P109, DOI 10.1016/j.soildyn.2013.02.003; Azadi M, 2010, TUNN UNDERGR SP TECH, V25, P158, DOI 10.1016/j.tust.2009.10.004; HULBERT GM, 1995, COMPUT METHOD APPL M, V126, P155, DOI 10.1016/0045-7825(95)00791-X; Cao ZZ, 2011, SOIL DYN EARTHQ ENG, V31, P1132, DOI 10.1016/j.soildyn.2011.04.001; Kontoe S, 2008, COMPUT GEOTECH, V35, P253, DOI 10.1016/j.compgeo.2007.05.001; Tang XW, 2005, SOIL DYN EARTHQ ENG, V25, P689, DOI 10.1016/j.soildyn.2004.11.014; Kavetski D, 2002, INT J NUMER METH ENG, V53, P1301, DOI 10.1002/nme.329; Bui QV, 2004, INT J NUMER METH ENG, V61, P1390, DOI 10.1002/nme.1114; Elgamal A, 2002, J EARTHQUAKE ENG, V6, P447, DOI 10.1142/S1363246902000802; Hamada M, 1994, P 5 US JAP WORKSH EA, P217; Hirthe EM, 2012, ADV WATER RESOUR, V49, P46, DOI 10.1016/j.advwatres.2012.07.021; Huang Y, 2009, J CENT SOUTH UNIV T, V16, P994, DOI 10.1007/s11771-009-0165-5; Huang Y, 2008, B ENG GEOL ENVIRON, V67, P31, DOI 10.1007/s10064-007-0097-y; Huang Y, 2013, NAT HAZARDS, V65, P2375, DOI 10.1007/s11069-012-0433-9; Ishihara K., 1990, SOILS FOUND, V30, P69; Jie Ying, 2008, Earthquake Engineering and Engineering Vibration, V7, DOI 10.1007/s11803-008-0790-2; LI XD, 1993, COMMUN NUMER METH EN, V9, P273, DOI 10.1002/cnm.1640090402; Marcuson W. F., 1978, J GEOTECH ENG DIV AS, V104, P1197; National Research Council, 1985, LIQ SOILS EARTHQ; Newmark N. M., 1959, J ENG MECHANICS DIVI, V85, P67; OKA F, 1992, PROCEEDINGS OF THE TENTH WORLD CONFERENCE ON EARTHQUAKE ENGINEERING, VOLS 1-10, P2529; OKA F, 1994, APPL SCI RES, V52, P209, DOI 10.1007/BF00853951; Romero I, 2006, INT J NUMER METH ENG, V66, P635, DOI 10.1002/nme.1568; Seed H. B., 1971, J SOIL MECHANICS FOU, V107, P1249; SHIBATA T, 1991, COMPUTER METHODS AND ADVANCES IN GEOMECHANICS, VOL 2, P869; Sloan SW, 1999, INT J NUMER ANAL MET, V23, P493, DOI 10.1002/(SICI)1096-9853(199905)23:6<493::AID-NAG950>3.0.CO;2-P; Tang GP, 2008, J HYDROL ENG, V13, P803, DOI 10.1061/(ASCE)1084-0699(2008)13:9(803); Wang MW, 2008, P 14 WORLD C EARTHQ; WIBERG NE, 1993, EARTHQUAKE ENG STRUC, V22, P465, DOI 10.1002/eqe.4290220602; Wilson E. L., 1973, EARTHQ ENG STRUCT D, V1, P241; Yang HT, 2001, COMMUN NUMER METH EN, V17, P597, DOI 10.1002/cnm.433; Yau JD, 2009, MA COMPUT SCI ENG, P465; Younes A, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008229; ZENG LF, 1992, EARTHQUAKE ENG STRUC, V21, P555, DOI 10.1002/eqe.4290210701; Zhang ZH, 2012, INT J COMPUT METHODS, V9, P13; Zhong WX, 1998, APPL MATH COMPUT, V89, P295; ZIENKIEWICZ OC, 1991, EARTHQUAKE ENG STRUC, V20, P871, DOI 10.1002/eqe.4290200907	47	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0267-7261	1879-341X		SOIL DYN EARTHQ ENG	Soil Dyn. Earthq. Eng.	APR	2015	71						100	113		10.1016/j.soildyn.2015.01.016		14	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CG6QE	WOS:000353426200010		
J	Kamagata, S; Takewaki, I				Kamagata, S.; Takewaki, I.			Non-linear transient behavior during soil liquefaction based on re-evaluation of seismic records	SOIL DYNAMICS AND EARTHQUAKE ENGINEERING			English	Article						Soil liquefaction; Frequency-shift; Pulse wave; Cyclic mobility; Non-stationary Fourier spectrum; Maximum amplitude spectrum; Frequency ratio of dominant components; Deterioration ratio of soil stiffness	CYCLIC MOBILITY; EARTHQUAKE	Focusing on soil liquefaction, the seismic records during the Niigata-ken earthquake in 1964, the southern Hyogo prefecture earthquake in 1995 and the 2011 off the Pacific coast of Tohoku earthquake are analyzed by the non-stationary Fourier spectra. The shift of dominant frequency in the seismic record of Kawagishi-cho during the Niigata-ken earthquake is evaluated based on the time-variant property of dominant frequencies. The reduction ratio of the soil stiffness is evaluated from the shift ratio of dominant frequency. It is detected that the pulse wave in the transient process during the progressing liquefaction is composed of the primary mode and the secondary modes. Using the seismic records at the underground of Port Island during the southern Hyogo prefecture earthquake in 1995, the amplification of liquefaction is evaluated by comparing the maximum amplitude spectra of seismic records at GL 0 m and GL-83 m. The average shear strain of underground is calculated from the numerically integrated displacement profiles and the deterioration ratio of stiffness is evaluated from the G-gamma relation. The amplification of liquefaction at Chiba bay area is evaluated by using the ratio of the maximum amplitude spectra of CHB024 and CHBH10 (Borehole) from the mainshock and the aftershock of the 2011 off the Pacific coast of Tohoku earthquake. (C) 2015 Elsevier Ltd. All rights reserved.	[Kamagata, S.] Kajima Corp, Nucl Power Dept, Tokyo 1078348, Japan; [Takewaki, I.] Kyoto Univ, Dept Architecture & Architectural Engn, Kyoto 6158540, Japan	Takewaki, I (reprint author), Kyoto Univ, Dept Architecture & Architectural Engn, Kyoto 6158540, Japan.	takewaki@archi.kyoto-u.ac.jp					SEED HB, 1979, J GEOTECH ENG-ASCE, V105, P201; [Anonymous], 1977, J GEOTECH ENG DIV AS; [Anonymous], 2009, JAPAN ASS EARTHQUAKE, V9; Elgamal A, 2003, INT J PLASTICITY, V19, P883, DOI 10.1016/S0749-6419(02)00010-4; Arai H, 2012, P 47 ANN M JAP GEOT; Castro G, 1975, J GEOTECHNICAL ENGIN, V101, P551; Chiba Prefectural Environmental Research Center, 2012, EARTH QUAK PAC COAST; Idriss IM, 2008, SOIL LIQUEFACTION EA; Japan Nuclear Energy Safety Organization, 2009, JNESSSD09004; Kamagata S, 2014, P 14 INT C INT ASS C; Kamagata S., 1991, NONSTATIONARY SPECTR; Kamagata S, 2013, SOIL DYN EARTHQ ENG, V53, P73, DOI 10.1016/j.soildyn.2013.06.007; Kamagata S, 2013, INT J EARHTQ ENG HAZ, V1, P9; Kamagata S, 2013, EARTHQ STRUCT, V4, P557, DOI 10.12989/eas.2013.4.5.557; Kojima K, 2014, NUCL ENG DES, V273, P271, DOI 10.1016/j.nucengdes.2014.03.023; Ministry of Land Infrastructure Transport and Tourism Kanto Regional Bureau, 2011, REP SURV LIQ PHEN KA; Nasu M, 2005, T JPN SOC CIVIL ENG; National Institute for Land and Infrastructure Management Ministry of Land Infrastructure Transport and Tourism Japan & Building Research Institute Incorporated Administrative Institute Japan, 2012, REP FIELD SURV SUBS; National Research Institute for Earth Science and Disaster Prevention, STRONG MOT SEISM NET; Niigata Local Meteorological Office, SEIEM TSUN HAZ NIIG; Okada T, 1986, UDC SEISAN KENKYU, V38; The Port and Harbour Research Institute Ministry of Transport Japan, 1997, DAM PORT PORT REL FA; Tokimatsu K, CRITERIA SOIL LIQUEF	23	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0267-7261	1879-341X		SOIL DYN EARTHQ ENG	Soil Dyn. Earthq. Eng.	APR	2015	71						163	184		10.1016/j.soildyn.2015.01.017		22	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CG6QE	WOS:000353426200015		
J	Jasaw, GS; Saito, O; Takeuchi, K				Jasaw, Godfred Seidu; Saito, Osamu; Takeuchi, Kazuhiko			Shea (Vitellaria paradoxa) Butter Production and Resource Use by Urban and Rural Processors in Northern Ghana	SUSTAINABILITY			English	Article							TIMBER FOREST PRODUCTS; COMMERCIALIZATION; FLOW	This article explores the use of field experimentation in presenting an account of input inventory, material quantities, and the process flow for shea butter production in Ghana. The shea fruit is a non-timber forest product (NTFP) that is indigenous to ecosystems in semi-arid regions of Africa. Current methods and equipment for processing shea kernel into butter impose a dilemma of excessive harvesting of fuel wood for heating and the use of large quantities of water. Thus, the nature of input requirement and production process presents implications for conflict over natural resource use and for sustainability as more processing takes place. Material flow analysis was applied to the data generated from the processing experiments. The outcome was discussed in focus group discussion sessions and individual interviews as a way of data triangulation to validate study parameters. Results from this experiment showed that the quantity of water used in urban processing sites was higher than that used in rural sites. On the other hand, fuel wood use and labor expended were found to be higher in rural sites per unit processing cycle. The nature of the processing equipment, accessibility to input resources, and target market for shea butter were key determinants of the varying resource quantities used in the production process.	[Jasaw, Godfred Seidu; Saito, Osamu] United Nations Univ Inst Adv Study Sustainabil UN, Shibuya Ku, Tokyo 1508925, Japan; [Takeuchi, Kazuhiko] Univ Tokyo, Integrated Res Syst Sustainabil Sci IR3S, Bunkyo Ku, Tokyo 1138654, Japan	Jasaw, GS (reprint author), United Nations Univ Inst Adv Study Sustainabil UN, Shibuya Ku, 5-53-70 Jingumae, Tokyo 1508925, Japan.	jasaw@isp.unu.edu; saito@unu.edu; takeuchi@unu.edu			Japan International Cooperation Agency (JICA); Japan Science and Technology Agency (JST)	This study was carried out within the framework of the "Enhancing Resilience for Climate and Ecosystem Change: An Integrated Approach in Semi-Arid Africa" (CECAR-Africa) project, funded by the Japan International Cooperation Agency (JICA) and the Japan Science and Technology Agency (JST). We thank Adams Mujeeb Rahman, Benedict Akpem, Abass Asaani, Ziem Romanus and Akram Ajaansuma Jasaw for their support during the fieldwork.	Addaquay J., 2004, SHEA BUTTER VALUE CH; Ahenkan A, 2010, J FOOD AGRIC ENVIRON, V8, P962; ALLENBY B. R., 1999, IND ECOLOGY POLICY F; Shackleton C, 2004, S AFR J SCI, V100, P658; Elias M, 2007, AFRICA, V77, P37, DOI 10.3366/afr.2007.77.1.37; Wang PC, 2014, SUSTAINABILITY-BASEL, V6, P6070, DOI 10.3390/su6096070; Pouliot M, 2012, ECON BOT, V66, P237, DOI 10.1007/s12231-012-9203-6; Tsuda K, 2013, SUSTAINABILITY-BASEL, V5, P123, DOI 10.3390/su5010123; Belcher B, 2007, DEV POLICY REV, V25, P355, DOI 10.1111/j.1467-7679.2007.00374.x; Lovett PN, 2000, AGROFOREST SYST, V48, P273, DOI 10.1023/A:1006379217851; Shackleton CM, 2014, FOREST POLICY ECON, V38, P1, DOI 10.1016/j.forpol.2013.07.004; Asante W. J., 2012, International Journal of Biosciences (IJB), V2, P146; Boafo Y. A., 2014, Journal of Disaster Research, V9, P501; Boffa J.M, 1999, AGROFORESTRY PARKLAN; Boffa J.M., 1991, SHEA NUT VITERALLIA; Bovenkerk M., 1997, P CONACCOUNT C WUPP, P28; Bringezu S., 1997, ACCOUNTING PHYS BASI, P170; Bringezu S., 1997, P CONACCOUNT WORKSH, P43; Bringezu S., 2000, IND ECOLOGY MAT FLOW; Bringezu S., 1996, P 2 INT C EC TSUK JA, P147; Burstrom F., 2000, J ENV ASSESS POLICY, V1, P297; Carette C., 2009, SHEANUT BUTTER GHANA; Clark G, 2014, J GEOGR HIGHER EDUC, V38, P511, DOI 10.1080/03098265.2014.936311; Cocoa Research Institute of Ghana (CRIG), RES DEV SHEA TREE IT; Collins A.M., 2014, J HUMAN SOC SCI RES, V3, P15; Danida Forest Seed Centre (DFSC), VIT PAR GAER F SEED; Dogbevi E.K., 2009, SHEA NUT EC ENV VALU; Fischer-Kowalski M., 1998, J IND ECOL, V2, P61, DOI DOI 10.1162/JIEC.1998.2.1.61; GEPA (Ghana Export Promotion Authority), 2014, SHEA PROD EXP  UNPUB; Glew D, 2014, J CLEAN PROD, V68, P73, DOI 10.1016/j.jclepro.2013.12.085; Hatskevich A., 2011, Agricultura Tropica et Subtropica, V44, P223; Issahaku H., 2011, Journal of Development and Agricultural Economics, V3, P165; Jasaw G.S., 2014, J SCI TECHNOL ENV, V4, P1; Kusakari Y., 2014, Journal of Disaster Research, V9, P516; Lovett P.N., 2004, SHEA BUTTER VALUE CH; OECD, 2008, MEAS SUST DEV REP JO; Rodriguez MTT, 2011, J HAZARD MATER, V192, P1705, DOI 10.1016/j.jhazmat.2011.07.003; ROS-TONEN M.A.F, 2005, PROPLE TREES LIVELIH, V15, P129; Saito O, 2013, J IND ECOL, V17, P578, DOI 10.1111/jiec.12007; Savanna Agricultural Research Unit (SARI), 2001, AGR MET UN; Seidu A., MARKET ACCESS CAPACI; Stichting Nederlandse Vrijwilligers (SNV), 2006, IMPROVING MARKET ACC; Udo de Haes H., 1997, REGIONAL NATL MAT FL; Van der Voet E., 1996, THESIS LEIDEN U LEID; Wunder S, 2014, WORLD DEV, V64, pS1, DOI 10.1016/j.worlddev.2014.03.007	45	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2071-1050			SUSTAINABILITY-BASEL	Sustainability	APR	2015	7	4					3592	3614		10.3390/su7043592		23	Environmental Sciences; Environmental Studies	Environmental Sciences & Ecology	CH0MV	WOS:000353715400004		
J	Lu, HL; Liu, GF				Lu, Heli; Liu, Guifang			Opportunity Costs of Carbon Emissions Stemming from Changes in Land Use	SUSTAINABILITY			English	Article							CELLULAR-AUTOMATA; DEFORESTATION; CONSERVATION; TERRESTRIAL; BENEFITS; REDD	The REDD (Reducing Emissions from Deforestation and Forest Degradation) mechanism allows carbon sinks to be used as carbon credits in order to offset emissions from other sources. However, this practice has raised a number of issues relating to financial incentives. In this study, we develop a spatially explicit model for predicting carbon emissions from deforestation that meet baseline levels as well as farmers' opportunity costs (measured in US dollars per ton of CO2e) under three temporal scenarios with several potential discount rates for agricultural income. Additionally, we use two different accounting methods recommended by the Intergovernmental Panel on Climate Change (IPCC), including the average storage method and the "ton-year approach," to evaluate emissions reductions. We find that farmers are more likely to prefer REDD in the short-run when discount rates are higher than 10%. However, further analysis indicates that opportunity costs would increase significantly over longer periods of time (middle-term schemes of 35 years or long-term schemes of 55 years), thereby dissuading farmers from choosing REDD. Our findings highlight the drawbacks in using REDD to mitigate global climate change and conserve forests based on farmers' financial incentives.	[Lu, Heli; Liu, Guifang] Henan Univ, Key Res Inst Yellow River Civilizat & Sustainable, Kaifeng 475004, Peoples R China; [Lu, Heli; Liu, Guifang] Henan Univ, Collaborat Innovat Ctr Yellow River Civilizat Hen, Kaifeng 475004, Peoples R China; [Lu, Heli; Liu, Guifang] Henan Univ, Inst Nat Resources & Environm Sci, Kaifeng 475004, Peoples R China; [Lu, Heli] United Nations Univ, Inst Adv Studies, Yokohama, Kanagawa 2208502, Japan	Lu, HL (reprint author), Henan Univ, Key Res Inst Yellow River Civilizat & Sustainable, Kaifeng 475004, Peoples R China.	luheli@henu.edu.cn; guif@henu.edu.cn			Japan Society for the Promotion of Science (JSPS);  [NSFC41430637];  [2012CB955800];  [NFSC41371525]	The authors thank the anonymous reviewers whose comments and suggestions were very helpful in improving the quality of this paper. This study is under the auspices of NSFC41430637, 2012CB955800, and NFSC41371525. The first author thanks the support for his research work by Japan Society for the Promotion of Science (JSPS). He is also indebted to Suneetha Mazhenchery Subramanian and Hiroji Isozaki for their assistance.	Angelsen A., 2008, MOVING AHEAD REDD IS, P53; White R, 1997, ENVIRON PLANN B, V24, P323, DOI 10.1068/b240323; Butler RA, 2009, CONSERV LETT, V2, P67, DOI 10.1111/j.1755-263X.2009.00047.x; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Barredo JI, 2003, LANDSCAPE URBAN PLAN, V64, P145, DOI 10.1016/S0169-2046(02)00218-9; MELILLO JM, 1993, NATURE, V363, P234, DOI 10.1038/363234a0; Ring I, 2010, CURR OPIN ENV SUST, V2, P50, DOI 10.1016/j.cosust.2010.02.004; WOLFRAM S, 1984, NATURE, V311, P419, DOI 10.1038/311419a0; [Anonymous], 2006, IPCC GUIDELINES NATL; Venter O, 2009, CONSERV LETT, V2, P123, DOI 10.1111/j.1755-263X.2009.00059.x; Barredo Jose I, 2010, Sustainability, V2, DOI 10.3390/su2051327; Bellassen V, 2008, ECOL ECON, V68, P336, DOI 10.1016/j.ecolecon.2008.03.015; Boucher D., 2008, OUT WOODS REALISTIC; Camino R. V., TEAK TECTONA GRANDIS; Cattaneo A., 2008, STOCK FLOW MECH; Chomitz K. M., 2000, EVALUATING CARBON OF; Dobes L., 1998, OCCASIONAL PAPERS BU, V115; Dutschke M., 2002, Mitigation and Adaptation Strategies for Global Change, V7, P381, DOI 10.1023/A:1024775814723; Fairhurst T., 2009, SUSTAINABLE OIL PALM; Fearnside P.M., 2000, MITIGATION ADAPTATIO, V5, P239, DOI DOI 10.1023/A:1009625122628; Forest Trends' Ecosystem Marketplace, 2013, MAN MOS STAT VOL CAR; Gregersen H., 2010, DOES OPPORTUNITY COS; Grieg-Gran M., 2008, COST AVOIDING DEFORE; Griscom B., 2009, IMPLICATIONS REDD BA; Houghton J.T., 1990, CLIMATE CHANGE IPCC; Houghton R. A., 1983, ECOL MONOGR, V53, P236, DOI DOI 10.2307/1942531; Houghton R. A., CARBON FLUX ATMOSPHE; Houghton R. A., 2003, EMISSIONS SINKS CARB; Huettner Michael, 2009, Carbon Balance Manag, V4, P4, DOI 10.1186/1750-0680-4-4; Hunt C, 2002, ENVIRON DEV ECON, V7, P325, DOI 10.1017/S1355770X02000207; IIED, COSTS REDD LESS AM; Intergovernmental Panel on Climate Change - IPCC, 1995, CLIM CHANG 1994 RAD; IPCC, 2013, 5 IPCC; IPCC, 2007, 4 IPCC; IPCC, 2001, CLIM CHANG 2001 WORK; Kanninen M., 2007, IMPLICATIONS DEFORES; Lu HL, 2013, LAND USE POLICY, V33, P54, DOI 10.1016/j.landusepol.2012.12.008; MacLaren J. P., 2000, FOREST RES B, V219; Marshall L., 2010, TIME VALUE CARBON CA; Moore B., 1981, MODELLING GLOBAL CAR; Moura-Costa P., 2000, MITIGATION ADAPTATIO, V5, P51, DOI DOI 10.1023/A:1009697625521; Moura-Costa P., 2000, CARBON ACCOUNTING TR; Nordhaus W. D., 2008, QUESTION BALANCE WEI; Pagiola S., ESTIMATING COSTS RED; Rahajoe J., ARCP2009 06CMY BRAIM; Ramankutty N, 2007, GLOBAL CHANGE BIOL, V13, P51, DOI 10.1111/j.1365-2486.2006.01272.x; Sathaye J. M. W., GHG MITIGATION POTEN; Schlamadinger B., 2000, LAND USE GLOBAL CLIM; SCHROEDER P, 1992, FOREST ECOL MANAG, V50, P31, DOI 10.1016/0378-1127(92)90312-W; Sedjo R. A., 2001, 0134 RFF; Sedjo RA, 2003, CLIM POLICY, V3, P435, DOI 10.1016/S1469-3062(03)00051-2; Smith K., DISCOUNTING RISK UNC; Stern NH, 2006, STERN REV EC CLIMATE; Strassburg B, 2009, GLOBAL ENVIRON CHANG, V19, P265, DOI 10.1016/j.gloenvcha.2008.11.004; Tom Blomley T., ESTIMATING COSTS RED; von Neumann J, 1996, THEORY SELF REPRODUC; Wertz-Kanounnikoff S., 2010, ESTIMATING COSTS RED; World Bank, 2011, EST OPP COSTS REDD T; WRI, 2005, NAV NUMB GREENH GAS; Yamamoto Y., 2012, Environmental Economics and Policy Studies, V14, P289, DOI 10.1007/s10018-012-0030-x	61	1	1	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2071-1050			SUSTAINABILITY-BASEL	Sustainability	APR	2015	7	4					3665	3682		10.3390/su7043665		18	Environmental Sciences; Environmental Studies	Environmental Sciences & Ecology	CH0MV	WOS:000353715400007		
J	Rubio-Bellido, C; Pulido-Arcas, JA; Cabeza-Lainez, JM				Rubio-Bellido, Carlos; Pulido-Arcas, Jesus A.; Cabeza-Lainez, Jose M.			Adaptation Strategies and Resilience to Climate Change of Historic Dwellings	SUSTAINABILITY			English	Article							THERMAL COMFORT; ENERGY PERFORMANCE; BUILDINGS; MODEL; ARCHITECTURE	Historic city centres have a large amount of dwellings in Europe, which were built to provide a comfortable shelter with the absence of mechanical means. The knowledge of climate responsive design strategies can play a significant role in reducing the energy demand of extant buildings, paving the way for its sustainable development in the face of the rising threat to its occupants of climate change. The residential architecture, developed, in most cases, in dense urban centres, was built using both available materials and traditional and academic construction technologies. This paper thoroughly investigates the extant urban conglomerate in Cadiz and analyses, in a qualitative and quantitative manner, which bioclimatic design strategies were applied and the city's adaptation for future climate scenarios. The results indicate that historic housing in Cadiz is creatively adapted to the local natural conditions by means of a combination of climate responsive strategies, and there is significant scope for improvement in the ongoing response to global warming.	[Rubio-Bellido, Carlos] Univ Seville, Higher Tech Sch Bldg Engn, E-41012 Seville, Spain; [Pulido-Arcas, Jesus A.] Canon Fdn, NL-1180 Amstelveen, Netherlands; [Cabeza-Lainez, Jose M.] Hokkaido Univ, Fac Sci, Sapporo, Hokkaido 0600808, Japan	Rubio-Bellido, C (reprint author), Univ Seville, Higher Tech Sch Bldg Engn, E-41012 Seville, Spain.	carlosrubio@us.es; jesus.a.pulido@gmail.com; wspole@gmail.com	Rubio-Bellido, Carlos/K-1861-2014	Rubio-Bellido, Carlos/0000-0001-6719-8793			Abdelsalam A., 2008, ENERGY BUILD, V40, P906; AHSRAE Standards Committee, 2004, THERM ENV COND HUM O; AHSRAE Technical Committes, 2005, 2005 ASHRAE HDB FUND, P636; Oktay D, 2002, BUILD ENVIRON, V37, P1003, DOI 10.1016/S0360-1323(01)00086-5; Kruger E, 2010, BUILD ENVIRON, V45, P1422, DOI 10.1016/j.buildenv.2009.12.005; Canas I, 2004, BUILD ENVIRON, V39, P1477, DOI 10.1016/j.buildenv.2004.04.007; Feriadi H, 2004, ENERG BUILDINGS, V36, P614, DOI 10.1016/j.enbuild.2004.01.011; Mavrogianni A, 2012, BUILD ENVIRON, V55, P117, DOI 10.1016/j.buildenv.2011.12.003; Aste N, 2009, ENERG BUILDINGS, V41, P1181, DOI 10.1016/j.enbuild.2009.06.005; [Anonymous], EPW WEATH DAT; Lomas KJ, 2012, BUILD ENVIRON, V55, P57, DOI 10.1016/j.buildenv.2011.12.006; van Hoof J, 2008, INDOOR AIR, V18, P182, DOI 10.1111/j.1600-0668.2007.00516.x; Schiermeier Q, 2010, NATURE, V463, P284, DOI 10.1038/463284a; Andreou E, 2014, RENEW ENERG, V63, P587, DOI 10.1016/j.renene.2013.09.051; [Anonymous], CLIM CONS 5 5 EN DES; de la Flor FJS, 2008, ENERG BUILDINGS, V40, P1984, DOI 10.1016/j.enbuild.2008.05.006; Bouden C, 2005, ENERG BUILDINGS, V37, P952, DOI 10.1016/j.enbuild.2004.12.003; Barbero-Barrera MM, 2014, BUILD ENVIRON, V82, P536, DOI 10.1016/j.buildenv.2014.09.023; Cabeza-Lainez J.M., 2010, FUNDAMENTOS TRANSFER; Cabeza-Lainez J.M., 2013, LESSONS VERNACULAR A, P143; Cabeza-Lainez J.M., 2012, SOLAR RAD, DOI [10.5772/33978, DOI 10.5772/33978]; Coley D.A., 2008, ENERGY CLIMATE CHANG; Crawley D., 2008, J BUILD PERFORM SIMU, V1, P91, DOI DOI 10.1080/19401490802182079; De Lama J.P., 1991, P PASS LOW EN ARCH S, P269; Dili AS, 2010, ENERG BUILDINGS, V42, P917, DOI 10.1016/j.enbuild.2010.01.002; European Commission (a), 2013, EU EN FIG STAT POCK; Falcon T., 2003, TROCADERO REV HIST M, V16, P501; Gagliano A, 2014, ENERG BUILDINGS, V72, P361, DOI 10.1016/j.enbuild.2013.12.060; Government of Spain, 2011, EN SAV EFF ACT PLAN; Groot AME, 2015, BUILD ENVIRON, V83, P177, DOI 10.1016/j.buildenv.2014.07.023; Humphreys MA, 2000, ASHRAE T, V206, P485; International Organization for Standardization (ISO), 2007, THERM PERF BUILD COM; International Organization for Standardization (ISO), 2007, BUILD COMP BUILD EL; International Organization for Standardization (ISO), 2006, THERM PERF WIND DO 1; Lin BR, 2004, ENERG BUILDINGS, V36, P73, DOI 10.1016/S0378-7788(03)00090-2; Ministerio de Fomento Secretaria de Estado de Infraestructuras, 2013, DOC AP DOC BAS DB HE; Robert A, 2012, BUILD ENVIRON, V55, P150, DOI 10.1016/j.buildenv.2011.12.014; Rubio-Bellido C., 2011, WIT T BUILT ENV, V123, P135; Rubio-Bellido C., 2012, P 3 INT C HER SUST E; Safarzadeh H, 2005, BUILD ENVIRON, V40, P89, DOI 10.1016/j.buildenv.2004.04.014; Sanchez-Montanes B., 2014, P INT C EN EFF HIST; Sanchez-Montanes B., 2007, P PASS LOW EN ARCH S, P447; Solomon S., 2007, CLIMATE CHANGE, P235, DOI DOI 10.1038/NCLIMATE1258; SUPIC P, 1982, ENERG BUILDINGS, V5, P43, DOI 10.1016/0378-7788(82)90027-5; van Hooff T, 2015, BUILD ENVIRON, V83, P142, DOI 10.1016/j.buildenv.2014.10.006	45	1	1	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2071-1050			SUSTAINABILITY-BASEL	Sustainability	APR	2015	7	4					3695	3713		10.3390/su7043695		19	Environmental Sciences; Environmental Studies	Environmental Sciences & Ecology	CH0MV	WOS:000353715400009		
J	Murakami, T; Nambu, T; Kato, T; Matsuda, Y; Yonemitsu, S; Muro, S; Oki, S				Murakami, Takaaki; Nambu, Takuo; Kato, Tomoko; Matsuda, Yuki; Yonemitsu, Shin; Muro, Seiji; Oki, Shogo			Add-on Treatment with Mitiglinide Improves Residual Postprandial Hyperglycemia in Type 2 Diabetic Patients Receiving the Combination Therapy with Insulin Glargine and Sitagliptin	TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE			English	Article						basal-supported oral therapy; continuous glucose monitoring; glinide; mitiglinide; sitagliptin	GLUCOSE-TOLERANCE; ORAL-THERAPY; MELLITUS; EFFICACY	The combination of a dipeptidyl peptidase-4 (DPP-4) inhibitor and a long-acting insulin analogue is widely used in clinical practice. However, some patients fail to achieve lower postprandial hyperglycemia. Mitiglinide, a short-acting insulinotropic sulfonylurea receptor ligand, is effective for postprandial hyperglycemia. Recently, it has been reported that the combination therapy of mitiglinide with a DPP-4 inhibitor could improve glycemic control. However, the efficacy of those under long-acting insulin analogue therapy remains to be investigated. Thus, we conducted a prospective single-center study of eight Japanese patients with type 2 diabetes mellitus receiving mitiglinide added to the combination therapy of sitagliptin and insulin glargine, and evaluated its efficacy and safety by continuous glucose monitoring (CGM). Participants' (four men and four women) mean age was 70.3 +/- 10.6 years. Their mean body mass index, HbA1c level, and urinary C-peptide level were 22.0 +/- 2.8 kg/m(2), 9.2 +/- 1.2%, and 50.0 +/- 31.4 mu g/day, respectively. CGM showed that as compared with the combination of only sitagliptin and insulin glargine, mitiglinide in combination with sitagliptin and insulin glargine significantly reduced glycennic fluctuation indices, total area for the range of 24-h glycemic fluctuations (p = 0.04), mean amplitude of glycemic excursions (p = 0.03), and the proportion of time in hyperglycemia (p = 0.02) without significant difference in the proportion of time in hypoglycemia (p = 0.18). Hence, we have demonstrated the efficacy and safety of the add-on treatment with mitiglinide in type 2 diabetic patients, receiving the combination therapy of sitagliptin and insulin glargine.	[Murakami, Takaaki; Nambu, Takuo; Kato, Tomoko; Matsuda, Yuki; Yonemitsu, Shin; Muro, Seiji; Oki, Shogo] Osaka Red Cross Hosp, Dept Endocrinol & Diabet, Osaka, Osaka 5430027, Japan	Murakami, T (reprint author), Osaka Red Cross Hosp, Dept Endocrinol & Diabet, Tennoji Ku, 5-30 Fudegasaki Cho, Osaka, Osaka 5430027, Japan.	t.murakami@osaka-med.jrc.or.jp					American Diabetes Association, 2014, DIABETES CARE S1, V37, pS14, DOI [DOI 10.2337/DC14-S014, 10.2337/dc14-S014]; Takahara M, 2012, ENDOCR J, V59, P1131; Tominaga M, 1999, DIABETES CARE, V22, P920, DOI 10.2337/diacare.22.6.920; Mori Y, 2013, DIABETES TECHNOL THE, V15, P237, DOI 10.1089/dia.2012.0214; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Holman RR, 2007, NEW ENGL J MED, V357, P1716, DOI 10.1056/NEJMoa075392; Duffy NA, 2007, EUR J PHARMACOL, V568, P278, DOI 10.1016/j.ejphar.2007.05.010; Borch-Johnsen K, 1999, LANCET, V354, P617; Ceriello A, 2014, DIABETES RES CLIN PR, V103, P256, DOI 10.1016/j.diabres.2012.08.002; Jung JA, 2013, ADV THER, V30, P1018, DOI 10.1007/s12325-013-0072-x; Kaku Kohei, 2014, Diabetes Ther, V5, P97, DOI 10.1007/s13300-014-0051-5; Kaku K, 2009, ENDOCR J, V56, P739, DOI 10.1507/endocrj.K09E-023; Kumashiro N, 2007, ENDOCR J, V54, P163, DOI 10.1507/endocrj.K06-153; Yoshihara T, 2006, ENDOCR J, V53, P67, DOI 10.1507/endocrj.53.67	14	1	1	TOHOKU UNIV MEDICAL PRESS	SENDAI	2-1, SEIRYO-MACHI, AOBA-KU, SENDAI, MIYAGI 980-8575, JAPAN	0040-8727	1349-3329		TOHOKU J EXP MED	Tohoku J. Exp. Med.	APR	2015	235	4					255	260		10.1620/tjem.235.255		6	Medicine, General & Internal; Medicine, Research & Experimental	General & Internal Medicine; Research & Experimental Medicine	CG9UE	WOS:000353664800001		
J	Inagaki, Y; Oshiro, Y; Hasegawa, N; Fukuda, K; Abei, M; Nishi, M; Okamoto, H; Ohkohehi, N				Inagaki, Yuki; Oshiro, Yukio; Hasegawa, Naoyuki; Fukuda, Kuniaki; Abei, Masato; Nishi, Masaaki; Okamoto, Hiroaki; Ohkohehi, Nobuhiro			Clinical Features of Hepatitis E Virus Infection in Ibaraki, Japan: Autochthonous Hepatitis E and Acute-on-Chronic Liver Failure	TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE			English	Article						acute hepatitis; acute-on-chronic liver failure; alcoholic liver disease; autoimmune hepatitis; hepatitis E virus	RISK-FACTORS; FULMINANT; TRANSMISSION; GENOTYPE-4; HOKKAIDO; STRAINS; GENOME; FORM; HEV	Hepatitis E caused by hepatitis E virus (HEV) is a serious public health concern in developing countries where HEV is mainly transmitted through contaminated water. Recently, in industrialized countries, autochthonous hepatitis E, a porcine zoonosis, has been increasingly recognized. In Japan, the number of national notifications of acute hepatitis E has increased since the introduction of anti-HEV IgA antibody measurement, covered by the national health insurance program, in 2011. In the past three years, we examined five patients of acute hepatitis or acute-on-chronic liver failure caused by HEV infection who presented various clinical courses in the southern area of lbaraki prefecture in Japan. Of these patients, 78-year-old and 63-year-old male patients presented acute hepatitis E and recovered by only bed rest. The latter patient had a history of consuming grilled or undercooked pork and shellfish prior to the onset of hepatitis E. Among the five patients examined, the infection route was detected only in this patient. Of note, a 65-year-old female patient presented severe hepatitis associated with painless thyroiditis. The patient was diagnosed with probable autoimmune hepatitis and was successfully treated with prednisolone (40 mg/day). Lastly, 58-year-old and 62-year-old male patients, both of whom had a history of diabetes mellitus and alcoholic liver disease, developed acute-on-chronic liver failure, and the latter patient with pre-existing liver cirrhosis died due to liver failure. Thus, patients with clinical HEV infection who display multiple underlying diseases can develop acute-on-chronic liver failure. In conclusion, HEV infection manifests the diverse clinical courses.	[Inagaki, Yuki; Oshiro, Yukio; Ohkohehi, Nobuhiro] Univ Tsulcuba, Fac Med, Dept Surg, Div Gastroenterol & Hepatobiliary Surg & Organ Tr, Tsukuba, Ibaraki 3058575, Japan; [Hasegawa, Naoyuki; Fukuda, Kuniaki; Abei, Masato] Univ Tsulcuba, Dept Gastroenterol, Tsukuba, Ibaraki 3058575, Japan; [Nishi, Masaaki] Tsukuba Gakuen Hosp, Dept Gastroenterol, Tsukuba, Ibaraki, Japan; [Okamoto, Hiroaki] Jichi Med Univ, Sch Med, Dept Infect & Immun, Div Virol, Shimotsuke, Tochigi, Japan	Oshiro, Y (reprint author), Univ Tsulcuba, Fac Med, Dept Surg, Div Gastroenterol & Hepatobiliary Surg & Organ Tr, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	oshiro@md.tsukuba.ac.jp	Okamoto, Hiroaki/H-4371-2011	Okamoto, Hiroaki/0000-0003-0827-0964			Alvarez F., 1999, Journal of Hepatology, V31, P929, DOI 10.1016/S0168-8278(99)80297-9; Tei S, 2003, LANCET, V362, P371, DOI 10.1016/S0140-6736(03)14025-1; Lu L, 2006, REV MED VIROL, V16, P5, DOI 10.1002/rmv.482; Purcell RH, 2008, J HEPATOL, V48, P494, DOI 10.1016/j.jhep.2007.12.008; Ohnishi S, 2006, HEPATOL RES, V36, P301, DOI 10.1016/j.hepres.2006.08.002; Suzuki K, 2002, NEW ENGL J MED, V347, P1456, DOI 10.1056/NEJM200210313471819; Vento S, 2004, AUTOIMMUN REV, V3, P61, DOI 10.1016/S1568-9972(03)00053-3; Tamada Y, 2004, J HEPATOL, V40, P869, DOI 10.1016/j.jhep.2003.12.026; Takahashi M, 2005, J CLIN MICROBIOL, V43, P49, DOI 10.1128/JCM.43.1.49-56.2005; Scobie L, 2013, J VIRAL HEPATITIS, V20, P1, DOI 10.1111/jvh.12024; Peron JM, 2011, J HEPATOL, V54, P1323, DOI 10.1016/j.jhep.2011.01.009; Yazaki Y, 2003, J GEN VIROL, V84, P2351, DOI 10.1099/vir.0.19242-0; Okamoto H, 2007, VIRUS RES, V127, P216, DOI 10.1016/j.virusres.2007.02.002; Gerolami R, 2011, J CLIN VIROL, V52, P60, DOI 10.1016/j.jcv.2011.06.004; Peron JM, 2007, J VIRAL HEPATITIS, V14, P298, DOI 10.1111/j.1365-2893.2007.00858.x; Takahashi M, 2003, J GEN VIROL, V84, P851, DOI 10.1099/vir.0.18918-0; Mizuo H, 2005, J MED VIROL, V76, P341, DOI 10.1002/jmv.20364; Xu B, 2012, WORLD J GASTROENTERO, V18, P7279, DOI 10.3748/wjg.v18.i48.7279; Inoue J, 2006, J MED VIROL, V78, P476, DOI 10.1002/jmv.20565; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Sugawara K, 2012, J GASTROENTEROL, V47, P849, DOI 10.1007/s00535-012-0624-x; Mochida S, 2014, HEPATOL RES, V44, P365, DOI 10.1111/hepr.12295; Wedemeyer H, 2012, GASTROENTEROLOGY, V142, P1388, DOI 10.1053/j.gastro.2012.02.014; Mizuo H, 2002, J CLIN MICROBIOL, V40, P3209, DOI 10.1128/JCM.40.9.3209-3218.2002; Kamar N, 2012, LANCET, V379, P2477, DOI 10.1016/S0140-6736(11)61849-7; Li TC, 2005, EMERG INFECT DIS, V11, P1958; Crossan C, 2012, EMERG INFECT DIS, V18, P2085, DOI 10.3201/eid1812.120924; Koizumi Y, 2004, J CLIN MICROBIOL, V42, P3883, DOI 10.1128/JCM.42.8.3883-3885.2004; Kumar AS, 2007, J HEPATOL, V46, P387; Ohnishi S, 2003, HEPATOL RES, V25, P213, DOI 10.1016/S1386-6346(03)00009-3; Okamoto H, 2003, INTERNAL MED, V42, P1065, DOI 10.2169/internalmedicine.42.1065; Pischke S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085330; Krishna Y. R., 2009, Liver International, V29, P392, DOI 10.1111/j.1478-3231.2008.01887.x; Takahashi K, 2001, VIROLOGY, V287, P9, DOI 10.1006/viro.2001.1017; Takahashi M, 2014, HEPATOL RES, V44, P43, DOI 10.1111/hepr.12175; Vieira Catarina Lima, 2013, World J Hepatol, V5, P152, DOI 10.4254/wjh.v5.i3.152	36	1	1	TOHOKU UNIV MEDICAL PRESS	SENDAI	2-1, SEIRYO-MACHI, AOBA-KU, SENDAI, MIYAGI 980-8575, JAPAN	0040-8727	1349-3329		TOHOKU J EXP MED	Tohoku J. Exp. Med.	APR	2015	235	4					275	282		10.1620/tjem.235.275		8	Medicine, General & Internal; Medicine, Research & Experimental	General & Internal Medicine; Research & Experimental Medicine	CG9UE	WOS:000353664800004		
J	Xu, J; Tang, Y; Zhao, S; Zhang, WY; Xiu, YJ; Liu, T; Wu, Y				Xu, Juan; Tang, Yuan; Zhao, Sha; Zhang, WenYan; Xiu, YingJie; Liu, Ting; Wu, Yu			Angioimmunoblastic T-Cell Lymphoma with Coexisting Plasma Cell Myeloma: A Case Report and Review of the Literature	TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE			English	Review						angioimmunoblastic T-cell lymphoma; cytokines; gene rearrangement; myeloma; plasma cell	MULTIPLE-MYELOMA; PERIPHERAL-BLOOD; PATIENT; PLASMACYTOSIS; PROLIFERATION; MARROW; BONE	Angioimmunoblastic T-cell lymphoma (AITL) is recognized as a distinct clinicopathological subtype of peripheral T-cell lymphomas. Its clinical features include generalized lynnphadenopathy, constitutional symptoms, and autoimnnune-related findings, such as hemolytic anemia. Pathologically, AITL is characterized by a polymorphous infiltrate in lymph nodes with prominent proliferation of high endothelial venules and follicular dendritic cells. We present an 80-year-old Chinese man with generalized lymphadenopathy and pulmonary infection, diagnosed as AITL based on the distinctive pathological findings and T-cell receptor gamma (TCR-gamma) gene rearrangement analysis of lymph nodes. Importantly, the patient suffered from a coexisting plasma cell myeloma, as judged by monoclonal immunoglobulin in the serum, immature plasma cells, and rearrangement of the immunoglobulin heavy-chain (IgH) gene in the bone marrow. The patient received two courses of the chemotherapy but died of pneumonia 6 months after diagnosis. AITL can be accompanied by polyclonal or clonal proliferation of B lymphocytes; however, AITL are rarely associated with plasma cell proliferation. In fact, 14 AITL cases with plasma cell proliferation have been reported in the literature, but none of them manifested the infiltration of monoclonal immature plasma cells in the bone marrow. To the best of our knowledge, this is the first report of newly diagnosed, concurrent AITL and plasma cell myeloma, providing the evidence for the interplay between malignant T cells and plasma cell proliferation. A review of the literature has also supported a relationship between AITL and plasma cell proliferation. Awareness of this relationship is important for correct diagnosis and appropriate treatment of AITL.	[Xu, Juan; Liu, Ting; Wu, Yu] Sichuan Univ, West China Hosp, Dept Hematol, Chengdu 610041, Peoples R China; [Xu, Juan; Liu, Ting; Wu, Yu] Sichuan Univ, West China Hosp, Hematol Res Lab, Chengdu 610041, Peoples R China; [Tang, Yuan; Zhao, Sha; Zhang, WenYan; Xiu, YingJie] Sichuan Univ, West China Hosp, Dept Pathol, Chengdu 610041, Peoples R China; [Wu, Yu] Kanazawa Univ, Canc Res Inst, Div Mol Bioregulat, Kanazawa, Ishikawa 920, Japan	Wu, Y (reprint author), Sichuan Univ, West China Hosp, Dept Hematol, Guoxuexiang 37, Chengdu 610041, Peoples R China.	wu_yu@scu.edu.cn			National Natural Science Foundation of China [81100330]	This project was supported by the National Natural Science Foundation of China (No. 81100330).	Ahsanuddin AN, 2011, INT J CLIN EXP PATHO, V4, P416; Dunleavy K, 2007, CURR OPIN HEMATOL, V14, P348, DOI 10.1097/MOH.0b013e328186ffbf; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Balague O, 2007, AM J SURG PATHOL, V31, P1310, DOI 10.1097/PAS.0b013e3180339f18; Dogan A, 2003, BRIT J HAEMATOL, V121, P681, DOI 10.1046/j.1365-2141.2003.04335.x; Zettl A, 2002, AM J CLIN PATHOL, V117, P368; Rudiger T, 2002, ANN ONCOL, V13, P140, DOI 10.1093/annonc/mdf033; Yamane A, 2007, ACTA HAEMATOL-BASEL, V117, P74, DOI 10.1159/000096894; Gaulard P, 2014, SEMIN CANCER BIOL, V24, P49, DOI 10.1016/j.semcancer.2013.11.004; BRUMANA N, 1993, HAEMATOLOGICA, V78, P335; BRYANT E, 1982, CANCER, V50, P2122, DOI 10.1002/1097-0142(19821115)50:10<2122::AID-CNCR2820501025>3.0.CO;2-E; Cartron G, 1999, EUR J HAEMATOL, V63, P354; Dogan A., 2008, WHO CLASSIFICATION T, P309; Gernone A, 2002, ANN HEMATOL, V81, P326, DOI 10.1007/s00277-002-0452-9; Huppmann AR, 2013, J CLIN ONCOL, V31, pE28, DOI 10.1200/JCO.2012.43.3797; Hwang JE, 2008, J KOREAN MED SCI, V23, P544, DOI 10.3346/jkms.2008.23.3.544; Nagoshi H, 2013, INT J HEMATOL, V98, P366, DOI 10.1007/s12185-013-1411-z; Sakai H, 2007, INTERNAL MED, V46, P419, DOI 10.2169/internalmedicine.46.6121; Takami A, 2000, AM J OPHTHALMOL, V130, P372, DOI 10.1016/S0002-9394(00)00663-2; Tangour M, 2011, J CUTAN PATHOL, V38, P298, DOI 10.1111/j.1600-0560.2009.01447.x; WEISS VC, 1984, ARCH DERMATOL, V120, P499, DOI 10.1001/archderm.120.4.499; Wickenhauser C, 1999, LEUKEMIA LYMPHOMA, V35, P201, DOI 10.3109/10428199909145720	22	0	0	TOHOKU UNIV MEDICAL PRESS	SENDAI	2-1, SEIRYO-MACHI, AOBA-KU, SENDAI, MIYAGI 980-8575, JAPAN	0040-8727	1349-3329		TOHOKU J EXP MED	Tohoku J. Exp. Med.	APR	2015	235	4					283	288		10.1620/tjem.235.283		6	Medicine, General & Internal; Medicine, Research & Experimental	General & Internal Medicine; Research & Experimental Medicine	CG9UE	WOS:000353664800005		
J	Watanabe, R; Fujii, H; Kamogawa, Y; Nakamura, K; Shirai, T; Ishii, T; Harigae, H				Watanabe, Ryu; Fujii, Hiroshi; Kamogawa, Yukiko; Nakamura, Kyohei; Shirai, Tsuyoshi; Ishii, Tomonori; Harigae, Hideo			Chronic Lupus Peritonitis Is Characterized by the Ascites with a Large Content of Interleukin-6	TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE			English	Article						ascites; cytokine; interleukin 6; lupus peritonitis; systemic lupus erythematosus	MASSIVE ASCITES; ERYTHEMATOSUS; IL-6	Systemic lupus erythematosus (SLE) is an autoimmune disease and can cause multi-organ damage. Peritoneal involvement, also called lupus peritonitis, is a rare but sometimes fatal manifestation. Deposition of immune complexes consisting of immunoglobulin G and complement is considered to be involved in the pathogenesis of lupus peritonitis; however, it remains unknown whether inflammatory cytokines contribute to the pathology of this manifestation. Here we present two patients with treatment-resistant lupus peritonitis: a 37-year-old woman with a 26-year history of SLE who had been treated with prednisolone and cyclophosphamide followed by azathioprine and a 65-year-old woman with a 33-year history of SLE who had been treated with prednisolone alone. Both patients were admitted to our department because of abdominal distention. Computed tomography scans showed massive ascites. Ascitic fluid examinations of both patients showed leukocytosis with no evidence of malignancy or infection. After eliminating other causes for ascites, they were diagnosed with lupus peritonitis. Despite the intensified immunosuppressive therapy, they died of uncontrolled peritonitis several months after admission. Examinations of the ascites at admission also revealed a large content of interleukin (IL)-6, compared with other inflammatory cytokines, IL-1 beta and tumor necrosis factor-a. In fact, the ascitic IL-6 levels of these two patients were 12,389 pg/mL and 5,486 pg/mL, much higher than their serum IL-6 levels of 36 pg/mL and 140 pg/mL, respectively. We therefore suggest that IL-6 may contribute to the pathogenesis of lupus peritonitis and that the inhibition of IL-6 signaling may provide a novel therapeutic strategy for lupus peritonitis.	[Watanabe, Ryu; Fujii, Hiroshi; Kamogawa, Yukiko; Nakamura, Kyohei; Shirai, Tsuyoshi; Ishii, Tomonori; Harigae, Hideo] Tohoku Univ, Grad Sch Med, Dept Hematol & Rheumatol, Sendai, Miyagi 9808574, Japan	Fujii, H (reprint author), Tohoku Univ, Grad Sch Med, Dept Hematol & Rheumatol, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	hfujii@med.tohoku.ac.jp					ANDUS T, 1992, J HEPATOL, V15, P378, DOI 10.1016/0168-8278(92)90072-W; Nishimoto N, 2006, NAT CLIN PRACT RHEUM, V2, P619, DOI 10.1038/ncprheurn0338; Yamamoto T, 2011, CYTOKINE, V53, P239, DOI 10.1016/j.cyto.2010.10.006; Man B, 2005, LUPUS, V14, P822, DOI 10.1191/0961203305lu2187oa; Light RW, 2002, NEW ENGL J MED, V346, P1971, DOI 10.1056/NEJMcp010731; Al Arfaj AS, 2009, LUPUS, V18, P465, DOI 10.1177/0961203308100660; Desai TR, 2002, J SURG RES, V104, P118, DOI 10.1006/jsre.2002.6415; Kishimoto T, 2010, INT IMMUNOL, V22, P347, DOI 10.1093/intimm/dxq030; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Goldman Julia L, 2014, Pulm Circ, V4, P280, DOI 10.1086/675991; Ito H, 2002, INTERNAL MED, V41, P1056, DOI 10.2169/internalmedicine.41.1056; KAKLAMANIS P, 1991, ANN RHEUM DIS, V50, P176, DOI 10.1136/ard.50.3.176; Kawashiri S, 2012, MOD RHEUMATOL, V22, P312, DOI 10.1007/s10165-011-0499-3; Okamoto T, 1981, Ryumachi, V21 Suppl, P189; Pott Júnior Henrique, 2012, Rev Bras Reumatol, V52, P116, DOI 10.1590/S0482-50042012000100012; Prasad S, 2012, INT J RHEUM DIS, V15, pe15, DOI 10.1111/j.1756-185X.2011.01659.x; PROVENZANO G, 1993, BRIT J RHEUMATOL, V32, P1116; Riche F, 2013, CRIT CARE, V17, DOI 10.1186/cc12895; SCHOCKET AL, 1978, J RHEUMATOL, V5, P33; SCHOUSBOE JT, 1988, SEMIN ARTHRITIS RHEU, V18, P121, DOI 10.1016/0049-0172(88)90004-2; Tsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359; Wei LH, 2013, J CLIN ENDOCR METAB, V98, pE472, DOI 10.1210/jc.2012-3462; Zhou L, 2014, REV MED CHILE, V142, P255, DOI 10.4067/S0034-98872014000200016	23	1	1	TOHOKU UNIV MEDICAL PRESS	SENDAI	2-1, SEIRYO-MACHI, AOBA-KU, SENDAI, MIYAGI 980-8575, JAPAN	0040-8727	1349-3329		TOHOKU J EXP MED	Tohoku J. Exp. Med.	APR	2015	235	4					289	294		10.1620/tjem.235.289		6	Medicine, General & Internal; Medicine, Research & Experimental	General & Internal Medicine; Research & Experimental Medicine	CG9UE	WOS:000353664800006		
J	Hisahara, S; Matsushita, T; Furuyama, H; Tajima, G; Shigematsu, Y; Imai, T; Shimohama, S				Hisahara, Shin; Matsushita, Takashi; Furuyama, Hiroyasu; Tajima, Go; Shigematsu, Yosuke; Imai, Tomihiro; Shimohama, Shun			A Heterozygous Missense Mutation in Adolescent-Onset Very Long-Chain Acyl-CoA Dehydrogenase Deficiency with Exercise-Induced Rhabdomyolysis	TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE			English	Article						acyl-CoA dehydrogenase; very long-chain gene; heterozygous missense mutation; rhabdomyolysis; tandem mass spectrometry; very long-chain acyl-CoA dehydrogenase deficiency	TANDEM MASS-SPECTROMETRY; BETA-OXIDATION; MOLECULAR HETEROGENEITY; COENZYME; DISEASE; GENE; IDENTIFICATION; JAPAN; CDNA	Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency is characterized by impaired mitochondrial beta-oxidation of fatty acids. The fatty acid oxidation plays a significant role in energy production especially in skeletal muscle. VLCAD is one of four acyl-CoA dehydrogenases with different-chain length specificity and catalyzes the initial step in mitochondrial beta-oxidation of fatty acids. While the clinical phenotypes in neonates and infants are described as severe, adolescent-onset or adult-onset VLCAD deficiency has a more benign course with only skeletal muscle involvement. These myopathic phenotypes are characterized by episodic muscle weakness and rhabdomyolysis triggered by fasting and strenuous exercise. We report a male teenager who manifested repeated episodes of rhabdomyolysis immediately after exertional exercise. Rhabdomyolysis was diagnosed based on the marked elevation of serum creatine kinase and nnyoglobinuria. Acylcarnitine analysis by tandem mass spectrometry (MS/MS) revealed elevation of serum tetradecenoylcarnitine (C14:1-AC), which represents an abnormal acylcarnitine profile associated with the mitochondrial beta-oxidation defect. High performance liquid chromatographic analysis showed decreased production of 2-hexadecenoyl-CoA (C16:1) from palmitoyl-CoA (C16:0), indicating the defect of VLCAD activity. Direct sequencing of the acyl-CoA dehydrogenase, very long-chain gene (ACADVL) that codes VLCAD revealed a heterozygous mutation (c.1242G>C) in exon 12 (E414D), which is a novel mutation in myopathic-type VLCAD deficiency. Because VLCAD functions as a homodimer, we assume that this heterozygous mutation may exhibit dominant-negative effect. This patient remains asymptomatic thereafter by avoiding exertional exercise. The findings of reduction of enzyme activity and clinical features associated with this novel missense mutation of VLCAD are discussed.	[Hisahara, Shin; Matsushita, Takashi; Imai, Tomihiro; Shimohama, Shun] Sapporo Med Univ, Sch Med, Dept Neurol, Sapporo, Hokkaido 0608556, Japan; [Furuyama, Hiroyasu] Sapporo Yamanoue Hosp, Dept Neurol, Sapporo, Hokkaido, Japan; [Tajima, Go] Hiroshima Univ, Grad Sch Biomed Sci & Hlth Sci, Dept Pediat, Hiroshima, Hiroshima, Japan; [Shigematsu, Yosuke] Univ Fukui, Fac Med Sci, Dept Hlth Sci, Fukui, Fukui 910, Japan; [Imai, Tomihiro] Sapporo Med Univ, Sch Hlth Sci, Dept Occupat Therapy, Sapporo, Hokkaido 0608556, Japan	Hisahara, S (reprint author), Sapporo Med Univ, Sch Med, Dept Neurol, Chuo Ku, South 1,West 17, Sapporo, Hokkaido 0608556, Japan.	hisahara@sapmed.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; SRF	This study was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan and the SRF.	Andresen BS, 1996, HUM MOL GENET, V5, P461, DOI 10.1093/hmg/5.4.461; Spiekerkoetter U, 2009, J INHERIT METAB DIS, V32, P488, DOI 10.1007/s10545-009-1125-9; Vianey-Saban C, 1998, CLIN CHIM ACTA, V269, P43, DOI 10.1016/S0009-8981(97)00185-X; Andresen BS, 1999, AM J HUM GENET, V64, P479, DOI 10.1086/302261; Kunau WH, 1995, PROG LIPID RES, V34, P267, DOI 10.1016/0163-7827(95)00011-9; Mathur A, 1999, CIRCULATION, V99, P1337; Gregersen N, 2008, J INHERIT METAB DIS, V31, P643, DOI 10.1007/s10545-008-0990-y; Laforet P, 2009, NEUROMUSCULAR DISORD, V19, P324, DOI 10.1016/j.nmd.2009.02.007; Bartlett K, 2004, EUR J BIOCHEM, V271, P462, DOI 10.1046/j.1432-1033.2003.03947.x; McAndrew RP, 2008, J BIOL CHEM, V283, P9435, DOI 10.1074/jbc.M709135200; Schymik I, 2006, J PEDIATR-US, V149, P128, DOI 10.1016/j.jpeds.2006.02.037; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; Arnold GL, 2009, MOL GENET METAB, V96, P85, DOI 10.1016/j.ymgme.2008.09.008; CORR PB, 1989, J CLIN INVEST, V83, P927, DOI 10.1172/JCI113978; Wilcken B, 2010, J INHERIT METAB DIS, V33, P501, DOI 10.1007/s10545-009-9001-1; AOYAMA T, 1995, J CLIN INVEST, V95, P2465, DOI 10.1172/JCI117947; AOYAMA T, 1993, BIOCHEM BIOPH RES CO, V191, P1369, DOI 10.1006/bbrc.1993.1368; AOYAMA T, 1994, J BIOL CHEM, V269, P19088; Fukao T, 2001, PEDIATR RES, V49, P227, DOI 10.1203/00006450-200102000-00016; Gobin-Limballe S, 2010, BBA-MOL BASIS DIS, V1802, P478, DOI 10.1016/j.bbadis.2010.01.001; Hornbak M, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-4; Isackson PJ, 2013, MUSCLE NERVE, V47, P224, DOI 10.1002/mus.23498; Pons R, 2000, PEDIATR NEUROL, V22, P98, DOI 10.1016/S0887-8994(99)00132-0; Shigematsu Y, 2002, J CHROMATOGR B, V776, P39, DOI 10.1016/S1570-0232(02)00077-6; Tajima G, 2008, PEDIATR RES, V64, P667, DOI 10.1203/PDR.0b013e318187cc44; Veitia RA, 2009, J PATHOL, V218, P409, DOI 10.1002/path.2583; Ventura FV, 1996, J INHERIT METAB DIS, V19, P161, DOI 10.1007/BF01799419; YAMAGUCHI S, 1993, PEDIATR RES, V34, P111, DOI 10.1203/00006450-199307000-00025	28	0	0	TOHOKU UNIV MEDICAL PRESS	SENDAI	2-1, SEIRYO-MACHI, AOBA-KU, SENDAI, MIYAGI 980-8575, JAPAN	0040-8727	1349-3329		TOHOKU J EXP MED	Tohoku J. Exp. Med.	APR	2015	235	4					305	310		10.1620/tjem.235.305		6	Medicine, General & Internal; Medicine, Research & Experimental	General & Internal Medicine; Research & Experimental Medicine	CG9UE	WOS:000353664800008		
J	Arata, Y; Horii, A; Saito, H; Miyamoto, M; Matsuoka, H; Kanatsuka, H				Arata, Yutaro; Horii, Akira; Saito, Hidemitsu; Miyamoto, Manabu; Matsuoka, Hiroo; Kanatsuka, Hiroshi			Life and Mental Health of Medical Students after the Great East Japan Earthquake	TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE			English	Article						data mining; disaster; education; tsunami; volunteers		Students of the Tohoku University School of Medicine experienced the Great East Japan Earthquake on March 11, 2011. We conducted a series of surveys to examine the relationships among their experiences and activities on the day of the earthquake, their physical, mental, and economic problems following the disaster, and how their problems changed over time. The initial survey was performed in April 2011, with three follow-up surveys in July 2011, February 2012, and April 2013. The initial survey focused on students' experiences and living conditions during the disaster, which contained questions on their locations and circumstances, family circumstances, lives after the earthquake, voluntary works, physical or mental health problems, and desire for counseling. The follow-up surveys included new items regarding their circumstances, changes in their health problems, and their desire for economic assistance. Students who answered the first survey to the 4th one, with response rates in the following bracket, were as follows: 472 (28.0%), 640 (29.9%), 681 (36.0%), and 678 (39.0%), respectively. Six months after the earthquake, about 20% having experienced physical and/or mental problems. Although there was a trend toward a reduction in suffering and health problems over time, some students' conditions remained unchanged or worsened. It is notable that students who had participated in voluntary activities, despite their own suffering of harm and distress, were identified as the group that required the closest attention. Our present results can be applied to appropriate supports for students in future large-scale disasters.	[Arata, Yutaro; Kanatsuka, Hiroshi] Tohoku Univ, Grad Sch Med, Off Med Educ, Sendai, Miyagi 9808575, Japan; [Horii, Akira] Tohoku Univ, Grad Sch Med, Dept Mol Pathol, Sendai, Miyagi 9808575, Japan; [Saito, Hidemitsu] Tohoku Univ, Grad Sch Med, Dept Psychiat Nursing, Sendai, Miyagi 9808575, Japan; [Miyamoto, Manabu] Osaka Med Coll, Educ Ctr, Takatsuki, Osaka 569, Japan; [Matsuoka, Hiroo] Tohoku Univ, Grad Sch Med, Dept Psychiat, Sendai, Miyagi 9808575, Japan	Arata, Y (reprint author), Tohoku Univ, Grad Sch Med, Off Med Educ, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	arata@med.tohoku.ac.jp			Tohoku University School of Medicine's Medical Student Welfare Committee	We would like to thank the following people for their guidance, without which we would not have completed this research: Associate Professor Seiichi Ishii and Associate Professor Junichi Kameoka of the Tohoku University Graduate School of Medicine, Office of Medical Education; Professor Naoto Ishii of the Department of Microbiology and Immunology; Associate Professor Seiichi Saitoh of the Kobe University Graduate School of Human Development and Environment; Instructor Yoshimi Suzukamo of the Tohoku University Department of Physical Medicine and Rehabilitation for her guidance on the analysis methodology. In addition, we would like to express our sincere appreciation to the Tohoku University School of Medicine's Medical Student Welfare Committee, the school affairs office, and the students for the support we received in conducting the surveys.	Agrawal R., 1993, P ACM SIGMOD C MAN D, V22, P207, DOI DOI 10.1145/170035.170072; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; HABERMAN SJ, 1973, BIOMETRICS, V29, P205, DOI 10.2307/2529686; Shibahara S, 2011, TOHOKU J EXP MED, V223, P305, DOI 10.1620/tjem.223.305; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; WEISS DS, 1992, J TRAUMA STRESS, V5, P365, DOI 10.1002/jts.2490050304; Fire and Disaster Management Agency, 2013, 148 FIR DIS MAN AG; Gakusei Borantia Kenkyukai, 2012, B SUMM REP DIS VOL S; Japan Meteorological Agency, 2013, 2011 PAC COAST TOH E; Kano Y., 2002, GRAPHICAL MULTIVARIA; Kin Y., 2012, OCCUP MENT HLTH S, V20, P2; National Center of Neurology and Psychology, 2012, DIS MENT HLTH GUID; National Police Agency, 2015, COUNT GREAT E JAP EA; Toyoda H., 2007, COVARIANCE STRUCTURE; Underwood P., 2005, J JPN SOC DISASTER N, V7, P23; Yamaguchi K., 2004, UNDERSTANDING BASICS; Yamazaki T., 2009, J J DISAST MED, V14, P157	17	1	1	TOHOKU UNIV MEDICAL PRESS	SENDAI	2-1, SEIRYO-MACHI, AOBA-KU, SENDAI, MIYAGI 980-8575, JAPAN	0040-8727	1349-3329		TOHOKU J EXP MED	Tohoku J. Exp. Med.	APR	2015	235	4					311	325		10.1620/tjem.235.311		15	Medicine, General & Internal; Medicine, Research & Experimental	General & Internal Medicine; Research & Experimental Medicine	CG9UE	WOS:000353664800009		
J	Descalzi, G; Ikegami, D; Ushijima, T; Nestler, EJ; Zachariou, V; Narita, M				Descalzi, Giannina; Ikegami, Daigo; Ushijima, Toshikazu; Nestler, Eric J.; Zachariou, Venetia; Narita, Minoru			Epigenetic mechanisms of chronic pain	TRENDS IN NEUROSCIENCES			English	Review						histone modifications; inflammatory pain; neuropathic pain; HDAC; miRNA; methylation; animal models	ANTERIOR CINGULATE CORTEX; ROSTRAL VENTROMEDIAL MEDULLA; SODIUM-CHANNEL EXPRESSION; PERIPHERAL-NERVE INJURY; SQUAMOUS-CELL CARCINOMA; CPG-BINDING PROTEIN-2; CHRONIC BACK-PAIN; NEUROPATHIC PAIN; SPINAL-CORD; INFLAMMATORY PAIN	Neuropathic and inflammatory pain promote a large number of persisting adaptations at the cellular and molecular level, allowing even transient tissue or nerve damage to elicit changes in cells that contribute to the development of chronic pain and associated symptoms. There is evidence that injury-induced changes in chromatin structure drive stable changes in gene expression and neural function, which may cause several symptoms, including allodynia, hyperalgesia, anxiety, and depression. Recent findings on epigenetic changes in the spinal cord and brain during chronic pain may guide fundamental advances in new treatments. Here, we provide a brief overview of epigenetic regulation in the nervous system and then discuss the still-limited literature that directly implicates epigenetic modifications in chronic pain syndromes.	[Descalzi, Giannina; Nestler, Eric J.; Zachariou, Venetia] Icahn Sch Med Mt Sinai, Friedman Brain Inst, Fishberg Dept Neurosci, New York, NY 10029 USA; [Ikegami, Daigo; Narita, Minoru] Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Pharmacol, Shinagawa Ku, Tokyo 1428501, Japan; [Ushijima, Toshikazu] Natl Canc Ctr, Div Epigen, Chuo Ku, Tokyo 1040045, Japan; [Ushijima, Toshikazu; Narita, Minoru] Life Sci Tokyo Adv Res Ctr L StaR, Shinagawa Ku, Tokyo 1428501, Japan	Zachariou, V (reprint author), Icahn Sch Med Mt Sinai, Friedman Brain Inst, Fishberg Dept Neurosci, New York, NY 10029 USA.	venetia.zachariou@mssm.edu; narita@hoshi.ac.jp			Banting Postdoctoral Fellowships program; NIDA [P01DA008227]; NINDS [R01NS086444]; JSPS [24791627, 26293346]; MEXT-Supported Program for the Strategic Research Foundation at Private Universities [2014-2018, S1411019]	Supported by the Banting Postdoctoral Fellowships program (G.D.), NIDA P01DA008227 (E.J.N., V.Z.) and NINDS R01NS086444 (V.Z.), JSPS Grant-in-Aid for Young Scientists (B) 24791627 (DI.), JSPS Grant-in-Aid for Scientific Research (B) 26293346 (UN.), and MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2014-2018, S1411019 (M.N., D.I.).	Alvarado S, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-21; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Burgess SE, 2002, J NEUROSCI, V22, P5129; Narita M, 2011, PAIN, V152, P1358, DOI 10.1016/j.pain.2011.02.016; Sima AAF, 2005, DIABETES CARE, V28, P89, DOI 10.2337/diacare.28.1.89; Russo SJ, 2013, NAT REV NEUROSCI, V14, P609, DOI 10.1038/nrn3381; Sweatt JD, 2013, NEURON, V80, P624, DOI 10.1016/j.neuron.2013.10.023; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Ossipov MH, 2010, J CLIN INVEST, V120, P3779, DOI 10.1172/JCI43766; Shi GD, 2013, GLIA, V61, P504, DOI 10.1002/glia.22451; Li XY, 2010, SCIENCE, V330, P1400, DOI 10.1126/science.1191792; Bushnell MC, 2013, NAT REV NEUROSCI, V14, P502, DOI 10.1038/nrn3516; Uchida H, 2010, J NEUROSCI, V30, P4806, DOI 10.1523/JNEUROSCI.5541-09.2010; Garcia-Larrea L, 2013, PAIN, V154, pS29, DOI 10.1016/j.pain.2013.09.001; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Winkler I, 2005, BRIT J PHARMACOL, V146, P198, DOI 10.1038/sj.bjp.0706310; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; TALBOT JD, 1991, SCIENCE, V251, P1355, DOI 10.1126/science.2003220; Geranton SM, 2007, J NEUROSCI, V27, P6163, DOI 10.1523/JNEUROSCI.1306-07.2007; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Deuis JR, 2013, PAIN, V154, P1749, DOI 10.1016/j.pain.2013.05.032; Peters CM, 2004, NEUROSCIENCE, V126, P1043, DOI 10.1016/j.neurosciene.2004.04.027; Ji RR, 1997, J NEUROSCI, V17, P1776; Baliki MN, 2010, NEURON, V66, P149, DOI 10.1016/j.neuron.2010.03.002; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; LaPlant Q, 2010, NAT NEUROSCI, V13, P1137, DOI 10.1038/nn.2619; Barrot M, 2012, NEUROSCIENCE, V211, P39, DOI 10.1016/j.neuroscience.2011.12.041; Bienvenu T, 2006, NAT REV GENET, V7, P415, DOI 10.1038/nrg1878; Jiang Y, 2008, J NEUROSCI, V28, P11753, DOI 10.1523/JNEUROSCI.3797-08.2008; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; Zhuo M, 2008, TRENDS NEUROSCI, V31, P199, DOI 10.1016/j.tins.2008.01.003; Chiechio S, 2009, MOL PHARMACOL, V75, P1014, DOI 10.1124/mol.108.054346; Dekker FJ, 2014, DRUG DISCOV TODAY, V19, P654, DOI 10.1016/j.drudis.2013.11.012; Yamashita A, 2014, SYNAPSE, V68, P235, DOI 10.1002/syn.21733; Bair MJ, 2008, PSYCHOSOM MED, V70, P890, DOI 10.1097/PSY.0b013e318185c510; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Viet CT, 2011, PAIN, V152, P2323, DOI 10.1016/j.pain.2011.06.025; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Mogil JS, 2009, NAT REV NEUROSCI, V10, P283, DOI 10.1038/nrn2606; Vialou V, 2013, ANNU REV PHARMACOL, V53, P59, DOI 10.1146/annurev-pharmtox-010611-134540; Nasca C, 2013, P NATL ACAD SCI USA, V110, P4804, DOI 10.1073/pnas.1216100110; BEHBEHANI MM, 1979, BRAIN RES, V170, P85, DOI 10.1016/0006-8993(79)90942-9; Zhang Z, 2011, NAT MED, V17, P1448, DOI 10.1038/nm.2442; Robison AJ, 2011, NAT REV NEUROSCI, V12, P623, DOI 10.1038/nrn3111; Derbyshire SWG, 2009, EUR J PAIN, V13, P542, DOI 10.1016/j.ejpain.2008.06.010; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Vignes M, 1997, NATURE, V388, P179; Zhao J, 2010, J NEUROSCI, V30, P10860, DOI 10.1523/JNEUROSCI.1980-10.2010; Chen HP, 2014, NEUROCHEM RES, V39, P76, DOI 10.1007/s11064-013-1192-z; Ito K, 2000, MOL CELL BIOL, V20, P6891, DOI 10.1128/MCB.20.18.6891-6903.2000; Craig AD, 2003, ANNU REV NEUROSCI, V26, P1, DOI 10.1146/annurev.neuro.26.041002.131022; Favereaux A, 2011, EMBO J, V30, P3830, DOI 10.1038/emboj.2011.249; Ikeda H, 2006, SCIENCE, V312, P1659, DOI 10.1126/science.1127233; Nelson ED, 2011, NEUROBIOL LEARN MEM, V96, P53, DOI 10.1016/j.nlm.2011.02.015; Sandkuhler J, 1998, EUR J NEUROSCI, V10, P2476, DOI 10.1046/j.1460-9568.1998.00278.x; Cordeiro-Silva MD, 2011, MOL BIOL REP, V38, P5435, DOI 10.1007/s11033-011-0698-1; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Neugebauer V, 2004, NEUROSCIENTIST, V10, P221, DOI 10.1177/1073858403261077; Dib-Hajj SD, 1999, PAIN, V83, P591, DOI 10.1016/S0304-3959(99)00169-4; Ni J, 2013, EUR J PAIN, V17, P313, DOI 10.1002/j.1532-2149.2012.00197.x; Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017; Kynast KL, 2013, PAIN, V154, P368, DOI 10.1016/j.pain.2012.11.010; Baliki MN, 2012, NAT NEUROSCI, V15, P1117, DOI 10.1038/nn.3153; Hutchison WD, 1999, NAT NEUROSCI, V2, P403, DOI 10.1038/8065; Hart AK, 2011, J NEUROSCI, V31, P18401, DOI 10.1523/JNEUROSCI.2816-11.2011; Guan ZH, 2002, CELL, V111, P483, DOI 10.1016/S0092-8674(02)01074-7; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Zhuo M, 1997, J NEUROPHYSIOL, V78, P746; Chiechio S, 2010, TRENDS PHARMACOL SCI, V31, P153, DOI 10.1016/j.tips.2009.12.003; Porreca F, 2002, TRENDS NEUROSCI, V25, P319, DOI 10.1016/S0166-2236(02)02157-4; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Imai S, 2011, J NEUROSCI, V31, P15294, DOI 10.1523/JNEUROSCI.0921-11.2011; Pickering V, 2008, EUR J PAIN, V12, P293, DOI 10.1016/j.ejpain.2007.06.001; Bai G, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-15; Bai GA, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-51; Buhler AV, 2008, PAIN, V135, P280, DOI 10.1016/j.pain.2007.06.010; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Cherng CH, 2014, J FORMOS MED ASSOC, V113, P513, DOI 10.1016/j.jfma.2013.04.007; Chiechio S, 2002, MOL PHARMACOL, V61, P989, DOI 10.1124/mol.61.5.989; Chiechio S, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-20; Crepaldi L, 2009, EPIGENETICS, V4, P23; Geranton SM, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-35; Hofbauer RK, 2006, CLIN J PAIN, V22, P104, DOI 10.1097/01.ajp.0000149798.93498.7c; Hyman S., 1993, MOL FDN PSYCHIAT; Imai S, 2013, BRAIN, V136, P828, DOI 10.1093/brain/aws330; Institute of Medicine, 2011, REL PAIN AM BLUEPR T; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kim CS, 2004, J BIOL CHEM, V279, P46464, DOI 10.1074/jbc.M403633200; Milian MJ., 2002, PROG NEUROBIOL, V66, P355, DOI DOI 10.1016/S0301-0082(02)00009-6; Narita M, 2005, J NEUROSCI, V25, P10000, DOI 10.1523/JNEUROSCI.2507-05.2005; Navratilova E, 2014, NAT NEUROSCI, V17, P1304, DOI 10.1038/nn.3811; Pohl K-W., 2011, EUR J PAIN, V15, p801e1; Purushothaman B, 2013, J ORTHOP SURG-HONG K, V21, P68; Rainville P, 2001, ANN NY ACAD SCI, V933, P130; Sakai A, 2013, BIOCHEM BIOPH RES CO, V435, P176, DOI 10.1016/j.bbrc.2013.04.089; Sakai A, 2013, BRAIN, V136, P2738, DOI 10.1093/brain/awt191; Scarpini E, 1997, J Peripher Nerv Syst, V2, P250; Tajerian M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055259; Toyoda H, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-4; Wei F, 1999, J NEUROSCI, V19, P9346; Yu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024612; Ziegler D, 2008, DIABETES-METAB RES, V24, pS52, DOI 10.1002/dmrr.817	104	2	2	ELSEVIER SCIENCE LONDON	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0166-2236			TRENDS NEUROSCI	Trends Neurosci.	APR	2015	38	4					237	246		10.1016/j.tins.2015.02.001		10	Neurosciences	Neurosciences & Neurology	CG2HU	WOS:000353096300007		
J	Do, LP; Bui, TM; Hasebe, F; Morita, K; Phan, NT				Loan Phuong Do; Trang Minh Bui; Hasebe, Futoshi; Morita, Kouichi; Nga Thi Phan			Molecular epidemiology of Japanese encephalitis in northern Vietnam, 1964-2011: genotype replacement	VIROLOGY JOURNAL			English	Article						Japanese encephalitis virus; JEV; Genotype replacement; E gene	EAST-ASIA; VIRUS; SEQUENCE; INTRODUCTIONS; EMERGENCE; REVEALS; STRAINS; ISOLATE; CHINA; SWINE	Background: Japanese encephalitis virus (JEV) is an arthropod-borne virus causing serious public health issues in Asia. JEV consists of five genotypes and recent studies have shown the emergence of JEV genotype I (GI) and its replacement of genotype III (GIII). Using an archival JEV collection, we investigated the molecular evolution of JEV in Vietnam over the last 48 years (1964-2012) in humans, mosquitoes, and pigs, within the global context. Methods: The nine JEV isolates from humans, pigs, and mosquitoes sequenced in this study and 29 sequences available in GenBank were used to analyze the envelope (E) protein of the Vietnamese JEVs. A collection of 225 cerebrospinal fluid specimens from patients with suspected Japanese encephalitis (JE) was also tested and genotyped with real-time RT-PCR. Results: The 38 E genes identified with sequencing and nine Vietnamese JEV strains genotyped with real-time RT-PCR, belonging to two lineages, evolved in accordance with those in the rest of the world. The first GIII strain was detected in humans in Vietnam in 1964, and in mosquitoes in 1979, whereas GI strains were first detected in humans and mosquitoes in 1990 and 1994, respectively. After 2004, GI was the only genotype detected in Vietnam, demonstrating that the GIIII strains had been displaced by GI strains. Five haplotypes were identified in the Vietnamese JEVs, with SKSS predominant. The S123N and S123R substitutions in the E protein were already present in the Vietnamese JEVs. Conclusion: This study describes the long evolutionary history of JEV in Vietnam over 34 years, which correlates well with the global evolution of JEV. The Vietnamese GIII strains have been replaced by GI strains in mosquitoes, pigs, and humans. The predominant haplotypes of the Vietnamese strains support this genotype displacement in Vietnam. Further surveillance is required to confirm the disappearance of the GIII strains in nature and the emergence of new pathogens causing encephalitis in Vietnam, after the long-term use of JEV vaccines in that country.	[Loan Phuong Do; Trang Minh Bui; Nga Thi Phan] Natl Inst Hyg & Epidemiol, Hanoi 10000, Vietnam; [Hasebe, Futoshi; Morita, Kouichi] Nagasaki Univ, Inst Trop Med, Nagasaki 8528523, Japan	Phan, NT (reprint author), Natl Inst Hyg & Epidemiol, Hanoi 10000, Vietnam.	pnga_arboviruses@yahoo.com			Vietnam National Foundation for Science and Technology Development (NAFOSTED) [106.16-2011.68]	This research was funded by the Vietnam National Foundation for Science and Technology Development (NAFOSTED) under grant number 106.16-2011.68.	ALI A, 1995, ARCH VIROL, V140, P1557, DOI 10.1007/BF01322530; Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233; Schuh AJ, 2010, J GEN VIROL, V91, P95, DOI 10.1099/vir.0.013631-0; Fulmali PV, 2011, EMERG INFECT DIS, V17, P319, DOI 10.3201/eid1702.100815; Nga PT, 2004, J GEN VIROL, V85, P1625, DOI 10.1099/vir.0.79797-0; Han N, 2014, J VIROL, V88, P11469, DOI 10.1128/JVI.02050-14; Kiwanuka N, 1999, CLIN INFECT DIS, V29, P1243, DOI 10.1086/313462; Erlanger TE, 2009, EMERG INFECT DIS, V15, P1, DOI 10.3201/eid1501.080311; Schuh AJ, 2014, J VIROL, V88, P4522, DOI 10.1128/JVI.02686-13; Kuno G, 1998, J VIROL METHODS, V72, P27, DOI 10.1016/S0166-0934(98)00003-2; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Ma SP, 2003, AM J TROP MED HYG, V69, P151; Williams DT, 2000, J GEN VIROL, V81, P2471; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Nam JH, 1996, ACTA VIROL, V40, P303; Tajima S, 2010, VIROLOGY, V396, P298, DOI 10.1016/j.virol.2009.10.035; Uchil PD, 2001, AM J TROP MED HYG, V65, P242; Solomon T, 2006, NEW ENGL J MED, V355, P869, DOI 10.1056/NEJMp058263; Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, p774A; Do PL, 2013, VIETNAM J PREMED, V11, P31; Fan JM, 2010, VIRUS GENES, V40, P357, DOI 10.1007/s11262-010-0464-9; HUONG VTQ, 1993, AM J TROP MED HYG, V49, P538; Lee E, 2004, J VIROL, V78, P8271, DOI 10.1128/JVI.78.15.8271-8280.2004; Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712; Nam JH, 2001, AM J TROP MED HYG, V65, P388; Nga PT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002215; Pyke AT, 2001, AM J TROP MED HYG, V65, P747; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Tang WF, 2010, INFECT GENET EVOL, V10, P329, DOI 10.1016/j.meegid.2009.12.005; Tsuchie H, 1997, AM J TROP MED HYG, V56, P153; Vu TTH, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000757; Wang HY, 2007, J GEN VIROL, V88, P885, DOI 10.1099/vir.0.82185-0; Yen Nguyen Thu, 2010, Am J Trop Med Hyg, V83, P816, DOI 10.4269/ajtmh.2010.10-0262; Yun SM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-127	34	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1743-422X			VIROL J	Virol. J.	APR 1	2015	12								51	10.1186/s12985-015-0278-4		7	Virology	Virology	CG9ZS	WOS:000353679200001		
J	Ujike, M; Taguchi, F				Ujike, Makoto; Taguchi, Fumihiro			Incorporation of Spike and Membrane Glycoproteins into Coronavirus Virions	VIRUSES-BASEL			English	Review							ACUTE RESPIRATORY SYNDROME; MOUSE HEPATITIS-VIRUS; INFECTIOUS-BRONCHITIS-VIRUS; TRANSMISSIBLE GASTROENTERITIS CORONAVIRUS; HEMAGGLUTININ-ESTERASE PROTEIN; GOLGI-COMPLEX; ENDOPLASMIC-RETICULUM; NUCLEOCAPSID PROTEIN; SARS-CORONAVIRUS; CYTOPLASMIC TAIL	The envelopes of coronaviruses (CoVs) contain primarily three proteins; the two major glycoproteins spike (S) and membrane (M), and envelope (E), a non-glycosylated protein. Unlike other enveloped viruses, CoVs bud and assemble at the endoplasmic reticulum (ER)-Golgi intermediate compartment (ERGIC). For efficient virion assembly, these proteins must be targeted to the budding site and to interact with each other or the ribonucleoprotein. Thus, the efficient incorporation of viral envelope proteins into CoV virions depends on protein trafficking and protein-protein interactions near the ERGIC. The goal of this review is to summarize recent findings on the mechanism of incorporation of the M and S glycoproteins into the CoV virion, focusing on protein trafficking and protein-protein interactions.	[Ujike, Makoto; Taguchi, Fumihiro] Nippon Vet & Life Sci Univ, Lab Virol & Viral Infect, Fac Vet Med, Tokyo 1808602, Japan	Ujike, M (reprint author), Nippon Vet & Life Sci Univ, Lab Virol & Viral Infect, Fac Vet Med, 1-7-1 Kyonan Cho, Tokyo 1808602, Japan.	ujike@nvlu.ac.jp; ftaguchi@nvlu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology in Japan [23790509, 30107429]	We thank Nagata Noriyo of the National Institute of Infectious Diseases in Tokyo, Japan for EM-image of SCoV. The work in our laboratory was supported by a Grant-in-Aid for Young Scientists (B; No. 23790509) and for Scientific Research (C; No. 30107429) from the Ministry of Education, Culture, Sports, Science and Technology in Japan.	Ben-Tekaya H, 2005, J CELL SCI, V118, P357, DOI 10.1242/jcs.01615; Glick BS, 2009, ANNU REV CELL DEV BI, V25, P113, DOI 10.1146/annurev.cellbio.24.110707.175421; Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147; Boscarino JA, 2008, J VIROL, V82, P2989, DOI 10.1128/JVI.01906-07; Nal B, 2005, J GEN VIROL, V86, P1423, DOI 10.1099/vir.0.080671-0; Woo PCY, 2005, J INFECT DIS, V192, P1898, DOI 10.1086/497151; Luini A, 2008, HISTOCHEM CELL BIOL, V129, P153, DOI 10.1007/s00418-007-0365-8; Stertz S, 2006, J INTERF CYTOK RES, V26, P650, DOI 10.1089/jir.2006.26.650; NILSSON T, 1993, FEBS LETT, V330, P1, DOI 10.1016/0014-5793(93)80906-B; NILSSON T, 1994, EMBO J, V13, P562; TYRRELL DAJ, 1965, BRIT MED J, V1, P1467; Nguyen VP, 1997, J VIROL, V71, P9278; Lim KP, 2001, J BIOL CHEM, V276, P17515, DOI 10.1074/jbc.M009731200; de Haan CAM, 1998, J VIROL, V72, P6838; Fouchier RAM, 2003, NATURE, V423, P240, DOI 10.1038/423240a; Oostra M, 2006, J VIROL, V80, P2326, DOI 10.1128/JVI.80.5.2326-2336.2006; Ruch TR, 2012, VIRUSES-BASEL, V4, P363, DOI 10.3390/v4030363; Arndt AL, 2010, J VIROL, V84, P11418, DOI 10.1128/JVI.01131-10; Baudoux P, 1998, J VIROL, V72, P8636; PENSAERT MB, 1978, ARCH VIROL, V58, P243, DOI 10.1007/BF01317606; Belouzard S, 2012, VIRUSES-BASEL, V4, P1011, DOI 10.3390/v4061011; DeDiego ML, 2007, J VIROL, V81, P1701, DOI 10.1128/JVI.01467-06; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; HAMRE D, 1966, P SOC EXP BIOL MED, V121, P190; Bonifacino JS, 1999, J CELL BIOL, V145, P923, DOI 10.1083/jcb.145.5.923; KLUMPERMAN J, 1994, J VIROL, V68, P6523; Brian DA, 2005, CURR TOP MICROBIOL, V287, P1, DOI 10.1007/3-540-26765-4_1; Li F, 2013, ANTIVIR RES, V100, P246, DOI [10.1016/j.antiviral.2013.08.014, 10.1016/j.antivira1.2013.08.014]; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Corse E, 2000, J VIROL, V74, P4319, DOI 10.1128/JVI.74.9.4319-4326.2000; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; de Haan CAM, 2005, ADV VIRUS RES, V64, P165, DOI 10.1016/S0065-3527(05)64006-7; Woo PCY, 2012, J VIROL, V86, P3995, DOI 10.1128/JVI.06540-11; Vennema H, 1996, EMBO J, V15, P2020; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; Jackson CL, 2009, J CELL SCI, V122, P443, DOI 10.1242/jcs.032581; Ziebuhr J, 2000, J GEN VIROL, V81, P853; Pyrc K, 2007, J VIROL, V81, P3051, DOI 10.1128/JVI.01466-06; Raamsman MJB, 2000, J VIROL, V74, P2333, DOI 10.1128/JVI.74.5.2333-2342.2000; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; Kuo LL, 2003, J VIROL, V77, P4597, DOI 10.1128/JVI.77.8.4597-4608.2003; de Haan CAM, 1999, J VIROL, V73, P7441; Fischer F, 1998, J VIROL, V72, P7885; Gorbalenya AE, 2006, VIRUS RES, V117, P17, DOI 10.1016/j.virusres.2006.01.017; Huang Y, 2004, J VIROL, V78, P12557, DOI 10.1128/JVI.78.22.12557-12565.2004; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; de Haan CAM, 2000, J VIROL, V74, P4967, DOI 10.1128/JVI.74.11.4967-4978.2000; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Desforges M, 2013, J VIROL, V87, P3097, DOI 10.1128/JVI.02699-12; Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019; ARMSTRONG J, 1990, J CELL SCI, V95, P191; ARMSTRONG J, 1991, J CELL SCI, V98, P567; ARMSTRONG J, 1984, NATURE, V308, P751, DOI 10.1038/308751a0; Banfield DK, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005264; Bos ECW, 1995, VIROLOGY, V214, P453, DOI 10.1006/viro.1995.0056; Bosch BJ, 2005, VIROLOGY, V334, P306, DOI 10.1016/j.virol.2005.02.001; Chang KW, 2000, VIROLOGY, V269, P212, DOI 10.1006/viro.2000.0219; Corse E, 2003, VIROLOGY, V312, P25, DOI 10.1016/S0042-6822(03)00175-2; De Groot R. J., 2012, FAMILY CORONAVIRIDAE; de Haan CAM, 1998, J BIOL CHEM, V273, P29905, DOI 10.1074/jbc.273.45.29905; Enjuanes L., 1995, The coronaviridae., P337; Escors D, 2001, J VIROL, V75, P12228, DOI 10.1128/JVI.75.24.12228-12240.2001; Gelhaus S, 2014, VIROLOGY, V464, P397, DOI 10.1016/j.virol.2014.07.035; Geva Y, 2014, CURR BIOL, V24, pR130, DOI 10.1016/j.cub.2013.12.008; Glick BS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005215; Godeke GJ, 2000, J VIROL, V74, P1566, DOI 10.1128/JVI.74.3.1566-1571.2000; He RT, 2004, BIOCHEM BIOPH RES CO, V316, P476, DOI 10.1016/j.bbrc.2004.02.074; Heald-Sargent T, 2012, VIRUSES-BASEL, V4, P557, DOI 10.3390/v4040557; HOLMES KV, 1981, VIROLOGY, V115, P334, DOI 10.1016/0042-6822(81)90115-X; Hsieh PK, 2005, J VIROL, V79, P13848, DOI 10.1128/JVI.79.22.13848-13855.2005; Huang Y. W., 2013, MBIO, V4, DOI DOI 10.1128/MBI0.00737-13; JACOBSEGEELS HEL, 1983, J GEN VIROL, V64, P1859, DOI 10.1099/0022-1317-64-9-1859; KRIJNSELOCKER J, 1994, J CELL BIOL, V124, P55, DOI 10.1083/jcb.124.1.55; Kuiken T, 2003, LANCET, V362, P263, DOI 10.1016/S0140-6736(03)13967-0; LAVIADA MD, 1990, VIRUS RES, V16, P247, DOI 10.1016/0168-1702(90)90051-C; Lissenberg A, 2005, J VIROL, V79, P15054, DOI 10.1128/JVI.79.24.15054-15063.2005; LOCKER JK, 1995, J BIOL CHEM, V270, P8815; LOCKER JK, 1992, J BIOL CHEM, V267, P14094; LOCKER JK, 1994, J BIOL CHEM, V269, P28263; Lontok E, 2004, J VIROL, V78, P5913, DOI 10.1128/JVI.78.11.5913-5922.2004; Luo HB, 2006, BIOCHEMISTRY-US, V45, P11827, DOI 10.1021/bi0609319; Luo HB, 2004, BIOPHYS CHEM, V112, P15, DOI 10.1016/j.bpc.2004.06.008; MACHAMER CE, 1987, J CELL BIOL, V105, P1205, DOI 10.1083/jcb.105.3.1205; MACHAMER CE, 1993, MOL BIOL CELL, V4, P695; MACHAMER CE, 1990, P NATL ACAD SCI USA, V87, P6944, DOI 10.1073/pnas.87.18.6944; Masters PS, 2006, ADV EXP MED BIOL, V581, P163; Matsuyama S, 2005, P NATL ACAD SCI USA, V102, P12543, DOI 10.1073/pnas.0503203102; MAYER T, 1988, J BIOL CHEM, V263, P14956; McBride CE, 2010, VIROLOGY, V405, P139, DOI 10.1016/j.virol.2010.05.031; McBride CE, 2010, J VIROL, V84, P1891, DOI 10.1128/JVI.02458-09; McBride CE, 2007, J VIROL, V81, P2418, DOI 10.1128/JVI.02146-06; MCINTOSH K, 1967, P NATL ACAD SCI USA, V57, P933, DOI 10.1073/pnas.57.4.933; Namy O, 2006, NATURE, V441, P244, DOI 10.1038/nature04735; Narayanan K, 2000, J VIROL, V74, P8127, DOI 10.1128/JVI.74.17.8127-8134.2000; Neuman BW, 2011, J STRUCT BIOL, V174, P11, DOI 10.1016/j.jsb.2010.11.021; Neuman BW, 2006, J VIROL, V80, P7918, DOI 10.1128/JVI.00645-06; NIEMANN H, 1984, EMBO J, V3, P665; NILSSON T, 1994, CURR OPIN CELL BIOL, V6, P517, DOI 10.1016/0955-0674(94)90070-1; OIE, OIE LIST DIS INF INF; OPSTELTEN DJE, 1995, J CELL BIOL, V131, P339, DOI 10.1083/jcb.131.2.339; Petit CM, 2007, VIROLOGY, V360, P264, DOI 10.1016/j.virol.2006.10.034; RISCO C, 1995, J VIROL, V69, P5269; ROBBINS SG, 1986, VIROLOGY, V150, P402, DOI 10.1016/0042-6822(86)90305-3; ROTTIER PJM, 1986, BIOCHEMISTRY-US, V25, P1335, DOI 10.1021/bi00354a022; ROTTIER PJM, 1981, J VIROL, V40, P350; ROTTIER PJM, 1987, J VIROL, V61, P2042; Schwegmann-Wessels C, 2004, J BIOL CHEM, V279, P43661, DOI 10.1074/jbc.M407233200; Shirato K, 2011, VIRUS RES, V161, P188, DOI 10.1016/j.virusres.2011.07.019; Shirato K, 2010, ARCH VIROL, V155, P1989, DOI 10.1007/s00705-010-0790-1; Shulla A, 2009, J BIOL CHEM, V284, P32725, DOI 10.1074/jbc.M109.043547; Siu YL, 2008, J VIROL, V82, P11318, DOI 10.1128/JVI.01052-08; Sjaak de Wit J. J., 2011, AVIAN PATHOL, V40, P223; Surjit M, 2004, BIOCHEM BIOPH RES CO, V317, P1030, DOI 10.1016/j.bbrc.2004.03.154; Thorp EB, 2006, J VIROL, V80, P1280, DOI 10.1128/JVI.80.3.1280-1289.2006; TO LT, 1991, VET MICROBIOL, V29, P361, DOI 10.1016/0378-1135(91)90143-4; TOOZE J, 1984, EUR J CELL BIOL, V33, P281; Tseng YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064013; Tseng YT, 2010, J BIOL CHEM, V285, P12862, DOI 10.1074/jbc.M109.030270; Ujike M, 2008, J VIROL, V82, P588, DOI 10.1128/JVI.01697-07; Ujike M, 2012, J GEN VIROL, V93, P823, DOI 10.1099/vir.0.038091-0; VENNEMA H, 1990, J VIROL, V64, P339; Voss D, 2006, FEBS LETT, V580, P968, DOI 10.1016/j.febslet.2006.01.026; Voss D, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-79; WEISZ OA, 1993, J CELL BIOL, V122, P1185, DOI 10.1083/jcb.122.6.1185; Winter C, 2008, J VIROL, V82, P2765, DOI 10.1128/JVI.02064-07; World Health Organization, 2014, MIDDL E RESP SYNDR C; Yang JH, 2012, VIROLOGY, V427, P98, DOI 10.1016/j.virol.2012.02.015; Youn S, 2005, J VIROL, V79, P13209, DOI 10.1128/JVI.79.21.13209-13217.2005; Yu IM, 2005, J BIOL CHEM, V280, P23280, DOI 10.1074/M501015200	129	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1999-4915			VIRUSES-BASEL	Viruses-Basel	APR	2015	7	4					1700	1725		10.3390/v7041700		26	Virology	Virology	CH0OH	WOS:000353720400011		
J	Theze, J; Takatsuka, J; Nakai, M; Arif, B; Herniou, EA				Theze, Julien; Takatsuka, Jun; Nakai, Madoka; Arif, Basil; Herniou, Elisabeth A.			Gene Acquisition Convergence between Entomopoxviruses and Baculoviruses	VIRUSES-BASEL			English	Article							HORIZONTAL TRANSFER; ADOXOPHYES-HONMAI; MYTHIMNA-SEPARATA; POXVIRUS GENOME; EVOLUTION; INSECT; VIRUSES; DIVERSITY; WIDESPREAD; INFECTION	Organisms from diverse phylogenetic origins can thrive within the same ecological niches. They might be induced to evolve convergent adaptations in response to a similar landscape of selective pressures. Their genomes should bear the signature of this process. The study of unrelated virus lineages infecting the same host panels guarantees a clear identification of phyletically independent convergent adaptation. Here, we investigate the evolutionary history of genes in the accessory genome shared by unrelated insect large dsDNA viruses: the entomopoxviruses (EPVs, Poxviridae) and the baculoviruses (BVs). EPVs and BVs have overlapping ecological niches and have independently evolved similar infection processes. They are, in theory, subjected to the same selective pressures from their host's immune responses. Their accessory genomes might, therefore, bear analogous genomic signatures of convergent adaption and could point out key genomic mechanisms of adaptation hitherto undetected in viruses. We uncovered 32 homologous, yet independent acquisitions of genes originating from insect hosts, different eukaryotes, bacteria and viruses. We showed different evolutionary levels of gene acquisition convergence in these viruses, underlining a continuous evolutionary process. We found both recent and ancient gene acquisitions possibly involved to the adaptation to both specific and distantly related hosts. Multidirectional and multipartite gene exchange networks appear to constantly drive exogenous gene assimilations, bringing key adaptive innovations and shaping the life histories of large DNA viruses. This evolutionary process might lead to genome level adaptive convergence.	[Theze, Julien; Herniou, Elisabeth A.] Univ Tours, Inst Rech Biol Insecte, UFR Sci & Tech, CNRS UMR 7261, F-37200 Tours, France; [Theze, Julien] Univ Poitiers, UMR CNRS Ecol & Biol Interact 7267, Equipe Ecol Evolut Symbiose, F-86073 Poitiers, France; [Takatsuka, Jun] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan; [Nakai, Madoka] Tokyo Univ Agr & Technol, Inst Agr, Saiwai Ku, Fuchu, Tokyo 1838509, Japan; [Arif, Basil] Great Lakes Forestry Ctr, Sault Ste Marie, ON P6A 2E5, Canada	Herniou, EA (reprint author), Univ Tours, Inst Rech Biol Insecte, UFR Sci & Tech, CNRS UMR 7261, F-37200 Tours, France.	theze.julien@gmail.com; junsan@ffpri.affrc.go.jp; madoka@cc.tuat.ac.jp; basil.arif@nrcan-rncan.gc.ca; elisabeth.herniou@univ-tours.fr	NAKAI, Madoka/G-1088-2013; 	NAKAI, Madoka/0000-0003-1929-9543; Herniou, Elisabeth/0000-0001-5362-6056	European Research Council [205206 GENOVIR]; JSPS KAKENHI [24380035, 24657064]	European Research Council grant 205206 GENOVIR funded J.T. and E.A.H. JSPS KAKENHI Grant numbers 24380035 and 24657064 supported J.T. We thank Juan Pino for providing noctuid moth samples.	MAY RM, 1988, SCIENCE, V241, P1441, DOI 10.1126/science.241.4872.1441; Theze J, 2011, P NATL ACAD SCI USA, V108, P15931, DOI 10.1073/pnas.1105580108; Anantharaman K, 2014, SCIENCE, V344, P757, DOI 10.1126/science.1252229; Boc A, 2010, SYST BIOL, V59, P195, DOI 10.1093/sysbio/syp103; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Mitsuhashi W, 2007, J VIROL, V81, P4235, DOI 10.1128/JVI.02300-06; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Parker J, 2013, NATURE, V502, P228, DOI 10.1038/nature12511; Zilber-Rosenberg I, 2008, FEMS MICROBIOL REV, V32, P723, DOI 10.1111/j.1574-6976.2008.00123.x; Filee J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-320; Garavaglia MJ, 2012, J VIROL, V86, P12069, DOI 10.1128/JVI.01873-12; Smillie CS, 2011, NATURE, V480, P241, DOI 10.1038/nature10571; Tenaillon O, 2012, SCIENCE, V335, P457, DOI 10.1126/science.1212986; Elde NC, 2012, CELL, V150, P831, DOI 10.1016/j.cell.2012.05.049; McLysaght A, 2003, P NATL ACAD SCI USA, V100, P15655, DOI 10.1073/pnas.2136653100; Shackelton LA, 2004, TRENDS MICROBIOL, V12, P458, DOI 10.1016/j.tim.2004.08.005; Breitbart M, 2005, TRENDS MICROBIOL, V13, P278, DOI 10.1016/j.tim.2005.04.003; Sabehi G, 2012, P NATL ACAD SCI USA, V109, P2037, DOI 10.1073/pnas.1115467109; Sharon I, 2009, NATURE, V461, P258, DOI 10.1038/nature08284; Hughes AL, 2002, INFECT GENET EVOL, V2, P3, DOI 10.1016/S1567-1348(02)00040-0; Bergin D, 2005, INFECT IMMUN, V73, P4161, DOI 10.1128/IAI.73.7.4161-4170.2005; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Cox FEG, 2001, PARASITOLOGY, V122, pS23, DOI 10.1017/S003118200001698X; Upton C, 2003, J VIROL, V77, P7590, DOI 10.1128/JVI.77.13.7590-7600.2003; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Hughes AL, 2003, MOL BIOL EVOL, V20, P979, DOI 10.1093/molbev/msg107; Bratke KA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-67; Brussow H, 2009, PHILOS T R SOC B, V364, P2263, DOI 10.1098/rstb.2009.0036; Clem RJ, 2007, CURR DRUG TARGETS, V8, P1069, DOI 10.2174/138945007782151405; Combes C., 2001, PARASITISM ECOLOGY E; Cory JS, 1997, MOL BIOTECHNOL, V7, P303, DOI 10.1007/BF02740821; Dall D, 2001, BIOESSAYS, V23, P184, DOI 10.1002/1521-1878(200102)23:2<184::AID-BIES1026>3.0.CO;2-H; Zanotto PMD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003500; Feschotte C, 2009, P NATL ACAD SCI USA, V106, P19747, DOI 10.1073/pnas.0910273106; Forterre P, 2009, RES MICROBIOL, V160, P466, DOI 10.1016/j.resmic.2009.07.008; Gilbert C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4348; Herniou EA, 2013, PHILOS T R SOC B, V12, P368, DOI DOI 10.1098/RSTB.2013.0051; Hughes AL, 2005, MOL PHYLOGENET EVOL, V35, P186, DOI 10.1016/j.ympev.2004.12.008; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Asgari S, 2010, INSECT VIROLOGY, P347; Katzourakis A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001191; King AMQ, 2011, VIRUS TAXONOMY 9 REP; Mukawa S, 2008, J GEN VIROL, V89, P915, DOI 10.1099/vir.0.83365-0; Nakai M, 2004, VIRUS RES, V101, P185, DOI 10.1016/j.virusres.2004.01.003; Pace JK, 2008, P NATL ACAD SCI USA, V105, P17023, DOI 10.1073/pnas.0806548105; Possee RD, 1997, BACULOVIRUSES, P109; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Takatsuka J, 2010, J INVERTEBR PATHOL, V105, P121, DOI 10.1016/j.jip.2010.04.010; Theze J, 2013, J VIROL, V87, P7992, DOI 10.1128/JVI.00453-13; XU JH, 1992, J INVERTEBR PATHOL, V60, P259, DOI 10.1016/0022-2011(92)90007-Q	50	1	1	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1999-4915			VIRUSES-BASEL	Viruses-Basel	APR	2015	7	4					1960	1974		10.3390/v7041960		15	Virology	Virology	CH0OH	WOS:000353720400020		
J	Koizumi, O; Hamada, S; Minobe, S; Hamaguchi-Hamada, K; Kurumata-Shigeto, M; Nakamura, M; Namikawa, H				Koizumi, Osamu; Hamada, Shun; Minobe, Sumiko; Hamaguchi-Hamada, Kayoko; Kurumata-Shigeto, Mami; Nakamura, Masaru; Namikawa, Hiroshi			The nerve ring in cnidarians: its presence and structure in hydrozoan medusae	ZOOLOGY			English	Article						Cnidaria; Hydrozoa; Medusa; Nerve ring; Nervous system	JELLYFISH TRIPEDALIA-CYSTOPHORA; AGLANTHA-DIGITALE; BOX JELLYFISH; CENTRAL CIRCUITRY; HYDRA; SYSTEM; IDENTIFICATION; NEUROPEPTIDE; HYPOSTOME; BEHAVIOR	In our previous studies of the Hydra nerve ring, we proposed the following hypothesis: "The nerve ring in the hypostome of Hydra is a central nervous system (CNS)-like neuronal structure." Related to this hypothesis, we have started to survey the nerve ring immunocytochemically using antibodies against neuropeptides throughout the whole phylum of cnidarians. In the present study, we describe nerve rings in hydrozoan medusae. We examined the medusae of five hydrozoan species belonging to three orders: Eirene sp. (order Leptomedusae), Craspedacusta sowerbyi (order Limnomedusae), Sarsia tubulosa, Turritopsis nutricula, and Cladonema radiatum (order Anthomedusae). We observed a well-developed nerve ring in all species. The nerve ring runs circumferentially around the margin of the bell. In all cases, the nerve ring was visualized by plural antibodies, suggesting that it contains different neural subpopulations. In C. radiatum, antibodies against four different neuropeptides labeled the nerve ring. We established clear (without undesirable cross-reactions) double-staining procedures with two rabbit primary antibodies. Using the double-staining method, three neural subsets visualized by three antibodies revealed completely separate neural populations. The results show that the nerve ring is a common feature in hydrozoan medusae and has a complex heterogeneous structure composed of different neural subsets. (C) 2014 Elsevier GmbH. All rights reserved.	[Koizumi, Osamu; Hamada, Shun; Minobe, Sumiko; Hamaguchi-Hamada, Kayoko; Kurumata-Shigeto, Mami] Fukuoka Womens Univ, Dept Environm Sci, Higashi Ku, Fukuoka 8138529, Japan; [Nakamura, Masaru] Okinawa Churashima Fdn, Okinawa 9050206, Japan; [Namikawa, Hiroshi] Natl Museum Nat & Sci, Dept Zool, Tsukuba, Ibaraki 3050005, Japan	Koizumi, O (reprint author), Fukuoka Womens Univ, Dept Environm Sci, Higashi Ku, Kasumiga Oka 1-1-1, Fukuoka 8138529, Japan.	koizumi@fwu.ac.jp					Yum S, 1998, BIOCHEM BIOPH RES CO, V248, P584, DOI 10.1006/bbrc.1998.8831; Takahashi T, 2003, COMP BIOCHEM PHYS B, V135, P309, DOI 10.1016/S1096-4959(03)00088-5; SPENCER AN, 1980, J NEUROBIOL, V11, P13, DOI 10.1002/neu.480110103; Koizumi O, 2002, CAN J ZOOL, V80, P1678, DOI 10.1129/Z02-134; Mackie GO, 2003, J EXP BIOL, V206, P2487, DOI 10.1242/jeb.00450; Koizumi O, 2007, BRAIN BEHAV EVOLUT, V69, P151, DOI 10.1159/000095204; Mackie GO, 2004, NEUROSIGNALS, V13, P5, DOI 10.1159/000076155; Marlow HQ, 2009, DEV NEUROBIOL, V69, P235, DOI 10.1002/dneu.20698; Garm A, 2007, CELL TISSUE RES, V329, P147, DOI 10.1007/s00441-007-0393-7; Nilsson DE, 2005, NATURE, V435, P201, DOI 10.1038/nature03484; Takahashi T, 1997, P NATL ACAD SCI USA, V94, P1241, DOI 10.1073/pnas.94.4.1241; Cartwright P, 2010, INTEGR COMP BIOL, V50, P456, DOI 10.1093/icb/icq089; KOIZUMI O, 1992, J COMP NEUROL, V326, P7, DOI 10.1002/cne.903260103; Skogh C, 2006, J MORPHOL, V267, P1391, DOI 10.1002/jmor.10472; Garm A, 2006, CELL TISSUE RES, V325, P333, DOI 10.1007/s00441-005-0134-8; SATTERLIE RA, 1983, J COMP PHYSIOL, V150, P195; Satterlie RA, 2011, J EXP BIOL, V214, P1215, DOI 10.1242/jeb.043687; Takahashi T, 2000, DEVELOPMENT, V127, P997; BLANQUET RS, 1968, SCIENCE, V159, P633, DOI 10.1126/science.159.3815.633; DUNNE JF, 1985, DEV BIOL, V109, P41, DOI 10.1016/0012-1606(85)90344-6; GRIMMELIKHUIJZEN CJP, 1985, CELL TISSUE RES, V241, P171, DOI 10.1007/BF00214639; Kayal E, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-5; KOIZUMI O, 1981, J COMP PHYSIOL, V142, P75; Mackie GO, 2000, J EXP BIOL, V203, P1797; Morishita F, 2003, PEPTIDES, V24, P17, DOI 10.1016/S0196-9781(02)00272-3; Oi V. T., 1980, SELECTED METHODS CEL, P351; ROBERTS A, 1980, J EXP BIOL, V84, P303; Rushforth N.B., 1973, INVERTEBRATE LEARNIN, V1, P123; RUSHFORTH N B, 1973, P3; SPENCER AN, 1984, J EXP BIOL, V110, P69; Yuura H, 2008, THESIS FUKUOKA WOMEN	31	2	2	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0944-2006			ZOOLOGY	Zoology	APR	2015	118	2			SI		79	88		10.1016/j.zool.2014.10.001		10	Zoology	Zoology	CH0VK	WOS:000353740300003		
J	Falson, J; Maryenko, D; Friess, B; Zhang, D; Kozuka, Y; Tsukazaki, A; Smet, JH; Kawasaki, M				Falson, J.; Maryenko, D.; Friess, B.; Zhang, D.; Kozuka, Y.; Tsukazaki, A.; Smet, J. H.; Kawasaki, M.			Even-denominator fractional quantum Hall physics in ZnO	NATURE PHYSICS			English	Article							HIGH LANDAU-LEVELS; 2-DIMENSIONAL ELECTRON-SYSTEMS; LEVEL FILLING FACTOR; COMPOSITE FERMIONS; MAGNETIC-FIELD; STATE	The fractional quantum Hall (FQH) effect emerges in high-quality two-dimensional electron systems exposed to a magnetic field when the Landau-level filling factor, nu(e), takes on a rational value. Although the overwhelming majority of FQH states have odd-denominator fillings, the physical properties of the rare and fragile even-denominator states are most tantalizing in view of their potential relevance for topological quantum computation. For decades, GaAs has been the preferred host for studying these even-denominator states, where they occur at nu(e) = 5/2 and 7/2. Here we report an anomalous series of quantized even-denominator FQH states outside the realm of III-V semiconductors in the MgZnO/ZnO 2DES electron at nu(e) = 3/2 and 7/2, with precursor features at 9/2; all while the 5/2 state is absent. The effect in this material occurs concomitantly with tunability of the orbital character of electrons at the chemical potential, thereby realizing a new experimental means for investigating these exotic ground states.	[Falson, J.; Kozuka, Y.; Kawasaki, M.] Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan; [Falson, J.; Kozuka, Y.; Kawasaki, M.] Univ Tokyo, Quantum Phase Elect Ctr, Tokyo 1138656, Japan; [Falson, J.] Univ Tokyo, Dept Adv Mat Sci, Kashiwa, Chiba 2778561, Japan; [Maryenko, D.; Kawasaki, M.] RIKEN, Ctr Emergent Matter Sci, Wako, Saitama 3510198, Japan; [Friess, B.; Zhang, D.; Smet, J. H.] Max Planck Inst Solid State Res, D-70569 Stuttgart, Germany; [Tsukazaki, A.] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Tsukazaki, A.] Japan Sci & Technol Agcy JST, PRESTO, Tokyo 1020075, Japan	Smet, JH (reprint author), Max Planck Inst Solid State Res, Heisenbergstr 1, D-70569 Stuttgart, Germany.	j.smet@fkf.mpg.de; kawasaki@ap.t.u-tokyo.ac.jp	Kawasaki, Masashi/B-5826-2008; Kozuka, Yusuke/E-6470-2010; Tsukazaki, Atsushi/C-3972-2008	Kozuka, Yusuke/0000-0002-2205-2421; 	MEXT, Japan [24226002]; Japan Society for the Promotion of Science(JSPS); German Ministry of Science and Education (BMBF); Marubun Research Promotion Foundation	We thank K. v. Klitzing, T. Arima, R. Morf, M. Shayegan, Y. Liu and V. Scarola for discussions. This work was partly supported by Grant-in-Aids for Scientific Research (S) No. 24226002 from MEXT, Japan, `Funding Program forWorld-Leading Innovative R&D on Science and Technology (FIRST)' Program from the Japan Society for the Promotion of Science (JSPS) initiated by the Council for Science and Technology Policy and the German Ministry of Science and Education (BMBF). J.F. acknowledges the support of the Marubun Research Promotion Foundation.	Pan W, 1999, PHYS REV LETT, V83, P3530, DOI 10.1103/PhysRevLett.83.3530; Stern A, 2010, NATURE, V464, P187, DOI 10.1038/nature08915; Lilly MP, 1999, PHYS REV LETT, V83, P824, DOI 10.1103/PhysRevLett.83.824; MACDONALD AH, 1986, PHYS REV B, V33, P4009, DOI 10.1103/PhysRevB.33.4009; Tsukazaki A, 2010, NAT MATER, V9, P889, DOI [10.1038/nmat2874, 10.1038/NMAT2874]; Nayak C, 2008, REV MOD PHYS, V80, P1083, DOI 10.1103/RevModPhys.80.1083; DU RR, 1995, PHYS REV LETT, V75, P3926, DOI 10.1103/PhysRevLett.75.3926; MOORE G, 1991, NUCL PHYS B, V360, P362, DOI 10.1016/0550-3213(91)90407-O; Lilly MP, 1999, PHYS REV LETT, V82, P394, DOI 10.1103/PhysRevLett.82.394; Fogler MM, 1997, PHYS REV B, V55, P9326, DOI 10.1103/PhysRevB.55.9326; Ki DK, 2014, NANO LETT, V14, P2135, DOI 10.1021/nl5003922; Luhman DR, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.266804; Falson J, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.091101; Papic Z, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.046602; SUEN YW, 1992, PHYS REV LETT, V68, P1379, DOI 10.1103/PhysRevLett.68.1379; Scarola VW, 2000, NATURE, V406, P863; EISENSTEIN JP, 1992, PHYS REV LETT, V68, P1383, DOI 10.1103/PhysRevLett.68.1383; De Poortere EP, 2000, SCIENCE, V290, P1546, DOI 10.1126/science.290.5496.1546; HALPERIN BI, 1983, HELV PHYS ACTA, V56, P75; JAIN JK, 1989, PHYS REV LETT, V63, P199, DOI 10.1103/PhysRevLett.63.199; Liu Y, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.165313; Eisenstein JP, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.076801; Pan W, 1999, PHYS REV LETT, V83, P820, DOI 10.1103/PhysRevLett.83.820; Vakili K, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.176402; Choi HC, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.081301; Das Sarma S., 1997, PERSPECTIVES QUANTUM; Gamez G, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.075308; Jungwirth T, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.216801; Liu Y, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.046804; Rezayi EH, 1999, PHYS REV LETT, V83, P1219, DOI 10.1103/PhysRevLett.83.1219; SODEMANN I, 2013, THEORY NATIVE ORIENT; Wiedmann S, 2011, J PHYS CONF SER, V334, DOI 10.1088/1742-6596/334/1/012026; WILLETT R, 1987, PHYS REV LETT, V59, P1776, DOI 10.1103/PhysRevLett.59.1776	33	6	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1745-2473	1745-2481		NAT PHYS	Nat. Phys.	APR	2015	11	4					347	351		10.1038/NPHYS3259		5	Physics, Multidisciplinary	Physics	CE9KO	WOS:000352163100019		
J	Daneshtalab, M; Mehdipour, F; Yu, ZY; Tenhunen, H				Daneshtalab, Masoud; Mehdipour, Farhad; Yu, Zhiyi; Tenhunen, Hannu			Special Issue on Emerging Many-Core Systems for Exascale Computing	ACM Journal on Emerging Technologies in Computing Systems			English	Editorial Material									[Daneshtalab, Masoud] Univ Turku, SF-20500 Turku, Finland; [Daneshtalab, Masoud; Tenhunen, Hannu] KTH Royal Inst Technol, Stockholm, Sweden; [Mehdipour, Farhad] Kyushu Univ, Fukuoka 812, Japan; [Yu, Zhiyi] Fudan Univ, Shanghai, Peoples R China	Daneshtalab, M (reprint author), Univ Turku, SF-20500 Turku, Finland.							0	0	0	ASSOC COMPUTING MACHINERY	NEW YORK	2 PENN PLAZA, STE 701, NEW YORK, NY 10121-0701 USA	1550-4832	1550-4840		ACM J EMERG TECH COM	ACM J. Emerg. Technol. Comput. Syst.	APR	2015	11	4			SI				39	10.1145/2717312		2	Computer Science, Hardware & Architecture; Engineering, Electrical & Electronic; Nanoscience & Nanotechnology	Computer Science; Engineering; Science & Technology - Other Topics	CG9NN	WOS:000353642700008		
J	Ohe, K; Hagiwara, M				Ohe, Kenji; Hagiwara, Masatoshi			Modulation of Alternative Splicing with Chemical Compounds in New Therapeutics for Human Diseases	ACS Chemical Biology			English	Review							SPINAL MUSCULAR-ATROPHY; PRE-MESSENGER-RNA; TISSUE-SPECIFIC EXPRESSION; PROTEIN-KINASE INHIBITORS; FAMILIAL DYSAUTONOMIA; HNRNP A1; IN-VIVO; DOWN-SYNDROME; GENE-EXPRESSION; SELECTIVE INHIBITOR	Alternative splicing is a critical step where a limited number of human genes generate a complex and diverse proteome. Various diseases, including inherited diseases with abnormalities in the genome code, have been found to result in an aberrant mis-spliced transcript code with correlation to the resulting phenotype. Chemical compound-based and nucleic acid-based strategies are trying to target this mis-spliced transcript code. We will briefly mention about how to obtain splicing-modifying-compounds by high-throughput screening and overview of what is known about compounds that modify splicing pathways. The main focus will be on RNA-binding protein kinase inhibitors. In the main text, we will refer to diseases where splicing-modifying-compounds have been intensively investigated, with comparison to nucleic acid-based strategies. The information on their involvement in mis-splicing as well as nonsplicing events will be helpful in finding better compounds with less off-target effects for future implications in mis-splicing therapy.	[Ohe, Kenji; Hagiwara, Masatoshi] Kyoto Univ, Grad Sch Med, Dept Anat & Dev Biol, Kyoto 6068315, Japan; [Ohe, Kenji] Kyoto Univ, Grad Sch Med, Training Program Leaders Integrated Med Syst Frui, Kyoto 6068315, Japan	Hagiwara, M (reprint author), Kyoto Univ, Grad Sch Med, Dept Anat & Dev Biol, Kyoto 6068315, Japan.	hagiwara.masatoshi.8c@kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [21249013, 24591920]; Research Program of Innovative Cell Biology from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [231006]; Platform for Drug Discovery from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; National Institute of Biomedical Innovation (NIBIO) [241011]; CREST of Japan Science and Technology Agency (JST) [231038]	This work was supported by Grants-in-Aid for Scientific Research (21249013 to M.H. and 24591920 to K.O.), Research Program of Innovative Cell Biology (231006 to MET), and Platform for Drug Discovery (to M.H.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan, and by Grants from National Institute of Biomedical Innovation (NIBIO, 241011 to M.H.) and CREST of Japan Science and Technology Agency (JST, 231038 to M.H.). The authors apologize to not properly cited research in this review owing to space limitations.	Adayev T, 2011, ARCH BIOCHEM BIOPHYS, V507, P212, DOI 10.1016/j.abb.2010.12.024; Anderson SL, 2003, BIOCHEM BIOPH RES CO, V310, P627, DOI 10.1016/j.bbrc.2003.09.019; BERGET SM, 1995, J BIOL CHEM, V270, P2411; Kaida D, 2012, CANCER SCI, V103, P1611, DOI 10.1111/j.1349-7006.2012.02356.x; Colwill K, 1996, EMBO J, V15, P265; Sanidas I, 2014, MOL CELL, V53, P577, DOI 10.1016/j.molcel.2013.12.018; Takeshima Y, 2006, PEDIATR RES, V59, P690, DOI 10.1203/01.pdr.0000215047.51278.7c; Kawaguchi S, 2012, BIOINFORMATICS, V28, P929, DOI 10.1093/bioinformatics/bts065; Dong ZY, 2013, MOL VIS, V19, P536; Li PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053268; Kotake Y, 2007, NAT CHEM BIOL, V3, P570, DOI 10.1038/nchembio.2007.16; Fedorov O, 2011, CHEM BIOL, V18, P67, DOI 10.1016/j.chembiol.2010.11.009; Ninomiya K, 2011, J CELL BIOL, V195, P27, DOI 10.1083/jcb.201107093; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Zhou ZH, 2012, MOL CELL, V47, P422, DOI 10.1016/j.molcel.2012.05.014; Eggert US, 2013, NAT CHEM BIOL, V9, P206, DOI 10.1038/nchembio.1206; Liu YY, 2013, NUCLEIC ACIDS RES, V41, P4949, DOI 10.1093/nar/gkt170; Fant X, 2014, MOL PHARMACOL, V85, P441, DOI 10.1124/mol.113.090837; Bonnal S, 2012, NAT REV DRUG DISCOV, V11, P847, DOI 10.1038/nrd3823; Anderson SL, 2001, AM J HUM GENET, V68, P753, DOI 10.1086/318808; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Corrionero A, 2011, GENE DEV, V25, P445, DOI 10.1101/gad.2014311; Katz Y, 2010, NAT METHODS, V7, P1009, DOI [10.1038/nmeth.1528, 10.1038/NMETH.1528]; Pozo N, 2013, J CLIN INVEST, V123, P2475, DOI 10.1172/JCI63623; Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131; Smith B, 2012, ACS CHEM NEUROSCI, V3, P857, DOI 10.1021/cn300094k; Boultwood Jacqueline, 2014, Advances in Biological Regulation, V54, P153, DOI 10.1016/j.jbior.2013.09.005; Shen ML, 2013, NUCLEIC ACIDS RES, V41, P3819, DOI 10.1093/nar/gkt063; Debdab M, 2011, J MED CHEM, V54, P4172, DOI 10.1021/jm200274d; Shi JH, 2008, J BIOL CHEM, V283, P28660, DOI 10.1074/jbc.M802645200; Chang JG, 2001, P NATL ACAD SCI USA, V98, P9808, DOI 10.1073/pnas.171105098; Siddiqui-Jain A, 2010, CANCER RES, V70, P10288, DOI 10.1158/0008-5472.CAN-10-1893; Luo YL, 2014, CHEMBIOCHEM, V15, P2041, DOI 10.1002/cbic.201402069; Nowak DG, 2010, J BIOL CHEM, V285, P5532, DOI 10.1074/jbc.M109.074930; Lunn MR, 2008, LANCET, V371, P2120, DOI 10.1016/S0140-6736(08)60921-6; Pandit S, 2013, MOL CELL, V50, P223, DOI 10.1016/j.molcel.2013.03.001; Axelrod FB, 2011, PEDIATR RES, V70, P480, DOI 10.1038/pr.2011.705; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; De la Torre R, 2014, MOL NUTR FOOD RES, V58, P278, DOI 10.1002/mnfr.201300325; GARRETT S, 1989, GENE DEV, V3, P1336, DOI 10.1101/gad.3.9.1336; Eskens FALM, 2013, CLIN CANCER RES, V19, P6296, DOI 10.1158/1078-0432.CCR-13-0485; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Amin EM, 2011, CANCER CELL, V20, P768, DOI 10.1016/j.ccr.2011.10.016; Velagapudi SP, 2014, NAT CHEM BIOL, V10, P291, DOI [10.1038/nchembio.1452, 10.1038/NCHEMBIO.1452]; Marchand V, 2002, J MOL BIOL, V323, P629, DOI 10.1016/S0022-2836(02)00967-1; Naryshkin NA, 2014, SCIENCE, V345, P688, DOI 10.1126/science.1250127; Webby CJ, 2009, SCIENCE, V325, P90, DOI 10.1126/science.1175865; Zhu J, 2001, MOL CELL, V8, P1351, DOI 10.1016/S1097-2765(01)00409-9; Eswarappa SM, 2014, CELL, V157, P1605, DOI 10.1016/j.cell.2014.04.033; George L, 2013, P NATL ACAD SCI USA, V110, P18698, DOI 10.1073/pnas.1308596110; Fu XD, 2014, NAT REV GENET, V15, P689, DOI 10.1038/nrg3778; Schneider M, 2010, NAT STRUCT MOL BIOL, V17, P216, DOI 10.1038/nsmb.1718; Lorson MA, 2012, FUTURE MED CHEM, V4, P2067, DOI [10.4155/fmc.12.131, 10.4155/FMC.12.131]; Slaugenhaupt SA, 2001, AM J HUM GENET, V68, P598, DOI 10.1086/318810; Letourneau A, 2014, NATURE, V508, P345, DOI 10.1038/nature13200; Bochner R, 2013, HUM MOL GENET, V22, P2785, DOI 10.1093/hmg/ddt126; Schwertz H, 2006, J EXP MED, V203, P2433, DOI 10.1084/jem.20061302; Stoilov P, 2008, P NATL ACAD SCI USA, V105, P11218, DOI 10.1073/pnas.0801661105; Seo J, 2013, BBA-MOL BASIS DIS, V1832, P2180, DOI 10.1016/j.bbadis.2013.08.005; Bordet T, 2007, J PHARMACOL EXP THER, V322, P709, DOI 10.1124/jpet.107.123000; Canzonetta C, 2008, AM J HUM GENET, V83, P388, DOI 10.1016/j.ajhg.2008.08.012; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nmb1209; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Anderson SL, 2003, BIOCHEM BIOPH RES CO, V306, P303, DOI 10.1016/S0006-291X(03)00971-9; Fan LY, 2011, ACS CHEM BIOL, V6, P582, DOI 10.1021/cb100356k; Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; Jean-Philippe J, 2013, INT J MOL SCI, V14, P18999, DOI 10.3390/ijms140918999; SEALY L, 1978, CELL, V14, P115, DOI 10.1016/0092-8674(78)90306-9; Zanetta C, 2014, CLIN THER, V36, P128, DOI 10.1016/j.clinthera.2013.11.006; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Muraki M, 2004, J BIOL CHEM, V279, P24246, DOI 10.1074/jbc.M314298200; Brahe C, 2005, EUR J HUM GENET, V13, P256, DOI 10.1038/sj.ejhg.5201320; O'Brien K, 2008, J BIOL CHEM, V283, P33147, DOI 10.1074/jbc.M805556200; Zhou ZH, 2013, CHROMOSOMA, V122, P191, DOI 10.1007/s00412-013-0407-z; Kuroyanagi H, 2006, NAT METHODS, V3, P909, DOI 10.1038/NMETH944; Damgaard CK, 2002, RNA, V8, P1401, DOI 10.1017/S1355838202023075; Kole R, 2012, NAT REV DRUG DISCOV, V11, P125, DOI 10.1038/nrd3625; Fairclough RJ, 2013, NAT REV GENET, V14, P373, DOI 10.1038/nrg3460; Slaugenhaupt SA, 2004, HUM MOL GENET, V13, P429, DOI 10.1093/hmg/ddh046; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Andreassi C, 2001, HUM MOL GENET, V10, P2841, DOI 10.1093/hmg/10.24.2841; Rollins C, 2014, BIOCHEMISTRY-US, V53, P2172, DOI 10.1021/bi500180p; Hasegawa M, 2011, ACS CHEM BIOL, V6, P229, DOI 10.1021/cb100248e; Anwar A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023246; Baldcour N., 2007, PLOS PATHOG, V3, P1530; Barman-Aksozen J, 2013, BLOOD CELL MOL DIS, V51, P151, DOI 10.1016/j.bcmd.2013.05.008; Bian Y, 2009, HUM MOL GENET, V18, P1229, DOI 10.1093/hmg/ddp023; Cheishvili D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094612; Cho SY, 2011, P NATL ACAD SCI USA, V108, P8233, DOI 10.1073/pnas.1017700108; Orengo JP, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl967; de Graaf Katrin, 2006, BMC Biochem, V7, P7, DOI 10.1186/1471-2091-7-7; DICKIE P, 1986, MOL PHARMACOL, V29, P427; Duncan PI, 1997, MOL CELL BIOL, V17, P5996; Fukuhara T, 2006, P NATL ACAD SCI USA, V103, P11329, DOI 10.1073/pnas.0604616103; Guedj F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004606; GUI JF, 1994, P NATL ACAD SCI USA, V91, P10824, DOI 10.1073/pnas.91.23.10824; GUI JF, 1994, NATURE, V369, P678, DOI 10.1038/369678a0; Hagiwara M, 2005, BBA-PROTEINS PROTEOM, V1754, P324, DOI 10.1016/j.bbapap.2005.09.010; Hastings ML, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000208; Hnilicova J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016727; Hong DS, 2014, INVEST NEW DRUG, V32, P436, DOI 10.1007/s10637-013-0046-5; Iwata Masao, 2004, Proceedings of the American Association for Cancer Research Annual Meeting, V45, P691; Kalman N., 2004, PROTEIN SCI, V13, P2059; Karakama Y, 2010, ANTIMICROB AGENTS CH, V54, P3179, DOI 10.1128/AAC.00113-10; Kendall GC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3005054; Keren H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015884; Kim H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094978; Kuroyanagi H, 2010, NAT PROTOC, V5, P1495, DOI 10.1038/nprot.2010.107; Liu B, 2013, FEBS J, V280, P3632, DOI 10.1111/febs.12355; MAYEDA A, 1992, CELL, V68, P365, DOI 10.1016/0092-8674(92)90477-T; Newman EA, 2006, RNA, V12, P1129, DOI 10.1261/rna.34906; Nishida A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1306; Ogawa Y, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1090; Ohno G, 2008, GENE DEV, V22, P360, DOI 10.1101/gad.1620608; Rossi F, 1996, NATURE, V381, P80, DOI 10.1038/381080a0; Schmitt C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087851; Sehested M, 1996, BIOCHEM PHARMACOL, V51, P879, DOI 10.1016/0006-2952(95)02241-4; SHER GD, 1995, NEW ENGL J MED, V332, P1606, DOI 10.1056/NEJM199506153322404; Somarelli JA, 2013, RNA, V19, P116, DOI 10.1261/rna.035097.112; Soret J, 2005, P NATL ACAD SCI USA, V102, P8764, DOI 10.1073/pnas.0409829102; Takeuchi A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010946; Toiber D, 2010, NEUROBIOL DIS, V40, P348, DOI 10.1016/j.nbd.2010.06.011; Yoshida M., 2015, P NATL ACAD IN PRESS; Zheng SK, 2013, GENOME RES, V23, P998, DOI 10.1101/gr.147546.112	128	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1554-8929	1554-8937		ACS CHEM BIOL	ACS Chem. Biol.	APR	2015	10	4					914	924		10.1021/cb500697f		11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CG5EY	WOS:000353315100001		
J	Saito, F; Noda, H; Bode, JW				Saito, Fumito; Noda, Hidetoshi; Bode, Jeffrey W.			Critical Evaluation and Rate Constants of Chemoselective Ligation Reactions for Stoichiometric Conjugations in Water	ACS Chemical Biology			English	Article							NATIVE CHEMICAL LIGATION; AZIDE-ALKYNE CYCLOADDITION; PICTET-SPENGLER LIGATION; FREE CLICK CHEMISTRY; BIOORTHOGONAL CHEMISTRY; PROTEINS; BIOCONJUGATION; CATALYSIS; SELECTIVITY; REACTIVITY	Chemoselective ligation reactions have contributed immensely to the development of organic synthesis and chemical biology. However, the ligation of stoichiometric amounts of large molecules for applications such as protein protein conjugates is still challenging. Conjugation reactions need to be fast enough to proceed under dilute conditions and chemoselective in the presence of unprotected functional groups; the starting materials and products must be stable under the reaction conditions. To compare known ligation reactions for their suitability under these conditions, we determined the second-Order rate constants of ligation reactions,using peptide substrates with unprotected functional groups. The reaction conditions, the chemoselectivity of the reactions, and the stability of the starting materials and products were carefully evaluated. In some cases, the stability could be improved by modifying the substrate structure. These data obtained under the ligation conditions provide a useful guide to choose an appropriate ligation reaction for synthesis of large Molecules by covalent ligation reactions of unprotected substrates in water.	[Saito, Fumito; Noda, Hidetoshi; Bode, Jeffrey W.] ETH, Organ Chem Lab, Dept Chem & Appl Biosci, CH-8093 Zurich, Switzerland; [Bode, Jeffrey W.] Nagoya Univ, Inst Transformat Biomol WPI ITbM, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Bode, JW (reprint author), ETH, Organ Chem Lab, Dept Chem & Appl Biosci, CH-8093 Zurich, Switzerland.	bode@org.chem.ethz.ch			ETH Zurich	This work was supported by ETH Zurich. We thank the LOC MS Service for analyses.	Fry SC, 1998, BIOCHEM J, V332, P507; King M, 2014, BIOCONJUGATE CHEM, V25, P825, DOI 10.1021/bc500028d; Kitov PI, 2014, J AM CHEM SOC, V136, P8149, DOI 10.1021/ja5023909; Gaulier C, 2012, CHEM COMMUN, V48, P4005, DOI 10.1039/c2cc30515a; Kumar A, 2011, CHEM COMMUN, V47, P3186, DOI 10.1039/c0cc05376g; Patterson DM, 2014, ACS CHEM BIOL, V9, P592, DOI 10.1021/cb400828a; Jewett JC, 2010, J AM CHEM SOC, V132, P3688, DOI 10.1021/ja100014q; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Sletten EM, 2009, ANGEW CHEM INT EDIT, V48, P6974, DOI 10.1002/anie.200900942; Chan TR, 2004, ORG LETT, V6, P2853, DOI 10.1021/ol0493094; Hudak JE, 2012, ANGEW CHEM INT EDIT, V51, P4161, DOI 10.1002/anie.201108130; Johnson ECB, 2006, J AM CHEM SOC, V128, P6640, DOI 10.1021/ja058344i; Blackman ML, 2008, J AM CHEM SOC, V130, P13518, DOI 10.1021/ja8053805; Dirksen A, 2006, ANGEW CHEM INT EDIT, V45, P7581, DOI 10.1002/anie.200602877; Lee LV, 2003, J AM CHEM SOC, V125, P9588, DOI 10.1021/ja0302836; Wang Q, 2003, J AM CHEM SOC, V125, P3192, DOI 10.1021/ja021381e; Schelte P, 2000, BIOCONJUGATE CHEM, V11, P118; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Prescher JA, 2004, NATURE, V430, P873, DOI 10.1038/nature02791; Kalia J, 2010, CURR ORG CHEM, V14, P138; Dieterich DC, 2006, P NATL ACAD SCI USA, V103, P9482, DOI 10.1073/pnas.0601637103; Dirksen A, 2008, BIOCONJUGATE CHEM, V19, P2543, DOI 10.1021/bc800310p; van Kasteren SI, 2007, NATURE, V446, P1105, DOI 10.1038/nature05757; Agarwal P, 2013, BIOCONJUGATE CHEM, V24, P846, DOI 10.1021/bc400042a; Hoyle CE, 2010, ANGEW CHEM INT EDIT, V49, P1540, DOI 10.1002/anie.200903924; Pollock SB, 2011, CHEM COMMUN, V47, P2342, DOI 10.1039/c0cc04120c; Hondal RJ, 2001, J AM CHEM SOC, V123, P5140, DOI 10.1021/ja005885t; Noda H, 2014, J AM CHEM SOC, V136, P5611, DOI 10.1021/ja5018442; Presolski SI, 2010, J AM CHEM SOC, V132, P14570, DOI 10.1021/ja105743g; Karver MR, 2011, BIOCONJUGATE CHEM, V22, P2263, DOI 10.1021/bc200295y; Sommer S, 2011, ANGEW CHEM INT EDIT, V50, P9888, DOI 10.1002/anie.201102531; Beatty KE, 2010, CHEMBIOCHEM, V11, P2092, DOI 10.1002/cbic.201000419; Lang K, 2014, CHEM REV, V114, P4764, DOI 10.1021/cr400355w; Palanki MSS, 2012, BIOORG MED CHEM LETT, V22, P4249, DOI 10.1016/j.bmcl.2012.05.040; Hong V, 2009, ANGEW CHEM INT EDIT, V48, P9879, DOI 10.1002/anie.200905087; Agarwal P, 2013, P NATL ACAD SCI USA, V110, P46, DOI 10.1073/pnas.1213186110; Bang D, 2006, ORG LETT, V8, P1049, DOI 10.1021/ol052811j; Best MD, 2009, BIOCHEMISTRY-US, V48, P6571, DOI 10.1021/bi9007726; Ng S, 2012, ACS CHEM BIOL, V7, P1482, DOI 10.1021/cb300187t; Presolsld S. I., 2011, CURR PROTOC CHEM BIO, V3, P153, DOI DOI 10.1002/9780470559277.CH110148; Spate AK, 2014, BIOCONJUGATE CHEM, V25, P147, DOI 10.1021/bc4004487; Wendeler M, 2014, BIOCONJUGATE CHEM, V25, P93, DOI 10.1021/bc400380f	42	5	5	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1554-8929	1554-8937		ACS CHEM BIOL	ACS Chem. Biol.	APR	2015	10	4					1026	1033		10.1021/cb5006728		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CG5EY	WOS:000353315100015		
J	Yokoyama, H; Sawada, J; Katoh, S; Matsuno, K; Ogo, N; Ishikawa, Y; Hashimoto, H; Fujii, S; Asai, A				Yokoyama, Hideshi; Sawada, Jun-ichi; Katoh, Shiori; Matsuno, Kenji; Ogo, Naohisa; Ishikawa, Yoshinobu; Hashimoto, Hiroshi; Fujii, Satoshi; Asai, Akira			Structural Basis of New Allosteric Inhibition in Kinesin Spindle Protein Eg5	ACS Chemical Biology			English	Article							TRITYL-L-CYSTEINE; CRYSTAL-STRUCTURE; KSP; MECHANISM; DERIVATIVES; ACTIVATION; COMPLEX; MODEL	Kinesin spindle protein Eg5 is a target for anticancer therapies, and small molecule inhibitors of its ATPase activity have been developed. We herein report for the first time the crystal structure of and biochemical studies on the Eg5 motor domain in complex with a new type of allosteric inhibitor. The biphenyl-type inhibitor PVZB1194 binds to the alpha 4/alpha 6 allosteric pocket 15 angstrom from the ATP-binding pocket, which differs from conventional allosteric inhibitors that bind to the allosteric L5/alpha 2/alpha 3 pocket of Eg5. Binding of the inhibitor is involved in the neck-linker conformation and also causes conformational changes around the ATP-binding pocket through Tyr104 to affect the interaction of ATP with the pocket. This structure provides useful information for the development of novel types of allosteric drugs as well as a novel insight into the molecular mechanism responsible for regulating the motor activity of kinesins.	[Yokoyama, Hideshi; Katoh, Shiori; Ishikawa, Yoshinobu; Hashimoto, Hiroshi; Fujii, Satoshi] Univ Shizuoka, Sch Pharmaceut Sci, Dept Phys Biochem, Shizuoka 4228526, Japan; [Sawada, Jun-ichi; Matsuno, Kenji; Ogo, Naohisa; Asai, Akira] Univ Shizuoka, Grad Sch Pharmaceut Sci, Ctr Drug Discovery, Shizuoka 4228526, Japan	Yokoyama, H (reprint author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Phys Biochem, Shizuoka 4228526, Japan.	h-yokoya@u-shizuoka-ken.ac.jp; aasai@u-shizuoka-ken.ac.jp			MEXT [21770122]; JSPS KAKENHI [22590067]; Pharma Valley Center	This work was supported by a MEXT Grant-in-Aid for Young Scientists (B) Grant Number 21770122, JSPS KAKENHI Grant Number 22590067, and a grant entitled "Drug Discovery Program" from Pharma Valley Center. We thank Associate Professor T. Shiba (Kyoto Institute of Technology, Japan) for providing us with valuable advice. We thank the Photon Factory staff for their assistance with data collection. We also thank C. Kawano, T. Murakami, Y. Hashizume, and K. Terai for their help with these experiments.	Parke CL, 2010, J BIOL CHEM, V285, P5859, DOI 10.1074/jbc.M109.071233; Knight SD, 2008, CURR TOP MED CHEM, V8, P888, DOI 10.2174/156802608784911626; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yan YW, 2004, J MOL BIOL, V335, P547, DOI 10.1016/j.jmb.2003.10.074; Maliga Z, 2002, CHEM BIOL, V9, P989, DOI 10.1016/S1074-5521(02)00212-0; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Sakowicz R, 2004, CANCER RES, V64, P3276, DOI 10.1158/0008-5472.CAN-03-3839; Turner J, 2001, J BIOL CHEM, V276, P25496, DOI 10.1074/jbc.M100395200; Nitta R, 2008, NAT STRUCT MOL BIOL, V15, P1067, DOI 10.1038/nsmb.1487; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Marcus AI, 2005, J BIOL CHEM, V280, P11569, DOI 10.1074/jbc.M413471200; Tao WK, 2005, CANCER CELL, V8, P49, DOI 10.1016/j.ccr.2005.06.003; Blangy A, 1995, CELL, V83, P1159; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; El-Nassan HB, 2013, EUR J MED CHEM, V62, P614, DOI 10.1016/j.ejmech.2013.01.031; Luo L, 2007, NAT CHEM BIOL, V3, P722, DOI 10.1038/nchembio.2007.34; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Skoufias DA, 2006, J BIOL CHEM, V281, P17559, DOI 10.1074/jbc.M511735200; Brunger A. T., 1998, ACTA CRYSTALLOGR D, VD54, P905; DeBonis S, 2004, MOL CANCER THER, V3, P1079; DeBonis S, 2008, J MED CHEM, V51, P1115, DOI 10.1021/jm070606z; Kaan HYK, 2010, BIOCHEM J, V425, P55, DOI 10.1042/BJ20091207; Lad L, 2008, BIOCHEMISTRY-US, V47, P3576, DOI 10.1021/bi702061g; Matsuno K, 2009, BIOORG MED CHEM LETT, V19, P1058, DOI 10.1016/j.bmcl.2009.01.018; Mild H., 2005, TRENDS CELL BIOL, V15, P467; Ogo N, 2007, BIOORG MED CHEM LETT, V17, P3921, DOI 10.1016/j.bmcl.2007.04.101; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parrish CA, 2007, J MED CHEM, V50, P4939, DOI 10.1021/jm070435y; Sheth PR, 2010, BIOCHEMISTRY-US, V49, P8350, DOI 10.1021/bi1005283; Shimizu M, 2010, BIOORG MED CHEM LETT, V20, P1578, DOI 10.1016/j.bmcl.2010.01.088; Talapatra SK, 2012, ACTA CRYSTALLOGR D, V68, P1311, DOI 10.1107/S0907444912027965; Ulaganathan V, 2013, J AM CHEM SOC, V135, P2263, DOI 10.1021/ja310377d; Zhang B, 2008, BIOCHEM BIOPH RES CO, V372, P565, DOI 10.1016/j.bbrc.2008.05.074	37	3	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1554-8929	1554-8937		ACS CHEM BIOL	ACS Chem. Biol.	APR	2015	10	4					1128	1136		10.1021/cb500939x		9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CG5EY	WOS:000353315100026		
J	Ogawa, T; Nakazono, K; Aoki, D; Uchida, S; Takata, T				Ogawa, Takahiro; Nakazono, Kazuko; Aoki, Daisuke; Uchida, Satoshi; Takata, Toshikazu			Effective Approach to Cyclic Polymer from Linear Polymer: Synthesis and Transformation of Macromolecular [1]Rotaxane	ACS Macro Letters			English	Article							EFFICIENT ROUTE; HIGH-PURITY; POLYSTYRENES; CRYSTALLIZATION; CYCLIZATION; COPOLYMERS; STRATEGIES; CHEMISTRY; PROTOCOL; BEHAVIOR	We report a convenient and scalable synthesis of cyclic poly(epsilon-caprolactone) (PCL) from its linear counterpart based on the rotaxane protocol. Cyclic PCL was prepared by ring-opening polymerization of epsilon-caprolactone (epsilon-CL) initiated by a pseudo[2]rotaxane initiator in the presence of diphenylphosphate (DPP) as a catalyst, followed by capping of the propagation end by using a bulky isocyanate to afford macromolecular [2]rotaxane. The successive intramolecular cyclization to macromolecular [1]rotaxane at the polymer terminus proceeded with good yield. The attractive interaction of the terminal ammonium/crown ether moiety was removed via N-acetylation. This enabled movement of the crown ether wheel along the axle PCL chain to the urethane region of the other terminus in solution state. Size-exclusion chromatography and 2D diffusion-ordered spectroscopy (DOSY) results demonstrated the formation of cyclic PCL from linear PCL, which is further supported by thermal property or crystallinity change before and after transformation.	[Ogawa, Takahiro; Nakazono, Kazuko; Aoki, Daisuke; Uchida, Satoshi; Takata, Toshikazu] Tokyo Inst Technol, Dept Organ & Polymer Mat, Meguro Ku, Tokyo 1528552, Japan	Takata, T (reprint author), Tokyo Inst Technol, Dept Organ & Polymer Mat, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528552, Japan.	ttakata@polymer.titech.ac.jp	Uchida, Satoshi/B-9501-2015	Uchida, Satoshi/0000-0002-8471-2181	MEXT, Japan [23245031, 24108712]	This work was financially supported by a Grant-in-Aid for Scientific Research (No. 23245031) and Scientific Research on Innovative Areas (Coordination Programming Area 2107, No. 24108712) from MEXT, Japan.	Doi Y, 2013, MACROMOLECULES, V46, P1075, DOI 10.1021/ma302511j; Kawaguchi D, 2006, MACROMOLECULES, V39, P5180, DOI 10.1021/ma060652t; Jia ZF, 2012, J POLYM SCI POL CHEM, V50, P2085, DOI 10.1002/pola.25999; Kawaguchi D, 2012, MACROMOLECULES, V45, P6748, DOI 10.1021/ma3006872; Glassner M, 2011, MACROMOL RAPID COMM, V32, P724, DOI 10.1002/marc.201100094; Schappacher M, 2011, J AM CHEM SOC, V133, P1630, DOI 10.1021/ja108821p; Shin EJ, 2011, ANGEW CHEM INT EDIT, V50, P6388, DOI 10.1002/anie.201101853; Ogawa T, 2015, CHEM COMMUN, V51, P5606, DOI 10.1039/c4cc08982k; Perez RA, 2014, REACT FUNCT POLYM, V80, P71, DOI 10.1016/j.reactfunctpolym.2013.10.013; Bielawski CW, 2002, SCIENCE, V297, P2041, DOI 10.1126/science.1075401; Aoki D, 2014, POLYM J, V46, P546, DOI 10.1038/pj.2014.22; Kricheldorf HR, 2010, J POLYM SCI POL CHEM, V48, P251, DOI 10.1002/pola.23755; Oike H, 2000, J AM CHEM SOC, V122, P9592, DOI 10.1021/ja001736z; Laurent BA, 2006, J AM CHEM SOC, V128, P4238, DOI 10.1021/ja0585836; Tezuka Y, 2002, MACROMOLECULES, V35, P8667, DOI 10.1021/ma021023w; Hoskins JN, 2009, MACROMOLECULES, V42, P6406, DOI 10.1021/ma9011076; Tezuka Y, 2008, MACROMOL RAPID COMM, V29, P1237, DOI 10.1002/marc.200800103; HADZIIOANNOU G, 1987, MACROMOLECULES, V20, P493, DOI 10.1021/ma00169a006; Gong CG, 1998, MACROMOLECULES, V31, P1814, DOI 10.1021/ma9713116; Castro-Osma JA, 2013, MACROMOLECULES, V46, P6388, DOI 10.1021/ma401216u; RIQUELURBET L, 1994, MACROMOLECULES, V27, P6318, DOI 10.1021/ma00100a014; Goldmann AS, 2008, POLYMER, V49, P2274, DOI 10.1016/j.polymer.2008.03.017; Hoskins JN, 2011, POLYM CHEM-UK, V2, P289, DOI 10.1039/c0py00102c; Makiguchi K, 2011, MACROMOLECULES, V44, P1999, DOI 10.1021/ma200043x; Tang QQ, 2014, MACROMOLECULES, V47, P3775, DOI 10.1021/ma500799w; Su HH, 2013, POLYMER, V54, P846, DOI 10.1016/j.polymer.2012.11.066; Tachibana Y, 2006, J ORG CHEM, V71, P5093, DOI 10.1021/jo0601563; Aoki D, 2014, ACS MACRO LETT, V3, P324, DOI 10.1021/mz5001306; Aoki D, 2013, ACS MACRO LETT, V2, P461, DOI 10.1021/mz400197d; Bilig T, 2008, CHEM LETT, V37, P468, DOI 10.1246/cl.2008.468; Brown HA, 2013, ACCOUNTS CHEM RES, V46, P2585, DOI 10.1021/ar400072z; BURCHARD W, 1980, POLYMER, V21, P745, DOI 10.1016/0032-3861(80)90289-X; Gong CG, 1997, J AM CHEM SOC, V119, P8585, DOI 10.1021/ja971385x; Hu JW, 2009, MACROMOLECULES, V42, P4638, DOI 10.1021/ma9006522; Kammiyada H, 2013, ACS MACRO LETT, V2, P531, DOI 10.1021/mz400191t; Kaneda N., 2008, J PHYS A, V41; Kihara N, 2000, CHEM LETT, P506, DOI 10.1246/cl.2000.506; Li H., 2006, ANGEW CHEM, V118, P2322, DOI 10.1002/ange.200503961; Lonsdale DE, 2010, CHEM COMMUN, V46, P7945, DOI 10.1039/c0cc02904a; MacLeish T, 2002, SCIENCE, V297, P2005; MacLeish T, 2008, NAT MATER, V7, P933; Semlyen J. A., 2000, CYCLIC POLYM; Yamamoto T, 2011, POLYM CHEM-UK, V2, P1930, DOI 10.1039/c1py00088h	43	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-1653			ACS MACRO LETT	ACS Macro Lett.	APR	2015	4	4					343	347		10.1021/acsmacrolett.5b00067		5	Polymer Science	Polymer Science	CG6UD	WOS:000353437000002		
J	Nishimura, T; Mukai, S; Sawada, S; Akiyoshi, K				Nishimura, Tomoki; Mukai, Sada-atsu; Sawada, Shin-ichi; Akiyoshi, Kazunari			Glyco Star Polymers as Helical Multivalent Host and Biofunctional Nano-Platform	ACS Macro Letters			English	Article							COIL BLOCK-COPOLYMERS; DNA STRAND EXCHANGE; ENZYMATIC-SYNTHESIS; AMYLOSE-PRIMER; CATALYZED POLYMERIZATION; INCLUSION COMPLEXES; IODINE; ACID; CHAPERONE; KINETICS	A series of amylose-based star polymers (1, 2, 4, and 8 arms) as a new glyco biomaterial was synthesized by a click reaction and enzymatic polymerization of specific primers with phosphorylase. The molecular weights were controlled by the enzymatic reaction. Further polymerization resulted in a viscous solution and, especially, for the 8-arm primer, a hydrogel was obtained due to effective cross-linking between the multiarmed structures. The star polymers with a degree of polymerization of about 60 per arm acted as an allosteric multivalent host for hydrophobic molecules by helical formation. A cationic 8-arm star polymer catalyzed DNA strand exchange as a nucleic acid chaperone. Amylose-based star polymers are promising building blocks for producing advanced hybrid glyco biomaterials.	[Nishimura, Tomoki; Mukai, Sada-atsu; Sawada, Shin-ichi; Akiyoshi, Kazunari] Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Nishikyo Ku, Kyoto 6158150, Japan; [Nishimura, Tomoki; Mukai, Sada-atsu; Sawada, Shin-ichi; Akiyoshi, Kazunari] JST, ERATO Akiyoshi Bionanotransporter Project, Kyoto 6158150, Japan	Akiyoshi, K (reprint author), Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Nishikyo Ku, Kyoto 6158150, Japan.	akiyoshi@bio.polym.kyoto-u.ac.jp	Nishimura, Tomoki/E-5189-2010		JST ERATO program	This work was financially supported by the JST ERATO program.	Akiyoshi K, 2002, BIOMACROMOLECULES, V3, P280, DOI 10.1021/bm010144l; Akiyoshi K, 1999, MACROMOL RAPID COMM, V20, P112, DOI 10.1002/(SICI)1521-3927(19990301)20:3<112::AID-MARC112>3.0.CO;2-Q; Jobling S, 2004, CURR OPIN PLANT BIOL, V7, P210, DOI 10.1016/j.pbi.2003.12.001; SAHEKI S, 1985, ANAL BIOCHEM, V148, P277, DOI 10.1016/0003-2697(85)90229-5; GIDLEY MJ, 1989, MACROMOLECULES, V22, P341, DOI 10.1021/ma00191a062; OKAMOTO Y, 1994, J CHROMATOGR A, V666, P403, DOI 10.1016/0021-9673(94)80400-1; Kim WJ, 2002, J AM CHEM SOC, V124, P12676, DOI 10.1021/ja0272080; Schatz C, 2010, MACROMOL RAPID COMM, V31, P1664, DOI 10.1002/marc.201000267; Kadokawa J, 2011, CHEM REV, V111, P4308, DOI 10.1021/cr100285v; Bernard J, 2005, MACROMOLECULES, V38, P5475, DOI 10.1021/ma050050u; Shimada N, 2008, J POLYM SCI POL CHEM, V46, P1440, DOI 10.1002/pola.22483; Milojevic S, 1996, J CONTROL RELEASE, V38, P75, DOI 10.1016/0168-3659(95)00112-3; Kobayashi K, 1996, MACROMOLECULES, V29, P8670, DOI 10.1021/ma9603443; Inoue K, 2000, PROG POLYM SCI, V25, P453, DOI 10.1016/S0079-6700(00)00011-3; ZIEGAST G, 1987, CARBOHYD RES, V160, P185, DOI 10.1016/0008-6215(87)80311-7; MILES MJ, 1985, CARBOHYD RES, V135, P257, DOI 10.1016/S0008-6215(00)90777-8; Star A, 2002, ANGEW CHEM INT EDIT, V41, P2508, DOI 10.1002/1521-3773(20020715)41:14<2508::AID-ANIE2508>3.0.CO;2-A; Lapienis G, 2009, PROG POLYM SCI, V34, P852, DOI 10.1016/j.progpolymsci.2009.04.006; Putseys JA, 2010, J CEREAL SCI, V51, P238, DOI 10.1016/j.jcs.2010.01.011; BANKS W, 1971, CARBOHYD RES, V17, P25, DOI 10.1016/S0008-6215(00)81539-6; Braunmuhl V. V., 1995, MACROMOLECULES, V28, P17, DOI 10.1021/ma00105a003; Cori GT, 1940, J BIOL CHEM, V135, P733; Frykholm K, 2009, LANGMUIR, V25, P1606, DOI 10.1021/la8032513; Gelders GG, 2005, BIOMACROMOLECULES, V6, P2622, DOI 10.1021/bm0502011; HANDA T, 1981, BIOPOLYMERS, V20, P2051, DOI 10.1002/bip.1981.360201003; Hsien-Chih H. W., 1978, CARBOHYD RES, V61, P27, DOI 10.1016/S0008-6215(00)84464-X; Kadokawa J, 2001, CHEM COMMUN, P449, DOI 10.1039/b008180i; Kamiya S, 1998, MACROMOL CHEM PHYS, V199, P1589, DOI 10.1002/(SICI)1521-3935(19980801)199:8<1589::AID-MACP1589>3.0.CO;2-V; Kaneko Y, 2007, BIOMACROMOLECULES, V8, P3959, DOI 10.1021/bm701000t; Kim WJ, 2001, CHEM-EUR J, V7, P176, DOI 10.1002/1521-3765(20010105)7:1<176::AID-CHEM176>3.0.CO;2-M; Loos K, 1997, MACROMOLECULES, V30, P7641, DOI 10.1021/ma971022h; Loos K, 2002, BIOMACROMOLECULES, V3, P368, DOI 10.1021/bm0156330; Morimoto N, 2013, LANGMUIR, V29, P7509, DOI 10.1021/la3047774; Morimoto N, 2007, J AM CHEM SOC, V129, P458, DOI 10.1021/ja065966a; Morimoto N, 2009, CHEM LETT, V38, P496, DOI 10.1246/cl.2009.496; Morimoto N, 2009, J BIOTECHNOL, V140, P246, DOI 10.1016/j.jbiotec.2009.01.013; Narumi A, 2003, POLYM BULL, V49, P405, DOI 10.1007/s00289-003-0126-3; Otsuka I., 2009, LANGMUIR, V26, P2325; Roger P, 2000, MACROMOLECULES, V33, P2446, DOI 10.1021/ma991302s; Sanji T, 2005, ANGEW CHEM INT EDIT, V44, P7301, DOI 10.1002/anie.200502073; Stern R, 2008, CHEM REV, V108, P5061, DOI 10.1021/cr078240l; Tanaka T, 2013, MACROMOL CHEM PHYS, V214, P2829, DOI 10.1002/macp.201300525; Vlassopoulos D, 2004, J POLYM SCI POL PHYS, V42, P2931, DOI 10.1002/polb.20152; Vlist J. v. d., 2012, POLYMERS, V4, P674	44	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-1653			ACS MACRO LETT	ACS Macro Lett.	APR	2015	4	4					367	371		10.1021/acsmacrolett.5b00049		5	Polymer Science	Polymer Science	CG6UD	WOS:000353437000007		
J	Koda, Y; Terashima, T; Takenaka, M; Sawamoto, M				Koda, Yuta; Terashima, Takaya; Takenaka, Mikihito; Sawamoto, Mitsuo			Star Polymer Gels with Fluorinated Microgels via Star-Star Coupling and Cross-Linking for Water Purification	ACS Macro Letters			English	Article							LIVING RADICAL POLYMERIZATION; MOLECULAR RECOGNITION; CONETWORKS SYNTHESIS; SEPARATION; COMPARTMENTS; CATALYSTS; STRATEGY; ROBUST	Two types of star polymer gels containing perfluorinated microgels were created as purification materials to separate polyfluorinated surfactants (e.g., perfluorooctanoic acid) from water. One macrogel is prepared by the radical coupling of fluorine and/or amine-functionalized microgel star polymers alone, while another is done by the radical cross-linking of the star polymers with poly(ethylene glycol) methyl ether methacrylate. Importantly, the reactive olefin remaining within the microgel cores was directly employed for both coupling and cross-linking reactions. Swelling properties of star polymer gels were effectively controlled by the latter cross-linking technique. Analyzed by small-angle X-ray scattering, a star star coupling gel typically consists of a three-dimensional network where star polymers are sequentially connected with the microgels at the constant interval of about 20 nm. Owing to the fluorous and acid/base cooperative interaction, star polymer gels carrying fluorine/amine-functionalized microgels efficiently captured polyfluorinated surfactants in water and successfully afforded the removal from water via simple mixing and filtration.	[Koda, Yuta; Terashima, Takaya; Takenaka, Mikihito; Sawamoto, Mitsuo] Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Katsura Nishikyo Ku, Kyoto 6158510, Japan	Terashima, T (reprint author), Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Katsura Nishikyo Ku, Kyoto 6158510, Japan.	terashima@living.polym.kyoto-u.ac.jp; sawamoto@star.polym.kyoto-u.ac.jp			Ministry of Education, Science, Sports and Culture [24245026, 26410134, 24750104]; Sumitomo Foundation; Japan Society for the Promotion of Sciences (JSPS) [DC1:24-6140]	This research was supported by the Ministry of Education, Science, Sports and Culture through Grants-in-Aids for Scientific Research (A: 24245026; C: 26410134) and Young Scientist (B: 24750104) and by the Sumitomo Foundation for which T.T. is grateful. Y.K. is grateful to the Japan Society for the Promotion of Sciences (JSPS) for a Grant-in-Aid for JSPS Research Fellows (DC1:24-6140). We also thank Mr. Yuuji Tanaka (Daikin Industries, Ltd.) for LC-MS/MS analysis, the company for kind supply of PFHxA, and Ms. Yi-Chin Wang and Mr. Eiji Makizuka for SAXS measurements. The SAXS measurements were performed at BL45XU in SPring-8 with the approval of RIKEN (Proposal No. 20140072).	Blencowe A, 2009, POLYMER, V50, P5, DOI 10.1016/j.polymer.2008.09.049; Lindstrom AB, 2011, ENVIRON SCI TECHNOL, V45, P7954, DOI 10.1021/es2011622; Gao HF, 2009, PROG POLYM SCI, V34, P317, DOI 10.1016/j.progpolymsci.2009.01.001; Kafouris D, 2009, MACROMOLECULES, V42, P2972, DOI 10.1021/ma802859d; Ide N, 1999, MACROMOLECULES, V32, P95, DOI 10.1021/ma9805349; D'eon JC, 2011, ENVIRON SCI TECHNOL, V45, P7974, DOI 10.1021/es200171y; Pafiti KS, 2010, MACROMOLECULES, V43, P5195, DOI 10.1021/ma100552v; Houde M, 2011, ENVIRON SCI TECHNOL, V45, P7962, DOI 10.1021/es104326w; Terashima T, 2011, ANGEW CHEM INT EDIT, V50, P7892, DOI 10.1002/anie.201101381; Terashima T, 2010, MACROMOLECULES, V43, P8218, DOI 10.1021/ma101235j; Terashima T, 2012, MACROMOL RAPID COMM, V33, P833, DOI 10.1002/marc.201200045; Koda Y, 2014, J AM CHEM SOC, V136, P15742, DOI 10.1021/ja508818j; Yoda H, 2010, MACROMOLECULES, V43, P5595, DOI 10.1021/ma100589b; HORVATH IT, 1994, SCIENCE, V266, P72, DOI 10.1126/science.266.5182.72; Terashima T, 2012, ACS SYM SER, V1101, P65; Studer A, 1997, SCIENCE, V275, P823, DOI 10.1126/science.275.5301.823; Terashima T, 2014, J AM CHEM SOC, V136, P10254, DOI 10.1021/ja505646p; Gao HF, 2012, MACROMOL RAPID COMM, V33, P722, DOI 10.1002/marc.201200005; Baek KY, 2001, MACROMOLECULES, V34, P7629, DOI 10.1021/ma010973z; Curran D. P., 1998, ANGEW CHEM INT EDIT, V37, P1174, DOI 10.1002/(SICI)1521-3773(19980518)37:9<1174::AID-ANIE1174>3.0.CO;2-P; Fukae K, 2012, MACROMOLECULES, V45, P3377, DOI 10.1021/ma300266k; Baek KY, 2002, MACROMOLECULES, V35, P1493, DOI 10.1021/ma011582n; Koda Y, 2011, MACROMOLECULES, V44, P4574, DOI 10.1021/ma201076y; Koda Y, 2015, POLYM CHEM-UK, V6, P5663, DOI 10.1039/c5py00113g; Terashima T, 2013, KOBUNSHI RONBUNSHU, V70, P432; Terashima T, 2014, POLYM J, V46, P664, DOI 10.1038/pj.2014.57	26	4	4	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-1653			ACS MACRO LETT	ACS Macro Lett.	APR	2015	4	4					377	380		10.1021/acsmacrolett.5b00127		4	Polymer Science	Polymer Science	CG6UD	WOS:000353437000009		
J	Okuda, H; Koyama, Y; Uchida, S; Michinobu, T; Sogawa, H; Takata, T				Okuda, Hitoshi; Koyama, Yasuhito; Uchida, Satoshi; Michinobu, Tsuyoshi; Sogawa, Hiromitsu; Takata, Toshikazu			Reversible Transformation of a One-Handed Helical Foldamer Utilizing a Planarity-Switchable Spacer and C-2-Chiral Spirobifluorene Units	ACS Macro Letters			English	Article							EXCELLENT OPTICAL-PROPERTIES; POLYTHIOPHENE DERIVATIVES; MOLECULAR STRANDS; RATIONAL DESIGN; ROTAXANE SWITCH; OLIGOMERS; POLYMER; CHIRALITY; PROTEIN; OLIGOTHIOPHENES	Polymeric quaterthiophenes containing optically active C-2-chiral spirobifluorene skeletons were synthesized as a new type of helical foldamers, and their higher-order structures were investigated. Oxidization of quaterthiophene moieties caused the spacer units to be in planar structure, leading the conformation of the polymer to be a coil-shaped, rigid helix. This transformation was reversibly performed.	[Okuda, Hitoshi; Koyama, Yasuhito; Uchida, Satoshi; Michinobu, Tsuyoshi; Sogawa, Hiromitsu; Takata, Toshikazu] Tokyo Inst Technol, Dept Organ & Polymer Mat, Meguro Ku, Tokyo 1528552, Japan	Takata, T (reprint author), Tokyo Inst Technol, Dept Organ & Polymer Mat, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528552, Japan.	ttakata@polymer.titech.ac.jp	Uchida, Satoshi/B-9501-2015	Uchida, Satoshi/0000-0002-8471-2181	JSPS KAKENHI [23245031]; JSPS	This work was supported by JSPS KAKENHI Grant Number 23245031. A JSPS Fellowship for Young Scientists (H.O.) is gratefully acknowledged.	Agata Y, 2002, POLYMER, V43, P4829, DOI 10.1016/S0032-3861(02)00319-1; Lahiri S, 2000, J AM CHEM SOC, V122, P11315, DOI 10.1021/ja002129e; Meudtner RM, 2008, ANGEW CHEM INT EDIT, V47, P4926, DOI 10.1002/anie.200800796; DiCesare N, 1999, J PHYS CHEM A, V103, P3864, DOI 10.1021/jp9901085; Li C, 2007, ORG LETT, V9, P1797, DOI 10.1021/ol070492l; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Zade SS, 2007, CHEM-EUR J, V13, P3688, DOI 10.1002/chem.200600819; Juwarker H, 2009, CHEM SOC REV, V38, P3316, DOI 10.1039/b909034g; Prince RB, 2000, J AM CHEM SOC, V122, P2758, DOI 10.1021/ja993830p; Haraguchi S, 2009, CHEM-EUR J, V15, P11221, DOI 10.1002/chem.200901003; Kim HJ, 2004, J AM CHEM SOC, V126, P7009, DOI 10.1021/ja049799v; Muller MM, 2009, ANGEW CHEM INT EDIT, V48, P922, DOI 10.1002/anie.200804996; Zhang HC, 2004, MACROMOLECULES, V37, P2695, DOI 10.1021/ma0354703; Yashima E, 2009, CHEM REV, V109, P6102, DOI 10.1021/cr900162q; Sugiura H, 2004, J AM CHEM SOC, V126, P14858, DOI 10.1021/ja0478882; Hill DJ, 2001, CHEM REV, V101, P3893, DOI 10.1021/cr990120t; Khan A, 2006, ANGEW CHEM INT EDIT, V45, P1878, DOI 10.1002/anie.200503849; Saraogi I, 2009, CHEM SOC REV, V38, P1726, DOI 10.1039/b819597h; Inouye M, 2004, J AM CHEM SOC, V126, P2022, DOI 10.1021/ja039371g; Nelson JC, 1997, SCIENCE, V277, P1793, DOI 10.1126/science.277.5333.1793; Maayan G, 2009, P NATL ACAD SCI USA, V106, P13679, DOI 10.1073/pnas.0903187106; Berl V, 2000, NATURE, V407, P720; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Bari L. D., 1999, J AM CHEM SOC, V121, P7998; Bouzzine SM, 2005, J MOL STRUC-THEOCHEM, V726, P271, DOI 10.1016/j.theochem.2005.04.023; Dai YJ, 1996, ANGEW CHEM INT EDIT, V35, P2109, DOI 10.1002/anie.199621091; Emmi SS, 1998, RES CHEM INTERMEDIAT, V24, P1, DOI 10.1163/156856798X00140; Furusho Y, 2001, CHEM LETT, P1020; Gin MS, 1999, J AM CHEM SOC, V121, P2643, DOI 10.1021/ja984017h; Goto H, 2002, J AM CHEM SOC, V124, P7943, DOI 10.1021/ja025900p; HARADA N, 1993, J SYN ORG CHEM JPN, V51, P563; Hecht S., 2007, FOLDAMERS STRUCTURE; Ishiwari F, 2011, CHEM-EUR J, V17, P12067, DOI 10.1002/chem.201101727; Ishiwari F, 2011, CHEM COMMUN, V47, P11739, DOI 10.1039/c1cc14404a; JOHNSSON K, 1993, NATURE, V365, P530, DOI 10.1038/365530a0; Kaneko T, 2007, POLYHEDRON, V26, P1825, DOI 10.1016/j.poly.2006.09.104; Ki H.-J., 2007, J AM CHEM SOC, V129, P10994; Kobayashi T, 2000, J NONLINEAR OPT PHYS, V9, P55, DOI 10.1142/S0218863500000054; Kolomiets E, 2007, CHEM-EUR J, V13, P5466, DOI 10.1002/chem.200601826; Masu H, 2005, J ORG CHEM, V70, P1423, DOI 10.1021/jo048233m; Mereau R, 2009, J PHYS CHEM A, V113, P6552, DOI 10.1021/jp904418r; Okuda H, 2010, J POLYM SCI POL CHEM, V48, P4192, DOI 10.1002/pola.24202; Okuda H, 2010, POLYM J, V42, P795, DOI 10.1038/pj.2010.77; ROUX C, 1994, CHEM MATER, V6, P620, DOI 10.1021/cm00041a011; Seto R, 2013, CHEM COMMUN, V49, P5486, DOI 10.1039/c3cc41685b; Shibaev PV, 1998, SYNTHETIC MET, V97, P97, DOI 10.1016/S0379-6779(98)00093-9; Shimoi Yukihiro, 2007, Oyo Buturi, V76; Suzuki S, 2014, POLYM J, V46, P355, DOI 10.1038/pj.2014.4; Suzuki S, 2012, CHEM COMMUN, V48, P6478, DOI 10.1039/c2cc18116a; Takagi K, 2007, MACROMOLECULES, V40, P8807, DOI 10.1021/ma071410b; Tanatani A., 2001, J AM CHEM SOC, V123, P179; Weston CJ, 2004, CHEMBIOCHEM, V5, P1075, DOI 10.1002/cbic.200300805	52	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-1653			ACS MACRO LETT	ACS Macro Lett.	APR	2015	4	4					462	466		10.1021/acsmacrolett.5b00176		5	Polymer Science	Polymer Science	CG6UD	WOS:000353437000026		
J	Kamiya, Y; Takagi, T; Ooi, H; Ito, H; Liang, X; Asanuma, H				Kamiya, Yukiko; Takagi, Toshiki; Ooi, Hideaki; Ito, Hiroshi; Liang, Xingguo; Asanuma, Hiroyuki			Synthetic Gene Involving Azobenzene-Tethered T7 Promoter for the Photocontrol of Gene Expression by Visible Light	ACS Synthetic Biology			English	Article						azobenzene; visible light; transcription; gene expression; photoactivated; D-threoninol scaffold	SUBSTITUTED AZOBENZENES; TRANS ISOMERIZATION; DNA HYBRIDIZATION; PHOTOREGULATION; TRANSCRIPTION; EFFICIENT; NANOSTRUCTURES; PHOTOSWITCHES; NANOMACHINE; THREONINOL	In the present study, we demonstrate photoregulation of gene expression in a cell-free translation system from a T7 promoter containing two azobenzene derivatives at specific positions. As photoswitches, we prepared azobenzene-4'-carbcodyic acid (Azo) and 2,6-dimethylazobenzene-4'-carboxylic acid (DM-Azo), which were isomerized from trans to cis upon irradiation with UV light (lambda < 370 nm), and 4-methylthioazobenzene-4'-carboxylic acid (S-Azo) and 2,6-dimethyl-4(methylthio)azobenzene-4'-carobxylic acid (S-DM-Azo), which were cis-isomerized by irradiation with 400 nm visible light. Expression of green fluorescent protein from a promoter modified with S-Azo or S-DM-Azo could be induced by harmless visible light whereas that from a promoter modified with Azo or DM-Azo was induced only by UV light (340-360 nm). Thus, efficient photoregulation of green fluorescent protein production was achieved in a cell-free translation system with visible light without photodamage.	[Kamiya, Yukiko; Takagi, Toshiki; Ooi, Hideaki; Ito, Hiroshi; Liang, Xingguo; Asanuma, Hiroyuki] Nagoya Univ, Grad Sch Engn, Dept Mol Design & Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Kamiya, Yukiko] Nagoya Univ, EcoTopia Sci Inst, Div Environm Res, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Asanuma, Hiroyuki] Ocean Univ China, Sch Food Sci & Engn, Qingdao 266003, Peoples R China	Liang, X (reprint author), Nagoya Univ, Grad Sch Engn, Dept Mol Design & Engn, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.	liangxg@ouc.edu.cn; asanuma@nubio.nagoya-u.ac.jp			MEXT of Japan [24750173, 25248037, 24104005, 26102518]	This work was supported by Grants-in-Aid for Scientific Research for Young Scientists (B) [No. 24750173], a Grant-inAid for Scientific Research (A) [No. 25248037], and a Grant-in Aid for Scientific Research on Innovative Areas "Molecular Robotics" [No. 24104005] and "Dynamical Ordering & Integrated Functions" [No. 26102518] from MEXT of Japan.	Brieke C, 2013, CHEM-EUR J, V19, P15726, DOI 10.1002/chem.201302640; Asanuma H, 2007, NAT PROTOC, V2, P203, DOI 10.1038/nprot.2006.465; Lohmann F, 2012, J AM CHEM SOC, V134, P11884, DOI 10.1021/ja3042096; Yang YY, 2012, J AM CHEM SOC, V134, P20645, DOI 10.1021/ja307785r; You MX, 2012, ACS NANO, V6, P7935, DOI 10.1021/nn302388e; Brieke C, 2012, ANGEW CHEM INT EDIT, V51, P8446, DOI 10.1002/anie.201202134; Liang XG, 2011, CHEM-EUR J, V17, P10388, DOI 10.1002/chem.201100215; Asanuma H, 1999, ANGEW CHEM INT EDIT, V38, P2393, DOI 10.1002/(SICI)1521-3773(19990816)38:16<2393::AID-ANIE2393>3.0.CO;2-7; Liang XG, 2009, SMALL, V5, P1761, DOI 10.1002/smll.200900223; Asanuma H, 2001, ANGEW CHEM INT EDIT, V40, P2671, DOI 10.1002/1521-3773(20010716)40:14<2671::AID-ANIE2671>3.0.CO;2-Z; Singer M, 2013, EUR J ORG CHEM, P2766, DOI 10.1002/ejoc.201300261; Fujii T, 2009, CHEM-EUR J, V15, P10092, DOI 10.1002/chem.200900962; Nishioka H, 2012, ANGEW CHEM INT EDIT, V51, P1165, DOI 10.1002/anie.201106093; ASANO T, 1986, J ORG CHEM, V51, P4454, DOI 10.1021/jo00373a021; Liang XG, 2008, CHEMBIOCHEM, V9, P702, DOI 10.1002/cbic.200700649; Ogasawara S, 2011, BIOORG MED CHEM LETT, V21, P5457, DOI 10.1016/j.bmcl.2011.06.119; NISHIMURA N, 1976, B CHEM SOC JPN, V49, P1381, DOI 10.1246/bcsj.49.1381; Young DD, 2008, CHEMBIOCHEM, V9, P1225, DOI 10.1002/cbic.200800051; Samanta S, 2012, ANGEW CHEM INT EDIT, V51, P6452, DOI 10.1002/anie.201202383; Szymanski W, 2013, CHEM REV, V113, P6114, DOI 10.1021/cr300179f; Beharry A. A., 2011, CHEM SOC REV, V40, P1422; Beyer C, 2010, SYNLETT, P1371, DOI 10.1055/s-0029-1219924; Cahova H, 2013, ANGEW CHEM INT EDIT, V52, P3186, DOI 10.1002/anie.201209943; Liang XG, 2010, FEBS J, V277, P1551, DOI 10.1111/j.1742-4658.2010.07583.x; Liu MZ, 2006, J AM CHEM SOC, V128, P1009, DOI 10.1021/ja055983k; Nishioka H, 2010, CHEM-EUR J, V16, P2054, DOI 10.1002/chem.200902789; Nishioka H, 2007, CHEM COMMUN, P4354, DOI 10.1039/b708952j; Uno S, 2009, ANGEW CHEM INT EDIT, V48, P7362, DOI 10.1002/anie.200903251; Zhou MG, 2010, ANGEW CHEM INT EDIT, V49, P2167, DOI 10.1002/anie.200907082	29	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-5063			ACS SYNTH BIOL	ACS Synth. Biol.	APR	2015	4	4					365	370		10.1021/sb5001092		6	Biochemical Research Methods	Biochemistry & Molecular Biology	CG5EJ	WOS:000353313600002		
J	Koketsu, K; Shomura, Y; Moriwaki, K; Hayashi, M; Mitsuhashi, S; Hara, R; Kino, K; Higuchi, Y				Koketsu, Kento; Shomura, Yasuhito; Moriwaki, Kei; Hayashi, Mikiro; Mitsuhashi, Satoshi; Hara, Ryotaro; Kino, Kuniki; Higuchi, Yoshiki			Refined Regio- and Stereoselective Hydroxylation of L-Pipecolic Acid by Protein Engineering of L-Proline cis-4-Hydroxylase Based on the X-ray Crystal Structure	ACS Synthetic Biology			English	Article						hydroxyproline; hydroxy-L-pipecolic acid; hydroxylation; proline hydroxylase; protein engineering	STEREOSPECIFIC HYDROXYLATION; TRANS-4-HYDROXY-L-PROLINE; 3-HYDROXYLASE; OXYGENASES	Enzymatic regio- and stereoselective hydroxylation are valuable for the production of hydroxylated chiral ingredients. Pro line hydroxylases are representative members of the nonheme Fe2+/alpha-ketoglutarate-dependent dioxygenase family. These enzymes catalyze the conversion of L-proline into hydroxy-L-prolines (Hyps). L-Proline cis-4-hydroxylases (cis-P4Hs) from Sinorhizobium rneliloti and Mesorhizobium loti catalyze the hydroxylation of L-proline, generating cis-4-hydroxy-L-proline, as well as the hydroxylation of L-pipecolic acid (L-Pip), generating two regioisomers, cis-5-Hypip and cis-3-Hypip. To selectively produce cis-5-Hypip without simultaneous production of two isomers, protein engineering of cis-P4Hs is required. We therefore carried out protein engineering of cis-P4H to facilitate the conversion of the majority of L-Pip into the cis-5-Hypip isomer. We first solved the X-ray crystal structure of cis-P4H in complex with each of L-Pro and L-Pip. Then, we conducted three rounds of directed evolution and successfully created a cis-P4H triple mutant, V97F/V95W/E114G, demonstrating the desired regioselectivity toward cis-5-Hypip.	[Koketsu, Kento; Moriwaki, Kei; Hayashi, Mikiro; Mitsuhashi, Satoshi] Kyowa Hakko Bio Co Ltd, Bioproc Dev Ctr, Tsukuba, Ibaraki 3050841, Japan; [Shomura, Yasuhito; Higuchi, Yoshiki] Univ Hyogo, Grad Sch Life Sci, Kamigori, Hyogo 6781297, Japan; [Hara, Ryotaro; Kino, Kuniki] Waseda Univ, Fac Sci & Engn, Dept Appl Chem, Shinjuku Ku, Tokyo 1698555, Japan	Koketsu, K (reprint author), Kyowa Hakko Bio Co Ltd, Bioproc Dev Ctr, Tsukuba, Ibaraki 3050841, Japan.	kento.koketsu@kyowa-kirin.co.jp			Academic Sinica; National Synchrotron Radiation Research Center (Taiwan, ROC)	We thank Dr. Satoshi Koizumi and Mr. Koichiro Miyake for useful advice. We gratefully acknowledge Ms. Risa Miyashita for her technical assistance. We also thank laboratory members for their advice. We thank the beamline staff of BL44XU at SPring-8 for their support and the provision of beam time. The MX225-HE detector of the beamline is financially supported by Academic Sinica and the National Synchrotron Radiation Research Center (Taiwan, ROC).	Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Pandey AK, 2013, J AM CHEM SOC, V135, P4333, DOI 10.1021/ja3109664; Reetz MT, 2013, J AM CHEM SOC, V135, P12480, DOI 10.1021/ja405051f; Strieker M, 2007, ACS CHEM BIOL, V2, P187, DOI 10.1021/cb700012y; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Wu GY, 2011, AMINO ACIDS, V40, P1053, DOI 10.1007/s00726-010-0715-z; Ogawa J, 2002, CURR OPIN BIOTECH, V13, P367, DOI 10.1016/S0958-1669(02)00331-2; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; Shibasaki T, 2000, BIOSCI BIOTECH BIOCH, V64, P746, DOI 10.1271/bbb.64.746; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Case D., 2014, AMBER 14; Clifton IJ, 2001, EUR J BIOCHEM, V268, P6625, DOI 10.1046/j.0014-2956.2001.02617.x; Hara R, 2009, BIOCHEM BIOPH RES CO, V379, P882, DOI 10.1016/j.bbrc.2008.12.158; Hayashi K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100049; Kalamkar NB, 2010, TETRAHEDRON LETT, V51, P6745, DOI 10.1016/j.tetlet.2010.10.036; Klein C, 2011, ADV SYNTH CATAL, V353, P1375, DOI 10.1002/adsc.201000863; Leslie AGW, 2007, NATO SCI SER II MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Mori H, 1996, APPL ENVIRON MICROB, V62, P1903; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Remuzon P, 1996, TETRAHEDRON, V52, P13803, DOI 10.1016/0040-4020(96)00822-8; Shibasaki T, 2000, J BIOSCI BIOENG, V90, P522, DOI 10.1016/S1389-1723(01)80033-5; Shibasaki T, 1999, TETRAHEDRON LETT, V40, P5227, DOI 10.1016/S0040-4039(99)00944-2; Shibasaki T, 1999, APPL ENVIRON MICROB, V65, P4028; Siloto RMP, 2012, BIOCATAL AGR BIOTECH, V1, P181	26	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-5063			ACS SYNTH BIOL	ACS Synth. Biol.	APR	2015	4	4					383	392		10.1021/sb500247a		10	Biochemical Research Methods	Biochemistry & Molecular Biology	CG5EJ	WOS:000353313600005		
J	Fukuda, N; Honda, S				Fukuda, Nobuo; Honda, Shinya			Rapid Evaluation of Tyrosine Kinase Activity of Membrane-Integrated Human Epidermal Growth Factor Receptor Using the Yeast G gamma Recruitment System	ACS Synthetic Biology			English	Article						tyrosine kinase; epidermal growth factor receptor; yeast; G gamma recruitment system; inhibitor screening	PROTEIN-PROTEIN INTERACTIONS; EGF RECEPTOR; SACCHAROMYCES-CEREVISIAE; LUNG-CANCER; ACTIVATION; GEFITINIB; ASSAYS; CELLS; AUTOPHOSPHORYLATION; TRANSFORMATION	Epidermal growth factor receptor (EGFR) is a member of the receptor tyrosine kinase family and plays key roles in the regulation of fundamental cellular processes, including cell proliferation, migration, differentiation, and survival. Deregulation of EGFR tyrosine kinase activity is involved in the development and progression of human cancers. In the present study, we attempted to develop a method to evaluate the tyrosine kinase activity of human EGFR using the yeast G gamma recruitment system. Autophosphorylation of tyrosine residues on the cytoplasmic tail of EGFR induces recruitment of Grb2-fused G gamma subunits to the inner leaflet of the plasma membrane in yeast cells, which leads to G-protein signal transduction and activation of downstream signaling events, including mating and diploid cell growth. We demonstrate that our system is applicable for the evaluation of tyrosine kinase inhibitors, which are regarded as promising drug candidates to prevent the growth of tumor cells. This approach provides a rapid and easy-to-use tool to select EGFR-targeting tyrosine kinase inhibitors that are able to permeate eukaryotic membranes and function in intracellular environments.	[Fukuda, Nobuo; Honda, Shinya] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Higashi Ku, Tsukuba, Ibaraki 3058566, Japan	Honda, S (reprint author), Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Higashi Ku, Tsukuba, Ibaraki 3058566, Japan.	s.honda@aist.go.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [23860074, 25820406]	Plasmid pco12-EGFR was provided by RIKEN BRC, which is a participating member of the National BioResource Project (NBRP) of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan. This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI (Grant Numbers 23860074 and 25820406).	Fukuda N, 2011, FEBS J, V278, P3086, DOI 10.1111/j.1742-4658.2011.08232.x; Gunde T, 2005, BIOTECHNIQUES, V39, P541, DOI 10.2144/000112011; Fukuda N, 2009, FEBS J, V276, P2636, DOI 10.1111/j.1742-4658.2009.06991.x; Brachmann CB, 1998, YEAST, V14, P115; Fukuda N, 2010, FEBS J, V277, P1704, DOI 10.1111/j.1742-4658.2010.07592.x; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; VELU TJ, 1987, SCIENCE, V238, P1408, DOI 10.1126/science.3500513; Broder YC, 1998, CURR BIOL, V8, P1121, DOI 10.1016/S0960-9822(98)70467-1; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Rojas M, 1996, J BIOL CHEM, V271, P27456; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Zaman GJR, 2003, COMB CHEM HIGH T SCR, V6, P313; HONEGGER AM, 1989, P NATL ACAD SCI USA, V86, P925, DOI 10.1073/pnas.86.3.925; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Bojko A, 2012, FOLIA HISTOCHEM CYTO, V50, P186, DOI 10.5603/FHC.2012.0028; Busti S, 2008, CURR GENET, V53, P153, DOI 10.1007/s00294-007-0173-7; Chen XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059314; CLARK AJL, 1986, BIOCHIM BIOPHYS ACTA, V867, P244, DOI 10.1016/0167-4781(86)90040-0; Fabbro D, 2002, CURR OPIN PHARMACOL, V2, P374, DOI 10.1016/S1471-4892(02)00179-0; Fukuda N, 2013, ACS SYNTH BIOL, V2, P697, DOI [10.1021/sb400016j, 10.1021/sb403016j]; Fukuda N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070100; Kim Y, 2012, BIOCHEMISTRY-US, V51, P5212, DOI 10.1021/bi300476v; Levitzki A, 1999, PHARMACOL THERAPEUT, V82, P231, DOI 10.1016/S0163-7258(98)00066-7; Minor LK, 2003, CURR OPIN DRUG DI DE, V6, P760; Richards KN, 2010, CANCER-AM CANCER SOC, V116, P3233, DOI 10.1002/cncr.25073; SHIGESADA K, 1985, MOL CELL BIOL, V5, P1735; Sims CE, 2003, CURR OPIN BIOTECH, V14, P23, DOI 10.1016/S0958-1669(02)00002-2; VELU TJ, 1989, J CELL BIOCHEM, V39, P153, DOI 10.1002/jcb.240390207	30	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-5063			ACS SYNTH BIOL	ACS Synth. Biol.	APR	2015	4	4					421	429		10.1021/sb500083t		9	Biochemical Research Methods	Biochemistry & Molecular Biology	CG5EJ	WOS:000353313600010		
J	Hiramoto, H; Dansako, H; Takeda, M; Satoh, S; Wakita, T; Ikeda, M; Kato, N				Hiramoto, Hiroki; Dansako, Hiromichi; Takeda, Midori; Satoh, Shinya; Wakita, Takaji; Ikeda, Masanori; Kato, Nobuyuki			Annexin A1 Negatively Regulates Viral RNA Replication of Hepatitis C Virus	ACTA MEDICA OKAYAMA			English	Article						HCV; annexin A1; Li23 cell line; Li23-derived D7 cells; HCV-JFH-1	BETA PRODUCTION; CORE PROTEIN; CELL-LINES; EXPRESSION; GENOME; INHIBITION; INFECTION; CLONING; KINASE; INFLAMMATION	Persistent infection with hepatitis C virus (HCV) often causes chronic hepatitis, and then shows a high rate of progression to liver cirrhosis and hepatocellular carcinoma. To clarify the mechanism of the persistent HCV infection is considered to be important for the discovery of new target(s) for the development of anti-HCV strategies. In the present study, we found that the expression level of annexin A1 (ANXA1) in human hepatoma cell line Li3-derived D7 cells was remarkably lower than that in parental Li23 cells, whereas the susceptibility of D7 cells to HCV infection was much higher than that of Li23 cells. Therefore, we hypothesized that ANXA1 negatively regulates persistent HCV infection through the inhibition of viral RNA replication. The results revealed that HCV production was significantly inhibited without a concomitant reduction in the amount of lipid droplets in the D7 cells stably expressing exogenous ANXAL Further, we demonstrated that ANXA1 negatively regulated the step of viral RNA replication rather than that of viral entry in human hepatocytes. These results suggest that ANXA1 would be a novel target for the development of anti-HCV strategies.	[Hiramoto, Hiroki; Dansako, Hiromichi; Takeda, Midori; Satoh, Shinya; Ikeda, Masanori; Kato, Nobuyuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Tumor Virol, Okayama 7008558, Japan; [Wakita, Takaji] Natl Inst Infect Dis, Dept Virol 2, Shinjuku Ku, Tokyo 1628640, Japan	Kato, N (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Tumor Virol, Okayama 7008558, Japan.	nkato@md.okayama-u.ac.jp			Ministry of Health, Labor, and Welfare of Japan; JSPS KAKENHI [25293110]	We thank Marie Iwado, Yoshiko Ueeda, and Takashi Nakamura for their technical assistance. We also thank Hiroe Sejima for providing the ANXA1 expression vector. We also thank Dr. Kyoko Mori for her helpful suggestions. This work was supported by Grants-in Aid for Research on Hepatitis from the Ministry of Health, Labor, and Welfare of Japan; and by JSPS KAKENHI Grant Number 25293110.	Xu S, 2012, J VIROL, V86, P13025, DOI 10.1128/JVI.01785-12; Younossi ZM, 2014, J HEPATOL, V60, P530, DOI 10.1016/j.jhep.2013.11.009; Ariumi Y, 2008, J VIROL, V82, P9639, DOI 10.1128/JVI.00351-08; Ariumi Y, 2007, J VIROL, V81, P13922, DOI 10.1128/JVI.01517-07; HIJIKATA M, 1991, P NATL ACAD SCI USA, V88, P5547, DOI 10.1073/pnas.88.13.5547; Kato N, 2009, VIRUS RES, V146, P41, DOI 10.1016/j.virusres.2009.08.006; Chevaliez S, 2007, ADV DRUG DELIVER REV, V59, P1222, DOI 10.1016/j.addr.2007.07.002; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Poveda E, 2014, ANTIVIR RES, V108, P181, DOI 10.1016/j.antiviral.2014.05.015; Kwon JH, 2012, J IMMUNOL, V188, P5665, DOI 10.4049/jimmunol.1102306; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Lim LHK, 1998, P NATL ACAD SCI USA, V95, P14535, DOI 10.1073/pnas.95.24.14535; KATO N, 1990, P NATL ACAD SCI USA, V87, P9524, DOI 10.1073/pnas.87.24.9524; HIJIKATA M, 1993, P NATL ACAD SCI USA, V90, P10773, DOI 10.1073/pnas.90.22.10773; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; WALLNER BP, 1986, NATURE, V320, P77, DOI 10.1038/320077a0; Dansako H, 2007, FEBS J, V274, P4161, DOI 10.1111/j.1742-4658.2007.05942.x; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Otsuka M, 2005, HEPATOLOGY, V41, P1004, DOI 10.1002/hep.20666; Dansako H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003345; Mori K, 2013, HEPATOLOGY, V58, P1236, DOI 10.1002/hep.26421; Ariumi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014517; Bist P, 2013, J IMMUNOL, V191, P4375, DOI 10.4049/jimmunol.1301504; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Dansako H, 2009, ARCH VIROL, V154, P801, DOI 10.1007/s00705-009-0375-z; Dansako H, 2005, BIOCHEM BIOPH RES CO, V336, P458, DOI 10.1016/j.bbrc.2005.08.112; Dansako H, 2014, VIROLOGY, V462, P166, DOI 10.1016/j.virol.2014.05.017; Dansako H, 2003, VIRUS RES, V97, P17, DOI 10.1016/S0168-1702(03)00218-1; Dansako H, 2008, VIRUS RES, V137, P72, DOI 10.1016/j.virusres.2008.06.001; Derry MEC, 2007, J GEN VIROL, V88, P19, DOI 10.1099/vir.0.82294-0; Gubern A, 2009, J BIOL CHEM, V284, P5697, DOI 10.1074/jbc.M806173200; Ikeda M, 2011, LIVER INT, V31, P873, DOI 10.1111/j.1478-3231.2011.02499.x; KAPLAN R, 1988, J BIOL CHEM, V263, P8037; Miyanari Y, 2007, NAT CELL BIOL, V9, P1268; Mori K, 2010, HEPATOL RES, V40, P1248, DOI 10.1111/j.1872-034X.2010.00730.x; Sejima H, 2012, VIRUS RES, V167, P74, DOI 10.1016/j.virusres.2012.04.008; Takeda M, 2012, J GEN VIROL, V93, P1422, DOI 10.1099/vir.0.040725-0	37	0	0	OKAYAMA UNIV MED SCHOOL	OKAYAMA	EDITORIAL OFFICE, ACTA MEDICA OKAYAMA OKAYAMA UNIVERSITY MEDICAL SCHOOL 2-5-1 SHIKATA-CHO, KITA-KU, OKAYAMA, 700-8558, JAPAN	0386-300X			ACTA MED OKAYAMA	Acta Med. Okayama	APR	2015	69	2					71	78				8	Medicine, Research & Experimental	Research & Experimental Medicine	CG3LM	WOS:000353181700001		
J	Ichimura, M; Sasaki, S; Mori, M; Ogino, T				Ichimura, Mika; Sasaki, Shinsuke; Mori, Masaharu; Ogino, Tetsuya			Tapping but Not Massage Enhances Vasodilation and Improves Venous Palpation of Cutaneous Veins	ACTA MEDICA OKAYAMA			English	Article						massage; tapping; vasodilation; venipuncture; venous palpation	SCIENTIFIC BASIS; NITRIC-OXIDE; ANCIENT-ART; AGE; FOREARM	This paper investigated whether tapping on the median cubital vein or massaging the forearm was more effective in obtaining better venous palpation for venipuncture. Forty healthy volunteers in their twenties were subjected to tapping (10 times in 5 sec) or massage (10 strokes in 20 sec from the wrist to the cubital fossa) under tourniquet inflation on the upper arm. Venous palpation was assessed using the venous palpation score (0-6, with 0 being impalpable). Three venous factors venous depth, cross-sectional area, and elevation-were also measured using ultrasonography. The venous palpation score increased significantly by tapping but not by massage. Moreover, all 3 venous measurements changed significantly by tapping, while only the depth decreased significantly by massage. The three venous measurements correlated significantly with the venous palpation score, indicating that they are useful objective indicators for evaluating vasodilation. We suggest that tapping is an effective vasodilation technique.	[Ichimura, Mika; Sasaki, Shinsuke] Okayama Prefectural Univ, Grad Sch Hlth & Welf Sci, Soja, Okayama 7191197, Japan; [Ogino, Tetsuya] Okayama Prefectural Univ, Fac Hlth & Welf Sci, Soja, Okayama 7191197, Japan; [Ichimura, Mika] Kibi Int Univ, Sch Hlth Sci & Social Welf, Takahashi, Okayama 7168508, Japan; [Sasaki, Shinsuke] Kansai Univ Social Welf, Fac Nursing, Ako, Hyogo 6780255, Japan; [Mori, Masaharu] Kurashiki Cent Hosp, Kurashiki, Okayama 7108602, Japan	Ichimura, M (reprint author), Okayama Prefectural Univ, Grad Sch Hlth & Welf Sci, Soja, Okayama 7191197, Japan.	Ichimura@kiui.ac.jp					ALGOTSSON A, 1995, J GERONTOL A-BIOL, V50, pM121; KANAI AJ, 1995, CIRC RES, V77, P284; Chun TH, 1997, HYPERTENSION, V29, P1296; BLAUW GJ, 1989, J CARDIOVASC PHARM, V14, P14, DOI 10.1097/00005344-198907000-00004; Bruce AN, 1913, Q J EXP PHYSIOL, V6, P339; GOATS GC, 1994, BRIT J SPORT MED, V28, P149; GOATS GC, 1994, BRIT J SPORT MED, V28, P153; Hadaway Lynn C, 2005, Nursing, V35 Suppl On, P1; Ichimura M, INT J NURS IN PRESS, DOI [10.1111/ijn.12313, DOI 10.1111/IJN.12313]; Ichimura M, 2011, B FAC HLTH WELFARE S, V18, P55; Kato A, 2010, J JPN SOC NURS RES, V33, P131; Kato A, 2009, JPN J NURS ART SCI, V8, P42; KindgenMilles D, 1996, PAIN, V64, P139, DOI 10.1016/0304-3959(95)00081-X; Lenhardt R, 2002, BRIT MED J, V325, P409, DOI 10.1136/bmj.325.7361.409; Marin J, 1999, EXP GERONTOL, V34, P503, DOI 10.1016/S0531-5565(99)00029-7; Mbamalu D, 1999, POSTGRAD MED J, V75, P459; Roberge RJ, 2004, J EMERG MED, V27, P69, DOI 10.1016/j.jemermed.2004.02.011; Sasaki S, 2012, ACTA MED OKAYAMA, V66, P67; Sasaki S, 2014, JPN J NURS ART SCI, V12, P14	19	0	0	OKAYAMA UNIV MED SCHOOL	OKAYAMA	EDITORIAL OFFICE, ACTA MEDICA OKAYAMA OKAYAMA UNIVERSITY MEDICAL SCHOOL 2-5-1 SHIKATA-CHO, KITA-KU, OKAYAMA, 700-8558, JAPAN	0386-300X			ACTA MED OKAYAMA	Acta Med. Okayama	APR	2015	69	2					79	85				7	Medicine, Research & Experimental	Research & Experimental Medicine	CG3LM	WOS:000353181700002		
J	Maruyama, H; Nakata, Y; Kanazawa, A; Watanabe, H; Shigemitsu, Y; Iwasaki, Y; Tokorodani, C; Miyazawa, M; Nishiuchi, R; Kikkawa, K				Maruyama, Hidehiko; Nakata, Yusei; Kanazawa, Akane; Watanabe, Hirokazu; Shigemitsu, Yusuke; Iwasaki, Yuka; Tokorodani, Chiho; Miyazawa, Mari; Nishiuchi, Ritsuo; Kikkawa, Kiyoshi			Ventriculoperitoneal Shunt Outcomes among Infants	ACTA MEDICA OKAYAMA			English	Article						head circumference; shunt failure; shunt infection; ventriculoperitoneal shunt	INTRACEREBRAL HEMORRHAGE SECONDARY; RISK-FACTORS; CLINICAL ARTICLE; INFECTION; HYDROCEPHALUS; CHILDREN; INSERTION	Ventriculoperitoneal shunts (VPSs) are used for the treatment of hydrocephalus. Here we analyzed the outcomes of VPS placements in 24 infants to determine the risk factors for shunt failure. The infants had undergone the initial VPS operation in our hospital between March 2005 and December 2013. They were observed until the end of January 2014. We obtained Kaplan-Meier curves and performed a multivariate Cox regression analysis of shunt failure. Of the 24 cases, the median (range) values for gestational age, birth weight, and birth head circumference (HC) were 37 (27-39) wks, 2,736 (686-3,788) g, and 35.3 (23.0-45.3) cm, respectively. The total number of shunt procedures was 45. Shunt failure rates were 0.51/shunt and 0.0053/shunt/year. Shunt infection rates were 0.13/shunt and 0.0014/shunt/year. The Kaplan-Meier analysis revealed an increased risk for shunt failure in infants <1 month old or in the HC > 90% tile. The Cox regression analysis yielded hazard ratios (HRs) of 2.93 (95% confidence interval (CI), 0.96-10.95, p = 0.059) for age <1 month, and 4.46 (95% CI: 1.20-28.91, p = 0.023) for the HC > 90 % tile. The multivariate Cox regression analysis showed adjusted HRs of 17.56 (95% CI: 2.69-202.8, p = 0.001) for age <1 month, and 2.95 (95% CI: 0.52-24.84, p = 0.228) for the HC > 90%tile. Our findings thus revealed that the risk factors for shunt failure in infants include age <1 month at the initial VPS placement.	[Maruyama, Hidehiko; Nakata, Yusei; Kanazawa, Akane; Watanabe, Hirokazu; Shigemitsu, Yusuke; Iwasaki, Yuka; Tokorodani, Chiho; Miyazawa, Mari; Nishiuchi, Ritsuo; Kikkawa, Kiyoshi] Kochi Hlth Sci Ctr, Dept Pediat, Kochi 7818555, Japan	Maruyama, H (reprint author), Kochi Hlth Sci Ctr, Dept Pediat, Kochi 7818555, Japan.	maruyamahidehiko@gmail.com					Patwardhan RV, 2005, NEUROSURGERY, V56, P139, DOI 10.1227/01.NEU.0000146206.40375.41; Simon TD, 2012, PEDIATR INFECT DIS J, V31, P551, DOI 10.1097/INF.0b013e31824da5bd; RENIER D, 1984, J NEUROSURG, V61, P1072, DOI 10.3171/jns.1984.61.6.1072; Stone JJ, 2013, J NEUROSURG-PEDIATR, V11, P15, DOI 10.3171/2012.9.PEDS1298; SCOTT M, 1955, J NEUROSURG, V12, P165, DOI 10.3171/jns.1955.12.2.0165; Lee JK, 2012, J KOREAN MED SCI, V27, P1563, DOI 10.3346/jkms.2012.27.12.1563; McGirt MJ, 2003, CLIN INFECT DIS, V36, P858, DOI 10.1086/368191; Drake JM, 2000, CHILD NERV SYST, V16, P800, DOI 10.1007/s003810000351; Kulkarni AV, 2013, J NEUROSURG-PEDIATR, V12, P334, DOI 10.3171/2013.7.PEDS12637; Kebriaei MA, 2013, J NEUROSURG-PEDIATR, V12, P44, DOI 10.3171/2013.4.PEDS12616; Wu Y, 2007, NEUROSURGERY, V61, P557, DOI 10.1227/01.NEU.0000280021.61888.C8; Kulkarni AV, 2001, J NEUROSURG, V94, P195, DOI 10.3171/jns.2001.94.2.0195; Bruinsma N, 2000, CLIN MICROBIOL INFEC, V6, P202, DOI 10.1046/j.1469-0691.2000.00052.x; Gathura E, 2010, J NEUROSURG-PEDIATR, V6, P329, DOI 10.3171/2010.7.PEDS09543; McGirt MJ, 2002, PEDIATR NEUROSURG, V36, P248, DOI 10.1159/000058428; Misaki K, 2010, NEUROL MED-CHIR, V50, P76; Patwardhan RV, 2005, NEUROSURGERY, V56, P144; POPLE IK, 1992, J NEUROSURG, V77, P29, DOI 10.3171/jns.1992.77.1.0029; Savitz MH, 1999, J NEUROSURG, V91, P32, DOI 10.3171/jns.1999.91.1.0032; Shahsavaran Shahram, 2012, J Pediatr Neurosci, V7, P114, DOI 10.4103/1817-1745.102572; Wu Y, 2007, NEUROSURGERY, V61, P562; Zhou F, 2012, INT J MED SCI, V9, P65	22	0	0	OKAYAMA UNIV MED SCHOOL	OKAYAMA	EDITORIAL OFFICE, ACTA MEDICA OKAYAMA OKAYAMA UNIVERSITY MEDICAL SCHOOL 2-5-1 SHIKATA-CHO, KITA-KU, OKAYAMA, 700-8558, JAPAN	0386-300X			ACTA MED OKAYAMA	Acta Med. Okayama	APR	2015	69	2					87	93				7	Medicine, Research & Experimental	Research & Experimental Medicine	CG3LM	WOS:000353181700003		
J	Sawada, D; Ogawa, T; Miyake, M; Hasui, Y; Yamaguchi, F; Izumori, K; Tokuda, M				Sawada, Daijo; Ogawa, Takaaki; Miyake, Minoru; Hasui, Yoshinori; Yamaguchi, Fuminori; Izumori, Ken; Tokuda, Masaaki			Potent Inhibitory Effects of D-tagatose on the Acid Production and Water-insoluble Glucan Synthesis of Streptococcus mutans GS5 in the Presence of Sucrose	ACTA MEDICA OKAYAMA			English	Article						Streptococcus mutans; D-tagatose; xylitol; acid production; water-insoluble glucan	D-PSICOSE; CLINICAL-TRIALS; XYLITOL; SUGARS; GLUCOSE; EXTRACT	We examined and compared the inhibitory effects of D-tagatose on the growth, acid production, and water-insoluble glucan synthesis of GS5, a bacterial strain of Streptococcus mutans, with those of xylitol, D-psicose, L-psicose and L-tagatose. GS5 was cultured for 12h in a medium containing 10% (w/v) of xylitol, D-psicose, L-psicose, D-tagatose or L-tagatose, and the inhibitory effect of GS5 growth was assessed. Each sugar showed different inhibitory effects on GS5. Both D-tagatose and xylitol significantly inhibited the acid production and water-insoluble glucan synthesis of GS5 in the presence of 1% (w/v) sucrose. However, the inhibitory effect of acid production by D-tagatose was significantly stronger than that of xylitol in presence of sucrose.	[Sawada, Daijo; Ogawa, Takaaki; Miyake, Minoru] Kagawa Univ, Fac Med, Dept Oral & Maxillofacial Surg, Miki, Kagawa 7610793, Japan; [Yamaguchi, Fuminori; Tokuda, Masaaki] Kagawa Univ, Fac Med, Dept Cell Physiol, Miki, Kagawa 7610793, Japan; [Sawada, Daijo; Hasui, Yoshinori] Hasui Dent Family Clin, Kagawa 7610704, Japan; [Izumori, Ken; Tokuda, Masaaki] Rare Sugar Res Ctr, Miki, Kagawa 7610793, Japan	Sawada, D (reprint author), Kagawa Univ, Fac Med, Dept Oral & Maxillofacial Surg, Miki, Kagawa 7610793, Japan.	daijo.sawada@gmail.com			Adaptable and Seamless Technology Transfer Program through Target-driven R&D, Japan Science and Technology Agency [AS242Z03885Q]	We thank Mr. Akihiro Yoshida (Department of Health Promotion, School of Dentistry, Kyushu Dental College) and Prof. Osamu Matsushita (Department of Bacteriology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences) for their help in our study. This research was supported by Adaptable and Seamless Technology Transfer Program through Target-driven R&D, Japan Science and Technology Agency (Study of effects on bacteria in the oral cavity of D-tagatose: AS242Z03885Q).	Matsumoto M, 1999, CARIES RES, V33, P441, DOI 10.1159/000016549; Lu Y, 2008, DIABETES OBES METAB, V10, P109, DOI 10.1111/j.1463-1326.2007.00799.x; Hayashi N, 2010, BIOSCI BIOTECH BIOCH, V74, P510, DOI 10.1271/bbb.90707; Hossain MA, 2011, BIOCHEM BIOPH RES CO, V405, P7, DOI 10.1016/j.bbrc.2010.12.091; Iida T, 2010, METABOLISM, V59, P206, DOI 10.1016/j.metabol.2009.07.018; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Hossain A, 2012, BIOCHEM BIOPH RES CO, V425, P717, DOI 10.1016/j.bbrc.2012.07.135; Yoshida A, 2002, APPL ENVIRON MICROB, V68, P6283, DOI 10.1128/AEM.62.12.6283-6291.2002; Bader JD, 2013, J AM DENT ASSOC, V144, P21; Bautista DA, 2000, J FOOD PROTECT, V63, P71; DONER LW, 1979, CARBOHYD RES, V70, P209, DOI 10.1016/S0008-6215(00)87101-3; FORBORD B, 1992, INT J BIOCHEM, V24, P509, DOI 10.1016/0020-711X(92)90047-5; GAUTHIER L, 1984, CARIES RES, V18, P289; Izumori K, 2002, NATURWISSENSCHAFTEN, V89, P120, DOI 10.1007/s00114-002-0297-z; Kishi M, 1999, J DENT HLTH, V49, P252; Levin Gilbert V., 2002, Journal of Medicinal Food, V5, P23, DOI 10.1089/109662002753723197; MARTINVILLA MC, 1981, AM J CLIN NUTR, V34, P2151; McDonald EJ, 1967, CARBOHYD RES, V5, P106, DOI 10.1016/0008-6215(67)85014-6; Mickenautsch S, 2012, INT DENT J, V62, P175, DOI 10.1111/j.1875-595X.2011.00113.x; Mickenautsch S, 2012, INT DENT J, V62, P6, DOI 10.1111/j.1875-595X.2011.00086.x; Ooshima T, 2000, ARCH ORAL BIOL, V45, P639, DOI 10.1016/S0003-9969(00)00042-X; Reid SJ, 2005, APPL MICROBIOL BIOT, V67, P312, DOI 10.1007/s00253-004-1885-y; TAKASHIO M, 1982, AGR BIOL CHEM TOKYO, V46, P1457	23	1	1	OKAYAMA UNIV MED SCHOOL	OKAYAMA	EDITORIAL OFFICE, ACTA MEDICA OKAYAMA OKAYAMA UNIVERSITY MEDICAL SCHOOL 2-5-1 SHIKATA-CHO, KITA-KU, OKAYAMA, 700-8558, JAPAN	0386-300X			ACTA MED OKAYAMA	Acta Med. Okayama	APR	2015	69	2					105	111				7	Medicine, Research & Experimental	Research & Experimental Medicine	CG3LM	WOS:000353181700005		
J	Inada, R; Nagasaka, T; Toshima, T; Mori, Y; Kondo, Y; Kishimoto, H; Hiraki, T; Oshiro, T; Kanemitsu, Y; Fujiwara, T				Inada, Ryo; Nagasaka, Takeshi; Toshima, Toshiaki; Mori, Yoshiko; Kondo, Yoshitaka; Kishimoto, Hiroyuki; Hiraki, Takao; Oshiro, Taihei; Kanemitsu, Yukihide; Fujiwara, Toshiyoshi			Aggressive Multimodality Treatment for Advanced Rectal Cancer	ACTA MEDICA OKAYAMA			English	Article						colorectal cancer; recurrence; total pelvic exenteration; radiofrequency ablation; systemic chemotherapy	METASTATIC COLORECTAL-CANCER; TOTAL PELVIC EXENTERATION; RADIOFREQUENCY ABLATION; 1ST-LINE TREATMENT; FOLLOW-UP; RESECTION; RECURRENCE; FLUOROURACIL; CHEMOTHERAPY; OXALIPLATIN	A case of advanced rectal cancer treated by aggressive local and systemic treatment who has survived more than 7 years from initial recurrence is presented. A 55-year-old woman was diagnosed with advanced lower rectal cancer and underwent a low anterior resection with complete removal of all regional lymph nodes and total mesorectal excision. The tumor was diagnosed as a moderately differentiated adenocarcinoma, pStage IIIB (T3, N2a, M0). Twenty-six months after the initial surgery, local recurrence in the pelvis was detected by computed tomography, and total pelvic exenteration with distal sacrectomy (TPES) was performed after systemic chemotherapy with a molecular-targeted drug. Six months after the TPES, multiple lung metastases were detected. Consequently, the patient underwent radiofrequency ablation (RFA) and chemotherapy. The disease has since been controlled for 38 months. As volume control is essential for cancer treatment, it may be important to combine appropriate local therapy with systemic therapy to metastatic or recurrent sites in order to achieve much longer disease control.	[Inada, Ryo; Nagasaka, Takeshi; Toshima, Toshiaki; Mori, Yoshiko; Kondo, Yoshitaka; Kishimoto, Hiroyuki; Fujiwara, Toshiyoshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Surg Gastroenterol, Okayama 7008558, Japan; [Hiraki, Takao] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Radiol, Okayama 7008558, Japan; [Oshiro, Taihei; Kanemitsu, Yukihide] Natl Canc Ctr, Colorectal Surg Div, Chuo Ku, Tokyo 1040045, Japan	Nagasaka, T (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Surg Gastroenterol, Okayama 7008558, Japan.	takeshin@cc.okayama-u.ac.jp					Soerjomataram I, 2012, LANCET, V380, P1840, DOI 10.1016/S0140-6736(12)60919-2; de Gramont A, 2000, J CLIN ONCOL, V18, P2938; Lochhead P, 2013, JNCI-J NATL CANCER I, V105, P1151, DOI 10.1093/jnci/djt173; Hiraki T, 2011, ACTA MED OKAYAMA, V65, P287; Douillard JY, 2000, LANCET, V355, P1041, DOI 10.1016/S0140-6736(00)02034-1; Abdalla EK, 2004, ANN SURG, V239, P818, DOI 10.1097/01.sla.0000128305.90650.71; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; GOYA T, 1989, CANCER, V64, P1418, DOI 10.1002/1097-0142(19891001)64:7<1418::AID-CNCR2820640709>3.0.CO;2-N; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; HEALD RJ, 1986, LANCET, V1, P1479; Moriya Y, 2004, DIS COLON RECTUM, V47, P2047, DOI 10.1007/s10350-004-0714-9; Akasu T, 2007, ANN SURG ONCOL, V14, P74, DOI 10.1245/s10434-006-9082-0; Edwards BK, 2013, CANCER, V120, P1290; Hahnloser D, 2003, ANN SURG, V237, P502, DOI 10.1097/00000658-200304000-00011; Ike H, 2002, DIS COLON RECTUM, V45, P468, DOI 10.1007/s10350-004-6222-0; Ike H, 2003, DIS COLON RECTUM, V46, P474, DOI 10.1097/01.DCR.0000059662.41713.DC; Sobin LH, 2009, TNM CLASSIFICATION M, V7th, P80	19	0	0	OKAYAMA UNIV MED SCHOOL	OKAYAMA	EDITORIAL OFFICE, ACTA MEDICA OKAYAMA OKAYAMA UNIVERSITY MEDICAL SCHOOL 2-5-1 SHIKATA-CHO, KITA-KU, OKAYAMA, 700-8558, JAPAN	0386-300X			ACTA MED OKAYAMA	Acta Med. Okayama	APR	2015	69	2					113	118				6	Medicine, Research & Experimental	Research & Experimental Medicine	CG3LM	WOS:000353181700006		
J	Terasaka, T; Hagiya, H; Kimura, K; Nada, T; Nakamura, E; Hanayama, Y; Sugiyama, H; Kobayashi, Y; Yanai, H; Otsuka, F				Terasaka, Tomohiro; Hagiya, Hideharu; Kimura, Kosuke; Nada, Takahiro; Nakamura, Eri; Hanayama, Yoshihisa; Sugiyama, Hitoshi; Kobayashi, Yasuyuki; Yanai, Hiroyuki; Otsuka, Fumio			A Paraganglioma in a Hypertensive Patient with Unilateral Renal Hypoplasia	ACTA MEDICA OKAYAMA			English	Article						catecholamine; paraganglioma; renal hypoplasia; renovascular hypertension; secondary hypertension	PHEOCHROMOCYTOMA; PATHOGENESIS; AGENESIS	We report the case of a 46-year-old hypertensive Japanese female with renal insufficiency related to unilateral renal hypoplasia. The patient was found to have developed paraganglioma in the retroperitoneal space over a 5-year period. Catecholamine-producing tumors are not usually recognized as conditions associated with renal hypoplasia. Our long-term observation of the patient eventually led us to the diagnosis of paraganglioma. In hypertensive patients with chronic kidney disease, not only the renin-angiotensin-aldosterone system but also catecholamine activity may be involved, particularly in the patients whose cases are complicated with unilateral renal hypoplasia.	[Terasaka, Tomohiro; Hagiya, Hideharu; Kimura, Kosuke; Nada, Takahiro; Nakamura, Eri; Hanayama, Yoshihisa; Otsuka, Fumio] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gen Med, Okayama 7008558, Japan; [Terasaka, Tomohiro; Sugiyama, Hitoshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med & Clin Sci, Okayama 7008558, Japan; [Kobayashi, Yasuyuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Urol, Okayama 7008558, Japan; [Yanai, Hiroyuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pathol, Okayama 7008558, Japan	Terasaka, T (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gen Med, Okayama 7008558, Japan.	teras-t@md.okayama-u.ac.jp					de Wailly P, 2012, LANGENBECK ARCH SURG, V397, P239, DOI 10.1007/s00423-011-0850-3; Andreasson A, 2013, EPIGENETICS-US, V8, P1347, DOI 10.4161/epi.26686; Gestblom C, 1999, AM J PATHOL, V155, P2167, DOI 10.1016/S0002-9440(10)65534-4; Mologni L, 2011, CURR MED CHEM, V18, P162, DOI 10.2174/092986711794088308; Camberos A, 2000, J PEDIATR SURG, V35, P714, DOI 10.1053/jpsu.2000.6032; Dahia PLM, 2014, NAT REV CANCER, V14, P108, DOI 10.1038/nrc3648; Galan SR, 2013, CLIN ENDOCRINOL, V78, P165, DOI 10.1111/cen.12071; Hibi Y, 2014, ENDOCR J, V61, P19; Wang HD, 2013, CHINESE MED J-PEKING, V126, P2996, DOI 10.3760/cma.j.issn.0366-6999.20122541	9	0	0	OKAYAMA UNIV MED SCHOOL	OKAYAMA	EDITORIAL OFFICE, ACTA MEDICA OKAYAMA OKAYAMA UNIVERSITY MEDICAL SCHOOL 2-5-1 SHIKATA-CHO, KITA-KU, OKAYAMA, 700-8558, JAPAN	0386-300X			ACTA MED OKAYAMA	Acta Med. Okayama	APR	2015	69	2					119	122				4	Medicine, Research & Experimental	Research & Experimental Medicine	CG3LM	WOS:000353181700007		
J	Waseda, K; Hagiya, H; Hanayama, Y; Terasaka, T; Kimura, K; Tsuzuki, T; Hasegawa, K; Nada, T; Nakamura, E; Murakami, K; Kondo, E; Otsuka, F				Waseda, Koichi; Hagiya, Hideharu; Hanayama, Yoshihisa; Terasaka, Tomohiro; Kimura, Kosuke; Tsuzuki, Takao; Hasegawa, Kou; Nada, Takahiro; Nakamura, Eri; Murakami, Kazutoshi; Kondo, Eisei; Otsuka, Fumio			Complication of Chronic Eosinophilic Pneumonia in an Elderly Patient with Sjogren Syndrome	ACTA MEDICA OKAYAMA			English	Article						bronchial alveolar lavage; eosinophilic pneumonia; eosinophilia; interstitial lung diseases; Sjogren syndrome	T-CELL LYMPHOMA; PULMONARY INVOLVEMENT; MANIFESTATIONS; PREVALENCE; MORTALITY; DISEASE; RANTES	An 81-year-old Japanese male with primary Sjogren syndrome (pSS) developed a low-grade fever and productive cough which were refractory to antibiotic therapy. Based on the high level of eosinophils observed in his bronchial alveolar lavage, he was diagnosed with chronic eosinophilic pneumonia (CEP) and successfully treated by oral prednisolone. Interstitial lung diseases associated with pSS (pSS-ILDs) usually present as nonspecific interstitial pneumonia or usual interstitial pneumonia; therefore, the present case is extremely unique in that the patient's condition was complicated with CEP. A diagnosis of advanced gallbladder cancer was made in the patient's clinical course, suggesting the advisability of a whole-body workup in cases of pSS, especially in elderly patients.	[Waseda, Koichi; Hagiya, Hideharu; Hanayama, Yoshihisa; Terasaka, Tomohiro; Kimura, Kosuke; Tsuzuki, Takao; Hasegawa, Kou; Nada, Takahiro; Nakamura, Eri; Murakami, Kazutoshi; Kondo, Eisei; Otsuka, Fumio] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gen Med, Okayama 7008558, Japan	Waseda, K (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gen Med, Okayama 7008558, Japan.	kazukazun2006@yahoo.co.jp					Alam M, 2007, SOUTH MED J, V100, P49; American Thoracic Society/European Respiratory Society, 2002, AM J RESP CRIT CARE, V165, P277; KAWASAKI A, 1991, TUMORI, V77, P527; Parambil JG, 2006, CHEST, V130, P1489, DOI 10.1378/chest.130.5.1489; Berkman N, 1996, AM J RESP CRIT CARE, V154, P1804; Asmussen K, 1996, J INTERN MED, V239, P475, DOI 10.1046/j.1365-2796.1996.418817000.x; Ramos-Casals M, 2005, ANN RHEUM DIS, V64, P347, DOI 10.1136/ard.2004.025676; CARRINGT.CB, 1969, NEW ENGL J MED, V280, P787, DOI 10.1056/NEJM196904102801501; Enomoto Y, 2013, PLOS ONE, V9; Gabriel SE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2669; Ishiguro T, 2008, INTERNAL MED, V47, P1419, DOI 10.2169/internalmedicine.47.1124; Ito I, 2005, AM J RESP CRIT CARE, V171, P632, DOI 10.1164/rccm.200403-417OC; Kokosi M, 2010, CLIN CHEST MED, V31, P489, DOI 10.1016/j.ccm.2010.05.007; Kurashima K, 1997, LAB INVEST, V76, P67; Marchand E, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-11; Minakuchi M, 2003, RESPIRATION, V70, P362, DOI 10.1159/000072898; Palm O, 2013, RHEUMATOLOGY, V52, P173, DOI 10.1093/rheumatology/kes311; Pertovaara M, 1999, ANN RHEUM DIS, V58, P423, DOI 10.1136/ard.58.7.423; Thiruchelvam JK, 2002, INT J ORAL MAX SURG, V31, P112, DOI 10.1054/ijom.2001.0112	19	0	0	OKAYAMA UNIV MED SCHOOL	OKAYAMA	EDITORIAL OFFICE, ACTA MEDICA OKAYAMA OKAYAMA UNIVERSITY MEDICAL SCHOOL 2-5-1 SHIKATA-CHO, KITA-KU, OKAYAMA, 700-8558, JAPAN	0386-300X			ACTA MED OKAYAMA	Acta Med. Okayama	APR	2015	69	2					123	127				5	Medicine, Research & Experimental	Research & Experimental Medicine	CG3LM	WOS:000353181700008		
J	Wang, ZF; Jiang, T; Zhang, DJ; Wang, YH; Zuo, QM; He, WJ				Wang Zhenfeng; Jiang Tao; Zhang Daojun; Wang Yahui; Zuo Qianmei; He Weijun			Evolution of deepwater sedimentary environments and its implication for hydrocarbon exploration in Qiongdongnan Basin, northwestern South China Sea	ACTA OCEANOLOGICA SINICA			English	Article						deepwater environment; Qiongdongnan Basin; hydrocarbon exploration; central canyon; submarine fan	RIVER SHEAR ZONE; CONTINENTAL-MARGIN; TECTONIC EVOLUTION; ASIA; ORIGIN; SYSTEM; CANYON; STRATIGRAPHY; ARCHITECTURE; FEATURES	Over the past several years, a number of hydrocarbon reservoirs have been discovered in the deepwater area of Qiongdongnan Basin, northwestern South China Sea. These oil/gas fields demonstrate that the evolution of the deepwater sedimentary environment are controlling the formation and distribution of large-scale clastic reservoirs. Integration between seismic and borehole data were necessary to best clarify the distribution and quality of these deepwater reservoirs. Geochemical and paleobiological evidence from discrete samples was also applied to document specific information regarding the sedimentary environment. Results show that the Qiongdongnan Basin has existed as a thriving marine environment since Oligocene, when several rifting depressions developed throughout the entire Qiongdongnan Basin. Triggered by the faults activities, several distinct provenances supplied the coarse sediments, transporting and depositing them in deep parts of the rifting depressions. A fan delta system then formed nearby the source in the deeper area of these rifting depressions. The sedimentary environment of Qiongdongnan gradiationally became deepwater since early Miocene. Consequently, abundances of sediments were transported from Hainan Island and Southern Uplift, and then sunk into the basin center. The submarine fans revealed by many boreholes in this area verified them as good reservoir. Because the area reached its lowest sea level at late Miocene and the Southern Uplift subsidenced under sea level, not providing any sediment, so that the carbonate mesa and biorhythms characteristic of this area also developed during this period. In the west part of Qiongdongnan Basin, sediments transported from Vietnam increased in response to the Tibetan Uplift. Consequently, a central canyon developed along the center of Qiongdongnan Basin, which has been confirmed by several boreholes as a favorable hydrocarbon reservoir. The clarification of the deepwater sedimentary environment's evolution is potentially highly beneficial to future hydrocarbon exploration in the deepwater area of Qiongdongnan Basin.	[Wang Zhenfeng; Zhang Daojun; Wang Yahui; Zuo Qianmei; He Weijun] CNOOC Ltd, Zhanjiang Branch, Zhanjiang 524057, Peoples R China; [Jiang Tao] China Univ Geosci, Key Lab Tecton & Petr Resources, Minist Educ, Wuhan 430074, Peoples R China; [Jiang Tao] Japan Agcy Marine Earth Sci & Technol, Kochi Inst Core Sample Res, Kochi 7838502, Japan	Jiang, T (reprint author), China Univ Geosci, Key Lab Tecton & Petr Resources, Minist Educ, Wuhan 430074, Peoples R China.	taojiang@cug.edu.cn			National Science and Technology Major Project of China [2011ZX05025-002-02]; National Natural Science Foundation of China [41476032, 41372112]	Foundation item: The National Science and Technology Major Project of China under contract No. 2011ZX05025-002-02; the National Natural Science Foundation of China under contract Nos 41476032 and 41372112.	Hall R, 2002, J ASIAN EARTH SCI, V20, P353, DOI 10.1016/S1367-9120(01)00069-4; Cullen A, 2010, PETROL GEOSCI, V16, P273, DOI 10.1144/1354-079309-908; SCHARER U, 1990, EARTH PLANET SC LETT, V97, P65, DOI 10.1016/0012-821X(90)90099-J; Wang YM, 2011, CHINESE SCI BULL, V56, P1488, DOI 10.1007/s11434-011-4441-z; TAPPONNIER P, 1990, NATURE, V343, P431, DOI 10.1038/343431a0; BRIAIS A, 1993, J GEOPHYS RES-SOL EA, V98, P6299, DOI 10.1029/92JB02280; Flower MFJ, 2001, TECTONOPHYSICS, V333, P9, DOI 10.1016/S0040-1951(00)00264-X; Su M, 2014, J ASIAN EARTH SCI, V79, P552, DOI 10.1016/j.jseaes.2012.12.038; Tapponnier P, 2001, SCIENCE, V294, P1671, DOI 10.1126/science.105978; Hutchison CS, 2004, MAR PETROL GEOL, V21, P1129, DOI 10.1016/j.marpetgeo.2004.07.002; He YL, 2013, MAR PETROL GEOL, V41, P264, DOI 10.1016/j.marpetgeo.2012.03.002; Yuan SQ, 2009, CHIN J OCEANOL LIMN, V27, P250, DOI [10.1007/s00343-009-9177-0, 10.1007/S00343-009-9177-0]; Ludmann T, 2001, MAR GEOL, V172, P331, DOI 10.1016/S0025-3227(00)00129-8; Cao LC, 2015, MAR GEOL, V361, P136, DOI 10.1016/j.margeo.2015.01.007; Leloup PH, 2001, J GEOPHYS RES-SOL EA, V106, P6683, DOI 10.1029/2000JB900322; Hayes DE, 2005, EARTH PLANET SC LETT, V237, P601, DOI 10.1016/j.epsl.2005.06.017; Xie XO, 2008, MAR GEOL, V247, P129, DOI 10.1016/j.margeo.2007.08.005; Xu YG, 2012, CHINESE SCI BULL, V57, P3150, DOI 10.1007/s11434-011-4921-1; Li XQ, 2013, J ASIAN EARTH SCI, V62, P685, DOI 10.1016/j.jseaes.2012.11.019; Xie XN, 2006, MAR PETROL GEOL, V23, P745, DOI 10.1016/j.marpetgeo.2006.03.004; Hori K, 2004, SEDIMENT GEOL, V164, P237, DOI 10.1016/j.sedgeo.2003.10.008; CHEN PPH, 1993, AAPG BULL, V77, P842; Clift PD, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004048; Hao F, 1998, AAPG BULL, V82, P1372; HOLLOWAY NH, 1982, AAPG BULL, V66, P1355; Jiang T, 2007, CHINESE SCI BULL, V52, P2429, DOI 10.1007/s11434-007-0348-0; Jiang T, 2013, MAR GEOPHYS RES, V34, P281, DOI 10.1007/s11001-013-9198-0; LALLEMAND S, 1986, EARTH PLANET SC LETT, V76, P375, DOI 10.1016/0012-821X(86)90088-9; Liu ZF, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001490; Lu XX, 2008, QUATERN INT, V186, P1, DOI 10.1016/j.quaint.2007.11.014; Song GZ, 2014, J EARTH SCI-CHINA, V25, P275, DOI 10.1007/s12583-014-0433-7; Tao Jiang, 2014, BASINS METHODS FORMA, P27; TAPPONNIER P, 1982, GEOLOGY, V10, P611, DOI 10.1130/0091-7613(1982)10<611:PETIAN>2.0.CO;2; Taylor B., 1983, AM GEOPHYS UNION GEO, V27, P23; Vail P.R., 1977, AAPG MEMOIR, V26, P99; Van Wagoner J.C., 1990, AAPG METHODS EXPLORA, V7	36	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0253-505X	1869-1099		ACTA OCEANOL SIN	Acta Oceanol. Sin.	APR	2015	34	4					1	10		10.1007/s13131-015-0645-4		10	Oceanography	Oceanography	CG2OA	WOS:000353112900001		
J	Nikl, M; Yoshikawa, A				Nikl, Martin; Yoshikawa, Akira			Recent R&D Trends in Inorganic Single-Crystal Scintillator Materials for Radiation Detection	Advanced Optical Materials			English	Review						scintillators; single crystals; radiation; detectors; rare earths	PRASEODYMIUM ACTIVATED LU3AL5O12; GAMMA-RAY SPECTROMETERS; YTTRIUM-ALUMINUM-GARNET; LUAG-CE CERAMICS; OPTICAL-PROPERTIES; CZOCHRALSKI GROWTH; YAG-CE; LIGHT YIELD; CSI-TL; LUMINESCENCE CHARACTERISTICS	In this review, the major achievements and research and development (R&D) trends from the last decade in the field of single crystal scintillator materials are described. Two material families are included, namely, those of halide and oxide compounds. In most cases, the host crystals are doped with Ce3+, Pr3+ or Eu2+ rare earth ions. Their spin- and parity-allowed 5d-4f transitions enable a rapid scintillation response, on the order of tens to hundreds of nanoseconds. Technological recipes, extended characterization by means of optical and magnetic spectroscopies, and theoretical studies are described. The latter provide further support to experimental results and provide a better understanding of the host electronic band structure, energy levels of specific defects, and the emission centers themselves. Applications in medical imaging and dosimetry, security measures, high-energy physics and the high-tech industry, in which X()-rays or particle beams are used and monitored, are recognized as the main driving factor for R&D activities in this field.	[Nikl, Martin] AS CR, Inst Phys, Prague 16253, Czech Republic; [Yoshikawa, Akira] Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan	Nikl, M (reprint author), AS CR, Inst Phys, Cukrovarnicka 10, Prague 16253, Czech Republic.	nikl@fzu.cz			Czech Science foundation [P204/12/0805]; MEYS, Kontakt [LH14266]; JST Program; Adaptable & Seamless Technology Transfer Program through Target-driven RD (A-STEP); Development of Systems and Technology for Advanced Measurement and Analysis	This research and article preparation was supported by grants from the Czech Science foundation (no. P204/12/0805) and MEYS, Kontakt, (no. LH14266). Partial support by the JST Program, Adaptable & Seamless Technology Transfer Program through Target-driven R&D (A-STEP) and Development of Systems and Technology for Advanced Measurement and Analysis are also greatly appreciated. Thanks are due to V. Babin for providing the unpublished experimental data for Figure 13, D. Ding for the photo in Figure 15, E. Mihokova for language corrections and E. Jurkova for technical help in the manuscript preparation.	Akchurin N, 2009, NUCL INSTRUM METH A, V604, P512, DOI 10.1016/j.nima.2009.03.101; Alekhin MS, 2014, J LUMIN, V145, P518, DOI 10.1016/j.jlumin.2013.08.019; Annenkov AA, 2002, NUCL INSTRUM METH A, V490, P30, DOI 10.1016/S0168-9002(02)00916-6; Conti M, 2009, PHYS MEDICA, V25, P1, DOI 10.1016/j.ejmp.2008.10.001; Alekhin MS, 2014, J LUMIN, V145, P723, DOI 10.1016/j.jlumin.2013.08.058; Pauwels D, 2000, IEEE T NUCL SCI, V47, P1787, DOI 10.1109/23.914446; Liu B, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/43/436215; Glodo J, 2010, IEEE T NUCL SCI, V57, P1228, DOI 10.1109/TNS.2009.2036352; Nikl M, 2006, MEAS SCI TECHNOL, V17, pR37, DOI 10.1088/0957-0233/17/4/R01; Chewpraditkul W, 2013, PHYS STATUS SOLIDI A, V210, P1903, DOI 10.1002/pssa.201329159; Yamaji A, 2012, PHYS STATUS SOLIDI C, V9, P2267, DOI 10.1002/pssc.201200333; Dujardin C, 2010, J APPL PHYS, V108, DOI 10.1063/1.3452358; Drozdowski W, 2014, OPT MATER EXPRESS, V4, P1207, DOI 10.1364/OME.4.001207; D'Olympia N, 2013, NUCL INSTRUM METH A, V728, P31, DOI 10.1016/j.nima.2013.06.084; Dorenbos P, 2005, PHYS STATUS SOLIDI A, V202, P195, DOI 10.1002/pssa.200460106; Zych E, 1997, J LUMIN, V75, P193, DOI 10.1016/S0022-2313(97)00103-8; Cooke DW, 2000, J APPL PHYS, V88, P7360, DOI 10.1063/1.1328775; TAKEDA T, 1980, J ELECTROCHEM SOC, V127, P438, DOI 10.1149/1.2129684; Feng H, 2008, J APPL PHYS, V103, DOI 10.1063/1.2906348; Higgins WM, 2008, J CRYST GROWTH, V310, P2085, DOI 10.1016/j.jcrysgro.2007.12.041; Blahuta S, 2013, IEEE T NUCL SCI, V60, P3134, DOI 10.1109/TNS.2013.2269700; ROTMAN SR, 1992, J APPL PHYS, V71, P1209, DOI 10.1063/1.351289; VISSER R, 1994, IEEE T NUCL SCI, V41, P689, DOI 10.1109/23.322789; SUZUKI H, 1992, NUCL INSTRUM METH A, V320, P263, DOI 10.1016/0168-9002(92)90784-2; van Loef EV, 2009, IEEE T NUCL SCI, V56, P869, DOI 10.1109/TNS.2009.2013947; [Anonymous], 2011, RAD DET MAT MARK 201; Singh DJ, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.214115; Smet PF, 2014, OPT MATER, V36, P1913, DOI 10.1016/j.optmat.2014.05.026; Chewpraditkul W, 2009, IEEE T NUCL SCI, V56, P3800, DOI 10.1109/TNS.2009.2033994; TAKAGI K, 1983, APPL PHYS LETT, V42, P43, DOI 10.1063/1.93760; WEBER MJ, 1973, SOLID STATE COMMUN, V12, P741, DOI 10.1016/0038-1098(73)90326-8; Du MH, 2014, J MATER CHEM C, V2, P4784, DOI 10.1039/c4tc00485j; Boatner LA, 2013, J CRYST GROWTH, V379, P63, DOI 10.1016/j.jcrysgro.2013.01.035; Drozdowski W, 2009, IEEE T NUCL SCI, V56, P320, DOI 10.1109/TNS.2008.2011269; Tyagi M, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/47/475302; Alekhin MS, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4803440; Boatner LA, 2013, NUCL INSTRUM METH A, V709, P95, DOI 10.1016/j.nima.2013.01.013; Harrison MJ, 2009, IEEE T NUCL SCI, V56, P1661, DOI 10.1109/TNS.2009.2021057; LEMPICKI A, 1993, NUCL INSTRUM METH A, V333, P304, DOI 10.1016/0168-9002(93)91170-R; Gektin AV, 2014, IEEE T NUCL SCI, V61, P262, DOI 10.1109/TNS.2013.2277883; Nikl M, 2008, PHYS STATUS SOLIDI B, V245, P1701, DOI 10.1002/pssb.200844039; Drozdowski W, 2008, IEEE T NUCL SCI, V55, P2420, DOI 10.1109/TNS.2008.2000845; Vasil'ev AN, 2014, IEEE T NUCL SCI, V61, P235, DOI 10.1109/TNS.2013.2282117; Ikesue A, 2008, NAT PHOTONICS, V2, P721, DOI 10.1038/nphoton.2008.243; Ching WY, 1999, PHYS REV B, V59, P12815, DOI 10.1103/PhysRevB.59.12815; Singh DJ, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.155145; Wu YT, 2013, OPT MATER, V35, P2146, DOI 10.1016/j.optmat.2013.05.039; Shirwadkar U, 2013, IEEE T NUCL SCI, V60, P1011, DOI 10.1109/TNS.2013.2240696; Shi Y, 2011, J APPL PHYS, V109, DOI 10.1063/1.3530679; Wu YT, 2014, APL MATER, V2, DOI 10.1063/1.4854375; Ye S, 2010, MAT SCI ENG R, V71, P1, DOI 10.1016/j.mser.2010.07.001; Nikl M, 2000, PHYS STATUS SOLIDI A, V178, P595, DOI 10.1002/1521-396X(200004)178:2<595::AID-PSSA595>3.0.CO;2-X; Nikl M, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.195121; Grim JQ, 2012, PHYS STATUS SOLIDI A, V209, P2421, DOI 10.1002/pssa.201200436; Li Q, 2013, PHYS STATUS SOLIDI B, V250, P233, DOI 10.1002/pssb.201200503; Chaudhry A, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.155105; Ogino H, 2006, J CRYST GROWTH, V292, P239, DOI 10.1016/j.jcrysgro.2006.04.021; HOFSTADTER R, 1949, PHYS REV, V75, P796, DOI 10.1103/PhysRev.75.796; Laguta VV, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.045114; Yang K, 2009, IEEE T NUCL SCI, V56, P2960, DOI 10.1109/TNS.2009.2027018; Srivastava AM, 2009, IEEE T NUCL SCI, V56, P986, DOI 10.1109/TNS.2009.2012707; Aberg D, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4880576; Pankratov V, 2013, RADIAT MEAS, V56, P13, DOI 10.1016/j.radmeas.2013.02.022; Patel AP, 2013, PHYS STATUS SOLIDI B, V250, P1624, DOI 10.1002/pssb.201248583; Tanner PA, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/21/216213; RODNYI PA, 1995, PHYS STATUS SOLIDI B, V187, P15, DOI 10.1002/pssb.2221870102; Drozdowski W, 2006, NUCL INSTRUM METH A, V562, P254, DOI 10.1016/j.nima.2006.01.127; Mihokova E, 2007, J LUMIN, V126, P77, DOI 10.1016/j.jlumin.2006.05.004; Yanagida T, 2013, OPT MATER, V35, P1987, DOI 10.1016/j.optmat.2012.11.002; Weber MJ, 2002, J LUMIN, V100, P35, DOI 10.1016/S0022-2313(02)00423-4; Liu SP, 2014, PHYS STATUS SOLIDI-R, V8, P105, DOI 10.1002/pssr.201308199; Nikl M, 2013, PROG CRYST GROWTH CH, V59, P47, DOI 10.1016/j.pcrysgrow.2013.02.001; MELCHER CL, 1992, NUCL INSTRUM METH A, V314, P212, DOI 10.1016/0168-9002(92)90517-8; Ueda J, 2013, OPT MATER, V35, P1952, DOI 10.1016/j.optmat.2012.11.016; Nikl M, 2014, CRYST GROWTH DES, V14, P4827, DOI 10.1021/cg501005s; Trummer J, 2005, NUCL INSTRUM METH A, V551, P339, DOI 10.1016/j.nima.2005.06.047; van Eijk CWE, 2008, RADIAT PROT DOSIM, V129, P13, DOI 10.1093/rpd/ncn043; Dorenbos P, 2010, IEEE T NUCL SCI, V57, P1162, DOI 10.1109/TNS.2009.2031140; Mares JA, 2004, RADIAT MEAS, V38, P353, DOI 10.1016/j.radmeas.2004.04.004; Ucer KB, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.165112; Loutts GB, 1997, J CRYST GROWTH, V174, P331, DOI 10.1016/S0022-0248(96)01171-2; Quarati FGA, 2013, NUCL INSTRUM METH A, V729, P596, DOI [10.1016/j.nima.2013.08.005, 10.1016/j.nina.2013.08.005]; Babin V, 2005, PHYS STATUS SOLIDI C, V2, P97, DOI 10.1002/pssc.200460120; WEBER MJ, 1973, J APPL PHYS, V44, P5495, DOI 10.1063/1.1662183; Aberg D, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.125134; Quarati FGA, 2012, NUCL INSTRUM METH A, V683, P46, DOI 10.1016/j.nima.2012.04.066; Spurrier MA, 2008, IEEE T NUCL SCI, V55, P1178, DOI 10.1109/TNS.2007.913486; Kuklja MM, 2000, J PHYS-CONDENS MAT, V12, P2953, DOI 10.1088/0953-8984/12/13/307; Li HL, 2005, J AM CERAM SOC, V88, P3226, DOI 10.1111/j.1551-2916.2005.00554.x; Kamada K, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/50/505104; Jiang SL, 2013, COMP MATER SCI, V69, P261, DOI 10.1016/j.commatsci.2012.11.045; Cherepy NJ, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2885728; Chewpraditkul W, 2013, OPT MATER, V35, P1679, DOI 10.1016/j.optmat.2013.04.024; Alekhin MS, 2011, IEEE T NUCL SCI, V58, P2519, DOI 10.1109/TNS.2011.2163642; Dorenbos P, 2000, PHYS REV B, V62, P15650, DOI 10.1103/PhysRevB.62.15650; Nikl M, 2010, IEEE T NUCL SCI, V57, P1168, DOI 10.1109/TNS.2010.2043116; Jary V, 2012, IEEE T NUCL SCI, V59, P2079, DOI 10.1109/TNS.2012.2190940; Sidletskiy O, 2012, CRYST GROWTH DES, V12, P4411, DOI 10.1021/cg300608t; Grim JQ, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.125117; Rothfuss HE, 2009, IEEE T NUCL SCI, V56, P958, DOI 10.1109/TNS.2008.2010621; Feng H, 2010, J APPL PHYS, V108, DOI 10.1063/1.3457856; Kramer KW, 2006, J MATER CHEM, V16, P2773, DOI 10.1039/b602762h; Quarati FGA, 2014, NUCL INSTRUM METH A, V735, P655, DOI 10.1016/j.nima.2013.10.004; WEBER MJ, 1973, J APPL PHYS, V44, P3205, DOI 10.1063/1.1662735; Przybylinska H, 2014, OPT MATER, V36, P1515, DOI 10.1016/j.optmat.2014.04.015; Belsky AN, 2001, IEEE T NUCL SCI, V48, P1095, DOI 10.1109/23.958730; Yanagida T, 2012, IEEE T NUCL SCI, V59, P2146, DOI 10.1109/TNS.2012.2189583; Nikl M, 2007, J APPL PHYS, V101, DOI 10.1063/1.2433706; Kanai T, 2008, J AM CERAM SOC, V91, P456, DOI 10.1111/j.1551-2916.2007.02123.x; Stanek CR, 2007, NUCL INSTRUM METH A, V579, P27, DOI 10.1016/j.nima.2007.04.006; Guss P, 2009, NUCL INSTRUM METH A, V608, P297, DOI 10.1016/j.nima.2009.06.096; Wu YT, 2014, CRYSTENGCOMM, V16, P3312, DOI 10.1039/c3ce42645a; Brandle CD, 2004, J CRYST GROWTH, V264, P593, DOI 10.1016/j.jcrysgro.2003.12.044; Sidletskiy O, 2010, J CRYST GROWTH, V312, P601, DOI 10.1016/j.jcrysgro.2009.11.048; VANSCIVER W, 1951, PHYS REV, V84, P1062, DOI 10.1103/PhysRev.84.1062.2; Yanagida T, 2005, IEEE T NUCL SCI, V52, P1836, DOI 10.1109/TNS.2005.856757; Dorenbos P, 2013, J LUMIN, V134, P310, DOI 10.1016/j.jlumin.2012.08.028; VANEIJK CWE, 1994, IEEE T NUCL SCI, V41, P738, DOI 10.1109/23.322798; Kamada K, 2014, OPT MATER, V36, P1942, DOI 10.1016/j.optmat.2014.04.001; Kokubun M, 2004, IEEE T NUCL SCI, V51, P1991, DOI 10.1109/TNS.2004.832921; ROBBINS DJ, 1980, J ELECTROCHEM SOC, V127, P2694, DOI 10.1149/1.2129574; Kurosawa S, 2014, NUCL INSTRUM METH A, V744, P30, DOI 10.1016/j.nima.2014.01.018; BRIXNER LH, 1987, MATER CHEM PHYS, V16, P253, DOI 10.1016/0254-0584(87)90102-7; Pidol L, 2003, J PHYS-CONDENS MAT, V15, P2091, DOI 10.1088/0953-8984/15/12/326; van Loef EVD, 2001, APPL PHYS LETT, V79, P1573, DOI 10.1063/1.1385342; Yoshikawa A, 2013, ACTA PHYS POL A, V124, P250; Auffray E, 2004, NUCL INSTRUM METH A, V527, P171, DOI 10.1016/j.nima.2004.03.115; Autrata E., 1983, SCANNING, V5, P91; AUTRATA R, 1978, J PHYS E SCI INSTRUM, V11, P707, DOI 10.1088/0022-3735/11/7/028; Bachmann W., 2009, CHEM MATER, V21, P2077; Bartram RH, 2006, NUCL INSTRUM METH A, V558, P458, DOI 10.1016/j.nima.2005.11.051; Belsky A, 2013, J PHYS CHEM LETT, V4, P3534, DOI 10.1021/jz401864w; Birowosuto MD, 2008, J APPL PHYS, V103, DOI 10.1063/1.2930884; Birowosuto MD, 2006, J APPL PHYS, V99, DOI 10.1063/1.2207689; Bourret-Courchesne ED, 2009, NUCL INSTRUM METH A, V612, P138, DOI 10.1016/j.nima.2009.10.146; Brecher C, 2006, NUCL INSTRUM METH A, V558, P450, DOI 10.1016/j.nima.2005.11.119; Brylew K, 2013, CENT EUR J PHYS, V11, P138, DOI 10.2478/s11534-012-0153-5; Chen HB, 2006, CRYST GROWTH DES, V6, P809, DOI 10.1021/cg050358c; Cherepy NJ, 2007, NUCL INSTRUM METH A, V579, P38, DOI 10.1016/j.nima.2007.04.009; Cherepy NJ, 2010, P SOC PHOTO-OPT INS, V7805, DOI 10.1117/12.862503; Cherepy NJ, 2011, PROC SPIE, V8142, DOI 10.1117/12.896656; Ching WY, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.245108; Derdzyan M, 2005, NUCL INSTRUM METH A, V537, P200, DOI 10.1016/j.nima.2004.08.008; Ding DZ, 2010, IEEE T NUCL SCI, V57, P1272, DOI 10.1109/TNS.2009.2036351; Dorenbos P, 2006, J LUMIN, V117, P147, DOI 10.1016/j.jlumin.2005.04.016; Drozdowski W, 2013, RADIAT MEAS, V56, P80, DOI 10.1016/j.radmeas.2013.01.065; Fasoli M, 2008, IEEE T NUCL SCI, V55, P1114, DOI 10.1109/TNS.2008.922818; Fasoli M, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.081102; Fowler WB, 1968, PHYS COLOR CTR; Fuchs A. W., 1960, IMAGE, V9, P4; Gascon M, 2014, J LUMIN, V156, P63, DOI 10.1016/j.jlumin.2014.07.017; Gerasymov Y. A., 2013, FUNCT MAT, V20, P15; Gilette R. H., 1950, REV SCI INSTRUM, V21, P294; Grahmaier R., 1994, LUMINESCENT MAT; Guillot-Noel O, 1999, J LUMIN, V85, P21, DOI 10.1016/S0022-2313(99)00063-0; Gumanskaya E. G., 1992, Optics and Spectroscopy, V72; Harrison MJ, 2010, P SOC PHOTO-OPT INS, V7806, DOI 10.1117/12.882643; Higgins WM, 2006, J CRYST GROWTH, V287, P239, DOI 10.1016/j.jcrysgro.2005.11.020; Hofstadter R., 1968, U.S. Patent, Patent No. [3,373,279, 3373279]; Hofstadter R., 1968, US Patent, Patent No. [3373279, 7151261]; Holsa J, 2009, J LUMIN, V129, P1606, DOI 10.1016/j.jlumin.2008.12.027; Hull G, 2007, P SOC PHOTO-OPT INS, V6706, P70617, DOI 10.1117/12.738961; ISHII M, 1991, PROG CRYST GROWTH CH, V23, P245; Ivanovskikh KV, 2013, ECS J SOLID STATE SC, V2, pR3148, DOI 10.1149/2.011302jss; Jary V, 2014, J PHYS CHEM C, V118, P26521, DOI 10.1021/jp5080384; Jary V, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/36/365304; Kamada K, 2012, PHYS STATUS SOLIDI C, V9, P2263, DOI 10.1002/pssc.201200264; Kamada K, 2015, OPT MATER, V41, P63, DOI 10.1016/j.optmat.2014.10.008; Kawamura S., 2006, IEEE NUCL SCI S, V2, P1160; Kawamura S, 2007, NUCL INSTRUM METH A, V583, P356, DOI 10.1016/j.nima.2007.09.021; Klimm D, 2010, J CRYST GROWTH, V312, P730, DOI 10.1016/j.jcrysgro.2009.12.030; Knoll G. F., 2000, RAD DETECTION MEASUR; Kolobanov V, 2006, PHYS STATUS SOLIDI B, V243, pR60, DOI 10.1002/pssb.200642211; KVAPIL J, 1981, J CRYST GROWTH, V52, P542, DOI 10.1016/0022-0248(81)90336-5; Laguta VV, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.064104; Lecoq P., 2006, INORGANIC SCINTILLAT; Lecoq P, 2009, J PHYS CONF SER, V160, DOI 10.1088/1742-6596/160/1/012016; Li CL, 2007, SOLID STATE COMMUN, V144, P220, DOI 10.1016/j.ssc.2007.08.040; Li HL, 2008, JPN J APPL PHYS, V47, P1657, DOI 10.1143/JJAP.47.1657; Liu B, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3109799; Mares JA, 2007, PHYS STATUS SOLIDI C, V4, P996, DOI [10.1002/pssc.200673858, 10.1002/pssc.2006.73858]; Moretti F, 2012, J LUMIN, V132, P461, DOI 10.1016/j.jlumin.2011.09.016; Moses WW, 2012, IEEE T NUCL SCI, V59, P2038, DOI 10.1109/TNS.2012.2186463; MOSZYNSKI M, 1994, NUCL INSTRUM METH A, V345, P461, DOI 10.1016/0168-9002(94)90500-2; Munoz-Garcia AB, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.184118; Munoz-Garcia AB, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.014105; Nagarkar VV, 2008, IEEE T NUCL SCI, V55, P1270, DOI 10.1109/TNS.2008.915689; NAGIRNYI V, 1994, CHEM PHYS LETT, V227, P533, DOI 10.1016/0009-2614(94)00857-4; Nikl M., 2013, RECENT ADV CERAMIC M, P127; Nikl M., 2010, SPRINGER HDB CRYSTAL, P1663, DOI 10.1007/978-3-540-74761-1_50; Nikl M, 2004, PHYS STATUS SOLIDI A, V201, pR41, DOI 10.1002/pssa.200409041; Nikl M, 2013, PHYS STATUS SOLIDI C, V10, P172, DOI 10.1002/pssc.201200499; Nikl M, 2000, PHYS STATUS SOLIDI A, V181, pR10, DOI 10.1002/1521-396X(200009)181:1<R10::AID-PSSA999910>3.0.CO;2-9; Nikl M, 2016, J LUMIN, V169, P539, DOI 10.1016/j.jlumin.2015.01.008; Ogieglo JM, 2013, J PHYS CHEM A, V117, P2479, DOI 10.1021/jp309572p; Petrosyan AG, 2007, NUCL INSTRUM METH A, V571, P325, DOI 10.1016/j.nima.2006.10.093; Petrosyan AG, 2013, J CRYST GROWTH, V377, P178, DOI 10.1016/j.jcrysgro.2013.04.054; Pidol L, 2004, IEEE T NUCL SCI, V51, P1084, DOI 10.1109/TNS.2004.829542; Pidol L., 2006, PHYS CHEM SOLIDS, V67, P643; Przybylinska H, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4812190; Qin LS, 2005, J CRYST GROWTH, V281, P518, DOI 10.1016/j.jcrysgro.2005.04.057; Ra S., 2008, IEEE T NUCL SCI, V5, P1221; Rodnyi P. A., 1997, PHYS PROCESSES INORG; Rogulis U, 2002, RADIAT EFF DEFECT S, V157, P951, DOI 10.1080/1042015021000052872; Röntgen W C, 1896, Science, V3, P227, DOI 10.1126/science.3.59.227; Runkle RC, 2010, J APPL PHYS, V108, DOI 10.1063/1.3503495; SCHIRMER OF, 1975, PHYS REV B, V11, P4201, DOI 10.1103/PhysRevB.11.4201; Seco J, 2014, PHYS MED BIOL, V59, pR303, DOI 10.1088/0031-9155/59/20/R303; Shah K. S., 2004, IEEE NUCL SCI S C RE, V7, P4278, DOI 10.1109/NSSMIC.2004.1466835; Shepherd JA, 1997, OPT ENG, V36, P3212, DOI 10.1117/1.601530; Shi HS, 2010, CRYST GROWTH DES, V10, P4433, DOI 10.1021/cg100557c; Shionoya S., 1998, PHOSPHOR HDB; Singh DJ, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2936079; Song K. S., 1993, SELF TRAPPED EXCITON, V1st; Stanek CR, 2006, J APPL PHYS, V99, DOI 10.1063/1.2200759; Suzuki A, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.102601; TOMIKI T, 1994, J PHYS SOC JPN, V63, P1976, DOI 10.1143/JPSJ.63.1976; Toropov N. A., 1961, RUSS CHEM B, V10, P497; Totsuka D, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.052601; Tous J, 2011, J INSTRUM, V6, DOI 10.1088/1748-0221/6/01/C01048; Usui T., 2006, IEEE NUCL SCI S, V2, P1166; van Eijk CWE, 2002, PHYS MED BIOL, V47, pR85, DOI 10.1088/0031-9155/47/8/201; van der Kolk E, 2003, APPL PHYS LETT, V83, P1740, DOI 10.1063/1.1603337; van Eijk CWE, 2012, IEEE T NUCL SCI, V59, P2242, DOI 10.1109/TNS.2012.2186154; van Loef EVD, 2003, J PHYS-CONDENS MAT, V15, P1367, DOI 10.1088/0953-8984/15/8/319; Vasilev AN, 1996, NUCL INSTRUM METH B, V107, P165, DOI 10.1016/0168-583X(95)01023-8; Vedda A, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.045113; Wei H, 2014, J LUMIN, V156, P175, DOI 10.1016/j.jlumin.2014.08.015; Wei H, 2013, J CRYST GROWTH, V384, P27, DOI 10.1016/j.jcrysgro.2013.09.007; Wojtowicz AJ, 2002, NUCL INSTRUM METH A, V486, P201, DOI 10.1016/S0168-9002(02)00703-9; Wojtowicz AJ, 1998, J LUMIN, V79, P275, DOI 10.1016/S0022-2313(98)00039-8; Wu YT, 2014, PHYS STATUS SOLIDI A, V211, P2586, DOI 10.1002/pssa.201431299; Wu YT, 2014, PHYS REV APPL, V2, DOI 10.1103/PhysRevApplied.2.044009; Xu YN, 1999, PHYS REV B, V59, P10530, DOI 10.1103/PhysRevB.59.10530; Yanagida S., 2009, IEEE T NUCL SCI, V56, P2955; Yanagida T, 2011, RADIAT MEAS, V46, P1503, DOI 10.1016/j.radmeas.2011.03.039; Yang K, 2011, PHYS STATUS SOLIDI-R, V5, P43, DOI 10.1002/pssr.201004434; Yokota Y, 2014, J CRYST GROWTH, V401, P343, DOI 10.1016/j.jcrysgro.2014.02.031; Kamada K, 2011, CRYST GROWTH DES, V11, P4484, DOI 10.1021/cg200694a; Zhao GJ, 2003, J CRYST GROWTH, V253, P290, DOI 10.1016/S0022-0248(03)01017-0; Zhao JB, 2009, J RARE EARTH, V27, P376, DOI 10.1016/S1002-0721(08)60254-9; Zhuravleva M, 2008, IEEE T NUCL SCI, V55, P1476, DOI 10.1109/TNS.2007.910233; Zych E., 1996, MATER SCI FORUM, V239-241, P257	243	12	12	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	2195-1071			ADV OPT MATER	Adv. Opt. Mater.	APR	2015	3	4			SI		463	481		10.1002/adom.201400571		19	Materials Science, Multidisciplinary; Optics	Materials Science; Optics	CG6IW	WOS:000353404400003		
J	Patel, NB; Tito, RY; Obregon-Tito, AJ; O'Neal, L; Trujillo-Villaroel, O; Marin-Reyes, L; Troncoso-Corzo, L; Guija-Poma, E; Hamada, M; Uchino, Y; Lewis, CM; Lawson, PA				Patel, Nisha B.; Tito, Raul Y.; Obregon-Tito, Alexandra J.; O'Neal, Lindsey; Trujillo-Villaroel, Omar; Marin-Reyes, Luis; Troncoso-Corzo, Luzmila; Guija-Poma, Emilio; Hamada, Moriyuki; Uchino, Yoshihito; Lewis, Cecil M., Jr.; Lawson, Paul A.			Ezakiella peruensis gen. nov., sp nov isolated from human fecal sample from a coastal traditional community in Peru	ANAEROBE			English	Article						Ezakiella peruensis gen. nov., sp nov.; 16S rRNA-phylogeny; Taxonomy	HUMAN MICROBIOME PROJECT; SEQUENCES; PROPOSAL; MEMBERS	A novel Gram-stain positive, non-motile, non-sporeforming coccus-shaped, obligately anaerobic bacterium was isolated from a fecal sample of an individual residing in a traditional Peruvian community. The organism was characterized using biochemical, chemotaxonomic and phylogenetic methods. Comparative 16S rRNA gene sequence analyses and phenotypic characteristics demonstrated that the organism was biochemically and phenotypically related, but distinct, from a group of organisms referred to as the Gram-stain positive anaerobic cocci (GPAC). The major cellular fatty acids of the novel isolate were determined to be C-16:0 (18.3%), C-18:1 omega 9c (39.8%), C-18:2 omega 6,C-9c/C-18:0 ANTE (13.2%). Fermentation end products from PYG are acetate and formate. Cell-wall peptidoglycan was found to be A4 alpha (L-Lys-L-Ala-L-Glu) and the G + C content was determined to be 38.4 mol%. Based on the phenotypic, chemotaxonomic, and phylogenetic results, Ezakiella peruensis gen. nov., sp. nov., is now proposed. The type strain is M6.X2(T) (DSM 27367(T) = NBRC 109957(T) = CCUG 64571(T)). (C) 2014 Elsevier Ltd. All rights reserved.	[Patel, Nisha B.; O'Neal, Lindsey; Lawson, Paul A.] Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA; [Tito, Raul Y.; Obregon-Tito, Alexandra J.; Lewis, Cecil M., Jr.] Univ Oklahoma, Dept Anthropol, Norman, OK 73019 USA; [Trujillo-Villaroel, Omar] Inst Nacl Salud, Ctr Nacl Salud Intercultural, Lima, Peru; [Tito, Raul Y.; Obregon-Tito, Alexandra J.; Troncoso-Corzo, Luzmila; Guija-Poma, Emilio] Univ Cient Sur, Lima, Peru; [Marin-Reyes, Luis] Inst Nacl Salud, Ctr Nacl Salud Publ, Lima, Peru; [Hamada, Moriyuki; Uchino, Yoshihito] Natl Inst Technol & Evaluat NBRC, Biol Resource Ctr, Chiba 2920818, Japan	Lawson, PA (reprint author), Univ Oklahoma, Dept Microbiol & Plant Biol, 770 Van Vleet Oval, Norman, OK 73019 USA.	paul.lawson@ou.edu			U.S. National Institutes of Health [RO1 GM089886]	This study was supported by the U.S. National Institutes of Health; RO1 GM089886. We would like to thank Universidad Cientifica del Sur, the personnel at the medical post in Tambo de Mora and the field team of the project Metagenomica e Inclusion Social for sample collection. We also thank Ken-ichiro Suzuki at Biological Resource Center, National Institute of Technology and Evaluation (NBRC) for facilitating the analysis of the peptidoglycan.	Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Lagier JC, 2012, CLIN MICROBIOL INFEC, V18, P1185, DOI 10.1111/1469-0691.12023; Blaser MJ, 2013, ISME J, V7, P85, DOI 10.1038/ismej.2012.81; Ulger-Toprak N, 2010, INT J SYST EVOL MICR, V60, P1013, DOI 10.1099/ijs.0.015909-0; Ezaki T, 2001, INT J SYST EVOL MICR, V51, P1521; Tindall BJ, 2006, INT J SYST EVOL MICR, V56, P2711, DOI 10.1099/ijs.0.64338-0; Murdoch DA, 1998, CLIN MICROBIOL REV, V11, P81; Kaeberlein T, 2002, SCIENCE, V296, P1127, DOI 10.1126/science.1070633; Gordon JI, 2012, SCIENCE, V336, P1251, DOI 10.1126/science.1224686; Lewis CM, 2012, TRENDS MICROBIOL, V20, P1, DOI 10.1016/j.tim.2011.10.004; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Hattori M, 2009, DNA RES, V16, P1, DOI 10.1093/dnares/dsn033; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; COLLINS MD, 1993, INT J SYST BACTERIOL, V43, P425; Contreras M, 2010, MICROBIOL-SGM, V156, P3282, DOI 10.1099/mic.0.043174-0; de Vos P., 2009, BERGYEYS MANUAL SYST, V3, P1130; EZAKI T, 2006, ANAEROBIC GRAMPOSITI, P795; Hamada M, 2012, J ANTIBIOT, V65, P427, DOI 10.1038/ja.2012.45; Hobson P. N., 1969, METHODS MICROBIOLO B, V3B, P133, DOI 10.1016/S0580-9517(08)70504-X; HUTSON RA, 1993, ANTON LEEUW INT J G, V64, P273; Johnson CN, 2014, INT J SYST EVOL MICR, V64, P3538, DOI 10.1099/ijs.0.058941-0; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Ludwig W., 2009, BERGEYS MANUAL SYSTE, V3, P1; MESBAH M, 1989, INT J SYST BACTERIOL, V39, P159; Sasser M, IDENTIFICATION BACTE; Ueki A, 2009, INT J SYST EVOL MICR, V59, P3161, DOI 10.1099/ijs.0.011858-0; Wylie KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035294; Zhou YJ, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-5-r66	29	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1075-9964	1095-8274		ANAEROBE	Anaerobe	APR	2015	32						43	48		10.1016/j.anaerobe.2014.12.002		6	Microbiology	Microbiology	CG6QN	WOS:000353427200009		
J	Vijayakumar, M; Ilavenil, S; Kim, DH; Arasu, MV; Priya, K; Choi, KC				Vijayakumar, Mayakrishnan; Ilavenil, Soundharrajan; Kim, Da Hye; Arasu, Mariadhas Valan; Priya, Kannappan; Choi, Ki Choon			In-vitro assessment of the probiotic potential of Lactobacillus plantarum KCC-24 isolated from Italian rye-grass (Lolium multiflorum) forage	ANAEROBE			English	Article						L. plantarum KCC-24; Antifungal; Probiotics; Auto-aggregation; Antioxidant	LACTIC-ACID BACTERIA; HUMAN GASTROINTESTINAL-TRACT; CELL-SURFACE; STRAINS; SURVIVAL; HYDROPHOBICITY; RESISTANCE; TOLERANCE; PRODUCTS; ADHESION	The aim of the present study was to determine the probiotic potential of the lactic acid bacteria Lactobacillus plantarum KCC-24 (L plantarum KCC-24), that was isolated and characterized from Italian ryegrass (Lolium multiflorum) forage. The following experiments were performed to assess the probiotic characteristics such as antifungal activity, antibiotic susceptibility, resistance to low pH, stimulated gastric juice and bile salts, proteolytic activity, auto-aggregation, cell surface hydrophobicity, and in vitro antioxidant property. The isolated L plantarum KCC-24 exhibited significant antifungal activity against the various fungal strains of Aspergillus fumigatus (73.43%), Penicillium cluysogenum (59.04%), Penicillium roqueforti (56.67%), Botrytis elliptica (40.23%), Fusarium oxysporum (52.47%) and it was susceptible to numerous antibiotics, survived in low pH, was resistant to stimulated gastric juices and bile salts (0.3% w/v). Moreover, L plantarum KCC-24 exhibited good proteolytic activity. In addition L plantarum KCC-24 showed potent antioxidant and hydrogen peroxide resistant property. In conclusion, the isolated L plantarum KCC-24 exhibited several characteristics to prove it's excellent as a potential probiotic candidate for developing quality food for ruminant animals and human. (C) 2015 Elsevier Ltd. All rights reserved.	[Vijayakumar, Mayakrishnan; Ilavenil, Soundharrajan; Choi, Ki Choon] Natl Inst Anim Sci, Grassland & Forage Div, Rural Dev Adm, Cheonan 330801, South Korea; [Kim, Da Hye] Tottori Univ, United Grad Sch Agr Sci, Tottori 6808553, Japan; [Arasu, Mariadhas Valan] King Saud Univ, Coll Sci, Addiriyah Chair Environm Studies, Dept Bot & Microbiol, Riyadh 11451, Saudi Arabia; [Priya, Kannappan] Affiliated Bharathiar Univ, PSG Coll Arts & Sci, Dept Biochem, Coimbatore 614014, Tamil Nadu, India	Choi, KC (reprint author), Natl Inst Anim Sci, Grassland & Forage Div, Rural Dev Adm, Cheonan 330801, South Korea.	choiwh@korea.kr			Rural Development Administration, Republic of Korea [PJ010186032014]; (National Institute of Animal Science), Rural Development Administration, Republic of Korea	This work was carried out with the support of Cooperative Research Program for Agriculture Science & Technology Development (Project title: Development of establishment and improvement of productivity in silvopastoral system; Project No. "PJ010186032014" Rural Development Administration, Republic of Korea. This study was supported by (2014) Postdoctoral Fellowship Program of (National Institute of Animal Science), Rural Development Administration, Republic of Korea.	Ouwehand AC, 1999, INT DAIRY J, V9, P43, DOI 10.1016/S0958-6946(99)00043-6; Chen FA, 2006, FOOD CHEM, V94, P14, DOI 10.1016/j.foodchem.2004.09.046; Karasu N, 2010, ANN MICROBIOL, V60, P227, DOI 10.1007/s13213-010-0031-6; Lee YK, 2003, J MED MICROBIOL, V52, P925, DOI 10.1099/jmm.0.05009-0; Holzapfel WH, 2002, FOOD RES INT, V35, P109, DOI 10.1016/S0963-9969(01)00171-5; Vinderola CG, 2003, FOOD RES INT, V36, P895, DOI 10.1016/S0963-9969(03)00098-X; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Lavermicocca P, 2003, APPL ENVIRON MICROB, V69, P634, DOI 10.1128/AEM.69.1.634-640.2003; Klaenhammer TR, 2005, FEMS MICROBIOL REV, V29, P393, DOI 10.1016/j.femsre.2005.04.007; ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1111/j.1574-6968.1980.tb05599.x; Del Re B, 2000, LETT APPL MICROBIOL, V31, P438, DOI 10.1046/j.1365-2672.2000.00845.x; Charteris WP, 1998, J APPL MICROBIOL, V84, P759; SCHIFFRIN EJ, 1995, J DAIRY SCI, V78, P491; Giraffa G, 2010, RES MICROBIOL, V161, P480, DOI 10.1016/j.resmic.2010.03.001; Arasu MV, 2013, J APPL MICROBIOL, V115, P1172, DOI 10.1111/jam.12319; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Michida H, 2006, BIOCHEM ENG J, V28, P73, DOI 10.1016/j.bej.2005.09.004; Caplice E, 1999, INT J FOOD MICROBIOL, V50, P131, DOI 10.1016/S0168-1605(99)00082-3; Turchi B, 2013, WORLD J MICROB BIOT, V29, P1913, DOI 10.1007/s11274-013-1356-7; GOLDIN BR, 1992, DIGEST DIS SCI, V37, P121, DOI 10.1007/BF01308354; Zhou JS, 2005, INT J FOOD MICROBIOL, V98, P211, DOI 10.1016/j.ijfoodmicro.2004.05.011; RAJAGOPAL SN, 1990, J DAIRY SCI, V73, P894; Brinques GB, 2011, J FOOD ENG, V103, P123, DOI 10.1016/j.jfoodeng.2010.10.006; Buchmeier N, 1997, INFECT IMMUN, V65, P3725; Christensen JE, 2003, J BACTERIOL, V185, P3297, DOI 10.1128/JB.185.11.3297-3306.2003; CONWAY PL, 1987, J DAIRY SCI, V70, P1; Esayas A., 2008, AFR J MICROBIOL RES, V2, P229; Guchte V.M., 2006, P NATL ACAD SCI USA, V103, P9274; Havenaar R., 1992, Probiotics: the scientific basis., P209; Pitt JI, 1999, FUNGI FOOD SPOILAGE; Sirilun S, 2010, AFR J MICROBIOL RES, V4, P994; Succi M, 2005, FEMS MICROBIOL LETT, V244, P129, DOI 10.1016/j.femsle.2005.01.037; Tambekar D.H., 2010, INTERNET J MICROBIOL, V8, P1; Tororov S.D., 2008, J APPL MICROBIOL, V104, P465; Vijayakumar M., 2013, ASIAN PAC J TROP MED, V6, P20	35	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1075-9964	1095-8274		ANAEROBE	Anaerobe	APR	2015	32						90	97		10.1016/j.anaerobe.2015.01.003		8	Microbiology	Microbiology	CG6QN	WOS:000353427200017		
J	Tong, B; Muramatsu, Y; Ohta, T; Kose, H; Yamashiro, H; Sugiyama, T; Yamada, T				Tong, Bin; Muramatsu, Youji; Ohta, Takeshi; Kose, Hiroyuki; Yamashiro, Hideaki; Sugiyama, Toshie; Yamada, Takashisa			ASSOCIATION OF THE EXPRESSION LEVEL OF THE MYBPC1 GENE IN SKELETAL MUSCLE WITH MARBLING TRAIT IN JAPANESE BLACK BEEF CATTLE	Annals of Animal Science			English	Article						intramuscular fat; Japanese Black breed; marbling; MYBPC1; skeletal muscle	BINDING-PROTEIN-C; INTRAMUSCULAR FAT; LONGISSIMUS MUSCLE; IMAGE-ANALYSIS; MYOSIN; DEPOSITION; CARCASS; STEERS	Marbling characterized by the amount and distribution of intramuscular fat (IMF) in longissimus muscle (LM) and measured as beef marbling score (BMS), is an economically important trait of beef cattle in Japan. The myosin binding protein C, slow type (MYBPC1) gene, involved in efficient energy metabolism and homeostasis during muscle contraction in slow skeletal muscle, has been previously shown to be expressed at different levels in the LM between high-marbled and low-marbled steer groups using differential-display PCR (ddPCR). In this study, we found that IMF area (%) in the sacrococcygeus muscle (SM) was positively correlated with BMS in the LM in Japanese Black steers (n=22, r=0.941, P<0.0001). This suggested that the IMF area (%) in the SM tends to equate marbling level in the LM. Furthermore, we showed that the MYBPC1 expression level in SM was significantly higher in the Japanese Black steers (n=5) with high BMS than in the Japanese Black steers (n=5) with low BMS (P<0.001). Moreover, correlation analyses showed that the expression level of the MYBPC1 gene was positively correlated with IMF area (%) (n=22, r=0.858, P<0.0001) and BMS (n=22, r=0.769, P<0.0001), indicating the association of MYBPC1 expression level with marbling trait. These results, together with the previous ddPCR result, suggested that high level of MYBPC1 expression may be associated with the development of marbling in Japanese Black beef cattle.	[Tong, Bin; Yamashiro, Hideaki; Sugiyama, Toshie; Yamada, Takashisa] Niigata Univ, Dept Agrobiol, Fac Agr, Niigata 9502181, Japan; [Muramatsu, Youji] Kansai Univ Welf Sci, Dept Nutr Sci Well Being, Fac Hlth Sci Welf, Osaka 5820026, Japan; [Ohta, Takeshi] Japan Tobacco Inc, Cent Pharmaceut Res Inst, Osaka 5691125, Japan; [Kose, Hiroyuki] Int Christian Univ, Div Nat Sci, Dept Life Sci, Tokyo 1818585, Japan	Tong, B (reprint author), Niigata Univ, Dept Agrobiol, Fac Agr, Niigata 9502181, Japan.	tongbin87@gmail.com			Ministry of Education, Culture, Sports, Science and Technology of Japan [14360166]; Japanese Livestock Technology Association	This work was supported by a Grant-in-Aid for Scientific Research (B) (no. 14360166) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by the research funds of Japanese Livestock Technology Association.	Annika M., 2013, NAT PROTOC, V8, P1149; Chen Z, 2011, BIOCHEM J, V436, P437, DOI 10.1042/BJ20102007; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Wang YH, 2009, J ANIM SCI, V87, P119, DOI 10.2527/jas.2008-1082; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; BRACKEBUSCH SA, 1991, J ANIM SCI, V69, P631; Jeong J, 2012, J ANIM SCI, V90, P2044, DOI 10.2527/jas.2011-4753; BUSBOOM JR, 1993, MEAT SCI, V35, P241, DOI 10.1016/0309-1740(93)90054-L; Yang XJ, 2006, J ANIM SCI, V84, P3251, DOI 10.2527/jas.2006-187; Harper GS, 2004, AUST J EXP AGR, V44, P653, DOI 10.1071/EA02114; GARRETT WN, 1971, J ANIM SCI, V33, P948; BOYLSTON TD, 1995, J AGR FOOD CHEM, V43, P1202, DOI 10.1021/jf00053a015; Japan Meat Grading Association (JMGA), 1988, NEW BEEF CARC GRAD S; Jurie C, 2007, J ANIM SCI, V85, P2660, DOI 10.2527/jas.2006-837; Matsuishi Masanori, 2001, Animal Science Journal, V72, P498; OFFER G, 1973, J MOL BIOL, V74, P653, DOI 10.1016/0022-2836(73)90055-7; Osawa T, 2008, J ANIM SCI, V86, P40, DOI 10.2527/jas.2007-0359; PARK B, 1994, J ANIM SCI, V72, P109; PEPE FA, 1975, J MOL BIOL, V99, P609, DOI 10.1016/S0022-2836(75)80175-6; Sasaki Y, 2006, ANIM GENET, V37, P40, DOI 10.1111/j.1365-2052.2005.01380.x; Sato N, 2003, MOL BIOL CELL, V14, P3180, DOI 10.1091/mbc.E02-10-0685; Smith S. B., 2000, PLAINS NUTR COUNC SP, P1; Tong B, 2014, ANIM GENET, V45, P611, DOI 10.1111/age.12172; Yamada T, 2009, ANIM GENET, V40, P209, DOI 10.1111/j.1365-2052.2008.01822.x	24	0	0	DE GRUYTER OPEN LTD	WARSAW	BOGUMILA ZUGA 32A ST, 01-811 WARSAW, POLAND	2300-8733			ANN ANIM SCI	Ann. Anim. Sci.	APR	2015	15	2					349	358		10.1515/aoas-2015-0014		10	Agriculture, Dairy & Animal Science	Agriculture	CG8WF	WOS:000353595700006		
J	Mizuno, E; Iwasaki, M; Sakai, I; Kamizawa, N				Mizuno, Eriko; Iwasaki, Misuzu; Sakai, Ikue; Kamizawa, Naotoshi			Experiences of Community-Dwelling Persons Recovering From Severe Mental Illness	ARCHIVES OF PSYCHIATRIC NURSING			English	Article							SOCIAL SUPPORT; SCHIZOPHRENIA; STIGMA; PEOPLE; DISCRIMINATION; INTEGRATION; PSYCHOSIS	This qualitative study explored experiences of recovery from severe mental illness based on semi-structured interviews with sixteen persons diagnosed with schizophrenia spectrum disorders using psychiatric rehabilitation facilities. The participants' transcripts revealed two major themes: (1) ongoing efforts to live better and (2) inconsistent self-acceptance as a person living with a mental illness. The participants were aware of their responsibility to live with integrity. They all had hopes and goals, were able to respond to social cues, and considered what they could do independently. They wanted to be recognized as people who adapted successfully in society while inconsistently perceiving themselves as either sick or healthy. It is necessary to examine approaches that support the identities of persons who have been treated for schizophrenia and allow them to live comfortable within their communities. (C) 2014 Elsevier Inc. All rights reserved.	[Mizuno, Eriko; Sakai, Ikue; Kamizawa, Naotoshi] Univ Yamanashi, Psychiat & Mental Hlth Nursing, Interdisciplinaly Grad Sch Med Engn, Chuoshi, Yamanashi, Japan; [Iwasaki, Misuzu] Iida Womens Jr Coll, Psychiat & Mental Hlth Nursing, Nagano, Japan	Mizuno, E (reprint author), Univ Yamanashi, Psychiat & Mental Hlth Nursing, Interdisciplinaly Grad Sch Med Engn, 1110 Shimokato, Chuoshi, Yamanashi, Japan.	seriko@yamanashi.ac.jp; misuzu@iidawjc.ac.jp; ikues@yamanashi.ac.jp; nkamizawa@yamanshi.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [24593475]	The authors would like to express sincere appreciation for all participants in this study and the staff at the hospitals and facilities. The study was supported by the Ministry of Education, Culture, Sports, Science and Technology Grant-in-Aid for Scientific Research in Japan (C)-24593475 in 2012-2014.	Abdallah C, 2009, PSYCHIAT SERV, V60, P1642, DOI 10.1176/appi.ps.60.12.1642; Andersen R, 2003, AUSTR NZ J PSYCHIAT, V37, P586; Link BG, 2001, PSYCHIATR SERV, V52, P1621, DOI 10.1176/appi.ps.52.12.1621; Morrison AP, 2013, PSYCHIAT RES, V208, P203, DOI 10.1016/j.psychres.2013.05.008; Lysaker PH, 2010, SCHIZOPHR RES, V121, P271, DOI 10.1016/j.schres.2010.03.003; Maslow AH, 1943, PSYCHOL REV, V50, P370, DOI 10.1037/h0054346; Harrow M, 2007, J NERV MENT DIS, V195, P406, DOI 10.1097/01.nmd.0000253783.32338.6e; Dunn DS, 2013, REHABIL PSYCHOL, V58, P148, DOI 10.1037/a0031691; Mueser KT, 2002, PSYCHIATR SERV, V53, P1272, DOI 10.1176/appi.ps.53.10.1272; Jenkins JH, 2009, J NERV MENT DIS, V197, P520, DOI 10.1097/NMD.0b013e3181aad5e9; Browne G, 2008, INT J MENT HEALTH NU, V17, P402, DOI 10.1111/j.1447-0349.2008.00575.x; Brugha TS, 2005, PSYCHOL MED, V35, P705, DOI 10.1017/S0033291704003903; Huxley P, 2003, BRIT J PSYCHIAT, V182, P289, DOI 10.1192/bjp.182.4.289; Noiseux S, 2008, INT J NURS STUD, V45, P1148, DOI 10.1016/j.ijnurstu.2007.07.008; Romano DM, 2010, EARLY INTERV PSYCHIA, V4, P243, DOI 10.1111/j.1751-7893.2010.00187.x; Pevalin DJ, 2003, PSYCHOL MED, V33, P299, DOI 10.1017/S0033291702006864; Anthony W. A., 1993, PSYCHOSOC REHABIL, V16, P11, DOI DOI 10.1037/H0095655; Borg M, 2004, J MENTAL HLTH, V13, P493, DOI 10.1080/09638230400006809; Frank AW, 1995, WOUNDED STORYTELLER; Fujimoto Y., 2013, JAPAN B SOCIAL PSYCH, V22, P20; HARDING CM, 1994, ACTA PSYCHIAT SCAND, V90, P140, DOI 10.1111/j.1600-0447.1994.tb05903.x; Henderson C, 2009, LANCET, V373, P1928, DOI 10.1016/S0140-6736(09)61046-1; Holloway I., 2007, J RES NURSING, V12, P703, DOI DOI 10.1177/1744987107084669; Holloway I., 2007, NARRATIVE RES NURSIN; Jenkins JH, 2008, MED ANTHROPOL Q, V22, P381, DOI 10.1111/j.1548-1387.2008.00038.x; Jenkins JH, 2005, CULT MED PSYCHIAT, V29, P379, DOI 10.1007/s11013-006-9000-8; Kylma J, 2006, J PSYCHIATR MENT HLT, V13, P651, DOI 10.1111/j.1365-2850.2006.01012.x; Liberman RP, 2005, PSYCHIAT SERV, V56, P735, DOI 10.1176/appi.ps.56.6.735; Minzenberg M. J., 2011, ESSENTIALS PSYCHIAT, P111; Roe D, 2012, J NERV MENT DIS, V200, P847, DOI 10.1097/NMD.0b013e31826b6d4a; Sakai I., 2011, J JAPAN ACAD NURSING, V31, P32; Shea Joyce M, 2010, J Am Psychiatr Nurses Assoc, V16, P43, DOI 10.1177/1078390309359197; Sibitz I., 2011, SCHIZOPHRENIA B, V37, P16; Stolovy Tali, 2009, J Nerv Ment Dis, V197, P133, DOI 10.1097/NMD.0b013e3181963ede; Suzuki Y., 2010, JAPAN B SOCIAL PSYCH, V18, P310; Tagaki M., 2006, DISABILITY DIS NORMA; Takeda H., 2006, JAPAN B SOCIAL PSYCH, V14, P306; Topor A, 2006, AM J PSYCHIAT REHABI, V9, P17, DOI DOI 10.1080/15487760500339410; Townley G, 2013, AM J COMMUN PSYCHOL, V52, P84, DOI 10.1007/s10464-013-9578-2	39	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9417	1532-8228		ARCH PSYCHIAT NURS	Arch. Psychiatr. Nurs.	APR	2015	29	2					127	131		10.1016/j.apnu.2014.12.001		5	Nursing; Psychiatry	Nursing; Psychiatry	CG5WR	WOS:000353367100010		
J	Kato, TN				Kato, Tsunehiko N.			PARTICLE ACCELERATION AND WAVE EXCITATION IN QUASI-PARALLEL HIGH-MACH-NUMBER COLLISIONLESS SHOCKS: PARTICLE-IN-CELL SIMULATION	ASTROPHYSICAL JOURNAL			English	Article						acceleration of particles; cosmic rays; ISM: supernova remnants; methods: numerical; plasmas shock waves	ELECTRON-ION PLASMAS; ASTROPHYSICAL SHOCKS; PERPENDICULAR SHOCK; INJECTION; SIGNATURE; UPSTREAM; SN-1006	We herein investigate shock formation and particle acceleration processes for both protons and electrons in a quasi-parallel high-Mach-number collisionless shock through a long-term, large-scale, particle-in-cell simulation. We show that both protons and electrons are accelerated in the shock and that these accelerated particles generate large-amplitude Alfvenic waves in the upstream region of the shock. After the upstream waves have grown sufficiently, the local structure of the collisionless shock becomes substantially similar to that of a quasi-perpendicular shock due to the large transverse magnetic field of the waves. A fraction of protons are accelerated in the shock with a power-law-like energy distribution. The rate of proton injection to the acceleration process is approximately constant, and in the injection process, the phase-trapping mechanism for the protons by the upstream waves can play an important role. The dominant acceleration process is a Fermi-like process through repeated shock crossings of the protons. This process is a "fast" process in the sense that the time required for most of the accelerated protons to complete one cycle of the acceleration process is much shorter than the diffusion time. A fraction of the electrons are also accelerated by the same mechanism, and have a power-law-like energy distribution. However, the injection does not enter a steady state during the simulation, which may be related to the intermittent activity of the upstream waves. Upstream of the shock, a fraction of the electrons are pre-accelerated before reaching the shock, which may contribute to steady electron injection at a later time.	[Kato, Tsunehiko N.] Hiroshima Univ, Grad Sch Sci, Dept Phys Sci, Higashihiroshima, Hiroshima 7398526, Japan	Kato, TN (reprint author), Natl Inst Nat Sci, Natl Astron Observ Japan, Ctr Computat Astrophys, 2-21-1 Osawa, Mitaka, Tokyo 1818588, Japan.	tsunehiko.kato@nao.ac.jp			JSPS KAKENHI [22740164, 24540277]	We thank the anonymous referee for valuable comments. This work was supported by JSPS KAKENHI grant Nos. 22740164, 24540277. Numerical computations were carried out on Cray XC30 at the Center for Computational Astrophysics, National Astronomical Observatory of Japan.	Amano T, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.181102; Ackermann M, 2013, SCIENCE, V339, P807, DOI 10.1126/science.1231160; Amano T, 2009, ASTROPHYS J, V690, P244, DOI 10.1088/0004-637X/690/1/244; Burgess D, 2005, SPACE SCI REV, V118, P205, DOI 10.1007/s11214-005-3832-3; Bamba A, 2003, ASTROPHYS J, V589, P827, DOI 10.1086/374687; WINSKE D, 1984, J GEOPHYS RES-SPACE, V89, P2673, DOI 10.1029/JA089iA05p02673; BLANDFORD R, 1987, PHYS REP, V154, P1, DOI 10.1016/0370-1573(87)90134-7; KOYAMA K, 1995, NATURE, V378, P255, DOI 10.1038/378255a0; Sugiyama T, 2001, J GEOPHYS RES-SPACE, V106, P21657, DOI 10.1029/2001JA900063; HOPPE MM, 1981, J GEOPHYS RES-SPACE, V86, P4471, DOI 10.1029/JA086iA06p04471; Sugiyama T, 1999, ADV SPACE RES, V24, P73, DOI 10.1016/S0273-1177(99)00427-5; Giacalone J, 2004, ASTROPHYS J, V609, P452, DOI 10.1086/421043; Oka M, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028156; Burgess D, 2012, SPACE SCI REV, V173, P5, DOI 10.1007/s11214-012-9901-5; Long KS, 2003, ASTROPHYS J, V586, P1162, DOI 10.1086/367832; Kato TN, 2010, ASTROPHYS J, V721, P828, DOI 10.1088/0004-637X/721/1/828; Kato TN, 2008, ASTROPHYS J LETT, V681, pL93, DOI 10.1086/590387; Lee MA, 2012, SPACE SCI REV, V173, P247, DOI 10.1007/s11214-012-9932-y; BELL AR, 1978, MON NOT R ASTRON SOC, V182, P147; Birdsall C. K., 1991, PLASMA PHYS VIA COMP; Niemiec J, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/1/73; Caprioli D, 2014, ASTROPHYS J, V783, DOI 10.1088/0004-637X/783/2/91; DRURY LOC, 1983, REP PROG PHYS, V46, P973, DOI 10.1088/0034-4885/46/8/002; Gargate L, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/1/67; GARY SP, 1981, J GEOPHYS RES-SPACE, V86, P6691, DOI 10.1029/JA086iA08p06691; Kato T. N., 2013, ARXIV13125507; Kato TN, 2003, MON NOT R ASTRON SOC, V342, P639, DOI 10.1046/j.1365-8711.2003.06583.x; Landau L D, 1980, STAT PHYS, V1; Masters A, 2013, NAT PHYS, V9, P164, DOI 10.1038/nphys2541; Matsumoto Y, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.215003; Reames DV, 2000, AIP CONF PROC, V516, P289; Reynoso EM, 2013, ASTRON J, V145, DOI 10.1088/0004-6256/145/4/104; Riquelme MA, 2011, ASTROPHYS J, V733, DOI 10.1088/0004-637X/733/1/63; Sironi L, 2011, ASTROPHYS J, V726, DOI 10.1088/0004-637X/726/2/75; Sugiyama T, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3552026	35	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	APR 1	2015	802	2							115	10.1088/0004-637X/802/2/115		17	Astronomy & Astrophysics	Astronomy & Astrophysics	CG1DZ	WOS:000353014500043		
J	Kisaka, S; Ioka, K; Takami, H				Kisaka, Shota; Ioka, Kunihito; Takami, Hajime			ENERGY SOURCES AND LIGHT CURVES OF MACRONOVAE	ASTROPHYSICAL JOURNAL			English	Article						binaries: general; gamma-ray burst: individual (GRB 130603B); infrared: stars; stars: neutron	NEUTRON-STAR MERGERS; GAMMA-RAY BURSTS; COMPACT BINARY MERGERS; RADIOACTIVELY POWERED TRANSIENTS; LONG-TERM EVOLUTION; HARD GRB 130603B; R-PROCESS; EXTENDED EMISSION; ELECTROMAGNETIC COUNTERPARTS; MILLISECOND MAGNETAR	A macronova (kilonova) was discovered with a short gamma-ray burst, GRB 130603B, which is widely believed to be powered by the radioactivity of r-process elements synthesized in the ejecta of a neutron star (NS)-binary merger. As an alternative, we propose that macronovae are energized by the central engine, i.e., a black hole or NS, and the injected energy is emitted after the adiabatic expansion of ejecta. This engine model is motivated by extended emission of short GRBs. In order to compare the theoretical models with observations, we develop analytical formulae for the light curves of macronovae. The engine model allows a wider parameter range, especially smaller ejecta mass, and a better fit to observations than the r-process model. Future observations of electromagnetic counterparts of gravitational waves should distinguish energy sources and constrain the activity of the central engine and the r-process nucleosynthesis.	[Kisaka, Shota; Ioka, Kunihito; Takami, Hajime] KEK, Ctr Theory, Inst Particle & Nucl Studies, Tsukuba, Ibaraki 3050801, Japan; [Ioka, Kunihito] Grad Univ Adv Studies, SOKENDAI, Dept Particle & Nucl Phys, Tsukuba, Ibaraki 3050801, Japan	Kisaka, S (reprint author), KEK, Ctr Theory, Inst Particle & Nucl Studies, Tsukuba, Ibaraki 3050801, Japan.	kisaka@post.kek.jp; kunihito.ioka@kek.jp; takami@post.kek.jp			KAKENHI [24103006, 24.9375, 24000004, 26247042, 26287051]	We thank K. Asano, K. Kashiyama, K. Kiuchi, H. Nagakura, T. Nakamura, Y. Sekiguchi, M. Shibata for fruitful discussions. This work is supported by KAKENHI 24103006 (S.K., K.I.), 24.9375 (H.T.), 24000004, 26247042, 26287051 (K.I.).	Aasi J, 2014, ASTROPHYS J SUPPL S, V211, DOI 10.1088/0067-0049/211/1/7; Abadie J, 2010, NUCL INSTRUM METH A, V624, P223, DOI 10.1016/j.nima.2010.07.089; Acernese F, 2015, CLASSICAL QUANT GRAV, V32, DOI 10.1088/0264-9381/32/2/024001; Nakar E, 2010, ASTROPHYS J, V725, P904, DOI 10.1088/0004-637X/725/1/904; Metzger BD, 2008, MON NOT R ASTRON SOC, V385, P1455, DOI 10.1111/J.1365-2966.2008.12923.X; Nakar E, 2011, NATURE, V478, P82, DOI 10.1038/nature10365; Hjorth J, 2005, ASTROPHYS J, V630, pL117, DOI 10.1086/491733; SAKURAI A, 1960, COMMUN PUR APPL MATH, V13, P353, DOI 10.1002/cpa.3160130303; Kiuchi K, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.064008; LATTIMER JM, 1974, ASTROPHYS J, V192, pL145, DOI 10.1086/181612; Rosswog S, 1999, ASTRON ASTROPHYS, V341, P499; Foucart F, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.024026; Kyutoku K, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.064018; Metzger BD, 2015, MON NOT R ASTRON SOC, V446, P1115, DOI 10.1093/mnras/stu2225; Rowlinson A, 2010, MON NOT R ASTRON SOC, V408, P383, DOI 10.1111/j.1365-2966.2010.17115.x; Piran T, 2013, MON NOT R ASTRON SOC, V430, P2121, DOI 10.1093/mnras/stt037; Metzger BD, 2010, MON NOT R ASTRON SOC, V406, P2650, DOI 10.1111/j.1365-2966.2010.16864.x; Korobkin O, 2012, MON NOT R ASTRON SOC, V426, P1940, DOI 10.1111/j.1365-2966.2012.21859.x; Dai ZG, 2006, SCIENCE, V311, P1127, DOI 10.1126/science.1123606; Hotokezaka K, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.024001; Churazov E, 2014, NATURE, V512, P406, DOI 10.1038/nature13672; Li LX, 1998, ASTROPHYS J, V507, pL59, DOI 10.1086/311680; Grossman D, 2014, MON NOT R ASTRON SOC, V439, P757, DOI 10.1093/mnras/stt2503; Piro AL, 2010, ASTROPHYS J, V708, P598, DOI 10.1088/0004-637X/708/1/598; Rosswog S, 2014, MON NOT R ASTRON SOC, V439, P744, DOI 10.1093/mnras/stt2502; Metzger BD, 2014, MON NOT R ASTRON SOC, V439, P3916, DOI 10.1093/mnras/stu247; NARAYAN R, 1992, ASTROPHYS J, V395, pL83, DOI 10.1086/186493; Ioka K, 2005, ASTROPHYS J, V631, P429, DOI 10.1086/432567; Bostanci ZF, 2013, MON NOT R ASTRON SOC, V428, P1623, DOI 10.1093/mnras/sts157; Dessart L, 2009, ASTROPHYS J, V690, P1681, DOI 10.1088/0004-637X/690/2/1681; Abadie J, 2010, CLASSICAL QUANT GRAV, V27, DOI 10.1088/0264-9381/27/17/173001; Just O, 2015, MON NOT R ASTRON SOC, V448, P541, DOI 10.1093/mnras/stv009; Tanvir NR, 2013, NATURE, V500, P547, DOI 10.1038/nature12505; Norris JP, 2010, ASTROPHYS J, V717, P411, DOI 10.1088/0004-637X/717/1/411; ARNETT WD, 1980, ASTROPHYS J, V237, P541, DOI 10.1086/157898; Barnes J, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/1/18; Barthelmy SD, 2005, ASTROPHYS J, V635, pL133, DOI 10.1086/499432; Berger E, 2013, ASTROPHYS J LETT, V774, DOI 10.1088/2041-8205/774/2/L23; Deaton MB, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/1/47; CHEVALIER RA, 1992, ASTROPHYS J, V394, P599, DOI 10.1086/171612; Cucchiara A, 2013, ASTROPHYS J, V777, DOI 10.1088/0004-637X/777/2/94; de Ugarte Postigo A., 2014, ASTRON ASTROPHYS, V563, P62; Essick R, 2015, ASTROPHYS J, V800, DOI 10.1088/0004-637X/800/2/81; Fan YZ, 2013, ASTROPHYS J LETT, V779, DOI 10.1088/2041-8205/779/2/L25; Fernandez R., 2014, ARXIV14094426; Fernandez R, 2013, MON NOT R ASTRON SOC, V435, P502, DOI 10.1093/mnras/stt1312; Fong W, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/2/118; Foucart F, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.084006; Goldfriend T., 2014, ARXIV14046313; Hotokezaka K, 2013, ASTROPHYS J LETT, V778, DOI 10.1088/2041-8205/778/1/L16; Jin ZP, 2013, ASTROPHYS J LETT, V775, DOI 10.1088/2041-8205/775/1/L19; Kann DA, 2011, ASTROPHYS J, V734, DOI 10.1088/0004-637X/734/2/96; Kasen D, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/1/25; Kawai N, 2014, PROC SPIE, V9144, DOI 10.1117/12.2057188; Kiuchi K., 2014, PHRVD, V90; Kulkarni S. R., 2005, ASTROPH0510256; Kuroda K, 2010, CLASSICAL QUANT GRAV, V27, DOI 10.1088/0264-9381/27/8/084004; Kyutoku K, 2014, MON NOT R ASTRON SOC, V437, pL6, DOI 10.1093/mnrasl/slt128; Kyutoku K., 2013, PHRVD, V88; Lovelace G, 2013, CLASSICAL QUANT GRAV, V30, DOI 10.1088/0264-9381/30/13/135004; Metzger BD, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/1/48; Murguia-Berthier A, 2014, ASTROPHYS J LETT, V788, DOI 10.1088/2041-8205/788/1/L8; Nagakura H, 2014, ASTROPHYS J LETT, V784, DOI 10.1088/2041-8205/784/2/L28; Nakamura T, 2014, ASTROPHYS J, V796, DOI 10.1088/0004-637X/796/1/13; Piran T., 2014, ARXIV14012166; POPOV DV, 1993, ASTROPHYS J, V414, P712, DOI 10.1086/173117; Rabinak I, 2011, ASTROPHYS J, V728, DOI 10.1088/0004-637X/728/1/63; Roberts LF, 2011, ASTROPHYS J LETT, V736, DOI 10.1088/2041-8205/736/1/L21; Rosswog S, 2007, MON NOT R ASTRON SOC, V376, pL48, DOI 10.1111/j.1745-3933.2007.00284.x; Ruffert M, 2001, ASTRON ASTROPHYS, V380, P544, DOI 10.1051/0004-6361:20011453; Rybicki G. B., 1979, RAD PROCESSES ASTROP; Sakamoto T, 2011, ASTROPHYS J SUPPL S, V195, DOI 10.1088/0067-0049/195/1/2; Shibata M, 2011, ASTROPHYS J LETT, V734, DOI 10.1088/2041-8205/734/2/L36; Takami H, 2014, ASTROPHYS J LETT, V789, DOI 10.1088/2041-8205/789/1/L6; Takami H, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.063006; Tanaka M, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/2/113; Wanajo S, 2014, ASTROPHYS J LETT, V789, DOI 10.1088/2041-8205/789/2/L39; Wang LJ, 2013, ASTROPHYS J LETT, V774, DOI 10.1088/2041-8205/774/2/L33; Yu YW, 2013, ASTROPHYS J LETT, V776, DOI 10.1088/2041-8205/776/2/L40	79	11	12	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	APR 1	2015	802	2							119	10.1088/0004-637X/802/2/119		18	Astronomy & Astrophysics	Astronomy & Astrophysics	CG1DZ	WOS:000353014500047		
J	Minezaki, T; Matsushita, K				Minezaki, Takeo; Matsushita, Kyoko			A NEW BLACK HOLE MASS ESTIMATE FOR OBSCURED ACTIVE GALACTIC NUCLEI	ASTROPHYSICAL JOURNAL			English	Article						black hole physics; galaxies: active; galaxies: nuclei; galaxies: Seyfert; polarization; X-rays: galaxies	BROAD-LINE REGION; K-ALPHA LINE; AGN MONITORING PROJECT; SEYFERT 2 GALAXIES; EMISSION-LINE; INNER RADIUS; DUST TORUS; MU-M; REVERBERATION MEASUREMENTS; INFRARED GALAXIES	We propose a new method for estimating the mass of a supermassive black hole, applicable to obscured active galactic nuclei (AGNs). This method estimates the black hole mass using the width of the narrow core of the neutral FeK alpha emission line in X-rays and the distance of its emitting region from the black hole based on the isotropic luminosity indicator via the luminosity scaling relation. Assuming the virial relation between the locations and the velocity widths of the neutral FeK alpha line core and the broad H beta emission line, the luminosity scaling relation of the neutral FeK alpha line core emitting region is estimated. We find that the velocity width of the neutral FeK alpha line core falls between that of the broad Balmer emission lines and the corresponding value at the dust reverberation radius for most of the target AGNs. The black hole mass M-BII,FeK alpha estimated with this method is then compared with other black hole mass estimates, such as the broad emission-line reverberation mass M-BH,M-rev for type 1 AGNs, the mass M-BH,M-H2O based on the H2O maser, and the single-epoch mass estimate M-BH,M-pol based on the polarized broad Balmer lines for type 2 AGNs. We find that MBH,FeK alpha is consistent with M-BH,M-rev and M-BH,M- pol, and find that M-BH,FeK alpha correlates well with M-BH,HO2. These results suggest that MBH,FeK alpha is a potential indicator of the black hole mass for obscured AGNs. In contrast, MBH,FeK alpha is systematically larger than MBH,H2O by about a factor of 5, and the possible origins are discussed.	[Minezaki, Takeo] Univ Tokyo, Inst Astron, Sch Sci, Mitaka, Tokyo 1810015, Japan; [Matsushita, Kyoko] Tokyo Univ Sci, Dept Phys, Shinjuku Ku, Tokyo 1628601, Japan	Minezaki, T (reprint author), Univ Tokyo, Inst Astron, Sch Sci, 2-21-1 Osawa, Mitaka, Tokyo 1810015, Japan.	minezaki@ioa.s.u-tokyo.ac.jp			Ministry of Education, Science, Culture and Sports of Japan [22540247, 25287062]; National Aeronautics and Space Administration	We thank T. Kawaguchi, M. Yoshida, K. Kawabata, and Y. Fukazawa for useful discussions and comments. We also thank the anonymous referee for valuable comments to improve the manuscript. This research has been partly supported by the Grants-in-Aid of Scientific Research (22540247 and 25287062) of the Ministry of Education, Science, Culture and Sports of Japan, and has made use of the NASA/IPAC Extragalactic Database (NED), which is operated by the Jet Propulsion Laboratory, California Institute of Technology, under contract with the National Aeronautics and Space Administration.	Hopkins PF, 2008, ASTROPHYS J SUPPL S, V175, P356, DOI 10.1086/524362; Denney KD, 2010, ASTROPHYS J, V721, P715, DOI 10.1088/0004-637X/721/1/715; Bianchi S, 2008, MON NOT R ASTRON SOC, V389, pL52, DOI 10.1111/j.1745-3933.2008.00521.x; SANDERS DB, 1988, ASTROPHYS J, V325, P74, DOI 10.1086/165983; Liu Y, 2010, ASTROPHYS J, V710, P1228, DOI 10.1088/0004-637X/710/2/1228; Moran EC, 2007, ASTROPHYS J, V668, pL31, DOI 10.1086/522697; Graham AW, 2011, MON NOT R ASTRON SOC, V412, P2211, DOI 10.1111/j.1365-2966.2010.18045.x; AWAKI H, 1991, PUBL ASTRON SOC JPN, V43, P195; Bentz MC, 2007, ASTROPHYS J, V662, P205, DOI 10.1086/516724; Suganuma M, 2006, ASTROPHYS J, V639, P46, DOI 10.1086/499326; Nandra K, 2007, MON NOT R ASTRON SOC, V382, P194, DOI 10.1111/j.1365-2966.2007.12331.x; Greenhill LJ, 1997, ASTROPHYS J, V481, pL23, DOI 10.1086/310643; Vestergaard M, 2006, ASTROPHYS J, V641, P689, DOI 10.1086/500572; Peterson BM, 2004, ASTROPHYS J, V613, P682, DOI 10.1086/423269; Young S, 2007, NATURE, V450, P74, DOI 10.1038/nature06319; KORMENDY J, 1995, ANNU REV ASTRON ASTR, V33, P581; Melendez M, 2008, ASTROPHYS J, V682, P94, DOI 10.1086/588807; McLure RJ, 2002, MON NOT R ASTRON SOC, V337, P109, DOI 10.1046/j.1365-8711.2002.05871.x; Yaqoob T, 2004, ASTROPHYS J, V604, P63, DOI 10.1086/381731; Zhang SY, 2008, ASTRON ASTROPHYS, V488, P113, DOI 10.1051/0004-6361:200810141; Magorrian J, 1998, ASTRON J, V115, P2285, DOI 10.1086/300353; Rigby JR, 2009, ASTROPHYS J, V700, P1878, DOI 10.1088/0004-637X/700/2/1878; Greenhill LJ, 2003, ASTROPHYS J, V590, P162, DOI 10.1086/374862; Greene JE, 2010, ASTROPHYS J, V723, P409, DOI 10.1088/0004-637X/723/1/409; MIYOSHI M, 1995, NATURE, V373, P127, DOI 10.1038/373127a0; Diamond-Stanic AM, 2009, ASTROPHYS J, V698, P623, DOI 10.1088/0004-637X/698/1/623; Spergel DN, 2007, ASTROPHYS J SUPPL S, V170, P377, DOI 10.1086/513700; Onken CA, 2004, ASTROPHYS J, V615, P645, DOI 10.1086/424655; Sanders DB, 1996, ANNU REV ASTRON ASTR, V34, P749, DOI 10.1146/annurev.astro.34.1.749; Ueda Y, 2007, ASTROPHYS J, V664, pL79, DOI 10.1086/520576; Kormendy J, 2013, ANNU REV ASTRON ASTR, V51, P511, DOI 10.1146/annurev-astro-082708-101811; Shu XW, 2010, ASTROPHYS J SUPPL S, V187, P581, DOI 10.1088/0067-0049/187/2/581; Woo JH, 2010, ASTROPHYS J, V716, P269, DOI 10.1088/0004-637X/716/1/269; Jiang P, 2011, SCI CHINA PHYS MECH, V54, P1354, DOI 10.1007/s11433-011-4352-7; Weaver KA, 2010, ASTROPHYS J, V716, P1151, DOI 10.1088/0004-637X/716/2/1151; Lodato G, 2003, ASTRON ASTROPHYS, V398, P517, DOI 10.1051/0004-6361:20021672; Barth AJ, 2013, ASTROPHYS J, V769, DOI 10.1088/0004-637X/769/2/128; Bentz MC, 2006, ASTROPHYS J, V651, P775, DOI 10.1086/507417; Chelouche D, 2014, ASTROPHYS J LETT, V783, DOI 10.1088/2041-8205/783/2/L34; Fukazawa Y, 2011, ASTROPHYS J, V727, DOI 10.1088/0004-637X/727/1/19; Greene JE, 2010, ASTROPHYS J, V721, P26, DOI 10.1088/0004-637X/721/1/26; Grier CJ, 2012, ASTROPHYS J, V755, DOI 10.1088/0004-637X/755/1/60; Grier CJ, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/2/90; Ho LC, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/1/17; Koshida S, 2009, ASTROPHYS J LETT, V700, pL109, DOI 10.1088/0004-637X/700/2/L109; Koshida S, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/2/159; Kuo CY, 2011, ASTROPHYS J, V727, DOI 10.1088/0004-637X/727/1/20; Laor A, 1998, ASTROPHYS J, V505, pL83, DOI 10.1086/311619; Liu T, 2010, ASTROPHYS J, V725, P2381, DOI 10.1088/0004-637X/725/2/2381; MARKERT TH, 1994, P SOC PHOTO-OPT INS, V2280, P168, DOI 10.1117/12.186812; Moran EC, 2000, ASTROPHYS J, V540, pL73, DOI 10.1086/312876; Nandra K, 2006, MON NOT R ASTRON SOC, V368, pL62, DOI 10.1111/j.1745-3933.2006.00158.x; Nenkova M, 2008, ASTROPHYS J, V685, P160, DOI 10.1086/590483; Nishiura S, 1998, ASTROPHYS J, V499, P134, DOI 10.1086/305646; Oliva E, 1998, ASTRON ASTROPHYS, V329, pL21; Ponti G, 2013, ASTRON ASTROPHYS, V549, DOI 10.1051/0004-6361/201219450; Shu XW, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/2/147; Takahashi K, 2002, PUBL ASTRON SOC JPN, V54, P373; Takahashi T., 2010, P SOC PHOTO-OPT INS, V7732, P77320; Tran HD, 2001, ASTROPHYS J, V554, pL19, DOI 10.1086/320926; TRAN HD, 1995, ASTROPHYS J, V440, P565, DOI 10.1086/175296; Young S, 1996, MON NOT R ASTRON SOC, V281, P1206	62	2	2	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	APR 1	2015	802	2							98	10.1088/0004-637X/802/2/98		7	Astronomy & Astrophysics	Astronomy & Astrophysics	CG1DZ	WOS:000353014500026		
J	Soma, T; Sakai, N; Watanabe, Y; Yamamoto, S				Soma, Tatsuya; Sakai, Nami; Watanabe, Yoshimasa; Yamamoto, Satoshi			METHANOL IN THE STARLESS CORE, TAURUS MOLECULAR CLOUD-1	ASTROPHYSICAL JOURNAL			English	Article						ISM: abundances; ISM: individual objects (TMC-1); ISM: molecules	CARBON-CHAIN MOLECULES; DENSE INTERSTELLAR CLOUDS; ISOTOPE FRACTIONATION; ORGANIC-MOLECULES; C-13 ISOTOPOMERS; CHEMICAL-MODELS; MASS PROTOSTAR; TMC-1; ABUNDANCES; CHEMISTRY	To explore the formation mechanisms of gas phase CH3OH in cold starless cores, we have conducted high spectral resolution observations toward the cyanopolyyne peak of Taurus Molecular Cloud-1 (TMC-1 CP) with the IRAM 30 m telescope, the Green Bank Telescope, and the Nobeyama 45 m telescope. The spectral lines of CH3OH toward TMC-1 CP are found to have a double-peaked profile separated by 0.5 km s(-1). Since the double-peaked profile is observed for (CH3OH)-C-13, it is not due to optical depth and/or self-absorption effects. The spectral line profile of CH3OH is much different from those of (CS)-S-34, C3S, and HC7N observed toward this source. The H-2 densities of the emitting region of CH3OH for the blueshifted and redshifted components are derived to be (1.7 +/- 0.5) x 10(4) cm(-3) and (4.3 +/- 1.2) x 10(4) cm(-3), respectively. These densities are similar to or slightly lower than those found for the other molecules. These results suggest a chemical differentiation between CH3OH and the other molecules, which has indeed been confirmed by mapping observations of the CH3OH and (CS)-S-34 lines. These results are consistent with the general idea that CH3OH is formed on dust grains and is liberated into the gas phase by non-thermal desorption. The grain-surface origin of CH3OH is further confirmed by the CH3OH/(CH3OH)-C-13 ratio. Weak shocks caused by accreting diffuse gas to the TMC-1 filament, photoevaporation caused by cosmic-ray induced UV radiation, and the desorption of excess reaction energy in the formation of CH3OH on dust grains are discussed for the desorption mechanisms.	[Soma, Tatsuya; Sakai, Nami; Watanabe, Yoshimasa; Yamamoto, Satoshi] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan	Soma, T (reprint author), Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan.	soma@taurus.phys.s.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technologies [25108005, 25400223]; Advanced Leading Graduate Course for Photon Science (ALPS)	This study is supported by Grant-in-Aids from the Ministry of Education, Culture, Sports, Science, and Technologies (25108005 and 25400223). T.S. thanks the Advanced Leading Graduate Course for Photon Science (ALPS) for financial support.	Aikawa Y, 2005, ASTROPHYS J, V620, P330, DOI 10.1086/427017; Dickens JE, 2001, ASTROPHYS J, V558, P693, DOI 10.1086/322292; Bachiller R, 1997, ASTROPHYS J, V487, pL93, DOI 10.1086/310877; Langston G, 2007, ASTROPHYS J, V658, P455, DOI 10.1086/511332; Takakuwa S, 2000, ASTROPHYS J, V542, P367, DOI 10.1086/309505; Pratap P, 1997, ASTROPHYS J, V486, P862, DOI 10.1086/304553; Sakai N, 2008, ASTROPHYS J, V672, P371, DOI 10.1086/523635; FRERKING MA, 1982, ASTROPHYS J, V262, P590, DOI 10.1086/160451; Herbst E, 2009, ANNU REV ASTRON ASTR, V47, P427, DOI 10.1146/annurev-astro-082708-101654; VANDISHOECK EF, 1995, ASTROPHYS J, V447, P760, DOI 10.1086/175915; HASEGAWA TI, 1993, MON NOT R ASTRON SOC, V263, P589; Caselli P, 1999, ASTROPHYS J, V523, pL165, DOI 10.1086/312280; BLAKE GA, 1987, ASTROPHYS J, V315, P621, DOI 10.1086/165165; BENSON PJ, 1989, ASTROPHYS J SUPPL S, V71, P89, DOI 10.1086/191365; Hirota T, 1998, ASTROPHYS J, V503, P717, DOI 10.1086/306032; Lucas R, 1998, ASTRON ASTROPHYS, V337, P246; LANGER WD, 1984, ASTROPHYS J, V277, P581, DOI 10.1086/161730; Muller HSP, 2005, J MOL STRUCT, V742, P215, DOI 10.1016/j.molstruc.2005.01.027; Geppert WD, 2006, FARADAY DISCUSS, V133, P177, DOI 10.1039/b516010c; Woods PM, 2009, ASTROPHYS J, V693, P1360, DOI 10.1088/0004-637X/693/2/1360; Milam SN, 2005, ASTROPHYS J, V634, P1126, DOI 10.1086/497123; Markwick AJ, 2000, ASTROPHYS J, V535, P256, DOI 10.1086/308814; van der Tak FFS, 2000, ASTRON ASTROPHYS, V361, P327; Garrod RT, 2007, ASTRON ASTROPHYS, V467, P1103, DOI 10.1051/0004-6361:20066704; Tafalla M, 2006, ASTRON ASTROPHYS, V455, P577, DOI 10.1051/0004-6361:20065311; HIRAHARA Y, 1992, ASTROPHYS J, V394, P539, DOI 10.1086/171605; Bacmann A, 2012, ASTRON ASTROPHYS, V541, DOI 10.1051/0004-6361/201219207; Caselli P, 2012, ASTROPHYS J LETT, V759, DOI 10.1088/2041-8205/759/2/L37; Furuya K, 2011, ASTROPHYS J, V731, DOI 10.1088/0004-637X/731/1/38; GOLDREIC.P, 1974, ASTROPHYS J, V189, P441, DOI 10.1086/152821; Guzman VV, 2013, ASTRON ASTROPHYS, V560, DOI 10.1051/0004-6361/201322460; LANGER WD, 1995, ASTROPHYS J, V453, P293, DOI 10.1086/176389; Liszt HS, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/1/55; Sakai N, 2013, J PHYS CHEM A, V117, P9831, DOI 10.1021/jp3127913; Sakai N, 2010, ASTROPHYS J LETT, V718, pL49, DOI 10.1088/2041-8205/718/2/L49; Sakai N, 2007, ASTROPHYS J, V663, P1174, DOI 10.1086/518595; Saruwatari O, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/2/147; Takano S, 1998, ASTRON ASTROPHYS, V329, P1156; TAKANO S, 1990, ASTROPHYS J, V361, pL15, DOI 10.1086/185816; vastel C., 2014, ASTROPHYS J LETT, V795, pLL2; Vasyunin AI, 2013, ASTROPHYS J, V769, DOI 10.1088/0004-637X/769/1/34	41	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	APR 1	2015	802	2							74	10.1088/0004-637X/802/2/74		9	Astronomy & Astrophysics	Astronomy & Astrophysics	CG1DZ	WOS:000353014500002		
J	Tahara, M; Kataoka, J; Takeuchi, Y; Totani, T; Sofue, Y; Hiraga, JS; Tsunemi, H; Inoue, Y; Kimura, M; Cheung, CC; Nakashima, S				Tahara, M.; Kataoka, J.; Takeuchi, Y.; Totani, T.; Sofue, Y.; Hiraga, J. S.; Tsunemi, H.; Inoue, Y.; Kimura, M.; Cheung, C. C.; Nakashima, S.			SUZAKU X-RAY OBSERVATIONS OF THE FERMI BUBBLES: NORTHERNMOST CAP AND SOUTHEAST CLAW DISCOVERED WITH MAXI-SSC	ASTROPHYSICAL JOURNAL			English	Article						acceleration of particles; cosmic rays; Galaxy: halo; X-rays: ISM	RADIO GALAXY; GALACTIC HALO; XMM-NEWTON; HOT GAS; ORBIT PERFORMANCE; EMISSION; MISSION; SPECTROSCOPY; TELESCOPE; SPECTRUM	We report on Suzaku observations of large-scale X-ray structures possibly related to the Fermi Bubbles obtained in 2013 with a total duration of similar or equal to 80 ks. The observed regions were (1) the northern cap (N-cap; l similar to 0 degrees, 45 degrees<b< 55 degrees) seen in the mid-band (1.7-4.0 keV) map recently provided by Monitor of All-sky X-ray Image Solid-state Slit Camera (MAXI-SSC) and (2) the southeast claw (SE-claw; l similar to 10 degrees, -20 degrees < b < -10 degrees) seen in the ROSAT all-sky map and MAXI-SSC low-band (0.7-1.7 keV) map. In each region, we detected diffuse X-ray emission, which is represented by a three-component plasma model consisting of an unabsorbed thermal component (kT similar or equal to 0.1 keV) from the Local Hot Bubble, absorbed kT = 0.30 +/- 0.05 keV emission representing the Galactic halo (GH), and a power-law component due to the isotropic cosmic X-ray background radiation. The emission measure of the GH component in the SE-claw shows an excess by a factor of similar or equal to 2.5 over the surrounding emission at 2 degrees away. We also found a broad excess in the 1.7-4.0 keV count rates across the N-cap after compiling other archival data from Suzaku and Swift. The spectral stacking analysis of the N-cap data indicates the presence of another thermal component with kT = 0.70(-0.11)(+0.22)keV. The temperature kT similar or equal to 0.3 keV of the GH is higher than the ubiquitous value of kT similar or equal to 0.2 keV near the Fermi bubbles, and can be even higher (similar to 0.7 keV). We discuss our findings in the context of the bubble-halo interaction.	[Tahara, M.; Kataoka, J.; Takeuchi, Y.] Waseda Univ, Res Inst Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Totani, T.] Univ Tokyo, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan; [Sofue, Y.] Univ Tokyo, Inst Astron, Mitaka, Tokyo 1810015, Japan; [Hiraga, J. S.] Univ Tokyo, Grad Sch Sci, Res Ctr Early Universe, Bunkyo Ku, Tokyo 1130033, Japan; [Tsunemi, H.] Osaka Univ, Dept Earth & Space Sci, Osaka 5600043, Japan; [Inoue, Y.; Kimura, M.] Inst Space & Astronaut Sci, JAXA, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan; [Cheung, C. C.] Naval Res Lab, Div Space Sci, Washington, DC 20375 USA; [Nakashima, S.] Kyoto Univ, Grad Sch Sci, Dept Phys, Sakyo Ku, Kyoto 6068502, Japan	Tahara, M (reprint author), Waseda Univ, Res Inst Sci & Engn, Shinjuku Ku, 3-4-1 Okubo, Tokyo 1698555, Japan.	taharamasaya@ruri.waseda.jp	XRAY, SUZAKU/A-1808-2009		NASA DPR [S-15633-Y]	We are grateful to the referee for useful comments that helped to improve the paper. Work by C.C.C. at NRL is supported in part by NASA DPR S-15633-Y.	Ackermann M, 2014, ASTROPHYS J, V793, DOI 10.1088/0004-637X/793/1/64; Atwood WB, 2009, ASTROPHYS J, V697, P1071, DOI 10.1088/0004-637X/697/2/1071; Burrows DN, 2005, SPACE SCI REV, V120, P165, DOI 10.1007/s11214-005-5097-2; Su M, 2010, ASTROPHYS J, V724, P1044, DOI 10.1088/0004-637X/724/2/1044; Gitti M, 2010, ASTROPHYS J, V714, P758, DOI 10.1088/0004-637X/714/1/758; Matsuoka M, 2009, PUBL ASTRON SOC JPN, V61, P999; [Anonymous], 2007, PASJ, DOI DOI 10.1093/PASJ/59.SPL.S237; EGGER RJ, 1995, ASTRON ASTROPHYS, V294, pL25; Wright EL, 2010, ASTRON J, V140, P1868, DOI 10.1088/0004-6256/140/6/1868; Dobler G, 2010, ASTROPHYS J, V717, P825, DOI 10.1088/0004-637X/717/2/825; Shelton DL, 2011, MON NOT R ASTRON SOC, V418, P811, DOI 10.1111/j.1365-2966.2011.19533.x; SNOWDEN SL, 1995, ASTROPHYS J, V454, P643, DOI 10.1086/176517; Willingale R, 2003, MON NOT R ASTRON SOC, V343, P995, DOI 10.1046/j.1365-8711.2003.06741.x; Kushino A, 2002, PUBL ASTRON SOC JPN, V54, P327; DICKEY JM, 1990, ANNU REV ASTRON ASTR, V28, P215; Henley DB, 2010, ASTROPHYS J, V723, P935, DOI 10.1088/0004-637X/723/1/935; Gehrels N, 2004, ASTROPHYS J, V611, P1005, DOI 10.1086/422091; Bland-Hawthorn J, 2003, ASTROPHYS J, V582, P246; BERKHUIJ.EM, 1971, ASTRON ASTROPHYS, V14, P252; Crocker RM, 2014, ASTROPHYS J LETT, V791, DOI 10.1088/2041-8205/791/2/L20; Croston JH, 2007, ASTROPHYS J, V660, P191, DOI 10.1086/513500; Day C., 1998, TECHNICAL REPORT; Fang TT, 2014, ASTROPHYS J LETT, V785, DOI 10.1088/2041-8205/785/2/L24; Fujimoto R., 2007, PASJ, V59, P133; Fujita Y, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/1/67; GIOMMI P, 1992, ASTR SOC P, V25, P100; Guo FL, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/2/181; Guo FL, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/2/182; Ishisaki Y., 2007, PASJ, V59, P113; Jetha NN, 2008, MON NOT R ASTRON SOC, V391, P1052, DOI 10.1111/j.1365-2966.2008.13959.x; Kataoka J, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/1/57; Kimura M, 2013, PUBL ASTRON SOC JPN, V65; Koyama K., 2007, PASJ, V59, P23; Lacki BC, 2014, MON NOT R ASTRON SOC, V444, pL39, DOI 10.1093/mnrasl/slu107; Mihara T., 2011, PASJ, V63, P623; Miller E. D., 2008, PASJ, V60, P95; Mitsuda K., 2007, PASJ, V59, P1; Mou GB, 2014, ASTROPHYS J, V790, DOI 10.1088/0004-637X/790/2/109; Randall SW, 2011, ASTROPHYS J, V726, DOI 10.1088/0004-637X/726/2/86; Serlemitsos P., 2007, PASJ, V59, P9; Henley DB, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/2/92; Siemiginowska A, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/2/124; Sofue Y, 2000, ASTROPHYS J, V540, P224, DOI 10.1086/309297; Stawarz L, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/1/48; Stawarz L, 2014, ASTROPHYS J, V794, DOI 10.1088/0004-637X/794/2/164; Takahashi T, 2007, PASJ, V59, P35; Tawa N., 2008, PASJ, V60, P11; Tsunemi H, 2010, PUBL ASTRON SOC JPN, V62, P1371; Wang Q. D., 2002, P S NEW VIS XRAY UN; Yao Y, 2010, ASTROPHYS J, V716, P1514, DOI 10.1088/0004-637X/716/2/1514; Yao Y, 2009, ASTROPHYS J, V690, P143, DOI 10.1088/0004-637X/690/1/143; Yao YS, 2005, ASTROPHYS J, V624, P751, DOI 10.1086/429537; Yoshino T, 2009, PUBL ASTRON SOC JPN, V61, P805	53	4	4	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	APR 1	2015	802	2							91	10.1088/0004-637X/802/2/91		13	Astronomy & Astrophysics	Astronomy & Astrophysics	CG1DZ	WOS:000353014500019		
J	Yatsu, Y; Kataoka, J; Takahashi, Y; Tachibana, Y; Kawai, N; Shibata, S; Pike, S; Yoshii, T; Arimoto, M; Saito, Y; Nakamori, T; Sekiguchi, K; Kuroda, D; Yanagisawa, K; Hanayama, H; Watanabe, M; Hamamoto, K; Nakao, H; Ozaki, A; Motohara, K; Konishi, M; Tateuchi, K; Matsunaga, N; Morokuma, T; Nagayama, T; Murata, K; Akitaya, H; Yoshida, M; Ali, GB; Mohamed, AE; Isogai, M; Arai, A; Takahashi, H; Hashimoto, O; Miyanoshita, R; Omodaka, T; Takahashi, J; Tokimasa, N; Matsuda, K; Okumura, S; Nishiyama, K; Urakawa, S; Nogami, D; Oasa, Y				Yatsu, Yoichi; Kataoka, Jun; Takahashi, Yosuke; Tachibana, Yutaro; Kawai, Nobuyuki; Shibata, Shimpei; Pike, Sean; Yoshii, Taketoshi; Arimoto, Makoto; Saito, Yoshihiko; Nakamori, Takeshi; Sekiguchi, Kazuhiro; Kuroda, Daisuke; Yanagisawa, Kenshi; Hanayama, Hidekazu; Watanabe, Makoto; Hamamoto, Ko; Nakao, Hikaru; Ozaki, Akihito; Motohara, Kentaro; Konishi, Masahiro; Tateuchi, Ken; Matsunaga, Noriyuki; Morokuma, Tomoki; Nagayama, Takahiro; Murata, Katsuhiro; Akitaya, Hiroshi; Yoshida, Michitoshi; Ali, Gamal B.; Mohamed, A. Essam; Isogai, Mizuki; Arai, Akira; Takahashi, Hidenori; Hashimoto, Osamu; Miyanoshita, Ryo; Omodaka, Toshihiro; Takahashi, Jun; Tokimasa, Noritaka; Matsuda, Kentaro; Okumura, Shin-Ichiro; Nishiyama, Kota; Urakawa, Seitaro; Nogami, Daisaku; Oasa, Yumiko		OISTER Team	MULTI-WAVELENGTH OBSERVATIONS OF THE BLACK WIDOW PULSAR 2FGL J2339.6-0532 WITH OISTER AND SUZAKU	ASTROPHYSICAL JOURNAL			English	Article						gamma rays: stars; pulsars: general; pulsars: individual (2FGL J2339.6-0532); X-rays: binaries	BINARY MILLISECOND PULSAR; HUBBLE-SPACE-TELESCOPE; X-RAY; CRAB-NEBULA; GAMMA-RAY; NEUTRON-STARS; ACCRETION; ROTATION; DISCOVERY; WIND	Multi-wavelength observations of the black widow binary system 2FGL J2339.6-0532 are reported. The Fermi gamma-ray source 2FGL J2339.6-0532 was recently categorized as a black widow in which a recycled millisecond pulsar (MSP) is evaporating the companion star with its powerful pulsar wind. Our optical observations show clear sinusoidal light curves due to the asymmetric temperature distribution of the companion star. Assuming a simple geometry, we constrained the range of the inclination angle of the binary system to 52 degrees < i < 59 degrees, which enables us to discuss the interaction between the pulsar wind and the companion in detail. The X-ray spectrum consists of two components: a soft, steady component that seems to originate from the surface of the MSP, and a hard, variable component from the wind-termination shock near the companion star. The measured X-ray luminosity is comparable to the bolometric luminosity of the companion, meaning that the heating efficiency is less than 0.5. In the companion orbit, 10(11) cm from the pulsar, the pulsar wind is already in the particle-dominant stage with a magnetization parameter of sigma < 0.1. In addition, we precisely investigated the time variations of the X-ray periodograms and detected a weakening of the orbital modulation. The observed phenomenon may be related to unstable pulsar wind activity or weak mass accretion, both of which can result in the temporal extinction of the radio pulse.	[Yatsu, Yoichi; Tachibana, Yutaro; Kawai, Nobuyuki; Yoshii, Taketoshi; Arimoto, Makoto; Saito, Yoshihiko] Tokyo Inst Technol, Dept Phys, Meguro Ku, Tokyo 1528551, Japan; [Kataoka, Jun; Takahashi, Yosuke] Waseda Univ, Res Inst Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Shibata, Shimpei; Nakamori, Takeshi] Yamagata Univ, Dept Phys, Yamagata 9908560, Japan; [Pike, Sean] Brown Univ, Dept Phys, Providence, RI 02912 USA; [Sekiguchi, Kazuhiro] Natl Astron Observ Japan, Natl Inst Nat Sci, Mitaka, Tokyo 1818588, Japan; [Kuroda, Daisuke; Yanagisawa, Kenshi] Natl Astron Observ Japan, Okayama Astrophys Observ, Asakuchi, Okayama 7190232, Japan; [Hanayama, Hidekazu] Natl Astron Observ Japan, Ishigakijima Astron Observ, Ishigaki, Okinawa 9070024, Japan; [Watanabe, Makoto; Hamamoto, Ko; Nakao, Hikaru; Ozaki, Akihito] Hokkaido Univ, Dept Cosmosci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Motohara, Kentaro; Konishi, Masahiro; Tateuchi, Ken; Morokuma, Tomoki; Takahashi, Hidenori] Univ Tokyo, Grad Sch Sci, Inst Astron, Mitaka, Tokyo 1810015, Japan; [Matsunaga, Noriyuki; Morokuma, Tomoki] Univ Tokyo, Grad Sch Sci, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan; [Nagayama, Takahiro; Murata, Katsuhiro] Nagoya Univ, Dept Astrophys, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Nagayama, Takahiro; Miyanoshita, Ryo; Omodaka, Toshihiro] Kagoshima Univ, Fac Sci, Kagoshima 8900065, Japan; [Akitaya, Hiroshi; Yoshida, Michitoshi] Hiroshima Univ, Hiroshima Astrophys Sci Ctr, Higashihiroshima, Hiroshima 7398526, Japan; [Ali, Gamal B.; Mohamed, A. Essam] Natl Res Inst Astron & Geophys, Cairo 11722, Egypt; [Isogai, Mizuki; Arai, Akira] Kyoto Sangyo Univ, Kamiyama Astron Observ, Kita Ku, Kyoto 6038555, Japan; [Takahashi, Hidenori; Hashimoto, Osamu] Gunma Astron Observ, Takayama, Gunma 3770702, Japan; [Takahashi, Jun; Tokimasa, Noritaka; Matsuda, Kentaro] Univ Hyogo, Ctr Astron, Nishi Harima Astron Observ, Sayo Cho, Hyogo 6795313, Japan; [Okumura, Shin-Ichiro; Nishiyama, Kota; Urakawa, Seitaro] Japan Spaceguard Assoc, Bisei Spaceguard Ctr, Ibara, Okayama 7141411, Japan; [Nogami, Daisaku] Kyoto Univ, Dept Astron, Sakyo Ku, Kyoto 6068502, Japan; [Oasa, Yumiko] Saitama Univ, Fac Educ, Sakura, Saitama, Japan	Yatsu, Y (reprint author), Tokyo Inst Technol, Dept Phys, Meguro Ku, 2-12-1 Ohokayama, Tokyo 1528551, Japan.	yatsu@hp.phys.titech.ac.jp	XRAY, SUZAKU/A-1808-2009		MEXT of Japan; NRIAG of Egypt; NAOJ Research Grant for Universities;  [21684006];  [22253002];  [22540258]	This research has made use of optical and near-infrared data obtained from the Optical and Near-Infrared Astronomy Inter-University Cooperation Program, supported by the MEXT of Japan and Kottamia Astronomical Observatory supported by the NRIAG of Egypt. This research has also made use of X-ray data obtained from the Suzaku satellite, a collaborative mission between the space agencies of Japan (JAXA) and the USA (NASA). Operation of ANIR on the miniTAO telescope is supported by Grant-in-Aid for Scientific Research (21684006, 22253002, and 22540258) and the Institutional Program for Young Researcher Overseas Visits, operated by Japan Society for the Promotion of Science (JSPS). Part of this work has been supported by NAOJ Research Grant for Universities. The authors thank the referee for useful suggestions that helped to improve the original manuscrip. Y.Y. is deeply grateful to Suguru Saito for generous support and encouragement.	Ackermann M, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/1/83; Aharonian FA, 2012, NATURE, V482, P507, DOI 10.1038/nature10793; Tokunaga AT, 2005, PUBL ASTRON SOC PAC, V117, P421, DOI 10.1086/429382; Becker W, 1997, ASTRON ASTROPHYS, V326, P682; Smith JA, 2002, ASTRON J, V123, P2121, DOI 10.1086/339311; Bogdanov S, 2005, ASTROPHYS J, V630, P1029, DOI 10.1086/432249; Kalberla PMW, 2005, ASTRON ASTROPHYS, V440, P775, DOI 10.1051/0004-6361:20041864; Papitto A, 2013, NATURE, V501, P517, DOI 10.1038/nature12470; Hester JJ, 2002, ASTROPHYS J, V577, pL49, DOI 10.1086/344132; Skrutskie MF, 2006, ASTRON J, V131, P1163, DOI 10.1086/498708; KENNEL CF, 1984, ASTROPHYS J, V283, P694, DOI 10.1086/162356; Fukugita M, 1996, ASTRON J, V111, P1748, DOI 10.1086/117915; STELLA L, 1986, ASTROPHYS J, V308, P669, DOI 10.1086/164538; Bogovalov SV, 2002, ASTRON LETT+, V28, P373, DOI 10.1134/1.1484137; ALPAR MA, 1982, NATURE, V300, P728, DOI 10.1038/300728a0; CARDELLI JA, 1989, ASTROPHYS J, V345, P245, DOI 10.1086/167900; Abdo AA, 2010, ASTROPHYS J SUPPL S, V188, P405, DOI 10.1088/0067-0049/188/2/405; Linares M, 2014, MON NOT R ASTRON SOC, V438, P251, DOI 10.1093/mnras/stt2167; DICKEY JM, 1990, ANNU REV ASTRON ASTR, V28, P215; Kataoka J, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/2/176; FRUCHTER AS, 1988, NATURE, V333, P237, DOI 10.1038/333237a0; Azzam Y. A., 2014, ARXIV14022926A; Bogdanov S, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/2/97; Bogdanov S, 2014, ASTROPHYS J, V781, DOI 10.1088/0004-637X/781/1/6; Bogdanov S, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/1/40; Chatterjee S, 2002, ASTROPHYS J, V575, P407, DOI 10.1086/341139; Ferrigno C, 2014, ASTRON ASTROPHYS, V567, DOI 10.1051/0004-6361/201322904; Gajjar V, 2012, MON NOT R ASTRON SOC, V424, P1197, DOI 10.1111/j.1365-2966.2012.21296.x; Itoh N., 2001, Publications of the National Astronomical Observatory of Japan, V6; Kargaltsev O., 2008, AIP C P, V983, P171, DOI DOI 10.1063/1.2900138; Kawabata KS, 2008, P SOC PHOTO-OPT INS, V7014, pL144, DOI 10.1117/12.788569; Kong AKH, 2012, ASTROPHYS J LETT, V747, DOI 10.1088/2041-8205/747/1/L3; Konishi M, 2015, PUBL ASTRON SOC JPN, V67, DOI 10.1093/pasj/psu148; Kotani T, 2005, NUOVO CIMENTO C, V28, P755, DOI 10.1393/ncc/i2005-10190-5; KULKARNI SR, 1988, NATURE, V335, P801, DOI 10.1038/335801a0; LANDOLT AU, 1992, ASTRON J, V104, P340, DOI 10.1086/116242; Longair M. S., 1994, HIGH ENERGY ASTROPHY, V2; Motohara K., 2010, P SOC PHOTO-OPT INS, V7735, P77353; Nagayama T, 2003, P SOC PHOTO-OPT INS, V4841, P459, DOI 10.1117/12.460770; PELLING RM, 1987, ASTROPHYS J, V319, P416, DOI 10.1086/165466; Ray P.S., 2014, BAAS, V223; Roberts M. S. E., 2013, IAU S, P127; Roberts MSE, 2011, AIP CONF PROC, V1357, P127, DOI 10.1063/1.3615095; Romani RW, 2011, ASTROPHYS J LETT, V743, DOI 10.1088/2041-8205/743/2/L26; Schlafly EF, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/2/103; Takahashi N., 2009, P GAO ITB JOINT WORK, V50; Watanabe M., 2012, P SOC PHOTO-OPT INS, V8446, P84462; Weisskopf MC, 2000, ASTROPHYS J, V536, pL81, DOI 10.1086/312733; Yanagisawa K, 2010, AIP CONF PROC, V1279, P466, DOI 10.1063/1.3509349; YOSHIDA MICHITOSHI, 2005, Journal of the Korean Astronomical Society, V38, P117	50	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	APR 1	2015	802	2							84	10.1088/0004-637X/802/2/84		11	Astronomy & Astrophysics	Astronomy & Astrophysics	CG1DZ	WOS:000353014500012		
J	Yuan, Q; Ioka, K				Yuan, Qiang; Ioka, Kunihito			TESTING THE MILLISECOND PULSAR SCENARIO OF THE GALACTIC CENTER GAMMA-RAY EXCESS WITH VERY HIGH ENERGY GAMMA-RAYS	ASTROPHYSICAL JOURNAL			English	Article						cosmic rays; gamma rays: ISM; pulsars: general; radiation mechanisms: non-thermal	LARGE-AREA TELESCOPE; FERMI BUBBLES; GLOBULAR-CLUSTERS; DARK-MATTER; MILKY-WAY; WIND NEBULAE; CRAB-NEBULA; EMISSION; PROPAGATION; ORIGIN	Recent analyses of Fermi Large Area Telescope data show an extended GeV gamma-ray excess on top of the expected diffuse background in the Galactic center region, which can be explained by annihilating dark matter (DM) or a population of millisecond pulsars (MSPs). We propose observations of very high energy (VHE) gamma-rays to distinguish the MSP scenario from the DM scenario. GeV gamma-ray MSPs should release most of their energy to the relativistic e(perpendicular to) wind, which will diffuse into the Galaxy and radiate TeV gamma-rays through inverse Compton scattering and bremsstrahlung processes. By calculating the spectrum and spatial distribution, we show that such emission is detectable with the next generation VHE gamma-ray observatory, the Cherenkov Telescope Array (CTA), under reasonable model parameters. It is essential to search for multi-wavelength counterparts to the GeV gamma-ray excess in order to solve this mystery in the high-energy universe.	[Yuan, Qiang] Univ Massachusetts, Dept Astron, Amherst, MA 01002 USA; [Yuan, Qiang; Ioka, Kunihito] KEK, Ctr Theory, Inst Particle & Nucl Studies, Tsukuba, Ibaraki 3050801, Japan; [Ioka, Kunihito] Grad Univ Adv Studies Sokendai, Dept Particle & Nucl Phys, Tsukuba, Ibaraki 3050801, Japan	Yuan, Q (reprint author), Univ Massachusetts, Dept Astron, Amherst, MA 01002 USA.				KAKENHI [24000004, 24103006, 26287051, 26247042]	We appreciate the anonymous referee for helpful suggestions on this paper. We thank M. Hayashida, D. Hooper, S. Kisaka, K. Kohri, T. Saito, H. Takami, and B. Zhang for useful comments. This work was initiated during Q. Y.'s stay in KEK as a Short-Term Invited Fellow. This work is supported by KAKENHI 24000004, 24103006, 26287051, and 26247042 (K.I.).	Abazajian K. N., 2014, ARXIV14106168; Abazajian KN, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.023526; Abazajian KN, 2011, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2011/03/010; Abdo AA, 2010, ASTRON ASTROPHYS, V524, DOI 10.1051/0004-6361/201014458; Abdo AA, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/2/17; Abramowski A, 2011, ASTRON ASTROPHYS, V531, DOI 10.1051/0004-6361/201117171; Ackermann M, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/2/91; Ackermann M, 2014, ASTROPHYS J, V793, DOI 10.1088/0004-637X/793/1/64; Aguilar M, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.121102; Aharonian F, 2004, ASTRON ASTROPHYS, V425, pL13, DOI 10.1051/0004-6361:200400055; Aharonian F, 2012, ASTRON ASTROPHYS, V547, DOI 10.1051/0004-6361/201220092; Aharonian F, 2009, ASTRON ASTROPHYS, V499, P273, DOI 10.1051/0004-6361/200811564; Strong AW, 1998, ASTROPHYS J, V509, P212, DOI 10.1086/306470; Kashiyama K, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.023002; Su M, 2010, ASTROPHYS J, V724, P1044, DOI 10.1088/0004-637X/724/2/1044; de Ona-Wilhelmi E, 2013, ASTROPART PHYS, V43, P287, DOI 10.1016/j.astropartphys.2012.08.009; Hooper D, 2013, PHYS DARK UNIVERSE, V2, P118, DOI 10.1016/j.dark.2013.06.003; Moskalenko IV, 1998, ASTROPHYS J, V493, P694, DOI 10.1086/305152; KENNEL CF, 1984, ASTROPHYS J, V283, P694, DOI 10.1086/162356; Kosack K, 2004, ASTROPHYS J, V608, pL97, DOI 10.1086/422469; Cordes JM, 2004, NEW ASTRON REV, V48, P1413, DOI 10.1016/j.newar.2004.09.040; Smits R, 2009, ASTRON ASTROPHYS, V493, P1161, DOI 10.1051/0004-6361:200810383; Revnivtsev M, 2008, ASTRON ASTROPHYS, V491, P209, DOI 10.1051/0004-6361:200810115; Boyarsky A, 2011, PHYS LETT B, V705, P165, DOI 10.1016/j.physletb.2011.10.014; REES MF, 1974, MON NOT R ASTRON SOC, V167, P1; KENNEL CF, 1984, ASTROPHYS J, V283, P710, DOI 10.1086/162357; Gordon C, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.083521; Bednarek W, 2013, MON NOT R ASTRON SOC, V435, pL14, DOI 10.1093/mnrasl/slt084; Dobler G, 2010, ASTROPHYS J, V717, P825, DOI 10.1088/0004-637X/717/2/825; Wang W, 2005, MON NOT R ASTRON SOC, V358, P263, DOI 10.1111/j.1365-2966.2005.08816.x; Aharonian F, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.261104; Zhao HS, 1996, MON NOT R ASTRON SOC, V278, P488; Crocker RM, 2011, MON NOT R ASTRON SOC, V413, P763, DOI 10.1111/j.1365-2966.2010.18170.x; Hooper D, 2011, PHYS LETT B, V697, P412, DOI 10.1016/j.physletb.2011.02.029; Navarro JF, 1997, ASTROPHYS J, V490, P493, DOI 10.1086/304888; Abazajian KN, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.083511; Aharonian F, 2006, NATURE, V439, P695, DOI 10.1038/nature04467; Bednarek W, 2007, MON NOT R ASTRON SOC, V377, P920, DOI 10.1111/j.1365-2966.2007.11664.x; Bringmann T, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.123001; Calore F., 2014, ARXIV14090042; Calore F, 2014, ASTROPHYS J, V796, DOI 10.1088/0004-637X/796/1/14; Carlson E, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.023015; Cheng KS, 2006, ASTROPHYS J, V641, P427, DOI 10.1086/500345; Cheng KS, 2010, ASTROPHYS J, V723, P1219, DOI 10.1088/0004-637X/723/2/1219; Chernyakova M, 2011, ASTROPHYS J, V726, DOI 10.1088/0004-637X/726/2/60; Cholis I., 2014, ARXIV14075625; Cirelli M., 2014, ARXIV14072173; Crocker RM, 2012, MON NOT R ASTRON SOC, V423, P3512, DOI 10.1111/j.1365-2966.2012.21149.x; Acharya BS, 2013, ASTROPART PHYS, V43, P3, DOI 10.1016/j.astropartphys.2013.01.007; Daylan T., 2014, ARXIV14026703; Fermi-LAT collaboration, 2014, 5 INT FERM S; GOLDREIC.P, 1969, ASTROPHYS J, V157, P869, DOI 10.1086/150119; Goodenough L., 2009, ARXIV09102998; Hagiwara K, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.015023; Hooper D, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.083009; Hooper D., 2014, ARXIV14101527; Huang W.-C., 2013, ARXIV13076862; Jin H.-B., 2014, ARXIV14100171; Kisaka S, 2012, MON NOT R ASTRON SOC, V421, P3543, DOI 10.1111/j.1365-2966.2012.20576.x; Lacroix T, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.043508; Macias O, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.063515; Mirabal N, 2013, MON NOT R ASTRON SOC, V436, P2461, DOI 10.1093/mnras/stt1740; Moskalenko IV, 2006, ASTROPHYS J, V640, pL155, DOI 10.1086/503524; Petrovic J, 2015, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2015/02/023; Petrovic J, 2014, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2014/10/052; Su M, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/1/61; Trotta R, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/2/106; Venter C, 2009, ASTROPHYS J LETT, V696, pL52, DOI 10.1088/0004-637X/696/1/L52; Vitale V., 2009, ARXIV09123828; Yang RZ, 2014, ASTRON ASTROPHYS, V567, DOI 10.1051/0004-6361/201423562; Yuan Q., 2014, JHEAP, V3, P1; Yusef-Zadeh F, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/1/33; Zhou B., 2014, ARXIV14066948	73	6	6	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	APR 1	2015	802	2							124	10.1088/0004-637X/802/2/124		6	Astronomy & Astrophysics	Astronomy & Astrophysics	CG1DZ	WOS:000353014500052		
J	Osawa, Y; Aoki, MN; Thiel, M; Bauer, RT				Osawa, Yumiko; Aoki, Masakazu N.; Thiel, Martin; Bauer, Raymond T.			Analysis of Life-History Traits in a Sex-Changing Marine Shrimp (Decapoda: Caridea: Rhynchocinetidae)	BIOLOGICAL BULLETIN			English	Article							PROTANDRIC SIMULTANEOUS HERMAPHRODITISM; ARTEMESIA-LONGINARIS DECAPODA; LYSMATA-WURDEMANNI DECAPODA; TROPICAL SEAGRASS MEADOW; EXHIPPOLYSMATA-OPLOPHOROIDES; LATITUDINAL VARIATION; POPULATION-STRUCTURE; TYPUS DECAPODA; REPRODUCTIVE-BIOLOGY; PALAEMONETES-PUGIO	The hypothesis of protandrous (male to female) sex change was tested for the first time in a rhynchocinetid shrimp, Rhynchocinetes uritai, with an analysis of life-history traits. Samples were taken monthly for 2 years in Oura Bay, Japan, using a combination of bait and refuge traps. Breeding was seasonal but extended from spring through autumn, with female-phase individuals (FPs) producing broods successively, with their ovaries maturing for a new spawn during incubation of a previous brood. Females incubated numerous (similar to 500-4000) embryos that suffered insignificant mortality before hatching. Recruitment of juveniles after planktonic larval development began in summer and peaked during the autumn, with negligible recruitment during winter and spring. Cohort analysis confirmed the hypothesis of protandric sex change in this species, with juveniles maturing into the male phase (MP) during their first reproductive season at an age of 6-10 mon, depending on the time of recruitment. Sex change occurred during the following winter when transitional individuals matured into FPs during their second reproductive season at an age of >= 18 mon. Two cohorts were followed from recruitment until the end of the study, indicating a life span of 21-25 mon. Aside from its sexual system, this sex-changing species showed no obvious differences in reproductive and other life-history traits from those of gonochoric species from similar latitudes and habitats.	[Osawa, Yumiko] Univ Tsukuba, Shimoda Marine Res Ctr, Shimoda 4150025, Japan; [Aoki, Masakazu N.] Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi 9818555, Japan; [Thiel, Martin] Univ Catolica Norte, Fac Ciencias Mar, Larrondo 1281, Coquimbo, Chile; [Thiel, Martin] Millennium Nucleus Ecol & Sustainable Management, Coquimbo, Chile; [Thiel, Martin] Ctr Estudios Avanzados Zonas Aridas CEAZA, Coquimbo, Chile; [Bauer, Raymond T.] Univ Louisiana, Dept Biol, Lafayette, LA 70504 USA	Bauer, RT (reprint author), Univ Louisiana, Dept Biol, Lafayette, LA 70504 USA.	rtbauer@louisiana.edu			Chiba Natural History Museum and Institute in Japan (CMNH); Chilean Millennium Initiative [NC120030]; Japanese Association for Marine Biology (JAMBIO) [24-53]	We thank Dr. Junji Okuno from the Chiba Natural History Museum and Institute in Japan (CMNH) for his support and discussion. We are grateful to the technical staff from the Shimoda Marine Research Center (SMRC) of the University of Tsukuba, Japan, for supplying temperature and conductivity data, as well as for their excellent support during sampling. We thank Dr. Shigeki Wada (SMRC) for allowing us to cite unpublished data on the pattern of cholorophyll a values near the study site, and for his helpful information about conductivity measures at SMRC. MT was supported by the Chilean Millennium Initiative (grant NC120030). This study was supported by a Grant-in-Aid from the Japanese Association for Marine Biology (JAMBIO, No. 24-53). This is Contribution No. 767 of Shimoda Marine Research Center, University of Tsukuba, and Contribution No. 165 of the University of Louisiana, Lafayette, Laboratory for Crustacean Research.	ALON NC, 1982, MAR BIOL, V68, P265, DOI 10.1007/BF00409593; Thiel M, 2010, J CRUSTACEAN BIOL, V30, P580, DOI 10.1651/09-3272.1; Bauer RT, 2011, J CRUSTACEAN BIOL, V31, P286, DOI 10.1651/10-3378.1; Lardies MA, 2001, OPHELIA, V55, P55; Correa C, 2003, J CRUSTACEAN BIOL, V23, P33, DOI 10.1651/0278-0372(2003)023[0033:MDHAMT]2.0.CO;2; De Grave S., 2011, Zoologische Mededelingen (Leiden), V85, P195; Correa C, 2000, J CRUSTACEAN BIOL, V20, P628, DOI 10.1651/0278-0372(2000)020[0628:MBAFSO]2.0.CO;2; Correa C, 2003, J CRUSTACEAN BIOL, V23, P849, DOI 10.1651/C-2388; Terossi M, 2010, J CRUSTACEAN BIOL, V30, P571, DOI 10.1651/09-3233.1; Bergstrom BI, 2000, ADV MAR BIOL, V38, P55, DOI 10.1016/S0065-2881(00)38003-8; Baldwin AP, 2003, MAR BIOL, V143, P157, DOI 10.1007/s00227-003-1043-6; CHARNOV EL, 1989, AM NAT, V134, P824, DOI 10.1086/285014; Fransozo V, 2005, REV BRAS ZOOL, V22, P1078, DOI 10.1590/S0101-81752005000400037; BAUER RT, 1992, INVERTEBR REPROD DEV, V22, P193, DOI 10.1080/07924259.1992.9672272; Castilho AL, 2007, J CRUSTACEAN BIOL, V27, P548, DOI 10.1651/S-2788.1; Marshall DJ, 2012, ANNU REV ECOL EVOL S, V43, P97, DOI 10.1146/annurev-ecolsys-102710-145004; COREY S, 1991, CRUSTACEANA, V60, P270, DOI 10.1163/156854091X00056; Bauer RT, 2012, J MAR BIOL ASSOC UK, V92, P521, DOI 10.1017/S0025315411000622; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; Baeza JA, 2004, BEHAV ECOL SOCIOBIOL, V55, P544, DOI 10.1007/s00265-003-0744-7; Amin SMN, 2009, INDIAN J MAR SCI, V38, P57; Baeza JA, 2014, ZOOL J LINN SOC-LOND, V172, P426, DOI 10.1111/zoj.12173; Baeza JA, 2010, MAR BIOL, V157, P2643, DOI 10.1007/s00227-010-1525-2; Baeza JA, 2010, INVERTEBR BIOL, V129, P266, DOI 10.1111/j.1744-7410.2010.00200.x; Baeza JA, 2010, BIOL BULL-US, V219, P151; Bauer RT, 2014, ZOOKEYS, P187, DOI 10.3897/zookeys.457.6512; Bauer RT, 1996, B MAR SCI, V59, P53; Bauer RT, 1998, MAR BIOL, V132, P223, DOI 10.1007/s002270050388; Bauer RT, 2000, J CRUSTACEAN BIOL, V20, P116; BAUER RT, 1989, J EXP MAR BIOL ECOL, V127, P175, DOI 10.1016/0022-0981(89)90183-4; Bauer RT, 2002, J CRUSTACEAN BIOL, V22, P742, DOI 10.1651/0278-0372(2002)022[0742:REOAPS]2.0.CO;2; Bauer R.T., 1991, Crustacean Issues, V7, P181; Bauer RT, 2000, INVERTEBR REPROD DEV, V38, P107, DOI 10.1080/07924259.2000.9652445; Bauer R.T., 2004, REMARKABLE SHRIMPS A; BAUER RT, 1986, BIOL BULL, V170, P11, DOI 10.2307/1541377; Braga AA, 2009, J CRUSTACEAN BIOL, V29, P34, DOI 10.1651/08.3015.1; Calado R., 2008, MARINE ORNAMENTAL SH; Chace Jr F. A., 1997, SMITHSON CONTRIB ZOO; CHARNOV E L, 1982; CHARNOV EL, 1981, MAR BIOL LETT, V2, P53; CHARNOV EL, 1978, SCIENCE, V200, P204, DOI 10.1126/science.200.4338.204; Chiba Susumu, 2007, Plankton & Benthos Research, V2, P107, DOI 10.3800/pbr.2.107; Fiedler G. Curt, 1998, Pacific Science, V52, P161; Gavio MA, 2006, J CRUSTACEAN BIOL, V26, P295, DOI 10.1651/C-2619.1; Gayanilo F., 2005, FAO ICLARM STOCK ASS; Hoglund H., 1943, SVENSKA HYDROGRAFISK, VII, P1; Kikuchi T., 1962, Records of Oceanographic Works in Japan Special, VNo. 6, P135; Laubenheimer H, 2008, J MAR BIOL ASSOC UK, V88, P301, DOI 10.1017/S0025315408000702; Li HY, 2011, J CRUSTACEAN BIOL, V31, P34, DOI 10.1651/10-3289.1; Lin J, 2001, MAR BIOL, V139, P1155; Longhurst A. R., 1981, ANAL MARINE ECOSYSTE; MAIHARA Y., 2002, SCI REPORTS MUSEUM T, V4, P59; McLaughlin P. A., 2005, COMMON SCI NAMES AQU; Okuno Junji, 1997, Records of the South Australian Museum (Adelaide), V30, P13; Okuno J, 1997, FONDS MEUBLES LAGONS, V3, P31; OMORI M, 1988, NIPPON SUISAN GAKK, V54, P365; Onaga H, 2012, J CRUSTACEAN BIOL, V32, P383, DOI 10.1163/193724012X626520; Orton JH, 1920, J MAR BIOL ASSOC UK, V12, P339, DOI DOI 10.1017/S0025315400000102; OYA F, 1987, MAR BIOL, V96, P225, DOI 10.1007/BF00427022; Pakhomov EA, 2000, POLAR BIOL, V23, P522, DOI 10.1007/s003000000116; PEARSE JS, 1991, AM ZOOL, V31, P65; Ramirez Llodra Eva, 2002, Adv Mar Biol, V43, P87, DOI 10.1016/S0065-2881(02)43004-0; Sastry A.N., 1983, P179; Semensato XEG, 2008, BOL INST PESCA, V34, P89; Serisawa Y, 2001, NIPPON SUISAN GAKK, V67, P1065; Than S. K., 2006, SRI LANKA J AQUAT SC, V11, P1; TURNER R. L., 1979, REPROD ECOLOGY MARIN, P25; Wehrtmann IS, 1999, SCI MAR, V63, P325; WICKLER W, 1981, Z TIERPSYCHOL, V57, P215; Wilson K, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P48, DOI 10.1017/CBO9780511542053.004; ZUPO V, 1994, J EXP MAR BIOL ECOL, V178, P131, DOI 10.1016/0022-0981(94)90229-1	71	1	1	MARINE BIOLOGICAL LABORATORY	WOODS HOLE	7 MBL ST, WOODS HOLE, MA 02543 USA	0006-3185	1939-8697		BIOL BULL-US	Biol. Bull.	APR 1	2015	228	2					125	136				12	Biology; Marine & Freshwater Biology	Life Sciences & Biomedicine - Other Topics; Marine & Freshwater Biology	CG8PC	WOS:000353569700005		
J	Eriksson, H; Clarke, S				Eriksson, Hampus; Clarke, Shelley			Chinese market responses to overexploitation of sharks and sea cucumbers	BIOLOGICAL CONSERVATION			English	Review						Consumption; Demand; Fisheries; Supply; Sustainability; Trade	DE-MER TRADE; HONG-KONG; SEAFOOD; CONSERVATION; PERSPECTIVES; STATISTICS; EXTINCTION; MANAGEMENT; RESOURCES; FISHERIES	Global exploitation of sharks and sea cucumbers to meet consumer demand in China is motivating a rising conservation concern. In order to analyze trends in resource exploitation and market dynamics, this paper reviews global production and trade data for these taxa. Sea cucumber capture production has plateaued, but overall production is still increasing because of rising aquaculture, limited public conservation concern and insufficient regulation of fishing and trade. Shark capture production has peaked and is declining, suggesting that one or more of these factors are constraining the shark fin trade. The trade networks for both commodities have been resilient to changing conditions (e.g. stock declines, closed fisheries, regulations, public opinion on conservation) and have become more widespread over the last 10 years. System resilience is evident in dynamic market attributes, such as developing new product forms and absorbing alternative target species, and presents substantial challenges for identifying conservation approaches. For shark fin, a government-led backlash against conspicuous consumption in China, combined with global conservation momentum, appears to have had some impact on traded volumes. Sea cucumbers do not enjoy the same level of attention in the global conservation discourse, despite seven species being endangered. For both taxa, the current regulatory environment is insufficient to safeguard resources and strengthened conservation strategies are required. Better resolution of trade data will improve the ability to evaluate trends and guide management and conservation. (C) 2015 Elsevier Ltd. All rights reserved.	[Eriksson, Hampus] WorldFish, Sayan Lepas 11960, Penang, Malaysia; [Eriksson, Hampus] Univ Wollongong, ANCORS, Wollongong, NSW 2522, Australia; [Clarke, Shelley] Sasama Consulting, Shizuoka 4280211, Japan; [Clarke, Shelley] Western & Cent Pacific Fisheries Commiss, Areas Natl Jurisdict Tuna Project, Kolonia 96941, Pohnpei, Micronesia	Eriksson, H (reprint author), WorldFish, Sayan Lepas 11960, Penang, Malaysia.	H.Eriksson@cgiar.org			Mistra (the Swedish Foundation for Strategic Environmental Research); Nereus Program at the Stockholm Resilience Centre; collaborative Nippon Foundation initiative; Australian Centre for International Agricultural Research (ACIAR) Project [FIS/2012/074]; CGIAR Research Program on Aquatic Agricultural Systems	This study was supported by Mistra (the Swedish Foundation for Strategic Environmental Research) through a core grant to the Stockholm Resilience Centre, the Nereus Program at the Stockholm Resilience Centre, a collaborative Nippon Foundation initiative, the Australian Centre for International Agricultural Research (ACIAR) Project FIS/2012/074 and the CGIAR Research Program on Aquatic Agricultural Systems. We thank S.W. Purcell and three anonymous reviewers for their constructive evaluation of the manuscript. We thank Henrik Osterblom, Max Troell, Beatrice Crona, Andrew Merie and Marc Metian for valuable discussions in the preparation of this study, Allen To at the World Wide Fund for Nature (WWF) Hong Kong for providing data and Neil Andrew for comments on the manuscript. HE also thanks his previous employer, the Department of Ecology, Environment and Plant Sciences at Stockholm University.	Akamine J., 2012, ACIAR P, V136, P203; Akamine J., 2009, BIOSPHERE CONSERV, V9, P1; Costello C, 2012, SCIENCE, V338, P517, DOI 10.1126/science.1223389; Xu P, 2012, FOOD CONTROL, V28, P74, DOI 10.1016/j.foodcont.2012.04.008; Cortes E, 2002, CONSERV BIOL, V16, P1048, DOI 10.1046/j.1523-1739.2002.00423.x; Fabinyi M, 2014, CONSERV SOC, V12, P218, DOI 10.4103/0972-4923.138423; Uthicke S, 2004, CONSERV BIOL, V18, P1395, DOI 10.1111/j.1523-1739.2004.00309.x; To Allen W.L., 2012, Traffic Bulletin, V24, P65; Clarke SC, 2006, CONSERV BIOL, V20, P201, DOI 10.1111/j.1523-1739.2006.00247.x; Berkes F, 2006, SCIENCE, V311, P1557, DOI 10.1126/science.1122804; Anderson SC, 2013, METHODS ECOL EVOL, V4, P971, DOI 10.1111/2041-210X.12093; Purcell SW, 2013, FISH FISH, V14, P34, DOI 10.1111/j.1467-2979.2011.00443.x; Clarke SC, 2013, CONSERV BIOL, V27, P197, DOI 10.1111/j.1523-1739.2012.01943.x; Swartz W, 2010, MAR POLICY, V34, P1366, DOI 10.1016/j.marpol.2010.06.011; McClenachan L, 2012, CONSERV LETT, V5, P73, DOI 10.1111/j.1755-263X.2011.00206.x; Cortes E, 2010, AQUAT LIVING RESOUR, V23, P25, DOI 10.1051/alr/2009044; Fabinyi M, 2012, ENVIRON CONSERV, V39, P83, DOI 10.1017/S0376892911000609; Clarke S, 2004, FISH FISH, V5, P53, DOI 10.1111/j.1467-2960.2004.00137.x; Alden C, 2005, SURVIVAL, V47, P147, DOI 10.1080/00396330500248086; Clarke S, 2007, MAR RESOUR ECON, V22, P305; Anderson SC, 2011, FISH FISH, V12, P317, DOI 10.1111/j.1467-2979.2010.00397.x; Mallory TG, 2013, MAR POLICY, V38, P99, DOI 10.1016/j.marpol.2012.05.024; Purcell SW, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3296; Branch TA, 2013, TRENDS ECOL EVOL, V28, P409, DOI 10.1016/j.tree.2013.03.003; Arrizabalaga H, 2011, AQUAT LIVING RESOUR, V24, P1, DOI 10.1051/alr/2011007; Cao Ngoc A., 2013, ASIAN CRIMINOLOGY, V8, P129; Cheung GCK, 2011, ASIA PAC BUS REV, V17, P343, DOI 10.1080/13602380903461623; Cinner J., 2012, GLOBAL ENVIRON CHANG, V21, P835; Clarke S, 2013, W CENTR PAC FISH COM; Clarke S., 2015, 588 FAO; Clarke S, 2004, SHARK PRODUCT TRADE; Clarke S., 2002, P 4 EUR EL ASS M LIV, P65; Clarke S., 2008, UNDERSTANDING CHINAS; CONAND C, 2014, BECHE INF BULL, V34, P43; Conand C, 1993, MAR FISH REV, V55, P1; Conand C, 1993, SPC BECHE DE MER B, V5, P4; DuIvy N.K., 2008, AQUAT CONSERV, V18, P459; Eilperin J., 2012, WASHINGTON POST; Eriksson H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035504; Eriksson H., 2013, FISH FISHER; Eriksson H, 2012, AMBIO, V41, P109, DOI 10.1007/s13280-011-0195-8; FAO, 2014, 14 FAO CITE AN COMM; FAO, 2013, FAO FISHSTATJ SOFTW; FAO (Food and Agriculture Organization of the United Nations), 2013, FAO WORKSH SEA CUC F; Ferdouse F., 1999, BECHE DE MER INFO B, V11, P3; Fischer J., 2012, C1076 FAO UN; Fong QSW, 2000, INFOFISH INT, V1, P28; Friedman K, 2011, FISH FISH, V12, P75, DOI 10.1111/j.1467-2979.2010.00384.x; Gerth K, 2010, CHINA GOES SO GOES W; Gillett R., 2011, 560 FAO UN; Gilman E., 2007, STRATEGIES REDUCE SH; Graham-Rowe D., 2011, NATURE, V480, P5101; Guilford G., 2013, QUARTZ NEW YORK 0801; Hanson A.J., 2011, GREENING CHINAS FISH, P151; Jaquemet S., 1999, SPC BECHE DE MER INF, V12, P11; Menkhoff T., 1994, MORAL EC TRADE ETHNI, P104; Payne J., 2000, THIS IS BORNEO, P176; PURCELL S, 2014, BECHE INF BULL, V34, P47; Purcell S., 2010, 520 FAO UN; Rabobank, 2012, 341 RAB; Rodrigue J. P., 2013, GEOGRAPHY TRANSPORT; Roelofs A., 2004, ECOLOGICAL ASSESSMEN; Schottenhammer A., 2010, WORLD, V1-2, P99; Manez KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011346; SeafoodSource, 2013, WILD AM SEA CUC LAT; Shotton R, 1999, 378 FAO UN; Skewes T., 2004, CONVERSION RATIOS CO; Stiff R., 1975, ADV CONSUM RES, V2, P203; Swartz W., 1950, PLOS ONE, V5; Toral-Granda V., 2008, 516 FAO UN; TRAFFIC, 1996, WORLD TRAD SHARKS CO, V2; TRAFFIC, 1996, WORLD TRAD SHARKS CO, V1; Tsui B., 2013, NEW YORK TIMES  0629; Wang Y., 2013, TIME MAGAZINE; Wang Z., 2013, CHINA DAILY; WCPFC (Western Central Pacific Fisheries Commission), 2014, 10 REG SESS 2 6 DEC	76	1	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0006-3207	1873-2917		BIOL CONSERV	Biol. Conserv.	APR	2015	184						163	173		10.1016/j.biocon.2015.01.018		11	Biodiversity Conservation; Ecology; Environmental Sciences	Biodiversity & Conservation; Environmental Sciences & Ecology	CG1BE	WOS:000353007200019		
J	Sakurai, R; Kobori, H; Nakamura, M; Kikuchi, T				Sakurai, Ryo; Kobori, Hiromi; Nakamura, Masako; Kikuchi, Takahiro			Factors influencing public participation in conservation activities in urban areas: A case study in Yokohama, Japan	BIOLOGICAL CONSERVATION			English	Article						Behavioral intentions; Civic participation; Community-based management; Nature restoration; Perception	BIODIVERSITY; RESTORATION; COMMUNITIES; HEALTH	The long-term success of conservation projects, particularly in urban areas, often depends on local buy-in and participation. However, it can be difficult to recruit local residents to participate in community-based management. Here we use an urban conservation project in Yokohama, the second largest city in Japan, as a case study to examine the factors associated with the willingness of residents to participate in five different conservation-related activities. We aimed to understand important factors that consist urban environmental stewardship and civic ecology in an Asian culture; japan. Our survey of residents suggests that participation was related to an individual's expectation that participating in the conservation activity would enhance social interactions among residents, their belief that the urban area lacked adequate "green" habitat features, such as gardens and other plantings, and their sense of responsibility to maintain the quality of the environment. Additionally, younger residents were more willing to participate than older residents. Our results suggest that emphasizing social interactions in conservation activities and highlighting the need for and social and aesthetic benefits of conservation improvements could enhance participation in these conservation activities. Particular motivating factors may vary from place to place, particularly across cultural boundaries, but some factors appear to be general across cultures. In cultures that emphasize collective responsibility and action, such as in Japan, it may be important to foster residents' sense that it is their responsibility to conserve the natural environment. We believe that greater understanding of the interests and motivation of the public to participate in conservation projects will enhance their efficacy. (C) 2015 Elsevier Ltd. All rights reserved.	[Sakurai, Ryo] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Japan Soc Promot Sci, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan; [Kobori, Hiromi; Nakamura, Masako; Kikuchi, Takahiro] Tokyo City Univ, Fac Environm, Tsuzuki Ku, Yokohama, Kanagawa 2240015, Japan	Sakurai, R (reprint author), Yokohama Natl Univ, Hodogaya Ku, Environm & Informat Sci Bldg 4,Room 206,79-7 Toki, Yokohama, Kanagawa 2408501, Japan.	ryo223sak@gmail.com			Ministry of Education, Culture, Sports, Science and Technology of Japan [25282044]	We would like to thank the district leader and committee of residents' association of Ushikubonishi district for helping us distribute and collect survey. This study was conducted as a part of the project by "Research Team of Tsuzuki Community Development Embracing Flower and Greenery". We thank A. Miller-Rushing for editing the manuscript, and S.K. Jacobson and two anonymous reviewers for helpful suggestions. This study was supported partially by the grant of Ministry of Education, Culture, Sports, Science and Technology of Japan to Hiromi Kobori (No. 25282044).	Andersson E, 2014, URBAN FOR URBAN GREE, V13, P221, DOI 10.1016/j.ufug.2013.11.002; Youngentob K, 2005, ENVIRON BEHAV, V37, P731, DOI 10.1177/0013916505275311; Rudd H, 2002, RESTOR ECOL, V10, P368, DOI 10.1046/j.1526-100X.2002.02041.x; Kobori H, 2003, AMBIO, V32, P307, DOI 10.1639/0044-7447(2003)032[0307:PCAFST]2.0.CO;2; Krasny ME, 2014, ECOSYST SERV, V7, P177, DOI 10.1016/j.ecoser.2013.11.002; Gobster PH, 2004, LANDSCAPE URBAN PLAN, V68, P147, DOI 10.1016/S0169-2046(03)00162-2; van den Berg AE, 2007, J SOC ISSUES, V63, P79, DOI 10.1111/j.1540-4560.2007.00497.x; Kuo FE, 2001, ENVIRON BEHAV, V33, P343, DOI 10.1177/00139160121973025; McIntyre NE, 2001, BASIC APPL ECOL, V2, P209; Lo AYH, 2010, CITIES, V27, P430, DOI 10.1016/j.cities.2010.07.001; Zanetell BA, 2004, WORLD DEV, V32, P793, DOI 10.1016/j.worlddev.2004.01.002; Lo AYH, 2012, LAND USE POLICY, V29, P577, DOI 10.1016/j.landusepol.2011.09.011; Marzluff JM, 2001, RESTOR ECOL, V9, P280, DOI 10.1046/j.1526-100x.2001.009003280.x; Krasny ME, 2012, FRONT ECOL ENVIRON, V10, P267, DOI 10.1890/110230; Association of Flowers and Greenery, 2013, GREEN COMM DEV PROJ; Campbell L, 2009, RESTORATIVE COMMONS; City of Yokohama, 2014, POPULATION NEWS 0201; De Valck J., 2012, BIOECONOMICS WORKING; [Department of Economic and Social Affairs United Nations Population Division], 2012, WORLD URB PROSP 2011; Ernstson H, 2010, ECOL SOC, V15; Hashimoto K., 2008, J HEALTH SCI, V30, P27; Hill Catherine M., 2008, P117; Horwitz P, 2001, ECOSYST HEALTH, V7, P253, DOI 10.1046/j.1526-0992.2001.01044.x; Jacobson S.K., 2007, CONSERVATION ED OUTR; Japan Automobile Manufacturers Associations, 2008, SURV TREND AUT MARK; Kaplan R, 2007, LANDSCAPE URBAN PLAN, V82, P17, DOI 10.1016/j.landurbplan.2007.01.012; Kobori H., 2014, ENV INFORM SCI, V43, P34; Locke D.H., 2014, J ENV STUD SCI, DOI http://dx.doi.org/10.1007/s13412-014-0176-x; McKenzie-Mohr D., 2006, FOSTERING SUSTAINABL; Ministry of Internal Affairs and Communications, 2012, WHIT PAP INF COMM JA; Nishinomiya City, 2012, COMM DEV EMBR FLOW G; Pharr S.J., 1996, MEDIA POLITICS JAPAN; Romolini M, 2012, WHAT IS URBAN ENV ST; Shinji I., 2014, ENV INFORM SCI, V43, P1; Svendsen ES, 2009, USDA FOR SERV N RES, P59; Takano S., 2010, NETWORK COMMUNITY KO; Tidball K. G., 2010, CITIES ENV, V3, P11; Urban Green Foundation, 2013, ASS WHICH REC 28 GRE; URBIO, 2010, NAG DECL URBIO 2010; Vaske J., 2008, SURVEY RES ANAL APPL; White Curtis, 2003, CITY COMMUNITY, V2, P239, DOI 10.1111/1540-6040.00053; Yokohama city, 2013, HOUS POP TSUZ WARD; Yokohama city, 2013, TAX YOK CIT YOK GREE; Yokohama city Tsuzuki ward, 2012, STAT REC TSUZ; Yokohama Environmental Planning Bureau, 2013, YOK GREEN UP PLAN	45	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0006-3207	1873-2917		BIOL CONSERV	Biol. Conserv.	APR	2015	184						424	430		10.1016/j.biocon.2015.02.012		7	Biodiversity Conservation; Ecology; Environmental Sciences	Biodiversity & Conservation; Environmental Sciences & Ecology	CG1BE	WOS:000353007200046		
J	Mohri, K; Kusuki, E; Ohtsuki, S; Takahashi, N; Endo, M; Hidaka, K; Sugiyama, H; Takahashi, Y; Takakura, Y; Nishikawa, M				Mohri, Kohta; Kusuki, Eri; Ohtsuki, Shozo; Takahashi, Natsuki; Endo, Masayuki; Hidaka, Kumi; Sugiyama, Hiroshi; Takahashi, Yuki; Takakura, Yoshinobu; Nishikawa, Makiya			Self-Assembling DNA Dendrimer for Effective Delivery of Immunostimulatory CpG DNA to Immune Cells	BIOMACROMOLECULES			English	Article							NUCLEIC-ACID NANOSTRUCTURES; BACTERIAL-DNA; STRUCTURED DNA; MOTIFS; OLIGODEOXYNUCLEOTIDES; OLIGONUCLEOTIDES; NANOCARRIERS; SYSTEMS; DESIGN	DNA dendrimers consisting of several branched DNA units connected to each other using DNA ligase were quite effective for the delivery of immunostimulatory CpG DNA to immune cells. Therapeutic application of such DNA dendrimers, however, is hampered by the use of the ligase. Here, we report that self-assembling DNA dendrimers with high immunostimulatory potency can be prepared without DNA ligases. Annealing of DNA consisting of DNA units with elongated adhesive ends resulted in the formation of DNA dendrimers. Atomic force microscopy revealed that the several preparations of DNA dendrimers resulted in dendritic structures as designed. The cellular uptake of DNA dendrimers by mouse macrophage-like RAW264.7 cells and subsequent release of tumor necrosis factor-alpha were dependent on the structural complexity of the dendrimers. These results indicate that the ligation-free, self-assembling DNA dendrimers are a potent system for the delivery of immunostimulatory CpG DNA to immune cells.	[Mohri, Kohta; Kusuki, Eri; Ohtsuki, Shozo; Takahashi, Natsuki; Takahashi, Yuki; Takakura, Yoshinobu; Nishikawa, Makiya] Kyoto Univ, Dept Biopharmaceut & Drug Metab, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan; [Endo, Masayuki; Sugiyama, Hiroshi] Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Sakyo Ku, Kyoto 6068501, Japan; [Hidaka, Kumi; Sugiyama, Hiroshi] Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan	Nishikawa, M (reprint author), Kyoto Univ, Dept Biopharmaceut & Drug Metab, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan.	makiya@pharm.kyoto-u.ac.jp	Sugiyama, Hiroshi/C-7687-2011; Endo, Masayuki/J-5874-2014		Japan Society for the Promotion of Science [26860021, 23390010, 26293008]; Ministry of Education, Culture, Sports, Science and Technology of Japan [25114706]	This work is supported in part by a Grants-in-Aid for Young Scientists (B) No. 26860021 to KM., Grants-in-Aid for Scientific Research (B) Nos. 23390010 and 26293008 to M.N. from the Japan Society for the Promotion of Science, and by a Grant-in-Aid for Scientific Research on Innovative Areas "Carcinogenic Spiral" No. 25114706 to M.N. from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Li YG, 2004, NAT MATER, V3, P38, DOI 10.1038/nmat1045; de Vries JW, 2013, J CONTROL RELEASE, V172, P467, DOI 10.1016/j.jconrel.2013.05.022; Mohri K, 2012, ACS NANO, V6, P5931, DOI 10.1021/nn300727j; Wang ZG, 2013, ADV MATER, V25, P3905, DOI 10.1002/adma.201301450; Klinman DM, 1996, P NATL ACAD SCI USA, V93, P2879, DOI 10.1073/pnas.93.7.2879; Mohri K, 2012, J CONTROL RELEASE, V163, P285, DOI 10.1016/j.jconrel.2012.08.001; Hemmi H, 2000, NATURE, V408, P740; Nishikawa M, 2008, IMMUNOLOGY, V124, P247, DOI 10.1111/j.1365-2567.2007.02762.x; Nishikawa M, 2011, BIOMATERIALS, V32, P488, DOI 10.1016/j.biomaterials.2010.09.013; Li J, 2011, ACS NANO, V5, P8783, DOI 10.1021/nn202774x; Rattanakiat S, 2009, BIOMATERIALS, V30, P5701, DOI 10.1016/j.biomaterials.2009.06.053; Charoenphol P, 2014, ACTA BIOMATER, V10, P1683, DOI 10.1016/j.actbio.2013.07.021; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Li J, 2013, ADV MATER, V25, P4386, DOI 10.1002/adma.201300875; Smith D, 2013, NANOMEDICINE-UK, V8, P105, DOI [10.2217/nnm.12.184, 10.2217/NNM.12.184]; Endo M, 2010, J AM CHEM SOC, V132, P1592, DOI 10.1021/ja907649w; Liu XW, 2012, NANO LETT, V12, P4254, DOI 10.1021/nl301877k; Mohri K, 2014, EUR J PHARM SCI, V58, P26, DOI 10.1016/j.ejps.2014.03.002; Vollmer J, 2009, ADV DRUG DELIVER REV, V61, P195, DOI 10.1016/j.addr.2008.12.008; Gupta GK, 2010, BIODRUGS, V24, P225, DOI 10.2165/11536140-000000000-00000; Klinman Dennis M, 2004, Nat Rev Immunol, V4, P249, DOI 10.1038/nri1329; Krieg A. M., 2006, DRUG DISCOV, V5, P471; Matsuoka N, 2010, J CONTROL RELEASE, V148, P311, DOI 10.1016/j.jconrel.2010.09.019; Nishikawa M, 2010, ADV DRUG DELIVER REV, V62, P626, DOI 10.1016/j.addr.2010.03.006; Nishikawa M, 2014, J CONTROL RELEASE, V180, P25, DOI 10.1016/j.jconrel.2014.02.001; Roberts TL, 2005, J IMMUNOL, V175, P3569; Roh Y. H., 2011, CHEM SOC REV, V44, P5730; Schiiller V. J., 2011, ACS NANO, V5, P9696; Sparwasser T, 1997, EUR J IMMUNOL, V27, P1671, DOI 10.1002/eji.1830270712; Uno S, 2014, NANOMED-NANOTECHNOL, V10, P765, DOI 10.1016/j.nano.2013.11.017	30	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1525-7797	1526-4602		BIOMACROMOLECULES	Biomacromolecules	APR	2015	16	4					1095	1101		10.1021/bm501731f		7	Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science	Biochemistry & Molecular Biology; Chemistry; Polymer Science	CG1AS	WOS:000353006000003		
J	Asayama, S; Nohara, A; Negishi, Y; Kawakami, H				Asayama, Shoichiro; Nohara, Atsushi; Negishi, Yoichi; Kawakami, Hiroyoshi			Plasmid DNA Mono-Ion Complex Stabilized by Hydrogen Bond for In Vivo Diffusive Gene Delivery	BIOMACROMOLECULES			English	Article							CRITICAL LIMB ISCHEMIA; CIRCULAR-DICHROISM; TRANSFECTION EFFICIENCY; BLOCK-COPOLYMER; B-DNA; POLY(1-VINYLIMIDAZOLE); CONFORMATION; POLYCATION; TRANSITION; MODEL	Our original concept of the mono-ion complex (MIC) between plasmid DNA (pDNA) and a monocationic biocompatible polymer has been stabilized by hydrogen bond formation. To form the hydrogen bond with pDNA, omega-amide-pentylimidazolium end-modified poly(ethylene glycol), that is, APe-Im-PEG, has been synthesized. Agarose gel retardation assay and circular dichroism measurement have revealed that the MIC between pDNA and APe-Im-PEG has been stabilized by the hydrogen bond between pDNA and the omega-amide group and that the stable MIC has surprisingly further migrated into gel, as compared with naked pDNA. The rise of melting temperature suggests that the specific hydrogen bond forms between an adenine-thymine base pair and the omega-amide group. The resulting pDNA MIC with APe-Im-PEG has enhanced gene expression by intramuscular administration in mice, as compared with a poly(ethylenimine) polyion complex (PIC). These results suggest that the pDNA MIC is diffusive in vivo administration site, as compared with pDNA PICs. Our methodology for MIC stabilization by a omega-amide group is expected to offer superior supramolecular systems to those by ubiquitous PICs for in vivo diffusive gene delivery.	[Asayama, Shoichiro; Nohara, Atsushi; Kawakami, Hiroyoshi] Tokyo Metropolitan Univ, Dept Appl Chem, Hachioji, Tokyo 1920397, Japan; [Negishi, Yoichi] Tokyo Univ Pharm & Life Sci, Dept Drug Delivery & Mol Biopharmaceut, Hachioji, Tokyo 1920392, Japan	Asayama, S (reprint author), Tokyo Metropolitan Univ, Dept Appl Chem, 1-1 Minami Osawa, Hachioji, Tokyo 1920397, Japan.	asayama-shoichiro@tmu.ac.jp			Japan Society for the Promotion of Science [24650281]	This research was supported by a Grant-in-Aid for challenging Exploratory Research (No. 24650281) from Japan Society for the Promotion of Science.	IVANOV VI, 1973, BIOPOLYMERS, V12, P89, DOI 10.1002/bip.1973.360120109; Aied A, 2013, DRUG DISCOV TODAY, V18, P1090, DOI 10.1016/j.drudis.2013.06.014; Nejedly K, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni008; Powell RJ, 2008, CIRCULATION, V118, P58, DOI 10.1161/CIRCULATIONAHA.107.727347; Salem AK, 2003, NAT MATER, V2, P668, DOI 10.1038/nmat974; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; Itaka K, 2003, BIOMATERIALS, V24, P4495, DOI 10.1016/S0142-9612(03)00347-8; Pouton CW, 2001, ADV DRUG DELIVER REV, V46, P187, DOI 10.1016/S0169-409X(00)00133-2; Roy K, 1999, NAT MED, V5, P387; IVANOV VI, 1974, J MOL BIOL, V87, P817, DOI 10.1016/0022-2836(74)90086-2; Fleige E, 2012, ADV DRUG DELIVER REV, V64, P866, DOI 10.1016/j.addr.2012.01.020; Sweeney P, 2003, CANCER RES, V63, P4017; Baumgartner I, 2009, MOL THER, V17, P914, DOI 10.1038/mt.2009.24; WING R, 1980, NATURE, V287, P755, DOI 10.1038/287755a0; Mastrobattista E, 2012, NAT MATER, V11, P10, DOI 10.1038/nmat3209; Asayama S, 2011, BIOCONJUGATE CHEM, V22, P1864, DOI 10.1021/bc2003378; Asayama S, 2014, BIOMACROMOLECULES, V15, P997, DOI 10.1021/bm401902j; Asayama S, 2007, BIOCONJUGATE CHEM, V18, P1662, DOI 10.1021/bc700205t; Asayama S, 2010, BIOCONJUGATE CHEM, V21, P646, DOI 10.1021/bc900411m; Asayama S, 2011, METALLOMICS, V3, P680, DOI 10.1039/c1mt00019e; Asayama S, 2008, MOL PHARMACEUT, V5, P898, DOI 10.1021/mp800094b; BRAHMS J, 1964, J MOL BIOL, V10, P73; Brgles M, 2012, INT J NANOMED, V7, P393, DOI 10.2147/IJN.S27471; DREW HR, 1981, P NATL ACAD SCI-BIOL, V78, P2179, DOI 10.1073/pnas.78.4.2179; Fritz A, 1998, FEBS LETT, V438, P66, DOI 10.1016/S0014-5793(98)01274-5; Huang YC, 2005, J BIOL CHEM, V280, P30349, DOI 10.1074/jbc.M505828200; Luo D., 2000, NAT BIOTECHNOL, V18, P133; Negishi Y, 2011, PHARM RES-DORDR, V28, P712, DOI 10.1007/s11095-010-0286-4; Osada K, 2005, ANGEW CHEM INT EDIT, V44, P3544, DOI 10.1002/anie.200500201; Preat J, 2011, BIOMACROMOLECULES, V12, P1298, DOI 10.1021/bm200022n; Unsworth J. M., 2003, J BIOMED MATER RES, V53, P617; Zhou JB, 2012, NAT MATER, V11, P82, DOI [10.1038/nmat3187, 10.1038/NMAT3187]	32	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1525-7797	1526-4602		BIOMACROMOLECULES	Biomacromolecules	APR	2015	16	4					1226	1231		10.1021/acs.biomac.5b00008		6	Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science	Biochemistry & Molecular Biology; Chemistry; Polymer Science	CG1AS	WOS:000353006000016		
J	Wang, Q; Qian, K; Liu, SS; Yang, YJ; Liang, B; Zheng, CS; Yang, XL; Xu, HB; Shen, AQ				Wang, Qin; Qian, Kun; Liu, Shanshan; Yang, Yajiang; Liang, Bin; Zheng, Chuansheng; Yang, Xiangliang; Xu, Huibi; Shen, Amy Q.			X-ray Visible and Uniform Alginate Microspheres Loaded with in Situ Synthesized BaSO4 Nanoparticles for in Vivo Transcatheter Arterial Embolization	BIOMACROMOLECULES			English	Article							BARIUM-SULFATE NANOPARTICLES; COMPUTED-TOMOGRAPHY; CELLULAR THERAPEUTICS; MAGNETIC-RESONANCE; MICROCAPSULES; IMMUNOPROTECTION; RADIOPACITY; PARTICLES; HYDROGELS; GEL	The lack of noninvasive tracking and mapping the fate of embolic agents has restricted the development and further applications of the transcatheter arterial embolization (TAE) therapy. In this work, inherent radiopaque embolic material, barium alginate (ALG) microspheres loaded with in situ synthesized BaSO4 (denoted as BaSO4/ALG microspheres), have been synthesized by a one-step droplet microfluidic technique. One of the advantages of our microfluidic approach is that radiopaque BaSO4 is in the form of nanoparticles and well dispersed inside ALG microspheres, thereby greatly enhancing the imaging quality. The crystal structure of in situ synthesized BaSO4 nanoparticles in ALG microspheres is confirmed by X-ray diffraction analysis. Results of in vitro and in vivo assays from digital subtraction angiography and computed tomography scans demonstrate that BaSO4/ALG microspheres possess excellent visibility under X-ray. Histopathological analysis verifies that the embolic efficacy of BaSO4/ALG microspheres is similar to that of commercially available alginate microsphere embolic agents. Furthermore, the visibility of radiopaque BaSO4/ALG microspheres under X-ray promises the direct detection of the embolic efficiency and position of embolic microspheres after embolism, which offers great promises in direct real-time in vivo investigations for TAE.	[Wang, Qin; Liu, Shanshan; Yang, Yajiang] Huazhong Univ Sci & Technol, Sch Chem & Chem Engn, Wuhan 430074, Peoples R China; [Yang, Xiangliang; Xu, Huibi] Huazhong Univ Sci & Technol, Natl Engn Res Ctr Nanomed, Wuhan 430074, Peoples R China; [Qian, Kun; Liang, Bin; Zheng, Chuansheng] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Radiol, Wuhan 430022, Peoples R China; [Shen, Amy Q.] Okinawa Inst Sci & Technol Grad Univ, Micro Bio Nanofluid Unit, Kunigami, Okinawa, Japan; [Shen, Amy Q.] Univ Washington, Mech Engn, Seattle, WA 98195 USA	Yang, YJ (reprint author), Huazhong Univ Sci & Technol, Sch Chem & Chem Engn, Wuhan 430074, Peoples R China.	yjyang@hust.edu.cn; amy.shen@oist.jp	Shen, Amy/B-5981-2015	Shen, Amy/0000-0002-1222-6264	National Natural Science Foundation of China [51103051]; National Basic Research Program of China [2012CB932500]; Cabinet Office, Government of Japan	This work was financially supported by the National Natural Science Foundation of China (51103051) and National Basic Research Program of China (2012CB932500). We thank the Analytical and Testing Center in Huazhong University of Science and Technology for the related measurements. A.Q.S. also thanks the OIST Graduate University for subsidy funding from the Cabinet Office, Government of Japan.	Agency for Toxic Substances and Disease Registry, 2007, TOX PROF BAR BAR COM; HANELT M, 1994, MYCOPATHOLOGIA, V128, P167, DOI 10.1007/BF01138479; Becker TA, 2005, NEUROSURGERY, V56, P793, DOI 10.1227/01.NEU.0000156494.94675.BB; Shen Y, 2007, J CHEM SCI, V119, P319, DOI 10.1007/s12039-007-0043-3; Mazutis L, 2013, NAT PROTOC, V8, P870, DOI 10.1038/nprot.2013.046; Lewis AL, 2006, J VASC INTERV RADIOL, V17, P335, DOI 10.1097/01.RVI.0000195323.46152.B3; Barnett BP, 2011, NAT PROTOC, V6, P1142, DOI 10.1038/nprot.2011.352; Kim HC, 2013, FIBER POLYM, V14, P292, DOI 10.1007/s12221-013-0292-3; Saralidze K, 2007, BIOMATERIALS, V28, P2457, DOI 10.1016/j.biomaterials.2006.12.031; Mawad D, 2008, BIOMACROMOLECULES, V9, P263, DOI 10.1021/bm700754m; Osuga K, 2012, INT J CLIN ONCOL, V17, P306, DOI 10.1007/s10147-012-0445-1; Becker TA, 2001, J BIOMED MATER RES, V54, P76, DOI 10.1002/1097-4636(200101)54:1<76::AID-JBM9>3.0.CO;2-V; Arifin DR, 2012, BIOMATERIALS, V33, P4681, DOI 10.1016/j.biomaterials.2012.03.008; Bendszus M, 2000, AM J NEURORADIOL, V21, P255; Barnett BP, 2006, MOL PHARMACEUT, V3, P531, DOI [10.1021/mp060056l, 10.1021/mp0600561]; Wang Q, 2013, GREEN CHEM, V15, P2222, DOI 10.1039/c3gc40728d; Sharma KV, 2010, J VASC INTERV RADIOL, V21, P865, DOI 10.1016/j.jvir.2010.02.031; Brule S, 2011, ADV MATER, V23, P787, DOI 10.1002/adma.201003763; Bartling SH, 2011, INVEST RADIOL, V46, P178, DOI 10.1097/RLI.0b013e318205af53; Rabin O, 2006, NAT MATER, V5, P118, DOI 10.1038/nmat1571; Barnett BP, 2011, J VASC INTERV RADIOL, V22, P203, DOI 10.1016/j.jvir.2010.10.010; Boelen EJH, 2005, BIOMATERIALS, V26, P6674, DOI 10.1016/j.biomaterials.2005.04.020; Jo HW, 2013, POLYM-KOREA, V37, P563, DOI 10.7317/pk.2013.37.5.563; Killer M, 2011, NEURORADIOLOGY, V53, P449, DOI 10.1007/s00234-010-0744-z; Killer M, 2009, AM J NEURORADIOL, V30, P1488, DOI [10.3174/ajnr.A1649, 10.3174/ajnr.A1549]; Lazzaro MA, 2011, FRONT NEUROL, V2, P1; Liang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076388; McCoy MR, 2010, EUR RADIOL, V20, P870, DOI 10.1007/s00330-009-1604-2; Sommer CM, 2013, INVEST RADIOL, V48, P213, DOI 10.1097/RLI.0b013e31827f6598; van Hooy-Corstjens CSJ, 2008, BIOMACROMOLECULES, V9, P84, DOI 10.1021/bm7008334; Wang Q, 2012, LAB CHIP, V12, P4781, DOI 10.1039/c2lc40740j; Xu F, 2011, ACTA NEUROCHIR, V153, P869, DOI 10.1007/s00701-010-0848-6; Zhao H, 2013, AM J NEURORADIOL, V34, P169, DOI 10.3174/ajnr.A3177	33	1	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1525-7797	1526-4602		BIOMACROMOLECULES	Biomacromolecules	APR	2015	16	4					1240	1246		10.1021/acs.biomac.5b00027		7	Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science	Biochemistry & Molecular Biology; Chemistry; Polymer Science	CG1AS	WOS:000353006000018		
J	Hayashi, T; Takasu, A				Hayashi, Terunari; Takasu, Akinori			Design of Electrophoretic and Biocompatible Poly(2-oxazoline)s Initiated by Perfluoroalkanesulfoneimides and Electrophoretic Deposition with Bioactive Glass	BIOMACROMOLECULES			English	Article							RING-OPENING POLYMERIZATION; COMPOSITE COATINGS; STAINLESS-STEEL; BIOGLASS(R); CHEMISTRY; ETHERS; ACID; PEEK	N-Methyl bis[(nonafluorobutane)sulfonyl]imide (Nf(2)NMe) was synthesized to serve as an initiator for polymerization of 2-oxazolines and the polymerization activity and control of molecular weight were compared with conventional methyl triflate (TfOMe). Ring-opening polymerization of the vinyl-containing 2-oxazoline, 2-(3-butenyl)-2-oxazoline, and a subsequent thiol-ene click reaction and oxidation resulted in the successful synthesis of electrophoretic poly(2-oxazoline)s containing pendent sulfone. It was possible to coat the polymeric sulfones obtained via oxone oxidation (conversion, >99%) on a stainless-steel anode selectively. Furthermore, hybridization of the poly(2-oxazoline)s with bioactive glass (Bioglass45S5) by electrophoretic deposition (EPD) was investigated, and the biocompatibility of the hybrid was also evaluated.	[Hayashi, Terunari; Takasu, Akinori] Nagoya Inst Technol, Grad Sch Engn, Dept Frontier Mat, Showa Ku, Nagoya, Aichi 4668555, Japan	Takasu, A (reprint author), Nagoya Inst Technol, Grad Sch Engn, Dept Frontier Mat, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.	takasu.akinori@nitech.ac.jp			Ministry of Education, Science, and Culture of Japan [24550132]	This work was funded by the Ministry of Education, Science, and Culture of Japan (Grant-in-Aid for Development Scientific Research, No. 24550132). The authors are grateful to Professor Aldo R. Boccaccin, Institute of Biomaterials, University of Erlangen-Nurnberg, for providing Bioglass45S5 and fruitful discussions.	Hruby M, 2010, MACROMOL BIOSCI, V10, P916, DOI 10.1002/mabi.201000034; Gaertner FC, 2007, J CONTROL RELEASE, V119, P291, DOI 10.1016/j.jconrel.2007.02.015; Rodriguez HH, 2008, CERAM INT, V34, P1303, DOI 10.1016/j.ceramint.2007.03.002; Luxenhofer R, 2012, MACROMOL RAPID COMM, V33, P1613, DOI 10.1002/marc.201200354; Corni I, 2009, SURF COAT TECH, V203, P1349, DOI 10.1016/j.surfcoat.2008.11.005; Roether JA, 2002, BIOMATERIALS, V23, P3871, DOI 10.1016/S0142-9612(02)00131-X; Gress A, 2007, MACROMOLECULES, V40, P7928, DOI 10.1021/ma071357r; Guo LJ, 2007, ADV MATER, V19, P495, DOI 10.1002/adma.200600882; BASSIRI TG, 1967, J POLYM SCI POL LETT, V5, P871, DOI 10.1002/pol.1967.110050927; Xiao XF, 2006, MATER LETT, V60, P2627, DOI 10.1016/j.matlet.2006.01.048; Sarkar P, 1996, J AM CERAM SOC, V79, P1987, DOI 10.1111/j.1151-2916.1996.tb08929.x; Luxenhofer R, 2006, MACROMOLECULES, V39, P3509, DOI 10.1021/ma052515m; Tang T, 2015, RSC ADV, V5, P819, DOI 10.1039/c4ra13020k; Boccaccini AR, 2006, J MATER SCI, V41, P8152, DOI 10.1007/s10853-006-0556-z; Pishbin F, 2011, SURF COAT TECH, V205, P5260, DOI 10.1016/j.surfcoat.2011.05.026; Van der Biest OO, 1999, ANNU REV MATER SCI, V29, P327, DOI 10.1146/annurev.matsci.29.1.327; Hussain H, 2013, CHEM REV, V113, P3329, DOI 10.1021/cr3004373; Lee SW, 2004, NANO LETT, V4, P387, DOI 10.1021/nl034911t; Seuss S, 2013, BIOMACROMOLECULES, V14, P3355, DOI 10.1021/bm401021b; Hoogenboom R, 2007, MACROMOL CHEM PHYSIC, V208, P18, DOI 10.1002/macp.200600558; Niko Y, 2012, MACROMOLECULES, V45, P2327, DOI 10.1021/ma3001252; Boccaccini A., 2010, J R SOC INTERFACE, V7, P581; Boccaccini A.R, 2002, SOLID STATE MAT SCI, V6, P251; Cortez MA, 2010, MACROMOLECULES, V43, P4081, DOI 10.1021/ma9028294; Dworak A, 1997, POLYM BULL, V38, P7, DOI 10.1007/s002890050012; Fukuoka T., 2014, RSC ADV, V31, P15983; Gabriel S, 1889, BER, V22, P1139, DOI 10.1002/cber.188902201248; Gastillo J., 2009, INTEGR BIOL, V1, P30; Glassner M., 2015, EUR POLYM J, DOI [10.1016/j.eurpolymj.2015.01.019., DOI 10.1016/J.EURP0LYMJ.2015.01.019]; GODDARD P, 1989, Journal of Controlled Release, V10, P5, DOI 10.1016/0168-3659(89)90013-8; Harsany E., 1933, U.S. Patent, Patent No. 1897902; Hayashi T., 2014, POLYM PREPR AM CHEM; Honda T., 2010, Japan Patent, Patent No. [2010/002345, 0023452010]; Hoogenboom R, 2009, ANGEW CHEM INT EDIT, V48, P7978; KAGIYA T, 1966, J POLYM SCI POL LETT, V4, P441, DOI 10.1002/pol.1966.110040701; Kameyama T., 2014, POLYM PREPR AM CHEM; KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607; Lava K., 2015, EUR POLYM J, DOI DOI 10.1016/J.EURP0LYMJ.2015.01.014; LIN PY, 1988, J POLYM SCI POL PHYS, V26, P603, DOI 10.1002/polb.1988.090260312; Ma R, 2011, J ALLOY COMPD, V509, pS510, DOI 10.1016/j.jallcom.2010.10.111; Moyori T, 2013, J POLYM SCI POL CHEM, V51, P3516, DOI 10.1002/pola.26753; Moyori T, 2012, BIOMACROMOLECULES, V13, P1240, DOI 10.1021/bm300231d; Nagao Y, 2012, MACROMOLECULES, V45, P3326, DOI 10.1021/ma300396p; Oshimura M, 2011, J POLYM SCI POL CHEM, V49, P1210, DOI 10.1002/pola.24539; Paulus RM, 2008, MACROMOL CHEM PHYSIC, V209, P794, DOI 10.1002/macp.200700506; Takasu A., 2010, POLYM J SCI A, V48, P5953; Takasu A., 2015, ENCY POLYM IN PRESS; Tang T., 2012, MACROMOLECULES, V46, P5464; TOMALIA DA, 1966, J POLYM SCI A1, V4, P2253, DOI 10.1002/pol.1966.150040919; Uematsu Y, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.022303; Wang Y, 2011, J COLLOID INTERF SCI, V362, P367, DOI 10.1016/j.jcis.2011.07.007	51	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1525-7797	1526-4602		BIOMACROMOLECULES	Biomacromolecules	APR	2015	16	4					1259	1266		10.1021/acs.biomac.5b00043		8	Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science	Biochemistry & Molecular Biology; Chemistry; Polymer Science	CG1AS	WOS:000353006000020		
J	Hayakawa, N; Fukumura, J; Yasuno, H; Fujimoto-Ouchi, K; Kitamura, H				Hayakawa, Naohiko; Fukumura, Junko; Yasuno, Hideyuki; Fujimoto-Ouchi, Kaori; Kitamura, Hidemitsu			1 alpha,25(OH)(2)D-3 downregulates gene expression levels of muscle ubiquitin ligases MAFbx and MuRF1 in human myotubes	BIOMEDICAL RESEARCH-TOKYO			English	Article							RANDOMIZED CONTROLLED-TRIALS; HUMAN SKELETAL-MUSCLE; NECROSIS-FACTOR-ALPHA; VITAMIN-D; TRANSCRIPTION FACTORS; ATROPHY; INTERLEUKIN-6; ACTIVATION; KINASE; CELLS	Clinical trials involving in patients with osteoporosis have reported that activated vitamin D-3 (1 alpha,25(OH)(2)D-3, calcitriol) can prevent falling by acting on the skeletal muscles. However, pharmacological mechanisms of 1 alpha,25(OH)(2)D-3 with respect to skeletal muscle hypertrophy or atrophy are still poorly understood. Therefore, we examined changes in the expression of several related genes in human myotubes to test whether 1 alpha,25(OH)(2)D-3 influences hypertrophy and atrophy of skeletal muscle. Myotubes treated with 1 alpha,25(OH)(2)D-3 increased interleukin-6 (IL-6) expression and inhibited expression of tumor necrosis factor alpha (TNF-alpha), whereas the expression of insulin-like growth factor-1 (IGF-1) that is involved in muscle hypertrophy was not affected. However, 1 alpha,25(OH)(2)D-3 treatment significantly inhibited the expression of muscle atrophy F-box (MAFbx) and muscle RING finger 1 (MuRF1), ubiquitin ligases involved in muscle atrophy. The analysis of pathways using microarray data suggested that 1 alpha,25(OH)(2)D-3 upregulates AKT-1 by inhibiting the expression of protein phosphatase 2 (PP2A), a phosphatase acting on AKT-1, in the phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway, thereby inhibiting the expression of ubiquitin ligases. Thus, this study showed that 1 alpha,25(OH)(2)D-3 might have an inhibitory effect on the expression of MAFbx and MuRF1 in skeletal muscle and a suppressive effect on muscle degradation in patients with osteoporosis.	[Hayakawa, Naohiko; Fukumura, Junko; Yasuno, Hideyuki; Fujimoto-Ouchi, Kaori] Chugai Pharmaceut Co Ltd, Kamakura Res Labs, Prod Res Dept, Kamakura, Kanagawa 2478530, Japan; [Kitamura, Hidemitsu] Hokkaido Univ, Inst Med Genet, Div Funct Immunol, Kita Ku, Sapporo, Hokkaido 0600815, Japan	Kitamura, H (reprint author), Hokkaido Univ, Inst Med Genet, Div Funct Immunol, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0600815, Japan.	kitamura@igm.hokudai.ac.jp					Ameri P, 2013, EUR J ENDOCRINOL, V169, P767, DOI 10.1530/EJE-13-0510; He CC, 2012, NATURE, V481, P511, DOI 10.1038/nature10758; Bischoff-Ferrari HA, 2005, JAMA-J AM MED ASSOC, V293, P2257, DOI 10.1001/jama.293.18.2257; Bischoff-Ferrari HA, 2004, JAMA-J AM MED ASSOC, V291, P1999, DOI 10.1001/jama.291.16.1999; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Ramm G, 2006, J BIOL CHEM, V281, P29174, DOI 10.1074/jbc.M603274200; Girgis CM, 2014, ENDOCRINOLOGY, V155, P347, DOI 10.1210/en.2013-1205; Faulkner KA, 2006, OSTEOPOROSIS INT, V17, P1318, DOI 10.1007/s00198-006-0071-8; Munoz-Canoves P, 2013, FEBS J, V280, P4131, DOI 10.1111/febs.12338; Cossu G, 1999, EMBO J, V18, P6867, DOI 10.1093/emboj/18.24.6867; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Moylan JS, 2008, AM J PHYSIOL-CELL PH, V295, pC986, DOI 10.1152/ajpcell.00041.2008; Steensberg A, 2002, AM J PHYSIOL-ENDOC M, V283, pE1272, DOI 10.1152/ajpendo.00255.2002; Hoene M, 2013, AM J PHYSIOL-CELL PH, V304, pC128, DOI 10.1152/ajpcell.00025.2012; Sakuma K, 2015, PFLUG ARCH EUR J PHY, V467, P213, DOI 10.1007/s00424-014-1527-x; Meeker S, 2014, CANCER RES, V74, P4398, DOI 10.1158/0008-5472.CAN-13-2820; Chang NC, 2012, HUM MOL GENET, V21, P2277, DOI 10.1093/hmg/dds048; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Glass DJ, 2010, CURR TOP MICROBIOL, V346, P267, DOI 10.1007/82_2010_78; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Michaud M, 2013, J AM MED DIR ASSOC, V14, P877, DOI 10.1016/j.jamda.2013.05.009; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Endo I, 2003, ENDOCRINOLOGY, V144, P5138, DOI 10.1210/en.2003-0502; Choi M, 2013, CYTOKINE, V63, P27, DOI 10.1016/j.cyto.2013.03.018; Li YP, 2005, FASEB J, V19, P362, DOI 10.1096/fj.04-2364com; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Sishi BJN, 2011, CYTOKINE, V54, P173, DOI 10.1016/j.cyto.2011.01.009; Reid MB, 2001, RESPIR RES, V2, P269, DOI 10.1186/rr67; Castillero E, 2013, METABOLISM, V62, P1495, DOI 10.1016/j.metabol.2013.05.018; Brandt C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/520258; Buitrago C, 2000, J CELL BIOCHEM, V79, P274, DOI 10.1002/1097-4644(20001101)79:2<274::AID-JCB100>3.0.CO;2-R; Buitrago C, 2013, J STEROID BIOCHEM, V136, P125, DOI 10.1016/j.jsbmb.2013.02.013; Bischoff-Ferrari HA, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3692; Dukas L, 2010, ARZNEIMITTEL-FORSCH, V60, P519, DOI 10.1055/s-0031-1296321; Grounds MD, 2002, BIOGERONTOLOGY, V3, P19, DOI 10.1023/A:1015234709314; Heo Yong-Seok, 2004, EMBO (European Molecular Biology Organization) Journal, V23, P2185, DOI 10.1038/sj.emboj.7600212; Howlett KF, 2007, DIABETES, V56, P1608, DOI 10.2337/db06-1398; Mori A, 2013, CLIN DRUG INVEST, V33, P837, DOI 10.1007/s40261-013-0132-7; Pratesi Alessandra, 2013, Clin Cases Miner Bone Metab, V10, P11, DOI 10.11138/ccmbm/2013.10.1.011; Sakai S, 2015, J BONE MINER RES, V30, P128, DOI 10.1002/jbmr.2317; Salles J, 2013, MOL NUTR FOOD RES, V57, P2137, DOI 10.1002/mnfr.201300074; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Strle K, 2006, ENDOCRINOLOGY, V147, P4363, DOI 10.1210/en.2005-1541; Ugi S, 2004, MOL CELL BIOL, V24, P8778, DOI 10.1128/MCB.24.19.8778-8789.2004; Wu W, 2007, CANCER LETT, V254, P75, DOI 10.1016/j.canlet.2007.02.013	45	0	0	BIOMEDICAL RESEARCH PRESS LTD	SAPPORO	HOKKAIDO UNIV, LAB HISTOLOGY & CYTOLOGY, C/O TOSHIHIKO IWANAGA, KITA 15-NISHI 7, SAPPORO, 060-8638, JAPAN	0388-6107	1880-313X		BIOMED RES-TOKYO	Biomed. Res.	APR	2015	36	2					71	80				10	Medicine, Research & Experimental	Research & Experimental Medicine	CG5FA	WOS:000353315300001		
J	Okudera, Y; Matsunaga, T; Sato, M; Chida, S; Hatakeyama, K; Watanabe, M; Shimada, Y				Okudera, Yoshihiko; Matsunaga, Toshiki; Sato, Mineyoshi; Chida, Satoaki; Hatakeyama, Kazutoshi; Watanabe, Motoyuki; Shimada, Yoichi			The impact of high-frequency magnetic stimulation of peripheral nerves: muscle hardness, venous blood flow, and motor function of upper extremity in healthy subjects	BIOMEDICAL RESEARCH-TOKYO			English	Article							ELECTRICAL-STIMULATION; ELASTOGRAPHY; PLASTICITY; THROMBOSIS; THERAPY; CORTEX	The purpose of this study was to investigate the impact of high-frequency peripheral nerve magnetic stimulation on the upper limb function. Twenty-five healthy adults (16 men and 9 women) participated in this study. The radial nerve of the non-dominant hand was stimulated by high-frequency magnetic stimulation device. A total of 600 impulses were applied at a frequency of 20 Hz and intensity of 1.2 resting motor threshold (rMT). At three time points (before, immediately after, and 15 min after stimulation), muscle hardness of the extensor digitorum muscle on the stimulated side was measured using a mechanical tissue hardness meter and a shear wave imaging device, cephalic venous blood flow on the stimulated side was measured using an ultrasound system, and the Box and Block test (BBT) was performed. Mechanical tissue hardness results did not show any significant differences between before, immediately after, and 15 min after stimulation. Measurements via shear wave imaging showed that muscle hardness significantly decreased both immediately and 15 min after stimulation compared to before stimulation (P < 0.05). Peripheral venous blood flow and BBT score significantly increased both immediately and 15 min after stimulation compared to before stimulation (P < 0.01). High-frequency peripheral nerve magnetic stimulation can achieve effects similar to electrical stimulation in a less invasive manner, and may therefore become an important element in next-generation rehabilitation.	[Okudera, Yoshihiko; Shimada, Yoichi] Akita Univ, Grad Sch Med, Dept Orthoped Surg, Akita 0108543, Japan; [Matsunaga, Toshiki; Sato, Mineyoshi; Chida, Satoaki; Hatakeyama, Kazutoshi; Watanabe, Motoyuki] Akita Univ Hosp, Dept Rehabil Med, Akita 0108543, Japan	Okudera, Y (reprint author), Akita Univ, Grad Sch Med, Dept Orthoped Surg, 1-1-1 Hondo, Akita 0108543, Japan.	one.punc@gmail.com					Panouilleres M, 2012, HUM BRAIN MAPP, V33, P1512, DOI 10.1002/hbm.21301; Sasaki K, 2012, BIOMED RES-TOKYO, V33, P89; BARKER AT, 1987, NEUROSURGERY, V20, P100; Nightingale K, 2003, ULTRASOUND MED BIOL, V29, P1715, DOI 10.1016/j.ultrasmedbio.2003.08.008; Hou LL, 2013, CANCER NURS, V36, P139, DOI 10.1097/NCC.0b013e3182483415; MASON JL, 1976, IEEE T BIO-MED ENG, V23, P405, DOI 10.1109/TBME.1976.324652; Ridding MC, 2000, EXP BRAIN RES, V131, P135, DOI 10.1007/s002219900269; RENSTROM P, 1985, SPORTS MED, V2, P316; Takeuchi N, 2008, J REHABIL MED, V40, P298, DOI 10.2340/16501977-0181; Tanter M, 2008, ULTRASOUND MED BIOL, V34, P1373, DOI 10.1016/j.ultrasmedbio.2008.02.002; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Wu CWH, 2005, NEUROIMAGE, V27, P872, DOI 10.1016/j.neuroimage.2005.05.055; Ferraioli G, 2014, J ULTRAS MED, V33, P197, DOI 10.7863/ultra.33.2.197; Athanasiou A, 2010, RADIOLOGY, V256, P297, DOI 10.1148/radiol.10090385; Czyrny JJ, 2010, VASCULAR, V18, P20, DOI 10.2310/6670.2010.00001; Kogo H, 2010, J PHYS THER SCI, V22, P173; COLES DR, 1957, J APPL PHYSIOL, V10, P461; Koesler TB, 2009, J NEUROL NEUROSUR PS, V80, P614; MATHIOWETZ V, 1985, AM J OCCUP THER, V39, P386; Matsunaga T, 2007, AKITA J MED, V34, P137; Poison MJ, 1982, MED BIOL ENG COMPUT, V20, P243; Sakuraba T, 2005, BIOMED RES-TOKYO, V26, P15, DOI 10.2220/biomedres.26.15; Sandberg ML, 2007, PHYS THER, V87, P1047, DOI 10.2522/ptj.20060178; Shimada Y, 1996, ARCH PHYS MED REHAB, V77, P1014, DOI 10.1016/S0003-9993(96)90061-1; Shimada Y, 1996, SPINAL CORD, V34, P615; Struppler A, 2007, NEUROIMAGE S2, V36, P174; Warwick DJ, 2013, BONE JOINT RES, V2, P179, DOI 10.1302/2046-3758.29.2000176	27	0	0	BIOMEDICAL RESEARCH PRESS LTD	SAPPORO	HOKKAIDO UNIV, LAB HISTOLOGY & CYTOLOGY, C/O TOSHIHIKO IWANAGA, KITA 15-NISHI 7, SAPPORO, 060-8638, JAPAN	0388-6107	1880-313X		BIOMED RES-TOKYO	Biomed. Res.	APR	2015	36	2					81	87				7	Medicine, Research & Experimental	Research & Experimental Medicine	CG5FA	WOS:000353315300002		
J	Seino, H; Wu, YY; Morohashi, S; Kawamoto, T; Fujimoto, K; Kato, Y; Takai, Y; Kijima, H				Seino, Hiroko; Wu, Yunyan; Morohashi, Satoko; Kawamoto, Takeshi; Fujimoto, Katsumi; Kato, Yukio; Takai, Yoshihiro; Kijima, Hiroshi			Basic helix-loop-helix transcription factor DEC1 regulates the cisplatin-induced apoptotic pathway of human esophageal cancer cells	BIOMEDICAL RESEARCH-TOKYO			English	Article							ACTIVATION; EXPRESSION; RESISTANCE; STRA13; INHIBITION; INDUCTION; CASPASE-9; PROTEINS	DEC1 [basic helix-loop-helix (BHLH) E40/Stra13/Sharp2] and DEC2 (BHLHE41/Sharpl) are BHLH transcription factors that are associated with the regulation of apoptosis, cell proliferation, and circadian rhythms, as well as malignancy in various cancers. However, the roles of DEC1 and DEC2 expression in esophageal cancer are poorly understood. In this study, we examined the roles of DEC1 and DEC2 in human esophageal cancer TE 5 and TE 10 cells that had been treated with cis-diamminedichloroplatinum (II) (cisplatin: CDDP). Expression of DEC1 and DEC2 was de, creased with CDDP treatment in TE 5 cells; however, knockdown or overexpression of DEC1/ DEC2 had little effects on CDDP-induced apoptosis in TE 5 cells. DEC1 expression was up-regulated in CDDP-treated TE 10 cells, whereas DEC2 expression was unchanged. DEC1 knockdown by siRNA in TE 10 decreased the amount of cleaved poly (ADP-ribose) polymerase (PARP) after treatment with CDDP, whereas DEC2 knockdown had no effects on the amount of cleaved PARP in both the presence and absence of CDDP. We also demonstrated that DEC1 overexpression promoted cleaved PARP expression, whereas DEC2 overexpression had no effects on the amount of cleaved PARP in TE 10 cells. These results suggested that DEC1 has pro-apoptotic effects on human esophageal cancer TE 10 cells of well-differentiated type.	[Seino, Hiroko; Wu, Yunyan; Morohashi, Satoko; Kijima, Hiroshi] Hirosaki Univ, Grad Sch Med, Dept Pathol & Biosci, Hirosaki, Aomori 0368562, Japan; [Kawamoto, Takeshi; Fujimoto, Katsumi; Kato, Yukio] Hiroshima Univ, Grad Sch Biomed Sci, Dept Dent & Med Biochem, Hiroshima 7348553, Japan; [Takai, Yoshihiro] Hirosaki Univ, Grad Sch Med, Dept Radiol, Hirosaki, Aomori 0368562, Japan; [Takai, Yoshihiro] Hirosaki Univ, Grad Sch Med, Dept Radiat Oncol, Hirosaki, Aomori 0368562, Japan	Kijima, H (reprint author), Hirosaki Univ, Grad Sch Med, Dept Pathol & Biosci, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.	hkijima@cc.hirosaki-u.ac.jp	Kawamoto, Takeshi/D-7938-2015	Kawamoto, Takeshi/0000-0003-3337-1775	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grant for Hirosaki University Institutional Research; Fund for Promotion of International Scientific Research	This study was supported by Grants-in-Aid for Science from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, a Grant for Hirosaki University Institutional Research, and the Fund for the Promotion of International Scientific Research.	Liu Y, 2010, GENES CELLS, V15, P315, DOI 10.1111/j.1365-2443.2010.01381.x; Kon N, 2008, NAT CELL BIOL, V10, P1463, DOI 10.1038/ncb1806; Brozovic A, 2007, CANCER LETT, V251, P1, DOI 10.1016/j.canlet.2006.10.007; Yamada K, 2003, J BIOL CHEM, V278, P30719, DOI 10.1074/jbc.M301597200; McDonnell MA, 2003, CELL DEATH DIFFER, V10, P1005, DOI 10.1038/sj.cdd.4401271; Miyazaki K, 2002, J BIOL CHEM, V277, P47014, DOI 10.1074/jbc.M204938200; Shinagawa A, 2011, INT J ONCOL, V39, P1359, DOI 10.3892/ijo.2011.1134; Wu YY, 2011, INT J MOL MED, V27, P491, DOI 10.3892/ijmm.2011.617; Wu YY, 2012, BIOMED RES-TOKYO, V33, P75; Li YX, 2002, BIOCHEM J, V367, P413, DOI 10.1042/BJ20020514; Yuan ZQ, 2003, J BIOL CHEM, V278, P23432, DOI 10.1074/jbc.M302674200; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Giatromanolaki A, 2003, J PATHOL, V200, P222, DOI 10.1002/path.1330; Berman DM, 1998, J BIOL CHEM, V273, P1269, DOI 10.1074/jbc.273.3.1269; Konstantakou EG, 2009, INT J ONCOL, V35, P401, DOI 10.3892/ijo_00000353; Bhawal UK, 2011, J PATHOL, V224, P420, DOI 10.1002/path.2878; Sato F, 2008, GENES CELLS, V13, P131, DOI 10.1111/j.1365-2443.2007.01153.x; Jiang XJ, 2000, J BIOL CHEM, V275, P31199, DOI 10.1074/jbc.C000405200; Chakrabarti J, 2004, BRIT J CANCER, V91, P954, DOI 10.1038/sj.bjc.6602059; Baba Yoshifumi, 2014, World J Gastrointest Oncol, V6, P121, DOI 10.4251/wjgo.v6.i5.121; Ding ZH, 2000, BIOCHEM BIOPH RES CO, V270, P415, DOI 10.1006/bbrc.2000.2432; GLOBOCAN, 2012, EST CANC INC MORT PR; Kondo J, 2006, INT J MOL MED, V17, P1053; LAMARCHE N, 1994, TRENDS GENET, V10, P436, DOI 10.1016/0168-9525(94)90114-7; Sato F, 2011, EUR J CANCER, V47, P1747, DOI 10.1016/j.ejca.2011.02.025; Thin TH, 2007, EMBO REP, V8, P401, DOI 10.1038/sj.embor.7400912	26	0	0	BIOMEDICAL RESEARCH PRESS LTD	SAPPORO	HOKKAIDO UNIV, LAB HISTOLOGY & CYTOLOGY, C/O TOSHIHIKO IWANAGA, KITA 15-NISHI 7, SAPPORO, 060-8638, JAPAN	0388-6107	1880-313X		BIOMED RES-TOKYO	Biomed. Res.	APR	2015	36	2					89	96				8	Medicine, Research & Experimental	Research & Experimental Medicine	CG5FA	WOS:000353315300003		
J	Tanabe, K; Inui, S				Tanabe, Kano; Inui, Seiji			Dominant negative form of alpha4 inhibits the BCR crosslinking-induced phosphorylation of Bcl-xL and apoptosis in an immature B cell line WEHI-231	BIOMEDICAL RESEARCH-TOKYO			English	Article							PROTEIN PHOSPHATASE 2A; SIGNAL-TRANSDUCTION; DEATH; LYMPHOCYTES; BCL-X(L); SUBUNIT; KINASES; PATHWAY	We previously demonstrated that c-Jun N-telininal kinase (INK) phosphorylates serine 62 of Bcl-xL to induce the degradation of Bcl-xL and apoptosis in WEHI-231 cells upon BCR crosslinking In order to elucidate the regulatory mechanisms underlying the phosphorylation of Bcl-xL, we prepared an assay system in which INK phosphorylated Bcl-xL in HEK293T cells. Consequently, we found that a signal transduction molecule, alpha4, enhanced the phosphorylation of Bcl-xL by INK, while the co-expression of C-terminal alpha4 (220-340) diminished the phosphorylation of Bcl-xL induced by INK. Furthelinore, full-length alpha4 associated with both INK and Bcl-xL, whereas C-terminal alpha4 (220-340) associated only with Bcl-xL, not INK. In addition, WEHI-231 cells transfected with the cDNA of C-terminal alpha4 (220-340) exhibited decreased phosphorylation of Bcl-xL and stronger resistance to apoptosis induced by BCR crosslinking These results indicate that alpha4 is an important regulatory molecule of apoptosis induced by BCR crosslinking in WEHI-231 cells and that C-terminal alpha4 (220-340) functions as a dominant negative form.	[Tanabe, Kano; Inui, Seiji] Kumamoto Univ, Fac Life Sci, Grad Sch Hlth Sci, Dept Immunol & Hematol, Kumamoto 860, Japan	Inui, S (reprint author), Kumamoto Univ, Fac Life Sci, Grad Sch Hlth Sci, Dept Immunol & Hematol, Kumamoto 860, Japan.	inui@kumamoto-u.ac.jp					Healy JI, 1998, ANNU REV IMMUNOL, V16, P645, DOI 10.1146/annurev.immunol.16.1.645; Rincon M, 1998, J EXP MED, V188, P1817, DOI 10.1084/jem.188.10.1817; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Kajihara R, 2014, J IMMUNOL, V192, P5720, DOI 10.4049/jimmunol.1302643; FANG W, 1995, J IMMUNOL, V155, P66; SUTTON A, 1991, MOL CELL BIOL, V11, P2133; Stefansson B, 2006, J BIOL CHEM, V281, P22624, DOI 10.1074/jbc.M601772200; Kong M, 2004, SCIENCE, V306, P695, DOI 10.1126/science.1100537; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Chen J, 1998, BIOCHEM BIOPH RES CO, V247, P827, DOI 10.1006/bbrc.1998.8792; Du LH, 2005, ONCOGENE, V24, P107, DOI 10.1038/sj.onc.1208189; INUI S, 1995, J IMMUNOL, V154, P2714; Inui S, 1998, BLOOD, V92, P539; Kajihara R, 2010, BIOCHEM BIOPH RES CO, V401, P350, DOI 10.1016/j.bbrc.2010.09.051; Maeda K, 1999, EUR J BIOCHEM, V264, P702, DOI 10.1046/j.1432-1327.1999.00571.x; King LB, 2000, IMMUNOL REV, V176, P86; Rothstein TL, 1996, CURR OPIN IMMUNOL, V8, P362, DOI 10.1016/S0952-7915(96)80126-9; Sakata A, 1999, IMMUNOL LETT, V68, P301, DOI 10.1016/S0165-2478(99)00053-X; Sun HP, 2012, PHYSIOLOGY, V27, P43, DOI 10.1152/physiol.00034.2011; Yi AK, 1996, J IMMUNOL, V157, P4918	21	0	0	BIOMEDICAL RESEARCH PRESS LTD	SAPPORO	HOKKAIDO UNIV, LAB HISTOLOGY & CYTOLOGY, C/O TOSHIHIKO IWANAGA, KITA 15-NISHI 7, SAPPORO, 060-8638, JAPAN	0388-6107	1880-313X		BIOMED RES-TOKYO	Biomed. Res.	APR	2015	36	2					97	102				6	Medicine, Research & Experimental	Research & Experimental Medicine	CG5FA	WOS:000353315300004		
J	Ishiguro-Oonuma, T; Ochiai, K; Hashizume, K; Morimatsu, M				Ishiguro-Oonuma, Toshina; Ochiai, Kazuhiko; Hashizume, Kazuyoshi; Morimatsu, Masami			The role of IFN-gamma in regulating Nfkbiz expression in epidermal keratinocytes	BIOMEDICAL RESEARCH-TOKYO			English	Article							NF-KAPPA-B; GENE-EXPRESSION; CXCL10 GENE; PROTEIN; MAIL; INTERFERON; ZETA; DISRUPTION; IL-1-BETA; RECEPTORS	Nfkbiz is an inhibitor of nuclear factor KB (IkB) protein localized to the nucleus. We previously found that Nfkbiz gene-disrupted mice showed atopic dermatitis-like lesion, implying the important role of Nfkbiz in skin homeostasis. The purpose of this study was to examine the effect of interferon (IFN)-gamma on Nfkbiz expression in keratinocytes. IFN-gamma induced Nfkbiz expression at a comparable level to IL-1. Promoter analysis revealed that interferon-stimulated response element (ISRE) located in the Nfkbiz promoter region is important for responding to the stimulation. Interestingly, IFN-gamma and IL-1 displayed synergism in terms of inducing Nfkbiz expression. By using selective inhibitors, we found that Janus activated kinase (JAK) 1 and nuclear factor (NF)-kB are important for Nfkbiz expression after IFN-gamma stimulation and for synergism between IFN-gamma and ILL These findings indicate a possible important role of Nfkbiz in modulating the progression of inflammatory diseases in which IFN-gamma and IL-1 are abundant.	[Ishiguro-Oonuma, Toshina] Ehime Univ, Integrated Ctr Sci, Dept Biol Resources, Matsuyama, Ehime 7910295, Japan; [Ochiai, Kazuhiko] Nippon Vet & Life Sci Univ, Sch Vet Sci, Dept Vet Nursing & Technol, Tokyo 1808602, Japan; [Hashizume, Kazuyoshi] Iwate Univ, Fac Agr, Codept Vet Med, Vet Physiol Lab, Morioka, Iwate 0208550, Japan; [Morimatsu, Masami] Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Lab Lab Anim Sci & Med, Sapporo, Hokkaido 0600818, Japan	Morimatsu, M (reprint author), Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Lab Lab Anim Sci & Med, Sapporo, Hokkaido 0600818, Japan.	mmorimat@vetmed.hokudai.ac.jp	Morimatsu, Masami/A-6698-2012	Morimatsu, Masami/0000-0003-0740-0157	KAKENHI scientific research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan [19380164, 26450400]; Japan Society for the Promotion of Science	This work was supported by Research Fellowships of Japan Society for the Promotion of Science for Young Scientists and KAKENHI scientific research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 19380164 and 26450400).	Kannan Y, 2011, BLOOD, V117, P2855, DOI 10.1182/blood-2010-07-294702; Haruta H, 2001, J BIOL CHEM, V276, P12485, DOI 10.1074/jbc.C100075200; Yamazaki S, 2001, J BIOL CHEM, V276, P27657, DOI 10.1074/jbc.M103426200; Yeruva S, 2008, INT J COLORECTAL DIS, V23, P305, DOI 10.1007/s00384-007-0396-6; Oonuma T, 2007, J VET MED SCI, V69, P279, DOI 10.1292/jvms.69.279; Shiina T, 2004, J BIOL CHEM, V279, P55493, DOI 10.1074/jbc.M409770200; Burke SJ, 2013, J IMMUNOL, V191, P323, DOI 10.4049/jimmunol.1300344; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Kitamura H, 2000, FEBS LETT, V485, P53, DOI 10.1016/S0014-5793(00)02185-2; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Okamoto K, 2010, NATURE, V464, P1381, DOI 10.1038/nature08922; Ramana CV, 2002, TRENDS IMMUNOL, V23, P96, DOI 10.1016/S1471-4906(01)02118-4; Wesoly J, 2007, ACTA BIOCHIM POL, V54, P27; Au-Yeung N, 2013, JAKSTAT, V2; Fujisawa H, 1997, J INTERF CYTOK RES, V17, P347, DOI 10.1089/jir.1997.17.347; Ito T, 2004, GENE, V342, P137, DOI 10.1016/j.gene.2004.07.032; Krappmann D, 2013, BLOOD, V122, P2146, DOI 10.1182/blood-2013-08-516864; NICKOLOFF BJ, 1987, J INVEST DERMATOL, V89, P132, DOI 10.1111/1523-1747.ep12470545; Okuma A, 2013, IMMUNITY, V38, P450, DOI 10.1016/j.immuni.2012.11.016	20	1	1	BIOMEDICAL RESEARCH PRESS LTD	SAPPORO	HOKKAIDO UNIV, LAB HISTOLOGY & CYTOLOGY, C/O TOSHIHIKO IWANAGA, KITA 15-NISHI 7, SAPPORO, 060-8638, JAPAN	0388-6107	1880-313X		BIOMED RES-TOKYO	Biomed. Res.	APR	2015	36	2					103	107				5	Medicine, Research & Experimental	Research & Experimental Medicine	CG5FA	WOS:000353315300005		
J	Nakano, T; Hayashi, H; Wu, H; Shimamoto, C; Sano, K				Nakano, Takashi; Hayashi, Hideki; Wu, Hong; Shimamoto, Chikao; Sano, Kouichi			Disinfection potential of electrolyzed strongly acidic water against Mycobacteria: Conditions of disinfection and recovery of disinfection potential by reelectrolysis	BIOMEDICAL RESEARCH-TOKYO			English	Article							SODIUM-CHLORIDE	We attempted to clarify in detail the conditions of disinfection using electrolyzed strongly acidic water (ESW) against Mycobacteria, and the recovery of the disinfection potential of inactivated ESW by re-electrolysis. We mixed ESW containing 10, 20, and 30 ppm free chlorine with M bovis cells (10(5)-10(8) CFU/mL) for 0-7 mm. The disinfection potential of ESW positively correlated with free chlorine concentration, and negatively correlated with the initial density of bacterial cells. To clarify the recovery of the disinfection potential of inactivated ESW by re-electrolysis, we mixed ESW containing 10 ppm free chlorine with M bovis cells (10(7) CFU/mL) for 1 min. The number of viable cells decreased to 1/10(3), but the cells were still detected. After re-electrolysis for 7 min, viable cells were not detected. Moreover, we confirmed by reusing the re-electrolyzed water against M bovis cells that it regained its disinfection potential. These findings indicate that ESW once inactivated during disinfection can be re-activated by re-electrolysis. In conclusion, we were able to clarify in detail the conditions of ESW against Mycobacteria, and found the recovery of the disinfection potential of inactivated ESW by re-electrolysis.	[Nakano, Takashi; Hayashi, Hideki; Shimamoto, Chikao; Sano, Kouichi] Osaka Med Coll, Cent Res Ctr, Project Team Med Applicat Electrolysis, Takatsuki, Osaka 5698686, Japan; [Nakano, Takashi; Hayashi, Hideki; Wu, Hong; Sano, Kouichi] Osaka Med Coll, Dept Microbiol & Infect Control, Takatsuki, Osaka 5698686, Japan; [Hayashi, Hideki] Kaigen Pharma Co Ltd, Prod Planning Dept, Chuo Ku, Osaka, Osaka 5410045, Japan; [Shimamoto, Chikao] Osaka Univ Pharmaceut Sci, Lab Pharmacotherapy 2, Takatsuki, Osaka 5691094, Japan	Nakano, T (reprint author), Osaka Med Coll, Dept Microbiol & Infect Control, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan.	tnakano@art.osaka-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	This study was performed under the university-industry collaboration contract between Osaka Medical College and Kaigen Pharma Co., Ltd., and under the interuniversity collaboration contract between Osaka Medical College and Osaka University of Pharmaceutical Sciences. This study was supported by a Grant for Industry-University and Inter-University Collaborative Study from the Ministry of Education, Culture, Sports, Science and Technology, Japan. We thank Mr. Tomohiro Higashiyama of Central Clinical Laboratory, Osaka Medical College Hospital for kindly providing the clinical strains of Mycobacteria, Ms. Hiroko Oki of Osaka Medical College for support in laboratory work, and Ms. Kanako Kira of Osaka Medical College for the preparation of the manuscript.	Ahishali E, 2009, DIGEST DIS SCI, V54, P2541, DOI 10.1007/s10620-008-0630-2; Kiura H, 2002, J MICROBIOL METH, V49, P285, DOI 10.1016/S0167-7012(01)00385-2; Tamaki S, 2014, ARCH VIROL, V159, P405, DOI 10.1007/s00705-013-1840-2; Tagawa M, 2000, J ANTIMICROB CHEMOTH, V46, P363, DOI 10.1093/jac/46.3.363; Cohen NL, 2006, GASTROENTEROL NURS, V29, P100, DOI 10.1097/00001610-200603000-00002; Iwasawa A, 1996, JPN J INFECT DIS, V70, P915; Iwasawa A, 1995, JPN J ENV INFECT, V10, P53; Kitano Jun-ichi, 2003, Bulletin of the Osaka Medical College, V49, P29; Kumon K, 1997, ARTIF ORGANS, V21, P2; Morita C, 2000, J VIROL METHODS, V85, P163, DOI 10.1016/S0166-0934(99)00165-2; Nelson D, 2000, GASTROENTEROL CLIN N, V2, P319; Olive-Monllau R, 2010, TALANTA, V81, P8378; The Scientific Board of Functional Water Foundation, 2001, COMPR GUID DENKAISUI; Tsuji S, 1999, ENDOSCOPY, V31, P528; Yamamoto TM, 2012, MED MOL MORPHOL, V45, P199, DOI 10.1007/s00795-011-0560-5	15	0	0	BIOMEDICAL RESEARCH PRESS LTD	SAPPORO	HOKKAIDO UNIV, LAB HISTOLOGY & CYTOLOGY, C/O TOSHIHIKO IWANAGA, KITA 15-NISHI 7, SAPPORO, 060-8638, JAPAN	0388-6107	1880-313X		BIOMED RES-TOKYO	Biomed. Res.	APR	2015	36	2					109	113				5	Medicine, Research & Experimental	Research & Experimental Medicine	CG5FA	WOS:000353315300006		
J	Kita, T; Arakaki, N				Kita, Toshiyuki; Arakaki, Naokatu			Contribution of extracellular ATP on the cell-surface F1F0-ATP synthase-mediated intracellular triacylglycerol accumulation	BIOMEDICAL RESEARCH-TOKYO			English	Article							SURAMIN ANALOG NF279; ENDOTHELIAL-CELLS; BETA-CHAIN; RECEPTOR; ANGIOSTATIN; INHIBITION; EXPRESSION; SYSTEM; P2X(1); MOTOR	Cell-surface F1F0-ATP synthase was involved in the cell signaling mediating various biological functions. Recently, we found that cell-surface F1F0-ATP synthase plays a role on intracellular triacylglycerol accumulation in adipocytes, and yet, the underlying mechanisms remained largely unknown. In this study, we investigated the role of extracellular ATP on the intracellular triacylglycerol accumulation. We demonstrated that significant amounts of ATP were produced extracellularly by cultured 3T3-L1 adipocytes and that the antibodies against alpha and beta subunits of F1F0-ATP synthase inhibited the extracellular ATP production. Piceatannol, a F1F0-ATP synthase inhibitor, and apyrase, an enzyme which degrades extracellular ATP, suppressed triacylglycerol accumulation. The selective P2Y(1) receptor antagonist MRS2500 significantly inhibited triacylglycerol accumulation, whereas the selective P2X receptor antagonist NF279 has less effect. The present results indicate that cell-surface F1F0-ATP synthase on adipocytes is functional in extracellular ATP production and that the extracellular ATP produced contributes, at least in part, to the cell-surface F1F0-ATP synthase-mediated intracellular triacylglycerol accumulation in adipocytes through P2Y(1) receptor.	[Kita, Toshiyuki] Kansai Med Univ, Inst Biomed Sci, Dept Mol Genet, Hirakata, Osaka 5731010, Japan; [Arakaki, Naokatu] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Mol Cell Biol & Med, Tokushima 7708505, Japan	Arakaki, N (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Mol Cell Biol & Med, Tokushima 7708505, Japan.	narakaki@tokushima-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [24590081]	This study was supported by a Grant-in-Aid for Scientific Research (C) (Grant number 24590081) from Japan Society for the Promotion of Science (JSPS).	Moser TL, 2001, P NATL ACAD SCI USA, V98, P6656, DOI 10.1073/pnas.131067798; Hwang SJ, 2012, J PHYSIOL-LONDON, V590, P1957, DOI 10.1113/jphysiol.2011.224634; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Cattaneo M, 2004, BIOCHEM PHARMACOL, V68, P1995, DOI 10.1016/j.bcp.2004.06.026; Kita T, 2009, J BIOCHEM, V146, P787, DOI 10.1093/jb/mvp124; Ma Z, 2010, ACTA BIOCH BIOPH SIN, V42, P530, DOI 10.1093/abbs/gmq063; DAS B, 1994, J EXP MED, V180, P273, DOI 10.1084/jem.180.1.273; Gledhill JR, 2005, BIOCHEM J, V386, P591, DOI 10.1042/BJ20041513; Kim BW, 2004, EXP MOL MED, V36, P476; Martinez LO, 2003, NATURE, V421, P75, DOI 10.1038/nature01250; Burnstock G, 2008, NAT REV DRUG DISCOV, V7, P575, DOI 10.1038/nrd2605; von Kugelgen I, 2006, PHARMACOL THERAPEUT, V110, P415, DOI 10.1016/j.pharmthera.2005.08.014; Zheng JB, 2000, BRIT J PHARMACOL, V130, P1115, DOI 10.1038/sj.bjp.0703397; Moser TL, 1999, P NATL ACAD SCI USA, V96, P2811, DOI 10.1073/pnas.96.6.2811; Capaldi RA, 2002, TRENDS BIOCHEM SCI, V27, P154, DOI 10.1016/S0968-0004(01)02051-5; Arakaki N, 2003, MOL CANCER RES, V1, P931; Burnstock G, 2009, ACTA PHYSIOL, V195, P415, DOI 10.1111/j.1748-1716.2009.01957.x; Arakaki N, 2007, FEBS LETT, V581, P3405, DOI 10.1016/j.febslet.2007.06.041; Buvinic S, 2007, J CELL SCI, V120, P4289, DOI 10.1242/jcs.03490; Kim TEL Kim SH, 2001, CELL BIOL INT, V38, P32; Klapperstuck M, 2000, EUR J PHARMACOL, V387, P245, DOI 10.1016/S0014-2999(99)00826-2; Omatsu-Kanbe M, 2006, BIOCHEM J, V393, P171, DOI 10.1042/BJ20051037; Ravelic V, 1998, PHARMACOL REV, V50, P413; Rettinger J, 2000, NEUROPHARMACOLOGY, V39, P2044, DOI 10.1016/S0028-3908(00)00022-8; Schodel J, 2004, BIOCHEM BIOPH RES CO, V321, P763; Wang TK, 2006, BBA-MOL CELL BIOL L, V1761, P1182, DOI 10.1016/j.bbalip.2006.08.009; Zhang Y, 2013, J CELL BIOCHEM, V114, P2959	27	0	0	BIOMEDICAL RESEARCH PRESS LTD	SAPPORO	HOKKAIDO UNIV, LAB HISTOLOGY & CYTOLOGY, C/O TOSHIHIKO IWANAGA, KITA 15-NISHI 7, SAPPORO, 060-8638, JAPAN	0388-6107	1880-313X		BIOMED RES-TOKYO	Biomed. Res.	APR	2015	36	2					115	120				6	Medicine, Research & Experimental	Research & Experimental Medicine	CG5FA	WOS:000353315300007		
J	Nanao, T; Koike, M; Yamaguchi, J; Sasaki, M; Uchiyama, Y				Nanao, Tomohisa; Koike, Masato; Yamaguchi, Junji; Sasaki, Mitsuho; Uchiyama, Yasuo			Cellular localization and tissue distribution of endogenous DFCP1 protein	BIOMEDICAL RESEARCH-TOKYO			English	Article							ENDOPLASMIC-RETICULUM; AUTOPHAGOSOME FORMATION; MITOCHONDRIA; MEMBRANE; PARTICIPATION; COMPARTMENTS; BIOGENESIS; NEURONS; DISEASE; COMPLEX	Autophagy is essential for the maintenance of cellular metabolism. Once autophagy is induced in cells, the isolation membrane forms a so-called phagophore. The endoplasmic reticulum (ER) is one of several candidates for the membrane source for phagophores. Recently, LC3-positive isolation membranes were found to emerge from a DFCP1 (double FYVE domain-containing protein)positive, ER-associated compartment called the omegasome. Although the GFP-tagged DFCP1 protein has been examined in cultured cells, little is known about the precise cellular and tissue distribution of this endogenous protein. To determine the expression of the endogenous DFCP1 protein, we produced antibodies specific to mouse DFCP1 protein. The antibody recognized both human and mouse DFCP1 proteins, both of which have molecular masses of approximately 87 kDa. In HeLa cells under normal conditions, immunoreactivity for DFCP1 was found dotted or tubular along Tom20-positive filamentous mitochondria and was only partially co-localized in the ER or Golgi apparatus. Moreover, under starved conditions, distinct DFCP1-positive structures became more dotted and scattered in the cytoplasm, while one part of the LC3-positive autophagosomes were immunopositive for DFCP1. These results indicate that an antibody raised against DFCP1 could be a useful tool in explaining the mechanism of phagophore formation from omegasome compartments.	[Nanao, Tomohisa; Yamaguchi, Junji; Uchiyama, Yasuo] Juntendo Univ, Grad Sch Med, Dept Cellular & Mol Neuropathol, Bunkyo Ku, Tokyo 1138421, Japan; [Koike, Masato] Juntendo Univ, Grad Sch Med, Dept Cell Biol & Neurosci, Bunkyo Ku, Tokyo 1138421, Japan; [Sasaki, Mitsuho] Natl Inst Biomed Innovat, Dept Anim Models Human Dis, Ibaraki, Osaka 5670085, Japan	Koike, M (reprint author), Juntendo Univ, Grad Sch Med, Dept Cell Biol & Neurosci, Bunkyo Ku, Tokyo 1138421, Japan.	mkoike@juntendo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported in part by Grants-in-Aid for Challenging Exploratory Research (Y.U.), Scientific Research on Innovative Areas (Y.U. and M.K.), Grants-in-Aid for Scientific Research (B) (Y.U.), Grants-in-Aid for Scientific Research (C) (M. K.), a Grant-in-Aid for challenging Exploratory Research (Y.U.), a Grant-in-Aid for the "High-Tech Research Center" Project for Private Universities, a matching fund subsidy (Y.U.), and the Program for the Strategic Research Foundation at Private Universities (Y.U.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Matsunaga K, 2010, J CELL BIOL, V190, P511, DOI 10.1083/jcb.200911141; Murrow L, 2013, ANNU REV PATHOL-MECH, V8, P105, DOI 10.1146/annurev-pathol-020712-163918; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; Itakura E, 2010, AUTOPHAGY, V6, P764; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Kim KH, 2014, NAT REV ENDOCRINOL, V10, P322, DOI 10.1038/nrendo.2014.35; Tachikawa M, 2004, EUR J NEUROSCI, V20, P144, DOI 10.1111/j.1460-9568.2004.03478.x; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; MORTIMORE GE, 1987, ANNU REV NUTR, V7, P539, DOI 10.1146/annurev.nu.07.070187.002543; Longatti A, 2012, J CELL BIOL, V197, P659, DOI 10.1083/jcb.201111079; Koike M, 2005, AM J PATHOL, V167, P1713, DOI 10.1016/S0002-9440(10)61253-9; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Koike M, 2013, EUR J NEUROSCI, V37, P816, DOI 10.1111/ejn.12096; Uemura T, 2014, MOL CELL BIOL, V34, P1695, DOI 10.1128/MCB.01327-13; Koike M, 2008, AM J PATHOL, V172, P454, DOI 10.2353/ajpath.2008.070876; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; DUNN WA, 1990, J CELL BIOL, V110, P1923, DOI 10.1083/jcb.110.6.1923; Yla-Anttila P, 2009, AUTOPHAGY, V5, P1180; Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Ge L, 2014, CURR OPIN CELL BIOL, V29, P18, DOI 10.1016/j.ceb.2014.02.005; Orsi A, 2012, MOL BIOL CELL, V23, P1860, DOI 10.1091/mbc.E11-09-0746; Ge L., 2014, ELIFE, V3; Koike M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063568; Lu ZH, 2005, ARCH HISTOL CYTOL, V68, P71, DOI 10.1679/aohc.68.71; Ridley SH, 2001, J CELL SCI, V114, P3991; Suyama M, 2014, J HISTOCHEM CYTOCHEM, V62, P645, DOI 10.1369/0022155414542300; Tamura H, 2010, J HISTOCHEM CYTOCHEM, V58, P443, DOI 10.1369/jhc.2010.955690; Wong YC, 2014, P NATL ACAD SCI USA, V111, pE4439, DOI 10.1073/pnas.1405752111; Yang JY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3428	31	0	0	BIOMEDICAL RESEARCH PRESS LTD	SAPPORO	HOKKAIDO UNIV, LAB HISTOLOGY & CYTOLOGY, C/O TOSHIHIKO IWANAGA, KITA 15-NISHI 7, SAPPORO, 060-8638, JAPAN	0388-6107	1880-313X		BIOMED RES-TOKYO	Biomed. Res.	APR	2015	36	2					121	133				13	Medicine, Research & Experimental	Research & Experimental Medicine	CG5FA	WOS:000353315300008		
J	Tomiyama, C; Watanabe, M; Honma, T; Inada, A; Hayakawa, T; Ryutuku, M; Abo, T				Tomiyama, Chikako; Watanabe, Mayumi; Honma, Takashi; Inada, Akihiro; Hayakawa, Takayoshi; Ryutuku, Masae; Abo, Toru			The effect of repetitive mild hyperthermia on body temperature, the autonomic nervous system, and innate and adaptive immunity	BIOMEDICAL RESEARCH-TOKYO			English	Article							EXTRATHYMIC T-CELLS; CANCER-PATIENTS; NK-CELLS; STRESS; GRANULOCYTES; FEVER; RESPONSES; GLUCOCORTICOIDS; CENTENARIANS; INCREASES	The effect of repetitive mild hyperthermia on body temperature, the autonomic nervous system, and innate and adaptive immunity was investigated using a new hyperthermia treatment system, nanomist sauna (NMS). Six healthy volunteers participated and the concentration of catecholamines and cortisol, and the frequency and function of leukocytes in the peripheral blood were investigated before and after successive 7 days of hyperthermia treatment (20 min/day, 40 degrees C, 100% relative humidity). After treatment, the blood level of adrenaline and cortisol on the 7th day was decreased compared with the 1st day, indicating the suppression of the sympathetic nervous system activity. Moreover, the frequency of CD56(+)NK, CD56(+)NKT and B cells on the 7th day tended to be increased compared with the 1st day. The frequency of HLA-DR-positive NK and NKT cells and expression of HLA-DR on B and T cells increased. The cytotoxicity of NK cells and proliferative response of B cells were also elevated. The results indicate that repetitive mild hyperthermia treatment might suppress excessive sympathetic dominance and modify immunity. Additionally, because it can provide the same effects as conventional hyperthermia treatments with minimal burden to the body, NMS may be a novel patient- and elderly-friendly hyperthermia treatment for health promotion.	[Tomiyama, Chikako] Niigata Univ, Grad Sch Hlth Sci, Dept Med Technol, Niigata, Japan; [Watanabe, Mayumi] Niigata Univ, Med & Dent Hosp, Dept Med Informat, Niigata, Japan; [Honma, Takashi; Inada, Akihiro; Hayakawa, Takayoshi] CORONA Corp, Niigata, Japan; [Ryutuku, Masae] Niigata Univ, Brain Res Inst, Niigata, Japan; [Abo, Toru] Niigata Univ, Sch Med, Dept Immunol, Niigata, Japan	Tomiyama, C (reprint author), Niigata Univ, Grad Sch Hlth Sci, Dept Med Technol, Niigata, Japan.	tomiyama@clg.niigata-u.ac.jp					ATHENS JW, 1961, J CLIN INVEST, V40, P159, DOI 10.1172/JCI104230; Thoma MV, 2012, BIOL PSYCHOL, V91, P342, DOI 10.1016/j.biopsycho.2012.07.008; Ostberg JR, 2007, J LEUKOCYTE BIOL, V82, P1322, DOI 10.1189/jlb.1106699; Hanson DF, 1997, ANN NY ACAD SCI, V813, P453, DOI 10.1111/j.1749-6632.1997.tb51733.x; ABO T, 1981, J IMMUNOL, V127, P1024; Burd R, 1998, J CELL PHYSIOL, V177, P137, DOI 10.1002/(SICI)1097-4652(199810)177:1<137::AID-JCP15>3.0.CO;2-A; Du GJ, 2013, INT IMMUNOPHARMACOL, V17, P245, DOI 10.1016/j.intimp.2013.06.018; Brazaitis M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109020; CIAVARRA RP, 1987, CELL IMMUNOL, V107, P293, DOI 10.1016/0008-8749(87)90238-3; Fames P, 1964, LANCET, V2, P1100; Huang YH, 1996, CLIN EXP IMMUNOL, V103, P61, DOI 10.1046/j.1365-2249.1996.00932.x; Ito A, 2001, CANCER IMMUNOL IMMUN, V50, P512; Jimenez C, 2007, EUR CYTOKINE NETW, V18, P154; KOGA S, 1983, CANCER, V52, P1173, DOI 10.1002/1097-0142(19831001)52:7<1173::AID-CNCR2820520708>3.0.CO;2-0; Kukkonen-Harjula K, 2006, INT J CIRCUMPOL HEAL, V65, P195; Maeda M, 2006, BIOMED THERMOL, V26, P58; Maruyama S, 1999, CELL IMMUNOL, V194, P28, DOI 10.1006/cimm.1999.1492; McCormick JK, 2003, J IMMUNOL, V171, P1385; Miyaji C, 1997, J CLIN IMMUNOL, V17, P420, DOI 10.1023/A:1027324626199; Miyaji C, 2000, HUM IMMUNOL, V61, P908, DOI 10.1016/S0198-8859(00)00153-1; Ohishi T, 2009, BIOMED RES-TOKYO, V30, P95; Ostberg JR, 2000, CELL STRESS CHAPERON, V5, P458, DOI 10.1379/1466-1268(2000)005<0458:ROIABM>2.0.CO;2; Pilch W, 2014, BIOL SPORT, V31, P145, DOI 10.5604/20831862.1099045; Sagiyama K, 2004, CLIN EXP IMMUNOL, V135, P56, DOI 10.1046/j.1365-2249.2004.02340.x; Shimizu T, 2000, SCAND J IMMUNOL, V51, P285; Tanaka Nobuyuki, 2011, Journal of  the Japanese Society of Balneology Climatology and Physical Medicine, V74, P263; Tomiyama-Miyaji C, 2007, BIOMED RES-TOKYO, V28, P119, DOI 10.2220/biomedres.28.119; Wang Xiu-Xia, 1999, Journal of Japanese Association of Physical Medicine Balneology and Climatology, V62, P129; Watanabe Mayumi, 2011, Journal of  the Japanese Society of Balneology Climatology and Physical Medicine, V74, P96; Won SJ, 1985, J APPL PHYSIOL, V79, P732	30	0	0	BIOMEDICAL RESEARCH PRESS LTD	SAPPORO	HOKKAIDO UNIV, LAB HISTOLOGY & CYTOLOGY, C/O TOSHIHIKO IWANAGA, KITA 15-NISHI 7, SAPPORO, 060-8638, JAPAN	0388-6107	1880-313X		BIOMED RES-TOKYO	Biomed. Res.	APR	2015	36	2					135	142				8	Medicine, Research & Experimental	Research & Experimental Medicine	CG5FA	WOS:000353315300009		
J	Satoh-Nakamura, T; Kurose, N; Kawanami, T; Nakamura, T; Iwao-Kawanami, H; Nakajima, A; Miki, M; Sakai, T; Fusita, Y; Tanaka, M; Fukushima, T; Masaki, Y				Satoh-Nakamura, Tomomi; Kurose, Nozomu; Kawanami, Takafumi; Nakamura, Takuji; Iwao-Kawanami, Haruka; Nakajima, Akio; Miki, Miyuki; Sakai, Tomoyuki; Fusita, Yoshimasa; Tanaka, Masao; Fukushima, Toshihiro; Masaki, Yasufumi			CD14(+) follicular dendritic cells in lymphoid follicles may play a role in the pathogenesis of IgG4-related disease	BIOMEDICAL RESEARCH-TOKYO			English	Article							REGULATORY IMMUNE-REACTIONS; AUTOIMMUNE PANCREATITIS; MIKULICZS-DISEASE; SCLEROSING PANCREATITIS; CARBONIC-ANHYDRASE; SJOGRENS-SYNDROME; TUBULOINTERSTITIAL NEPHRITIS; CLASSIFICATION CRITERIA; IGG4 CONCENTRATIONS; T-CELLS	Proliferated IgG4(+) plasma cells are polyclonal, suggesting that the pathogenesis of IgG4-related disease (IgG4-RD) involves upstream events related to the regulation of IgG4 expansion. We hypothesized that lymphoid follicle formation may play an important role in the pathogenesis of IgG4-RD. Using various antibodies, especially against monocyte, macrophage, and follicular dendritic cell markers, we immunohistochemically assessed the distribution of immune cells in lymphoid follicles. Pathological findings of tissue samples from patients with IgG4-RD (n = 22), reactive hyperplasia (n = 3), multicentric Castleman's disease (n = 3), and Sjogren's syndrome (n = 13) were analyzed. CD14-positive lymphoid follicles were observed only in patients with IgG4-RD, and CD14-positive cells were identified as follicular dendritic cells by multicolor immunohistochemistry. There were few differences in the distributions of other cell types between the IgG4-RD and control groups. The presence of CD14(+) follicular dendritic cells in lymphoid follicles may play a pathophysiological role in IgG4-RD.	[Satoh-Nakamura, Tomomi; Kawanami, Takafumi; Nakamura, Takuji; Iwao-Kawanami, Haruka; Nakajima, Akio; Miki, Miyuki; Sakai, Tomoyuki; Fusita, Yoshimasa; Tanaka, Masao; Fukushima, Toshihiro; Masaki, Yasufumi] Kanazawa Med Univ, Dept Hematol & Immunol, Uchinada, Ishikawa 9200296, Japan; [Kurose, Nozomu] Kanazawa Med Univ, Dept Pathol & Lab Med, Uchinada, Ishikawa 9200296, Japan	Masaki, Y (reprint author), Kanazawa Med Univ, Hematol & Immunol, 1-1 Daigaku, Uchinada, Ishikawa 9200296, Japan.	yasum@kanazawa-med.ac.jp			Research Program of Intractable Disease - Ministry of Health, Labor, and Welfare (MHLW) of Japan; Japanese Ministry of Education, Culture, Sports, Science and Technology [17591060]; Kanazawa Medical University Research Foundation [S2004-16, S2007-5]; Kanazawa Medical University [K2011-7, AR2012-06]; High-Tech Research Center of Kanazawa Medical University [H2011-11]	This work was partially supported by the Research Program of Intractable Disease provided by the Ministry of Health, Labor, and Welfare (MHLW) of Japan and by the Japanese Ministry of Education, Culture, Sports, Science and Technology (Grant No. 17591060), Kanazawa Medical University Research Foundation (Grant Nos. S2004-16 and S2007-5), Grant for Assist KAKEN from Kanazawa Medical University (Grant No. K2011-7), Grant for Project Research from High-Tech Research Center of Kanazawa Medical University (Grant No. H2011-11), and Grant for Alumni Research (A) from Kanazawa Medical University (AR2012-06).	Zen Y, 2013, J HEPATOL, V59, P1059, DOI 10.1016/j.jhep.2013.06.016; Mattoo H, 2014, ALLERGY, V69, P399, DOI 10.1111/all.12342; Stone JH, 2012, NEW ENGL J MED, V366, P539, DOI 10.1056/NEJMra1104650; Masaki Y, 2009, ANN RHEUM DIS, V68, P1310, DOI 10.1136/ard.2008.089169; Umehara H, 2012, MOD RHEUMATOL, V22, P21, DOI 10.1007/s10165-011-0571-z; Deshpande V, 2012, MODERN PATHOL, V25, P1181, DOI 10.1038/modpathol.2012.72; Ranoa DRE, 2013, J BIOL CHEM, V288, P9729, DOI 10.1074/jbc.M113.453266; SIMMONS DL, 1989, BLOOD, V73, P284; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Smeltzer JP, 2014, CLIN CANCER RES, V20, P2862, DOI 10.1158/1078-0432.CCR-13-2367; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Umehara H, 2012, MOD RHEUMATOL, V22, P1, DOI 10.1007/s10165-011-0508-6; Frulloni L, 2009, NEW ENGL J MED, V361, P2135, DOI 10.1056/NEJMoa0903068; Pitzalis C, 2014, NAT REV IMMUNOL, V14, P447, DOI 10.1038/nri3700; Tapping RI, 2000, CHEM IMMUNOL, V74, P108; Shiboski SC, 2012, ARTHRIT CARE RES, V64, P475, DOI 10.1002/acr.21591; Kamisawa T, 2003, J GASTROENTEROL, V38, P982, DOI 10.1007/s00535-003-1175-y; Lohr JM, 2010, AM J GASTROENTEROL, V105, P2060, DOI 10.1038/ajg.2010.141; Tanaka A, 2012, ARTHRITIS RHEUM-US, V64, P254, DOI 10.1002/art.33320; MORGAN WS, 1953, AM J PATHOL, V29, P471; Kamisawa T, 2006, J GASTROENTEROL, V41, P613, DOI 10.1007/s00535-006-1862-6; Moriyama M, 2014, J AUTOIMMUN, V51, P81, DOI 10.1016/j.jaut.2013.07.007; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; Nishimori I, 2005, GUT, V54, P274, DOI 10.1136/gut.2004.049064; Masaki Y, 2010, J RHEUMATOL, V37, P1380, DOI 10.3899/jrheum.091153; Maehara T, 2012, ANN RHEUM DIS, V71, P2011, DOI 10.1136/annrheumdis-2012-201477; Zen Y, 2007, HEPATOLOGY, V45, P1538, DOI 10.1002/hep.21697; Aparisi L, 2005, GUT, V54, P703, DOI 10.1136/gut.2004.047142; Egawa M, 2013, IMMUNITY, V38, P570, DOI 10.1016/j.immuni.2012.11.014; Fujibayashi T, 2004, MOD RHEUMATOL, V14, P425; Heinemann DEH, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-23; Jimenez F, 2010, J IMMUNOL, V184, P5571, DOI 10.4049/jimmunol.0803494; Kim F, 2011, INTERNAL MED, V50, P1239, DOI 10.2169/internalmedicine.50.5102; Kitchens RL, 2000, CHEM IMMUNOL, V74, P61; Lieberam I, 1999, EUR J IMMUNOL, V29, P2684, DOI 10.1002/(SICI)1521-4141(199909)29:09<2684::AID-IMMU2684>3.0.CO;2-Y; Masaki Y, 2011, CURR IMMUNOL REV, P7172; Masaki Yasufumi, 2011, J Clin Exp Hematop, V51, P13; Nishi H, 2007, NEPHROL DIAL TRANSPL, V22, P1273, DOI 10.1093/ndt/gfl672; Sato Y, 2010, PATHOL INT, V60, P247, DOI 10.1111/j.1440-1827.2010.02524.x; Schraufstatter IU, 2011, IMMUNOLOGY, V135, P287; Yamada K, 2008, CLIN EXP IMMUNOL, V152, P432, DOI 10.1111/j.1365-2249.2008.03651.x; Yamamoto M, 2004, SCAND J RHEUMATOL, V33, P432, DOI 10.1080/03009740410006439; Zeljic K, 2014, ORAL DIS, V20, P416, DOI 10.1111/odi.12144	43	0	0	BIOMEDICAL RESEARCH PRESS LTD	SAPPORO	HOKKAIDO UNIV, LAB HISTOLOGY & CYTOLOGY, C/O TOSHIHIKO IWANAGA, KITA 15-NISHI 7, SAPPORO, 060-8638, JAPAN	0388-6107	1880-313X		BIOMED RES-TOKYO	Biomed. Res.	APR	2015	36	2					143	153				11	Medicine, Research & Experimental	Research & Experimental Medicine	CG5FA	WOS:000353315300010		
J	Ochiai, K; Ishiguro-Oonuma, T; Yoshikawa, Y; Udagawa, C; Kato, Y; Watanabe, M; Bonkobara, M; Morimatsu, M; Omi, T				Ochiai, Kazuhiko; Ishiguro-Oonuma, Toshina; Yoshikawa, Yasunaga; Udagawa, Chihiro; Kato, Yuiko; Watanabe, Masami; Bonkobara, Makoto; Morimatsu, Masami; Omi, Toshinori			Polymorphisms of canine BRCA2 BRC repeats affecting interaction with RAD51	BIOMEDICAL RESEARCH-TOKYO			English	Article							MAMMARY-TUMORS; RECOMBINATION; STABILITY; DNA	Mutations in the breast cancer susceptibility gene BRCA2 leading to the failure of interactions with the recombinase RAD51 are associated with an increased risk of cancer in humans. This interaction depends on the eight BRC repeat (BRC1-8) sequences in BRCA2. We previously reported that canine BRC3 has two polymorphisms (T1425P and K1435R) influencing the interaction with RAD51, and 1435R was identified in mammary tumor dog samples. In this study, we investigated the sequence variations of BRC3 and 4 in 236 dogs of five breeds. Allele frequencies of 1425P and 1435R were 0.063 and 0.314, respectively, and there was no other polymorphism in the sequenced region. A mammalian two-hybrid assay using BRC3-4 sequences demonstrated that 1425P allele reduced the binding strength with RAD51 but 1435R had no effect. These results may provide an insight into the functions of not only individual but also multiple BRC repeats of BRCA2 in dogs.	[Ochiai, Kazuhiko; Udagawa, Chihiro; Kato, Yuiko; Omi, Toshinori] Nippon Vet & Life Sci Univ, Sch Vet Sci, Dept Vet Nursing & Technol, Tokyo 1808602, Japan; [Ishiguro-Oonuma, Toshina] Ehime Univ, Integrated Ctr Sci, Dept Biol Resources, Matsuyama, Ehime 7910295, Japan; [Yoshikawa, Yasunaga] Kitasato Univ, Sch Vet Med, Vet Biochem Lab, Minato 0348628, Japan; [Watanabe, Masami] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Urol, Okayama 7008558, Japan; [Bonkobara, Makoto] Nippon Vet & Life Sci Univ, Sch Vet Sci, Dept Vet Clin Pathol, Tokyo 1808602, Japan; [Morimatsu, Masami] Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Lab Lab Anim Sci & Med, Sapporo, Hokkaido 0600818, Japan	Morimatsu, M (reprint author), Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Lab Lab Anim Sci & Med, Kita 18 Nishi 9 Kita Ku, Sapporo, Hokkaido 0600818, Japan.	mmorimat@vetmed.hokudai.ac.jp	Morimatsu, Masami/A-6698-2012	Morimatsu, Masami/0000-0003-0740-0157	Ministry of Education, Culture, Sports, Science and Technology of Japan [24780313, 26450400]	This work was supported by KAKENHI scientific research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 24780313 and 26450400). The authors thank Ms. Yuka Ohsawa, Yumie Shioiri, Saori Someda and Rie Harada from Nippon Veterinary and Life Science University for their valuable assistance.	Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Trenaman A, 2013, NUCLEIC ACIDS RES, V41, P943, DOI 10.1093/nar/gks1192; Ochiai K, 2011, FEBS LETT, V585, P1771, DOI 10.1016/j.febslet.2011.05.027; Yoshikawa Y, 2008, AM J VET RES, V69, P1323, DOI 10.2460/ajvr.69.10.1323; Wong AKC, 1997, J BIOL CHEM, V272, P31941, DOI 10.1074/jbc.272.51.31941; Rivera P, 2009, CANCER RES, V69, P8770, DOI 10.1158/0008-5472.CAN-09-1725; Carreira A, 2009, CELL, V136, P1032, DOI 10.1016/j.cell.2009.02.019; Bignell G, 1997, HUM MOL GENET, V6, P53, DOI 10.1093/hmg/6.1.53; Carreira A, 2011, P NATL ACAD SCI USA, V108, P13920; Enginler SO, 2014, VET RES COMMUN, V38, P21, DOI 10.1007/s11259-013-9577-7; Hsu WL, 2010, VET J, V184, P351, DOI 10.1016/j.tvjl.2009.03.022; Ochiai K, 2004, BIOMED RES-TOKYO, V25, P269, DOI 10.2220/biomedres.25.269; Ochiai K, 2011, VET J, V190, P293, DOI 10.1016/j.tvjl.2010.11.001; Ochiai K, 2001, J VET MED SCI, V63, P1103, DOI 10.1292/jvms.63.1103; Shahid T, 2014, NAT STRUCT MOL BIOL, V21, P962, DOI 10.1038/nsmb.2899; Tal A, 2009, J MOL BIOL, V393, P1007, DOI 10.1016/j.jmb.2009.09.011; Udagawa C, 2014, BMC RES NOTES, V71, P904; Sivacolundhu RK, 2013, SMALL ANIMAL SOFT TISSUE SURGERY, P573; Yoshikawa Y, 2005, BIOMED RES-TOKYO, V26, P109, DOI 10.2220/biomedres.26.109; Yoshikawa Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045833	21	2	2	BIOMEDICAL RESEARCH PRESS LTD	SAPPORO	HOKKAIDO UNIV, LAB HISTOLOGY & CYTOLOGY, C/O TOSHIHIKO IWANAGA, KITA 15-NISHI 7, SAPPORO, 060-8638, JAPAN	0388-6107	1880-313X		BIOMED RES-TOKYO	Biomed. Res.	APR	2015	36	2					155	158				4	Medicine, Research & Experimental	Research & Experimental Medicine	CG5FA	WOS:000353315300011		
J	Walter, HS; Hutchinson, CV; Sharpe, J; Duffy, K; Nishimura, A; Abe, S; Honda, H; Yasuhiro, T; Yoshizawa, T; Birkett, J; Courtenay-Luck, N; Dyer, MJS				Walter, H. S.; Hutchinson, C. V.; Sharpe, J.; Duffy, K.; Nishimura, A.; Abe, S.; Honda, H.; Yasuhiro, T.; Yoshizawa, T.; Birkett, J.; Courtenay-Luck, N.; Dyer, M. J. S.			Single centre experience of a Bruton's tyrosine kinase (BTK) specific inhibitor (ONO-4059) in relapsed mantle cell lymphoma (MCL)	BRITISH JOURNAL OF HAEMATOLOGY			English	Meeting Abstract	55th Annual Scientific Meeting of the British-Society-for-Haematology	APR 20-22, 2015	Edinburgh, SCOTLAND	British Soc Haematol					[Walter, H. S.; Hutchinson, C. V.; Dyer, M. J. S.] Univ Hosp Leicester, Dept Haematol, Leicester, Leics, England; [Sharpe, J.; Duffy, K.; Nishimura, A.; Abe, S.; Birkett, J.; Courtenay-Luck, N.] ONO Pharma UK LTD, London, England; [Honda, H.; Yasuhiro, T.; Yoshizawa, T.] Ono Pharmaceut Co Ltd, Osaka, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1048	1365-2141		BRIT J HAEMATOL	Br. J. Haematol.	APR	2015	169			1	SI	140	58	59				2	Hematology	Hematology	CG4CZ	WOS:000353231200141		
J	Heywood, C				Heywood, Christopher			Found: The 'Lost' Portrait of Emily Bronte	Bronte Studies			English	Article						Bradford; Charlotte Bronte; Emily Bronte; Haworth; Henry de Garrs; John Hunter Thompson; Martha Brown; Nancy Garrs; picture framing; Sheffield; William Robertson Nicoll		An illustration in The Woman at Home (1894), captioned 'EMILY BRONTE. From a painting by Charlotte Bronte, hitherto unpublished', matches an unsigned portrait, recently found in a private collection. The illustration was copied from the portrait of Emily Bronte that was seen in Haworth in 1879 by William Robertson Nicoll (1851-1923), owner and editor of The Woman at Home. A pencilled inscription on the back of the newly found portrait, apparently in Charlotte's handwriting, reads: 'Emily Bronte / Sister of Charlotte Bro[nte] / Currer Bell'. In 1908 Nicoll declared in an article that the original portrait had become 'irrevocably lost'. This article proposes that it has been found. The painter is identified here as the Bradford portrait artist, John Hunter Thompson (1808-90).	[Heywood, Christopher] Univ Sheffield, Sheffield S10 2TN, S Yorkshire, England; [Heywood, Christopher] Okayama Univ, Okayama 7008530, Japan		christopher.123@zen.co.uk					Alexander Christine, 2006, OXFORD COMPANION BRO, P81; Alexander Christine, 1995, ART BRONTES; [Anonymous], 1984, B PORTRAITS NATL POR; [Anonymous], 1908, BRIT WEEKLY     1029, P101; [Anonymous], 1886, KEIGHLEY NEWS   0403; BPM, 1886, SALE CATALOGUE; Bracken B, 2013, BRONTE STUD, V38, P8, DOI 10.1179/1474893212Z.00000000048; Bronte Charlotte, 1996, BELGIAN ESSAYS, P358; Carlyle Leslie, 2001, ARTISTS ASSISTANT, P228; Constable W. G., 1954, PAINTERS WORKSHOP, P27; Constable W. G., 1954, PAINT WORKSH OXF OUP, P55; Darlow T. H., 1925, WR NICOLL LIFE LETT, P11; Darlow T. H., 1925, WR NICOLL LIFE LETT, P67; Darlow T. H., 1925, WR NICOLL, P273; de Garrs Allen D. N., 1955, PROFESSOR APPL MATH; Garrs Nancy, 1885, ILLUSTRATED WEEKLY T; Green Dudley, 2008, P BRONTE FATHER GENI, P103; Heywood C, 2010, BRONTE STUD, V35, P40, DOI 10.1179/174582209X12593347526960; Heywood C, 2009, BRONTE STUD, V34, P1, DOI 10.1179/147489309X427831; Horn Pamela, 1995, RISE FALL VICTORIAN, P128; Hutchinson C., 1968, HSIT ROYAL ACAD 1768, P30; Macdonald Frederika, 1894, WOMAN HOME, V2, P279; Macdonald Frederika, 1914, SECRET C BRONTE, P61; Margaret, 1999, MY DEAR BOY, p[116, 48]; Mohen Jean-Pierre, 2006, M LISA INSIDE PAINTI; Ruhemann Helmut, 1968, CLEANING PAINTINGS P, P79; Ruijssenaars Eric, 2000, C BRONTES PROMISED L, P44; Shorter C. K., 1896, C BRONTE HER CIRCLE, P124; Smith Margaret, 1995, LETT C BRONTE, Vi, P355	29	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	1474-8932	1745-8226		BRONTE STUD	Bronte Stud.	APR	2015	40		2				85	103		10.1179/1474893215Z.000000000142		19	Literature, British Isles	Literature	CG4WM	WOS:000353288200002		
J	Yamashita, R; Sato, M; Kakumu, T; Hase, T; Yogo, N; Maruyama, E; Sekido, Y; Kondo, M; Hasegawa, Y				Yamashita, Ryo; Sato, Mitsuo; Kakumu, Tomohiko; Hase, Tetsunari; Yogo, Naoyuki; Maruyama, Eiichi; Sekido, Yoshitaka; Kondo, Masashi; Hasegawa, Yoshinori			Growth inhibitory effects of miR-221 and miR-222 in non-small cell lung cancer cells	CANCER MEDICINE			English	Article						Apoptosis; cell cycle; epithelial-mesenchymal transition; lung neoplasms; microRNAs	BRONCHIAL EPITHELIAL-CELLS; TO-MESENCHYMAL TRANSITION; TRAIL RESISTANCE; DNA-DAMAGE; MICRORNAS; SURVIVAL; PROLIFERATION; GAMMA-H2AX; MODULATION; EXPRESSION	Both pro- and anti-oncogenic roles of miR-221 and miR-222 microRNAs are reported in several types of human cancers. A previous study suggested their oncogenic role in invasiveness in lung cancer, albeit only one cell line (H460) was used. To further evaluate involvement of miR-221 and miR-222 in lung cancer, we investigated the effects of miR-221 and miR-222 overexpression on six lung cancer cell lines, including H460, as well as one immortalized normal human bronchial epithelial cell line, HBEC4. miR-221 and miR-222 induced epithelial-to-mesenchymal transition (EMT)-like changes in a minority of HBEC4 cells but, unexpectedly, both the microRNAs rather suppressed their invasiveness. Consistent with the prior report, miR-221 and miR-222 promoted growth in H460; however, miR-221 suppressed growth in four other cell lines with no effects in one, and miR-222 suppressed growth in three cell lines but promoted growth in two. These are the first results to show tumor-suppressive effects of miR-221 and miR-222 in lung cancer cells, and we focused on clarifying the mechanisms. Cell cycle and apoptosis analyses revealed that growth suppression by miR-221 and miR-222 occurred through intra-S-phase arrest and/or apoptosis. Finally, lung cancer cell lines transfected with miR-221 or miR-222 became more sensitive to the S-phase targeting drugs, possibly due to an increased S-phase population. In conclusion, our data are the first to show tumor-suppressive effects of miR-221 and miR-222 on lung cancer, warranting testing their potential as therapeutics for the disease.	[Yamashita, Ryo; Sato, Mitsuo; Kakumu, Tomohiko; Hase, Tetsunari; Yogo, Naoyuki; Maruyama, Eiichi; Kondo, Masashi; Hasegawa, Yoshinori] Nagoya Univ, Dept Resp Med, Grad Sch Med, Showa Ku, Nagoya, Aichi 4668550, Japan; [Sekido, Yoshitaka] Nagoya Univ, Grad Sch Med, Dept Canc Genet, Showa Ku, Nagoya, Aichi 4668550, Japan; [Sekido, Yoshitaka] Aichi Canc Ctr Res Inst, Div Mol Oncol, Chikusa Ku, Nagoya, Aichi 4648681, Japan	Sato, M (reprint author), Nagoya Univ, Dept Resp Med, Grad Sch Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	msato@med.nagoya-u.ac.jp			Japan Society for the Promotion of Science [26670416, 26293197, 23591144]	This work was supported, in part, by a Grant-in-Aid for Exploratory Research 26670416 and a Grant-in-Aid for Scientific Research (B) 26293197 (both to M. Sato), and a Grant-in-Aid for Scientific Research (C) 23591144 (to M. Kondo) from the Japan Society for the Promotion of Science.	Bouyssou JMC, 2014, BBA-REV CANCER, V1845, P255, DOI [10.1016/j.bbcan.2014.02.002, 10.1016/j.bbcan2014.02.002]; Takeyama Y, 2010, CANCER LETT, V296, P216, DOI 10.1016/j.canlet.2010.04.008; Tiwari N, 2012, SEMIN CANCER BIOL, V22, P194, DOI 10.1016/j.semcancer.2012.02.013; Garofalo M, 2008, ONCOGENE, V27, P3845, DOI 10.1038/onc.2008.6; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; [Anonymous], 2009, NUCLEIC ACIDS RES; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Sato M, 2013, MOL CANCER RES, V11, P638, DOI 10.1158/1541-7786.MCR-12-0634-T; Smith J, 2010, ADV CANCER RES, V108, P73, DOI [10.1016/B978-0-12-380888-2.00003-0, 10.1016/S0065.230X(10)08002.4]; Shenouda SK, 2009, CANCER METAST REV, V28, P369, DOI 10.1007/s10555-009-9188-5; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Larsen JE, 2011, CLIN CHEST MED, V32, P703, DOI 10.1016/j.ccm.2011.08.003; Sato M, 2006, CANCER RES, V66, P2116, DOI 10.1158/0008-5472.CAN-05-2521; Olena AF, 2010, J CELL PHYSIOL, V222, P540, DOI 10.1002/jcp.21993; Kneitz B, 2014, CANCER RES, V74, P2591, DOI 10.1158/0008-5472.CAN-13-1606; Howe EN, 2012, J MAMMARY GLAND BIOL, V17, P65, DOI 10.1007/s10911-012-9244-6; Fornari F, 2008, ONCOGENE, V27, P5651, DOI 10.1038/onc.2008.178; Ivashkevich A, 2012, CANCER LETT, V327, P123, DOI 10.1016/j.canlet.2011.12.025; Medina R, 2008, CANCER RES, V68, P2773, DOI 10.1158/0008-5472.CAN-07-6754; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Sato M, 2007, J THORAC ONCOL, V2, P327; Elshazley M, 2012, INT J CANCER, V131, P2820, DOI 10.1002/ijc.27598; Azzoli CG, 2012, J ONCOL PRACT, V8, P63; dasHuang W, 2009, NAT PROTOC, V4, P44; Gandhi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004576; Hase T, 2011, CANCER SCI, V102, P1493, DOI 10.1111/j.1349-7006.2011.01973.x; Horio M., 2011, ANN SURG ONCOL S3, V19, pS634; Matthias E., 2005, NEW ENGL J MED, V352, P23; O'Hara AJ, 2009, BLOOD, V113, P5938, DOI 10.1182/blood-2008-09-179168; Okamoto K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077623; Rounak Nassirpour P. P. M., 2013, PLOS ONE, V8; Stinson S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001538	35	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2045-7634			CANCER MED-US	Cancer Med.	APR	2015	4	4					551	564		10.1002/cam4.412		14	Oncology	Oncology	CG1MR	WOS:000353037300010		
J	Nam, SO; Yotsumoto, F; Miyata, K; Fukagawa, S; Yamada, H; Kuroki, M; Miyamoto, S				Nam, Sung Ouk; Yotsumoto, Fusanori; Miyata, Kohei; Fukagawa, Satoshi; Yamada, Hiromi; Kuroki, Masahide; Miyamoto, Shingo			Warburg effect regulated by amphiregulin in the development of colorectal cancer	CANCER MEDICINE			English	Article						Aerobic glycolysis; amphiregulin; colorectal cancer; glucose metabolism; MLX	GROWTH-FACTOR RECEPTOR; PANCREATIC-CANCER; GLUCOSE-METABOLISM; CELL METABOLISM; EXPRESSION; THERAPY; MLX; GLYCOLYSIS; INDUCTION; METFORMIN	Colorectal cancer (CRC) is one of the most frequently occurring cancers with high morbidity and mortality worldwide. Amphiregulin (AREG), a member of the epidermal growth factor family and a rational target for CRC therapy, is essential for the three-dimensional structure of tumor formation. To clone the genes associated with increased AREG expression, we performed a cDNA microarray analysis in two CRC cell lines undergoing two-dimensional (2DC) and three-dimensional culture (3DC). Upregulated (>2.0-fold) and downregulated (<0.5-fold) genes in 3DC compared with 2DC were selected. Pathway analysis using DAVID based on the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway databases revealed a number of genes involved in glycolysis. In CRC cells, glucose elevated the expression of GLUT1 and AREG as well as the activity of the hypoxia-inducible factor 1 (HIF-1) luciferase reporter promoter. The suppression of AREG expression reduced the uptake of glucose and production of lactate. Luciferase assay identified a critical regulatory region for AREG expression between -130 and -180bp upstream of the start site, which contained a carbohydrate response element (ChoRE). Max-like protein X (MLX) bound to ChoRE and enhanced the expression of AREG. Together these data suggest that AREG plays a pivotal role in the development of CRC through activation of the Warburg effect.	[Nam, Sung Ouk; Miyata, Kohei; Fukagawa, Satoshi; Miyamoto, Shingo] Fukuoka Univ, Fac Med, Dept Obstet & Gynecol, Fukuoka 8140180, Japan; [Nam, Sung Ouk; Yotsumoto, Fusanori; Miyata, Kohei; Fukagawa, Satoshi; Yamada, Hiromi; Kuroki, Masahide; Miyamoto, Shingo] Fukuoka Univ, Cent Res Inst Adv Mol Med, Fukuoka 8140180, Japan; [Yotsumoto, Fusanori; Yamada, Hiromi; Kuroki, Masahide] Fukuoka Univ, Fac Med, Dept Biochem, Fukuoka 8140180, Japan	Miyamoto, S (reprint author), Fukuoka Univ, Fac Med, Dept Obstet & Gynecol, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.	smiya@cis.fukuoka-u.ac.jp			Central Research Institute of Fukuoka University [22790536, 141011, 26670731, 23592470, 26293362]; Center for Advanced Molecular Medicine, Fukuoka University from the Ministry of Education, Culture, Sports, Science and Technology (Tokyo, Japan); Kakihara Science and Technology Foundation (Fukuoka, Japan); Princess Takamatsu Cancer Research Fund	This work was supported in part by a Grant-in-Aid for Young Scientists (B) (no. 22790536), Challenging Exploratory Research (26670731), Scientific Research (C) (no. 23592470), (B) (no. 26293362), and funds from the Central Research Institute (141011) of Fukuoka University; The Center for Advanced Molecular Medicine, Fukuoka University from the Ministry of Education, Culture, Sports, Science and Technology (Tokyo, Japan); a Grant-in-Aid from the Kakihara Science and Technology Foundation (Fukuoka, Japan); and Princess Takamatsu Cancer Research Fund to S. Miyamoto.	Stoltzman CA, 2008, P NATL ACAD SCI USA, V105, P6912, DOI 10.1073/pnas.0712199105; Berasain C, 2005, GASTROENTEROLOGY, V128, P424, DOI 10.1053/j.gastro.2004.11.006; Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087; Russo GL, 2013, BIOCHEM PHARMACOL, V86, P339, DOI 10.1016/j.bcp.2013.05.023; Bi XZ, 2006, MOL CELL PROTEOMICS, V5, P1119, DOI 10.1074/mcp.M500432-MCP200; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Yotsumoto F, 2010, CANCER SCI, V101, P2351, DOI 10.1111/j.1349-7006.2010.01671.x; Sunnarborg SW, 2002, J BIOL CHEM, V277, P12838, DOI 10.1074/jbc.M112050200; Zakikhani M, 2006, CANCER RES, V66, P10269, DOI 10.1158/0008-5472.CAN-06-1500; Dwarakanath BS, 2009, FUTURE ONCOL, V5, P581, DOI [10.2217/fon.09.44, 10.2217/FON.09.44]; EBERT M, 1994, CANCER RES, V54, P3959; Yang WW, 2012, NAT CELL BIOL, V14, P1295, DOI 10.1038/ncb2629; SHOYAB M, 1989, SCIENCE, V243, P1074, DOI 10.1126/science.2466334; Sans CL, 2006, MOL CELL BIOL, V26, P4863, DOI 10.1128/MCB.00657-05; Renehan A, 2010, LANCET, V375, P2201, DOI 10.1016/S0140-6736(10)60706-4; Zhang Y, 2013, CANCER BIOL THER, V14, P81, DOI 10.4161/cbt.22958; Yotsumoto F, 2008, BIOCHEM BIOPH RES CO, V365, P555, DOI 10.1016/j.bbrc.2007.11.015; Belfiore A, 2011, ENDOCR-RELAT CANCER, V18, pR125, DOI 10.1530/ERC-11-0074; Price GS, 1996, CANCER CHEMOTH PHARM, V38, P129, DOI 10.1007/s002800050460; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; CIARDIELLO F, 1991, P NATL ACAD SCI USA, V88, P7792, DOI 10.1073/pnas.88.17.7792; Metukuri MR, 2012, DIABETES, V61, P2004, DOI 10.2337/db11-0802; Velpula KK, 2013, CANCER RES, V73, P7277, DOI 10.1158/0008-5472.CAN-13-1868; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Inatomi O, 2006, INT J MOL MED, V18, P497; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Chai TF, 2011, FEBS LETT, V585, P492, DOI 10.1016/j.febslet.2010.12.033; Shao JY, 2003, CANCER RES, V63, P5218; Szablewski L, 2013, BBA-REV CANCER, V1835, P164, DOI 10.1016/j.bbcan.2012.12.004; Soranna D, 2012, ONCOLOGIST, V17, P813, DOI 10.1634/theoncologist.2011-0462; Stoeckman AK, 2004, J BIOL CHEM, V279, P15662, DOI 10.1074/jbc.M311301200; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; Havula E, 2012, SEMIN CELL DEV BIOL, V23, P640, DOI 10.1016/j.semcdb.2012.02.007; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Chang SH, 2005, CANCER RES, V65, P4496, DOI 10.1158/0008-5472.CAN-05-0129; Boyle T, 2011, CANCER CAUSE CONTROL, V22, P1647, DOI 10.1007/s10552-011-9841-5; Buller CL, 2011, AM J PHYSIOL-RENAL, V301, pF588, DOI 10.1152/ajprenal.00472.2010; Denechaud PD, 2008, J CLIN INVEST, V118, P956, DOI 10.1172/JCI34314; Ganapathy-Kanniappan S, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-152; Jang M, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.85; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Stolzenberg-Solomon RZ, 2005, JAMA-J AM MED ASSOC, V294, P2872, DOI 10.1001/jama.294.22.2872; Vander Heiden MG, 2009, SCIENCE, V324, P1029, DOI DOI 10.1126/SCIENCE.1160809; VansCutsem E, 2009, NEW ENGL J MED, V360, P1408; Yeh CS, 2008, ONCOL REP, V19, P81; Zhou M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-33	50	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2045-7634			CANCER MED-US	Cancer Med.	APR	2015	4	4					575	587		10.1002/cam4.416		13	Oncology	Oncology	CG1MR	WOS:000353037300012		
J	Harada, H; Harada, Y				Harada, Hironori; Harada, Yuka			Recent advances in myelodysplastic syndromes: Molecular pathogenesis and its implications for targeted therapies	CANCER SCIENCE			English	Review						DNA methylation; gene mutations; myelodysplastic syndromes; RNA splicing; RUNX1	ACUTE MYELOID-LEUKEMIA; METHYLTRANSFERASE GENE EZH2; SOMATIC MUTATIONS IDENTIFY; STEM-CELLS; HEMATOPOIETIC DIFFERENTIATION; CLINICAL-SIGNIFICANCE; RECURRENT MUTATIONS; CLONAL ARCHITECTURE; RING SIDEROBLASTS; MONOMAC SYNDROME	Myelodysplastic syndromes (MDS) are defined as stem cell disorders caused by various gene abnormalities. Recent analysis using next-generation sequencing has provided great advances in identifying relationships between gene mutations and clinical phenotypes of MDS. Gene mutations affecting RNA splicing machinery, DNA methylation, histone modifications, transcription factors, signal transduction proteins and components of the cohesion complex participate in the pathogenesis and progression of MDS. Mutations in RNA splicing and DNA methylation occur early and are considered founding mutations, whereas others that occur later are regarded as subclonal mutations. RUNX1 mutations are more likely to subclonal; however, they apparently play a pivotal role in familial MDS. These genetic findings may lead to future therapies for MDS.	[Harada, Hironori; Harada, Yuka] Juntendo Univ, Dept Hematol, Sch Med, Tokyo 1138421, Japan	Harada, H (reprint author), Juntendo Univ, Dept Hematol, Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	hharada@juntendo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Hahn CN, 2011, NAT GENET, V43, P1012, DOI 10.1038/ng.913; Harada H, 2003, BLOOD, V101, P673, DOI 10.1182/blood-2002-04-1010; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Ostergaard P, 2011, NAT GENET, V43, P929, DOI 10.1038/ng.923; Thol F, 2012, BLOOD, V119, P3578, DOI 10.1182/blood-2011-12-399337; Inoue D, 2013, J CLIN INVEST, V123, P4627, DOI 10.1172/JCI70739; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Busque L, 2012, NAT GENET, V44, P1179, DOI 10.1038/ng.2413; Walter MJ, 2013, LEUKEMIA, V27, P1275, DOI 10.1038/leu.2013.58; Woll PS, 2014, CANCER CELL, V25, P794, DOI 10.1016/j.ccr.2014.03.036; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Itzykson R, 2013, BLOOD, V121, P2186, DOI 10.1182/blood-2012-06-440347; Kato N, 2011, BLOOD, V117, P221, DOI 10.1182/blood-2010-02-270181; Harada Y, 2009, J CELL PHYSIOL, V220, P16, DOI 10.1002/jcp.21769; Dickinson RE, 2011, BLOOD, V118, P2656, DOI 10.1182/blood-2011-06-360313; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Wu SJ, 2012, BLOOD, V120, P3106, DOI 10.1182/blood-2012-02-412296; Malcovati L, 2011, BLOOD, V118, P6239, DOI 10.1182/blood-2011-09-377275; Sekeres MA, 2014, BLOOD, V123, P829, DOI 10.1182/blood-2013-08-496935; Papaemmanuil E, 2013, BLOOD, V122, P3616, DOI 10.1182/blood-2013-08-518886; Hsu AP, 2011, BLOOD, V118, P2653, DOI 10.1182/blood-2011-05-356352; Daubner GM, 2012, EMBO J, V31, P162, DOI 10.1038/emboj.2011.367; Watanabe-Okochi N, 2008, BLOOD, V111, P4297, DOI 10.1182/blood-2007-01-068346; Pasquet M, 2013, BLOOD, V121, P822, DOI 10.1182/blood-2012-08-447367; Damm F, 2013, BLOOD, V122, P3169, DOI 10.1182/blood-2012-11-469619; Harada H, 2004, BLOOD, V103, P2316, DOI 10.1182/blood-2003-09-3074; Kulasekararaj AG, 2013, BRIT J HAEMATOL, V162, P587, DOI 10.1111/bjh.12435; Makishima H, 2012, BLOOD, V119, P3203, DOI 10.1182/blood-2011-12-399774; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Bejar R, 2012, J CLIN ONCOL, V30, P3376, DOI 10.1200/JCO.2011.40.7379; Jadersten M, 2011, J CLIN ONCOL, V29, P1971, DOI 10.1200/JCO.2010.31.8576; Jerez A, 2012, BLOOD, V119, P6109, DOI 10.1182/blood-2011-12-397620; Fenaux P, 2013, BLOOD, V121, P4280, DOI 10.1182/blood-2013-02-453068; Bejar R, 2011, NEW ENGL J MED, V364, P2496, DOI 10.1056/NEJMoa1013343; Graubert TA, 2012, NAT GENET, V44, P53, DOI 10.1038/ng.1031; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Kon A, 2013, NAT GENET, V45, P1232, DOI 10.1038/ng.2731; Walter MJ, 2011, LEUKEMIA, V25, P1153, DOI 10.1038/leu.2011.44; Visconte V, 2012, BLOOD, V120, P3173, DOI 10.1182/blood-2012-05-430876; Harada Y, 2013, BLOOD, V121, P3434, DOI 10.1182/blood-2012-06-434423; Haferlach T, 2014, LEUKEMIA, V28, P241, DOI 10.1038/leu.2013.336; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; Liew E, 2011, HAEMATOL-HEMATOL J, V96, P1536, DOI 10.3324/haematol.2011.043422; Traina F, 2014, LEUKEMIA, V28, P78, DOI 10.1038/leu.2013.269; Bejar R, 2014, BLOOD, V124, P2793, DOI 10.1182/blood-2014-04-522136; Bejar R, 2014, BLOOD, V124, P2705, DOI 10.1182/blood-2014-06-582809; Cazzola M, 2013, BLOOD, V121, P260, DOI 10.1182/blood-2012-09-399725; Cazzola M, 2013, BLOOD, V122, P4021, DOI 10.1182/blood-2013-09-381665; Harada Y, 2011, J CELL BIOCHEM, V112, P425, DOI 10.1002/jcb.22974; Jaiswal S, 2014, CANCER CELL, V25, P713, DOI 10.1016/j.ccr.2014.06.001; Kulasekararaj AG, 2014, BLOOD, V124, P2698, DOI 10.1182/blood-2014-05-574889; Malcovati L, 2014, BLOOD, V124, P1513, DOI 10.1182/blood-2014-03-560227; Nakajima H, 2014, CANCER SCI, V105, P1093, DOI 10.1111/cas.12484; Sakurai M, 2014, LEUKEMIA, V28, P2344, DOI 10.1038/leu.2014.136; Sashida G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5177; Taskesen E, 2014, BLOOD, V123, P3327, DOI 10.1182/blood-2013-07-512855; Thota S, 2014, BLOOD, V124, P1790, DOI 10.1182/blood-2014-04-567057; Visconte V, 2015, LEUKEMIA, V29, P188, DOI 10.1038/leu.2014.170; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733; Yoshimi A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5770	61	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	APR	2015	106	4					329	336		10.1111/cas.12614		8	Oncology	Oncology	CG5MQ	WOS:000353336400001		
J	Omoto, Y; Iwase, H				Omoto, Yoko; Iwase, Hirotaka			Clinical significance of estrogen receptor beta in breast and prostate cancer from biological aspects	CANCER SCIENCE			English	Review						Breast cancer; estrogen receptor alpha; estrogen receptor beta; hormone therapy; prostate cancer	MOUSE VENTRAL PROSTATE; RODENT MAMMARY-GLAND; ER-BETA; OPPOSING ROLES; RAT PROSTATE; CELL-LINE; DIFFERENTIAL EXPRESSION; TAMOXIFEN THERAPY; SPLICE VARIANT; ALPHA	Breast and prostate cancers are among the most common of all cancers. They are referred to as hormone-dependent cancers, because estrogen and androgen are involved in their development and growth. The effects of these hormones are mediated by their respective receptors, estrogen receptor (ER) and androgen receptor. Around 18years ago, a second ER, ER, which has a very similar structure to ER, was discovered. Its function has been investigated using a variety of methods and biological systems, leading to our present understanding that ER can interact with or inhibit ER and androgen receptor function directly and/or indirectly, suppress cell growth, and influence responsiveness to endocrine therapy. In order to apply the inhibition of cell growth function to cancer treatment, several specific ER agonists have been synthesized and are being tested for effectiveness in cancer treatment. We need to keep our eyes on ER.	[Omoto, Yoko; Iwase, Hirotaka] Kumamoto Univ, Grad Sch Med Sci, Dept Breast & Endocrine Surg, Kumamoto 8608556, Japan; [Omoto, Yoko] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Endocrinol & Breast Surg, Kyoto, Japan; [Omoto, Yoko] Tanabe Cent Hosp, Dept Breast Surg, Kyotanabe, Japan	Iwase, H (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Breast & Endocrine Surg, 1-1-1 Honjo, Kumamoto 8608556, Japan.	hiwase@kumamoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [26461952, 2459191000]	Ministry of Education, Culture, Sports, Science and Technology of Japan (#26461952). (#2459191000).	Dondi D, 2010, ENDOCR-RELAT CANCER, V17, P731, DOI 10.1677/ERC-10-0032; Roger P, 2001, CANCER RES, V61, P2537; Lau KM, 2000, CANCER RES, V60, P3175; Leav I, 2001, AM J PATHOL, V159, P79, DOI 10.1016/S0002-9440(10)61676-8; Prins GS, 2001, CANCER RES, V61, P6089; Hartman J, 2006, CANCER RES, V66, P11207, DOI 10.1158/0008-5472.CAN-06-0017; Omoto Y, 2002, EUR J CANCER, V38, P380, DOI 10.1016/S0959-8049(01)00383-5; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Forster C, 2002, P NATL ACAD SCI USA, V99, P15578, DOI 10.1073/pnas.192561299; Dey P, 2014, ONCOGENE, V33, P4213, DOI 10.1038/onc.2013.384; Ricke WA, 2008, FASEB J, V22, P1512, DOI 10.1096/fj.07-9526com; Guerini V, 2005, CANCER RES, V65, P5445, DOI 10.1158/0008-5472.CAN-04-1941; Corey E, 2002, CLIN CANCER RES, V8, P1003; Omoto Y, 2005, P NATL ACAD SCI USA, V102, P1484, DOI 10.1073/pnas.0409168102; Hopp TA, 2004, CLIN CANCER RES, V10, P7490, DOI 10.1158/1078-0432.CCR-04-1114; Imamov O, 2004, P NATL ACAD SCI USA, V101, P9375, DOI 10.1073/pnas.0403041101; Bonkhoff H, 2009, EUR UROL, V55, P533, DOI 10.1016/j.eururo.2008.10.035; Weihua Z, 2002, P NATL ACAD SCI USA, V99, P13589, DOI 10.1073/pnas.162477299; Dey P, 2012, MOL ENDOCRINOL, V26, P1991, DOI 10.1210/me.2012.1227; Webb P, 1999, MOL ENDOCRINOL, V13, P1672, DOI 10.1210/me.13.10.1672; Speirs V, 2002, J CLIN PATHOL, V55, P371; Huang B, 2014, P NATL ACAD SCI USA, V111, P1933, DOI 10.1073/pnas.1323719111; Behrens D, 2007, MOL CELL ENDOCRINOL, V274, P19, DOI 10.1016/j.mce.2007.05.012; Nilsson S, 2011, NAT REV DRUG DISCOV, V10, P778, DOI 10.1038/nrd3551; Paech K, 1997, SCIENCE, V277, P1508, DOI 10.1126/science.277.5331.1508; Attia DMA, 2012, PROSTATE, V72, P1013, DOI 10.1002/pros.21507; WALTER P, 1985, P NATL ACAD SCI USA, V82, P7889, DOI 10.1073/pnas.82.23.7889; Mak P, 2010, CANCER CELL, V17, P319, DOI 10.1016/j.ccr.2010.02.030; Fujimura T, 2001, BIOCHEM BIOPH RES CO, V289, P692, DOI 10.1006/bbrc.2001.6038; Pravettoni A, 2007, MOL CELL ENDOCRINOL, V263, P46, DOI 10.1016/j.mce.2006.08.008; Chu S, 1997, MOL CELL ENDOCRINOL, V132, P195, DOI 10.1016/S0303-7207(97)00133-0; Oliveira AG, 2007, STEROIDS, V72, P914, DOI 10.1016/j.steroids.2007.08.001; Ogawa S, 1998, NUCLEIC ACIDS RES, V26, P3505, DOI 10.1093/nar/26.15.3505; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Ellem SJ, 2009, ANN NY ACAD SCI, V1155, P174, DOI 10.1111/j.1749-6632.2009.04360.x; Shaaban AM, 2008, CLIN CANCER RES, V14, P5228, DOI 10.1158/1078-0432.CCR-07-4528; Paruthiyil S, 2004, CANCER RES, V64, P423, DOI 10.1158/0008-5472.CAN-03-2446; Murphy LC, 2005, J MOL ENDOCRINOL, V34, P553, DOI 10.1677/jme.1.01688; Fritz WA, 2002, MOL CELL ENDOCRINOL, V186, P89, DOI 10.1016/S0303-7207(01)00663-3; Saji S, 2000, P NATL ACAD SCI USA, V97, P337, DOI 10.1073/pnas.97.1.337; Celhay O, 2010, J UROLOGY, V184, P2172, DOI 10.1016/j.juro.2010.06.089; Horvath LG, 2001, CANCER RES, V61, P5331; Cheng GJ, 2004, P NATL ACAD SCI USA, V101, P3739, DOI 10.1073/pnas.0307864100; Honma N, 2008, J CLIN ONCOL, V26, P3727, DOI 10.1200/JCO.2007.14.2968; Cheng J, 2004, FEBS LETT, V566, P169, DOI 10.1016/j.febslet.2004.04.025; McPherson SJ, 2010, P NATL ACAD SCI USA, V107, P3123, DOI 10.1073/pnas.0905524107; BARNES ROGER W., 1959, CALIFORNIA MED, V91, P57; BEEKMAN JM, 1993, MOL ENDOCRINOL, V7, P1266, DOI 10.1210/me.7.10.1266; Cappelletti V, 2004, ENDOCR-RELAT CANCER, V11, P761, DOI 10.1677/erc.1.00822; Chang WY, 1999, PROSTATE, V40, P115; Ciruelos G, 2014, CANC TREAT REV, V40, P862, DOI [10.1016/j.ctrv.2014.03.004, DOI 10.1016/J.CTRV.2014.03.004]; Helguero LA, 2008, CANCER RES, V68, P8695, DOI 10.1158/0008-5472.CAN-08-0788; HORNING ES, 1949, BRIT J CANCER, V3, P211, DOI 10.1038/bjc.1949.22; Huggins C, 1943, SCIENCE, V97, P541, DOI 10.1126/science.97.2529.541; Iwase H, 2003, CANCER CHEMOTH PHARM, V52, pS34, DOI 10.1007/s00280-003-0592-1; Jerusalem Guy, 2014, Breast Cancer (Dove Med Press), V6, P43, DOI 10.2147/BCTT.S38679; Lamartiniere CA, 2002, J NUTR, V132, p552S; Lin CY, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1667; Muthusamy S, 2011, P NATL ACAD SCI USA, V108, P20090, DOI 10.1073/pnas.1117772108; Omoto Y, 2003, ONCOGENE, V22, P5011, DOI 10.1038/sj.onc.1206787; Omoto Y, 2008, ENDOCRINOLOGY, V149, P4421, DOI 10.1210/en.2007-1413; Palmieri C, 2004, J MOL ENDOCRINOL, V33, P35, DOI 10.1677/jme.0.0330035; Pasquali D, 2001, MOL CELL ENDOCRINOL, V178, P47, DOI 10.1016/S0303-7207(01)00418-X; Petersen DN, 1998, ENDOCRINOLOGY, V139, P1082, DOI 10.1210/en.139.3.1082; Porter W, 1997, MOL ENDOCRINOL, V11, P1569, DOI 10.1210/me.11.11.1569; Prins GS, 1997, ENDOCRINOLOGY, V138, P1801, DOI 10.1210/en.138.5.1801; Risbridger G, 2001, DEV BIOL, V229, P432, DOI 10.1006/dbio.2000.9994; Saji S, 2002, CANCER RES, V62, P4849; Savolainen S, 2007, AM J PATHOL, V171, P1013, DOI 10.2353/ajpath.2007.060979; Slater M, 2002, PROSTATE CANCER P D, V5, P16, DOI 10.1038/sj/pcan/4500546; SUPERTIFURGA G, 1991, P NATL ACAD SCI USA, V88, P5114, DOI 10.1073/pnas.88.12.5114; Thellenberg-Karlsson C, 2006, CLIN CANCER RES, V12, P1936, DOI 10.1158/1078-0432.CCR-05-0269; Toren P, 2014, INT J ONCOL, V45, P1793, DOI 10.3892/ijo.2014.2601; Vinayagam R, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-131; Wang LJ, 2013, ONCOL REP, V29, P1563, DOI 10.3892/or.2013.2245; Weihua Zhang, 2001, Proceedings of the National Academy of Sciences of the United States of America, V98, P6330, DOI 10.1073/pnas.111150898	76	1	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	APR	2015	106	4					337	343		10.1111/cas.12613		7	Oncology	Oncology	CG5MQ	WOS:000353336400002		
J	Utsunomiya, A; Choi, I; Chihara, D; Seto, M				Utsunomiya, Atae; Choi, Ilseung; Chihara, Dai; Seto, Masao			Recent advances in the treatment of adult T-cell leukemia-lymphomas	CANCER SCIENCE			English	Review						Adult T-cell leukemia-lymphoma; allogeneic hematopoietic stem cell transplantation; antiviral therapy; chemotherapy; molecular targeted therapy	VIRUS TYPE-I; MONOCLONAL-ANTIBODY KW-0761; INTERFERON-ALPHA; UNITED-STATES; LEUKEMIA/LYMPHOMA; TRANSPLANTATION; HTLV-1; JAPAN; EXPRESSION; ZIDOVUDINE	Recent advances in treatment for adult T-cell leukemia-lymphoma (ATL) are reviewed herein. It is currently possible to select a therapeutic strategy for ATL and predict prognosis by classification of patients by clinical subtypes and clinicopathological factors. Although the overall survival (OS) of patients with ATL has increased marginally because of advances in chemotherapy, further prolongation of survival might be difficult with conventional chemotherapy alone. Promising results have been reported for antiviral therapy using zidovudine and interferon-, and, indeed, antiviral therapy is currently the standard treatment for patients with ATL in western countries. Remarkably, the 5-year OS rates are 100% for both the smoldering-type and chronic-type ATL. Recently, treatments for ATL have included allogeneic hematopoietic stem cell transplantation and molecular targeted therapies. Furthermore, the anti-CCR4 monoclonal antibody mogamulizumab has been shown to have marked cytotoxic effects on ATL cells, especially in the leukemic type of ATL. In the lymphoma type of ATL, the response rate may be improved by combining mogamulizumab with chemotherapy. It should be recognized that prevention of infection from carriers of human T-cell leukemia virus type-I and transfer of the virus from mother to infant are crucial issues for the eradication of ATL.	[Utsunomiya, Atae] Imamura Bun in Hosp, Dept Hematol, Kagoshima 8900064, Japan; [Choi, Ilseung] Kyushu Natl Canc Ctr, Dept Hematol, Fukuoka, Japan; [Chihara, Dai] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 464, Japan; [Seto, Masao] Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka 830, Japan; [Seto, Masao] Immuno Biol Labs, Dept Pharmaceut Dev, Fujioka 8900064, Japan	Utsunomiya, A (reprint author), Imamura Bun in Hosp, Dept Hematol, 11-23 Kamoikeshinmachi, Kagoshima 8900064, Japan.	autsunomiya@jiaikai.jp			Ministry of Health, Labor, and Welfare of Japan [H22-Ganrinsho-Ippan-028]; Japan Society for the Promotion of Science [24390249]	Ministry of Health, Labor, and Welfare of Japan (#H22-Ganrinsho-Ippan-028). Japan Society for the Promotion of Science (#24390249).	MURPHY EL, 1989, INT J CANCER, V43, P250, DOI 10.1002/ijc.2910430214; Ishida T, 2003, CLIN CANCER RES, V9, P3625; Chihara D, 2014, BRIT J HAEMATOL, V164, P536, DOI 10.1111/bjh.12659; Bangham CRM, 2014, SEMIN CANCER BIOL, V26, P89, DOI 10.1016/j.semcancer.2013.11.003; Kannagi M, 2005, CANCER SCI, V96, P249, DOI 10.1111/j.1349-7006.2005.00050.x; Yoshida M, 2001, ANNU REV IMMUNOL, V19, P475, DOI 10.1146/annurev.immunol.19.1.475; Tsukasaki K, 2007, J CLIN ONCOL, V25, P5458, DOI 10.1200/JCO.2007.11.9958; Umino A, 2011, BLOOD, V117, P5473, DOI 10.1182/blood-2010-12-327791; Proietti FA, 2005, ONCOGENE, V24, P6058, DOI 10.1038/sj.onc.1208968; Ishii T, 2010, CLIN CANCER RES, V16, P1520, DOI 10.1158/1078-0432.CCR-09-2697; Ishida T, 2012, J CLIN ONCOL, V30, P837, DOI 10.1200/JCO.2011.37.3472; Satake M, 2012, J MED VIROL, V84, P327, DOI 10.1002/jmv.23181; UCHIYAMA T, 1977, BLOOD, V50, P481; Satou Y, 2004, LEUKEMIA, V18, P1357, DOI 10.1038/sj.leu.2403400; Bazarbachi A, 2010, J CLIN ONCOL, V28, P4177, DOI 10.1200/JCO.2010.28.0669; SHIMOYAMA M, 1991, BRIT J HAEMATOL, V79, P428, DOI 10.1111/j.1365-2141.1991.tb08051.x; Katsuya H, 2012, J CLIN ONCOL, V30, P1635, DOI 10.1200/JCO.2011.38.2101; Ishida T, 2012, BLOOD, V120, P1734, DOI 10.1182/blood-2012-03-414490; Kinpara S, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-52; SHIMOYAMA M, 1991, LEUKEMIA RES, V15, P81; Iwanaga M, 2010, BLOOD, V116, P1211, DOI 10.1182/blood-2009-12-257410; Takasaki Y, 2010, BLOOD, V115, P4337, DOI 10.1182/blood-2009-09-242347; HERMINE O, 1995, NEW ENGL J MED, V332, P1749, DOI 10.1056/NEJM199506293322604; OKAMOTO T, 1989, JPN J CANCER RES, V80, P191; Utsunomiya A, 2001, BONE MARROW TRANSPL, V27, P15, DOI 10.1038/sj.bmt.1702731; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Yonekura K, 2008, BONE MARROW TRANSPL, V41, P1029, DOI 10.1038/bmt.2008.39; Bazarbachi A, 2011, BLOOD, V118, P1736, DOI 10.1182/blood-2011-03-345702; GILL PS, 1995, NEW ENGL J MED, V332, P1744, DOI 10.1056/NEJM199506293322603; Bazarbachi A, 2014, BONE MARROW TRANSPL, V49, P1266, DOI 10.1038/bmt.2014.143; Chihara D, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.57; Chihara D, 2012, CANCER SCI, V103, P1857, DOI 10.1111/j.1349-7006.2012.02373.x; Choi I, 2011, BONE MARROW TRANSPL, V46, P116, DOI 10.1038/bmt.2010.92; Harashima N, 2004, CANCER RES, V64, P391, DOI 10.1158/0008-5472.CAN-03-1452; Hematopoietic Cell Transplantation in Japan, 2014, HEM CELL TRANSPL JAP; Hishizawa M, 2011, BLOOD, V116, P1369; Ishida T, 2015, BR J HAEMAT IN PRESS; Ishitsuka K, 2014, LANCET ONCOL, V15, pE517, DOI 10.1016/S1470-2045(14)70202-5; Itonaga H, 2013, BLOOD, V121, P219, DOI 10.1182/blood-2012-07-444372; Kanda J, 2012, BLOOD, V119, P2141, DOI 10.1182/blood-2011-07-368233; Nishioka C, 2008, LEUKEMIA RES, V32, P287, DOI 10.1016/j.leukres.2007.05.026; Ohno N, 2001, BLOOD, V98, P1160, DOI 10.1182/blood.V98.4.1160; Okamura J, 2005, BLOOD, V105, P4143, DOI 10.1182/blood-2004-11-4193; Shimoyama M, 1994, ADULT T CELL LEUKEMI, P221; Suehiro Y, 2015, BRIT J HAEMATOL, V169, P356, DOI 10.1111/bjh.13302; Tsukasaki K, 1999, BONE MARROW TRANSPL, V23, P87, DOI 10.1038/sj.bmt.1701533; Tsukasaki K, 2012, LEUK RES TREATMENT, V2012; Tsukasaki K, 2012, JPN J CLIN ONCOL, V42, P85, DOI 10.1093/jjco/hyr168; Uozumi Kimiru, 2010, J Clin Exp Hematop, V50, P9; Zhao TJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00247	50	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	APR	2015	106	4					344	351		10.1111/cas.12617		8	Oncology	Oncology	CG5MQ	WOS:000353336400003		
J	Sakurai, T; Yada, N; Watanabe, T; Arizumi, T; Hagiwara, S; Ueshima, K; Nishida, N; Fujita, J; Kudo, M				Sakurai, Toshiharu; Yada, Norihisa; Watanabe, Tomohiro; Arizumi, Tadaaki; Hagiwara, Satoru; Ueshima, Kazuomi; Nishida, Naoshi; Fujita, Jun; Kudo, Masatoshi			Cold-inducible RNA-binding protein promotes the development of liver cancer	CANCER SCIENCE			English	Article						CD133; HCC; recurrence; ROS; stem cell	SIGNAL-REGULATED KINASE; NEURAL STEM-CELLS; HEPATOCELLULAR-CARCINOMA; OXIDATIVE STRESS; CHEMICAL HEPATOCARCINOGENESIS; COMPENSATORY PROLIFERATION; STAT3 ACTIVATION; SELF-RENEWAL; CIRP; INFLAMMATION	Most hepatocellular carcinomas (HCCs) develop in the context of chronic liver inflammation. Oxidative stress is thought to play a major role in the pathogenesis of HCC development. In this study, we examined whether cold-inducible RNA-binding protein (Cirp) controls reactive oxygen species (ROS) accumulation and development of HCC by using murine models of hepatocarcinogenesis and human liver samples. Cirp expression, ROS accumulation, and CD133 expression were increased in the liver of tumor-harboring mice. Cirp deficiency reduced production of interleukin-1 and interleukin-6 in Kupffer cells, ROS accumulation, and CD133 expression, leading to attenuated hepatocarcinogenesis. Thioacetamide treatment enhanced hepatic expression of CD133 and phosphorylated signal transducer and activator of transcription 3 (STAT3), which was prevented by treatment with the antioxidant butylated hydroxyanisole. Intriguingly, the risk of human HCC recurrence is positively correlated with Cirp expression in liver. Cirp appears to play a critical carcinogenic function and its expression might be a useful biomarker for HCC risk prediction.	[Sakurai, Toshiharu; Yada, Norihisa; Arizumi, Tadaaki; Hagiwara, Satoru; Ueshima, Kazuomi; Nishida, Naoshi; Kudo, Masatoshi] Kinki Univ, Dept Gastroenterol & Hepatol, Fac Med, Osaka, Osaka 5898511, Japan; [Watanabe, Tomohiro] Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Kyoto, Japan; [Fujita, Jun] Kyoto Univ, Grad Sch Med, Dept Clin Mol Biol, Kyoto, Japan	Sakurai, T (reprint author), Kinki Univ, Dept Gastroenterol & Hepatol, Fac Med, 377-2 Ohno Higashi, Osaka, Osaka 5898511, Japan.	sakurai@med.kindai.ac.jp; m-kudo@med.kindai.ac.jp			Yasuda Medical Foundation; Takeda Science Foundation; Japan Foundation for Research and Promotion of Endoscopy; Japan Society for the Promotion of Science	Yasuda Medical Foundation; Takeda Science Foundation; Japan Foundation for Research and Promotion of Endoscopy; Japan Society for the Promotion of Science.	Saito K, 2010, BRAIN RES, V1358, P20, DOI 10.1016/j.brainres.2010.08.048; White DL, 2012, CLIN GASTROENTEROL H, V10, P1342, DOI 10.1016/j.cgh.2012.10.001; AMES BN, 1983, SCIENCE, V221, P1256, DOI 10.1126/science.6351251; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Boumahdi S, 2014, NATURE, V511, P246, DOI 10.1038/nature13305; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Qiang XL, 2013, NAT MED, V19, P1489, DOI 10.1038/nm.3368; Woo RA, 2004, GENE DEV, V18, P1317, DOI 10.1101/gad.1165204; Moudgil V, 2013, J ENVIRON PATHOL TOX, V32, P165; Myant KB, 2013, CELL STEM CELL, V12, P761, DOI 10.1016/j.stem.2013.04.006; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Sakurai T, 2006, P NATL ACAD SCI USA, V103, P10544, DOI 10.1073/pnas.0603499103; Smith J, 2000, P NATL ACAD SCI USA, V97, P10032, DOI 10.1073/pnas.170209797; Nikolaou K, 2013, CLIN CANCER RES, V19, P2810, DOI 10.1158/1078-0432.CCR-12-1961; De Leeuw F, 2007, EXP CELL RES, V313, P4130, DOI 10.1016/j.yexcr.2007.09.017; Sakurai T, 2006, BBA-MOL CELL RES, V1763, P290, DOI 10.1016/j.bbamcr.2006.02.007; Liu KC, 2013, CELL STEM CELL, V12, P304, DOI 10.1016/j.stem.2013.01.007; Wellmann S, 2004, J CELL SCI, V117, P1785, DOI 10.1242/jcs.01026; Morf J, 2012, SCIENCE, V338, P379, DOI 10.1126/science.1217726; Artero-Castro A, 2009, MOL CELL BIOL, V29, P1855, DOI 10.1128/MCB.01386-08; Sakurai T, 2013, CANCER RES, V73, P215, DOI 10.1158/0008-5472.CAN-12-1602; Grek CL, 2010, CURR OPIN PHARMACOL, V10, P362, DOI 10.1016/j.coph.2010.05.003; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; He GB, 2010, CANCER CELL, V17, P286, DOI 10.1016/j.ccr.2009.12.048; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Sakurai T, 2008, CANCER CELL, V14, P156, DOI 10.1016/j.ccr.2008.06.016; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Fujita Jun, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P243; GUPTA DN, 1955, NATURE, V175, P257, DOI 10.1038/175257a0; Imamura H, 2003, J HEPATOL, V38, P200, DOI 10.1016/S0168-8278(02)00360-4; Kim DY, 2012, LIVER CANC, V1, P2, DOI DOI 10.1159/000339016; Lengerke C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-42; Lo Regina Cheuk-Lam, 2013, Liver Cancer, V2, P84, DOI 10.1159/000343844; Masuda T, 2012, P NATL ACAD SCI USA, V109, P10885, DOI 10.1073/pnas.1121524109; Myung SJ, 2012, BIOMED PHARMACOTHER, V66, P612, DOI 10.1016/j.biopha.2012.08.011; Nishiyama H, 1997, J CELL BIOL, V137, P899, DOI 10.1083/jcb.137.4.899; Oishi Naoki, 2014, Liver Cancer, V3, P71, DOI 10.1159/000343863; Qi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028486; Parola M, 2001, J HEPATOL, V35, P297, DOI 10.1016/S0168-8278(01)00142-8; Sakurai Toshiharu, 2013, Liver Cancer, V2, P365, DOI 10.1159/000343851; Sakurai T, 2014, CANCER RES, V74, P6119, DOI 10.1158/0008-5472.CAN-14-0471; Yang CL, 2001, J BIOL CHEM, V276, P47277, DOI 10.1074/jbc.M105396200; Yang RQ, 2006, NUCLEIC ACIDS RES, V34, P1224, DOI 10.1093/nar/gkj519; ZIMMERMANN T, 1987, Z VERSUCHSTIERKD, V30, P165	46	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	APR	2015	106	4					352	358		10.1111/cas.12611		7	Oncology	Oncology	CG5MQ	WOS:000353336400004		
J	Yamaguchi, T; Kurita, T; Nishio, K; Tsukada, J; Hachisuga, T; Morimoto, Y; Iwai, Y; Izumi, H				Yamaguchi, Takahiro; Kurita, Tomoko; Nishio, Kazuto; Tsukada, Junichi; Hachisuga, Toru; Morimoto, Yasuo; Iwai, Yoshiko; Izumi, Hiroto			Expression of BAF57 in ovarian cancer cells and drug sensitivity	CANCER SCIENCE			English	Article						Anticancer agents; BAF57; BCRP; cell cycle; chemotherapy	MULTIDRUG-RESISTANCE PROTEINS; MITOCHONDRIAL TRANSCRIPTION FACTOR; BREAST-CANCER; THERAPEUTIC STRATEGIES; SWI/SNF; ABCG2; HMG; LINES; 5-FLUOROURACIL; PROLIFERATION	The SMARCE1 (SWI / SNF-related, matrix-associated, and actin-dependent regulator of chromatin, subfamily e, member 1) encodes BAF57 protein. Previously, we reported that BAF57 is a predictive marker of endometrial carcinoma. In this study, we investigated BAF57 expression in ovarian cancer cell lines and their sensitivities to cisplatin, doxorubicin, paclitaxel, and 5-fluorouracil. BAF57 expression was strongly correlated with sensitivities to cisplatin, doxorubicin, and 5-fluorouracil in 10 ovarian cancer cell lines. Paclitaxel sensitivity was also correlated with BAF57 expression, but without significance. In A2780 ovarian cancer cells, knockdown of BAF57 using specific siRNA increased cell cycle arrest at G(1) phase and the sensitivities to these anticancer agents. cDNA microarray analysis of A2780 cells transfected with BAF57 siRNA showed that 134 genes were positively regulated by BAF57, including ATP-binding cassette, sub-family G (WHITE), member 2 (ABCG2) encoding breast cancer resistance protein (BCRP). We confirmed that knockdown of BAF57 decreased BCRP expression in ovarian cancer cells by Western blot analysis, and that ABCG2 gene expression might be regulated transcriptionally. These results suggested that BAF57 is involved in ovarian cancer cell growth and sensitivity to anticancer agents, and that BAF57 may be a target for ovarian cancer therapy. BAF57 expression was strongly correlated with sensitivities to cisplatin, doxorubicin, and 5-FU in 10 ovarian cancer cell lines. We found that BAF57 might be associated with cell cycle and transport of anti-cancer agents.	[Yamaguchi, Takahiro; Tsukada, Junichi] Univ Occupat & Environm Hlth, Hematol, Kitakyushu, Fukuoka 8058555, Japan; [Kurita, Tomoko; Hachisuga, Toru] Univ Occupat & Environm Hlth, Dept Obstet & Gynecol, Kitakyushu, Fukuoka 8058555, Japan; [Nishio, Kazuto] Kinki Univ, Fac Med, Dept Genome Biol, Higashiosaka, Osaka 577, Japan; [Morimoto, Yasuo; Izumi, Hiroto] Univ Occupat & Environm Hlth, Dept Occupat Pneumol, Kitakyushu, Fukuoka 8058555, Japan; [Iwai, Yoshiko] Univ Occupat & Environm Hlth, Dept Mol Biol, Kitakyushu, Fukuoka 8058555, Japan	Izumi, H (reprint author), Univ Occupat & Environm Hlth, Inst Ind Ecol Sci, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8058555, Japan.	h-izumi@med.uoeh-u.ac.jp					Jayson GC, 2014, LANCET, V384, P1376, DOI 10.1016/S0140-6736(13)62146-7; Takahashi M, 2010, CANCER SCI, V101, P1367, DOI 10.1111/j.1349-7006.2010.01534.x; Jemal A, 2002, CA-CANCER J CLIN, V52, P23; Kurita T, 2012, CANCER SCI, V103, P239, DOI 10.1111/j.1349-7006.2011.02156.x; Link KA, 2008, CANCER RES, V68, P4551, DOI 10.1158/0008-5472.CAN-07-6392; Chen ZS, 2011, FEBS J, V278, P3226, DOI 10.1111/j.1742-4658.2011.08235.x; Jedlitschky G, 2006, EXPERT OPIN DRUG MET, V2, P351, DOI 10.1517/17425255.2.3.351; Robey RW, 2009, ADV DRUG DELIVER REV, V61, P3, DOI 10.1016/j.addr.2008.11.003; Ni ZL, 2010, CURR DRUG METAB, V11, P603; Foley OW, 2013, ONCOLOGY-NY, V27, P288; Baumann KH, 2012, FUTURE ONCOL, V8, P1135, DOI [10.2217/fon.12.112, 10.2217/FON.12.112]; WEIR HM, 1993, EMBO J, V12, P1311; Chi TH, 2002, NATURE, V418, P195, DOI 10.1038/nature00876; Izumi H, 2010, CANCER SCI, V101, P2538, DOI 10.1111/j.1349-7006.2010.01725.x; Sakai Y, 2011, J BIOSCI BIOENG, V111, P85, DOI 10.1016/j.jbiosc.2010.08.014; Zhang N, 2008, MOLECULES, V13, P1551, DOI 10.3390/molecules13081551; Igarashi T, 2007, ONCOGENE, V26, P4749, DOI 10.1038/sj.onc.1210289; Kashiwagi E, 2011, CANCER SCI, V102, P382, DOI 10.1111/j.1349-7006.2010.01784.x; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Slot AJ, 2011, ESSAYS BIOCHEM, V50, P179, DOI [10.1042/bse0500179, 10.1042/BSE0500179]; Soullier S, 1999, J MOL EVOL, V48, P517, DOI 10.1007/PL00006495; Elowe S, 2011, MOL CELL BIOL, V31, P3085, DOI 10.1128/MCB.05326-11; Han B, 2011, BIOCHEM BIOPH RES CO, V408, P45, DOI 10.1016/j.bbrc.2011.03.114; Izumi H, 2011, CANCER SCI, V102, P1007, DOI 10.1111/j.1349-7006.2011.01908.x; Yuan JH, 2009, CANCER CHEMOTH PHARM, V63, P1103, DOI 10.1007/s00280-008-0838-z; Ceckova M, 2008, TOXICOL IN VITRO, V22, P1846, DOI 10.1016/j.tiv.2008.09.001; Chen Z, 2010, INT J CANCER, V126, P841, DOI 10.1002/ijc.24796; dusBois A, 2001, EJC SUPPL, V37, pS1; Guo CH, 2006, MOL CANCER RES, V4, P957, DOI 10.1158/1541-7786.MCR-06-0168; Hah N, 2010, CANCER RES, V70, P4402, DOI 10.1158/0008-5472.CAN-09-2767; Kagami S, 2012, HISTOL HISTOPATHOL, V27, P593; Kim A, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-14; Kiskinis E, 2006, BREAST CANCER RES TR, V98, P191, DOI 10.1007/s10549-005-9149-9; LANDSMAN D, 1991, MOL CELL BIOL, V11, P4483; Link KA, 2005, MOL CELL BIOL, V25, P2200, DOI 10.1128/MCB.25.6.2200-2215.2005; Mei L, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007414.pub3; Muchardt C, 2001, ONCOGENE, V20, P3067, DOI 10.1038/sj.onc.1204331; Noguchi Kohji, 2014, Pharmgenomics Pers Med, V7, P53, DOI 10.2147/PGPM.S38295; O'Flaherty E, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-13; Takeda T, 2014, TUMOR BIOL, V35, P10555, DOI 10.1007/s13277-014-2328-8; Xie J, 2014, AM J CANCER RES, V4, P698; Yoshida Y, 2011, J PHYS CHEM BIOPHYS, V1, P101	42	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	APR	2015	106	4					359	366		10.1111/cas.12612		8	Oncology	Oncology	CG5MQ	WOS:000353336400005		
J	Sakamoto, S; Inoue, H; Ohba, S; Kohda, Y; Usami, I; Masuda, T; Kawada, M; Nomoto, A				Sakamoto, Shuichi; Inoue, Hiroyuki; Ohba, Shunichi; Kohda, Yasuko; Usami, Ihomi; Masuda, Tohru; Kawada, Manabu; Nomoto, Akio			New metastatic model of human small-cell lung cancer by orthotopic transplantation in mice	CANCER SCIENCE			English	Article						Hepatocyte growth factor; MET; metastasis; orthotopic transplantation; small-cell lung cancer	HEPATOCYTE GROWTH-FACTOR; ANTITUMOR-ACTIVITY; TYROSINE KINASE; MOUSE MODELS; NUDE-MICE; IN-VITRO; ARQ 197; MET; CARCINOMA; INHIBITOR	Small-cell lung cancer (SCLC) is an aggressive cancer with high metastatic ability and novel strategies against the metastasis are urgently needed to improve SCLC treatment. However, the mechanism of metastasis of SCLC remains largely to be elucidated. For further studies of SCLC metastasis, we developed a new orthotopic transplantation model in mice. We established a GFP-labeled subline from the human SCLC cell line DMS273 and transplanted them orthotopically into the lung of nude mice with Matrigel. The GFP-labeled cells showed significant metastatic activity and formed metastatic foci in distant tissues such as bone, kidney, and brain, as observed in SCLC patients. From a bone metastasis focus of the mouse, we isolated another subline, termed G3H, with enhanced metastatic potential and higher hepatocyte growth factor (HGF) expression than the parental line. Further studies indicated that the HGF/MET signaling pathway was involved in in vitro motility and invasion activities of the G3H cells and treatments with MET inhibitors decreased formation of distant metastases in our orthotopic model using G3H cells. These data indicated that our model mimics the clinical aspect of SCLC such as metastatic tropism and autocrine of HGF/MET signaling. Compared with other orthotopic SCLC models, our model has a superior ability to form distant metastases. Therefore, our model will provide a valuable tool for the study of SCLC metastasis.	[Sakamoto, Shuichi; Inoue, Hiroyuki; Ohba, Shunichi; Kohda, Yasuko; Usami, Ihomi; Masuda, Tohru; Kawada, Manabu; Nomoto, Akio] Inst Microbial Chem, Numazu, Japan	Kawada, M (reprint author), Inst Microbial Chem, 18-24 Miyamoto, Shizuoka 4100301, Japan.	kawadam@bikaken.or.jp			Japan Society for the Promotion of Science [23790452, 26460481]	Japan Society for the Promotion of Science (23790452). (26460481).	PRICE JE, 1990, CANCER RES, V50, P717; Christensen JG, 2003, CANCER RES, V63, P7345; Daniel VC, 2009, CANCER RES, V69, P3364, DOI 10.1158/0008-5472.CAN-08-4210; Dan S, 2010, CANCER RES, V70, P4982, DOI 10.1158/0008-5472.CAN-09-4172; Maulik G, 2002, CLIN CANCER RES, V8, P620; William WN, 2011, NAT REV CLIN ONCOL, V8, P611, DOI 10.1038/nrclinonc.2011.90; Munshi N, 2010, MOL CANCER THER, V9, P1544, DOI 10.1158/1535-7163.MCT-09-1173; Hoffman RM, 1999, INVEST NEW DRUG, V17, P343, DOI 10.1023/A:1006326203858; Jacoby JJ, 2010, J THORAC ONCOL, V5, P940, DOI 10.1097/JTO.0b013e3181dc211f; Pedersen N, 2003, CANCER RES, V63, P1943; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Nicholson SA, 2002, AM J SURG PATHOL, V26, P1184, DOI 10.1097/01.PAS.0000022995.91977.CD; Katayama R, 2013, CANCER RES, V73, P3087, DOI 10.1158/0008-5472.CAN-12-3256; Hann CL, 2007, TRENDS MOL MED, V13, P150, DOI 10.1016/j.molmed.2007.02.003; Smolen GA, 2006, P NATL ACAD SCI USA, V103, P2316, DOI 10.1073/pnas.0508776103; CARNEY DN, 1985, CANCER RES, V45, P2913; Ghiso E, 2013, CURR OPIN PHARMACOL, V13, P511, DOI 10.1016/j.coph.2013.05.018; Ma PC, 2007, BRIT J CANCER, V97, P368, DOI 10.1038/sj.bjc.6603884; Arriola E, 2011, BRIT J CANCER, V105, P814, DOI 10.1038/bjc.2011.298; Bharti A, 2004, ANTICANCER RES, V24, P1031; Isobe T, 2013, J THORAC ONCOL, V8, P140, DOI 10.1097/JTO.0b013e3182725ff9; Ma PC, 2003, CANCER RES, V63, P6272; Onn A, 2003, CLIN CANCER RES, V9, P5532; PETTENGILL OS, 1980, EXP CELL BIOL, V48, P279; SHTIVELMAN E, 1995, P NATL ACAD SCI USA, V92, P4661, DOI 10.1073/pnas.92.10.4661; Takigawa N, 1997, LUNG CANCER-J IASLC, V17, P211, DOI 10.1016/S0169-5002(97)00651-X	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	APR	2015	106	4					367	374		10.1111/cas.12624		8	Oncology	Oncology	CG5MQ	WOS:000353336400006		
J	Hata, K; Tochigi, T; Sato, I; Kawamura, S; Shiozaki, K; Wada, T; Takahashi, K; Moriya, S; Yamaguchi, K; Hosono, M; Miyagi, T				Hata, Keiko; Tochigi, Tatsuo; Sato, Ikuro; Kawamura, Sadafumi; Shiozaki, Kazuhiro; Wada, Tadashi; Takahashi, Kohta; Moriya, Setsuko; Yamaguchi, Kazunori; Hosono, Masahiro; Miyagi, Taeko			Increased sialidase activity in serum of cancer patients: Identification of sialidase and inhibitor activities in human serum	CANCER SCIENCE			English	Article						Cancer serum; diagnostic marker; ganglioside; prostate cancer; sialidase	MEMBRANE-ASSOCIATED SIALIDASE; HUMAN COLON-CANCER; GANGLIOSIDE SIALIDASE; APOPTOSIS SUPPRESSION; CYTOSOLIC SIALIDASE; MOLECULAR-CLONING; PROSTATE-CANCER; EXPRESSION; NEU3; MICRODOMAINS	Aberrant sialylation in glycoproteins and glycolipids is a characteristic feature of malignancy. Human sialidases, which catalyze the removal of sialic acid residues from glycoconjugates, have been implicated in cancer progression. They have been detected in a wide variety of human cells and tissues, but few studies have focused on their existence in human serum. Among the four types identified to date, we previously demonstrated that plasma membrane-associated ganglioside sialidase (NEU3) is markedly upregulated in various human cancers, including examples in the colon and prostate. Here, using a sensitive assay method, we found a significant increase of sialidase activity in the serum of patients with prostate cancer compared with that in healthy subjects having low activity, if any. Activity was apparent with gangliosides as substrates, but only to a very limited extent with 4-methylumbelliferyl sialic acid, a good synthetic substrate for sialidases other than human NEU3. The serum sialidase was also almost entirely immunoprecipitated with anti-NEU3 antibody, but not with antibodies for other sialidases. Interestingly, sera additionally contained inhibitory activity against the sialidase and also against recombinant human NEU3. The sialidase and inhibitor activities could be separated by exosome isolation and by hydrophobic column chromatography. The serum sialidase was assessed by a sandwich ELISA method using two anti-NEU3 antibodies. The results provide strong evidence that the serum sialidase is, in fact, NEU3, and this subtype may, therefore, be a potential utility for novel diagnosis of human cancers.	[Hata, Keiko; Wada, Tadashi; Takahashi, Kohta; Moriya, Setsuko; Miyagi, Taeko] Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Canc Glycosylat Res, Sendai, Miyagi 9818558, Japan; [Tochigi, Tatsuo; Kawamura, Sadafumi] Miyagi Canc Ctr, Dept Urol, Natori, Miyagi 9811293, Japan; [Sato, Ikuro] Miyagi Canc Ctr, Res Inst, Div Pathol, Natori, Miyagi 9811293, Japan; [Shiozaki, Kazuhiro] Kagoshima Univ, Fac Fisheries, Kagoshima 890, Japan; [Shiozaki, Kazuhiro] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima 890, Japan; [Takahashi, Kohta; Hosono, Masahiro] Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Cell Recognit Study, Sendai, Miyagi 9818558, Japan; [Yamaguchi, Kazunori] Miyagi Canc Ctr, Res Inst, Div Mol & Cellular Oncol, Natori, Miyagi 9811293, Japan	Miyagi, T (reprint author), Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Canc Glycosylat Res, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	tmiyagi@tohoku-pharm.ac.jp			CREST of Japan Science and Technology Agency;  [241FT0338]	This research supported in part by Grants-in-Aid for Scientific Research on FS A-Step (241FT0338) and by CREST of Japan Science and Technology Agency.	Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; Miyagi T, 2012, GLYCOBIOLOGY, V22, P880, DOI 10.1093/glycob/cws057; Miyagi T, 1999, J BIOL CHEM, V274, P5004, DOI 10.1074/jbc.274.8.5004; Uemura T, 2009, ONCOGENE, V28, P1218, DOI 10.1038/onc.2008.471; Nomura H, 2006, ONCOL RES, V16, P289; Kakugawa Y, 2002, P NATL ACAD SCI USA, V99, P10718, DOI 10.1073/pnas.152597199; Miyagi T, 2008, J BIOCHEM, V144, P279, DOI 10.1093/jb/mvn089; Miyagi T, 2012, GLYCOCONJUGATE J, V29, P567, DOI 10.1007/s10719-012-9394-1; Koseki K, 2012, BIOCHEM BIOPH RES CO, V428, P142, DOI 10.1016/j.bbrc.2012.10.028; Wang Y, 2002, J BIOL CHEM, V277, P26252, DOI 10.1074/jbc.M110515200; Hata K, 2008, ANTIMICROB AGENTS CH, V52, P3484, DOI 10.1128/AAC.00344-08; Hakomori S, 2010, FEBS LETT, V584, P1901, DOI 10.1016/j.febslet.2009.10.065; Ueno S, 2006, J BIOL CHEM, V281, P7756, DOI 10.1074/jbc.M509668200; BERGELSON LD, 1995, IMMUNOL TODAY, V16, P483, DOI 10.1016/0167-5699(95)80032-8; Bilyy R, 2011, J MOL RECOGNIT, V24, P576, DOI 10.1002/jmr.1071; GALJART NJ, 1988, CELL, V54, P755, DOI 10.1016/S0092-8674(88)90999-3; KATOPODIS N, 1982, CANCER RES, V42, P5270; Kawamura S, 2012, CELL DEATH DIFFER, V19, P170, DOI 10.1038/cdd.2011.83; LI K, 1992, J CHROMATOGR-BIOMED, V579, P209, DOI 10.1016/0378-4347(92)80384-3; Lumen N, 2012, INT J UROL, V19, P100, DOI 10.1111/j.1442-2042.2011.02912.x; MIYAGI T, 1993, J BIOL CHEM, V268, P26435; SENN HJ, 1989, EUR J BIOCHEM, V181, P657, DOI 10.1111/j.1432-1033.1989.tb14773.x; Wada T, 1999, BIOCHEM BIOPH RES CO, V261, P21, DOI 10.1006/bbrc.1999.0973; Yamanami H, 2007, CANCER SCI, V98, P299, DOI 10.1111/j.1349-7006.2007.00403.x	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	APR	2015	106	4					383	389		10.1111/cas.12627		7	Oncology	Oncology	CG5MQ	WOS:000353336400008		
J	Lu, FJ; Kishida, S; Mu, P; Huang, P; Cao, DL; Tsubota, S; Kadomatsu, K				Lu, Fangjin; Kishida, Satoshi; Mu, Ping; Huang, Peng; Cao, Dongliang; Tsubota, Shoma; Kadomatsu, Kenji			NeuroD1 promotes neuroblastoma cell growth by inducing the expression of ALK	CANCER SCIENCE			English	Article						ALK; neuroblastoma; NeuroD1; proliferation; tumorsphere	ACTIVATING MUTATIONS; DIFFERENTIATION; MICE; HIPPOCAMPUS; MIGRATION; SURVIVAL; KINASE; TARGET; GENE	Neuroblastoma is derived from the sympathetic neuronal lineage of neural crest cells, and is the most frequently observed of the extracranial pediatric solid tumors. The neuronal differentiation factor, NeuroD1, has previously been shown to promote cell motility in neuroblastoma by suppressing the expression of Slit2. Here we report that NeuroD1 is also involved in the proliferation of neuroblastoma cells, including human cell lines and primary tumorspheres cultured from the tumor tissues of model mice. Interestingly, the growth inhibition of neuroblastoma cells induced by knockdown of NeuroD1 was accompanied by a reduction of ALK expression. ALK is known to be one of the important predisposition genes for neuroblastoma. The phenotype resulting from knockdown of NeuroD1 was suppressed by forced expression of ALK and, therefore, NeuroD1 appears to act mainly through ALK to promote the proliferation of neuroblastoma cells. Furthermore, we showed that NeuroD1 directly bound to the promoter region of ALK gene. In addition, the particular E-box in the promoter was responsible for NeuroD1-mediated ALK expression. These results indicate that ALK should be a direct target gene of NeuroD1. Finally, the expressions of NeuroD1 and ALK in the early tumor lesions of neuroblastoma model mice coincided invivo. We conclude that the novel mechanism would regulate the expression of ALK in neuroblastoma and that NeuroD1 should be significantly involved in neuroblastoma tumorigenesis.	[Lu, Fangjin; Kishida, Satoshi; Mu, Ping; Cao, Dongliang; Tsubota, Shoma; Kadomatsu, Kenji] Nagoya Univ, Grad Sch Med, Dept Biochem, Nagoya, Aichi 4668550, Japan; [Huang, Peng] Mayo Clin, Dept Lab Med & Pathol, Jacksonville, FL 32224 USA	Kishida, S (reprint author), Nagoya Univ, Grad Sch Med, Dept Biochem, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	kishida@med.nagoya-u.ac.jp	Kadomatsu, Kenji/G-8083-2012		National Cancer Center Research and Development Fund [22-4]; Ministry of Health, Labour and Welfare MEXT [24590377]	National Cancer Center Research and Development Fund (22-4). Ministry of Health, Labour and Welfare MEXT (24590377).	Liu M, 2000, GENE DEV, V14, P2839, DOI 10.1101/gad.840500; Nakagawara A, 2004, CANCER LETT, V204, P213, DOI 10.1016/S0304-3835(03)00457-9; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; Gao ZL, 2009, NAT NEUROSCI, V12, P1090, DOI 10.1038/nn.2385; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Morrow EM, 1999, DEVELOPMENT, V126, P23; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Kim WY, 2001, DEVELOPMENT, V128, P417; Hansford LM, 2007, CANCER RES, V67, P11234, DOI 10.1158/0008-5472.CANT-07-0718; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; Cao DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086813; Hasan MK, 2013, SCI REP-UK, V3, DOI 10.1038/srep03450; Huang P, 2011, CANCER RES, V71, P2938, DOI 10.1158/0008-5472.CAN-10-3524; Osborne JK, 2013, P NATL ACAD SCI USA, V110, P6524, DOI 10.1073/pnas.1303932110; Schwab MH, 2000, J NEUROSCI, V20, P3714; Seo S, 2007, EMBO J, V26, P5093, DOI 10.1038/sj.emboj.7601923	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	APR	2015	106	4					390	396		10.1111/cas.12628		7	Oncology	Oncology	CG5MQ	WOS:000353336400009		
J	Mayanagi, S; Kitago, M; Sakurai, T; Matsuda, T; Fujita, T; Higuchi, H; Taguchi, J; Takeuchi, H; Itano, O; Aiura, K; Hamamoto, Y; Takaishi, H; Okamoto, M; Sunamura, M; Kawakami, Y; Kitagawa, Y				Mayanagi, Shuhei; Kitago, Minoru; Sakurai, Toshiharu; Matsuda, Tatsuo; Fujita, Tomonobu; Higuchi, Hajime; Taguchi, Junichi; Takeuchi, Hiroya; Itano, Osamu; Aiura, Koichi; Hamamoto, Yasuo; Takaishi, Hiromasa; Okamoto, Masato; Sunamura, Makoto; Kawakami, Yutaka; Kitagawa, Yuko			Phase I pilot study of Wilms tumor gene 1 peptide-pulsed dendritic cell vaccination combined with gemcitabine in pancreatic cancer	CANCER SCIENCE			English	Article						Delayed-type hypersensitivity; dendritic cell vaccination; first-line therapy; immunotherapy; neutrophil lymphocyte ratio	RESISTANT PROSTATE-CANCER; BILIARY-TRACT CANCER; SUPPRESSOR-CELLS; DUCTAL ADENOCARCINOMA; WT1; IMMUNOTHERAPY; TRIAL; CARCINOMA; THERAPY; COMBINATION	This study aimed to evaluate the feasibility of and immune response to Wilms tumor gene 1 (WT1) peptide-pulsed dendritic cell vaccination combined with gemcitabine (DCGEM) as a first-line therapy among patients with advanced pancreatic cancer. Ten HLA-A*2402 patients were treated with WT1 peptide-pulsed DC vaccination (1x10(7) cells) on days 8 and 22 and gemcitabine (1000mg/m(2)) on days 1, 8 and 15. Induction of a WT1-specific immune response was evaluated using the delayed-type hypersensitivity (DTH) skin test, interferon- enzyme-linked immunospot and HLA tetramer assays, along with assays for various immunological factors. DCGEM was well-tolerated, and the relative dose intensity of gemcitabine was 87%. Disease control associated with a low neutrophil/lymphocyte ratio was observed in all three patients with DTH positivity; it was also correlated with a low percentage of granulocytic myeloid derived suppressor cells in the pretreatment peripheral blood (P=0.017). Patients with liver metastases and high levels of inflammatory markers such as C-reactive protein and interleukin-8 (IL-8) showed poor survival even though a WT1-specific immune response was induced in them. WT1 peptide-pulsed DCGEM is feasible and effective for inducing anti-tumor T-cell responses. Our results support future investigations for pancreatic cancer patients with non-liver metastases and favorable immunological conditions. This trial was registered with the University hospital Medical Information Network (UMIN) Clinical Trials Registry ( number: UMIN-000004855).	[Mayanagi, Shuhei; Kitago, Minoru; Matsuda, Tatsuo; Takeuchi, Hiroya; Itano, Osamu; Kitagawa, Yuko] Keio Univ, Dept Surg, Sch Med, Tokyo 1608582, Japan; [Sakurai, Toshiharu; Fujita, Tomonobu; Okamoto, Masato; Kawakami, Yutaka] Keio Univ, Inst Adv Med Res, Sch Med, Div Cellular Signaling, Tokyo 1608582, Japan; [Higuchi, Hajime] Kitasato Univ, Kitasato Inst Hosp, Clin Oncol Ctr, Dept Internal Med, Tokyo, Japan; [Taguchi, Junichi] Tokyo Midtown Clin, Tokyo, Japan; [Aiura, Koichi] Kawasaki Municipal Hosp, Dept Surg, Kawasaki, Kanagawa, Japan; [Hamamoto, Yasuo; Takaishi, Hiromasa] Keio Univ, Dept Internal Med, Sch Med, Tokyo 1608582, Japan; [Okamoto, Masato] Kitasato Univ, Sch Pharm, Dept Adv Immunotherapeut, Tokyo, Japan; [Sunamura, Makoto] Tokyo Med Univ, Hachioji Med Ctr, Dept Digest Tract Surg & Transplantat Surg, Tokyo 1608402, Japan	Kitago, M (reprint author), Keio Univ, Dept Surg, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	dragonpegasus@a3.keio.jp; yutakawa@z5.keio.jp			Japan Society for Promotion of Science [26221005]; Project for Development of Innovative Research on Cancer Therapeutics (P-Direct), Ministry of Education, Culture, Sports, Science and Technology; tella Inc.	Grants-in-Aid for Scientific Research from the Japan Society for Promotion of Science (26221005). Project for Development of Innovative Research on Cancer Therapeutics (P-Direct), Ministry of Education, Culture, Sports, Science and Technology. tella Inc.	Soeda A, 2009, JPN J CLIN ONCOL, V39, P797, DOI 10.1093/jjco/hyp112; Chen Y, 2012, WORLD J GASTROENTERO, V18, P1123, DOI 10.3748/wjg.v18.i10.1123; Ueno H, 2013, J CLIN ONCOL, V31, P1640, DOI 10.1200/JCO.2012.43.3680; Takahara A, 2011, CANCER IMMUNOL IMMUN, V60, P1289, DOI 10.1007/s00262-011-1033-3; Mitsunaga S, 2013, BRIT J CANCER, V108, P2063, DOI 10.1038/bjc.2013.174; Kobayashi M, 2013, J GASTROINTEST SURG, V17, P1609, DOI 10.1007/s11605-013-2286-2; Kimura Y, 2012, PANCREAS, V41, P195, DOI 10.1097/MPA.0b013e31822398c6; Ohnishi M, 2005, BRIT J HAEMATOL, V131, P472, DOI 10.1111/j.1365-2141.2005.05800.x; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Suzuki E, 2005, CLIN CANCER RES, V11, P6713, DOI 10.1158/1078-0432.CCR-05-0883; Rodriguez PC, 2009, CANCER RES, V69, P1553, DOI 10.1158/0008-5472.CAN-08-1921; Pine JK, 2009, EJSO-EUR J SURG ONC, V35, P605, DOI 10.1016/j.ejso.2008.12.002; Sinha P, 2007, J IMMUNOL, V179, P977; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Nishida S, 2014, J IMMUNOTHER, V37, P105, DOI 10.1097/CJI.0000000000000020; Oji Y, 2004, CANCER SCI, V95, P583, DOI 10.1111/j.1349-7006.2004.tb02490.x; Tsuboi A, 2002, CANCER IMMUNOL IMMUN, V51, P614, DOI 10.1007/s00262-002-0328-9; Aapro MS, 1998, ANTI-CANCER DRUG, V9, P191, DOI 10.1097/00001813-199803000-00001; Dima SO, 2012, PANCREAS, V41, P1001, DOI 10.1097/MPA.0b013e3182546e13; Figdor CG, 2004, NAT MED, V10, P475, DOI 10.1038/nm1039; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; GASHLER AL, 1992, P NATL ACAD SCI USA, V89, P10984, DOI 10.1073/pnas.89.22.10984; Stotz M, 2013, BRIT J CANCER, V109, P416, DOI 10.1038/bjc.2013.332; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Le HK, 2009, INT IMMUNOPHARMACOL, V9, P900, DOI 10.1016/j.intimp.2009.03.015; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Sugiyama H, 2005, EXPERT REV VACCINES, V4, P503, DOI 10.1586/14760584.4.4-503; Hersey P, 2004, CANCER IMMUNOL IMMUN, V53, P125, DOI 10.1007/s00262-003-0429-0; Belknap SM, 2006, CANCER, V106, P2051, DOI 10.1002/cncr.21808; Burris HA, 1997, J CLIN ONCOL, V15, P2403; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; desVries IJ, 2005, J CLIN ONCOL, V23, P5779; DRUMMOND IA, 1992, SCIENCE, V257, P674, DOI 10.1126/science.1323141; Green MR, 1996, SEMIN ONCOL, V23, P32; HARRINGTON MA, 1993, J BIOL CHEM, V268, P21271; Kaida M, 2011, J IMMUNOTHER, V34, P92, DOI 10.1097/CJI.0b013e3181fb65b9; Kuwana M, 2003, AM J MED, V114, P322, DOI 10.1016/S0002-9343(02)01522-X; Matsuno O, 2007, TOHOKU J EXP MED, V212, P49, DOI 10.1620/tjem.212.49; Matsuno O, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-39; Miyatake T, 2013, J CANCER RES CLIN, V139, P457, DOI 10.1007/s00432-012-1348-2; Ohno S, 2012, ANTICANCER RES, V32, P2263; Reyes D, 2013, BRIT J CANCER, V109, P1488, DOI 10.1038/bjc.2013.494; Shimizu K, 2014, HUM VACC IMMUNOTHER, V10, P970, DOI 10.4161/hv.27678; Shirakata T, 2012, ANTICANCER RES, V32, P1081	45	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	APR	2015	106	4					397	406		10.1111/cas.12621		10	Oncology	Oncology	CG5MQ	WOS:000353336400010		
